Citrus Sinensis ID: 046084

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360---
Protein Sequence
LSSENAPPPQEFKGNKGKPQKVPSRLVVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVRKTLYQLK
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHccccccccccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHcccccccccccEEEEcccEEEEEEcccccccccHHHccccccccccHHHHHHHHHHHHHHHHHHccccccccEEcccccccccccccccccccccccccccccccccccEEEccccccHHHHcccccccccccccHHHHHHHHHHHccccccccccccccccHHHHccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccHEEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHEEEEccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEccccHcHEEEcccccccHccccHHEEccccccccEEEEEEcccccHHHHHccccccccHHHHHHEEEEEEHcccccccHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHccccHcccccHHHHHHHcccccHHHcc
Coil and Loop (DISEMBL)
lssenapppqefkgnkgkpqkvpsrLVVIILPIVLLLILVCIFTFlclrrpkvrkakptetkktrcgdefsvwnydgriTFQEMIVATedfdikycigtggygsvyraqlpsgkkVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYlhcdcipsivhrdissnnillnSKLEAFVADFGVARllhsdssnrtvvagthgyiapelAYTMVLTEKCDVYSFGVVALEVLmgrhpgdllssvnpkIMLIDLldqrvpspiddqtvIQDIILVSKIVFAClrskptsrpmqrVSQEFLVRKTLYQLK
Flexible Loop (DISEMBL)
lssenapppqefkgnkgkpqkvpsRLVVIILPIVLLLILVCIFTflclrrpkvrkakptetkktrcgdefsvwnydGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLrskptsrpmqrvsqeflvrktlyqlk
Low Complexity Region (SEG)
LSSENAPPPQEFKGNKGKPQKVPSRlvviilpivlllilvCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVRKTLYQLK
Disordered region (IsUnstruct)
************************RLVVIILPIVLLLILVCIFTFLCLRRPKVR*********TRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLR*************************
Disordered Region (DISOPRED)
***************************VIILPIVLLLILVCIFTFLCLR**********************VWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK****************TEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID*QTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLV*K******
Disordered Region (DISEMBL)
*********************VPSRLVVIILPIVLLLILVCIFTFLCLRRPKV***********RCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVRKTLYQLK
Disordered Region (DISPRO)
*********************VPSRLVVIILPIVLLLILVCIFTFLCLRRPKV*********************YDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLV********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LSSENAPPPQEFKGNKGKPQKVPSRLVVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVRKTLYQLK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	363	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.939	0.326	0.444	2e-87
Q9LP24	1120	Probable leucine-rich rep	no	no	0.909	0.294	0.456	2e-82
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.884	0.291	0.401	4e-61
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.735	0.242	0.437	5e-61
O49318	1124	Probable leucine-rich rep	no	no	0.741	0.239	0.413	7e-56
C0LGF5	1072	Probable LRR receptor-lik	no	no	0.884	0.299	0.354	2e-52
Q9SSL9	1123	Leucine-rich repeat recep	no	no	0.823	0.266	0.352	6e-50
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.906	0.262	0.323	2e-48
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.771	0.276	0.385	7e-48
C0LGW6	966	LRR receptor-like serine/	no	no	0.889	0.334	0.338	1e-47

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  322 bits (826), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 168/378 (44%), Positives = 242/378 (64%), Gaps = 37/378 (9%)

Query: 8    PPQEFKGNKG-----------KPQKVPSR---------LVVIILPIV--LLLILVCIFTF 45
            PP  F+GNK            KP  + S          ++ I++PI+  ++++ VC   F
Sbjct: 672  PPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIF 731

Query: 46   LCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSV 105
            +C R  K  K     T     G+  S++++DG++ +QE+I AT +FD KY IGTGG+G V
Sbjct: 732  ICFR--KRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKV 789

Query: 106  YRAQLPSGKKVALKKLHHSE----TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC 161
            Y+A+LP+   +A+KKL+ +     +  +  + F  E   L++IRHRN+VKL+GFC H++ 
Sbjct: 790  YKAKLPNAI-MAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRN 848

Query: 162  MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISS 221
             FL+Y+YM RGSL  +L NDDEA +LDW KR+N+VK +AHALSY+H D  P+IVHRDISS
Sbjct: 849  TFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISS 908

Query: 222  NNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGV 281
             NILL    EA ++DFG A+LL  DSSN + VAGT+GY+APELAY M +TEKCDVYSFGV
Sbjct: 909  GNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGV 968

Query: 282  VALEVLMGRHPGDLLSSV-----NPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFAC 336
            + LEV+ G HPGDL+S++     +  + L  + D R+P P  +  + ++++ + K+   C
Sbjct: 969  LTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPE--IKEEVLEILKVALLC 1026

Query: 337  LRSKPTSRP-MQRVSQEF 353
            L S P +RP M  +S  F
Sbjct: 1027 LHSDPQARPTMLSISTAF 1044

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  306 bits (783), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 159/348 (45%), Positives = 238/348 (68%), Gaps = 18/348 (5%)

Query: 18   KPQKVPSRLVVIILPI--VLLLILVCIFTFL-CLRRPKVRKAKPTETKKTRCGDEFSVWN 74
            KP+K  + +V I++PI  VL+++ +C  TF  C+R+ K++  + T+ +    G+  S+++
Sbjct: 778  KPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPE---TGENMSIFS 834

Query: 75   YDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHS-ETELA---F 130
             DG+  +Q++I +T +FD  + IGTGGY  VYRA L     +A+K+LH + + E++    
Sbjct: 835  VDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKRLHDTIDEEISKPVV 893

Query: 131  LESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWT 190
             + F  E   L++IRHRN+VKL+GFC H++  FLIY+YM +GSL  +L ND+EA RL WT
Sbjct: 894  KQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWT 953

Query: 191  KRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250
            KR+N+VK +AHALSY+H D I  IVHRDISS NILL++   A ++DFG A+LL +DSSN 
Sbjct: 954  KRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNW 1013

Query: 251  TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK----IMLI 306
            + VAGT+GY+APE AYTM +TEKCDVYSFGV+ LE+++G+HPGDL+SS++      + L 
Sbjct: 1014 SAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLR 1073

Query: 307  DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF 353
             + D+RV  P       + ++ + ++   CL++ P SRP M  +S  F
Sbjct: 1074 SISDERVLEPRGQNR--EKLLKMVEMALLCLQANPESRPTMLSISTTF 1119

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  235 bits (600), Expect = 4e-61,   Method: Compositional matrix adjust.
 Identities = 143/356 (40%), Positives = 205/356 (57%), Gaps = 35/356 (9%)

Query: 17   GKPQKVPSRLVVIILPIVL---LLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVW 73
            GKP  + S  ++ I   V+    L+L+ +  +L +RRP    A   +  +     E S+ 
Sbjct: 728  GKPGGMRSSKIIAITAAVIGGVSLMLIALIVYL-MRRPVRTVASSAQDGQP---SEMSLD 783

Query: 74   NY----DGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKL---HHSET 126
             Y    +G  TFQ+++ AT++FD  + +G G  G+VY+A LP+G  +A+KKL   H    
Sbjct: 784  IYFPPKEG-FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGN 842

Query: 127  ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR 186
                  SF+ E   L  IRHRNIVKL+GFC H+    L+Y+YM +GSL  IL   D +  
Sbjct: 843  NNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH--DPSCN 900

Query: 187  LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL--- 243
            LDW+KR  I    A  L+YLH DC P I HRDI SNNILL+ K EA V DFG+A+++   
Sbjct: 901  LDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 960

Query: 244  HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP-------GDLL 296
            HS S   + +AG++GYIAPE AYTM +TEK D+YS+GVV LE+L G+ P       GD++
Sbjct: 961  HSKS--MSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVV 1018

Query: 297  SSVNPKI----MLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQR 348
            + V   I    +   +LD R+   ++D+ ++  ++ V KI   C    P +RP  R
Sbjct: 1019 NWVRSYIRRDALSSGVLDARL--TLEDERIVSHMLTVLKIALLCTSVSPVARPSMR 1072

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  235 bits (599), Expect = 5e-61,   Method: Compositional matrix adjust.
 Identities = 123/281 (43%), Positives = 174/281 (61%), Gaps = 14/281 (4%)

Query: 80   TFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAH 139
            T+Q ++ AT +F     +G G  G+VY+A++  G+ +A+KKL+      +   SF+ E  
Sbjct: 788  TYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEIS 847

Query: 140  LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
             L +IRHRNIVKLYGFC H+    L+Y+YM +GSL   L+  ++   LDW  R  I    
Sbjct: 848  TLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGA 907

Query: 200  AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHG 258
            A  L YLH DC P IVHRDI SNNILL+ + +A V DFG+A+L+  S S + + VAG++G
Sbjct: 908  AEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYG 967

Query: 259  YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP-------GDLLS----SVNPKIMLID 307
            YIAPE AYTM +TEKCD+YSFGVV LE++ G+ P       GDL++    S+   I  I+
Sbjct: 968  YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIE 1027

Query: 308  LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQR 348
            + D R+ +  +D+  + ++ LV KI   C  + P SRP  R
Sbjct: 1028 MFDARLDT--NDKRTVHEMSLVLKIALFCTSNSPASRPTMR 1066

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  218 bits (554), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 120/290 (41%), Positives = 173/290 (59%), Gaps = 21/290 (7%)

Query: 78   RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLES---- 133
            R T ++++ AT+ F   Y +G G  G+VY+A +PSGK +A+KKL  +        +    
Sbjct: 806  RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDN 865

Query: 134  -FQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLIYKYMRRGSLFCILRNDDEAIRLDWT 190
             F+ E   L +IRHRNIV+LY FC H+      L+Y+YM RGSL  +L    ++  +DW 
Sbjct: 866  SFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLH-GGKSHSMDWP 924

Query: 191  KRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-SSN 249
             R  I    A  L+YLH DC P I+HRDI SNNIL++   EA V DFG+A+++    S +
Sbjct: 925  TRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKS 984

Query: 250  RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP-------GDLLSSVNPK 302
             + VAG++GYIAPE AYTM +TEKCD+YSFGVV LE+L G+ P       GDL +     
Sbjct: 985  VSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNH 1044

Query: 303  I----MLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQR 348
            I    +  ++LD  + + ++D  ++  +I V+KI   C +S P+ RP  R
Sbjct: 1045 IRDHSLTSEILDPYL-TKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMR 1093

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2

 Score =  206 bits (525), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 128/361 (35%), Positives = 192/361 (53%), Gaps = 40/361 (11%)

Query: 17   GKPQKVPSRLVVIILPIVLLLILVCIFT--FLCLRRPKVRKAKPTETKKTRCGDEFSV-W 73
            G+   V S  +V +  ++L  I + I     L LR   + K     +      ++FS  W
Sbjct: 694  GQNNGVKSPKIVALTAVILASITIAILAAWLLILRNNHLYKTSQNSSSSPSTAEDFSYPW 753

Query: 74   NYDGRITFQEMIVATED----FDIKYCIGTGGYGSVYRAQLPSGKKVALKKL----HHSE 125
             +   I FQ++ +   +       +  IG G  G VY+A++P+G  VA+KKL     ++E
Sbjct: 754  TF---IPFQKLGITVNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAVKKLWKTKDNNE 810

Query: 126  TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI 185
               + ++SF  E  +L  IRHRNIVKL G+C +K    L+Y Y   G+L  +L+ +    
Sbjct: 811  EGESTIDSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQGNR--- 867

Query: 186  RLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
             LDW  R  I    A  L+YLH DC+P+I+HRD+  NNILL+SK EA +ADFG+A+L+ +
Sbjct: 868  NLDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKLMMN 927

Query: 246  DSSNRTV---VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP-----GDLL- 296
              +       VAG++GYIAPE  YTM +TEK DVYS+GVV LE+L GR       GD L 
Sbjct: 928  SPNYHNAMSRVAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGRSAVEPQIGDGLH 987

Query: 297  ---------SSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQ 347
                      +  P + ++D+  Q +P    DQ ++Q+++    I   C+   P  RP  
Sbjct: 988  IVEWVKKKMGTFEPALSVLDVKLQGLP----DQ-IVQEMLQTLGIAMFCVNPSPVERPTM 1042

Query: 348  R 348
            +
Sbjct: 1043 K 1043

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1

 Score =  198 bits (503), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 116/329 (35%), Positives = 181/329 (55%), Gaps = 30/329 (9%)

Query: 45   FLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDG-RITFQEMIVATEDFDIKYCIGTGGYG 103
            F+CLRR   RK +P +       D +     +G  +   +++ AT++ + KY IG G +G
Sbjct: 790  FICLRR---RKGRPEK-------DAYVFTQEEGPSLLLNKVLAATDNLNEKYTIGRGAHG 839

Query: 104  SVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF 163
             VYRA L SGK  A+K+L  + + +   +S   E   + ++RHRN++KL GF L K    
Sbjct: 840  IVYRASLGSGKVYAVKRLVFA-SHIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDDGL 898

Query: 164  LIYKYMRRGSLFCILRN-DDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSN 222
            ++Y+YM +GSL+ +L     +   LDW+ R N+   +AH L+YLH DC P IVHRDI   
Sbjct: 899  MLYRYMPKGSLYDVLHGVSPKENVLDWSARYNVALGVAHGLAYLHYDCHPPIVHRDIKPE 958

Query: 223  NILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVV 282
            NIL++S LE  + DFG+ARLL   + +   V GT GYIAPE A+  V   + DVYS+GVV
Sbjct: 959  NILMDSDLEPHIGDFGLARLLDDSTVSTATVTGTTGYIAPENAFKTVRGRESDVYSYGVV 1018

Query: 283  ALEVLMGRHPGD---------------LLSSVNPKI--MLIDLLDQRVPSPIDDQTVIQD 325
             LE++  +   D                LSS N  +  M+  ++D  +   + D ++ + 
Sbjct: 1019 LLELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNVEDMVTTIVDPILVDELLDSSLREQ 1078

Query: 326  IILVSKIVFACLRSKPTSRPMQRVSQEFL 354
            ++ V+++  +C +  P  RP  R + + L
Sbjct: 1079 VMQVTELALSCTQQDPAMRPTMRDAVKLL 1107

Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  193 bits (491), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 125/386 (32%), Positives = 202/386 (52%), Gaps = 57/386 (14%)

Query: 14   GNKGKPQKVPSRLVVII----LPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDE 69
            G+K +    P  +V+I     L  + L++LV I  F         K      KK R G+ 
Sbjct: 863  GSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFF---------KQNHDLFKKVRGGNS 913

Query: 70   -------------FSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKV 116
                         FS       I + +++ AT   + ++ IG+GG G VY+A+L +G+ +
Sbjct: 914  AFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETI 973

Query: 117  ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK--CMFLIYKYMRRGSL 174
            A+KK+   + +L   +SF  E   L  IRHR++VKL G+C  K      LIY+YM  GS+
Sbjct: 974  AVKKILWKD-DLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSV 1032

Query: 175  FCILRNDDEAIR---LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE 231
            +  L  ++   +   L W  R+ I   +A  + YLH DC+P IVHRDI S+N+LL+S +E
Sbjct: 1033 WDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIE 1092

Query: 232  AFVADFGVARLL----HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
            A + DFG+A++L     +++ + T+ AG++GYIAPE AY++  TEK DVYS G+V +E++
Sbjct: 1093 AHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIV 1152

Query: 288  MGRHPGDLLSSVNPKIM-----LID----------LLDQRVPS--PIDDQTVIQDIILVS 330
             G+ P + +      ++     ++D          L+D  + S  P +++   Q    V 
Sbjct: 1153 TGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQ----VL 1208

Query: 331  KIVFACLRSKPTSRPMQRVSQEFLVR 356
            +I   C +S P  RP  R + E+L+ 
Sbjct: 1209 EIALQCTKSYPQERPSSRQASEYLLN 1234

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  191 bits (485), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 118/306 (38%), Positives = 170/306 (55%), Gaps = 26/306 (8%)

Query: 66  CGDEFSVWNYDGRITFQEMIVATEDF---DIKYCI------GTGGYGSVYRAQLPSGKKV 116
           CGDE +     G   ++ M      F   DI  CI      G G  G VY+A++     V
Sbjct: 668 CGDETA---SKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTV 724

Query: 117 -ALKKLHHSETEL--AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGS 173
            A+KKL  S  ++       F  E +LL ++RHRNIV+L GF  + K M ++Y++M  G+
Sbjct: 725 LAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGN 784

Query: 174 LFCILRNDDEAIRL--DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE 231
           L   +   + A RL  DW  R NI   +AH L+YLH DC P ++HRDI SNNILL++ L+
Sbjct: 785 LGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLD 844

Query: 232 AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRH 291
           A +ADFG+AR++       ++VAG++GYIAPE  YT+ + EK D+YS+GVV LE+L GR 
Sbjct: 845 ARIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRR 904

Query: 292 P--------GDLLSSVNPKIM-LIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPT 342
           P         D++  V  KI   I L +   P+  + + V ++++LV +I   C    P 
Sbjct: 905 PLEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPK 964

Query: 343 SRPMQR 348
            RP  R
Sbjct: 965 DRPSMR 970

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1

 Score =  190 bits (482), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 114/337 (33%), Positives = 186/337 (55%), Gaps = 14/337 (4%)

Query: 26  LVVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRI-TFQEM 84
           L+ I+L ++ LL ++ +  +  +++ K+ +     +K+     +  + + D  I TF ++
Sbjct: 585 LICIVLGVITLLCMIFLAVYKSMQQKKILQGS---SKQAEGLTKLVILHMDMAIHTFDDI 641

Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           +  TE+ + K+ IG G   +VY+  L S + +A+K+L++       L  F+TE   +  I
Sbjct: 642 MRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPH--NLREFETELETIGSI 699

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RHRNIV L+G+ L      L Y YM  GSL+ +L    + ++LDW  R+ I    A  L+
Sbjct: 700 RHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLA 759

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL-HSDSSNRTVVAGTHGYIAPE 263
           YLH DC P I+HRDI S+NILL+   EA ++DFG+A+ +  S +   T V GT GYI PE
Sbjct: 760 YLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVLGTIGYIDPE 819

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI 323
            A T  + EK D+YSFG+V LE+L G+   D  ++++ +++L    D  V   +D +  +
Sbjct: 820 YARTSRINEKSDIYSFGIVLLELLTGKKAVDNEANLH-QLILSKADDNTVMEAVDPEVTV 878

Query: 324 --QDIILVSK---IVFACLRSKPTSRP-MQRVSQEFL 354
              D+  + K   +   C +  P  RP M  VS+  L
Sbjct: 879 TCMDLGHIRKTFQLALLCTKRNPLERPTMLEVSRVLL 915

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	363
224108669	811	predicted protein [Populus trichocarpa]	0.906	0.405	0.620	1e-117
224110020	1048	predicted protein [Populus trichocarpa]	0.837	0.290	0.657	1e-116
296085303	789	unnamed protein product [Vitis vinifera]	0.944	0.434	0.587	1e-116
359484066	843	PREDICTED: probable LRR receptor-like se	0.944	0.406	0.587	1e-116
224110038	964	predicted protein [Populus trichocarpa]	0.900	0.339	0.630	1e-116
224093626	1039	predicted protein [Populus trichocarpa]	0.906	0.316	0.617	1e-116
224098415	667	predicted protein [Populus trichocarpa]	0.933	0.508	0.595	1e-116
224110024	827	predicted protein [Populus trichocarpa]	0.837	0.367	0.654	1e-115
296085307	874	unnamed protein product [Vitis vinifera]	0.953	0.395	0.569	1e-115
359484068	868	PREDICTED: probable leucine-rich repeat	0.953	0.398	0.569	1e-115

>gi|224108669|ref|XP_002333361.1| predicted protein [Populus trichocarpa] gi|222836312|gb|EEE74733.1| predicted protein [Populus trichocarpa]

 Score =  426 bits (1096), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 208/335 (62%), Positives = 261/335 (77%), Gaps = 6/335 (1%)

Query: 27  VVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIV 86
           + I LPI  + + +       L R K  + +PT  K    GD FS+WNYDGRI ++++I 
Sbjct: 454 IKIFLPISTISLCLLCLGCCYLSRCKATQPEPTSLKN---GDLFSIWNYDGRIAYEDIIA 510

Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIR 145
           ATE+FD++YCIG+GGYGSVYRAQLPSGK VALKKLHH E E  AF +SF+ E  LL+QIR
Sbjct: 511 ATENFDLRYCIGSGGYGSVYRAQLPSGKLVALKKLHHREAEEPAFDKSFKNEVELLTQIR 570

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           HR+IV+LYGFCLH++CMFL+Y+YM +GSLFC LRND EA+ L W KR +I+K +AHALSY
Sbjct: 571 HRSIVRLYGFCLHQRCMFLVYEYMEKGSLFCALRNDVEAVELKWMKRAHIIKDIAHALSY 630

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           LH +C P IVHRDISS+N+LLNS+ ++FVADFGVARLL  DSSN TV+AGT+GYIAPELA
Sbjct: 631 LHHECNPPIVHRDISSSNVLLNSESKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELA 690

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD 325
           YTMV+TEKCDVYSFGVVALE LMG+HPGD+LSS    + L ++LD R+P P  ++ VIQ+
Sbjct: 691 YTMVVTEKCDVYSFGVVALETLMGKHPGDILSSSARAMTLKEVLDPRLPPPT-NEIVIQN 749

Query: 326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL 359
           I +++ + F+CL S P SRP M+ VSQEFL  K L
Sbjct: 750 ICIIASLAFSCLHSNPKSRPSMKFVSQEFLSPKRL 784

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224110020|ref|XP_002333160.1| predicted protein [Populus trichocarpa] gi|222835013|gb|EEE73462.1| predicted protein [Populus trichocarpa]

 Score =  426 bits (1094), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 202/307 (65%), Positives = 249/307 (81%), Gaps = 3/307 (0%)

Query: 55   KAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGK 114
            KA   ET  ++ GD FS+WNYDGRI ++++I ATE+FD++YCIGTGGYGSVYRAQLPSGK
Sbjct: 716  KATEPETTSSKNGDLFSIWNYDGRIAYEDIIAATENFDLRYCIGTGGYGSVYRAQLPSGK 775

Query: 115  KVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGS 173
             VALKKLH  E E  AF +SF+ E  LL+QIRHR+IVKLYGFCLH++CMFL+Y+YM +GS
Sbjct: 776  LVALKKLHRREAEEPAFDKSFKNEVELLTQIRHRSIVKLYGFCLHQRCMFLVYEYMEKGS 835

Query: 174  LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF 233
            LFC LRND  A+ L W KR +I++ +AHALSYLH +C P IVHRDISS+N+LLNS+ ++F
Sbjct: 836  LFCALRNDVGAVELKWMKRAHIIEDIAHALSYLHHECNPPIVHRDISSSNVLLNSESKSF 895

Query: 234  VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPG 293
            VADFGVARLL  DSSN TV+AGT+GYIAPELAYTMV+TEKCDVYSFGVVALE LMGRHPG
Sbjct: 896  VADFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETLMGRHPG 955

Query: 294  DLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE 352
            D+LSS    I L ++LD R+P P  ++ VIQ+I  ++ ++F+CL S P +RP M+ VSQE
Sbjct: 956  DILSSSAQAITLKEVLDPRLPPPT-NEIVIQNICTIASLIFSCLHSNPKNRPSMKFVSQE 1014

Query: 353  FLVRKTL 359
            FL  K L
Sbjct: 1015 FLSPKRL 1021

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera]

 Score =  425 bits (1092), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 214/364 (58%), Positives = 267/364 (73%), Gaps = 21/364 (5%)

Query: 11  EFKGNKG-----------KPQKVPSRLVVIILPIVLLLILVCIFTFLCLRRPKVRKAKPT 59
            F  NKG           K +   +R++VI L   L L  V +  FL L R K RK +  
Sbjct: 411 SFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFV-VLGFLLLSR-KTRKIQTK 468

Query: 60  ETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK 119
           E   T+ GD FSVWNYDG+I ++++I ATEDFDIKYCIGTGGYGSVY+AQLP+G  VALK
Sbjct: 469 EIP-TKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALK 527

Query: 120 KLHHSETELA-FLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCIL 178
           KLH  E + A +L+SFQ E  +LS+IRHRNIVKL G+CLHK+CMFLIY YM RGSL+C+L
Sbjct: 528 KLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVL 587

Query: 179 RNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG 238
            N+ EA+ LDW KRVN+VKS+ HA+ Y+H DC P I+HRDISSNNILL+SKL+AF++DFG
Sbjct: 588 SNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFG 647

Query: 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLL-- 296
            ARLLH DSSN+T++AGT+GYIAPELAYTMV+TEKCDVYSFGVVALE +MG+HPG+L   
Sbjct: 648 TARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTL 707

Query: 297 --SSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF 353
             SS    IML ++LD R+PSP  DQ V +D++LV  +   C+ S P SRP MQ +  + 
Sbjct: 708 LSSSSTQNIMLTNILDSRLPSP-QDQQVARDVVLVVWLALKCIHSNPRSRPTMQHILSKL 766

Query: 354 LVRK 357
           L + 
Sbjct: 767 LTQS 770

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  425 bits (1092), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 214/364 (58%), Positives = 267/364 (73%), Gaps = 21/364 (5%)

Query: 11  EFKGNKG-----------KPQKVPSRLVVIILPIVLLLILVCIFTFLCLRRPKVRKAKPT 59
            F  NKG           K +   +R++VI L   L L  V +  FL L R K RK +  
Sbjct: 465 SFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFV-VLGFLLLSR-KTRKIQTK 522

Query: 60  ETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK 119
           E   T+ GD FSVWNYDG+I ++++I ATEDFDIKYCIGTGGYGSVY+AQLP+G  VALK
Sbjct: 523 EIP-TKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALK 581

Query: 120 KLHHSETELA-FLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCIL 178
           KLH  E + A +L+SFQ E  +LS+IRHRNIVKL G+CLHK+CMFLIY YM RGSL+C+L
Sbjct: 582 KLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVL 641

Query: 179 RNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG 238
            N+ EA+ LDW KRVN+VKS+ HA+ Y+H DC P I+HRDISSNNILL+SKL+AF++DFG
Sbjct: 642 SNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFG 701

Query: 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLL-- 296
            ARLLH DSSN+T++AGT+GYIAPELAYTMV+TEKCDVYSFGVVALE +MG+HPG+L   
Sbjct: 702 TARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTL 761

Query: 297 --SSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF 353
             SS    IML ++LD R+PSP  DQ V +D++LV  +   C+ S P SRP MQ +  + 
Sbjct: 762 LSSSSTQNIMLTNILDSRLPSP-QDQQVARDVVLVVWLALKCIHSNPRSRPTMQHILSKL 820

Query: 354 LVRK 357
           L + 
Sbjct: 821 LTQS 824

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224110038|ref|XP_002333164.1| predicted protein [Populus trichocarpa] gi|222835017|gb|EEE73466.1| predicted protein [Populus trichocarpa]

 Score =  424 bits (1091), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 210/333 (63%), Positives = 257/333 (77%), Gaps = 6/333 (1%)

Query: 27  VVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIV 86
           + I LPI  + + +       L R K  + +PT  K    GD FS+WNYDGRI ++++I 
Sbjct: 607 IKIFLPISTISLCLLCLGCCYLSRCKATQPEPTSLKN---GDLFSIWNYDGRIAYEDIIA 663

Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIR 145
           ATE+FD++YCIG+GGYGSVYRAQLPSGK VALKKLHH E E  AF +SF+ E  LL+QIR
Sbjct: 664 ATENFDLRYCIGSGGYGSVYRAQLPSGKLVALKKLHHREAEEPAFDKSFKNEVELLTQIR 723

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           HR+IVKLYGFCLH++CMFL+Y+YM +GSLFC LRND  A+ L W KR +I+K +AHALSY
Sbjct: 724 HRSIVKLYGFCLHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSY 783

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           LH DC P IVHRDISS+N+LLNS  ++FVADFGVARLL  DSSN TV+AGT+GYIAPELA
Sbjct: 784 LHHDCNPPIVHRDISSSNVLLNSVSKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELA 843

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD 325
           YTMV+TEKCDVYSFG VALE LMGRHPGD+LSS    I L ++LD R+ SP  D+ VIQ+
Sbjct: 844 YTMVVTEKCDVYSFGAVALETLMGRHPGDILSSSARAITLKEVLDPRL-SPPTDEIVIQN 902

Query: 326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK 357
           I +++ + F+CL S P SRP M+ VSQEFL  K
Sbjct: 903 ICIIATLAFSCLHSNPKSRPSMKFVSQEFLSPK 935

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224093626|ref|XP_002334827.1| predicted protein [Populus trichocarpa] gi|222875006|gb|EEF12137.1| predicted protein [Populus trichocarpa]

 Score =  424 bits (1091), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 207/335 (61%), Positives = 258/335 (77%), Gaps = 6/335 (1%)

Query: 27   VVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIV 86
            + I LPI    I +C+    C    + +  +P E   ++ GD FS+WNYDGRI ++++I 
Sbjct: 682  IKIFLPITT--ISLCLLVLGCCSLSRCKATQP-EATSSKNGDLFSIWNYDGRIAYEDIIA 738

Query: 87   ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIR 145
            ATE+FD++YCIGTGGYGSVYRAQLPSGK VALKKLH  E E  AF +SF+ E  LL+QIR
Sbjct: 739  ATENFDLRYCIGTGGYGSVYRAQLPSGKLVALKKLHRREAEEPAFDKSFKNEVELLTQIR 798

Query: 146  HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
            HR+IVKLYGFCLH++CMFL+Y+YM +GSLFC LRND  A+ L W KR +I+K +AHALSY
Sbjct: 799  HRSIVKLYGFCLHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSY 858

Query: 206  LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
            LH +C P IVHRDISS+N+LLNS+ ++FVADFGVARLL  DSSN TV+AGT+GYIAPELA
Sbjct: 859  LHHECNPPIVHRDISSSNVLLNSESKSFVADFGVARLLDPDSSNNTVLAGTYGYIAPELA 918

Query: 266  YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD 325
            YTMV+TEKCDVYSFGVVALE LMGRHPGD+LSS    I L ++LD R+P P  ++ VIQ+
Sbjct: 919  YTMVVTEKCDVYSFGVVALETLMGRHPGDILSSSARAITLKEVLDPRLPPPT-NEIVIQN 977

Query: 326  IILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL 359
            I +++ + F+CL S P  RP M+ VS EFL  K L
Sbjct: 978  ICIIASLAFSCLHSNPKYRPSMKFVSLEFLSPKRL 1012

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224098415|ref|XP_002334562.1| predicted protein [Populus trichocarpa] gi|222873082|gb|EEF10213.1| predicted protein [Populus trichocarpa]

 Score =  424 bits (1089), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 212/356 (59%), Positives = 267/356 (75%), Gaps = 17/356 (4%)

Query: 12  FKGNK---------GKPQKVPSRL--VVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTE 60
           F+GNK           P K   R+  + I LPI  + + +       L R +  + +PT 
Sbjct: 316 FEGNKDLHPDFSNCSLPSKTNRRIHSIKIFLPITTISLCLLCLGCCYLSRCEATQPEPTS 375

Query: 61  TKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKK 120
           +K    G  FS+WNYDGRI ++++I ATE+FD++YCIG+GGYGSVYRAQLPSGK VALKK
Sbjct: 376 SKN---GGLFSIWNYDGRIAYEDIITATENFDLRYCIGSGGYGSVYRAQLPSGKLVALKK 432

Query: 121 LHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR 179
           LHH E E  AF +SF+ E  LL+QIRHR+IVKLYGFCLH++CMFL+Y+YM +GSLFC LR
Sbjct: 433 LHHREAEEPAFDKSFKNEVKLLTQIRHRSIVKLYGFCLHQRCMFLVYEYMEKGSLFCALR 492

Query: 180 NDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239
           ND EA+ L W KR +I+K +AHALSYLH DC P IVHRDISS+N+LLNS+ ++FVADFGV
Sbjct: 493 NDVEAVELKWMKRAHIIKDIAHALSYLHHDCNPPIVHRDISSSNVLLNSESKSFVADFGV 552

Query: 240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV 299
           ARLL  DSSN TV+AGT+GYIAPELAYTMV+TEKCDVYSFGVVALE LMG+HPGD+LSS 
Sbjct: 553 ARLLDPDSSNHTVLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETLMGKHPGDILSSS 612

Query: 300 NPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL 354
              + L ++LD R+P P  ++ VIQ+I +++ + F+CL S P  RP M+ VSQEFL
Sbjct: 613 ARAMTLKEVLDPRLPPPT-NEIVIQNICIIASLAFSCLHSNPKYRPSMKFVSQEFL 667

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224110024|ref|XP_002333161.1| predicted protein [Populus trichocarpa] gi|222835014|gb|EEE73463.1| predicted protein [Populus trichocarpa]

 Score =  422 bits (1085), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 201/307 (65%), Positives = 245/307 (79%), Gaps = 3/307 (0%)

Query: 55  KAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGK 114
           KA   E    + GD FS+WNYDGRI ++++I ATE+FD++YCIG+GGYGSVYRAQLPSGK
Sbjct: 495 KATQPEATSLKNGDLFSIWNYDGRIAYEDIIAATENFDLRYCIGSGGYGSVYRAQLPSGK 554

Query: 115 KVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGS 173
            VALKKLHH E E  AF +S + E  LL+QIRHR+IVKLYGFCLH++CMFL+Y+YM +GS
Sbjct: 555 LVALKKLHHREAEEPAFDKSLKNEVELLTQIRHRSIVKLYGFCLHQRCMFLVYEYMEKGS 614

Query: 174 LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF 233
           LFC LRND  A+ L W KR +I+K +AHALSYLH DC P IVHRDISS+N+LLNS+ ++F
Sbjct: 615 LFCALRNDVGAVELKWMKRAHIIKDIAHALSYLHHDCNPPIVHRDISSSNVLLNSEFKSF 674

Query: 234 VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPG 293
           VADFGVARLL  DSSN TV+AGT+GYIAPELAYTM +TEKCDVYSFGVVALE LMGRHPG
Sbjct: 675 VADFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMAVTEKCDVYSFGVVALETLMGRHPG 734

Query: 294 DLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE 352
           D+LSS    I L ++LD R+P P  ++ VIQ+I  ++ ++F+CL S P  RP M+ VSQE
Sbjct: 735 DILSSSAQAITLKEVLDPRLPPPT-NEIVIQNICTIASLIFSCLHSNPKYRPSMKFVSQE 793

Query: 353 FLVRKTL 359
           FL  K L
Sbjct: 794 FLSPKRL 800

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera]

 Score =  422 bits (1085), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 208/365 (56%), Positives = 268/365 (73%), Gaps = 19/365 (5%)

Query: 8   PPQEFKGNKG---KPQKVP------SRLVVIILPIVLLLILVCIFTFLCLRRPKVRKAKP 58
           PP+ F  NKG   + + +P        +++I L  +L L  V +   L  R+ +  + K 
Sbjct: 495 PPRVFGHNKGLCGEREGLPHCKRGHKTILIISLSTILFLSFVALGILLLSRKTRRNQTKA 554

Query: 59  TETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVAL 118
           T TK    GD FSVWNYDG+I ++++I ATEDFDIKYCIGTGGYGSVY+AQLP+G  VAL
Sbjct: 555 TSTKN---GDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYKAQLPTGNVVAL 611

Query: 119 KKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCI 177
           KKLH  E  E  +L+SFQ E  +LS+I+HRNI+KL+G+CLHK+CMFLIYKYM RGSL+C+
Sbjct: 612 KKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCMFLIYKYMERGSLYCV 671

Query: 178 LRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADF 237
           L N+ EA+ LDW KRVN++KS+ HAL Y+H D  P I+HRD+SSNNILL+ KL+AF++DF
Sbjct: 672 LSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDVSSNNILLDFKLDAFLSDF 731

Query: 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLL- 296
           G ARLLH DSSN+T++AGT+GYIAPELAYTM +TEKCDVYSFGVVALE +MGRHP +L  
Sbjct: 732 GTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYSFGVVALETMMGRHPRELFT 791

Query: 297 ---SSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE 352
              SS    IML D+LD R+PSP D Q V +D++LV  +   C+ S P SRP MQ +S +
Sbjct: 792 LLSSSSAQNIMLTDILDSRLPSPQDRQ-VARDVVLVVWLALKCIHSNPRSRPTMQHISSK 850

Query: 353 FLVRK 357
            L++ 
Sbjct: 851 LLIQS 855

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484068|ref|XP_002271708.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera]

 Score =  422 bits (1084), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 208/365 (56%), Positives = 268/365 (73%), Gaps = 19/365 (5%)

Query: 8   PPQEFKGNKG---KPQKVP------SRLVVIILPIVLLLILVCIFTFLCLRRPKVRKAKP 58
           PP+ F  NKG   + + +P        +++I L  +L L  V +   L  R+ +  + K 
Sbjct: 489 PPRVFGHNKGLCGEREGLPHCKRGHKTILIISLSTILFLSFVALGILLLSRKTRRNQTKA 548

Query: 59  TETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVAL 118
           T TK    GD FSVWNYDG+I ++++I ATEDFDIKYCIGTGGYGSVY+AQLP+G  VAL
Sbjct: 549 TSTKN---GDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYKAQLPTGNVVAL 605

Query: 119 KKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCI 177
           KKLH  E  E  +L+SFQ E  +LS+I+HRNI+KL+G+CLHK+CMFLIYKYM RGSL+C+
Sbjct: 606 KKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCMFLIYKYMERGSLYCV 665

Query: 178 LRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADF 237
           L N+ EA+ LDW KRVN++KS+ HAL Y+H D  P I+HRD+SSNNILL+ KL+AF++DF
Sbjct: 666 LSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDVSSNNILLDFKLDAFLSDF 725

Query: 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLL- 296
           G ARLLH DSSN+T++AGT+GYIAPELAYTM +TEKCDVYSFGVVALE +MGRHP +L  
Sbjct: 726 GTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYSFGVVALETMMGRHPRELFT 785

Query: 297 ---SSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE 352
              SS    IML D+LD R+PSP D Q V +D++LV  +   C+ S P SRP MQ +S +
Sbjct: 786 LLSSSSAQNIMLTDILDSRLPSPQDRQ-VARDVVLVVWLALKCIHSNPRSRPTMQHISSK 844

Query: 353 FLVRK 357
            L++ 
Sbjct: 845 LLIQS 849

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	363
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.848	0.294	0.473	5.2e-79
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.845	0.274	0.464	2.1e-72
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.735	0.242	0.437	2.4e-55
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.730	0.240	0.436	4.7e-54
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.741	0.239	0.417	1.2e-51
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.776	0.278	0.391	1.8e-44
TAIR|locus:2206179	592	FEI1 "FEI 1" [Arabidopsis thal	0.829	0.508	0.373	2.4e-44
TAIR|locus:2019938	718	PERK11 "proline-rich extensin-	0.771	0.389	0.370	3.4e-44
TAIR|locus:2032697	1123	PEPR1 "PEP1 receptor 1" [Arabi	0.776	0.251	0.376	3.8e-44
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.735	0.430	0.382	5e-44

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 775 (277.9 bits), Expect = 5.2e-79, Sum P(2) = 5.2e-79
 Identities = 153/323 (47%), Positives = 224/323 (69%)

Query:    41 CIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTG 100
             C   F+C R+   +  + T+++    G+  S++++DG++ +QE+I AT +FD KY IGTG
Sbjct:   727 CAGIFICFRKRTKQIEEHTDSESG--GETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTG 784

Query:   101 GYGSVYRAQLPSGKKVALKKLHHS-ETELA---FLESFQTEAHLLSQIRHRNIVKLYGFC 156
             G+G VY+A+LP+   +A+KKL+ + ++ ++     + F  E   L++IRHRN+VKL+GFC
Sbjct:   785 GHGKVYKAKLPNAI-MAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFC 843

Query:   157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
              H++  FL+Y+YM RGSL  +L NDDEA +LDW KR+N+VK +AHALSY+H D  P+IVH
Sbjct:   844 SHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVH 903

Query:   217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDV 276
             RDISS NILL    EA ++DFG A+LL  DSSN + VAGT+GY+APELAY M +TEKCDV
Sbjct:   904 RDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDV 963

Query:   277 YSFGVVALEVLMGRHPGDLLSSVNPK-----IMLIDLLDQRVPSPIDDQTVIQDIILVSK 331
             YSFGV+ LEV+ G HPGDL+S+++       + L  + D R+P P  +  + ++++ + K
Sbjct:   964 YSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPE--IKEEVLEILK 1021

Query:   332 IVFACLRSKPTSRP-MQRVSQEF 353
             +   CL S P +RP M  +S  F
Sbjct:  1022 VALLCLHSDPQARPTMLSISTAF 1044

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 737 (264.5 bits), Expect = 2.1e-72, P = 2.1e-72
 Identities = 150/323 (46%), Positives = 220/323 (68%)

Query:    41 CIFTFL-CLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGT 99
             C  TF  C+R+ K++  + T+ +    G+  S+++ DG+  +Q++I +T +FD  + IGT
Sbjct:   803 CANTFTYCIRKRKLQNGRNTDPET---GENMSIFSVDGKFKYQDIIESTNEFDPTHLIGT 859

Query:   100 GGYGSVYRAQLPSGKKVALKKLHHS-ETELA---FLESFQTEAHLLSQIRHRNIVKLYGF 155
             GGY  VYRA L     +A+K+LH + + E++     + F  E   L++IRHRN+VKL+GF
Sbjct:   860 GGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGF 918

Query:   156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
             C H++  FLIY+YM +GSL  +L ND+EA RL WTKR+N+VK +AHALSY+H D I  IV
Sbjct:   919 CSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIV 978

Query:   216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCD 275
             HRDISS NILL++   A ++DFG A+LL +DSSN + VAGT+GY+APE AYTM +TEKCD
Sbjct:   979 HRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCD 1038

Query:   276 VYSFGVVALEVLMGRHPGDLLSSVNPK----IMLIDLLDQRVPSPIDDQTVIQDIILVSK 331
             VYSFGV+ LE+++G+HPGDL+SS++      + L  + D+RV  P       + ++ + +
Sbjct:  1039 VYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLRSISDERVLEPRGQNR--EKLLKMVE 1096

Query:   332 IVFACLRSKPTSRP-MQRVSQEF 353
             +   CL++ P SRP M  +S  F
Sbjct:  1097 MALLCLQANPESRPTMLSISTTF 1119

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 580 (209.2 bits), Expect = 2.4e-55, P = 2.4e-55
 Identities = 123/281 (43%), Positives = 174/281 (61%)

Query:    80 TFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAH 139
             T+Q ++ AT +F     +G G  G+VY+A++  G+ +A+KKL+      +   SF+ E  
Sbjct:   788 TYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEIS 847

Query:   140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
              L +IRHRNIVKLYGFC H+    L+Y+YM +GSL   L+  ++   LDW  R  I    
Sbjct:   848 TLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGA 907

Query:   200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHG 258
             A  L YLH DC P IVHRDI SNNILL+ + +A V DFG+A+L+  S S + + VAG++G
Sbjct:   908 AEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYG 967

Query:   259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP-------GDLLS----SVNPKIMLID 307
             YIAPE AYTM +TEKCD+YSFGVV LE++ G+ P       GDL++    S+   I  I+
Sbjct:   968 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIE 1027

Query:   308 LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQR 348
             + D R+ +  +D+  + ++ LV KI   C  + P SRP  R
Sbjct:  1028 MFDARLDT--NDKRTVHEMSLVLKIALFCTSNSPASRPTMR 1066

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 568 (205.0 bits), Expect = 4.7e-54, P = 4.7e-54
 Identities = 124/284 (43%), Positives = 174/284 (61%)

Query:    80 TFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKL---HHSETELAFLESFQT 136
             TFQ+++ AT++FD  + +G G  G+VY+A LP+G  +A+KKL   H          SF+ 
Sbjct:   793 TFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRA 852

Query:   137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
             E   L  IRHRNIVKL+GFC H+    L+Y+YM +GSL  IL   D +  LDW+KR  I 
Sbjct:   853 EILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIA 910

Query:   197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-SSNRTVVAG 255
                A  L+YLH DC P I HRDI SNNILL+ K EA V DFG+A+++    S + + +AG
Sbjct:   911 LGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAG 970

Query:   256 THGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP-------GDLLSSVNPKI----M 304
             ++GYIAPE AYTM +TEK D+YS+GVV LE+L G+ P       GD+++ V   I    +
Sbjct:   971 SYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDAL 1030

Query:   305 LIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQR 348
                +LD R+   ++D+ ++  ++ V KI   C    P +RP  R
Sbjct:  1031 SSGVLDARLT--LEDERIVSHMLTVLKIALLCTSVSPVARPSMR 1072

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 546 (197.3 bits), Expect = 1.2e-51, P = 1.2e-51
 Identities = 121/290 (41%), Positives = 174/290 (60%)

Query:    78 RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLH-----HSETELAFLE 132
             R T ++++ AT+ F   Y +G G  G+VY+A +PSGK +A+KKL      ++        
Sbjct:   806 RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDN 865

Query:   133 SFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLIYKYMRRGSLFCILRNDDEAIRLDWT 190
             SF+ E   L +IRHRNIV+LY FC H+      L+Y+YM RGSL  +L    ++  +DW 
Sbjct:   866 SFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGG-KSHSMDWP 924

Query:   191 KRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-SSN 249
              R  I    A  L+YLH DC P I+HRDI SNNIL++   EA V DFG+A+++    S +
Sbjct:   925 TRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKS 984

Query:   250 RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP-------GDLLSSVNPK 302
              + VAG++GYIAPE AYTM +TEKCD+YSFGVV LE+L G+ P       GDL +     
Sbjct:   985 VSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNH 1044

Query:   303 I----MLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQR 348
             I    +  ++LD  + + ++D  ++  +I V+KI   C +S P+ RP  R
Sbjct:  1045 IRDHSLTSEILDPYL-TKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMR 1093

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 478 (173.3 bits), Expect = 1.8e-44, P = 1.8e-44
 Identities = 119/304 (39%), Positives = 171/304 (56%)

Query:    66 CGDEF-SVWNYDGRITFQEMIVATEDFDIKYCI------GTGGYGSVYRAQLPSGKKV-A 117
             CGDE  S   +  R+     +  T   DI  CI      G G  G VY+A++     V A
Sbjct:   668 CGDETASKGEWPWRLMAFHRLGFTAS-DILACIKESNMIGMGATGIVYKAEMSRSSTVLA 726

Query:   118 LKKLHHSETEL--AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF 175
             +KKL  S  ++       F  E +LL ++RHRNIV+L GF  + K M ++Y++M  G+L 
Sbjct:   727 VKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLG 786

Query:   176 CILRNDDEAIRL--DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF 233
               +   + A RL  DW  R NI   +AH L+YLH DC P ++HRDI SNNILL++ L+A 
Sbjct:   787 DAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDAR 846

Query:   234 VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP- 292
             +ADFG+AR++       ++VAG++GYIAPE  YT+ + EK D+YS+GVV LE+L GR P 
Sbjct:   847 IADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPL 906

Query:   293 ----G---DLLSSVNPKIM-LIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSR 344
                 G   D++  V  KI   I L +   P+  + + V ++++LV +I   C    P  R
Sbjct:   907 EPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDR 966

Query:   345 PMQR 348
             P  R
Sbjct:   967 PSMR 970

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 467 (169.5 bits), Expect = 2.4e-44, P = 2.4e-44
 Identities = 118/316 (37%), Positives = 171/316 (54%)

Query:    47 CLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITF--QEMIVATEDFDIKYCIGTGGYGS 104
             C    K+ K +     K   G   S+  + G + +  +++I   E  + ++ IG GG+G+
Sbjct:   261 CFLYKKLGKVEIKSLAKD-VGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 319

Query:   105 VYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL 164
             VY+  +  GK  ALK++   +    F   F+ E  +L  I+HR +V L G+C       L
Sbjct:   320 VYKLAMDDGKVFALKRI--LKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 377

Query:   165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNI 224
             +Y Y+  GSL   L + +   +LDW  RVNI+   A  LSYLH DC P I+HRDI S+NI
Sbjct:   378 LYDYLPGGSLDEAL-HVERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNI 436

Query:   225 LLNSKLEAFVADFGVARLLHSDSSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVA 283
             LL+  LEA V+DFG+A+LL  + S+  T+VAGT GY+APE   +   TEK DVYSFGV+ 
Sbjct:   437 LLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLV 496

Query:   284 LEVLMGRHPGD---LLSSVNPKIMLIDLLDQRVPSPIDDQTV----IQDIILVSKIVFAC 336
             LEVL G+ P D   +   +N    L  L+ ++ P  I D       ++ +  +  I   C
Sbjct:   497 LEVLSGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQC 556

Query:   337 LRSKPTSRP-MQRVSQ 351
             +   P  RP M RV Q
Sbjct:   557 VSPSPEERPTMHRVVQ 572

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0030243 "cellulose metabolic process" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 449 (163.1 bits), Expect = 3.4e-44, Sum P(2) = 3.4e-44
 Identities = 110/297 (37%), Positives = 171/297 (57%)

Query:    80 TFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAH 139
             T++E+   TE F   + +G GG+G VY+  L  GK VA+K+L     E  + E F+ E  
Sbjct:   359 TYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAE-GYRE-FKAEVE 416

Query:   140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
             ++S++ HR++V L G+C+ ++  FLIY+++   +L   L   +  + L+W++RV I    
Sbjct:   417 IISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPV-LEWSRRVRIAIGA 475

Query:   200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN-RTVVAGTHG 258
             A  L+YLH DC P I+HRDI S+NILL+ + EA VADFG+ARL  +  S+  T V GT G
Sbjct:   476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFG 535

Query:   259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGD---------LLSSVNPKIM-LIDL 308
             Y+APE A +  LT++ DV+SFGVV LE++ GR P D         L+    P+++  I+ 
Sbjct:   536 YLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEK 595

Query:   309 LD-QRVPSP-IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQL 362
              D   V  P +++  V  ++  + +   +C+R     RP M +V +    R  L  L
Sbjct:   596 GDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRDDLSDL 652

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 476 (172.6 bits), Expect = 3.8e-44, P = 3.8e-44
 Identities = 114/303 (37%), Positives = 173/303 (57%)

Query:    45 FLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDG-RITFQEMIVATEDFDIKYCIGTGGYG 103
             F+CLRR   RK +P +       D +     +G  +   +++ AT++ + KY IG G +G
Sbjct:   790 FICLRR---RKGRPEK-------DAYVFTQEEGPSLLLNKVLAATDNLNEKYTIGRGAHG 839

Query:   104 SVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF 163
              VYRA L SGK  A+K+L  + + +   +S   E   + ++RHRN++KL GF L K    
Sbjct:   840 IVYRASLGSGKVYAVKRLVFA-SHIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDDGL 898

Query:   164 LIYKYMRRGSLFCILR--NDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISS 221
             ++Y+YM +GSL+ +L   +  E + LDW+ R N+   +AH L+YLH DC P IVHRDI  
Sbjct:   899 MLYRYMPKGSLYDVLHGVSPKENV-LDWSARYNVALGVAHGLAYLHYDCHPPIVHRDIKP 957

Query:   222 NNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGV 281
              NIL++S LE  + DFG+ARLL   + +   V GT GYIAPE A+  V   + DVYS+GV
Sbjct:   958 ENILMDSDLEPHIGDFGLARLLDDSTVSTATVTGTTGYIAPENAFKTVRGRESDVYSYGV 1017

Query:   282 VALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP---IDDQ-TVIQDIILVSKIVFACL 337
             V LE++  +   D   S      ++  +   + S    ++D  T I D ILV +++ + L
Sbjct:  1018 VLLELVTRKRAVD--KSFPESTDIVSWVRSALSSSNNNVEDMVTTIVDPILVDELLDSSL 1075

Query:   338 RSK 340
             R +
Sbjct:  1076 REQ 1078

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0045087 "innate immune response" evidence=TAS

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006955 "immune response" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 464 (168.4 bits), Expect = 5.0e-44, P = 5.0e-44
 Identities = 107/280 (38%), Positives = 161/280 (57%)

Query:    78 RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTE 137
             R T +E++VAT++F  K  +G GG+G VY+ +L  G  VA+K+L    T+   L+ FQTE
Sbjct:   281 RFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQ-FQTE 339

Query:   138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI-RLDWTKRVNIV 196
               ++S   HRN+++L GFC+      L+Y YM  GS+   LR   E    LDW KR +I 
Sbjct:   340 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIA 399

Query:   197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL-HSDSSNRTVVAG 255
                A  L+YLH  C   I+HRD+ + NILL+ + EA V DFG+A+L+ ++DS   T V G
Sbjct:   400 LGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRG 459

Query:   256 THGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK-IMLID-----LL 309
             T G+IAPE   T   +EK DV+ +GV+ LE++ G+   DL    N   IML+D     L 
Sbjct:   460 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLK 519

Query:   310 DQRVPSPIDDQT----VIQDIILVSKIVFACLRSKPTSRP 345
             ++++ S +D +     V  ++  + ++   C +S    RP
Sbjct:   520 EKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERP 559

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_scaffold_482000003 hypothetical protein (811 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	363
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-49
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-45
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-40
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-38
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-38
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-32
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-29
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-29
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-28
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-27
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-26
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-23
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-22
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-19
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-15
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-14
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-13
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-10
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.002
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.002

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  167 bits (426), Expect = 6e-50
 Identities = 73/258 (28%), Positives = 117/258 (45%), Gaps = 18/258 (6%)

Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           ++I   +G G +G VY A+   +GK VA+K +   +      E    E  +L +++H NI
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKK-IKKDRERILREIKILKKLKHPNI 59

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           V+LY     +  ++L+ +Y   G LF +L+     +  D  +    ++ +  AL YLH  
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARF--YLRQILSALEYLHSK 116

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
               IVHRD+   NILL+      +ADFG+AR L       T V GT  Y+APE+     
Sbjct: 117 G---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-GTPEYMAPEVLLGKG 172

Query: 270 LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD--II 327
             +  D++S GV+  E+L G+ P       +  + L   + +  P     +  I      
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP---FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD 229

Query: 328 LVSKIVFACLRSKPTSRP 345
           L+ K     L   P  R 
Sbjct: 230 LIRK----LLVKDPEKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (419), Expect = 6e-49
 Identities = 76/260 (29%), Positives = 119/260 (45%), Gaps = 16/260 (6%)

Query: 91  FDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           +++   +G+G +G+VY+A+    GK VA+K L     +    ++ + E  +L ++ H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           V+L      K  ++L+ +Y   G LF  L        L   +   I   +   L YLH +
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSN 117

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE--LAYT 267
               I+HRD+   NILL+      +ADFG+A+ L   SS+ T   GT  Y+APE  L   
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD 325
                K DV+S GV+  E+L G+ P  G+ +      I  I       P   D+      
Sbjct: 175 GY-GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI----LGPPLEFDEPKWSSG 229

Query: 326 IILVSKIVFACLRSKPTSRP 345
                 ++  CL   P+ RP
Sbjct: 230 SEEAKDLIKKCLNKDPSKRP 249

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  154 bits (392), Expect = 1e-45
 Identities = 69/192 (35%), Positives = 110/192 (57%), Gaps = 9/192 (4%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G GG+G+VY A+   +GKKVA+K +   ++  + LE    E  +L ++ H NIVKLYG 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
              +  ++L+ +Y   GSL  +L+ ++   +L   + + I+  +   L YLH      I+
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLH-SN--GII 114

Query: 216 HRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTEK 273
           HRD+   NILL+S   +  +ADFG+++LL SD S    + GT  Y+APE L      +EK
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 274 CDVYSFGVVALE 285
            D++S GV+  E
Sbjct: 175 SDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  141 bits (358), Expect = 6e-40
 Identities = 73/267 (27%), Positives = 120/267 (44%), Gaps = 42/267 (15%)

Query: 97  IGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +G VY+  L      +  KVA+K L    +E    E F  EA ++ ++ H NIV+
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE-REEFLEEASIMKKLSHPNIVR 65

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
           L G C   + ++++ +YM  G L   LR   E + L     + +   +A  + YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE---- 119

Query: 212 PS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APEL 264
            S   VHRD+++ N L+   L   ++DFG++R ++ D   R       G +     APE 
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR---KRGGGKLPIKWMAPES 175

Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPID 318
                 T K DV+SFGV+  E+  +G  P        P +   ++L+      R+P P +
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQP-------YPGMSNEEVLELLEDGYRLPRPEN 228

Query: 319 DQTVIQDIILVSKIVFACLRSKPTSRP 345
               + +++L       C    P  RP
Sbjct: 229 CPDELYELML------QCWAYDPEDRP 249

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  138 bits (351), Expect = 6e-39
 Identities = 69/204 (33%), Positives = 111/204 (54%), Gaps = 9/204 (4%)

Query: 90  DFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
            F+I   IG GG+G VY+A    +GK+VA+K +     E    E    E  +L + +H N
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE--KKEKIINEIQILKKCKHPN 58

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           IVK YG  L K  ++++ ++   GSL  +L++ ++   L  ++   + K +   L YLH 
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIAYVCKELLKGLEYLHS 116

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
           +    I+HRDI + NILL S  E  + DFG++  L SD+  R  + GT  ++APE+    
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPYWMAPEVINGK 172

Query: 269 VLTEKCDVYSFGVVALEVLMGRHP 292
               K D++S G+ A+E+  G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  137 bits (348), Expect = 2e-38
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 33/263 (12%)

Query: 96  CIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            +G G +GSVY A    +G+ +A+K +  S      LE+ + E  +LS ++H NIV+ YG
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 155 FCLHK-KCMFLIY-KYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYLHC 208
               + K    I+ +Y+  GSL  +L+      +  IR  +T+++         L+YLH 
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK-YTRQI------LEGLAYLHS 119

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAY 266
           + I   VHRDI   NIL++S     +ADFG A+ L    +      V GT  ++APE+  
Sbjct: 120 NGI---VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP----GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
                   D++S G   +E+  G+ P    G+ ++++  KI       + +P  + ++  
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-KIGSSGEPPE-IPEHLSEE-- 232

Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
            +D +        CLR  P  RP
Sbjct: 233 AKDFLR------KCLRRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  136 bits (344), Expect = 6e-38
 Identities = 70/265 (26%), Positives = 118/265 (44%), Gaps = 38/265 (14%)

Query: 97  IGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +G VY+  L         +VA+K L    +E   +E F  EA ++ ++ H NIVK
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ-IEEFLREARIMRKLDHPNIVK 65

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
           L G C  ++ + ++ +YM  G L   LR +     L  +  ++    +A  + YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN- 123

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APELAY 266
              +HRD+++ N L+   L   ++DFG++R L+ D   +       G +     APE   
Sbjct: 124 --FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV----KGGKLPIRWMAPESLK 177

Query: 267 TMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPIDDQ 320
               T K DV+SFGV+  E+  +G  P        P +   ++L+      R+P P +  
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP-------YPGMSNAEVLEYLKKGYRLPKPPNCP 230

Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
             +  ++L       C    P  RP
Sbjct: 231 PELYKLML------QCWAEDPEDRP 249

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  136 bits (344), Expect = 8e-38
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 39/265 (14%)

Query: 97  IGTGGYGSVYRAQL--PSGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +G VY+ +L    GKK   VA+K L    +E   +E F  EA ++ ++ H N+VK
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ-IEEFLREARIMRKLDHPNVVK 65

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
           L G C  ++ ++++ +YM  G L   LR +   + L     ++    +A  + YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLS--DLLSFALQIARGMEYLE---S 120

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPELAY 266
            + +HRD+++ N L+   L   ++DFG++R L+ D   R       G     ++APE   
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK----RGGKLPIRWMAPESLK 176

Query: 267 TMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPIDDQ 320
               T K DV+SFGV+  E+  +G  P        P +   ++L+      R+P P +  
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQP-------YPGMSNEEVLEYLKNGYRLPQPPNCP 229

Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
             + D++L       C    P  RP
Sbjct: 230 PELYDLML------QCWAEDPEDRP 248

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  129 bits (328), Expect = 2e-35
 Identities = 69/266 (25%), Positives = 120/266 (45%), Gaps = 33/266 (12%)

Query: 97  IGTGGYGSVYRAQLPSGKK----VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           +G G +G VY+ +L         VA+K L    +E    + F  EA ++ ++ H N+V+L
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-EERKDFLKEARVMKKLGHPNVVRL 61

Query: 153 YGFCLHKKCMFLIYKYMRRGSL------FCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            G C  ++ ++L+ +YM  G L         +    E   L     ++    +A  + YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----A 261
                   VHRD+++ N L+   L   ++DFG++R ++ D   R     T G +     A
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK---KTGGKLPIRWMA 175

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLD-QRVPSPIDD 319
           PE     + T K DV+SFGV+  E+  +G  P      ++ + +L  L    R+P P   
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLSNEEVLEYLRKGYRLPKPEYC 232

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
              + +++L      +C +  P  RP
Sbjct: 233 PDELYELML------SCWQLDPEDRP 252

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  132 bits (333), Expect = 2e-35
 Identities = 76/272 (27%), Positives = 123/272 (45%), Gaps = 21/272 (7%)

Query: 90  DFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH-R 147
            + I   +G G +G VY A+    K VALK L      +   +E F  E  +L+ + H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           NIVKLY F   +  ++L+ +Y+  GSL  +L+       L  ++ + I+  +  AL YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFV-ADFGVARLLHSDSSNRTVVA------GTHGYI 260
                 I+HRDI   NILL+         DFG+A+LL    S  ++ A      GT GY+
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 261 APELAYTMVL---TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV---- 313
           APE+   + L   +   D++S G+   E+L G  P +   + +     + ++ +      
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            SP+            S ++   L   P +R 
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRL 267

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  124 bits (315), Expect = 1e-33
 Identities = 76/273 (27%), Positives = 120/273 (43%), Gaps = 43/273 (15%)

Query: 90  DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
            ++I   IG G +G VY  +    GK   LK++  S       E    E  +L ++ H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR-------LDWTKRVNIVKSMAH 201
           I+K Y     K  + ++ +Y   G L   ++   +  +       LDW   V +      
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCL---- 114

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS-NRTVVAGTHGYI 260
           AL YLH      I+HRDI   NI L S     + DFG++++L S     +TVV GT  Y+
Sbjct: 115 ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYL 170

Query: 261 APEL----AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVP 314
           +PEL     Y      K D++S G V  E+   +HP  G+ L  +  KI+      +   
Sbjct: 171 SPELCQNKPY----NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL------KGQY 220

Query: 315 SPIDDQ--TVIQDIILVSKIVFACLRSKPTSRP 345
            PI  Q  + +++++       + L+  P  RP
Sbjct: 221 PPIPSQYSSELRNLV------SSLLQKDPEERP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  125 bits (315), Expect = 1e-33
 Identities = 73/265 (27%), Positives = 119/265 (44%), Gaps = 23/265 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            D +    +G G  G VY+ +  P+GK  ALKK+H    E  F +    E   L      
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESP 59

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV--NIVKSMAHALSY 205
            +VK YG    +  + ++ +YM  GSL  +L+           + V   I + +   L Y
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLK-----KVGKIPEPVLAYIARQILKGLDY 114

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL- 264
           LH      I+HRDI  +N+L+NSK E  +ADFG++++L +         GT  Y++PE  
Sbjct: 115 LHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172

Query: 265 ---AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT 321
              +Y+       D++S G+  LE  +G+ P       +   ++  + D   PS   ++ 
Sbjct: 173 QGESYSY----AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228

Query: 322 VIQDIILVSKIVFACLRSKPTSRPM 346
             +    +S    ACL+  P  RP 
Sbjct: 229 SPEFRDFIS----ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 6e-32
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 17/209 (8%)

Query: 90  DFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           ++ +   IG G +G VY+   L +G  VA+K++   + +   L+S   E  LL  ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-----NDDEAIRLDWTKRVNIVKSMAHAL 203
           IVK  G       +++I +Y   GSL  I++      +              V  +   L
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY--------VYQVLQGL 112

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           +YLH      ++HRDI + NIL        +ADFGVA  L+  S +   V GT  ++APE
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +      +   D++S G   +E+L G  P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 8e-31
 Identities = 82/261 (31%), Positives = 127/261 (48%), Gaps = 22/261 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKK--LHHSETELAFLESFQTEAHLLSQIR 145
           E F +  CIG G +G VY+A    + + VA+K   L  +E E+  +   Q E   LSQ R
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDI---QQEIQFLSQCR 57

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
              I K YG  L    +++I +Y   GS   +L+      +LD T    I++ +   L Y
Sbjct: 58  SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEY 113

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           LH +     +HRDI + NILL+ + +  +ADFGV+  L S  S R    GT  ++APE+ 
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDLLDQRVPSPIDDQTVIQ 324
                 EK D++S G+ A+E+  G  P   LS ++P +++   L+ +  P  ++     +
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP---LSDLHPMRVLF--LIPKNNPPSLEGNKFSK 225

Query: 325 DIILVSKIVFACLRSKPTSRP 345
                   V  CL   P  RP
Sbjct: 226 PF---KDFVSLCLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  115 bits (291), Expect = 6e-30
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 13/215 (6%)

Query: 83  EMIVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTE 137
           + IV+  D    Y     IG G  G VY+A    +GK+VA+KK+   +      E    E
Sbjct: 9   KDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINE 65

Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
             ++   +H NIV  Y   L    ++++ +YM  GSL  I+  +   +R++  +   + +
Sbjct: 66  ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCR 123

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +   L YLH     +++HRDI S+NILL+      +ADFG A  L  + S R  V GT 
Sbjct: 124 EVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTP 180

Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
            ++APE+        K D++S G++ +E+  G  P
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 3e-29
 Identities = 81/265 (30%), Positives = 126/265 (47%), Gaps = 39/265 (14%)

Query: 97  IGTGGYGSVYRA--QLPSGK--KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G V R   +LP  K   VA+K L    ++   L+ F TEA ++ Q  H NI++L
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIRL 70

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL--HCDC 210
            G     + + +I +YM  GSL   LR +D   +    + V +++ +A  + YL      
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN-- 126

Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG--YIAPE-LAYT 267
               VHRD+++ NIL+NS L   V+DFG++R L    +  T   G     + APE +AY 
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 268 MVLTEKCDVYSFGVVALEVL-MGRHP------GDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
              T   DV+SFG+V  EV+  G  P       D++ +V            R+P P+D  
Sbjct: 184 -KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED--------GYRLPPPMDCP 234

Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
           + +  ++L       C +     RP
Sbjct: 235 SALYQLML------DCWQKDRNERP 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  112 bits (283), Expect = 4e-29
 Identities = 72/224 (32%), Positives = 109/224 (48%), Gaps = 33/224 (14%)

Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           E FDI   +G G YGSVY+A    +G+ VA+K +   E     L+    E  +L Q    
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSP 58

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-----DDEAIRLDWTKRVNIVKSMAHA 202
            IVK YG       ++++ +Y   GS+  I++       +E I         I+      
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLKG 111

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L YLH +     +HRDI + NILLN + +A +ADFGV+  L    + R  V GT  ++AP
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168

Query: 263 ELAYTMVLTE-----KCDVYSFGVVALEVLMGRHPGDLLSSVNP 301
           E     V+ E     K D++S G+ A+E+  G+ P    S ++P
Sbjct: 169 E-----VIQEIGYNNKADIWSLGITAIEMAEGKPP---YSDIHP 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  112 bits (282), Expect = 6e-29
 Identities = 79/272 (29%), Positives = 127/272 (46%), Gaps = 31/272 (11%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +D+++   IG G    VY A  LP+ +KVA+K++   E     ++  + E   +SQ  H 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHP 59

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK Y   +    ++L+  Y+  GSL  I+++      LD      ++K +   L YLH
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN----RTVVAGTHGYIAPE 263
            +     +HRDI + NILL       +ADFGV+  L          R    GT  ++APE
Sbjct: 120 SN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 264 L-----AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDLLDQRVPSPI 317
           +      Y      K D++SFG+ A+E+  G  P    S   P K++++ L  Q  P  +
Sbjct: 177 VMEQVHGY----DFKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTL--QNDPPSL 227

Query: 318 DDQTVIQDIILVSK----IVFACLRSKPTSRP 345
           +      D    SK    ++  CL+  P+ RP
Sbjct: 228 ETGA---DYKKYSKSFRKMISLCLQKDPSKRP 256

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  110 bits (276), Expect = 5e-28
 Identities = 82/265 (30%), Positives = 135/265 (50%), Gaps = 28/265 (10%)

Query: 93  IKYCIGTGGYGSVYRAQL-PSGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG G +G V R +L   GK+   VA+K L    TE    + F +EA ++ Q  H N
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPN 66

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I+ L G     + + +I ++M  G+L   LR +D   +    + V +++ +A  + YL  
Sbjct: 67  IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYL-- 122

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APE 263
               + VHRD+++ NIL+NS L   V+DFG++R L  D+S+ T  +   G I     APE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 264 LAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQ 320
                  T   DV+S+G+V  EV+  G  P   +S+ +    +I+ ++Q  R+P P+D  
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VINAIEQDYRLPPPMDCP 237

Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
           T +  ++L       C +    +RP
Sbjct: 238 TALHQLML------DCWQKDRNARP 256

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  114 bits (287), Expect = 9e-28
 Identities = 86/336 (25%), Positives = 157/336 (46%), Gaps = 31/336 (9%)

Query: 21  KVPSR-LVVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRI 79
           K PS    +       L++ +  F F+ +R     + K  E +      +F        I
Sbjct: 624 KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSI 683

Query: 80  TFQEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEA 138
           T  +++ + ++ ++   I  G  G+ Y+ + + +G +  +K+++   +      S   + 
Sbjct: 684 TINDILSSLKEENV---ISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIAD- 736

Query: 139 HLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS 198
             + +++H NIVKL G C  +K  +LI++Y+   +L  +LRN      L W +R  I   
Sbjct: 737 --MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIG 788

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           +A AL +LHC C P++V  ++S   I+++ K E  +    +  LL +D+      A    
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA---- 843

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM------LIDL-LDQ 311
           Y+APE   T  +TEK D+Y FG++ +E+L G+ P D    V+  I+        D  LD 
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903

Query: 312 RVPSPIDDQTVI--QDIILVSKIVFACLRSKPTSRP 345
            +   I     +   +I+ V  +   C  + PT+RP
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939

Length = 968

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 4e-27
 Identities = 80/258 (31%), Positives = 127/258 (49%), Gaps = 30/258 (11%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH---RNIVKL 152
           IG G YG+VYR   +P+G+ VALK ++  +T    +   Q E  LLSQ+R     NI K 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIIN-LDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           YG  L    +++I +Y   GS+  +++    A  +       I++ +  AL Y+H     
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKV--- 120

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI + NIL+ +     + DFGVA LL+ +SS R+   GT  ++APE     V+TE
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE-----VITE 175

Query: 273 ------KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
                 K D++S G+   E+  G  P     S       + L+ +  P  ++D    + +
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP----YSDVDAFRAMMLIPKSKPPRLEDNGYSKLL 231

Query: 327 ILVSKIVFACLRSKPTSR 344
               + V ACL  +P  R
Sbjct: 232 ---REFVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  106 bits (266), Expect = 1e-26
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 28/260 (10%)

Query: 97  IGTGGYGSVYRAQLP-SGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G V+R  L   G+K   VA+K L    TE    + F +EA ++ Q  H NI++L
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHHNIIRL 71

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDD---EAIRLDWTKRVNIVKSMAHALSYLHCD 209
            G     K   +I +YM  G+L   LR+ D    + +L     V +++ +A  + YL   
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYL--- 123

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAY 266
              + VHRD+++ NIL+NS LE  V+DFG++R+L  D       +G      + APE   
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 267 TMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD 325
               T   DV+SFG+V  EV+  G  P   +S  N ++M       R+P+P+D  + +  
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--NHEVMKAINDGFRLPAPMDCPSAVYQ 241

Query: 326 IILVSKIVFACLRSKPTSRP 345
           ++L       C +     RP
Sbjct: 242 LML------QCWQQDRARRP 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  106 bits (266), Expect = 1e-26
 Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 26/219 (11%)

Query: 90  DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHH---SETELAFLESFQTEAHLLSQIR 145
           D+++   IG G +G+V + +    GK +  K++ +   +E E   L S   E ++L +++
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS---EVNILRELK 57

Query: 146 HRNIVKLYGFCLHK--KCMFLIYKYMRRGSLFCILRN--------DDEAIRLDWTKRVNI 195
           H NIV+ Y   + +  + ++++ +Y   G L  +++         ++E I   W     I
Sbjct: 58  HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI---W----RI 110

Query: 196 VKSMAHALSYLH--CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
           +  +  AL   H   D   +++HRD+   NI L++     + DFG+A++L  DSS     
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170

Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
            GT  Y++PE    M   EK D++S G +  E+     P
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  104 bits (262), Expect = 4e-26
 Identities = 78/265 (29%), Positives = 129/265 (48%), Gaps = 29/265 (10%)

Query: 90  DFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           DF+I   IG G +G V++    + K+V A+K++  S+      E    EA +L+++    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND------DEAIRLDWTKRVNIVKSMAHA 202
           I++ Y   L K  + ++ +Y   G L  +L+        ++ +   W   + I+      
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV---WRFFIQILL----G 113

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYI 260
           L++LH      I+HRDI S N+ L++     + D GVA+LL SD++N   T+V GT  Y+
Sbjct: 114 LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIV-GTPYYL 168

Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           +PEL       EK DV++ GVV  E   G+HP D     N +  LI  + + V  P+  Q
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGALILKIIRGVFPPV-SQ 223

Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
              Q +    +++  CL      RP
Sbjct: 224 MYSQQLA---QLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  103 bits (259), Expect = 9e-26
 Identities = 76/274 (27%), Positives = 137/274 (50%), Gaps = 29/274 (10%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           E+F ++  +G+G +G V+     +  +VA+K L     +L   + FQ E   L ++RH++
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKIL--KSDDLLKQQDFQKEVQALKRLRHKH 63

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           ++ L+  C   + +++I + M +GSL   LR+ +  + L     +++   +A  ++YL  
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEE 122

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD---SSNRTVVAGTHGYIAPELA 265
               + +HRD+++ NIL+   L   VADFG+ARL+  D   SS++ +    + + APE A
Sbjct: 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAA 176

Query: 266 YTMVLTEKCDVYSFGVVALEVLM-GR--HPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQ 320
                + K DV+SFG++  E+   G+  +PG     V       D +    R+P P    
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV------YDQITAGYRMPCPAKCP 230

Query: 321 TVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
             I  I+L       C  ++P  RP  +  +E L
Sbjct: 231 QEIYKIML------ECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  102 bits (255), Expect = 4e-25
 Identities = 68/270 (25%), Positives = 106/270 (39%), Gaps = 29/270 (10%)

Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKV-ALK---KLHHSETELAFLESFQTEAHLLSQIRH 146
           F++   IG G +G V   Q    KK+ A+K   K    E       +   E  +L ++ H
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSV--RNVLNERRILQELNH 59

Query: 147 RNIVKL-YGFCLHKKCMFLIYKYMRRGSL-FCILRN---DDEAIRLDWTKRVNIVKSMAH 201
             +V L Y F   +  M+L+   +  G L + + +     +E ++         +  +  
Sbjct: 60  PFLVNLWYSFQDEEN-MYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVL 111

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL YLH      I+HRDI  +NILL+ +    + DF +A  +    +  T  +GT GY+A
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMA 167

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT 321
           PE+      +   D +S GV A E L G+ P    S      +        V  P    T
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWST 227

Query: 322 VIQDIILVSKIVFACLRSKPTSRPMQRVSQ 351
              D I         L   P  R    +  
Sbjct: 228 EAIDAIN------KLLERDPQKRLGDNLKD 251

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 4e-25
 Identities = 79/267 (29%), Positives = 133/267 (49%), Gaps = 31/267 (11%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G +G V+        KVA+K L        AFL+    EA ++ ++RH  +V+LY  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ----EAQIMKKLRHDKLVQLYAV 69

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           C  ++ ++++ +YM +GSL   L+   E  +L   + V++   +A  ++YL      + +
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYI 125

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---APELAYTMVLTE 272
           HRD+++ NIL+   L   +ADFG+ARL+  D    T   G    I   APE A     T 
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTI 183

Query: 273 KCDVYSFGVVALEVLM-GR--HPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTVIQDII 327
           K DV+SFG++  E++  GR  +PG      N ++  ++ +++  R+P P +    + D++
Sbjct: 184 KSDVWSFGILLTEIVTYGRVPYPG----MTNREV--LEQVERGYRMPRPPNCPEELYDLM 237

Query: 328 LVSKIVFACLRSKPTSRPMQRVSQEFL 354
           L       C    P  RP     Q FL
Sbjct: 238 L------QCWDKDPEERPTFEYLQSFL 258

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  102 bits (255), Expect = 4e-25
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 34/214 (15%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G VY A  L +G+ +A+K++   + +   ++    E  +L  ++H N+VK YG 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 156 CLHKKCMFLIYKYMRRGSLFCIL---RNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
            +H++ +++  +Y   G+L  +L   R  DE +     +       +   L+YLH     
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILDEHV----IRV--YTLQLLEGLAYLHSH--- 118

Query: 213 SIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDSSNRTVV-------AGTHGYIA 261
            IVHRDI   NI L+     KL     DFG A  L    +N T +       AGT  Y+A
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKL----GDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMA 171

Query: 262 PELAYTMVLTEK---CDVYSFGVVALEVLMGRHP 292
           PE+             D++S G V LE+  G+ P
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 5e-25
 Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 19/223 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           ++  +   IG G +G V       G+KVA+K L   + +    ++F  EA +++ +RH N
Sbjct: 6   KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCL---KDDSTAAQAFLAEASVMTTLRHPN 61

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G  L    ++++ +YM +GSL   LR+   A+ +   +++     +   + YL  
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEE 120

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
               + VHRD+++ N+L++  L A V+DFG+A+     S  +        + APE     
Sbjct: 121 K---NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEALREK 174

Query: 269 VLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLD 310
             + K DV+SFG++  E+   GR P        P+I L D++ 
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVP 210

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  101 bits (253), Expect = 7e-25
 Identities = 72/254 (28%), Positives = 113/254 (44%), Gaps = 18/254 (7%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G  G V +    P+GK +A+K +   E   A  +    E  +L +     IV  YG 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
             +   + +  +YM  GSL  IL+     I      ++ +  ++   L+YLH      I+
Sbjct: 68  FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKH--KII 123

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCD 275
           HRD+  +NIL+NS+ +  + DFGV+  L  +S  +T V GT  Y+APE       + K D
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFV-GTSSYMAPERIQGNDYSVKSD 181

Query: 276 VYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV--PSPIDDQTVIQDIILVSKIV 333
           ++S G+  +E+  GR P       +P   + +LL   V  P P     +           
Sbjct: 182 IWSLGLSLIELATGRFP--YPPENDPPDGIFELLQYIVNEPPP----RLPSGKFSPDFQD 235

Query: 334 F--ACLRSKPTSRP 345
           F   CL   P  RP
Sbjct: 236 FVNLCLIKDPRERP 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  101 bits (252), Expect = 9e-25
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 32/266 (12%)

Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 63

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK 122

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 123 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESL 177

Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL++  R+  P   
Sbjct: 178 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKGYRMERPEGC 230

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
              + +++       AC +  P+ RP
Sbjct: 231 PPKVYELMR------ACWQWNPSDRP 250

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 4e-24
 Identities = 68/255 (26%), Positives = 122/255 (47%), Gaps = 25/255 (9%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G G +G V+     +   VA+K L     +    + F  EA ++ ++RH  +++LY  C
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP---KDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
             ++ ++++ + M+ GSL   L+       L   + +++   +A  ++YL      + +H
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126

Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---APELAYTMVLTEK 273
           RD+++ N+L+       VADFG+AR++  D        G    I   APE A     + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE--GAKFPIKWTAPEAALYNRFSIK 184

Query: 274 CDVYSFGVVALE-VLMGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTVIQDIILVS 330
            DV+SFG++  E V  GR P   ++  N ++  +  +DQ  R+P P      + DI+L  
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMT--NAEV--LQQVDQGYRMPCPPGCPKELYDIML-- 238

Query: 331 KIVFACLRSKPTSRP 345
                C +  P  RP
Sbjct: 239 ----DCWKEDPDDRP 249

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 99.5 bits (249), Expect = 5e-24
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 25/206 (12%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG VY+A+   +G+ VALKK+     +  F  +   E  LL ++RH NIV+L   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 156 CLHKKC--MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
              K    ++++++YM    L  +L + +        K    +K +   L YLH      
Sbjct: 67  VTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKC--YMKQLLEGLQYLH---SNG 120

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTVVAGTHGYIAPEL----- 264
           I+HRDI  +NIL+N+     +ADFG+AR     +S    NR +   T  Y  PEL     
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI---TLWYRPPELLLGAT 177

Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGR 290
            Y      + D++S G +  E+ +G+
Sbjct: 178 RY----GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 6e-24
 Identities = 72/234 (30%), Positives = 117/234 (50%), Gaps = 29/234 (12%)

Query: 97  IGTGGYGSVYRAQ-LPSGKK----VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G+G +G+VY+   +P G+K    VA+K L    +  A  E    EA++++ + H ++V+
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE-ILDEAYVMASVDHPHVVR 73

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR----LDWTKRVNIVKSMAHALSYLH 207
           L G CL  +   LI + M  G L   +RN  + I     L+W   V I K M    SYL 
Sbjct: 74  LLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGM----SYLE 126

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYIAPELA 265
                 +VHRD+++ N+L+ +     + DFG+A+LL  D        G     ++A E  
Sbjct: 127 ---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 266 YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLD--QRVPSP 316
              + T K DV+S+GV   E++  G  P + + +V       DLL+  +R+P P
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP----DLLEKGERLPQP 233

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 98.4 bits (245), Expect = 8e-24
 Identities = 77/269 (28%), Positives = 136/269 (50%), Gaps = 34/269 (12%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G G +G V+        KVA+K L          E+F  EA+L+ Q++H  +V+LY   
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYA-V 69

Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           + ++ +++I +YM  GSL   L+   E I+L   K +++   +A  ++++      + +H
Sbjct: 70  VTQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125

Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVLTEK 273
           RD+ + NIL++  L   +ADFG+ARL+  + +  T   G      + APE       T K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 274 CDVYSFGVVALE-VLMGR--HPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTVIQDIIL 328
            DV+SFG++  E V  GR  +PG      NP++  I  L++  R+P P +    + +++ 
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPG----MTNPEV--IQNLERGYRMPRPDNCPEELYELMR 237

Query: 329 VSKIVFACLRSKPTSRP----MQRVSQEF 353
                  C + KP  RP    ++ V ++F
Sbjct: 238 ------LCWKEKPEERPTFEYLRSVLEDF 260

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 98.0 bits (245), Expect = 8e-24
 Identities = 77/265 (29%), Positives = 114/265 (43%), Gaps = 47/265 (17%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLH------HSETELAFLESFQTEAHLLSQIRHRNI 149
           +G G +G V   +   +GK  A+K L         E E        TE ++LS+I H  I
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-----TERNILSRINHPFI 55

Query: 150 VKL-YGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALS 204
           VKL Y F   +K ++L+ +Y   G LF  L       +E  R            +  AL 
Sbjct: 56  VKLHYAFQTEEK-LYLVLEYAPGGELFSHLSKEGRFSEERARF-------YAAEIVLALE 107

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           YLH      I++RD+   NILL++     + DFG+A+ L S+ S      GT  Y+APE 
Sbjct: 108 YLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE- 163

Query: 265 AYTMVLTEK-----CDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
               VL  K      D +S GV+  E+L G+ P     + + K +   +L   +  P   
Sbjct: 164 ----VLLGKGYGKAVDWWSLGVLLYEMLTGKPP---FYAEDRKEIYEKILKDPLRFPEFL 216

Query: 320 QTVIQDIILVSKIVFACLRSKPTSR 344
               +D+I         L+  PT R
Sbjct: 217 SPEARDLIS------GLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 98.2 bits (244), Expect = 1e-23
 Identities = 79/276 (28%), Positives = 130/276 (47%), Gaps = 28/276 (10%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   +   +G G +G V+        KVA+K L          ESF  EA ++ ++R
Sbjct: 3   IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLR 59

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H  +V+LY   + ++ ++++ +YM +GSL   L+ D E   L     V++   +A  ++Y
Sbjct: 60  HDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAY 117

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPEL 264
           +      + +HRD+ S NIL+   L   +ADFG+ARL+  +  + R        + APE 
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174

Query: 265 AYTMVLTEKCDVYSFGVVALE-VLMGRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPID 318
           A     T K DV+SFG++  E V  GR P        P +   ++L+Q     R+P P D
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVP-------YPGMNNREVLEQVERGYRMPCPQD 227

Query: 319 DQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
               + +++L       C +  P  RP     Q FL
Sbjct: 228 CPISLHELML------QCWKKDPEERPTFEYLQSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 98.2 bits (244), Expect = 1e-23
 Identities = 80/269 (29%), Positives = 127/269 (47%), Gaps = 20/269 (7%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G V++      +KV   K+   E     +E  Q E  +LSQ     + K YG  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L    +++I +Y+  GS   +L    E   LD T+   I++ +   L YLH +     +H
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KKIH 124

Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDV 276
           RDI + N+LL+   E  +ADFGVA  L      R    GT  ++APE+        K D+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184

Query: 277 YSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFAC 336
           +S G+ A+E+  G  P    S ++P  +L  L+ +  P  ++          + + V AC
Sbjct: 185 WSLGITAIELAKGEPPH---SELHPMKVLF-LIPKNNPPTLEGNYSKP----LKEFVEAC 236

Query: 337 LRSKPTSRPMQR--VSQEFLVR---KTLY 360
           L  +P+ RP  +  +  +F+VR   KT Y
Sbjct: 237 LNKEPSFRPTAKELLKHKFIVRFAKKTSY 265

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 96.7 bits (240), Expect = 4e-23
 Identities = 76/276 (27%), Positives = 132/276 (47%), Gaps = 28/276 (10%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 3   IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 59

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +     L   + V++   +A  ++Y
Sbjct: 60  HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAY 117

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPEL 264
           +      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE 
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174

Query: 265 AYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPID 318
           A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPPE 227

Query: 319 DQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
               + D++        C R +P  RP     Q FL
Sbjct: 228 CPESLHDLMC------QCWRKEPEERPTFEYLQAFL 257

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 96.8 bits (242), Expect = 5e-23
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT----EAHLLSQIRHRNIV 150
            +G G YG VY+A+   +G+ VALKK+     E    E   +    E  LL +++H NIV
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE----EGIPSTALREISLLKELKHPNIV 61

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
           KL      ++ ++L+++Y     L   L      +  +  K   I+  +   L+Y H   
Sbjct: 62  KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHSHR 118

Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL-----A 265
              I+HRD+   NIL+N      +ADFG+AR         T    T  Y APE+      
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           Y+  +    D++S G +  E++ G+   PGD
Sbjct: 176 YSTAV----DIWSVGCIFAEMITGKPLFPGD 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 96.1 bits (239), Expect = 7e-23
 Identities = 79/263 (30%), Positives = 127/263 (48%), Gaps = 26/263 (9%)

Query: 93  IKYCIGTGGYGSVY--RAQLPSGKK--VALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG G +G V   R +LP  ++  VA+K L    TE      F +EA ++ Q  H N
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPN 66

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I+ L G     K + ++ +YM  GSL   LR  D   +    + V +++ +A  + YL  
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYL-S 123

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELA 265
           D     VHRD+++ NIL+NS L   V+DFG++R+L  D        G      + APE  
Sbjct: 124 DM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 266 YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTV 322
                T   DV+S+G+V  EV+  G  P   +S+ +    +I  +++  R+P+P+D    
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VIKAIEEGYRLPAPMDCPAA 237

Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
           +  ++L       C +     RP
Sbjct: 238 LHQLML------DCWQKDRNERP 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 28/230 (12%)

Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQLPSGKK------VALKKLHHSETELAFLESFQTEA 138
            V  +   +K  +G G +G V+  +    +       VA+K L  + +  A  + F+ EA
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA-RKDFEREA 59

Query: 139 HLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-NDDEAIRLDWTKR----- 192
            LL+  +H NIVK YG C       ++++YM  G L   LR +  +A  L          
Sbjct: 60  ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 193 -----VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
                + I   +A  + YL        VHRD+++ N L+   L   + DFG++R +++  
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD 176

Query: 248 SNRTVVAGTH----GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
             R  V G       ++ PE       T + DV+SFGVV  E+   G+ P
Sbjct: 177 YYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 2e-22
 Identities = 67/223 (30%), Positives = 111/223 (49%), Gaps = 26/223 (11%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALK--KLHHSETELAFLESFQTEAHLLSQIR 145
           ED+++   IG+G YG VY+A+ + +G+ VA+K  KL   +      E  Q E  +L + R
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD----FEIIQQEISMLKECR 58

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H NIV  +G  L +  ++++ +Y   GSL  I +       L   +   + +     L+Y
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGLAY 116

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           LH       +HRDI   NILL    +  +ADFGV+  L +  + R    GT  ++APE+A
Sbjct: 117 LHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173

Query: 266 -------YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP 301
                  Y      KCD+++ G+ A+E+   + P   +  ++P
Sbjct: 174 AVERKGGY----DGKCDIWALGITAIELAELQPP---MFDLHP 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 94.8 bits (236), Expect = 3e-22
 Identities = 72/259 (27%), Positives = 118/259 (45%), Gaps = 27/259 (10%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G G +G VY+AQ       A  K+   E+E   LE F  E  +LS+ +H NIV LY   
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIR-LDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
            ++  ++++ ++   G+L  I+    E  R L   +   + + M  AL++LH      ++
Sbjct: 72  FYENKLWILIEFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE--- 272
           HRD+ + NILL    +  +ADFGV+    S    R    GT  ++APE+    V  E   
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV----VACETFK 181

Query: 273 ------KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
                 K D++S G+  +E+     P      +NP  +L+ +   +   P  DQ      
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPH---HELNPMRVLLKI--LKSEPPTLDQPSKWSS 236

Query: 327 ILVSKIVFACLRSKPTSRP 345
              +  + +CL   P  RP
Sbjct: 237 SF-NDFLKSCLVKDPDDRP 254

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 79/271 (29%), Positives = 128/271 (47%), Gaps = 24/271 (8%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G V++     + + VA+K +   E E   +E  Q E  +LSQ     + K YG 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
            L    +++I +Y+  GS   +LR    A   D  +   ++K +   L YLH +     +
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KKI 123

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCD 275
           HRDI + N+LL+ + +  +ADFGVA  L      R    GT  ++APE+        K D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 276 VYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK-IVF 334
           ++S G+ A+E+  G  P    S ++P  M +  L  +   P    T+  +     K  + 
Sbjct: 184 IWSLGITAIELAKGEPPN---SDMHP--MRVLFLIPKNNPP----TLTGEFSKPFKEFID 234

Query: 335 ACLRSKPTSRPMQR--VSQEFLV---RKTLY 360
           ACL   P+ RP  +  +  +F+V   +KT Y
Sbjct: 235 ACLNKDPSFRPTAKELLKHKFIVKNAKKTSY 265

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 94.3 bits (234), Expect = 4e-22
 Identities = 76/264 (28%), Positives = 122/264 (46%), Gaps = 17/264 (6%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G VY+      K+V   K+   E     +E  Q E  +LSQ     I + YG  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L    +++I +Y+  GS   +L+       L+ T    I++ +   L YLH +     +H
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE---RKIH 124

Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDV 276
           RDI + N+LL+ + +  +ADFGVA  L      R    GT  ++APE+        K D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184

Query: 277 YSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFAC 336
           +S G+ A+E+  G  P    S ++P  +L  L+ +  P  ++ Q          + V AC
Sbjct: 185 WSLGITAIELAKGEPPN---SDLHPMRVLF-LIPKNSPPTLEGQYSKP----FKEFVEAC 236

Query: 337 LRSKPTSRPMQR--VSQEFLVRKT 358
           L   P  RP  +  +  +F+ R T
Sbjct: 237 LNKDPRFRPTAKELLKHKFITRYT 260

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 93.9 bits (233), Expect = 4e-22
 Identities = 69/263 (26%), Positives = 129/263 (49%), Gaps = 21/263 (7%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G G +G V+     +  KVA+K L      +   ++F  EA+L+  ++H  +V+LY   
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
             ++ +++I +YM +GSL   L++ DE  ++   K ++    +A  ++Y+      + +H
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 126

Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPELAYTMVLTEKCD 275
           RD+ + N+L++  L   +ADFG+AR++  +  + R        + APE       T K D
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 276 VYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVF 334
           V+SFG++  E++  G+ P   +S  N  +M       R+P   +    + DI+       
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQRGYRMPRMENCPDELYDIMKT----- 239

Query: 335 ACLRSKPTSRP----MQRVSQEF 353
            C + K   RP    +Q V  +F
Sbjct: 240 -CWKEKAEERPTFDYLQSVLDDF 261

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 24/222 (10%)

Query: 87  ATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI- 144
            T  F++   IG G YG VY+A    +G+ VA+K +   E E    E  + E ++L +  
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE---EEIKEEYNILRKYS 60

Query: 145 RHRNIVKLYGFCLHKKC------MFLIYKYMRRGS---LFCILRNDDEAIRLDWTKRVNI 195
            H NI   YG  + K        ++L+ +    GS   L   LR   + ++ +W     I
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--I 118

Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
           ++     L+YLH +    ++HRDI   NILL    E  + DFGV+  L S    R    G
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIG 175

Query: 256 THGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           T  ++APE+             + DV+S G+ A+E+  G+ P
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 91.6 bits (227), Expect = 2e-21
 Identities = 76/279 (27%), Positives = 133/279 (47%), Gaps = 44/279 (15%)

Query: 89  EDFDIKYCIGTGGYGSV----YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           ++  +   IG G +G V    YR     G KVA+K + +  T  AFL     EA +++Q+
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDATAQAFL----AEASVMTQL 56

Query: 145 RHRNIVKLYGFCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           RH N+V+L G  + +K  ++++ +YM +GSL   LR+   ++ L     +     +  A+
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAM 115

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS--DSSNRTVVAGTHGYIA 261
            YL  +   + VHRD+++ N+L++    A V+DFG+ +   S  D+    V      + A
Sbjct: 116 EYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTA 167

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ-----RVPS 315
           PE       + K DV+SFG++  E+   GR P        P+I L D++ +     ++ +
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPRVEKGYKMDA 220

Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           P     V+ D++        C      +RP     +E L
Sbjct: 221 PDGCPPVVYDVMK------QCWHLDAATRPSFLQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 91.4 bits (227), Expect = 4e-21
 Identities = 62/214 (28%), Positives = 112/214 (52%), Gaps = 28/214 (13%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHS-------ETELAFLESFQTEAHLLSQIRHRN 148
           IG+G +GSVY      SG+ +A+K++          + + + L++   E  LL +++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALS 204
           IV+  G  L    + +  +Y+  GS+  +L N    ++  +R       N V+ +   L+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-------NFVRQILKGLN 120

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS------SNRTVVAGTHG 258
           YLH      I+HRDI   NIL+++K    ++DFG+++ L ++S        R  + G+  
Sbjct: 121 YLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           ++APE+      T K D++S G + +E+L G+HP
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 6e-21
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 42/266 (15%)

Query: 97  IGTGGYGSVYRA--QLPSGK--KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           +G G +GSV +    + SGK  +VA+K L   E   A  + F  EA +++Q+ H  IV+L
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS----YLHC 208
            G C  +  M L+ +    G L   L+   E          ++ K +AH ++    YL  
Sbjct: 62  IGVCKGEPLM-LVMELAPLGPLLKYLKKRRE------IPVSDL-KELAHQVAMGMAYLES 113

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPE 263
                 VHRD+++ N+LL ++ +A ++DFG++R L + S      A T G     + APE
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPE 168

Query: 264 LAYTMVLTEKCDVYSFGVVALEVL-MGRHP-GDLLSSVNPKIMLIDLLDQ--RVPSPIDD 319
                  + K DV+S+GV   E    G  P G++      +++   +L+   R+P P + 
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---KGAEVI--AMLESGERLPRPEEC 223

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
              I  I+L      +C + +P  RP
Sbjct: 224 PQEIYSIML------SCWKYRPEDRP 243

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 90.2 bits (224), Expect = 6e-21
 Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 16/196 (8%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFL-ESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G VY+  L    +VA+K      T    L   F  EA +L Q  H NIVKL G 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSI 214
           C+ K+ ++++ + +  GSL   LR   +  RL   K + +    A  + YL   +CI   
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKNCI--- 115

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVL 270
            HRD+++ N L+       ++DFG++R    +    TV  G       + APE       
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 271 TEKCDVYSFGVVALEV 286
           T + DV+S+G++  E 
Sbjct: 173 TSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.1 bits (223), Expect = 1e-20
 Identities = 70/263 (26%), Positives = 137/263 (52%), Gaps = 22/263 (8%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G G +G V+ A      KVA+K +      +   E+F  EA+++  ++H  +VKL+   
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQHDKLVKLHA-V 69

Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           + K+ +++I ++M +GSL   L++D E  +    K ++    +A  ++++      + +H
Sbjct: 70  VTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 125

Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPELAYTMVLTEKCD 275
           RD+ + NIL+++ L   +ADFG+AR++  +  + R        + APE       T K D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185

Query: 276 VYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVF 334
           V+SFG++ +E++  GR P   +S  NP+++       R+P P +    + +I++      
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRMPRPENCPEELYNIMM------ 237

Query: 335 ACLRSKPTSRP----MQRVSQEF 353
            C +++P  RP    +Q V  +F
Sbjct: 238 RCWKNRPEERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 89.8 bits (223), Expect = 1e-20
 Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 15/194 (7%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G+G +G V+  +      VA+K +   + +E  F+E    EA ++ ++ H N+V+LYG 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQLYGV 67

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           C  ++ +F++ +YM  G L   LR     +  +W   +++   +  A+ YL  +     +
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FI 122

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---APELAYTMVLTE 272
           HRD+++ N L+       V+DFG+AR +  D    T   GT   +    PE+      + 
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--TSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 273 KCDVYSFGVVALEV 286
           K DV+SFGV+  EV
Sbjct: 181 KSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 10/202 (4%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG VY+A+   +G+ VA+KK+          ++   E  LL ++ H NI+KL   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
             HK  ++L++++M    L+ +++  D    L  +   + +  +   L++ H      I+
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIK--DRQRGLPESLIKSYLYQLLQGLAFCHSH---GIL 120

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VLTEKC 274
           HRD+   N+L+N++    +ADFG+AR   S     T    T  Y APEL       +   
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180

Query: 275 DVYSFGVVALEVLMGR--HPGD 294
           D++S G +  E+L  R   PG 
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGK 202

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.2 bits (224), Expect = 1e-20
 Identities = 79/283 (27%), Positives = 111/283 (39%), Gaps = 67/283 (23%)

Query: 97  IGTGGYGSVYRAQLPSGKKV-ALKKLHHSET---------ELAFLESFQTEAHLLSQIRH 146
           +G G  GSV + +L +   + ALK +              EL   +S +           
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK----------S 58

Query: 147 RNIVKLYGFCLHKK-CMFLI-YKYMRRGSLFCILRNDDEAIRLDWTKRVN------IVKS 198
             IVK YG  L +      I  +Y   GSL  I +            R+       I +S
Sbjct: 59  PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK-----VKKRGGRIGEKVLGKIAES 113

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-RLLHSDSSNRTVVAGTH 257
           +   LSYLH      I+HRDI  +NILL  K +  + DFGV+  L++S +   T   GT 
Sbjct: 114 VLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTS 167

Query: 258 GYIAPE----LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL---- 309
            Y+APE      Y++      DV+S G+  LEV   R P        P +  I+LL    
Sbjct: 168 FYMAPERIQGKPYSI----TSDVWSLGLTLLEVAQNRFP--FPPEGEPPLGPIELLSYIV 221

Query: 310 DQRVPSPIDDQTV-------IQDIILVSKIVFACLRSKPTSRP 345
           +   P   D+           +D I        CL   PT RP
Sbjct: 222 NMPNPELKDEPGNGIKWSEEFKDFIKQ------CLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 43/234 (18%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLE----SFQTEAHLLSQ 143
           +DF     IG G + +V  A+   + K+ A+K L   +      E      + E  +L++
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL---DKRQLIKEKKVKYVKIEKEVLTR 57

Query: 144 I-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKS 198
           +  H  I+KLY     ++ ++ + +Y   G L   +R     D++  R            
Sbjct: 58  LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-------YAAE 110

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--------- 249
           +  AL YLH      I+HRD+   NILL+  +   + DFG A++L  +SS          
Sbjct: 111 ILLALEYLH-SK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167

Query: 250 -----------RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                           GT  Y++PEL       +  D+++ G +  ++L G+ P
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 88.5 bits (220), Expect = 4e-20
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 32/214 (14%)

Query: 97  IGTGGYGSVYRAQLPS-GKKVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYG 154
           I  G YG V+ A+  S G   A+K +  ++      ++   TE  +LSQ +   +VKLY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
               KK ++L+ +Y+  G L  +L N    D++  R         +  +  AL YLH + 
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-------IYIAEIVLALEYLHSN- 112

Query: 211 IPSIVHRDISSNNILLNS----KLEAFVADFGVARL----LHSDSSNRTV----VAGTHG 258
              I+HRD+  +NIL++S    KL     DFG++++       + ++       + GT  
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKL----TDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           YIAPE+      ++  D +S G +  E L+G  P
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.5 bits (219), Expect = 6e-20
 Identities = 68/232 (29%), Positives = 112/232 (48%), Gaps = 33/232 (14%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQL----PSGKK--VALKKLHHSETELAFLESFQTEAH 139
           +   D  +K  +G G +G V+ A+     P+  K  VA+K L   +  LA  + FQ EA 
Sbjct: 2   IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREAE 59

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDEAIRLD--------- 188
           LL+ ++H +IVK YG C     + ++++YM+ G L   LR    D  I +D         
Sbjct: 60  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119

Query: 189 --WTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
              ++ ++I   +A  + YL        VHRD+++ N L+ + L   + DFG++R ++S 
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176

Query: 247 SSNRTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHP 292
              R    G H      ++ PE       T + DV+SFGV+  E+   G+ P
Sbjct: 177 DYYRV---GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 87.4 bits (216), Expect = 8e-20
 Identities = 73/276 (26%), Positives = 130/276 (47%), Gaps = 28/276 (10%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   +   +G G +G V+        KVA+K L   +      E+F  EA ++ ++R
Sbjct: 3   IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLR 59

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H  +V LY   + ++ ++++ ++M +GSL   L+  D    L   + V++   +A  ++Y
Sbjct: 60  HDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAY 117

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPEL 264
           +      + +HRD+ + NIL+   L   +ADFG+ARL+  +  + R        + APE 
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174

Query: 265 AYTMVLTEKCDVYSFGVVALE-VLMGRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPID 318
           A     T K DV+SFG++  E V  GR P        P ++  ++L+Q     R+P P  
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVP-------YPGMVNREVLEQVERGYRMPCPQG 227

Query: 319 DQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
               + +++ +      C +  P  RP     Q FL
Sbjct: 228 CPESLHELMKL------CWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 87.7 bits (217), Expect = 1e-19
 Identities = 71/236 (30%), Positives = 117/236 (49%), Gaps = 30/236 (12%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ----LPSGKK--VALKKLHHSETELAFLESFQTEAH 139
           +   D  +K+ +G G +G V+ A+    LP   K  VA+K L  + +E A  + FQ EA 
Sbjct: 2   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQD-FQREAE 59

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND--DEAI----------RL 187
           LL+ ++H++IV+ YG C   + + ++++YMR G L   LR+   D  I          +L
Sbjct: 60  LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119

Query: 188 DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
              + + I   +A  + YL        VHRD+++ N L+   L   + DFG++R ++S  
Sbjct: 120 TLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176

Query: 248 SNRTVVAGTH----GYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSS 298
             R  V G       ++ PE       T + D++SFGVV  E+   G+ P   LS+
Sbjct: 177 YYR--VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 86.9 bits (215), Expect = 1e-19
 Identities = 63/199 (31%), Positives = 108/199 (54%), Gaps = 18/199 (9%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G+V + +  +G+KVA+K +    T  AFLE    E  +++++ H+N+V+L G  
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLE----ETAVMTKLHHKNLVRLLGVI 68

Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           LH   ++++ + M +G+L   LR    A+ +   + +     +A  + YL       +VH
Sbjct: 69  LHNG-LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 217 RDISSNNILLNSKLEAFVADFGVARL--LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           RD+++ NIL++    A V+DFG+AR+  +  D+S   V      + APE       + K 
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFSSKS 178

Query: 275 DVYSFGVVALEVL-MGRHP 292
           DV+S+GV+  EV   GR P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 87.2 bits (216), Expect = 1e-19
 Identities = 64/264 (24%), Positives = 126/264 (47%), Gaps = 30/264 (11%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKL----HHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +GTG + S Y+A+ + +G  +A+K++    + S  +   +E+ + E  L++++ H +I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIVKSMAHALSYLHC 208
           + G         L  ++M  GS+  +L       EA+ +++T+++         LSYLH 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYLHE 121

Query: 209 DCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSN----RTVVAGTHGYIAPE 263
           +    I+HRD+   N+L++S  +   +ADFG A  L +  +     +  + GT  ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ--T 321
           +         CDV+S G V +E+   + P +     N   ++  +        I +    
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238

Query: 322 VIQDIILVSKIVFACLRSKPTSRP 345
            ++D+ L       CL  +P  RP
Sbjct: 239 GLRDVTL------RCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 11/203 (5%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G V++A+   +G+ VALKK+     E         E   L   +H  +VKL   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
             H     L+ +YM    L  +LR+++  +     K    ++ +   ++Y+H +    I+
Sbjct: 68  FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMHAN---GIM 121

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVAGTHGYIAPELAY-TMVLTEK 273
           HRD+   N+L+++     +ADFG+ARL   +     +    T  Y APEL Y        
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181

Query: 274 CDVYSFGVVALEVLMGR--HPGD 294
            D+++ G +  E+L G    PG+
Sbjct: 182 VDLWAVGCIFAELLNGSPLFPGE 204

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 80/273 (29%), Positives = 120/273 (43%), Gaps = 37/273 (13%)

Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69

Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + L+ +Y+  GSL   L+   E  RLD  K +     +   + YL   
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLG-- 125

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---APELAY 266
                VHRD+++ NIL+ S+    + DFG+ ++L  D     V       I   APE   
Sbjct: 126 -SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 267 TMVLTEKCDVYSFGVVALEVL----MGRHPGDLLSSV------NPKIM--LIDLL--DQR 312
               +   DV+SFGVV  E+         P      +         I+  LI+LL  + R
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR 244

Query: 313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +P+P      I  I+        C  + P+ RP
Sbjct: 245 LPAPPGCPAEIYAIMK------ECWNNDPSQRP 271

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 40/281 (14%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG+G  G+VY+    P+G+  ALK ++ +  +         E  +L  + H N+VK +  
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHED-TVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
             H   + ++ ++M  GSL      D++ +        ++ + +   ++YLH      IV
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFL-------ADVARQILSGIAYLHRR---HIV 190

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHS--DSSNRTVVAGTHGYIAPE-----LAYTM 268
           HRDI  +N+L+NS     +ADFGV+R+L    D  N +V  GT  Y++PE     L +  
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHGA 248

Query: 269 VLTEKCDVYSFGVVALEVLMGRHP------GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
                 D++S GV  LE  +GR P      GD  S     +M    + Q   +P      
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS-----LMCAICMSQPPEAPATASRE 303

Query: 323 IQDIILVSKIVFACLRSKPTSRP--MQRVSQEFLVRKTLYQ 361
            +  I        CL+ +P  R   MQ +   F++R    Q
Sbjct: 304 FRHFISC------CLQREPAKRWSAMQLLQHPFILRAQPGQ 338

Length = 353

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 86.4 bits (214), Expect = 3e-19
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 29/213 (13%)

Query: 97  IGTGGYGSVYRAQL--PSGKK----VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY+ +L  P+ +     VA+K L     E    + F+ EA L+S ++H NIV
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHPNIV 71

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSL--FCILR---------NDDEAIR--LDWTKRVNIVK 197
            L G C  ++   ++++Y+  G L  F +           + DE ++  LD +  ++I  
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL        VHRD+++ N L+   L   ++DFG++R ++S    R  V    
Sbjct: 132 QIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR--VQSKS 186

Query: 258 ----GYIAPELAYTMVLTEKCDVYSFGVVALEV 286
                ++ PE       T + D++SFGVV  E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G YG V + +   +G+ VA+KK   SE +    ++   E  +L Q+RH NIV L   
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
              K  ++L+++Y+ R  L  +  +      +A+R         +  +  A++Y H    
Sbjct: 69  FRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS-------YIWQLLQAIAYCHSH-- 119

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVAGTHGYIAPELAYTMVL 270
            +I+HRDI   NIL++      + DFG AR L +  ++  T    T  Y APEL      
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 271 TEK-CDVYSFGVVALEVLMGR--HPGD 294
             K  DV++ G +  E+L G    PGD
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGD 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 86.0 bits (213), Expect = 4e-19
 Identities = 78/266 (29%), Positives = 132/266 (49%), Gaps = 21/266 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           ED +    +G G  GSV + + +P+G  +A KK+ H   + +  +    E  ++ + R  
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSP 63

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
            IV  YG  L++  + +  ++M  GSL  I +     I ++   +  I  ++   L+YL+
Sbjct: 64  YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGK--IAVAVVEGLTYLY 120

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
              +  I+HRDI  +NIL+NS+ +  + DFGV+  L +  ++  V  GT  Y++PE    
Sbjct: 121 N--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV--GTSTYMSPERIQG 176

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP-----GDLLSSVNPKIMLIDLLDQRV--PSP-IDD 319
              T K DV+S G+  +E+ +G+ P      D     +P + ++DLL Q V  P P +  
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP-MGILDLLQQIVQEPPPRLPS 235

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
               +D+      V ACL   PT RP
Sbjct: 236 SDFPEDLRD---FVDACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 85.3 bits (211), Expect = 5e-19
 Identities = 64/255 (25%), Positives = 123/255 (48%), Gaps = 26/255 (10%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +GTG +G V   +      VA+K +   S +E  F+E    EA ++ ++ H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLSHEKLVQLYGV 67

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           C  ++ ++++ +YM  G L   LR   +  R   ++ + + K +   ++YL        +
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFI 122

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVLTE 272
           HRD+++ N L++ +    V+DFG++R +  D    +V  G+     +  PE+      + 
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV--GSKFPVRWSPPEVLLYSKFSS 180

Query: 273 KCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP-IDDQTVIQDIILVS 330
           K DV++FGV+  EV  +G+ P +  +  N + +       R+  P +  + V        
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFN--NSETVEKVSQGLRLYRPHLASEKVYA------ 232

Query: 331 KIVFACLRSKPTSRP 345
            I+++C   K   RP
Sbjct: 233 -IMYSCWHEKAEERP 246

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 6e-19
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 15/222 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKK-VALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           +D +    +GTG +G V+  +    +   ALK +   E   L   +    E  +L ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             I++L+     ++ ++++ +Y+  G LF  LRN   + R   +  +     +  AL YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYL 117

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIAPELA 265
           H      IV+RD+   NILL+ +    + DFG A+ L     +RT  + GT  Y+APE+ 
Sbjct: 118 HSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----DRTWTLCGTPEYLAPEVI 170

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIML 305
            +    +  D ++ G++  E+L+G  P   D    +  KI+ 
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 61/230 (26%), Positives = 109/230 (47%), Gaps = 37/230 (16%)

Query: 87  ATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKK-LHHSETELAFLESFQTEAHLLSQI 144
              D++I   +G G +G VY+A Q+ +G+ VALKK L H+E +   + + + E  +L ++
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64

Query: 145 RHRNIVKLYGFCLH--------KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           +H N+V L    +         +  ++++  YM    L  +L N    ++L  ++    +
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYM 121

Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN------- 249
             +   ++YLH +    I+HRDI + NIL++++    +ADFG+AR       N       
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 250 ----RTVVAGTHGYIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGR 290
                T +  T  Y  PEL    +L E+      D++  G V  E+   R
Sbjct: 179 GTRKYTNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 69/221 (31%), Positives = 102/221 (46%), Gaps = 18/221 (8%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG VYRA+   SG+ VALKK+           S   E  LL  +RH NIV+L   
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 156 CL--HKKCMFLIYKYMRR--GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            +  H   +FL+ +Y  +   SL      D+       ++   ++  +   L YLH +  
Sbjct: 75  VVGKHLDSIFLVMEYCEQDLASLL-----DNMPTPFSESQVKCLMLQLLRGLQYLHENF- 128

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VL 270
             I+HRD+  +N+LL  K    +ADFG+AR     +   T    T  Y APEL       
Sbjct: 129 --IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186

Query: 271 TEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           T   D+++ G +  E+L  +   PG   S +    ++I LL
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLPGK--SEIEQLDLIIQLL 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.5 bits (210), Expect = 1e-18
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 21/209 (10%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQT---EAHLLSQIRHRNIVKL 152
           +G G Y  VY+A    +G+ VA+KK+   E + A      T   E  LL +++H NI+ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
                HK  + L++++M    L  +++  D++I L      + +      L YLH +   
Sbjct: 68  LDVFGHKSNINLVFEFME-TDLEKVIK--DKSIVLTPADIKSYMLMTLRGLEYLHSN--- 121

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL-----AYT 267
            I+HRD+  NN+L+ S     +ADFG+AR   S +   T    T  Y APEL      Y 
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYG 181

Query: 268 MVLTEKCDVYSFGVVALEVLMGRH--PGD 294
           +      D++S G +  E+L+     PGD
Sbjct: 182 V----GVDMWSVGCIFAELLLRVPFLPGD 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 70/263 (26%), Positives = 117/263 (44%), Gaps = 26/263 (9%)

Query: 97  IGTGGYGSVY--RAQLPSGKKVALKK--LHHSETELAFLESFQTEAHLLS-------QIR 145
           +G+G +G VY  R +      +ALK+  +H+        E  ++   ++S       Q+R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSL---FCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           H NIV+ Y   L    ++++   +    L   F  L+   +  R    +  NI   M  A
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQ--RFTEERIWNIFVQMVLA 125

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L YLH +    IVHRD++ NNI+L    +  + DFG+A+      S  T V GT  Y  P
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSCP 182

Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
           E+       EK DV++FG +  ++   + P     S N   +   +++  V  P+ +   
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNMLSLATKIVEA-VYEPLPEGMY 238

Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
            +D+  V     +CL     +RP
Sbjct: 239 SEDVTDVIT---SCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 74/270 (27%), Positives = 117/270 (43%), Gaps = 24/270 (8%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKK--LHHSETELA--FLESFQTEAHLLSQIRHRNIVKL 152
           +G G YG+VY      G+ +A+K+  L  S    A    E  Q E  LL  ++H NIV+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
            G CL    + +  +++  GS+  IL          + K     K +   ++YLH +C  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT------VVAGTHGYIAPELAY 266
            +VHRDI  NN++L       + DFG AR L     + T       + GT  ++APE+  
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
                 K D++S G    E+  G+ P   L+S++    +  +   R   P    +     
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238

Query: 327 ILVSKIVFACLRSKPTSRP--MQRVSQEFL 354
           I     V +CL      RP  +Q +  +FL
Sbjct: 239 I---DFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 78/277 (28%), Positives = 121/277 (43%), Gaps = 31/277 (11%)

Query: 97  IGTGGYGSVYRAQLP------SGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           +G+G +G VY           SG  +VA+K L    T+    E F  EAHL+S   H NI
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHPNI 61

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR----LDWTKRVNIVKSMAHALSY 205
           VKL G CL  +  ++I + M  G L   LR+          L   + ++I   +A    Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAF-----VADFGVARLLHSDSSNRTVVAGTHG-- 258
           L        +HRD+++ N L++ K         + DFG+AR ++     R    G     
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPI 317
           ++APE       T + DV+SFGV+  E+L +G+ P   L+  N +++       R+  P 
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHVTAGGRLQKPE 236

Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    I  ++        C    P+ RP     QE L
Sbjct: 237 NCPDKIYQLMTN------CWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 83.4 bits (206), Expect = 2e-18
 Identities = 65/253 (25%), Positives = 126/253 (49%), Gaps = 22/253 (8%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G+G +G V+  +  +  KVA+K ++  + +E  F+E    EA ++ ++ H  +V+LYG 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYGV 67

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           C  +K ++++ ++M  G L   LR     +  D    +++ + +   + YL  +   S +
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFI 122

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG-THGYIAPELAYTMVLTEKC 274
           HRD+++ N L++S     V+DFG+ R +  D    +  A     +  PE+      + K 
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 275 DVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSP-IDDQTVIQDIILVSKI 332
           DV+SFGV+  EV   G+ P +     N +++ +     R+  P +   TV        ++
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE--KKSNYEVVEMISRGFRLYRPKLASMTVY-------EV 233

Query: 333 VFACLRSKPTSRP 345
           +++C   KP  RP
Sbjct: 234 MYSCWHEKPEGRP 246

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 67/275 (24%), Positives = 131/275 (47%), Gaps = 42/275 (15%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKL--------HHSETELAFLESFQTEAHLLSQIRHR 147
           IG G YG VY A  + +G+ +A+K++         H   +   +++ ++E   L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHAL 203
           NIV+  GF   ++ + +  +Y+  GS+   LR     +++ +R          + +   L
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-------FFTEQVLEGL 121

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS----DSSNRTVVAGTHGY 259
           +YLH      I+HRD+ ++N+L+++     ++DFG+++   S    D+     + G+  +
Sbjct: 122 AYLHSK---GILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFW 176

Query: 260 IAPEL--AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPI 317
           +APE+  +Y+   + K D++S G V LE+  GR P     ++     +  L ++R   PI
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---MFKLGNKRSAPPI 233

Query: 318 DDQTVIQDIILVSKI----VFACLRSKPTSRPMQR 348
                +     +S +    + AC    P +RP  R
Sbjct: 234 PPDVSMN----LSPVALDFLNACFTINPDNRPTAR 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 82.4 bits (204), Expect = 4e-18
 Identities = 73/264 (27%), Positives = 109/264 (41%), Gaps = 35/264 (13%)

Query: 97  IGTGGYGSVYRAQL--PSGK--KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           +G G +G V R +     GK   VA+K L  S+     ++ F  EA ++  + H N+++L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLK-SDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEA---IRLDWTKRVNIVKSMAHALSYLHCD 209
           YG  L    M ++ +    GSL   LR D      I       V I   M     YL   
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR----YLE-- 114

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLL------HSDSSNRTVVAGTHGYIAPE 263
                +HRD+++ NILL S  +  + DFG+ R L      +    +  V      + APE
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWCAPE 170

Query: 264 LAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIM-LIDLLDQRVPSPIDDQT 321
              T   +   DV+ FGV   E+   G  P   LS    +I+  ID   +R+  P     
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEGERLERPEACPQ 228

Query: 322 VIQDIILVSKIVFACLRSKPTSRP 345
            I +++L       C    P  RP
Sbjct: 229 DIYNVML------QCWAHNPADRP 246

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 5e-18
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 27/199 (13%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR---HRNIVKL 152
           IG G YG+VY+A+ L +G+ VALKK+    +E     S   E  LL Q+    H NIV+L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 153 YGFCL-----HKKCMFLIYKYMRRGSLFCILRN------DDEAIRLDWTKRVNIVKSMAH 201
              C       +  + L+++++ +  L   L          E I+       ++++ +  
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-------DLMRQLLR 118

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
            + +LH   I   VHRD+   NIL+ S  +  +ADFG+AR+   + +  +VV  T  Y A
Sbjct: 119 GVDFLHSHRI---VHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-TLWYRA 174

Query: 262 PELAYTMVLTEKCDVYSFG 280
           PE+          D++S G
Sbjct: 175 PEVLLQSSYATPVDMWSVG 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 82.6 bits (205), Expect = 5e-18
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 27/214 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           +DF+    +GTG +G V   +   SGK  ALK L  ++  +L  +E    E  +L  IRH
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK--RVNIVKSMAHALS 204
             +V LYG       ++L+ +Y+  G LF  LR           +     +V     AL 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVL----ALE 115

Query: 205 YLH-CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIAP 262
           YLH  D    IV+RD+   N+LL+S     + DFG A+ +      RT  + GT  Y+AP
Sbjct: 116 YLHSLD----IVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYTLCGTPEYLAP 167

Query: 263 ELAYTMVLTEKC----DVYSFGVVALEVLMGRHP 292
           E    ++L++      D ++ G++  E+L G  P
Sbjct: 168 E----IILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.1 bits (203), Expect = 6e-18
 Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 27/257 (10%)

Query: 97  IGTGGYGS--VYR----AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G   +YR      L   K+V L +L   E   A       E  +LS ++H NI+
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA-----LNEIVILSLLQHPNII 62

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
             Y   +    + +  +Y   G+L+  +    +    +    +  +  +  A+SY+H   
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA- 120

Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL 270
              I+HRDI + NI L       + DFG++++L S+ S    V GT  Y++PEL   +  
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKY 178

Query: 271 TEKCDVYSFGVVALEVLMGRH--PGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
             K D+++ G V  E+L  +         ++  KI+      Q   +P+      + I L
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV------QGNYTPVVSVYSSELISL 232

Query: 329 VSKIVFACLRSKPTSRP 345
           V     + L+  P  RP
Sbjct: 233 VH----SLLQQDPEKRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.5 bits (202), Expect = 9e-18
 Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 19/203 (9%)

Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKL-HHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           +G GG+G V   ++    +  ALK +      E    E   +E  +L +  H  IVKLY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
               KK ++++ +Y   G L+ ILR   +    D       +  +  A  YLH      I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNR---GI 114

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK- 273
           ++RD+   N+LL+S     + DFG A+ L S     T   GT  Y+APE     ++  K 
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-GTPEYVAPE-----IILNKG 168

Query: 274 ----CDVYSFGVVALEVLMGRHP 292
                D +S G++  E+L GR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 30/228 (13%)

Query: 93  IKYCIGTGGYGSVYRAQL----PSGKK--VALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           +K  +G G +G V+ A+     P   K  VA+K L  +       + F  EA LL+ ++H
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQH 66

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR----------NDDEAIRLDWTKRVNIV 196
            +IVK YG C+    + ++++YM+ G L   LR            +    L  ++ ++I 
Sbjct: 67  EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL        VHRD+++ N L+   L   + DFG++R ++S    R    G 
Sbjct: 127 QQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV---GG 180

Query: 257 HG-----YIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSS 298
           H      ++ PE       T + DV+S GVV  E+   G+ P   LS+
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 29/243 (11%)

Query: 97  IGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +G V   +       +G++VA+K L+HS  E      F+ E  +L  + H NIVK
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS-GEEQHRSDFEREIEILRTLDHENIVK 70

Query: 152 LYGFC--LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C     + + LI +Y+  GSL   L+   +  +++  + +     +   + YL   
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ 128

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---APELAY 266
                +HRD+++ NIL+ S+    ++DFG+A++L  D     V       I   APE   
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 267 TMVLTEKCDVYSFGVVALEVL-MGRH----PGDLLSSVNPKIM------LIDLLD--QRV 313
           T   +   DV+SFGV   E+   G      P + L  +           L++LL   +R+
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL 245

Query: 314 PSP 316
           P P
Sbjct: 246 PRP 248

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 11/212 (5%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRA--QLPSGKKVALK-KLHHSETELAFLESFQTEAHLLS 142
           +  ED  +  CIG G +G VY+     P  +K+A+  K   + T  +  E F  EA+++ 
Sbjct: 3   IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62

Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H +IVKL G       ++++ +    G L   L+ +     LD    +     ++ A
Sbjct: 63  QFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTA 119

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVAGTHGYIA 261
           L+YL        VHRDI++ N+L++S     + DFG++R L  +S  + +       ++A
Sbjct: 120 LAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHP 292
           PE       T   DV+ FGV   E+LM G  P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 14/213 (6%)

Query: 85  IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAH 139
           IV+  D   KY     IG G  G+VY A  + +G++VA+K+++  +      E    E  
Sbjct: 11  IVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEIL 68

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           ++ + +H NIV      L    ++++ +Y+  GSL  ++        +D  +   + +  
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 124

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
             AL +LH +    ++HRDI S+NILL       + DFG    +  + S R+ + GT  +
Sbjct: 125 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +APE+        K D++S G++A+E++ G  P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 16/208 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLH---HSETELAFLESFQTEAHLLSQI 144
              D    IG G  G V  A    +G++VA+KK+        EL F      E  ++   
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-----NEVVIMRDY 73

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           +H NIV++Y   L    ++++ +++  G+L  I+       R++  +   +  ++  ALS
Sbjct: 74  QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALS 129

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           +LH      ++HRDI S++ILL S     ++DFG    +  +   R  + GT  ++APE+
Sbjct: 130 FLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEV 186

Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
              +    + D++S G++ +E++ G  P
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 80.5 bits (198), Expect = 4e-17
 Identities = 70/270 (25%), Positives = 127/270 (47%), Gaps = 27/270 (10%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G  G V  A +  SG++VA+K +        EL F      E  ++   +H+N+V++
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQHQNVVEM 83

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y   L  + ++++ ++++ G+L  I+       RL+  +   + +S+  AL YLH     
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ--- 136

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI S++ILL       ++DFG    +  D   R  + GT  ++APE+        
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196

Query: 273 KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI 332
           + D++S G++ +E++ G  P     S +P   +  L D   P        +++   +S +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPP---YFSDSPVQAMKRLRDSPPPK-------LKNAHKISPV 246

Query: 333 VFACLRSKPTSRPMQRVS-QEFLVRKTLYQ 361
           +   L    T  P +R + QE L    L Q
Sbjct: 247 LRDFLERMLTREPQERATAQELLDHPFLLQ 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 31/195 (15%)

Query: 91  FDIKYCIGTGGYGSVYRAQL---PSGKKVALKKLHHSETELA-FLESFQTEAHLLSQIRH 146
           ++I+ CIG G YG VY+A+      GK+ A+KK    + +     +S   E  LL +++H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 147 RNIVKLYGFCLHK--KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV--NIVKSMA-- 200
            N+V L    L    K ++L++ Y     L+ I++   +A R      +  ++VKS+   
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKR----VSIPPSMVKSLLWQ 116

Query: 201 --HALSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSD-----SSN 249
             + + YLH +    ++HRD+   NIL+  +        + D G+ARL ++        +
Sbjct: 117 ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173

Query: 250 RTVVAGTHGYIAPEL 264
             VV  T  Y APEL
Sbjct: 174 PVVV--TIWYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 79.9 bits (197), Expect = 5e-17
 Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 27/261 (10%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G YGSVY+    P+G  +A+K++   E + +       E  +L +     IV  YG 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
              +  +++  +YM  GSL  +         +       I  ++   L +L  +   +I+
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNII 125

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE----------LA 265
           HRD+   N+L+N   +  + DFGV+  L +  +   +  G   Y+APE            
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--GCQSYMAPERIKSGGPNQNPT 183

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS-PIDDQTVIQ 324
           YT+    + DV+S G+  LE+ +GR+P    +  N    L  ++D   P+ P       Q
Sbjct: 184 YTV----QSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ 239

Query: 325 DIILVSKIVFACLRSKPTSRP 345
           D   V+K    CL   P  RP
Sbjct: 240 D--FVAK----CLNKIPNRRP 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 79.2 bits (195), Expect = 6e-17
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH---SETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G +G V+       +KVA+K +     SE      E F  EA ++ ++ H  +V+LY
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE------EDFIEEAQVMMKLSHPKLVQLY 65

Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
           G C  +  + L++++M  G L   LR   +  +      + +   +   ++YL       
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN--- 120

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVL 270
           ++HRD+++ N L+       V+DFG+ R +  D    T   GT     + +PE+      
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSFSKY 178

Query: 271 TEKCDVYSFGVVALEVLM-GRHPGD 294
           + K DV+SFGV+  EV   G+ P +
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 79.3 bits (195), Expect = 7e-17
 Identities = 66/240 (27%), Positives = 113/240 (47%), Gaps = 27/240 (11%)

Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRN 148
           F++   +G G YG VY+ + + +G+  A+K +  +E E    E  + E ++L +   HRN
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKKYSHHRN 74

Query: 149 IVKLYGFCL------HKKCMFLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAH 201
           I   YG  +      H   ++L+ ++   GS+  +++N    A++ DW     I + +  
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREILR 132

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
            L++LH      ++HRDI   N+LL    E  + DFGV+  L      R    GT  ++A
Sbjct: 133 GLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 189

Query: 262 PELAYT-----MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
           PE+             + D++S G+ A+E+  G  P   L  ++P  M    L  R P P
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP---LCDMHP--MRALFLIPRNPPP 244

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 79.0 bits (195), Expect = 7e-17
 Identities = 69/258 (26%), Positives = 121/258 (46%), Gaps = 27/258 (10%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKK---LHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           +G+G +GSVY    L  G   A+K+       +T    ++  + E  LLS+++H NIV+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYLHC 208
            G    +  +++  + +  GSL  +L+      +  IRL +T++  I+      L YLH 
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL-YTRQ--ILL----GLEYLHD 120

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYT 267
               + VHRDI   NIL+++     +ADFG+A+ +   S  ++   G+  ++APE +A  
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK-GSPYWMAPEVIAQQ 176

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
                  D++S G   LE+  G+ P    S +     +  +   +   PI D    +   
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP---WSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233

Query: 328 LVSKIVFACLRSKPTSRP 345
            + K    CL+  P+ RP
Sbjct: 234 FILK----CLQRDPSLRP 247

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.0 bits (194), Expect = 1e-16
 Identities = 57/213 (26%), Positives = 107/213 (50%), Gaps = 14/213 (6%)

Query: 85  IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAH 139
           IV+  D   KY     IG G  G+V+ A  + +G++VA+K+++  +      E    E  
Sbjct: 11  IVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK--ELIINEIL 68

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           ++ ++++ NIV      L    +F++ +Y+  GSL  ++        +D  +   + +  
Sbjct: 69  VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCREC 124

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
             AL +LH +    ++HRDI S+N+LL       + DFG    +  + S R+ + GT  +
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +APE+        K D++S G++A+E++ G  P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 64/191 (33%), Positives = 98/191 (51%), Gaps = 28/191 (14%)

Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           FDI   IG G YG VY+A+   +G+ VALKK+     +  F  +   E  +L Q+ HRNI
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 150 VKLY----------GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR--VNIVK 197
           V L            F   K   +L+++YM    L  +L    E+  + +++    + +K
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL----ESGLVHFSEDHIKSFMK 123

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTVV 253
            +   L+Y H     + +HRDI  +NILLN+K +  +ADFG+ARL +S+ S    N+ + 
Sbjct: 124 QLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179

Query: 254 AGTHGYIAPEL 264
             T  Y  PEL
Sbjct: 180 --TLWYRPPEL 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 78.3 bits (193), Expect = 1e-16
 Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 19/260 (7%)

Query: 90  DFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           DF +   +G G YGSVY+ +  S  +  ALK++          E    E  +L+ + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV-NIVKSMAHALSYLH 207
           I+      L    + ++ +Y   G L   +    +  +L   + +  I   +   L  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+ S NILL +     + D G++++L  + + +T + GT  Y+APE+   
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA-KTQI-GTPHYMAPEVWKG 175

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD 325
              + K D++S G +  E+     P     +  +  K+        R   P       QD
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-------RGKYPPIPPIYSQD 228

Query: 326 IILVSKIVFACLRSKPTSRP 345
           +      + + L+ KP  RP
Sbjct: 229 L---QNFIRSMLQVKPKLRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 77.7 bits (191), Expect = 2e-16
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 28/215 (13%)

Query: 91  FDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           ++I   IG G +G +Y A+  S  +   +K++  ++  +   E+ + E  LL++++H NI
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 150 VKLYGFCLHKKCMFLIYKY-----------MRRGSLFCILRNDDEAIRLDWTKRVNIVKS 198
           V  +        +F++ +Y            +RG LF       E   L W  ++++   
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF------SEDQILSWFVQISL--- 112

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRTVVAGTH 257
               L ++H      I+HRDI S NI L+   + A + DFG+AR L+          GT 
Sbjct: 113 ---GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166

Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
            Y++PE+        K D++S G V  E+   +HP
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 14/213 (6%)

Query: 85  IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAH 139
           IV+  D   KY     IG G  G+VY A  + +G++VA+K+++  +      E    E  
Sbjct: 11  IVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK--ELIINEIL 68

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           ++ + ++ NIV      L    ++++ +Y+  GSL  ++        +D  +   + +  
Sbjct: 69  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 124

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
             AL +LH +    ++HRDI S+NILL       + DFG    +  + S R+ + GT  +
Sbjct: 125 LQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +APE+        K D++S G++A+E++ G  P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 96  CIGTGGYGSVYRA-QLPSGKKVALKKLH------HSETELAFLESFQTEAHLLSQIRHRN 148
            +G G +G VY    + +G+++A+K++        ++ E+  LE    E  LL  ++H  
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC---EIQLLKNLQHER 65

Query: 149 IVKLYGFCLHKKCMFLIY-KYMRRGSLFCILRND---DEAIRLDWTKRVNIVKSMAHALS 204
           IV+ YG CL       I+ +YM  GS+   L+      E +   +T+++         + 
Sbjct: 66  IVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVE 118

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL---HSDSSNRTVVAGTHGYIA 261
           YLH +    IVHRDI   NIL +S     + DFG ++ L    S  +    V GT  +++
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+        K DV+S G   +E+L  + P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 72/270 (26%), Positives = 116/270 (42%), Gaps = 25/270 (9%)

Query: 91  FDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           F +   +G G +GSV  AQL     S +KVA+K L       + +E F  EA  + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 147 RNIVKLYGFCLHKKCM------FLIYKYMRRGSLFCIL---RNDDEAIRLDWTKRVNIVK 197
            N++KL G  L  +         +I  +M+ G L   L   R  +E   L     V  + 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL      + +HRD+++ N +LN  +   VADFG+++ ++S    R   A   
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 258 --GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS 315
              ++A E     V T   DV++FGV   E+ M R         N +I    +   R+  
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEI-MTRGQTPYAGVENSEIYNYLIKGNRLKQ 236

Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           P D    + +++        C   +P  RP
Sbjct: 237 PPDCLEDVYELM------CQCWSPEPKCRP 260

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 17/204 (8%)

Query: 97  IGTGGYGSVYRAQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G G +GSV   QL       KVA+K +  +    + +E F +EA  + +  H N+++L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 154 GFCLHKK------CMFLIYKYMRRGSLFCIL---RNDDEAIRLDWTKRVNIVKSMAHALS 204
           G CL            +I  +M+ G L   L   R  D    L     V  +  +A  + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAP 262
           YL      S +HRD+++ N +LN  +   VADFG+++ +++    R   +      +IA 
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 263 ELAYTMVLTEKCDVYSFGVVALEV 286
           E     V T K DV+SFGV   E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.8 bits (189), Expect = 4e-16
 Identities = 54/193 (27%), Positives = 97/193 (50%), Gaps = 7/193 (3%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G +G V+   +    K V +K++   +       + Q E  +L  + H NI++ Y  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
            L  K + ++ +Y   G+L   ++    ++ LD    ++    +  AL ++H      I+
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTK---LIL 123

Query: 216 HRDISSNNILLNS-KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           HRD+ + NILL+  K+   + DFG++++L S S   TVV GT  YI+PEL       +K 
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPCYISPELCEGKPYNQKS 182

Query: 275 DVYSFGVVALEVL 287
           D+++ G V  E+ 
Sbjct: 183 DIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 64/241 (26%)

Query: 97  IGTGGYGSVYRAQ------LPSGKKVALKKLHH--SETEL-AFLESFQTEAHLLSQIRHR 147
           +G G +G V +A             VA+K L    S +EL   L  F     LL Q+ H 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN----LLKQVNHP 63

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR----------------------NDDE-- 183
           +++KLYG C     + LI +Y + GSL   LR                      N DE  
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 184 -----AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG 238
                 I   W     I + M + L+ +       +VHRD+++ N+L+    +  ++DFG
Sbjct: 124 LTMGDLISFAW----QISRGMQY-LAEM------KLVHRDLAARNVLVAEGRKMKISDFG 172

Query: 239 VARLLHSD------SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRH 291
           ++R ++ +      S  R  V     ++A E  +  + T + DV+SFGV+  E++ +G +
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228

Query: 292 P 292
           P
Sbjct: 229 P 229

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 76.7 bits (188), Expect = 6e-16
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 27/240 (11%)

Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRN 148
           F++   +G G YG VY+ + + +G+  A+K +  +  E    E  + E ++L +   HRN
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 64

Query: 149 IVKLYGFCLHKKC------MFLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAH 201
           I   YG  + K        ++L+ ++   GS+  +++N     ++ +W     I + +  
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILR 122

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
            LS+LH      ++HRDI   N+LL    E  + DFGV+  L      R    GT  ++A
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179

Query: 262 PELAYT-----MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
           PE+             K D++S G+ A+E+  G  P   L  ++P   L   L  R P+P
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LCDMHPMRAL--FLIPRNPAP 234

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 72/243 (29%), Positives = 112/243 (46%), Gaps = 26/243 (10%)

Query: 88  TEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLSQI- 144
           T+ ++I   IG G YG VY+      G   A+K L   S+ +    E  + E ++L  + 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEAEYNILQSLP 76

Query: 145 RHRNIVKLYG-FCLHKKC----MFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKS 198
            H N+VK YG F    K     ++L+ +    GS+  +++       RLD      I+  
Sbjct: 77  NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
               L +LH +    I+HRD+  NNILL ++    + DFGV+  L S    R    GT  
Sbjct: 137 ALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 193

Query: 259 YIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV 313
           ++APE+      Y      +CDV+S G+ A+E+  G  P   L  ++P   L  +   R 
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP---LFDMHPVKTLFKI--PRN 248

Query: 314 PSP 316
           P P
Sbjct: 249 PPP 251

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.2 bits (187), Expect = 7e-16
 Identities = 68/261 (26%), Positives = 118/261 (45%), Gaps = 34/261 (13%)

Query: 97  IGTGGYGSVYRAQLPSGKK-VALKKLHHS---ETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G V+  +L +    VA+K    +   + +  FL+    EA +L Q  H NIV+L
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ----EARILKQYSHPNIVRL 58

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
            G C  K+ ++++ + ++ G     LR   E  RL   + + +V++ A  + YL      
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH-- 114

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-------YIAPELA 265
             +HRD+++ N L+  K    ++DFG++R          V A T G       + APE  
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEAL 168

Query: 266 YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
                + + DV+SFG++  E   +G  P   LS+   +    + ++Q V  P  +     
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR----EAIEQGVRLPCPELCPDA 224

Query: 325 DIILVSKIVFACLRSKPTSRP 345
               V +++  C    P  RP
Sbjct: 225 ----VYRLMERCWEYDPGQRP 241

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 76.7 bits (188), Expect = 8e-16
 Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 14/213 (6%)

Query: 85  IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAH 139
           IV+  D   KY     IG G  G+VY A  + +G++VA+++++  +      E    E  
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEIL 69

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           ++ + ++ NIV      L    ++++ +Y+  GSL  ++        +D  +   + +  
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 125

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
             AL +LH +    ++HRDI S+NILL       + DFG    +  + S R+ + GT  +
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +APE+        K D++S G++A+E++ G  P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 29/234 (12%)

Query: 97  IGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G+G +G+VY+   +P G+ V    A+K L+ +    A +E F  EA +++ + H ++V+
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 73

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI----RLDWTKRVNIVKSMAHALSYLH 207
           L G CL    + L+ + M  G L   +    + I     L+W   V I K M +      
Sbjct: 74  LLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQIAKGMMYLEER-- 128

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYIAPELA 265
                 +VHRD+++ N+L+ S     + DFG+ARLL  D        G     ++A E  
Sbjct: 129 -----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 266 YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLD--QRVPSP 316
           +    T + DV+S+GV   E++  G  P D +    P   + DLL+  +R+P P
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI----PTREIPDLLEKGERLPQP 233

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 56/200 (28%), Positives = 101/200 (50%), Gaps = 16/200 (8%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G  G V  A +  +GK+VA+KK+        EL F      E  ++    H N+V +
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDYHHENVVDM 84

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y   L    ++++ +++  G+L  I+ +     R++  +   +  S+  ALSYLH     
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ--- 137

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI S++ILL S     ++DFG    +  +   R  + GT  ++APE+   +    
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197

Query: 273 KCDVYSFGVVALEVLMGRHP 292
           + D++S G++ +E++ G  P
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 25/211 (11%)

Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKL----HHSETELAFLESFQTEAHLLSQIRH 146
           +G G +G V  A      +  +  KVA+K L    H SE E A +   +  +HL +   H
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE-ALMSELKIMSHLGN---H 98

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIV L G C     + +I +Y   G L   LR   E+  L     ++    +A  +++L
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL 157

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAP 262
                 + +HRD+++ N+LL       + DFG+AR + +DS+   VV G       ++AP
Sbjct: 158 ASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN--YVVKGNARLPVKWMAP 212

Query: 263 ELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           E  +  V T + DV+S+G++  E+  +G +P
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 67/227 (29%), Positives = 108/227 (47%), Gaps = 39/227 (17%)

Query: 92  DIKYC--IGTGGYGSVYRAQLP---SGKK---VALKKLHHSETELAFLESFQTEAHLLSQ 143
           +I+Y   IG G +G V++A+ P     +    VA+K L   E        FQ EA L+++
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAE 64

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-----------NDDEAIR------ 186
             H NIVKL G C   K M L+++YM  G L   LR           +   + R      
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 187 --LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
             L  T+++ I K +A  ++YL        VHRD+++ N L+   +   +ADFG++R ++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 245 SD-----SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEV 286
           S      S N  +      ++ PE  +    T + DV+++GVV  E+
Sbjct: 182 SADYYKASENDAIPI---RWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 25/215 (11%)

Query: 97  IGTGGYGSVYRAQL----PSGKKVALKKLH---HSETELAFLESFQTEAHLLSQIRHRNI 149
           +G G +GSV   QL     S  KVA+K +    H+ +E+   E F +EA  +    H N+
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI---EEFLSEAACMKDFDHPNV 63

Query: 150 VKLYGFCLHKKCM------FLIYKYMRRGSLFCIL---RNDDEAIRLDWTKRVNIVKSMA 200
           +KL G C     +       +I  +M+ G L   L   R      +L     +  +  +A
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--G 258
             + YL      + +HRD+++ N +L   +   VADFG+++ ++S    R          
Sbjct: 124 LGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           +IA E     V T K DV++FGV   E+   G+ P
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 16/200 (8%)

Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G  G V  A +  SGK VA+KK+        EL F      E  ++   +H N+V++
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 82

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y   L    ++++ +++  G+L  I+ +     R++  +   +  ++  ALS LH     
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ--- 135

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI S++ILL       ++DFG    +  +   R  + GT  ++APEL   +    
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195

Query: 273 KCDVYSFGVVALEVLMGRHP 292
           + D++S G++ +E++ G  P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 97  IGTGGYGSVYR---AQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY      +  G+   +VA+K ++ + +    +E F  EA ++ +    ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVV 72

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN---DDEAIRL----DWTKRVNIVKSMAHAL 203
           +L G     +   ++ + M +G L   LR+   + E           K + +   +A  +
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG----- 258
           +YL        VHRD+++ N ++   L   + DFG+ R ++     R    G  G     
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK---GGKGLLPVR 186

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVL 287
           ++APE     V T K DV+SFGVV  E+ 
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 16/204 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALK--KLHHSETELAFLESFQTEAHLLSQIR 145
           EDF++   IG+G YG VY+A+ + +G+  A+K  KL   E         Q E  ++   +
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED----FAVVQQEIIMMKDCK 64

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H NIV  +G  L +  +++  ++   GSL  I         L  ++   + +     L Y
Sbjct: 65  HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYY 121

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           LH       +HRDI   NILL       +ADFGV+  + +  + R    GT  ++APE+A
Sbjct: 122 LHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178

Query: 266 YTMV---LTEKCDVYSFGVVALEV 286
                    + CD+++ G+ A+E+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 14/208 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           ++++    I  G YG VYRA+   +G+ VALKKL   + +  F  +   E ++L +++H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 148 NIVKL----YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           NIV +     G  L K  ++++ +Y+    L  ++    +       K   ++  +   +
Sbjct: 65  NIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEVK--CLMLQLLSGV 119

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           ++LH +    I+HRD+ ++N+LLN++    + DFG+AR   S     T +  T  Y APE
Sbjct: 120 AHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176

Query: 264 LAY-TMVLTEKCDVYSFGVVALEVLMGR 290
           L       +   D++S G +  E+L  +
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.9 bits (181), Expect = 5e-15
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 16/204 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALK--KLHHSETELAFLESFQTEAHLLSQIR 145
            D+++   +G+G YG VY+A+ L +G+  A+K  KL   +         Q E  ++ + +
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD----FSLIQQEIFMVKECK 64

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H NIV  +G  L ++ +++  +Y   GSL  I         L   +   + +     L+Y
Sbjct: 65  HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAY 121

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           LH       +HRDI   NILL    +  +ADFGVA  + +  + R    GT  ++APE+A
Sbjct: 122 LHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178

Query: 266 YTMV---LTEKCDVYSFGVVALEV 286
                    + CD+++ G+ A+E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 32/218 (14%)

Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHS---ETELAFLESFQTEAHLLSQIRHR 147
           +G G +G VY              +VA+K L  S   + E  FL     EA ++S+  H+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL----MEALIMSKFNHQ 69

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR----NDDEAIRLDWTKRVNIVKSMAHAL 203
           NIV+L G    +   F++ + M  G L   LR      +    L     +   + +A   
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLE---AFVADFGVARLLHSDSSNRTVVAGTHG-- 258
            YL  +     +HRDI++ N LL  K     A +ADFG+AR ++  S  R    G     
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK---GGRAML 183

Query: 259 ---YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
              ++ PE     + T K DV+SFGV+  E+  +G  P
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 75/284 (26%), Positives = 132/284 (46%), Gaps = 36/284 (12%)

Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKK----VALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+K    VA+K+L  + +  A  E    EA+
Sbjct: 3   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 61

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 118

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL +D        G    
Sbjct: 119 AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175

Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLD--QRVP 314
            ++A E     + T + DV+S+GV   E++  G  P D +    P   +  +L+  +R+P
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILEKGERLP 231

Query: 315 SP----IDDQTVIQDIILVSKIVFACLRSKPTSRPMQR-VSQEF 353
            P    ID          V  I+  C      SRP  R +  EF
Sbjct: 232 QPPICTID----------VYMIMVKCWMIDADSRPKFRELIIEF 265

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 23/204 (11%)

Query: 97  IGTGGYGSV-YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G+G YG+V       +G KVA+KKL+       F +    E  LL  ++H N++ L   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 156 CLHKKCM------FLIYKYMRR--GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                 +      +L+  +M    G L    +  ++ I+        +V  M   L Y+H
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYIH 135

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+   N+ +N   E  + DFG+AR   +DS     V  T  Y APE+   
Sbjct: 136 A---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV-TRWYRAPEVILN 189

Query: 268 -MVLTEKCDVYSFGVVALEVLMGR 290
            M  T+  D++S G +  E+L G+
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 9/205 (4%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +DF+    +G G  G V +    PSG  +A +KL H E + A       E  +L +    
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMA-RKLIHLEIKPAIRNQIIRELKVLHECNSP 59

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
            IV  YG       + +  ++M  GSL  +L+   +A R+       I  ++   L+YL 
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLR 116

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++PE    
Sbjct: 117 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQG 172

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T + D++S G+  +E+ +GR+P
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 75.6 bits (186), Expect = 8e-15
 Identities = 68/255 (26%), Positives = 110/255 (43%), Gaps = 35/255 (13%)

Query: 91  FDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLES-FQTEAHLLSQIRHRN 148
           +DI   IG GG G VY A  P   ++VALKK+    +E   L+  F  EA + + + H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           IV +Y  C     ++    Y+   +L  +L++  +   L  +K +    S+   LS  H 
Sbjct: 64  IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHK 121

Query: 209 DC-----IPS--IVHRDISSNNILLNSKLEAFVADFGVA---------------RLLHSD 246
            C     + S  ++HRD+  +NILL    E  + D+G A                  +  
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 247 SSNRTV---VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI 303
            S+ T+   + GT  Y+APE    +  +E  D+Y+ GV+  ++L    P         KI
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP--YRRKKGRKI 239

Query: 304 MLIDLLDQRVPSPID 318
                    + SPI+
Sbjct: 240 S----YRDVILSPIE 250

Length = 932

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 74.1 bits (182), Expect = 9e-15
 Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 38/225 (16%)

Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHS----ETELAFLESFQTEAHLLSQ 143
           +DFD+K  +G G +G V    +  +G   A+K +  S    +  ++F   F+ E  +LS 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSF---FEEERDILSI 57

Query: 144 IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRN-----DDEAIRLDWTKRVNIVK 197
                I +L Y F   K  ++L+ +Y   G L  +L       D++  +    + V  + 
Sbjct: 58  SNSPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA--- 254
           S+ H + Y         VHRDI   N+L++      +ADFG A  L   ++N+ V +   
Sbjct: 117 SV-HQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARL---TANKMVNSKLP 163

Query: 255 -GTHGYIAPELAYTMVLTEK------CDVYSFGVVALEVLMGRHP 292
            GT  YIAPE+  TM    K      CD +S GV+A E++ GR P
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.3 bits (181), Expect = 9e-15
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 48/217 (22%)

Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT-----EAHLLSQI-RHRN 148
            +G G +GSVY A+   +G+ VA+KK+           S++      E   L ++  H N
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKK------FYSWEECMNLREVKSLRKLNEHPN 59

Query: 149 IVKLYGFCLHKKCMFLIYKYM----------RRGSLFCILRNDDEAIRLDWTKRVNIVKS 198
           IVKL         ++ +++YM          R+G  F      +  IR       +I+  
Sbjct: 60  IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPF-----SESVIR-------SIIYQ 107

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           +   L+++H        HRD+   N+L++      +ADFG+AR + S     T    T  
Sbjct: 108 ILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS-RPPYTDYVSTRW 163

Query: 259 YIAPELAYTMVLTEKC-----DVYSFGVVALEVLMGR 290
           Y APE+    +L         D+++ G +  E+   R
Sbjct: 164 YRAPEI----LLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 14/224 (6%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G G +G VY+A+      +A  K+  +++E   LE +  E  +L+   H  IVKL G  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
                ++++ ++   G++  I+   D  +     +   I + M  AL YLH      I+H
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ--VICRQMLEALQYLHSM---KIIH 133

Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE---- 272
           RD+ + N+LL    +  +ADFGV+         R    GT  ++APE+     + +    
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193

Query: 273 -KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS 315
            K D++S G+  +E+     P   L   NP  +L+ +     P+
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHEL---NPMRVLLKIAKSEPPT 234

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 7/204 (3%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           +DF+    +G G  G V + Q      +  +KL H E + A       E  +L +     
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           IV  YG       + +  ++M  GSL  +L+   EA R+       +  ++   L+YL  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLRE 121

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
                I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++PE     
Sbjct: 122 K--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT 177

Query: 269 VLTEKCDVYSFGVVALEVLMGRHP 292
             + + D++S G+  +E+ +GR+P
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 60/205 (29%), Positives = 91/205 (44%), Gaps = 26/205 (12%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G+G YGSV  A    +G+KVA+KKL        F +    E  LL  ++H N++ L   
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 156 CLHKKCM------FLIYKYMRRGSLFCILRNDDEAIR---LDWTKRVNIVKSMAHALSYL 206
                        +L+  YM+          D + I    L   K   +V  M   L Y+
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQ---------TDLQKIMGHPLSEDKVQYLVYQMLCGLKYI 133

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      I+HRD+   N+ +N   E  + DFG+AR  H+D+     V  T  Y APE+  
Sbjct: 134 HS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV-TRWYRAPEVIL 187

Query: 267 T-MVLTEKCDVYSFGVVALEVLMGR 290
             M   +  D++S G +  E+L G+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 53/224 (23%), Positives = 99/224 (44%), Gaps = 31/224 (13%)

Query: 78  RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLP----SGKK--VALKKLHHSETELAFL 131
           R   QE+            +G G +G V+ A+       G +  V +K L  ++ E    
Sbjct: 4   RSNLQEITT----------LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS 53

Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR----- 186
           E F+ E  +  ++ H+N+V+L G C   +  ++I +Y   G L   LR            
Sbjct: 54  E-FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP 112

Query: 187 -LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
            L   ++V +   +A  + +L        VHRD+++ N L++S+ E  V+   +++ +++
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169

Query: 246 DSS---NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEV 286
                    ++     ++APE       + K DV+SFGV+  EV
Sbjct: 170 SEYYKLRNALIPLR--WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 6/197 (3%)

Query: 97  IGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G YG V   +  + GK+  +KKL+         ++ + EA LLSQ++H NIV     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 156 CLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
              +  + +++  +   G L+  L+     +  +  + V     +A AL YLH      I
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHEK---HI 123

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           +HRD+ + N+ L       V D G+AR+L +     + + GT  Y++PEL        K 
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKS 183

Query: 275 DVYSFGVVALEVLMGRH 291
           DV++ G    E+   +H
Sbjct: 184 DVWALGCCVYEMATLKH 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 69/239 (28%), Positives = 108/239 (45%), Gaps = 36/239 (15%)

Query: 97  IGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L    G+K+  A+K L+   T+L  +E F  E  ++    H N++ L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 153 YGFCLHKKCMFLI-YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM-------AHALS 204
            G CL  +   L+   YM+ G L   +R++              VK +       A  + 
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGME 112

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----Y 259
           YL        VHRD+++ N +L+      VADFG+AR ++ D    +V   T       +
Sbjct: 113 YLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIY-DKEYYSVHNHTGAKLPVKW 168

Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPSP 316
           +A E   T   T K DV+SFGV+  E++  G  P      V+   + + LL  +R+  P
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVDSFDITVYLLQGRRLLQP 224

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 53/281 (18%)

Query: 97  IGTGGYGSVYRAQ---LPSGKK---VALKKLHHSETELAFLESFQTEAHLLSQI-RHRNI 149
           +G G +G V +A+   L +  +   VA+K L    TE    +   +E  ++  I +H+NI
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHKNI 78

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILR-----------NDDEAIRLDWTKR--VNIV 196
           + L G C  +  ++++ +Y   G+L   LR           +D        T++  V+  
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 197 KSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS-DSSNRTVVA 254
             +A  + +L    CI    HRD+++ N+L+       +ADFG+AR +H  D   +T   
Sbjct: 139 YQVARGMEFLASKKCI----HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT--- 191

Query: 255 GTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI---MLI 306
            T+G     ++APE  +  V T + DV+SFGV+  E+        L  S  P I    L 
Sbjct: 192 -TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGSPYPGIPVEELF 244

Query: 307 DLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            LL +  R+  P   Q   Q+   +  ++  C    P+ RP
Sbjct: 245 KLLKEGYRMEKP---QNCTQE---LYHLMRDCWHEVPSQRP 279

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 70/279 (25%), Positives = 118/279 (42%), Gaps = 42/279 (15%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G YG V + +   +G+ VA+KK   SE +    +    E  +L Q+RH N+V L   
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIR--LDWTKRVNIVKSMAHALSYLHCDCIPS 213
              KK ++L+++++    L     +D E     LD ++    +  +   + + H     +
Sbjct: 69  FRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHN 120

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           I+HRDI   NIL++      + DFG AR L +     T    T  Y APEL   +V   K
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL---LVGDTK 177

Query: 274 ----CDVYSFGVVALEVLMGR--HPGDL---------------------LSSVNPKIMLI 306
                D+++ G +  E+L G    PGD                      +   NP    +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237

Query: 307 DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            L + +   P++ +      +++  +   CLR  P  RP
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLD-LAKQCLRIDPDDRP 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 33/240 (13%)

Query: 90  DFDIKY----CIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           D   +Y     IG+G YG V  A    SGKKVA+KK+ H+       +    E  +L   
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61

Query: 145 RHRNIVKLYGFCLHK----KCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIV 196
           +H NI+ +           K ++++   M    L  I+ +D    +E IR         +
Sbjct: 62  KHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRY-------FL 113

Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR----TV 252
             +   L Y+H   +   +HRD+  +N+L+N   E  + DFG+AR L S  +      T 
Sbjct: 114 YQLLRGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170

Query: 253 VAGTHGYIAPELAYTMV-LTEKCDVYSFGVVALEVLMGRH--PGDLLSSVNPKIMLIDLL 309
              T  Y APEL  ++   T   D++S G +  E+L  R   PG   + V+   +++ +L
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK--NYVHQLKLILSVL 228

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 62/258 (24%), Positives = 114/258 (44%), Gaps = 30/258 (11%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH---SETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G G +G V++  L     VA+K        E ++ FL    +EA +L Q  H NIVKL 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFL----SEARILKQYDHPNIVKLI 58

Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIP 212
           G C  ++ ++++ + +  G     LR   + ++    + V      A  ++YL   +CI 
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI- 115

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARL----LHSDSSNRTVVAGTHGYIAPELAYTM 268
              HRD+++ N L+       ++DFG++R     ++S S  + +      + APE     
Sbjct: 116 ---HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYG 169

Query: 269 VLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
             + + DV+S+G++  E   +G  P   +++   +  +        P    D        
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDD------- 222

Query: 328 LVSKIVFACLRSKPTSRP 345
            V K++  C   KP +RP
Sbjct: 223 -VYKVMQRCWDYKPENRP 239

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 21/206 (10%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G YG VY A+ L +  ++A+K++   E +  +++    E  L S ++HRNIV+  G 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRN------DDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
                   +  + +  GSL  +LR+      D+E   + +TK++         L YLH +
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI------LEGLKYLHDN 127

Query: 210 CIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
               IVHRDI  +N+L+N+      ++DFG ++ L   +       GT  Y+APE+    
Sbjct: 128 ---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG 184

Query: 269 V--LTEKCDVYSFGVVALEVLMGRHP 292
                   D++S G   +E+  G+ P
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.9 bits (173), Expect = 5e-14
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 29/212 (13%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLH------HSETELAFLESFQTEAHLLSQIRHRNI 149
           +G G +G VY    + +G+++A K++        +  E++ LE    E  LL  ++H  I
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALE---CEIQLLKNLQHERI 66

Query: 150 VKLYGFCLH---KKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIVKSMAHAL 203
           V+ YG CL    +K + +  +YM  GS+   L+      E++   +T+++         +
Sbjct: 67  VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGM 119

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT---VVAGTHGYI 260
           SYLH + I   VHRDI   NIL +S     + DFG ++ L +   + T    V GT  ++
Sbjct: 120 SYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +PE+        K DV+S G   +E+L  + P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.4 bits (176), Expect = 6e-14
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG+G YG V  A    +G+KVA+KK+ +   +L   +    E  LL  +RH NI+ L   
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 156 CLHKKCM-----FLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYL 206
                       +++ + M    L  ++++     D+ I+         +  +   L YL
Sbjct: 68  LRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQY-------FLYQILRGLKYL 119

Query: 207 HCDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-----VVAGTHGY 259
           H     S  ++HRD+  +NIL+NS  +  + DFG+AR +  D   +      VV  T  Y
Sbjct: 120 H-----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV--TRWY 172

Query: 260 IAPELAYTMVLTEKC----DVYSFGVVALEVLMGRH--PG 293
            APEL   ++ + +     D++S G +  E+L  +   PG
Sbjct: 173 RAPEL---LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 30/232 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSE----TELAFLESFQTEAHLLSQ 143
           EDFD+   IG G +G V   +  S K+V A+K L   E    ++ AF   F  E  +++ 
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF---FWEERDIMAH 99

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK--RVNIVKSMA- 200
                IV+L+      K ++++ +YM  G L  ++ N D  I   W +     +V ++  
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDA 157

Query: 201 -HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-GTHG 258
            H++ +         +HRD+  +N+LL+      +ADFG    + ++   R   A GT  
Sbjct: 158 IHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD 208

Query: 259 YIAPEL----AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIM 304
           YI+PE+            +CD +S GV   E+L+G  P   D L     KIM
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 66/239 (27%), Positives = 101/239 (42%), Gaps = 49/239 (20%)

Query: 82  QEMIVATEDFDIKY----CIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQT 136
           QE+     +   +Y     +G+G YG V  A    +G+KVA+KKL            FQ+
Sbjct: 4   QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL---------SRPFQS 54

Query: 137 EAH---------LLSQIRHRNIVKLYG-FCLHKKCM-----FLIYKYMRRGSLFCILRND 181
             H         LL  + H N++ L   F            +L+   M    L  I++  
Sbjct: 55  AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQ 113

Query: 182 ---DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG 238
              D+ I+        +V  +   L Y+H      I+HRD+  +NI +N   E  + DFG
Sbjct: 114 KLSDDHIQF-------LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFG 163

Query: 239 VARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           +AR  H+D      VA T  Y APE+    M   +  D++S G +  E+L G+   PG 
Sbjct: 164 LAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 35/224 (15%)

Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHK 81

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSL---------------FCILRNDDEAIRLDWTKR 192
           NI+ L G C     +++I +Y  +G+L               + I R  DE  ++ +   
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE--QMTFKDL 139

Query: 193 VNIVKSMAHALSYLHCD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
           V+    +A  + YL    CI    HRD+++ N+L+       +ADFG+AR +++    + 
Sbjct: 140 VSCTYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 252 VVAGTH--GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
              G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 14/224 (6%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G G +G VY+AQ      +A  K+  +++E   LE +  E  +L+   H NIVKL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
            ++  ++++ ++   G++  ++   +  +     + V   K    AL+YLH +    I+H
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVV--CKQTLEALNYLHEN---KIIH 126

Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE---- 272
           RD+ + NIL     +  +ADFGV+         R    GT  ++APE+       +    
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186

Query: 273 -KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS 315
            K DV+S G+  +E+     P   L   NP  +L+ +     P+
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHEL---NPMRVLLKIAKSEPPT 227

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 13/199 (6%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTE-AHLLSQIRHRNIVKLY 153
           I  G +GSVY A+   +G   A+K L  S+      + + + E A ++ Q     + KLY
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                K  ++L+ +Y+  G    +++     +  DW K    +  +   +  LH      
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAK--QYIAEVVLGVEDLHQR---G 117

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           I+HRDI   N+L++      + DFG++R       N+  V GT  Y+APE    +   + 
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFV-GTPDYLAPETILGVGDDKM 173

Query: 274 CDVYSFGVVALEVLMGRHP 292
            D +S G V  E L G  P
Sbjct: 174 SDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 90  DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHR 147
           DF++   +GTG +G V  A+   +G+  A+K L   E  ++  ++    E  +L ++ H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA----- 202
            IV +      +  ++ + +++  G LF  LR           +  N V    HA     
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--------RFPNDVAKFYHAELVLA 130

Query: 203 LSYLH-CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYI 260
             YLH  D    I++RD+   N+LL++K    V DFG A+ +     +RT  + GT  Y+
Sbjct: 131 FEYLHSKD----IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYL 182

Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           APE+  +    +  D ++ GV+  E + G  P
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLL---SQIRHRNIVKL 152
           IG G YG+VY+A+ P SG  VALK +     E     S   E  LL       H NIV+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 153 YGFCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
              C   +      + L+++++ +     + +     +  +  K  ++++     L +LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFLH 125

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
            +CI   VHRD+   NIL+ S  +  +ADFG+AR ++S     T V  T  Y APE+   
Sbjct: 126 ANCI---VHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVVTLWYRAPEVLLQ 181

Query: 268 MVLTEKCDVYSFGVVALEVL 287
                  D++S G +  E+ 
Sbjct: 182 STYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 27/211 (12%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H NIVKL  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 66

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK----RVNIVKS----MAHALSYL 206
               +  ++L+++++          + D    +D +      + ++KS    +   L++ 
Sbjct: 67  VIHTENKLYLVFEFL----------HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L 
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 21/216 (9%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           EDF+I   IG G +G V   +L +  KV A+K L+  E  + A    F+ E  +L    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK----RVNIVKSMAHA 202
           + I  L+     +  ++L+  Y   G L  +L   ++ +  D  +     + I     H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-RLLHSDSSNRTVVAGTHGYIA 261
           L Y         VHRDI  +NIL++      +ADFG   +L+   +   +V  GT  YI+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 262 PELAYTMV-----LTEKCDVYSFGVVALEVLMGRHP 292
           PE+   M         +CD +S GV   E+L G  P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 69.1 bits (170), Expect = 2e-13
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 21/153 (13%)

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           + N +KLY      K   LI  Y++ G LF +L+ +    +L   +   I++ +  AL+ 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALND 124

Query: 206 LHCDCIPSIVHRDISSNNILLN-SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           LH     +I+H DI   N+L + +K   ++ D+G+ +++ + S       GT  Y +PE 
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPE- 176

Query: 265 AYTMVLTEKCDVYSF-----GVVALEVLMGRHP 292
               +     D  SF     GV+  E+L G+HP
Sbjct: 177 ---KIKGHNYD-VSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 42/275 (15%)

Query: 93  IKYCIGTGGYGSVYRA--QLPSGKK--VALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  +GTG +G + R   +LPS ++  VA+  L    ++      F  EA  L Q  H N
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRR-GFLAEALTLGQFDHSN 67

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           IV+L G       M ++ +YM  G+L   LR  +   +L   + + ++  +A  + YL  
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYL-- 123

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFG-----VARLLHSDSSNRTVVAGTHGYIAPE 263
                 VH+ ++++ +L+NS L   ++ F       +  +++  S ++ V     + APE
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL----WAAPE 178

Query: 264 LAYTMVLTEKCDVYSFGVVALEVL-MGRHP------GDLLSSVNPKIMLIDLLDQRVPSP 316
                  +   DV+SFG+V  EV+  G  P       D++ +V            R+P+P
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--------RLPAP 230

Query: 317 IDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQ 351
            +   ++  ++L       C + +   RP  R SQ
Sbjct: 231 RNCPNLLHQLML------DCWQKERGERP--RFSQ 257

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 69/254 (27%), Positives = 112/254 (44%), Gaps = 21/254 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           +DF+I   IG G +G V   ++ +  +V A+K L+  E  + A    F+ E  +L     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 147 RNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           R I  L Y F   +  ++L+  Y   G L  +L   ++ +  D  +    +  M  A+  
Sbjct: 61  RWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--LAEMVLAIDS 117

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-GTHGYIAPEL 264
           +H       VHRDI  +N+LL+      +ADFG    L +D + ++ VA GT  YI+PE+
Sbjct: 118 VH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174

Query: 265 AYTM-----VLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIM----LIDLLDQRV 313
              M         +CD +S GV   E+L G  P   + L     KIM             
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234

Query: 314 PSPIDDQTVIQDII 327
               + + +I+ +I
Sbjct: 235 DVSEEAKDLIRRLI 248

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 16/209 (7%)

Query: 90  DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
            +++   +G G +G     Q + S +K A+K++   ++  A +E  + EA LL++++H N
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA-VEDSRKEAVLLAKMKHPN 59

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD-----EAIRLDWTKRVNIVKSMAHAL 203
           IV           ++++ +Y   G L   ++        E   L W         M   +
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGV 113

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
            ++H      ++HRDI S NI L    +  + DFG ARLL S  +      GT  Y+ PE
Sbjct: 114 QHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +   M    K D++S G +  E+   +HP
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 53/186 (28%), Positives = 80/186 (43%), Gaps = 20/186 (10%)

Query: 116 VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF 175
           VA+K L    ++ A  E F  E  +LS++   NI +L G C     + +I +YM  G L 
Sbjct: 49  VAVKVLRPDASDNA-REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 176 CILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS---------IVHRDISSNNILL 226
             L+   + +        N        L Y+    I S          VHRD+++ N L+
Sbjct: 108 QFLQ---KHVAETSGLACNSKSLSFSTLLYM-ATQIASGMRYLESLNFVHRDLATRNCLV 163

Query: 227 NSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVLTEKCDVYSFGVV 282
                  +ADFG++R L+S    R  V G       ++A E       T K DV++FGV 
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYR--VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221

Query: 283 ALEVLM 288
             E+L 
Sbjct: 222 LWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 17/197 (8%)

Query: 97  IGTGGYGSVYRA---QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V +       S K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
           G C  +  M L+ +    G L   L+ +      + T+ V+ V SM   + YL      +
Sbjct: 63  GICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQV-SMG--MKYLEET---N 115

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPELAYTM 268
            VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG     + APE     
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNYY 173

Query: 269 VLTEKCDVYSFGVVALE 285
             + K DV+SFGV+  E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)

Query: 97  IGTGGYG-SVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G ++       GK+  +K+++ S+      E  + E  +LS ++H NIV+    
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 156 CLHKKCMFLIYKYMRRGSLFC-------ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
                 ++++  Y   G L+        +L  +D+   LDW  ++ +      AL ++H 
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWFVQICL------ALKHVHD 119

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
                I+HRDI S NI L       + DFG+AR+L+S         GT  Y++PE+    
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR 176

Query: 269 VLTEKCDVYSFGVVALEVLMGRH 291
               K D+++ G V  E+   +H
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKH 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 20/203 (9%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQ---TEAHLLSQIRHRNIVKL 152
           IG G +G+VY A    + + VA+KK+ +S  +    E +Q    E   L Q++H N ++ 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN--EKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
            G  L +   +L+ +Y   GS   +L    +   L   +   I       L+YLH   + 
Sbjct: 87  KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHNM- 142

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
             +HRDI + NILL    +  +ADFG A    S SS      GT  ++APE+   M   +
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSA----SKSSPANSFVGTPYWMAPEVILAMDEGQ 196

Query: 273 ---KCDVYSFGVVALEVLMGRHP 292
              K DV+S G+  +E L  R P
Sbjct: 197 YDGKVDVWSLGITCIE-LAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 18/200 (9%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V++ +   +G+ VA+KK   SE +    +    E  +L Q++H N+V L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYLHC-DC 210
              K+ + L+++Y     L  + +N     +  I+        I+     A+++ H  +C
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCHKHNC 121

Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY-TMV 269
           I    HRD+   NIL+  + +  + DFG AR+L     + T    T  Y APEL      
Sbjct: 122 I----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177

Query: 270 LTEKCDVYSFGVVALEVLMG 289
                DV++ G V  E+L G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 69.5 bits (171), Expect = 3e-13
 Identities = 71/224 (31%), Positives = 106/224 (47%), Gaps = 46/224 (20%)

Query: 91  FDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAH-------LLS 142
           ++I   +G G YG V++A    + + VALKK+       AF     T+A         L 
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD-----AF--RNATDAQRTFREIMFLQ 61

Query: 143 QIR-HRNIVKLYGFCLHK----KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
           ++  H NIVKL    + K    K ++L+++YM       I  N    I  D  KR  I+ 
Sbjct: 62  ELGDHPNIVKLLN--VIKAENDKDIYLVFEYMETDLHAVIRAN----ILEDVHKRY-IMY 114

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV----- 252
            +  AL Y+H     +++HRD+  +NILLNS     +ADFG+AR L     N        
Sbjct: 115 QLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 253 -VAGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGR 290
            VA T  Y APE+      Y    T+  D++S G +  E+L+G+
Sbjct: 172 YVA-TRWYRAPEILLGSTRY----TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 6/208 (2%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELA-FLESFQTEAHLLSQIR 145
             +F I+  IG G +  VY+A  L  G+ VALKK+   E   A   +    E  LL Q+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV-NIVKSMAHALS 204
           H N++K     +    + ++ +    G L  ++++  +  RL   + +      +  AL 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           ++H      I+HRDI   N+ + +     + D G+ R   S ++    + GT  Y++PE 
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
            +      K D++S G +  E+   + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 68/254 (26%), Positives = 114/254 (44%), Gaps = 30/254 (11%)

Query: 79  ITFQEMIVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKL---HHSETELAFLESF 134
           I F      ++ ++I   IG G YG V++     +G K A+K L   H  + E+      
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI------ 61

Query: 135 QTEAHLLSQIR-HRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRND-DEAIRL 187
           + E ++L  +  H N+VK YG    K       ++L+ +    GS+  +++       R+
Sbjct: 62  EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121

Query: 188 DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
           +      I+      L +LH +     +HRD+  NNILL ++    + DFGV+  L S  
Sbjct: 122 EEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178

Query: 248 SNRTVVAGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK 302
             R    GT  ++APE+             +CDV+S G+ A+E+  G  P   L+ ++P 
Sbjct: 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP---LADLHPM 235

Query: 303 IMLIDLLDQRVPSP 316
             L  +   R P P
Sbjct: 236 RALFKI--PRNPPP 247

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 47/230 (20%)

Query: 97  IGTGGYGSVYRAQL----------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-R 145
           +G G +G V RA+                V + K + ++ +LA L S   E  L+  I +
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS---EMELMKLIGK 76

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSL---------------FCILRNDDEAIRLDWT 190
           H+NI+ L G C  +  +++I +Y  +G+L               F I +  +E  +L + 
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE--QLSFK 134

Query: 191 KRVNIVKSMAHALSYLHCD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH----- 244
             V+    +A  + YL    CI    HRD+++ N+L+       +ADFG+AR +H     
Sbjct: 135 DLVSCAYQVARGMEYLESRRCI----HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190

Query: 245 -SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
              S+ R  V     ++APE  +  V T + DV+SFG++  E+  +G  P
Sbjct: 191 KKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 30/271 (11%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQ---TEAHLLSQIRHRNIVKL 152
           IG G +G+VY A+ + + + VA+KK+ +S  +    E +Q    E   L Q+RH N ++ 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
            G  L +   +L+ +Y   GS   IL    + ++    +   I       L+YLH     
Sbjct: 81  KGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEV--EIAAICHGALQGLAYLHSHER- 136

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM---V 269
             +HRDI + NILL       +ADFG A L+    +N  V  GT  ++APE+   M    
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLV--SPANSFV--GTPYWMAPEVILAMDEGQ 190

Query: 270 LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS-PIDDQTVIQDIIL 328
              K DV+S G+  +E+   + P   L ++N    L  +     P+   +D +       
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNDSPTLSSNDWS--DYFR- 244

Query: 329 VSKIVFACLRSKPTSRPMQR--VSQEFLVRK 357
               V +CL+  P  RP     +   F++R+
Sbjct: 245 --NFVDSCLQKIPQDRPSSEELLKHRFVLRE 273

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 41/280 (14%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPS-GKKV--ALKKLHHSETELAFLESFQTEAHLLSQI- 144
           ED   +  IG G +G V RA +   G K+  A+K L    +E      F  E  +L ++ 
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH-RDFAGELEVLCKLG 60

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-------------DEAIRLDWTK 191
            H NI+ L G C ++  +++  +Y   G+L   LR                 A  L   +
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
            +     +A  + YL        +HRD+++ N+L+   L + +ADFG++R          
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEV 171

Query: 252 VVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIML 305
            V  T G     ++A E     V T K DV+SFGV+  E++ +G  P   ++       L
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231

Query: 306 IDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                   P   DD+        V +++  C R +P  RP
Sbjct: 232 PQGYRMEKPRNCDDE--------VYELMRQCWRDRPYERP 263

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 66/273 (24%), Positives = 124/273 (45%), Gaps = 38/273 (13%)

Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G   +G VY+  L         + VA+K L   + E    E F+ EA + S+++H NIV
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSL--FCILR---------NDDEAIR--LDWTKRVNIVK 197
            L G    ++ + +I+ Y     L  F ++R         +DD+ ++  L+    V+IV 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + +L       +VH+D+++ N+L+  KL   ++D G+ R ++  +++   + G  
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY--AADYYKLMGNS 186

Query: 258 ----GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQR 312
                +++PE       +   D++S+GVV  EV   G  P       N  ++ +    Q 
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQDVIEMIRNRQV 244

Query: 313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +P P D    +  ++L       C    P+ RP
Sbjct: 245 LPCPDDCPAWVYTLML------ECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 32/233 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSE----TELAFLESFQTEAHLLSQ 143
           ED+D+   IG G +G V   +  S +KV A+K L   E    ++ AF   F  E  +++ 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAF 99

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
                +V+L+      K ++++ +YM  G L  ++ N D  +   W K       +  AL
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYT--AEVVLAL 155

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR------LLHSDSSNRTVVAGTH 257
             +H      ++HRD+  +N+LL+      +ADFG         ++  D++      GT 
Sbjct: 156 DAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-----VGTP 207

Query: 258 GYIAPELAYTM----VLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIM 304
            YI+PE+  +         +CD +S GV   E+L+G  P   D L     KIM
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 49/234 (20%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT------------EAHLLSQ 143
           +G G YG V +A    +GK VA+KK+   E      +  Q             E  ++++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           I+H NI+ L    +    + L+   M    L  ++   D  IRL  ++   I+  + + L
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV---DRKIRLTESQVKCILLQILNGL 132

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT------------ 251
           + LH       +HRD+S  NI +NSK    +ADFG+AR       + T            
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 252 ----VVAGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
               VV  T  Y APEL      Y        D++S G +  E+L G+   PG+
Sbjct: 190 MTSKVV--TLWYRAPELLMGAEKY----HFAVDMWSVGCIFAELLTGKPLFPGE 237

Length = 335

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 34/268 (12%)

Query: 51  PKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQL 110
           P +RK K  +    R  D  +          +++ +  ED+++   IG G +G V   + 
Sbjct: 13  PALRKNKNIDNFLNRYKDTIN--------KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 64

Query: 111 PSGKKV-ALKKLHHSE----TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI 165
            S +KV A+K L   E    ++ AF   F  E  +++      +V+L+      + ++++
Sbjct: 65  KSTRKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121

Query: 166 YKYMRRGSLFCILRNDD--EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNN 223
            +YM  G L  ++ N D  E     +T  V +     H++ +         +HRD+  +N
Sbjct: 122 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVKPDN 172

Query: 224 ILLNSKLEAFVADFGVARLLHSDSSNRTVVA-GTHGYIAPELAYTM----VLTEKCDVYS 278
           +LL+      +ADFG    ++ +   R   A GT  YI+PE+  +         +CD +S
Sbjct: 173 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232

Query: 279 FGVVALEVLMGRHP--GDLLSSVNPKIM 304
            GV   E+L+G  P   D L     KIM
Sbjct: 233 VGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 39/226 (17%)

Query: 97  IGTGGYGSVYRAQ---LPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+   L   K     KVA+K L    TE   L    +E  ++  I +H+
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHK 84

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSL-------------FCILRNDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L             +C         +L +   V+
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 195 IVKSMAHALSYLHCD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS-DSSNRTV 252
               +A  + YL    CI    HRD+++ N+L+       +ADFG+AR +H  D   +T 
Sbjct: 145 CAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 199

Query: 253 VAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
              T+G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 200 ---TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 29/225 (12%)

Query: 136 TEAHLLSQIRHRNIVKLYG-FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
           TEAH+L  I H +I++L G F  +K    ++ +Y  +  L+C L        +     + 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKR---NIAICDILA 186

Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-V 253
           I +S+  A+ YLH +    I+HRDI + NI +N   +  + DFG A      ++N+    
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243

Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--------GDLLSSVNPKIML 305
           AGT    APEL          D++S G+V  E+              GD  S  + +I L
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDS--DRQIKL 301

Query: 306 IDLLDQRVPS--PIDDQTVIQDIILVSKIVFACLRS--KPTSRPM 346
           I       P+  PID Q  + +I +         +S  KP SRP+
Sbjct: 302 IIRRSGTHPNEFPIDAQANLDEIYIGL-----AKKSSRKPGSRPL 341

Length = 391

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 74/265 (27%), Positives = 120/265 (45%), Gaps = 29/265 (10%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQ---TEAHLLSQIRHRNIVKL 152
           IG G +G+VY A+ + + + VA+KK+ +S  +    E +Q    E   L +I+H N ++ 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN--EKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
            G  L +   +L+ +Y   GS   +L    +   L   +   I       L+YLH     
Sbjct: 91  KGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSH--- 144

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           +++HRDI + NILL    +  +ADFG A +    +S      GT  ++APE+   M   +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQ 200

Query: 273 ---KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILV 329
              K DV+S G+  +E+   + P   L ++N    L  +      SP        D    
Sbjct: 201 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE--SPTLQSNEWSDYF-- 253

Query: 330 SKIVFACLRSKPTSRPMQRVSQEFL 354
              V +CL+  P  RP    S+E L
Sbjct: 254 RNFVDSCLQKIPQDRP---TSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 18/207 (8%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG VY+A+   + + +ALKK+   + +     +   E  LL +++H NIV+L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS----MAHALSYLHCDCI 211
              +K ++L+++Y+       + ++ D +   D+ K   ++K+    +   ++Y H    
Sbjct: 70  VHSEKRLYLVFEYLD----LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH-- 121

Query: 212 PSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMV 269
             ++HRD+   N+L++ +  A  +ADFG+AR         T    T  Y APE L  +  
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRH 180

Query: 270 LTEKCDVYSFGVVALEVLMGR--HPGD 294
            +   D++S G +  E++  +   PGD
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKPLFPGD 207

Length = 294

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 66/260 (25%), Positives = 119/260 (45%), Gaps = 22/260 (8%)

Query: 92  DIKY--CIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           DI+Y   +G G  G+VY+A     +++   K+   +  +   +   +E  +L +     I
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI-RLDWTKRVNIVKSMAHALSYLHC 208
           +  YG    +  + +  ++M  GSL    +  +  + R+     V +VK + +  S    
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRI----AVAVVKGLTYLWSL--- 114

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
                I+HRD+  +N+L+N++ +  + DFGV+  L  +S  +T V GT+ Y+APE     
Sbjct: 115 ----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYV-GTNAYMAPERISGE 168

Query: 269 VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
                 DV+S G+  +E+ +GR P   +      +M + LL   V    +D  V+     
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD---EDPPVLPVGQF 225

Query: 329 VSKIVF---ACLRSKPTSRP 345
             K V     C+R +P  RP
Sbjct: 226 SEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 17/206 (8%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLH---HSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           +G G +G VY      +G+++A+K++     S      + + + E  LL  + H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 153 YGFCLH---KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           YG CL    ++ + +  ++M  GS+   L++   A+  + T++    + +   +SYLH +
Sbjct: 70  YG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYT--RQILEGVSYLHSN 125

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS---DSSNRTVVAGTHGYIAPELAY 266
            I   VHRDI   NIL +S     + DFG ++ L +     +    V GT  +++PE+  
Sbjct: 126 MI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
                 K D++S G   +E+L  + P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 69/270 (25%), Positives = 121/270 (44%), Gaps = 28/270 (10%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQ---TEAHLLSQIRHRNIVKL 152
           IG G +G+VY A+ + + + VA+KK+ +S  +    E +Q    E   L ++RH N ++ 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
            G  L +   +L+ +Y   GS   +L    +   L   +   +       L+YLH     
Sbjct: 81  RGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSH--- 134

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           +++HRD+ + NILL+      + DFG A ++   +       GT  ++APE+   M   +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQ 190

Query: 273 ---KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILV 329
              K DV+S G+  +E+   + P   L ++N    L  +      SP        +    
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE--SPALQSGHWSEYF-- 243

Query: 330 SKIVFACLRSKPTSRPMQRV--SQEFLVRK 357
              V +CL+  P  RP   V     F++R+
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 9/205 (4%)

Query: 89  EDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +DF+    +G G  G V++ +  PSG  +A +KL H E + A       E  +L +    
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLEIKPAIRNQIIRELQVLHECNSP 63

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
            IV  YG       + +  ++M  GSL  +L+     I      +V+I  ++   L+YL 
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSI--AVIKGLTYLR 120

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++PE    
Sbjct: 121 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQG 176

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              + + D++S G+  +E+ +GR+P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 45/274 (16%)

Query: 97  IGTGGYGSVYRAQLPS-GKKV--ALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKL 152
           IG G +G V +A++   G ++  A+K++    ++      F  E  +L ++  H NI+ L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINL 61

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRND-------------DEAIRLDWTKRVNIVKSM 199
            G C H+  ++L  +Y   G+L   LR                 A  L   + ++    +
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG- 258
           A  + YL        +HRD+++ NIL+     A +ADFG++R           V  T G 
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGR 172

Query: 259 ----YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP--GDLLSSVNPKIMLIDLLDQ 311
               ++A E     V T   DV+S+GV+  E++ +G  P  G   + +  K+     L++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232

Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             P   DD+        V  ++  C R KP  RP
Sbjct: 233 --PLNCDDE--------VYDLMRQCWREKPYERP 256

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 13/212 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           +DF+I   IG G +G V   ++   +++ A+K L+  E  + A    F+ E ++L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
           + I  L+     +  ++L+  Y   G L  +L   ++ +  D  +    +  M  A+  +
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--IAEMVLAIHSI 118

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-GTHGYIAPELA 265
           H       VHRDI  +N+LL+      +ADFG    ++ D + ++ VA GT  YI+PE+ 
Sbjct: 119 HQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175

Query: 266 YTM-----VLTEKCDVYSFGVVALEVLMGRHP 292
             M         +CD +S GV   E+L G  P
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 69/241 (28%), Positives = 111/241 (46%), Gaps = 22/241 (9%)

Query: 91  FDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           + I+  IG G YG V  A    +G+KVA+KK++     ++       E  LL  +RH +I
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 150 VKLYGFCLHK-----KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           V++    L       K ++++++ M       I  NDD    L        +  +  AL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD----LTPEHHQFFLYQLLRALK 117

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIA 261
           Y+H     ++ HRD+   NIL N+  +  + DFG+AR+  +D+      T    T  Y A
Sbjct: 118 YIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 262 PEL--AYTMVLTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLLDQRVPSPI 317
           PEL  ++    T   D++S G +  EVL G+   PG   + V+   ++ DLL    P  I
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLITDLLGTPSPETI 232

Query: 318 D 318
            
Sbjct: 233 S 233

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 47/281 (16%)

Query: 92  DIKY--CIGTGGYGSVYRAQLPSG---KKVALKKLHHSETELAFLESFQTEAHLLSQI-R 145
           DIK+   IG G +G V +A++         A+K++    ++      F  E  +L ++  
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGH 66

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-------------DDEAIRLDWTKR 192
           H NI+ L G C H+  ++L  +Y   G+L   LR              +  A  L   + 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
           ++    +A  + YL        +HRD+++ NIL+     A +ADFG++R           
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVY 177

Query: 253 VAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP--GDLLSSVNPKIM 304
           V  T G     ++A E     V T   DV+S+GV+  E++ +G  P  G   + +  K+ 
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237

Query: 305 LIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
               L++  P   DD+        V  ++  C R KP  RP
Sbjct: 238 QGYRLEK--PLNCDDE--------VYDLMRQCWREKPYERP 268

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 97  IGTGGYGSVYRAQLPSGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G V +      KK   VA+K L  +E E +  +    EA ++ Q+ +  IV++ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLK-NENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS----YLHCD 209
           G C  +  M L+ +    G L   L    + I +      N+V+ M H +S    YL   
Sbjct: 62  GVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVS-----NVVELM-HQVSMGMKYLEGK 114

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
              + VHRD+++ N+LL ++  A ++DFG+++ L +D S     A + G     + APE 
Sbjct: 115 ---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPEC 169

Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 + + DV+S+G+   E    G+ P
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 72/262 (27%), Positives = 120/262 (45%), Gaps = 27/262 (10%)

Query: 97  IGTGGYGSVYRA-QLPSGKK----VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G+G +G+VY+   +P G+     VA+K L  + +  A  E    EA++++ +    + +
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAGVGSPYVCR 73

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
           L G CL      L+ + M  G L   +R + +  R+     +N    +A  +SYL     
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLE---E 127

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYIAPELAYTMV 269
             +VHRD+++ N+L+ S     + DFG+ARLL  D +      G     ++A E      
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187

Query: 270 LTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLD--QRVPSPIDDQTVIQDI 326
            T + DV+S+GV   E++  G  P D +    P   + DLL+  +R+P P          
Sbjct: 188 FTHQSDVWSYGVTVWELMTFGAKPYDGI----PAREIPDLLEKGERLPQPPICT------ 237

Query: 327 ILVSKIVFACLRSKPTSRPMQR 348
           I V  I+  C       RP  R
Sbjct: 238 IDVYMIMVKCWMIDSECRPRFR 259

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 62/245 (25%), Positives = 115/245 (46%), Gaps = 30/245 (12%)

Query: 97  IGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G   +G +Y+  L        + VA+K L        + E FQ EA L++++ H NIV 
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-FQQEASLMAELHHPNIVC 71

Query: 152 LYGFCLHKKCMFLIYKYMRRGSL--FCILR----------NDDEAIR--LDWTKRVNIVK 197
           L G    ++ + ++++Y+ +G L  F I+R          ++D  ++  LD    ++I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL        VH+D+++ NIL+  +L   ++D G++R ++S    R V   + 
Sbjct: 132 QIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR-VQPKSL 187

Query: 258 ---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRV 313
               ++ PE       +   D++SFGVV  E+   G  P    S  N +++ +    Q +
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQEVIEMVRKRQLL 245

Query: 314 PSPID 318
           P   D
Sbjct: 246 PCSED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 71/250 (28%), Positives = 110/250 (44%), Gaps = 19/250 (7%)

Query: 90  DFDIKYCIGTGGYGSVYRAQLPSG----KKVALKKLHHSE--TELAFLESFQTEAHLLSQ 143
           +F++   +GTG YG V+  +  SG    K  A+K L  +    +    E  +TE  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 144 IRHRN-IVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
           IR    +V L Y F    K + LI  Y+  G LF  L    +  R    +       +  
Sbjct: 61  IRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVL 116

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-VAGTHGYI 260
           AL +LH      I++RDI   NILL+S     + DFG+++  H D   R     GT  Y+
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 261 APELAY--TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID-LLDQRVPSPI 317
           AP++         +  D +S GV+  E+L G  P  +    N +  +   +L    P P 
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 233

Query: 318 DDQTVIQDII 327
           +   + +DII
Sbjct: 234 EMSALAKDII 243

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 17/206 (8%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHH---SETELAFLESFQTEAHLLSQIRHRNIVKL 152
           +G G +G VY      +G+++A+K++     S+     + + + E  LL  +RH  IV+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 153 YGFCLH---KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           YG CL    +K + +  +YM  GS+   L+    A+  + T+R    + +   +SYLH +
Sbjct: 70  YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYT--RQILQGVSYLHSN 125

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT---VVAGTHGYIAPELAY 266
            I   VHRDI   NIL +S     + DFG ++ + +   + T    V GT  +++PE+  
Sbjct: 126 MI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
                 K DV+S     +E+L  + P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 29/214 (13%)

Query: 90  DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHR 147
           DF I   +G GGYG V+ A+   +G+ VALK++  S    L  +    TE  +L+  +  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 148 NIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHA 202
            +VKL Y F    + ++L  +Y+  G    +L N     ++  R    +    V ++ H 
Sbjct: 62  WLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL-HE 119

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR----LLHSDSSNRTVVAGTHG 258
           L Y+H D  P          N L+++     + DFG+++      +S       V G+  
Sbjct: 120 LGYIHRDLKPE---------NFLIDASGHIKLTDFGLSKGIVTYANS-------VVGSPD 163

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+          D +S G +  E L G  P
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 33/219 (15%)

Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
             +     IG G YG V  A   P+G KVA+KK+   E +     + + E  +L + +H 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHE 63

Query: 148 NIVKLY------GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN------I 195
           NI+ +        F      ++++ + M           + +  +L  T+ ++       
Sbjct: 64  NIIGILDIIRPPSFESFND-VYIVQELM-----------ETDLYKLIKTQHLSNDHIQYF 111

Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL---LHSDSSNRTV 252
           +  +   L Y+H     +++HRD+  +N+LLN+  +  + DFG+AR+    H  +   T 
Sbjct: 112 LYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168

Query: 253 VAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGR 290
              T  Y APE+       T+  D++S G +  E+L  R
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 67/263 (25%), Positives = 117/263 (44%), Gaps = 19/263 (7%)

Query: 90  DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHR 147
           +F I+  IG G +  VYRA  L  G  VALKK+   +  +         E  LL Q+ H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV-NIVKSMAHALSYL 206
           N++K Y   +    + ++ +    G L  ++++  +  RL   K V      +  AL ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      ++HRDI   N+ + +     + D G+ R   S ++    + GT  Y++PE  +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP--GDLLS--SVNPKIMLIDLLDQRVPSPIDDQTV 322
                 K D++S G +  E+   + P  GD ++  S+  KI   D      P P D  + 
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY----PPLPSDHYS- 234

Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
            +++    ++V  C+   P  RP
Sbjct: 235 -EEL---RQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 64.6 bits (157), Expect = 9e-12
 Identities = 68/240 (28%), Positives = 112/240 (46%), Gaps = 41/240 (17%)

Query: 97  IGTGGYGSVYRA-QLPSGKK----VALKKLHHSETELAFLESFQTEAHLLS--QIRHRNI 149
           +G+G +G+V++   +P G      VA+K +        F E      H+L+   + H  I
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQE---ITDHMLAMGSLDHAYI 71

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR----LDWTKRVNIVKSMAHALSY 205
           V+L G C     + L+ +    GSL   +R   +++     L+W   V I K M     Y
Sbjct: 72  VRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGM----YY 124

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD------SSNRTVVAGTHGY 259
           L    +   VHR++++ NILL S     +ADFGVA LL+ D      S ++T +     +
Sbjct: 125 LEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----W 177

Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLD--QRVPSP 316
           +A E       T + DV+S+GV   E++  G  P    + + P   + DLL+  +R+  P
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP---YAGMRPH-EVPDLLEKGERLAQP 233

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 25/226 (11%)

Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G V+    P  GK+VALKK+ +    L   +    E  +L   +H N++     
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 156 -------CLHKKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIVKSMAHALSY 205
                     +  ++++ + M+      I+       + +++        +  +   L Y
Sbjct: 68  LQPPHIDPFEE--IYVVTELMQSDLHKIIVSPQPLSSDHVKV-------FLYQILRGLKY 118

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS-NRTVVAGTHGYIAPE- 263
           LH      I+HRDI   N+L+NS     + DFG+AR+   D S + T    T  Y APE 
Sbjct: 119 LHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI 175

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL 309
           L  +   T   D++S G +  E+L  R      S +    ++ DLL
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL 221

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 59/188 (31%), Positives = 87/188 (46%), Gaps = 33/188 (17%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKK-LHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           IG G +G V++A+   + + VALKK L  +E E  F  +   E  +L  ++H N+V L  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIE 78

Query: 155 FCLHKKCMFLIYKYMRRGSL-----FC------ILRNDDEAIRLDWTKRVNIVKSMAHAL 203
            C  K   +  YK    GS      FC      +L N +    L   K+V  +K + + L
Sbjct: 79  ICRTKATPYNRYK----GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV--MKMLLNGL 132

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-------SNRTVVAGT 256
            Y+H +    I+HRD+ + NIL+       +ADFG+AR             +NR V   T
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV---T 186

Query: 257 HGYIAPEL 264
             Y  PEL
Sbjct: 187 LWYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 141

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 198

Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 199 VDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 67/252 (26%), Positives = 104/252 (41%), Gaps = 62/252 (24%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQT-----EAHLLS 142
           +DF+    IG G +G V   Q   +G   A+KKL  SE     LE  Q      E  +L+
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE----MLEKEQVAHVRAERDILA 56

Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD----EAIRLDWTKRVNIVKS 198
           +  +  +VKLY     +  ++LI +Y+  G +  +L   D    E  R    + +  + S
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS---------- 248
           + H L Y         +HRDI  +N+LL++K    ++DFG+   L               
Sbjct: 117 I-HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 249 ------------------------NRTVVA----GTHGYIAPELAYTMVLTEKCDVYSFG 280
                                   NR  +A    GT  YIAPE+       ++CD +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 281 VVALEVLMGRHP 292
           V+  E+L+G  P
Sbjct: 227 VIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 19/205 (9%)

Query: 97  IGTGGYGSVY---------RAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +G G +G+VY           +L   K++ + +L+ +ET  A  E     A LLS++ H 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE-----AQLLSKLDHP 62

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR-LDWTKRVNIVKSMAHALSYL 206
            IVK +   L +    +I +Y     L C L       + L   +       +   + Y+
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      I+HRD+ + NI L + L   + DFGV+RLL       T   GT  Y++PE   
Sbjct: 123 H---QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRH 291
                 K D++S G +  E+    H
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCCLAH 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 38/220 (17%)

Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    T+   L    +E  ++  I +H+
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD-LSDLVSEMEMMKMIGKHK 78

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-----DEAI--------RLDWTKRVN 194
           NI+ L G C     ++++ +Y  +G+L   LR       D +         +L +   V+
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 195 IVKSMAHALSYLHCD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS-DSSNRTV 252
               +A  + YL    CI    HRD+++ N+L+       +ADFG+AR +H+ D   +T 
Sbjct: 139 CAYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT- 193

Query: 253 VAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVL 287
              T+G     ++APE  +  V T + DV+SFGV+  E+ 
Sbjct: 194 ---TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 57/280 (20%), Positives = 110/280 (39%), Gaps = 39/280 (13%)

Query: 96  CIGTGGYGSVYRAQLPSGKKVALKKLH---HSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           C        + + + P+   VA+KK++    S+ +L  L   Q E     Q++H NI+  
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLL---QQEIITSRQLQHPNILPY 64

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRN------DDEAIRLDWTKRVNIVKSMAHALSYL 206
               +    ++++   M  GS   +L+        + AI         I+K + +AL Y+
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-------ILKDVLNALDYI 117

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR-LLHSDSSNRTVVAGTHG------Y 259
           H       +HR + +++ILL+   +  ++    +  ++      R V            +
Sbjct: 118 HSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 260 IAPELAYTMVL--TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPI 317
           ++PE+    +    EK D+YS G+ A E+  G  P      +    ML++ +   VP  +
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP---FKDMPATQMLLEKVRGTVPCLL 231

Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSR---PMQRV-SQEF 353
           D  T       +S+   +            P  R  S+ F
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHF 271

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.2 bits (153), Expect = 4e-11
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 24/228 (10%)

Query: 97  IGTGGYGSVYRAQLPS-----GKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIV 150
           IG G Y  V   +L         KV  K+L + + ++ ++   QTE H+  Q   H  +V
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWV---QTEKHVFEQASNHPFLV 59

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYL 206
            L+     +  +F + +Y+  G L   ++      +E  R  ++  +++      AL+YL
Sbjct: 60  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISL------ALNYL 112

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      I++RD+  +N+LL+S+    + D+G+ +         +   GT  YIAPE+  
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLL-SSVNPKIMLIDLLDQRV 313
                   D ++ GV+  E++ GR P D++ SS NP     D L Q +
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 9/199 (4%)

Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHRNIVKL-Y 153
           +G GG+G V   Q+  +GK  A KKL     +    E     E  +L ++  R IV L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
            F   K  + L+   M  G L   + N  E       + +     +   L +LH      
Sbjct: 61  AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQR---R 115

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           IV+RD+   N+LL+      ++D G+A  L          AGT GY+APE+    V    
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ G    E++ GR P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 49/241 (20%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSE----TELAFLESFQTEAHLLSQ 143
           +DF++   IG G +G V+  +     +V A+K L  S+     ++A     + E  +L+ 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH---VRAERDILAD 57

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
                IVKLY     ++ ++L+ +YM  G L  +L   D     +  +    +  +  AL
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD-VFPEETARF--YIAELVLAL 114

Query: 204 SYLH---CDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-------------------- 240
             +H          +HRDI  +NIL+++     +ADFG+                     
Sbjct: 115 DSVHKLGF------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 241 -----RLLHSDSSNRTV----VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRH 291
                 +   D   R V      GT  YIAPE+        +CD +S GV+  E+L G  
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228

Query: 292 P 292
           P
Sbjct: 229 P 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 16/204 (7%)

Query: 97  IGTGGYGSVYRAQ--LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR---HRNIVK 151
           IG G YG V++A+     G+ VALK++     E     S   E  +L  +    H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 152 LYGFCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
           L+  C   +      + L+++++ +     + +  +  +  +  K  +++  +   L +L
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDFL 126

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +VHRD+   NIL+ S  +  +ADFG+AR ++S     T V  T  Y APE+  
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVTLWYRAPEVLL 182

Query: 267 TMVLTEKCDVYSFGVVALEVLMGR 290
                   D++S G +  E+   +
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.0 bits (153), Expect = 4e-11
 Identities = 67/292 (22%), Positives = 112/292 (38%), Gaps = 35/292 (11%)

Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           +VA+  + +   +  G  G V+ A  P      + K+    T L        EA LL  +
Sbjct: 62  VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL-------IEAMLLQNV 114

Query: 145 RHRNIVKLYGFCLHKK--CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
            H +++++    +     CM L +       L+  L        L   + + I K +   
Sbjct: 115 NHPSVIRMKDTLVSGAITCMVLPH---YSSDLYTYLTKRSR--PLPIDQALIIEKQILEG 169

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L YLH      I+HRD+ + NI +N   +  + D G A+           +AGT    AP
Sbjct: 170 LRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAP 225

Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLL---------SSVNPKIMLIDLLDQRV 313
           E+        K D++S G+V  E+L   +P  +             +    L+ ++    
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSR--PMQRV----SQEFLVRKTL 359
             P +        ++   I +A L  +P +R    QRV      EFLV K L
Sbjct: 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKML 335

Length = 357

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 49/227 (21%)

Query: 92  DIKY----CIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAF---LESFQT--EAHLL 141
           D KY     IG G YG V  A    + +KVA+KK+ +     AF   +++ +T  E  LL
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-----AFDNRIDAKRTLREIKLL 58

Query: 142 SQIRHRNIVKLYGFCLHKKCM-----------FLIYKYMRRGSLFCILRNDDEAIRLDWT 190
             + H N++ +      K  M           +++Y+ M    L  I+R+  + +  D  
Sbjct: 59  RHLDHENVIAI------KDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSS-QTLSDDHC 110

Query: 191 KRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250
           +    +  +   L Y+H     +++HRD+  +N+LLN+  +  + DFG+AR         
Sbjct: 111 QY--FLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM 165

Query: 251 TVVAGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           T    T  Y APEL      YT  +    DV+S G +  E L+GR P
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAI----DVWSVGCIFAE-LLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 97  IGTGGYGSVY--RAQLP--SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           +G G +G V+  R      +G+  A+K L  +  ++      + E  +L+++ H  IVKL
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 153 -YGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYLH 207
            Y F    K ++LI  ++R G LF  L  +    +E ++         +  +A AL +LH
Sbjct: 64  HYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELALALDHLH 115

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I++RD+   NILL+ +    + DFG+++             GT  Y+APE+   
Sbjct: 116 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T+  D +SFGV+  E+L G  P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 14/208 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGK--KVALKKLHHSET-ELAFLESFQTEAHLLSQIR 145
           EDF+    +GTG +G V  A   +     VA+K+   S+  +   ++   +E  +L+ I 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H   V LYG    +  ++L+ +++  G  F  LR +       +   V    +    L +
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-----FPNDVGCFYAAQIVLIF 144

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIAPEL 264
            +   + +IV+RD+   N+LL+      + DFG A+++ +    RT  + GT  YIAPE+
Sbjct: 145 EYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT----RTYTLCGTPEYIAPEI 199

Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
              +   +  D ++ G+   E+L+G  P
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 27/220 (12%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSG-------KKVALKKLHHSETELAFLESFQTEA 138
           VA E   +   +G G +G VY   +  G        +VA+K ++ + +    +E F  EA
Sbjct: 3   VAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEA 60

Query: 139 HLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDWTK 191
            ++ +    ++V+L G     +   +I + M RG L   LR       N+         K
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
            + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R ++     R 
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177

Query: 252 VVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
              G  G     +++PE     V T   DV+SFGVV  E+
Sbjct: 178 ---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 10/208 (4%)

Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKK-VALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           F++   +G G YG V + +    K+ VA+KK   SE      E+   E  +L  ++  NI
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           V+L      +  ++L+++Y+ +  L  +    +        K  + +  +  A+ + H +
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---EKVRSYIYQLIKAIHWCHKN 119

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVAR-LLHSDSSNRTVVAGTHGYIAPELAYTM 268
               IVHRDI   N+L++      + DFG AR L    ++N T    T  Y +PEL    
Sbjct: 120 ---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176

Query: 269 VLTEKCDVYSFGVVALEVLMGR--HPGD 294
              +  D++S G +  E+  G+   PG+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQPLFPGE 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 41/225 (18%)

Query: 90  DFDIKYCIGTGGYGSVYRAQLPSG------------KKVAL----KKLHHSETELAFLES 133
           +F++   +GTG YG V+  +  +G            +K AL    K + H+ TE   LE 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 134 FQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD----EAIRLDW 189
            +    L++   H      Y F    K + LI  Y+  G +F  L   D    + +R   
Sbjct: 61  VRQSPFLVTL--H------YAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSEDEVRF-- 109

Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
                    +  AL +LH      IV+RDI   NILL+S+    + DFG+++   S+   
Sbjct: 110 -----YSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161

Query: 250 RTV-VAGTHGYIAPELAYTMVLTEKC-DVYSFGVVALEVLMGRHP 292
           RT    GT  Y+APE+        K  D +S G++  E+L G  P
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 12/202 (5%)

Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQ---TEAHLLSQIRHRNIVKL 152
           +G GG+G V   Q+  +GK  A KKL  ++  L   + ++    E  +L+++  R IV L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKL--NKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 153 -YGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
            Y F   K  + L+   M  G L + I   D+E       +       +   L +LH   
Sbjct: 59  AYAF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116

Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL 270
              I++RD+   N+LL++     ++D G+A  L    S     AGT G++APEL      
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEY 174

Query: 271 TEKCDVYSFGVVALEVLMGRHP 292
               D ++ GV   E++  R P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)

Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAF-LESFQTEAHLLS-QIRHRNIVKLY 153
           +G G +G V+ A+L  + +  A+K L      +   +E    E  +LS    H  +  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                K+ +F + +Y+  G L   +++     + D  +       +   L +LH      
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSK---G 116

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           IV+RD+  +NILL++     +ADFG+ +      +      GT  YIAPE+         
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176

Query: 274 CDVYSFGVVALEVLMGRHP 292
            D +SFGV+  E+L+G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 23/204 (11%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G Y +VY+ +   +G+ VALK++H    E     + + E  L+ +++H NIV+L+  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66

Query: 156 CLHKKCMFLIYKYMRRG-SLFCILRNDDEAIRLDWTKRVNIVKSMAHAL----SYLHCDC 210
              +  + L+++YM +    +        A+        N VKS  + L    ++ H + 
Sbjct: 67  IHTENKLMLVFEYMDKDLKKYMDTHGVRGALDP------NTVKSFTYQLLKGIAFCHEN- 119

Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLH---SDSSNRTVVAGTHGYIAPE-LAY 266
              ++HRD+   N+L+N + E  +ADFG+AR      +  SN  V   T  Y AP+ L  
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPDVLLG 174

Query: 267 TMVLTEKCDVYSFGVVALEVLMGR 290
           +   +   D++S G +  E++ GR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 45/220 (20%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           IG G YG VY+A+   +G+ VALKK+   +E E     + + E  LL ++ H NIV+L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLLD 65

Query: 155 FCLHKKCMFLIY--------KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS----MAHA 202
               +  ++L++        KYM    L  +                 ++KS    +   
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPP--------------LIKSYLYQLLQG 111

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---- 258
           ++Y H      ++HRD+   N+L++ +    +ADFG+AR     +    V   TH     
Sbjct: 112 IAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR-----AFGVPVRTYTHEVVTL 163

Query: 259 -YIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
            Y APE L  +   +   D++S G +  E++  R   PGD
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 13/127 (10%)

Query: 100 GGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK 159
           G YG +++ +      V LK L  S     + ESF   A ++SQ+ H+++V  YG C+  
Sbjct: 20  GDYGELHKTE------VLLKVLDKSHRN--YSESFFEAASMMSQLSHKHLVLNYGVCVCG 71

Query: 160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDI 219
               ++ +Y++ GSL   L+ +   I + W  ++ + K +A AL +L       + H ++
Sbjct: 72  DESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGNV 126

Query: 220 SSNNILL 226
            + N+LL
Sbjct: 127 CAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 6/206 (2%)

Query: 90  DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHR 147
           +F I+  IG G +  VYRA  L   K VALKK+   E  +    +    E  LL Q+ H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV-NIVKSMAHALSYL 206
           N++K     +    + ++ +    G L  +++   +  RL   + V      +  A+ ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      ++HRDI   N+ + +     + D G+ R   S ++    + GT  Y++PE  +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
                 K D++S G +  E+   + P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 25/199 (12%)

Query: 116 VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF 175
           VA+K L    T+ A    F  E  ++S++++ NI++L G C+    + +I +YM  G L 
Sbjct: 47  VAVKMLRADVTKTA-RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 176 CILRNDDEAIRLDWTKRVNI-----------VKSMAHALSYLHCDCIPSIVHRDISSNNI 224
             L   +  I   +T   NI              +A  + YL      + VHRD+++ N 
Sbjct: 106 QFLSQRE--IESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160

Query: 225 LLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL----TEKCDVYSFG 280
           L+ +     +ADFG++R L+S    R  + G        +A+  +L    T   DV++FG
Sbjct: 161 LVGNHYTIKIADFGMSRNLYSGDYYR--IQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218

Query: 281 VVALEV--LMGRHPGDLLS 297
           V   E+  L    P  LLS
Sbjct: 219 VTLWEMFTLCKEQPYSLLS 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 19/152 (12%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG+V++A+   + + VALK++   + +     S   E  LL +++H+NIV+LY  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 156 CLHKKCMFLIYKYMRRG--SLFCILRNDDEAIRLDWTKRVNIVKS----MAHALSYLHCD 209
               K + L+++Y  +     F     D +           IVKS    +   L++ H  
Sbjct: 68  LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP---------EIVKSFMFQLLKGLAFCHSH 118

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
              +++HRD+   N+L+N   E  +ADFG+AR
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 97  IGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLESFQTEAHLLSQ-------IRHRN 148
           IG G +G V  A+  + +K  A+K L       A L+  + E H++S+       ++H  
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKK----AILKK-KEEKHIMSERNVLLKNVKHPF 57

Query: 149 IVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           +V L + F    K ++ +  Y+  G LF  L+   E   L+   R      +A AL YLH
Sbjct: 58  LVGLHFSFQTADK-LYFVLDYINGGELFYHLQR--ERCFLEPRARF-YAAEIASALGYLH 113

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                +IV+RD+   NILL+S+    + DFG+ +     +   +   GT  Y+APE+ + 
Sbjct: 114 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK 170

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
                  D +  G V  E+L G  P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 13/150 (8%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG VY+ +   +G+ VA+KK+     E     +   E  LL +++H NIV L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS----MAHALSYLHCDCI 211
            + +  ++LI+++     L   L+   +++         +VKS    +   + + H    
Sbjct: 68  LMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR-- 120

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVAR 241
             ++HRD+   N+L+++K    +ADFG+AR
Sbjct: 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 9/195 (4%)

Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G Y +VY+ +   +GK VALK +   E E     + + EA LL  ++H NIV L+  
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
              K+ + L+++Y+    L   +      +  +  K    +  +   LSY+H      I+
Sbjct: 72  IHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKL--FLFQLLRGLSYIHQR---YIL 125

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC- 274
           HRD+   N+L++   E  +ADFG+AR     S   +    T  Y  P++         C 
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCL 185

Query: 275 DVYSFGVVALEVLMG 289
           D++  G + +E++ G
Sbjct: 186 DMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 19/180 (10%)

Query: 115 KVALKKLH--HSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172
           KV LK L   H +  LAF E+    A ++ Q+ H++IV LYG C+      ++ +++  G
Sbjct: 34  KVILKVLDPSHRDISLAFFET----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89

Query: 173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEA 232
            L   +    + +   W  +  + K +A ALSYL       +VH ++ + NILL    E 
Sbjct: 90  PLDLFMHRKSDVLTTPW--KFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAR--EG 142

Query: 233 FVADFGVARLLHSDSSNRTVVAGTH-----GYIAPE-LAYTMVLTEKCDVYSFGVVALEV 286
              + G    L       TV++         +IAPE +  +  L+   D +SFG    E+
Sbjct: 143 IDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 11/203 (5%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A      +KVA+KKL      L        E  LL  ++H N++ L   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F            Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---AGI 139

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR   +D      VA T  Y APE+    M   + 
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVA-TRWYRAPEIMLNWMHYNQT 196

Query: 274 CDVYSFGVVALEVLMGR--HPGD 294
            D++S G +  E+L G+   PG+
Sbjct: 197 VDIWSVGCIMAELLKGKALFPGN 219

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 15/183 (8%)

Query: 112 SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLIYKYM 169
           +G++VA+K L   E+    +   + E  +L  + H NIVK  G C       + LI +++
Sbjct: 32  TGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90

Query: 170 RRGSLFCILRNDDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN 227
             GSL   L  +   I L    +  V I K M +  S  +       VHRD+++ N+L+ 
Sbjct: 91  PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQY-------VHRDLAARNVLVE 143

Query: 228 SKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAYTMVLTEKCDVYSFGVVAL 284
           S+ +  + DFG+ + + +D    TV         + APE           DV+SFGV   
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203

Query: 285 EVL 287
           E+L
Sbjct: 204 ELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 24/225 (10%)

Query: 97  IGTGGYGSVYRAQLPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           IG G Y  V   +L         KV  K+L H + ++ ++   QTE H+  Q      + 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWV---QTEKHVFEQASSNPFLV 59

Query: 152 LYGFCLHKKC-MFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYL 206
               C      +FL+ +Y+  G L   ++      +E  R  +   + I      AL++L
Sbjct: 60  GLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICI------ALNFL 112

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      I++RD+  +N+LL++     + D+G+ +         +   GT  YIAPE+  
Sbjct: 113 H---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ 311
                   D ++ GV+  E++ GR P D+++  NP +   D L Q
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITD-NPDMNTEDYLFQ 213

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 42/226 (18%)

Query: 90  DFDIKYCIGTGGYGSVYRAQLPSG------------KKVAL----KKLHHSETELAFLES 133
           +F++   +GTG YG V+  +   G            KK  +    K   H+ TE   LE+
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 134 FQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCIL----RNDDEAIRLDW 189
            +    L++   H      Y F    K + LI  Y+  G LF  L       +  +R+  
Sbjct: 61  VRRCPFLVTL--H------YAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESEVRV-- 109

Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
                 +  +  AL +LH      I++RDI   NILL+S+    + DFG+++   ++   
Sbjct: 110 -----YIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161

Query: 250 RTV-VAGTHGYIAPELAYTMVL--TEKCDVYSFGVVALEVLMGRHP 292
           R     GT  Y+APE+         +  D +S GV+  E+L G  P
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 13/201 (6%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAH---LLSQIRHRNIVKL- 152
           IG G +G V  A+     K    K+   +  L   E     A    LL  ++H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI-VKSMAHALSYLHCDCI 211
           Y F   +K ++ +  ++  G LF  L+ +    R     R       +A AL YLH    
Sbjct: 63  YSFQTTEK-LYFVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLHS--- 114

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
            +IV+RD+   NILL+S+    + DFG+ +   + S   T   GT  Y+APE+       
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 272 EKCDVYSFGVVALEVLMGRHP 292
              D +  G V  E+L G  P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 15/108 (13%)

Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
           I  S+  AL YLH     S++HRD+  +N+L+N   +  + DFG++  L  DS  +T+ A
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDA 164

Query: 255 GTHGYIAPEL--------AYTMVLTEKCDVYSFGVVALEVLMGRHPGD 294
           G   Y+APE          Y +    K DV+S G+  +E+  GR P D
Sbjct: 165 GCKPYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.8 bits (142), Expect = 8e-10
 Identities = 67/272 (24%), Positives = 115/272 (42%), Gaps = 37/272 (13%)

Query: 97  IGTGGYGSV--YR---AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +G V  Y    A   +G+ VA+K L   E        ++ E ++L  + H NIVK
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 152 LYGFCLHK--KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C  +  K + LI +Y+  GSL   L       +L+  + +   + +   ++YLH  
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ 126

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ N+LL++     + DFG+A+ +        V         + A E   
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 267 TMVLTEKCDVYSFGVVALEVLMG-----RHPGDLLSSVNPK------IMLIDLLD--QRV 313
               +   DV+SFGV   E+L         P      + PK      + LI+LL+   R+
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           P P +    +        ++  C  ++   RP
Sbjct: 244 PCPKNCPQEVY------ILMKNCWETEAKFRP 269

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 12/200 (6%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQT--EAHLLSQIRHRNIVKL- 152
           +G G +G V    +  SGK  A+K L   E  +A  E   T  E+ +L   RH  +  L 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y F    +  F++ +Y+  G LF  L + +     D T+       +  AL YLH     
Sbjct: 62  YSFQTKDRLCFVM-EYVNGGELFFHL-SRERVFSEDRTRFYG--AEIVSALDYLHSG--- 114

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            IV+RD+   N++L+      + DFG+ +   +D++      GT  Y+APE+        
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 273 KCDVYSFGVVALEVLMGRHP 292
             D +  GVV  E++ GR P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 13/201 (6%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAH---LLSQIRHRNIVKL- 152
           IG G +G V  A+  S       K+   +T L   E     A    LL  ++H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS-MAHALSYLHCDCI 211
           Y F   +K ++ +  Y+  G LF  L+ +    R     R     + +A A+ YLH    
Sbjct: 63  YSFQTAEK-LYFVLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHS--- 114

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
            +I++RD+   NILL+S+    + DFG+ +         +   GT  Y+APE+       
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 272 EKCDVYSFGVVALEVLMGRHP 292
              D +  G V  E+L G  P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 44/219 (20%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN---IVKL 152
           IG G +G+V +    PSG  +A+K++  +  E    E  +    L   +R  +   IVK 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK---EQKRLLMDLDVVMRSSDCPYIVKF 68

Query: 153 YGFCLHKK----CMFLI-------YKYMRRGSLFCILR-NDDEAIRLDWTKRVNIVKSMA 200
           YG    +     CM L+       YKY     ++ +L+    E I       V  VK   
Sbjct: 69  YGALFREGDCWICMELMDISLDKFYKY-----VYEVLKSVIPEEILGKIA--VATVK--- 118

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
            AL+YL  +    I+HRD+  +NILL+      + DFG++  L  DS  +T  AG   Y+
Sbjct: 119 -ALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDAGCRPYM 174

Query: 261 APEL-------AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           APE         Y +    + DV+S G+   EV  G+ P
Sbjct: 175 APERIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 97  IGTGGYGSVYRAQLPSGKKV----ALKK---LHHSETELAFLESFQTEAHLLS-QIRHRN 148
           +G G +G V  A+L    +     ALKK   L   + E   +E       +L+    H  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVER-----RVLALAWEHPF 57

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           +  L+     K+ +F + +Y+  G L F I      + R D  +       +   L +LH
Sbjct: 58  LTHLFCTFQTKEHLFFVMEYLNGGDLMFHI----QSSGRFDEARARFYAAEIICGLQFLH 113

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I++RD+  +N+LL+      +ADFG+ +   +     +   GT  YIAPE+   
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
               E  D +SFGV+  E+L+G+ P
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 58/198 (29%), Positives = 85/198 (42%), Gaps = 32/198 (16%)

Query: 112 SGKKVALKKLH--HSETELAFLESFQTEAHLLSQIRHRNIVKLY--GFCLHKKCMFLIYK 167
           +G +VA+K L     E E      F+ E  L +++ H NIV L   G       +F +++
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQR-ARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59

Query: 168 YMRRGSLFCILRND-----DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSN 222
           Y+   +L  +L  D      E  RL           M   L  L C     IVHRD+   
Sbjct: 60  YVPGRTLREVLAADGALPAGETGRL-----------MLQVLDALACAHNQGIVHRDLKPQ 108

Query: 223 NILLNS---KLEAFVADFGVARLL---HSDSSNR----TVVAGTHGYIAPELAYTMVLTE 272
           NI+++    +  A V DFG+  LL              T V GT  Y APE      +T 
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168

Query: 273 KCDVYSFGVVALEVLMGR 290
             D+Y++G++ LE L G+
Sbjct: 169 NSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 28/221 (12%)

Query: 97  IGTGGYGSVY--RAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           +G G Y +V+  R++L +   VALK++     E A   + + E  LL  ++H NIV L+ 
Sbjct: 13  LGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRND-----DEAIRLDWTKRVNIVK-SMAHALSYLHC 208
               ++C+ L+++Y         L +D     D    L     V I    +   LSY H 
Sbjct: 71  IIHTERCLTLVFEY---------LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYT 267
                I+HRD+   N+L+N K E  +ADFG+AR     +   +    T  Y  P+ L  +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178

Query: 268 MVLTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLI 306
              +   D++  G +  E+  GR   PG   S+V  ++ LI
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPG---STVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 33/247 (13%)

Query: 97  IGTGGYGSVYRAQLPSGKKVA---LKKLHHSET---ELAFLESFQTEAHLLSQIRHRNIV 150
           IG G +G V   +   G   A   +K+L  S T   +L FL+  Q       ++ H N++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQP----YRELNHPNVL 58

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH----ALSYL 206
           +  G C+      L+ ++   G L   LR++   +     K V  ++ MA      L +L
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQRMACEVASGLLWL 116

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG----YIAP 262
           H       +H D++  N  L + L   + D+G+A  L     +  +    H     ++AP
Sbjct: 117 HQA---DFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLAP 171

Query: 263 ELA-------YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVP 314
           EL             T+K +++S GV   E+      P   LS       ++   D ++P
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Query: 315 SPIDDQT 321
            P  D  
Sbjct: 232 KPQLDLK 238

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 21/205 (10%)

Query: 97  IGTGGYGSVYRAQLPSGKKV----ALKK---LHHSETELAFLESFQTEAHLLSQI-RHRN 148
           +G G +G V  A+L    ++     LKK   L   +     +E   TE  +L+   +H  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD-----VECTMTEKRVLALAGKHPF 57

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           + +L+     K  +F + +Y+  G L F I R+     R D  +       +   L +LH
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLH 113

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I++RD+  +N+LL+S+    +ADFG+ +         +   GT  YIAPE+   
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
                  D ++ GV+  E+L G+ P
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 14/201 (6%)

Query: 97  IGTGGYGSVYRAQLPSGKKV----ALKKLH-HSETELAFLESFQTEAHLLSQIRHRNIVK 151
           IG G +G V + +    +++     ++K H  S +E+    + +T   +L+Q+    IV 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT---VLAQVNCPFIVP 57

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
           L       + ++L+  ++  G LF  L+ +    R D ++       +  AL  LH    
Sbjct: 58  LKFSFQSPEKLYLVLAFINGGELFHHLQREG---RFDLSRARFYTAELLCALENLHK--- 111

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
            ++++RD+   NILL+ +    + DFG+ +L   D        GT  Y+APEL      T
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171

Query: 272 EKCDVYSFGVVALEVLMGRHP 292
           +  D ++ GV+  E+L G  P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 61/245 (24%), Positives = 105/245 (42%), Gaps = 51/245 (20%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           +DF+    IG G +G V   Q   +G   A+K L  ++  E   +   + E  +L +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD----EAIRLDWTKRVNIVKSMAHA 202
             +VK++     K+ ++LI +++  G +  +L   D    EA +    + V  + ++ H 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQ 119

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-------------RLLHSDSS- 248
           L +         +HRDI  +N+LL++K    ++DFG+               L H+  S 
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170

Query: 249 -----------------NRTVVA----GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
                            NR  +A    GT  YIAPE+       + CD +S GV+  E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 288 MGRHP 292
           +G  P
Sbjct: 231 IGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 64/245 (26%), Positives = 103/245 (42%), Gaps = 51/245 (20%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           EDF+    IG G +G V   Q   +G   A+K L  ++  E   +   + E  +L +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD----EAIRLDWTKRVNIVKSMAHA 202
             +VK++     K  ++LI +++  G +  +L   D    E  +    + V  + S+ H 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQ 119

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-------------RLLHSDSS- 248
           L +         +HRDI  +N+LL+SK    ++DFG+               L HS  S 
Sbjct: 120 LGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 249 -----------------NRTVVA----GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
                            NR  +A    GT  YIAPE+       + CD +S GV+  E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 288 MGRHP 292
           +G  P
Sbjct: 231 IGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 38/242 (15%)

Query: 100 GGYGSVYRAQL----PSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           G +G ++   L    P  ++    K    H SE ++  L     E+ LL  + H+NI+ +
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLL---LQESCLLYGLSHQNILPI 73

Query: 153 YGFC--LHKKCMFLIYKYMRRGSLFCILRN-----DDEAIRLDWTKRVNIVKSMAHALSY 205
              C    +   F++Y YM  G+L   L+       +    L   + V++   +A  +SY
Sbjct: 74  LHVCIEDGEP-PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL-----HS--DSSNRTVVAGTHG 258
           LH      ++H+DI++ N +++ +L+  + D  ++R L     H   D+ NR V      
Sbjct: 133 LHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV-----K 184

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALE-VLMGRHPGDLLSSVNPKIMLIDLLD-QRVPSP 316
           ++A E       +   DV+SFGV+  E + +G+ P      ++P  M   L D  R+  P
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP---YVEIDPFEMAAYLKDGYRLAQP 241

Query: 317 ID 318
           I+
Sbjct: 242 IN 243

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 14/203 (6%)

Query: 97  IGTGGYGSVYRAQL----PSGKKVALKKLHHSETELAFLESFQTEA--HLLSQIRHRNIV 150
           +G GGYG V++ +      +GK  A+K L  +       ++  T+A  ++L  ++H  IV
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 151 KL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
            L Y F    K ++LI +Y+  G LF  L  + E I ++ T    + + ++ AL +LH  
Sbjct: 64  DLIYAFQTGGK-LYLILEYLSGGELFMHL--EREGIFMEDTACFYLSE-ISLALEHLHQQ 119

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
               I++RD+   NILL+++    + DFG+ +    + +      GT  Y+APE+     
Sbjct: 120 ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176

Query: 270 LTEKCDVYSFGVVALEVLMGRHP 292
             +  D +S G +  ++L G  P
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 55/231 (23%), Positives = 85/231 (36%), Gaps = 43/231 (18%)

Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           +G G  G V+  +L  +GK  ALK L   E  +   ++   TE  +L+ + H  +  LY 
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH----ALSYLHCDC 210
               +  + L+  Y   G LF +L+       L       + +  A     AL YLH   
Sbjct: 69  SFQTETYLCLVMDYCPGGELFRLLQRQPGK-CL----SEEVARFYAAEVLLALEYLHLL- 122

Query: 211 IPSIVHRDISSNNILLN-------------------SKLEAFVADFGVARLLHSDSSNRT 251
              IV+RD+   NILL+                       +     G  R   +   + T
Sbjct: 123 --GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 252 VVA----------GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                        GT  YIAPE+          D ++ G++  E+L G  P
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 30/197 (15%)

Query: 115 KVALKKL--HHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172
           +V LK L   H +  LAF E+    A L+SQ+ H ++  ++G C+      ++ +++  G
Sbjct: 46  RVVLKVLDPSHRDIALAFFET----ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHG 101

Query: 173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK--- 229
            L   LR +   + + W  ++ + + +A ALSYL      ++VH ++ + NILL      
Sbjct: 102 PLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156

Query: 230 --LEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVAL 284
                F+  +D GV+    S       +     +IAPE +     L+   D +SFG   L
Sbjct: 157 EGTSPFIKLSDPGVSFTALSREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLL 212

Query: 285 EV-------LMGRHPGD 294
           E+       L  R P +
Sbjct: 213 EICFDGEVPLKERTPSE 229

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 14/201 (6%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQT--EAHLLSQIRHRNIVKL- 152
           +G G +G V    +  +G+  A+K L   E  +A  E   T  E+ +L   RH  +  L 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS-MAHALSYLHCDCI 211
           Y F  H +  F++ +Y   G LF  L  +    R+   +R     + +  AL YLH    
Sbjct: 62  YAFQTHDRLCFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR-- 114

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
             +V+RDI   N++L+      + DFG+ +   SD +      GT  Y+APE+       
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 272 EKCDVYSFGVVALEVLMGRHP 292
              D +  GVV  E++ GR P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 17/203 (8%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +G V    +  +G+  A+K L      ++ E+A      TE  +L   RH  +  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLTA 59

Query: 152 L-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS-MAHALSYLHCD 209
           L Y F  H +  F++ +Y   G LF  L  +    R+    R     + +  AL YLH +
Sbjct: 60  LKYSFQTHDRLCFVM-EYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSE 114

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
              ++V+RD+   N++L+      + DFG+ +    D +      GT  Y+APE+     
Sbjct: 115 --KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172

Query: 270 LTEKCDVYSFGVVALEVLMGRHP 292
                D +  GVV  E++ GR P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 24/235 (10%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G G +G V  A+   +G+ VA+KK+    +     +    E  LL  +RH NI+ L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F    + ++ + + +    L  +L     +  L+       +  +   L Y+H      +
Sbjct: 78  FISPLEDIYFVTELLGT-DLHRLL----TSRPLEKQFIQYFLYQILRGLKYVHS---AGV 129

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           VHRD+  +NIL+N   +  + DFG+AR+        T    T  Y APE+  T      +
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQKYDVE 186

Query: 274 CDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
            D++S G +  E+L G+   PG     VN   ++ DLL     +P DD  VI  I
Sbjct: 187 VDIWSAGCIFAEMLEGKPLFPGK--DHVNQFSIITDLLG----TPPDD--VINTI 233

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 41/230 (17%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKK------LHHSETELAFLESFQTEAHLL 141
           EDF+    I  G YG+VY  +   + ++ A+KK      +  ++ +  F+E       +L
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVER-----DIL 55

Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD----EAIRLDWTKRVNIVK 197
           +   +  +V ++     K+ + ++ +Y+  G    +L+N      +  R+ + + V    
Sbjct: 56  TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETV---- 111

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL-----------LHSD 246
               AL YLH      IVHRD+  +N+L+ S     + DFG++++            H +
Sbjct: 112 ---LALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165

Query: 247 SSNRTV----VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
              R      V GT  YIAPE+       +  D ++ G++  E L+G  P
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 9/199 (4%)

Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHRNIVKLYG 154
           +G GG+G V   Q+  +GK  A KKL     +    ES    E  +L ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 155 FCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
               K  + L+   M  G L F I    +     +  + V     +   L  LH +    
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLHQE---R 122

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           IV+RD+   NILL+      ++D G+A  +    + +  V GT GY+APE+      T  
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFS 181

Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ G +  E++ G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 45/135 (33%), Positives = 66/135 (48%), Gaps = 12/135 (8%)

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLH---SDSSNRTVVAGTHGYIAPELAYTMVL 270
           ++HRDI S NILL S     + DFG +++     SD   RT   GT  Y+APE+      
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-CGTPYYVAPEIWRRKPY 222

Query: 271 TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVS 330
           ++K D++S GV+  E+L  + P D  +    ++M   L  +  P P      +Q+     
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFDGENM--EEVMHKTLAGRYDPLPPSISPEMQE----- 275

Query: 331 KIVFACLRSKPTSRP 345
            IV A L S P  RP
Sbjct: 276 -IVTALLSSDPKRRP 289

Length = 496

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 35/134 (26%), Positives = 66/134 (49%), Gaps = 6/134 (4%)

Query: 159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRD 218
           K+ +F + +++  G L   +++     R D  +       +   L +LH      I++RD
Sbjct: 68  KEHLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRD 121

Query: 219 ISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYS 278
           +  +N++L+      +ADFG+ +      +  +   GT  YIAPE+   +  T   D +S
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWS 181

Query: 279 FGVVALEVLMGRHP 292
           FGV+  E+L+G+ P
Sbjct: 182 FGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 22/153 (14%)

Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G Y +VY+ +   +G+ VALK++     E A   + + EA LL  ++H NIV L+  
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDI 71

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV---NIVK----SMAHALSYLHC 208
              KK + L+++Y+            D    +D        + V+     +   L+Y H 
Sbjct: 72  IHTKKTLTLVFEYLDT----------DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
                ++HRD+   N+L++ + E  +ADFG+AR
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 12/160 (7%)

Query: 136 TEAHLLSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
           TE+ +L   RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+    R  
Sbjct: 44  TESRVLQNTRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRE----RVFSEDRAR 98

Query: 195 IVKS-MAHALSYLH-CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
              + +  AL YLH CD    +V+RD+   N++L+      + DFG+ +   SD +    
Sbjct: 99  FYGAEIVSALGYLHSCD----VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154

Query: 253 VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             GT  Y+APE+          D +  GVV  E++ GR P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 13/201 (6%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAF--LESFQTEAHLLSQIR-HRNIVKLY 153
           +G G +G V  A+L    ++   K+   +  L    +E   TE  +LS  R H  + +LY
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 154 GFCLHK-KCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
             C      +F + +++  G L F I ++     R D  +       +  AL +LH    
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK-- 115

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
             I++RD+  +N+LL+ +    +ADFG+ +    +    +   GT  YIAPE+   M+  
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 272 EKCDVYSFGVVALEVLMGRHP 292
              D ++ GV+  E+L G  P
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 26/193 (13%)

Query: 116 VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF 175
           VA+K L     + A    F  E  +LS+++  NI++L G C+ +  + +I +YM  G L 
Sbjct: 49  VAVKILRPDANKNA-RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 176 CILRN---DDEA-------------IRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDI 219
             L +   DD+                + ++  +++   +A  + YL      + VHRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDL 164

Query: 220 SSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL----TEKCD 275
           ++ N L+   L   +ADFG++R L++    R  + G        +A+  +L    T   D
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYR--IQGRAVLPIRWMAWECILMGKFTTASD 222

Query: 276 VYSFGVVALEVLM 288
           V++FGV   E+LM
Sbjct: 223 VWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 9/196 (4%)

Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G Y +VY+ +   +   VALK++     E A   + + E  LL  ++H NIV L+  
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
              +K + L+++Y+ +  L   L +   +I +   K    +  +   L+Y H      ++
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKL--FLFQLLRGLNYCHRR---KVL 126

Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTEKC 274
           HRD+   N+L+N + E  +ADFG+AR     +   +    T  Y  P+ L  +   + + 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186

Query: 275 DVYSFGVVALEVLMGR 290
           D++  G +  E+  GR
Sbjct: 187 DMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 58/200 (29%), Positives = 86/200 (43%), Gaps = 11/200 (5%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAH---LLSQIRHRNIVKL- 152
           IG G +G V  A+  +  K    K+   +  L   E     A    LL  ++H  +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y F    K  F++  Y+  G LF  L+   E    +   R      +A AL YLH     
Sbjct: 63  YSFQTADKLYFVL-DYVNGGELFFHLQR--ERSFPEPRARF-YAAEIASALGYLHS---L 115

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           +I++RD+   NILL+S+    + DFG+ +     S   +   GT  Y+APE+        
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175

Query: 273 KCDVYSFGVVALEVLMGRHP 292
             D +  G V  E+L G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 51/174 (29%), Positives = 76/174 (43%), Gaps = 26/174 (14%)

Query: 193 VNIVKSMAHALSYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-RLLHSDSS 248
           V IVK    AL YL   H      ++HRD+  +NILL++     + DFG++ RL+  DS 
Sbjct: 121 VAIVK----ALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSK 169

Query: 249 NRTVVAGTHGYIAPELAYTMVLTEK----CDVYSFGVVALEVLMGRHPGDLLSSVNPKIM 304
            +T  AG   Y+APE         K     DV+S G+  +E+  G+ P     +     +
Sbjct: 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--V 227

Query: 305 LIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQR--VSQEFLVR 356
           L  +L +  PS   ++    D       V  CL      RP  R  +   F+ R
Sbjct: 228 LTKILQEEPPSLPPNEGFSPDFC---SFVDLCLTKDHRKRPKYRELLQHPFIRR 278

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 51/214 (23%), Positives = 100/214 (46%), Gaps = 23/214 (10%)

Query: 97  IGTGGYGSVYRAQLPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIV 150
           IG G Y  V   +L   +     KV  K+L + + ++ ++   QTE H+      H  +V
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWV---QTEKHVFETASNHPFLV 59

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSL-FCILRN---DDEAIRLDWTKRVNIVKSMAHALSYL 206
            L+     +  +F + +++  G L F + R     +E  R  ++  +++      AL++L
Sbjct: 60  GLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-YSAEISL------ALNFL 112

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      I++RD+  +N+LL+++    + D+G+ +         +   GT  YIAPE+  
Sbjct: 113 HER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN 300
                   D ++ GV+  E++ GR P D++   +
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 18/216 (8%)

Query: 97  IGTGGYGSVY--RAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           +G G Y +V+  R++L +   VALK++     E A   + + E  LL  ++H NIV L+ 
Sbjct: 14  LGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI-VKSMAHALSYLHCDCIPS 213
                K + L+++Y+ +     + +  D+   +     V I +  +   L+Y H      
Sbjct: 72  IVHTDKSLTLVFEYLDKD----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTE 272
           ++HRD+   N+L+N + E  +ADFG+AR     +   +    T  Y  P+ L  +   + 
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Query: 273 KCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLI 306
           + D++  G +  E+  GR   PG   S+V  ++ LI
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPG---STVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 15/162 (9%)

Query: 136 TEAHLLSQIRHRNIVKLYGFCLHKK--CMFL-IYKYMRRGSLFCILRNDDEAIRLDWTKR 192
            E  +L  I HR I+ L      K   CM +  YK      LF  +   D +  L   + 
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYV---DRSGPLPLEQA 187

Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL--HSDSSNR 250
           + I + +  AL+YLH      I+HRD+ + NI L+    A + DFG A  L  H D+   
Sbjct: 188 ITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244

Query: 251 TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
              +GT    +PEL        K D++S G+V  E+ +    
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 33/100 (33%), Positives = 57/100 (57%), Gaps = 12/100 (12%)

Query: 199 MAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
           +A  + +L   +CI    HRD+++ N+LL     A + DFG+AR + +DS+   VV G  
Sbjct: 221 VAQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--YVVKGNA 274

Query: 258 ----GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                ++APE  +  V T + DV+S+G++  E+  +G+ P
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 9/199 (4%)

Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHRNIVKLYG 154
           +G GG+G V   Q+  +GK  A KKL     +    E+    E  +L ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 155 FCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
               K  + L+   M  G L F I    +     D  + +     +   L  L  +    
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDLQRE---R 122

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           IV+RD+   NILL+ +    ++D G+A  +    + R  V GT GY+APE+      T  
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINNEKYTFS 181

Query: 274 CDVYSFGVVALEVLMGRHP 292
            D +  G +  E++ G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 52.6 bits (126), Expect = 7e-08
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 19/204 (9%)

Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKL------HHSETELAFLESFQTEAHLLSQIRHRNI 149
           +G GG+G V   Q+  +GK  A KKL        S  ++A LE       +L ++    I
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEK-----EILEKVNSPFI 55

Query: 150 VKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           V L Y F   K  + L+   M  G L   + N  E   L+  + ++    +   + +LH 
Sbjct: 56  VNLAYAF-ESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS 113

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
                IV+RD+   N+LL+ +    ++D G+A  L  D    T  AGT+GY+APE+    
Sbjct: 114 ---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEE 169

Query: 269 VLTEKCDVYSFGVVALEVLMGRHP 292
             +   D ++ G    E++ GR P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 36/118 (30%), Positives = 64/118 (54%), Gaps = 12/118 (10%)

Query: 181 DDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGV 239
           +++ + LD    ++    +A  +S+L   +CI    HRD+++ NILL       + DFG+
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGL 260

Query: 240 ARLLHSDSSNRTVVAGTH----GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           AR + +DS+   VV G       ++APE  +  V T + DV+S+G++  E+  +G  P
Sbjct: 261 ARDIRNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 9/199 (4%)

Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHRNIVKLYG 154
           +G GG+G V   Q+  +GK  A K+L     +    ES    E  +L ++  + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 155 FCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
               K  + L+   M  G L F I    +     +  + +     +   L  LH +   +
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE--RALFYAAEILCGLEDLHRE---N 122

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
            V+RD+   NILL+      ++D G+A  +    S R  V GT GY+APE+      T  
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQRYTLS 181

Query: 274 CDVYSFGVVALEVLMGRHP 292
            D +  G +  E++ G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 36/113 (31%), Positives = 61/113 (53%), Gaps = 11/113 (9%)

Query: 115 KVALKKLHHS-ETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGS 173
            V LK L       LAF E+    A L+SQ+ H+++VKLYG C+  + + ++ +Y++ G 
Sbjct: 32  SVVLKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGP 86

Query: 174 LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL 226
           L   L  +   + L W  ++++ K +A AL YL       +VH ++   NIL+
Sbjct: 87  LDVFLHREKNNVSLHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAF--LESFQTEAHLLSQIR-HRNIVKLY 153
           +G G +G V  A+L    +V   K+   +  L    ++   TE  +L+    H  +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 154 GFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
                K  +F + +Y+  G L F I R    + + D  +       +  AL +LH     
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH--- 115

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            +++RD+  +NILL+++    +ADFG+ +    +    T   GT  YIAPE+   +    
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175

Query: 273 KCDVYSFGVVALEVLMGRHP 292
             D ++ GV+  E++ G+ P
Sbjct: 176 SVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 18/184 (9%)

Query: 116 VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF 175
           VA+K L     + A    F  E  ++S+++  NI++L   C+    + +I +YM  G L 
Sbjct: 49  VAVKMLREDANKNA-RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 176 CILRN--------DDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN 227
             L            + + + ++  + +   +A  + YL      + VHRD+++ N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVG 164

Query: 228 SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL----TEKCDVYSFGVVA 283
                 +ADFG++R L+S    R  + G        +++  +L    T   DV++FGV  
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYR--IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222

Query: 284 LEVL 287
            E+L
Sbjct: 223 WEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 39/132 (29%), Positives = 63/132 (47%), Gaps = 7/132 (5%)

Query: 162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISS 221
           ++L+  YM  G LF  L+ +    R    +    +  +  AL +LH      IV+RD+  
Sbjct: 71  LYLVTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKP 124

Query: 222 NNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTEKCDVYSFG 280
            NILL++     + DFG+++   +D+       GT  Y+APE L      T+  D +S G
Sbjct: 125 ENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184

Query: 281 VVALEVLMGRHP 292
           V+  E+  G  P
Sbjct: 185 VLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 63/259 (24%), Positives = 103/259 (39%), Gaps = 67/259 (25%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET----ELAFLESFQTEAHLLSQ 143
           EDF     IG G +G V   Q   +GK  A+K L  SE     +LA +++   E  +L++
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKA---ERDVLAE 57

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD---EAIRLDWTKRVNIVKSMA 200
                +V LY      + ++LI +++  G L  +L   D   E +   +     +     
Sbjct: 58  SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-------------RLLHSDS 247
           H L +         +HRDI  +NIL++      ++DFG++             +LL   S
Sbjct: 118 HKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168

Query: 248 S------------------------------NRTVVA----GTHGYIAPELAYTMVLTEK 273
           +                              NR ++A    GT  YIAPE+       ++
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228

Query: 274 CDVYSFGVVALEVLMGRHP 292
           CD +S G +  E L+G  P
Sbjct: 229 CDWWSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 52/250 (20%), Positives = 104/250 (41%), Gaps = 25/250 (10%)

Query: 104 SVYRAQLPSGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGF----CLH 158
           S+Y+    + K+V ++            ++  + E   L +I   NI+K+YGF       
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHR 217
              + LI +Y  RG L  +L  + +   L +  ++++       L  L+     P   ++
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147

Query: 218 DISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV--LTEKCD 275
           +++S + L+    +  +   G+ ++L S             Y + ++   +    T K D
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV---NFMVYFSYKMLNDIFSEYTIKDD 204

Query: 276 VYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFA 335
           +YS GVV  E+  G+ P + L++     ++I+  +  +  P+D    I+       IV A
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS-LKLPLDCPLEIKC------IVEA 257

Query: 336 CLRSKPTSRP 345
           C       RP
Sbjct: 258 CTSHDSIKRP 267

Length = 283

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 17/200 (8%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G Y +VY+     +G+ VALK +   +TE     +   EA LL  ++H NIV L+  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
              K+ +  +++YM       ++++        +RL        +  +   L+Y+H    
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIHGQ-- 122

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVL 270
             I+HRD+   N+L++   E  +ADFG+AR     S   +    T  Y  P+ L      
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181

Query: 271 TEKCDVYSFGVVALEVLMGR 290
           +   D++  G + +E+L G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 17/200 (8%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG+G  G V  A     G  VA+KKL          +    E  LL  + H+NI+ L   
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 156 CLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
              +K +      +L+ + M   +L  ++  +     LD  +   ++  M   + +LH  
Sbjct: 89  FTPQKSLEEFQDVYLVMELMD-ANLCQVIHME-----LDHERMSYLLYQMLCGIKHLHS- 141

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
               I+HRD+  +NI++ S     + DFG+AR   ++      V  T  Y APE+   M 
Sbjct: 142 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMG 198

Query: 270 LTEKCDVYSFGVVALEVLMG 289
             E  D++S G +  E++ G
Sbjct: 199 YKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 34/224 (15%)

Query: 111 PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL--------YGFCLHKKCM 162
           P  +++  K++         LE+   E   L ++ H NI+K+          + + +K  
Sbjct: 190 PKCERLIAKRVKAGSRAAIQLEN---EILALGRLNHENILKIEEILRSEANTYMITQKYD 246

Query: 163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSN 222
           F +Y +M   +       D +   L    R  I+K +  A+ Y+H      ++HRDI   
Sbjct: 247 FDLYSFMYDEAF------DWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLE 296

Query: 223 NILLNSKLEAFVADFGVARLLHSDSSNRTV-VAGTHGYIAPELAYTMVLTEKCDVYSFGV 281
           NI LN   +  + DFG A     +         GT    +PE+       E  D++S G+
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGL 356

Query: 282 VALEVLM---------GRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
           + L++L          G  PG  L  +   I  + + D+  P P
Sbjct: 357 ILLDMLSHDFCPIGDGGGKPGKQLLKI---IDSLSVCDEEFPDP 397

Length = 501

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 25/219 (11%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRA---QLPSGK---KVALKKLHHSETELAFLESFQTEAH 139
           V+ E   +   +G G +G VY      +  G+   +VA+K ++ S +    +E F  EA 
Sbjct: 3   VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEAS 61

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-----DDEAIRLDWTKR-- 192
           ++      ++V+L G     +   ++ + M  G L   LR+     ++   R   T +  
Sbjct: 62  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
           + +   +A  ++YL+       VHRD+++ N ++       + DFG+ R ++     R  
Sbjct: 122 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK- 177

Query: 253 VAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
             G  G     ++APE     V T   D++SFGVV  E+
Sbjct: 178 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 5/97 (5%)

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL-LHSDSSNRTVVAGTH 257
           +A  L +LH      I++RD+  +N++L+++    +ADFG+ +  +    + RT   GT 
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165

Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGD 294
            YIAPE+       +  D ++FGV+  E+L G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           E+F I   I  G +G VY  +   + K  A+K +  ++      +   Q E   L+  + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRG---SLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
             IV LY        ++L+ +Y+  G   SL  I    DE + + +      +  +A AL
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY------ISEVALAL 117

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242
            YLH      I+HRD+  +N+L++++    + DFG++++
Sbjct: 118 DYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 26/81 (32%), Positives = 45/81 (55%)

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           I++RD+  +N++L+S+    +ADFG+ +    D        GT  YIAPE+       + 
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 274 CDVYSFGVVALEVLMGRHPGD 294
            D +++GV+  E+L G+ P D
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.9 bits (121), Expect = 4e-07
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)

Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 136

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 192

Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 193 MGYKENVDIWSVGCIMGE--MVRH 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 14/150 (9%)

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+V L+ + + +  +FL+ ++   G L+  +      I  +  KR      M  AL  LH
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN-IPEECVKR--WAAEMVVALDALH 102

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
            +    IV RD++ NNILL+ +    +  F     +  DS +   V     Y APE+   
Sbjct: 103 RE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-EDSCDGEAVENM--YCAPEVGGI 156

Query: 268 MVLTEKCDVYSFGVVALEVLMGR-----HP 292
              TE CD +S G +  E+L G+     HP
Sbjct: 157 SEETEACDWWSLGAILFELLTGKTLVECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 19/194 (9%)

Query: 107 RAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY 166
           R   P  K VA   + + E + A+  S   E H L+   H  IVK +        + LI 
Sbjct: 88  RGSDPKEKVVAKFVMLNDERQAAYARS---ELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144

Query: 167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY---LHCDCIPS--IVHRDISS 221
           +Y   G L       ++ I+    + +   +     L Y   L  D + S  ++HRD+ S
Sbjct: 145 EYGSGGDL-------NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197

Query: 222 NNILLNSKLEAFVADFGVARLLHSDSSNRTVVA---GTHGYIAPELAYTMVLTEKCDVYS 278
            NI L       + DFG ++  +SDS +  V +   GT  Y+APEL      ++K D++S
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQ-YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWS 256

Query: 279 FGVVALEVLMGRHP 292
            GV+  E+L    P
Sbjct: 257 LGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 3/96 (3%)

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           +A  L +LH      I++RD+  +N++L+S+    +ADFG+ +    D        GT  
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGD 294
           YIAPE+       +  D ++FGV+  E+L G+ P +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 20/139 (14%)

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVL 270
           +HRD+++ NILL+      + DFG+AR ++ D     V  G+      ++APE  +  V 
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGSARLPLKWMAPESIFDKVY 253

Query: 271 TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVS 330
           T + DV+SFGV+  E+        L +S  P + + +   QR    + D T ++     +
Sbjct: 254 TTQSDVWSFGVLLWEIF------SLGASPYPGVQINEEFCQR----LKDGTRMRAPENAT 303

Query: 331 ----KIVFACLRSKPTSRP 345
               +I+ AC +  P  RP
Sbjct: 304 PEIYRIMLACWQGDPKERP 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 7/198 (3%)

Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHRNIVKLYG 154
           +G GG+G V   Q+  +GK  A KKL     +    E+    E  +L ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
               K  + L+   M  G L   + N       D  + V     +   L  LH +    I
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLHRE---RI 123

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           V+RD+   NILL+      ++D G+A  +    + R  V GT GY+APE+      T   
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEVVKNERYTFSP 182

Query: 275 DVYSFGVVALEVLMGRHP 292
           D +  G +  E++ G+ P
Sbjct: 183 DWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 37/216 (17%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAH---------LLSQIRH 146
           IG+G  G V  A    +G+ VA+KKL            FQ   H         L+  + H
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLS---------RPFQNVTHAKRAYRELVLMKLVNH 74

Query: 147 RNIVKLYG-FCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMA 200
           +NI+ L   F   K       ++L+ + M   +L  +++ D     LD  +   ++  M 
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQML 128

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
             + +LH      I+HRD+  +NI++ S     + DFG+AR   +       V  T  Y 
Sbjct: 129 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYR 184

Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           APE+   M   E  D++S G +  E++ G    PG 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 42/210 (20%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-------HRN 148
           IG G +  V +AQ   +GK  A+K +      L        + + L +I+       H N
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-------QVNNLREIQALRRLSPHPN 59

Query: 149 IVKLYGFCLHKK--CMFLIYKYMRRGSLFCILRNDDEAIR-----LDWTKRVNIVKSMAH 201
           I++L      +K   + L+++ M   +L+       E I+     L   +  + +  +  
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMD-MNLY-------ELIKGRKRPLPEKRVKSYMYQLLK 111

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           +L ++H +    I HRDI   NIL+     KL    ADFG  R ++S     T    T  
Sbjct: 112 SLDHMHRN---GIFHRDIKPENILIKDDILKL----ADFGSCRGIYSKPP-YTEYISTRW 163

Query: 259 YIAPELAYTM-VLTEKCDVYSFGVVALEVL 287
           Y APE   T      K D+++ G V  E+L
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 28/217 (12%)

Query: 91  FDIKYC-IGTGGYGSVYRAQLPSG---KKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           F+ + C +G G YG VY+A+   G   K+ ALK++  +   +    S   E  LL +++H
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISM----SACREIALLRELKH 57

Query: 147 RNIVKLYG-FCLHK-KCMFLIYKYMRRGSLFCIL------RNDDEAIRLDWTKRVNIVKS 198
            N++ L   F  H  + ++L++ Y     L+ I+      + + + ++L  +   +++  
Sbjct: 58  PNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILL----NSKLEAFVADFGVARLLHS---DSSNRT 251
           +   + YLH +    ++HRD+   NIL+      +    +AD G ARL +S     ++  
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 252 VVAGTHGYIAPELAY-TMVLTEKCDVYSFGVVALEVL 287
            V  T  Y APEL       T+  D+++ G +  E+L
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.0 bits (116), Expect = 3e-06
 Identities = 54/238 (22%), Positives = 109/238 (45%), Gaps = 44/238 (18%)

Query: 90  DFDIKYCIGTGGYGSVY-----RAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQ 143
           ++++   IG G +G V+     R Q     K ++ + L   E           E +++ +
Sbjct: 14  EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-----QLVIEVNVMRE 68

Query: 144 IRHRNIVKLYGFCLHK--KCMFLIYKYMRRGSLFCILRNDDEAIRL----DWTKRVNIVK 197
           ++H+NIV+     L+K  + ++++ ++   G L    RN  +  ++    +    V+I +
Sbjct: 69  LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLS---RNIQKCYKMFGKIEEHAIVDITR 125

Query: 198 SMAHALSYLH-CDCIPS---IVHRDISSNNILLNSKLE-----------------AFVAD 236
            + HAL+Y H     P+   ++HRD+   NI L++ +                  A + D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 237 FGVARLLHSDSSNRTVVAGTHGYIAPELAY--TMVLTEKCDVYSFGVVALEVLMGRHP 292
           FG+++ +  +S   + V GT  Y +PEL    T    +K D+++ G +  E+  G+ P
Sbjct: 186 FGLSKNIGIESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 21/203 (10%)

Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89

Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   +       V  T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILG 199

Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
           M   E  D++S G +  E++ G 
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 7/83 (8%)

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVL 270
           +HRD+++ NILL+      + DFG+AR ++ D     V  G       ++APE  +  V 
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVY 258

Query: 271 TEKCDVYSFGVVALEVL-MGRHP 292
           T + DV+SFGV+  E+  +G  P
Sbjct: 259 TIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 58/238 (24%), Positives = 101/238 (42%), Gaps = 60/238 (25%)

Query: 91  FDI--KYC----IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQ 143
           FD+  +Y     +G G  G V+ A      K+VA+KK+         L   Q+  H L +
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI--------VLTDPQSVKHALRE 52

Query: 144 IR------HRNIVKLY--------------GFCLHKKCMFLIYKYMRRGSLFCILRNDDE 183
           I+      H NIVK+Y              G       ++++ +YM        L N  E
Sbjct: 53  IKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLE 107

Query: 184 AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARL 242
              L        +  +   L Y+H     +++HRD+   N+ +N++ L   + DFG+AR+
Sbjct: 108 QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Query: 243 LHSDSSNR-----TVVAGTHGYIAPELAYTMVL-----TEKCDVYSFGVVALEVLMGR 290
           +    S++      +V  T  Y +P L    +L     T+  D+++ G +  E+L G+
Sbjct: 165 VDPHYSHKGYLSEGLV--TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 7/83 (8%)

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVL 270
           +HRD+++ NILL+      + DFG+AR ++ D     V  G       ++APE  +  V 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPESIFDKVY 252

Query: 271 TEKCDVYSFGVVALEVL-MGRHP 292
           T + DV+SFGV+  E+  +G  P
Sbjct: 253 TTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 28/217 (12%)

Query: 91  FDIKYC-IGTGGYGSVYRAQLPSG---KKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           F+ + C +G G YG VY+A+   G   +  ALK++  +   +    S   E  LL +++H
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISM----SACREIALLRELKH 57

Query: 147 RNIVKLYGFCLH--KKCMFLIYKYMRRGSLFCIL------RNDDEAIRLDWTKRVNIVKS 198
            N++ L    L    + ++L++ Y     L+ I+      + + + ++L      +++  
Sbjct: 58  PNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILL----NSKLEAFVADFGVARLLHS---DSSNRT 251
           +   + YLH +    ++HRD+   NIL+      +    +AD G ARL +S     ++  
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 252 VVAGTHGYIAPELAY-TMVLTEKCDVYSFGVVALEVL 287
            V  T  Y APEL       T+  D+++ G +  E+L
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.7 bits (111), Expect = 7e-06
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 35/220 (15%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN-IVKLYG 154
           IG G YG VY+A+   +GK VALKK      E     +   E  LL  +     IV+L  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL-- 66

Query: 155 FCLH-------KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR-------VNIVKSMA 200
             +        K  ++L+++Y+          + D    +D   R          +KS  
Sbjct: 67  LDVEHVEEKNGKPSLYLVFEYL----------DSDLKKFMDSNGRGPGRPLPAKTIKSFM 116

Query: 201 HAL--SYLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTH 257
           + L     HC     ++HRD+   N+L++ +     +AD G+ R       + T    T 
Sbjct: 117 YQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL 175

Query: 258 GYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
            Y APE L  +   +   D++S G +  E+   +   PGD
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 24/207 (11%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHRN----IV 150
           IG GG+G VY   +  +GK  A+K L     ++   E+    E  +LS +   +    + 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYL 206
             Y F    K  F I   M  G L   L       ++ +R   T+   I+  + H  +  
Sbjct: 62  MTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFSEKEMRFYATE---IILGLEHMHNRF 117

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
                  +V+RD+   NILL+      ++D G+A        + +V  GTHGY+APE L 
Sbjct: 118 -------VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEVLQ 168

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHP 292
                    D +S G +  ++L G  P
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)

Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-- 252
           + + +  A+ Y+H +    I+HRDI + N+L+N   +  + DFG A       S      
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 253 VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS 298
           +AGT    APE+      T   D++S G+V  E  +  H   L S+
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV--HTASLFSA 365

Length = 461

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 26/80 (32%), Positives = 41/80 (51%), Gaps = 3/80 (3%)

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTE 272
           +V+RD+   NILL+      ++D G+A        + +V  GTHGY+APE L   +    
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEVLQKGVAYDS 175

Query: 273 KCDVYSFGVVALEVLMGRHP 292
             D +S G +  ++L G  P
Sbjct: 176 SADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 19/102 (18%)

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR--LLHSDSSNRTVVAGTHGY 259
            L YLH +    IV+RD+  +N+LL+++    +ADFG+ +  +   D +  +   GT  +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--STFCGTPEF 167

Query: 260 IAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP--GD 294
           +APE     VLTE       D +  GV+  E+L+G  P  GD
Sbjct: 168 LAPE-----VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 49/223 (21%)

Query: 97  IGTGGYG---SVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKL 152
           +G G YG   S   A+    + VA+KK+ +  ++    +    E  LL   R H+NI  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM-----AH------ 201
           Y        M +++       L+      +E +  D  +   I++S      AH      
Sbjct: 68  YD-------MDIVFPGNFNE-LYLY----EELMEADLHQ---IIRSGQPLTDAHFQSFIY 112

Query: 202 ----ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG-- 255
                L Y+H     +++HRD+   N+L+N+  E  + DFG+AR     S N    AG  
Sbjct: 113 QILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR---GFSENPGENAGFM 166

Query: 256 -----THGYIAPELAYTMV-LTEKCDVYSFGVVALEVLMGRHP 292
                T  Y APE+  +    T+  DV+S G +  E L+GR P
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 29/216 (13%)

Query: 97  IGTGGYGSVYRAQLPSG---KKVALKKLHHS---ETELAFLESFQTEAHLLSQIRHRNIV 150
           IG G +G V   ++ SG    +V +K+L  S   + ++ FLE    EA     ++H N++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE----EAQPYRSLQHSNLL 58

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRL--DWTKRVNIVKSMAHALSYLHC 208
           +  G C       L+ ++   G L   LR+  +A  +  D T    +   +A  L +LH 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD----SSNRTVVAGTHGYIAPEL 264
           +   + +H D++  N LL + L   + D+G++   + +    + ++  V     +IAPEL
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR--WIAPEL 173

Query: 265 -----AYTMVL--TEKCDVYSFGVVALEVL-MGRHP 292
                   +V+  T++ +V+S GV   E+  +G  P
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 56/248 (22%), Positives = 98/248 (39%), Gaps = 65/248 (26%)

Query: 97  IGTGGYGSVYRAQLPSGKKV-ALKKLHHSET----ELAFLESFQTEAHLLSQIRHRNIVK 151
           IG G +G V   +      + A+K L  ++     + A +++   E  +L++  +  +VK
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA---ERDILAEADNEWVVK 65

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRL----DWTKRVNIVKSMAHALSYLH 207
           LY     K  ++ +  Y+  G +  +L      IRL    +   R  I + +  A+  +H
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLL------IRLGIFEEDLARFYIAE-LTCAIESVH 118

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVA---RLLH-------------------- 244
                  +HRDI  +NIL++      + DFG+    R  H                    
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 245 --SDSSNRTV------------------VAGTHGYIAPELAYTMVLTEKCDVYSFGVVAL 284
             S+     +                  + GT  YIAPE+      T+ CD +S GV+  
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235

Query: 285 EVLMGRHP 292
           E+L+G+ P
Sbjct: 236 EMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 20/139 (14%)

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVL 270
           VHRD+++ N+LL       + DFG+AR +  DS+   V  G+      ++APE  +  + 
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN--YVSKGSTFLPVKWMAPESIFDNLY 316

Query: 271 TEKCDVYSFGVVALEVL-MG--RHPGDLL-SSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
           T   DV+S+G++  E+  +G   +PG ++ S+   KI        R+  P      + DI
Sbjct: 317 TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK----SGYRMAKPDHATQEVYDI 372

Query: 327 ILVSKIVFACLRSKPTSRP 345
           ++       C  S+P  RP
Sbjct: 373 MV------KCWNSEPEKRP 385

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 40/212 (18%)

Query: 104 SVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM 162
           SVY A+  P+G  V ++           L++ Q E  L    RH NI+  +        +
Sbjct: 15  SVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74

Query: 163 FLIYKYMRRGSLFCILRN------DDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           ++I  +M  GS   +L+        +  I        NI+      L+YLH +     +H
Sbjct: 75  WVISPFMAYGSANSLLKTYFPEGMSEALIG-------NILFGALRGLNYLHQN---GYIH 124

Query: 217 RDISSNNILLN----------SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL-- 264
           R+I +++IL++          S L + V +   A++++      T V     +++PEL  
Sbjct: 125 RNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLR 181

Query: 265 ----AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                Y +    K D+YS G+ A E+  GR P
Sbjct: 182 QDLYGYNV----KSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 54/251 (21%), Positives = 101/251 (40%), Gaps = 67/251 (26%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSE----TELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +G V  A ++ +    A+K L   +     ++A +++   E  +L++  +  +VK
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKA---ERDILAEADNEWVVK 65

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDD---EAIRLDWTKRVNIVKSMAHALSYLHC 208
           LY     K  ++ +  Y+  G +  +L   +   E +   +   + +     H + +   
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF--- 122

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVA---RLLHS-------------------- 245
                 +HRDI  +NIL++      + DFG+    R  H+                    
Sbjct: 123 ------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 246 --DSSN-------RTV---------------VAGTHGYIAPELAYTMVLTEKCDVYSFGV 281
             D SN       +T+               + GT  YIAPE+      T+ CD +S GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236

Query: 282 VALEVLMGRHP 292
           +  E+L+G+ P
Sbjct: 237 ILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 56/251 (22%), Positives = 100/251 (39%), Gaps = 67/251 (26%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAF-LESFQTEAHLLSQIRHRNIVKLYG 154
           +G G +G V  A ++ +    A+K L   +  L   +   + E  +L++  +  +V+LY 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH-ALSYLHCDCIPS 213
               K  ++ +  Y+  G +  +L      IR+         + +A   ++ L C  + S
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLL------IRMGIFP-----EDLARFYIAELTC-AVES 116

Query: 214 I-----VHRDISSNNILLNSKLEAFVADFGVA---RLLH--------------------- 244
           +     +HRDI  +NIL++      + DFG+    R  H                     
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 245 -SDSSN-------------------RTV---VAGTHGYIAPELAYTMVLTEKCDVYSFGV 281
             D +N                   R +   + GT  YIAPE+      T+ CD +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 282 VALEVLMGRHP 292
           +  E+L+G+ P
Sbjct: 237 ILYEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 25/76 (32%), Positives = 41/76 (53%), Gaps = 4/76 (5%)

Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVLT 271
           VHRD+++ N+L+       + DFG+AR +  DS N      T     ++APE  +  + T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDS-NYISKGSTFLPLKWMAPESIFNNLYT 319

Query: 272 EKCDVYSFGVVALEVL 287
              DV+SFG++  E+ 
Sbjct: 320 TLSDVWSFGILLWEIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 28/98 (28%), Positives = 44/98 (44%), Gaps = 12/98 (12%)

Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLH---HSETELAFLESFQTEAHLLSQIRHR 147
           +G G +G V  A      +  +  +VA+K L    H++   A +   +  +HL    +H+
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG---QHK 102

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI 185
           NIV L G C H   + +I +Y   G L   LR   E  
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 14/150 (9%)

Query: 97  IGTGGYGSVYRAQL---PSGKKVALKKLH---HSETELAFLESFQTEAHLLSQIRHRNIV 150
           IG G +G V  +++       +V +K+L     S+ +  FL+  Q + + + Q  H NI+
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQ--QGDPYRILQ--HPNIL 58

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN-IVKSMAHALSYLHCD 209
           +  G C+      L+++Y   G L   L  +    R      +  +   +A  ++++H  
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGV 239
              + +H D++  N  L S L   V D+G+
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 45/165 (27%), Positives = 68/165 (41%), Gaps = 24/165 (14%)

Query: 93  IKYCIGTGGYGSVYRAQLPSGKKV---ALKKLHHSETELAFLESFQTEAHL--------- 140
           I   IG GG+G VY  Q  S   +   A+ K+ + E E   +E+                
Sbjct: 16  IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWK 75

Query: 141 -LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR--LDWTKRV--NI 195
            +  I H  I K YG    K+C      Y R   L  ++ N  E  +      K++  NI
Sbjct: 76  NIHNIDHLGIPKYYGCGSFKRCRM----YYRFILLEKLVENTKEIFKRIKCKNKKLIKNI 131

Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240
           +K M   L Y+H      I H DI   NI+++     ++ D+G+A
Sbjct: 132 MKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	363
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
PRK10345	210	hypothetical protein; Provisional	99.85
smart00090	237	RIO RIO-like kinase.	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.68
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.6
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.54
KOG1243	690	consensus Protein kinase [General function predict	99.51
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.5
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.34
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.34
KOG3087	229	consensus Serine/threonine protein kinase [General	99.31
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.2
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.13
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.1
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.97
PRK09902	216	hypothetical protein; Provisional	98.89
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.87
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.87
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.84
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.76
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.72
PF01636	239	APH: Phosphotransferase enzyme family This family	98.59
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.52
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.51
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.46
PLN02876	822	acyl-CoA dehydrogenase	98.39
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.38
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.35
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.34
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.33
PRK10593	297	hypothetical protein; Provisional	98.24
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.18
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.16
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.04
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.02
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.97
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.87
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.83
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.79
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.69
PRK05231	319	homoserine kinase; Provisional	97.68
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.6
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.57
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.56
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.4
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.39
PLN02756	418	S-methyl-5-thioribose kinase	97.25
KOG2270	520	consensus Serine/threonine protein kinase involved	97.23
PLN02236	344	choline kinase	97.13
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.06
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.79
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.77
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.58
PRK11768	325	serine/threonine protein kinase; Provisional	96.56
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.56
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.38
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.25
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	96.24
PRK06148	1013	hypothetical protein; Provisional	96.19
PRK12396	409	5-methylribose kinase; Reviewed	96.16
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.11
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.98
COG2334	331	Putative homoserine kinase type II (protein kinase	95.89
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	95.89

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-54  Score=389.98  Aligned_cols=276  Identities=38%  Similarity=0.624  Sum_probs=228.9

Q ss_pred             CCCCccHHHHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeee
Q 046084           75 YDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG  154 (363)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  154 (363)
                      ....+++.++..++++|.-.+.||+|+||.||+|...+|..||||++.......  ..+|..|++++.+++|||+|+|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG  138 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG  138 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence            345689999999999999999999999999999999999999999887765532  255999999999999999999999


Q ss_pred             EEeeCC-eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceE
Q 046084          155 FCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF  233 (363)
Q Consensus       155 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  233 (363)
                      ||.+.+ ..+|||||+++|+|.++++..... .++|..+++|+.++|+||+|||+.+.+.|+||||||+|||||+++++|
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            999999 599999999999999999886654 789999999999999999999999888899999999999999999999


Q ss_pred             EEeeccceeccCCCCCceee-ccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc---hh------
Q 046084          234 VADFGVARLLHSDSSNRTVV-AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP---KI------  303 (363)
Q Consensus       234 l~Dfg~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---~~------  303 (363)
                      |+|||+++............ .||.+|+|||+...+..+.|+||||||++++||+||+.|.+.......   ..      
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999996653312222222 799999999999989999999999999999999999988764321111   11      


Q ss_pred             ---hHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          304 ---MLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       304 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                         ...+++|..+......  .......+..+...|++.+|++|| |.||+.+|..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~--~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYP--DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             HCcchhheeCCCccCCCCC--hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence               1233444443321111  114555689999999999999999 9999998843

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-53  Score=381.57  Aligned_cols=257  Identities=32%  Similarity=0.529  Sum_probs=213.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-eEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-CMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  166 (363)
                      ..++.+.+.||+|+||+||+|.+.....||||++..........+.|.+|+.+|.+++|||||+++|+|.+.. ..++||
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            4445556669999999999999954444999999877654444679999999999999999999999999987 789999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEEeCCCCCCeeecCCC-ceEEEeeccceecc
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS-IVHRDISSNNILLNSKL-EAFVADFGVARLLH  244 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  244 (363)
                      ||+++|+|..+++.. ....+++..+++++.|||+||.|||+.   + |+||||||+|||++.++ ++||+|||+++...
T Consensus       120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            999999999999874 223799999999999999999999999   8 99999999999999997 99999999998765


Q ss_pred             CCCCCceeeccccccccccccc--cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhh--hcccCCCCCCCh
Q 046084          245 SDSSNRTVVAGTHGYIAPELAY--TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDL--LDQRVPSPIDDQ  320 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  320 (363)
                      ......+...||..|||||++.  ...|+.|+||||||+++|||+||+.||......   .....+  ...++..+..++
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~v~~~~~Rp~~p~~~~  272 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASAVVVGGLRPPIPKECP  272 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcCCCCCCCccCC
Confidence            4333444467999999999999  569999999999999999999999998876541   222222  223333333333


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .      .+..|+..||+.||+.|| +.+++..|....
T Consensus       273 ~------~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  273 P------HLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             H------HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence            2      388899999999999999 999999987543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-53  Score=363.00  Aligned_cols=257  Identities=29%  Similarity=0.442  Sum_probs=217.5

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-eEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-CMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  166 (363)
                      .+.+..+.||+|..|+||++.+ ++++.+|+|++... .+....+++.+|+++++..+|||||.+||.|..++ .++++|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            4556677899999999999966 47888999999543 34455688999999999999999999999999999 499999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||++|+|++++...+   ++++...-+++.++++||.|||. +   +|+||||||+|||++..|++||||||.+..+..
T Consensus       158 EYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             hhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            9999999999998664   69999999999999999999996 5   999999999999999999999999999988754


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCC--cCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLL--SSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      .  ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.||...  .....-..+..+.++..|.....    
T Consensus       232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~----  305 (364)
T KOG0581|consen  232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG----  305 (364)
T ss_pred             h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc----
Confidence            4  445678999999999999999999999999999999999999998654  12344455666666554433322    


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      ....+++.+|..||++||.+|| +.|++.+-..++.
T Consensus       306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            1122489999999999999999 9999988776654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-51  Score=376.25  Aligned_cols=252  Identities=25%  Similarity=0.434  Sum_probs=220.2

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .+|...+.||+|+|+.+|.++. .+|+.||+|++..... .....+...+|+++.++|+|||||+++++|++.+++|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5689999999999999999977 8899999999977432 2233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      |+|.+++|..+++...   ++++.+++.++.||+.||.|||++   +|+|||||..|+|++++.++||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999998554   799999999999999999999999   9999999999999999999999999999999888


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      .....+.+|||.|.|||++....++..+||||+||++|.|+.|++||+..   +-++....+....+..|...+.     
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk---~vkety~~Ik~~~Y~~P~~ls~-----  243 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK---TVKETYNKIKLNEYSMPSHLSA-----  243 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc---hHHHHHHHHHhcCcccccccCH-----
Confidence            88888999999999999999999999999999999999999999998753   2334445555555544443222     


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                       .-.+||.++|++||.+|| ..+|+.+-.+
T Consensus       244 -~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  244 -EAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             -HHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence             267899999999999999 9999876554

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-52  Score=374.55  Aligned_cols=256  Identities=27%  Similarity=0.504  Sum_probs=211.3

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      +.+..+.+++.+.||+|.||.||.|.+....+||+|.++......   +.|.+|+++|++|+|+|||+++++|..++.+|
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            334455667788899999999999999777799999998765433   67889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ||||||+.|+|.++|+.. ....+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+++..
T Consensus       278 IVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             EEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence            999999999999999873 233688999999999999999999999   9999999999999999999999999999955


Q ss_pred             cCCCCCc-eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          244 HSDSSNR-TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       244 ~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ..+.+.. ....-+..|.|||.+....++.|||||||||+||||+| |+.||...+..  +....-....+++.|..++.
T Consensus       354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--ev~~~le~GyRlp~P~~CP~  431 (468)
T KOG0197|consen  354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--EVLELLERGYRLPRPEGCPD  431 (468)
T ss_pred             CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--HHHHHHhccCcCCCCCCCCH
Confidence            4433322 11223568999999999999999999999999999998 99997665432  22222223457777776664


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .      +.+++..||+.+|++|| +..+...+.
T Consensus       432 ~------vY~lM~~CW~~~P~~RPtF~~L~~~l~  459 (468)
T KOG0197|consen  432 E------VYELMKSCWHEDPEDRPTFETLREVLE  459 (468)
T ss_pred             H------HHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence            4      88899999999999999 655544443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-53  Score=352.24  Aligned_cols=260  Identities=23%  Similarity=0.317  Sum_probs=215.8

Q ss_pred             cCCcccCeeeecCceeEEEE-EeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeee-EEeeCCe-EEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG-FCLHKKC-MFLI  165 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  165 (363)
                      .+|.+.++||+|+||+||++ ...+|..+|.|.++....+....+....|+.+|++++|||||++++ .+.+++. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            45777888999999999999 5578999999999977666666778999999999999999999998 3444444 8999


Q ss_pred             EEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          166 YKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIP-SIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ||+|.+|+|...++... ....+++..+|+++.|++.||.++|+.... -++||||||.||+++.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999886532 344689999999999999999999984221 3999999999999999999999999999999


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ..........+|||.||+||.+.+..|+.+|||||+||++|||+.-++||...   +-......+.....++..    ..
T Consensus       179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~~~~p----~~  251 (375)
T KOG0591|consen  179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDYPPLP----DE  251 (375)
T ss_pred             cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCCCCCc----HH
Confidence            88777778889999999999999999999999999999999999999998654   333344445454443222    12


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .....+.+||..|+.+||+.|| +..++..+..
T Consensus       252 ~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  252 HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            3334589999999999999999 6666666554

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-51  Score=359.25  Aligned_cols=262  Identities=24%  Similarity=0.347  Sum_probs=215.0

Q ss_pred             HhcCCcccCeeeecCceeEEEE-EeCCCCEEEEEEeccccchH-----HHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETEL-----AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      ..+.|.+.+.||+|+||.|-+| ..++|+.||||+++......     .......+|+++|++++|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4566888999999999999999 55689999999997654221     11123579999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC---CceEEEee
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK---LEAFVADF  237 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Df  237 (363)
                      ..|+||||++||.|.+.+-.+.   .+.+..-..+++|++.|+.|||++   ||+||||||+|||++.+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999987665   466667778999999999999999   99999999999999766   88999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccccccC---CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL---TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP  314 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  314 (363)
                      |+|+... ......+.+||+.|.|||++.+..+   ..++|+||+||+||-+++|.+||+....  .......+..+++.
T Consensus       324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~eQI~~G~y~  400 (475)
T KOG0615|consen  324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKEQILKGRYA  400 (475)
T ss_pred             chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHHHHhcCccc
Confidence            9999875 4556778899999999999986543   3478999999999999999999865432  22245566677766


Q ss_pred             CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhh
Q 046084          315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL  359 (363)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~  359 (363)
                      .....  +.....+-.+||.+||..||++|| +.|.+.+-+.+...
T Consensus       401 f~p~~--w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  401 FGPLQ--WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ccChh--hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            54321  222233578999999999999999 99999998887543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=352.74  Aligned_cols=201  Identities=30%  Similarity=0.543  Sum_probs=183.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..+|.+.+.||+|+||+||+|++ .++..||||.+..........+.+..|+.+|+.++|||||++++++...+.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            46788899999999999999965 46789999999887655666788999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC------CceEEEeeccc
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK------LEAFVADFGVA  240 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~------~~~kl~Dfg~~  240 (363)
                      |||.||+|.+|++..+   .+++.....++.|+|.||++||++   +|+||||||.|||++..      -.+||+|||++
T Consensus        89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999999876   699999999999999999999999   99999999999999764      46899999999


Q ss_pred             eeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCC
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDL  295 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~  295 (363)
                      +.+.. .....+.+|++-|||||++....|+.|+|+||+|+++|||++|+.||+.
T Consensus       163 R~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  163 RFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            98863 4445667899999999999999999999999999999999999999764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-50  Score=345.77  Aligned_cols=245  Identities=27%  Similarity=0.443  Sum_probs=211.5

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      ...++|++.+.||+|+||+||.++. ++++.+|+|++++.... ....+....|..+|..++||.||++.-.|++.+.+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            3467899999999999999999954 56889999999876532 223567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +|+||+.||.|...|++.+   .+++..+.-++..|+.||.|||+.   +|+||||||+|||+|.+|+++|+|||+++..
T Consensus       102 lVld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            9999999999999998766   699999999999999999999999   9999999999999999999999999999976


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC-Chhh
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID-DQTV  322 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  322 (363)
                      ........+.+||+.|||||++.+..|+.++|.||||+++|||++|.+||...   +.......+...+.+.+.. .+. 
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~---~~~~~~~~I~~~k~~~~p~~ls~-  251 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE---DVKKMYDKILKGKLPLPPGYLSE-  251 (357)
T ss_pred             ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc---cHHHHHHHHhcCcCCCCCccCCH-
Confidence            66666667789999999999999999999999999999999999999997643   4455666666666333322 221 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                           ..++++...|+.||++|-
T Consensus       252 -----~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  252 -----EARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----HHHHHHHHHhccCHHHhc
Confidence                 377899999999999993

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-49  Score=375.64  Aligned_cols=258  Identities=26%  Similarity=0.453  Sum_probs=214.5

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH  158 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  158 (363)
                      .+...+....+.||+|+||+||+|+..      +..-||||.++...+.. ...+|++|++++..++|||||+++|+|.+
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~-~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ-ARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH-HHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            345667788899999999999999753      34579999999876653 35889999999999999999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDE-----------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN  227 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~  227 (363)
                      ++..++|+|||..|+|..+|....+           ..+++..+.+.|+.|||.||.||.++   .+|||||..+|+||.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence            9999999999999999999965321           22388999999999999999999999   999999999999999


Q ss_pred             CCCceEEEeeccceeccCCCCCce--eeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhh
Q 046084          228 SKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM  304 (363)
Q Consensus       228 ~~~~~kl~Dfg~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~  304 (363)
                      ++..|||+|||+++......+...  ...-+.+|||||.+..++||.+||||||||+|||+++ |+.||...+.   +++
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~EV  714 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QEV  714 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HHH
Confidence            999999999999987654433221  2234679999999999999999999999999999997 9999766543   233


Q ss_pred             HHhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          305 LIDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       305 ~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...+..+ .++.|.+++.      .+.+|+..||+.+|++|| +.||-..|..
T Consensus       715 Ie~i~~g~lL~~Pe~CP~------~vY~LM~~CW~~~P~~RPsF~eI~~~L~~  761 (774)
T KOG1026|consen  715 IECIRAGQLLSCPENCPT------EVYSLMLECWNENPKRRPSFKEIHSRLQA  761 (774)
T ss_pred             HHHHHcCCcccCCCCCCH------HHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence            3333333 3455555543      488999999999999999 9999988865

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.1e-49  Score=329.60  Aligned_cols=259  Identities=24%  Similarity=0.364  Sum_probs=211.9

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      +.|+....+|+|+||.||+++++ +|+.||||++..+.++....+-.++|+.+|++++|+|+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45777889999999999999764 69999999999888877777788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      ||+..-|. -++....  .++.+.+.+++.|++.|+.|+|++   +++||||||+|||++.++.+||||||+|+.+..+.
T Consensus        82 ~~dhTvL~-eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLH-ELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHH-HHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            99885444 4444333  478899999999999999999999   99999999999999999999999999999998777


Q ss_pred             CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---------------
Q 046084          248 SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---------------  311 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------  311 (363)
                      ...+.++.|.+|+|||.+.+ .+|...+||||+||++.||++|.+-|...++.+.-......+..               
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            77788899999999998887 78999999999999999999999988776665433332221111               


Q ss_pred             ---cCCCCCCChh----hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          312 ---RVPSPIDDQT----VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       312 ---~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                         .+|.+.....    .......+.+++..||+.||.+|+ ..|++.+-
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~  285 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP  285 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence               1121111111    111122478999999999999999 88777543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=352.36  Aligned_cols=265  Identities=25%  Similarity=0.445  Sum_probs=218.3

Q ss_pred             ccHHHHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 046084           79 ITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH  158 (363)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  158 (363)
                      .+.+++++..+++.+.+.||+|+||+||+|.+..  .||||+++......+..+.|+.|+..+++-+|.||+-+.|+|..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            4457888888999999999999999999999843  69999999988888889999999999999999999999999998


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      ... .+|+.||+|.+|+.+++..+.  .++..+.+.|+.|+|+||.|||.+   +|+|||||..|||+.++++|||+|||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence            887 999999999999999987653  689999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccC--CCCCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          239 VARLLHS--DSSNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       239 ~~~~~~~--~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      ++..-..  .........|...|||||++.   ..+|++.+||||||+++|||++|..||..   .+.+..+..+-++ +
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi---~~~dqIifmVGrG-~  609 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI---QNRDQIIFMVGRG-Y  609 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC---CChhheEEEeccc-c
Confidence            9965322  122233345788999999876   45799999999999999999999999872   2233333332222 1


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      -.+........+...+.+|+..||..++++|| +.+++..|+.
T Consensus       610 l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~  652 (678)
T KOG0193|consen  610 LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEE  652 (678)
T ss_pred             cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHH
Confidence            11222222233344599999999999999999 9999996654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-49  Score=364.75  Aligned_cols=254  Identities=30%  Similarity=0.493  Sum_probs=218.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      .....+.+.||.|.||.|++|+++    ....||||.++....+ ....+|+.|+.+|-+++||||++|.|+......+.
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte-kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH-HHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence            345578899999999999999764    2347999999987655 34678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +++|||++|+|+.+|+.+++  .+++.++.-++++||.||.||.+.   ++|||||..+|||++.+..+|++|||+++.+
T Consensus       707 IiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence            99999999999999998775  489999999999999999999999   9999999999999999999999999999988


Q ss_pred             cCCCCCce-eecc--ccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCCC
Q 046084          244 HSDSSNRT-VVAG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       244 ~~~~~~~~-~~~g--~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      ..+..... +..|  +.+|.|||.+...+++.+|||||||++|||.++ |..||=+++  +.+....-..+.++|+|.++
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--NQdVIkaIe~gyRLPpPmDC  859 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVIKAIEQGYRLPPPMDC  859 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--hHHHHHHHHhccCCCCCCCC
Confidence            66553322 2222  578999999999999999999999999999886 999964443  44444444556788999888


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +..      |.+|++.||++|-.+|| +.|++..|..
T Consensus       860 P~a------L~qLMldCWqkdR~~RP~F~qiV~~lDk  890 (996)
T KOG0196|consen  860 PAA------LYQLMLDCWQKDRNRRPKFAQIVSTLDK  890 (996)
T ss_pred             cHH------HHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence            766      88899999999999999 9999998854

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-47  Score=344.31  Aligned_cols=258  Identities=24%  Similarity=0.390  Sum_probs=217.2

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch---HHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCC
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE---LAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKK  160 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  160 (363)
                      ...+.|.+.+.||+|+||+|+.|.. .+++.||+|++......   ....+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3467899999999999999999954 57899999977654111   123456778999999998 999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-CceEEEeecc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGV  239 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~  239 (363)
                      ..++||||+.||+|.+++...+   ++.+.....++.|++.|++|||+.   +|+||||||+|+|++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999998744   688899999999999999999999   99999999999999999 9999999999


Q ss_pred             ceeccCCCCCceeecccccccccccccccc-CC-ccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCC
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMV-LT-EKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPI  317 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  317 (363)
                      +...........+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||+..   +.......+.......+.
T Consensus       168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~---~~~~l~~ki~~~~~~~p~  244 (370)
T KOG0583|consen  168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS---NVPNLYRKIRKGEFKIPS  244 (370)
T ss_pred             ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc---cHHHHHHHHhcCCccCCC
Confidence            988744455667789999999999999877 76 7899999999999999999998862   333344446666555554


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ...     ......|+.+||..||.+|+ ..+++..-+.+.
T Consensus       245 ~~~-----S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  245 YLL-----SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CcC-----CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            331     11378899999999999999 999998777765

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=330.98  Aligned_cols=264  Identities=25%  Similarity=0.433  Sum_probs=219.1

Q ss_pred             HHhcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ...++|++.+.||.|..++||+|. .+.++.||||++.....+.+ .+.+.+|+..|+.++||||++++..|..+..+|+
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            346789999999999999999995 56789999999988776655 6889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||.||.+|++.+++...-.. .+++..+..|++++++||.|||.+   |.+|||+|+.|||++++|.|||+|||.+..+.
T Consensus       102 VmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99999999999999764332 489999999999999999999999   99999999999999999999999999887765


Q ss_pred             CCCCCc----eeecccccccccccccc--ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          245 SDSSNR----TVVAGTHGYIAPELAYT--MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       245 ~~~~~~----~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      ......    .+.+|++.|||||++..  ..|+.|+||||||++..||.+|+.||..+..   -.++...+...++.+..
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP---mkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP---MKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh---HHHHHHHhcCCCCCccc
Confidence            444332    34589999999999653  4689999999999999999999999876643   33444445555443322


Q ss_pred             ----ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          319 ----DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       319 ----~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                          ....-.....+.++|..||++||++|| +.++++.-.+++
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~  298 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK  298 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence                112222334689999999999999999 999888766544

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=334.53  Aligned_cols=257  Identities=27%  Similarity=0.447  Sum_probs=205.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC--eEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK--CMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  164 (363)
                      ..++...+.||+|+||+||++... +|+..|||.....+...  .+.+.+|+.+|++++|||||+++|......  ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            345777888999999999999764 48999999987764332  577899999999999999999999754444  6889


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC-CCceEEEeeccceec
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS-KLEAFVADFGVARLL  243 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~  243 (363)
                      .|||+++|+|.+++...+.  .+++..+..+..|+++||+|||++   +++||||||+|||++. ++.+||+|||++...
T Consensus        94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            9999999999999987764  599999999999999999999999   9999999999999999 799999999999877


Q ss_pred             cC--C-CCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc-CC-CCC
Q 046084          244 HS--D-SSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR-VP-SPI  317 (363)
Q Consensus       244 ~~--~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~-~~~  317 (363)
                      ..  . ........||+.|||||++..+ ....++|||||||++.||+||+.||...  .........+.... .| .|.
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P~ip~  246 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLPEIPD  246 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCCCCCc
Confidence            53  1 1223346799999999999853 3335999999999999999999998764  12222223333222 11 122


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhh
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL  359 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~  359 (363)
                      ..+      ....+++..|++.||++|| +.+++.+.......
T Consensus       247 ~ls------~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  247 SLS------DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ccC------HHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            111      1377899999999999999 99999988765543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=345.46  Aligned_cols=250  Identities=25%  Similarity=0.402  Sum_probs=215.0

Q ss_pred             hcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ...|....+||+|+.|.||.+. ..+++.||||++.......  .+-+..|+.+|+..+|+|||.+++.+...+.+++||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            3567888899999999999994 5678899999998766543  266889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||++||+|.+.+...    .+++.++..|+.++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus       350 Eym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            999999999998765    499999999999999999999999   9999999999999999999999999999988777


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc---CCCCCCChhhH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR---VPSPIDDQTVI  323 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  323 (363)
                      .....+.+||+.|||||+.....|.++.||||||++++||+-|.+||-..   ++...+..+.+..   +..+...+   
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE---~PlrAlyLIa~ng~P~lk~~~klS---  496 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE---NPLRALYLIATNGTPKLKNPEKLS---  496 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC---ChHHHHHHHhhcCCCCcCCccccC---
Confidence            77778889999999999999999999999999999999999999997553   3333334343333   22232222   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                         ..+.+++.+||+.|+++|| +.|+|++-..
T Consensus       497 ---~~~kdFL~~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  497 ---PELKDFLDRCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             ---HHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence               2489999999999999999 9999987544

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-47  Score=340.79  Aligned_cols=255  Identities=24%  Similarity=0.394  Sum_probs=216.8

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCe
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (363)
                      ....++|.+++.||.|+|++|++|+ ..+++.||||++.....- ..-.+-...|-..|.+| +||.|++|+..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3456789999999999999999995 457899999998765321 11234467888899999 89999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      +|+|+||+++|+|.+++...+   .+++.....++.+|+.||+|||+.   |||||||||+|||||+|++++|+|||.++
T Consensus       149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence            999999999999999998876   699999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCC-----------C--ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhh
Q 046084          242 LLHSDSS-----------N--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDL  308 (363)
Q Consensus       242 ~~~~~~~-----------~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~  308 (363)
                      .+.....           .  ....+||..|.+||++.....+..+|+|+||||+|+|+.|.+||..   .+....+..+
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra---~NeyliFqkI  299 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA---ANEYLIFQKI  299 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc---ccHHHHHHHH
Confidence            7743211           1  1457899999999999999999999999999999999999999754   4556667777


Q ss_pred             hcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          309 LDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      +.-.+..+...+..      ..+||.+.|..||++|+ ..|+-++..
T Consensus       300 ~~l~y~fp~~fp~~------a~dLv~KLLv~dp~~Rlt~~qIk~HpF  340 (604)
T KOG0592|consen  300 QALDYEFPEGFPED------ARDLIKKLLVRDPSDRLTSQQIKAHPF  340 (604)
T ss_pred             HHhcccCCCCCCHH------HHHHHHHHHccCccccccHHHHhhCcc
Confidence            77777777655533      77899999999999999 777665543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-47  Score=342.37  Aligned_cols=264  Identities=25%  Similarity=0.348  Sum_probs=212.5

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .+.+...+.++||+|.||.|.++....+..||||+++..+... ...+|.+|+++|.+++||||++++|+|..++.++++
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN-ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh-HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            4556678899999999999999999778999999999876543 357899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      +|||++|+|..++..+... ........+|+.||+.||+||.+.   ++|||||.++|+|++.++++||+|||+++.+..
T Consensus       614 ~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence            9999999999999887533 245566778999999999999999   999999999999999999999999999997655


Q ss_pred             CCCCc--eeeccccccccccccccccCCccccchHHHHHHHHHHh--CCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          246 DSSNR--TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM--GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       246 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ..+..  ...+-+.+|||||.+..++++.++|||+||+++||+++  ...||+...+....+..-...+...... ..+.
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~-~l~~  768 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV-VLSR  768 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce-eccC
Confidence            44322  22456789999999999999999999999999999875  7889876655443333333333221110 0011


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +.-++..+.+++..||+.|.++|| +.++...|..
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            111223488999999999999999 8887776653

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=312.43  Aligned_cols=239  Identities=27%  Similarity=0.420  Sum_probs=211.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      -++|++.+.||.|+||+|.+++.+ +|..+|+|++....- .....+....|..+|+.+.||.++++++.|.+.+.+|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            357888999999999999999654 678899999987642 344456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||.+||.|..+++..+   ++++..+..++.||+.||+|||+.   +|++|||||+|||+|.+|.+||+|||.++....
T Consensus       123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            99999999999998876   799999999999999999999999   999999999999999999999999999998743


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .   .-+.+||+.|+|||++....|..++|.|||||++|||+.|.+||...   ++......++...+..|...+..   
T Consensus       197 r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~---~~~~iY~KI~~~~v~fP~~fs~~---  267 (355)
T KOG0616|consen  197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD---NPIQIYEKILEGKVKFPSYFSSD---  267 (355)
T ss_pred             c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC---ChHHHHHHHHhCcccCCcccCHH---
Confidence            3   45678999999999999999999999999999999999999997654   44667778888887777655544   


Q ss_pred             HHHHHHHHHHccCCCCCCC
Q 046084          326 IILVSKIVFACLRSKPTSR  344 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~R  344 (363)
                         +.+|+...|+.|-.+|
T Consensus       268 ---~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  268 ---AKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ---HHHHHHHHHhhhhHhh
Confidence               7788889999999988

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-46  Score=363.43  Aligned_cols=257  Identities=27%  Similarity=0.463  Sum_probs=214.0

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC--CCC----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP--SGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      ..++.+....||+|.||.||.|...  +|.    .||+|.+....+.. ...+|.+|..+|+.++|||||+++|+|.+..
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~-~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ-EVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH-HHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            4566778889999999999999653  232    59999998765543 3578999999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEe
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDE----AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVAD  236 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  236 (363)
                      ..++++|||++|+|..++++.+.    ...++..+.+.++.|||+|+.||+++   ++|||||..+|+||+....|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            99999999999999999987621    33689999999999999999999999   999999999999999999999999


Q ss_pred             eccceeccCCCCC-ceee-ccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccC
Q 046084          237 FGVARLLHSDSSN-RTVV-AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       237 fg~~~~~~~~~~~-~~~~-~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      ||+|+.+...... .... .-...|||||.+..+.++.|+|||||||++||++| |..||...+.  .+....-...+++
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--~~v~~~~~~ggRL  923 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--FEVLLDVLEGGRL  923 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--HHHHHHHHhCCcc
Confidence            9999954333222 2212 23568999999999999999999999999999998 8999765543  2223334455688


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +.|..++..      +.+++.+||+.+|++|| +..++..+..
T Consensus       924 ~~P~~CP~~------ly~lM~~CW~~~pe~RP~F~~i~~q~~~  960 (1025)
T KOG1095|consen  924 DPPSYCPEK------LYQLMLQCWKHDPEDRPSFRTIVEQDPA  960 (1025)
T ss_pred             CCCCCCChH------HHHHHHHHccCChhhCccHHHHHhhhhh
Confidence            888877655      77999999999999999 9999886543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-46  Score=339.44  Aligned_cols=255  Identities=26%  Similarity=0.410  Sum_probs=219.4

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|.+.+.||+|+||.||+|+. .+.+.||+|.+.+........+.+.+|+++++.++||||+.++++|+.....++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5788889999999999999954 467899999998887777778899999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+.| +|..++...+   .++++.+..++.|+..||.|||+.   +|.|||+||.|||++.++.+|+||||+++.+..+.
T Consensus        82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9987 9999998776   699999999999999999999999   99999999999999999999999999999887766


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      .-.+...||+-|||||+..+.+|+..+|.||+||++||+++|++||-..+   .......+.......|...+.      
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~~I~~d~v~~p~~~S~------  225 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVKSILKDPVKPPSTASS------  225 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHHHHhcCCCCCcccccH------
Confidence            66677789999999999999999999999999999999999999974322   223334444444444443332      


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHHHhchhhh
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL  359 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~  359 (363)
                      .+..++...|++||.+|- -.+++.+-.-+...
T Consensus       226 ~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  226 SFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             HHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence            378899999999999999 88877665544433

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-46  Score=341.31  Aligned_cols=253  Identities=23%  Similarity=0.391  Sum_probs=221.6

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .-|++++.||.|+.|.|-+|++ .+|+.+|||++.... ........+.+|+.+|+.+.|||++++|+++++...+|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3478899999999999999965 689999999998763 23333457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|.|++++-..+   ++++.+..++++||+.|+.|+|..   +|+||||||+|+|||..+++||+|||+|..- .+
T Consensus        92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE-VP  164 (786)
T ss_pred             EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc-cC
Confidence            9999999999998776   699999999999999999999999   9999999999999999999999999999754 45


Q ss_pred             CCCceeeccccccccccccccccCC-ccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLT-EKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .....+.||++.|.|||++.+.+|. .++||||.|||||.|+||+.||+   +.+....+..+..+.+..|..-+..   
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~G~f~MPs~Is~e---  238 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQRGVFEMPSNISSE---  238 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHcCcccCCCcCCHH---
Confidence            5556778999999999999998885 68999999999999999999987   4567777888888877776544433   


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                         ..+|+.+||..||++|- +.||+++.+...
T Consensus       239 ---aQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  239 ---AQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             ---HHHHHHHHhccCccccccHHHHhhCchhhc
Confidence               66789999999999999 999999876643

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=342.41  Aligned_cols=261  Identities=25%  Similarity=0.444  Sum_probs=211.6

Q ss_pred             HHHHHHhcCCcccCeeeecCceeEEEEEeCC--C---CEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCceeeeeeE
Q 046084           82 QEMIVATEDFDIKYCIGTGGYGSVYRAQLPS--G---KKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGF  155 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  155 (363)
                      +.++...++..+.+.||+|+||.||+|++..  +   ..||+|..+... .....+.+|..|+++|++++|||||+++|+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            4455666777888999999999999996532  2   238999988632 444557899999999999999999999999


Q ss_pred             EeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEE
Q 046084          156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVA  235 (363)
Q Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  235 (363)
                      +.....+++|||+|.||+|.++|+....  .++..+++.++.+.|.||+|||+.   +++||||..+|+|++.++.+||+
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence            9999999999999999999999998764  589999999999999999999999   99999999999999999999999


Q ss_pred             eeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc--c
Q 046084          236 DFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--R  312 (363)
Q Consensus       236 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~--~  312 (363)
                      |||+++.-...........-+..|+|||.+....|+.++|||||||++||+++ |..||.....   ......+...  +
T Consensus       305 DFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---~~v~~kI~~~~~r  381 (474)
T KOG0194|consen  305 DFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---YEVKAKIVKNGYR  381 (474)
T ss_pred             ccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH---HHHHHHHHhcCcc
Confidence            99998764311111112234678999999999999999999999999999998 8889765443   3333444232  2


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .+.+...+      ..+..++.+||..||++|| |.++.+.+...
T Consensus       382 ~~~~~~~p------~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~  420 (474)
T KOG0194|consen  382 MPIPSKTP------KELAKVMKQCWKKDPEDRPTMSTIKKKLEAL  420 (474)
T ss_pred             CCCCCCCH------HHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence            33333222      2478889999999999999 99999888653

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-45  Score=336.54  Aligned_cols=258  Identities=25%  Similarity=0.411  Sum_probs=201.7

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLH  158 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (363)
                      +..++|++.+.||+|+||.||+|..      .++..||+|++...... ...+.+..|+.++..+ +||||++++++|..
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA-SEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch-HHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            4567899999999999999999963      23567999998754332 2346788999999999 89999999998876


Q ss_pred             CC-eEEEEEEeccCCChhhhhhcCCC------------------------------------------------------
Q 046084          159 KK-CMFLIYKYMRRGSLFCILRNDDE------------------------------------------------------  183 (363)
Q Consensus       159 ~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  183 (363)
                      .+ ..+++|||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            54 58899999999999998865321                                                      


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC--Cceeeccc
Q 046084          184 -----AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGT  256 (363)
Q Consensus       184 -----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~  256 (363)
                           ...+++.++..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||+++.......  ......++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                 12478889999999999999999999   999999999999999999999999999976533221  11223456


Q ss_pred             cccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccC-CCCCCChhhHHHHHHHHHHHH
Q 046084          257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRV-PSPIDDQTVIQDIILVSKIVF  334 (363)
Q Consensus       257 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~  334 (363)
                      ..|+|||++.+..++.++||||||+++|||++ |..||......  ............ ..+...      ...+.+++.
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~------~~~l~~li~  311 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQRLKDGTRMRAPENA------TPEIYRIML  311 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHhcCCCCCCCCCC------CHHHHHHHH
Confidence            78999999998889999999999999999997 99998654321  111222222211 111111      124889999


Q ss_pred             HccCCCCCCCC-hHHHHHHHhc
Q 046084          335 ACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       335 ~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +||+.||++|| +.++++.|..
T Consensus       312 ~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         312 ACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHccCChhhCcCHHHHHHHHHH
Confidence            99999999999 9999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-46  Score=332.12  Aligned_cols=260  Identities=26%  Similarity=0.397  Sum_probs=208.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMF  163 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  163 (363)
                      ..+.|+..++||+|.||.||+|+ ..+|+.||+|++.....+..+..-..+||.+|++|+||||++|.+...+.  +.+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            45668888999999999999995 56899999999998877666667788999999999999999999999887  6899


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ||+|||++ +|..++....  ..+++.++..+++|++.||.|+|++   ++.|||||.+|||||++|.+||+|||+|+++
T Consensus       195 lVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            99999987 8888776543  4699999999999999999999999   9999999999999999999999999999977


Q ss_pred             cCCCC-Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---------c
Q 046084          244 HSDSS-NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---------R  312 (363)
Q Consensus       244 ~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------~  312 (363)
                      ..... ..+..+-|.+|+|||++.+ ..|+.+.|+||.||||.||+.|++.|....+...-.....+...         .
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            65443 3566778999999998886 46999999999999999999999998765543322222222211         1


Q ss_pred             CC-----CCC-CChhhHH-----HHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          313 VP-----SPI-DDQTVIQ-----DIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       313 ~~-----~~~-~~~~~~~-----~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ++     .+. .......     -.....+|+..+|..||.+|. +.+.+..
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            11     000 0000111     122367899999999999999 7777654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=339.68  Aligned_cols=241  Identities=28%  Similarity=0.485  Sum_probs=201.8

Q ss_pred             CcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEecc
Q 046084           91 FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (363)
                      ....+-||+|+.|.||+|++ .++.||||+++...         ..+|.-|++|+||||+.+.|+|....++|||||||.
T Consensus       126 IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhhhhccCcccceeeeec-cCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            34456699999999999999 67899999886432         357888999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCc
Q 046084          171 RGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR  250 (363)
Q Consensus       171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  250 (363)
                      .|.|...|+..+   +++......|.++||.||.|||.+   .|+|||||.-||||+.+..+||+|||-++..... ...
T Consensus       196 ~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STk  268 (904)
T KOG4721|consen  196 QGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STK  268 (904)
T ss_pred             cccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhh
Confidence            999999998765   688888999999999999999999   9999999999999999999999999999876433 455


Q ss_pred             eeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCC-chhhHHhhhcccCCCCCCChhhHHHHHHH
Q 046084          251 TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN-PKIMLIDLLDQRVPSPIDDQTVIQDIILV  329 (363)
Q Consensus       251 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  329 (363)
                      ..++||..|||||++.+.+.++|+|||||||+||||+||..||.+.+... ...+-...+  .++.|..++.      .+
T Consensus       269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL--~LpvPstcP~------Gf  340 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSL--HLPVPSTCPD------GF  340 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcc--cccCcccCch------HH
Confidence            56789999999999999999999999999999999999999987654321 001111111  2333333332      37


Q ss_pred             HHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          330 SKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       330 ~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .-|+++||+-.|.+|| +.+++.++...
T Consensus       341 klL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  341 KLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             HHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            7799999999999999 99999998653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.5e-46  Score=305.20  Aligned_cols=259  Identities=24%  Similarity=0.353  Sum_probs=209.2

Q ss_pred             cCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|...+.||+|.||.||+|+ ..+|+.||||+++.............+|+..|+.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467788899999999999995 4689999999998876554444678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |++. +|+..++...  ..++..++..++.++++|++|||.+   .|.||||||.|+|++++|.+||+|||+++.+..+.
T Consensus        82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9976 8998887654  3689999999999999999999999   99999999999999999999999999999987777


Q ss_pred             CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---------------
Q 046084          248 SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---------------  311 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------  311 (363)
                      ...+..+-|.+|+|||.+.+ ..|+...|+||.|||+.||+-|.+-|...++.+.-......+..               
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            66666678999999998876 56999999999999999999988776655443322222221111               


Q ss_pred             -----cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          312 -----RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       312 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                           .+..+... ..........+|+..||..||.+|. +.|.+++--
T Consensus       236 ~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y  283 (318)
T KOG0659|consen  236 VKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPY  283 (318)
T ss_pred             HHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence                 11111110 1111122368899999999999999 988887643

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-47  Score=332.18  Aligned_cols=254  Identities=30%  Similarity=0.437  Sum_probs=214.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ...|+..+.||+|+||.||+|.+ ..++.||+|++.......+ ++++..|+.++.+++++||.++|+.+..+..++++|
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchh-hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            34577778999999999999954 5788999999987655433 578899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      |||.||++.+.++...   .+++..+.-++.++..|+.|||.+   +.+|||||+.|||+..+|.+|++|||.+..+...
T Consensus        91 ey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence            9999999999997655   457778888999999999999999   9999999999999999999999999999988777


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      .....+.+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+.....   ...+..+.+..+|....     +..
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---mrvlflIpk~~PP~L~~-----~~S  236 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---MRVLFLIPKSAPPRLDG-----DFS  236 (467)
T ss_pred             hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---ceEEEeccCCCCCcccc-----ccC
Confidence            7777888999999999999998999999999999999999999999765443   33344444444333222     111


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+.+++..||++||+.|| +.+++++-..+
T Consensus       237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk  267 (467)
T KOG0201|consen  237 PPFKEFVEACLDKNPEFRPSAKELLKHKFIK  267 (467)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhhHHHH
Confidence            2488999999999999999 99998765443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=332.83  Aligned_cols=262  Identities=22%  Similarity=0.320  Sum_probs=208.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCC-eEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKK-CMF  163 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~  163 (363)
                      ..++|.+.++||.|+||.||+|+ ..+|+.||||+++..-..-+. ..-.+|+.-|++++ ||||+++.+++.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            45789999999999999999995 457889999999876433221 23468999999998 999999999999988 899


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +|||||+. +|+.+++.++  ..+++..+..|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+|+..
T Consensus        87 fVfE~Md~-NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            99999976 9999998763  4799999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCceeeccccccccccccc-cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhh------------------
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAY-TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM------------------  304 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~------------------  304 (363)
                      .+.. ..+.++.|.+|+|||++. ...|+.+.|+|++|||++|+.+-++-|-..++.+.-..                  
T Consensus       161 ~Skp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  161 RSKP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             ccCC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            5433 455678999999999876 57799999999999999999999888766554332222                  


Q ss_pred             HHhhhcccCCCCCCCh---hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          305 LIDLLDQRVPSPIDDQ---TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +...+.-+.+.....+   ..........++|.+||++||.+|| +.|.+++..++
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq  295 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ  295 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence            2222222222211110   0011233588999999999999999 88888765543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.4e-45  Score=329.73  Aligned_cols=246  Identities=26%  Similarity=0.404  Sum_probs=204.6

Q ss_pred             HHhcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      ...++|++.+.||+|+||.||+++ ..+|+.+|+|+++.... ....++..+.|-.+|...++|+||+++-.|.+.+++|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            456899999999999999999995 45799999999987753 3344677889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      |||||++||++..+|...+   .|++..+..++.+++.|+.-||..   |++||||||+|+|||..|++||+|||++.-+
T Consensus       218 LiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999998876   699999999999999999999999   9999999999999999999999999998533


Q ss_pred             cCC-----------------------CC----Cc--------------------eeeccccccccccccccccCCccccc
Q 046084          244 HSD-----------------------SS----NR--------------------TVVAGTHGYIAPELAYTMVLTEKCDV  276 (363)
Q Consensus       244 ~~~-----------------------~~----~~--------------------~~~~g~~~y~aPE~~~~~~~~~~~Dv  276 (363)
                      ...                       ..    ..                    ...+|||.|||||++.+..|+..+|.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            110                       00    00                    11369999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc--CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC
Q 046084          277 YSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR--VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       277 wslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                      ||||||+|||+.|.+||...   ++......+...+  +..|......    .+-.+||.+||. ||++|-
T Consensus       372 WSLG~ImyEmLvGyPPF~s~---tp~~T~rkI~nwr~~l~fP~~~~~s----~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSE---TPQETYRKIVNWRETLKFPEEVDLS----DEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhhhccCCCcCccc----HHHHHHHHHHhc-CHHHhc
Confidence            99999999999999997643   4444445554443  3333332222    247789999999 999997

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-46  Score=333.80  Aligned_cols=256  Identities=21%  Similarity=0.346  Sum_probs=219.1

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe-EEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC-MFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  166 (363)
                      ++|...+.+|+|+||.++..+. .++..+++|.+..........+....|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5788899999999999999854 367799999998776555555678899999999999999999999999988 99999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      +||+||++.+.+.... ...++++.+..++.|++.|+.|||+.   .|.|||||+.|||++.++.++|+|||+++.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999987665 44699999999999999999999988   9999999999999999999999999999998877


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      .....+.+||+.||+||.+.+.+|..|+|||||||++|||++-+++|+..+.   ......+...... |.    ...+.
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~ki~~~~~~-Pl----p~~ys  231 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELILKINRGLYS-PL----PSMYS  231 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHHHHhhccCC-CC----Ccccc
Confidence            7677788999999999999999999999999999999999999999876543   3334444444321 11    11122


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .++..+|..||+.+|+.|| +.+++.+....
T Consensus       232 ~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  232 SELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             HHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence            2489999999999999999 99999885544

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-45  Score=326.04  Aligned_cols=239  Identities=26%  Similarity=0.391  Sum_probs=199.1

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999764 688999999875432 2233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999997654   588999999999999999999999   9999999999999999999999999999765332


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                         .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....   .......+.......+...+      
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~------  222 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKILAGKLEFPRHLD------  222 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCcCCCccCC------
Confidence               223468999999999998889999999999999999999999986532   22333444444433332221      


Q ss_pred             HHHHHHHHHccCCCCCCCC
Q 046084          327 ILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP  345 (363)
                      ..+.+++.+||+.||.+||
T Consensus       223 ~~~~~li~~~l~~dp~~R~  241 (291)
T cd05612         223 LYAKDLIKKLLVVDRTRRL  241 (291)
T ss_pred             HHHHHHHHHHcCCCHHHcc
Confidence            1378999999999999999

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-44  Score=330.07  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=204.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            357899999999999999999764 688999999875432 223346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+.+|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999987654   588889999999999999999999   999999999999999999999999999986533


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .   .....|++.|+|||.+.+..++.++|||||||++|||++|+.||....   .......+.......+...+     
T Consensus       171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~p~~~~-----  239 (329)
T PTZ00263        171 R---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEKILAGRLKFPNWFD-----  239 (329)
T ss_pred             C---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCcCCCCCCC-----
Confidence            2   223568999999999999889999999999999999999999986432   22333444444443332222     


Q ss_pred             HHHHHHHHHHccCCCCCCCC-h-----HHHHHHHh
Q 046084          326 IILVSKIVFACLRSKPTSRP-M-----QRVSQEFL  354 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~-----~~v~~~l~  354 (363)
                       ..+.+++.+||+.||++|| +     .+++.+-.
T Consensus       240 -~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~  273 (329)
T PTZ00263        240 -GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY  273 (329)
T ss_pred             -HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence             1378899999999999998 3     56665543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.6e-44  Score=328.42  Aligned_cols=236  Identities=23%  Similarity=0.308  Sum_probs=193.9

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      +.||+|+||.||++.. .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999965 4788999999875432 2233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCcee
Q 046084          173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV  252 (363)
Q Consensus       173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  252 (363)
                      +|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++............
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            9999887654   689999999999999999999999   9999999999999999999999999998754333333445


Q ss_pred             eccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHH
Q 046084          253 VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI  332 (363)
Q Consensus       253 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  332 (363)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||...+   .......+.......+...+      ..+.++
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~~~p~~~~------~~~~~l  225 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIRFPRTLS------PEAKSL  225 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCC------HHHHHH
Confidence            679999999999999899999999999999999999999985432   22223333333333222221      248899


Q ss_pred             HHHccCCCCCCCC
Q 046084          333 VFACLRSKPTSRP  345 (363)
Q Consensus       333 i~~cl~~dP~~RP  345 (363)
                      +.+||+.||++||
T Consensus       226 i~~~L~~dP~~R~  238 (323)
T cd05571         226 LAGLLKKDPKQRL  238 (323)
T ss_pred             HHHHccCCHHHcC
Confidence            9999999999999

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.5e-44  Score=319.42  Aligned_cols=244  Identities=21%  Similarity=0.336  Sum_probs=198.1

Q ss_pred             CeeeecCceeEEEEEeCCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEee----CCeEEEEEEec
Q 046084           95 YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLH----KKCMFLIYKYM  169 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  169 (363)
                      ..||+|++|.||+|.+ +|+.||+|.+...... ....+.+.+|+.+|++++||||++++|++.+    ....+++|||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 7899999999765432 2335778899999999999999999999877    34689999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  249 (363)
                      ++|+|.+++....   .+++...+.++.|++.||.|||+..  +++||||||+|||+++++.+||+|||++.......  
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            9999999997654   5889999999999999999999732  78899999999999999999999999987653322  


Q ss_pred             ceeecccccccccccccc--ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc--cCCCCCCChhhHHH
Q 046084          250 RTVVAGTHGYIAPELAYT--MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTVIQD  325 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  325 (363)
                       ....++..|+|||.+.+  ..++.++|||||||++|||++|+.||....   .......+...  +.+.+...      
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~------  247 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLIINKNNSLKLPLDC------  247 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcCCCCCCCCcC------
Confidence             23457889999999876  678999999999999999999999987543   22223333222  22222112      


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ...+.+++.+||+.||++|| +.+++..|..-
T Consensus       248 ~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        248 PLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            22488999999999999999 99999888654

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-45  Score=299.51  Aligned_cols=254  Identities=30%  Similarity=0.431  Sum_probs=214.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      -++|++.+.||+|-||.||.|+. +++-.||+|++...... ....+++.+|+++-+.++||||+++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46899999999999999999954 56778999999766532 22335789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      +||..+|.+...|..... .++++.....++.|+|.|+.|+|..   +++||||||+|+|++.++..|++|||.+-.  .
T Consensus       101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~--~  174 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH--A  174 (281)
T ss_pred             EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee--c
Confidence            999999999999985432 2688899999999999999999999   999999999999999999999999999854  3


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      +.....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||...+   ......++..-.+..|...+.    
T Consensus       175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~p~~is~----  247 (281)
T KOG0580|consen  175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKFPSTISG----  247 (281)
T ss_pred             CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccCCcccCh----
Confidence            3566778899999999999999999999999999999999999999987654   333444444444444432222    


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                        ...++|..|+..+|.+|. -.|++..-+..
T Consensus       248 --~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~  277 (281)
T KOG0580|consen  248 --GAADLISRLLVKNPIERLALTEVMDHPWIV  277 (281)
T ss_pred             --hHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence              277899999999999999 89998876543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-45  Score=317.01  Aligned_cols=252  Identities=23%  Similarity=0.399  Sum_probs=216.3

Q ss_pred             HhcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ...+|++.+.||+|.||.|-++. ...|+.||||.++.... +.+..-.+.+|+++|+.++||||+.++++|++.+.+.+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            35679999999999999999994 47899999999987653 33345578999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||..+|.|++|+...+   .+++.+...++.||..|+.|+|.+   +++|||||.+|||+|.++++||+|||++..+.
T Consensus       131 vMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999998876   699999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                       +....++++|++-|.+||+..+.+| .+.+|-||||++||.|+.|..||+..+   -+.....+-.+.+..|...+   
T Consensus       205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQIs~GaYrEP~~PS---  277 (668)
T KOG0611|consen  205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQISRGAYREPETPS---  277 (668)
T ss_pred             -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHhhcccccCCCCCc---
Confidence             3445677899999999999999888 478999999999999999999988654   34445555555555444322   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                          .-.-||.+||..||++|- ..+|..+-+.
T Consensus       278 ----dA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  278 ----DASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             ----hHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence                245689999999999999 8888876543

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.1e-44  Score=322.61  Aligned_cols=257  Identities=22%  Similarity=0.346  Sum_probs=199.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCC-----------------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCcee
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPS-----------------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV  150 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  150 (363)
                      .++|.+.+.||+|+||.||++.+.+                 +..||+|.+...... .....|.+|+.++..++||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-NARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-HHHHHHHHHHHHHhhcCCCCee
Confidence            4678999999999999999997532                 336999998765432 3356789999999999999999


Q ss_pred             eeeeEEeeCCeEEEEEEeccCCChhhhhhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 046084          151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD----------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI  214 (363)
Q Consensus       151 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  214 (363)
                      ++++++.+.+..+++|||+++|+|.+++....                ....+++..+++++.|++.||+|||+.   ++
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence            99999999999999999999999999885421                112478889999999999999999999   99


Q ss_pred             EEeCCCCCCeeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh--CC
Q 046084          215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM--GR  290 (363)
Q Consensus       215 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~  290 (363)
                      +||||||+|||++.++.+||+|||++.........  .....++..|+|||.+.+..++.++||||||+++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            99999999999999999999999999765332211  112335778999999988889999999999999999987  56


Q ss_pred             CCCCCCcCCCchhhHHhhhccc-----CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          291 HPGDLLSSVNPKIMLIDLLDQR-----VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       291 ~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .||...................     ...+...      +..+.+++.+||+.||++|| +.++...|.
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPC------PQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCC------CHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            6766543222111111111110     0111111      12488999999999999999 999987764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1e-43  Score=317.57  Aligned_cols=253  Identities=23%  Similarity=0.260  Sum_probs=199.7

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .|+..+.||+|+||.||++.. .+|+.||+|.+...... ......+.+|+.+++.++|+|++++++++.+.+..+++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999965 57899999998754322 2223467889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++|+|.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+|||+++++.++|+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999999888754322 2588999999999999999999999   99999999999999999999999999997653222


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH-hhhcccCCCCCCChhhHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI-DLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  326 (363)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||............. .........+...+      
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s------  229 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFS------  229 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCC------
Confidence             2233468999999999999999999999999999999999999987544322111111 12121111111111      


Q ss_pred             HHHHHHHHHccCCCCCCCC------hHHHHHHH
Q 046084          327 ILVSKIVFACLRSKPTSRP------MQRVSQEF  353 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP------~~~v~~~l  353 (363)
                      ..+.+|+.+||+.||++||      +.+++.+-
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~  262 (285)
T cd05631         230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP  262 (285)
T ss_pred             HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence            1378899999999999998      46666543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.2e-44  Score=331.20  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=203.4

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCL  157 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  157 (363)
                      ....++|++.+.||+|+||.||+|+.      .++..||+|+++..... ...+.+.+|+.+++.+ +||||++++++|.
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            34466899999999999999999963      24568999998754432 2246788999999999 8999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhhhcCCC------------------------------------------------------
Q 046084          158 HKKCMFLIYKYMRRGSLFCILRNDDE------------------------------------------------------  183 (363)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  183 (363)
                      ..+..++||||+++|+|.+++.....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            99999999999999999998864221                                                      


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          184 ------------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       184 ------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                                        ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                              12478899999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc--CCCCCCCh
Q 046084          246 DSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR--VPSPIDDQ  320 (363)
Q Consensus       246 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  320 (363)
                      ....  .....++..|+|||.+.+..++.++||||||+++|||++ |..||......   ......+...  ...+... 
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~-  342 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMIKEGYRMLSPECA-  342 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHHHhCccCCCCCCC-
Confidence            2221  112234567999999999899999999999999999998 88997654321   1112222221  1111111 


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                           ...+.+|+.+||+.||++|| +.++++.|+.
T Consensus       343 -----~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         343 -----PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             -----CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                 12488999999999999999 9999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-44  Score=323.86  Aligned_cols=243  Identities=24%  Similarity=0.349  Sum_probs=197.9

Q ss_pred             eeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCCh
Q 046084           97 IGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus        97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      ||+|+||.||++... +++.||+|.+..... .......+..|+.++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999764 578999999875421 223346788899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeec
Q 046084          175 FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA  254 (363)
Q Consensus       175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  254 (363)
                      .+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++..............
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            99987644   589999999999999999999999   999999999999999999999999999976433333344457


Q ss_pred             cccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHH
Q 046084          255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVF  334 (363)
Q Consensus       255 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  334 (363)
                      ||+.|+|||.+.+..++.++|||||||++|||++|+.||....   .......+.......+...+      ..+.+++.
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~li~  225 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQEPLRFPDGFD------RDAKDLLI  225 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCCCCCCcCC------HHHHHHHH
Confidence            8999999999999899999999999999999999999986432   22333344444333332222      13788999


Q ss_pred             HccCCCCCCCC----hHHHHHHHh
Q 046084          335 ACLRSKPTSRP----MQRVSQEFL  354 (363)
Q Consensus       335 ~cl~~dP~~RP----~~~v~~~l~  354 (363)
                      +||+.||++||    +.+++.+-.
T Consensus       226 ~~L~~dp~~R~~~~~~~e~l~hp~  249 (312)
T cd05585         226 GLLSRDPTRRLGYNGAQEIKNHPF  249 (312)
T ss_pred             HHcCCCHHHcCCCCCHHHHHcCCC
Confidence            99999999997    456665533

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-44  Score=328.94  Aligned_cols=256  Identities=22%  Similarity=0.318  Sum_probs=205.4

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||+|... +++.||+|++..... .......+..|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999765 588999999875432 1233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999997654   588999999999999999999999   999999999999999999999999999976533 


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc--ccCCCCCCChhhHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD--QRVPSPIDDQTVIQ  324 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  324 (363)
                        ......|++.|+|||.+.+..++.++|||||||++|||++|+.||.....   ......+..  .....+........
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~  228 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLKYWKETLQRPVYDDPRFN  228 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHHhccccccCCCCCccccc
Confidence              22345689999999999988999999999999999999999999865332   122222111  11111111100011


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ....+.+++.+||+.+|++|| +.+++.+....
T Consensus       229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~  261 (333)
T cd05600         229 LSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK  261 (333)
T ss_pred             cCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence            122488999999999999999 99998875543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.7e-44  Score=326.48  Aligned_cols=249  Identities=24%  Similarity=0.381  Sum_probs=203.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCC--CCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPS--GKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      .++|++.+.||+|+||.||+|.+.+  +..||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4579999999999999999997533  35899999865432 22334678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+++|+|.+++....   .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus       109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999997654   589999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+.......+...+.   
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~---  253 (340)
T PTZ00426        183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKILEGIIYFPKFLDN---  253 (340)
T ss_pred             CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCH---
Confidence            32   234568999999999988889999999999999999999999986432   223333444443333322221   


Q ss_pred             HHHHHHHHHHHccCCCCCCC-----C-hHHHHHHHh
Q 046084          325 DIILVSKIVFACLRSKPTSR-----P-MQRVSQEFL  354 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~R-----P-~~~v~~~l~  354 (363)
                         .+.+++.+||+.||++|     | +.+++.+..
T Consensus       254 ---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~  286 (340)
T PTZ00426        254 ---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW  286 (340)
T ss_pred             ---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence               37789999999999999     4 666665543

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-43  Score=327.00  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=198.1

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|+..+.||+|+||.||++... +++.||+|++..... ....+.+.+|+++++.++|+||+++++++...+..+++||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            45667788999999999999754 688999999865443 2334678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++|+|.+..       ..++..+..++.||+.||+|||+.   +++||||||+|||+++++.+||+|||++.......
T Consensus       153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            99999986432       356777889999999999999999   99999999999999999999999999998764433


Q ss_pred             CCceeecccccccccccccc-----ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChh
Q 046084          248 SNRTVVAGTHGYIAPELAYT-----MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQT  321 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  321 (363)
                      .......|+..|+|||.+..     ...+.++|||||||++|||++|+.||......+.......+... ....+...  
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--  300 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA--  300 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc--
Confidence            33344578999999998743     23456899999999999999999998743322212122222111 11111111  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                          ...+.++|.+||+.||++|| +.|++.+-+..+.
T Consensus       301 ----~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        301 ----SREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             ----CHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                12488999999999999999 9999988665544

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-44  Score=329.70  Aligned_cols=246  Identities=23%  Similarity=0.379  Sum_probs=209.7

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCe
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (363)
                      ...-++|.+.+.||+|+||+|+++.. .+++.+|||.+++..- ..+.++..+.|..++... +||.++.++..|...++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            34567899999999999999999966 4678999999987652 233457788898888877 59999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      +|.||||+.||++..+.+..    .+++.++..++..++.||+|||++   +|++||||.+|||||.+|.+||+|||+++
T Consensus       444 l~fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999955444322    599999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      .--.......+.+||+.|||||++.+..|+.++|.|||||+||||+.|..||...   +.++....++......|...+.
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd---dEee~FdsI~~d~~~yP~~ls~  593 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD---DEEEVFDSIVNDEVRYPRFLSK  593 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCCCCCCcccH
Confidence            7655556777889999999999999999999999999999999999999997653   4455666666665555543332


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-h
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-M  346 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~  346 (363)
                            +...++.++|.+||++|- +
T Consensus       594 ------ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  594 ------EAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ------HHHHHHHHHhccCcccccCC
Confidence                  367899999999999998 6

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.8e-44  Score=320.06  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=200.2

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||.||++... +++.||+|++..........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999774 67889999987654444445678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |++++.+..+.....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEMPN---GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999887765544322   588999999999999999999999   99999999999999999999999999998754322


Q ss_pred             C-CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc----------------
Q 046084          248 S-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD----------------  310 (363)
Q Consensus       248 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------------  310 (363)
                      . ......|+..|+|||++.+..++.++|||||||++|||++|+.||...+.............                
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            1 22234688999999999888899999999999999999999999875432111111111000                


Q ss_pred             --ccCCCCCCChhh-----HHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          311 --QRVPSPIDDQTV-----IQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       311 --~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                        ...+........     ......+.+++.+||+.||++|| +.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence              000000000000     00123488999999999999999 9988764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-43  Score=314.20  Aligned_cols=253  Identities=25%  Similarity=0.388  Sum_probs=201.7

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      ..++|++.+.||+|+||.||+|.+.    .+..||+|.++..... .....+.+|+..++.++||||+++++++...+..
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            3567899999999999999999653    4568999999865433 2246789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++||||+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++++|||.+..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999999876432  589999999999999999999999   999999999999999999999999998765


Q ss_pred             ccCCCCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCC
Q 046084          243 LHSDSSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDD  319 (363)
Q Consensus       243 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  319 (363)
                      ....... .....++..|+|||.+.+..++.++||||||+++||+++ |..||......   .....+.+. ..+.+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~  233 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVEDGFRLPAPRNC  233 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCCCCCCCCC
Confidence            4222111 111234568999999988899999999999999999875 99998654322   222222222 12222222


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                            +..+.+++.+||+.+|++|| +.++.+.|.
T Consensus       234 ------~~~~~~li~~c~~~~p~~RP~~~~i~~~l~  263 (266)
T cd05064         234 ------PNLLHQLMLDCWQKERGERPRFSQIHSILS  263 (266)
T ss_pred             ------CHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence                  22488899999999999999 999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-43  Score=327.81  Aligned_cols=261  Identities=26%  Similarity=0.421  Sum_probs=203.8

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFC  156 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (363)
                      +....++|++.+.||+|+||.||++..      .++..||+|.+....... ..+.+.+|+.+++.+ +|+||++++++|
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD-EREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH-HHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            345567899999999999999999863      234579999997654332 246788999999999 899999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCC------------------------------------------------------
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDD------------------------------------------------------  182 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------  182 (363)
                      ...+..+++|||+++|+|.+++....                                                      
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            99999999999999999999885421                                                      


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC
Q 046084          183 -------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       183 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  249 (363)
                                   ...++++..+++++.|+++||+|||+.   +++||||||+|||+++++.+||+|||++.........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                         112478889999999999999999999   9999999999999999999999999999765332211


Q ss_pred             --ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          250 --RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       250 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                        .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......   .................    ..
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~----~~  341 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQMSRPDF----AP  341 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCccCCCC----CC
Confidence              112234567999999988889999999999999999997 999986543211   12222222111111110    01


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..+.+++.+||+.||++|| +.++++.|..
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            2488999999999999999 9999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-44  Score=316.89  Aligned_cols=247  Identities=34%  Similarity=0.568  Sum_probs=193.2

Q ss_pred             ccCeeeecCceeEEEEEeC-----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           93 IKYCIGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        93 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      +.+.||.|.||.||+|.+.     .+..|+||.++..... +..+.|.+|++.+++++||||++++|++...+..++|+|
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE-EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH-HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc-ccceeeeeccccccccccccccccccccccccccccccc
Confidence            4678999999999999875     3568999999664333 335789999999999999999999999998888999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++|+|.+++.... ...+++..++.++.|+++||+|||+.   +++|+||+++||++++++.+||+|||++.......
T Consensus        82 ~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             --TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            999999999998762 22689999999999999999999999   99999999999999999999999999998763221


Q ss_pred             CC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc-CCCCCCChhhH
Q 046084          248 SN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR-VPSPIDDQTVI  323 (363)
Q Consensus       248 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  323 (363)
                      ..  .........|+|||.+.+..++.++||||||+++|||++ |+.||....   .......+.+.. .+.+...+.  
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~--  232 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLKQGQRLPIPDNCPK--  232 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHHTTEETTSBTTSBH--
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccceeccchhH--
Confidence            11  122346678999999988889999999999999999999 789976542   222333332222 222222222  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                          .+.+++.+||+.||++|| +.++++.|
T Consensus       233 ----~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  233 ----DIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                388999999999999999 99998875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-43  Score=322.10  Aligned_cols=236  Identities=23%  Similarity=0.312  Sum_probs=192.5

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      +.||+|+||.||++.. .+|..||+|.+..... .......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999965 4688999999875432 2223456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCcee
Q 046084          173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV  252 (363)
Q Consensus       173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  252 (363)
                      +|..++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++............
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            9998887554   589999999999999999999999   9999999999999999999999999998754333333344


Q ss_pred             eccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHH
Q 046084          253 VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI  332 (363)
Q Consensus       253 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  332 (363)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|+.||...+   .......+.......+...+      ..+.++
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~~~~~~~~~p~~~~------~~~~~l  225 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIRFPRTLS------PEAKSL  225 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCCCCCCCC------HHHHHH
Confidence            568999999999998889999999999999999999999986432   22223333333332222222      137889


Q ss_pred             HHHccCCCCCCCC
Q 046084          333 VFACLRSKPTSRP  345 (363)
Q Consensus       333 i~~cl~~dP~~RP  345 (363)
                      +.+||+.||++||
T Consensus       226 i~~~L~~dP~~R~  238 (323)
T cd05595         226 LAGLLKKDPKQRL  238 (323)
T ss_pred             HHHHccCCHHHhC
Confidence            9999999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=340.76  Aligned_cols=255  Identities=23%  Similarity=0.363  Sum_probs=207.9

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCC-CEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEE-eeC---
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSG-KKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFC-LHK---  159 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~-~~~---  159 (363)
                      +...++++.+.|.+|||+.||++.+..+ .+||+|++...+  ....+...+|+++|+.|+ |+|||.+++.. ...   
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d--e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND--EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC--HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            4566788999999999999999987665 999999998773  344688999999999995 99999999932 211   


Q ss_pred             ---CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEe
Q 046084          160 ---KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVAD  236 (363)
Q Consensus       160 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  236 (363)
                         -.++|+||||+||.|.++|...... .|++.++++|+.|+++|+++||.. .++|+|||||-+||||+.++..||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence               2478999999999999999865443 499999999999999999999976 66799999999999999999999999


Q ss_pred             eccceeccCCCCCc---------eeecccccccccccc---ccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhh
Q 046084          237 FGVARLLHSDSSNR---------TVVAGTHGYIAPELA---YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM  304 (363)
Q Consensus       237 fg~~~~~~~~~~~~---------~~~~g~~~y~aPE~~---~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~  304 (363)
                      ||.++.........         ....-|+.|+|||.+   .+...++|+|||+|||+||-|+....||+.-..      
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------  263 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------  263 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence            99997543322111         012358899999965   477889999999999999999999999876432      


Q ss_pred             HHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          305 LIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                       ..|++..+..|...    .+...+.+||..||++||++|| ..||+.++..
T Consensus       264 -laIlng~Y~~P~~p----~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  264 -LAILNGNYSFPPFP----NYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             -eeEEeccccCCCCc----cHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence             35667776666532    2333589999999999999999 9999888754

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.9e-44  Score=325.31  Aligned_cols=239  Identities=25%  Similarity=0.342  Sum_probs=196.2

Q ss_pred             CeeeecCceeEEEEEe----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEecc
Q 046084           95 YCIGTGGYGSVYRAQL----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (363)
                      +.||+|+||.||++..    .+|+.||+|++............+..|++++++++||||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5699999999999864    367899999997654333334567789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCc
Q 046084          171 RGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR  250 (363)
Q Consensus       171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  250 (363)
                      +|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..........
T Consensus        82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            999999986543   589999999999999999999999   99999999999999999999999999997654433333


Q ss_pred             eeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHH
Q 046084          251 TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVS  330 (363)
Q Consensus       251 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  330 (363)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||....   .......+.......+...+      ..+.
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~~~~~~p~~~~------~~~~  226 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILKAKLGMPQFLS------PEAQ  226 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHcCCCCCCCCCC------HHHH
Confidence            44578999999999988888999999999999999999999986532   22333333333333222211      1378


Q ss_pred             HHHHHccCCCCCCCC-hHH
Q 046084          331 KIVFACLRSKPTSRP-MQR  348 (363)
Q Consensus       331 ~li~~cl~~dP~~RP-~~~  348 (363)
                      +++.+||+.||++|| +.+
T Consensus       227 ~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         227 SLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             HHHHHHhhcCHhHcCCCCC
Confidence            899999999999999 544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-43  Score=322.43  Aligned_cols=239  Identities=24%  Similarity=0.355  Sum_probs=192.7

Q ss_pred             CcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHH---hcCCCCceeeeeeEEeeCCeEEEE
Q 046084           91 FDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLL---SQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      |++.+.||+|+||.||++.. .+|+.||+|.+..... .....+.+..|+.++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            66788999999999999965 4688999999975431 122234566666554   566899999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|..++...    .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999998887543    589999999999999999999999   999999999999999999999999999875433


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .........|++.|+|||.+.+..++.++|||||||++|||++|+.||....   .......+.......+...+     
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~~~~p~~~~-----  225 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFDSIVNDEVRYPRFLS-----  225 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCCCC-----
Confidence            3333445678999999999998889999999999999999999999986432   22233334333333332222     


Q ss_pred             HHHHHHHHHHccCCCCCCCC
Q 046084          326 IILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP  345 (363)
                       ..+.+++.+||+.||++||
T Consensus       226 -~~~~~li~~~L~~dP~~R~  244 (324)
T cd05589         226 -REAISIMRRLLRRNPERRL  244 (324)
T ss_pred             -HHHHHHHHHHhhcCHhHcC
Confidence             1378899999999999999

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.9e-43  Score=321.92  Aligned_cols=245  Identities=23%  Similarity=0.311  Sum_probs=197.7

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      +.||+|+||.||++.. .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999965 4688999999875432 2233467888999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCcee
Q 046084          173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV  252 (363)
Q Consensus       173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  252 (363)
                      +|..++....   .+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++............
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            9998886544   589999999999999999999999   9999999999999999999999999998754333333344


Q ss_pred             eccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHH
Q 046084          253 VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI  332 (363)
Q Consensus       253 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  332 (363)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|+.||.....   ......+.......+...+      ..+.++
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~~p~~~~------~~~~~l  225 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEDIKFPRTLS------ADAKSL  225 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHHhccCCccCCCCCC------HHHHHH
Confidence            5789999999999988899999999999999999999999864322   2222223222222222211      137889


Q ss_pred             HHHccCCCCCCCC------hHHHHHHHh
Q 046084          333 VFACLRSKPTSRP------MQRVSQEFL  354 (363)
Q Consensus       333 i~~cl~~dP~~RP------~~~v~~~l~  354 (363)
                      +.+||+.||++||      +.+++.+..
T Consensus       226 i~~~L~~dP~~R~~~~~~~~~~il~h~~  253 (328)
T cd05593         226 LSGLLIKDPNKRLGGGPDDAKEIMRHSF  253 (328)
T ss_pred             HHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence            9999999999994      677766543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1e-43  Score=318.17  Aligned_cols=257  Identities=22%  Similarity=0.283  Sum_probs=196.6

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||.|+||.||+|... +++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            56899999999999999999654 6889999998754322 112467789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++ +|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          84 YLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            9975 88888865432  478899999999999999999999   99999999999999999999999999997654433


Q ss_pred             CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc--------------
Q 046084          248 SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR--------------  312 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  312 (363)
                      .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...................              
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            33344567899999998765 568899999999999999999999986433211100000000000              


Q ss_pred             ----CCCCCCChh---hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          313 ----VPSPIDDQT---VIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       313 ----~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                          .+.....+.   .........+++.+||+.||.+|| +.|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                000000000   000112477899999999999999 9998865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-43  Score=320.49  Aligned_cols=236  Identities=24%  Similarity=0.363  Sum_probs=193.3

Q ss_pred             CeeeecCceeEEEEEe----CCCCEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           95 YCIGTGGYGSVYRAQL----PSGKKVALKKLHHSET--ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +.||+|+||.||+++.    .+++.||+|.+.....  .......+..|+.+++.++||||+++++++..++..+++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999965    3578999999875432  122235678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++....   .+.+..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999987654   578888889999999999999999   999999999999999999999999999875433333


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL  328 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ......|++.|+|||++.+..++.++||||||+++|||++|+.||....   .......+.......+...+      ..
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~~~~~~~~~~~~~~~------~~  226 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTIDKILKGKLNLPPYLT------PE  226 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCC------HH
Confidence            3344568999999999998889999999999999999999999986532   22333444444433332222      13


Q ss_pred             HHHHHHHccCCCCCCCC
Q 046084          329 VSKIVFACLRSKPTSRP  345 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP  345 (363)
                      +.+++.+||+.||++||
T Consensus       227 ~~~li~~~l~~~p~~R~  243 (323)
T cd05584         227 ARDLLKKLLKRNPSSRL  243 (323)
T ss_pred             HHHHHHHHcccCHhHcC
Confidence            78999999999999998

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.6e-43  Score=310.11  Aligned_cols=248  Identities=25%  Similarity=0.460  Sum_probs=201.2

Q ss_pred             cCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      ++|++.+.||+|+||.||++.+.++..+|+|.+......   .+.+..|+.+++.++||||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            568889999999999999999888889999988754432   25688899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++|+|.+++.....  .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          81 MENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            999999999875432  588999999999999999999999   999999999999999999999999999876532221


Q ss_pred             Cc-eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHH
Q 046084          249 NR-TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQD  325 (363)
Q Consensus       249 ~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  325 (363)
                      .. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+... ....+...      
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~~------  226 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGFRLYRPKLA------  226 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCCCCCCCCC------
Confidence            11 11234567999999988889999999999999999999 8999865432   2222222222 11122211      


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      ...+.+++.+||+.||++|| +.+++..|
T Consensus       227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            12488999999999999999 99998876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.6e-43  Score=319.77  Aligned_cols=241  Identities=22%  Similarity=0.341  Sum_probs=196.3

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCC-ceeeeeeEEeeCCeEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHR-NIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  166 (363)
                      +|++.+.||+|+||.||+|... +++.||+|++..... .....+.+..|..++..++|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5888999999999999999764 567899999875432 222346678899999999764 6888999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999887554   588999999999999999999999   9999999999999999999999999998754333


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ........|++.|+|||++.+..++.++|||||||++|||++|+.||....   .......+.......+...+      
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~~~~~~~------  225 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIMEHNVSYPKSLS------  225 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCC------
Confidence            333445679999999999999889999999999999999999999986533   22333334444333332222      


Q ss_pred             HHHHHHHHHccCCCCCCCC
Q 046084          327 ILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP  345 (363)
                      ..+.+++.+||+.||++|+
T Consensus       226 ~~~~~li~~~l~~~P~~R~  244 (324)
T cd05587         226 KEAVSICKGLLTKHPAKRL  244 (324)
T ss_pred             HHHHHHHHHHhhcCHHHcC
Confidence            1378899999999999999

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-43  Score=312.39  Aligned_cols=254  Identities=27%  Similarity=0.488  Sum_probs=207.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ...+|++.+.||.|+||.||+|...++..+++|.+......  ....+..|+.+++.++||||+++++++.+.+..+++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh--hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            45679999999999999999999888999999998765432  2357889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++.... ...+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+......
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          82 ELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             eecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            9999999999997643 23689999999999999999999999   9999999999999999999999999999765433


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQ  324 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  324 (363)
                      ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ......+... ..+.+...+    
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~----  230 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITAGYRMPCPAKCP----  230 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHhCCcCCCCCCCC----
Confidence            222223345678999999988889999999999999999998 8999865332   2222222221 222222121    


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        ..+.+++.+||+.||++|| +.++++.|..
T Consensus       231 --~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         231 --QEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             --HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence              2488999999999999999 9999998864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.3e-43  Score=320.14  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=204.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||++... ++..+|+|.+..... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            578999999999999999999764 678899998876533 233567999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+..  +++||||||+|||++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          83 EHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            9999999999997654   5889999999999999999999852  5999999999999999999999999998765322


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhh----------------------
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM----------------------  304 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~----------------------  304 (363)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||...........                      
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP  235 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence              22334689999999999988899999999999999999999999864321100000                      


Q ss_pred             ---------------------HHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          305 ---------------------LIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       305 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                                           ...+.....+ .....   .....+.+|+.+||+.||++|| +.+++++...+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~  306 (331)
T cd06649         236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPP-KLPNG---VFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR  306 (331)
T ss_pred             ccccccccccccccchhHHHHHHHHHhCCCc-CCCCc---cccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence                                 0000000000 00000   1122488999999999999999 999998876543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.1e-43  Score=317.32  Aligned_cols=260  Identities=23%  Similarity=0.297  Sum_probs=199.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||+|... +++.||+|++....... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            467999999999999999999764 68899999987543321 1245678999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+. ++|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          83 EYVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             ECCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            9996 577777765432  588889999999999999999999   9999999999999999999999999999765433


Q ss_pred             CCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhh---ccc----------
Q 046084          247 SSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL---DQR----------  312 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~----------  312 (363)
                      ........+++.|+|||++.+ ..++.++|||||||++|||++|+.||.......  .....+.   ...          
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhh
Confidence            333344568899999998765 457889999999999999999999987543211  1111110   000          


Q ss_pred             --------CC--CCCCChhhHH---HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          313 --------VP--SPIDDQTVIQ---DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       313 --------~~--~~~~~~~~~~---~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                              ..  .+......+.   ....+.+++.+||+.||++|| +.|++.+-..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence                    00  0000000000   112477899999999999999 99998776554

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.5e-43  Score=311.07  Aligned_cols=252  Identities=25%  Similarity=0.455  Sum_probs=203.7

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..++|++.+.||+|+||.||+|...++..||+|.+......   .+.+..|+.+++.++|+||+++++.+...+..+++|
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh---HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            45689999999999999999998888889999998754332   367889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++.... ...+++..++.++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          81 EYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             ecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999999986543 23588899999999999999999999   9999999999999999999999999999875432


Q ss_pred             CCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhH
Q 046084          247 SSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVI  323 (363)
Q Consensus       247 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  323 (363)
                      ... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ......+... ..+....     
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~-----  228 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRGYRMPRMEN-----  228 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCCCCCCC-----
Confidence            211 112235668999999988889999999999999999998 9999854322   1222222222 1111111     


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                       ....+.+++.+||+.+|++|| +.++.+.|+
T Consensus       229 -~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  259 (261)
T cd05072         229 -CPDELYDIMKTCWKEKAEERPTFDYLQSVLD  259 (261)
T ss_pred             -CCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence             112488999999999999999 998888775

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.9e-43  Score=308.13  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=206.5

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||+|++|.||++... +++.|++|.+..........+.+..|+++++.++|||++++++++.+.+..+++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            5778899999999999999764 688999999876543344457889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++.... ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999987642 23689999999999999999999999   999999999999999999999999999987654443


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL  328 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ......++..|+|||+..+..++.++|+||||+++|+|++|+.||....   .............+....     .....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~  228 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRGVFPPVSQ-----MYSQQ  228 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCcc-----ccCHH
Confidence            3344568889999999998889999999999999999999999986543   222223333332222111     11224


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      +.+++.+||+.+|++|| +.+++..
T Consensus       229 ~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         229 LAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHhhC
Confidence            88999999999999999 9998865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.5e-43  Score=309.32  Aligned_cols=250  Identities=24%  Similarity=0.441  Sum_probs=201.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .++|++.+.||+|+||.||+++..++..+|+|.+......   .+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            3568889999999999999998877778999988754432   2568899999999999999999999999888999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+.+|+|.+++.....  .+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||.+.......
T Consensus        80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            9999999999876432  589999999999999999999999   99999999999999999999999999987654332


Q ss_pred             CCc-eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCC-CCCCChhhHH
Q 046084          248 SNR-TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVP-SPIDDQTVIQ  324 (363)
Q Consensus       248 ~~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  324 (363)
                      ... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+...... .+...     
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~-----  226 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLRLYRPHLA-----  226 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCCCCCCCCC-----
Confidence            211 11234567999999988889999999999999999998 9999764432   1222222222211 11111     


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                       ...+.+++.+||+.||++|| +.+++..++
T Consensus       227 -~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         227 -SEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             12488999999999999999 999988763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3e-43  Score=319.56  Aligned_cols=245  Identities=25%  Similarity=0.374  Sum_probs=197.1

Q ss_pred             CeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||++... +++.||+|++..... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999764 578999999875421 122345677888888776 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            99999887654   589999999999999999999999   999999999999999999999999999876433333344


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||....   .......+.......+...+      ..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~------~~~~~  225 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVVYPTWLS------QDAVD  225 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCCCCCCCCC------HHHHH
Confidence            4578999999999998889999999999999999999999986533   22333344443333222111      13788


Q ss_pred             HHHHccCCCCCCCC-h------HHHHHHHh
Q 046084          332 IVFACLRSKPTSRP-M------QRVSQEFL  354 (363)
Q Consensus       332 li~~cl~~dP~~RP-~------~~v~~~l~  354 (363)
                      ++.+||+.||++|| +      .+++.+-.
T Consensus       226 li~~~L~~dP~~R~~~~~~~~~~~~~~h~~  255 (320)
T cd05590         226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPF  255 (320)
T ss_pred             HHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence            99999999999999 7      55555433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-43  Score=322.03  Aligned_cols=246  Identities=22%  Similarity=0.304  Sum_probs=198.0

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      +.||+|+||.||++.. .+|+.||+|.+..... .......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999965 4788999999875432 2223456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      +|..++....   .+++..+..++.|++.||+|||+ .   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence            9998886544   58999999999999999999997 6   999999999999999999999999999876433333334


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||.....   ......+.......+...+      ..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~~------~~~~~  225 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEIRFPRTLS------PEAKS  225 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCCCCCCCCC------HHHHH
Confidence            45699999999999988899999999999999999999999864322   2222333333333222222      13788


Q ss_pred             HHHHccCCCCCCC-----C-hHHHHHHHhc
Q 046084          332 IVFACLRSKPTSR-----P-MQRVSQEFLV  355 (363)
Q Consensus       332 li~~cl~~dP~~R-----P-~~~v~~~l~~  355 (363)
                      ++.+||+.||++|     | +.+++.+-..
T Consensus       226 li~~~L~~dP~~R~~~~~~~~~~il~h~~~  255 (325)
T cd05594         226 LLSGLLKKDPKQRLGGGPDDAKEIMQHKFF  255 (325)
T ss_pred             HHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence            9999999999999     4 6777765443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.4e-43  Score=316.88  Aligned_cols=242  Identities=24%  Similarity=0.375  Sum_probs=192.2

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQ-IRHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||+|.. .+++.||+|.++.... .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999976 4578899999875432 12223445566666664 4899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|..++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            99999887654   589999999999999999999999   999999999999999999999999999976543333344


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.....   ......+.......+...+      ..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~------~~~~~  225 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILNDRPHFPRWIS------KEAKD  225 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCCCCC------HHHHH
Confidence            55789999999999988899999999999999999999999865432   2233333333222222111      13788


Q ss_pred             HHHHccCCCCCCCC-hH-HHHH
Q 046084          332 IVFACLRSKPTSRP-MQ-RVSQ  351 (363)
Q Consensus       332 li~~cl~~dP~~RP-~~-~v~~  351 (363)
                      ++.+||+.||++|| +. ++..
T Consensus       226 ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         226 CLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             HHHHHccCCHHHcCCChHHHHc
Confidence            99999999999999 54 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.2e-42  Score=355.86  Aligned_cols=250  Identities=28%  Similarity=0.517  Sum_probs=196.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ...+...+.||+|+||.||+|.. .++..||+|++......      ...|++.+++++||||++++|+|.+.+..++||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            34677888999999999999976 57899999998754321      124688899999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.++++      .++|.++.+++.|+++||+|||..+.++++||||||+||+++.++.+++. ||....... 
T Consensus       763 Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        763 EYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-  834 (968)
T ss_pred             eCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-
Confidence            9999999999995      38899999999999999999996656699999999999999999888875 665543221 


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhh-----------HHhhhcccCCC
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM-----------LIDLLDQRVPS  315 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~-----------~~~~~~~~~~~  315 (363)
                         .....++..|+|||++.+..++.++|||||||++|||++|+.||+..........           ...+.+.....
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence               1223578899999999999999999999999999999999999854322111110           01111222111


Q ss_pred             CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .  ..........+.+++.+||+.||++|| +.|++++|...
T Consensus       912 ~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        912 D--VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             C--CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            1  111234455688999999999999999 99999998754

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.7e-43  Score=312.44  Aligned_cols=255  Identities=24%  Similarity=0.431  Sum_probs=203.5

Q ss_pred             cCCcccCeeeecCceeEEEEEeCC------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPS------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      ++|++.+.||+|+||.||+|....      ...|++|.+...... .....+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            478899999999999999997532      257999998755432 3346789999999999999999999999998999


Q ss_pred             EEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC
Q 046084          163 FLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK  229 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  229 (363)
                      +++|||+++++|.+++.....             ...+++..++.++.|++.||+|||+.   +++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence            999999999999999865321             13588899999999999999999999   99999999999999999


Q ss_pred             CceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHH
Q 046084          230 LEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLI  306 (363)
Q Consensus       230 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~  306 (363)
                      +.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   .....
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~  237 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIE  237 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence            9999999999976533221  1222345788999999988889999999999999999998 9999865432   22222


Q ss_pred             hhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          307 DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+.....+. ..    ...+..+.+|+.+||+.||.+|| +.++++.|..
T Consensus       238 ~i~~~~~~~-~~----~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 MIRSRQLLP-CP----EDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCCcCC-Cc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            222222211 11    11223488999999999999999 9999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5e-43  Score=319.29  Aligned_cols=247  Identities=23%  Similarity=0.371  Sum_probs=195.6

Q ss_pred             CeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||++... +++.||+|.+..... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999764 678999999876432 223345677888888776 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|..++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            99998886544   589999999999999999999999   999999999999999999999999999875433333334


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCC-----c-hhhHHhhhcccCCCCCCChhhHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN-----P-KIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      ...||..|+|||++.+..++.++||||||+++|||++|+.||.......     . ......+.......+...+     
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~-----  229 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS-----  229 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCC-----
Confidence            4578999999999999999999999999999999999999986432111     1 1122223333333222221     


Q ss_pred             HHHHHHHHHHccCCCCCCCC-h------HHHHHHH
Q 046084          326 IILVSKIVFACLRSKPTSRP-M------QRVSQEF  353 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~------~~v~~~l  353 (363)
                       ..+.+++.+||+.||++|| +      .+++.+-
T Consensus       230 -~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp  263 (329)
T cd05618         230 -VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP  263 (329)
T ss_pred             -HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence             1377899999999999999 4      4665543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.5e-43  Score=315.94  Aligned_cols=255  Identities=25%  Similarity=0.360  Sum_probs=192.5

Q ss_pred             cCCcccCeeeecCceeEEEEEe--CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC---CCCceeeeeeEEee-----
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL--PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI---RHRNIVKLYGFCLH-----  158 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----  158 (363)
                      ++|++.+.||+|+||.||+|..  .++..||+|.+............+.+|+.+++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688999999999999999975  2467899999876543322224455677776665   69999999999863     


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      ....+++|||+. ++|.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346899999996 589888865432 2589999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc-CCCCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR-VPSPI  317 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  317 (363)
                      ++...... .......|+..|+|||.+.+..++.++||||||+++|||++|++||.......   ....+.+.. .+.+.
T Consensus       156 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~  231 (290)
T cd07862         156 LARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE  231 (290)
T ss_pred             ceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChh
Confidence            99765433 22334568999999999988889999999999999999999999987543321   111111100 00000


Q ss_pred             C---------------Chhh-----HHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          318 D---------------DQTV-----IQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       318 ~---------------~~~~-----~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .               ....     ......+.+++.+||+.||++|| +.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0               0000     00112477899999999999999 9998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=311.36  Aligned_cols=253  Identities=28%  Similarity=0.442  Sum_probs=191.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC--CCCceeeeeeEEeeCC----e
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI--RHRNIVKLYGFCLHKK----C  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----~  161 (363)
                      .....+.+.+|+|.||.||+|.+ +++.||||++....     .+.|..|-++++..  +|+||++++++-....    .
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            34556677899999999999999 56999999997543     36788888887754  7999999998876555    6


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCcEEeCCCCCCeeecCCCceEEE
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC------IPSIVHRDISSNNILLNSKLEAFVA  235 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~dlkp~Nill~~~~~~kl~  235 (363)
                      .+||+||.+.|+|.+||..+    .++|....+++..+++||+|||+..      .++|+|||||++||||.+|+++.|+
T Consensus       283 ywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence            89999999999999999876    5999999999999999999999873      4789999999999999999999999


Q ss_pred             eeccceeccCCCC--Cceeecccccccccccccccc-CC-----ccccchHHHHHHHHHHhCCCCCC--------CCcC-
Q 046084          236 DFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMV-LT-----EKCDVYSFGVVALEVLMGRHPGD--------LLSS-  298 (363)
Q Consensus       236 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-~~-----~~~DvwslG~il~el~~g~~p~~--------~~~~-  298 (363)
                      |||++..+.....  .....+||.+|||||++.+.. +.     .+.||||+|.+||||+++..-.+        ...+ 
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            9999988754332  223368999999999987643 22     36899999999999999654332        1110 


Q ss_pred             ---C--CchhhHHhhhcccC-CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHH
Q 046084          299 ---V--NPKIMLIDLLDQRV-PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVS  350 (363)
Q Consensus       299 ---~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~  350 (363)
                         .  ..+.+.......+. |...+.-.....+..+.+.+..||..||+-|- +.=+-
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence               0  11222222222211 11111111223455699999999999999999 43333

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=325.58  Aligned_cols=253  Identities=24%  Similarity=0.377  Sum_probs=204.7

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|.+.+.||+|+||.||++... +|+.||+|++....... .....+..|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999764 68899999987543221 33467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            9999999999997653   689999999999999999999998   9999999999999999999999999999765433


Q ss_pred             C-----------------------------CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCc
Q 046084          247 S-----------------------------SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLS  297 (363)
Q Consensus       247 ~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~  297 (363)
                      .                             .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                             12233568999999999999999999999999999999999999986543


Q ss_pred             CCCchhhHHhhhc--ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC--hHHHHHHHhc
Q 046084          298 SVNPKIMLIDLLD--QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP--MQRVSQEFLV  355 (363)
Q Consensus       298 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--~~~v~~~l~~  355 (363)
                      .   ......+..  .....+....    ....+.++|..||+ ||.+||  +.+++.+...
T Consensus       235 ~---~~~~~~i~~~~~~~~~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~  288 (350)
T cd05573         235 L---QETYNKIINWKESLRFPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF  288 (350)
T ss_pred             H---HHHHHHHhccCCcccCCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence            2   222223332  2222221111    11248889999998 999999  7777766543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-43  Score=308.05  Aligned_cols=254  Identities=24%  Similarity=0.459  Sum_probs=204.9

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +..++|++.+.||+|++|.||+|...+++.||+|.++.....   .+.+.+|+.++++++|||++++++++...+..+++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            345679999999999999999998877888999998765432   35688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++.... ...+++..+..++.|++.|+.|||+.   +++||||||+||++++++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            99999999999987643 33689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCce-eeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhh
Q 046084          246 DSSNRT-VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTV  322 (363)
Q Consensus       246 ~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  322 (363)
                      ...... ....+..|+|||.+.+..++.++||||||+++|||++ |+.||....   .......+... ..+.+...   
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~---  229 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQVDQGYRMPCPPGC---  229 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCcC---
Confidence            221111 1122357999999988889999999999999999999 999986432   22222222221 11222111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                         ...+.+++.+||+.+|++|| +.+++..|+.
T Consensus       230 ---~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         230 ---PKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence               12488999999999999999 9999988863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-43  Score=324.09  Aligned_cols=259  Identities=26%  Similarity=0.402  Sum_probs=196.4

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----eEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-----CMF  163 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  163 (363)
                      +|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478899999999999999975 46889999998754333333457889999999999999999999886432     479


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ++|||+. ++|.+++....   .+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus        81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68888886544   589999999999999999999999   9999999999999999999999999999754


Q ss_pred             cCCCC---Cceeecccccccccccccc--ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh-----------
Q 046084          244 HSDSS---NRTVVAGTHGYIAPELAYT--MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID-----------  307 (363)
Q Consensus       244 ~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~-----------  307 (363)
                      .....   ......|++.|+|||++.+  ..++.++|||||||++|||++|+.||.............+           
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32221   1233568999999998765  6788999999999999999999999865332110000000           


Q ss_pred             ------------hhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          308 ------------LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       308 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                  ......+.+.. .........+.+++.+||+.||++|| +.|++.+-..+
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~  294 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFS-QKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK  294 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchH-HhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence                        00001110000 00000112478899999999999999 99999876543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7e-43  Score=317.74  Aligned_cols=241  Identities=22%  Similarity=0.350  Sum_probs=196.8

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      +|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788999999999999999764 577999999875432 122234566788888777 5899999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999999887554   588999999999999999999999   9999999999999999999999999999764433


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+.......+...+      
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s------  225 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNVAYPKSMS------  225 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCcCC------
Confidence            333445678999999999999999999999999999999999999986533   23334444444443333222      


Q ss_pred             HHHHHHHHHccCCCCCCCC
Q 046084          327 ILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP  345 (363)
                      ..+.+++.+||+.||++|+
T Consensus       226 ~~~~~li~~~l~~~p~~R~  244 (323)
T cd05616         226 KEAVAICKGLMTKHPGKRL  244 (323)
T ss_pred             HHHHHHHHHHcccCHHhcC
Confidence            1378899999999999999

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.6e-43  Score=333.73  Aligned_cols=250  Identities=22%  Similarity=0.261  Sum_probs=201.7

Q ss_pred             CCcccCeeeecCceeEEEEEeC-C-CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-S-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .|.+.+.||+|++|.||++... + ++.||+|.+.....  .....+..|+.+++.++||||+++++++...+..++|||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            4889999999999999999653 3 57888887754433  223567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          168 YMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       168 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      |+++|+|.+++... ....++++.++..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999999887642 2233688999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CC--CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC-CCCCChhhH
Q 046084          247 SS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP-SPIDDQTVI  323 (363)
Q Consensus       247 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  323 (363)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+...... .+...+   
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~s---  296 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLYGKYDPFPCPVS---  296 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCccCC---
Confidence            21  2334568999999999998899999999999999999999999986432   22233333333222 111111   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                         ..+.++|..||+.||++|| +.+++..-
T Consensus       297 ---~~~~~li~~~L~~dP~~Rps~~~~l~~~  324 (478)
T PTZ00267        297 ---SGMKALLDPLLSKNPALRPTTQQLLHTE  324 (478)
T ss_pred             ---HHHHHHHHHHhccChhhCcCHHHHHhCH
Confidence               2488999999999999999 99887653

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.2e-43  Score=319.90  Aligned_cols=244  Identities=27%  Similarity=0.365  Sum_probs=195.0

Q ss_pred             CCcccCeeeecCceeEEEEEe----CCCCEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL----PSGKKVALKKLHHSET--ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (363)
                      +|++.+.||+|+||.||+++.    .+++.||+|++.....  .....+.+..|+.+++.+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            588899999999999999865    3678999999865321  222345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      +++|||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999987544   588999999999999999999999   999999999999999999999999999976


Q ss_pred             ccCCCC-Cceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCch-hhHHhhhcccCCCCCCC
Q 046084          243 LHSDSS-NRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK-IMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       243 ~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  319 (363)
                      ...... ......||..|+|||.+.+. .++.++|||||||++|||++|+.||......... .....+.....+.+...
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI  234 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence            533222 22345689999999998765 4788999999999999999999998754332222 22222333222222211


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                      +      ..+.+++.+||+.||++||
T Consensus       235 ~------~~~~~li~~~l~~dp~~R~  254 (332)
T cd05614         235 G------PEAQDLLHKLLRKDPKKRL  254 (332)
T ss_pred             C------HHHHHHHHHHcCCCHHHcC
Confidence            1      1378899999999999999

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.6e-43  Score=318.91  Aligned_cols=238  Identities=24%  Similarity=0.341  Sum_probs=190.2

Q ss_pred             CeeeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHHHH-HHhcCCCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAH-LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||+||++... +|+.||+|++...... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999764 6889999998754321 112234444544 56789999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|..++....   .+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            99999887644   588999999999999999999999   999999999999999999999999999875433333334


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||...+   .......+.......+...      ...+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~------~~~~~~  225 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNILNKPLRLKPNI------SVSARH  225 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCC------CHHHHH
Confidence            4568999999999999889999999999999999999999986432   2233333433333222211      124788


Q ss_pred             HHHHccCCCCCCCC-hH
Q 046084          332 IVFACLRSKPTSRP-MQ  347 (363)
Q Consensus       332 li~~cl~~dP~~RP-~~  347 (363)
                      ++.+||+.||++|| +.
T Consensus       226 li~~~l~~~p~~R~~~~  242 (323)
T cd05575         226 LLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHhhcCHHhCCCCC
Confidence            99999999999999 64

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=293.61  Aligned_cols=262  Identities=21%  Similarity=0.323  Sum_probs=210.2

Q ss_pred             HHhcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK----  160 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  160 (363)
                      +..++|++.+.||+|||+-||+++ ..++..+|+|++.....  +..+..++|++..++++|||++++++++..+.    
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~--~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ--EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch--HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            567899999999999999999996 56788999999987663  33578899999999999999999998876543    


Q ss_pred             -eEEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          161 -CMFLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       161 -~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                       ..|++++|...|+|.+.+.... ++..+++.+++.|+.++++||.+||+. .+++.||||||.|||+++++.+++.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence             4899999999999999987643 233689999999999999999999988 3359999999999999999999999999


Q ss_pred             cceeccCCCCC---------ceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH
Q 046084          239 VARLLHSDSSN---------RTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI  306 (363)
Q Consensus       239 ~~~~~~~~~~~---------~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~  306 (363)
                      .++...-....         ......|..|+|||.+.   +...++++|||||||++|+|+.|..||+.... .......
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSlaL  253 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLAL  253 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEEE
Confidence            98754321111         11123578899999876   44568899999999999999999999976544 3333334


Q ss_pred             hhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          307 DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+....+..|....    ....+.++|.+||++||.+|| ..+++..+..
T Consensus       254 Av~n~q~s~P~~~~----yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  254 AVQNAQISIPNSSR----YSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             eeeccccccCCCCC----ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence            44555555554333    233589999999999999999 9999987754

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-42  Score=306.91  Aligned_cols=260  Identities=22%  Similarity=0.294  Sum_probs=206.5

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+.... ........+..|+.+++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5789999999999999999975 478899999876532 22333467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          167 KYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      ||+++++|.+++.... ....+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885422 123578899999999999999999999   999999999999999999999999999887654


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .........++..|+|||.+.+..++.++|+||||+++|||++|+.||..... +...... .+......+..   ....
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~~---~~~~  233 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQ-KIEQCDYPPLP---TEHY  233 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHH-HHhcCCCCCCC---hhhc
Confidence            33333344678899999999888889999999999999999999999754321 1112222 22221111111   1112


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ...+.+++.+||+.+|++|| +.++++.+...
T Consensus       234 ~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         234 SEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            23488999999999999999 99999988653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.7e-43  Score=311.53  Aligned_cols=256  Identities=22%  Similarity=0.366  Sum_probs=202.2

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK  159 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (363)
                      +..++|++.+.||+|+||.||+|...      ++..||+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            45778999999999999999998652      3467999998654332 2245688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCce
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDE-------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEA  232 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  232 (363)
                      ...+++|||+++++|.+++.....       ...+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence            999999999999999999865321       22467888999999999999999999   99999999999999999999


Q ss_pred             EEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhh
Q 046084          233 FVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLL  309 (363)
Q Consensus       233 kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~  309 (363)
                      +|+|||++.........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||....   .........
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~---~~~~~~~~~  235 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQVLRFVM  235 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHH
Confidence            99999998755332211  112234678999999988889999999999999999999 788876432   222222222


Q ss_pred             cccC-CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          310 DQRV-PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       310 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .... ..+...      ...+.+++.+||+.||++|| +.+++..|+
T Consensus       236 ~~~~~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         236 EGGLLDKPDNC------PDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCCcCCCCCCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            2222 112111      12488999999999999999 999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=312.70  Aligned_cols=257  Identities=24%  Similarity=0.336  Sum_probs=204.0

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch------------HHHHHHHHHHHHHHhcCCCCceeeee
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE------------LAFLESFQTEAHLLSQIRHRNIVKLY  153 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~niv~l~  153 (363)
                      .-++|++.+.||+|.||.|-+|.. .+++.||||++......            ..-.+...+|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            346899999999999999999965 47889999999754321            11235788999999999999999999


Q ss_pred             eEEeeC--CeEEEEEEeccCCChhhhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC
Q 046084          154 GFCLHK--KCMFLIYKYMRRGSLFCILRNDDEAIR-LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL  230 (363)
Q Consensus       154 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  230 (363)
                      ++..+.  +.+|||+|||..|.+...=    .... +++.+.++++.++..||.|||.+   +|+||||||+|+||+++|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence            998875  5799999999988874322    2223 89999999999999999999999   999999999999999999


Q ss_pred             ceEEEeeccceeccCCC-----CCceeecccccccccccccccc----CCccccchHHHHHHHHHHhCCCCCCCCcCCCc
Q 046084          231 EAFVADFGVARLLHSDS-----SNRTVVAGTHGYIAPELAYTMV----LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP  301 (363)
Q Consensus       231 ~~kl~Dfg~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~p~~~~~~~~~  301 (363)
                      ++||+|||.+.......     ......+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-..   ..
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~---~~  324 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD---FE  324 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc---hH
Confidence            99999999998763221     1122357999999999877632    346889999999999999999997432   33


Q ss_pred             hhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          302 KIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ......+....+..|...    .....+.+||.+||.+||++|- ..+|..+.+..+
T Consensus       325 ~~l~~KIvn~pL~fP~~p----e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  325 LELFDKIVNDPLEFPENP----EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHHHHhcCcccCCCcc----cccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            345556666666666543    1122488999999999999999 888877766543

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-43  Score=306.77  Aligned_cols=249  Identities=25%  Similarity=0.470  Sum_probs=200.6

Q ss_pred             cCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+.......   +.+.+|+++++.++||||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            4688899999999999999988777889999986543322   4678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++.....  .+++..++.++.|++.|++|||+.   +++||||||+||++++++.+||+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          81 MANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             CCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            999999999875433  589999999999999999999999   999999999999999999999999999876533221


Q ss_pred             Cc-eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHH
Q 046084          249 NR-TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQD  325 (363)
Q Consensus       249 ~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  325 (363)
                      .. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||+......   ....+... ..+.+...      
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~------  226 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVSAGYRLYRPKLA------  226 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHHHcCCcCCCCCCC------
Confidence            11 11123457999999988889999999999999999999 899986543321   11222111 11222111      


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ...+.+++.+||+.+|++|| +.++++.|.
T Consensus       227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            22488999999999999999 999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.2e-43  Score=316.55  Aligned_cols=245  Identities=24%  Similarity=0.343  Sum_probs=197.9

Q ss_pred             CeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||++... +++.||+|.+..... .....+.+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999764 578999999875432 222345677888888887 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|..++....   .+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++...........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence            99998887654   589999999999999999999999   999999999999999999999999999875433333334


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...|+..|+|||++.+..++.++|||||||++|+|++|+.||...+   .......+.......+...+      ..+.+
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~------~~~~~  225 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILEDEVRYPRWLS------KEAKS  225 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCCCCCcCC------HHHHH
Confidence            4568999999999999999999999999999999999999986433   22233333333332222111      24789


Q ss_pred             HHHHccCCCCCCCC-h-----HHHHHHHh
Q 046084          332 IVFACLRSKPTSRP-M-----QRVSQEFL  354 (363)
Q Consensus       332 li~~cl~~dP~~RP-~-----~~v~~~l~  354 (363)
                      ++.+||+.||++|| +     .+++..-.
T Consensus       226 li~~~l~~dP~~R~s~~~~~~~~ll~~~~  254 (318)
T cd05570         226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPF  254 (318)
T ss_pred             HHHHHccCCHHHcCCCCCCCHHHHhcCCC
Confidence            99999999999999 8     77766543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-43  Score=307.27  Aligned_cols=264  Identities=24%  Similarity=0.433  Sum_probs=202.0

Q ss_pred             ccHHHHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhc--CCCCceeeeeeEE
Q 046084           79 ITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQ--IRHRNIVKLYGFC  156 (363)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~  156 (363)
                      +++--.....++..+.+.||+|.||.||+|++ .|+.||||++...++     +.+.+|.++++.  |+|+||+.+++.-
T Consensus       201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE-----~SWfrEtEIYqTvmLRHENILgFIaaD  274 (513)
T KOG2052|consen  201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE-----RSWFRETEIYQTVMLRHENILGFIAAD  274 (513)
T ss_pred             chhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch-----hhhhhHHHHHHHHHhccchhhhhhhcc
Confidence            33333445567889999999999999999999 789999999987665     456677777765  4999999998765


Q ss_pred             eeCC----eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEEeCCCCCCeeec
Q 046084          157 LHKK----CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD-----CIPSIVHRDISSNNILLN  227 (363)
Q Consensus       157 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dlkp~Nill~  227 (363)
                      ..++    .++||++|.+.|+|.|||...    .++....++++..+|.||+|||..     ..|.|.|||||+.|||+.
T Consensus       275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK  350 (513)
T KOG2052|consen  275 NKDNGSWTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  350 (513)
T ss_pred             ccCCCceEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence            5432    589999999999999999874    599999999999999999999976     458899999999999999


Q ss_pred             CCCceEEEeeccceeccCCC----CCceeecccccccccccccccc----C--CccccchHHHHHHHHHHhC--------
Q 046084          228 SKLEAFVADFGVARLLHSDS----SNRTVVAGTHGYIAPELAYTMV----L--TEKCDVYSFGVVALEVLMG--------  289 (363)
Q Consensus       228 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~----~--~~~~DvwslG~il~el~~g--------  289 (363)
                      +++.+.|+|+|+|-......    ......+||.+|||||++...-    +  -..+||||||.++||+...        
T Consensus       351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e  430 (513)
T KOG2052|consen  351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE  430 (513)
T ss_pred             cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence            99999999999997654432    2234568999999999886432    1  1358999999999998863        


Q ss_pred             --CCCCCCCcCCCc--hhhH----HhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          290 --RHPGDLLSSVNP--KIML----IDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       290 --~~p~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        +.||.+.-+.++  +++.    .+.+++.++....+...   +..+.+|++.||..||.-|- +-.+=+.|..
T Consensus       431 ey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~---l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  431 EYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPA---LRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             hhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHH---HHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence              467655443332  2222    22333444444433333   34588999999999999999 6666555533

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.2e-43  Score=333.73  Aligned_cols=255  Identities=24%  Similarity=0.279  Sum_probs=204.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-----  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  160 (363)
                      ..++|.+.+.||+|+||+||++.. .+|+.||+|.+............+.+|+..+..++|+|++++.+.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            457899999999999999999964 57899999998765544444567889999999999999999987765432     


Q ss_pred             ---eEEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEe
Q 046084          161 ---CMFLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVAD  236 (363)
Q Consensus       161 ---~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  236 (363)
                         ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               3679999999999999886532 233689999999999999999999999   999999999999999999999999


Q ss_pred             eccceeccCCC--CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC
Q 046084          237 FGVARLLHSDS--SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP  314 (363)
Q Consensus       237 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  314 (363)
                      ||+++......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..............
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~~~~~~~~  263 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHKTLAGRYD  263 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHhcCCCC
Confidence            99997654321  12234568999999999999899999999999999999999999986432   22233333332222


Q ss_pred             -CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          315 -SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       315 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                       .+...      ...+.+++..||+.||++|| +.+++.+.
T Consensus       264 ~~~~~~------~~~l~~li~~~L~~dP~~RPs~~ell~~p  298 (496)
T PTZ00283        264 PLPPSI------SPEMQEIVTALLSSDPKRRPSSSKLLNMP  298 (496)
T ss_pred             CCCCCC------CHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence             11111      12488999999999999999 99988754

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-42  Score=309.91  Aligned_cols=240  Identities=26%  Similarity=0.319  Sum_probs=191.7

Q ss_pred             eeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCCh
Q 046084           97 IGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus        97 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      ||+|+||+||++.. .+++.||+|.+...... ....+.+..|+.+++.++||||+++.+++...+..+++|||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999965 46889999998754322 22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceee
Q 046084          175 FCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV  253 (363)
Q Consensus       175 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  253 (363)
                      .+++.... ....+++..++.++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.............
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            88775322 233689999999999999999999999   99999999999999999999999999997664443333445


Q ss_pred             ccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc-hhhHHhhhcccCCCCCCChhhHHHHHHHHHH
Q 046084          254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDLLDQRVPSPIDDQTVIQDIILVSKI  332 (363)
Q Consensus       254 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  332 (363)
                      .|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ..............+..      ....+.++
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l  231 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK------FSPASKSF  231 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCccc------CCHHHHHH
Confidence            689999999999999999999999999999999999999875433211 11222222222221111      11248899


Q ss_pred             HHHccCCCCCCCC
Q 046084          333 VFACLRSKPTSRP  345 (363)
Q Consensus       333 i~~cl~~dP~~RP  345 (363)
                      +.+||+.||++||
T Consensus       232 i~~~l~~~P~~R~  244 (280)
T cd05608         232 CEALLAKDPEKRL  244 (280)
T ss_pred             HHHHhcCCHHHhc
Confidence            9999999999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.9e-43  Score=318.87  Aligned_cols=260  Identities=24%  Similarity=0.353  Sum_probs=203.9

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ..++|++.+.||+|+||.||++.+. ++..+|+|.+..... ....+.+.+|+++++.++||||+++++++.+.+..+++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            4578999999999999999999764 678899998876433 23346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++|+|.+++....   .+++..+..++.|++.||.|||+..  +++|+||||+|||++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999997654   5888999999999999999999742  699999999999999999999999999875432


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH-------------------
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI-------------------  306 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~-------------------  306 (363)
                      .  ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.............                   
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             h--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence            2  1223468899999999988889999999999999999999999986433211000000                   


Q ss_pred             ---------------------hhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          307 ---------------------DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       307 ---------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                                           ..............   .....+.+|+.+||+.||++|| +.|++.+-..+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~  304 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSG---VFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  304 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCC---CcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence                                 00000000000000   0112478999999999999999 999988776644

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.2e-43  Score=310.60  Aligned_cols=255  Identities=25%  Similarity=0.430  Sum_probs=204.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      .++|.+.+.||+|+||.||+|...      ++..||+|.+...... ...+.+.+|+++++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            456888999999999999999763      3478999998765443 234789999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC
Q 046084          162 MFLIYKYMRRGSLFCILRNDDE-----------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL  230 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  230 (363)
                      .+++|||+++++|.+++.....           ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence            9999999999999999975421           23578899999999999999999999   999999999999999999


Q ss_pred             ceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHh
Q 046084          231 EAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLID  307 (363)
Q Consensus       231 ~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~  307 (363)
                      .++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~  236 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIEC  236 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH
Confidence            999999999976432221  1122345678999999999999999999999999999998 9999754332   222233


Q ss_pred             hhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          308 LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      +..........     .....+.+++.+||+.||++|| +.|+++.|.
T Consensus       237 ~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 ITQGRLLQRPR-----TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHcCCcCCCCC-----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            33332222111     1112488999999999999999 999998874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-42  Score=317.13  Aligned_cols=239  Identities=22%  Similarity=0.369  Sum_probs=192.9

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||++.. .+++.||+|+++.... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3699999999999976 4678999999976432 223345688899999888 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            99998886543   689999999999999999999999   999999999999999999999999999875333333344


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCC------chhhHHhhhcccCCCCCCChhhHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN------PKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||+......      .......+.......+...+     
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-----  229 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS-----  229 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCC-----
Confidence            5678999999999999899999999999999999999999996432211      11122233333333222221     


Q ss_pred             HHHHHHHHHHccCCCCCCCC
Q 046084          326 IILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP  345 (363)
                       ..+.+++.+||+.||++||
T Consensus       230 -~~~~~li~~~L~~dP~~R~  248 (329)
T cd05588         230 -VKASSVLKGFLNKDPKERL  248 (329)
T ss_pred             -HHHHHHHHHHhccCHHHcC
Confidence             1378899999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-42  Score=306.39  Aligned_cols=253  Identities=30%  Similarity=0.468  Sum_probs=203.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCC----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPS----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      .++|++.+.||+|+||.||+|.+..    ...|++|.+...... .....|.+|+.+++.++||||+++++++.+.+..+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD-KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh-HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            4679999999999999999997642    357999998765433 23467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ++|||+++++|.+++.....  .+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++...
T Consensus        82 iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          82 IITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            99999999999999876443  689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCCce--eeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCC
Q 046084          244 HSDSSNRT--VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDD  319 (363)
Q Consensus       244 ~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  319 (363)
                      ........  ...++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+... ..+.+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~  233 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYRLPPPMDC  233 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCCCCCCCC
Confidence            42222111  1234568999999988889999999999999999998 9999754332   1122222221 22222222


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +      ..+.+++.+||+.+|++|| +.++++.|..
T Consensus       234 ~------~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         234 P------SALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             C------HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            2      2488999999999999999 9999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.9e-43  Score=307.09  Aligned_cols=252  Identities=28%  Similarity=0.496  Sum_probs=202.7

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +..++|++.+.||+|+||.||+|...+++.||+|.+.......   +.+.+|+.+++.++|+|++++++++. .+..+++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH---HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            4567899999999999999999998889999999987655432   57889999999999999999999874 4568999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+.+++|.+++.... ...+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            99999999999886543 23689999999999999999999999   999999999999999999999999999976642


Q ss_pred             CCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhh
Q 046084          246 DSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTV  322 (363)
Q Consensus       246 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  322 (363)
                      ... ......++..|+|||.+....++.++||||||+++|||++ |+.||.....   .......... ..+.+...   
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~---  228 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLERGYRMPRPDNC---  228 (260)
T ss_pred             CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHcCCCCCCCCCC---
Confidence            221 1122345678999999988889999999999999999999 9999864432   1112222111 11211111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                         ...+.+++.+||+.+|++|| +.++...|+
T Consensus       229 ---~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         229 ---PEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             ---CHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence               12488999999999999999 888888765

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.5e-43  Score=315.98  Aligned_cols=251  Identities=26%  Similarity=0.458  Sum_probs=199.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCC----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      ..+|++.+.||+|+||.||+|.+. +++    .||+|.+..... ....+++..|+.+++.++||||++++|+|... ..
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            457999999999999999999753 333    489999875433 23346788999999999999999999999875 46


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++++||+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++..
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            799999999999999876542  488899999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCCce--eeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc--cCCCCC
Q 046084          243 LHSDSSNRT--VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPI  317 (363)
Q Consensus       243 ~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  317 (363)
                      .........  ...++..|+|||.+.+..++.++||||||+++|||++ |+.||+......    ...+...  ..+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~~~~~~  234 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQPP  234 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhCCCCCCCCC
Confidence            643322211  1224568999999998899999999999999999997 999986543211    1222222  222222


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..+      ..+.+++.+||+.||++|| +.+++..+..
T Consensus       235 ~~~------~~~~~li~~cl~~~p~~Rps~~~l~~~l~~  267 (316)
T cd05108         235 ICT------IDVYMIMVKCWMIDADSRPKFRELIIEFSK  267 (316)
T ss_pred             CCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            121      2478899999999999999 9999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-43  Score=300.86  Aligned_cols=261  Identities=23%  Similarity=0.268  Sum_probs=207.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  164 (363)
                      .++|+..+.|++|+||.||+|++ ++++.||+|+++.......+--.-.+|+.+|.+++|||||.+-++....  +.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            35688889999999999999965 5788999999988765544444567899999999999999998877654  56999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      |||||+. +|..++....  +++...++.-+..|+++|++|||.+   .|+||||||+|+|+++.|.+||+|||+|+.+.
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999987 8999888765  3688999999999999999999999   99999999999999999999999999999998


Q ss_pred             CCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC---------
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP---------  314 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  314 (363)
                      .+....+..+-|.+|+|||.+.+ ..|+.+.|+||+|||+.||+++++-|...++.+.-......+...-.         
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            88777777888999999998876 56999999999999999999999988766554433332222211100         


Q ss_pred             ---------CCCCChh-----hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          315 ---------SPIDDQT-----VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       315 ---------~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                               .....+.     ...-...=.+|+..+|..||.+|- +.|-+.+=.
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~  363 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY  363 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence                     0000000     000112356899999999999999 888776543

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.8e-43  Score=323.69  Aligned_cols=253  Identities=20%  Similarity=0.311  Sum_probs=198.1

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .|++.+.||+|+||+||+|.. .+++.||+|++..... .......+..|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999965 5678999999976432 23335678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999987654   588899999999999999999999   99999999999999999999999999975321000


Q ss_pred             C-----------------------------------------------CceeeccccccccccccccccCCccccchHHH
Q 046084          248 S-----------------------------------------------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFG  280 (363)
Q Consensus       248 ~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG  280 (363)
                      .                                               ......||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                               01234689999999999988899999999999


Q ss_pred             HHHHHHHhCCCCCCCCcCCCchhhHHhhhc--ccCCCCCCChhhHHHHHHHHHHHHH--ccCCCCCCCC-hHHHHHHHhc
Q 046084          281 VVALEVLMGRHPGDLLSSVNPKIMLIDLLD--QRVPSPIDDQTVIQDIILVSKIVFA--CLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       281 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      |++|||++|+.||.....   ......+..  .....+....    ......+++.+  |+..+|..|| +.+++.+-..
T Consensus       236 ~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~----~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f  308 (381)
T cd05626         236 VILFEMLVGQPPFLAPTP---TETQLKVINWENTLHIPPQVK----LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF  308 (381)
T ss_pred             hHHHHHHhCCCCCcCCCH---HHHHHHHHccccccCCCCCCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcCccc
Confidence            999999999999865432   122222221  1111111110    11136677777  5566666799 9999887554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.4e-42  Score=303.95  Aligned_cols=260  Identities=22%  Similarity=0.310  Sum_probs=208.0

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||+|... +|+.|++|.++.... .....+.+.+|++++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999775 789999998864332 2233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          167 KYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      ||+++++|.+++.... ....+++.+++.++.+++.||+|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886532 233589999999999999999999999   999999999999999999999999999876644


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .........++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..............+ +...   ...
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~---~~~  233 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDYP-PLPA---DHY  233 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCCC-CCCh---hhc
Confidence            33333445688899999999888899999999999999999999999754321 111111111111111 1111   112


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ...+.++|.+||+.+|++|| +.+++.++...
T Consensus       234 ~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         234 SEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            23488999999999999999 99999988654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.8e-43  Score=307.68  Aligned_cols=252  Identities=27%  Similarity=0.441  Sum_probs=201.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..+|.+.+.||+|+||.||+|... +++.|++|.+......   .+.+.+|+++++.++||||+++++++...+..+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH---HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            456888999999999999999654 5788999998754322   367889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++..... ..+++..++.++.|+++||+|||+.   +++||||||+||++++++.+||+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          82 EFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            99999999999865432 3589999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCCc-eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhH
Q 046084          247 SSNR-TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVI  323 (363)
Q Consensus       247 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  323 (363)
                      .... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.....   .......... ....+...    
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~----  230 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGYRMERPEGC----  230 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCCCCCCCCC----
Confidence            2211 11223567999999988889999999999999999998 9999764322   1111112111 11222211    


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        +..+.+++.+||+.||++|| +.+++++|..
T Consensus       231 --~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         231 --PPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             --CHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence              12488999999999999999 9999998864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-42  Score=316.06  Aligned_cols=236  Identities=23%  Similarity=0.361  Sum_probs=192.6

Q ss_pred             CeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||+|+.. +++.||+|++..... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            35899999999999764 578999999875432 222345677888888866 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|..++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence            99998887554   588999999999999999999999   999999999999999999999999999876443333344


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||....   .......+.......+...+      ..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~------~~~~~  225 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHDDVLYPVWLS------KEAVS  225 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCC------HHHHH
Confidence            5568999999999998889999999999999999999999986543   23333344443333332222      13788


Q ss_pred             HHHHccCCCCCCCC
Q 046084          332 IVFACLRSKPTSRP  345 (363)
Q Consensus       332 li~~cl~~dP~~RP  345 (363)
                      ++..||+.||++||
T Consensus       226 ll~~~L~~dp~~R~  239 (321)
T cd05591         226 ILKAFMTKNPNKRL  239 (321)
T ss_pred             HHHHHhccCHHHcC
Confidence            99999999999999

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.4e-42  Score=308.51  Aligned_cols=253  Identities=23%  Similarity=0.409  Sum_probs=200.6

Q ss_pred             cCCcccCeeeecCceeEEEEEe-----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      ++|++.+.||+|+||.||+|..     .++..|++|.+...... .....+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            5688899999999999999964     35678999999754432 33467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC
Q 046084          164 LIYKYMRRGSLFCILRNDDE--------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK  229 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  229 (363)
                      ++|||+++++|.+++.....              ...+++..++.++.|++.||+|||+.   +++||||||+|||++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence            99999999999999853211              23478899999999999999999999   99999999999999999


Q ss_pred             CceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHH
Q 046084          230 LEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLI  306 (363)
Q Consensus       230 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~  306 (363)
                      +.+||+|||++........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   .....
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence            9999999999976533221  1222335677999999988889999999999999999998 9999754322   11122


Q ss_pred             hhhccc-CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          307 DLLDQR-VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       307 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ...... ++.+...+      ..+.+++.+||+.||++|| +.++++.|.
T Consensus       238 ~~~~~~~~~~~~~~~------~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         238 MVRKRQLLPCSEDCP------PRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             HHHcCCcCCCCCCCC------HHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            221111 12222111      2488899999999999999 999988875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-42  Score=316.78  Aligned_cols=243  Identities=24%  Similarity=0.303  Sum_probs=190.4

Q ss_pred             CeeeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHH-HHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTE-AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e-~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||++... +++.||+|++...... ......+..| ..+++.++||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999764 5678999998754321 1112333444 3456788999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|.+++....   .+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            99999987644   578888889999999999999999   999999999999999999999999999975433333344


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||....   .......+...........+      ..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~------~~~~~  225 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNKPLQLKPNIT------NSARH  225 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCcCCCCCCC------HHHHH
Confidence            5679999999999999999999999999999999999999986432   22223333333222221111      13788


Q ss_pred             HHHHccCCCCCCCC-hHHHHHH
Q 046084          332 IVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       332 li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ++.+||+.||.+|| +.+.+.+
T Consensus       226 li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         226 LLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             HHHHHcccCHHHCCCCCCCHHH
Confidence            99999999999999 6644333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.3e-42  Score=304.20  Aligned_cols=244  Identities=24%  Similarity=0.389  Sum_probs=195.2

Q ss_pred             eeeecCceeEEEEEe---CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           96 CIGTGGYGSVYRAQL---PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      .||+|+||.||+|.+   .++..+|+|++..........+.+..|+.+++.++||||+++++++.. +..+++|||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999964   357789999987665555556789999999999999999999998864 4678999999999


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC---
Q 046084          173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN---  249 (363)
Q Consensus       173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---  249 (363)
                      +|.+++....   .+++..+..++.|++.||+|||+.   +++||||||.||++++++.++|+|||++.........   
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999987543   588999999999999999999999   9999999999999999999999999999765433221   


Q ss_pred             ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHHHH
Q 046084          250 RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQDII  327 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  327 (363)
                      .....++..|+|||.+....++.++|+||||+++|||++ |..||.....   ......+... ..+.+...+      .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~~~------~  225 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIESGERMECPQRCP------P  225 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHCCCCCCCCCCCC------H
Confidence            111223578999999888888999999999999999998 9999865432   1222222221 122222222      2


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+.++|.+||+.||++|| +.+|...|..
T Consensus       226 ~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         226 EMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             HHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            488999999999999999 9999888753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.3e-42  Score=313.28  Aligned_cols=243  Identities=23%  Similarity=0.345  Sum_probs=192.3

Q ss_pred             CeeeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||++... +|+.||+|.++..... ....+.+..|..++... +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999764 6789999998754321 12234566677777654 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|..++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++...........
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            99999887643   588999999999999999999999   999999999999999999999999999875433333344


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||...+.   ......+.......+...+      ..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~  225 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRVDTPHYPRWIT------KESKD  225 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCCCC------HHHHH
Confidence            56789999999999998999999999999999999999999864332   2222222222222222111      13788


Q ss_pred             HHHHccCCCCCCCC-hH-HHHHH
Q 046084          332 IVFACLRSKPTSRP-MQ-RVSQE  352 (363)
Q Consensus       332 li~~cl~~dP~~RP-~~-~v~~~  352 (363)
                      ++.+||+.||++|| +. ++..+
T Consensus       226 li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         226 ILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             HHHHHccCCHHHcCCChHHHHcC
Confidence            99999999999999 64 55543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.4e-42  Score=305.80  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=200.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.......  ...+..|+.+++.++||||+++++++...+..++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~--~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD--FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch--HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            46799999999999999999975 578899999987543322  356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          86 EYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            9999999999887543   588999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          247 SSNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ........++..|+|||.+.   ...++.++||||||+++|||++|+.||........   ...+.......+.. ....
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~-~~~~  235 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMSKSNFQPPKL-KDKT  235 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---heeeecCCCCCCCC-cccc
Confidence            33333456888999999874   34477899999999999999999999754332111   11111111111100 0001


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      .....+.+++.+||+.||++|| +.+++..+
T Consensus       236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1123588999999999999999 99988765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.9e-42  Score=319.86  Aligned_cols=258  Identities=23%  Similarity=0.386  Sum_probs=202.3

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEee
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLH  158 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  158 (363)
                      ...++|.+.+.||+|+||.||+|+..      .+..||+|++...... ...+.+.+|+.++++++ ||||++++++|.+
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS-SEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            34678999999999999999999752      2347999999765433 23467899999999996 9999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCC-------------------------------------------------------
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDE-------------------------------------------------------  183 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  183 (363)
                      .+..++||||+++|+|.+++.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999988764210                                                       


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCee
Q 046084          184 --------------------------------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNIL  225 (363)
Q Consensus       184 --------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  225 (363)
                                                            ...+++..++.++.|+++||+|||+.   +++||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                  12478888999999999999999999   9999999999999


Q ss_pred             ecCCCceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCch
Q 046084          226 LNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPK  302 (363)
Q Consensus       226 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~  302 (363)
                      +++++.+||+|||++........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......  
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--  347 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--  347 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--
Confidence            99999999999999976533221  1122346678999999988889999999999999999997 999976432211  


Q ss_pred             hhHHhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          303 IMLIDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       303 ~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .....+... ..+.+..      ....+.+++.+||+.||++|| +.++.+.|..
T Consensus       348 ~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         348 TFYNKIKSGYRMAKPDH------ATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             HHHHHHhcCCCCCCCcc------CCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence            111111111 1111111      122488999999999999999 9999988764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-42  Score=315.01  Aligned_cols=241  Identities=22%  Similarity=0.343  Sum_probs=195.4

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  166 (363)
                      +|++.+.||+|+||.||++.. .+|+.||+|++..... .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477888999999999999965 4688999999875432 1223456778888888885 577888999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++.++..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999887654   589999999999999999999999   9999999999999999999999999998754333


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ........||+.|+|||++.+..++.++||||||+++|||++|+.||....   .......+.......+...+      
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~~p~~~~------  225 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIMEHNVSYPKSLS------  225 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCccCC------
Confidence            333344568999999999998889999999999999999999999986543   22333334443333332222      


Q ss_pred             HHHHHHHHHccCCCCCCCC
Q 046084          327 ILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP  345 (363)
                      ..+.+++.+||+.||.+|+
T Consensus       226 ~~~~~li~~~l~~~p~~R~  244 (323)
T cd05615         226 KEAVSICKGLMTKHPSKRL  244 (323)
T ss_pred             HHHHHHHHHHcccCHhhCC
Confidence            1378899999999999999

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=321.99  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=198.6

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||+||++... +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999764 688999999975432 2233466889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999987654   589999999999999999999999   9999999999999999999999999998754321


Q ss_pred             CC--------------------------------------CceeeccccccccccccccccCCccccchHHHHHHHHHHh
Q 046084          247 SS--------------------------------------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM  288 (363)
Q Consensus       247 ~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~  288 (363)
                      ..                                      .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            10                                      0012358999999999998889999999999999999999


Q ss_pred             CCCCCCCCcCCCchhhHHhhhccc--CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC----hHHHHHHH
Q 046084          289 GRHPGDLLSSVNPKIMLIDLLDQR--VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP----MQRVSQEF  353 (363)
Q Consensus       289 g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----~~~v~~~l  353 (363)
                      |..||.....   ......+....  ...+....    ....+.++|.+|+. +|.+|+    +.+++.+-
T Consensus       235 G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~----~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~  297 (364)
T cd05599         235 GYPPFCSDNP---QETYRKIINWKETLQFPDEVP----LSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP  297 (364)
T ss_pred             CCCCCCCCCH---HHHHHHHHcCCCccCCCCCCC----CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence            9999865432   22222232221  12221111    11237789999997 888888    45555543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.7e-42  Score=314.96  Aligned_cols=236  Identities=23%  Similarity=0.340  Sum_probs=188.8

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHH-HHHhcCCCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEA-HLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||+++. .+++.||+|++..... .......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999976 4678999999875432 112223455554 467889999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|...+....   .+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++...........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            99988886543   588889999999999999999999   999999999999999999999999999875433333334


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||...+   .......+.......+...+      ..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~------~~~~~  225 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHKPLQLPGGKT------VAACD  225 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCC------HHHHH
Confidence            4568999999999988889999999999999999999999986432   22333444444333332221      13788


Q ss_pred             HHHHccCCCCCCCC
Q 046084          332 IVFACLRSKPTSRP  345 (363)
Q Consensus       332 li~~cl~~dP~~RP  345 (363)
                      ++.+||+.||.+||
T Consensus       226 li~~~l~~~p~~R~  239 (321)
T cd05603         226 LLVGLLHKDQRRRL  239 (321)
T ss_pred             HHHHHccCCHhhcC
Confidence            99999999999999

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=331.56  Aligned_cols=251  Identities=26%  Similarity=0.434  Sum_probs=207.4

Q ss_pred             CcccCeeeecCceeEEEEEe-CCCC----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           91 FDIKYCIGTGGYGSVYRAQL-PSGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .+..++||+|+||+||+|.+ ++|+    +||+|++.......+ ..++.+|+..|.+++|||+++++|+|.... +.||
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~-s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA-SIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh-hHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            44567899999999999954 4554    789999876654333 367999999999999999999999999876 7899


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      ++|++.|+|.+|++.+++  .+-.+..+.|..|||+||.|||.+   +++||||..+|||+..-..+|+.|||+++.+..
T Consensus       776 tq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            999999999999988665  578889999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCceeec--cccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          246 DSSNRTVVA--GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       246 ~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      +........  -.+.|||-|.+....|+.++|||||||++||++| |..|++.....+....+..  ..+++.|..+.-+
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~--geRLsqPpiCtiD  928 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK--GERLSQPPICTID  928 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc--cccCCCCCCccHH
Confidence            554433322  3568999999999999999999999999999998 9999877654433322221  2345655555433


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                            +..++.+||..|+..|| +.++..+|..+
T Consensus       929 ------Vy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  929 ------VYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             ------HHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence                  77889999999999999 99999988654

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.2e-42  Score=319.42  Aligned_cols=254  Identities=23%  Similarity=0.359  Sum_probs=197.3

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||+||++.. .+++.||+|++..... .......+..|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4789999999999999999965 4688999999975432 2233467888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999997654   689999999999999999999999   9999999999999999999999999998754221


Q ss_pred             CC-----------------------------------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCC
Q 046084          247 SS-----------------------------------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRH  291 (363)
Q Consensus       247 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~  291 (363)
                      ..                                   .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            00                                   0123469999999999999899999999999999999999999


Q ss_pred             CCCCCcCCCchhhHHhhhcc--cCCCCCCChhhHHHHHHHHHHHHHccC--CCCCCCC-hHHHHHHHhc
Q 046084          292 PGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLR--SKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       292 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RP-~~~v~~~l~~  355 (363)
                      ||....   .......+...  .+..+...+.    .....++|.+++.  .++..|| +.|++.+-..
T Consensus       235 Pf~~~~---~~~~~~~i~~~~~~~~~p~~~~~----s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f  296 (363)
T cd05628         235 PFCSET---PQETYKKVMNWKETLIFPPEVPI----SEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFF  296 (363)
T ss_pred             CCCCCC---HHHHHHHHHcCcCcccCCCcCCC----CHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCC
Confidence            986433   22223333321  1111111110    1125566666443  2344578 8898876443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3e-42  Score=312.42  Aligned_cols=242  Identities=24%  Similarity=0.366  Sum_probs=191.3

Q ss_pred             CeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQ-IRHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||+|... +++.||+|.++.... .....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999764 578999999876431 11223456667777775 4899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence            99999987543   588999999999999999999999   999999999999999999999999999875433333334


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.....   ......+.......+...+      ..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~------~~~~~  225 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMDNPCYPRWLT------REAKD  225 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCccCC------HHHHH
Confidence            45689999999999988899999999999999999999999865332   2222222222221111111      13788


Q ss_pred             HHHHccCCCCCCCC-hH-HHHH
Q 046084          332 IVFACLRSKPTSRP-MQ-RVSQ  351 (363)
Q Consensus       332 li~~cl~~dP~~RP-~~-~v~~  351 (363)
                      ++.+||+.||++|| +. ++..
T Consensus       226 li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         226 ILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHHHhccCHhhcCCChHHHHc
Confidence            99999999999999 65 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.9e-42  Score=304.14  Aligned_cols=251  Identities=28%  Similarity=0.503  Sum_probs=200.6

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..++|++.+.||+|+||.||++...++..+|+|.+.......   +.+.+|+.++++++|+|++++++++.. +..+++|
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT   79 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence            456789999999999999999988888899999987654432   568899999999999999999998854 5678999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++..... ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          80 EYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            99999999999875432 2589999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhH
Q 046084          247 SSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVI  323 (363)
Q Consensus       247 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  323 (363)
                      ... .....++..|+|||...+..++.++||||||+++|||++ |..||.....   ......+... ..+.+..     
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~-----  227 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVERGYRMPCPQD-----  227 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCc-----
Confidence            211 112234567999999888889999999999999999999 8999865332   2222222221 1111211     


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                       ....+.+++.+||+.||++|| +.++.+.|.
T Consensus       228 -~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         228 -CPISLHELMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             -CCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence             122488999999999999999 888877664

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-42  Score=316.14  Aligned_cols=242  Identities=24%  Similarity=0.320  Sum_probs=191.8

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHH-HHhcCCCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAH-LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||++.. .+|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3599999999999965 4688999999875422 1122344555554 56778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|..++....   .+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            99998887544   589999999999999999999999   999999999999999999999999999875433333344


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||...+   .......+...........+      ..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~  225 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNILHKPLVLRPGAS------LTAWS  225 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHHcCCccCCCCCC------HHHHH
Confidence            5678999999999999899999999999999999999999986432   22333333333332222111      13778


Q ss_pred             HHHHccCCCCCCCC-hHHHHH
Q 046084          332 IVFACLRSKPTSRP-MQRVSQ  351 (363)
Q Consensus       332 li~~cl~~dP~~RP-~~~v~~  351 (363)
                      ++.+||+.||++|| +.+.+.
T Consensus       226 ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         226 ILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             HHHHHhccCHHhcCCCCCCHH
Confidence            99999999999999 653333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.7e-42  Score=302.03  Aligned_cols=246  Identities=26%  Similarity=0.429  Sum_probs=194.2

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGS  173 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  173 (363)
                      +.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+++++.++||||+++++++...+..++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            3689999999999976 4788999998765432 2334678999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCc--e
Q 046084          174 LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR--T  251 (363)
Q Consensus       174 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~  251 (363)
                      |.+++....  ..+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++..........  .
T Consensus        80 L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          80 FLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            999987543  2588999999999999999999999   99999999999999999999999999987543221111  1


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVS  330 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  330 (363)
                      ....+..|+|||.+.+..++.++||||||+++|||++ |..||.......   ... ........+...    .....+.
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~~-~~~~~~~~~~~~----~~~~~~~  226 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TRE-AIEQGVRLPCPE----LCPDAVY  226 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HHH-HHHcCCCCCCcc----cCCHHHH
Confidence            1123456999999988889999999999999999998 889976543221   111 111111111111    1122488


Q ss_pred             HHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          331 KIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       331 ~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      +++.+||+.||++|| +.++.++|.
T Consensus       227 ~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         227 RLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHh
Confidence            999999999999999 999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.1e-42  Score=313.12  Aligned_cols=239  Identities=23%  Similarity=0.368  Sum_probs=192.9

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||++.. .+++.||+|++..... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999976 4678899999976432 223346688899999888 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|..++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence            99998886544   589999999999999999999999   999999999999999999999999999875433333344


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC---Cc-hhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV---NP-KIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||+.....   .. ......+.......+...+      .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~------~  228 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLS------V  228 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCC------H
Confidence            567999999999999999999999999999999999999999643321   11 1222233333322222221      1


Q ss_pred             HHHHHHHHccCCCCCCCC
Q 046084          328 LVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP  345 (363)
                      .+.+++.+||+.||++||
T Consensus       229 ~~~~li~~~L~~dP~~R~  246 (327)
T cd05617         229 KASHVLKGFLNKDPKERL  246 (327)
T ss_pred             HHHHHHHHHhccCHHHcC
Confidence            377899999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-42  Score=321.88  Aligned_cols=257  Identities=23%  Similarity=0.340  Sum_probs=203.8

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      ...++|++.+.||+|+||.||++... +++.||+|.+..... .....+.+..|+.+++.++||||+++++++.+.+..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34568999999999999999999764 688999999865322 1222345788999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +||||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            999999999999998654    478888889999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCC-Cceeeccccccccccccccc----cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc--CCCC
Q 046084          244 HSDSS-NRTVVAGTHGYIAPELAYTM----VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR--VPSP  316 (363)
Q Consensus       244 ~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~  316 (363)
                      ..... ......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.....   ......+....  +..+
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~  269 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMDHKNSLTFP  269 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHHHcCCCcCCCC
Confidence            43222 22345689999999987643    478899999999999999999999865432   22333333322  1112


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCC--CC-hHHHHHHHhch
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTS--RP-MQRVSQEFLVR  356 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RP-~~~v~~~l~~~  356 (363)
                      ...    .....+.++|.+||+.+|++  || +.+++.+-..+
T Consensus       270 ~~~----~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~  308 (370)
T cd05596         270 DDI----EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK  308 (370)
T ss_pred             CcC----CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence            110    11224788999999999988  99 99998776543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4e-43  Score=309.30  Aligned_cols=255  Identities=29%  Similarity=0.477  Sum_probs=204.7

Q ss_pred             CcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           91 FDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      |++.+.||+|+||+||++... +++.+|+|.+...............|+..+++++||||+++++++.+....+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567889999999999999775 4568999999988766554455567999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  249 (363)
                      ++++|.+++....   .+++..++.++.|+++||++||+.   +++|+||||+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             ccccccccccccc---cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999998333   589999999999999999999999   9999999999999999999999999999764333334


Q ss_pred             ceeeccccccccccccc-cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHH
Q 046084          250 RTVVAGTHGYIAPELAY-TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL  328 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      .....++..|+|||.+. +..++.++||||+|+++|+|++|..||......+.....................  .....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  232 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR--EKSEE  232 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT--TSHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc--hhHHH
Confidence            44556889999999988 7889999999999999999999999987652222222222222211111111000  00135


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      +.+++..||+.||++|| +.+++++-
T Consensus       233 l~~li~~~l~~~p~~R~~~~~l~~~~  258 (260)
T PF00069_consen  233 LRDLIKKMLSKDPEQRPSAEELLKHP  258 (260)
T ss_dssp             HHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCC
Confidence            89999999999999999 99988653

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.2e-42  Score=304.43  Aligned_cols=253  Identities=26%  Similarity=0.416  Sum_probs=196.9

Q ss_pred             CcccCeeeecCceeEEEEEeCCCC---EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------Ce
Q 046084           91 FDIKYCIGTGGYGSVYRAQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------KC  161 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  161 (363)
                      |.+.+.||+|+||.||+|.+.++.   .+|+|.++.........+.+..|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            356788999999999999765432   689998876544444467889999999999999999999987542      24


Q ss_pred             EEEEEEeccCCChhhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          162 MFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      .++++||+++|+|.+++...   .....+++..+..++.|++.||+|||+.   +++||||||+|||+++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887432   1223589999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccC-C
Q 046084          239 VARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRV-P  314 (363)
Q Consensus       239 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~-~  314 (363)
                      ++.........  .....++..|+|||...+..++.++||||||+++|||++ |+.||.....   ......+..... +
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~  234 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQGNRLK  234 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCCCC
Confidence            99875432211  122345678999999998889999999999999999999 8899865322   222222222211 1


Q ss_pred             CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+...      ...+.+++.+||+.||++|| +.++++.|..
T Consensus       235 ~~~~~------~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         235 QPPDC------LDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCCC------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            11111      12488999999999999999 9999988754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.1e-42  Score=307.94  Aligned_cols=259  Identities=22%  Similarity=0.278  Sum_probs=197.3

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||+|++|.||+|... +++.||+|.+..........+.+..|+.+++.++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5788899999999999999764 688999999876543333346678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      ++ ++|.+++........+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 58888886644444689999999999999999999999   999999999999999999999999999976543333


Q ss_pred             Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc----------------
Q 046084          249 NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ----------------  311 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------------  311 (363)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..................                
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            2333456889999998765 45788999999999999999999998643221110000000000                


Q ss_pred             -cCCCCCC---ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 -RVPSPID---DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 -~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                       ..+....   ..........+.++|.+||+.||++|| +.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             0000000   000000112477899999999999999 8888764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.6e-42  Score=308.10  Aligned_cols=254  Identities=26%  Similarity=0.453  Sum_probs=202.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      .++|.+.+.||+|+||.||++..      .++..+|+|.+.....  ...+.+.+|++++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            46789999999999999999964      2345689998875443  234678999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc
Q 046084          162 MFLIYKYMRRGSLFCILRNDD----------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE  231 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  231 (363)
                      .+++|||+++++|.+++....          ....+++..++.++.|++.||+|||+.   +++||||||+||++++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999999999986432          123489999999999999999999999   9999999999999999999


Q ss_pred             eEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhh
Q 046084          232 AFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDL  308 (363)
Q Consensus       232 ~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~  308 (363)
                      ++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i  235 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECI  235 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH
Confidence            99999999976533221  1112234678999999988889999999999999999998 8999754332   2222233


Q ss_pred             hcccCC-CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          309 LDQRVP-SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       309 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...... .+...+      ..+.+++.+||+.||.+|| +.++...|..
T Consensus       236 ~~~~~~~~~~~~~------~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~  278 (288)
T cd05093         236 TQGRVLQRPRTCP------KEVYDLMLGCWQREPHMRLNIKEIHSLLQN  278 (288)
T ss_pred             HcCCcCCCCCCCC------HHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            332221 111111      2488999999999999999 9999888754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.8e-42  Score=302.43  Aligned_cols=250  Identities=23%  Similarity=0.362  Sum_probs=202.8

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||+|+||.||++... +++.+++|.++..... ...+.+..|+.+++.++|||++++++.+...+..+++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            5788899999999999999654 6889999998654332 2346788899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++.... ...+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++++|||++........
T Consensus        80 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          80 CDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            99999999886432 22578999999999999999999999   999999999999999999999999999987654433


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL  328 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ......++..|+|||++.+..++.++|+||||+++|+|++|..||....   ................. .    .....
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~-~----~~~~~  227 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLILKVCQGSYKPLP-S----HYSYE  227 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHHHHHhcCCCCCCC-c----ccCHH
Confidence            3344568889999999988889999999999999999999999986432   22222222222222111 1    11124


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      +.+++.+||+.||++|| +.+++..
T Consensus       228 ~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         228 LRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHhCCcccCCCHHHHhhc
Confidence            78899999999999999 9998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.1e-43  Score=300.73  Aligned_cols=261  Identities=24%  Similarity=0.315  Sum_probs=203.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCc-eeeeeeEEeeCC-----
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN-IVKLYGFCLHKK-----  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~-----  160 (363)
                      ...|...++||+|+||+||+|+. .+|+.||+|++.....++..-....+|+.+++.++|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34566677899999999999954 57899999999876553223345679999999999999 999999999877     


Q ss_pred             -eEEEEEEeccCCChhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          161 -CMFLIYKYMRRGSLFCILRNDDEA-IRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       161 -~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                       ..++|+||++. +|..++...... ..++...+..++.||+.||+|||++   +|+||||||.|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             78999999965 899999775532 3467788999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc------
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ------  311 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------  311 (363)
                      +++...-+....+..++|..|+|||++.+. .|+...||||+|||+.||++++.-|...++.+.-....+.+..      
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            999776555556667889999999998876 7999999999999999999999888765542221111111111      


Q ss_pred             ---------cCCCCCCC-hhhHHH-----HHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 ---------RVPSPIDD-QTVIQD-----IILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 ---------~~~~~~~~-~~~~~~-----~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                               ..+.+... +.....     .....+++.+||+.+|.+|. +...+.+
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                     10111000 000000     01377899999999999999 8888776

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.2e-42  Score=308.27  Aligned_cols=252  Identities=22%  Similarity=0.371  Sum_probs=202.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..+|++.+.||+|+||.||+|.. .+++.|++|.+.......  .+.+.+|+.+++.++|||++++++.+......++||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            45789999999999999999975 468899999987654432  366889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++...    .+++.++..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        97 e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             cccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            999999999998643    478999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......  ..............  .+  ....
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~--~~--~~~~  243 (296)
T cd06654         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIATNGTPELQ--NP--EKLS  243 (296)
T ss_pred             ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHhcCCCCCCC--Cc--cccC
Confidence            333334468889999999988888999999999999999999999986543211  11111111111111  11  1112


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ..+.+++.+||+.||++|| +.+++..-+
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~  272 (296)
T cd06654         244 AIFRDFLNRCLDMDVEKRGSAKELLQHQF  272 (296)
T ss_pred             HHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence            2488899999999999999 999988643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.8e-42  Score=314.33  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=200.5

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLH  158 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (363)
                      +..++|++.+.||+|+||.||+|..      .+++.||+|++....... ..+.+..|+.++.++ +|+||++++++|..
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~-~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS-EYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH-HHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            4456899999999999999999953      234789999987654332 245678899999999 89999999998875


Q ss_pred             C-CeEEEEEEeccCCChhhhhhcCCC------------------------------------------------------
Q 046084          159 K-KCMFLIYKYMRRGSLFCILRNDDE------------------------------------------------------  183 (363)
Q Consensus       159 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  183 (363)
                      . ...++++||+++++|.+++.....                                                      
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            4 568899999999999998854211                                                      


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC--Cceeecccc
Q 046084          184 ----AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTH  257 (363)
Q Consensus       184 ----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~  257 (363)
                          ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++..+.....  ......++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                12588999999999999999999999   999999999999999999999999999986533221  122234567


Q ss_pred             ccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHc
Q 046084          258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFAC  336 (363)
Q Consensus       258 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  336 (363)
                      .|+|||++.+..++.++|||||||++|||++ |..||......   ......+..........    .....+.+++.+|
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~c  312 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---EEFCRRLKEGTRMRAPE----YATPEIYSIMLDC  312 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---HHHHHHHhccCCCCCCc----cCCHHHHHHHHHH
Confidence            8999999999999999999999999999998 99998643211   11222221111111100    1112488999999


Q ss_pred             cCCCCCCCC-hHHHHHHHhc
Q 046084          337 LRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       337 l~~dP~~RP-~~~v~~~l~~  355 (363)
                      |+.+|++|| +.+++++|..
T Consensus       313 l~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         313 WHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             ccCChhhCcCHHHHHHHHHH
Confidence            999999999 9999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.9e-42  Score=304.19  Aligned_cols=249  Identities=24%  Similarity=0.283  Sum_probs=194.6

Q ss_pred             eeecCceeEEEEEe-CCCCEEEEEEeccccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCCh
Q 046084           97 IGTGGYGSVYRAQL-PSGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus        97 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      ||+|+||.||++.. .+|+.||+|.+....... .....+..|+++++.++||||+++++++......+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999965 468999999986533211 1123456799999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeec
Q 046084          175 FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA  254 (363)
Q Consensus       175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  254 (363)
                      .+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~  155 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA  155 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence            98876443 22588999999999999999999999   99999999999999999999999999987654322 223346


Q ss_pred             cccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC-CchhhHHhhhcccCCCCCCChhhHHHHHHHHHHH
Q 046084          255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV-NPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIV  333 (363)
Q Consensus       255 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  333 (363)
                      |+..|+|||++.+..++.++|||||||++|||++|+.||...... ...................     .....+.+++
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li  230 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ-----NFTEESKDIC  230 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccc-----cCCHHHHHHH
Confidence            889999999998888999999999999999999999998654321 1122222222222221111     1122488999


Q ss_pred             HHccCCCCCCCC-hHHHHHHHhc
Q 046084          334 FACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       334 ~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+||+.||++|| +.|++.+++.
T Consensus       231 ~~~L~~~P~~R~~~~~~~~~~~~  253 (277)
T cd05607         231 RLFLAKKPEDRLGSREKNDDPRK  253 (277)
T ss_pred             HHHhccCHhhCCCCccchhhhhc
Confidence            999999999999 8776655543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-42  Score=306.12  Aligned_cols=245  Identities=23%  Similarity=0.263  Sum_probs=195.2

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      +|++.+.||+|+||.||++.. .+++.||+|.+...... ......+.+|+.+++.++||||+++++.+...+..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            478889999999999999975 46889999998754322 2223457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++|+|.+++.... ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999998876432 23589999999999999999999999   99999999999999999999999999997653322


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh-hhcccCCCCCCChhhHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID-LLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  326 (363)
                       ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||.............. +.......+..      ..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~  229 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK------FS  229 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc------cC
Confidence             22334688999999999888899999999999999999999999875433221111111 11111111111      12


Q ss_pred             HHHHHHHHHccCCCCCCCC
Q 046084          327 ILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP  345 (363)
                      ..+.+++.+||+.||++||
T Consensus       230 ~~~~~li~~~l~~~P~~R~  248 (285)
T cd05605         230 EAARSICRQLLTKDPGFRL  248 (285)
T ss_pred             HHHHHHHHHHccCCHHHhc
Confidence            2488999999999999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-42  Score=302.75  Aligned_cols=253  Identities=25%  Similarity=0.432  Sum_probs=199.6

Q ss_pred             CcccCeeeecCceeEEEEEeCC----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe-----
Q 046084           91 FDIKYCIGTGGYGSVYRAQLPS----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC-----  161 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  161 (363)
                      |.+.+.||+|+||.||+|....    +..||+|.++.........+.+..|+..++.++|||++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999997642    3679999998655444445789999999999999999999998876554     


Q ss_pred             -EEEEEEeccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEee
Q 046084          162 -MFLIYKYMRRGSLFCILRNDD---EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADF  237 (363)
Q Consensus       162 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  237 (363)
                       .++++||+++|+|..++....   ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             789999999999998885432   223689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc-C
Q 046084          238 GVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR-V  313 (363)
Q Consensus       238 g~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~-~  313 (363)
                      |+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ........... .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~  234 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRHGNRL  234 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC
Confidence            999866433221  111234668999999988889999999999999999999 8899754332   22222222221 1


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..+...      ...+.+++.+||+.||++|| +.+++..|..
T Consensus       235 ~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         235 KQPEDC------LDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             CCCcCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            122111      22488999999999999999 9999988753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.2e-42  Score=336.58  Aligned_cols=257  Identities=26%  Similarity=0.417  Sum_probs=199.6

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||+|... +|+.||+|++..... .....+++.+|+++++.++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999764 588999999875432 2333567999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          167 KYMRRGSLFCILRNDD--------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      ||++||+|.+++....        ....+++..++.++.|+++||+|||+.   +++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886421        112456778899999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCC------------------CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCC
Q 046084          239 VARLLHSDS------------------SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN  300 (363)
Q Consensus       239 ~~~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~  300 (363)
                      ++.......                  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            998652111                  00112468999999999999999999999999999999999999986532211


Q ss_pred             chhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC--hHHHHHHHh
Q 046084          301 PKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP--MQRVSQEFL  354 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--~~~v~~~l~  354 (363)
                        .......    ..+.........+..+.+++.+||+.||++||  +.++...+.
T Consensus       239 --i~~~~~i----~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le  288 (932)
T PRK13184        239 --ISYRDVI----LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE  288 (932)
T ss_pred             --hhhhhhc----cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence              1111111    11111001111222488899999999999998  555655554

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-43  Score=317.50  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=211.2

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC---CCC--EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP---SGK--KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      +..+..+..+.||.|.||.||+|...   .|+  .||||..+.+.+... .+.|..|+.+|++++||||++++|+|.+. 
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            44555667788999999999999653   233  589999887655433 68899999999999999999999999875 


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..++|||.++.|.|..|++.+..  .++......++.||+.||+|||+.   +.|||||..+|||+.....+||+|||++
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence            47999999999999999988765  588888999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCce-eeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          241 RLLHSDSSNRT-VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       241 ~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      +.+..+..... ...-+..|||||.+.-..++.+||||-||+.+||+++ |..||......+  ....-....++|.|.+
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--VI~~iEnGeRlP~P~n  616 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--VIGHIENGERLPCPPN  616 (974)
T ss_pred             hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--eEEEecCCCCCCCCCC
Confidence            99876554332 2334678999999999999999999999999999996 999987654322  2222234567777777


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ++..      +..|+.+||..||.+|| +.|+...|.
T Consensus       617 CPp~------LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  617 CPPA------LYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             CChH------HHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            7766      77889999999999999 888776653

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.1e-42  Score=302.96  Aligned_cols=252  Identities=26%  Similarity=0.441  Sum_probs=200.0

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..++|++.+.||+|+||.||+|.+.++..||+|.+......   .+.+.+|+++++.++||||+++++++.+ +..+++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   79 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence            35679999999999999999998877778999998754432   2568899999999999999999998754 5579999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++.... ...+++..++.++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          80 EYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999999997542 22578999999999999999999999   9999999999999999999999999999765433


Q ss_pred             CCCc-eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          247 SSNR-TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       247 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .... ....++..|+|||...+..++.++||||||+++|||++ |..||.....   ......+... ...+..    ..
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~-~~~~~~----~~  227 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERG-YRMPCP----PE  227 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhcC-CCCCCc----cc
Confidence            2211 12335678999999988889999999999999999999 8888764322   2222222221 111111    11


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ....+.+++.+||+.||++|| +.++++.|+
T Consensus       228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~  258 (262)
T cd05071         228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLE  258 (262)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            223488999999999999999 999888765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.8e-42  Score=317.94  Aligned_cols=255  Identities=22%  Similarity=0.284  Sum_probs=196.9

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ...+|++.+.||+|+||.||++.. .+++.||+|....        ..+.+|+++++.++||||+++++++......+++
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            346799999999999999999965 4688999996432        3467899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      +|++. ++|..++....   .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       162 ~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        162 LPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            99985 68888876543   588999999999999999999999   999999999999999999999999999975422


Q ss_pred             C-CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCC----chhhHHhhhc----------
Q 046084          246 D-SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN----PKIMLIDLLD----------  310 (363)
Q Consensus       246 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~----------  310 (363)
                      . ........||+.|+|||++.+..++.++|||||||++|||++|+.|+-......    ....+..++.          
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            2 122234569999999999998899999999999999999999998863221110    0001111100          


Q ss_pred             ----------------ccCCCCCCC---hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          311 ----------------QRVPSPIDD---QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       311 ----------------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                      .....+...   .........+.+|+.+||+.||++|| +.|++.+-..+
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~  380 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ  380 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence                            000000000   00111233588999999999999999 99998766553

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-42  Score=320.41  Aligned_cols=253  Identities=24%  Similarity=0.343  Sum_probs=198.6

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||++.. .+++.||+|++..... .....+.+..|+++++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4788999999999999999965 5788999999865432 2233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999987644   588999999999999999999999   9999999999999999999999999998632110


Q ss_pred             CC-----------------------------------------------CceeeccccccccccccccccCCccccchHH
Q 046084          247 SS-----------------------------------------------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSF  279 (363)
Q Consensus       247 ~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl  279 (363)
                      ..                                               ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00                                               0012358999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc--cCCCCCCChhhHHHHHHHHHHHHHccCCCCCC---CC-hHHHHHHH
Q 046084          280 GVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTS---RP-MQRVSQEF  353 (363)
Q Consensus       280 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~---RP-~~~v~~~l  353 (363)
                      ||++|||++|+.||.....   ......+...  .+..+...    .....+.+++.+||+ +|.+   || +.+++.+-
T Consensus       235 Gvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~----~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp  306 (377)
T cd05629         235 GAIMFECLIGWPPFCSENS---HETYRKIINWRETLYFPDDI----HLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP  306 (377)
T ss_pred             chhhhhhhcCCCCCCCCCH---HHHHHHHHccCCccCCCCCC----CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence            9999999999999865332   2222223221  12212110    011247889999998 6665   56 88888775


Q ss_pred             hc
Q 046084          354 LV  355 (363)
Q Consensus       354 ~~  355 (363)
                      +.
T Consensus       307 ~~  308 (377)
T cd05629         307 FF  308 (377)
T ss_pred             Cc
Confidence            54

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.8e-42  Score=320.93  Aligned_cols=249  Identities=20%  Similarity=0.315  Sum_probs=193.7

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      +|++.+.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999965 4678999999875432 22335678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999987654   588888999999999999999999   99999999999999999999999999975321000


Q ss_pred             -----------------------------------------------CCceeeccccccccccccccccCCccccchHHH
Q 046084          248 -----------------------------------------------SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFG  280 (363)
Q Consensus       248 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG  280 (363)
                                                                     .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                           001124689999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCCCcCCCchhhHHhhhc--ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC----hHHHHHH
Q 046084          281 VVALEVLMGRHPGDLLSSVNPKIMLIDLLD--QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP----MQRVSQE  352 (363)
Q Consensus       281 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----~~~v~~~  352 (363)
                      |++|||++|+.||.....   ......+..  .....+....    ......+++.+|+ .+|++|+    +.+++.+
T Consensus       236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~----~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         236 VILYEMLVGQPPFLAQTP---LETQMKVINWQTSLHIPPQAK----LSPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             HHHHHHHhCCCCCCCCCH---HHHHHHHHccCCCcCCCCccc----CCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            999999999999865432   222222222  1122221111    0113667777765 4999997    4555544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.5e-42  Score=301.92  Aligned_cols=260  Identities=22%  Similarity=0.313  Sum_probs=205.8

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|++|.||++.. .++..+++|.+..... .......+..|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999975 5789999998865432 2333467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          167 KYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      ||+++++|.+++.... ....+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 233689999999999999999999999   999999999999999999999999999876644


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .........++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..............+. ....   ..
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~-~~~~---~~  233 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPP-LPSD---HY  233 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhhhhcCCCCC-CCcc---cc
Confidence            33333345688899999999888899999999999999999999999854321 1111111121111111 1110   11


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ...+.+++.+||+.||++|| +.+|++.+...
T Consensus       234 ~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         234 SEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             cHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            22488999999999999999 99888877543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.7e-42  Score=301.34  Aligned_cols=250  Identities=30%  Similarity=0.478  Sum_probs=203.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCC-CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||++...+ +..+++|.+.....    .+.+.+|+++++.++|||++++++++......++++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            3678999999999999999997754 78999999865432    478999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....  ..+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999986543  2589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ........++..|+|||.+.+..++.++||||||+++|+|++|+.||........   ...... ........+  ....
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~~~~~-~~~~~~~~~--~~~~  226 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IFMIPN-KPPPTLSDP--EKWS  226 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hhhhcc-CCCCCCCch--hhcC
Confidence            3333445578899999999888899999999999999999999999875433211   111111 111111111  1112


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ..+.+++.+||+.||++|| +.|++.+
T Consensus       227 ~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         227 PEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             HHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            2488999999999999999 9998864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.4e-42  Score=316.81  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=202.2

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|.+.+.||+|+||+||++.. .+|+.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4789999999999999999965 4688999999976533 2233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++.....  .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999976532  589999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCC-ceeeccccccccccccc------cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc--CCCCC
Q 046084          247 SSN-RTVVAGTHGYIAPELAY------TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR--VPSPI  317 (363)
Q Consensus       247 ~~~-~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~  317 (363)
                      ... .....||+.|+|||++.      ...++.++||||||+++|||++|+.||.....   ......+....  ...+.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~  232 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNFQRFLKFPE  232 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcCCCccCCCC
Confidence            222 22346899999999886      45678899999999999999999999865332   22222222211  11111


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..    .....+.+|+..||+ +|.+|| +.+++.+-..
T Consensus       233 ~~----~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~  266 (330)
T cd05601         233 DP----KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF  266 (330)
T ss_pred             CC----CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence            10    011237889999998 999999 9988876443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.4e-42  Score=318.18  Aligned_cols=257  Identities=23%  Similarity=0.351  Sum_probs=202.2

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      ...++|++.+.||+|+||.||++... +++.+|+|.+..... .......+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999764 578999999864321 1222356788999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +||||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            999999999999998654    478889999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCC-Cceeeccccccccccccccc----cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc--CCCC
Q 046084          244 HSDSS-NRTVVAGTHGYIAPELAYTM----VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR--VPSP  316 (363)
Q Consensus       244 ~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~  316 (363)
                      ..... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+.   ......+....  +..+
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~p  269 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---VGTYSKIMDHKNSLNFP  269 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCcccCCC
Confidence            43222 22345699999999988654    378899999999999999999999865432   22333333322  2222


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCC--CC-hHHHHHHHhch
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTS--RP-MQRVSQEFLVR  356 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RP-~~~v~~~l~~~  356 (363)
                      ...    .....+.+++..||+.++.+  || +.+++++-+.+
T Consensus       270 ~~~----~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~  308 (370)
T cd05621         270 EDV----EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK  308 (370)
T ss_pred             Ccc----cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence            111    11123778899999866554  88 99998876554

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.7e-42  Score=305.66  Aligned_cols=252  Identities=26%  Similarity=0.459  Sum_probs=199.4

Q ss_pred             CCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      +|.+.+.||+|+||.||+|...      ....+++|.+...... .....+..|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            4778899999999999999652      2356888888755443 22467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCC
Q 046084          164 LIYKYMRRGSLFCILRNDD---------------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSN  222 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  222 (363)
                      +++||+.+++|.+++....                     ....+++..++.++.|++.||.|||+.   +++||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence            9999999999999876421                     123578999999999999999999999   9999999999


Q ss_pred             CeeecCCCceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCC
Q 046084          223 NILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSV  299 (363)
Q Consensus       223 Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~  299 (363)
                      |||+++++.++|+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... 
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-  235 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-  235 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence            99999999999999999976533221  1122335678999999888889999999999999999998 9999854322 


Q ss_pred             CchhhHHhhhccc--CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          300 NPKIMLIDLLDQR--VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       300 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        .. ........  .+.+...      ...+.+++.+||+.+|++|| +.++++.|..
T Consensus       236 --~~-~~~~~~~~~~~~~~~~~------~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         236 --ER-LFNLLKTGYRMERPENC------SEEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             --HH-HHHHHhCCCCCCCCCCC------CHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence              22 22222221  1112211      12488999999999999999 9999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.1e-42  Score=307.87  Aligned_cols=257  Identities=25%  Similarity=0.429  Sum_probs=203.3

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLH  158 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (363)
                      +..++|++.+.||+|+||.||++...      +...+|+|.+....... ....+.+|+++++.+ +|+||+++++++..
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-HHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            45667999999999999999999753      23579999987654332 346688999999999 89999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCee
Q 046084          159 KKCMFLIYKYMRRGSLFCILRND-------------DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNIL  225 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  225 (363)
                      .+..+++|||+++|+|.+++...             .....+++..++.++.|++.||+|||+.   +++||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence            99999999999999999998642             2234689999999999999999999999   9999999999999


Q ss_pred             ecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCch
Q 046084          226 LNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPK  302 (363)
Q Consensus       226 l~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~  302 (363)
                      +++++.+||+|||++.........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....   .
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~  241 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---E  241 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---H
Confidence            999999999999999865432211  111224567999999988889999999999999999997 9999754322   1


Q ss_pred             hhHHhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          303 IMLIDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       303 ~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ......... ....+...      ...+.+++.+||+.||++|| +.++++.|..
T Consensus       242 ~~~~~~~~~~~~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         242 ELFKLLKEGYRMEKPQNC------TQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             HHHHHHHcCCcCCCCCCC------CHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence            112212111 11222211      12488999999999999999 9999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.2e-42  Score=304.88  Aligned_cols=255  Identities=27%  Similarity=0.395  Sum_probs=200.1

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCC------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPS------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      ..++|.+.+.||+|++|.||+|.+.+      +..|++|.+....... ....|..|+.+++.++|+||+++++++.+.+
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-DESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            45679999999999999999997643      5678999886544332 2356889999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC---ceE
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDE----AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL---EAF  233 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~k  233 (363)
                      ..+++|||+++++|.+++.....    ...+++..++.++.||+.|++|||+.   +++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence            99999999999999999875432    23589999999999999999999999   999999999999998654   689


Q ss_pred             EEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc
Q 046084          234 VADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD  310 (363)
Q Consensus       234 l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  310 (363)
                      |+|||++.........  ......+..|+|||++.+..++.++|||||||++|||++ |+.||+....   ......+..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~~~  236 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFVTG  236 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Confidence            9999999865322211  111223467999999988889999999999999999997 9999865332   111221211


Q ss_pred             -ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          311 -QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       311 -~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                       .....+...      ...+.+++.+||+.+|++|| +.++++.|.
T Consensus       237 ~~~~~~~~~~------~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 GGRLDPPKGC------PGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCcCCCCCCC------CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             122222211      12488999999999999999 999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=319.61  Aligned_cols=260  Identities=27%  Similarity=0.453  Sum_probs=216.8

Q ss_pred             HHHHHHHhcCCcccCeeeecCceeEEEEEeCC-CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 046084           81 FQEMIVATEDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK  159 (363)
Q Consensus        81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (363)
                      +++++....+..+..+||-|.||.||.|.|+. ...||||.++....+   +++|+.|+.+|+.++|||+|+|+|+|..+
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe---veEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh---HHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            46677777888999999999999999998754 457999999865543   58999999999999999999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      ..+|||+|||.+|+|.+||+..+.. .++.-..+.++.||+.||.||..+   +++||||..+|+|+.++..+|++|||+
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence            9999999999999999999876533 467777889999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCCCcee-eccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhh--cccCCC
Q 046084          240 ARLLHSDSSNRTV-VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLL--DQRVPS  315 (363)
Q Consensus       240 ~~~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~--~~~~~~  315 (363)
                      ++.+..+.+.... ..-...|.|||.+....++.|+|||+||++|||+.| |-.||...+-.+    ....+  +.++..
T Consensus       412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----VY~LLEkgyRM~~  487 (1157)
T KOG4278|consen  412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYGLLEKGYRMDG  487 (1157)
T ss_pred             hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----HHHHHhccccccC
Confidence            9998665443221 123568999999999999999999999999999998 888876543222    22222  234555


Q ss_pred             CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      |..++..      +.+|+.+||+++|.+|| ++|+-..|+...
T Consensus       488 PeGCPpk------VYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  488 PEGCPPK------VYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             CCCCCHH------HHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            6655544      88999999999999999 999988886543

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.2e-42  Score=306.66  Aligned_cols=256  Identities=27%  Similarity=0.430  Sum_probs=202.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      .++|.+.+.||+|+||.||++...      ++..+++|.+.....  ...+.+.+|+++++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            356888899999999999999642      345688888865443  223678899999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC
Q 046084          162 MFLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS  228 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~  228 (363)
                      .++||||+++++|.+++.....             ...+++..++.++.|++.|++|||++   +++||||||+||++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence            9999999999999999865321             22488999999999999999999999   9999999999999999


Q ss_pred             CCceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhH
Q 046084          229 KLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIML  305 (363)
Q Consensus       229 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~  305 (363)
                      ++.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ....
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~  235 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVI  235 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence            99999999999976533221  1122345778999999988889999999999999999998 9999754332   2222


Q ss_pred             HhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          306 IDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+.....+....     ..+..+.+++.+||+.||++|| +.+++++|..-
T Consensus       236 ~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         236 ECITQGRVLERPR-----VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             HHHhCCCCCCCCc-----cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            2222222221111     1122488999999999999999 99999998643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.1e-41  Score=296.76  Aligned_cols=253  Identities=22%  Similarity=0.340  Sum_probs=207.7

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|+..+.||.|+||.||.++. .+++.+++|.+............+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578899999999999999864 4688999999876654445557788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++.... ...+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999987653 23589999999999999999999999   999999999999999999999999999987644443


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL  328 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ......++..|+|||...+..++.++||||||+++|||++|..||...   +.......+.........     ......
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~  228 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT---NPLNLVVKIVQGNYTPVV-----SVYSSE  228 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCCCCc-----cccCHH
Confidence            334456889999999998888899999999999999999999997542   222333333333332211     111224


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      +.+++.+||+.+|++|| +.++++.+.
T Consensus       229 ~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         229 LISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             HHHHHHHHcccCcccCCCHHHHhhCcC
Confidence            88899999999999999 999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-41  Score=303.65  Aligned_cols=251  Identities=23%  Similarity=0.353  Sum_probs=199.3

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+...... .....+..|+.++++++||||+++++++...+..+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV-ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh-HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            4678889999999999999965 57889999998654332 234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|..+.       .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++...... 
T Consensus        80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            99999986542       467888899999999999999999   9999999999999999999999999999765332 


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCch----hhHHhhhcccCCCCCCChhhH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK----IMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  323 (363)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.........    .....+.....+... ...  
T Consensus       149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--  224 (279)
T cd06619         149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP-VGQ--  224 (279)
T ss_pred             -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC-CCc--
Confidence             223346889999999999888999999999999999999999998654322111    111111111111110 000  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       ....+.+++.+||+.||++|| +.+++.....+
T Consensus       225 -~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~  257 (279)
T cd06619         225 -FSEKFVHFITQCMRKQPKERPAPENLMDHPFIV  257 (279)
T ss_pred             -CCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence             112478999999999999999 99998876543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-42  Score=301.24  Aligned_cols=253  Identities=28%  Similarity=0.518  Sum_probs=205.0

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +..++|.+.+.||+|+||.||++...++..|++|.+......   .+++.+|+.+++.++|+|++++++++......+++
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            456789999999999999999998888889999998765433   25688999999999999999999999988899999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++..... ..+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EeccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            999999999999976432 3589999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhh
Q 046084          246 DSSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTV  322 (363)
Q Consensus       246 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  322 (363)
                      .... ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||....   .......+... ..+.+...   
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~---  229 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQVERGYRMPRPPNC---  229 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCC---
Confidence            2111 111224567999999988889999999999999999998 999985432   22222222221 11222222   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                         ...+.+++.+||+.+|++|| +.++...|+
T Consensus       230 ---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         230 ---PEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             ---CHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence               22488999999999999999 999988765

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.5e-42  Score=304.82  Aligned_cols=253  Identities=27%  Similarity=0.463  Sum_probs=200.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      .++|.+.+.||+|+||.||++...      ++..+++|.+.....  ...+.+..|+++++.++|+||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH--HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            467888999999999999999642      355789998775443  334679999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC
Q 046084          162 MFLIYKYMRRGSLFCILRNDDE------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK  229 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  229 (363)
                      .+++|||+++++|.+++.....            ...+++..++.++.|++.|++|||+.   +++||||||+|||++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence            9999999999999999875432            12588999999999999999999999   99999999999999999


Q ss_pred             CceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHH
Q 046084          230 LEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLI  306 (363)
Q Consensus       230 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~  306 (363)
                      +.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   .....
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~  235 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIE  235 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHH
Confidence            9999999999876533221  1112234678999999988889999999999999999998 8999754322   22222


Q ss_pred             hhhccc-CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          307 DLLDQR-VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       307 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ...... ...+...+      ..+.+++.+||+.||++|| +.++++.|.
T Consensus       236 ~~~~~~~~~~~~~~~------~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 CITQGRELERPRTCP------PEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHcCccCCCCCCCC------HHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            222221 11121111      2488999999999999999 999998775

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=297.96  Aligned_cols=253  Identities=23%  Similarity=0.374  Sum_probs=201.8

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE---LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ++|++.+.||+|++|.||++.. .+++.|++|.+......   ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5789999999999999999965 46889999988754321   2234578899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ++||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999887654   588899999999999999999999   99999999999999999999999999987653


Q ss_pred             CCCCCc---eeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          245 SDSSNR---TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       245 ~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ......   ....++..|+|||.+.+..++.++||||||+++|||++|+.||.....   ..................  
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~--  230 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPTNPQLPS--  230 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHHHHHHhccCCCCCCCc--
Confidence            321111   224577889999999988899999999999999999999999864322   111222222211111111  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                        .....+.+++.+||+.+|++|| +.+++....
T Consensus       231 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         231 --HVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             --cCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence              1112388899999999999999 999887643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.5e-42  Score=317.06  Aligned_cols=261  Identities=21%  Similarity=0.344  Sum_probs=203.5

Q ss_pred             HHHHHHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 046084           82 QEMIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK  159 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (363)
                      .+.....++|++.+.||+|+||.||++... +++.||+|.+..... .....+.+.+|+.+++.++||||+++++.+.+.
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344456689999999999999999999764 678999999865322 222235678899999999999999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      +..++||||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            9999999999999999998654    478888899999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCC-Cceeeccccccccccccccc----cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc--
Q 046084          240 ARLLHSDSS-NRTVVAGTHGYIAPELAYTM----VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR--  312 (363)
Q Consensus       240 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--  312 (363)
                      +........ ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+.   ......+....  
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~  265 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHKNS  265 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCc
Confidence            987643322 22345699999999988653    378899999999999999999999865332   22233333221  


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHccCCCCCC--CC-hHHHHHHHhch
Q 046084          313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTS--RP-MQRVSQEFLVR  356 (363)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RP-~~~v~~~l~~~  356 (363)
                      ...+..    ......+.++|..||+.++.+  || +.+++.+...+
T Consensus       266 ~~~~~~----~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~  308 (371)
T cd05622         266 LTFPDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  308 (371)
T ss_pred             ccCCCc----CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccC
Confidence            122211    011224788999999844443  77 88888876554

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.8e-41  Score=297.16  Aligned_cols=245  Identities=24%  Similarity=0.407  Sum_probs=196.2

Q ss_pred             CeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCCh
Q 046084           95 YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      +.||+|+||.||+|...++..+|+|.+...... .....+..|+++++.++||||+++++++...+..+++|||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            358999999999998888899999998765433 2235688999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCc-eee
Q 046084          175 FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVV  253 (363)
Q Consensus       175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~  253 (363)
                      .+++.....  .+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......... ...
T Consensus        80 ~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          80 LSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            998865432  578999999999999999999999   99999999999999999999999999987543222111 112


Q ss_pred             ccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHHHHHHHH
Q 046084          254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       254 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~  331 (363)
                      .++..|+|||.+.+..++.++||||||+++|++++ |..||......   .....+... ....+...      ...+.+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~------~~~~~~  225 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEKGYRMSCPQKC------PDDVYK  225 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCCCCCCCCC------CHHHHH
Confidence            34567999999988889999999999999999998 99998644221   111122111 11111111      124889


Q ss_pred             HHHHccCCCCCCCC-hHHHHHHHh
Q 046084          332 IVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       332 li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ++.+||+.+|++|| +.+++++|.
T Consensus       226 li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         226 VMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHcccCcccCCCHHHHHHHhc
Confidence            99999999999999 999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.4e-41  Score=303.41  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=202.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ..+.|++.+.||+|+||.||+|... ++..+++|.+.....  ...+.+..|+.+++.++|||++++++.+...+..++|
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            3467999999999999999999764 578999999875543  3357788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|..++.....  .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          88 IEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            999999999888754332  589999999999999999999999   999999999999999999999999999876433


Q ss_pred             CCCCceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          246 DSSNRTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      .........++..|+|||.+.     ...++.++||||||+++|||++|+.||.....   ............+......
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~  239 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTLSQPS  239 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCCCccCCCCc
Confidence            333334456788999999874     34467899999999999999999999765432   2222222222211111111


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                         .....+.+++.+||+.||++|| +.+++..-..
T Consensus       240 ---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  272 (292)
T cd06644         240 ---KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV  272 (292)
T ss_pred             ---ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence               1112478899999999999999 9999876543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-41  Score=304.07  Aligned_cols=253  Identities=25%  Similarity=0.362  Sum_probs=200.2

Q ss_pred             CcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           91 FDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      |++.+.||+|+||.||++... ++..+++|.+.....  ...+.+..|+++++.++|||++++++++...+..++++||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            577888999999999999765 467888888865432  23467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  249 (363)
                      ++++|..++....  ..+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||++.........
T Consensus        85 ~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  159 (282)
T cd06643          85 AGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  159 (282)
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence            9999988876532  2589999999999999999999999   9999999999999999999999999998765433333


Q ss_pred             ceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          250 RTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .....++..|+|||.+.     +..++.++||||||+++|||++|+.||.....   ......+.....+......   .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~---~  233 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTLAQPS---R  233 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhhcCCCCCCCcc---c
Confidence            33456889999999873     34577899999999999999999999865432   2222222222111111000   1


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ....+.+++.+||+.||++|| +.+++..-+..
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  266 (282)
T cd06643         234 WSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT  266 (282)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence            122488999999999999999 99998776554

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-41  Score=302.42  Aligned_cols=252  Identities=25%  Similarity=0.434  Sum_probs=197.7

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeC-----
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHK-----  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----  159 (363)
                      +.+.|++.+.||+|+||.||+|.. .+++.||+|.+......   ...+..|+.+++.+ +|+|++++++++...     
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            456788899999999999999965 46788999998765432   25677899999998 799999999998753     


Q ss_pred             -CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          160 -KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                       ...+++|||+.+++|.+++..... ..+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence             458899999999999999876432 3588999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCCCceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      ++..............|+..|+|||++.     +..++.++||||||+++|||++|+.||.........   ........
T Consensus       157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~---~~~~~~~~  233 (272)
T cd06637         157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPRNPA  233 (272)
T ss_pred             CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH---HHHhcCCC
Confidence            9986543333344456889999999875     345788999999999999999999998654322111   11111111


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .. ....   .....+.+++.+||+.||++|| +.+++.+
T Consensus       234 ~~-~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         234 PR-LKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             CC-CCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            11 1000   1112488999999999999999 9988765

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=293.18  Aligned_cols=257  Identities=22%  Similarity=0.341  Sum_probs=210.4

Q ss_pred             HhcCCcccCeeeecCceeEEEE-EeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ..++|++-+.||+|.|+.|+++ ..++|+.+|+|++..........+.+.+|+.+-+.++||||+++.+...+.+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            3567888899999999999998 557899999998876554444557889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceEEEeecccee
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARL  242 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~  242 (363)
                      +|++.|++|..-+-..   ..+++..+-..+.||++||.|+|.+   +|+|||+||+|+++..   ..-+||+|||++..
T Consensus        89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            9999999986544322   2478888889999999999999999   9999999999999943   45689999999998


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      +. +.......+|||.|||||++...+|+..+|||+.|++||-|+.|++||..   ++.......+..+.+..+...-..
T Consensus       163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~yd~~~~~w~~  238 (355)
T KOG0033|consen  163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAYDYPSPEWDT  238 (355)
T ss_pred             eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhccccCCCCcccCc
Confidence            87 55566677899999999999999999999999999999999999999754   344455666666555433311111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        ...+-.+|+.+||..||.+|- +.|.+.+-+.
T Consensus       239 --is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi  270 (355)
T KOG0033|consen  239 --VTPEAKSLIRRMLTVNPKKRITADEALKHPWI  270 (355)
T ss_pred             --CCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence              112467899999999999999 8887766554

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-41  Score=306.41  Aligned_cols=254  Identities=23%  Similarity=0.393  Sum_probs=204.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||++.. .+++.||+|.+.......  .+.+..|+.+++.++|||++++++++...+..++||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            46799999999999999999975 578999999987654332  356888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++...    .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            999999999998653    478899999999999999999999   9999999999999999999999999998765443


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||........   .........+. ...+  ....
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~-~~~~--~~~~  242 (297)
T cd06656         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNGTPE-LQNP--ERLS  242 (297)
T ss_pred             ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eeeeccCCCCC-CCCc--cccC
Confidence            3333345688899999999888899999999999999999999999865432211   11111111111 0011  1111


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+.+++.+||+.||++|| +.+++.+-+.+
T Consensus       243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (297)
T cd06656         243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFLK  273 (297)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence            2478899999999999999 99999876554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.4e-42  Score=310.70  Aligned_cols=261  Identities=20%  Similarity=0.273  Sum_probs=199.2

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+....... ....+.+|+.+++.++||||+++++++..++..+++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            57899999999999999999764 67789999987543321 12457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++ +|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          85 YLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            9975 78877765432  478899999999999999999999   99999999999999999999999999997654433


Q ss_pred             CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---------------
Q 046084          248 SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---------------  311 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------  311 (363)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...........               
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            33334567889999998764 46789999999999999999999998654322111111111000               


Q ss_pred             ---cCCCCCCCh---hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          312 ---RVPSPIDDQ---TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       312 ---~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                         ..+......   ........+.+++.+||+.||.+|| +.|++.+-..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence               000000000   0000112477999999999999999 99998876654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=298.43  Aligned_cols=248  Identities=27%  Similarity=0.476  Sum_probs=202.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .++|++.+.||.|+||.||++.. .|+.|++|.+.....   ..+.+..|+.+++.++|+|++++++++...+..+++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            46789999999999999999987 478999999976544   34678899999999999999999999999889999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          81 YMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             ecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999876442 2589999999999999999999999   99999999999999999999999999997663222


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQD  325 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  325 (363)
                      .   ....+..|+|||.+....++.++||||||+++|||++ |..||.....   .......... ....+..      .
T Consensus       157 ~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~------~  224 (256)
T cd05039         157 D---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKGYRMEAPEG------C  224 (256)
T ss_pred             c---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCCCCCccC------C
Confidence            1   2234567999999988889999999999999999997 9999764422   2222221111 1111111      1


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...+.+++.+||+.+|++|| +.+++++|..
T Consensus       225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         225 PPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            12488999999999999999 9999998853

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-42  Score=304.40  Aligned_cols=256  Identities=23%  Similarity=0.360  Sum_probs=203.4

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK  159 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (363)
                      +..++|.+.+.||+|+||.||+|...      ++..|++|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            34568999999999999999999653      2468999998755432 2245788999999999999999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCce
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDE-------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEA  232 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  232 (363)
                      ...+++|||+++|+|.+++.....       ...+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence            999999999999999999865321       22478899999999999999999999   99999999999999999999


Q ss_pred             EEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhh
Q 046084          233 FVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLL  309 (363)
Q Consensus       233 kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~  309 (363)
                      ||+|||+++.......  ......++..|+|||.+.+..++.++||||||+++||+++ |..||...+.   ........
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~  235 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVI  235 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHh
Confidence            9999999876533221  1122345778999999988889999999999999999998 9999754332   22222222


Q ss_pred             cc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          310 DQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       310 ~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .. ....+...      ...+.+++.+||+.+|++|| +.+++..|.
T Consensus       236 ~~~~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 DGGHLDLPENC------PDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             cCCCCCCCCCC------CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            22 12222222      22488999999999999999 999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=309.69  Aligned_cols=256  Identities=24%  Similarity=0.347  Sum_probs=215.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchH-HHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  164 (363)
                      ...|++.+.||+|.||.||++..+ +|+.+|+|.+....... ...+.+.+|+.+|+++. ||||+.+.+.+++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            557888999999999999999765 49999999997665321 12467899999999998 9999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC----CceEEEeeccc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK----LEAFVADFGVA  240 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~  240 (363)
                      |||++.||.|.+.+...    .+++.....++.|++.+++|||+.   +++||||||+|+|+...    +.+|++|||++
T Consensus       114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999999998765    289999999999999999999999   99999999999999543    57999999999


Q ss_pred             eeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      ..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.....   ......+....+...... 
T Consensus       187 ~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~---~~~~~~i~~~~~~f~~~~-  261 (382)
T KOG0032|consen  187 KFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE---FEIFLAILRGDFDFTSEP-  261 (382)
T ss_pred             eEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh---hHHHHHHHcCCCCCCCCC-
Confidence            98766 5567778999999999999999999999999999999999999999865443   233345555555333221 


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       .........++|..|+..||.+|+ +.+++++.+.+
T Consensus       262 -w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~  297 (382)
T KOG0032|consen  262 -WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK  297 (382)
T ss_pred             -ccccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence             112233578899999999999999 99999987654

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-41  Score=306.02  Aligned_cols=253  Identities=23%  Similarity=0.399  Sum_probs=204.2

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .+|++.+.||.|++|.||+|.. .+++.|++|.+.......  .+.+.+|+..++.++|||++++++++...+..++++|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK--KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch--HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            4689999999999999999964 578899999987544322  3678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|..++...    .+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          97 YLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             ecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            99999999988643    489999999999999999999999   99999999999999999999999999987654433


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+...   ....+.....+.. ..+  .....
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~---~~~~~~~~~~~~~-~~~--~~~~~  243 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNGTPEL-QNP--EKLSP  243 (296)
T ss_pred             ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCCccc-CCc--ccCCH
Confidence            33334467889999999988889999999999999999999999986543211   1111211111110 000  01112


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .+.++|.+||+.||++|| +.+++.+-+.+
T Consensus       244 ~~~~li~~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             HHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence            488899999999999999 99998876554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.5e-42  Score=305.68  Aligned_cols=253  Identities=24%  Similarity=0.377  Sum_probs=200.6

Q ss_pred             cCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .+|.+.+.||+|+||.||+|...      ++..||+|++...... ...+.+..|+.++..++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            35777888999999999999753      2468999999765432 3346788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC
Q 046084          163 FLIYKYMRRGSLFCILRNDD-------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK  229 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  229 (363)
                      ++++||+.+++|.+++....             ....+++..++.++.|++.||+|||+.   +++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence            99999999999999885321             122478888999999999999999999   99999999999999999


Q ss_pred             CceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHH
Q 046084          230 LEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLI  306 (363)
Q Consensus       230 ~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~  306 (363)
                      +.+||+|||+++........  .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.....   .....
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~  237 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIE  237 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence            99999999998765332211  122335678999999988889999999999999999998 8888765322   22333


Q ss_pred             hhhcccCC-CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          307 DLLDQRVP-SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       307 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .+...... .+...      ...+.+++.+||+.+|++|| +.+++..|.
T Consensus       238 ~i~~~~~~~~~~~~------~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         238 MIRNRQVLPCPDDC------PAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HHHcCCcCCCCCCC------CHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            33333222 12222      22488999999999999999 999998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.1e-41  Score=298.10  Aligned_cols=244  Identities=21%  Similarity=0.387  Sum_probs=191.7

Q ss_pred             eeeecCceeEEEEEeC---CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           96 CIGTGGYGSVYRAQLP---SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      .||+|+||.||+|.+.   ++..||+|.+..... ....+.+.+|+.++++++||||+++++++.. ...++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            3899999999999653   345799999876543 3344679999999999999999999998864 5689999999999


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCc--
Q 046084          173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR--  250 (363)
Q Consensus       173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--  250 (363)
                      +|.+++.....  .+++..+++++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..........  
T Consensus        80 ~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          80 PLNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99999875332  589999999999999999999999   99999999999999999999999999997654332211  


Q ss_pred             -eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc-CCCCCCChhhHHHHH
Q 046084          251 -TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR-VPSPIDDQTVIQDII  327 (363)
Q Consensus       251 -~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  327 (363)
                       ....++..|+|||.+....++.++||||||+++||+++ |..||......   .....+.... .+.+...      ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~------~~  225 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFIEQGKRLDCPAEC------PP  225 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCCCCCCCCC------CH
Confidence             11123568999999888889999999999999999996 99998654321   2222222221 1222111      12


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+.+++.+||+.||++|| +.++.+.|..
T Consensus       226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         226 EMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            488999999999999999 9999888753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-41  Score=300.37  Aligned_cols=252  Identities=26%  Similarity=0.445  Sum_probs=199.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .++|.+.+.||+|++|.||++...++..+++|.+......   .+.+.+|+.+++.++|||++++++++.. +..+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence            4568899999999999999998877778999988654332   2568889999999999999999998754 56789999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+.+++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          81 FMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999997543 23578999999999999999999999   99999999999999999999999999997654322


Q ss_pred             CC-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          248 SN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       248 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .. .....++..|+|||...+..++.++||||||+++|||++ |+.||.....   ......+... ...+...    ..
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~-~~~~~~~----~~  228 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERG-YRMPCPQ----GC  228 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcC-CCCCCCc----cc
Confidence            11 112235678999999988889999999999999999999 8999764322   1222222221 1111110    11


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...+.+++.+||+.||++|| +.++++.|..
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         229 PESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            23488999999999999999 9999888753

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-41  Score=299.01  Aligned_cols=251  Identities=25%  Similarity=0.389  Sum_probs=199.9

Q ss_pred             CCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccc----hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSET----ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +|++.+.||+|+||.||+|...+++.+|+|.+.....    .......+.+|+++++.++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999888899999998865421    223346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      +||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999997644   578999999999999999999999   999999999999999999999999999875422


Q ss_pred             CC------CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCC
Q 046084          246 DS------SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       246 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      ..      .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+...   ....+.......+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~  231 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFYIGAHRGLMPRLP  231 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH---HHHHhhhccCCCCCCC
Confidence            11      11123457889999999988889999999999999999999999986543221   1111111100111000


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .   .....+.++|.+||+.+|++|| +.+++..
T Consensus       232 ~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         232 D---SFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             C---CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0   1122488999999999999999 9888764

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-41  Score=306.27  Aligned_cols=253  Identities=27%  Similarity=0.441  Sum_probs=197.2

Q ss_pred             cCCcccCeeeecCceeEEEEEeCC-CC--EEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPS-GK--KVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (363)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++..... ...+.+..|+.++.++ +||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH-HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            578999999999999999997643 33  4788888743322 2246788999999999 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc
Q 046084          165 IYKYMRRGSLFCILRNDD-------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE  231 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  231 (363)
                      ++||+++++|.+++....             ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence            999999999999986532             112488899999999999999999999   9999999999999999999


Q ss_pred             eEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc
Q 046084          232 AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD  310 (363)
Q Consensus       232 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  310 (363)
                      +||+|||++....... .......+..|+|||...+..++.++||||||+++|||++ |..||.....   .........
T Consensus       158 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~~~~~~  233 (297)
T cd05089         158 SKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELYEKLPQ  233 (297)
T ss_pred             EEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhc
Confidence            9999999986432111 1111123457999999988889999999999999999997 9999864332   222222222


Q ss_pred             c-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          311 Q-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       311 ~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      . ....+...      ...+.+++.+||+.+|.+|| +.+++..|..
T Consensus       234 ~~~~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  274 (297)
T cd05089         234 GYRMEKPRNC------DDEVYELMRQCWRDRPYERPPFAQISVQLSR  274 (297)
T ss_pred             CCCCCCCCCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1 11111111      12488999999999999999 9999888754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=297.76  Aligned_cols=260  Identities=24%  Similarity=0.324  Sum_probs=201.9

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee-----CC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH-----KK  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~  160 (363)
                      ....|...+.||+|+||.|+.+.. .+|+.||||++...-......++..+|+.+|+.++|+||+.+++++..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            345566678899999999999954 578999999998655555556788899999999999999999998876     24


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      .+|+|+|+| +.+|...++...   .++......++.|+++||.|+|+.   +++||||||+|+|++.+...||+|||+|
T Consensus       100 DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence            689999999 458888887654   599999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCC--CCCceeeccccccccccccc-cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhh-------------
Q 046084          241 RLLHSD--SSNRTVVAGTHGYIAPELAY-TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM-------------  304 (363)
Q Consensus       241 ~~~~~~--~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~-------------  304 (363)
                      +.....  ....+.++.|.+|.|||++. ...|+.+.||||.|||+.||++|++-|...+..+.-..             
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            987542  23345567899999999765 56799999999999999999999998865443211111             


Q ss_pred             -------HHhhhcccCCCCCCC-hhh-HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          305 -------LIDLLDQRVPSPIDD-QTV-IQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       305 -------~~~~~~~~~~~~~~~-~~~-~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                             ....+...+..+... ... ......-.+|+.+||..||.+|+ +.|.+++-
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence                   111122111111110 000 01111367899999999999999 88887754

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.5e-42  Score=305.41  Aligned_cols=257  Identities=22%  Similarity=0.344  Sum_probs=202.3

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK  159 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (363)
                      +..++|++.+.||+|+||.||+|...      .+..||+|.+....... ....+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH-HHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            45778999999999999999999643      24579999887554322 235678899999999999999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCce
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDE-------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEA  232 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  232 (363)
                      +..+++|||+++|+|.+++.....       ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence            999999999999999999965321       23457788899999999999999999   99999999999999999999


Q ss_pred             EEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhh
Q 046084          233 FVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLL  309 (363)
Q Consensus       233 kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~  309 (363)
                      +|+|||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+.
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~  235 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLKFVM  235 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH
Confidence            99999998755332211  112234677999999988889999999999999999998 7888764322   22222232


Q ss_pred             cccC-CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          310 DQRV-PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       310 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +... ..+...+      ..+.+++.+||+.||++|| +.++++.+..
T Consensus       236 ~~~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  277 (288)
T cd05061         236 DGGYLDQPDNCP------ERVTDLMRMCWQFNPKMRPTFLEIVNLLKD  277 (288)
T ss_pred             cCCCCCCCCCCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            2221 2222111      2488999999999999999 9999988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-41  Score=301.79  Aligned_cols=251  Identities=26%  Similarity=0.393  Sum_probs=196.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCC----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||.||+|.+. +++    .+++|.+...... ....++..|+..++.++||||+++++++.. ...
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR-QTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch-HHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            357888999999999999999763 344    4788887644332 234577888889999999999999998864 457


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++++||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++.
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            889999999999999975432  589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc--cCCCCC
Q 046084          243 LHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPI  317 (363)
Q Consensus       243 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  317 (363)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......   . ..+.+..  ..+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~-~~~~~~~~~~~~~~~  234 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---E-VPDLLEKGERLAQPQ  234 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---H-HHHHHHCCCcCCCCC
Confidence            533221  1223346678999999988889999999999999999998 99998653221   1 1222221  112121


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..      ...+.+++.+||..||++|| +.|++..|..
T Consensus       235 ~~------~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         235 IC------TIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             CC------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            11      12377899999999999999 9999988754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9.2e-42  Score=316.34  Aligned_cols=260  Identities=24%  Similarity=0.306  Sum_probs=198.1

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----eEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-----CMF  163 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  163 (363)
                      +|++.+.||+|+||.||++.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            578899999999999999975 47899999998765433334467889999999999999999999998776     789


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +++||+. ++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus        81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 57777775443   689999999999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCC-Cceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh--------------
Q 046084          244 HSDSS-NRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID--------------  307 (363)
Q Consensus       244 ~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~--------------  307 (363)
                      ..... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||.............+              
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            33221 22234578899999988764 478999999999999999999999865432211110000              


Q ss_pred             ------hhcccCCCCCCCh---hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          308 ------LLDQRVPSPIDDQ---TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       308 ------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                            +.......+....   ........+.+++.+||+.||++|| +.|++.+-..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  292 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD  292 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence                  0000000000000   0000122478999999999999999 99998876543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.7e-42  Score=315.40  Aligned_cols=260  Identities=22%  Similarity=0.281  Sum_probs=198.2

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-----  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  160 (363)
                      ..++|++.+.||+|+||.||++.. .+|..||+|.+............+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999965 46889999999765443444567889999999999999999999986543     


Q ss_pred             -eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          161 -CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       161 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                       ..+++|||+.+ +|...+..     .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence             47999999976 56555532     478888999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhh---------------
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM---------------  304 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~---------------  304 (363)
                      +....... ......+|..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......               
T Consensus       170 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         170 ARTACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             ccccccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            97643322 22334688999999999999999999999999999999999999875432110000               


Q ss_pred             ----HHhhhcccCCCCC--------------CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          305 ----LIDLLDQRVPSPI--------------DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       305 ----~~~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                          ...........+.              ...........+.+|+.+||+.||++|| +.|++.+-+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence                0000001000000              0000000122478999999999999999 99999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.8e-41  Score=299.13  Aligned_cols=257  Identities=23%  Similarity=0.384  Sum_probs=198.2

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      .+++++.....||+|+||.||+|.+. ++..|++|.+......  ..+.+.+|+.+++.++|+||+++++++..++..++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH--HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            34556666678999999999999754 5778999988765432  24678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC-CCceEEEeeccceec
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS-KLEAFVADFGVARLL  243 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~  243 (363)
                      ++||+++++|.+++.........++..+..++.|++.||+|||+.   +++||||+|+||+++. ++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999999987643222237888889999999999999999   9999999999999976 679999999998765


Q ss_pred             cCCCCCceeecccccccccccccccc--CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMV--LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ...........++..|+|||.+....  ++.++||||||+++|+|++|+.||......................+..   
T Consensus       160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  236 (268)
T cd06624         160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES---  236 (268)
T ss_pred             ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcc---
Confidence            43333333345788999999876543  7889999999999999999999986433211111111111111111111   


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                         ....+.+++.+||+.+|++|| +.+++.+-
T Consensus       237 ---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  266 (268)
T cd06624         237 ---LSAEAKNFILRCFEPDPDKRASAHDLLQDP  266 (268)
T ss_pred             ---cCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence               112488899999999999999 99988753

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.4e-41  Score=303.92  Aligned_cols=261  Identities=22%  Similarity=0.333  Sum_probs=201.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCC-----------------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCcee
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPS-----------------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV  150 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  150 (363)
                      .++|++.+.||+|+||.||++...+                 +..||+|.+...... ...+.+.+|++++++++|||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEe
Confidence            4679999999999999999986532                 245899998765443 3457889999999999999999


Q ss_pred             eeeeEEeeCCeEEEEEEeccCCChhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCC
Q 046084          151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD--------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSN  222 (363)
Q Consensus       151 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  222 (363)
                      ++++++...+..++++||+++++|.+++....        ....+++..++.++.|++.||+|||+.   +++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence            99999999999999999999999999987543        122589999999999999999999999   9999999999


Q ss_pred             CeeecCCCceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh--CCCCCCCCcC
Q 046084          223 NILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM--GRHPGDLLSS  298 (363)
Q Consensus       223 Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~p~~~~~~  298 (363)
                      ||++++++.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            99999999999999999876533221  1222345678999999888889999999999999999998  6778754332


Q ss_pred             CCchhhHHhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          299 VNPKIMLIDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       299 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ............. ........  ....+..+.+++.+||+.||++|| +.+++..|.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPR--PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHHhccccccccccCCC--ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1111111111000 00000000  001112489999999999999999 999988775

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3e-42  Score=320.07  Aligned_cols=252  Identities=20%  Similarity=0.303  Sum_probs=195.2

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||+++. .+++.||+|.+..... .......+.+|+++++.++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3689999999999999999965 4688999999865432 1223456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999997654   578888899999999999999999   9999999999999999999999999997532100


Q ss_pred             C-------------------------------------------CCceeeccccccccccccccccCCccccchHHHHHH
Q 046084          247 S-------------------------------------------SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVA  283 (363)
Q Consensus       247 ~-------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il  283 (363)
                      .                                           .......||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                           001124689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCcCCCchhhHHhhhcc--cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC----hHHHHHHHh
Q 046084          284 LEVLMGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP----MQRVSQEFL  354 (363)
Q Consensus       284 ~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----~~~v~~~l~  354 (363)
                      |||++|+.||......   .....+...  ....+....    ....+.++|.+|+ .+|++|+    +.+++.+-.
T Consensus       235 yell~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~  303 (376)
T cd05598         235 YEMLVGQPPFLADTPA---ETQLKVINWETTLHIPSQAK----LSREASDLILRLC-CGAEDRLGKNGADEIKAHPF  303 (376)
T ss_pred             eehhhCCCCCCCCCHH---HHHHHHhccCccccCCCCCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence            9999999998654321   222222221  111111111    1113667787876 4999999    356555533

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-41  Score=303.48  Aligned_cols=259  Identities=22%  Similarity=0.349  Sum_probs=204.7

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCC-----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee-C
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPS-----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH-K  159 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~  159 (363)
                      +..++|.+.+.||+|+||.||+|.+.+     +..|++|.+..... ....+.+.+|+.+++.++|||++++++++.. .
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-EIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            346789999999999999999998755     67899998875433 3335778899999999999999999998876 4


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEE
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEA-----IRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFV  234 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl  234 (363)
                      ...++++||+++++|.+++......     ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence            6688999999999999998654322     4689999999999999999999999   9999999999999999999999


Q ss_pred             EeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc
Q 046084          235 ADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ  311 (363)
Q Consensus       235 ~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~  311 (363)
                      +|||+++.+......  .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.....   ........+.
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~  235 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKDG  235 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHcC
Confidence            999999765322211  112235667999999988889999999999999999999 9999865322   2222212111


Q ss_pred             -cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       312 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                       .+..+...      +..+.+++.+||+.||++|| +.+++..|....
T Consensus       236 ~~~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         236 YRLAQPINC------PDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             CCCCCCCcC------CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence             11111111      12488999999999999999 999999887644

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.1e-41  Score=297.99  Aligned_cols=251  Identities=24%  Similarity=0.394  Sum_probs=202.3

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH-KKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  167 (363)
                      +|++.+.||+|++|.||++... +++.|++|.+..........+.+..|+++++.++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999754 57889999987654434445678899999999999999999988764 446789999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|.+++.... ...+++.+++.++.|++.|+++||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999887532 22589999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||+...   .......+.....+....     ....
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~  228 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNSLVYRIIEGKLPPMPK-----DYSP  228 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCCCCCcc-----ccCH
Confidence            33444568899999999998889999999999999999999999976432   222222333333222110     1112


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .+.+++.+||+.||++|| +.+++.+
T Consensus       229 ~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         229 ELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HHHHHHHHHhccCcccCCCHHHHhcC
Confidence            488999999999999999 9998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.1e-41  Score=299.81  Aligned_cols=253  Identities=29%  Similarity=0.467  Sum_probs=201.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      ..+|++.+.||+|+||.||+|...    .+..+|+|.+...... ...+.+..|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            357889999999999999999653    2337999998765433 23467899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ++|||+++++|.+++.....  .+++.+++.++.|++.|++|||+.   +++||||||+|||++.++.++|+|||++...
T Consensus        82 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999999976432  589999999999999999999999   9999999999999999999999999999866


Q ss_pred             cCCCCCcee---eccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCC
Q 046084          244 HSDSSNRTV---VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPID  318 (363)
Q Consensus       244 ~~~~~~~~~---~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  318 (363)
                      .........   ..++..|+|||.+.+..++.++|+||||+++||+++ |..||......   .....+.+. +.+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~  233 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGYRLPAPMD  233 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCCcCCCCCC
Confidence            433221111   123467999999988889999999999999999886 99998654322   122222221 1222221


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .      +..+.+++.+||+.+|++|| +.++++.|..
T Consensus       234 ~------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         234 C------PAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             C------CHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            1      12478999999999999999 9999988753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-41  Score=306.85  Aligned_cols=254  Identities=26%  Similarity=0.434  Sum_probs=197.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCC--EEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK--KVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  163 (363)
                      .++|++.+.||+|+||.||+|.+. ++.  .+++|.+..... ......+.+|++++.++ +||||+++++++...+..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC-HHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            457899999999999999999764 444  457777664332 23346788999999999 8999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC
Q 046084          164 LIYKYMRRGSLFCILRNDD-------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL  230 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  230 (363)
                      ++|||+++++|.+++....             ....+++..++.++.|++.|++|||+.   +++||||||+|||++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence            9999999999999986532             123588999999999999999999999   999999999999999999


Q ss_pred             ceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhh
Q 046084          231 EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLL  309 (363)
Q Consensus       231 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~  309 (363)
                      .+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||+| |..||......   .......
T Consensus       162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~  237 (303)
T cd05088         162 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP  237 (303)
T ss_pred             cEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHHHh
Confidence            99999999986432111 1111224567999999888889999999999999999998 99998643321   1122221


Q ss_pred             cc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          310 DQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       310 ~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .. ....+...      ...+.+++.+||+.+|++|| +.+++..+..
T Consensus       238 ~~~~~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         238 QGYRLEKPLNC------DDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             cCCcCCCCCCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11 11111111      12478999999999999999 9999988753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.8e-41  Score=303.10  Aligned_cols=258  Identities=25%  Similarity=0.372  Sum_probs=199.6

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|++|.||++... +|+.||+|++..........+.+.+|+.+++.++|||++++++++......+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999765 58899999887544322333567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|..+.....   .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999988887765443   589999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---------------
Q 046084          248 SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---------------  311 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------  311 (363)
                      .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+...........               
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence            33333457788999998765 55788999999999999999999998654332111111100000               


Q ss_pred             ---cCCCCCCChh----hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 ---RVPSPIDDQT----VIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 ---~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                         ..+.+.....    .......+.+++.+||+.||++|| +.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence               0000000000    001123488999999999999999 9888764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.5e-43  Score=288.55  Aligned_cols=256  Identities=25%  Similarity=0.370  Sum_probs=210.8

Q ss_pred             hcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccc------hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeC
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET------ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHK  159 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  159 (363)
                      -+.|.-.+.||.|..++|-++. ..+|...|+|++.....      .....+.-..|+.+|+++ .||||+.+.++++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            4567778889999999999884 45788999998865432      233445667899999998 799999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      ...++|+|.|+.|.|.+++...-   .+++++..+|+.|+.+|+.|||..   +|+||||||+|||++++.+++|+|||+
T Consensus        96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence            99999999999999999997644   799999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCCCceeecccccccccccccc------ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYT------MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      ++.+.. .......+||++|+|||.+..      ..|+...|.|++|+|+|.|+.|.+||-..   ..-.++..+..+.+
T Consensus       170 a~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQmlMLR~ImeGky  245 (411)
T KOG0599|consen  170 ACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQMLMLRMIMEGKY  245 (411)
T ss_pred             eeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HHHHHHHHHHhccc
Confidence            998754 445566789999999998753      35788999999999999999999996321   22233445556665


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+..  +...+......+||.+||+.||++|- +.|.+++-..
T Consensus       246 qF~s--peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  246 QFRS--PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             ccCC--cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence            5432  22333444688999999999999999 9999887655

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-41  Score=304.31  Aligned_cols=263  Identities=25%  Similarity=0.412  Sum_probs=202.3

Q ss_pred             cHHHHHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 046084           80 TFQEMIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCL  157 (363)
Q Consensus        80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  157 (363)
                      .++.+....++|++.+.||+|+||.||++.. .+++.+++|.+......   ...+..|+.+++.+ +|||++++++++.
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---DEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch---HHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            3455556788999999999999999999965 46789999988654322   24677899999999 6999999999885


Q ss_pred             -----eCCeEEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc
Q 046084          158 -----HKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE  231 (363)
Q Consensus       158 -----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  231 (363)
                           .++..+++|||+++++|.+++... .....+++..+..++.|+++||.|||+.   +++||||+|+||++++++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence                 345689999999999999887532 1223688899999999999999999999   9999999999999999999


Q ss_pred             eEEEeeccceeccCCCCCceeecccccccccccccc-----ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH
Q 046084          232 AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-----MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI  306 (363)
Q Consensus       232 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~  306 (363)
                      ++|+|||++..............|+..|+|||.+..     ..++.++||||||+++|||++|+.||......   ....
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~  239 (286)
T cd06638         163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALF  239 (286)
T ss_pred             EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHh
Confidence            999999999876443333344568899999998753     44788999999999999999999998654321   1111


Q ss_pred             hhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          307 DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .......+ ....+.  .....+.+++.+||+.||++|| +.++++...
T Consensus       240 ~~~~~~~~-~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         240 KIPRNPPP-TLHQPE--LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             hccccCCC-cccCCC--CcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            11111111 110000  0112488899999999999999 999988754

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=303.76  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=205.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||.|+||.||++... ++..+|+|.+.....  ...+.+..|+.+++.++|||++++++++......++||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE--EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            467889999999999999999764 688999999875433  23467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++.....  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          82 EFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999999876432  589999999999999999999999   9999999999999999999999999998765443


Q ss_pred             CCCceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          247 SSNRTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ........++..|+|||.+.     ...++.++|+||||+++|||++|+.||...+.   ......+.....+...... 
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~-  232 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVLLKILKSEPPTLDQPS-  232 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHHHHHhcCCCCCcCCcc-
Confidence            33344456889999999874     34467799999999999999999999865432   2222333322221111100 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                        .....+.+++..||+.+|++|| +.++++.-+...
T Consensus       233 --~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         233 --KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             --cCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence              1112478899999999999999 999988765443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-41  Score=298.48  Aligned_cols=250  Identities=22%  Similarity=0.359  Sum_probs=204.1

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||+|+||.+|++.. .+|+.|++|.+..........+++.+|+.+++.++||||+++++++...+..++++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478899999999999999965 4688999999876543333446789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +.+++|.+++..... ..+++..++.++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999998865332 2578899999999999999999999   999999999999999999999999999987644333


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC-CCCCChhhHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP-SPIDDQTVIQDII  327 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  327 (363)
                      ......++..|+|||.+.+..++.++|+||||+++++|++|+.||...   +.......+.....+ .+...      ..
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~  227 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRGSYPPVSSHY------SY  227 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHhcCCCCCCcccC------CH
Confidence            333445788899999998888999999999999999999999997643   222233333333322 11111      12


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .+.++|.+||+.+|++|| +.+++++
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         228 DLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            488999999999999999 9999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.7e-41  Score=300.13  Aligned_cols=254  Identities=24%  Similarity=0.345  Sum_probs=196.3

Q ss_pred             CcccCeeeecCceeEEEEEe-----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEE
Q 046084           91 FDIKYCIGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMF  163 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  163 (363)
                      |.+.+.||+|+||+||++..     .++..||+|.+...... ...+.+.+|+++++.++||||+++++++...  ...+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            38889999999999988642     36778999998765432 2346788999999999999999999988764  3588


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ++|||+++++|.+++...    .+++..++.++.|++.||.|||+.   +++||||||+||++++++.++|+|||++...
T Consensus        85 lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          85 LIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence            999999999999998654    489999999999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc-----------hhhHHhhh
Q 046084          244 HSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-----------KIMLIDLL  309 (363)
Q Consensus       244 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-----------~~~~~~~~  309 (363)
                      ......   .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........           ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            432211   1112345679999999888899999999999999999999999754321100           00011111


Q ss_pred             cccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          310 DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ......+..    ......+.+++.+||+.||++|| +.+++..|...
T Consensus       238 ~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         238 ERGMRLPCP----KNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hcCCCCCCC----CCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            111111110    01123588999999999999999 99999988653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.1e-41  Score=298.69  Aligned_cols=253  Identities=25%  Similarity=0.466  Sum_probs=201.7

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +..++|.+.+.||+|+||.||++...++..+++|.+.....   ..+.+.+|+.+++.++|+|++++++++.+ ...+++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh---HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            45678999999999999999999887888899998875432   23678899999999999999999999887 678999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++.... ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          79 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            99999999999997643 23578899999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          246 DSSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       246 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      .... .....++..|+|||.+....++.++|+||||+++|++++ |+.||...+..   .....+ ......+...    
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~-~~~~~~~~~~----  226 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL-ERGYRMPRPE----  226 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH-hCCCCCCCcc----
Confidence            2211 112234567999999988889999999999999999998 99998653321   111111 1211111111    


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .....+.+++.+||+.+|++|| +.++.+.|.
T Consensus       227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence            1122488999999999999999 999888775

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-41  Score=297.14  Aligned_cols=247  Identities=28%  Similarity=0.489  Sum_probs=201.4

Q ss_pred             CeeeecCceeEEEEEeCC----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEecc
Q 046084           95 YCIGTGGYGSVYRAQLPS----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (363)
                      +.||+|+||.||++....    +..|++|.+....... ..+.+.+|++.++.++|+|++++++++......+++|||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            368999999999997654    7899999998765543 35788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          171 RGSLFCILRNDDE------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       171 ~g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      +++|.+++.....      ...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence            9999999987521      24689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCC--CCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCCh
Q 046084          245 SDS--SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQ  320 (363)
Q Consensus       245 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  320 (363)
                      ...  .......++..|+|||.+....++.++||||||+++|||++ |..||.....   .......... ....+... 
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~-  232 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGYRLPKPEYC-  232 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCCCccC-
Confidence            432  12223456788999999888889999999999999999999 6999876532   2222222221 12222211 


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                           ...+.+++.+||+.||++|| +.+++..|.
T Consensus       233 -----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         233 -----PDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 22488999999999999999 999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.3e-41  Score=301.49  Aligned_cols=252  Identities=27%  Similarity=0.469  Sum_probs=198.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCC----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      ..++|++.+.||+|+||+||+|++ .++.    .||+|.+...... ...+.+..|+.+++.++||||+++++++... .
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-KANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH-HHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            356789999999999999999974 3444    4899998765433 2346788999999999999999999999764 4


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++++||+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            6789999999999999875432  589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCCCc--eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc--cCCCC
Q 046084          242 LLHSDSSNR--TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSP  316 (363)
Q Consensus       242 ~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~  316 (363)
                      .........  ....++..|+|||...+..++.++||||||+++|||++ |..||+....   .. ....+..  ..+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~-~~~~~~~~~~~~~~  233 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---RE-IPDLLEKGERLPQP  233 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HH-HHHHHHCCCcCCCC
Confidence            764332211  11234568999999988889999999999999999998 8999764332   11 1112221  11111


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...      ...+.+++.+||+.||++|| +.+++..|..
T Consensus       234 ~~~------~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~  267 (279)
T cd05109         234 PIC------TIDVYMIMVKCWMIDSECRPRFRELVDEFSR  267 (279)
T ss_pred             ccC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111      12478899999999999999 9999987754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.2e-41  Score=313.62  Aligned_cols=259  Identities=24%  Similarity=0.401  Sum_probs=204.3

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEE
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFC  156 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~  156 (363)
                      +.+..++|.+.+.||+|+||.||+|.+.      .+..||+|+++...... ..+.+..|+.++..+. ||||++++++|
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS-EKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh-HHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            4456678889999999999999999753      34589999998654332 2357889999999997 99999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCCC-----------------------------------------------------
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDDE-----------------------------------------------------  183 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  183 (363)
                      ...+..++|+||+.+|+|.++++....                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            999999999999999999999864321                                                     


Q ss_pred             ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCC
Q 046084          184 ------------------------------------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISS  221 (363)
Q Consensus       184 ------------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp  221 (363)
                                                                ...+++..++.++.|++.||+|||+.   +++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence                                                      12367788899999999999999998   999999999


Q ss_pred             CCeeecCCCceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcC
Q 046084          222 NNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSS  298 (363)
Q Consensus       222 ~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~  298 (363)
                      +|||+++++.+||+|||++........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999976532221  1122346788999999988889999999999999999998 8899764322


Q ss_pred             CCchhhHHhhhcc--cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          299 VNPKIMLIDLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       299 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                         .......+..  .++.+...      ...+.+++.+||+.+|++|| +.+++..|+.
T Consensus       348 ---~~~~~~~~~~~~~~~~p~~~------~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         348 ---NEQFYNAIKRGYRMAKPAHA------SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             ---hHHHHHHHHcCCCCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               1112222222  12222211      12488999999999999999 9999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.4e-41  Score=298.39  Aligned_cols=248  Identities=26%  Similarity=0.440  Sum_probs=199.1

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-------hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-------ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      +|.+...||+|++|.||+|.. .+++.+|+|.+.....       .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            467888999999999999965 4678999998865432       12234678899999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++++||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999997654   588889999999999999999999   99999999999999999999999999987


Q ss_pred             eccCCCC------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC-C
Q 046084          242 LLHSDSS------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV-P  314 (363)
Q Consensus       242 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~  314 (363)
                      .......      ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......   ........... .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~  231 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFKIGENASPE  231 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHHHhccCCCc
Confidence            6642211      112235788999999998888899999999999999999999998754321   11122222111 1


Q ss_pred             CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .+..      ....+.+++.+||+.||++|| +.+++..
T Consensus       232 ~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         232 IPSN------ISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CCcc------cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            1111      112488999999999999999 9888764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4e-41  Score=302.55  Aligned_cols=257  Identities=23%  Similarity=0.381  Sum_probs=199.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-----------------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCcee
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-----------------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV  150 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  150 (363)
                      .++|++.+.||+|+||.||++...                 ++..||+|.+..... ......+..|+.+++.++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcc
Confidence            457999999999999999998532                 234689999875533 23346789999999999999999


Q ss_pred             eeeeEEeeCCeEEEEEEeccCCChhhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCC
Q 046084          151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDE--------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSN  222 (363)
Q Consensus       151 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  222 (363)
                      ++++++...+..+++|||+++++|.+++.....        ...+++..++.++.|++.||+|||+.   +++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~  159 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR  159 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence            999999999999999999999999999875321        12477889999999999999999999   9999999999


Q ss_pred             CeeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh--CCCCCCCCcC
Q 046084          223 NILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM--GRHPGDLLSS  298 (363)
Q Consensus       223 Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~p~~~~~~  298 (363)
                      |||++.++.++|+|||++.........  .....++..|+|||...+..++.++||||||+++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            999999999999999998765332211  112234578999998888889999999999999999998  7788754432


Q ss_pred             CCchhhHHhhhc-----ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          299 VNPKIMLIDLLD-----QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       299 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ............     ...+.+...+      ..+.+++.+||+.||++|| +.++++.|.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 EQVIENTGEFFRDQGRQVYLPKPALCP------DSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHHHhhccccccCCCCCCCC------HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            211111111110     0111111111      2488999999999999999 999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.8e-41  Score=306.42  Aligned_cols=258  Identities=25%  Similarity=0.409  Sum_probs=202.0

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC--------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP--------SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCL  157 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  157 (363)
                      ..++|.+.+.||+|+||.||++...        ++..+|+|.+...... .....+..|+.+++.+ +||||+++++++.
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh-HHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            3467999999999999999999642        2346999999765332 2246788899999999 7999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCe
Q 046084          158 HKKCMFLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNI  224 (363)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  224 (363)
                      ..+..+++|||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.   +++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence            99999999999999999999975421             12488999999999999999999999   999999999999


Q ss_pred             eecCCCceEEEeeccceeccCCCCCc--eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCc
Q 046084          225 LLNSKLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNP  301 (363)
Q Consensus       225 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~  301 (363)
                      +++.++.++|+|||++..........  ....++..|+|||.+.+..++.++||||||+++|||++ |..||....   .
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---~  248 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---V  248 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---H
Confidence            99999999999999987653221111  11223468999999988889999999999999999998 888875422   2


Q ss_pred             hhhHHhhhccc-CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          302 KIMLIDLLDQR-VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       302 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ........... ...+...      ...+.+++.+||+.+|++|| +.++++.|..-.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         249 EELFKLLKEGHRMDKPSNC------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             HHHHHHHHcCCCCCCCCcC------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            22222221111 1222211      12488899999999999999 999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.2e-41  Score=299.63  Aligned_cols=252  Identities=27%  Similarity=0.430  Sum_probs=199.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|.++.....  ....+.+|+.+++.++||||+++++.+...+..++++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            45788888999999999999965 46889999998765432  2356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....   .+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          86 EFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999999987654   589999999999999999999999   9999999999999999999999999998766443


Q ss_pred             CCCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCC-CCChhh
Q 046084          247 SSNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP-IDDQTV  322 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  322 (363)
                      ........|+..|+|||.+.   ...++.++|+||||+++|+|++|..||......   .............+ ....  
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~--  234 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---RALFLMTKSNFQPPKLKDK--  234 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch---hhHHhhhccCCCCCccccc--
Confidence            33334456889999999874   455788999999999999999999997543221   11111111111111 1110  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ......+.+++.+||+.||++|| +.+++.+
T Consensus       235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            01112478899999999999999 8888754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=299.92  Aligned_cols=254  Identities=32%  Similarity=0.485  Sum_probs=206.4

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||.|++|.||+|... +++.|++|.+...... .....+..|+.+++.++|+|++++++++.+....++++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE-DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc-hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            36888899999999999999764 6889999998765422 234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|.+++...    .+++..++.++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          80 YCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            99999999998754    589999999999999999999999   99999999999999999999999999998775443


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.....   ......+.....+......    ...
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~  225 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKNNPPSLEGNK----FSK  225 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhcCCCCCcccc----cCH
Confidence            333445678899999999888899999999999999999999999865432   2222222222221111110    122


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .+.+++.+||+.||++|| +.+++.+-....
T Consensus       226 ~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~  256 (274)
T cd06609         226 PFKDFVSLCLNKDPKERPSAKELLKHKFIKK  256 (274)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence            488999999999999999 999988765543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-41  Score=295.35  Aligned_cols=244  Identities=26%  Similarity=0.438  Sum_probs=193.5

Q ss_pred             CeeeecCceeEEEEEeC--C--CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEecc
Q 046084           95 YCIGTGGYGSVYRAQLP--S--GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (363)
                      +.||+|+||.||+|...  +  +..+|+|.+...... ...+.+..|+.+++.++|||++++++++.. +..+++|||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            46999999999999642  2  268999998866543 334678999999999999999999998764 45799999999


Q ss_pred             CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCc
Q 046084          171 RGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR  250 (363)
Q Consensus       171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  250 (363)
                      +|+|.+++....   .+++..++.++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||++..........
T Consensus        79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            999999997654   589999999999999999999999   99999999999999999999999999998664333221


Q ss_pred             e---eeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHH
Q 046084          251 T---VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQD  325 (363)
Q Consensus       251 ~---~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  325 (363)
                      .   ...++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+... ..+.+...+     
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~-----  224 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGERLPRPEECP-----  224 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCcCCCCCCCC-----
Confidence            1   1123457999999988889999999999999999998 9999865432   1122222111 112221111     


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                       ..+.+++.+||+.||++|| +.++++.|..
T Consensus       225 -~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         225 -QEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             -HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence             2488999999999999999 9999988754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4e-41  Score=298.17  Aligned_cols=252  Identities=31%  Similarity=0.482  Sum_probs=200.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CC---CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SG---KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      .++|+..+.||+|+||.||+|... ++   ..+++|.+...... ...+.+..|+++++.++|||++++.+++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH-HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            457888999999999999999764 23   36999988765332 22467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ++|||+++++|.+++....  ..+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++|+|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999999987543  2589999999999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCCCcee---eccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCC
Q 046084          244 HSDSSNRTV---VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPID  318 (363)
Q Consensus       244 ~~~~~~~~~---~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  318 (363)
                      .........   ...+..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+... ..+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~  234 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDGFRLPAPMD  234 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcCCCCCCCCC
Confidence            432221111   123457999999988889999999999999999997 9999854332   2222222221 2222221


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .      ...+.+++.+||+.+|++|| +.++++.|.
T Consensus       235 ~------~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~  265 (268)
T cd05063         235 C------PSAVYQLMLQCWQQDRARRPRFVDIVNLLD  265 (268)
T ss_pred             C------CHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            1      22488999999999999999 999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-41  Score=314.06  Aligned_cols=259  Identities=22%  Similarity=0.273  Sum_probs=197.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (363)
                      ..++|++.+.||+|+||.||++.. ..++.||+|.+............+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999965 4688999999976544444456788899999999999999999988644      


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      ...+++|||+++ ++...+..     .+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence            357999999976 56666542     478889999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhH--------------
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIML--------------  305 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~--------------  305 (363)
                      ++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||............              
T Consensus       166 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         166 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             cccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            97653322 223346899999999999888999999999999999999999998653321100000              


Q ss_pred             -----HhhhcccCC--------------CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          306 -----IDLLDQRVP--------------SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       306 -----~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                           .........              .+............+.+++.+||+.||++|| +.|++.+-..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~  314 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI  314 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence                 000000000              0000000001122478999999999999999 9999987544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-41  Score=295.31  Aligned_cols=259  Identities=24%  Similarity=0.322  Sum_probs=212.7

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCC-CCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      +.-+.|++.+.||+|.-|+||+++..+ +..+|+|++...... .....+...|-++|+.++||.++.||..++.+...|
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            344567888899999999999998754 578999999876532 333567888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ++||||+||+|..+.+... ...+++..+..++.+++-||+|||..   |||.|||||+||||-++|++.|+||.++...
T Consensus       154 l~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999999999887654 34799999999999999999999999   9999999999999999999999999987432


Q ss_pred             cC---------------------------------C-C----------------------CCceeecccccccccccccc
Q 046084          244 HS---------------------------------D-S----------------------SNRTVVAGTHGYIAPELAYT  267 (363)
Q Consensus       244 ~~---------------------------------~-~----------------------~~~~~~~g~~~y~aPE~~~~  267 (363)
                      ..                                 . .                      ......+||-+|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            10                                 0 0                      00112468999999999999


Q ss_pred             ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-h
Q 046084          268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-M  346 (363)
Q Consensus       268 ~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~  346 (363)
                      ...+.++|.|+|||++|||+.|..||...   +.+..+..++.+.+..+...    .......+||...|.+||++|- .
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~---~~~~Tl~NIv~~~l~Fp~~~----~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGS---NNKETLRNIVGQPLKFPEEP----EVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCC---CchhhHHHHhcCCCcCCCCC----cchhHHHHHHHHHhccChhhhhcc
Confidence            99999999999999999999999997654   45566777887777666543    2223488999999999999998 5


Q ss_pred             HHHHHHHhc
Q 046084          347 QRVSQEFLV  355 (363)
Q Consensus       347 ~~v~~~l~~  355 (363)
                      ..=..++..
T Consensus       383 ~rGA~eIK~  391 (459)
T KOG0610|consen  383 KRGAAEIKR  391 (459)
T ss_pred             ccchHHhhc
Confidence            444444443

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.6e-41  Score=295.33  Aligned_cols=245  Identities=25%  Similarity=0.441  Sum_probs=196.8

Q ss_pred             CeeeecCceeEEEEEeCC--C--CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEecc
Q 046084           95 YCIGTGGYGSVYRAQLPS--G--KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (363)
                      +.||+|++|.||+|.+.+  +  ..||+|.+...... ...+.+..|+..+++++||||+++++++.. ...++++||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            358999999999997643  3  26999999876654 445789999999999999999999999988 88999999999


Q ss_pred             CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC-
Q 046084          171 RGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN-  249 (363)
Q Consensus       171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  249 (363)
                      +++|.+++..... ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++......... 
T Consensus        79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            9999999976543 3689999999999999999999999   9999999999999999999999999999876442211 


Q ss_pred             --ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc--ccCCCCCCChhhHH
Q 046084          250 --RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD--QRVPSPIDDQTVIQ  324 (363)
Q Consensus       250 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  324 (363)
                        .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......   .....+..  .....+..      
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~------  225 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDKEGERLERPEA------  225 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCcCCCCcc------
Confidence              112346778999999988889999999999999999998 99998643321   22222221  11111111      


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .+..+.+++.+||+.+|++|| +.+++..|.
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            122488999999999999999 999988764

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.2e-41  Score=296.05  Aligned_cols=247  Identities=26%  Similarity=0.431  Sum_probs=196.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEe-eCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCL-HKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  166 (363)
                      .++|.+.+.||+|+||.||++.. .|..|++|.+.....    .+.+..|+.+++.++|+|++++++++. ..+..++++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCch----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            45789999999999999999987 578899999865432    356889999999999999999999765 445789999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++..... ..+++..++.++.|++.||+|||++   +++||||||+||++++++.+||+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999876442 2488999999999999999999999   9999999999999999999999999998764332


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .   ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+.. ........    ..
T Consensus       156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~-~~~~~~~~----~~  224 (256)
T cd05082         156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEK-GYKMDAPD----GC  224 (256)
T ss_pred             C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhc-CCCCCCCC----CC
Confidence            2   12234567999999988889999999999999999997 9999754321   111121211 11111110    11


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ...+.+++.+||+.+|++|| +.++++.|.
T Consensus       225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  254 (256)
T cd05082         225 PPVVYDVMKQCWHLDAATRPSFLQLREQLE  254 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence            12488999999999999999 999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.1e-41  Score=319.41  Aligned_cols=259  Identities=20%  Similarity=0.306  Sum_probs=191.7

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (363)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++....      ....+|+.+++.++||||+++++++...      
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            456799999999999999999976 468899999886432      2234699999999999999999877542      


Q ss_pred             --CeEEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC-ceEEE
Q 046084          160 --KCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-EAFVA  235 (363)
Q Consensus       160 --~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~  235 (363)
                        ...++||||+++ +|.+++... .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence              246789999975 676665431 2233689999999999999999999999   999999999999998664 79999


Q ss_pred             eeccceeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---
Q 046084          236 DFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---  311 (363)
Q Consensus       236 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---  311 (363)
                      |||+++...... ......+|+.|+|||++.+ ..++.++|||||||++|||++|.+||...............+..   
T Consensus       214 DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        214 DFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            999998664322 2233468999999998765 46899999999999999999999998654322111111111100   


Q ss_pred             --------c---CCCCCCChhhH------HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          312 --------R---VPSPIDDQTVI------QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       312 --------~---~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                              .   ...+.......      .....+.+|+.+||+.||++|| +.|++.+-...
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~  355 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD  355 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence                    0   00000000000      0123488999999999999999 99998876643

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-41  Score=302.26  Aligned_cols=251  Identities=29%  Similarity=0.451  Sum_probs=202.1

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      .|+..+.||+|+||.||+|.+ .++..||+|.+....... ..+.+..|+.+++.++||||+++++++...+..++|+||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            466677899999999999965 457789999887554332 346789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++...    .+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          84 LGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            9999999988643    588999999999999999999999   999999999999999999999999999976644333


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL  328 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......   .....+.....+. ..    ......
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~-~~----~~~~~~  228 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLFLIPKNSPPT-LE----GQYSKP  228 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHhhhhcCCCCC-CC----cccCHH
Confidence            333345788999999998888999999999999999999999997643321   1111111111111 11    111224


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +.+++.+||+.+|++|| +.+++.+-...
T Consensus       229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06642         229 FKEFVEACLNKDPRFRPTAKELLKHKFIT  257 (277)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence            88999999999999999 99999876554

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.7e-41  Score=297.45  Aligned_cols=239  Identities=23%  Similarity=0.347  Sum_probs=186.5

Q ss_pred             CeeeecCceeEEEEEeCC-------------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           95 YCIGTGGYGSVYRAQLPS-------------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      +.||+|+||.||+|...+             ...|++|.+.....  .....+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--DISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            368999999999997532             22588898765433  334678889999999999999999999999988


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc-------eEE
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE-------AFV  234 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-------~kl  234 (363)
                      .+++|||+++|+|..++.....  .+++..++.++.|+++||+|||+.   +++||||||+|||++.++.       +++
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence            9999999999999988865432  589999999999999999999999   9999999999999987654       899


Q ss_pred             EeeccceeccCCCCCceeeccccccccccccc-cccCCccccchHHHHHHHHHH-hCCCCCCCCcCCCchhhHHhhhccc
Q 046084          235 ADFGVARLLHSDSSNRTVVAGTHGYIAPELAY-TMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       235 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~-~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      +|||++......    ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+........    .......
T Consensus       154 ~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~~  225 (262)
T cd05077         154 SDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERFYEGQ  225 (262)
T ss_pred             CCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHHHhcC
Confidence            999998654322    2235778899999876 466889999999999999998 58888754322111    1111111


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .......      ...+.+|+.+||+.||++|| +.+++.+++
T Consensus       226 ~~~~~~~------~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         226 CMLVTPS------CKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ccCCCCC------hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1111111      12488999999999999999 999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.9e-41  Score=305.13  Aligned_cols=258  Identities=25%  Similarity=0.424  Sum_probs=201.5

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC--------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP--------SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFC  156 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (363)
                      ...++|.+.+.||+|+||.||++...        ....+|+|.+...... .....+..|+.+++.+ +||||+++++++
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh-HHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34567899999999999999999642        2446899988754433 3356788999999999 699999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNN  223 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  223 (363)
                      ...+..+++|||+++|+|.+++.....             ...+++.++..++.|++.||.|||+.   +++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence            999999999999999999999865321             23588999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEEeeccceeccCCCCCc--eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCC
Q 046084          224 ILLNSKLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVN  300 (363)
Q Consensus       224 ill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~  300 (363)
                      ||+++++.+||+|||+++.........  ....++..|+|||.+.+..++.++||||||+++|||++ |..||.....  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--  242 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--  242 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence            999999999999999997653322111  11223457999999988889999999999999999999 8899754322  


Q ss_pred             chhhHHhhhccc-CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          301 PKIMLIDLLDQR-VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       301 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       ......+.... ...+...      ...+.+++.+||+.||++|| +.+++..|...
T Consensus       243 -~~~~~~~~~~~~~~~~~~~------~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         243 -EELFKLLREGHRMDKPSNC------THELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             -HHHHHHHHcCCCCCCCCCC------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence             22222222221 1122211      12478899999999999999 99999988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.8e-41  Score=302.28  Aligned_cols=258  Identities=24%  Similarity=0.403  Sum_probs=203.6

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLH  158 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (363)
                      ...++|.+.+.||+|+||.||++..      ..+..||+|.++..... ...+.+..|+.+++++ +||||+++++++..
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS-SEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh-HHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            4556899999999999999999964      13457999998765432 3346789999999999 79999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      .+..+++|||+.+|+|.+++..... ..+++.++..++.|++.||+|||+.   +++|+||||+|||++.++.++++|||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence            9999999999999999999875432 2389999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCC
Q 046084          239 VARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPS  315 (363)
Q Consensus       239 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  315 (363)
                      ++.........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ..............
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~---~~~~~~~~~~~~~~  263 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV---DSKFYKLIKEGYRM  263 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc---hHHHHHHHHcCCcC
Confidence            99765332211  112235678999999988889999999999999999998 9999764332   11222222222111


Q ss_pred             CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .....    ....+.+++.+||+.+|++|| +.+++..|..
T Consensus       264 ~~~~~----~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         264 AQPEH----APAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             CCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            11110    112488999999999999999 9999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-41  Score=302.82  Aligned_cols=257  Identities=23%  Similarity=0.339  Sum_probs=198.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCC---------------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeee
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPS---------------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL  152 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  152 (363)
                      .++|++.+.||+|+||.||++...+               ...||+|.+..... ......+.+|++++++++|||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            4689999999999999999986532               22589999876433 2334678999999999999999999


Q ss_pred             eeEEeeCCeEEEEEEeccCCChhhhhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 046084          153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDE---------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNN  223 (363)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  223 (363)
                      ++++...+..+++|||+++++|.+++.....         ...+++..++.++.|++.||+|||+.   +++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence            9999999999999999999999998864321         12368889999999999999999999   99999999999


Q ss_pred             eeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh--CCCCCCCCcCC
Q 046084          224 ILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM--GRHPGDLLSSV  299 (363)
Q Consensus       224 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~p~~~~~~~  299 (363)
                      |++++++.+||+|||++.........  .....++..|+|||.+.+..++.++||||||+++|+|++  |..||......
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            99999999999999999765332211  112234678999999988889999999999999999998  66776654321


Q ss_pred             CchhhHHhhhc---cc--CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          300 NPKIMLIDLLD---QR--VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       300 ~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ...........   ..  ...+...      +..+.+++.+||+.||++|| +.++++.|.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QVIENTGEFFRNQGRQIYLSQTPLC------PSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHhhhhccccccCCCCCCC------CHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            11111111111   10  0111111      12489999999999999999 999988774

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.4e-41  Score=295.79  Aligned_cols=248  Identities=24%  Similarity=0.452  Sum_probs=200.0

Q ss_pred             cCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      .+|++.+.||+|+||.||++.+.++..+++|.+.......   ..+..|+++++.++|||++++++++......++++||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            4688899999999999999988778899999987554332   4688899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++.....  .+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          81 MEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            999999999875432  578999999999999999999999   999999999999999999999999999876533221


Q ss_pred             C-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHH
Q 046084          249 N-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQD  325 (363)
Q Consensus       249 ~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  325 (363)
                      . .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+... ....+...      
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~------  226 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAGFRLYKPRLA------  226 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCCCCCCCCCCC------
Confidence            1 112234568999999988889999999999999999998 9999764322   1222222111 11111111      


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      ...+.+++.+||+.+|++|| +.+++++|
T Consensus       227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         227 SQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            12488999999999999999 99999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-41  Score=300.48  Aligned_cols=257  Identities=24%  Similarity=0.369  Sum_probs=202.0

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||.||++... ++..||+|.+...... .....+.+|+.++++++||||+++++.+...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH-HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            46888999999999999999765 7889999988754332 234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|..++........+++..+..++.|++.||.|||+..  +++|+||+|+||+++.++.++|+|||++...... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999998876433336899999999999999999999632  8999999999999999999999999998765322 


Q ss_pred             CCceeeccccccccccccccc------cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          248 SNRTVVAGTHGYIAPELAYTM------VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                       ......++..|+|||.+.+.      .++.++|+||||+++|+|++|+.||..............+.....+... .  
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~--  232 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP-S--  232 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC-c--
Confidence             22334578899999987543      3478999999999999999999998654332211222222232221111 1  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        .....+.+++.+||+.+|++|| +.+++..-+.
T Consensus       233 --~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~  265 (286)
T cd06622         233 --GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL  265 (286)
T ss_pred             --ccCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence              1122488899999999999999 9998876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-41  Score=313.71  Aligned_cols=259  Identities=22%  Similarity=0.279  Sum_probs=197.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (363)
                      ..++|.+.+.||+|+||.||++.. ..++.||||++............+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            357899999999999999999965 4688999999976543334456788899999999999999999987643      


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      ...++||||+++ +|..++..     .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999975 67666643     478889999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh------------
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID------------  307 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~------------  307 (363)
                      +....... ......++..|+|||++.+..++.++|||||||++|||++|+.||...+..........            
T Consensus       173 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         173 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             ccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            97653322 22334689999999999999999999999999999999999999865432111000000            


Q ss_pred             -------hhcccCC--------------CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          308 -------LLDQRVP--------------SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       308 -------~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                             ....+..              .+............+.+++.+||+.||++|| +.+++.+-..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence                   0000000              0000000000112478999999999999999 9999887543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6e-41  Score=303.07  Aligned_cols=257  Identities=25%  Similarity=0.344  Sum_probs=201.9

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||.||++... ++..+++|.+..... ....+.+.+|++++++++||||+++++++...+..+++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            46889999999999999999654 677889998875433 2334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|.+++....   .+++..+..++.|+++||.|||+..  +++|+||+|+|||+++++.++|+|||++...... 
T Consensus        80 y~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          80 HMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             ccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            999999999997653   5889999999999999999999732  8999999999999999999999999998755322 


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH---------------------
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI---------------------  306 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~---------------------  306 (363)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............                     
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence             1233468889999999888889999999999999999999999985432111000000                     


Q ss_pred             ------------hhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          307 ------------DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       307 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                                  .......+. ..   .......+.+++.+||+.||++|| +.+++.+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPK-LP---SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCcc-Cc---CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                        000000000 00   000122488999999999999999 999998876544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.1e-41  Score=300.23  Aligned_cols=246  Identities=22%  Similarity=0.255  Sum_probs=194.0

Q ss_pred             CcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           91 FDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      |+..+.||+|+||+||++.. .+++.||+|.+...... ......+.+|+++++.++|+|++.+.+.+...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778899999999999966 46889999998654322 22234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999998886433 22589999999999999999999999   99999999999999999999999999987653322 


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchh-hHHhhhcccCCCCCCChhhHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI-MLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.......... ............+...      ..
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~  230 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF------SE  230 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccC------CH
Confidence            2233468999999999988889999999999999999999999987543211111 1111111111111111      12


Q ss_pred             HHHHHHHHccCCCCCCCC-hH
Q 046084          328 LVSKIVFACLRSKPTSRP-MQ  347 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~  347 (363)
                      .+.+|+..||+.||++|| +.
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         231 EAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             HHHHHHHHHccCCHhHcCCCc
Confidence            378899999999999999 54

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.9e-41  Score=295.81  Aligned_cols=257  Identities=28%  Similarity=0.465  Sum_probs=204.8

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||.|+||+||+|.. .++..+++|++....... ....+.+|+..++.++|+|++++++.+...+..++++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            4789999999999999999975 467899999987554333 45778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      ++++++|.+++........+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999997654333689999999999999999999999   99999999999999999999999999987664432


Q ss_pred             CC----ceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          248 SN----RTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       248 ~~----~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ..    .....++..|+|||.+... .++.++|+||||+++|+|++|+.||......   ...........+........
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPSLETGADY  233 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCCcCCcccc
Confidence            22    1334578899999988766 7889999999999999999999998654332   22222222221111111100


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ......+.+++..||+.||++|| +.+++..
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             ccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11223478999999999999999 9998864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.8e-41  Score=302.40  Aligned_cols=255  Identities=28%  Similarity=0.463  Sum_probs=202.6

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      ..++|++.+.||+|+||.||++...      ++..||+|.+...... .....+.+|+.+++.++||||+++++++.+.+
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            3568999999999999999999753      4678999998765432 33467889999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCC
Q 046084          161 CMFLIYKYMRRGSLFCILRNDD-------------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISS  221 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp  221 (363)
                      ..++++||+++|+|.+++....                   ....+++..++.++.|++.||+|||+.   +++||||+|
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence            9999999999999999986421                   112478889999999999999999999   999999999


Q ss_pred             CCeeecCCCceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcC
Q 046084          222 NNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSS  298 (363)
Q Consensus       222 ~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~  298 (363)
                      +||++++++.++|+|||++........  .......+..|+|||.+.+..++.++||||||+++|||++ |..||.... 
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-  237 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-  237 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence            999999999999999999876533221  1112234567999999888889999999999999999997 888875332 


Q ss_pred             CCchhhHHhhhcccCCC-CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          299 VNPKIMLIDLLDQRVPS-PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                        .......+.+..... +..      ....+.+++.+||+.||++|| +.|++..|+
T Consensus       238 --~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         238 --HEEVIYYVRDGNVLSCPDN------CPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             --HHHHHHHHhcCCCCCCCCC------CCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence              222233333332221 111      122488999999999999999 999998875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.6e-41  Score=298.76  Aligned_cols=251  Identities=28%  Similarity=0.459  Sum_probs=203.2

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ..|+..+.||.|+||.||+|... ++..||+|.+...... .....+..|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            45777888999999999999764 5789999988755432 234678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|.+++...    ++++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          83 YLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999999988643    488899999999999999999999   99999999999999999999999999997764433


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      .......++..|+|||.+.+..++.++|+||||+++|||++|..||......   .....+.... +...    ......
T Consensus       156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~-~~~~----~~~~~~  227 (277)
T cd06640         156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLFLIPKNN-PPTL----TGEFSK  227 (277)
T ss_pred             cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhhhhhcCC-CCCC----chhhhH
Confidence            3333446788899999998888999999999999999999999997644321   1111111111 1111    112233


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+.+++.+||+.+|++|| +.+++..-+.
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06640         228 PFKEFIDACLNKDPSFRPTAKELLKHKFI  256 (277)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence            588999999999999999 9999877554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-41  Score=294.64  Aligned_cols=254  Identities=29%  Similarity=0.448  Sum_probs=203.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||.|+||.||++... +++.+++|.+......  ..+.+..|+++++.++||||+++++++...+..+++|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            467899999999999999999764 5788999998765433  3477889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            9999999999887642  2588999999999999999999999   9999999999999999999999999998765443


Q ss_pred             CCCceeeccccccccccccccc---cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTM---VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ........++..|+|||.+.+.   .++.++|+||||+++|||++|+.||......   .............+. .....
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---~~~~~~~~~~~~~~~-~~~~~  230 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---RALFLISKSNFPPPK-LKDKE  230 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCcc-ccchh
Confidence            3333445678899999998776   7889999999999999999999998654321   111112222111111 01112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .....+.+++.+||+.||.+|| +.+++.+
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             hhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            2233588999999999999999 9888753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.8e-41  Score=299.35  Aligned_cols=255  Identities=23%  Similarity=0.267  Sum_probs=198.6

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .|+..+.||+|+||.||++.. .+++.||+|.+...... ....+.+..|+.+++.++|+|++.+++.+.+.+..+++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            367788899999999999965 46889999998654322 2223457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999998864332 2588999999999999999999999   99999999999999999999999999987653322


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC-CCCCCChhhHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV-PSPIDDQTVIQDI  326 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  326 (363)
                       ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.................... ..+...      .
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  229 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKF------S  229 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccC------C
Confidence             22234689999999999988899999999999999999999999875432211111111111111 011111      1


Q ss_pred             HHHHHHHHHccCCCCCCCC------hHHHHHHHhc
Q 046084          327 ILVSKIVFACLRSKPTSRP------MQRVSQEFLV  355 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP------~~~v~~~l~~  355 (363)
                      ..+.+++.+||+.||++||      +.|++.+-..
T Consensus       230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~  264 (285)
T cd05630         230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF  264 (285)
T ss_pred             HHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence            2378999999999999999      3566664443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-41  Score=314.17  Aligned_cols=252  Identities=22%  Similarity=0.347  Sum_probs=197.0

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||++... +++.||+|++..... .......+..|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999664 688999999875432 2233467888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999987654   589999999999999999999999   9999999999999999999999999998654211


Q ss_pred             CC-----------------------------------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCC
Q 046084          247 SS-----------------------------------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRH  291 (363)
Q Consensus       247 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~  291 (363)
                      ..                                   .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            00                                   0112468999999999999999999999999999999999999


Q ss_pred             CCCCCcCCCchhhHHhhhcc--cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-h---HHHHHHHh
Q 046084          292 PGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-M---QRVSQEFL  354 (363)
Q Consensus       292 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~---~~v~~~l~  354 (363)
                      ||.....   ......+...  .+..+...+    ......++|.+|+. ||.+|+ .   .+++.+-.
T Consensus       235 Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~----~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~  295 (360)
T cd05627         235 PFCSETP---QETYRKVMNWKETLVFPPEVP----ISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF  295 (360)
T ss_pred             CCCCCCH---HHHHHHHHcCCCceecCCCCC----CCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence            9865432   2222223221  111111111    01136778888764 999998 3   55555433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.1e-41  Score=296.42  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=189.0

Q ss_pred             CeeeecCceeEEEEEeCC---CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLPS---GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||+|...+   +..+++|.+........ ...+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH-HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            358999999999997543   45799998876554322 35688899999999999999999999998899999999999


Q ss_pred             CChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC-
Q 046084          172 GSLFCILRNDD--EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS-  248 (363)
Q Consensus       172 g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  248 (363)
                      |+|.+++....  .....++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++........ 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            99999987532  223467778889999999999999999   999999999999999999999999999875432221 


Q ss_pred             -Cceeeccccccccccccccc-------cCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCCCC
Q 046084          249 -NRTVVAGTHGYIAPELAYTM-------VLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       249 -~~~~~~g~~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                       ......++..|+|||++.+.       .++.++|+||||+++|||++ |+.||....................+.+...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence             11223467889999987532       35789999999999999996 9999865433221111111111112221111


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ...   ...+.+++..|| .+|++|| +.+++..|.
T Consensus       237 ~~~---~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         237 LPL---SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCC---ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111   113778999999 5899999 999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-42  Score=312.24  Aligned_cols=235  Identities=26%  Similarity=0.337  Sum_probs=184.3

Q ss_pred             eeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC---CCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           97 IGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI---RHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        97 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      ||+|+||+||+|.. .+++.||+|++..... .......+..|..++...   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999975 4688999999865322 112223445566666554   699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|..++....   .+++..+..++.||++||+|||+.   +++||||||+|||++.++.++|+|||++...........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            99998887544   589999999999999999999999   999999999999999999999999999876433333344


Q ss_pred             eeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVS  330 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  330 (363)
                      ...||..|+|||.+.+. .++.++|||||||++|||++|+.||....   .......+.......+...     ....+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~-----~~~~~~  226 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIAFGKVRFPKNV-----LSDEGR  226 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHHHcCCCCCCCcc-----CCHHHH
Confidence            56799999999988754 47899999999999999999999986432   2222333333322222111     111378


Q ss_pred             HHHHHccCCCCCCCC
Q 046084          331 KIVFACLRSKPTSRP  345 (363)
Q Consensus       331 ~li~~cl~~dP~~RP  345 (363)
                      +++.+||+.||++||
T Consensus       227 ~li~~~L~~~P~~R~  241 (330)
T cd05586         227 QFVKGLLNRNPQHRL  241 (330)
T ss_pred             HHHHHHcCCCHHHCC
Confidence            899999999999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.1e-41  Score=303.06  Aligned_cols=257  Identities=26%  Similarity=0.338  Sum_probs=189.8

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC---CCCceeeeeeEEeeC-----C
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI---RHRNIVKLYGFCLHK-----K  160 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~  160 (363)
                      +|++.+.||+|+||+||+|... +++.||+|.+............+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788999999999999999664 688999998875432221123455666666655   799999999988653     4


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..+++|||+.+ +|.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999975 88888865432 2589999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---------
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---------  311 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------  311 (363)
                      ....... ......++..|+|||++.+..++.++|||||||++|||++|++||..................         
T Consensus       156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         156 RIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             ccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            7654322 222345788999999998888999999999999999999999998543321111111111000         


Q ss_pred             ------cCCCCCC---ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 ------RVPSPID---DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 ------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                            .......   ..........+.+++.+||+.||++|| +.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  0000000   000001122478999999999999999 9988864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.3e-41  Score=297.57  Aligned_cols=252  Identities=29%  Similarity=0.481  Sum_probs=199.5

Q ss_pred             cCCcccCeeeecCceeEEEEEeCC-C---CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPS-G---KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      .+|++.+.||+|+||.||+|.... +   ..|++|.+..... ......|..|+.+++.++||||+++++++.+.+..++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            457889999999999999997642 3   3699999876533 2335789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      +|||+++++|.+++.....  .+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          83 ITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999999876432  589999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCCCCce---eec--cccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc-ccCCCCC
Q 046084          245 SDSSNRT---VVA--GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPSPI  317 (363)
Q Consensus       245 ~~~~~~~---~~~--g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  317 (363)
                      .......   ...  .+..|+|||.+.+..++.++||||||+++||+++ |..||...+..   .....+.. ...+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~~~~~~~  234 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDYRLPPPM  234 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCcCCCcc
Confidence            3221111   111  1347999999988889999999999999999886 99998654321   12222211 1222222


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..      +..+.+++.+||+.+|++|| +.+++..|..
T Consensus       235 ~~------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         235 DC------PTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             cC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            22      22478899999999999999 9999988753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5e-41  Score=307.98  Aligned_cols=257  Identities=24%  Similarity=0.390  Sum_probs=198.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHK  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  159 (363)
                      ..++|++.+.||+|+||.||+|..      .+++.||||.++..... .....+.+|+.++.++ +||||+++++++...
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            456899999999999999999963      35678999999765433 2246788999999999 689999999988754


Q ss_pred             -CeEEEEEEeccCCChhhhhhcCCC-------------------------------------------------------
Q 046084          160 -KCMFLIYKYMRRGSLFCILRNDDE-------------------------------------------------------  183 (363)
Q Consensus       160 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  183 (363)
                       ...+++|||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             467899999999999998864211                                                       


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC--Ccee
Q 046084          184 ---------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTV  252 (363)
Q Consensus       184 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~  252 (363)
                               ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++........  ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     12367888899999999999999999   999999999999999999999999999876532221  1112


Q ss_pred             eccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHHHHHHH
Q 046084          253 VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQDIILVS  330 (363)
Q Consensus       253 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~  330 (363)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||......  .......... ....+...      ...+.
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~------~~~~~  312 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTRMRAPDYT------TPEMY  312 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhccCCCCCCCCC------CHHHH
Confidence            234567999999988889999999999999999997 99998653221  1111111111 11111111      11488


Q ss_pred             HHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          331 KIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       331 ~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +++..||+.||++|| +.++++.|..
T Consensus       313 ~~~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         313 QTMLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHH
Confidence            999999999999999 9999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.7e-41  Score=296.22  Aligned_cols=252  Identities=23%  Similarity=0.386  Sum_probs=202.9

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee--CCeEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH--KKCMFLIY  166 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  166 (363)
                      +|++.+.||.|+||.||++.. .++..+++|.+..........+.+..|+++++.++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999965 467899999987655444445778899999999999999999998764  35689999


Q ss_pred             EeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          167 KYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALSYLH-----CDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       167 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ||+++++|.+++... .....+++..++.++.|++.||+|||     +.   +++|+||+|+||++++++.++|+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999998653 12336899999999999999999999     66   9999999999999999999999999999


Q ss_pred             eeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      ..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||....   .......+.....+ .... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~-~~~~-  232 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGKFR-RIPY-  232 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcCCCC-CCcc-
Confidence            876544432344568899999999988889999999999999999999999987543   12222222222221 1111 


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                         .....+.+++.+||+.+|++|| +.+++++
T Consensus       233 ---~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         233 ---RYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence               1122488999999999999999 9999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.2e-41  Score=302.06  Aligned_cols=260  Identities=25%  Similarity=0.415  Sum_probs=203.6

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe--------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL--------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFC  156 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (363)
                      +..++|.+.+.||+|+||.||++..        .++..||+|.+...... .....+.+|+.+++.+ +||||+++++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch-HHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            4466789999999999999999963        13447999988754332 3346788999999999 899999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNN  223 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  223 (363)
                      ...+..+++|||+.+|+|.+++.....             ...+++..+..++.|+++||+|||+.   +++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence            999999999999999999999875321             23578889999999999999999999   99999999999


Q ss_pred             eeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCC
Q 046084          224 ILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVN  300 (363)
Q Consensus       224 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~  300 (363)
                      |++++++.+||+|||++.........  .....++..|+|||++.+..++.++||||||+++|||++ |..||.....  
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--  245 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  245 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence            99999999999999999866432221  112234678999999988889999999999999999998 7888754321  


Q ss_pred             chhhHHhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          301 PKIMLIDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       301 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                       ......+... ....+...      ...+.+++.+||+.+|++|| +.++++.|..-..
T Consensus       246 -~~~~~~~~~~~~~~~~~~~------~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         246 -EELFKLLKEGHRMDKPANC------TNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             -HHHHHHHHcCCcCCCCCCC------CHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence             2222222111 11112111      22488899999999999999 9999999865443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-40  Score=297.80  Aligned_cols=257  Identities=28%  Similarity=0.421  Sum_probs=196.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--C
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--K  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~  160 (363)
                      .++|++.+.||+|+||.||++..     .++..|++|.+.....  ...+.+..|+++++.++||||+++++++...  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            35788899999999999999964     3578999999876543  3346789999999999999999999987543  4


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..++++||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+||++++++.++|+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence            68899999999999999865432  589999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCc---eeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCC------------chhhH
Q 046084          241 RLLHSDSSNR---TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN------------PKIML  305 (363)
Q Consensus       241 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~------------~~~~~  305 (363)
                      ..........   ....++..|+|||.+.+..++.++||||||+++|||++|..|+.......            .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence            8654322211   11123445999999988889999999999999999999877753221110            00001


Q ss_pred             HhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          306 IDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+........+...    .....+.+++.+||+.+|++|| +.++++.|..
T Consensus       236 ~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         236 IELLKNNGRLPAPP----GCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HHHHhcCCcCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            11121111111111    1112488999999999999999 9999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-41  Score=333.19  Aligned_cols=261  Identities=20%  Similarity=0.324  Sum_probs=201.3

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--Ce
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KC  161 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  161 (363)
                      ....++|.+.+.||+|+||+||++... ++..+|+|.+............+..|+.+++.++||||+++++++...  ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            345678999999999999999999764 567899998876554444457789999999999999999999988654  56


Q ss_pred             EEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCcEEeCCCCCCeeecC--------
Q 046084          162 MFLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCI----PSIVHRDISSNNILLNS--------  228 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~dlkp~Nill~~--------  228 (363)
                      +|+||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+...    .+|+||||||+|||++.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999986532 12368999999999999999999998521    25999999999999964        


Q ss_pred             ---------CCceEEEeeccceeccCCCCCceeecccccccccccccc--ccCCccccchHHHHHHHHHHhCCCCCCCCc
Q 046084          229 ---------KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT--MVLTEKCDVYSFGVVALEVLMGRHPGDLLS  297 (363)
Q Consensus       229 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~  297 (363)
                               ...+||+|||++....... ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                     2358999999997654322 2234568999999998854  458899999999999999999999986433


Q ss_pred             CCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          298 SVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .  .. .+...+......+....     ...+.+||..||+.+|.+|| +.|++..-+
T Consensus       248 ~--~~-qli~~lk~~p~lpi~~~-----S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~  297 (1021)
T PTZ00266        248 N--FS-QLISELKRGPDLPIKGK-----SKELNILIKNLLNLSAKERPSALQCLGYQI  297 (1021)
T ss_pred             c--HH-HHHHHHhcCCCCCcCCC-----CHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence            2  11 22222222222221111     12488999999999999999 999886543

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-43  Score=317.95  Aligned_cols=255  Identities=24%  Similarity=0.397  Sum_probs=216.2

Q ss_pred             cCCcccCeeeecCceeEEEEEeCC-CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      +-|++...||.|+||.||++..++ +-..|.|++.....  +.+++|.-|+++|...+||+||+|++.|...+.++++.|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse--EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE--EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch--hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            446778889999999999997654 34456677765443  336899999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      ||.||.....+-..+.  .+++.++.-+++|++.||.|||++   +|+|||||..|||++-+|.++|+|||.+.......
T Consensus       110 FC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             ecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            9999999888765443  699999999999999999999999   99999999999999999999999999986544444


Q ss_pred             CCceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          248 SNRTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      .....+.||+.|||||+..     ..+|+.++||||||++|.||..+.+|   ..+.++-.++..+....+|.....+.+
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP---HhelnpMRVllKiaKSePPTLlqPS~W  261 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP---HHELNPMRVLLKIAKSEPPTLLQPSHW  261 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC---ccccchHHHHHHHhhcCCCcccCcchh
Confidence            4456678999999999764     56799999999999999999999999   777788888888888777765555444


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..   .+.+++..||.+||..|| +.+++.+-...
T Consensus       262 s~---~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  262 SR---SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             hh---HHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            33   488999999999999999 99999876654

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-41  Score=305.99  Aligned_cols=256  Identities=26%  Similarity=0.351  Sum_probs=196.9

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||++... +++.||+|++..... .....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999754 688999999875322 2223456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999975332  588999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CC-Cceeecccccccccccccc-----ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc--cCCCCCC
Q 046084          247 SS-NRTVVAGTHGYIAPELAYT-----MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPID  318 (363)
Q Consensus       247 ~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  318 (363)
                      .. ......||+.|+|||++..     ..++.++|||||||++|||++|+.||.....   ......+...  ....+..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~  232 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHKEHFQFPPD  232 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH---HHHHHHHHcCCCcccCCCc
Confidence            22 2233468999999998863     4578899999999999999999999864322   1222222221  1111111


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCC--CCC-hHHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPT--SRP-MQRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~--~RP-~~~v~~~l~~  355 (363)
                      ...   ....+.+++.+||..+++  .|| +.+++.+-..
T Consensus       233 ~~~---~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~  269 (331)
T cd05597         233 VTD---VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF  269 (331)
T ss_pred             cCC---CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence            110   112477888888765444  378 8888877544

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-41  Score=301.42  Aligned_cols=257  Identities=26%  Similarity=0.362  Sum_probs=203.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||+||++... +++.||+|++..... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            467888999999999999999754 688899998865433 233577899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....   .+++..+..++.+++.||.|||+..  +++|+||+|+||++++++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          83 EFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             ecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999999887643   5899999999999999999999732  8999999999999999999999999998654222


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC-----Cch---hhHHhhhcccCCCCCC
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV-----NPK---IMLIDLLDQRVPSPID  318 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-----~~~---~~~~~~~~~~~~~~~~  318 (363)
                      .  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||+.....     ...   .....+.....+....
T Consensus       158 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd06620         158 I--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS  235 (284)
T ss_pred             c--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence            1  22346889999999988888999999999999999999999998754331     000   1111222211111110


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                          ......+.+++.+||+.||++|| +.|++.+....
T Consensus       236 ----~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         236 ----SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             ----hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence                11223488999999999999999 99999876443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.9e-41  Score=298.50  Aligned_cols=260  Identities=25%  Similarity=0.418  Sum_probs=201.8

Q ss_pred             ccHHHHHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 046084           79 ITFQEMIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFC  156 (363)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (363)
                      .++.+...+.+.|++.+.||+|+||.||+|.. .+++.+|+|.+......   ...+..|+.+++.+ +|+|++++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE---EEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH---HHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            34555556778999999999999999999976 46789999988654322   35678899999988 799999999998


Q ss_pred             ee------CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC
Q 046084          157 LH------KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL  230 (363)
Q Consensus       157 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  230 (363)
                      ..      .+..+++|||+++|+|.+++..... ..+++..+..++.|++.|++|||+.   +++|+||+|+||++++++
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            53      4578999999999999998875432 2578888999999999999999999   999999999999999999


Q ss_pred             ceEEEeeccceeccCCCCCceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhH
Q 046084          231 EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIML  305 (363)
Q Consensus       231 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~  305 (363)
                      .++|+|||++..............++..|+|||.+.     ...++.++||||||+++|||++|+.||.......   ..
T Consensus       159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---~~  235 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR---AL  235 (282)
T ss_pred             CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh---hh
Confidence            999999999876543333334456889999999875     3457889999999999999999999986443211   11


Q ss_pred             HhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          306 IDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ........+... ..   .....+.++|.+||+.||.+|| +.|++..
T Consensus       236 ~~~~~~~~~~~~-~~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         236 FLIPRNPPPKLK-SK---KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hhHhhCCCCCCc-cc---ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            111111111111 10   1122488999999999999999 9988764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.4e-41  Score=303.34  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=199.8

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      .|.....||+|+||.||++.. .++..||+|.+.....  ...+.+.+|+..++.++|||++++++.+...+..+++|||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            344456699999999999965 4688999999865433  2346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++...    .+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++........
T Consensus       101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            9999999988543    488999999999999999999999   999999999999999999999999999876543333


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL  328 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ......++..|+|||...+..++.++||||||+++|||++|+.||......   .....+. ...+.......  .....
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~-~~~~~~~~~~~--~~~~~  247 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRRIR-DNLPPRVKDSH--KVSSV  247 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH-hcCCCcccccc--ccCHH
Confidence            334456889999999998888999999999999999999999998643321   1111111 11111111100  11124


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +.+++.+||+.||++|| +.++++.-+.+
T Consensus       248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         248 LRGFLDLMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence            78899999999999999 99999875543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=291.87  Aligned_cols=244  Identities=26%  Similarity=0.449  Sum_probs=196.8

Q ss_pred             CeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCCh
Q 046084           95 YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      +.||+|+||.||++.+.+++.|++|.+...... .....+..|++++++++|+||+++++++.+....+++|||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            368999999999998877999999998765544 3356789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCc--ee
Q 046084          175 FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR--TV  252 (363)
Q Consensus       175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~  252 (363)
                      .+++.....  .+++..++.++.+++.|++|||++   +++||||+|+||+++.++.++|+|||++..........  ..
T Consensus        80 ~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          80 LTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            999865432  578899999999999999999999   99999999999999999999999999987653211111  11


Q ss_pred             eccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc--cCCCCCCChhhHHHHHHH
Q 046084          253 VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTVIQDIILV  329 (363)
Q Consensus       253 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l  329 (363)
                      ...+..|+|||.+.+..++.++|+||||+++|||++ |..||.......    .......  ..+.+...      +..+
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~------~~~~  224 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----TRERIESGYRMPAPQLC------PEEI  224 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----HHHHHhcCCCCCCCccC------CHHH
Confidence            223567999999988889999999999999999999 888876543211    1111111  11122111      2248


Q ss_pred             HHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          330 SKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       330 ~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .+++.+||+.+|++|| +.|++..|.
T Consensus       225 ~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         225 YRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHhccChhhCcCHHHHHHHhh
Confidence            8999999999999999 999998875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-40  Score=303.73  Aligned_cols=257  Identities=20%  Similarity=0.309  Sum_probs=194.9

Q ss_pred             ccCeeeec--CceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           93 IKYCIGTG--GYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        93 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      +.+.||+|  +|++||++.. .+|+.||+|.+..........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45679999  6889999965 57899999999766544444567888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC-
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS-  248 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  248 (363)
                      ++|+|.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++++||+.......... 
T Consensus        82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            99999999865432 2488999999999999999999999   999999999999999999999999986543321111 


Q ss_pred             ------Cceeecccccccccccccc--ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC------
Q 046084          249 ------NRTVVAGTHGYIAPELAYT--MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP------  314 (363)
Q Consensus       249 ------~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  314 (363)
                            ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......   ..........+      
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~  234 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKLNGTVPCLLDTT  234 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH---HHHHHhcCCcccccccc
Confidence                  0112245677999999875  458899999999999999999999986533211   00000000000      


Q ss_pred             -----------------------------CC-----CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          315 -----------------------------SP-----IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       315 -----------------------------~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                                   .+     ...+........+.+++.+||+.||++|| +.+++.+...+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence                                         00     00000001122488999999999999999 99998876554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3e-40  Score=291.67  Aligned_cols=257  Identities=27%  Similarity=0.433  Sum_probs=210.1

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|++|.||++... +++.|++|++...... .....+..|+..+..++|+|++++++++...+..++++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            36888999999999999999775 5899999998776543 335778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      |+++++|.+++....   .+++..++.++.|+++|++|||+ .   +++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          80 YMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            999999999997653   68999999999999999999999 8   9999999999999999999999999999876544


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||..............+.....+. .....   ..
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~  229 (264)
T cd06623         154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS-LPAEE---FS  229 (264)
T ss_pred             CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC-CCccc---CC
Confidence            443334567889999999988889999999999999999999999986654322222222333222211 11110   12


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+.+++.+||+.+|++|| +.+++..-+.+
T Consensus       230 ~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~  260 (264)
T cd06623         230 PEFRDFISACLQKDPKKRPSAAELLQHPFIK  260 (264)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence            2488999999999999999 99998865443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=297.23  Aligned_cols=252  Identities=29%  Similarity=0.473  Sum_probs=214.6

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      -|.+.++||+|+||.||++.+ ..|+.+|||.+.....    ++++..|+.+|++.+.|++|++||.+.....+++||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            377889999999999999954 5799999999876543    46788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      |..|+..+.++..+.  ++++.++..++.+-++||+|||..   .-+|||||..|||++-+|.+||+|||.+..+...-.
T Consensus       110 CGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  110 CGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             cCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            999999999987653  799999999999999999999999   899999999999999999999999999988766555


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL  328 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ...++.||+.|||||++..-.|+.++||||||++..||..|++||.+.....   ... ++-.++++....+..|..  .
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIF-MIPT~PPPTF~KPE~WS~--~  258 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIF-MIPTKPPPTFKKPEEWSS--E  258 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---eeE-eccCCCCCCCCChHhhhh--H
Confidence            6677889999999999999999999999999999999999999976544321   111 222334444445555544  6


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +.+++++||-++|++|- +.+++++-..+
T Consensus       259 F~DFi~~CLiK~PE~R~TA~~L~~H~Fik  287 (502)
T KOG0574|consen  259 FNDFIRSCLIKKPEERKTALRLCEHTFIK  287 (502)
T ss_pred             HHHHHHHHhcCCHHHHHHHHHHhhhhhhc
Confidence            88999999999999999 99988775443

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=315.37  Aligned_cols=256  Identities=25%  Similarity=0.456  Sum_probs=209.6

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC--CCC--EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP--SGK--KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      +..++....++||+|.||.|++|.|.  +|+  .||||.++...... ...+|.+|+..|.+|+|||+++|||+..+ ..
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence            44556677788999999999999774  344  69999998766543 46899999999999999999999999987 56


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      ..+|+|.++.|+|.+.|+. .....|-......++.|||.||+||.++   ++|||||..+|+|+.....+||+|||+.+
T Consensus       185 ~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             hhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccccee
Confidence            7899999999999999987 3333577888899999999999999999   99999999999999999999999999999


Q ss_pred             eccCCCCCcee---eccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhh-hcccCCCC
Q 046084          242 LLHSDSSNRTV---VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDL-LDQRVPSP  316 (363)
Q Consensus       242 ~~~~~~~~~~~---~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~  316 (363)
                      .+..+......   ..-...|+|||.+....++.++|||+|||++|||+| |.-||-.....   ..+..+ ...+++.+
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---qIL~~iD~~erLpRP  337 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---QILKNIDAGERLPRP  337 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---HHHHhccccccCCCC
Confidence            87654433221   123567999999999999999999999999999998 78887654332   222222 34567777


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..++..      |++++..||..+|.+|| +..+.+++...
T Consensus       338 k~csed------IY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  338 KYCSED------IYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             CCChHH------HHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            776655      88899999999999999 88887666543

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.2e-41  Score=302.60  Aligned_cols=258  Identities=25%  Similarity=0.381  Sum_probs=199.3

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||.||+|... +++.||+|.+..........+.+.+|+++++.++||||+++++++...+..++++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999775 58899999887654433344678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|..+.....   .+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999998888765443   489999999999999999999999   99999999999999999999999999998764443


Q ss_pred             CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhh-----------hcc----
Q 046084          248 SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDL-----------LDQ----  311 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~-----------~~~----  311 (363)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|++||...............           ...    
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            33334567889999998765 44778999999999999999999998643321100000000           000    


Q ss_pred             -cCCCC-CCChhh-----HHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 -RVPSP-IDDQTV-----IQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 -~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                       ....+ ......     ......+.+++.+||+.+|++|| +.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence             00000 000000     01123488999999999999999 9888764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.1e-41  Score=305.65  Aligned_cols=260  Identities=24%  Similarity=0.407  Sum_probs=203.0

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEeC--------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeE
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQLP--------SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGF  155 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~  155 (363)
                      ++...+|++.+.||+|+||.||++...        .+..||+|.+...... ...+.+..|+.+++++ +||||++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-HHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            344567999999999999999999642        1236899988754332 3356789999999999 89999999999


Q ss_pred             EeeCCeEEEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCC
Q 046084          156 CLHKKCMFLIYKYMRRGSLFCILRNDD-------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSN  222 (363)
Q Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  222 (363)
                      |...+..++++||+++|+|.+++....             ....+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence            999999999999999999999986532             123588899999999999999999999   9999999999


Q ss_pred             CeeecCCCceEEEeeccceeccCCCCCc--eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCC
Q 046084          223 NILLNSKLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSV  299 (363)
Q Consensus       223 Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~  299 (363)
                      |||++.++.+||+|||+++.........  ....++..|+|||.+.+..++.++||||||+++|||++ |..||....  
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--  241 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--  241 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence            9999999999999999997654322111  11223467999999988889999999999999999998 888875432  


Q ss_pred             CchhhHHhhhccc-CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          300 NPKIMLIDLLDQR-VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       300 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                       .......+.... .+.+...      ...+.+++.+||+.+|++|| +.+++..|..-.
T Consensus       242 -~~~~~~~~~~~~~~~~~~~~------~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         242 -VEELFKLLKEGHRMDKPANC------THELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             -HHHHHHHHHcCCCCCCCCCC------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence             222222222221 1112111      12488999999999999999 999999986543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4e-41  Score=303.31  Aligned_cols=262  Identities=20%  Similarity=0.245  Sum_probs=198.6

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+....... ....+.+|+.+++.++||||+++++++...+..+++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            57899999999999999999764 67899999987543221 12457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+. ++|..++.....  .+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          85 YLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            997 588888765432  578899999999999999999999   99999999999999999999999999997654333


Q ss_pred             CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---------------
Q 046084          248 SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---------------  311 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------  311 (363)
                      .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..............               
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            33333456889999998765 45788999999999999999999998654321110000000000               


Q ss_pred             ---cCCCCCC-Ch--hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          312 ---RVPSPID-DQ--TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       312 ---~~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                         ..+.... ..  ........+.+||.+||+.||.+|| +.|++.+-+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence               0000000 00  0000112478999999999999999 999998766543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-40  Score=300.47  Aligned_cols=260  Identities=24%  Similarity=0.326  Sum_probs=207.6

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|++|.||++... +++.||+|.+...... ....+.+..|+++++.++||||+++++.+.+....+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46888999999999999999765 5889999999765433 234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+.+++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999987542 23689999999999999999999999   9999999999999999999999999998654221


Q ss_pred             CC-----------------------------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCc
Q 046084          247 SS-----------------------------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLS  297 (363)
Q Consensus       247 ~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~  297 (363)
                      ..                             ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            10                             1112357888999999988889999999999999999999999986443


Q ss_pred             CCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhh
Q 046084          298 SVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL  359 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~  359 (363)
                      .   ......+.......+....    ....+.+++.+||+.||++|| ++..+.+++.-.-+
T Consensus       237 ~---~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~  292 (316)
T cd05574         237 R---DETFSNILKKEVTFPGSPP----VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF  292 (316)
T ss_pred             h---HHHHHHHhcCCccCCCccc----cCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence            2   2233333333333222211    223589999999999999999 77777777654433

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.3e-41  Score=299.77  Aligned_cols=261  Identities=26%  Similarity=0.383  Sum_probs=201.6

Q ss_pred             HHHHHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 046084           81 FQEMIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLH  158 (363)
Q Consensus        81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (363)
                      ..++..+.++|.+.+.||+|+||.||++.. .+++.+|+|.+......   ...+..|+.+++++ +|||++++++++..
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV---DEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH---HHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344445678899999999999999999976 46889999998654322   25577889999998 89999999999875


Q ss_pred             C-----CeEEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCce
Q 046084          159 K-----KCMFLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEA  232 (363)
Q Consensus       159 ~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  232 (363)
                      .     +..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            4     35899999999999999886421 223689999999999999999999999   99999999999999999999


Q ss_pred             EEEeeccceeccCCCCCceeeccccccccccccccc-----cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh
Q 046084          233 FVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-----VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID  307 (363)
Q Consensus       233 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~  307 (363)
                      +|+|||++..............++..|+|||.+...     .++.++||||||+++|||++|+.||.....   ......
T Consensus       168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~~  244 (291)
T cd06639         168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTLFK  244 (291)
T ss_pred             EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHHH
Confidence            999999987654333333345678899999987543     367899999999999999999999865432   112222


Q ss_pred             hhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          308 LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      +.....+... .+  ......+.++|.+||+.||++|| +.+++.+-
T Consensus       245 ~~~~~~~~~~-~~--~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  288 (291)
T cd06639         245 IPRNPPPTLL-HP--EKWCRSFNHFISQCLIKDFEARPSVTHLLEHP  288 (291)
T ss_pred             HhcCCCCCCC-cc--cccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence            2222111111 11  11122488999999999999999 99988753

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=295.02  Aligned_cols=247  Identities=26%  Similarity=0.441  Sum_probs=191.2

Q ss_pred             CeeeecCceeEEEEEeCC-CC--EEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEEecc
Q 046084           95 YCIGTGGYGSVYRAQLPS-GK--KVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  170 (363)
                      +.||+|+||.||+|.+.+ +.  .+++|.+...... ...+.+..|++++.++ +||||+++++++...+..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH-HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            358999999999997643 33  4688888743322 2346788999999999 79999999999999999999999999


Q ss_pred             CCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEee
Q 046084          171 RGSLFCILRNDD-------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADF  237 (363)
Q Consensus       171 ~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  237 (363)
                      +|+|.+++....             ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence            999999986532             122478999999999999999999998   9999999999999999999999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCC
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPS  315 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~  315 (363)
                      |++....... .......+..|+|||++....++.++||||||+++|||++ |..||.....   .......... ....
T Consensus       157 gl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~~~~  232 (270)
T cd05047         157 GLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQGYRLEK  232 (270)
T ss_pred             CCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHHhCCCCCCC
Confidence            9985322111 1111223567999999988889999999999999999997 9999854322   1111222111 1111


Q ss_pred             CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +...      ...+.+++.+||+.||.+|| +.+++..|..
T Consensus       233 ~~~~------~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         233 PLNC------DDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             CCcC------CHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            2111      12488999999999999999 9999998853

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-40  Score=295.29  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=185.3

Q ss_pred             eeeecCceeEEEEEeCC---CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           96 CIGTGGYGSVYRAQLPS---GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      .||+|+||.||+|...+   ...+++|.+..... ......+.+|+..++.++||||+++++.+.+....+++|||+++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            58999999999996533   34688887765433 233467889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC--
Q 046084          173 SLFCILRNDDE--AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--  248 (363)
Q Consensus       173 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  248 (363)
                      +|.+++.....  ....++.....++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++........  
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999876432  12356778889999999999999999   999999999999999999999999999865432211  


Q ss_pred             Cceeeccccccccccccc-------cccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc---cCCCCC
Q 046084          249 NRTVVAGTHGYIAPELAY-------TMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ---RVPSPI  317 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~  317 (363)
                      ......++..|+|||+..       ...++.++||||||+++|||++ |..||......   .........   ..+.+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHhhccCccCCCCc
Confidence            112233567799999864       3456789999999999999999 78887654321   112221111   122221


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      ....   ....+.+++..|| .||++|| +.+|++.+
T Consensus       235 ~~~~---~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         235 LDLK---YSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             cccc---CCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            1111   1123677888898 5999999 88888775

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-40  Score=295.91  Aligned_cols=237  Identities=24%  Similarity=0.376  Sum_probs=184.5

Q ss_pred             eeeecCceeEEEEEeCC-------------------------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCcee
Q 046084           96 CIGTGGYGSVYRAQLPS-------------------------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV  150 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  150 (363)
                      .||+|+||.||+|....                         ...|++|.+.....  .....+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence            59999999999996411                         13588998865433  2346788899999999999999


Q ss_pred             eeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC
Q 046084          151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL  230 (363)
Q Consensus       151 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  230 (363)
                      +++++|.+....++||||+++|+|..++.....  .+++..+..++.|+++||+|||+.   +++||||||+|||++..+
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG  154 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence            999999999999999999999999998865332  588899999999999999999999   999999999999997643


Q ss_pred             -------ceEEEeeccceeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHH-hCCCCCCCCcCCCc
Q 046084          231 -------EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNP  301 (363)
Q Consensus       231 -------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~-~g~~p~~~~~~~~~  301 (363)
                             .++++|||++......    ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||........
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                   3799999987543221    12346788999998765 56889999999999999995 69999865432211


Q ss_pred             hhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          302 KIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                          ..........+....      ..+.+++.+||+.+|++|| +.+++..|
T Consensus       231 ----~~~~~~~~~~~~~~~------~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 ----ERFYEKKHRLPEPSC------KELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             ----HHHHHhccCCCCCCC------hHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence                111121111111111      1378899999999999999 99999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-40  Score=298.01  Aligned_cols=239  Identities=29%  Similarity=0.419  Sum_probs=198.4

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||++... +++.+|+|.+..... .....+.+.+|++++++++||||+++++++.+.+..+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999764 688999999865432 2233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....   .+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999987654   689999999999999999999999   9999999999999999999999999999776433


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                         .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||....   .......+.....+.+...+      
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~------  222 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEGKVRFPSFFS------  222 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCccCCccCC------
Confidence               233468899999999888888999999999999999999999986543   22223333333333332221      


Q ss_pred             HHHHHHHHHccCCCCCCCC
Q 046084          327 ILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP  345 (363)
                      ..+.+++.+||+.||++||
T Consensus       223 ~~l~~li~~~l~~~p~~R~  241 (290)
T cd05580         223 PDAKDLIRNLLQVDLTKRL  241 (290)
T ss_pred             HHHHHHHHHHccCCHHHcc
Confidence            2488999999999999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-41  Score=308.48  Aligned_cols=258  Identities=24%  Similarity=0.339  Sum_probs=196.0

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (363)
                      ..++|.+.+.||+|+||.||++.. .+++.||+|++..........+.+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            457899999999999999999965 4678999999876544333446678899999999999999999887543      


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      ...++++|++ +++|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence            3468999987 77888877543    589999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc--------
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD--------  310 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------  310 (363)
                      +......   .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.................        
T Consensus       165 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         165 ARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             ceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9865432   233468999999998876 5688999999999999999999999864322110000000000        


Q ss_pred             -----------ccCC-CCCCC-hh-hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          311 -----------QRVP-SPIDD-QT-VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       311 -----------~~~~-~~~~~-~~-~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                                 ..++ .+... .. .......+.+|+.+||+.||++|| +.|++.+-..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~  301 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF  301 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence                       0000 00000 00 000011367899999999999999 9999987544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-40  Score=293.57  Aligned_cols=246  Identities=27%  Similarity=0.428  Sum_probs=189.2

Q ss_pred             CeeeecCceeEEEEEeC----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeEEEEEEec
Q 046084           95 YCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH-KKCMFLIYKYM  169 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  169 (363)
                      +.||+|+||.||+|.+.    ++..||+|.+..... ....+.+..|+.+++.++|||++++++++.. ++..++++||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            35899999999999753    235799998864332 2234678899999999999999999998764 45688999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC-
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS-  248 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  248 (363)
                      .+|+|.+++.....  .+++..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++....... 
T Consensus        80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          80 KHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999999875432  467788889999999999999999   999999999999999999999999999875532211 


Q ss_pred             ---CceeeccccccccccccccccCCccccchHHHHHHHHHHhC-CCCCCCCcCCCchhhHHhhhccc-CCCCCCChhhH
Q 046084          249 ---NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMG-RHPGDLLSSVNPKIMLIDLLDQR-VPSPIDDQTVI  323 (363)
Q Consensus       249 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  323 (363)
                         ......++..|+|||.+.+..++.++||||||+++|||++| .+||.....   ........... .+.+...+   
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~---  228 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQGRRLLQPEYCP---  228 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcCCCCCCCCcCC---
Confidence               11123356789999998888899999999999999999995 566543321   12222222221 11111111   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                         ..+.+++.+||+.+|++|| +.+++.+|..
T Consensus       229 ---~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         229 ---DPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             ---HHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence               2488999999999999999 9999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-40  Score=295.35  Aligned_cols=255  Identities=23%  Similarity=0.404  Sum_probs=198.0

Q ss_pred             cCCcccCeeeecCceeEEEEEe-----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--Ce
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KC  161 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  161 (363)
                      +.|++.+.||+|+||.||++..     .++..||+|.++..... .....+.+|+.+++.++|||++++++++...  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            4578889999999999999963     35778999998755432 3346799999999999999999999998875  56


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .+++|||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            8899999999999999865432  589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcC-----------CCchhhHHh
Q 046084          242 LLHSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS-----------VNPKIMLID  307 (363)
Q Consensus       242 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~-----------~~~~~~~~~  307 (363)
                      ........   .....++..|+|||.+.+..++.++||||||+++|||++++.|+.....           .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            66433221   1223466789999998888899999999999999999998776422110           000001111


Q ss_pred             hhcc--cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          308 LLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       308 ~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ....  ..+.+..      ....+.+++.+||+.||++|| +.+++..|..
T Consensus       238 ~~~~~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         238 VLEEGKRLPRPPN------CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHHcCccCCCCCC------CCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            1111  1111111      122488999999999999999 9999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.3e-42  Score=297.04  Aligned_cols=254  Identities=26%  Similarity=0.377  Sum_probs=192.4

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----eEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-----CMF  163 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  163 (363)
                      .|...+.+|+|+||.||+|... +++.||||+.-....-      -.+|+++|+.++|||||++.-+|....     +..
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            4667788999999999999764 4689999998765432      236899999999999999998887542     245


Q ss_pred             EEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-CceEEEeeccce
Q 046084          164 LIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVAR  241 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~  241 (363)
                      +||||++. +|...++.. .....++...+.-+.+||.+||+|||+.   +|+||||||.|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999987 888887641 1123577778888999999999999998   99999999999999987 999999999999


Q ss_pred             eccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---------
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---------  311 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------  311 (363)
                      .+..+..+ ..+..|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|...+..+.-....+++..         
T Consensus       175 ~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  175 VLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            88655444 45567889999998876 56999999999999999999999998775543322222222111         


Q ss_pred             --c-----CC----CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          312 --R-----VP----SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       312 --~-----~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                        .     .+    .+...-..........+++.++|+.+|.+|. +.|++.+-.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f  308 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF  308 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence              0     00    0000000001112478999999999999999 888887643

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.4e-40  Score=293.37  Aligned_cols=254  Identities=24%  Similarity=0.392  Sum_probs=200.0

Q ss_pred             CCcccCeeeecCceeEEEEEeCC--CCEEEEEEecccc--------chHHHHHHHHHHHHHHhc-CCCCceeeeeeEEee
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLPS--GKKVALKKLHHSE--------TELAFLESFQTEAHLLSQ-IRHRNIVKLYGFCLH  158 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  158 (363)
                      +|++.+.||+|+||.||++....  ++.+|+|.+....        .......++..|+.++.. ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999998754  6789999876432        122234567788888765 799999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCCceEEEe
Q 046084          159 KKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVAD  236 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~D  236 (363)
                      .+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999887542 222368999999999999999999996 5   899999999999999999999999


Q ss_pred             eccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCC
Q 046084          237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP  316 (363)
Q Consensus       237 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  316 (363)
                      ||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.....   ...............
T Consensus       158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~  233 (269)
T cd08528         158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIVEAVYEPL  233 (269)
T ss_pred             ccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHHhhccCCcC
Confidence            99998754433 33345688899999999888899999999999999999999999754322   222222222222211


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .. ..   ....+.+++.+||+.||++|| +.|+.+++.
T Consensus       234 ~~-~~---~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         234 PE-GM---YSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             Cc-cc---CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11 01   112488999999999999999 999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=301.88  Aligned_cols=254  Identities=22%  Similarity=0.354  Sum_probs=215.4

Q ss_pred             cCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .-|.+.+.||+|.|..|-+++ .-+|+.||||++.....+.-....+..|+.+|+.++|||||++|++......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            457888899999999999984 3589999999998877655555678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee-cCCCceEEEeeccceeccCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL-NSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      .-.+|+|++|+..+..  .+.+.-..+++.||+.|+.|+|+.   .+|||||||+||.+ ..-|-+||.|||++..+. +
T Consensus        98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-P  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-P  171 (864)
T ss_pred             ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC-C
Confidence            9999999999987765  488888999999999999999999   89999999999976 456899999999998764 4


Q ss_pred             CCCceeeccccccccccccccccCC-ccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLT-EKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      ....++.+|+..|-|||++.+..|+ +++||||||+|||-|++|++||+...   ..+.+..+++-.+..|.-.+     
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN---DSETLTmImDCKYtvPshvS-----  243 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN---DSETLTMIMDCKYTVPSHVS-----  243 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc---chhhhhhhhcccccCchhhh-----
Confidence            4556677899999999999988875 68999999999999999999987643   34456667776665554222     


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                       .+.++||..||..||.+|- ..+++..-+.+.
T Consensus       244 -~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~  275 (864)
T KOG4717|consen  244 -KECRDLIQSMLVRDPKKRASLEEIVSTSWLQA  275 (864)
T ss_pred             -HHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence             2488999999999999999 888877666543

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.4e-40  Score=298.58  Aligned_cols=254  Identities=24%  Similarity=0.397  Sum_probs=203.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||++.. .++..|++|.+.......  .+.+..|+.+++.++|||++++++++...+..++|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK--KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH--HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            36789999999999999999965 467899999986543322  367889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++...    .+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            999999999998654    478899999999999999999999   9999999999999999999999999998765443


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ........++..|+|||.+....++.++|+||||+++|++++|+.||........   .........+ ....  .....
T Consensus       169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~~~~~~~~~-~~~~--~~~~~  242 (293)
T cd06647         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNGTP-ELQN--PEKLS  242 (293)
T ss_pred             ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---eeehhcCCCC-CCCC--ccccC
Confidence            3333445688899999998888889999999999999999999999865432111   1111111111 1111  11112


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+.+++.+||+.+|++|| +.+++.+-..+
T Consensus       243 ~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~  273 (293)
T cd06647         243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (293)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence            2488999999999999999 99999875443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.5e-40  Score=293.63  Aligned_cols=250  Identities=30%  Similarity=0.474  Sum_probs=202.2

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      -|++.+.||+|+||.||+|.. .++..||+|.+...... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            477788999999999999965 46789999988654432 3346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            9999999988643    488999999999999999999999   999999999999999999999999999876644333


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL  328 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ......+.....+. ...    .....
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~~----~~~~~  228 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKNNPPT-LEG----NYSKP  228 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcCCCCC-CCc----ccCHH
Confidence            33334578899999999888889999999999999999999999864332   11122222221111 110    11124


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +.+++.+||+.+|++|| +.+++.+-..
T Consensus       229 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  256 (277)
T cd06641         229 LKEFVEACLNKEPSFRPTAKELLKHKFI  256 (277)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence            88899999999999999 9999987544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-40  Score=290.45  Aligned_cols=247  Identities=24%  Similarity=0.377  Sum_probs=199.9

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc---hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET---ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +|+..+.||+|++|.||+|... +++.|++|.+.....   ..+..+.+..|+.+++.++|+|++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999775 788999998865432   223456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      +||+++++|.+++....   .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999997653   588999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCCceeecccccccccccccccc-CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc-ccCC-CCCCChhh
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMV-LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD-QRVP-SPIDDQTV  322 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~  322 (363)
                      .. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.....   ......... ...+ .+...   
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~---  227 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRSKELPPIPDHL---  227 (258)
T ss_pred             cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHHHhcccCCCcCCCc---
Confidence            32 223445788999999887666 88999999999999999999999865442   111122222 1111 11111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                         ...+.+++.+||+.+|++|| +.+++..
T Consensus       228 ---~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         228 ---SDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ---CHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence               12378899999999999999 9988764

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.7e-40  Score=291.12  Aligned_cols=251  Identities=27%  Similarity=0.430  Sum_probs=201.8

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|.+.+.||+|+||.||++.. .+++.|++|.+..........+.+..|+.+++.++|+||+++++++...+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            578889999999999999975 4688999999987665445567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999987643   478889999999999999999999   999999999999999999999999999887643322


Q ss_pred             Cce----eecccccccccccccccc---CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc-cCCCCCCCh
Q 046084          249 NRT----VVAGTHGYIAPELAYTMV---LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQ  320 (363)
Q Consensus       249 ~~~----~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  320 (363)
                      ...    ...++..|+|||.+.+..   ++.++||||||+++|++++|+.||...+..  ......+... ....+... 
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~-  231 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVGAGHKPPIPDSL-  231 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHhcCCCCCCCccc-
Confidence            211    245788999999988765   788999999999999999999998654321  1111111111 11111111 


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                         .....+.+++.+||+.+|++|| +.+++..
T Consensus       232 ---~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         232 ---QLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             ---ccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence               1122477899999999999999 9888754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.7e-41  Score=311.58  Aligned_cols=256  Identities=23%  Similarity=0.281  Sum_probs=198.2

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC---CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP---SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      ...+|.+.+.||+|+||.||++...   .+..|++|.+....       ...+|+.+++.++||||+++++++......+
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            4567999999999999999999643   45689999876432       3457999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ++||++. ++|.+++....   .+++..++.++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++...
T Consensus       163 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9999986 58888884433   689999999999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc----------
Q 046084          244 HSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ----------  311 (363)
Q Consensus       244 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------  311 (363)
                      ......  .....||..|+|||++.+..++.++|||||||++|||++|+.||...........+..+...          
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            433221  22356899999999999889999999999999999999999998543322111111111100          


Q ss_pred             ---------------cCCCCCCChhh---HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          312 ---------------RVPSPIDDQTV---IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       312 ---------------~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                     ....+...+..   ......+.++|.+||+.||++|| +.+++.+-.+.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~  379 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT  379 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence                           00000000000   01123477899999999999999 99999887654

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=294.87  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=200.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCC----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      ..+|++.+.||+|+||.||+|.+. +|.    .+|+|.+..... ......+.+|+..++.++|||++++++++.. ...
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            467888999999999999999753 333    589998876543 2334678899999999999999999999987 678


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++++||+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++..
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999999876543  489999999999999999999998   999999999999999999999999999987


Q ss_pred             ccCCCCCcee--eccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCC
Q 046084          243 LHSDSSNRTV--VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPID  318 (363)
Q Consensus       243 ~~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  318 (363)
                      ..........  ..++..|+|||......++.++|+||||+++||+++ |+.||+....   ......+... ..+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~  235 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPDLLEKGERLPQPPI  235 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhCCCCCCCCCC
Confidence            6432221111  123567999999888889999999999999999998 9999865432   2222222222 1222222


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+      ..+.+++.+||..||++|| +.+++..|..
T Consensus       236 ~~------~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~  267 (279)
T cd05057         236 CT------IDVYMVLVKCWMIDAESRPTFKELINEFSK  267 (279)
T ss_pred             CC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            22      1378899999999999999 9999988865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.3e-40  Score=291.06  Aligned_cols=249  Identities=22%  Similarity=0.377  Sum_probs=201.4

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|+..+.||+|+||.||++.. .+++.+++|.+............+..|+++++.++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999965 4678999999876544444457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-CceEEEeeccceeccCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDS  247 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~  247 (363)
                      +++++|.+++.... ...+++..+..++.++++|++|||++   +++|+||+|+||+++++ +.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999997643 22589999999999999999999999   99999999999999865 468999999998764332


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC-CCCCChhhHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP-SPIDDQTVIQDI  326 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  326 (363)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....   .......+...... .+...      .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~------~  226 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVLKIMSGTFAPISDRY------S  226 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc---hHHHHHHHHhcCCCCCCCCc------C
Confidence             2223457889999999988888999999999999999999999976432   22222233222221 11111      1


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ..+.+++.+||+.||++|| +.|++.+
T Consensus       227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         227 PDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            1388999999999999999 9999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-40  Score=292.50  Aligned_cols=245  Identities=27%  Similarity=0.467  Sum_probs=196.4

Q ss_pred             cCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      ++|++.+.||+|+||.||++.. +++.||+|.+.....    .+.+.+|+.+++.++|||++++++++...+ .+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT----AQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch----HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEEC
Confidence            5688999999999999999976 778899999865432    256889999999999999999999987654 7899999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++..... ..+++..++.++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++....... 
T Consensus        80 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          80 MSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            999999999976432 3588999999999999999999999   99999999999999999999999999987643211 


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQDI  326 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  326 (363)
                        .....+..|+|||.+.+..++.++|+||||+++|||++ |+.||.....   ......+... .+..+..      .+
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~------~~  223 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECVEKGYRMEPPEG------CP  223 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhCCCCCCCCCc------CC
Confidence              11234567999999988889999999999999999997 9999765432   1222222221 1111111      12


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..+.+++.+||+.+|++|| +.+++..|..
T Consensus       224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         224 ADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            2488999999999999999 9999988753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.5e-41  Score=294.72  Aligned_cols=248  Identities=25%  Similarity=0.354  Sum_probs=201.4

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      +|++.+.||.|+||.||++... +++.|++|.+..... .....+.+.+|++++++++||||+++++++.+.+..++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999765 588999999875432 22345788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|.+++....   .+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            999999999987652   689999999999999999999999   99999999999999999999999999987654332


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......................+...+      .
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  227 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWS------T  227 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCc------H
Confidence             223345788999999998888999999999999999999999998765433222222222212222222211      3


Q ss_pred             HHHHHHHHccCCCCCCCC-h--HHHH
Q 046084          328 LVSKIVFACLRSKPTSRP-M--QRVS  350 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~--~~v~  350 (363)
                      .+.+++.+||+.||.+|| +  .|++
T Consensus       228 ~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         228 EAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HHHHHHHHHccCChhHcCCccHHHHh
Confidence            488999999999999999 7  4443

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=295.57  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=200.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCC----
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKK----  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----  160 (363)
                      ++++|++.+.||+|++|.||+|... +++.+++|.+......   .+.+.+|+.+++++ +|+||+++++++....    
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            4678999999999999999999764 5788999998765432   36788999999999 7999999999997644    


Q ss_pred             --eEEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEee
Q 046084          161 --CMFLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADF  237 (363)
Q Consensus       161 --~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  237 (363)
                        ..+++|||+++++|.+++.... ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence              4899999999999999886532 123689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccCCCCCceeecccccccccccccc-----ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAYT-----MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      |++..............++..|+|||.+..     ..++.++||||||+++|+|++|+.||.....   ......+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~  234 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALFKIPRNP  234 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHHHhhccC
Confidence            998765443333344568889999998753     3467889999999999999999999864322   22222222222


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .+ .....  ......+.+++.+||+.||++|| +.+++.+
T Consensus       235 ~~-~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         235 PP-TLKSP--ENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             CC-CCCch--hhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11 11111  11223588999999999999999 9998864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.9e-41  Score=320.80  Aligned_cols=262  Identities=18%  Similarity=0.278  Sum_probs=192.9

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC------CCceeeeeeEE
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR------HRNIVKLYGFC  156 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~  156 (363)
                      +....++|++.+.||+|+||+||+|.+ .+++.||||+++....   ....+..|+.++..++      |.+++++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            334568899999999999999999965 4578899999864322   1234556666666664      45688999988


Q ss_pred             eeC-CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCC----
Q 046084          157 LHK-KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKL----  230 (363)
Q Consensus       157 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~----  230 (363)
                      ... ...++|||++ +++|.+++....   .+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence            765 4688999987 678888886543   58999999999999999999997 5   899999999999998765    


Q ss_pred             ------------ceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcC
Q 046084          231 ------------EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS  298 (363)
Q Consensus       231 ------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~  298 (363)
                                  .+||+|||.+....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||+....
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                        49999999875432   223345789999999999999999999999999999999999999975432


Q ss_pred             CCchhhHHhhhccc--------------------C-CCCCCChhh------------HHHHHHHHHHHHHccCCCCCCCC
Q 046084          299 VNPKIMLIDLLDQR--------------------V-PSPIDDQTV------------IQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       299 ~~~~~~~~~~~~~~--------------------~-~~~~~~~~~------------~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                      ..........+...                    . ..+...+..            ......+.+||..||+.||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            11111111100000                    0 000000000            00112477999999999999999


Q ss_pred             -hHHHHHHHhchhh
Q 046084          346 -MQRVSQEFLVRKT  358 (363)
Q Consensus       346 -~~~v~~~l~~~~~  358 (363)
                       +.|++.+-...+.
T Consensus       431 ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        431 NARQMTTHPYVLKY  444 (467)
T ss_pred             CHHHHhcCcccccc
Confidence             9999987766543

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.7e-40  Score=293.22  Aligned_cols=254  Identities=27%  Similarity=0.416  Sum_probs=200.1

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCC----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPS----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      ..++|.+.+.||+|+||.||+|...+    ...|++|........ ...+.+..|+.+++.++||||+++++++.+ +..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-SVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            34678899999999999999997533    246899988765432 334678999999999999999999999875 457


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      +++|||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            899999999999999976432  589999999999999999999999   999999999999999999999999999976


Q ss_pred             ccCCCCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc-ccCCCCCCC
Q 046084          243 LHSDSSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPSPIDD  319 (363)
Q Consensus       243 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  319 (363)
                      ....... .....++..|+|||.+....++.++||||||+++||+++ |..||......   .....+.. ...+.+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~  233 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIENGERLPMPPNC  233 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCcCCCCCCC
Confidence            5433211 112224567999999888889999999999999999996 99998654322   11222222 122222222


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +      ..+.+++.+||..+|++|| +.+++..|..-
T Consensus       234 ~------~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         234 P------PTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             C------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1      2488899999999999999 99999888653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.1e-41  Score=300.27  Aligned_cols=250  Identities=25%  Similarity=0.398  Sum_probs=198.5

Q ss_pred             CcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           91 FDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      |+....||+|+||.||++.. .+++.||+|.+.......  .+.+.+|+..++.++|||++++++++..++..++++||+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch--HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            33445699999999999965 468899999986543322  356889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  249 (363)
                      ++++|..++...    .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus       101 ~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~  173 (297)
T cd06659         101 QGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  173 (297)
T ss_pred             CCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence            999999887543    488999999999999999999999   9999999999999999999999999998765433333


Q ss_pred             ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHH
Q 046084          250 RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILV  329 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  329 (363)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||......   .....+.....+......   .....+
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~l  247 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRDSPPPKLKNAH---KISPVL  247 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhccCCCCccccC---CCCHHH
Confidence            34456889999999998888999999999999999999999998643321   111121111111111111   111247


Q ss_pred             HHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          330 SKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       330 ~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+++.+||+.+|++|| +.+++..-..
T Consensus       248 ~~~i~~~l~~~P~~Rps~~~ll~~~~~  274 (297)
T cd06659         248 RDFLERMLTREPQERATAQELLDHPFL  274 (297)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhhChhh
Confidence            8899999999999999 9999886443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=310.36  Aligned_cols=247  Identities=27%  Similarity=0.396  Sum_probs=202.0

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .|.-.+.||+|+||.||-+.+ .+.+.||||++..... ..+.+.++..|+..|++++|||++.+-|++..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            355667899999999999965 5678899999987654 23446789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      ||-| +-.|++.-...  ++.+.++..|..+.+.||+|||+.   +.+|||||..|||+++.|.|||+|||.+....   
T Consensus       107 YClG-SAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---  177 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA---  177 (948)
T ss_pred             HHhc-cHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC---
Confidence            9955 77777765543  688899999999999999999999   99999999999999999999999999997753   


Q ss_pred             CCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          248 SNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                       ....++|||.|||||++.   .+.|+-++||||||++..||.-.++|.-.+   +.-..+..+.....| ....+ .|.
T Consensus       178 -PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM---NAMSALYHIAQNesP-tLqs~-eWS  251 (948)
T KOG0577|consen  178 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESP-TLQSN-EWS  251 (948)
T ss_pred             -chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc---hHHHHHHHHHhcCCC-CCCCc-hhH
Confidence             234568999999999876   467999999999999999999999995433   333334444443322 22233 333


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      +  .+++++..||++-|.+|| +.+++.+-
T Consensus       252 ~--~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  252 D--YFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             H--HHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence            3  489999999999999999 87777654

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-40  Score=302.86  Aligned_cols=255  Identities=25%  Similarity=0.338  Sum_probs=196.5

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||++... +++.+|+|.+..... .......+..|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999764 567899999864322 2222345888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999976332  588999999999999999999999   9999999999999999999999999998765332


Q ss_pred             CC-Cceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc--CCCCCC
Q 046084          247 SS-NRTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR--VPSPID  318 (363)
Q Consensus       247 ~~-~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~  318 (363)
                      .. ......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+   .......+....  .+.+..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~  232 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKERFQFPAQ  232 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC---HHHHHHHHhCCCccccCCCc
Confidence            22 222356899999999875     3457889999999999999999999986433   222223332221  111111


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCC--CC-hHHHHHHHh
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTS--RP-MQRVSQEFL  354 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~--RP-~~~v~~~l~  354 (363)
                      ..   .....+.+++.+|+..++.+  || +.+++.+-.
T Consensus       233 ~~---~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~  268 (332)
T cd05623         233 VT---DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF  268 (332)
T ss_pred             cc---cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence            11   11123778899988765544  67 788877643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.9e-40  Score=295.50  Aligned_cols=256  Identities=28%  Similarity=0.430  Sum_probs=206.7

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ..+.|+..+.||+|++|.||++... ++..+++|.+.....   ..+.+..|++.++.++|+|++++++.+...+..+++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            3566888889999999999999775 688999999976544   246788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      +||+++++|.+++....  ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            99999999999998754  3589999999999999999999998   999999999999999999999999999876544


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .........++..|+|||.+.+..++.++|+||||+++|+|++|+.||......   .....+.....+.... .  ...
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~-~--~~~  242 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLITTKGIPPLKN-P--EKW  242 (286)
T ss_pred             chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCCCcc-h--hhC
Confidence            333333345778999999998888999999999999999999999997643321   1222222222211111 1  001


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ...+.++|.+||+.+|.+|| +.+++......
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  274 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK  274 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence            22488999999999999999 99998765544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.9e-40  Score=302.59  Aligned_cols=255  Identities=24%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+..... .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999764 677899999865321 2222356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999976332  588899999999999999999999   9999999999999999999999999999766433


Q ss_pred             CCC-ceeecccccccccccccc-----ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc--cCCCCCC
Q 046084          247 SSN-RTVVAGTHGYIAPELAYT-----MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPID  318 (363)
Q Consensus       247 ~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  318 (363)
                      ... .....|++.|+|||++.+     ..++.++||||||+++|||++|+.||.....   ......+...  +.+.+..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~  232 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHEERFQFPSH  232 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH---HHHHHHHHcCCCcccCCCc
Confidence            222 223568999999998865     4578899999999999999999999864322   2222223222  1211111


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCC--CC-hHHHHHHHh
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTS--RP-MQRVSQEFL  354 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~--RP-~~~v~~~l~  354 (363)
                      ..   .....+.+++.+||..++++  |+ +.+++.+..
T Consensus       233 ~~---~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~  268 (331)
T cd05624         233 IT---DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF  268 (331)
T ss_pred             cc---cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence            11   11224788999999876554  44 666665543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.3e-40  Score=293.96  Aligned_cols=266  Identities=27%  Similarity=0.355  Sum_probs=204.4

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLI  165 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  165 (363)
                      ++|+..+.||.|++|.||++... +++.+|+|.+...... .....+.+|++++++++||||+++++++.+.  +..+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            46888899999999999999764 6788999998755432 3346788999999999999999999988654  468999


Q ss_pred             EEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          166 YKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      |||+++++|.+++.... ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999999988875321 233588899999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcC--CCchhhHHhhhcccCCCCCCC-hh
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS--VNPKIMLIDLLDQRVPSPIDD-QT  321 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~  321 (363)
                      ....  ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....  ...............+..... ..
T Consensus       157 ~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd06621         157 NSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN  234 (287)
T ss_pred             cccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence            2221  233567889999999888899999999999999999999999875432  111111222222111111100 00


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhhh
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLY  360 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~~  360 (363)
                      .......+.+++.+||+.||++|| +.|++..-+.+....
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            011123588999999999999999 999999877655443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-40  Score=291.25  Aligned_cols=237  Identities=27%  Similarity=0.443  Sum_probs=188.0

Q ss_pred             CeeeecCceeEEEEEeCCCC-----------EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           95 YCIGTGGYGSVYRAQLPSGK-----------KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      +.||+|+||.||+|.+.+..           .+++|.+......   ...+.+|+.+++.++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            36899999999999775433           5778877654332   4678899999999999999999999988 7789


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC-------ceEEEe
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-------EAFVAD  236 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-------~~kl~D  236 (363)
                      ++|||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+|||++.++       .++|+|
T Consensus        77 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence            99999999999999876442  588999999999999999999999   999999999999999887       799999


Q ss_pred             eccceeccCCCCCceeeccccccccccccccc--cCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccC
Q 046084          237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTM--VLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       237 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      ||++.....    .....++..|+|||.+.+.  .++.++||||||+++|||++ |..|+.......... ... .....
T Consensus       152 fg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~-~~~~~  225 (259)
T cd05037         152 PGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQ-DQHRL  225 (259)
T ss_pred             CCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HHh-cCCCC
Confidence            999976533    2223466789999998776  78899999999999999999 577775543221111 111 11111


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      +.+..        ..+.+++.+||+.+|++|| +.++++.|.
T Consensus       226 ~~~~~--------~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         226 PMPDC--------AELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCCCc--------hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11111        2488999999999999999 999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=297.10  Aligned_cols=257  Identities=26%  Similarity=0.385  Sum_probs=200.2

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|++|.||+|... +++.|++|.++.........+.+..|+++++.++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999765 57899999987654444445778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |++++.+..+.....   .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999877766654433   489999999999999999999999   99999999999999999999999999988765433


Q ss_pred             C-Cceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc---------------
Q 046084          248 S-NRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD---------------  310 (363)
Q Consensus       248 ~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------------  310 (363)
                      . ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+..........               
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence            2 22335678899999998877 789999999999999999999999864332111000000000               


Q ss_pred             --c-cCCCCCCChhhH------HHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          311 --Q-RVPSPIDDQTVI------QDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       311 --~-~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                        . ..+.. ......      .....+.++|.+||+.+|++|| +.+++..
T Consensus       235 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         235 FAGVAFPEP-SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccCCC-CCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence              0 00000 000000      0123588999999999999999 8888754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.9e-40  Score=290.57  Aligned_cols=253  Identities=23%  Similarity=0.413  Sum_probs=200.4

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc----hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET----ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      +|+..+.||+|++|.||++.. .+++.||+|.+.....    .....+.+..|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477888999999999999965 5788999999875431    22345788999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC-ceEEEeeccceec
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLL  243 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~  243 (363)
                      ++||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999987644   588999999999999999999999   999999999999998775 6999999998766


Q ss_pred             cCCCC----CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCC
Q 046084          244 HSDSS----NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       244 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      .....    ......++..|+|||.+.+..++.++||||+|+++|+|++|..||......................... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  233 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP-  233 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc-
Confidence            43321    1122457889999999988888999999999999999999999986543322222222222111111111 


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                         ......+.+++.+||+.+|++|| +.+++..
T Consensus       234 ---~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         234 ---EHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ---hhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence               11112488899999999999999 9988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-40  Score=298.07  Aligned_cols=261  Identities=25%  Similarity=0.304  Sum_probs=200.1

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE---LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +|++.+.||+|++|.||+|... +|+.|++|.+......   ......+..|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999764 6889999999765432   22335677899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+ +++|.+++....  ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999987643  2589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc------------
Q 046084          246 DSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR------------  312 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------  312 (363)
                      .........++..|+|||.+.+ ..++.++||||||+++|||++|.+||...................            
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            4333333456788999998754 457889999999999999999988875433211111111000000            


Q ss_pred             ------CCCCCC-ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          313 ------VPSPID-DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       313 ------~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                            ...+.. ..........+.++|.+||+.||++|| +.|++..-+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~  286 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS  286 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence                  000000 000011123588999999999999999 99999875443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.4e-40  Score=291.23  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=195.0

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE---TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCM  162 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  162 (363)
                      .+|+..+.||+|+||.||++.. .++..|++|.+....   ........+.+|+.+++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4788999999999999999965 468899999886442   2223346788999999999999999999988763  568


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++++||+++++|.+++....   .+++...+.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999987644   588899999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCC---CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCC
Q 046084          243 LHSDS---SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       243 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      .....   .......++..|+|||.+.+..++.++||||||+++|||++|+.||.....   ............. +...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~~~~~~~~~-~~~~  231 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPTN-PQLP  231 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHHHHhcCCCC-CCCc
Confidence            53211   111224578899999999888899999999999999999999999865422   1111112111111 1100


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                         ......+.+++ .||..+|++|| +.|++.+-
T Consensus       232 ---~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp  262 (266)
T cd06651         232 ---SHISEHARDFL-GCIFVEARHRPSAEELLRHP  262 (266)
T ss_pred             ---hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence               01111366677 68889999999 99998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-40  Score=292.84  Aligned_cols=252  Identities=29%  Similarity=0.496  Sum_probs=201.5

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC---CCceeeeeeEEeeCCeEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR---HRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  165 (363)
                      .|++.+.||+|+||.||+|.+ .+++.|++|.+...... ...+.+.+|+.+++.++   |||++++++++......+++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            477788999999999999975 57889999998754332 22467888999999986   99999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++...    .+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            9999999999998653    589999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .........|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........   .........+ ......   
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~~~~-~~~~~~---  226 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLIPKSKPP-RLEDNG---  226 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhccccCCCC-CCCccc---
Confidence            4433444568889999998764 4568899999999999999999999865432211   1111111111 111110   


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ....+.+++.+||+.||++|| +.+++..-+.+
T Consensus       227 ~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~  259 (277)
T cd06917         227 YSKLLREFVAACLDEEPKERLSAEELLKSKWIK  259 (277)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHhhChHhh
Confidence            122488999999999999999 99998876553

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-40  Score=297.47  Aligned_cols=258  Identities=23%  Similarity=0.301  Sum_probs=196.2

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||.|++|.||+|+.. +|+.|++|.+............+..|++++++++||||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999764 688999999876543333345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +. ++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 588888765432 3589999999999999999999999   999999999999999999999999999876543333


Q ss_pred             Cceeecccccccccccccccc-CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc---------------
Q 046084          249 NRTVVAGTHGYIAPELAYTMV-LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR---------------  312 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  312 (363)
                      ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...+..+............               
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            333345678899999876544 5889999999999999999999986433211111111100000               


Q ss_pred             --CCCCCC-Ch-h-hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          313 --VPSPID-DQ-T-VIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       313 --~~~~~~-~~-~-~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                        .+.... .. . .......+.++|.+||+.||++|| +.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence              000000 00 0 000112477899999999999999 9998865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.4e-40  Score=293.75  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=202.7

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee--CCe
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH--KKC  161 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~  161 (363)
                      ++|++.+.||+|+||.||++...     ++..+|+|.+...... ...+.+..|+++++.++||||+++++++..  ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            46788899999999999999753     3678999999866554 345789999999999999999999999887  557


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .+++|||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            8999999999999999976542  589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCCCc---eeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc-----------hhhHHh
Q 046084          242 LLHSDSSNR---TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-----------KIMLID  307 (363)
Q Consensus       242 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-----------~~~~~~  307 (363)
                      .........   ....++..|+|||...+..++.++||||||+++|||++|+.|+........           ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            764322211   112345679999999888899999999999999999999999754322110           111122


Q ss_pred             hhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          308 LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+......+...    .....+.+++.+||+.+|++|| +.+++++|..
T Consensus       238 ~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         238 LLKEGERLPRPP----SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHHcCCcCCCCc----cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            222222111111    1123588999999999999999 9999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.3e-40  Score=291.57  Aligned_cols=256  Identities=23%  Similarity=0.383  Sum_probs=202.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      .++|++...||+|+||.||+|+..      +.+.|++|.+...... ...+.+..|++++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-HHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            467889999999999999999753      3457999988654432 345779999999999999999999999999899


Q ss_pred             EEEEEEeccCCChhhhhhcCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEE
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEA------IRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVA  235 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  235 (363)
                      .+++|||+++|+|.+++......      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence            99999999999999998765422      1589999999999999999999999   99999999999999999999999


Q ss_pred             eeccceeccCCC-CCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccC
Q 046084          236 DFGVARLLHSDS-SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       236 Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      |||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~~~~~  236 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRLQAGKL  236 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHHHcCCc
Confidence            999986543221 11222345678999999888888999999999999999998 7888754322   222222222222


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ..+....    .+..+.+++.+||+.||++|| +.+++..|.
T Consensus       237 ~~~~~~~----~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         237 ELPVPEG----CPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCCCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            2211111    112488999999999999999 999998874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.3e-41  Score=308.10  Aligned_cols=198  Identities=23%  Similarity=0.394  Sum_probs=172.1

Q ss_pred             hcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-C-----CceeeeeeEEeeCC
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-H-----RNIVKLYGFCLHKK  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~  160 (363)
                      ..+|++.+.||+|+||.|.+|. ..+++.||||+++...   .+..+-..|+.+|..++ |     -|+|+++++|...+
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            3489999999999999999994 5679999999998654   44566778999999996 3     48999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC--CceEEEeec
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK--LEAFVADFG  238 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfg  238 (363)
                      +.|||+|.+.. +|+++++.+... .++...+..++.||+.||.+||..   +|||+||||+||||.+.  ..+||+|||
T Consensus       262 HlciVfELL~~-NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  262 HLCIVFELLST-NLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ceeeeehhhhh-hHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence            99999999854 999999887654 589999999999999999999999   99999999999999653  479999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLL  296 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~  296 (363)
                      .++.......   ++..+..|+|||++.+.+|+.+.|+||||||+.||++|.+-|...
T Consensus       337 SSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  337 SSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             cccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            9987543322   567889999999999999999999999999999999998766543

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-41  Score=304.27  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=207.1

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (363)
                      +....|++.+.||+||.+.||++...+.+.+|+|++.....+.+.+..|..|+.+|.++ .|.+|++|++|-..++.+||
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            44567999999999999999999998889999998877776777788999999999999 59999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      |||+- ..+|..+|...... ..+| .+..+..|++.|+.++|.+   ||||.||||.|+|+-. |.+||+|||+|..+.
T Consensus       438 vmE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence            99975 45899999875532 2334 6778999999999999999   9999999999999854 699999999998876


Q ss_pred             CCCCC--ceeecccccccccccccccc-----------CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc
Q 046084          245 SDSSN--RTVVAGTHGYIAPELAYTMV-----------LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ  311 (363)
Q Consensus       245 ~~~~~--~~~~~g~~~y~aPE~~~~~~-----------~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  311 (363)
                      .+...  ....+||+.||+||.+....           .+.++||||||||||+|+.|+.||......  ...+..+.++
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~--~aKl~aI~~P  588 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ--IAKLHAITDP  588 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH--HHHHHhhcCC
Confidence            54432  34568999999999886543           456899999999999999999998765422  2233444444


Q ss_pred             --cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          312 --RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       312 --~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                        .++.+.-.+..     ++.++++.||+.||.+|| ..+++.+-..+
T Consensus       589 ~~~Iefp~~~~~~-----~li~~mK~CL~rdPkkR~si~eLLqhpFl~  631 (677)
T KOG0596|consen  589 NHEIEFPDIPEND-----ELIDVMKCCLARDPKKRWSIPELLQHPFLQ  631 (677)
T ss_pred             CccccccCCCCch-----HHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence              23444322222     278899999999999999 99988765443

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-40  Score=292.96  Aligned_cols=256  Identities=26%  Similarity=0.367  Sum_probs=205.1

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|++|.||++... +++.+++|.+...... ...+.+.+|+++++.++||||+++++.+...+..++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            36788889999999999999765 6889999998765433 334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      |+++++|.+++....  ..+++..+..++.|++.|++|||+ .   +++|+||+|+||++++++.++|+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          80 YMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             ecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            999999999997653  368899999999999999999999 7   9999999999999999999999999998765322


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC--CchhhHHhhhcccCCCCCCChhhHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV--NPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ...  ...++..|+|||.+.+..++.++||||||+++|+|++|+.||......  ..............+.....    .
T Consensus       155 ~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~  228 (265)
T cd06605         155 LAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG----K  228 (265)
T ss_pred             Hhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChh----h
Confidence            211  156788999999998888999999999999999999999998654321  11112222222221111100    0


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ....+.++|.+||..||++|| +.+++..-+.+
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~  261 (265)
T cd06605         229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK  261 (265)
T ss_pred             cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence            222488999999999999999 99998876553

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.5e-40  Score=291.50  Aligned_cols=255  Identities=25%  Similarity=0.424  Sum_probs=197.8

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc--------hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET--------ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      +|.+.+.||+|+||.||+|.. .+|+.||+|.+.....        .....+.+..|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999965 4688999998764221        1223457888999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..++||||+++++|.+++....   .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999987653   688999999999999999999999   9999999999999999999999999998


Q ss_pred             eeccCCCC--Cceeecccccccccccccccc--CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCC
Q 046084          241 RLLHSDSS--NRTVVAGTHGYIAPELAYTMV--LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP  316 (363)
Q Consensus       241 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  316 (363)
                      ........  ......++..|+|||.+....  ++.++|+||||+++||+++|..||.....   ...............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~  232 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKRSAPP  232 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHHHHhhccccCCc
Confidence            76432211  122345788999999887654  78899999999999999999999854322   111111111111111


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      ............+.+++.+||+.+|++|| +.+++++-
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (272)
T cd06629         233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP  270 (272)
T ss_pred             CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence            11111011123588999999999999999 99988753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-40  Score=297.93  Aligned_cols=256  Identities=22%  Similarity=0.296  Sum_probs=194.6

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||+|+||.||++... +|+.|++|.+............+.+|+++++.++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999764 688999999876443333335677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +.+ +|.+++.....  .+++..++.++.||++||.|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            974 77777754332  589999999999999999999999   999999999999999999999999999976544333


Q ss_pred             Cceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc-----------------
Q 046084          249 NRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD-----------------  310 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----------------  310 (363)
                      ......++..|+|||.+.+. .++.++||||||+++|||++|..|+......  ......+..                 
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhhcc
Confidence            33334578899999987664 4788999999999999999999885332211  111111100                 


Q ss_pred             -ccCCCCCCChhh-----HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          311 -QRVPSPIDDQTV-----IQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       311 -~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                       ............     ......+.+++.+||+.||.+|| +.+++.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence             000000000000     01122478999999999999999 99987653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.8e-40  Score=295.44  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=197.0

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||++... +++.|++|.+...... ....+.+..|+.+++.++||||+++++.+..++..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999764 5789999988765422 233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999997654   588999999999999999999999   9999999999999999999999999988642110


Q ss_pred             C---------------CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc
Q 046084          247 S---------------SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ  311 (363)
Q Consensus       247 ~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  311 (363)
                      .               .......++..|+|||.+.+..++.++|+||||+++|||++|..||....   ...........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~~~~~~  231 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFGQVISD  231 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc
Confidence            0               00112346788999999988889999999999999999999999985432   22233333333


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHH
Q 046084          312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVS  350 (363)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~  350 (363)
                      ....+....   .....+.+++.+||+.||++|| +.++.
T Consensus       232 ~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~  268 (305)
T cd05609         232 DIEWPEGDE---ALPADAQDLISRLLRQNPLERLGTGGAF  268 (305)
T ss_pred             ccCCCCccc---cCCHHHHHHHHHHhccChhhccCccCHH
Confidence            222222111   1122488999999999999999 53333

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.3e-40  Score=297.56  Aligned_cols=252  Identities=27%  Similarity=0.460  Sum_probs=197.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCC----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      ..++|+..+.||+|+||.||+|.+. +|.    .||+|.+...... .....+.+|+.+++.++||||+++++++... .
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP-KANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            3567888999999999999999653 444    5788988755432 2235688999999999999999999998764 4


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++++||+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence            6789999999999999875432  478899999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc--cCCCC
Q 046084          242 LLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSP  316 (363)
Q Consensus       242 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~  316 (363)
                      ........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......    .......  ..+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~~~~~  233 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLLEKGERLPQP  233 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCCCCCCC
Confidence            65432221  112334678999999988889999999999999999997 899976432211    1122221  12211


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...      ...+.+++..||..+|++|| +.+++..|..
T Consensus       234 ~~~------~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         234 PIC------TIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             CCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111      12478899999999999999 9999998765

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.8e-40  Score=297.92  Aligned_cols=194  Identities=26%  Similarity=0.437  Sum_probs=158.8

Q ss_pred             cCeeeecCceeEEEEEeC---CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee--CCeEEEEEEe
Q 046084           94 KYCIGTGGYGSVYRAQLP---SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH--KKCMFLIYKY  168 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~  168 (363)
                      .+.||+|+||+||+|...   +++.||+|.+......    ..+.+|+.+++.++||||+++++++..  ....++++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            457999999999999754   4678999998755432    346789999999999999999998864  3568899999


Q ss_pred             ccCCChhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee----cCCCceEEEeec
Q 046084          169 MRRGSLFCILRNDD------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL----NSKLEAFVADFG  238 (363)
Q Consensus       169 ~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg  238 (363)
                      +.+ +|.+++....      ....+++..+..++.|++.||+|||+.   +++||||||+|||+    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            864 7877765321      123588999999999999999999999   99999999999999    456789999999


Q ss_pred             cceeccCCCC---Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCC
Q 046084          239 VARLLHSDSS---NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDL  295 (363)
Q Consensus       239 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~  295 (363)
                      ++........   ......+|+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            9987643321   1233568999999998876 4588999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.1e-40  Score=291.57  Aligned_cols=252  Identities=21%  Similarity=0.362  Sum_probs=201.7

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||+|+||.||++... +|..+|+|.+..........+.+.+|+.+++.++|+|++++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999764 578899999876533223346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC-ceEEEeeccceeccCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLLHSDS  247 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  247 (363)
                      +++++|.+++..... ..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++ .++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999999875432 2579999999999999999999999   999999999999998885 46999999997765433


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      .......|+..|+|||...+..++.++|+||||+++|||++|..||....   ..................     ....
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~  228 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVLKICQGYFAPISP-----NFSR  228 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHhcccCCCCCC-----CCCH
Confidence            33334468889999999888889999999999999999999999976432   222222233322221110     0112


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      .+.+++.+||+.+|++|| +.+++++-
T Consensus       229 ~~~~~i~~~l~~~p~~Rpt~~~ll~~~  255 (257)
T cd08225         229 DLRSLISQLFKVSPRDRPSITSILKRP  255 (257)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHhhCC
Confidence            488999999999999999 99998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.7e-40  Score=289.35  Aligned_cols=248  Identities=19%  Similarity=0.308  Sum_probs=184.3

Q ss_pred             eeeecCceeEEEEEeCCC---CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           96 CIGTGGYGSVYRAQLPSG---KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      .||+|+||.||++...++   ..+++|.+...... ...+.+.+|+.+++.++||||+++++.|......+++|||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS-KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh-HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            589999999999965433   34667766554332 23467899999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC--CC
Q 046084          173 SLFCILRNDDE-AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SN  249 (363)
Q Consensus       173 ~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  249 (363)
                      +|.+++..... ....++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++.......  ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999876432 22467777889999999999999999   99999999999999999999999999986432211  11


Q ss_pred             ceeecccccccccccccc-------ccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc---CCCCCC
Q 046084          250 RTVVAGTHGYIAPELAYT-------MVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR---VPSPID  318 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~  318 (363)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||.....   ...........   ...+..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQQVKLFKPQL  234 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhcccccCCCcc
Confidence            223457889999998743       245789999999999999997 5778754332   11222222111   111111


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ...   ....+.+++..|| .+|++|| +.++++.|.
T Consensus       235 ~~~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 ELP---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCC---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111   1123778999999 5799999 999988763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.4e-40  Score=290.41  Aligned_cols=253  Identities=28%  Similarity=0.455  Sum_probs=196.3

Q ss_pred             CcccCeeeecCceeEEEEEeC----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC------
Q 046084           91 FDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK------  160 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (363)
                      |.+.+.||+|+||.||+|.+.    +++.||+|.+..........+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567788999999999999653    4678999999765544444577889999999999999999999886542      


Q ss_pred             eEEEEEEeccCCChhhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEee
Q 046084          161 CMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADF  237 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  237 (363)
                      ..++++||+.+|+|.+++...   .....+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            247889999999998877432   1223578899999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cC
Q 046084          238 GVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RV  313 (363)
Q Consensus       238 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~  313 (363)
                      |++........  ......++..|++||.+.+..++.++||||||+++|||++ |+.||.....   ......+... ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~  234 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIKGNRL  234 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCCcC
Confidence            99886533221  1112234578999999988889999999999999999999 8888754322   1122222221 11


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..+...      ...+.+++.+||+.+|++|| +.+++..|..
T Consensus       235 ~~~~~~------~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         235 KQPPDC------LEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCCCCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            111111      12488999999999999999 9999998863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.2e-40  Score=291.69  Aligned_cols=258  Identities=23%  Similarity=0.385  Sum_probs=195.1

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHH-HhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHL-LSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||++... +|+.||+|.+......... ..+..|+.. ++..+|||++++++++...+..+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            47889999999999999999764 6899999998765432222 344445554 66679999999999999999999999


Q ss_pred             EeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          167 KYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       167 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      ||++ |+|.+++... .....+++..++.++.|++.||+|||++.  +++||||||+||+++.++.+||+|||++.....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9997 5887777542 22346899999999999999999999753  799999999999999999999999999876533


Q ss_pred             CCCCceeecccccccccccccc----ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          246 DSSNRTVVAGTHGYIAPELAYT----MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      .. ......++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||.....  .............+... .. 
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~-~~-  231 (283)
T cd06617         157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSPQLP-AE-  231 (283)
T ss_pred             cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCCCCC-cc-
Confidence            21 2223457889999998764    4468899999999999999999999864322  11122222222111111 10 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                        .....+.+++.+||+.+|++|| +.+++..-..+.
T Consensus       232 --~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  266 (283)
T cd06617         232 --KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL  266 (283)
T ss_pred             --ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence              1122488999999999999999 999988655544

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1e-39  Score=287.21  Aligned_cols=249  Identities=28%  Similarity=0.492  Sum_probs=198.8

Q ss_pred             CcccCeeeecCceeEEEEEeCC-----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           91 FDIKYCIGTGGYGSVYRAQLPS-----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +++.+.||.|+||.||++...+     +..||+|.+....... ..+.+..|+.+++.++|+|++++++++.+.+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            4567889999999999997643     4789999997654432 346889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++...... .+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        80 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             EeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            9999999999998764421 289999999999999999999999   999999999999999999999999999987644


Q ss_pred             CCCCce-eeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc-CCCCCCChhh
Q 046084          246 DSSNRT-VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR-VPSPIDDQTV  322 (363)
Q Consensus       246 ~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  322 (363)
                      ...... ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||....   ............ ...+..    
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~----  228 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVLEYLKKGYRLPKPEN----  228 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCCCCCCCc----
Confidence            322111 1236788999999888889999999999999999998 888876422   222222222221 111111    


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                        ....+.+++.+||+.||++|| +.+++..|
T Consensus       229 --~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      229 --CPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              222488899999999999999 99988764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.3e-40  Score=293.15  Aligned_cols=259  Identities=23%  Similarity=0.336  Sum_probs=200.2

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||+|++|.||+|.. .+|+.|++|++..........+.+.+|+.++++++|||++++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            478889999999999999976 4688999999887654334456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      + +++|.+++....  ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999987544  3589999999999999999999999   999999999999999999999999999987644321


Q ss_pred             -Cceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---------------
Q 046084          249 -NRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---------------  311 (363)
Q Consensus       249 -~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------  311 (363)
                       ......++..|+|||.+.+. .++.++||||+|+++|||++|.+||..................               
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence             12234578899999987654 4688999999999999999998887543221110000000000               


Q ss_pred             -cCCCCCCChhhH-----HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          312 -RVPSPIDDQTVI-----QDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       312 -~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                       ....+.......     .....+.+++.+||+.||++|| +.+++.+-.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~  284 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY  284 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence             000000000000     1123588999999999999999 999987643

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=285.62  Aligned_cols=248  Identities=27%  Similarity=0.441  Sum_probs=204.3

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||+|++|.||++... +++.|++|.+..........+.+.+|++++++++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999664 678999999987765445567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++....   .+++..++.++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            99999999987653   689999999999999999999999   999999999999999999999999999987655443


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC-CCCCCChhhHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV-PSPIDDQTVIQDII  327 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  327 (363)
                      ......++..|+|||...+..++.++||||+|+++|+|++|+.||.....   ............ ..+...      ..
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~------~~  225 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQDDHPPLPEGI------SP  225 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhccCCCCCCCCC------CH
Confidence            33445678899999998877788999999999999999999999865432   111222221111 111111      12


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .+.+++.+||+.+|++|| +.+++..
T Consensus       226 ~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         226 ELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             HHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            488999999999999999 9888753

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.8e-40  Score=292.21  Aligned_cols=251  Identities=23%  Similarity=0.358  Sum_probs=199.6

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|...+.||+|++|.||++.. .+++.+++|.+......  ..+.+.+|+.+++.++|||++++++++...+..++++||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            345557899999999999975 47889999988654332  235688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++...    ++++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||.+........
T Consensus        98 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          98 LEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            9999999998762    588999999999999999999999   999999999999999999999999998876543333


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL  328 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ......|+..|+|||...+..++.++||||||+++|||++|+.||.....   ............+.....   ......
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~  244 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDNLPPKLKNL---HKVSPR  244 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhcCCCCCccc---ccCCHH
Confidence            33345688899999999888899999999999999999999999754321   122222222211111111   001124


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +.+++.+||+.+|++|| +.+++++-..
T Consensus       245 l~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (285)
T cd06648         245 LRSFLDRMLVRDPAQRATAAELLNHPFL  272 (285)
T ss_pred             HHHHHHHHcccChhhCcCHHHHccCccc
Confidence            88999999999999999 9998875443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3e-40  Score=296.40  Aligned_cols=258  Identities=23%  Similarity=0.295  Sum_probs=197.5

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLI  165 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  165 (363)
                      ++|++.+.||+|+||.||+|... +++.+++|.++...........+.+|+.++++++||||+++++++...  +..+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            47888999999999999999775 578999999976554433345677899999999999999999999877  789999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      +||+.+ +|.+++.....  .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999975 89888865442  589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc----------cCC
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ----------RVP  314 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~  314 (363)
                      .........++..|+|||.+.+. .++.++|+||||+++|+|++|..||..................          .++
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            43333334578889999987654 4688999999999999999999998654321111100000000          000


Q ss_pred             --------CCCC---ChhhHH--HHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          315 --------SPID---DQTVIQ--DIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       315 --------~~~~---~~~~~~--~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                              ....   ......  ....+.++|.+||+.||++|| +.|++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                    0000   000000  122478899999999999999 9998864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-40  Score=311.26  Aligned_cols=254  Identities=23%  Similarity=0.308  Sum_probs=193.8

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ..|.+.+.||+|+||.||++.+. .++.||+|....        ..+.+|++++++++|+||+++++++...+..+++||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46899999999999999999764 578899996432        335679999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      ++. ++|.+++.....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||+++......
T Consensus       241 ~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        241 KYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             ccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            995 688888765432  589999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CC--ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC----CchhhHHhhhcc-c-----CCC
Q 046084          248 SN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV----NPKIMLIDLLDQ-R-----VPS  315 (363)
Q Consensus       248 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~-~-----~~~  315 (363)
                      ..  .....||..|+|||++.+..++.++|||||||++|||++|..|+-.....    ........++.. .     .+.
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            21  22346899999999999999999999999999999999987664221110    001111111111 0     000


Q ss_pred             -------------------CCCChhhH----HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          316 -------------------PIDDQTVI----QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       316 -------------------~~~~~~~~----~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                         +......+    .....+.+||.+||+.||.+|| +.|++++-.++
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~  459 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ  459 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence                               00000001    0112477899999999999999 99999876543

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9e-40  Score=293.47  Aligned_cols=263  Identities=21%  Similarity=0.301  Sum_probs=197.2

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|++|.||+|... +|+.|++|.+..........+.+..|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            47889999999999999999764 68899999987654333334568889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC-CCceEEEeeccceeccCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS-KLEAFVADFGVARLLHSD  246 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~  246 (363)
                      |++ ++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 478777754432 2467888889999999999999999   9999999999999985 567999999999765433


Q ss_pred             CCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCC----------
Q 046084          247 SSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS----------  315 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------  315 (363)
                      ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+...............          
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            322333456889999998765 457889999999999999999999986543211111111110000000          


Q ss_pred             --------CCCCh--hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          316 --------PIDDQ--TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       316 --------~~~~~--~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                              .....  ........+.+++.+||+.||++|| +.+++.+-..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence                    00000  0001122478899999999999999 99998765544

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.9e-40  Score=291.31  Aligned_cols=246  Identities=28%  Similarity=0.471  Sum_probs=192.5

Q ss_pred             eeeecCceeEEEEEeCC-------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           96 CIGTGGYGSVYRAQLPS-------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      .||+|+||.||+|+..+       +..+++|.+...... .....+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD-QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccch-hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            58999999999997642       257899987654322 2246788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC-----ceEEEeecc
Q 046084          169 MRRGSLFCILRNDD----EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-----EAFVADFGV  239 (363)
Q Consensus       169 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-----~~kl~Dfg~  239 (363)
                      +++++|.+++....    ....+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986532    122478899999999999999999999   999999999999999877     899999999


Q ss_pred             ceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc-ccCCC
Q 046084          240 ARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPS  315 (363)
Q Consensus       240 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~  315 (363)
                      +........  ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+.. .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~~~~  234 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTAGGRLQK  234 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhcCCccCC
Confidence            876532221  1112235678999999998889999999999999999998 9999764322   111111111 11222


Q ss_pred             CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      +...      +..+.+++.+||+.+|++|| +.++++.|.
T Consensus       235 ~~~~------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         235 PENC------PDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cccc------hHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            2111      22488999999999999999 999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=310.78  Aligned_cols=251  Identities=25%  Similarity=0.426  Sum_probs=204.8

Q ss_pred             eeeecCceeEEEEEeCC-CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCCh
Q 046084           96 CIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      .||+|.||+||-|++.+ ...+|||.+...+...  .+-+.+|+.+-++++|.|||+++|.+.+++..-+.||-++||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~--~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE--VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchh--hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            59999999999997654 4579999998766543  46788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec-CCCceEEEeeccceeccCCCCCceee
Q 046084          175 FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN-SKLEAFVADFGVARLLHSDSSNRTVV  253 (363)
Q Consensus       175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~  253 (363)
                      .++++..-+..+-.+..+-.+.+||++||.|||.+   .|||||||-.|||++ -.|.+||+|||-++.+..-.....+.
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            99998765543347888889999999999999999   999999999999996 47999999999999886655666778


Q ss_pred             ccccccccccccccc--cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          254 AGTHGYIAPELAYTM--VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       254 ~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      .||..|||||++..+  .|..++|||||||++.||.||++||-.............+.+-.++.|.      +-..+...
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe------elsaeak~  810 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE------ELSAEAKN  810 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcH------HHHHHHHH
Confidence            899999999999854  4889999999999999999999998665443322222223332222222      22234778


Q ss_pred             HHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          332 IVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       332 li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      +|.+|+.+||.+|| +.+++..-..++
T Consensus       811 FilrcFepd~~~R~sA~~LL~DpFlq~  837 (1226)
T KOG4279|consen  811 FILRCFEPDPCDRPSAKDLLQDPFLQH  837 (1226)
T ss_pred             HHHHHcCCCcccCccHHHhccCccccc
Confidence            99999999999999 999987655443

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.5e-39  Score=286.23  Aligned_cols=251  Identities=22%  Similarity=0.350  Sum_probs=196.4

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE---TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCM  162 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  162 (363)
                      ++|++.+.||+|+||.||++.. .++..|++|.+....   ......+.+.+|+.+++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5789999999999999999976 458899999886432   1223356788999999999999999999988764  467


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      +++|||+++++|.+++....   .+++...++++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999987543   478888999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCC---CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCC
Q 046084          243 LHSDS---SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       243 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      .....   .......++..|+|||.+.+..++.++||||||+++|||++|+.||.....   ............ .+.. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~-~~~~-  230 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPT-NPVL-  230 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHHHHHhcCCC-CCCC-
Confidence            53211   112234578899999999888889999999999999999999999865422   111222221111 1111 


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                        .......+.+++.+||. +|++|| +.+++..-
T Consensus       231 --~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         231 --PPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             --chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence              11122247789999995 999999 98887653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.4e-39  Score=284.61  Aligned_cols=250  Identities=29%  Similarity=0.432  Sum_probs=206.2

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLIY  166 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  166 (363)
                      +|...+.||+|++|.||+|... ++..|++|.+..........+.+.+|+..+++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777889999999999999775 688999999877665444567899999999999999999999999988  8899999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999987654   689999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CC--CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc--ccCCCCCCChhh
Q 046084          247 SS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD--QRVPSPIDDQTV  322 (363)
Q Consensus       247 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  322 (363)
                      ..  ......++..|+|||...+...+.++||||||+++|+|++|..||....  +..........  .....+...   
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~---  229 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEPPEIPEHL---  229 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccCCCcCCCccc---
Confidence            32  1334567889999999988889999999999999999999999987654  12222222221  111111111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                         ...+.+++.+||+.||++|| +.+++..-
T Consensus       230 ---~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~  258 (260)
T cd06606         230 ---SEEAKDFLRKCLRRDPKKRPTADELLQHP  258 (260)
T ss_pred             ---CHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence               22488999999999999999 99988753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.7e-40  Score=289.74  Aligned_cols=239  Identities=22%  Similarity=0.426  Sum_probs=186.6

Q ss_pred             CeeeecCceeEEEEEeCC--------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           95 YCIGTGGYGSVYRAQLPS--------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      +.||+|+||.||+|....        ..+|++|.+....  ....+.+.+|+.+++.++|||++++++++...+..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            368999999999996532        2348888875433  233467889999999999999999999999988999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc--------eEEEeec
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE--------AFVADFG  238 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--------~kl~Dfg  238 (363)
                      ||+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.        ++++|||
T Consensus        79 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          79 EYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             ecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence            99999999999976543  578999999999999999999999   9999999999999987765        5899999


Q ss_pred             cceeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCC-CCCCCCcCCCchhhHHhhhcccCCCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGR-HPGDLLSSVNPKIMLIDLLDQRVPSP  316 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~  316 (363)
                      ++.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+.......    ...........+
T Consensus       154 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~~  225 (258)
T cd05078         154 ISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK----KLQFYEDRHQLP  225 (258)
T ss_pred             cccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH----HHHHHHccccCC
Confidence            8865432    223457888999999876 45788999999999999999984 6654332211    111122222222


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ....      ..+.+++.+||+.||++|| +.++++.|.
T Consensus       226 ~~~~------~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         226 APKW------TELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             CCCc------HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1111      1388999999999999999 999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.7e-40  Score=292.33  Aligned_cols=258  Identities=22%  Similarity=0.325  Sum_probs=197.8

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||.|++|.||+|+.. +|..||+|.+....... ..+.+..|+.+++.++|||++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc-chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            5888999999999999999774 68899999987654321 235677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++ +|.+++........+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++|+|||++........
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            985 8888886654444689999999999999999999999   999999999999999999999999999976543333


Q ss_pred             Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhh-----------------c
Q 046084          249 NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL-----------------D  310 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------------~  310 (363)
                      ......++..|++||.+.+ ..++.++||||||+++|+|++|+.||...+..+......+..                 .
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            3333457888999998765 456889999999999999999999986543221111111100                 0


Q ss_pred             ccCCCCCCChh---hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          311 QRVPSPIDDQT---VIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       311 ~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ...+.......   .......+.+++..||+.||++|| +.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00000000000   001123478999999999999999 9888754

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=292.51  Aligned_cols=257  Identities=23%  Similarity=0.310  Sum_probs=194.3

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|++|.||+|... +++.||+|.+....... ....+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999764 67899999987543221 12346789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+.+ +|.+++.....  .+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          84 YLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9985 89888865432  588999999999999999999999   99999999999999999999999999987643322


Q ss_pred             CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc-hhhHHhhhcc--------------
Q 046084          248 SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDLLDQ--------------  311 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~--------------  311 (363)
                      .......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........ .....+....              
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            22233346788999998765 4578899999999999999999999864431100 0000000000              


Q ss_pred             ----cCCCCCCCh-----hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 ----RVPSPIDDQ-----TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 ----~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                          ........+     ........+.+++.+||+.||++|| +.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                000000000     0000012467899999999999999 9888764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.7e-39  Score=283.12  Aligned_cols=249  Identities=30%  Similarity=0.510  Sum_probs=202.0

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|+..+.||+|++|.||++... +++.+++|++.....  .....+.+|++.++.++|+|++++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            4778899999999999999775 688999999977654  2347788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++++|.+++....  ..+++..+..++.|++.|+++||..   +++||||+|+||++++++.++|+|||.+........
T Consensus        79 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          79 CSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            99999999987653  2689999999999999999999998   999999999999999999999999999876644322


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL  328 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+...   ..........+. ....  ......
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~-~~~~--~~~~~~  226 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFKIATNGPPG-LRNP--EKWSDE  226 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhcCCCC-cCcc--cccCHH
Confidence             334568889999999988888999999999999999999999986543211   111111111111 1111  001224


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      +.+++.+||+.||++|| +.+++..
T Consensus       227 ~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         227 FKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcC
Confidence            88999999999999999 9988764

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.6e-39  Score=285.60  Aligned_cols=252  Identities=27%  Similarity=0.407  Sum_probs=206.4

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||.|+||.||++... ++..+++|.+............+..|+++++.++|||++++.+.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999764 688999999987655444557788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          169 MRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       169 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999987642 123689999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      .......+++.|+|||...+..++.++|+||+|+++|+|++|+.||+...   .............+....     ....
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~  229 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQYPPIPS-----QYSS  229 (258)
T ss_pred             ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcCCCCCCCC-----CCCH
Confidence            33344568889999999888889999999999999999999999976543   222222222222221111     1112


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .+.+++.+||+.+|++|| +.+++..
T Consensus       230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         230 ELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            488999999999999999 9998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.2e-40  Score=301.38  Aligned_cols=192  Identities=24%  Similarity=0.357  Sum_probs=163.7

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ....+|++.+.||+|+||.||+|... +++.||+|.....        ....|+.++++++||||+++++++...+..++
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            44568999999999999999999764 5678999975432        23458899999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      |+|++. ++|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus       135 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            999995 58888876533  2589999999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCC
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP  292 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  292 (363)
                      .. .......||..|+|||++.+..++.++|||||||++|||+++..|
T Consensus       209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        209 VA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             cC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence            22 222335689999999999998999999999999999999986554

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-40  Score=292.83  Aligned_cols=257  Identities=23%  Similarity=0.287  Sum_probs=195.4

Q ss_pred             CcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           91 FDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      |++.+.||.|++|.||+|.. .+|..|++|++..........+.+..|+++++.++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56788999999999999975 47899999998765433333356788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  249 (363)
                      + ++|.+++..... ..+++..++.++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 689988865432 3589999999999999999999999   9999999999999999999999999999765433322


Q ss_pred             ceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc-----------------c
Q 046084          250 RTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD-----------------Q  311 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----------------~  311 (363)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.........+...                 .
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            2333567889999987654 578899999999999999999999864432111000000000                 0


Q ss_pred             cCCC---CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 RVPS---PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 ~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ..+.   .............+.+++.+||+.||++|| +.|++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000   000000001112478999999999999999 9988764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.8e-39  Score=292.09  Aligned_cols=251  Identities=27%  Similarity=0.388  Sum_probs=197.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .+.|.+.+.||+|+||.||+|... +++.||+|.+..... .......+.+|+++++.++|||++++.+++...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            456888999999999999999764 688999998865432 223346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      +||+. |++.+++.....  .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 577666654322  589999999999999999999999   999999999999999999999999999876432


Q ss_pred             CCCCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          246 DSSNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      .    ....++..|+|||.+.   ...++.++||||||+++|||++|+.||.....   ......+.....+... ..  
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~-~~--  237 (307)
T cd06607         168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPTLS-SN--  237 (307)
T ss_pred             C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCCCC-ch--
Confidence            2    2345788999999874   35678899999999999999999999754322   1111222211111111 11  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                       .....+.+++.+||+.||++|| +.+++.+...
T Consensus       238 -~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  270 (307)
T cd06607         238 -DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV  270 (307)
T ss_pred             -hhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence             1122488999999999999999 9999886554

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.6e-40  Score=296.45  Aligned_cols=263  Identities=28%  Similarity=0.355  Sum_probs=197.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  164 (363)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.+............+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            46799999999999999999976 4689999999875443222223466799999999999999999998765  56899


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+.+ +|.+++....  ..+++..++.++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 7888776533  3589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc------------
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ------------  311 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------  311 (363)
                      ..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..............            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            43323333345778999998765 55789999999999999999999998654322111111110000            


Q ss_pred             ----cC--C-CCCCC-hhh-HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          312 ----RV--P-SPIDD-QTV-IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       312 ----~~--~-~~~~~-~~~-~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                          ..  + .+... ... ......+.++|.+||+.||++|| +.+++.+-+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                00  0 00000 000 00122467899999999999999 99999876654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-40  Score=300.32  Aligned_cols=253  Identities=24%  Similarity=0.377  Sum_probs=214.6

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ....|.+...||+|.|+.|.++++ .++..||+|.+.+...+......+.+|+++|..++||||++++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            356789999999999999999954 4789999999998877766667789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+.+|.+++|+.+++   +..+.....++.|+.+|++|||++   .|+|||||++|+||+.+.++||+|||++..+. 
T Consensus       134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD-  206 (596)
T ss_pred             EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-
Confidence            99999999999998876   466678888999999999999999   99999999999999999999999999999886 


Q ss_pred             CCCCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ......+.+|++.|.|||++.+..| .+++|+||+|+++|.|+.|..||+..   +.+....+.+.+++.-+...+..  
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~---~lk~Lr~rvl~gk~rIp~~ms~d--  281 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ---NLKELRPRVLRGKYRIPFYMSCD--  281 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc---ccccccchheeeeecccceeech--
Confidence            3445566789999999999998776 57899999999999999999998753   22333344444444333322222  


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                          ..+|+.++|-.+|.+|+ ..++....+.
T Consensus       282 ----ce~lLrk~lvl~Pskr~~~dqim~~~W~  309 (596)
T KOG0586|consen  282 ----CEDLLRKFLVLNPSKRGPCDQIMKDRWR  309 (596)
T ss_pred             ----hHHHHHHhhccCccccCCHHHhhhhccc
Confidence                66789999999999999 9988877654

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.9e-39  Score=292.44  Aligned_cols=193  Identities=27%  Similarity=0.446  Sum_probs=157.7

Q ss_pred             CeeeecCceeEEEEEeC---CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee--CCeEEEEEEec
Q 046084           95 YCIGTGGYGSVYRAQLP---SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH--KKCMFLIYKYM  169 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  169 (363)
                      ..||+|+||.||+|+..   ++..||+|.+......    ..+.+|+.+++.++||||+++++++..  ....++++||+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            57999999999999764   4568999998754432    356789999999999999999998854  45789999998


Q ss_pred             cCCChhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee----cCCCceEEEeecc
Q 046084          170 RRGSLFCILRND------DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL----NSKLEAFVADFGV  239 (363)
Q Consensus       170 ~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~  239 (363)
                      .+ +|.+++...      .....+++..+..++.|++.||+|||+.   +++||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            75 777766422      1223588999999999999999999999   99999999999999    4567999999999


Q ss_pred             ceeccCCCC---Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCC
Q 046084          240 ARLLHSDSS---NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDL  295 (363)
Q Consensus       240 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~  295 (363)
                      ++.......   ......+|..|+|||.+.+ ..++.++||||||+++|||++|++||..
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            987643322   1223467899999998876 4578999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-39  Score=292.44  Aligned_cols=256  Identities=23%  Similarity=0.268  Sum_probs=193.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|.+.+.||+|+||.||+|.. .+|..|++|.+...... .....+.+|+.+++.++|+||+++++++...+..++++
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            46799999999999999999965 46889999998654322 11235678999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+. +++.+++.....  .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 677766654322  477888889999999999999999   9999999999999999999999999998765433


Q ss_pred             CCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc---------------
Q 046084          247 SSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD---------------  310 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------------  310 (363)
                      ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||+.....  .........               
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhh
Confidence            333333457889999998865 45788999999999999999999998754321  011111000               


Q ss_pred             ------ccCCC--CCCChh---hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          311 ------QRVPS--PIDDQT---VIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       311 ------~~~~~--~~~~~~---~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                            .....  +.....   .......+.+++.+|++.||++|| +.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                  00000  000000   001123478899999999999999 9888754

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.1e-39  Score=293.03  Aligned_cols=261  Identities=22%  Similarity=0.268  Sum_probs=195.0

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCe-----
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKC-----  161 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  161 (363)
                      ++|++.+.||+|+||.||+|... +++.||+|.+............+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999764 6889999988765433333456788999999995 6999999999887665     


Q ss_pred             EEEEEEeccCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC-CCceEEEeec
Q 046084          162 MFLIYKYMRRGSLFCILRNDDE--AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS-KLEAFVADFG  238 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg  238 (363)
                      .+++|||+++ +|.+++.....  ...+++..++.++.||++||+|||+.   +++||||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 78887754321  24689999999999999999999999   9999999999999998 8999999999


Q ss_pred             cceeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc-----
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR-----  312 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----  312 (363)
                      ++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+...............     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            98765433333333356788999998764 457899999999999999999999986533211111000000000     


Q ss_pred             -----------CCC--CCCChh-hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          313 -----------VPS--PIDDQT-VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       313 -----------~~~--~~~~~~-~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                                 .+.  +..... .......+.++|.+||+.||++|| +.+++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~  292 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP  292 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCC
Confidence                       000  000000 001123488999999999999999 99888653

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.9e-39  Score=287.71  Aligned_cols=247  Identities=26%  Similarity=0.301  Sum_probs=193.0

Q ss_pred             eeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCCh
Q 046084           97 IGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus        97 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      ||+|+||+||++.. .+|+.|++|.+...... ......+..|+++++.++|||++++++.+...+..+++|||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999965 46889999998754322 22234667899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeec
Q 046084          175 FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA  254 (363)
Q Consensus       175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  254 (363)
                      .+++..... ..+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||.+..... ........
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA  155 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccccc
Confidence            999875443 3589999999999999999999999   999999999999999999999999999876543 22223345


Q ss_pred             cccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH-hhhcccCCCCCCChhhHHHHHHHHHHH
Q 046084          255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI-DLLDQRVPSPIDDQTVIQDIILVSKIV  333 (363)
Q Consensus       255 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li  333 (363)
                      ++..|+|||.+.+..++.++||||||+++|+|++|+.||............. .........+...      ...+.+++
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~li  229 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF------SPEAKDLC  229 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccC------CHHHHHHH
Confidence            7789999999888889999999999999999999999986544322111111 1111111111111      12488999


Q ss_pred             HHccCCCCCCCC-hHH-HHHHHh
Q 046084          334 FACLRSKPTSRP-MQR-VSQEFL  354 (363)
Q Consensus       334 ~~cl~~dP~~RP-~~~-v~~~l~  354 (363)
                      .+||+.||++|| ..+ .+.+++
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~ll  252 (277)
T cd05577         230 EALLQKDPEKRLGCRGGSADEVR  252 (277)
T ss_pred             HHHccCChhHccCCCcccHHHHH
Confidence            999999999999 666 444443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-40  Score=305.18  Aligned_cols=250  Identities=25%  Similarity=0.421  Sum_probs=200.5

Q ss_pred             cccCeeeecCceeEEEEEe-CCCCEEEEEEeccc--cchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe--EEEEE
Q 046084           92 DIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHS--ETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC--MFLIY  166 (363)
Q Consensus        92 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  166 (363)
                      +....||+|+|-+||+|.+ .+|..||--.++..  .......++|..|+.+|+.|+||||+++|.++.+...  +-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4456799999999999965 35666664333222  2234446889999999999999999999999988765  77899


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-CceEEEeeccceeccC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHS  245 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~  245 (363)
                      |.+..|+|..|..+.+   ..+.+.+..|+.||++||.|||++ .|+|+|||||..||||+.+ |.|||+|+|+|.....
T Consensus       123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            9999999999998876   688999999999999999999987 6799999999999999875 9999999999988754


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      ...  ..+.|||.|||||... ..|++.+||||||++++||.|+..||..=  .++-.....+..+..|.....-.+   
T Consensus       199 s~a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC--~n~AQIYKKV~SGiKP~sl~kV~d---  270 (632)
T KOG0584|consen  199 SHA--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC--TNPAQIYKKVTSGIKPAALSKVKD---  270 (632)
T ss_pred             ccc--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh--CCHHHHHHHHHcCCCHHHhhccCC---
Confidence            433  3478999999999877 77999999999999999999999997532  244445555555554433221111   


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                       ..++++|.+||.. .++|| +.|++..-.+
T Consensus       271 -Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff  299 (632)
T KOG0584|consen  271 -PEVREFIEKCLAT-KSERLSAKELLKDPFF  299 (632)
T ss_pred             -HHHHHHHHHHhcC-chhccCHHHHhhChhh
Confidence             1489999999999 99999 9999876543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.6e-39  Score=287.34  Aligned_cols=246  Identities=22%  Similarity=0.266  Sum_probs=186.1

Q ss_pred             eeeecCceeEEEEEe-CCCCEEEEEEeccccchHH-HHHHHHHHHHHH---hcCCCCceeeeeeEEeeCCeEEEEEEecc
Q 046084           96 CIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELA-FLESFQTEAHLL---SQIRHRNIVKLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (363)
                      .||+|+||.||++.. .+++.+|+|.+........ ....+..|..++   ...+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999976 4688999998865432111 112233444333   34479999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCc
Q 046084          171 RGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR  250 (363)
Q Consensus       171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  250 (363)
                      +++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.......  .
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~  152 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence            999999887554   589999999999999999999999   99999999999999999999999999987553322  2


Q ss_pred             eeeccccccccccccc-cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHH
Q 046084          251 TVVAGTHGYIAPELAY-TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILV  329 (363)
Q Consensus       251 ~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  329 (363)
                      ....|+..|+|||... +..++.++||||+|+++|||++|..||......................+..      ....+
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~  226 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS------FSPEL  226 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccc------cCHHH
Confidence            2346899999999876 4568899999999999999999999986544332222111111111111111      11248


Q ss_pred             HHHHHHccCCCCCCCC------hHHHHHHHhc
Q 046084          330 SKIVFACLRSKPTSRP------MQRVSQEFLV  355 (363)
Q Consensus       330 ~~li~~cl~~dP~~RP------~~~v~~~l~~  355 (363)
                      .+++.+||+.||++||      +.+++++...
T Consensus       227 ~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~  258 (279)
T cd05633         227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF  258 (279)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence            8999999999999998      6666665444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.8e-39  Score=282.89  Aligned_cols=235  Identities=28%  Similarity=0.423  Sum_probs=192.1

Q ss_pred             eeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCCh
Q 046084           97 IGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus        97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      ||.|++|.||++... +++.|++|.+..... .....+.+..|+.+++.++||||+++++++.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999774 488999999875442 223346789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeec
Q 046084          175 FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA  254 (363)
Q Consensus       175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  254 (363)
                      .+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~  153 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC  153 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence            99997654   488999999999999999999999   99999999999999999999999999998764432 223346


Q ss_pred             cccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc--ccCCCCCCChhhHHHHHHHHHH
Q 046084          255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD--QRVPSPIDDQTVIQDIILVSKI  332 (363)
Q Consensus       255 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l  332 (363)
                      ++..|++||.+.+..++.++|+||||+++|+|++|..||..... +.......+..  .....+...      ...+.++
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~  226 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKLEFPNYI------DKAAKDL  226 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCCCCCccc------CHHHHHH
Confidence            78899999998888889999999999999999999999875542 22233333332  222222211      2248999


Q ss_pred             HHHccCCCCCCCC
Q 046084          333 VFACLRSKPTSRP  345 (363)
Q Consensus       333 i~~cl~~dP~~RP  345 (363)
                      +.+||+.||++||
T Consensus       227 i~~~l~~~p~~R~  239 (262)
T cd05572         227 IKQLLRRNPEERL  239 (262)
T ss_pred             HHHHccCChhhCc
Confidence            9999999999999

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.9e-39  Score=289.73  Aligned_cols=246  Identities=23%  Similarity=0.391  Sum_probs=195.8

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGS  173 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  173 (363)
                      ..||+|+||.||++.. .+++.||+|++.....  .....+..|+.+++.++|+|++++++.+...+..+++|||+++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            5699999999999966 4788999998865433  224678899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceee
Q 046084          174 LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV  253 (363)
Q Consensus       174 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  253 (363)
                      |.+++...    .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++.............
T Consensus       104 L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657         104 LTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            99987543    478999999999999999999999   99999999999999999999999999987654433333345


Q ss_pred             ccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHH
Q 046084          254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIV  333 (363)
Q Consensus       254 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  333 (363)
                      .++..|+|||...+..++.++|+||+|+++|+|++|..||......   ... .......+......  ......+.+++
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~-~~~~~~~~~~~~~~--~~~~~~l~~li  250 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAM-KMIRDNLPPKLKNL--HKVSPSLKGFL  250 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH-HHHHhhCCcccCCc--ccCCHHHHHHH
Confidence            6888999999988888899999999999999999999997643221   111 11111111111000  00112378899


Q ss_pred             HHccCCCCCCCC-hHHHHHHHhc
Q 046084          334 FACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       334 ~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+||+.||.+|| +.+++.+-..
T Consensus       251 ~~~l~~~P~~R~~~~~ll~~~~~  273 (292)
T cd06657         251 DRLLVRDPAQRATAAELLKHPFL  273 (292)
T ss_pred             HHHHhCCcccCcCHHHHhcChHH
Confidence            999999999999 9998886443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-39  Score=290.57  Aligned_cols=260  Identities=23%  Similarity=0.309  Sum_probs=195.1

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|...+.||+|+||.||++.. .+++.||+|.+...... .....+..|+..+.++. |+||+++++++..++..+++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            3566677899999999999965 46789999998765433 23467889999999995 999999999999998999999


Q ss_pred             EeccCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          167 KYMRRGSLFCILRN--DDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       167 e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||+.. ++.++...  ......+++..+..++.|++.||+|||+..  +++||||||+||+++.++.++|+|||++....
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            99864 55443321  111236899999999999999999999632  89999999999999999999999999987653


Q ss_pred             CCCCCceeeccccccccccccccc---cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTM---VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      .... .....++..|+|||.+.+.   .++.++||||||+++|||++|+.||.....  .............+... ...
T Consensus       160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~-~~~  235 (288)
T cd06616         160 DSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILS-NSE  235 (288)
T ss_pred             cCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCC-CcC
Confidence            3222 2233578899999998765   688999999999999999999999865431  11112222222111111 111


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .......+.+|+.+||+.||++|| +.+++..-..+
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~  271 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK  271 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence            011223588999999999999999 99998875553

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.8e-39  Score=295.59  Aligned_cols=260  Identities=22%  Similarity=0.301  Sum_probs=197.7

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  159 (363)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|.+............+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999965 4788999999875433333346677899999999999999999988644      


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      ...++||||+.+ +|.+.+..     .++...+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence            347999999964 78777753     278889999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH-------------
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI-------------  306 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~-------------  306 (363)
                      +........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.........             
T Consensus       165 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         165 ARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             ceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            987543222 233457889999999999899999999999999999999999986432110000000             


Q ss_pred             ------hhhcccCCC--------------CC-CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          307 ------DLLDQRVPS--------------PI-DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       307 ------~~~~~~~~~--------------~~-~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                            .........              +. ...........+.+++.+||+.||++|| +.|++..-+.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence                  000000000              00 0000001123478999999999999999 99999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.6e-38  Score=288.45  Aligned_cols=251  Identities=25%  Similarity=0.374  Sum_probs=197.1

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      +.|+..+.||+|+||.||++.. .++..||+|.+..... .......+..|+++++.++|||++++++++.+....+++|
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            3477788899999999999975 4688999999875432 2233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+.+ ++.+++....  ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++..... 
T Consensus       105 e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         105 EYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             eCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            99975 7777765433  2589999999999999999999999   999999999999999999999999999865432 


Q ss_pred             CCCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          247 SSNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                         .....++..|+|||.+.   ...++.++||||||+++|||++|+.||....   .......+.....+... ...  
T Consensus       178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~-~~~--  248 (317)
T cd06635         178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPTLQ-SNE--  248 (317)
T ss_pred             ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhccCCCCC-Ccc--
Confidence               22345788999999874   4568889999999999999999999975432   22222223222221111 111  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       ....+.+++.+||+.+|.+|| +.+++..+...
T Consensus       249 -~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         249 -WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             -ccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence             112488999999999999999 99999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=279.06  Aligned_cols=265  Identities=21%  Similarity=0.343  Sum_probs=217.0

Q ss_pred             HHHHHHHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeee
Q 046084           81 FQEMIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG  154 (363)
Q Consensus        81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  154 (363)
                      .+++.+...+++....+-+|.||.||.|.+.      +.+.|.+|.++....+.+ ...+..|.-++..+.|||+..+.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQ-v~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQ-VNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHH-HHHHHHHHHHHhcCcCCCccceeE
Confidence            3566677788999999999999999999543      445688888887766544 577899999999999999999999


Q ss_pred             EEeeC-CeEEEEEEeccCCChhhhhh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC
Q 046084          155 FCLHK-KCMFLIYKYMRRGSLFCILR-----NDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS  228 (363)
Q Consensus       155 ~~~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~  228 (363)
                      ++.+. ...++++.++..|+|..++.     .......++..+...++.|++.|++|||.+   +++|.||..+|+++|+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence            98765 46788999999999999998     444455688889999999999999999999   9999999999999999


Q ss_pred             CCceEEEeeccceeccCCCCCc--eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhH
Q 046084          229 KLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIML  305 (363)
Q Consensus       229 ~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~  305 (363)
                      ..++||+|=.+++.+....+..  ...-.+..||+||.+....|+.++||||||+++|||+| |+.|+...   ++.++.
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI---DPfEm~  508 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI---DPFEME  508 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc---CHHHHH
Confidence            9999999999998765443321  11224568999999999999999999999999999998 99996544   444444


Q ss_pred             Hhhhc-ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          306 IDLLD-QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       306 ~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      .-+.+ .++..|.+++.      ++..++..||..+|++|| +.|++.-|..++.
T Consensus       509 ~ylkdGyRlaQP~NCPD------eLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  509 HYLKDGYRLAQPFNCPD------ELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             HHHhccceecCCCCCcH------HHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            44443 36667776653      388999999999999999 9999988866554

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.6e-39  Score=286.89  Aligned_cols=244  Identities=28%  Similarity=0.393  Sum_probs=192.0

Q ss_pred             CCcccCeeeecCceeEEEEEe----CCCCEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL----PSGKKVALKKLHHSET--ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (363)
                      +|++.+.||+|+||.||++..    .+|..||+|.+.....  .....+.+..|+.+++.+ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999975    3688999999875432  122346678899999999 699999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++++||+++++|.+++....   .+++..+..++.|+++||.|||+.   +++||||+|+|||++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999987654   588899999999999999999999   999999999999999999999999999976


Q ss_pred             ccCCCC-Cceeeccccccccccccccc--cCCccccchHHHHHHHHHHhCCCCCCCCcCCCc-hhhHHhhhcccCCCCCC
Q 046084          243 LHSDSS-NRTVVAGTHGYIAPELAYTM--VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDLLDQRVPSPID  318 (363)
Q Consensus       243 ~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~  318 (363)
                      ...... ......++..|+|||.+...  .++.++||||||+++|+|++|..||........ ............+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  234 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCcc
Confidence            543221 22234578899999988653  467899999999999999999999864332222 11222222222222221


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                      .+      ..+.+++.+||+.||++||
T Consensus       235 ~~------~~~~~ll~~~l~~~p~~R~  255 (290)
T cd05613         235 MS------ALAKDIIQRLLMKDPKKRL  255 (290)
T ss_pred             CC------HHHHHHHHHHhcCCHHHhc
Confidence            11      2478899999999999996

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.1e-39  Score=292.03  Aligned_cols=259  Identities=21%  Similarity=0.322  Sum_probs=191.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK------  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (363)
                      -++|++.+.||+|+||.||++... +++.||+|.+............+.+|+.++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999764 6889999988654433222345678999999999999999999987654      


Q ss_pred             --eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          161 --CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       161 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                        ..+++|||+.+ +|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence              45999999965 7877776543  2589999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCCC----ceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc-
Q 046084          239 VARLLHSDSSN----RTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR-  312 (363)
Q Consensus       239 ~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-  312 (363)
                      ++.........    .....++..|+|||.+.+. .++.++||||||+++|||++|+.||..............+.... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99765432211    1223467889999987654 46889999999999999999999986543211111111111000 


Q ss_pred             -----------------CCCCCCChhh-----HHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          313 -----------------VPSPIDDQTV-----IQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       313 -----------------~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                                       .+........     ......+.++|.+||+.||++|| +.+++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence                             0000000000     00112367899999999999999 9998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.2e-39  Score=290.91  Aligned_cols=261  Identities=28%  Similarity=0.364  Sum_probs=196.7

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK----  160 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  160 (363)
                      ...++|++.+.||+|+||.||+|... +|+.||+|.++...........+.+|+++++.++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999764 5889999998765433333356778999999999999999999987654    


Q ss_pred             ------eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEE
Q 046084          161 ------CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFV  234 (363)
Q Consensus       161 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl  234 (363)
                            ..++++||+++ ++..++....  ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 6766665432  2589999999999999999999999   9999999999999999999999


Q ss_pred             EeeccceeccCCCC-Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          235 ADFGVARLLHSDSS-NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       235 ~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      +|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...................
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999976643332 1122345778999998764 457889999999999999999999987543221111111111111


Q ss_pred             CCCCC---------------------CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          313 VPSPI---------------------DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       313 ~~~~~---------------------~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .+...                     ........+..+.+++.+||+.||++|| +.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00000                     0000001123588999999999999999 9888764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.2e-39  Score=283.01  Aligned_cols=250  Identities=23%  Similarity=0.316  Sum_probs=203.2

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|++.+.||+|+||.||++.. .+++.+++|.+............+..|+++++.++|+||+++.+++......++++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            478889999999999999965 4678999999876554344456788899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          169 MRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       169 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      +++++|.+++.... ....+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999886522 123589999999999999999999999   9999999999999999999999999999776443 


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                       ......++..|+|||...+..++.++|+||||+++|+|++|+.||+..+.   ............+... .    ....
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~-~----~~~~  227 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQRGKYPPIP-P----IYSQ  227 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCCc-h----hhCH
Confidence             22234578899999999888899999999999999999999999865432   2222222222222111 1    2223


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .+.+++.+||+.+|++|| +.+++..
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         228 DLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            589999999999999999 9998764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-39  Score=287.11  Aligned_cols=256  Identities=24%  Similarity=0.337  Sum_probs=198.3

Q ss_pred             CcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           91 FDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      |++.+.||+|++|.||++... +++.+++|.+............+..|+.+++.++|+||+++++++..++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567788999999999999764 6889999998766544334567888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  249 (363)
                      ++ ++.+++....  ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence            75 8888776543  2689999999999999999999999   9999999999999999999999999999876544322


Q ss_pred             ceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc----------------
Q 046084          250 RTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR----------------  312 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------  312 (363)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+............                
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            2334577889999988766 78899999999999999999999986443211111110000000                


Q ss_pred             CCCCC----C-ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          313 VPSPI----D-DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       313 ~~~~~----~-~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ...+.    . ..........+.++|.+||+.||++|| +.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000    0 000111234588999999999999999 9998865

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.9e-39  Score=296.59  Aligned_cols=262  Identities=24%  Similarity=0.335  Sum_probs=198.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee----CCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH----KKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  162 (363)
                      .++|++.+.||+|++|.||++.. .+|+.||+|++............+..|+.+++.++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            46899999999999999999965 468999999987654433345677889999999999999999988763    3468


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++|+||+. ++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 58888886543   589999999999999999999999   999999999999999999999999999976


Q ss_pred             ccCCCCC----ceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH-----------
Q 046084          243 LHSDSSN----RTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI-----------  306 (363)
Q Consensus       243 ~~~~~~~----~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~-----------  306 (363)
                      .......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.........           
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5432211    123467889999998765 458899999999999999999999986543211000000           


Q ss_pred             ---------hhhcccCC-CCCCCh-hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          307 ---------DLLDQRVP-SPIDDQ-TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       307 ---------~~~~~~~~-~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                               ........ ...... ........+.++|.+||+.+|++|| +.+++...+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~  298 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA  298 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence                     00000000 000000 0011123588999999999999999 99988876553

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=312.67  Aligned_cols=261  Identities=26%  Similarity=0.432  Sum_probs=210.8

Q ss_pred             HHHHHhcCCcccCeeeecCceeEEEEEeC----C----CCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeee
Q 046084           83 EMIVATEDFDIKYCIGTGGYGSVYRAQLP----S----GKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLY  153 (363)
Q Consensus        83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~  153 (363)
                      .+++..++..+.+.||+|.||.|++|...    .    ...||||.++..... ...+.+..|+++|+.+ +|+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            45566677778889999999999999642    1    457999999887766 4568899999999999 699999999


Q ss_pred             eEEeeCCeEEEEEEeccCCChhhhhhcCC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCC
Q 046084          154 GFCLHKKCMFLIYKYMRRGSLFCILRNDD-------E----A--IRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDIS  220 (363)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~----~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk  220 (363)
                      |+|...+..++|+||+..|+|.++++..+       .    .  ..++..+.+.++.|||.||+||++.   +++||||.
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA  445 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA  445 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence            99999999999999999999999998765       0    1  1388999999999999999999999   99999999


Q ss_pred             CCCeeecCCCceEEEeeccceeccCCCCCc-eeec--cccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCC
Q 046084          221 SNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVA--GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLL  296 (363)
Q Consensus       221 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~--g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~  296 (363)
                      .+|||++.+..+||+|||+++......... ....  -...|||||.+....|+.++||||||++||||+| |..||...
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            999999999999999999998654333222 1111  2456999999999999999999999999999998 88997652


Q ss_pred             cCCCchhhHHhhhc-ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          297 SSVNPKIMLIDLLD-QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       297 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..  .......+.+ .++..|..+..      ++.++++.||+.+|++|| +.++...|..
T Consensus       526 ~~--~~~l~~~l~~G~r~~~P~~c~~------eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  526 PP--TEELLEFLKEGNRMEQPEHCSD------EIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             Cc--HHHHHHHHhcCCCCCCCCCCCH------HHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            21  1122222222 24455554432      388999999999999999 9999888876

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-39  Score=297.02  Aligned_cols=261  Identities=23%  Similarity=0.309  Sum_probs=197.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----Ce
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-----KC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (363)
                      .++|.+.+.||+|+||.||++.. .+++.||+|.+............+..|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45789999999999999999965 4688999999875432222235677899999999999999999987654     34


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++++||+. ++|.+++....   .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 68888886543   589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc--------
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR--------  312 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  312 (363)
                      .............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+...............        
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            66443223334457889999998764 468899999999999999999999986532211000000000000        


Q ss_pred             -----------CCCCCC---ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          313 -----------VPSPID---DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       313 -----------~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                                 .+....   ..........+.+++.+||+.||++|| +.+++.+-+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~  294 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL  294 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence                       000000   000011223478999999999999999 9999987544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=289.09  Aligned_cols=204  Identities=27%  Similarity=0.447  Sum_probs=167.0

Q ss_pred             CCcccCeeeecCceeEEEEEeC---CCCEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP---SGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMF  163 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  163 (363)
                      .|++.+.||+|+||.||+|...   ++..||+|.+.... ......+.+.+|+.+++.++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999764   47899999988643 1112235677899999999999999999999988  7899


Q ss_pred             EEEEeccCCChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC----CCceEEEee
Q 046084          164 LIYKYMRRGSLFCILRNDD--EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADF  237 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl~Df  237 (363)
                      +||||+++ ++.+++....  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6666654322  123688999999999999999999999   9999999999999999    899999999


Q ss_pred             ccceeccCCCC---Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCc
Q 046084          238 GVARLLHSDSS---NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLS  297 (363)
Q Consensus       238 g~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~  297 (363)
                      |++........   ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            99986543322   1223457888999998765 457889999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1e-38  Score=289.28  Aligned_cols=256  Identities=21%  Similarity=0.283  Sum_probs=192.7

Q ss_pred             ccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           93 IKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      +.+.+|.|+++.|+++.. +++.||+|++..........+.+..|+++++.++|+||+++++++.+.+..+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455556656666555 7899999999866434445678999999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC----
Q 046084          173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----  248 (363)
Q Consensus       173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----  248 (363)
                      +|.+++..... ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||.+........    
T Consensus        85 ~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99999876432 2588899999999999999999999   999999999999999999999999998875532211    


Q ss_pred             ---Cceeecccccccccccccc--ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC---------
Q 046084          249 ---NRTVVAGTHGYIAPELAYT--MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP---------  314 (363)
Q Consensus       249 ---~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  314 (363)
                         ......++..|+|||.+..  ..++.++|+||||+++|||++|+.||.......   ...+......+         
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccCccccccCchh
Confidence               1122346778999998865  357889999999999999999999986543211   11111100000         


Q ss_pred             -------------------CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          315 -------------------SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       315 -------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                         ..............+.+++.+||+.||++|| +.+++++-..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~  299 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK  299 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence                               0000000111123478899999999999999 99999876654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=283.46  Aligned_cols=256  Identities=27%  Similarity=0.332  Sum_probs=193.3

Q ss_pred             CcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC---CCCceeeeeeEEeeCCe-----
Q 046084           91 FDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI---RHRNIVKLYGFCLHKKC-----  161 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  161 (363)
                      |++.+.||+|+||.||+|... +++.||+|.+............+..|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999875 488999999975543333234566677776655   69999999999998776     


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .+++|||+.+ +|.+++..... ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 78888865432 2589999999999999999999999   99999999999999999999999999997


Q ss_pred             eccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc----------
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ----------  311 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------  311 (363)
                      ........ ....++..|+|||.+.+..++.++|+||||+++|||++|++||......+...........          
T Consensus       156 ~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         156 IYSFEMAL-TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             eccCCccc-ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            76433221 2234688899999999888999999999999999999999998754332111111110000          


Q ss_pred             -----cCCC---CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 -----RVPS---PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 -----~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                           ..+.   .............+.+++.+||+.||++|| +.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                 0000   000000111223578999999999999999 9988754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.8e-39  Score=281.91  Aligned_cols=243  Identities=27%  Similarity=0.424  Sum_probs=195.7

Q ss_pred             eeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCCh
Q 046084           97 IGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus        97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      ||.|+||.||++... +|+.+++|.+..... .....+.+..|++++++++||||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999875 489999999875533 223456788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC------
Q 046084          175 FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS------  248 (363)
Q Consensus       175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------  248 (363)
                      .+++....   .+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99997654   589999999999999999999999   999999999999999999999999999876433311      


Q ss_pred             --CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          249 --NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       249 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                        ......++..|+|||.......+.++||||||+++|++++|..||....   ...............+....    ..
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~----~~  227 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNILNGKIEWPEDVE----VS  227 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCcCCCcccc----CC
Confidence              2233457889999999888888999999999999999999999986433   22233333333333332211    12


Q ss_pred             HHHHHHHHHccCCCCCCCC-h---HHHHHH
Q 046084          327 ILVSKIVFACLRSKPTSRP-M---QRVSQE  352 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~---~~v~~~  352 (363)
                      ..+.+++.+||+.+|++|| +   .+++..
T Consensus       228 ~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             HHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            2488999999999999999 8   555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2e-38  Score=284.67  Aligned_cols=254  Identities=19%  Similarity=0.274  Sum_probs=182.7

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCC----CCEEEEEEeccccchHHH---------HHHHHHHHHHHhcCCCCceeee
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPS----GKKVALKKLHHSETELAF---------LESFQTEAHLLSQIRHRNIVKL  152 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l  152 (363)
                      +..++|.+.+.||+|+||.||+|...+    +..+++|...........         ......+...+..++|+|++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            345689999999999999999997654    345666654332221100         0112233445667789999999


Q ss_pred             eeEEeeCC----eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC
Q 046084          153 YGFCLHKK----CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS  228 (363)
Q Consensus       153 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~  228 (363)
                      ++++....    ..++++|++.. ++.+.+....   ..++..+..++.|++.||+|||+.   +++||||||+|||++.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~  161 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG  161 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence            99776543    34677777643 5656554432   357788899999999999999999   9999999999999999


Q ss_pred             CCceEEEeeccceeccCCC-------CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc
Q 046084          229 KLEAFVADFGVARLLHSDS-------SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP  301 (363)
Q Consensus       229 ~~~~kl~Dfg~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~  301 (363)
                      ++.++|+|||+++......       .......||+.|+|||+..+..++.++|||||||++|||++|+.||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            9999999999998653221       112234689999999999999999999999999999999999999976532211


Q ss_pred             h------hhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          302 K------IMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       302 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      .      .....+.......+ ..      ...+.+++..||+.+|++|| +.++.+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGKIKIK-NA------NKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHhHHHHHHHhhhhhhccC-CC------CHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0      11111222221111 11      12488999999999999999 99988765

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3e-38  Score=287.99  Aligned_cols=258  Identities=22%  Similarity=0.297  Sum_probs=195.5

Q ss_pred             Ceeeec--CceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTG--GYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      ..||+|  +||+||++.+ .+|+.||+|.+..........+.+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  9999999976 4789999999876554444557889999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC--
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--  249 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  249 (363)
                      +++.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+.........  
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999998876432 2588999999999999999999999   9999999999999999999999999865432211111  


Q ss_pred             -----ceeeccccccccccccccc--cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC--------
Q 046084          250 -----RTVVAGTHGYIAPELAYTM--VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP--------  314 (363)
Q Consensus       250 -----~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  314 (363)
                           .....++..|+|||++.+.  .++.++||||||+++|||++|+.||......   ............        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT---QMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH---HHHHHHhcCCCCCCcccccc
Confidence                 0112345679999998763  4788999999999999999999998654321   111111111000        


Q ss_pred             ---------------------------------CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhh
Q 046084          315 ---------------------------------SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL  359 (363)
Q Consensus       315 ---------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~  359 (363)
                                                       .....+........+.+|+.+||+.||++|| +.+++++-+.+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                             0000111122334588999999999999999 99999887765443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-39  Score=306.86  Aligned_cols=264  Identities=19%  Similarity=0.228  Sum_probs=186.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCC--CCEEEEEEe---------------ccccchHHHHHHHHHHHHHHhcCCCCce
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPS--GKKVALKKL---------------HHSETELAFLESFQTEAHLLSQIRHRNI  149 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~---------------~~~~~~~~~~~~~~~e~~~l~~l~h~ni  149 (363)
                      ..++|++.+.||+|+||+||++....  +..++.|.+               +...........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999986432  222222211               0011112234568899999999999999


Q ss_pred             eeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec
Q 046084          150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDE--AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN  227 (363)
Q Consensus       150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~  227 (363)
                      +++++++...+..|+++|++. ++|.+++.....  .......++..++.|++.||+|||+.   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            999999999999999999985 467666643221  11234566778999999999999999   999999999999999


Q ss_pred             CCCceEEEeeccceeccCCCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCC-CCCCcCCCchhhH
Q 046084          228 SKLEAFVADFGVARLLHSDSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP-GDLLSSVNPKIML  305 (363)
Q Consensus       228 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p-~~~~~~~~~~~~~  305 (363)
                      .++.+||+|||++..+..... ......|+..|+|||++.+..++.++|||||||++|||++|..+ +.... ......+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~-~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG-GKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC-CCHHHHH
Confidence            999999999999987644322 22235689999999999998999999999999999999998754 33221 1111111


Q ss_pred             Hhhhcc------cCCC-----------------CCCChhhHH---HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          306 IDLLDQ------RVPS-----------------PIDDQTVIQ---DIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       306 ~~~~~~------~~~~-----------------~~~~~~~~~---~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..++..      ..+.                 +...+....   ....+.+++.+||+.||.+|| +.|++.+-++
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            111110      0000                 000000000   012356779999999999999 9999987554

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.1e-38  Score=278.12  Aligned_cols=248  Identities=21%  Similarity=0.338  Sum_probs=190.3

Q ss_pred             HHHHHHhcCCcccCee--eecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 046084           82 QEMIVATEDFDIKYCI--GTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCL  157 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  157 (363)
                      .+.....++|++.+.+  |+|+||.||++.. .++..+|+|.+.......     .  |+.....+ +|||++++++.+.
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~--e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----I--EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----h--hHHHHHHhhcCCCEEEEEEEEe
Confidence            3333445677777776  9999999999965 467889999886543211     1  22222222 7999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC-ceEEEe
Q 046084          158 HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-EAFVAD  236 (363)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~D  236 (363)
                      ..+..++||||+++++|.+++....   .+++..+..++.|+++||.|||+.   +++||||+|+||+++.++ .++|+|
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence            9999999999999999999997654   689999999999999999999999   999999999999999988 999999


Q ss_pred             eccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCch-hhHHhhhcccCCC
Q 046084          237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK-IMLIDLLDQRVPS  315 (363)
Q Consensus       237 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~  315 (363)
                      ||++......    ....++..|+|||++.+..++.++||||||+++|||++|+.||......... ...........+.
T Consensus       154 fg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  229 (267)
T PHA03390        154 YGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF  229 (267)
T ss_pred             CccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc
Confidence            9998765432    2235788999999999888999999999999999999999998744332211 1111111211111


Q ss_pred             CCCChhhHHHHHHHHHHHHHccCCCCCCCC-h-HHHHHH
Q 046084          316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-M-QRVSQE  352 (363)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~-~~v~~~  352 (363)
                      +.      .....+.+++.+||+.||.+|| + .+++++
T Consensus       230 ~~------~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        230 IK------NVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             cc------ccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            11      1122488999999999999999 5 777654

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-39  Score=294.32  Aligned_cols=260  Identities=23%  Similarity=0.340  Sum_probs=200.9

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----eEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-----CMF  163 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  163 (363)
                      +|++.+.||.|++|.||+|... +++.|++|.+..........+.+.+|+.+++.++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788999999999999999764 4889999998765433344567889999999999999999999988775     789


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ++|||+++ +|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999974 8888886544   689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCC---CCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCC----
Q 046084          244 HSDS---SNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS----  315 (363)
Q Consensus       244 ~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----  315 (363)
                      ....   .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....................+.    
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            5433   122334578899999998877 78999999999999999999999986543211110111100000000    


Q ss_pred             -------------CCCChhhH-----HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          316 -------------PIDDQTVI-----QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       316 -------------~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                   ........     .....+.+++.+||+.+|++|| +.+++.+-+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~  293 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA  293 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence                         00000000     0123478999999999999999 99998875543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-38  Score=277.44  Aligned_cols=250  Identities=22%  Similarity=0.347  Sum_probs=195.8

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE---TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCM  162 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  162 (363)
                      .+|++.+.||+|+||.||++.. .++..|++|.+....   ........+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5789999999999999999975 468899999875432   1233456789999999999999999999998764  458


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++++||+++++|.+++....   .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999987543   478899999999999999999999   999999999999999999999999999976


Q ss_pred             ccCCC---CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCC
Q 046084          243 LHSDS---SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       243 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      .....   .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....   ................. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~p-  231 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQPTKPMLP-  231 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHHcCCCCCCCC-
Confidence            53211   112234578899999999888889999999999999999999999865322   12222222221111111 


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .   .....+.+++.+||+ +|..|| +.+++.+
T Consensus       232 ~---~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         232 D---GVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             c---ccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            0   111248899999999 579999 7776654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=283.47  Aligned_cols=256  Identities=26%  Similarity=0.392  Sum_probs=195.4

Q ss_pred             CcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEEEEEE
Q 046084           91 FDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLIYK  167 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  167 (363)
                      |++.+.||.|++|.||+|... +++.+++|.+............+.+|+++++.++|||++++++++...  +..++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999765 578999999987653333446788999999999999999999999988  78999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++ +|.+++....  ..+++..++.++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 8888876543  2689999999999999999999999   99999999999999999999999999998764432


Q ss_pred             C-Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC------------
Q 046084          248 S-NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV------------  313 (363)
Q Consensus       248 ~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------  313 (363)
                      . ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+...................            
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence            1 1222346788999997664 4578999999999999999999999865432111111111000000            


Q ss_pred             ------CCCCCC--hhhHH--HHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          314 ------PSPIDD--QTVIQ--DIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       314 ------~~~~~~--~~~~~--~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                            ......  .....  ....+.+++.+||+.+|++|| +.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                  000000  00000  133588999999999999999 8888764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.6e-39  Score=284.45  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=201.0

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  165 (363)
                      ++|.+.+.||+|++|.||++... +++.|++|++..... .....+.+..|..++++++ ||||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999764 788999999876332 2222367888999999998 99999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999997654   699999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCC--------------------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhH
Q 046084          246 DSS--------------------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIML  305 (363)
Q Consensus       246 ~~~--------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~  305 (363)
                      ...                    ......++..|+|||......++.++|+||||++++++++|+.||.....   ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~  231 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTF  231 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHH
Confidence            221                    11223567899999998888889999999999999999999999875442   1122


Q ss_pred             HhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-h----HHHHHH
Q 046084          306 IDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-M----QRVSQE  352 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~----~~v~~~  352 (363)
                      ..........+...      ...+.+++.+||+.||++|| +    .+++.+
T Consensus       232 ~~~~~~~~~~~~~~------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         232 QKILKLEYSFPPNF------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHHhcCCCCCCcc------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            22222222222211      12388999999999999999 8    666654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=300.75  Aligned_cols=203  Identities=31%  Similarity=0.469  Sum_probs=175.5

Q ss_pred             CcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC------eEE
Q 046084           91 FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK------CMF  163 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  163 (363)
                      |...+.||+|+||.||+|+ ..+|+.||||.++.... ....+...+|+++|++++|+|||+++++-.+..      ...
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            4556779999999999997 56899999999987542 223477889999999999999999998766543      467


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec--CCC--ceEEEeecc
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN--SKL--EAFVADFGV  239 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~--~~kl~Dfg~  239 (363)
                      ++||||.+|+|+..|........+++.+.+.++.+++.||.|||++   +|+||||||.||++-  .+|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999999888777899999999999999999999999   999999999999983  323  468999999


Q ss_pred             ceeccCCCCCceeeccccccccccccc-cccCCccccchHHHHHHHHHHhCCCCCCCCcC
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAY-TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS  298 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~  298 (363)
                      |+.++.+. .....+||..|++||... ...|+..+|.|||||++|++.||..||.....
T Consensus       171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            99886554 556678999999999998 58899999999999999999999999865543

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=278.14  Aligned_cols=240  Identities=23%  Similarity=0.329  Sum_probs=185.6

Q ss_pred             CeeeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHH-HhcCCCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHL-LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||+|.. .+++.||+|.+...... ......+..|... ....+|+|++++++++...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999966 46889999998754321 1222334445444 4455899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      ++|.+++....   .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....    ..
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  151 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK  151 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence            99999997654   588999999999999999999999   999999999999999999999999999875432    22


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|..||....   .......+.......+....  ......+.+
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  226 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET---PDAVFDNILSRRINWPEEVK--EFCSPEAVD  226 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcccCCCCccc--ccCCHHHHH
Confidence            3457889999999888888999999999999999999999986432   22222222222221111111  011224889


Q ss_pred             HHHHccCCCCCCCC-hHHH
Q 046084          332 IVFACLRSKPTSRP-MQRV  349 (363)
Q Consensus       332 li~~cl~~dP~~RP-~~~v  349 (363)
                      ++.+||+.||++|| +.++
T Consensus       227 ~i~~~l~~~p~~R~~~~~~  245 (260)
T cd05611         227 LINRLLCMDPAKRLGANGY  245 (260)
T ss_pred             HHHHHccCCHHHccCCCcH
Confidence            99999999999999 6444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-39  Score=294.26  Aligned_cols=259  Identities=22%  Similarity=0.342  Sum_probs=193.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----e
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-----C  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~  161 (363)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.+...... .....+..|+.+++.++||||+++++++....     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            46899999999999999999965 57889999998643322 23456788999999999999999999876543     5


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++++||+.+ +|..++...    .+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          83 VYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            7999999975 777777543    589999999999999999999999   99999999999999999999999999987


Q ss_pred             eccCCCCC---ceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchh------------hH
Q 046084          242 LLHSDSSN---RTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI------------ML  305 (363)
Q Consensus       242 ~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~------------~~  305 (363)
                      ........   .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..........            ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            65332211   122457889999998654 568899999999999999999999986432111000            00


Q ss_pred             Hhhhccc-------CCCCCCC--h-hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          306 IDLLDQR-------VPSPIDD--Q-TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       306 ~~~~~~~-------~~~~~~~--~-~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..+....       .+.....  . ........+.+++.+||+.||++|| +.+++.+-..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~  295 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL  295 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence            0000000       0000000  0 0001123488999999999999999 9999887544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.9e-38  Score=284.00  Aligned_cols=257  Identities=23%  Similarity=0.356  Sum_probs=196.1

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCC-CCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (363)
                      ..++|++.+.||+|++|.||+|...+ ++.||+|.+........ ...+..|+..+... +||||+++++++.+....++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-HHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            34678899999999999999998754 88999999876543322 34566677766666 59999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +|||+. +++.+++.....  .+++..+..++.|++.||+|||+ .   +++||||+|+||++++++.++|+|||++...
T Consensus        92 v~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          92 CMELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             EeeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            999985 477776654332  68999999999999999999997 5   8999999999999999999999999998765


Q ss_pred             cCCCCCceeecccccccccccccccc----CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCC
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMV----LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      ..... .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.....  .............+.....
T Consensus       166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~  242 (296)
T cd06618         166 VDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEEPPSLPPN  242 (296)
T ss_pred             cCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCCCCCC
Confidence            33222 22234678899999887543    78899999999999999999999864321  1122223333322211111


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .   .....+.+++.+||+.||++|| +.+++.+.+.+
T Consensus       243 ~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  277 (296)
T cd06618         243 E---GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR  277 (296)
T ss_pred             C---CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence            1   1122488999999999999999 99998876643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=285.59  Aligned_cols=249  Identities=23%  Similarity=0.274  Sum_probs=202.3

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHH-HHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAF-LESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      +..+.|+.-+.||+|+||.||-+.. .+|+-+|.|++......... -.....|-.+|.+++.+.||.+--.++..+.++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            4456788889999999999999854 57899999988665432221 234678999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +|+..|.||+|.-++.+.+. ..+++.+++.++.+|+.||.+||..   +||.|||||+|||+|+.|+++|+|+|+|..+
T Consensus       262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999988877664 3699999999999999999999999   9999999999999999999999999999887


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCch-hhHHhhhcccCCCCCCChhh
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK-IMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  322 (363)
                      .... .....+||.+|||||++.+..|+...|.|||||++|||+.|+.||....+.... +....++......+...+. 
T Consensus       338 ~~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~-  415 (591)
T KOG0986|consen  338 PEGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE-  415 (591)
T ss_pred             CCCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH-
Confidence            5433 333458999999999999999999999999999999999999998765443322 2222333322222222221 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                           ....|....|++||++|-
T Consensus       416 -----eakslc~~LL~Kdp~~RL  433 (591)
T KOG0986|consen  416 -----EAKSLCEGLLTKDPEKRL  433 (591)
T ss_pred             -----HHHHHHHHHHccCHHHhc
Confidence                 367788899999999987

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-38  Score=291.68  Aligned_cols=258  Identities=28%  Similarity=0.397  Sum_probs=195.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeC--CeEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHK--KCMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~  163 (363)
                      .++|++.+.||+|+||.||+|.+. +|+.+|+|++............+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            567889999999999999999764 678999998865433323345677899999999 999999999998654  3689


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +||||+. ++|..++...    .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++...
T Consensus        86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9999997 4888888653    478889999999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCC-----Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhh---------
Q 046084          244 HSDSS-----NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDL---------  308 (363)
Q Consensus       244 ~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~---------  308 (363)
                      .....     ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+........         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            43221     2223457889999998754 55788999999999999999999998643321110000000         


Q ss_pred             -----------hcc---cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          309 -----------LDQ---RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       309 -----------~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                                 ++.   ....+.. .........+.++|.+||+.||++|| +.+++..-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~  297 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY  297 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence                       000   0000000 00000123588999999999999999 999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.9e-38  Score=278.59  Aligned_cols=236  Identities=22%  Similarity=0.256  Sum_probs=181.4

Q ss_pred             eeeecCceeEEEEEe-CCCCEEEEEEeccccchH-HHHHHHHHH---HHHHhcCCCCceeeeeeEEeeCCeEEEEEEecc
Q 046084           96 CIGTGGYGSVYRAQL-PSGKKVALKKLHHSETEL-AFLESFQTE---AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  170 (363)
                      .||+|+||.||++.. .+++.||+|.+....... .....+..|   +..++...||||+++.+++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999965 468899999887543211 111123333   334455689999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCc
Q 046084          171 RGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR  250 (363)
Q Consensus       171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  250 (363)
                      +++|..++....   .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++......  ..
T Consensus        81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~  152 (278)
T cd05606          81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP  152 (278)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CC
Confidence            999999886543   689999999999999999999999   9999999999999999999999999998755322  22


Q ss_pred             eeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHH
Q 046084          251 TVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILV  329 (363)
Q Consensus       251 ~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  329 (363)
                      ....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||......................+...      ...+
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------s~~~  226 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF------SPEL  226 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcC------CHHH
Confidence            234689999999998744 688999999999999999999999876533222222222222222222111      1248


Q ss_pred             HHHHHHccCCCCCCCC
Q 046084          330 SKIVFACLRSKPTSRP  345 (363)
Q Consensus       330 ~~li~~cl~~dP~~RP  345 (363)
                      .+++.+||+.+|++||
T Consensus       227 ~~li~~~l~~~p~~R~  242 (278)
T cd05606         227 RSLLEGLLQRDVNRRL  242 (278)
T ss_pred             HHHHHHHhhcCHHhcc
Confidence            8899999999999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=268.40  Aligned_cols=253  Identities=20%  Similarity=0.333  Sum_probs=196.9

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++.+....||+|+.|+|++++. .+|...|||.+......++ .+++...++++..- .+|+||+.+|+|..+..+++.|
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            3455667799999999999965 4688999999988776544 46777778776655 5899999999999999899999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      |.|.. .++.++.....  ++++..+-++...+.+||.||.+++  +|+|||+||+|||+|+.|++||||||++..+...
T Consensus       171 elMs~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  171 ELMST-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHH-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence            98743 55566654433  5888888899999999999999887  9999999999999999999999999999877543


Q ss_pred             CCCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          247 SSNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      .. .+...|-+.|||||.+.   ...|+-++||||||++++||.||..||..-..  .-+.+..+++..+|.........
T Consensus       246 kA-htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvln~ePP~L~~~~gFS  322 (391)
T KOG0983|consen  246 KA-HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVLNEEPPLLPGHMGFS  322 (391)
T ss_pred             cc-cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHHhcCCCCCCcccCcC
Confidence            33 33446889999999876   34688899999999999999999999865322  22344455554332211111111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      .   .+.+++..||++|+.+|| ..+++++-
T Consensus       323 p---~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  323 P---DFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             H---HHHHHHHHHhhcCcccCcchHHHhcCc
Confidence            1   388899999999999999 88887754

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=275.43  Aligned_cols=245  Identities=24%  Similarity=0.327  Sum_probs=205.4

Q ss_pred             HHhcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      +.-++|+..+.||+|.||.|.+++ ..+++.+|+|+++.... ..+....-..|-.+|+..+||.+..+--.|...+.+|
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            345789999999999999999995 45789999999986532 2222345668999999999999999988889999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      .||||..||.|.-.+....   .+++.+...+...|..||.|||++   +|+.||||.+|.|+|.+|++||+|||+++.-
T Consensus       245 FVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence            9999999999998887654   688888899999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ........+.+||+.|+|||++....|..++|.|.+|+++|||++|+.||...+   .+....-++-..+..|..-+.. 
T Consensus       319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d---h~kLFeLIl~ed~kFPr~ls~e-  394 (516)
T KOG0690|consen  319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD---HEKLFELILMEDLKFPRTLSPE-  394 (516)
T ss_pred             ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc---hhHHHHHHHhhhccCCccCCHH-
Confidence            666667778899999999999999999999999999999999999999976532   2333444444444444433322 


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC
Q 046084          324 QDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP  345 (363)
                           -..|+...|.+||.+|-
T Consensus       395 -----AktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  395 -----AKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -----HHHHHHHHhhcChHhhc
Confidence                 55678899999999995

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.1e-38  Score=281.65  Aligned_cols=253  Identities=23%  Similarity=0.272  Sum_probs=189.3

Q ss_pred             CcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeC--CeEEEEE
Q 046084           91 FDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHK--KCMFLIY  166 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  166 (363)
                      |++.+.||+|+||.||++.. .+++.||+|.++........ .....|+..+.++. |+|++++++++.+.  +..++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            56788899999999999975 46889999998765332222 23456888888884 99999999999987  8899999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++ ++.+.+....  ..+++.+++.++.|++.||+|||+.   +++||||+|+||+++. +.+||+|||++......
T Consensus        80 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          80 ELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             ecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            99974 7777776533  2589999999999999999999999   9999999999999999 99999999999866433


Q ss_pred             CCCceeeccccccccccccc-cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc--------------
Q 046084          247 SSNRTVVAGTHGYIAPELAY-TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ--------------  311 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--------------  311 (363)
                      .. .....++..|+|||.+. +..++.++|||||||++|||++|..||...+..+...........              
T Consensus       153 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         153 PP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            22 22345788999999764 455788999999999999999999998654321110000000000              


Q ss_pred             -cCCCCCCChh-----hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 -RVPSPIDDQT-----VIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 -~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                       ....+.....     .......+.++|.+||++||++|| +.+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence             0000000000     011234689999999999999999 9988865

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=270.90  Aligned_cols=261  Identities=23%  Similarity=0.384  Sum_probs=211.3

Q ss_pred             cHHHHHHHhcCCcccCeeeecCceeEEEE-EeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 046084           80 TFQEMIVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCL  157 (363)
Q Consensus        80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  157 (363)
                      +|++....+++     .||+|+|+.|-.+ ...+|..+|||++.+.....  ..+..+|++++.+. .|+||+++++||+
T Consensus        74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs--R~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS--RSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchH--HHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            46666666653     4999999999988 56789999999998775433  46788999999988 5999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC---ceEE
Q 046084          158 HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL---EAFV  234 (363)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl  234 (363)
                      ++...|||||-|.||+|...++...   .+++.++.++.++|+.||.|||.+   ||.||||||+|||..+..   -+||
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence            9999999999999999999988765   699999999999999999999999   999999999999996654   4799


Q ss_pred             EeeccceeccCCC-------CCceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCC--
Q 046084          235 ADFGVARLLHSDS-------SNRTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN--  300 (363)
Q Consensus       235 ~Dfg~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~--  300 (363)
                      +||.+..-+....       ....+.+|+..|||||+..     ...|+.++|.||||+|+|-|++|.+||...-..+  
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            9999886532211       1234467999999999753     3458899999999999999999999997654321  


Q ss_pred             ----------chhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          301 ----------PKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       301 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                                .+.....+.++.+.+|..+......  +-.++|...|-.|+.+|- +.+++..-+.
T Consensus       301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~--eakdlisnLlvrda~~rlsa~~vlnhPw~  364 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISS--EAKDLISNLLVRDAKQRLSAAQVLNHPWV  364 (463)
T ss_pred             ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhH--HHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence                      2445667778888888755444333  566899999999999999 8888775443

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.3e-38  Score=284.41  Aligned_cols=250  Identities=25%  Similarity=0.380  Sum_probs=195.1

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      +.|+..+.||+|+||.||+|... +++.+++|.+.... .......++.+|+++++.++|+|++++.+++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34667788999999999999764 67889999886432 22233456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+. |++.+++....  ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9996 57777765433  2588999999999999999999999   9999999999999999999999999998765322


Q ss_pred             CCCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          247 SSNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                          ....++..|+|||.+.   ...++.++||||||+++|+|++|+.||.....   ............+.....    
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~----  237 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPALQSG----  237 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH---HHHHHHHhhcCCCCcCcc----
Confidence                2345788999999874   34578899999999999999999999754322   112222222222211110    


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .....+.++|.+||+.+|++|| +.+++.....
T Consensus       238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             cccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence            1122488999999999999999 9998877654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.9e-38  Score=281.38  Aligned_cols=252  Identities=25%  Similarity=0.360  Sum_probs=196.1

Q ss_pred             CCcccCeeeecCceeEEEEEe----CCCCEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL----PSGKKVALKKLHHSET--ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (363)
                      +|++.+.||+|++|.||++..    .+++.||+|.+.....  .....+.+..|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999864    3567899999875422  222345688999999999 699999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++||||+.+++|.+++....   .+++..+..++.|+++||.|||+.   +++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999886543   588999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCCC-ceeecccccccccccccccc--CCccccchHHHHHHHHHHhCCCCCCCCcCCCc-hhhHHhhhcccCCCCCC
Q 046084          243 LHSDSSN-RTVVAGTHGYIAPELAYTMV--LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDLLDQRVPSPID  318 (363)
Q Consensus       243 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~  318 (363)
                      ....... .....++..|+|||...+..  .+.++||||||+++|||++|..||........ ............+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT  234 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcc
Confidence            5433221 22345788999999887654  68899999999999999999999864322211 12222222222222221


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      .+      ..+.+++.+||+.||++|| +.++...|
T Consensus       235 ~~------~~l~~li~~~l~~~p~~R~t~~~~~~~l  264 (288)
T cd05583         235 MS------AEARDFIQKLLEKDPKKRLGANGADEIK  264 (288)
T ss_pred             cC------HHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence            11      2478899999999999999 66554433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=274.44  Aligned_cols=235  Identities=29%  Similarity=0.394  Sum_probs=193.2

Q ss_pred             eeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCCh
Q 046084           97 IGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus        97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      ||.|+||.||++... +++.+++|.+...... ....+.+..|+.+++.++|||++++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999764 5889999998765432 22356788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeec
Q 046084          175 FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA  254 (363)
Q Consensus       175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  254 (363)
                      .+++....   .+++..+..++.|+++|+.|||+.   +++|+||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            99997654   589999999999999999999998   999999999999999999999999999987644333334456


Q ss_pred             cccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHH
Q 046084          255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVF  334 (363)
Q Consensus       255 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  334 (363)
                      ++..|+|||...+...+.++|+||||+++|++++|..||...+.   ......+.....+.+...+      ..+.+++.
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~------~~l~~~i~  225 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPLRFPEFLS------PEARDLIS  225 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCCCCCCCCC------HHHHHHHH
Confidence            78899999999888889999999999999999999999864432   2223333333333332221      24788999


Q ss_pred             HccCCCCCCCC-h
Q 046084          335 ACLRSKPTSRP-M  346 (363)
Q Consensus       335 ~cl~~dP~~RP-~  346 (363)
                      +||..||++|| +
T Consensus       226 ~~l~~~p~~R~~~  238 (250)
T cd05123         226 GLLQKDPTKRLGS  238 (250)
T ss_pred             HHhcCCHhhCCCc
Confidence            99999999999 7

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-38  Score=288.87  Aligned_cols=263  Identities=23%  Similarity=0.330  Sum_probs=197.5

Q ss_pred             HHHHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-
Q 046084           82 QEMIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-  159 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-  159 (363)
                      .++....++|.+.+.||+|+||.||++.. .+++.||+|++..........+.+.+|+.++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            34455678999999999999999999964 5788999999976543333346788899999999999999999988643 


Q ss_pred             -----CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEE
Q 046084          160 -----KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFV  234 (363)
Q Consensus       160 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl  234 (363)
                           ...+++++++ +++|.+++...    .+++..+..++.|+++||+|||+.   +++||||||+||++++++.++|
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence                 3467888876 77898877543    489999999999999999999999   9999999999999999999999


Q ss_pred             EeeccceeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhh-----
Q 046084          235 ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDL-----  308 (363)
Q Consensus       235 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~-----  308 (363)
                      +|||++.....   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............     
T Consensus       162 ~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         162 LDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             ecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999876432   2223457889999998765 56788999999999999999999998543221100000000     


Q ss_pred             ------------------hcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          309 ------------------LDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       309 ------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                        ......... ..........+.++|..||+.||++|| +.+++.+-..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~  304 (345)
T cd07877         239 AELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  304 (345)
T ss_pred             HHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence                              000000000 000000122478999999999999999 98988776543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-38  Score=288.65  Aligned_cols=259  Identities=24%  Similarity=0.349  Sum_probs=191.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK------  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (363)
                      .++|++.+.||+|+||.||+|... +++.+++|.+............+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999754 6889999988654332222245678999999999999999999875433      


Q ss_pred             --eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          161 --CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       161 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                        ..++++||+.+ ++...+....  ..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999875 6666665432  2689999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCCC-----------ceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH
Q 046084          239 VARLLHSDSSN-----------RTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI  306 (363)
Q Consensus       239 ~~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~  306 (363)
                      ++.........           .....+++.|+|||.+.+ ..++.++||||||+++|||++|++||.............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99765332211           122346788999998765 457889999999999999999999986543321111111


Q ss_pred             hhhcccC----------CC------CCCChh-----hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          307 DLLDQRV----------PS------PIDDQT-----VIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       307 ~~~~~~~----------~~------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .......          +.      ....+.     .......+.+++.+||+.||++|| +.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1100000          00      000000     001113478999999999999999 8888764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.8e-37  Score=281.01  Aligned_cols=247  Identities=26%  Similarity=0.360  Sum_probs=192.8

Q ss_pred             CcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           91 FDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      |...+.||+|+||.||+|+. .+++.|++|.+..... .......+..|+++++.++|||++++++++.+....+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            56667799999999999976 4688999999865432 223345788899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +. |++.+++....  ..+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++....    
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            96 57777775433  2589999999999999999999999   99999999999999999999999999986432    


Q ss_pred             Cceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          249 NRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      ......++..|+|||.+.   ...++.++||||||+++|||++|..||.....   ............+..... .   .
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~-~---~  245 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPTLQSN-E---W  245 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCcc-c---c
Confidence            122345788999999874   35678899999999999999999999755432   111222222222111110 0   1


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ...+.+++.+||+.+|.+|| +.+++..-+
T Consensus       246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~  275 (313)
T cd06633         246 TDSFRGFVDYCLQKIPQERPASAELLRHDF  275 (313)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            12478899999999999999 999887643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=322.48  Aligned_cols=251  Identities=26%  Similarity=0.394  Sum_probs=204.1

Q ss_pred             cCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      -++.-...||.|.||.||.+. ..+|+-.|+|-+..............+|..++..++|||+|+++|+-.+.+..+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            456667889999999999994 5678999999888776665556778899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      ||++|+|.+.+...+   ..++.....+..|++.|++|||++   |||||||||.||+|+.+|.+|++|||.|..+..+.
T Consensus      1315 yC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            999999999997654   355666667889999999999999   99999999999999999999999999998875543


Q ss_pred             CC----ceeecccccccccccccccc---CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          248 SN----RTVVAGTHGYIAPELAYTMV---LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       248 ~~----~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      ..    .....||+-|||||++.+..   ...+.||||+||++.||+||+.||..++.... .+........++.|...+
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-IMy~V~~gh~Pq~P~~ls 1467 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-IMYHVAAGHKPQIPERLS 1467 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-HHhHHhccCCCCCchhhh
Confidence            21    23467999999999987543   45689999999999999999999987664321 222233334444444322


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                            .+=.+++..||+.||++|. +.|+++.
T Consensus      1468 ------~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1468 ------SEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ------HhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                  2356799999999999999 6677764

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.8e-38  Score=289.02  Aligned_cols=262  Identities=24%  Similarity=0.265  Sum_probs=195.4

Q ss_pred             cCCc-ccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHH------------HHHHHHHHHHHHhcCCCCceeeeee
Q 046084           89 EDFD-IKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELA------------FLESFQTEAHLLSQIRHRNIVKLYG  154 (363)
Q Consensus        89 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~  154 (363)
                      ++|. +.+.||.|+||.||+|... +++.||+|.+........            ....+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 4577999999999999754 688999998865432110            0124678999999999999999999


Q ss_pred             EEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEE
Q 046084          155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFV  234 (363)
Q Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl  234 (363)
                      ++...+..+++|||+. |+|.+++....   .+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence            9999999999999997 58988886543   588999999999999999999999   9999999999999999999999


Q ss_pred             EeeccceeccCC--------------CCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCC
Q 046084          235 ADFGVARLLHSD--------------SSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSV  299 (363)
Q Consensus       235 ~Dfg~~~~~~~~--------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~  299 (363)
                      +|||++......              ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999765411              1111223467789999988754 4688999999999999999999998654322


Q ss_pred             CchhhHHhhhcccCCC------------------CCCC-hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          300 NPKIMLIDLLDQRVPS------------------PIDD-QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~------------------~~~~-~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ................                  +... .........+.+++.+||+.+|++|| +.+++.+-+.+.
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~  318 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS  318 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence            1111111111100000                  0000 00001123478999999999999999 999998776654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.4e-39  Score=311.38  Aligned_cols=254  Identities=26%  Similarity=0.442  Sum_probs=194.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEe---------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCL---------  157 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~---------  157 (363)
                      ..+|+..+.||+||||.||+++.+ ||+.||||++.... .......+.+|+.++++|+|||||+++..+.         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            467888999999999999999764 89999999998876 4444567889999999999999999974220         


Q ss_pred             ---------------------------------------------------------------------e----------
Q 046084          158 ---------------------------------------------------------------------H----------  158 (363)
Q Consensus       158 ---------------------------------------------------------------------~----------  158 (363)
                                                                                           +          
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                 0          


Q ss_pred             -----------------------C--------CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046084          159 -----------------------K--------KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH  207 (363)
Q Consensus       159 -----------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  207 (363)
                                             +        ..+||-||||+..++.++++.+...  -.....|+++.+|++||+|+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHH
Confidence                                   0        1367889999998888888765421  146778999999999999999


Q ss_pred             hCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc------------------CCCCCceeeccccccccccccccc-
Q 046084          208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH------------------SDSSNRTVVAGTHGYIAPELAYTM-  268 (363)
Q Consensus       208 ~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~------------------~~~~~~~~~~g~~~y~aPE~~~~~-  268 (363)
                      +.   ||+||||||.||++++++.|||+|||+++...                  .+....+..+||.-|+|||++.+. 
T Consensus       715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            99   99999999999999999999999999998621                  011133456799999999998765 


Q ss_pred             --cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-
Q 046084          269 --VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-  345 (363)
Q Consensus       269 --~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-  345 (363)
                        .|+.|+|+||||++++||+.   ||...  -+....+...-++.+|.+.+.  .......=..+|.+|++.||++|| 
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~g~iP~~~~f--~~~~~~~e~slI~~Ll~hdP~kRPt  864 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLRKGSIPEPADF--FDPEHPEEASLIRWLLSHDPSKRPT  864 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcccCCCCCCccc--ccccchHHHHHHHHHhcCCCccCCC
Confidence              49999999999999999996   44422  122333444445566655110  111111246799999999999999 


Q ss_pred             hHHHHHHHh
Q 046084          346 MQRVSQEFL  354 (363)
Q Consensus       346 ~~~v~~~l~  354 (363)
                      +.|++..=+
T Consensus       865 A~eLL~s~l  873 (1351)
T KOG1035|consen  865 ATELLNSEL  873 (1351)
T ss_pred             HHHHhhccC
Confidence            999887543

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=283.09  Aligned_cols=256  Identities=25%  Similarity=0.320  Sum_probs=197.4

Q ss_pred             CcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           91 FDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      |+..+.||+|++|.||+|... +++.+++|.+..........+.+..|+.+++.++|+|++++++++.+.+..++++||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556778999999999999765 5899999999876533333467788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  249 (363)
                      + ++|.+++....  ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++.........
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            8 58999987653  2589999999999999999999999   9999999999999999999999999999776443323


Q ss_pred             ceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhh-----------------cc
Q 046084          250 RTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL-----------------DQ  311 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------------~~  311 (363)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|+.||................                 +.
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            3333457789999988766 78899999999999999999999986543211100000000                 00


Q ss_pred             cCCCCCCChh---hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 RVPSPIDDQT---VIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 ~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ..+.......   .......+.+++.+||+.||++|| +.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            1110000000   001123589999999999999999 9998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.8e-38  Score=287.87  Aligned_cols=259  Identities=24%  Similarity=0.329  Sum_probs=195.3

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH-KKCMF  163 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~  163 (363)
                      ..+++|++.+.||.|+||.||++.. .+++.||+|++..........+.+..|+++++.++|||++++++++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            3577899999999999999999965 478899999886543322334667889999999999999999998876 45788


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +++||+ +++|..++...    .+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++|+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 56888887643    478888889999999999999999   9999999999999999999999999998754


Q ss_pred             cCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc------------
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD------------  310 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------  310 (363)
                      ...   .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.............+.+.            
T Consensus       159 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         159 DPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             CCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            321   223356788999998765 5688999999999999999999999864332111000000000            


Q ss_pred             c-------cCC--CCCCChhh-HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          311 Q-------RVP--SPIDDQTV-IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       311 ~-------~~~--~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .       ...  .+...... ......+.++|.+||+.+|++|| +.+++..-..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~  291 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL  291 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence            0       000  00000000 00123588999999999999999 9988876543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=278.08  Aligned_cols=255  Identities=23%  Similarity=0.360  Sum_probs=193.0

Q ss_pred             CcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEEEe
Q 046084           91 FDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      |.+.+.||+|++|.||+|... +++.|++|.+........ .....+|+..+++++ |||++++++++...+..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            567889999999999999875 578899999875543221 123456899999998 99999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      + +|+|.+++.... ...+++..+..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        80 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          80 M-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             C-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence            9 789988887643 23589999999999999999999999   999999999999999999999999999986643222


Q ss_pred             Cceeeccccccccccccc-cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc----------------
Q 046084          249 NRTVVAGTHGYIAPELAY-TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ----------------  311 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------------  311 (363)
                       .....++..|+|||.+. ...++.++|+||||+++|||++|+.||......+...........                
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence             22345788899999875 455789999999999999999999998544321111111111000                


Q ss_pred             --cCCCCCCCh-h--hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 --RVPSPIDDQ-T--VIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 --~~~~~~~~~-~--~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                        ..+...... .  .......+.+++.+||+.||++|| +.|++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence              000000000 0  001123488999999999999999 9988764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.4e-38  Score=278.11  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=193.6

Q ss_pred             CCcccCeeeecCceeEEEEEeCC-CCEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSE---TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +|.+.+.||+|+||.||++.... +..+++|.++...   ........+..|+.+++.++|||++++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999997643 4445555554321   1112224567789999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          166 YKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      +||+++++|.+++... .....+++..++.++.|++.|+.|||+.   +++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888642 1223689999999999999999999999   9999999999999975 569999999987764


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ..........++..|+|||...+..++.++|+||||+++|+|++|..||....   .............+...     ..
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-----~~  228 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRIVEGPTPSLP-----ET  228 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCCCCCCc-----ch
Confidence            43333334557889999999888888999999999999999999999975322   22222222222222111     11


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ....+.++|.+||+.||++|| +.+++..
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         229 YSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             hcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            122488999999999999999 9998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=267.38  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=205.0

Q ss_pred             HhcCCccc-CeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeC----
Q 046084           87 ATEDFDIK-YCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHK----  159 (363)
Q Consensus        87 ~~~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----  159 (363)
                      .+++|++. +.||-|-.|.|..+. ..+++++|+|++....       ..++|+++--.. .|||||.+++++.+.    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            35667665 468999999999984 4578999999986432       344677664444 799999999988753    


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceEEEe
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVAD  236 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~D  236 (363)
                      .++.+|||+|+||.|.+.++..+. ..+++.++..|+.||+.|+.|||+.   +|.||||||+|+|.+.   |..+||+|
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            568899999999999999987653 3699999999999999999999999   9999999999999954   56799999


Q ss_pred             eccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCc-CCCchhhHHhhhcccCCC
Q 046084          237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLS-SVNPKIMLIDLLDQRVPS  315 (363)
Q Consensus       237 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~  315 (363)
                      ||+++.... .....+.+-|+.|.|||++...+|+..+|+||+|+++|-|++|.+||-... ..-...+..++..+.+.+
T Consensus       208 fGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  208 FGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             cccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            999987643 344566788999999999999999999999999999999999999985433 233445566777777766


Q ss_pred             CCCChhhHHHH-HHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          316 PIDDQTVIQDI-ILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       316 ~~~~~~~~~~~-~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      |..   .|++. ....++|+.+|..+|++|- ..+++..-+.
T Consensus       287 P~p---EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi  325 (400)
T KOG0604|consen  287 PEP---EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI  325 (400)
T ss_pred             CCh---hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence            653   33333 3467899999999999999 8888876554

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-38  Score=286.44  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=195.7

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-----  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  160 (363)
                      ..++|++.+.||+|+||.||++.. .++..||+|.+..........+.+..|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            467899999999999999999964 57889999998654433334467889999999999999999999887653     


Q ss_pred             -eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          161 -CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       161 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                       ..++||||+ +++|.+++...    .+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence             358999998 67888887643    589999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc-------
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ-------  311 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-------  311 (363)
                      +......   .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......   ....+...       
T Consensus       165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~  238 (343)
T cd07880         165 ARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD---QLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence            9765332   223357889999998765 457889999999999999999999986433211   11110000       


Q ss_pred             ---------------cCCCCCCCh---hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          312 ---------------RVPSPIDDQ---TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       312 ---------------~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                     ..+......   ........+.+++.+||+.||++|| +.+++.+-..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~  302 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE  302 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence                           000000000   0001112478999999999999999 99988765543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.3e-38  Score=286.96  Aligned_cols=252  Identities=26%  Similarity=0.349  Sum_probs=190.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK------  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (363)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            46899999999999999999975 46899999998754333333456889999999999999999999987543      


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..++++||+.. +|..+..     ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999864 6666542     1488999999999999999999999   9999999999999999999999999998


Q ss_pred             eeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc---------
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD---------  310 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------  310 (363)
                      ......   .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......   ....+..         
T Consensus       165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~  238 (342)
T cd07879         165 RHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGPEF  238 (342)
T ss_pred             cCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHH
Confidence            754321   223456888999998765 468889999999999999999999986533211   1111100         


Q ss_pred             --------------ccCCCCCCC-hh-hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          311 --------------QRVPSPIDD-QT-VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       311 --------------~~~~~~~~~-~~-~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                                    .....+... .. .......+.++|.+||+.||++|| +.+++.+-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~  299 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY  299 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence                          000000000 00 000112478999999999999999 999987643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-38  Score=288.31  Aligned_cols=256  Identities=23%  Similarity=0.335  Sum_probs=196.6

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe----
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC----  161 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  161 (363)
                      ..++|++.+.||+|++|.||+|... +++.||+|++..........+.+.+|+.+++.++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3568999999999999999999764 57899999987654333344667889999999999999999987766554    


Q ss_pred             --EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          162 --MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       162 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                        .++++||+ +++|.+++...    .+++..++.++.|+++||+|||+.   +++||||+|+||++++++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 56998888652    589999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc------
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR------  312 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------  312 (363)
                      +......   .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......   .....+.+..      
T Consensus       165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~  238 (343)
T cd07851         165 ARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVGTPDEE  238 (343)
T ss_pred             ccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCHH
Confidence            9765332   223457888999998764 46788999999999999999999998643221   1111111100      


Q ss_pred             ----------------CCCCCCC---hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          313 ----------------VPSPIDD---QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       313 ----------------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                      .+.....   .........+.+++.+||+.||++|| +.+++.+-+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~  302 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA  302 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence                            0000000   00001123588999999999999999 99988765443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.9e-37  Score=279.92  Aligned_cols=259  Identities=23%  Similarity=0.324  Sum_probs=190.6

Q ss_pred             CCcccCeeeecCceeEEEEEeC-C--CCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeC----Ce
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-S--GKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHK----KC  161 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  161 (363)
                      +|++.+.||+|+||.||++... +  +..||+|.+..........+.+..|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999764 3  67899999875433323345678899999999 599999999876433    35


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++++||+. ++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788888886 58888886543   589999999999999999999999   99999999999999999999999999997


Q ss_pred             eccCCCC----Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCC------------chhh
Q 046084          242 LLHSDSS----NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN------------PKIM  304 (363)
Q Consensus       242 ~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~------------~~~~  304 (363)
                      .......    ......|+..|+|||...+ ..++.++||||||+++|+|++|+.||...+...            ....
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6543221    1123467889999998765 568899999999999999999999986533110            0000


Q ss_pred             HHhhhcc----------cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          305 LIDLLDQ----------RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       305 ~~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...+...          ..+...-..........+.+++.+||+.||++|| +.+++..-..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence            0000000          0000000000000122488999999999999999 9888766543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.9e-37  Score=284.28  Aligned_cols=256  Identities=20%  Similarity=0.288  Sum_probs=191.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-------  159 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  159 (363)
                      ..+|.+.+.||.|+||.||+|.. .+|+.||+|.+......  ..+.+.+|+++++.++||||+++++++...       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~--~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ--SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc--hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            36789999999999999999965 46889999998765442  246788899999999999999999766543       


Q ss_pred             -------CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC-CCc
Q 046084          160 -------KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS-KLE  231 (363)
Q Consensus       160 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~  231 (363)
                             ...++++||++ ++|.+++...    .+++..+..++.|+++||.|||+.   +++||||||+||+++. ++.
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~  153 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence                   35789999997 5888877543    488999999999999999999999   9999999999999974 567


Q ss_pred             eEEEeeccceeccCCCCC---ceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh
Q 046084          232 AFVADFGVARLLHSDSSN---RTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID  307 (363)
Q Consensus       232 ~kl~Dfg~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~  307 (363)
                      ++|+|||++.........   .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........   ...
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~  230 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ---MQL  230 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence            899999999765332111   122346788999997654 5678899999999999999999999864432110   000


Q ss_pred             hhcc----------------------cCCCCCCChh--hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          308 LLDQ----------------------RVPSPIDDQT--VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       308 ~~~~----------------------~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+.                      ....+.....  .......+.+++.+||+.||++|| +.+++.+-..+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence            0000                      0000000000  001112477899999999999999 99998765543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=290.73  Aligned_cols=258  Identities=25%  Similarity=0.433  Sum_probs=214.0

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEee---
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLH---  158 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---  158 (363)
                      ....++-|++.+.||.|.+|.||+++. .+++.+|+|++....+..   ++...|.++++.. .|||++.++|++..   
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            334567799999999999999999954 578889999988776544   5677889999888 69999999999875   


Q ss_pred             --CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEe
Q 046084          159 --KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVAD  236 (363)
Q Consensus       159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  236 (363)
                        ++.++||||||.+|+..+++++.. +.++.|..+..|+..++.|+.+||..   .++|||+|-.|||++.++.|||+|
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence              467999999999999999998766 55799999999999999999999999   999999999999999999999999


Q ss_pred             eccceeccCCCCCceeeccccccccccccccc-----cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc
Q 046084          237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-----VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ  311 (363)
Q Consensus       237 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  311 (363)
                      ||++..++.......+..||+.|||||++...     .|+..+|+||||++..||--|.+|+-++.   +-..+..+...
T Consensus       167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH---PmraLF~IpRN  243 (953)
T KOG0587|consen  167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH---PMRALFLIPRN  243 (953)
T ss_pred             eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc---hhhhhccCCCC
Confidence            99999988777777888999999999988643     36778999999999999999999965443   33344444443


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      .++. ..-+..|..  .+.++|..||.+|-++|| +.+++.+-.
T Consensus       244 PPPk-Lkrp~kWs~--~FndFIs~cL~Kd~e~RP~~~~ll~hpF  284 (953)
T KOG0587|consen  244 PPPK-LKRPKKWSK--KFNDFISTCLVKDYEQRPSTEELLKHPF  284 (953)
T ss_pred             CCcc-ccchhhHHH--HHHHHHHHHHhhccccCcchhhhccCCc
Confidence            3333 222333333  588999999999999999 888876543

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=268.66  Aligned_cols=255  Identities=25%  Similarity=0.365  Sum_probs=196.9

Q ss_pred             CCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHh-cCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLS-QIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      +.+-...||.|+||+|++.. .+.|+..|||+++....+.+ ..++..|.+... .-+.||||++||.+..++..++.||
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            34445679999999999984 46799999999988776444 366777777544 4479999999999999999999999


Q ss_pred             eccCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          168 YMRRGSLFCILRN--DDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       168 ~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      .|.- +|..+-..  .-....+++.-+-.|......||.||...+  .|+|||+||+|||++..|.+||||||++..+..
T Consensus       144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            9954 65543321  011225888888888888999999998776  899999999999999999999999999987643


Q ss_pred             CCCCceeecccccccccccccc--ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYT--MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      . ...+...|-..|||||.+..  ..|+-+|||||||++|||+.||+.|+..++..  -+.+..+..+.++.-..+....
T Consensus       221 S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv--feql~~Vv~gdpp~l~~~~~~~  297 (361)
T KOG1006|consen  221 S-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV--FEQLCQVVIGDPPILLFDKECV  297 (361)
T ss_pred             H-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH--HHHHHHHHcCCCCeecCccccc
Confidence            2 33444568889999998863  34889999999999999999999998876542  2223334444444444444444


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHH
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQ  351 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~  351 (363)
                      .....+..+|..||.+|-+.|| ..++.+
T Consensus       298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  298 HYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            4555699999999999999999 777654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-36  Score=298.50  Aligned_cols=147  Identities=27%  Similarity=0.435  Sum_probs=131.7

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|.+.+.||+|+||.||+|.+. +++.||+|++.... ........+..|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999765 68899999987543 22334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      ||+.+++|.+++....   .+++..++.++.||+.||+|||..   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999987544   578889999999999999999999   99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=272.37  Aligned_cols=271  Identities=20%  Similarity=0.320  Sum_probs=210.9

Q ss_pred             cCCCCccHHHHHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC--CC---
Q 046084           74 NYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR--HR---  147 (363)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~---  147 (363)
                      +.+|++-|+.....+++|.+...+|+|.||.|..+.+ ..+..||+|+++...   ...+..+-|++++.++.  .|   
T Consensus        74 D~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~  150 (415)
T KOG0671|consen   74 DKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGK  150 (415)
T ss_pred             CCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCc
Confidence            4556666776777789999999999999999999954 457899999997654   33466778999999994  23   


Q ss_pred             -ceeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee
Q 046084          148 -NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL  226 (363)
Q Consensus       148 -niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill  226 (363)
                       -++++.+||.-.++.|+|+|.+ |-++.+++..+.. .+++...+..+++|++++++|||+.   +++|.||||+|||+
T Consensus       151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILf  225 (415)
T KOG0671|consen  151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILF  225 (415)
T ss_pred             eEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEE
Confidence             2678888999999999999987 5599999987654 3689999999999999999999999   99999999999998


Q ss_pred             cC--------------------CCceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHH
Q 046084          227 NS--------------------KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEV  286 (363)
Q Consensus       227 ~~--------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el  286 (363)
                      .+                    +..++++|||.+.....   .....+.|..|.|||++.+-.++..+||||+||||.|+
T Consensus       226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             eccceEEEeccCCccceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence            31                    34578999999986533   33566789999999999999999999999999999999


Q ss_pred             HhCCCCCCCCcCCCchhhHHhhhcccC------------------C-----------------CCCC--ChhhHHHHHHH
Q 046084          287 LMGRHPGDLLSSVNPKIMLIDLLDQRV------------------P-----------------SPID--DQTVIQDIILV  329 (363)
Q Consensus       287 ~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------~-----------------~~~~--~~~~~~~~~~l  329 (363)
                      ++|..-|+..+..+.-.++..++.+.+                  .                 .+..  ......+-..|
T Consensus       303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L  382 (415)
T KOG0671|consen  303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL  382 (415)
T ss_pred             eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence            999999887664332223333322111                  0                 0000  00011233459


Q ss_pred             HHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          330 SKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       330 ~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+|+..||..||.+|+ +.|.+.+-.+
T Consensus       383 fDLl~~mL~fDP~~RiTl~EAL~HpFF  409 (415)
T KOG0671|consen  383 FDLLRRMLEFDPARRITLREALSHPFF  409 (415)
T ss_pred             HHHHHHHHccCccccccHHHHhcCHHh
Confidence            9999999999999999 9998876544

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.1e-37  Score=262.84  Aligned_cols=203  Identities=28%  Similarity=0.384  Sum_probs=170.1

Q ss_pred             cCCcccCeeeecCceeEEEEEeC---C--CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP---S--GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH-KKCM  162 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  162 (363)
                      ..|+....||+|.||.||++...   +  +..+|+|+++........-...-+|+.+++.++|||++.+..++.+ +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46899999999999999999432   2  2379999998775433333567789999999999999999999888 7789


Q ss_pred             EEEEEeccCCChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC----CceEEEe
Q 046084          163 FLIYKYMRRGSLFCILRNDD--EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK----LEAFVAD  236 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~D  236 (363)
                      ++++||.+. +|+..++.+.  ....++...+..|++||+.|+.|||++   -+.||||||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 8888886543  234688889999999999999999999   89999999999999887    9999999


Q ss_pred             eccceeccCCCCC---ceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCC
Q 046084          237 FGVARLLHSDSSN---RTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDL  295 (363)
Q Consensus       237 fg~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~  295 (363)
                      ||+++.+..+-..   ...++-|.+|+|||.+.+. -||.+.|||+.|||+.||+|-.+-|..
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999987654332   3345679999999998875 589999999999999999998877654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=282.09  Aligned_cols=242  Identities=23%  Similarity=0.298  Sum_probs=193.8

Q ss_pred             hcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ++.|++...+|.|+|+.|-.+. ..+++..++|++.....      +-.+|+.++... +||||+++.+.+.+....|+|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            5678899999999999998884 45788899999987632      223466555544 799999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee-cCCCceEEEeeccceecc
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL-NSKLEAFVADFGVARLLH  244 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||.+.|+-+.+.+....    ....++..|+.+|+.|+.|||.+   +++||||||+|||+ ++.++++|+|||.++...
T Consensus       395 ~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             ehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            99999998877776544    22367778999999999999999   99999999999999 688999999999998765


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ..   ..+.+-|..|.|||++....|++++|+||||++||+|++|+.||......  ......+..+...  ...+    
T Consensus       468 ~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s--~~vS----  536 (612)
T KOG0603|consen  468 RS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS--ECVS----  536 (612)
T ss_pred             hh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc--cccC----
Confidence            43   33446788999999999999999999999999999999999998765432  2222333222222  1111    


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        ..-.+|+.+||+.||.+|| +.++..+-+.
T Consensus       537 --~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  537 --DEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             --HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence              1377899999999999999 9998877655

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=269.94  Aligned_cols=245  Identities=23%  Similarity=0.352  Sum_probs=204.3

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (363)
                      +...+|.+...||+|+||.|.++..+ +.+.+|||+++.... +....+--+.|-++|... +-|.++++..++...+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            44568999999999999999999653 567899999886532 111123345567777766 577899999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      |.||||+.||+|-..+++-+   ++.+..+..++..||-||-|||++   +|+.||||..|||+|.+|++||+|||+++.
T Consensus       426 yFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence            99999999999988888765   577888889999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      -..+.....+.+||+.|+|||++...+|+.++|.||||++||||+.|++||+..   +..+....+.+.+...|...+. 
T Consensus       500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe---DE~elF~aI~ehnvsyPKslSk-  575 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQAIMEHNVSYPKSLSK-  575 (683)
T ss_pred             cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHccCcCcccccH-
Confidence            555666777889999999999999999999999999999999999999997764   4456677777777666553332 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                           +-..++...|.+.|.+|-
T Consensus       576 -----EAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  576 -----EAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -----HHHHHHHHHhhcCCcccc
Confidence                 255688889999999996

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=297.94  Aligned_cols=250  Identities=27%  Similarity=0.348  Sum_probs=199.8

Q ss_pred             HHHHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 046084           82 QEMIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK  159 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (363)
                      .++....++|.+.+.||+|+||.|..++. .+++.||.|++..-.-- .....-|.+|-++|..-+.+-|+++.-.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            34556678999999999999999999976 46788999998763211 11235688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      .++|+||||++||+|..++...+   ++++.-+..++..|.-||.-||+.   |+|||||||.|||+|..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999998776   688888899999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCC-Cceeeccccccccccccc----c-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc--
Q 046084          240 ARLLHSDSS-NRTVVAGTHGYIAPELAY----T-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ--  311 (363)
Q Consensus       240 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~----~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--  311 (363)
                      +-.+..++. .....+|||.|.+||++.    + +.|...+|.||+||++|||+.|..||...+-   ......+++.  
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl---veTY~KIm~hk~  298 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL---VETYGKIMNHKE  298 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH---HHHHHHHhchhh
Confidence            877764443 455678999999999875    3 5688999999999999999999999854322   1223334433  


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC
Q 046084          312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                      .+.+|... .   .+....+||.+.+. +|+.|-
T Consensus       299 ~l~FP~~~-~---VSeeakdLI~~ll~-~~e~RL  327 (1317)
T KOG0612|consen  299 SLSFPDET-D---VSEEAKDLIEALLC-DREVRL  327 (1317)
T ss_pred             hcCCCccc-c---cCHHHHHHHHHHhc-Chhhhc
Confidence            34444111 1   12236677777776 667665

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.6e-36  Score=258.91  Aligned_cols=218  Identities=22%  Similarity=0.240  Sum_probs=172.2

Q ss_pred             cCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCChhhhh
Q 046084          100 GGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCIL  178 (363)
Q Consensus       100 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l  178 (363)
                      |.+|.||++.+ .+++.||+|.+.....       +..|...+....||||+++++++.+.+..+++|||+++|+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            89999999965 4788999999875432       223444455567999999999999999999999999999999988


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeeccccc
Q 046084          179 RNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG  258 (363)
Q Consensus       179 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~  258 (363)
                      ....   .+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++++|||.+.......   ....++..
T Consensus        77 ~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~  147 (237)
T cd05576          77 SKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENM  147 (237)
T ss_pred             HHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCcc
Confidence            7543   589999999999999999999999   99999999999999999999999999876553321   22345677


Q ss_pred             cccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccC
Q 046084          259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLR  338 (363)
Q Consensus       259 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  338 (363)
                      |+|||...+..++.++||||+|+++|||++|+.|+........     .......+...        ...+.+++.+||+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----~~~~~~~~~~~--------~~~~~~li~~~l~  214 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----THTTLNIPEWV--------SEEARSLLQQLLQ  214 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----cccccCCcccC--------CHHHHHHHHHHcc
Confidence            9999998888889999999999999999999988653221100     00000111111        1247889999999


Q ss_pred             CCCCCCC-h
Q 046084          339 SKPTSRP-M  346 (363)
Q Consensus       339 ~dP~~RP-~  346 (363)
                      .||++|| +
T Consensus       215 ~dp~~R~~~  223 (237)
T cd05576         215 FNPTERLGA  223 (237)
T ss_pred             CCHHHhcCC
Confidence            9999999 5

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=275.10  Aligned_cols=249  Identities=25%  Similarity=0.353  Sum_probs=196.6

Q ss_pred             cCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           94 KYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      .+.||+|.||+||-|++ ++|+.||||++.+..-....-.+++.|+.+|+++.||.||.+...|+..+.+++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            46799999999999954 58999999999776544343478899999999999999999999999999999999999664


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceEEEeeccceeccCCCCC
Q 046084          173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~  249 (363)
                      -|+-++....  .++++.....++.||+.||.|||.+   +|+|+||||+|||+.+   --++||||||.++.+.. ...
T Consensus       649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-ksF  722 (888)
T KOG4236|consen  649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-KSF  722 (888)
T ss_pred             HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch-hhh
Confidence            4444444333  2688888888999999999999999   9999999999999954   35899999999998854 444


Q ss_pred             ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH-HH
Q 046084          250 RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI-IL  328 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  328 (363)
                      ...++||+.|+|||++.+..|...-|+||.|+|+|--++|..||...++.+     ..+.+.....|.   .+|.+. ..
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-----dQIQNAaFMyPp---~PW~eis~~  794 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-----DQIQNAAFMYPP---NPWSEISPE  794 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-----HHhhccccccCC---CchhhcCHH
Confidence            566789999999999999999999999999999999999999986544322     122222222222   122222 24


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      -.+||...|+..-.+|- ...-+.+.+.+
T Consensus       795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq  823 (888)
T KOG4236|consen  795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQ  823 (888)
T ss_pred             HHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence            66899999999888887 55555554443

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=266.86  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=199.3

Q ss_pred             HHHhcCCcccCeeeecCceeEEEE-EeCCCCEEEEEEeccccc-----hHHHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSET-----ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH  158 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  158 (363)
                      ....++|-+...||+|+|+.||++ .+.+.+-||||+-.....     .....+...+|..+-+.++||.||++|+++.-
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            345677888899999999999999 456778899997655432     22334456789999999999999999999875


Q ss_pred             -CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceEE
Q 046084          159 -KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFV  234 (363)
Q Consensus       159 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl  234 (363)
                       .+.+|-|+|||+|.+|.-||..+.   .++++++..|+.||+.||.||... .++|+|.||||.|||+-+   .|.+||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence             456889999999999999998776   589999999999999999999876 678999999999999944   488999


Q ss_pred             EeeccceeccCCCCCc-------eeecccccccccccccc----ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchh
Q 046084          235 ADFGVARLLHSDSSNR-------TVVAGTHGYIAPELAYT----MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI  303 (363)
Q Consensus       235 ~Dfg~~~~~~~~~~~~-------~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~  303 (363)
                      +|||+++.++.+....       ....||.+|++||.+.-    ...+.++||||.|||+|+++.|+.||...-......
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL  694 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL  694 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence            9999999987654431       23468999999998753    347889999999999999999999997543322111


Q ss_pred             hHHhhhcc----cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          304 MLIDLLDQ----RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       304 ~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ....++..    .++.|...+       +-..+|.+||+..-++|- ..++...
T Consensus       695 qeNTIlkAtEVqFP~KPvVss-------eAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  695 QENTILKATEVQFPPKPVVSS-------EAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             hhhchhcceeccCCCCCccCH-------HHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            12223322    122222222       356789999999988888 7666544

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-36  Score=234.62  Aligned_cols=257  Identities=23%  Similarity=0.310  Sum_probs=195.9

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|.-.++||+|.||+||+++. .+++.||+|.++..+.++..-....+|+.+++.++|.|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            455567899999999999965 4688999999988776555556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      |.. +|..+....++  .++.+....++.|+++||.|+|++   ++.||||||.|.|++.+|+.|++|||+++.+.-+..
T Consensus        83 cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            965 78887765443  588899999999999999999999   999999999999999999999999999998765554


Q ss_pred             Cceeeccccccccccccccc-cCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc---------------
Q 046084          249 NRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ---------------  311 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~---------------  311 (363)
                      .....+-|..|.+|.++.+. -|+...|+||-|||+.|+.. |++-|...+..+.-......+..               
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            44445678999999998875 48899999999999999997 55444432221111111111111               


Q ss_pred             cCCCCCCChhhHHHH-----HHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          312 RVPSPIDDQTVIQDI-----ILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       312 ~~~~~~~~~~~~~~~-----~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ...+.......+.+.     ..=+++++..|.-+|.+|- +.+.++.
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            000001111122221     1246788899999999999 7666554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.8e-34  Score=250.88  Aligned_cols=239  Identities=28%  Similarity=0.436  Sum_probs=191.9

Q ss_pred             CceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCChhhhhh
Q 046084          101 GYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR  179 (363)
Q Consensus       101 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~  179 (363)
                      +||.||+|... +|+.+++|++........ .+.+..|++.+++++|+|++++++++......++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999875 488999999986654322 4788999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeecccccc
Q 046084          180 NDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY  259 (363)
Q Consensus       180 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y  259 (363)
                      ...   .+++..++.++.+++.++.+||+.   +++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus        80 ~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~  152 (244)
T smart00220       80 KRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEY  152 (244)
T ss_pred             hcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCC
Confidence            644   388999999999999999999999   99999999999999999999999999998764432 22334578899


Q ss_pred             ccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCC
Q 046084          260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRS  339 (363)
Q Consensus       260 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  339 (363)
                      ++||......++.++||||||+++|+|++|..||.....  ....................   .....+.+++.+||+.
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~~l~~  227 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPFPPPEW---KISPEAKDLIRKLLVK  227 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCCccccc---cCCHHHHHHHHHHccC
Confidence            999999888889999999999999999999999865321  12222222222222111100   0122488999999999


Q ss_pred             CCCCCC-hHHHHHH
Q 046084          340 KPTSRP-MQRVSQE  352 (363)
Q Consensus       340 dP~~RP-~~~v~~~  352 (363)
                      +|++|| +.++++.
T Consensus       228 ~p~~Rp~~~~~~~~  241 (244)
T smart00220      228 DPEKRLTAEEALQH  241 (244)
T ss_pred             CchhccCHHHHhhC
Confidence            999999 9998863

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=270.37  Aligned_cols=242  Identities=25%  Similarity=0.365  Sum_probs=198.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCC-EEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGK-KVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      -.+++....||-|+||.|-++...+.. .+|+|.++...- +....+....|-.+|...+.|.||++|-.|.+...+|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            346677788999999999999774433 378887765432 223346678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      ||-|-||.|+..++..+   .++......++..+.+|++|||.+   +|+.|||||+|.+++.+|-+||.|||+++.+..
T Consensus       499 mEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999999998776   588888889999999999999999   999999999999999999999999999998876


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc--CCCCCCChhhH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR--VPSPIDDQTVI  323 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  323 (363)
                      ....+ +.+||+.|.|||++.+...+.++|.||||+++|||++|.+||+..+.   -.....++.+.  +..|..-..  
T Consensus       573 g~KTw-TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~ILkGid~i~~Pr~I~k--  646 (732)
T KOG0614|consen  573 GRKTW-TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLILKGIDKIEFPRRITK--  646 (732)
T ss_pred             CCcee-eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHhhhhhhhcccccch--
Confidence            55544 56899999999999999999999999999999999999999876543   33333344331  122211111  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC
Q 046084          324 QDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP  345 (363)
                          .-.+||++.+..+|.+|-
T Consensus       647 ----~a~~Lik~LCr~~P~ERL  664 (732)
T KOG0614|consen  647 ----TATDLIKKLCRDNPTERL  664 (732)
T ss_pred             ----hHHHHHHHHHhcCcHhhh
Confidence                255788899999999997

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-37  Score=250.95  Aligned_cols=260  Identities=23%  Similarity=0.370  Sum_probs=194.5

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--------
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--------  159 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  159 (363)
                      +.|+-..++|+|.||.||+++. ++|+.||+|+.........+-....+|+.+|..++|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4466677899999999999965 4677899988766555444455677899999999999999999888643        


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      ..+|+|+.+|+. +|..++.+..  .+++..++.+++.++..||.|+|..   .|+|||+||.|+|++.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            358999999987 8888887653  3688999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCC----CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhh----------
Q 046084          240 ARLLHSDS----SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM----------  304 (363)
Q Consensus       240 ~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~----------  304 (363)
                      ++.+....    ...+..+-|..|++||.+.+ ..|+++.|||.-||++.||++|.+-++...+...-..          
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            97664332    22344566899999998775 5689999999999999999999888765332111000          


Q ss_pred             ----------HHhhhcccCCCCCCChhhHHH-------HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          305 ----------LIDLLDQRVPSPIDDQTVIQD-------IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       305 ----------~~~~~~~~~~~~~~~~~~~~~-------~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                                +...+... |-+........+       ...-.+|+.+++..||.+|+ +.+++.+-.+
T Consensus       251 evWP~~d~lpL~~sie~e-Pl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F  318 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELE-PLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF  318 (376)
T ss_pred             ccCCCcccchHHHhccCC-CCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence                      01111000 000000000000       00356899999999999999 8888876544

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-35  Score=248.29  Aligned_cols=247  Identities=23%  Similarity=0.390  Sum_probs=200.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  163 (363)
                      .-++|.+.+.||+|+|..|..+++ ++.+.+|+|+++..-- +.+.++=.+.|-.+..+- +||.+|.+..+|..+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            456899999999999999999965 4677899998875421 112233455677777666 7999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      .|.||.+||+|--.++...   +++++.+..+...|.-||.|||++   ||+.||||..|||+|..|.+||+|+|+++.-
T Consensus       328 fvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999977776554   699999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc-----hhhHHhhhcccCCCCCC
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-----KIMLIDLLDQRVPSPID  318 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~  318 (363)
                      -.+.....+.+||+.|.|||++.+..|....|.|+||++++||+.|+.||+.....++     ......++...+..|..
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs  481 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS  481 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence            5666677788999999999999999999999999999999999999999986543332     23334444444433332


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                      .+-      .-..+++.-|++||.+|-
T Consensus       482 lsv------kas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  482 LSV------KASHVLKGFLNKDPKERL  502 (593)
T ss_pred             eeh------hhHHHHHHhhcCCcHHhc
Confidence            221      245677889999999985

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-35  Score=231.88  Aligned_cols=221  Identities=24%  Similarity=0.378  Sum_probs=174.8

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCe
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQ-IRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~  161 (363)
                      .++..++..-...||+|++|.|-+.++ .+|...|+|.+........ .++...|+++..+ ..+|.+|.+||.......
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~-q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE-QKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH-HHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            445666677778899999999988854 5789999999987665433 3566777776554 479999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          162 MFLIYKYMRRGSLFCILRN-DDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      +++.||.|.- +|..+-.. -..+...++..+-+|+..+..||.|||++.  .++|||+||+|||++.+|++|+||||++
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence            9999999854 77655432 122336889999999999999999999986  8999999999999999999999999999


Q ss_pred             eeccCCCCCceeeccccccccccccc----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAY----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ  311 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  311 (363)
                      ..+... -..+...|-..|||||.+.    ...|+-++||||||+++.||.+++.||+.+.  .+-..+..+...
T Consensus       197 G~L~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~--tpF~qLkqvVee  268 (282)
T KOG0984|consen  197 GYLVDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG--TPFQQLKQVVEE  268 (282)
T ss_pred             eeehhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC--CHHHHHHHHhcC
Confidence            887543 2334456888999999765    3468999999999999999999999987543  233334444443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=276.73  Aligned_cols=247  Identities=26%  Similarity=0.366  Sum_probs=189.7

Q ss_pred             CcccCeeeecCcee-EEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEEe
Q 046084           91 FDIKYCIGTGGYGS-VYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        91 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      |.-.+.+|.|+-|+ ||+|.. +|+.||||++-...     .+-..+|+..|+.- +||||+++++.-.+....|+..|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            33445689999875 699998 78999999986433     24567899999888 699999999988888999999999


Q ss_pred             ccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---C--CceEEEeecccee
Q 046084          169 MRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---K--LEAFVADFGVARL  242 (363)
Q Consensus       169 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~--~~~kl~Dfg~~~~  242 (363)
                      |.. +|.+++.... +.........+.++.|+++||++||+.   +|+||||||.||||+.   +  ..++|+|||+++.
T Consensus       585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            965 9999998741 111122245577899999999999998   9999999999999965   2  5789999999998


Q ss_pred             ccCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHhC-CCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          243 LHSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMG-RHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       243 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      +..+...   .....||-+|+|||++....-+.++||||+||++|+.++| .+||......     ...++.+...-..-
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-----~~NIl~~~~~L~~L  735 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-----QANILTGNYTLVHL  735 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-----hhhhhcCccceeee
Confidence            8655432   3446799999999999988888899999999999999985 9998754332     23334333221110


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+.. ++  +-.+||.+|++++|..|| +.+|+.+-++
T Consensus       736 ~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlF  770 (903)
T KOG1027|consen  736 EPLP-DC--EAKDLISRMLNPDPQLRPSATDVLNHPLF  770 (903)
T ss_pred             ccCc-hH--HHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence            0001 01  367899999999999999 9999876543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.7e-34  Score=273.68  Aligned_cols=261  Identities=19%  Similarity=0.225  Sum_probs=168.1

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-C----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeE------
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-S----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF------  155 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------  155 (363)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||+|++.......    ....+  .+....+.++..+...      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            4678999999999999999999764 4    6899999886533211    11111  1112122222221111      


Q ss_pred             EeeCCeEEEEEEeccCCChhhhhhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeC
Q 046084          156 CLHKKCMFLIYKYMRRGSLFCILRNDDEA-----------------IRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRD  218 (363)
Q Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  218 (363)
                      +......++++||+.+++|.+++......                 .......+..++.|++.||+|||+.   +|+|||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD  280 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD  280 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence            24456789999999999999988654211                 0112334567999999999999999   999999


Q ss_pred             CCCCCeeecC-CCceEEEeeccceeccCCC-CCceeeccccccccccccccc----------------------cCCccc
Q 046084          219 ISSNNILLNS-KLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPELAYTM----------------------VLTEKC  274 (363)
Q Consensus       219 lkp~Nill~~-~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~  274 (363)
                      |||+|||++. ++.+||+|||++..+.... .......+++.|+|||.+...                      .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 5899999999997653322 222345689999999965322                      234467


Q ss_pred             cchHHHHHHHHHHhCCCCCCCCcCC--------Cc-hhhHHhhhcccCCCCCCC--hhhHHHHHHHHHHHHHccCCCCCC
Q 046084          275 DVYSFGVVALEVLMGRHPGDLLSSV--------NP-KIMLIDLLDQRVPSPIDD--QTVIQDIILVSKIVFACLRSKPTS  343 (363)
Q Consensus       275 DvwslG~il~el~~g~~p~~~~~~~--------~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~  343 (363)
                      |||||||++|||+++..|++.....        .. ..................  ...........+|+.+||+.||++
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k  440 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ  440 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence            9999999999999987774421000        00 000000111110000000  000000112458999999999999


Q ss_pred             CC-hHHHHHHHhch
Q 046084          344 RP-MQRVSQEFLVR  356 (363)
Q Consensus       344 RP-~~~v~~~l~~~  356 (363)
                      || +.+++++-...
T Consensus       441 R~ta~e~L~Hpff~  454 (566)
T PLN03225        441 RISAKAALAHPYFD  454 (566)
T ss_pred             CCCHHHHhCCcCcC
Confidence            99 99999876553

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-33  Score=264.08  Aligned_cols=262  Identities=18%  Similarity=0.241  Sum_probs=180.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-----------------CCCCEEEEEEeccccchH--H----------HHHHHHHH
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-----------------PSGKKVALKKLHHSETEL--A----------FLESFQTE  137 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~--~----------~~~~~~~e  137 (363)
                      ..++|++.++||+|+||.||+|..                 .+++.||||++.......  +          ..+.+..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999953                 235679999987543211  0          01223456


Q ss_pred             HHHHhcCCCCce-----eeeeeEEee--------CCeEEEEEEeccCCChhhhhhcCCC---------------------
Q 046084          138 AHLLSQIRHRNI-----VKLYGFCLH--------KKCMFLIYKYMRRGSLFCILRNDDE---------------------  183 (363)
Q Consensus       138 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  183 (363)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     667777653        3468999999999999998864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCc-eeeccccccccc
Q 046084          184 AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVAGTHGYIAP  262 (363)
Q Consensus       184 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~g~~~y~aP  262 (363)
                      ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.......... ....+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            11356778889999999999999999   99999999999999999999999999997653322111 112347899999


Q ss_pred             ccccccc--------------------C--CccccchHHHHHHHHHHhCCC-CCCCCcCCCchhh--------HHhhhcc
Q 046084          263 ELAYTMV--------------------L--TEKCDVYSFGVVALEVLMGRH-PGDLLSSVNPKIM--------LIDLLDQ  311 (363)
Q Consensus       263 E~~~~~~--------------------~--~~~~DvwslG~il~el~~g~~-p~~~~~~~~~~~~--------~~~~~~~  311 (363)
                      |.+....                    +  ..+.||||+||++|||++|.. |+......+.+..        .......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9875322                    1  124699999999999999875 6543221111100        0111111


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHccCCCC---CCCC-hHHHHHHHhc
Q 046084          312 RVPSPIDDQTVIQDIILVSKIVFACLRSKP---TSRP-MQRVSQEFLV  355 (363)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RP-~~~v~~~l~~  355 (363)
                      ....+.    .........+|+.+||..+|   .+|+ +.|++.+-.+
T Consensus       460 ~~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f  503 (507)
T PLN03224        460 KYDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF  503 (507)
T ss_pred             CCCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence            221111    11112247789999999866   6899 9999987654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-33  Score=254.50  Aligned_cols=206  Identities=23%  Similarity=0.371  Sum_probs=174.3

Q ss_pred             cCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..|...+.||-|+||.|.++. ..+...+|.|.+++.+- ........+.|-++|..-+.+-||+||-.|.+.+++|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            457778899999999999994 44566899999977653 2333456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc--
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH--  244 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~--  244 (363)
                      +|++||++-.+|-..+   .+.+.-+..++.++..|+++.|..   |++||||||.|||||.+|++||+|||++.-+.  
T Consensus       709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999887765   588888888999999999999999   99999999999999999999999999985431  


Q ss_pred             -------CCCCC---------------------------------ceeeccccccccccccccccCCccccchHHHHHHH
Q 046084          245 -------SDSSN---------------------------------RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVAL  284 (363)
Q Consensus       245 -------~~~~~---------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~  284 (363)
                             .....                                 ....+||+.|+|||++....|+..+|.||.|+|||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                   00000                                 01135999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCcCCC
Q 046084          285 EVLMGRHPGDLLSSVN  300 (363)
Q Consensus       285 el~~g~~p~~~~~~~~  300 (363)
                      ||+.|+.||.......
T Consensus       863 em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHhhCCCCccCCCCCc
Confidence            9999999997655443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2e-31  Score=226.31  Aligned_cols=211  Identities=34%  Similarity=0.622  Sum_probs=182.8

Q ss_pred             eeecCceeEEEEEeCC-CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCChh
Q 046084           97 IGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF  175 (363)
Q Consensus        97 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  175 (363)
                      ||+|++|.||++...+ ++.+++|.+....... ..+.+.+|+..++.++|++++++++++......++++|++.+++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            6899999999998754 8899999998765432 2467889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC-CCceEEEeeccceeccCCCCCceeec
Q 046084          176 CILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS-KLEAFVADFGVARLLHSDSSNRTVVA  254 (363)
Q Consensus       176 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~  254 (363)
                      +++....  ..+++..++.++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+..............
T Consensus        80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          80 DLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence            9987652  2588999999999999999999999   9999999999999999 89999999999987644332233345


Q ss_pred             cccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHH
Q 046084          255 GTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIV  333 (363)
Q Consensus       255 g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  333 (363)
                      +...|++||..... .++.++|+|++|+++++|                                        ..+.+++
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------~~~~~~l  194 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------PELKDLI  194 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------HHHHHHH
Confidence            77889999988776 788899999999999999                                        2488999


Q ss_pred             HHccCCCCCCCC-hHHHHHHH
Q 046084          334 FACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       334 ~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      ..|++.||++|| +.++++.+
T Consensus       195 ~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         195 RKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHhhCCcccCcCHHHHhhCC
Confidence            999999999999 99888653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.4e-32  Score=239.95  Aligned_cols=133  Identities=23%  Similarity=0.453  Sum_probs=111.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-----C---CceeeeeeEEee
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-----H---RNIVKLYGFCLH  158 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~  158 (363)
                      ..+|.+.++||.|-|++||++.+ .+.+.||+|+.+...   .+.+....||.+|++++     |   .+||+|++.|..
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            37899999999999999999954 466789999987543   33467788999999884     3   369999999986


Q ss_pred             C----CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec
Q 046084          159 K----KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN  227 (363)
Q Consensus       159 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~  227 (363)
                      .    .++|||+|++ |.+|..++...... .++...+.+|++||+.||.|||..+  +|+|.||||+|||+.
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            5    4799999998 66888888765432 5888999999999999999999998  999999999999983

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.9e-30  Score=222.01  Aligned_cols=199  Identities=36%  Similarity=0.553  Sum_probs=171.7

Q ss_pred             CcccCeeeecCceeEEEEEeCC-CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           91 FDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      |.+.+.||.|++|.||++...+ ++.+++|.+...... ...+.+..|++.++.++|+|++++++++......++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            5667889999999999998764 889999999866543 23578889999999999999999999999989999999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC-C
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-S  248 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  248 (363)
                      ++++|.+++.....  .+++..+..++.+++.++.+||+.   +++|+|++|.||+++.++.++|+|||.+....... .
T Consensus        80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       80 EGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            99999999876542  178899999999999999999999   99999999999999999999999999998765432 1


Q ss_pred             Cceeecccccccccccc-ccccCCccccchHHHHHHHHHHhCCCCCCC
Q 046084          249 NRTVVAGTHGYIAPELA-YTMVLTEKCDVYSFGVVALEVLMGRHPGDL  295 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~p~~~  295 (363)
                      ......++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22334577889999988 666778899999999999999999999843

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=6.3e-32  Score=219.00  Aligned_cols=254  Identities=19%  Similarity=0.305  Sum_probs=191.7

Q ss_pred             HhcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCC--eE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKK--CM  162 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~  162 (363)
                      ..++|++.+++|+|.|+.||.|. ..++++++||+++....     +.+.+|+.+|..+. ||||+.++++..+..  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk-----kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK-----KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH-----HHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            45789999999999999999995 46788999999986543     56889999999995 999999999988754  46


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-CceEEEeeccce
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVAR  241 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~  241 (363)
                      .+++||..+.+...+-.      .++...+..++.+++.||.|+|+.   ||+|||+||.|+++|.. ...+|+|+|++.
T Consensus       111 aLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence            79999999988766553      477788899999999999999999   99999999999999875 578999999998


Q ss_pred             eccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCC-Cchhh---------------
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV-NPKIM---------------  304 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-~~~~~---------------  304 (363)
                      +..... .....+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||-.-.+. +.-..               
T Consensus       182 FYHp~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  182 FYHPGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             hcCCCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            765433 3444566778889998765 45788899999999999999999997432221 11000               


Q ss_pred             ---------HHhhhcccCCCCC----CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          305 ---------LIDLLDQRVPSPI----DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       305 ---------~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                               ..+++......+.    ......-...+..+++...|..|-++|| +.|.+.+-.+
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence                     1111111111000    0000000012477899999999999999 8888766543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=251.68  Aligned_cols=251  Identities=27%  Similarity=0.467  Sum_probs=205.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|+....+|.|.||.||++++ ..++..|+|+++......  ......|+-+++..+||||+.++|.+...+..++.|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            56899999999999999999965 578899999988665432  355678999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      |||.+|+|.+.-+..+   ++++.++..+.+..++|++|||+.   +-+|||||-.|||+++.+.+|+.|||.+..+...
T Consensus        92 EycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             EecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence            9999999999877665   689999999999999999999999   9999999999999999999999999999877665


Q ss_pred             CCCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC-CCCCChhh
Q 046084          247 SSNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP-SPIDDQTV  322 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  322 (363)
                      ........||+.|||||+..   .+.|...+|||++|++..|+---++|   ..+..+...+.-+-+..+. ....++..
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp---lfdlhpmr~l~LmTkS~~qpp~lkDk~k  242 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP---LFDLHPMRALFLMTKSGFQPPTLKDKTK  242 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc---ccccchHHHHHHhhccCCCCCcccCCcc
Confidence            56666778999999999754   55688999999999999999888888   3333333333333333332 22344444


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHH
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQ  351 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~  351 (363)
                      |..  .+-++++.||.++|.+|| +..++.
T Consensus       243 ws~--~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  243 WSE--FFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             chH--HHHHHHHHHhcCCCccCCChhhhee
Confidence            544  478899999999999999 655544

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-33  Score=231.22  Aligned_cols=200  Identities=30%  Similarity=0.387  Sum_probs=163.5

Q ss_pred             cccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----eEEEE
Q 046084           92 DIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-----CMFLI  165 (363)
Q Consensus        92 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  165 (363)
                      +-.+-||.|+||.||.+++ ++|+.|+.|++.........-+.+.+|+.+|..++|.|++..+++..-..     .+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3455699999999999976 47999999999776555555578899999999999999999888765432     35777


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      +|.|.. +|..++-...   .++...+.-++.||++||.|||+.   +|.||||||.|.|++.+...||||||+++.-+.
T Consensus       136 TELmQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELMQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence            887754 6766665433   688888888999999999999999   999999999999999999999999999987544


Q ss_pred             CCC-Cceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcC
Q 046084          246 DSS-NRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSS  298 (363)
Q Consensus       246 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~  298 (363)
                      +.. ..+..+-|..|.|||++.+. .|+.+.||||.|||+.|++..+.-|+....
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P  263 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP  263 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence            332 23334568899999999874 589999999999999999998888765444

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=6.6e-32  Score=241.81  Aligned_cols=210  Identities=21%  Similarity=0.285  Sum_probs=177.7

Q ss_pred             CCccHHHHHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC------CCce
Q 046084           77 GRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR------HRNI  149 (363)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni  149 (363)
                      |-+.++-.++...+|.+....|+|-|++|.+|.+ ..|+.||||++.......   +.=+.|+++|++|+      --|.
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~---KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH---KTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh---hhhhHHHHHHHHhhccCchhhhHH
Confidence            4456666778899999999999999999999965 357799999998765432   44567999999995      2478


Q ss_pred             eeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC
Q 046084          150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK  229 (363)
Q Consensus       150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  229 (363)
                      ++++-.|...+++|||+|-+. -+|.+.|...+....|....+..++.|+.-||..|...   +++|.||||.|||+++.
T Consensus       497 lrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  497 LRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence            999999999999999999874 49999998877777799999999999999999999988   99999999999999875


Q ss_pred             -CceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCC
Q 046084          230 -LEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDL  295 (363)
Q Consensus       230 -~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~  295 (363)
                       ..+||||||.|.....+.  .+.+.-+..|.|||++.+.+|+...|+||.||+||||.||+.-|..
T Consensus       573 k~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             cceeeeccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence             667999999997764332  2233456789999999999999999999999999999999987654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=242.53  Aligned_cols=199  Identities=25%  Similarity=0.359  Sum_probs=168.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccch--HHH----HHHHHHHHHHHhcCC---CCceeeeeeEEe
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE--LAF----LESFQTEAHLLSQIR---HRNIVKLYGFCL  157 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~----~~~~~~e~~~l~~l~---h~niv~l~~~~~  157 (363)
                      ..+|+..+.+|.|+||.|+.+.++ +...|+||.+.+..--  ...    +-..-.|+++|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            346888999999999999999765 4567899988764321  110    112457999999997   999999999999


Q ss_pred             eCCeEEEEEEec-cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEe
Q 046084          158 HKKCMFLIYKYM-RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVAD  236 (363)
Q Consensus       158 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  236 (363)
                      +.+..|++||-. ++-+|.+++....   .+++.+...|++|++.|+++||++   +|+|||||-+||.++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            999999999964 4568999998765   699999999999999999999999   999999999999999999999999


Q ss_pred             eccceeccCCCCCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCC
Q 046084          237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGD  294 (363)
Q Consensus       237 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~  294 (363)
                      ||.+....+  ......+||.+|.|||++.+.+| ...-|||++|++||.++....||-
T Consensus       714 fgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999976532  33456789999999999998877 456899999999999999999964

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-31  Score=222.96  Aligned_cols=255  Identities=24%  Similarity=0.304  Sum_probs=189.1

Q ss_pred             hcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------C
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------K  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  160 (363)
                      ..+|.-...+|.|.- .|..+. .-.+++||+|++..........++..+|..++..++|+||++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            345666777888888 555553 23688999998876544344457788999999999999999999988754      3


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..|+|||+|.. +|...+..     .++-..+..++.|++.|++|||+.   +|+||||||+||++..+..+||.|||++
T Consensus        95 e~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence            57999999954 88777662     367788889999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCC-----------chhhHH---
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN-----------PKIMLI---  306 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~-----------~~~~~~---  306 (363)
                      +.-... ...+..+.+..|.|||++.+..+.+.+||||+||++.||++|+.-|...+..+           +.....   
T Consensus       166 r~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             cccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            865433 34455678899999999999889999999999999999999998765322110           000000   


Q ss_pred             ----------------hhhcccCC---CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          307 ----------------DLLDQRVP---SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       307 ----------------~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                                      .......+   .+.............++++.+||-.||++|- ..+++.+-
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence                            00000000   0110011111223478899999999999999 88887653

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=216.08  Aligned_cols=243  Identities=21%  Similarity=0.370  Sum_probs=179.7

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeee-EEeeCCeEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYG-FCLHKKCMF  163 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~  163 (363)
                      ..+.|.+.+.||+|.||.+-+++++ ++..+++|-+......   .++|.+|...--.| .|.||+.-|+ .|...+...
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            3567999999999999999999764 5678999998776544   36788888765556 5889998775 455667777


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec--CCCceEEEeeccce
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN--SKLEAFVADFGVAR  241 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~~~  241 (363)
                      .++||++.|+|.+-+...+    +.+....+++.|+++|+.|||+.   ++||||||.+|||+-  +..++||||||+.+
T Consensus        99 F~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence            8999999999988776544    77888889999999999999999   999999999999993  34689999999987


Q ss_pred             eccCCCCCceeeccccccccccccccc-----cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhh-HHhhhcccCCC
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYTM-----VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM-LIDLLDQRVPS  315 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~  315 (363)
                      .....-   .....+..|.+||.....     ...+.+|+|.||++++.++||+.||+.....++... ...+..+..+.
T Consensus       172 k~g~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~  248 (378)
T KOG1345|consen  172 KVGTTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA  248 (378)
T ss_pred             ccCcee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence            643221   122245678999965422     346789999999999999999999985544333332 22333332221


Q ss_pred             -CCCChhhHHHHHHHHHHHHHccCCCCCCCC
Q 046084          316 -PIDDQTVIQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       316 -~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                       |........   ...++.++-|.++|++|=
T Consensus       249 ~P~~F~~fs~---~a~r~Fkk~lt~~~~drc  276 (378)
T KOG1345|consen  249 LPKKFNPFSE---KALRLFKKSLTPRFKDRC  276 (378)
T ss_pred             CchhhcccCH---HHHHHHHHhcCCcccccc
Confidence             111111111   367788899999999993

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.7e-28  Score=202.13  Aligned_cols=165  Identities=22%  Similarity=0.184  Sum_probs=125.3

Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |+|.+++...+.  .+++.+++.++.|++.||+|||+.   +      ||+|||++.++.+++  ||++.......    
T Consensus         1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            688999875432  599999999999999999999988   5      999999999999999  99987654322    


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCC-CCCChhhHHHH--HH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS-PIDDQTVIQDI--IL  328 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~  328 (363)
                       ..|++.|+|||++.+..++.++|||||||++|||++|+.||.......  ...........+. +..........  ..
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESVSAARS  140 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHHHhhhh
Confidence             257899999999999999999999999999999999999986543221  1122222211111 11111111111  24


Q ss_pred             HHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          329 VSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       329 l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +.+++.+||+.||++|| +.+++.++...
T Consensus       141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      141 FADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            89999999999999999 99999988654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.1e-29  Score=254.29  Aligned_cols=198  Identities=18%  Similarity=0.234  Sum_probs=138.7

Q ss_pred             cCCC-CceeeeeeEE-------eeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 046084          143 QIRH-RNIVKLYGFC-------LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI  214 (363)
Q Consensus       143 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  214 (363)
                      .++| +||.+++++|       .+...++.++|++ +++|.+++....  ..+++.+++.++.||++||+|||++   +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            3445 5777777776       2234567778877 569999997532  3589999999999999999999999   99


Q ss_pred             EEeCCCCCCeeecCC-------------------CceEEEeeccceeccCCC----------------CCceeecccccc
Q 046084          215 VHRDISSNNILLNSK-------------------LEAFVADFGVARLLHSDS----------------SNRTVVAGTHGY  259 (363)
Q Consensus       215 ~H~dlkp~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~----------------~~~~~~~g~~~y  259 (363)
                      +||||||+|||++..                   +.+|++|||+++......                .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   445566666654321100                001113578889


Q ss_pred             ccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCC
Q 046084          260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRS  339 (363)
Q Consensus       260 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  339 (363)
                      ||||++.+..++.++|||||||++|||++|..|+.....     ..........+...     .........++.+||++
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~L~~  251 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHRVLPPQI-----LLNWPKEASFCLWLLHP  251 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHhhcChhh-----hhcCHHHHHHHHHhCCC
Confidence            999999999999999999999999999999888542211     11111111111110     01111356788899999


Q ss_pred             CCCCCC-hHHHHHHHhch
Q 046084          340 KPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       340 dP~~RP-~~~v~~~l~~~  356 (363)
                      ||.+|| +.|++.+....
T Consensus       252 ~P~~Rps~~eil~h~~~~  269 (793)
T PLN00181        252 EPSCRPSMSELLQSEFIN  269 (793)
T ss_pred             ChhhCcChHHHhhchhhh
Confidence            999999 99998766543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=9.9e-29  Score=216.97  Aligned_cols=198  Identities=28%  Similarity=0.432  Sum_probs=165.4

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEeC----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLH  158 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (363)
                      .....+.|...+.||.|.|++||++.+.    .++.||+|.+......    ..+..|+++|..+ .+.||+++.+++..
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            3445678999999999999999999653    4678999999876543    5678999999999 59999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-CceEEEee
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADF  237 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Df  237 (363)
                      ++.+.+|+||++.....++...      ++..++..++..+..||+++|..   ||+|||+||+|+|.+.. +.-.|+||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence            9999999999999999888863      66788899999999999999999   99999999999999865 66789999


Q ss_pred             ccceeccCCC--------------C------------------------------Cceeecccccccccccccc-ccCCc
Q 046084          238 GVARLLHSDS--------------S------------------------------NRTVVAGTHGYIAPELAYT-MVLTE  272 (363)
Q Consensus       238 g~~~~~~~~~--------------~------------------------------~~~~~~g~~~y~aPE~~~~-~~~~~  272 (363)
                      |++...+...              .                              ..-...||++|.|||++.. ...++
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9996211000              0                              0011359999999998875 45688


Q ss_pred             cccchHHHHHHHHHHhCCCCCC
Q 046084          273 KCDVYSFGVVALEVLMGRHPGD  294 (363)
Q Consensus       273 ~~DvwslG~il~el~~g~~p~~  294 (363)
                      ++||||.|+|++.+++++.||-
T Consensus       258 aiDiws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             ccceeeccceeehhhccccccc
Confidence            9999999999999999999974

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-28  Score=202.93  Aligned_cols=250  Identities=20%  Similarity=0.346  Sum_probs=190.4

Q ss_pred             CCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      +..+..+|.....|..|+|++ +|..+++|++..........++|.+|.-.|+.+.||||+.++|.|....+..++..||
T Consensus       191 ~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            344556788899999999999 5667888988877766665678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  249 (363)
                      +.|+|+..++... ....+..+..+++.++|+|++|||+. ++-|.---|++..+++|++.+++|+- +-.++...    
T Consensus       270 p~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfq----  342 (448)
T KOG0195|consen  270 PFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ----  342 (448)
T ss_pred             cchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeee----
Confidence            9999999998654 33577888999999999999999987 33344556999999999999988752 11111111    


Q ss_pred             ceeeccccccccccccccccC---CccccchHHHHHHHHHHhCCCCCCCCcCCCchh-hHHhhhcccCCCCCCChhhHHH
Q 046084          250 RTVVAGTHGYIAPELAYTMVL---TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI-MLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~~~~~---~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      ......++.||+||.+...+-   -.++|+|||.+++||+.|...||...+..+... ...+-++..+|+...  .    
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis--~----  416 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGIS--R----  416 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCcc--H----
Confidence            111234688999999876653   357999999999999999999998776543221 122223333333321  1    


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        .+.+|+.-|++.||.+|| +..++-.|+.
T Consensus       417 --hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  417 --HMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             --HHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence              278899999999999999 8877766553

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=5.7e-26  Score=205.61  Aligned_cols=164  Identities=19%  Similarity=0.169  Sum_probs=127.7

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC--CCCEEEEEEeccccc---hHHHHHHHHHHHHHHhcCCCCceee-eeeEEeeC
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP--SGKKVALKKLHHSET---ELAFLESFQTEAHLLSQIRHRNIVK-LYGFCLHK  159 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~  159 (363)
                      ...++|.+.+.||+|+||+||+|.+.  +++.||||++.....   .....+.|.+|+++|++++|+|+++ ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            45678999999999999999999764  577789998753311   2233467999999999999999985 4432    


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCC-CCCCeeecCCCceEEEeec
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDI-SSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfg  238 (363)
                      +..++||||++|++|.. ...      ..   ...++.++++||.|||+.   +++|||| ||+|||++.++.++|+|||
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            45799999999999963 211      11   145789999999999999   9999999 9999999999999999999


Q ss_pred             cceeccCCCCC--------ceeeccccccccccccc
Q 046084          239 VARLLHSDSSN--------RTVVAGTHGYIAPELAY  266 (363)
Q Consensus       239 ~~~~~~~~~~~--------~~~~~g~~~y~aPE~~~  266 (363)
                      +++........        .....+++.|+|||.+.
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99876443211        12345778899999875

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.4e-25  Score=200.09  Aligned_cols=253  Identities=20%  Similarity=0.263  Sum_probs=187.2

Q ss_pred             CCcccCeeeecCceeEEEEEeCCC--CEEEEEEeccccchHHHHHHHHHHHHHHhcCCC----CceeeeeeEE-eeCCeE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLPSG--KKVALKKLHHSETELAFLESFQTEAHLLSQIRH----RNIVKLYGFC-LHKKCM  162 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~  162 (363)
                      +|.+.+.||+|+||.||.+...+.  ..+|+|..........  ..+..|..++..+..    +++..+++.. ......
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            799999999999999999976543  4788887765432211  156778888888862    5888888888 477788


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-----CceEEEee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-----LEAFVADF  237 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Df  237 (363)
                      ++||+.+ |.+|.++..... ...++....+.++.|++.+|.+||+.   |++||||||.|+++...     ..+.|.||
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            9999977 779999886555 45799999999999999999999999   99999999999999765     46899999


Q ss_pred             ccce--eccCCCC-------C-ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh
Q 046084          238 GVAR--LLHSDSS-------N-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID  307 (363)
Q Consensus       238 g~~~--~~~~~~~-------~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~  307 (363)
                      |+++  .......       . .....||..|.++.+..+...+.+.|+||++.++.|++.|..||..............
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~  251 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK  251 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence            9998  3211111       1 1234599999999999999999999999999999999999999976654333222222


Q ss_pred             hhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          308 LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      .......... ....   +..+.++...+-..+...+| ...+...+
T Consensus       252 ~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l  294 (322)
T KOG1164|consen  252 DPRKLLTDRF-GDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELL  294 (322)
T ss_pred             Hhhhhccccc-cCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence            2222221110 0001   11255555566668999999 66666554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=4e-24  Score=194.03  Aligned_cols=257  Identities=29%  Similarity=0.420  Sum_probs=196.2

Q ss_pred             CcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHH-HHHHHHHHHHHHhcCCCC-ceeeeeeEEeeCCeEEEEEEe
Q 046084           91 FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELA-FLESFQTEAHLLSQIRHR-NIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  168 (363)
                      |.+.+.||.|+||.||++...  ..+++|.+........ ....+.+|+..++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999875  7889999887655432 457899999999999988 799999999777778999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC-ceEEEeeccceeccCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLLHSDS  247 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  247 (363)
                      +.++++.+++........+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997766543112588889999999999999999999   999999999999999988 79999999998654433


Q ss_pred             C------Cceeecccccccccccccc---ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC----C
Q 046084          248 S------NRTVVAGTHGYIAPELAYT---MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV----P  314 (363)
Q Consensus       248 ~------~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~  314 (363)
                      .      ......++..|+|||...+   ..++...|+||+|++++++++|..||...............+....    .
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence            2      2355679999999999887   5788899999999999999999999655442101111122111111    1


Q ss_pred             CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      ..............+.+++..|+..+|..|. +.+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111110011122477899999999999999 6655543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.4e-25  Score=216.03  Aligned_cols=259  Identities=21%  Similarity=0.315  Sum_probs=189.8

Q ss_pred             cccCeeeecCceeEEEEEe-CCCCEEEEEEec----cccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           92 DIKYCIGTGGYGSVYRAQL-PSGKKVALKKLH----HSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        92 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .....+|.|++|.|+.... ...+..+.|...    ...........+..|..+-..+.|||++..+..+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4567799999998877743 233334444332    33333333344778888888999999988777777766655569


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      |||++ +|..++....   .++..++..+++|+..|++|||+.   |+.|||+|++|++++.++.+||+|||.+..+..+
T Consensus       401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999987653   478888889999999999999999   9999999999999999999999999999876554


Q ss_pred             CCC----ceeeccccccccccccccccCCc-cccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          247 SSN----RTVVAGTHGYIAPELAYTMVLTE-KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       247 ~~~----~~~~~g~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ...    ....+|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+.........++.-........
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~  553 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL  553 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence            432    33467899999999999988876 6899999999999999999987654433221111111111111111111


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ....+..-+.++.+||+.||.+|- +.++++.-+.+.
T Consensus       554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~  590 (601)
T KOG0590|consen  554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS  590 (601)
T ss_pred             HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence            122233577899999999999999 999988766543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=8.3e-24  Score=180.74  Aligned_cols=216  Identities=19%  Similarity=0.279  Sum_probs=179.9

Q ss_pred             hcCCcccCeeeecCceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .-.|++.++||+|+||.++.|+ +-+++.||||.-......    -++..|....+.| ..++|..++-|..++.+-.||
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            3479999999999999999994 468999999986655443    3567788888888 578999999888888888899


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-----CceEEEeeccc
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-----LEAFVADFGVA  240 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Dfg~~  240 (363)
                      +|.. |-+|+|+..-.+.  +++.+.+..++.|++.-++|+|++   .+|.|||||+|+||...     ..+.++|||++
T Consensus       103 idLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            9987 7799998876543  699999999999999999999999   99999999999999643     45789999999


Q ss_pred             eeccCCCCC-------ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          241 RLLHSDSSN-------RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       241 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      +....+...       .....||.+||+-....+...+.+.|+=|||-+++..+-|..||+.....+.+.....+-+..-
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr  256 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR  256 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence            876544322       2345799999999999999999999999999999999999999998877666666666655443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3.8e-24  Score=175.18  Aligned_cols=249  Identities=18%  Similarity=0.283  Sum_probs=193.7

Q ss_pred             HHhcCCcccCeeeecCceeEEEE-EeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  163 (363)
                      +....|.+.+.||+|+||.+|.| ...+|+.||||.-......    .++.-|..+.+.++ ...|..+..+..+...-.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            44567999999999999999999 4578999999987665543    34667888898886 467888888888888899


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceEEEeeccc
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVADFGVA  240 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~  240 (363)
                      +||+.. |.+|++++.-...  .++...++-++-|++.-++|+|.+   +.+||||||+|+|..-   ...+.++|||++
T Consensus        88 lVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence            999987 7799988865432  588999999999999999999999   9999999999999854   356889999999


Q ss_pred             eeccCCCC-------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          241 RLLHSDSS-------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       241 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      +.......       ......||.+|.+-....+...+...|+-|+|.+|..+.-|..||+.............+.....
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~  241 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM  241 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence            87643221       22345799999998888888888999999999999999999999998877766666666666555


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                      ..+... .+...+.++.-.+.-|=+.-=++-|
T Consensus       242 s~~ie~-LC~G~P~EF~myl~Y~R~L~F~E~P  272 (341)
T KOG1163|consen  242 STPIEV-LCKGFPAEFAMYLNYCRGLGFEEKP  272 (341)
T ss_pred             CCCHHH-HhCCCcHHHHHHHHHHhhcCCCCCC
Confidence            433211 1111222355556666666666666

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=5.6e-24  Score=179.45  Aligned_cols=191  Identities=14%  Similarity=0.160  Sum_probs=143.0

Q ss_pred             CcccccCCCCccHHHH--HHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccch-HHHHHH------HHHHHH
Q 046084           69 EFSVWNYDGRITFQEM--IVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETE-LAFLES------FQTEAH  139 (363)
Q Consensus        69 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~------~~~e~~  139 (363)
                      .+.++..+....|.++  ....++|+..+.+|.|+||.||+... ++..+|+|.+...... ......      +.+|+.
T Consensus         9 ~~~~~~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~   87 (232)
T PRK10359          9 GYTVFYKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIV   87 (232)
T ss_pred             ceEEEecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHH
Confidence            3444445555444443  35688999999999999999999866 6778999999765432 222233      679999


Q ss_pred             HHhcCCCCceeeeeeEEeeC--------CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 046084          140 LLSQIRHRNIVKLYGFCLHK--------KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI  211 (363)
Q Consensus       140 ~l~~l~h~niv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  211 (363)
                      .+.+++|++|..+.+++...        +..+++|||++|.+|.++..       ++.    ....+++.++..+|..  
T Consensus        88 ~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~--  154 (232)
T PRK10359         88 QTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH--  154 (232)
T ss_pred             HHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc--
Confidence            99999999999998886643        35789999999999977632       332    2456999999999999  


Q ss_pred             CCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHH
Q 046084          212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL  287 (363)
Q Consensus       212 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  287 (363)
                       +++|||++|+||++++++ ++|+|||.......+....            .......+..++|+||||+++....
T Consensus       155 -gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        155 -GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH------------HHHHHhHhcccccccceeEeehHHH
Confidence             999999999999999988 9999999886542211110            0233344567899999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=7.9e-24  Score=176.53  Aligned_cols=141  Identities=19%  Similarity=0.202  Sum_probs=108.1

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHH------------------------HHHHHHHHHHHhcCCCCce
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAF------------------------LESFQTEAHLLSQIRHRNI  149 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni  149 (363)
                      ...||+|++|.||+|...+|+.||+|+++........                        ......|+..+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999998888999999999764321100                        1122459999999987776


Q ss_pred             eeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEEeCCCCCCeeecC
Q 046084          150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL-HCDCIPSIVHRDISSNNILLNS  228 (363)
Q Consensus       150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlkp~Nill~~  228 (363)
                      .....+...  ..++||||++++++........   .++......++.|++.+|.++ |+.   +++||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            433332222  2389999999887765432222   588899999999999999999 688   999999999999998 


Q ss_pred             CCceEEEeeccceec
Q 046084          229 KLEAFVADFGVARLL  243 (363)
Q Consensus       229 ~~~~kl~Dfg~~~~~  243 (363)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=5.2e-25  Score=213.14  Aligned_cols=238  Identities=22%  Similarity=0.302  Sum_probs=177.1

Q ss_pred             CCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHH--HHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELA--FLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++...+.||++.|=+|.+|++++|. |+||++-..+....  ...+-.+|++ ...++|||.+++.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6778889999999999999998887 89999876653322  1223334444 556689999998877666677788888


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc---
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH---  244 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~---  244 (363)
                      |..+ +|+|.+..+.   -+...+..-|+.|++.|+..+|..   +|+|||||.+|||++.-+.+.|+||...+...   
T Consensus       102 yvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            8866 8999887654   366677778999999999999999   99999999999999999999999998775432   


Q ss_pred             CCCCCceee----ccccccccccccccc----------c-CCccccchHHHHHHHHHHh-CCCCCCCCc--------CCC
Q 046084          245 SDSSNRTVV----AGTHGYIAPELAYTM----------V-LTEKCDVYSFGVVALEVLM-GRHPGDLLS--------SVN  300 (363)
Q Consensus       245 ~~~~~~~~~----~g~~~y~aPE~~~~~----------~-~~~~~DvwslG~il~el~~-g~~p~~~~~--------~~~  300 (363)
                      .+.......    .....|+|||.+...          . .+++.||||+||++.||++ |++||....        ..+
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD  254 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence            111111111    223479999976531          1 5678999999999999998 788875421        111


Q ss_pred             chhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          301 PKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .+..+..+.+     .           .+++++..|++.||++|- +.++++.
T Consensus       255 ~e~~Le~Ied-----~-----------~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  255 PEQLLEKIED-----V-----------SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHhCcC-----c-----------cHHHHHHHHHccCchhccCHHHHHHh
Confidence            2222222211     1           289999999999999999 9998876

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.1e-22  Score=170.36  Aligned_cols=141  Identities=21%  Similarity=0.289  Sum_probs=110.9

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccchH------------------------HHHHHHHHHHHHHhcCCCCce
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETEL------------------------AFLESFQTEAHLLSQIRHRNI  149 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~~l~h~ni  149 (363)
                      ...||+|++|.||+|...+|+.||||+++......                        .....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            56799999999999988789999999987653110                        001234678999999999887


Q ss_pred             eeeeeEEeeCCeEEEEEEeccCCChhhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeec
Q 046084          150 VKLYGFCLHKKCMFLIYKYMRRGSLFCI-LRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLN  227 (363)
Q Consensus       150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~  227 (363)
                      .....+....  .++||||++++++... +..    ..++..+...++.|++.++.++|+ .   +++||||||+||+++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            5444433332  4899999998855433 322    247788899999999999999999 8   999999999999999


Q ss_pred             CCCceEEEeeccceecc
Q 046084          228 SKLEAFVADFGVARLLH  244 (363)
Q Consensus       228 ~~~~~kl~Dfg~~~~~~  244 (363)
                       ++.++|+|||++....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             7899999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=2.7e-23  Score=180.50  Aligned_cols=235  Identities=19%  Similarity=0.236  Sum_probs=149.3

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCC----------CceeeeeeEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH----------RNIVKLYGFCL  157 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~  157 (363)
                      .+...+.||.|+++.||.+++. +|+.+|+|++..... .....+++++|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3456778999999999999775 589999998765543 22235677777765555432          12222222221


Q ss_pred             ---------eCC--------eEEEEEEeccCCChhhhhhc---C-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEE
Q 046084          158 ---------HKK--------CMFLIYKYMRRGSLFCILRN---D-DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH  216 (363)
Q Consensus       158 ---------~~~--------~~~lv~e~~~~g~L~~~l~~---~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  216 (363)
                               ...        +.+++|+-+ .++|.+++..   . .....+....++.+..|+++.+++||+.   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                     111        235677766 4578776542   1 1122345566677889999999999999   9999


Q ss_pred             eCCCCCCeeecCCCceEEEeeccceeccCCCCCceeecccccccccccccc--------ccCCccccchHHHHHHHHHHh
Q 046084          217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT--------MVLTEKCDVYSFGVVALEVLM  288 (363)
Q Consensus       217 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~  288 (363)
                      +||+|+|++++.+|.++|+||+........   ......+..|.+||....        -.++.+.|.|+||+++|.|++
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999999999999999877653221   111234567899996643        247889999999999999999


Q ss_pred             CCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCC
Q 046084          289 GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSR  344 (363)
Q Consensus       289 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  344 (363)
                      |+.||+..........       ..   ..+.   +.+..+..||..+|+.||.+|
T Consensus       246 ~~lPf~~~~~~~~~~~-------~f---~~C~---~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW-------DF---SRCR---DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG-------GG---TTSS------HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc-------cc---hhcC---CcCHHHHHHHHHHccCCcccC
Confidence            9999987654332221       11   1111   223358899999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.8e-24  Score=199.51  Aligned_cols=234  Identities=24%  Similarity=0.309  Sum_probs=186.2

Q ss_pred             eeecCceeEEEEEe----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           97 IGTGGYGSVYRAQL----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        97 lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +|+|+||.|+++..    ..|.-+|.|.++..............|..++...+ ||.++++.-.+..+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            78999999998732    34667888887665432222224456777788886 99999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      |.|...+....   .+++.....+...++-+++++|+.   +++|||+|++||+++.+|.+++.|||+++..-.....  
T Consensus        82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             chhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            99988776554   577888888899999999999999   9999999999999999999999999999876433222  


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHH
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK  331 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  331 (363)
                        +||..|||||++.  ....++|.||||++++||+||..||..       .....++...+..|.....      ...+
T Consensus       154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~p~~l~~------~a~~  216 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEMPRELSA------EARS  216 (612)
T ss_pred             --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCCchhhhH------HHHH
Confidence              8999999999987  567889999999999999999999875       4455666655555542221      3778


Q ss_pred             HHHHccCCCCCCCC--hHHHHHHHhc
Q 046084          332 IVFACLRSKPTSRP--MQRVSQEFLV  355 (363)
Q Consensus       332 li~~cl~~dP~~RP--~~~v~~~l~~  355 (363)
                      ++..++..+|.+|-  ..+.+.+.+.
T Consensus       217 ~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  217 LFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             HHHHHHhhCHHHHhccCcchhHHHhc
Confidence            88999999999998  3455555543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.89  E-value=1.7e-22  Score=186.41  Aligned_cols=209  Identities=29%  Similarity=0.495  Sum_probs=157.6

Q ss_pred             HhcCCCCceeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc-EEeCC
Q 046084          141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI-VHRDI  219 (363)
Q Consensus       141 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-~H~dl  219 (363)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+....  ..+++.-...++++++.||+|||+.   .+ .|+.|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            467899999999999999999999999999999999998733  4689999999999999999999988   55 99999


Q ss_pred             CCCCeeecCCCceEEEeeccceeccC--CCCCceeecccccccccccccccc-------CCccccchHHHHHHHHHHhCC
Q 046084          220 SSNNILLNSKLEAFVADFGVARLLHS--DSSNRTVVAGTHGYIAPELAYTMV-------LTEKCDVYSFGVVALEVLMGR  290 (363)
Q Consensus       220 kp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~~g~  290 (363)
                      +++|+++|....+||+|||+......  .........-..-|.|||.+....       .+.++||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999877632  111111122345699999876531       467899999999999999999


Q ss_pred             CCCCCCcCCC-chhhHHhhhc-cc-CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          291 HPGDLLSSVN-PKIMLIDLLD-QR-VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       291 ~p~~~~~~~~-~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .||+...... ..+....+.+ +. ...|...... .....+..++.+||..+|++|| +.++-..+..
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~  223 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT  223 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence            9997644322 2223333322 11 1122111111 2222588899999999999999 8777666644

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=7.5e-22  Score=163.05  Aligned_cols=184  Identities=14%  Similarity=0.105  Sum_probs=138.3

Q ss_pred             cccCeeeecCceeEEEEEeCCCCEEEEEEeccccchH--HHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEEEe
Q 046084           92 DIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETEL--AFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        92 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      .+...|++|+||+||.+.. .+.+++.+.+.......  -....+.+|+++|++++ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998876 77888888877654421  12236889999999995 5889999886    346899999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCC-CCCCeeecCCCceEEEeeccceeccCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDI-SSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      +.|.+|......          ....++.|++++|.++|+.   |++|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999888643311          1135788999999999999   9999999 7999999999999999999998654332


Q ss_pred             CC-------------ceeeccccccccccccccc-cCC-ccccchHHHHHHHHHHhCCCCC
Q 046084          248 SN-------------RTVVAGTHGYIAPELAYTM-VLT-EKCDVYSFGVVALEVLMGRHPG  293 (363)
Q Consensus       248 ~~-------------~~~~~g~~~y~aPE~~~~~-~~~-~~~DvwslG~il~el~~g~~p~  293 (363)
                      ..             ......++.|++|+...-. ..+ ...+.++.|.-+|.++|+..+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            11             0112246777777743211 222 4678899999999999999884

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2e-21  Score=169.95  Aligned_cols=190  Identities=24%  Similarity=0.373  Sum_probs=131.7

Q ss_pred             CCCceeeeeeEEee---------------------------CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHH
Q 046084          145 RHRNIVKLYGFCLH---------------------------KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK  197 (363)
Q Consensus       145 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  197 (363)
                      +|||||+++++|.+                           +...|+||...+. +|..|+-.+.    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            59999999987754                           2357888887755 8888886553    55566677899


Q ss_pred             HHHHHHHHHHhCCCCCcEEeCCCCCCeee--cCCC--ceEEEeeccceeccCCC-----C-Cceeecccccccccccccc
Q 046084          198 SMAHALSYLHCDCIPSIVHRDISSNNILL--NSKL--EAFVADFGVARLLHSDS-----S-NRTVVAGTHGYIAPELAYT  267 (363)
Q Consensus       198 ~i~~~l~~LH~~~~~~i~H~dlkp~Nill--~~~~--~~kl~Dfg~~~~~~~~~-----~-~~~~~~g~~~y~aPE~~~~  267 (363)
                      |+++|+.|||.+   ++.|||+|+.|||+  |+|+  ...++|||++-.-....     . ..-...|...-||||+...
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999999   99999999999998  4554  45689999875432211     1 1112335667899998764


Q ss_pred             cc------CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC-CCCCCChhhHHHHHHHHHHHHHccCCC
Q 046084          268 MV------LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV-PSPIDDQTVIQDIILVSKIVFACLRSK  340 (363)
Q Consensus       268 ~~------~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~d  340 (363)
                      .+      .-.++|.|+.|.+.||+++...||-...+..-+  ........+ ..+...+..      +++++...|+.|
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--~r~Yqe~qLPalp~~vpp~------~rqlV~~lL~r~  497 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--TRTYQESQLPALPSRVPPV------ARQLVFDLLKRD  497 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec--hhhhhhhhCCCCcccCChH------HHHHHHHHhcCC
Confidence            33      124899999999999999999998652221100  011111222 223333333      788999999999


Q ss_pred             CCCCChHHHH
Q 046084          341 PTSRPMQRVS  350 (363)
Q Consensus       341 P~~RP~~~v~  350 (363)
                      |++||..+|.
T Consensus       498 pskRvsp~iA  507 (598)
T KOG4158|consen  498 PSKRVSPNIA  507 (598)
T ss_pred             ccccCCccHH
Confidence            9999944433

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=2.2e-20  Score=157.25  Aligned_cols=136  Identities=18%  Similarity=0.231  Sum_probs=104.8

Q ss_pred             cccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-----CCCceeeeeeEEeeCC---eEE
Q 046084           92 DIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-----RHRNIVKLYGFCLHKK---CMF  163 (363)
Q Consensus        92 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~  163 (363)
                      .-.+.||+|+||.||.  +++....+||++......  ..+.+.+|+.+++.+     +||||++++|++.++.   ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            3456799999999996  433333479988764322  236789999999999     5799999999999874   434


Q ss_pred             -EEEEe--ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCcEEeCCCCCCeeecC----CCceEEE
Q 046084          164 -LIYKY--MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL-SYLHCDCIPSIVHRDISSNNILLNS----KLEAFVA  235 (363)
Q Consensus       164 -lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl~  235 (363)
                       +|+||  +.+++|.+++.+.    .+++.  ..++.+++.++ +|||++   +|+||||||+|||++.    +..++|+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence             78999  5579999999653    25544  35677888777 999999   9999999999999974    3489999


Q ss_pred             eeccc
Q 046084          236 DFGVA  240 (363)
Q Consensus       236 Dfg~~  240 (363)
                      |++.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            94444

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=7.7e-20  Score=157.66  Aligned_cols=143  Identities=21%  Similarity=0.216  Sum_probs=111.5

Q ss_pred             CCcccCeeeecCceeEEEEE--eCCCCEEEEEEeccccch----------------------HHHHHHHHHHHHHHhcCC
Q 046084           90 DFDIKYCIGTGGYGSVYRAQ--LPSGKKVALKKLHHSETE----------------------LAFLESFQTEAHLLSQIR  145 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~  145 (363)
                      -|.+.+.||+|++|.||+|.  ..+|+.||+|.++.....                      ......+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998  568999999998754311                      001134678999999997


Q ss_pred             CC--ceeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEEeCCCCC
Q 046084          146 HR--NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS-IVHRDISSN  222 (363)
Q Consensus       146 h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dlkp~  222 (363)
                      +.  .+++++++    ...++||||+++++|........   .+...+...++.|++.++++||+.   + ++||||||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~  178 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY  178 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence            53  34444443    23489999999988876543222   355666788999999999999999   9 999999999


Q ss_pred             CeeecCCCceEEEeeccceec
Q 046084          223 NILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       223 Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ||+++ ++.++|+|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.2e-20  Score=185.84  Aligned_cols=198  Identities=24%  Similarity=0.316  Sum_probs=155.9

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC---CCceeeeeeEEeeCC
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR---HRNIVKLYGFCLHKK  160 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~  160 (363)
                      ..+..+.|.|.+.||+|+||+||+|...+|+.||+|+-+.....+     |.--.+++.+|+   -+-|+.+.....-.+
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence            345567789999999999999999988889999999987665421     111223334444   122344444444455


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec-------CCCceE
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN-------SKLEAF  233 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-------~~~~~k  233 (363)
                      ..++|+||.+.|+|.+++....   .+++.-+..++.|++..+.+||..   +||||||||+|+||.       +...++
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             cceeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            6789999999999999998444   689999999999999999999999   999999999999994       235689


Q ss_pred             EEeeccceecc--CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCC
Q 046084          234 VADFGVARLLH--SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP  292 (363)
Q Consensus       234 l~Dfg~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  292 (363)
                      |+|||.+..+.  .+...-...++|-.+-++|...+..++...|.|.+..+++-|+.|+.-
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99999986542  233334456788899999999999999999999999999999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=1e-20  Score=171.72  Aligned_cols=173  Identities=23%  Similarity=0.359  Sum_probs=134.9

Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      +.|+.|++|+..+|.+++.........++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            478999999999999999877766678889999999999999999   6   9999999999999999999999999998


Q ss_pred             eeccCCC------CCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccC
Q 046084          241 RLLHSDS------SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       241 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      .......      ...+...||..||+||.+.+..|+.++||||||++++|++. -..++.      ......++-++.+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~~t~~d~r~g~i  477 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------RIATLTDIRDGII  477 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------HHHhhhhhhcCCC
Confidence            7764433      12344579999999999999999999999999999999997 222221      1222344445555


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHH
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVS  350 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~  350 (363)
                      |+......+     .=..++.+++...|.+|| +.++.
T Consensus       478 p~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  478 PPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             ChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHh
Confidence            522111111     234688899999999999 54443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.8e-19  Score=152.47  Aligned_cols=136  Identities=18%  Similarity=0.341  Sum_probs=113.6

Q ss_pred             CeeeecCceeEEEEEeCCCCEEEEEEeccccch------HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           95 YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETE------LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +.||+|++|.||+|.. +|..+++|........      ......+..|+.++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5689999999999987 7788999986543211      11124578899999999999988777777777788999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++|++|.+++....      . .+..++.+++.+|.++|+.   +++|||++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886432      2 7788999999999999999   999999999999999 78999999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=3e-19  Score=150.62  Aligned_cols=146  Identities=18%  Similarity=0.196  Sum_probs=111.7

Q ss_pred             HHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchH--------------------HHHHHHHHHHHHHh
Q 046084           83 EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETEL--------------------AFLESFQTEAHLLS  142 (363)
Q Consensus        83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~  142 (363)
                      ++......|.+.+.||+|+||.||++...+|+.||||++.......                    .....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3433344488889999999999999988889999999876432100                    01123667888888


Q ss_pred             cCCCCc--eeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCC
Q 046084          143 QIRHRN--IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDIS  220 (363)
Q Consensus       143 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk  220 (363)
                      .+.|++  ++..++    ....+++|||+++++|......         .....++.+++.++.++|+.   +++||||+
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence            887774  444443    2345899999999998765321         23456889999999999998   99999999


Q ss_pred             CCCeeecCCCceEEEeeccceecc
Q 046084          221 SNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       221 p~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      |+||++++++.++|+|||++....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCC
Confidence            999999999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=8.4e-19  Score=148.15  Aligned_cols=132  Identities=20%  Similarity=0.349  Sum_probs=107.1

Q ss_pred             eeeecCceeEEEEEeCCCCEEEEEEeccccc------hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           96 CIGTGGYGSVYRAQLPSGKKVALKKLHHSET------ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      .||+|+||.||+|.. ++..|++|.......      .....+++.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 678899998654321      1112356788999999998887655555555666778999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      +|++|.+++....    .      .++.+++.+|.+||+.   +++|||++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998875422    0      6899999999999999   999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=3.5e-18  Score=165.28  Aligned_cols=139  Identities=19%  Similarity=0.276  Sum_probs=111.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccc-cc-----hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHS-ET-----ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      ...|...+.||+|+||+||+|.+.+. .+++|+.... ..     .....+.+.+|+++++.++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34456688999999999999987544 4444432211 11     11223568899999999999999888777777777


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++||||+++++|.+++.           ....++.+++++|.+||+.   +++||||||+|||+ +++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999988875           3467899999999999999   99999999999999 67799999999997


Q ss_pred             e
Q 046084          242 L  242 (363)
Q Consensus       242 ~  242 (363)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.76  E-value=9.8e-19  Score=169.82  Aligned_cols=207  Identities=26%  Similarity=0.399  Sum_probs=144.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..+|+.++.+..|+||.||..+++ ..+++|.| +++...       +.+-  ++.....|.+|                
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee----------------
Confidence            457899999999999999999775 35567773 332211       1110  12222233322                


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                           |+=.+.+...+   +++.        +++.+++|||+.   +|+|||+||.|.+++.-|++|+.|||+++..-..
T Consensus       136 -----gDc~tllk~~g---~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----GDCATLLKNIG---PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----chhhhhcccCC---CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                 33334444333   2222        227899999999   9999999999999999999999999998653211


Q ss_pred             C---------------CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc
Q 046084          247 S---------------SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ  311 (363)
Q Consensus       247 ~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  311 (363)
                      .               ......+||+.|.|||++....|...+|.|++|+|+||.+.|+.||...   .+++.+...+..
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd---tpeelfg~visd  273 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TPEELFGQVISD  273 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC---CHHHHHhhhhhh
Confidence            0               0112357999999999999999999999999999999999999997653   344455555544


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC
Q 046084          312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                      ....++.+.....   +.++++.+.|+.+|..|-
T Consensus       274 ~i~wpE~dea~p~---Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  274 DIEWPEEDEALPP---EAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hccccccCcCCCH---HHHHHHHHHHHhChHhhc
Confidence            4444443332222   378899999999999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=1.4e-17  Score=139.20  Aligned_cols=138  Identities=20%  Similarity=0.234  Sum_probs=98.7

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHH----------------------HHHHHHHHhcCCCC--ce
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLES----------------------FQTEAHLLSQIRHR--NI  149 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~h~--ni  149 (363)
                      .+.||+|+||.||+|...+|+.||||++............                      ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999998888999999998754322111111                      13455566665433  24


Q ss_pred             eeeeeEEeeCCeEEEEEEeccCCChhhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeec
Q 046084          150 VKLYGFCLHKKCMFLIYKYMRRGSLFCI-LRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLN  227 (363)
Q Consensus       150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~  227 (363)
                      .+.++.    ...+++|||++++.+... +....    .. .+...++.+++.++.++|. .   +++|+||+|+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            444433    235899999999654321 21111    11 5567899999999999999 7   999999999999999


Q ss_pred             CCCceEEEeeccceecc
Q 046084          228 SKLEAFVADFGVARLLH  244 (363)
Q Consensus       228 ~~~~~kl~Dfg~~~~~~  244 (363)
                       ++.++++|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=9.4e-17  Score=129.06  Aligned_cols=135  Identities=17%  Similarity=0.162  Sum_probs=113.0

Q ss_pred             ccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCC--CceeeeeeEEeeCCeEEEEEEecc
Q 046084           93 IKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH--RNIVKLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~  170 (363)
                      +.+.||+|.++.||++...+ ..+++|.......    ...+..|+..++.++|  .++++++++....+..++++||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            45679999999999998844 7899999866543    3568889999999976  588999988888788999999999


Q ss_pred             CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          171 RGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++.+..+          +......++.++++++++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        77 g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8777543          4456677899999999999986444799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.4e-16  Score=136.24  Aligned_cols=136  Identities=17%  Similarity=0.250  Sum_probs=105.0

Q ss_pred             Ceee-ecCceeEEEEEeCCCCEEEEEEeccccc-----------hHHHHHHHHHHHHHHhcCCCCce--eeeeeEEeeCC
Q 046084           95 YCIG-TGGYGSVYRAQLPSGKKVALKKLHHSET-----------ELAFLESFQTEAHLLSQIRHRNI--VKLYGFCLHKK  160 (363)
Q Consensus        95 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~  160 (363)
                      ..|| .|+.|+||.+.. ++..+++|.+.....           .......+.+|++++..++|+++  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4587 899999999988 477899998754211           01123467889999999988775  66777654432


Q ss_pred             ----eEEEEEEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEE
Q 046084          161 ----CMFLIYKYMRR-GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVA  235 (363)
Q Consensus       161 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  235 (363)
                          ..++|+|+++| .+|.+++...    .++..    .+.+++.++.+||+.   ||+|+||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence                23599999997 6888887542    34443    357899999999999   99999999999999999999999


Q ss_pred             eecccee
Q 046084          236 DFGVARL  242 (363)
Q Consensus       236 Dfg~~~~  242 (363)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9999865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=4.8e-18  Score=164.00  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=183.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC--CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP--SGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  164 (363)
                      ...|.+.+.||+|+|+.|-.....  ....+|+|.+..........+....|..+-..+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            345777888999999999887553  3345666766555433333455566777777776 9999999999999999999


Q ss_pred             EEEeccCCChhhhh-hcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCcEEeCCCCCCeeecCCC-ceEEEeeccce
Q 046084          165 IYKYMRRGSLFCIL-RNDDEAIRLDWTKRVNIVKSMAHALSYLH-CDCIPSIVHRDISSNNILLNSKL-EAFVADFGVAR  241 (363)
Q Consensus       165 v~e~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~  241 (363)
                      .++|..++++.+.+ .....  ..+....-.++.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||++.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999998877 33221  2344455678999999999999 77   999999999999999999 99999999998


Q ss_pred             eccC-CCC--Cceeecc-ccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc-CCC
Q 046084          242 LLHS-DSS--NRTVVAG-THGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR-VPS  315 (363)
Q Consensus       242 ~~~~-~~~--~~~~~~g-~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~  315 (363)
                      .... ...  .....+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....+.......-.... -..
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL  253 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC
Confidence            7654 222  2233567 9999999998874 45678999999999999999999987665543221111111111 111


Q ss_pred             CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHH
Q 046084          316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRV  349 (363)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v  349 (363)
                      +...-     .....+++.+++..+|+.|. ..++
T Consensus       254 ~~~~~-----~~~~~~~l~k~l~~~~~~r~s~~~~  283 (601)
T KOG0590|consen  254 PWNSI-----SDQAHDLLHKILKENPSNRLSIEEL  283 (601)
T ss_pred             ccccC-----ChhhhhcccccccCCchhccccccc
Confidence            11111     11266788899999999998 4444

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.60  E-value=8.3e-15  Score=137.37  Aligned_cols=142  Identities=22%  Similarity=0.275  Sum_probs=99.8

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccchH----------------------------HHHH----------HHH
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETEL----------------------------AFLE----------SFQ  135 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------~~~~----------~~~  135 (363)
                      .+.||.|++|.||+|++.+|+.||||+.+....+.                            ...+          +|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            35799999999999999999999999986542110                            0000          244


Q ss_pred             HHHHHHhcCC-----CCceeeeeeEE-eeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 046084          136 TEAHLLSQIR-----HRNIVKLYGFC-LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH-ALSYLHC  208 (363)
Q Consensus       136 ~e~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~  208 (363)
                      .|+..+.+++     ++++. +-.++ ...+..+++|||++|++|.++......  ..+   ...++.+++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHh
Confidence            5666555552     34332 22222 223446899999999999887653211  122   3446666665 4778898


Q ss_pred             CCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       209 ~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      .   |++|+|++|.||++++++.++++|||++..+.
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   99999999999999999999999999997764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=4.3e-15  Score=137.71  Aligned_cols=254  Identities=22%  Similarity=0.195  Sum_probs=179.7

Q ss_pred             hcCCcccCeeee--cCceeEEEEEe---CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCe
Q 046084           88 TEDFDIKYCIGT--GGYGSVYRAQL---PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (363)
                      ...|.+...+|.  |.+|.+|.+..   .++..+|+|+-+..-........=.+|+...+++ .|+|.++.+..+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345677888999  99999999965   4677899987443332211112234566666666 49999998899999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCcEEeCCCCCCeeecCC-CceEEEe
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH----ALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVAD  236 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~D  236 (363)
                      .++-+|++. .+|..+......  -++....+..+.+..+    |+.++|+.   +++|.|++|.||+...+ ...+++|
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ceeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence            999999985 688777765442  3666777888888888    99999999   99999999999999998 8899999


Q ss_pred             eccceeccCCCCCcee-----eccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc
Q 046084          237 FGVARLLHSDSSNRTV-----VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ  311 (363)
Q Consensus       237 fg~~~~~~~~~~~~~~-----~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  311 (363)
                      ||+...+....-....     ..|...|++||...+ .++..+|+|++|.++.+-.++..+......     ..+..+++
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----~~W~~~r~  340 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN-----SSWSQLRQ  340 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC-----CCcccccc
Confidence            9999887654422222     256778999998654 467889999999999999988665322100     00111111


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCChHHHHHHHhch
Q 046084          312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVR  356 (363)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP~~~v~~~l~~~  356 (363)
                      .+-+...+   ......+...+.+|++.+|-.|++.+++..+..-
T Consensus       341 ~~ip~e~~---~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i  382 (524)
T KOG0601|consen  341 GYIPLEFC---EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVI  382 (524)
T ss_pred             ccCchhhh---cCcchhhhhHHHHhcCcchhhhhHHHHHhccccc
Confidence            11111111   1111136668899999999999977777766543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=4.5e-15  Score=127.58  Aligned_cols=203  Identities=25%  Similarity=0.343  Sum_probs=139.8

Q ss_pred             HHHhcCCCCceeeeeeEEeeCC-----eEEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 046084          139 HLLSQIRHRNIVKLYGFCLHKK-----CMFLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIP  212 (363)
Q Consensus       139 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  212 (363)
                      ..+-++-|.||+++..|+.+..     ...++.|||..|++..+|++.. ....+......+|+.||..||.|||+. .|
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            3445567999999998887643     4678899999999999997643 233577788889999999999999976 77


Q ss_pred             CcEEeCCCCCCeeecCCCceEEEeeccceeccCC-----CCCceeeccccccccccccccccCCccccchHHHHHHHHHH
Q 046084          213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-----SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL  287 (363)
Q Consensus       213 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  287 (363)
                      .++|+++..+.|++..++-+|+.--. .......     ........+-++|.+||.-.....+.++|||+||...+||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            89999999999999999988874211 1111100     01111223567899999877777788999999999999998


Q ss_pred             hCCCC-CCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          288 MGRHP-GDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       288 ~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+..- ....+....+......+-.. ...           .=+.++..|++..|..|| |.+++.+.+.
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~l-en~-----------lqr~~i~kcl~~eP~~rp~ar~llfHpll  334 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGL-ENG-----------LQRGSITKCLEGEPNGRPDARLLLFHPLL  334 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeec-cCc-----------cccCcCcccccCCCCCCcchhhhhcCcee
Confidence            87643 11111111111111111110 001           123577799999999999 8888766543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.51  E-value=1.8e-13  Score=128.30  Aligned_cols=169  Identities=18%  Similarity=0.238  Sum_probs=127.7

Q ss_pred             EeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCC
Q 046084          109 QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLD  188 (363)
Q Consensus       109 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~  188 (363)
                      +..++.+|.|...+....  ...+...+.++.|+.++||||+++++.+...+..|+|+|-+.  .|..++.+      +.
T Consensus        33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~  102 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LG  102 (690)
T ss_pred             eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hH
Confidence            445788888888776655  223556778889999999999999999999999999999874  56666654      33


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeeccccccccccccccc
Q 046084          189 WTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM  268 (363)
Q Consensus       189 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  268 (363)
                      .....--+.||+.||.|||+.+  +++|+++.-..|+++..|..||++|.++...............-..|..|+.+...
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence            4556667899999999999665  99999999999999999999999999886543322211222222345666644322


Q ss_pred             cCCccccchHHHHHHHHHHhCCC
Q 046084          269 VLTEKCDVYSFGVVALEVLMGRH  291 (363)
Q Consensus       269 ~~~~~~DvwslG~il~el~~g~~  291 (363)
                      .  -..|.|-||++++|++.|..
T Consensus       181 ~--~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCccc
Confidence            2  24699999999999999943

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.50  E-value=2.9e-14  Score=135.37  Aligned_cols=146  Identities=20%  Similarity=0.243  Sum_probs=93.4

Q ss_pred             cCCcccCeeeecCceeEEEEEeCC-CCEEEEEEeccccch----------------------------H----HHHHH--
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETE----------------------------L----AFLES--  133 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------~----~~~~~--  133 (363)
                      .+|+. +.||+|++|.||+|++.+ |+.||||+.+.....                            .    +..+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 789999999999999877 999999999754211                            0    11112  


Q ss_pred             ----HHHHHHHHhcCC----CCceeeeeeEEee-CCeEEEEEEeccCCChhhhh--hcCC-CCCCCCHHHHHHHHHHHHH
Q 046084          134 ----FQTEAHLLSQIR----HRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCIL--RNDD-EAIRLDWTKRVNIVKSMAH  201 (363)
Q Consensus       134 ----~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~-~~~~l~~~~~~~i~~~i~~  201 (363)
                          |.+|+..+.+++    +.+.+.+-.++.+ ....++||||+.|+.+.++.  ...+ ....+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence                334444444442    3332332222222 34467999999999997642  2221 00112222233333443  


Q ss_pred             HHHHHHhCCCCCcEEeCCCCCCeeecCCC----ceEEEeeccceeccC
Q 046084          202 ALSYLHCDCIPSIVHRDISSNNILLNSKL----EAFVADFGVARLLHS  245 (363)
Q Consensus       202 ~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~  245 (363)
                           ...   |++|+|++|.||+++.++    .+++.|||+...++.
T Consensus       277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 345   999999999999999888    999999999987643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=3.6e-13  Score=110.60  Aligned_cols=130  Identities=22%  Similarity=0.221  Sum_probs=94.6

Q ss_pred             CeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEEEEEEeccCCC
Q 046084           95 YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI-VKLYGFCLHKKCMFLIYKYMRRGS  173 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  173 (363)
                      +.++.|.++.||+++. .+..+++|........   ...+..|+..++.+.+.++ ++++.+..  ...++||||++|.+
T Consensus         4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eecCCcccCceEEEEE-CCeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            4578999999999987 4778999987654321   1345678888888865444 44555433  33579999999988


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          174 LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC--IPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       174 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      +...    .   ..    ....+.+++++|+.||...  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        78 l~~~----~---~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTE----D---FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc----c---cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            7543    0   01    1235689999999999882  11259999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=3.7e-12  Score=105.46  Aligned_cols=138  Identities=19%  Similarity=0.219  Sum_probs=97.7

Q ss_pred             cCeeeecCceeEEEEEeCC-------CCEEEEEEeccccc-----------h---------HHHHHHH----HHHHHHHh
Q 046084           94 KYCIGTGGYGSVYRAQLPS-------GKKVALKKLHHSET-----------E---------LAFLESF----QTEAHLLS  142 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-----------~---------~~~~~~~----~~e~~~l~  142 (363)
                      ...||.|--+.||.|...+       +..+|||+.+....           +         ......+    .+|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999997543       47899997653211           0         0011223    38999999


Q ss_pred             cCCC--CceeeeeeEEeeCCeEEEEEEeccCCChhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEEeC
Q 046084          143 QIRH--RNIVKLYGFCLHKKCMFLIYKYMRRGSLFC-ILRNDDEAIRLDWTKRVNIVKSMAHALSYL-HCDCIPSIVHRD  218 (363)
Q Consensus       143 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~d  218 (363)
                      ++..  -+++.++++    ..-++||||+.++.+.. .+...    .++..+...+..+++.+|..| |..   +++|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            8853  456666654    34578999997754421 22221    245556677889999999999 788   999999


Q ss_pred             CCCCCeeecCCCceEEEeeccceec
Q 046084          219 ISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       219 lkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      |++.||++++ +.+.|+|||.+-..
T Consensus       151 Ls~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEEC-CcEEEEECCCceeC
Confidence            9999999974 67999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=1.7e-13  Score=127.14  Aligned_cols=250  Identities=18%  Similarity=0.175  Sum_probs=174.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe--CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL--PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  163 (363)
                      ...+|..+..||.|.|+.|+....  .++..|++|.+............-..|+.+...+ .|.+.++++..+......|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            345788889999999999999843  4677899998776543322112224566666666 5888998888888878888


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-CceEEEeecccee
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARL  242 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~  242 (363)
                      +--|||+++++......   ...++...++++..|++.++.++|+.   .++|+|++|+||++..+ +..+++|||.+..
T Consensus       343 ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence            88999999988765522   22577788899999999999999988   99999999999999886 7888999999864


Q ss_pred             ccCCCCCceeeccccccc--cccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          243 LHSDSSNRTVVAGTHGYI--APELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      +...   ........+++  +++......+..+.|++|||..+.|.+++..--...      .....+..+..+......
T Consensus       417 ~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~------~~~~~i~~~~~p~~~~~~  487 (524)
T KOG0601|consen  417 LAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG------VQSLTIRSGDTPNLPGLK  487 (524)
T ss_pred             ccee---cccccccccccccchhhccccccccccccccccccccccccCcccCccc------ccceeeecccccCCCchH
Confidence            3211   11112233344  555666777888999999999999999986541111      111122222233222221


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                         .   .+..+...+..+++..|| +.+........+
T Consensus       488 ---~---~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  488 ---L---QLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ---H---hhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence               1   366677889999999999 777665554443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=2.1e-11  Score=97.72  Aligned_cols=132  Identities=20%  Similarity=0.328  Sum_probs=97.8

Q ss_pred             eeeecCceeEEEEEeCCCCEEEEEEecccc-----chHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           96 CIGTGGYGSVYRAQLPSGKKVALKKLHHSE-----TELA-FLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      .+++|+-+.+|.+.+ -|.++++|.-....     .+.. ..++-.+|+.++..++--.|....=+..+.+...++|||.
T Consensus         3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            478999999999977 44456666432211     1111 1235668999998886545444444555667778999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      +|..|.+.+...          ...++..+-.-+.-||..   +|+||||+++||++.+++ +.++|||++..
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888654          135677788888889999   999999999999998875 88999999974

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.34  E-value=1.4e-11  Score=105.69  Aligned_cols=143  Identities=19%  Similarity=0.243  Sum_probs=109.2

Q ss_pred             CeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCC--CceeeeeeEEeeCC---eEEEEEEec
Q 046084           95 YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH--RNIVKLYGFCLHKK---CMFLIYKYM  169 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~  169 (363)
                      +.|+.|..+.+|+++..+|+.+++|........ .....+..|.++++.+.+  .++.+++.+.....   ..+++|||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            458999999999998866789999987654321 123567889999999865  34577777776543   568999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC---------------------------------------  210 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  210 (363)
                      +|.++.+.+..    ..++..+...++.+++++|..||+..                                       
T Consensus        83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99888765532    14677777788888888888888531                                       


Q ss_pred             --------------CCCcEEeCCCCCCeeecC--CCceEEEeecccee
Q 046084          211 --------------IPSIVHRDISSNNILLNS--KLEAFVADFGVARL  242 (363)
Q Consensus       211 --------------~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~  242 (363)
                                    ...++|+|+.|.||++++  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          236799999999999998  66788999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.31  E-value=4.4e-11  Score=95.46  Aligned_cols=145  Identities=19%  Similarity=0.236  Sum_probs=103.4

Q ss_pred             ccCeeeecCceeEEEEEeCCCCEEEEEEecccc-----c-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           93 IKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSE-----T-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ....+-+|+-+.|+++.+ .|+.+.||.-....     . ..-..++-..|+..+.++.--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            456788999999999998 78888887533221     1 1112356778999988876444443333455566667899


Q ss_pred             EeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC---ceEEEeecccee
Q 046084          167 KYMRR-GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL---EAFVADFGVARL  242 (363)
Q Consensus       167 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~  242 (363)
                      ||.+| .++.+++........ .......++..|-+.+.-||..   +++||||+.+||++.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 467777765433222 2233367889999999999999   999999999999996554   347999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.20  E-value=4.1e-12  Score=124.44  Aligned_cols=247  Identities=22%  Similarity=0.288  Sum_probs=164.6

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ..+.+.+.+-+-+|.++.++.++-. .|...+.|.......- ....+....+-.++-..++|-+++..--+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4566777888889999999877432 2322333332211110 0001112222222222234555543333344567899


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      +++|..+++|...++...   ..+..-....+..+..+.++||+.   .+.|+|++|.|.+...++..++.|||......
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence            999999999999998765   345555566778888999999988   79999999999999999999999998332110


Q ss_pred             ------CC--C-----------------------CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCC
Q 046084          245 ------SD--S-----------------------SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPG  293 (363)
Q Consensus       245 ------~~--~-----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~  293 (363)
                            ..  .                       .......+|+.|.+||...+......+|.|++|++++|.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence                  00  0                       0012245899999999999999999999999999999999999996


Q ss_pred             CCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC
Q 046084          294 DLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                      ..   ..+......+....++.+.......   ....+++...+..+|.+|-
T Consensus      1036 na---~tpq~~f~ni~~~~~~~p~g~~~~s---~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1036 NA---ETPQQIFENILNRDIPWPEGPEEGS---YEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred             CC---cchhhhhhccccCCCCCCCCccccC---hhhhhhhhhhhccCchhcc
Confidence            54   3444555666666655544222111   1366788889999999987

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=1.1e-09  Score=95.94  Aligned_cols=141  Identities=18%  Similarity=0.134  Sum_probs=99.3

Q ss_pred             eeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHH----------HHHHHHHHHhcCCCCc--eeeeeeEEee-----
Q 046084           96 CIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLE----------SFQTEAHLLSQIRHRN--IVKLYGFCLH-----  158 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~----------~~~~e~~~l~~l~h~n--iv~l~~~~~~-----  158 (363)
                      .+-......|++... +|+.+.||......... ..+          .+.+|...+..+..-+  .+.++++...     
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~-~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGE-IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHH-HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            344444455777777 67899999764433111 111          3678888887774333  3344555543     


Q ss_pred             CCeEEEEEEeccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC-------CC
Q 046084          159 KKCMFLIYKYMRRG-SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS-------KL  230 (363)
Q Consensus       159 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-------~~  230 (363)
                      ....++|+|++++. +|.+++..... ...+......++.+++..+.-||..   |++|+|++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            23478999999886 78888753211 2355667778999999999999999   9999999999999975       46


Q ss_pred             ceEEEeecccee
Q 046084          231 EAFVADFGVARL  242 (363)
Q Consensus       231 ~~kl~Dfg~~~~  242 (363)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            789999998853

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=3.2e-09  Score=95.11  Aligned_cols=251  Identities=16%  Similarity=0.198  Sum_probs=152.4

Q ss_pred             cccCeeeecCceeEEEE-EeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEE------eeCC-eE
Q 046084           92 DIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFC------LHKK-CM  162 (363)
Q Consensus        92 ~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~------~~~~-~~  162 (363)
                      .....||+|+-+.+|-. ...   ..+.|+.+..-....  .   ..+..|... .||-+..-+.|-      -+++ ..
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCCccccCCccceeeecchhh---chhheeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            34667999999999965 322   234566654432211  1   122334443 566433211111      1122 25


Q ss_pred             EEEEEeccCCC-hhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          163 FLIYKYMRRGS-LFCILR---NDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       163 ~lv~e~~~~g~-L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      -++|...++.. ...+..   ....-...+|.-.++.+..++.+.+.||..   |.+-||++++|+|+++++.+.|.|-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence            67777776542 222221   122222478999999999999999999999   99999999999999999999999855


Q ss_pred             cceeccCCCCCceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhC-CCCCCCCcC----CCchhhHH--
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMG-RHPGDLLSS----VNPKIMLI--  306 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g-~~p~~~~~~----~~~~~~~~--  306 (363)
                      ....- .+.......+|...|.+||.-.     +..-+..+|-|.||+++++++.| ++||+....    .++.+...  
T Consensus       163 sfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         163 SFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             ceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            44322 2222333457889999999643     34456789999999999999986 999875421    11111000  


Q ss_pred             -------hhhcccCCCCCCChhhHHHHHHHHHHHHHccCC--CCCCCC-hHHHHHHHhc
Q 046084          307 -------DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRS--KPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       307 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RP-~~~v~~~l~~  355 (363)
                             +...+..+.|. .....--...+.-|..+|+..  ++.-|| ++.++..|-.
T Consensus       242 g~f~ya~~~~~g~~p~P~-~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         242 GRFAYASDQRRGLKPPPR-SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             ceeeechhccCCCCCCCC-CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence                   11111111111 111111112366788899876  467899 8888887754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.13  E-value=6.8e-10  Score=91.67  Aligned_cols=127  Identities=24%  Similarity=0.343  Sum_probs=82.6

Q ss_pred             eEEEEEeCCCCEEEEEEecccc------------------------chHHHHHHHHHHHHHHhcCCCC--ceeeeeeEEe
Q 046084          104 SVYRAQLPSGKKVALKKLHHSE------------------------TELAFLESFQTEAHLLSQIRHR--NIVKLYGFCL  157 (363)
Q Consensus       104 ~V~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  157 (363)
                      .||.|...+|..+|+|..+...                        ..........+|.+.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998899999999765321                        0111224567899999999755  466666542 


Q ss_pred             eCCeEEEEEEecc--CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCcEEeCCCCCCeeecCCCceEE
Q 046084          158 HKKCMFLIYKYMR--RGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY-LHCDCIPSIVHRDISSNNILLNSKLEAFV  234 (363)
Q Consensus       158 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dlkp~Nill~~~~~~kl  234 (363)
                       .  -.+||||++  |..+..+....     ++......++.+++..+.. +|..   +++||||.+.||+++++ .+.+
T Consensus        80 -~--~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 -R--NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             -T--TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             -C--CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence             2  369999998  54554433221     1123345677788886555 5677   99999999999999988 9999


Q ss_pred             Eeeccceec
Q 046084          235 ADFGVARLL  243 (363)
Q Consensus       235 ~Dfg~~~~~  243 (363)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.10  E-value=3.3e-09  Score=97.35  Aligned_cols=170  Identities=17%  Similarity=0.298  Sum_probs=127.0

Q ss_pred             CceeEEEEE-eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee----CCeEEEEEEeccC-CCh
Q 046084          101 GYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH----KKCMFLIYKYMRR-GSL  174 (363)
Q Consensus       101 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L  174 (363)
                      .-.+.|++. ..||..|++|+++......  ......-++.++++.|+|+|++.+++..    ...+++||+|.++ ++|
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            345778884 4589999999995433211  1122345778999999999999988773    3468899999886 466


Q ss_pred             hhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          175 FCILRNDD------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       175 ~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      .++-....            .....++..+|.++.|+..||.++|+.   |+.-+-|.|++|+++.+.+++|+..|....
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence            65543221            123477899999999999999999999   999999999999999999999999888776


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCC
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP  292 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  292 (363)
                      +..+..              |.+.+   -.+-|.=.||.+++.|.||..-
T Consensus       443 l~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  443 LQEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             ecCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            654431              11111   2357999999999999999643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.97  E-value=7.7e-09  Score=88.08  Aligned_cols=136  Identities=24%  Similarity=0.267  Sum_probs=97.9

Q ss_pred             CcccCeeeecCceeEEEEEeCCCCEEEEEEeccccch--------------------HHHHHHHHHHHHHHhcCCCC--c
Q 046084           91 FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETE--------------------LAFLESFQTEAHLLSQIRHR--N  148 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~h~--n  148 (363)
                      ..+.+.||-|--+.||.|..++|.++|+|.=+...+.                    .-.....++|.+.|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4567889999999999999999999999954322110                    11123467899999988544  5


Q ss_pred             eeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC
Q 046084          149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS  228 (363)
Q Consensus       149 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~  228 (363)
                      +++.+++    +.-.+||||.+|-.|...-        ++.+..-.++..|++-+..+-..   |++|||+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            6666543    3457999999986664321        12333344556666666656666   9999999999999999


Q ss_pred             CCceEEEeeccce
Q 046084          229 KLEAFVADFGVAR  241 (363)
Q Consensus       229 ~~~~kl~Dfg~~~  241 (363)
                      +|.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999996553

>PRK09902 hypothetical protein; Provisional

Probab=98.89  E-value=4e-08  Score=81.74  Aligned_cols=140  Identities=17%  Similarity=0.117  Sum_probs=100.5

Q ss_pred             eeecCceeEEEEEeCCCCEEEEEEeccccc-h---HHHHHHHHHHHHHHhcCCC--CceeeeeeEEe-eC----CeEEEE
Q 046084           97 IGTGGYGSVYRAQLPSGKKVALKKLHHSET-E---LAFLESFQTEAHLLSQIRH--RNIVKLYGFCL-HK----KCMFLI  165 (363)
Q Consensus        97 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~---~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~-~~----~~~~lv  165 (363)
                      -|+||-+-|++... +|..+-+|.-...-. .   +.....|.+|...+..+..  -.++++. ++. ..    -..+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            46788889999887 455788887642110 0   1123578899999988853  2344544 332 21    136799


Q ss_pred             EEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc--eEEEeecccee
Q 046084          166 YKYMRR-GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE--AFVADFGVARL  242 (363)
Q Consensus       166 ~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~  242 (363)
                      +|-+.+ -+|.+++..... .+.+......++.+++.+++-||..   ++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 478888755322 2467777788999999999999999   9999999999999986666  89999976654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.87  E-value=8.7e-10  Score=104.40  Aligned_cols=153  Identities=16%  Similarity=0.186  Sum_probs=100.8

Q ss_pred             HHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC---------ceeeccccccccccccc
Q 046084          196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN---------RTVVAGTHGYIAPELAY  266 (363)
Q Consensus       196 ~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---------~~~~~g~~~y~aPE~~~  266 (363)
                      +.+++.|+.|+|..  +++||++|.|++|.++.++.+||+.|+.+-....+...         .........|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34455999999976  48999999999999999999999999987544321110         01122456799999999


Q ss_pred             cccCCccccchHHHHHHHHHHhCCCC-CCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC
Q 046084          267 TMVLTEKCDVYSFGVVALEVLMGRHP-GDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       267 ~~~~~~~~DvwslG~il~el~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  345 (363)
                      ....+.++|+||+|+++|.+..|..+ +....... ........+ ........+   ..+.++.+=+.+++..++.-||
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~~~-~~~~~~~s~---~~p~el~~~l~k~l~~~~~~rp  257 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRNLL-NAGAFGYSN---NLPSELRESLKKLLNGDSAVRP  257 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhccc-ccccccccc---cCcHHHHHHHHHHhcCCcccCc
Confidence            88888999999999999999954444 32221111 111111111 111111111   1122488888999999999999


Q ss_pred             -hHHHHHHHhc
Q 046084          346 -MQRVSQEFLV  355 (363)
Q Consensus       346 -~~~v~~~l~~  355 (363)
                       +.++......
T Consensus       258 ~~~~l~~~~ff  268 (700)
T KOG2137|consen  258 TLDLLLSIPFF  268 (700)
T ss_pred             chhhhhccccc
Confidence             7766655544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=2.4e-08  Score=84.53  Aligned_cols=106  Identities=21%  Similarity=0.312  Sum_probs=81.4

Q ss_pred             HHHHHHHHHHhcCCC--CceeeeeeEEeeCC----eEEEEEEeccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 046084          132 ESFQTEAHLLSQIRH--RNIVKLYGFCLHKK----CMFLIYKYMRRG-SLFCILRNDDEAIRLDWTKRVNIVKSMAHALS  204 (363)
Q Consensus       132 ~~~~~e~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~  204 (363)
                      ....+|...+..+..  -..++.+++.....    ..++++|++++. +|.+++....   ..+......++.+++..++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHHH
Confidence            346677777776642  23455666665532    458999999884 7888887633   2555667789999999999


Q ss_pred             HHHhCCCCCcEEeCCCCCCeeecCCC---ceEEEeeccceec
Q 046084          205 YLHCDCIPSIVHRDISSNNILLNSKL---EAFVADFGVARLL  243 (363)
Q Consensus       205 ~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~  243 (363)
                      -||..   |++|+|+++.|||++.+.   .+.++||+-++..
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   999999999999998887   8899999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.84  E-value=2.9e-08  Score=94.16  Aligned_cols=142  Identities=23%  Similarity=0.236  Sum_probs=92.1

Q ss_pred             CeeeecCceeEEEEEeCCCCEEEEEEeccccch--------------------------------HHHHH------HHHH
Q 046084           95 YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETE--------------------------------LAFLE------SFQT  136 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------------~~~~~------~~~~  136 (363)
                      +-|+.++-|.||+|++++|+.||||+.+..-..                                .+..+      ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            568999999999999999999999998653221                                01111      1334


Q ss_pred             HHHHHhcCC-----CCceeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 046084          137 EAHLLSQIR-----HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA-LSYLHCDC  210 (363)
Q Consensus       137 e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l~~LH~~~  210 (363)
                      |+..+.+++     .+++.--.=++.-.+...++|||++|-.+.+.......  ..+.+.+   +..++++ +..+-.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~i---a~~~~~~f~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKEL---AELLVRAFLRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHHH---HHHHHHHHHHHHHhc-
Confidence            555555442     33332211122223456899999999988877432221  2554433   3333332 2223224 


Q ss_pred             CCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       211 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                        |+.|.|..|.||+++.++++.+.|||+...+.
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence              99999999999999999999999999997664

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.76  E-value=2e-07  Score=79.90  Aligned_cols=133  Identities=17%  Similarity=0.190  Sum_probs=84.3

Q ss_pred             CeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCc--eeeeeeEEeeCCeEEEEEEeccCC
Q 046084           95 YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN--IVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      ..||+|..+.||+.   .|..+++|........    ....+|.+.++.+..-.  +.+.++++...+...++||+++|.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~----~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDK----ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCCH----HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            46899999999984   2556788887654322    34578898888875333  467788887777788999999986


Q ss_pred             C-hhhhhhcCCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHhC-CC
Q 046084          173 S-LFCILRNDDEAIRLDWTKRVNIVKSMAHA---------------------------------------LSYLHCD-CI  211 (363)
Q Consensus       173 ~-L~~~l~~~~~~~~l~~~~~~~i~~~i~~~---------------------------------------l~~LH~~-~~  211 (363)
                      + +...+.       .+....-.++.++++.                                       ..+|... ..
T Consensus        80 ~~~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~  152 (226)
T TIGR02172        80 RSFSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT  152 (226)
T ss_pred             cchhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence            3 211110       0000111111111111                                       1222211 12


Q ss_pred             CCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          212 PSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       212 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      +.++|+|+.|.||++++++ +.++||+.+..
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            3678999999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.72  E-value=3.9e-07  Score=76.20  Aligned_cols=141  Identities=18%  Similarity=0.215  Sum_probs=93.8

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHH-HHHH------HHHHHHHHhcCC---CCceeeeeeE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELA-FLES------FQTEAHLLSQIR---HRNIVKLYGF  155 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~e~~~l~~l~---h~niv~l~~~  155 (363)
                      +...+|...+.+-......|.+... +|..+++|..+......+ ....      ..+++..+..++   -.....++.+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4678898888888888777877777 778999998876543211 1111      123334333332   2222232222


Q ss_pred             Eee-----CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC
Q 046084          156 CLH-----KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL  230 (363)
Q Consensus       156 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  230 (363)
                      ...     ....+++|||++|..|.++..       ++.    .+...+.+++..||..   |+.|||..|.|+++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc
Confidence            222     234568999999988766532       222    2456677889999999   999999999999998654


Q ss_pred             ceEEEeecccee
Q 046084          231 EAFVADFGVARL  242 (363)
Q Consensus       231 ~~kl~Dfg~~~~  242 (363)
                       +++.||+..+.
T Consensus       173 -i~iID~~~k~~  183 (229)
T PF06176_consen  173 -IRIIDTQGKRM  183 (229)
T ss_pred             -EEEEECccccc
Confidence             88999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.59  E-value=1.5e-06  Score=74.93  Aligned_cols=143  Identities=20%  Similarity=0.215  Sum_probs=82.4

Q ss_pred             CeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCC--ceeeeeeEEee---CCeEEEEEEec
Q 046084           95 YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR--NIVKLYGFCLH---KKCMFLIYKYM  169 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~  169 (363)
                      +.++.|..+.||+....+ ..+++|.....    .....+..|..+++.+...  .+.+++.++..   ....+++|+++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            468999999999999866 69999997654    2235667788888877422  35666664433   33578999999


Q ss_pred             cCCChhh----------------hh---hcC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 046084          170 RRGSLFC----------------IL---RND-DEAIRLDWTK---------RVNI------------VKSMAH-ALSYLH  207 (363)
Q Consensus       170 ~~g~L~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~i~~-~l~~LH  207 (363)
                      +|..+..                .+   +.. .....+....         ....            ...+.+ .++.++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9987776                11   111 0001111100         0000            111222 233333


Q ss_pred             h----CCCCCcEEeCCCCCCeeec-CCCceEEEeecccee
Q 046084          208 C----DCIPSIVHRDISSNNILLN-SKLEAFVADFGVARL  242 (363)
Q Consensus       208 ~----~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~  242 (363)
                      .    .....++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2    1234799999999999999 556667999988753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.52  E-value=2.2e-06  Score=72.58  Aligned_cols=153  Identities=20%  Similarity=0.218  Sum_probs=98.2

Q ss_pred             ccHHHHHHHhcCCcccCeee---ecCceeEEEEEeCCCCEEEEEEeccccchHHH---------------------HH-H
Q 046084           79 ITFQEMIVATEDFDIKYCIG---TGGYGSVYRAQLPSGKKVALKKLHHSETELAF---------------------LE-S  133 (363)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~lg---~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---------------------~~-~  133 (363)
                      .+...+....++..+....|   +|--+.||+|...++..+|+|+.+.....-..                     .. =
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            34455555566666665544   56667899998888999999998654321110                     00 0


Q ss_pred             HHHHHHHHhcCC--CCceeeeeeEEeeCCeEEEEEEeccCCC-hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 046084          134 FQTEAHLLSQIR--HRNIVKLYGFCLHKKCMFLIYKYMRRGS-LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-D  209 (363)
Q Consensus       134 ~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~  209 (363)
                      ...|...|+++.  +-.+++.+++.    .-.|||||+.... -.-.|...    ++...+...+..++++.+.-|-. .
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhc
Confidence            234666666653  22333333332    2368999986541 11112211    23333566778888888888876 5


Q ss_pred             CCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       210 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                         ++||+||..=|||+. ++.+.++|+|-+-..
T Consensus       187 ---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 ---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             ---CcccccchhhheEEE-CCeEEEEECcccccc
Confidence               999999999999999 889999999988654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=8.7e-07  Score=83.98  Aligned_cols=142  Identities=19%  Similarity=0.200  Sum_probs=90.4

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccch-----------------------------HHHHH------HHHHHH
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETE-----------------------------LAFLE------SFQTEA  138 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------------------~~~~~------~~~~e~  138 (363)
                      .+.||.-+.|.||+|++++|+.||||+-+..-..                             .+..+      +|..|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            3569999999999999999999999987653221                             01111      133444


Q ss_pred             HHHhcC----CCCc------eeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 046084          139 HLLSQI----RHRN------IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC  208 (363)
Q Consensus       139 ~~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  208 (363)
                      +...+.    .|-+      |++++-.  -.....|+||||+|..+.+.-.-...  .++...+..-+.+...-+-+-| 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf~~-  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIFKT-  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHHhc-
Confidence            443333    2444      3333322  23356899999999877654322111  2555554444444333333333 


Q ss_pred             CCCCCcEEeCCCCCCeeecC----CCceEEEeeccceecc
Q 046084          209 DCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLH  244 (363)
Q Consensus       209 ~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg~~~~~~  244 (363)
                          |.+|+|-.|.||++..    ++.+.+.|||+...+.
T Consensus       321 ----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  321 ----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ----CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence                9999999999999983    6789999999987653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.46  E-value=2.7e-06  Score=74.06  Aligned_cols=139  Identities=14%  Similarity=0.129  Sum_probs=84.1

Q ss_pred             eeecCc-eeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEEEeccCCCh
Q 046084           97 IGTGGY-GSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus        97 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      |..|.. ..||+.... +..+++|......     ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            444555 788999764 4788888876543     134567888887773 44466778877776678899999999777


Q ss_pred             hhhh-------------------hcCC-CCCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----
Q 046084          175 FCIL-------------------RNDD-EAIRLDW--TKRVNIVK--------------------SMAHALSYLHC----  208 (363)
Q Consensus       175 ~~~l-------------------~~~~-~~~~l~~--~~~~~i~~--------------------~i~~~l~~LH~----  208 (363)
                      ....                   +... ...++..  ........                    .+...+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            5432                   1110 0001110  00000000                    01111222211    


Q ss_pred             CCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       209 ~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      ...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            123468999999999999998778899998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.39  E-value=5.3e-06  Score=84.72  Aligned_cols=80  Identities=19%  Similarity=0.349  Sum_probs=57.4

Q ss_pred             cCeeeecCceeEEEEEeCCC---CEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCce--eeeeeEEeeC---CeEEE
Q 046084           94 KYCIGTGGYGSVYRAQLPSG---KKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNI--VKLYGFCLHK---KCMFL  164 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~l  164 (363)
                      .+.++.|.++.+|+.+..++   ..+++|+........ ....+.+|..+++.+. |+++  ++++.+|.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            45688999999999877554   467788765432111 1246789999999985 6654  7788888764   45789


Q ss_pred             EEEeccCCCh
Q 046084          165 IYKYMRRGSL  174 (363)
Q Consensus       165 v~e~~~~g~L  174 (363)
                      ||||++|..+
T Consensus       122 VME~v~G~~~  131 (822)
T PLN02876        122 IMEYLEGRIF  131 (822)
T ss_pred             EEEecCCccc
Confidence            9999988653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.38  E-value=7.2e-08  Score=90.84  Aligned_cols=182  Identities=20%  Similarity=0.191  Sum_probs=128.6

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCc-eeeeeeEEeeCCeEEEEEEeccCC
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN-IVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      -..+++|+++.++|.+-.-.+....+.+...       ....-++++|.+++||| .+..++-+..+...++.++++.++
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            3457889999999886532223334444322       33456889999999999 667777777777889999999877


Q ss_pred             -ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          173 -SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       173 -~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                       +-......  ....+..-+...+...-+++++++|+.   .-+|+|    ||+..+ +..+..||+....+.... ...
T Consensus       320 rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~  388 (829)
T KOG0576|consen  320 RSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPR  388 (829)
T ss_pred             ccccccCCh--hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc-ccc
Confidence             22211111  111233334445666777889999977   568888    777766 688999999887664332 344


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCCC
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPG  293 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~  293 (363)
                      +..+++.|+|||+.....+....|+|++|.-..++--|-+|-
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            567899999999999999999999999998877887777773

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.35  E-value=4.9e-06  Score=66.69  Aligned_cols=129  Identities=19%  Similarity=0.253  Sum_probs=89.2

Q ss_pred             cccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCcee-eeeeEEeeCCeEEEEEEecc
Q 046084           92 DIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV-KLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        92 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~  170 (363)
                      ...+.||+|.+|.||+|.+ .|..+|+|+-+.++.    ...+..|+++|..+.-.++. +++.|..+    ++.|||..
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhhcccccEEEEeec-cCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            4456799999999999999 456889998766554    36788999999988765553 45554433    35599999


Q ss_pred             CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCC-CCCeeecCCCceEEEeecccee
Q 046084          171 RGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDIS-SNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk-p~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      |-.|.+....      .+.+    -+..+++.---|-..   ||-|+.|. |...++.+++.+.|+||..++.
T Consensus        96 G~~L~~~~~~------~~rk----~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIG------GDRK----HLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             Ccchhhhhhc------ccHH----HHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9887654432      1222    334455554445555   89999986 5555555555999999998874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.34  E-value=2.1e-05  Score=65.65  Aligned_cols=134  Identities=20%  Similarity=0.317  Sum_probs=92.3

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEecccc--------------chHHHHHHHHHHHHHHhcCC------CCceeeee
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSE--------------TELAFLESFQTEAHLLSQIR------HRNIVKLY  153 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~niv~l~  153 (363)
                      ...||+|+.-.||.  ++++....||+.....              ......++..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45699999999985  4556667889887665              00111345566666655554      78899999


Q ss_pred             eEEeeCCeEEEEEEeccC------CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec
Q 046084          154 GFCLHKKCMFLIYKYMRR------GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN  227 (363)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~  227 (363)
                      |+..++...-+|+|...+      -+|.+++....    ++. .   +...+-+-..||-..   .|+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence            999999888999998643      25777775443    444 3   333444555677777   899999999999995


Q ss_pred             CC--C--ceEEEe-eccc
Q 046084          228 SK--L--EAFVAD-FGVA  240 (363)
Q Consensus       228 ~~--~--~~kl~D-fg~~  240 (363)
                      ..  +  .+.|+| ||..
T Consensus       153 ~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ecCCCceEEEEEeCCCCc
Confidence            32  2  566777 5544

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.33  E-value=3.9e-06  Score=69.63  Aligned_cols=104  Identities=23%  Similarity=0.323  Sum_probs=81.3

Q ss_pred             HHHHHHhcCCC-CceeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 046084          136 TEAHLLSQIRH-RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI  214 (363)
Q Consensus       136 ~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  214 (363)
                      .|.-+++.+++ +++++++|+|-.    +++.||...+++...-..-..-...+|..+.+|+.++++.+.++++.....+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47778888865 699999999943    6788999877664321010111146899999999999999999998654468


Q ss_pred             EEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          215 VHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       215 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ...|++++|+-+++++++|+.|.......
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            88999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=98.24  E-value=2.9e-05  Score=69.57  Aligned_cols=78  Identities=21%  Similarity=0.205  Sum_probs=56.6

Q ss_pred             cccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCC---CceeeeeeEEeeC---CeEEEE
Q 046084           92 DIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH---RNIVKLYGFCLHK---KCMFLI  165 (363)
Q Consensus        92 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---~~~~lv  165 (363)
                      .-.+.||.|..+.||+....++ .+++|..+....    ...+..|...++.+..   -.+++++++|...   +..++|
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEeccccc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            3455699999999999987555 466777443111    1467889999988842   3678888887643   568999


Q ss_pred             EEeccCCCh
Q 046084          166 YKYMRRGSL  174 (363)
Q Consensus       166 ~e~~~~g~L  174 (363)
                      ||+++++++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.18  E-value=1.6e-05  Score=68.74  Aligned_cols=73  Identities=10%  Similarity=0.190  Sum_probs=44.8

Q ss_pred             CeeeecCce-eEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCC---ceeeeeeEEeeC---CeEEEEEE
Q 046084           95 YCIGTGGYG-SVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR---NIVKLYGFCLHK---KCMFLIYK  167 (363)
Q Consensus        95 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e  167 (363)
                      +.++.|+.. .||+..    ..+++|..+....    ...+.+|.+.+..+...   .+.++++.....   ...+++|+
T Consensus         3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~~~~----~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRLG----DDMSVRLPSAAGY----AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEcC----CceEEEcCCccch----HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            456766665 588752    3567776543221    24678899988877421   344455444332   23578999


Q ss_pred             eccCCChh
Q 046084          168 YMRRGSLF  175 (363)
Q Consensus       168 ~~~~g~L~  175 (363)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.16  E-value=1.1e-05  Score=81.51  Aligned_cols=199  Identities=16%  Similarity=0.179  Sum_probs=136.7

Q ss_pred             HHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE----EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046084          132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF----LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH  207 (363)
Q Consensus       132 ~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  207 (363)
                      .....|...+..+.|+|++.+++|..+....-    +..+++..-++...++.-.   ..+....+.+..++.+|+.|+|
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHH
Confidence            44556777888889999999999987764332    3457787778877776654   5778888889999999999999


Q ss_pred             hCCCCCcEEeCCCCC---CeeecCCCceEEE--eeccceeccCCCCCceeeccccccccccccccccCCc--cccchHHH
Q 046084          208 CDCIPSIVHRDISSN---NILLNSKLEAFVA--DFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE--KCDVYSFG  280 (363)
Q Consensus       208 ~~~~~~i~H~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~DvwslG  280 (363)
                      +.   .+.|.-|..+   +.-.+.++.+.++  ||+.+........ ......+..|.++|......+..  ..|+|++|
T Consensus       304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccchhhhhhHHHHHH
Confidence            98   6666666655   4455666777766  8888876543322 22223445577888766555444  47999999


Q ss_pred             HHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          281 VVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       281 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .....+..|..+-.....      ....++.....            .+.+....|+..++++|+ +.+++.+...
T Consensus       380 ll~~~~~~~~~i~~~~~~------~~~~l~~~~~~------------~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~  437 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAV------PVSLLDVLSTS------------ELLDALPKCLDEDSEERLSALELLTHPFL  437 (1351)
T ss_pred             HHHhhhhhcCcccccccc------hhhhhccccch------------hhhhhhhhhcchhhhhccchhhhhhchhc
Confidence            999999998766222110      11111111000            256677899999999999 8888876543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.04  E-value=7.4e-05  Score=64.60  Aligned_cols=73  Identities=14%  Similarity=0.153  Sum_probs=46.6

Q ss_pred             CeeeecCceeEEEEEeCC--CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCc-eeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLPS--GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN-IVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.|..|-...+|+....+  +..|++|........   .-...+|+.+++.+...+ .+++++.+.  +  .++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence            356778888999998764  678999976543211   112346787888774323 344544432  2  379999998


Q ss_pred             CCh
Q 046084          172 GSL  174 (363)
Q Consensus       172 g~L  174 (363)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.02  E-value=3.7e-05  Score=67.45  Aligned_cols=138  Identities=12%  Similarity=0.107  Sum_probs=77.5

Q ss_pred             eeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEEEEEEeccCCChh
Q 046084           97 IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI-VKLYGFCLHKKCMFLIYKYMRRGSLF  175 (363)
Q Consensus        97 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~  175 (363)
                      +..|-.+.+|+.+. ++..+++|..........  -....|..+++.+....+ .+++..+.    -++|+||++|..+.
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALG--VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCccccccc--CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            45688889999874 567888887554322110  124678888887753323 34444432    36899999987653


Q ss_pred             hh-----------------hhcCC-CCCCCCHHHH-HHHHHHH---------HHHHHHHHhC-----CCCCcEEeCCCCC
Q 046084          176 CI-----------------LRNDD-EAIRLDWTKR-VNIVKSM---------AHALSYLHCD-----CIPSIVHRDISSN  222 (363)
Q Consensus       176 ~~-----------------l~~~~-~~~~l~~~~~-~~i~~~i---------~~~l~~LH~~-----~~~~i~H~dlkp~  222 (363)
                      .-                 ++... ...+++.... ..+..++         ...+..+-..     ....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21                 11111 1112222211 1211111         1112222111     1236899999999


Q ss_pred             CeeecCCCceEEEeecccee
Q 046084          223 NILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       223 Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ||++++++ +.++||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999988753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.97  E-value=0.0001  Score=61.06  Aligned_cols=127  Identities=23%  Similarity=0.420  Sum_probs=89.8

Q ss_pred             cCCcccCeeeecCc-eeEEEEEeCCCCEEEEEEecc---ccc----------hH------HHHHHHHHHHHHHhcCC---
Q 046084           89 EDFDIKYCIGTGGY-GSVYRAQLPSGKKVALKKLHH---SET----------EL------AFLESFQTEAHLLSQIR---  145 (363)
Q Consensus        89 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~----------~~------~~~~~~~~e~~~l~~l~---  145 (363)
                      .+++..+.||.|.. |.||+++. +|+.+|+|.+..   ...          ..      ...+.|..|.+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67889999999999 99999999 778999999322   110          00      23345778888887774   


Q ss_pred             CCce--eeeeeEEeeCC------------------eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 046084          146 HRNI--VKLYGFCLHKK------------------CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY  205 (363)
Q Consensus       146 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~  205 (363)
                      +.++  ++++||..-..                  ...||.||.+...            .++..    -+.+|.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHH
Confidence            4566  89999875331                  1346667665432            12222    35566777788


Q ss_pred             HHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       206 LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      +|..   +|+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            9998   9999999999975     4578999864

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.87  E-value=0.00021  Score=66.08  Aligned_cols=77  Identities=21%  Similarity=0.223  Sum_probs=52.8

Q ss_pred             CeeeecCceeEEEEEeCCC-CEEEEEEeccccc---h--HHHHHHHHHHHHHHhcCC---CCceeeeeeEEeeCCeEEEE
Q 046084           95 YCIGTGGYGSVYRAQLPSG-KKVALKKLHHSET---E--LAFLESFQTEAHLLSQIR---HRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~---~--~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  165 (363)
                      +.||.|.+..||++...+| +.++||.-.....   +  .-..+++..|.+.|+.+.   ..++++++.+.  .+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence            4689999999999998777 4899997542110   0  112356677788887762   24577777763  3556899


Q ss_pred             EEeccCCC
Q 046084          166 YKYMRRGS  173 (363)
Q Consensus       166 ~e~~~~g~  173 (363)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99988643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.83  E-value=0.00023  Score=63.88  Aligned_cols=142  Identities=16%  Similarity=0.154  Sum_probs=82.5

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCC--ceeeeee------EEeeCCeEEEE
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR--NIVKLYG------FCLHKKCMFLI  165 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~------~~~~~~~~~lv  165 (363)
                      .+.+..|....+|+.... +..+++|+... ..    .+....|+.++..+.+.  .+++++.      +....+..+++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~-~~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK-VS----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC-CC----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            345777877899998764 44788898764 21    13455677777766422  2444433      12234456899


Q ss_pred             EEeccCCChhh----h----------hhcC----CC----CCCCCHHHHH----------HHHHHHHHHHHHHHh----C
Q 046084          166 YKYMRRGSLFC----I----------LRND----DE----AIRLDWTKRV----------NIVKSMAHALSYLHC----D  209 (363)
Q Consensus       166 ~e~~~~g~L~~----~----------l~~~----~~----~~~l~~~~~~----------~i~~~i~~~l~~LH~----~  209 (363)
                      ++|++|..+..    .          ++..    ..    .....|....          .....+..++.++..    .
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99999876532    0          0100    00    0011221110          011123344445443    1


Q ss_pred             CCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          210 CIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       210 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      ...+++|+|+.|.||++++++.+.|.||+.+.
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            22479999999999999998777899998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.79  E-value=0.00041  Score=62.04  Aligned_cols=140  Identities=19%  Similarity=0.287  Sum_probs=87.5

Q ss_pred             ccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCC--CceeeeeeEEeeCC--eEEEEEEe
Q 046084           93 IKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH--RNIVKLYGFCLHKK--CMFLIYKY  168 (363)
Q Consensus        93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~  168 (363)
                      +.+.+..|..-.+|..... ++++++. ...............+|..+++.+.-  --....+++|.++.  ..+.||+|
T Consensus        29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            3344434444455555543 7788888 33222222334566778888887743  23455677777766  67999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHH-HHHHHHHHHHHhC--------------------------------------
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIV-KSMAHALSYLHCD--------------------------------------  209 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~-~~i~~~l~~LH~~--------------------------------------  209 (363)
                      ++|..+.+.+....    ..    .+++ ..+++.|+-||+-                                      
T Consensus       107 veGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p  178 (321)
T COG3173         107 VEGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP  178 (321)
T ss_pred             ecceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence            99865443332111    11    1122 2555555555544                                      


Q ss_pred             -----------------CCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          210 -----------------CIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       210 -----------------~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                                       ..+.++|||+.+.|++++++.-+-+.||+++..
T Consensus       179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                             124799999999999999998899999999865

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.69  E-value=0.00038  Score=62.67  Aligned_cols=139  Identities=24%  Similarity=0.292  Sum_probs=79.9

Q ss_pred             eeeecCceeEEEEEeCC-------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCc-eeeeeeEEeeCCeEEEEEE
Q 046084           96 CIGTGGYGSVYRAQLPS-------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN-IVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  167 (363)
                      .+..|-...+|+....+       ++.+++|+.......   ......|..++..+.... ..++++++. +   ..|+|
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e   77 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEE   77 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhh
Confidence            45567777899987655       578999986553221   134456777777774322 345555553 2   35899


Q ss_pred             eccCCChhhh-----------------hhcCCCCC------CCC--HHHHHH--------------------------HH
Q 046084          168 YMRRGSLFCI-----------------LRNDDEAI------RLD--WTKRVN--------------------------IV  196 (363)
Q Consensus       168 ~~~~g~L~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~  196 (363)
                      |++|..+...                 ++......      ..+  +..+..                          +.
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            9988766431                 11111100      010  111101                          11


Q ss_pred             HHHHHHHHHHHh------CCCCCcEEeCCCCCCeeecCC----CceEEEeeccce
Q 046084          197 KSMAHALSYLHC------DCIPSIVHRDISSNNILLNSK----LEAFVADFGVAR  241 (363)
Q Consensus       197 ~~i~~~l~~LH~------~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~  241 (363)
                      ..+...+..+..      .....++|+|+.+.||+++++    +.+.++||..+.
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            122223334432      133478999999999999885    889999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.68  E-value=0.0013  Score=59.62  Aligned_cols=142  Identities=15%  Similarity=0.122  Sum_probs=75.0

Q ss_pred             CeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCC--Cceeeeee------EEeeCCeEEEEE
Q 046084           95 YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH--RNIVKLYG------FCLHKKCMFLIY  166 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~  166 (363)
                      +.++.|....+|+.+..+| .+++|+.. ... .   +....|..++..+..  -.+.+.+.      +....+..++++
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~-~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFE-RLT-A---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEec-cCC-h---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            4466777789999987555 68889876 211 1   222234444444421  11233332      122345678999


Q ss_pred             EeccCCChhh-----h---------hhcCCC--------CCCC-CHHHHHH------------HHHH-HHHHHHHHHhC-
Q 046084          167 KYMRRGSLFC-----I---------LRNDDE--------AIRL-DWTKRVN------------IVKS-MAHALSYLHCD-  209 (363)
Q Consensus       167 e~~~~g~L~~-----~---------l~~~~~--------~~~l-~~~~~~~------------i~~~-i~~~l~~LH~~-  209 (363)
                      ||.+|..+..     .         ++....        ...+ .|.....            .+.+ +...++.+... 
T Consensus       102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  181 (319)
T PRK05231        102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA  181 (319)
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence            9999875421     1         111000        0011 1111111            1111 11122333211 


Q ss_pred             ---CCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          210 ---CIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       210 ---~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                         ...+++|+|+.|.||+++++...-|+||+.+..
T Consensus       182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               334899999999999999776668999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.60  E-value=0.0019  Score=58.31  Aligned_cols=143  Identities=17%  Similarity=0.132  Sum_probs=79.2

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCC--ceeeeeeE------EeeCCeEEEE
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR--NIVKLYGF------CLHKKCMFLI  165 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lv  165 (363)
                      .+.++.|....+|+.+..+| .+++|........    +....|.+++..+...  .+++++..      ....+..+++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~----~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l  101 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKA----EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL  101 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCCH----HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence            34567777789999876444 6778876553221    2234455666555321  23343331      1223567899


Q ss_pred             EEeccCCChhhh--------------hhcCCCC------C---CCCHHHHH------------HHHHHHHHHHHHHHh--
Q 046084          166 YKYMRRGSLFCI--------------LRNDDEA------I---RLDWTKRV------------NIVKSMAHALSYLHC--  208 (363)
Q Consensus       166 ~e~~~~g~L~~~--------------l~~~~~~------~---~l~~~~~~------------~i~~~i~~~l~~LH~--  208 (363)
                      ++|++|..+...              ++.....      .   .-.|....            .....+.+.++++..  
T Consensus       102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~  181 (307)
T TIGR00938       102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW  181 (307)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence            999988553210              1110000      0   01111100            001123334555532  


Q ss_pred             --CCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          209 --DCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       209 --~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                        ....+++|+|+.+.||++++++...|+||+.+.
T Consensus       182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence              233589999999999999998777899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.57  E-value=0.00076  Score=59.85  Aligned_cols=74  Identities=19%  Similarity=0.262  Sum_probs=47.8

Q ss_pred             ccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC---CCceeeeeeEEeeCCeEEEEEEec
Q 046084           93 IKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR---HRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      -.+.++.|....+|+.+ .+++.+.||.-.....     ..|..|.+-|+.|.   --.+++++++....+..++++||.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~-----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGR-----DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGC-----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecChhhH-----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            34568889999999988 4788999998763222     45777888887773   445778888888777789999998


Q ss_pred             cCC
Q 046084          170 RRG  172 (363)
Q Consensus       170 ~~g  172 (363)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.56  E-value=0.00014  Score=64.21  Aligned_cols=134  Identities=16%  Similarity=0.188  Sum_probs=91.1

Q ss_pred             CcccCeeeecCceeEEEEEeCCCCEEEEEEeccccch-----------------HH-HH--HHHHHHHHHHhcCC-CC-c
Q 046084           91 FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETE-----------------LA-FL--ESFQTEAHLLSQIR-HR-N  148 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~-~~--~~~~~e~~~l~~l~-h~-n  148 (363)
                      +.+.+.||-|--+.||.+-..+|++.++|.-+.....                 .+ .+  -...+|...|+.+. |- -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            6788999999999999999989999998843221110                 00 01  12346778887774 22 2


Q ss_pred             eeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC
Q 046084          149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS  228 (363)
Q Consensus       149 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~  228 (363)
                      +++.+++    +.-++|||+..+-.|...-+-.+         .-.+...+..-+--|..+   |++|||.+-=||++++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d---------~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVED---------PPTLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeecCC---------hHHHHHHHHHHHHHHHHc---CceecccchheeEEec
Confidence            3444433    34578999998877765432211         122444445555566667   9999999999999999


Q ss_pred             CCceEEEeeccc
Q 046084          229 KLEAFVADFGVA  240 (363)
Q Consensus       229 ~~~~kl~Dfg~~  240 (363)
                      ++.++++||--.
T Consensus       238 d~~i~vIDFPQm  249 (465)
T KOG2268|consen  238 DDKIVVIDFPQM  249 (465)
T ss_pred             CCCEEEeechHh
Confidence            999999999754

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.40  E-value=1.8e-05  Score=81.92  Aligned_cols=162  Identities=12%  Similarity=0.014  Sum_probs=114.9

Q ss_pred             HHHHHHHHHHhcCCCCceeeeeeEEee--CCeEEEEEEeccCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 046084          132 ESFQTEAHLLSQIRHRNIVKLYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDE-AIRLDWTKRVNIVKSMAHALSYLHC  208 (363)
Q Consensus       132 ~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~  208 (363)
                      +....|...++...|+++.....=...  ....+..++++.+|.+.+.+-+..+ ...++..-+.....+......-+|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            334455555666788887765443322  2345788999999999988765432 2234443333333333555566565


Q ss_pred             CCC--CCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHH
Q 046084          209 DCI--PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEV  286 (363)
Q Consensus       209 ~~~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el  286 (363)
                      ..+  .-.+|++|++.|.++..+..++++++|+.+.............+++-|++|++.....++.++|+|..|+-+|+.
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence            532  236899999999999999999999999998544444444556678889999998888889899999999999999


Q ss_pred             HhCCCCC
Q 046084          287 LMGRHPG  293 (363)
Q Consensus       287 ~~g~~p~  293 (363)
                      ..|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            9888775

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.39  E-value=0.0015  Score=57.79  Aligned_cols=31  Identities=23%  Similarity=0.443  Sum_probs=25.7

Q ss_pred             CCcEEeCCCCCCeeecCCCc-eEEEeecccee
Q 046084          212 PSIVHRDISSNNILLNSKLE-AFVADFGVARL  242 (363)
Q Consensus       212 ~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~  242 (363)
                      +.++|+|+.|.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 45999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.25  E-value=0.0039  Score=57.72  Aligned_cols=75  Identities=17%  Similarity=0.163  Sum_probs=48.6

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEecc-----ccchHHHHHHHHHHHHHHhcCC---CCceeeeeeEEeeCCeEEEE
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHH-----SETELAFLESFQTEAHLLSQIR---HRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  165 (363)
                      .+.||.|....||+.... +..++||.-..     .........+-..|...|+.+.   ..++++++.++.+.  .+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence            456899999999999874 55789997652     1100001233334566666553   24788888888744  5678


Q ss_pred             EEeccC
Q 046084          166 YKYMRR  171 (363)
Q Consensus       166 ~e~~~~  171 (363)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.23  E-value=0.0019  Score=58.12  Aligned_cols=142  Identities=21%  Similarity=0.304  Sum_probs=93.9

Q ss_pred             cccCeeeecCceeEEEEEeCCCCEEEEEEeccccc-----------------------hHHHHHH-HHHHHHHHhcCCCC
Q 046084           92 DIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSET-----------------------ELAFLES-FQTEAHLLSQIRHR  147 (363)
Q Consensus        92 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~-~~~e~~~l~~l~h~  147 (363)
                      .+...|..|--+.||.+.-.+|..+|||+.+.+-.                       ....++. ...|+.-|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            34567888999999999999999999998653210                       0111111 24577777777654


Q ss_pred             ceeeeeeEEeeCCeEEEEEEeccCCCh-hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee
Q 046084          148 NIVKLYGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL  226 (363)
Q Consensus       148 niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill  226 (363)
                      .|.-.--+...  .-.|||+|+..... .-.|..    ..++...+..+-.+++.-|.-|.+.|  ++||.||.-=|+|+
T Consensus       227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCCceeee--cceEeeeeccCCCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            44321111111  23689999853221 112222    24676777788888999899888776  99999999999998


Q ss_pred             cCCCceEEEeecccee
Q 046084          227 NSKLEAFVADFGVARL  242 (363)
Q Consensus       227 ~~~~~~kl~Dfg~~~~  242 (363)
                      .+ |.+.++|-+-+-.
T Consensus       299 hd-G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  299 HD-GKLYIIDVSQSVE  313 (520)
T ss_pred             EC-CEEEEEEcccccc
Confidence            65 5788889876643

>PLN02236 choline kinase

Probab=97.13  E-value=0.0054  Score=56.20  Aligned_cols=139  Identities=17%  Similarity=0.273  Sum_probs=77.5

Q ss_pred             eeecCceeEEEEEeCC-----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEEEEEEecc
Q 046084           97 IGTGGYGSVYRAQLPS-----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI-VKLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        97 lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~  170 (363)
                      +-.|-...+|+....+     ++.|++|.......  ..++ -..|..+++.+..-++ .++++.+.. +   .+.+|++
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~  116 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH  116 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence            4447778899987532     36788887755321  1112 2567778777753333 345565533 2   4789998


Q ss_pred             CCChhhh-----------------hhcCC-C--CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 046084          171 RGSLFCI-----------------LRNDD-E--AIRLDWTKRVNIVKSM-----------------AHALSYL----HC-  208 (363)
Q Consensus       171 ~g~L~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~i-----------------~~~l~~L----H~-  208 (363)
                      +.++...                 ++... .  .....+.++.++..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7665311                 11111 0  0011233333332221                 1112122    21 


Q ss_pred             CCCCCcEEeCCCCCCeeecC-CCceEEEeecccee
Q 046084          209 DCIPSIVHRDISSNNILLNS-KLEAFVADFGVARL  242 (363)
Q Consensus       209 ~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~  242 (363)
                      .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            12236899999999999986 46899999988753

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.06  E-value=0.0065  Score=55.29  Aligned_cols=75  Identities=13%  Similarity=0.189  Sum_probs=46.5

Q ss_pred             eeeecCceeEEEEEeCCC-CEEEEEEeccc-----cchHHHHHHHHHHHHHHhcCC--CC-ceeeeeeEEeeCCeEEEEE
Q 046084           96 CIGTGGYGSVYRAQLPSG-KKVALKKLHHS-----ETELAFLESFQTEAHLLSQIR--HR-NIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~~-----~~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  166 (363)
                      .||.|...-||++..++| +.|+||.-...     ...+-..++..-|...|+...  -| .+++++.+  +.+...++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999987655 58999964321     111112244456677776653  34 45555543  445566899


Q ss_pred             EeccCC
Q 046084          167 KYMRRG  172 (363)
Q Consensus       167 e~~~~g  172 (363)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998553

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.79  E-value=0.039  Score=46.67  Aligned_cols=75  Identities=17%  Similarity=0.235  Sum_probs=51.2

Q ss_pred             CeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC---CCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI---RHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.+.-|.--..|...+ +..++.||+-..     .....|..|+.-|..+   +.-++.+++.+..+.+..|+|+||.+-
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~-----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~   95 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR-----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT   95 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecch-----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence            3344444444555554 456788887432     2245678888777766   345678888888889999999999988


Q ss_pred             CChh
Q 046084          172 GSLF  175 (363)
Q Consensus       172 g~L~  175 (363)
                      +.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            6654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.77  E-value=0.035  Score=50.06  Aligned_cols=29  Identities=34%  Similarity=0.563  Sum_probs=25.1

Q ss_pred             CCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          212 PSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       212 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .+++|||+.+.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999988 568899998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.58  E-value=0.018  Score=52.43  Aligned_cols=139  Identities=14%  Similarity=0.210  Sum_probs=75.5

Q ss_pred             eeecCceeEEEEEeCC----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEEEEEEeccC
Q 046084           97 IGTGGYGSVYRAQLPS----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI-VKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        97 lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      |..|-...+|+....+    +..|++|+......  . .-.-..|..+++.+..-++ +++++++. .+   ++.+|+++
T Consensus        22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             eCCcccceEEEEEecCCCCCCceEEEEEecCCcC--e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            4447777889886533    23788887754322  1 1123467777777754444 34555553 22   48899877


Q ss_pred             CChhh-------h----------hhcCC-C-CC-CCCHHHHHHHHHHH----------------------HHHHHHH---
Q 046084          172 GSLFC-------I----------LRNDD-E-AI-RLDWTKRVNIVKSM----------------------AHALSYL---  206 (363)
Q Consensus       172 g~L~~-------~----------l~~~~-~-~~-~l~~~~~~~i~~~i----------------------~~~l~~L---  206 (363)
                      ..+..       .          ++... . .. .--+..+.++..++                      .+-+..+   
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65521       0          11111 0 00 11233332222221                      1111111   


Q ss_pred             H-hC-CCCCcEEeCCCCCCeeecC-CCceEEEeecccee
Q 046084          207 H-CD-CIPSIVHRDISSNNILLNS-KLEAFVADFGVARL  242 (363)
Q Consensus       207 H-~~-~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~  242 (363)
                      . .. ....++|+|+.+.|||+++ ++.++++||..+..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1 11 1124799999999999975 57899999998853

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.56  E-value=0.083  Score=48.04  Aligned_cols=72  Identities=14%  Similarity=0.120  Sum_probs=42.8

Q ss_pred             cCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCC--ceeee---ee--EEeeCCeEEEEEEeccCC
Q 046084          100 GGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR--NIVKL---YG--FCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus       100 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l---~~--~~~~~~~~~lv~e~~~~g  172 (363)
                      +.-..||+....++..+++|..+.....   ...+..|++.+..+...  .++..   -|  +...++..+.++++.+|.
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~  112 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR  112 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence            4556799998878889999987643322   23455666666655211  12221   11  122345677899999876


Q ss_pred             Ch
Q 046084          173 SL  174 (363)
Q Consensus       173 ~L  174 (363)
                      ..
T Consensus       113 ~~  114 (325)
T PRK11768        113 AP  114 (325)
T ss_pred             CC
Confidence            43

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.56  E-value=0.013  Score=52.92  Aligned_cols=54  Identities=22%  Similarity=0.305  Sum_probs=48.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          187 LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       187 l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      -.+++.+.++.+.+..++-+....  ..-|||+.-.|||++ +|++.|+||-+++.-
T Consensus       318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecc
Confidence            467889999999999999888775  788999999999999 999999999999843

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.38  E-value=0.0061  Score=51.66  Aligned_cols=30  Identities=33%  Similarity=0.475  Sum_probs=21.5

Q ss_pred             CcEEeCCCCCCeee-cCCCceEEEeecccee
Q 046084          213 SIVHRDISSNNILL-NSKLEAFVADFGVARL  242 (363)
Q Consensus       213 ~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~~  242 (363)
                      .++|+|+.|.|||+ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            67999999999999 8889999999988854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.25  E-value=0.067  Score=48.27  Aligned_cols=31  Identities=19%  Similarity=0.389  Sum_probs=27.8

Q ss_pred             CCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          212 PSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       212 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      .+++|+|+.+.|+|+++++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4799999999999999999999999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=96.24  E-value=0.0038  Score=36.58  Aligned_cols=27  Identities=26%  Similarity=0.576  Sum_probs=14.9

Q ss_pred             eEEEehhHHHHHHHHHHHHHHHHhhcc
Q 046084           25 RLVVIILPIVLLLILVCIFTFLCLRRP   51 (363)
Q Consensus        25 ~~~~ii~~~~~~~~l~~~~~~~~~~r~   51 (363)
                      ..+.+++++++++++++++.++++||+
T Consensus        13 Ia~~VvVPV~vI~~vl~~~l~~~~rR~   39 (40)
T PF08693_consen   13 IAVGVVVPVGVIIIVLGAFLFFWYRRK   39 (40)
T ss_pred             EEEEEEechHHHHHHHHHHhheEEecc
Confidence            345566666665555555555555543

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PRK06148 hypothetical protein; Provisional

Probab=96.19  E-value=0.13  Score=54.07  Aligned_cols=151  Identities=17%  Similarity=0.221  Sum_probs=80.4

Q ss_pred             HhcCCccc---CeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-------CCCceeeee-e-
Q 046084           87 ATEDFDIK---YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-------RHRNIVKLY-G-  154 (363)
Q Consensus        87 ~~~~~~~~---~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~l~-~-  154 (363)
                      ..+.|-+.   +.|+ |..-.+|+.+..+|..+++|+.+.....    .....|...|..+       .-|.+++-. | 
T Consensus        20 ~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~----~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~   94 (1013)
T PRK06148         20 LAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEPR----VESDFQTAALDHLAAVAPDLPVPRLIPSLSGA   94 (1013)
T ss_pred             HHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccch----hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCC
Confidence            44445443   3454 4567889998878889999999865322    2223344445433       233333321 1 


Q ss_pred             ---EEee-CC--eEEEEEEeccCCChhhhhh---------------------c--CC-CCCCCCHHH-------------
Q 046084          155 ---FCLH-KK--CMFLIYKYMRRGSLFCILR---------------------N--DD-EAIRLDWTK-------------  191 (363)
Q Consensus       155 ---~~~~-~~--~~~lv~e~~~~g~L~~~l~---------------------~--~~-~~~~l~~~~-------------  191 (363)
                         .... .+  ..+-+++|.+|..+.+...                     .  .. ....+.|..             
T Consensus        95 ~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i  174 (1013)
T PRK06148         95 SLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFI  174 (1013)
T ss_pred             eEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhc
Confidence               1111 22  4567899999977654110                     0  00 011122211             


Q ss_pred             ----HHHHHHHHHHHHHH----HHhCCCCCcEEeCCCCCCeeecCCC--ceE-EEeecccee
Q 046084          192 ----RVNIVKSMAHALSY----LHCDCIPSIVHRDISSNNILLNSKL--EAF-VADFGVARL  242 (363)
Q Consensus       192 ----~~~i~~~i~~~l~~----LH~~~~~~i~H~dlkp~Nill~~~~--~~k-l~Dfg~~~~  242 (363)
                          ...++.++.+...-    .-......++|+|+++.|||++.+.  .+. |+|||-+..
T Consensus       175 ~d~~~r~~l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        175 DDPEDRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence                11222233322211    1112334799999999999999875  555 999998753

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.16  E-value=0.015  Score=53.60  Aligned_cols=76  Identities=17%  Similarity=0.143  Sum_probs=47.6

Q ss_pred             cCeeeecCceeEEEEEeCC-CCEEEEEEecc----ccchHHHHHHHHHHHHHHhcCC--CC-ceeeeeeEEeeCCeEEEE
Q 046084           94 KYCIGTGGYGSVYRAQLPS-GKKVALKKLHH----SETELAFLESFQTEAHLLSQIR--HR-NIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~----~~~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv  165 (363)
                      .+.||.|.-.-||++...+ +..|+||.-..    .....-..++..-|.+.|+...  -| .+++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4568999999999998743 56799985421    1111122345566777777663  34 45556544  44445678


Q ss_pred             EEeccC
Q 046084          166 YKYMRR  171 (363)
Q Consensus       166 ~e~~~~  171 (363)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888854

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.11  E-value=0.019  Score=52.64  Aligned_cols=60  Identities=20%  Similarity=0.219  Sum_probs=41.0

Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN  227 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~  227 (363)
                      ..++-+|++|-++..++....    .++.-..+++.-.++|+-.|---.  +.+|.|+.|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence            345667888888888887654    344455556665666655443221  899999999999994

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.98  E-value=0.0085  Score=56.37  Aligned_cols=49  Identities=18%  Similarity=0.280  Sum_probs=37.3

Q ss_pred             HHHHHHHHHhcCCCCceeeeeeEEeeC-CeEEEEEEeccCCChhhhhhcCC
Q 046084          133 SFQTEAHLLSQIRHRNIVKLYGFCLHK-KCMFLIYKYMRRGSLFCILRNDD  182 (363)
Q Consensus       133 ~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~  182 (363)
                      .+.....+++.+.|+|+-.++++.... ....+|+|++ +-+|++++....
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            455667889999999999988877654 3467889988 458888886543

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.89  E-value=0.24  Score=44.91  Aligned_cols=139  Identities=20%  Similarity=0.244  Sum_probs=79.1

Q ss_pred             eeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCc------eeeeeeEE--eeCC--eEEEEE
Q 046084           97 IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN------IVKLYGFC--LHKK--CMFLIY  166 (363)
Q Consensus        97 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~--~~~~--~~~lv~  166 (363)
                      |.+ .-..+|+....+|.. ++|+.... ...   .+...|...+..+.-.+      +..+-|-.  .-.+  ..+-++
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            444 556789998866665 88887765 222   44556777777663111      22222211  1123  677899


Q ss_pred             EeccCCChhh-hh--------------hc--------CCC-CCCCCHHH-------------HHHHHHHHHHHHHHHHhC
Q 046084          167 KYMRRGSLFC-IL--------------RN--------DDE-AIRLDWTK-------------RVNIVKSMAHALSYLHCD  209 (363)
Q Consensus       167 e~~~~g~L~~-~l--------------~~--------~~~-~~~l~~~~-------------~~~i~~~i~~~l~~LH~~  209 (363)
                      +|++|..+.. ..              +.        +.. .....|..             ......++...+..+.+.
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999987762 11              00        000 11123320             001233344444444433


Q ss_pred             C----CCC---cEEeCCCCCCeeecCCCc-eEEEeeccce
Q 046084          210 C----IPS---IVHRDISSNNILLNSKLE-AFVADFGVAR  241 (363)
Q Consensus       210 ~----~~~---i~H~dlkp~Nill~~~~~-~kl~Dfg~~~  241 (363)
                      .    ...   ++|+|+.|.||+++.+.. +-+.||+-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            2    223   899999999999999885 8899999875

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=95.89  E-value=0.004  Score=46.97  Aligned_cols=30  Identities=20%  Similarity=0.439  Sum_probs=17.4

Q ss_pred             eEEEehhHHHHHHHHHHHHHHHHhhccccc
Q 046084           25 RLVVIILPIVLLLILVCIFTFLCLRRPKVR   54 (363)
Q Consensus        25 ~~~~ii~~~~~~~~l~~~~~~~~~~r~~~~   54 (363)
                      .++.|++++++.+++++++++||+||++++
T Consensus        65 ~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk   94 (122)
T PF01102_consen   65 AIIGIIFGVMAGVIGIILLISYCIRRLRKK   94 (122)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred             ceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence            445566666666666666666666655544

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	363
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-45
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-45
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-30
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-30
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-29
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-29
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-27
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-27
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-27
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-27
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-27
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-27
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-27
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-27
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-26
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-26
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-26
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-26
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-26
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-26
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-26
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-26
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-26
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-26
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-26
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-26
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-26
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-26
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-26
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-26
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-26
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-26
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-26
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-26
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-26
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-26
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-26
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-26
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-25
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-25
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-24
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-24
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-24
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-23
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-23
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-23
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-23
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-23
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-23
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-22
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-21
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-21
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-21
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-21
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-21
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-21
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-21
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-21
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-21
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-20
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-20
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-19
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-17
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-17
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-15
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-13
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-13
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-11
3soa_A	444	Full-Length Human Camkii Length = 444		6e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		8e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-06
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		7e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 105/284 (36%), Positives = 154/284 (54%), Gaps = 21/284 (7%)
Query: 78  RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTE 137
           R + +E+ VA+++F  K  +G GG+G VY+ +L  G  VA+K+L     +   L+ FQTE
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQ-FQTE 85
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR-LDWTKRVNIV 196
             ++S   HRN+++L GFC+      L+Y YM  GS+   LR   E+   LDW KR  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL-HSDSSNRTVVAG 255
              A  L+YLH  C P I+HRD+ + NILL+ + EA V DFG+A+L+ + D      V G
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 205
Query: 256 THGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN-PKIMLID------- 307
           T G+IAPE   T   +EK DV+ +GV+ LE++ G+   DL    N   +ML+D       
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 265
Query: 308 ------LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                 L+D  +     D+ V Q I    ++   C +S P  RP
Sbjct: 266 EKKLEALVDVDLQGNYKDEEVEQLI----QVALLCTQSSPMERP 305

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 105/284 (36%), Positives = 154/284 (54%), Gaps = 21/284 (7%)
Query: 78  RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTE 137
           R + +E+ VA+++F  K  +G GG+G VY+ +L  G  VA+K+L    T+   L+ FQTE
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ-FQTE 77
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR-LDWTKRVNIV 196
             ++S   HRN+++L GFC+      L+Y YM  GS+   LR   E+   LDW KR  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL-HSDSSNRTVVAG 255
              A  L+YLH  C P I+HRD+ + NILL+ + EA V DFG+A+L+ + D      V G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 197
Query: 256 THGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN-PKIMLID------- 307
             G+IAPE   T   +EK DV+ +GV+ LE++ G+   DL    N   +ML+D       
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 308 ------LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                 L+D  +     D+ V Q I    ++   C +S P  RP
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLI----QVALLCTQSSPMERP 297

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 89/216 (41%), Positives = 119/216 (55%), Gaps = 8/216 (3%)
Query: 78  RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTE 137
           R+   ++  AT +FD K+ IG G +G VY+  L  G KVALK+     ++   +E F+TE
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ--GIEEFETE 85
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIV 196
              LS  RH ++V L GFC  +  M LIYKYM  G+L   L   D   + + W +R+ I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL-LHSDSSN-RTVVA 254
              A  L YLH     +I+HRD+ S NILL+      + DFG+++     D ++   VV 
Sbjct: 146 IGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVK 202
Query: 255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGR 290
           GT GYI PE      LTEK DVYSFGVV  EVL  R
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 88/216 (40%), Positives = 117/216 (54%), Gaps = 8/216 (3%)
Query: 78  RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTE 137
           R+   ++  AT +FD K+ IG G +G VY+  L  G KVALK+     ++   +E F+TE
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ--GIEEFETE 85
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIV 196
              LS  RH ++V L GFC  +  M LIYKYM  G+L   L   D   + + W +R+ I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR--LLHSDSSNRTVVA 254
              A  L YLH     +I+HRD+ S NILL+      + DFG+++       +    VV 
Sbjct: 146 IGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVK 202
Query: 255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGR 290
           GT GYI PE      LTEK DVYSFGVV  EVL  R
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 139/275 (50%), Gaps = 17/275 (6%)
Query: 75  YDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESF 134
           + G +   +M +   D +IK  IG G +G+V+RA+   G  VA+K L   +     +  F
Sbjct: 23  FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEF 81
Query: 135 QTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
             E  ++ ++RH NIV   G       + ++ +Y+ RGSL+ +L       +LD  +R++
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
           +   +A  ++YLH +  P IVHRD+ S N+L++ K    V DFG++RL  S        A
Sbjct: 142 MAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA 200
Query: 255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK--IMLIDLLDQR 312
           GT  ++APE+       EK DVYSFGV+  E+   + P     ++NP   +  +    +R
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP---WGNLNPAQVVAAVGFKCKR 257
Query: 313 --VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             +P  ++ Q        V+ I+  C  ++P  RP
Sbjct: 258 LEIPRNLNPQ--------VAAIIEGCWTNEPWKRP 284

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 140/275 (50%), Gaps = 17/275 (6%)
Query: 75  YDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESF 134
           + G +   +M +   D +IK  IG G +G+V+RA+   G  VA+K L   +     +  F
Sbjct: 23  FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEF 81
Query: 135 QTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
             E  ++ ++RH NIV   G       + ++ +Y+ RGSL+ +L       +LD  +R++
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
           +   +A  ++YLH +  P IVHR++ S N+L++ K    V DFG++RL  S   +    A
Sbjct: 142 MAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK--IMLIDLLDQR 312
           GT  ++APE+       EK DVYSFGV+  E+   + P     ++NP   +  +    +R
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP---WGNLNPAQVVAAVGFKCKR 257
Query: 313 --VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             +P  ++ Q        V+ I+  C  ++P  RP
Sbjct: 258 LEIPRNLNPQ--------VAAIIEGCWTNEPWKRP 284

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 136/266 (51%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y  RG ++  L+   +  + D  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTATYITELANALS 127
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 235
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 236 EGARDLISRL----LKHNPSQRPMLR 257

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 116/208 (55%), Gaps = 10/208 (4%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 148
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 203
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
               +  EK D++S GV+  E L+G+ P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 233
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 234 EGARDLISRL----LKHNPSQRPMLR 255

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 127
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 235
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 236 EGARDLISRL----LKHNPSQRPMLR 257

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 116/208 (55%), Gaps = 10/208 (4%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 139
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 194
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
               +  EK D++S GV+  E L+G+ P
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 140/264 (53%), Gaps = 19/264 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 177
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
               +  EK D++S GV+  E L+G+ P +  ++       I  ++   P  + +    +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGA--R 234
Query: 325 DIILVSKIVFACLRSKPTSRPMQR 348
           D  L+S++    L+  P+ RPM R
Sbjct: 235 D--LISRL----LKHNPSQRPMLR 252

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 140/264 (53%), Gaps = 19/264 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 126
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
               +  EK D++S GV+  E L+G+ P +  ++       I  ++   P  + +    +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGA--R 238
Query: 325 DIILVSKIVFACLRSKPTSRPMQR 348
           D  L+S++    L+  P+ RPM R
Sbjct: 239 D--LISRL----LKHNPSQRPMLR 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 140/264 (53%), Gaps = 19/264 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 121
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 176
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
               +  EK D++S GV+  E L+G+ P +  ++       I  ++   P  + +    +
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGA--R 233
Query: 325 DIILVSKIVFACLRSKPTSRPMQR 348
           D  L+S++    L+  P+ RPM R
Sbjct: 234 D--LISRL----LKHNPSQRPMLR 251

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y  RG ++  L+   +  + D  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTATYITELANALS 127
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS R  + GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPEM 182
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 235
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 236 EGARDLISRL----LKHNPSQRPMLR 257

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 233
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 234 EGARDLISRL----LKHNPSQRPMLR 255

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 140/264 (53%), Gaps = 19/264 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 123
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +   H+ SS RT ++GT  Y+ PE+
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPPEM 178
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
               +  EK D++S GV+  E L+G+ P +  ++       I  ++   P  + +    +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGA--R 235
Query: 325 DIILVSKIVFACLRSKPTSRPMQR 348
           D  L+S++    L+  P+ RPM R
Sbjct: 236 D--LISRL----LKHNPSQRPMLR 253

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 140/264 (53%), Gaps = 19/264 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEM 177
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
               +  EK D++S GV+  E L+G+ P +  ++       I  ++   P  + +    +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGA--R 234
Query: 325 DIILVSKIVFACLRSKPTSRPMQR 348
           D  L+S++    L+  P+ RPM R
Sbjct: 235 D--LISRL----LKHNPSQRPMLR 252

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 114/206 (55%), Gaps = 10/206 (4%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQIRH 146
           EDFDI   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NI++LYG+      ++LI +Y   G+++   R   +  R D  +    +  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSRFDEQRTATYITELANALSYC 128
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+  
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 183
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
             +  EK D++S GV+  E L+G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEM 177
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 230
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 231 EGARDLISRL----LKHNPSQRPMLR 252

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 140/264 (53%), Gaps = 19/264 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 119
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 174
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
               +  EK D++S GV+  E L+G+ P +  ++       I  ++   P  + +    +
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGA--R 231
Query: 325 DIILVSKIVFACLRSKPTSRPMQR 348
           D  L+S++    L+  P+ RPM R
Sbjct: 232 D--LISRL----LKHNPSQRPMLR 249

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 230
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 231 EGARDLISRL----LKHNPSQRPMLR 252

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 230
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 231 EGARDLISRL----LKHNPSQRPMLR 252

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 123
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 178
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 231
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 232 EGARDLISRL----LKHNPSQRPMLR 253

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 127
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 182
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 235
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 236 EGARDLISRL----LKHNPSQRPMLR 257

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+  + K + ALK L  ++ E A +E   + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS R  + GT  Y+ PE+
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRI-------SRVEFTFPDFVT 230
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 231 EGARDLISRL----LKHNPSQRPMLR 252

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 140/264 (53%), Gaps = 19/264 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 124
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +A+FG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 179
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
               +  EK D++S GV+  E L+G+ P +  ++       I  ++   P  + +    +
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGA--R 236
Query: 325 DIILVSKIVFACLRSKPTSRPMQR 348
           D  L+S++    L+  P+ RPM R
Sbjct: 237 D--LISRL----LKHNPSQRPMLR 254

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 140/264 (53%), Gaps = 19/264 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +A+FG +  +H+ SS RT + GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
               +  EK D++S GV+  E L+G+ P +  ++       I  ++   P  + +    +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGA--R 237
Query: 325 DIILVSKIVFACLRSKPTSRPMQR 348
           D  L+S++    L+  P+ RPM R
Sbjct: 238 D--LISRL----LKHNPSQRPMLR 255

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 139/264 (52%), Gaps = 19/264 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS R  + GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 180
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
               +  EK D++S GV+  E L+G+ P +  ++       I  ++   P  + +    +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGA--R 237
Query: 325 DIILVSKIVFACLRSKPTSRPMQR 348
           D  L+S++    L+  P+ RPM R
Sbjct: 238 D--LISRL----LKHNPSQRPMLR 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 139/264 (52%), Gaps = 19/264 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS R  + GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
               +  EK D++S GV+  E L+G+ P +  ++       I  ++   P  + +    +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGA--R 234
Query: 325 DIILVSKIVFACLRSKPTSRPMQR 348
           D  L+S++    L+  P+ RPM R
Sbjct: 235 D--LISRL----LKHNPSQRPMLR 252

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 139/264 (52%), Gaps = 19/264 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 124
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS R  + GT  Y+ PE+
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 179
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
               +  EK D++S GV+  E L+G+ P +  ++       I  ++   P  + +    +
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGA--R 236
Query: 325 DIILVSKIVFACLRSKPTSRPMQR 348
           D  L+S++    L+  P+ RPM R
Sbjct: 237 D--LISRL----LKHNPSQRPMLR 254

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 134/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 123
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS R  + GT  Y+ PE+
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEM 178
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 231
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 232 EGARDLISRL----LKHNPSQRPMLR 253

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 114/208 (54%), Gaps = 10/208 (4%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 127
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE 
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEX 182
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                  EK D++S GV+  E L+G+ P
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 134/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS R  + GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 177
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 230
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 231 EGARDLISRL----LKHNPSQRPMLR 252

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 115/208 (55%), Gaps = 10/208 (4%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 148
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS R  + GT  Y+ PE+
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 203
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
               +  EK D++S GV+  E L+G+ P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 134/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS R  + GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 180
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 233
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 234 EGARDLISRL----LKHNPSQRPMLR 255

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 113/206 (54%), Gaps = 10/206 (4%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQIRH 146
           EDFDI   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NI++LYG+      ++LI +Y   G+++   R   +  R D  +    +  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSRFDEQRTATYITELANALSYC 128
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS R  + GT  Y+ PE+  
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIE 183
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
             +  EK D++S GV+  E L+G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 95/302 (31%), Positives = 147/302 (48%), Gaps = 35/302 (11%)
Query: 80  TFQEMIVATEDFDIKYC------IGTGGYGSVYRAQLPSGKKVALKKLHH--SETELAFL 131
           +F E+   T +FD +        +G GG+G VY+  + +   VA+KKL      T     
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           + F  E  ++++ +H N+V+L GF      + L+Y YM  GSL   L   D    L W  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
           R  I +  A+ +++LH +     +HRDI S NILL+    A ++DFG+AR   S+   +T
Sbjct: 135 RCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA--SEKFAQT 189
Query: 252 V----VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMG-------RHPGDLL---- 296
           V    + GT  Y+APE A    +T K D+YSFGVV LE++ G       R P  LL    
Sbjct: 190 VMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248
Query: 297 SSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVR 356
              + +  + D +D+++     D T ++ +  V+     CL  K   RP  +  Q+ L  
Sbjct: 249 EIEDEEKTIEDYIDKKMNDA--DSTSVEAMYSVAS---QCLHEKKNKRPDIKKVQQLLQE 303
Query: 357 KT 358
            T
Sbjct: 304 MT 305

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 95/302 (31%), Positives = 147/302 (48%), Gaps = 35/302 (11%)
Query: 80  TFQEMIVATEDFDIKYC------IGTGGYGSVYRAQLPSGKKVALKKLHH--SETELAFL 131
           +F E+   T +FD +        +G GG+G VY+  + +   VA+KKL      T     
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           + F  E  ++++ +H N+V+L GF      + L+Y YM  GSL   L   D    L W  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
           R  I +  A+ +++LH +     +HRDI S NILL+    A ++DFG+AR   S+   +T
Sbjct: 135 RCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA--SEKFAQT 189
Query: 252 V----VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMG-------RHPGDLL---- 296
           V    + GT  Y+APE A    +T K D+YSFGVV LE++ G       R P  LL    
Sbjct: 190 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248
Query: 297 SSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVR 356
              + +  + D +D+++     D T ++ +  V+     CL  K   RP  +  Q+ L  
Sbjct: 249 EIEDEEKTIEDYIDKKMNDA--DSTSVEAMYSVAS---QCLHEKKNKRPDIKKVQQLLQE 303
Query: 357 KT 358
            T
Sbjct: 304 MT 305

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 113/213 (53%), Gaps = 17/213 (7%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETE--LAFLESFQTEAHLLSQIRHR 147
           +  ++  IG GG+G VYRA    G +VA+K   H   E     +E+ + EA L + ++H 
Sbjct: 8   ELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           NI+ L G CL +  + L+ ++ R G L  +L       R+     VN    +A  ++YLH
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLH 122
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAF--------VADFGVARLLHSDSSNRTVVAGTHGY 259
            + I  I+HRD+ S+NIL+  K+E          + DFG+AR  H   + +   AG + +
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAW 180
Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +APE+    + ++  DV+S+GV+  E+L G  P
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 134/266 (50%), Gaps = 23/266 (8%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQI 144
           A EDF+I   +G G +G+VY A+    K + ALK L  ++ E A +E   + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI++LYG+      ++LI +Y   G+++   R   +  + D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS R  + GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 180
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
               +  EK D++S GV+  E L+G+ P   +       +I        RV     D   
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDFVT 233
Query: 323 IQDIILVSKIVFACLRSKPTSRPMQR 348
                L+S++    L+  P+ RPM R
Sbjct: 234 EGARDLISRL----LKHNPSQRPMLR 255

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 146/302 (48%), Gaps = 35/302 (11%)
Query: 80  TFQEMIVATEDFDIKYC------IGTGGYGSVYRAQLPSGKKVALKKLHH--SETELAFL 131
           +F E+   T +FD +        +G GG+G VY+  + +   VA+KKL      T     
Sbjct: 10  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 68
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           + F  E  ++++ +H N+V+L GF      + L+Y YM  GSL   L   D    L W  
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 128
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
           R  I +  A+ +++LH +     +HRDI S NILL+    A ++DFG+AR   S+   + 
Sbjct: 129 RCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA--SEKFAQX 183
Query: 252 V----VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMG-------RHPGDLL---- 296
           V    + GT  Y+APE A    +T K D+YSFGVV LE++ G       R P  LL    
Sbjct: 184 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 242
Query: 297 SSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVR 356
              + +  + D +D+++     D T ++ +  V+     CL  K   RP  +  Q+ L  
Sbjct: 243 EIEDEEKTIEDYIDKKMNDA--DSTSVEAMYSVAS---QCLHEKKNKRPDIKKVQQLLQE 297
Query: 357 KT 358
            T
Sbjct: 298 MT 299

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/259 (32%), Positives = 128/259 (49%), Gaps = 23/259 (8%)
Query: 96  CIGTGGYGSVYRAQL--PSGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
            IG G +G VY+  L   SGKK   VA+K L    TE   ++ F  EA ++ Q  H NI+
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNII 109
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
           +L G     K M +I +YM  G+L   LR  D    +   + V +++ +A  + YL    
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLRGIAAGMKYL---A 164
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYT 267
             + VHRD+++ NIL+NS L   V+DFG++R+L  D       +G      + APE    
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 268 MVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
              T   DV+SFG+V  EV+  G  P   LS  N ++M       R+P+P+D  + I  +
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAINDGFRLPTPMDCPSAIYQL 282
Query: 327 ILVSKIVFACLRSKPTSRP 345
           ++       C + +   RP
Sbjct: 283 MM------QCWQQERARRP 295

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 135/265 (50%), Gaps = 28/265 (10%)
Query: 93  IKYCIGTGGYGSVYRAQLPS-GKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG G +G V R +L + GKK   VA+K L    TE    E F +EA ++ Q  H N
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRRE-FLSEASIMGQFEHPN 76
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I++L G   +   + ++ ++M  G+L   LR +D    +   + V +++ +A  + YL  
Sbjct: 77  IIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYL-- 132
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPE 263
               S VHRD+++ NIL+NS L   V+DFG++R L  +SS+ T  +   G     + APE
Sbjct: 133 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 264 LAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQ 320
                  T   D +S+G+V  EV+  G  P   +S+ +    +I+ ++Q  R+P P D  
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD----VINAIEQDYRLPPPPDCP 247
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
           T +  ++L       C +    +RP
Sbjct: 248 TSLHQLML------DCWQKDRNARP 266

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 135/265 (50%), Gaps = 28/265 (10%)
Query: 93  IKYCIGTGGYGSVYRAQLPS-GKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG G +G V R +L + GKK   VA+K L    TE    E F +EA ++ Q  H N
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRRE-FLSEASIMGQFEHPN 78
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I++L G   +   + ++ ++M  G+L   LR +D    +   + V +++ +A  + YL  
Sbjct: 79  IIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYL-- 134
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPE 263
               S VHRD+++ NIL+NS L   V+DFG++R L  +SS+ T  +   G     + APE
Sbjct: 135 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 264 LAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQ 320
                  T   D +S+G+V  EV+  G  P   +S+ +    +I+ ++Q  R+P P D  
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD----VINAIEQDYRLPPPPDCP 249
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
           T +  ++L       C +    +RP
Sbjct: 250 TSLHQLML------DCWQKDRNARP 268

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 139/271 (51%), Gaps = 20/271 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQIRH 146
           +DFDI   +G G +G+VY A+    K + ALK L  S+ E   +E   + E  + S +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NI+++Y +   +K ++L+ ++  RG L+  L+      R D  +    ++ +A AL Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYC 131
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      ++HRDI   N+L+  K E  +ADFG +  +H+ S  R  + GT  Y+ PE+  
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIE 186
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
                EK D++  GV+  E L+G  P D  S       +++ +D + P  + D +  +D 
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-VDLKFPPFLSDGS--KD- 242
Query: 327 ILVSKIVFACLRSKPTSR-PMQRVSQEFLVR 356
            L+SK+    LR  P  R P++ V +   V+
Sbjct: 243 -LISKL----LRYHPPQRLPLKGVMEHPWVK 268

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 139/271 (51%), Gaps = 20/271 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLE-SFQTEAHLLSQIRH 146
           +DFDI   +G G +G+VY A+    K + ALK L  S+ E   +E   + E  + S +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NI+++Y +   +K ++L+ ++  RG L+  L+      R D  +    ++ +A AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYC 130
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      ++HRDI   N+L+  K E  +ADFG +  +H+ S  R  + GT  Y+ PE+  
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
                EK D++  GV+  E L+G  P D  S       +++ +D + P  + D +  +D 
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-VDLKFPPFLSDGS--KD- 241
Query: 327 ILVSKIVFACLRSKPTSR-PMQRVSQEFLVR 356
            L+SK+    LR  P  R P++ V +   V+
Sbjct: 242 -LISKL----LRYHPPQRLPLKGVMEHPWVK 267

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 138/300 (46%), Gaps = 31/300 (10%)
Query: 80  TFQEMIVATEDFDIKYC------IGTGGYGSVYRAQLPSGKKVALKKLHH--SETELAFL 131
           +F E+   T +FD +         G GG+G VY+  + +   VA+KKL      T     
Sbjct: 7   SFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 65
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           + F  E  + ++ +H N+V+L GF      + L+Y Y   GSL   L   D    L W  
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX 125
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH--SDSSN 249
           R  I +  A+ +++LH +     +HRDI S NILL+    A ++DFG+AR     +    
Sbjct: 126 RCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVX 182
Query: 250 RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMG-------RHPGDLL----SS 298
            + + GT  Y APE A    +T K D+YSFGVV LE++ G       R P  LL      
Sbjct: 183 XSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 241
Query: 299 VNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVRKT 358
            + +  + D +D++      D T ++    V+     CL  K   RP  +  Q+ L   T
Sbjct: 242 EDEEKTIEDYIDKKXNDA--DSTSVEAXYSVAS---QCLHEKKNKRPDIKKVQQLLQEXT 296

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 121/246 (49%), Gaps = 18/246 (7%)
Query: 93  IKYCIGTGGYGSVYRAQLP-SGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG G +G V    L   GK+   VA+K L    TE      F +EA ++ Q  H N
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPN 95
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           ++ L G       + +I ++M  GSL   LR +D    +   + V +++ +A  + YL  
Sbjct: 96  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL-A 152
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPE 263
           D   + VHRD+++ NIL+NS L   V+DFG++R L  D+S+ T  +   G     + APE
Sbjct: 153 DM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 264 LAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
                  T   DV+S+G+V  EV+  G  P       N  ++     D R+P P+D  + 
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTNQDVINAIEQDYRLPPPMDCPSA 268
Query: 323 IQDIIL 328
           +  ++L
Sbjct: 269 LHQLML 274

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 20/271 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLE-SFQTEAHLLSQIRH 146
           +DF+I   +G G +G+VY A +  S   VALK L  S+ E   +E   + E  + + + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NI++LY +   ++ ++LI +Y  RG L+  L+   ++   D  +   I++ +A AL Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQ---KSCTFDEQRTATIMEELADALMYC 139
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      ++HRDI   N+LL  K E  +ADFG +  +H+ S  R  + GT  Y+ PE+  
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
             +  EK D++  GV+  E+L+G  P +  +S N     I  +D + P+ +   T  QD 
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPPFE-SASHNETYRRIVKVDLKFPASVP--TGAQD- 250
Query: 327 ILVSKIVFACLRSKPTSR-PMQRVSQEFLVR 356
            L+SK+    LR  P+ R P+ +VS    VR
Sbjct: 251 -LISKL----LRHNPSERLPLAQVSAHPWVR 276

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 131/268 (48%), Gaps = 29/268 (10%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           ++  ++ +++  +G G +G V +A+    K VA+K++  SE+E    ++F  E   LS++
Sbjct: 5   MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESER---KAFIVELRQLSRV 59
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKLYG CL+  C  L+ +Y   GSL+ +L   +          ++     +  ++
Sbjct: 60  NHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 117
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           YLH     +++HRD+   N+LL +      + DFG A  + +  +N     G+  ++APE
Sbjct: 118 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPE 174
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI------DLLDQRVPSPI 317
           +      +EKCDV+S+G++  EV+  R P D +     +IM          L + +P PI
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 234
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +             ++  C    P+ RP
Sbjct: 235 ES------------LMTRCWSKDPSQRP 250

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 131/268 (48%), Gaps = 29/268 (10%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           ++  ++ +++  +G G +G V +A+    K VA+K++  SE+E    ++F  E   LS++
Sbjct: 4   MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESER---KAFIVELRQLSRV 58
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKLYG CL+  C  L+ +Y   GSL+ +L   +          ++     +  ++
Sbjct: 59  NHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           YLH     +++HRD+   N+LL +      + DFG A  + +  +N     G+  ++APE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPE 173
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI------DLLDQRVPSPI 317
           +      +EKCDV+S+G++  EV+  R P D +     +IM          L + +P PI
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +             ++  C    P+ RP
Sbjct: 234 ES------------LMTRCWSKDPSQRP 249

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 75/246 (30%), Positives = 120/246 (48%), Gaps = 18/246 (7%)
Query: 93  IKYCIGTGGYGSVYRAQLP-SGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG G +G V    L   GK+   VA+K L    TE      F +EA ++ Q  H N
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPN 69
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           ++ L G       + +I ++M  GSL   LR +D    +   + V +++ +A  + YL  
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL-A 126
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPE 263
           D   + VHR +++ NIL+NS L   V+DFG++R L  D+S+ T  +   G     + APE
Sbjct: 127 DM--NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 264 LAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
                  T   DV+S+G+V  EV+  G  P       N  ++     D R+P P+D  + 
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTNQDVINAIEQDYRLPPPMDCPSA 242
Query: 323 IQDIIL 328
           +  ++L
Sbjct: 243 LHQLML 248

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 95
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ +YM  GSL   LR  D    +   + V ++
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGML 153
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL  D     VHRD+++ NIL+NS L   V+DFG+AR+L  D        G 
Sbjct: 154 RGIASGMKYL-SDM--GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGG 210
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 266
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 267 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 295

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 129/265 (48%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G G +G V+        KVA+K L          ESF  EA ++ +++H  +V+LY   
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP---ESFLEEAQIMKKLKHDKLVQLYA-V 72
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           + ++ ++++ +YM +GSL   L+ D E   L     V++   +A  ++Y+      + +H
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIH 128
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGYIAPELAYTMVLTEKCD 275
           RD+ S NIL+ + L   +ADFG+ARL+  ++ + R        + APE A     T K D
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 276 VYSFGVVALE-VLMGRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPIDDQTVIQDIILV 329
           V+SFG++  E V  GR P        P +   ++L+Q     R+P P D    + ++++ 
Sbjct: 189 VWSFGILLTELVTKGRVP-------YPGMNNREVLEQVERGYRMPCPQDCPISLHELMI- 240
Query: 330 SKIVFACLRSKPTSRPMQRVSQEFL 354
                 C +  P  RP     Q FL
Sbjct: 241 -----HCWKKDPEERPTFEYLQSFL 260

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 95
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ +YM  GSL   LR  D    +   + V ++
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGML 153
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL  D     VHRD+++ NIL+NS L   V+DFG++R+L  D        G 
Sbjct: 154 RGIASGMKYL-SDM--GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 266
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 267 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 295

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 72  HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMA 128
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+++ NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 129 YVERM---NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 238
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R  P  RP     Q FL
Sbjct: 239 ECPESLHDLMC------QCWRKDPEERPTFEYLQAFL 269

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 8   IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 64
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 65  HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMA 121
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 122 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 178
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 231
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R +P  RP     Q FL
Sbjct: 232 ECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 262

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 134/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ +IR
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKIR 71
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 72  HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMA 128
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 129 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 238
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R  P  RP     Q FL
Sbjct: 239 ECPESLHDLMC------QCWRKDPEERPTFEYLQAFL 269

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 95
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ +YM  GSL   LR  D    +   + V ++
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGML 153
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL  D     VHRD+++ NIL+NS L   V+DFG++R+L  D        G 
Sbjct: 154 RGIASGMKYL-SDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 266
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 267 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 295

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 95
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ +YM  GSL   LR  D    +   + V ++
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGML 153
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL  D     VHRD+++ NIL+NS L   V+DFG++R+L  D        G 
Sbjct: 154 RGIASGMKYL-SDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 266
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 267 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 295

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 95
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ +YM  GSL   LR  D    +   + V ++
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGML 153
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL  D     VHRD+++ NIL+NS L   V+DFG++R+L  D        G 
Sbjct: 154 RGIASGMKYL-SDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 266
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 267 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 295

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 26  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 83
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ +YM  GSL   LR  D    +   + V ++
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGML 141
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL        VHRD+++ NIL+NS L   V+DFG++R+L  D        G 
Sbjct: 142 RGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 198
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 199 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 254
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 255 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 283

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 12  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 68
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 69  HEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRL--PQLVDMSAQIASGMA 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 126 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPE 182
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 235
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R +P  RP     Q FL
Sbjct: 236 ECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 266

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 95
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ +YM  GSL   LR  D    +   + V ++
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGML 153
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL  D     VHRD+++ NIL+NS L   V+DFG+ R+L  D        G 
Sbjct: 154 RGIASGMKYL-SDM--GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 266
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 267 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 295

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 95
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ +YM  GSL   LR  D    +   + V ++
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGML 153
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL  D     VHRD+++ NIL+NS L   V+DFG++R+L  D        G 
Sbjct: 154 RGIASGMKYL-SDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 266
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 267 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 295

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 36  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 93
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ +YM  GSL   LR  D    +   + V ++
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGML 151
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL  D     VHRD+++ NIL+NS L   V+DFG++R+L  D        G 
Sbjct: 152 RGIASGMKYL-SDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 208
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 209 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 264
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 265 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 293

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 66
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ +YM  GSL   LR  D    +   + V ++
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGML 124
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL        VHRD+++ NIL+NS L   V+DFG++R+L  D        G 
Sbjct: 125 RGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 237
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 238 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 266

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 10/205 (4%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           E FD+   +G G YGSVY+A    +G+ VA+K++         L+    E  ++ Q    
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSP 84
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           ++VK YG       ++++ +Y   GS+  I+R  ++ +  D  +   I++S    L YLH
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED--EIATILQSTLKGLEYLH 142
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                  +HRDI + NILLN++  A +ADFGVA  L    + R  V GT  ++APE+   
Sbjct: 143 ---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQE 199
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
           +      D++S G+ A+E+  G+ P
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 12  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 68
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 69  HEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRL--PQLVDMSAQIASGMA 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 126 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 182
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 235
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R +P  RP     Q FL
Sbjct: 236 ECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 266

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 72  HEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMA 128
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  ++ + R        + APE
Sbjct: 129 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPE 185
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 238
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R  P  RP     Q FL
Sbjct: 239 ECPESLHDLMC------QCWRKDPEERPTFEYLQAFL 269

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 136/262 (51%), Gaps = 18/262 (6%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+ A      KVA+K +      +   E+F  EA+++  ++
Sbjct: 12  IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQ 68
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H  +VKL+   + K+ +++I ++M +GSL   L++D E  +    K ++    +A  +++
Sbjct: 69  HDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAF 126
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPEL 264
           +      + +HRD+ + NIL+++ L   +ADFG+AR++  +  + R        + APE 
Sbjct: 127 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 183
Query: 265 AYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI 323
                 T K DV+SFG++ +E++  GR P   +S  NP+++       R+P P +    +
Sbjct: 184 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRMPRPENCPEEL 241
Query: 324 QDIILVSKIVFACLRSKPTSRP 345
            +I++       C +++P  RP
Sbjct: 242 YNIMM------RCWKNRPEERP 257

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 6   IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 62
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 63  HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMA 119
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 120 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 176
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 229
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R  P  RP     Q FL
Sbjct: 230 ECPESLHDLMC------QCWRKDPEERPTFEYLQAFL 260

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 4   IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 60
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 61  HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMA 117
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 118 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 174
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 227
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R  P  RP     Q FL
Sbjct: 228 ECPESLHDLMC------QCWRKDPEERPTFEYLQAFL 258

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 237
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 238 HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMA 294
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 295 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 404
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R +P  RP     Q FL
Sbjct: 405 ECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 435

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 72  HEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMA 128
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 129 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 238
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R  P  RP     Q FL
Sbjct: 239 ECPESLHDLMC------QCWRKDPEERPTFEYLQAFL 269

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 237
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 238 HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMA 294
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 295 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 404
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R +P  RP     Q FL
Sbjct: 405 ECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 435

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 72  HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMA 128
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 129 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 238
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R  P  RP     Q FL
Sbjct: 239 ECPESLHDLMC------QCWRKDPEERPTFEYLQAFL 269

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 320
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 321 HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMA 377
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 378 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 487
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R +P  RP     Q FL
Sbjct: 488 ECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 518

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 237
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 238 HEKLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMA 294
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 295 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 404
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R +P  RP     Q FL
Sbjct: 405 ECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 435

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 123/261 (47%), Gaps = 22/261 (8%)
Query: 93  IKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG G +G V   R +LP  ++  VA+K L    TE      F  EA ++ Q  H N
Sbjct: 26  IERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 84
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I+ L G     K + ++ +YM  GSL   L+ +D    +   + V +++ ++  + YL  
Sbjct: 85  IIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--IQLVGMLRGISAGMKYL-S 141
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELA 265
           D     VHRD+++ NIL+NS L   V+DFG++R+L  D        G      + APE  
Sbjct: 142 DM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 199
Query: 266 YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
                T   DV+S+G+V  EV+  G  P       N  ++       R+PSP+D    + 
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVSYGERP--YWEMTNQDVIKAVEEGYRLPSPMDCPAALY 257
Query: 325 DIILVSKIVFACLRSKPTSRP 345
            ++L       C + +  SRP
Sbjct: 258 QLML------DCWQKERNSRP 272

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 5   IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 61
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ + ++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 62  HEKLVQLYA-VVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMA 118
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  ++ + R        + APE
Sbjct: 119 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPE 175
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 228
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R +P  RP     Q FL
Sbjct: 229 ECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 259

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 72  HEKLVQLYA-VVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMA 128
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 238
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R  P  RP     Q FL
Sbjct: 239 ECPESLHDLMC------QCWRKDPEERPTFEYLQAFL 269

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 127/263 (48%), Gaps = 26/263 (9%)
Query: 93  IKYCIGTGGYGSVYRAQLP-SGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG G +G V   +L   GK+   VA+K L    T+      F +EA ++ Q  H N
Sbjct: 33  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPN 91
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I+ L G     K + +I +YM  GSL   LR +D   R    + V +++ +   + YL  
Sbjct: 92  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG--RFTVIQLVGMLRGIGSGMKYLS- 148
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELA 265
               S VHRD+++ NIL+NS L   V+DFG++R+L  D        G      + APE  
Sbjct: 149 --DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 206
Query: 266 YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTV 322
                T   DV+S+G+V  EV+  G  P   +S+ +    +I  +++  R+P P+D    
Sbjct: 207 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VIKAIEEGYRLPPPMDCPIA 262
Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
           +  ++L       C + + + RP
Sbjct: 263 LHQLML------DCWQKERSDRP 279

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G V++      +KV   K+   E     +E  Q E  +LSQ     + K YG  
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L    +++I +Y+  GS   +L    E   LD T+   I++ +   L YLH +     +H
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KKIH 147
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDV 276
           RDI + N+LL+   E  +ADFGVA  L      R    GT  ++APE+        K D+
Sbjct: 148 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 207
Query: 277 YSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFAC 336
           +S G+ A+E+  G  P    S ++P  +L  L+ +  P  ++          + + V AC
Sbjct: 208 WSLGITAIELARGEPPH---SELHPMKVLF-LIPKNNPPTLEGNYSKP----LKEFVEAC 259
Query: 337 LRSKPTSRPMQR--VSQEFLVR 356
           L  +P+ RP  +  +  +F++R
Sbjct: 260 LNKEPSFRPTAKELLKHKFILR 281

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G V++      +KV   K+   E     +E  Q E  +LSQ     + K YG  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L    +++I +Y+  GS   +L    E   LD T+   I++ +   L YLH +     +H
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KKIH 127
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDV 276
           RDI + N+LL+   E  +ADFGVA  L      R    GT  ++APE+        K D+
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 277 YSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFAC 336
           +S G+ A+E+  G  P    S ++P  +L  L+ +  P  ++          + + V AC
Sbjct: 188 WSLGITAIELARGEPPH---SELHPMKVLF-LIPKNNPPTLEGNYSKP----LKEFVEAC 239
Query: 337 LRSKPTSRPMQR--VSQEFLVR 356
           L  +P+ RP  +  +  +F++R
Sbjct: 240 LNKEPSFRPTAKELLKHKFILR 261

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G V++      +KV   K+   E     +E  Q E  +LSQ     + K YG  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L    +++I +Y+  GS   +L    E   LD T+   I++ +   L YLH +     +H
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KKIH 142
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDV 276
           RDI + N+LL+   E  +ADFGVA  L      R    GT  ++APE+        K D+
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 202
Query: 277 YSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFAC 336
           +S G+ A+E+  G  P    S ++P  +L  L+ +  P  ++          + + V AC
Sbjct: 203 WSLGITAIELARGEPPH---SELHPMKVLF-LIPKNNPPTLEGNYSKP----LKEFVEAC 254
Query: 337 LRSKPTSRPMQR--VSQEFLVR 356
           L  +P+ RP  +  +  +F++R
Sbjct: 255 LNKEPSFRPTAKELLKHKFILR 276

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G V++      +KV   K+   E     +E  Q E  +LSQ     + K YG  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L    +++I +Y+  GS   +L    E   LD T+   I++ +   L YLH +     +H
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KKIH 127
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDV 276
           RDI + N+LL+   E  +ADFGVA  L      R    GT  ++APE+        K D+
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 277 YSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFAC 336
           +S G+ A+E+  G  P    S ++P  +L  L+ +  P  ++          + + V AC
Sbjct: 188 WSLGITAIELARGEPPH---SELHPMKVLF-LIPKNNPPTLEGNYSKP----LKEFVEAC 239
Query: 337 LRSKPTSRPMQR--VSQEFLVR 356
           L  +P+ RP  +  +  +F++R
Sbjct: 240 LNKEPSFRPTAKELLKHKFILR 261

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 123/264 (46%), Gaps = 17/264 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G V++      ++V   K+   E     +E  Q E  +LSQ     + K YG  
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L    +++I +Y+  GS   +LR    A   D  +   ++K +   L YLH +     +H
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KKIH 143
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDV 276
           RDI + N+LL+ + +  +ADFGVA  L      R    GT  ++APE+        K D+
Sbjct: 144 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 203
Query: 277 YSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFAC 336
           +S G+ A+E+  G  P    S ++P  +L  +     P+ + D T         + + AC
Sbjct: 204 WSLGITAIELAKGEPPN---SDMHPMRVLFLIPKNNPPTLVGDFTKS-----FKEFIDAC 255
Query: 337 LRSKPTSRPMQR--VSQEFLVRKT 358
           L   P+ RP  +  +  +F+V+ +
Sbjct: 256 LNKDPSFRPTAKELLKHKFIVKNS 279

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 127/263 (48%), Gaps = 26/263 (9%)
Query: 93  IKYCIGTGGYGSVYRAQLP-SGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG G +G V   +L   GK+   VA+K L    T+      F +EA ++ Q  H N
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPN 76
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I+ L G     K + +I +YM  GSL   LR +D   R    + V +++ +   + YL  
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG--RFTVIQLVGMLRGIGSGMKYLS- 133
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELA 265
               S VHRD+++ NIL+NS L   V+DFG++R+L  D        G      + APE  
Sbjct: 134 --DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 266 YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTV 322
                T   DV+S+G+V  EV+  G  P   +S+ +    +I  +++  R+P P+D    
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VIKAIEEGYRLPPPMDCPIA 247
Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
           +  ++L       C + + + RP
Sbjct: 248 LHQLML------DCWQKERSDRP 264

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 136/262 (51%), Gaps = 18/262 (6%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+ A      KVA+K +      +   E+F  EA+++  ++
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQ 241
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H  +VKL+   + K+ +++I ++M +GSL   L++D E  +    K ++    +A  +++
Sbjct: 242 HDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAF 299
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPEL 264
           +      + +HRD+ + NIL+++ L   +ADFG+AR++  +  + R        + APE 
Sbjct: 300 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356
Query: 265 AYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI 323
                 T K DV+SFG++ +E++  GR P   +S  NP+++       R+P P +    +
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRMPRPENCPEEL 414
Query: 324 QDIILVSKIVFACLRSKPTSRP 345
            +I++       C +++P  RP
Sbjct: 415 YNIMM------RCWKNRPEERP 430

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 127/263 (48%), Gaps = 26/263 (9%)
Query: 93  IKYCIGTGGYGSVYRAQLP-SGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG G +G V   +L   GK+   VA+K L    T+      F +EA ++ Q  H N
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPN 70
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I+ L G     K + +I +YM  GSL   LR +D   R    + V +++ +   + YL  
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG--RFTVIQLVGMLRGIGSGMKYLS- 127
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELA 265
               S VHRD+++ NIL+NS L   V+DFG++R+L  D        G      + APE  
Sbjct: 128 --DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 266 YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTV 322
                T   DV+S+G+V  EV+  G  P   +S+ +    +I  +++  R+P P+D    
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VIKAIEEGYRLPPPMDCPIA 241
Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
           +  ++L       C + + + RP
Sbjct: 242 LHQLML------DCWQKERSDRP 258

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 133/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 182 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP---EAFLQEAQVMKKLR 238
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +GSL   L+ +  + +RL   + V++   +A  ++
Sbjct: 239 HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMA 295
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ RL+  +  + R        + APE
Sbjct: 296 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPE 352
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 405
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R  P  RP     Q FL
Sbjct: 406 ECPESLHDLMC------QCWRKDPEERPTFEYLQAFL 436

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 133/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +G L   L+ +  + +RL   + V++   +A  ++
Sbjct: 72  HEKLVQLYA-VVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRL--PQLVDMAAQIASGMA 128
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 238
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R  P  RP     Q FL
Sbjct: 239 ECPESLHDLMC------QCWRKDPEERPTFEYLQAFL 269

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 133/277 (48%), Gaps = 30/277 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++R
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS 204
           H  +V+LY   + ++ ++++ +YM +G L   L+ +  + +RL   + V++   +A  ++
Sbjct: 72  HEKLVQLYA-VVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRL--PQLVDMAAQIASGMA 128
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPE 263
           Y+      + VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 238
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFL 354
           +    + D++        C R  P  RP     Q FL
Sbjct: 239 ECPESLHDLMC------QCWRKDPEERPTFEYLQAFL 269

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 95
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ + M  GSL   LR  D    +   + V ++
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGML 153
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL  D     VHRD+++ NIL+NS L   V+DFG++R+L  D        G 
Sbjct: 154 RGIASGMKYL-SDM--GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 266
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 267 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 295

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 95
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ + M  GSL   LR  D    +   + V ++
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGML 153
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL  D     VHRD+++ NIL+NS L   V+DFG++R+L  D        G 
Sbjct: 154 RGIASGMKYL-SDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 266
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 267 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 295

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSV--YRAQLPSGKK--VALKKLHHSETELAFLESFQT 136
           F + + AT +  I   +G G +G V   R +LPS K+  VA+K L    TE      F  
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLG 66
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ Q  H NI++L G     K + ++ + M  GSL   LR  D    +   + V ++
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGML 124
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL        VHRD+++ NIL+NS L   V+DFG++R+L  D        G 
Sbjct: 125 RGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 257 H---GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ- 311
                + +PE       T   DV+S+G+V  EV+  G  P   +S+ +    +I  +D+ 
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVDEG 237
Query: 312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R+P P+D    +  ++L       C +    +RP
Sbjct: 238 YRLPPPMDCPAALYQLML------DCWQKDRNNRP 266

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 133/275 (48%), Gaps = 30/275 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKK---LHHSETELAFLESFQT---EAH 139
           +A  + + +  IG GG+G V++ +L   K V   K   L  SE E   +E FQ    E  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           ++S + H NIVKLYG   +   M  + +++  G L+  L   D+A  + W+ ++ ++  +
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDI 131
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLE-----AFVADFGVARL-LHSDSSNRTVV 253
           A  + Y+     P IVHRD+ S NI L S  E     A VADFG+++  +HS S     +
Sbjct: 132 ALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG----L 186
Query: 254 AGTHGYIAPEL--AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ 311
            G   ++APE   A     TEK D YSF ++   +L G  P D  S    KI  I+++ +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--KIKFINMIRE 244
Query: 312 RVPSPIDDQTVIQDI-ILVSKIVFACLRSKPTSRP 345
               P    T+ +D    +  ++  C    P  RP
Sbjct: 245 EGLRP----TIPEDCPPRLRNVIELCWSGDPKKRP 275

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 132/275 (48%), Gaps = 30/275 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKK---LHHSETELAFLESFQT---EAH 139
           +A  + + +  IG GG+G V++ +L   K V   K   L  SE E   +E FQ    E  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           ++S + H NIVKLYG   +   M  + +++  G L+  L   D+A  + W+ ++ ++  +
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDI 131
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLE-----AFVADFGVARL-LHSDSSNRTVV 253
           A  + Y+     P IVHRD+ S NI L S  E     A VADFG ++  +HS S     +
Sbjct: 132 ALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSG----L 186
Query: 254 AGTHGYIAPEL--AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ 311
            G   ++APE   A     TEK D YSF ++   +L G  P D  S    KI  I+++ +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--KIKFINMIRE 244
Query: 312 RVPSPIDDQTVIQDI-ILVSKIVFACLRSKPTSRP 345
               P    T+ +D    +  ++  C    P  RP
Sbjct: 245 EGLRP----TIPEDCPPRLRNVIELCWSGDPKKRP 275

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 6/205 (2%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            ED+++ Y IGTG YG   + +  S GK +  K+L +     A  +   +E +LL +++H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 147 RNIVKLYGFCLHKK--CMFLIYKYMRRGSLFCIL-RNDDEAIRLDWTKRVNIVKSMAHAL 203
            NIV+ Y   + +    ++++ +Y   G L  ++ +   E   LD    + ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 204 SYLH--CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
              H   D   +++HRD+   N+ L+ K    + DFG+AR+L+ D+S      GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 184
Query: 262 PELAYTMVLTEKCDVYSFGVVALEV 286
           PE    M   EK D++S G +  E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 6/205 (2%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            ED+++ Y IGTG YG   + +  S GK +  K+L +     A  +   +E +LL +++H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 147 RNIVKLYGFCLHKK--CMFLIYKYMRRGSLFCIL-RNDDEAIRLDWTKRVNIVKSMAHAL 203
            NIV+ Y   + +    ++++ +Y   G L  ++ +   E   LD    + ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 204 SYLH--CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
              H   D   +++HRD+   N+ L+ K    + DFG+AR+L+ D+S      GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 262 PELAYTMVLTEKCDVYSFGVVALEV 286
           PE    M   EK D++S G +  E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 12/224 (5%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 16  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 72
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 73  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 130
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  ++ + R        + A
Sbjct: 131 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA 187
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR P   ++  NP+++
Sbjct: 188 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI 229

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 12/224 (5%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 69
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 70  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 127
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  ++ + R        + A
Sbjct: 128 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA 184
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR P   ++  NP+++
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI 226

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 12/224 (5%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 15  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 71
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 72  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 129
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  ++ + R        + A
Sbjct: 130 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA 186
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR P   ++  NP+++
Sbjct: 187 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI 228

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 106/208 (50%), Gaps = 26/208 (12%)
Query: 97  IGTGGYGSVYR-AQLPSGKKVALKKL--HHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G G +G   +     +G+ + +K+L     ET+  FL+    E  ++  + H N++K  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK----EVKVMRCLEHPNVLKFI 73
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
           G     K +  I +Y++ G+L  I+++ D   +  W++RV+  K +A  ++YLH     +
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLL--------------HSDSSNRTVVAGTHGY 259
           I+HRD++S+N L+       VADFG+ARL+                D   R  V G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVL 287
           +APE+       EK DV+SFG+V  E++
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 12/224 (5%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 63
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 64  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 121
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  ++ + R        + A
Sbjct: 122 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA 178
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR P   ++  NP+++
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI 220

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 12/224 (5%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 9   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 65
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 66  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 123
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  ++ + R        + A
Sbjct: 124 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA 180
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR P   ++  NP+++
Sbjct: 181 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI 222

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 116/224 (51%), Gaps = 12/224 (5%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 69
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 70  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 127
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  +  + R        + A
Sbjct: 128 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 184
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR P   ++  NP+++
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI 226

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 26/263 (9%)
Query: 93  IKYCIGTGGYGSV--YRAQLPSGKKVA--LKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG G +G V   R +LP  + VA  +K L    TE      F  EA ++ Q  H N
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ-RRDFLCEASIMGQFDHPN 105
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V L G     K + ++ ++M  G+L   LR  D    +   + V +++ +A  + YL  
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV--IQLVGMLRGIAAGMRYL-- 161
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELA 265
                 VHRD+++ NIL+NS L   V+DFG++R++  D        G      + APE  
Sbjct: 162 -ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 266 YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTV 322
                T   DV+S+G+V  EV+  G  P   +S+ +    +I  +++  R+P+P+D    
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VIKAIEEGYRLPAPMDCPAG 276
Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
           +  ++L       C + +   RP
Sbjct: 277 LHQLML------DCWQKERAERP 293

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 117/226 (51%), Gaps = 16/226 (7%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 8   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 64
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 65  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 122
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  ++ + R        + A
Sbjct: 123 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA 179
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GR--HPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR  +PG      NP+++
Sbjct: 180 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG----MTNPEVI 221

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 116/224 (51%), Gaps = 12/224 (5%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 17  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 73
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 74  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 131
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  +  + R        + A
Sbjct: 132 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 188
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR P   ++  NP+++
Sbjct: 189 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI 230

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 116/224 (51%), Gaps = 12/224 (5%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 12  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 68
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 69  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 126
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  +  + R        + A
Sbjct: 127 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 183
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR P   ++  NP+++
Sbjct: 184 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI 225

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 30/275 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKK---LHHSETELAFLESFQT---EAH 139
           +A  + + +  IG GG+G V++ +L   K V   K   L  SE E   +E FQ    E  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           ++S + H NIVKLYG   +   M  + +++  G L+  L   D+A  + W+ ++ ++  +
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDI 131
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLE-----AFVADFGVARL-LHSDSSNRTVV 253
           A  + Y+     P IVHRD+ S NI L S  E     A VADF +++  +HS S     +
Sbjct: 132 ALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSG----L 186
Query: 254 AGTHGYIAPEL--AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ 311
            G   ++APE   A     TEK D YSF ++   +L G  P D  S    KI  I+++ +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--KIKFINMIRE 244
Query: 312 RVPSPIDDQTVIQDI-ILVSKIVFACLRSKPTSRP 345
               P    T+ +D    +  ++  C    P  RP
Sbjct: 245 EGLRP----TIPEDCPPRLRNVIELCWSGDPKKRP 275

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 113/213 (53%), Gaps = 17/213 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G +G V+     +  KVA+K L      + AFLE    EA+L+  ++H  +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTLQHDKLVRLYAV 76
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
              ++ +++I +YM +GSL   L++ DE  ++   K ++    +A  ++Y+      + +
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 132
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPELAYTMVLTEKC 274
           HRD+ + N+L++  L   +ADFG+AR++  +  + R        + APE       T K 
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 275 DVYSFGVVALEVLM-------GRHPGDLLSSVN 300
           DV+SFG++  E++        GR   D++++++
Sbjct: 193 DVWSFGILLYEIVTYGKIPYPGRTNADVMTALS 225

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 131/258 (50%), Gaps = 22/258 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 157 LHKKCMFLIYKYMRRGSLFC---ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
             K  + ++ ++    SL+    I+    E I+L     ++I +  A  + YLH     S
Sbjct: 74  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAK---S 124
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVA--RLLHSDSSNRTVVAGTHGYIAPELAYTM--- 268
           I+HRD+ SNNI L+  L   + DFG+A  +   S S     ++G+  ++APE+       
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 269 VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
             + + DVY+FG+V  E++ G+ P    S++N +  +I ++ +   SP   +        
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 329 VSKIVFACLRSKPTSRPM 346
           + +++  CL+ K   RP+
Sbjct: 242 MKRLMAECLKKKRDERPL 259

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 117/226 (51%), Gaps = 16/226 (7%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 63
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 64  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 121
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  ++ + R        + A
Sbjct: 122 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA 178
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GR--HPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR  +PG      NP+++
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG----MTNPEVI 220

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 130/254 (51%), Gaps = 16/254 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
             K  + ++ ++    SL+  L   +   + +  K ++I +  A  + YLH     SI+H
Sbjct: 90  T-KPQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIH 143
Query: 217 RDISSNNILLNSKLEAFVADFGVA--RLLHSDSSNRTVVAGTHGYIAPE---LAYTMVLT 271
           RD+ SNNI L+      + DFG+A  +   S S     ++G+  ++APE   +  +   +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 272 EKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK 331
            + DVY+FG+V  E++ G+ P    S++N +  +I+++ +   SP   +        + +
Sbjct: 204 FQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260
Query: 332 IVFACLRSKPTSRP 345
           ++  CL+ K   RP
Sbjct: 261 LMAECLKKKRDERP 274

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 122/264 (46%), Gaps = 17/264 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G VY+      K+V   K+   E     +E  Q E  +LSQ     I + +G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L    +++I +Y+  GS   +L+       L+ T    I++ +   L YLH +     +H
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE---RKIH 139
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDV 276
           RDI + N+LL+ + +  +ADFGVA  L      R    GT  ++APE+        K D+
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADI 199
Query: 277 YSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFAC 336
           +S G+ A+E+  G  P    S ++P  +L  L+ +  P  ++ Q          + V AC
Sbjct: 200 WSLGITAIELAKGEPPN---SDLHPMRVLF-LIPKNSPPTLEGQHSKP----FKEFVEAC 251
Query: 337 LRSKPTSRPMQR--VSQEFLVRKT 358
           L   P  RP  +  +  +F+ R T
Sbjct: 252 LNKDPRFRPTAKELLKHKFITRYT 275

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 130/254 (51%), Gaps = 16/254 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
             K  + ++ ++    SL+  L   +   + +  K ++I +  A  + YLH     SI+H
Sbjct: 78  T-KPQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIH 131
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLH--SDSSNRTVVAGTHGYIAPE---LAYTMVLT 271
           RD+ SNNI L+      + DFG+A +    S S     ++G+  ++APE   +  +   +
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 272 EKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK 331
            + DVY+FG+V  E++ G+ P    S++N +  +I+++ +   SP   +        + +
Sbjct: 192 FQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 248
Query: 332 IVFACLRSKPTSRP 345
           ++  CL+ K   RP
Sbjct: 249 LMAECLKKKRDERP 262

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 131/258 (50%), Gaps = 22/258 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 157 LHKKCMFLIYKYMRRGSLFC---ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
             K  + ++ ++    SL+    I+    E I+L     ++I +  A  + YLH     S
Sbjct: 102 T-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAK---S 152
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVA--RLLHSDSSNRTVVAGTHGYIAPELAYTM--- 268
           I+HRD+ SNNI L+  L   + DFG+A  +   S S     ++G+  ++APE+       
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 269 VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
             + + DVY+FG+V  E++ G+ P    S++N +  +I ++ +   SP   +        
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 269
Query: 329 VSKIVFACLRSKPTSRPM 346
           + +++  CL+ K   RP+
Sbjct: 270 MKRLMAECLKKKRDERPL 287

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 131/258 (50%), Gaps = 22/258 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 157 LHKKCMFLIYKYMRRGSLFC---ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
             K  + ++ ++    SL+    I+    E I+L     ++I +  A  + YLH     S
Sbjct: 102 T-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAK---S 152
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLH--SDSSNRTVVAGTHGYIAPELAYTM--- 268
           I+HRD+ SNNI L+  L   + DFG+A +    S S     ++G+  ++APE+       
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 269 VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
             + + DVY+FG+V  E++ G+ P    S++N +  +I ++ +   SP   +        
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 269
Query: 329 VSKIVFACLRSKPTSRPM 346
           + +++  CL+ K   RP+
Sbjct: 270 MKRLMAECLKKKRDERPL 287

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 131/258 (50%), Gaps = 22/258 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 157 LHKKCMFLIYKYMRRGSLFC---ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
             K  + ++ ++    SL+    I+    E I+L     ++I +  A  + YLH     S
Sbjct: 101 T-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAK---S 151
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARL--LHSDSSNRTVVAGTHGYIAPELAYTM--- 268
           I+HRD+ SNNI L+  L   + DFG+A +    S S     ++G+  ++APE+       
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 269 VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
             + + DVY+FG+V  E++ G+ P    S++N +  +I ++ +   SP   +        
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 268
Query: 329 VSKIVFACLRSKPTSRPM 346
           + +++  CL+ K   RP+
Sbjct: 269 MKRLMAECLKKKRDERPL 286

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 131/258 (50%), Gaps = 22/258 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 157 LHKKCMFLIYKYMRRGSLFC---ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
             K  + ++ ++    SL+    I+    E I+L     ++I +  A  + YLH     S
Sbjct: 94  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAK---S 144
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVA--RLLHSDSSNRTVVAGTHGYIAPELAYTM--- 268
           I+HRD+ SNNI L+  L   + DFG+A  +   S S     ++G+  ++APE+       
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 269 VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
             + + DVY+FG+V  E++ G+ P    S++N +  +I ++ +   SP   +        
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 261
Query: 329 VSKIVFACLRSKPTSRPM 346
           + +++  CL+ K   RP+
Sbjct: 262 MKRLMAECLKKKRDERPL 279

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 116/226 (51%), Gaps = 16/226 (7%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 63
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 64  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 121
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  +  + R        + A
Sbjct: 122 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GR--HPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR  +PG      NP+++
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG----MTNPEVI 220

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 131/258 (50%), Gaps = 22/258 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 157 LHKKCMFLIYKYMRRGSLFC---ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
             K  + ++ ++    SL+    I+    E I+L     ++I +  A  + YLH     S
Sbjct: 79  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAK---S 129
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARL--LHSDSSNRTVVAGTHGYIAPELAYTM--- 268
           I+HRD+ SNNI L+  L   + DFG+A +    S S     ++G+  ++APE+       
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 269 VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
             + + DVY+FG+V  E++ G+ P    S++N +  +I ++ +   SP   +        
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 246
Query: 329 VSKIVFACLRSKPTSRPM 346
           + +++  CL+ K   RP+
Sbjct: 247 MKRLMAECLKKKRDERPL 264

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 131/258 (50%), Gaps = 22/258 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 157 LHKKCMFLIYKYMRRGSLFC---ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
             K  + ++ ++    SL+    I+    E I+L     ++I +  A  + YLH     S
Sbjct: 76  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAK---S 126
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARL--LHSDSSNRTVVAGTHGYIAPELAYTM--- 268
           I+HRD+ SNNI L+  L   + DFG+A +    S S     ++G+  ++APE+       
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 269 VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
             + + DVY+FG+V  E++ G+ P    S++N +  +I ++ +   SP   +        
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 243
Query: 329 VSKIVFACLRSKPTSRPM 346
           + +++  CL+ K   RP+
Sbjct: 244 MKRLMAECLKKKRDERPL 261

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 131/258 (50%), Gaps = 22/258 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 157 LHKKCMFLIYKYMRRGSLFC---ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
             K  + ++ ++    SL+    I+    E I+L     ++I +  A  + YLH     S
Sbjct: 74  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAK---S 124
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARL--LHSDSSNRTVVAGTHGYIAPELAYTM--- 268
           I+HRD+ SNNI L+  L   + DFG+A +    S S     ++G+  ++APE+       
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 269 VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
             + + DVY+FG+V  E++ G+ P    S++N +  +I ++ +   SP   +        
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 329 VSKIVFACLRSKPTSRPM 346
           + +++  CL+ K   RP+
Sbjct: 242 MKRLMAECLKKKRDERPL 259

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 131/258 (50%), Gaps = 22/258 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 157 LHKKCMFLIYKYMRRGSLFC---ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
             K  + ++ ++    SL+    I+    E I+L     ++I +  A  + YLH     S
Sbjct: 79  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAK---S 129
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARL--LHSDSSNRTVVAGTHGYIAPELAYTM--- 268
           I+HRD+ SNNI L+  L   + DFG+A +    S S     ++G+  ++APE+       
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 269 VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
             + + DVY+FG+V  E++ G+ P    S++N +  +I ++ +   SP   +        
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 246
Query: 329 VSKIVFACLRSKPTSRPM 346
           + +++  CL+ K   RP+
Sbjct: 247 MKRLMAECLKKKRDERPL 264

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 117/250 (46%), Gaps = 28/250 (11%)
Query: 93  IKYCIGTGGYGSV--YRAQLPSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG+G  G V   R ++P  + V  A+K L    TE      F +EA ++ Q  H N
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPN 111
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I++L G     +   ++ +YM  GSL   LR  D    +   + V +++ +   + YL  
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL-S 168
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELA 265
           D     VHRD+++ N+L++S L   V+DFG++R+L  D        G      + APE  
Sbjct: 169 DL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAI 226
Query: 266 YTMVLTEKCDVYSFGVVALEVLM-GRHP------GDLLSSVNPKIMLIDLLDQRVPSPID 318
                +   DV+SFGVV  EVL  G  P       D++SSV            R+P+P+ 
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY--------RLPAPMG 278
Query: 319 DQTVIQDIIL 328
               +  ++L
Sbjct: 279 CPHALHQLML 288

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 6/205 (2%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            ED+++ Y IGTG YG   + +  S GK +  K+L +     A  +   +E +LL +++H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 147 RNIVKLYGFCLHKK--CMFLIYKYMRRGSLFCIL-RNDDEAIRLDWTKRVNIVKSMAHAL 203
            NIV+ Y   + +    ++++ +Y   G L  ++ +   E   LD    + ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 204 SYLH--CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
              H   D   +++HRD+   N+ L+ K    + DFG+AR+L+ D        GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184
Query: 262 PELAYTMVLTEKCDVYSFGVVALEV 286
           PE    M   EK D++S G +  E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 134/276 (48%), Gaps = 29/276 (10%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +D++++  IG+G    V  A   P  +KVA+K+++  + + + ++    E   +SQ  H 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQCHHP 73
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-----DDEAIRLDWTKRVNIVKSMAHA 202
           NIV  Y   + K  ++L+ K +  GS+  I+++     + ++  LD +    I++ +   
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-----SSNRTVVAGTH 257
           L YLH +     +HRD+ + NILL       +ADFGV+  L +      +  R    GT 
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 258 GYIAPELAYTMVLTE-KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++APE+   +   + K D++SFG+ A+E+  G  P        P  +L+  L    PS 
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP---YHKYPPMKVLMLTLQNDPPSL 247
Query: 317 IDDQTVIQDIILVS-------KIVFACLRSKPTSRP 345
              +T +QD  ++        K++  CL+  P  RP
Sbjct: 248 ---ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 134/276 (48%), Gaps = 29/276 (10%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +D++++  IG+G    V  A   P  +KVA+K+++  + + + ++    E   +SQ  H 
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQCHHP 68
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-----DDEAIRLDWTKRVNIVKSMAHA 202
           NIV  Y   + K  ++L+ K +  GS+  I+++     + ++  LD +    I++ +   
Sbjct: 69  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-----SSNRTVVAGTH 257
           L YLH +     +HRD+ + NILL       +ADFGV+  L +      +  R    GT 
Sbjct: 129 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 258 GYIAPELAYTMVLTE-KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++APE+   +   + K D++SFG+ A+E+  G  P        P  +L+  L    PS 
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP---YHKYPPMKVLMLTLQNDPPSL 242
Query: 317 IDDQTVIQDIILVS-------KIVFACLRSKPTSRP 345
              +T +QD  ++        K++  CL+  P  RP
Sbjct: 243 ---ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 275

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 116/226 (51%), Gaps = 16/226 (7%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 2   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 58
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 59  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 116
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIA 261
           ++++      + +HRD+ + NIL++  L   +ADFG+ARL+  +  + R        + A
Sbjct: 117 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 173
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GR--HPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR  +PG      NP+++
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG----MTNPEVI 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 134/261 (51%), Gaps = 26/261 (9%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +  E   ++  +G G +G V+ A      KVA+K +      +   E+F  EA+++  ++
Sbjct: 179 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQ 235
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H  +VKL+   + K+ +++I ++M +GSL   L++D E  +    K ++    +A  +++
Sbjct: 236 HDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAF 293
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           +      + +HRD+ + NIL+++ L   +ADFG+AR+       +  +  T    APE  
Sbjct: 294 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARV-----GAKFPIKWT----APEAI 341
Query: 266 YTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
                T K DV+SFG++ +E++  GR P   +S  NP+++       R+P P +    + 
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRMPRPENCPEELY 399
Query: 325 DIILVSKIVFACLRSKPTSRP 345
           +I++       C +++P  RP
Sbjct: 400 NIMM------RCWKNRPEERP 414

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 130/254 (51%), Gaps = 16/254 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
              + + ++ ++    SL+  L   +   + +  K ++I +  A  + YLH     SI+H
Sbjct: 90  TAPQ-LAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIH 143
Query: 217 RDISSNNILLNSKLEAFVADFGVA--RLLHSDSSNRTVVAGTHGYIAPE---LAYTMVLT 271
           RD+ SNNI L+      + DFG+A  +   S S     ++G+  ++APE   +  +   +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 272 EKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK 331
            + DVY+FG+V  E++ G+ P    S++N +  +I+++ +   SP   +        + +
Sbjct: 204 FQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260
Query: 332 IVFACLRSKPTSRP 345
           ++  CL+ K   RP
Sbjct: 261 LMAECLKKKRDERP 274

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 117/250 (46%), Gaps = 28/250 (11%)
Query: 93  IKYCIGTGGYGSV--YRAQLPSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           I+  IG+G  G V   R ++P  + V  A+K L    TE      F +EA ++ Q  H N
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPN 111
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I++L G     +   ++ +YM  GSL   LR  D    +   + V +++ +   + YL  
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL-S 168
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELA 265
           D     VHRD+++ N+L++S L   V+DFG++R+L  D        G      + APE  
Sbjct: 169 DL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 266 YTMVLTEKCDVYSFGVVALEVLM-GRHP------GDLLSSVNPKIMLIDLLDQRVPSPID 318
                +   DV+SFGVV  EVL  G  P       D++SSV            R+P+P+ 
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY--------RLPAPMG 278
Query: 319 DQTVIQDIIL 328
               +  ++L
Sbjct: 279 CPHALHQLML 288

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 112/210 (53%), Gaps = 12/210 (5%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G G  G V+        KVA+K L          ++F  EA+L+ Q++H+ +V+LY   
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA-V 76
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           + ++ +++I +YM  GSL   L+     I+L   K +++   +A  ++++      + +H
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGYIAPELAYTMVLTEKCD 275
           RD+ + NIL++  L   +ADFG+ARL+  ++ + R        + APE       T K D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 276 VYSFGVVALEVLM-GRHPGDLLSSVNPKIM 304
           V+SFG++  E++  GR P   ++  NP+++
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMT--NPEVI 220

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 131/258 (50%), Gaps = 22/258 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH NI+   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 157 LHKKCMFLIYKYMRRGSLFC---ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
              + + ++ ++    SL+    I+    E I+L     ++I +  A  + YLH     S
Sbjct: 74  TAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAK---S 124
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARL--LHSDSSNRTVVAGTHGYIAPELAYTM--- 268
           I+HRD+ SNNI L+  L   + DFG+A +    S S     ++G+  ++APE+       
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 269 VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIIL 328
             + + DVY+FG+V  E++ G+ P    S++N +  +I ++ +   SP   +        
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 329 VSKIVFACLRSKPTSRPM 346
           + +++  CL+ K   RP+
Sbjct: 242 MKRLMAECLKKKRDERPL 259

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 71
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 130
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 131 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPESL 185
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 186 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 238
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 239 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 272

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 141/298 (47%), Gaps = 36/298 (12%)
Query: 75  YDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLES 133
           + G   + +  +   D  +K+ +G G YG VY          VA+K L     E+   E 
Sbjct: 12  FQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EE 68
Query: 134 FQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV 193
           F  EA ++ +I+H N+V+L G C  +   ++I ++M  G+L   LR  +    ++    +
Sbjct: 69  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLL 127
Query: 194 NIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
            +   ++ A+ YL      + +HRD+++ N L+       VADFG++RL+  D+   T  
Sbjct: 128 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAH 182
Query: 254 AGTH---GYIAPE-LAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLI 306
           AG      + APE LAY    + K DV++FGV+  E+    M  +PG  LS V       
Sbjct: 183 AGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------Y 235
Query: 307 DLL--DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
           +LL  D R+  P      + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 236 ELLEKDYRMERPEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 284

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 72
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 131
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 132 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPESL 186
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 187 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 239
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 240 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 273

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 71
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 130
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 131 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPESL 185
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 186 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 238
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 239 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 272

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 116/224 (51%), Gaps = 12/224 (5%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E  V  E   +   +G G +G V+        KVA+K L          ++F  EA+L+ 
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 59
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q++H+ +V+LY   + ++ +++I +YM  GSL   L+     I+L   K +++   +A  
Sbjct: 60  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEG 117
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIA 261
           ++++      + +HR++ + NIL++  L   +ADFG+ARL+  +  + R        + A
Sbjct: 118 MAFIEER---NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 174
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM 304
           PE       T K DV+SFG++  E++  GR P   ++  NP+++
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI 216

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 114/240 (47%), Gaps = 33/240 (13%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQL----PSGKK--VALKKLHHSETELAFLESFQTEAH 139
           +   D  +K  +G G +G V+ A+     P+  K  VA+K L   +  LA  + FQ EA 
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREAE 69
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDEAIRLDWTKR----- 192
           LL+ ++H +IVK YG C     + ++++YM+ G L   LR    D  I +D   R     
Sbjct: 70  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 193 ------VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
                 ++I   +A  + YL        VHRD+++ N L+ + L   + DFG++R ++S 
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 247 SSNRTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVN 300
              R    G H      ++ PE       T + DV+SFGV+  E+   G+ P   LS+  
Sbjct: 187 DYYRV---GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 75
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 134
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPESL 189
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 190 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 242
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 243 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 276

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 75
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 134
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 189
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 190 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 242
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 243 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 276

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 70
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 129
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 130 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 184
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 185 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 237
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 238 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 271

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 113/213 (53%), Gaps = 17/213 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G +G V+     +  KVA+K L      + AFLE    EA+L+  ++H  +V+LY  
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTLQHDKLVRLYAV 75
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
              ++ +++I ++M +GSL   L++ DE  ++   K ++    +A  ++Y+      + +
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 131
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPELAYTMVLTEKC 274
           HRD+ + N+L++  L   +ADFG+AR++  +  + R        + APE       T K 
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 275 DVYSFGVVALEVLM-------GRHPGDLLSSVN 300
           +V+SFG++  E++        GR   D++S+++
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALS 224

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 75
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 134
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 189
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 190 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 242
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 243 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 276

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 75
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 134
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 189
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 190 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 242
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 243 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 276

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 74
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 133
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 134 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 188
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 189 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 241
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 242 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 275

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 138/287 (48%), Gaps = 44/287 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 70
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDE--AIRLDWTKRVNIVKSMAHALS 204
           +V+L G C  +   ++I ++M  G+L   LR  N  E  A+ L     + +   ++ A+ 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAME 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIA 261
           YL      + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + A
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 180
Query: 262 PE-LAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPS 315
           PE LAY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  
Sbjct: 181 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMER 233
Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
           P      + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 234 PEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 271

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 72
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 131
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 132 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 186
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 187 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 239
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 240 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 273

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 138/287 (48%), Gaps = 44/287 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 75
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDE--AIRLDWTKRVNIVKSMAHALS 204
           +V+L G C  +   ++I ++M  G+L   LR  N  E  A+ L     + +   ++ A+ 
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAME 130
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIA 261
           YL      + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + A
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 185
Query: 262 PE-LAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPS 315
           PE LAY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  
Sbjct: 186 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMER 238
Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
           P      + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 239 PEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 276

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 138/287 (48%), Gaps = 44/287 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 70
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDE--AIRLDWTKRVNIVKSMAHALS 204
           +V+L G C  +   ++I ++M  G+L   LR  N  E  A+ L     + +   ++ A+ 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAME 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIA 261
           YL      + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + A
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 180
Query: 262 PE-LAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPS 315
           PE LAY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  
Sbjct: 181 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMER 233
Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
           P      + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 234 PEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 271

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 72
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 131
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 132 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 186
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 187 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 239
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 240 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 273

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 138/287 (48%), Gaps = 44/287 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 70
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDE--AIRLDWTKRVNIVKSMAHALS 204
           +V+L G C  +   ++I ++M  G+L   LR  N  E  A+ L     + +   ++ A+ 
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAME 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIA 261
           YL      + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + A
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 180
Query: 262 PE-LAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPS 315
           PE LAY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  
Sbjct: 181 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMER 233
Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
           P      + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 234 PEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 271

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 129/268 (48%), Gaps = 36/268 (13%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 89
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDEAIRLDWTKRVNIVKSMAHALSYL 206
           +V+L G C  +   +++ +YM  G+L   LR  N +E   +     + +   ++ A+ YL
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAV---VLLYMATQISSAMEYL 146
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE 263
                 + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE
Sbjct: 147 EKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 201
Query: 264 -LAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPI 317
            LAY    + K DV++FGV+  E+    M  +PG  LS V       DLL++  R+  P 
Sbjct: 202 SLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YDLLEKGYRMEQPE 254
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRP 345
                + +++       AC +  P  RP
Sbjct: 255 GCPPKVYELMR------ACWKWSPADRP 276

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 138/287 (48%), Gaps = 44/287 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 70
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDE--AIRLDWTKRVNIVKSMAHALS 204
           +V+L G C  +   ++I ++M  G+L   LR  N  E  A+ L     + +   ++ A+ 
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAME 125
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIA 261
           YL      + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + A
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 180
Query: 262 PE-LAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPS 315
           PE LAY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  
Sbjct: 181 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMER 233
Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
           P      + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 234 PEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 271

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 32/266 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 70
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 129
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 130 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 184
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 185 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 237
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
              + +++       AC +  P+ RP
Sbjct: 238 PEKVYELMR------ACWQWNPSDRP 257

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 139/287 (48%), Gaps = 44/287 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 68
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDE--AIRLDWTKRVNIVKSMAHALS 204
           +V+L G C  +   ++I ++M  G+L   LR  N  E  A+ L     + +   ++ A+ 
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAME 123
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIA 261
           YL      + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + A
Sbjct: 124 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTA 178
Query: 262 PE-LAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPS 315
           PE LAY    + K DV++FGV+  E+    M  +PG     ++P   + +LL  D R+  
Sbjct: 179 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG-----IDPS-QVYELLEKDYRMER 231
Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
           P      + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 232 PEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 269

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 121/258 (46%), Gaps = 16/258 (6%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           EDF +   +G G +  VYRA+ + +G +VA+K +      +   ++  Q E  +  Q++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            +I++LY +      ++L+ +    G +   L+N  +    +  +  + +  +   + YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGMLYL 128
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      I+HRD++ +N+LL   +   +ADFG+A  L         + GT  YI+PE+A 
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
                 + DV+S G +   +L+GR P D   +V   +  + L D  +PS +         
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFD-TDTVKNTLNKVVLADYEMPSFLS-------- 236
Query: 327 ILVSKIVFACLRSKPTSR 344
           I    ++   LR  P  R
Sbjct: 237 IEAKDLIHQLLRRNPADR 254

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 114/238 (47%), Gaps = 30/238 (12%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ----LPSGKK--VALKKLHHSETELAFLESFQTEAH 139
           +   D  +K+ +G G +G V+ A+    LP   K  VA+K L   E   +  + FQ EA 
Sbjct: 15  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAE 72
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR------------L 187
           LL+ ++H++IV+ +G C   + + ++++YMR G L   LR+     +            L
Sbjct: 73  LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 132
Query: 188 DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
              + + +   +A  + YL        VHRD+++ N L+   L   + DFG++R ++S  
Sbjct: 133 GLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 189
Query: 248 ----SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVN 300
                 RT++     ++ PE       T + DV+SFGVV  E+   G+ P   LS+  
Sbjct: 190 YYRVGGRTMLPIR--WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 245

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 113/234 (48%), Gaps = 30/234 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQ----LPSGKK--VALKKLHHSETELAFLESFQTEAHLLSQ 143
           D  +K+ +G G +G V+ A+    LP   K  VA+K L   E   +  + FQ EA LL+ 
Sbjct: 42  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTM 99
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR------------LDWTK 191
           ++H++IV+ +G C   + + ++++YMR G L   LR+     +            L   +
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS---- 247
            + +   +A  + YL        VHRD+++ N L+   L   + DFG++R ++S      
Sbjct: 160 LLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 216
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVN 300
             RT++     ++ PE       T + DV+SFGVV  E+   G+ P   LS+  
Sbjct: 217 GGRTMLPIR--WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 139/287 (48%), Gaps = 44/287 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 68
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDE--AIRLDWTKRVNIVKSMAHALS 204
           +V+L G C  +   ++I ++M  G+L   LR  N  E  A+ L     + +   ++ A+ 
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAME 123
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIA 261
           YL      + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + A
Sbjct: 124 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF--TAHAGAKFPIKWTA 178
Query: 262 PE-LAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPS 315
           PE LAY    + K DV++FGV+  E+    M  +PG     ++P   + +LL  D R+  
Sbjct: 179 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG-----IDPS-QVYELLEKDYRMER 231
Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
           P      + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 232 PEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 269

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 114/238 (47%), Gaps = 30/238 (12%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ----LPSGKK--VALKKLHHSETELAFLESFQTEAH 139
           +   D  +K+ +G G +G V+ A+    LP   K  VA+K L   E   +  + FQ EA 
Sbjct: 9   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAE 66
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR------------L 187
           LL+ ++H++IV+ +G C   + + ++++YMR G L   LR+     +            L
Sbjct: 67  LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 126
Query: 188 DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
              + + +   +A  + YL        VHRD+++ N L+   L   + DFG++R ++S  
Sbjct: 127 GLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 183
Query: 248 ----SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVN 300
                 RT++     ++ PE       T + DV+SFGVV  E+   G+ P   LS+  
Sbjct: 184 YYRVGGRTMLPIR--WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 239

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 138/287 (48%), Gaps = 44/287 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 277
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDE--AIRLDWTKRVNIVKSMAHALS 204
           +V+L G C  +   ++I ++M  G+L   LR  N  E  A+ L     + +   ++ A+ 
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAME 332
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIA 261
           YL      + +HR++++ N L+       VADFG++RL+  D+   T  AG      + A
Sbjct: 333 YLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 387
Query: 262 PE-LAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPS 315
           PE LAY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  
Sbjct: 388 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMER 440
Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
           P      + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 441 PEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 478

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 139/287 (48%), Gaps = 44/287 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G +G VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 68
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILR--NDDE--AIRLDWTKRVNIVKSMAHALS 204
           +V+L G C  +   ++I ++M  G+L   LR  N  E  A+ L     + +   ++ A+ 
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAME 123
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIA 261
           YL      + +HRD+++ N L+       VADFG++RL+  D+   T  AG      + A
Sbjct: 124 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTA 178
Query: 262 PE-LAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPS 315
           PE LAY    + K DV++FGV+  E+    M  +PG     ++P   + +LL  D R+  
Sbjct: 179 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG-----IDPS-QVYELLEKDYRMER 231
Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
           P      + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 232 PEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 269

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H N
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 316
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+L G C  +   ++I ++M  G+L   LR  +    ++    + +   ++ A+ YL  
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 375
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
               + +HR++++ N L+       VADFG++RL+  D+   T  AG      + APE L
Sbjct: 376 K---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 430
Query: 265 AYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLL--DQRVPSPIDD 319
           AY    + K DV++FGV+  E+    M  +PG  LS V       +LL  D R+  P   
Sbjct: 431 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGC 483
Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ 361
              + +++       AC +  P+ RP    + Q F   +T++Q
Sbjct: 484 PEKVYELMR------ACWQWNPSDRPSFAEIHQAF---ETMFQ 517

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           D  +  C+G G YG V+R     G+ VA+K     + +  F E   TE +    +RH NI
Sbjct: 9   DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENI 64
Query: 150 VKLYGFCLHKK----CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           +      +  +     ++LI  Y   GSL+  L    +   LD    + IV S+A  L++
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAH 120
Query: 206 LHCDCI-----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-----G 255
           LH +       P+I HRD+ S NIL+    +  +AD G+A ++HS S+N+  V      G
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVG 179
Query: 256 THGYIAPELAYTMVLTE------KCDVYSFGVVALEV 286
           T  Y+APE+    +  +      + D+++FG+V  EV
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 126/255 (49%), Gaps = 16/255 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G+VY+ +      VA+K L   +      ++F+ E  +L + RH NI+   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY- 100
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           + K  + ++ ++    SL+  L   +   ++   + ++I +  A  + YLH     +I+H
Sbjct: 101 MTKDNLAIVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLHAK---NIIH 155
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV--AGTHGYIAPE---LAYTMVLT 271
           RD+ SNNI L+  L   + DFG+A +    S ++ V    G+  ++APE   +      +
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 272 EKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK 331
            + DVYS+G+V  E++ G  P    S +N +  +I ++ +   SP   +        + +
Sbjct: 216 FQSDVYSYGIVLYELMTGELP---YSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKR 272
Query: 332 IVFACLRSKPTSRPM 346
           +V  C++     RP+
Sbjct: 273 LVADCVKKVKEERPL 287

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 96  CIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           C+G G YG V+R     G+ VA+K     + +  F E   TE +    +RH NI+     
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENILGFIAS 70
Query: 156 CLHKK----CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            +  +     ++LI  Y   GSL+  L    +   LD    + IV S+A  L++LH +  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 212 -----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-----GTHGYIA 261
                P+I HRD+ S NIL+    +  +AD G+A ++HS S+N+  V      GT  Y+A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 262 PELAYTMVLTE------KCDVYSFGVVALEV 286
           PE+    +  +      + D+++FG+V  EV
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 96  CIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           C+G G YG V+R     G+ VA+K     + +  F E   TE +    +RH NI+     
Sbjct: 44  CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENILGFIAS 99
Query: 156 CLHKK----CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            +  +     ++LI  Y   GSL+  L    +   LD    + IV S+A  L++LH +  
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 212 -----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-----GTHGYIA 261
                P+I HRD+ S NIL+    +  +AD G+A ++HS S+N+  V      GT  Y+A
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 262 PELAYTMVLTE------KCDVYSFGVVALEV 286
           PE+    +  +      + D+++FG+V  EV
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 97  IGTGGYGSVYRAQLPSG---------KKVALKKLHHSETEL---AFLESFQTEAHLLSQI 144
           +G+G YG V   +  +G         KK    K  +S+       F E    E  LL  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NI+KL+     KK  +L+ ++   G LF  + N     + D     NI+K +   + 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGIC 160
Query: 205 YLHCDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           YLH     +IVHRDI   NILL   NS L   + DFG++     D   R  + GT  YIA
Sbjct: 161 YLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-GTAYYIA 216
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+       EKCDV+S GV+   +L G  P
Sbjct: 217 PEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 120/256 (46%), Gaps = 20/256 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +GTG +G V   +      VA+K +   S +E  F+E    EA ++  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           C  ++ +F+I +YM  G L   LR  +   R    + + + K +  A+ YL        +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 142
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-GYIAPELAYTMVLTEKC 274
           HRD+++ N L+N +    V+DFG++R +  D    +V +     +  PE+      + K 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 275 DVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIV 333
           D+++FGV+  E+  +G+ P +  ++      +   L    P    ++        V  I+
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--------VYTIM 254
Query: 334 FACLRSKPTSRPMQRV 349
           ++C   K   RP  ++
Sbjct: 255 YSCWHEKADERPTFKI 270

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 79
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK 137
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 138 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 195 ESKFSVASDVWSFGVVLYELF 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 78
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 133
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 194 ESKFSVASDVWSFGVVLYELF 214

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 126/254 (49%), Gaps = 24/254 (9%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G+G +G V   +      VA+K +   E  ++  E FQ EA  + ++ H  +VK YG C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMI--KEGSMSEDEFFQ-EAQTMMKLSHPKLVKFYGVC 72
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
             +  ++++ +Y+  G L   LR+  +   L+ ++ + +   +   +++L        +H
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVLTEK 273
           RD+++ N L++  L   V+DFG+ R +  D    +V  GT     + APE+ +    + K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVKWSAPEVFHYFKYSSK 185
Query: 274 CDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP-IDDQTVIQDIILVSK 331
            DV++FG++  EV  +G+ P DL +  N +++L      R+  P +   T+ Q       
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYT--NSEVVLKVSQGHRLYRPHLASDTIYQ------- 236
Query: 332 IVFACLRSKPTSRP 345
           I+++C    P  RP
Sbjct: 237 IMYSCWHELPEKRP 250

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 73
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 128
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 189 ESKFSVASDVWSFGVVLYELF 209

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 74
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 129
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 190 ESKFSVASDVWSFGVVLYELF 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 75
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 130
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 106
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 161
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 222 ESKFSVASDVWSFGVVLYELF 242

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 80
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 135
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 196 ESKFSVASDVWSFGVVLYELF 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 75
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 130
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 120/256 (46%), Gaps = 20/256 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +GTG +G V   +      VA+K +   S +E  F+E    EA ++  + H  +V+LYG 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 71
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           C  ++ +F+I +YM  G L   LR  +   R    + + + K +  A+ YL        +
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 126
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-GYIAPELAYTMVLTEKC 274
           HRD+++ N L+N +    V+DFG++R +  D    +V +     +  PE+      + K 
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 275 DVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIV 333
           D+++FGV+  E+  +G+ P +  ++      +   L    P    ++        V  I+
Sbjct: 187 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--------VYTIM 238
Query: 334 FACLRSKPTSRPMQRV 349
           ++C   K   RP  ++
Sbjct: 239 YSCWHEKADERPTFKI 254

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 81
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 136
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 197 ESKFSVASDVWSFGVVLYELF 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 82
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 137
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 198 ESKFSVASDVWSFGVVLYELF 218

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 120/256 (46%), Gaps = 20/256 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +GTG +G V   +      VA+K +   S +E  F+E    EA ++  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           C  ++ +F+I +YM  G L   LR  +   R    + + + K +  A+ YL        +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 142
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-GYIAPELAYTMVLTEKC 274
           HRD+++ N L+N +    V+DFG++R +  D    +V +     +  PE+      + K 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 275 DVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIV 333
           D+++FGV+  E+  +G+ P +  ++      +   L    P    ++        V  I+
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--------VYTIM 254
Query: 334 FACLRSKPTSRPMQRV 349
           ++C   K   RP  ++
Sbjct: 255 YSCWHEKADERPTFKI 270

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 120/256 (46%), Gaps = 20/256 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +GTG +G V   +      VA+K +   S +E  F+E    EA ++  + H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 67
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           C  ++ +F+I +YM  G L   LR  +   R    + + + K +  A+ YL        +
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-GYIAPELAYTMVLTEKC 274
           HRD+++ N L+N +    V+DFG++R +  D    +V +     +  PE+      + K 
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 275 DVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIV 333
           D+++FGV+  E+  +G+ P +  ++      +   L    P    ++        V  I+
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--------VYTIM 234
Query: 334 FACLRSKPTSRPMQRV 349
           ++C   K   RP  ++
Sbjct: 235 YSCWHEKADERPTFKI 250

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G V       G KVA+K + +  T  AFL     EA +++Q+RH N+V+L G  
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFL----AEASVMTQLRHSNLVQLLGVI 74
Query: 157 LHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           + +K  ++++ +YM +GSL   LR+   ++ L     +     +  A+ YL  +   + V
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NFV 130
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCD 275
           HRD+++ N+L++    A V+DFG+ +     SS +        + APE       + K D
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREAAFSTKSD 187
Query: 276 VYSFGVVALEVL-MGRHP 292
           V+SFG++  E+   GR P
Sbjct: 188 VWSFGILLWEIYSFGRVP 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 120/256 (46%), Gaps = 20/256 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +GTG +G V   +      VA+K +   S +E  F+E    EA ++  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           C  ++ +F+I +YM  G L   LR  +   R    + + + K +  A+ YL        +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 127
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-GYIAPELAYTMVLTEKC 274
           HRD+++ N L+N +    V+DFG++R +  D    +V +     +  PE+      + K 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 275 DVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIV 333
           D+++FGV+  E+  +G+ P +  ++      +   L    P    ++        V  I+
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--------VYTIM 239
Query: 334 FACLRSKPTSRPMQRV 349
           ++C   K   RP  ++
Sbjct: 240 YSCWHEKADERPTFKI 255

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 93
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 148
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 209 ESKFSVASDVWSFGVVLYELF 229

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 93
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 148
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 209 ESKFSVASDVWSFGVVLYELF 229

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 120/256 (46%), Gaps = 20/256 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +GTG +G V   +      VA+K +   S +E  F+E    EA ++  + H  +V+LYG 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 78
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           C  ++ +F+I +YM  G L   LR  +   R    + + + K +  A+ YL        +
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 133
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-GYIAPELAYTMVLTEKC 274
           HRD+++ N L+N +    V+DFG++R +  D    +V +     +  PE+      + K 
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 275 DVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIV 333
           D+++FGV+  E+  +G+ P +  ++      +   L    P    ++        V  I+
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--------VYTIM 245
Query: 334 FACLRSKPTSRPMQRV 349
           ++C   K   RP  ++
Sbjct: 246 YSCWHEKADERPTFKI 261

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 30/228 (13%)
Query: 93  IKYCIGTGGYGSVYRAQL----PSGKK--VALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           +K  +G G +G V+ A+     P   K  VA+K L  +       + F  EA LL+ ++H
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQH 74
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR----------NDDEAIRLDWTKRVNIV 196
            +IVK YG C+    + ++++YM+ G L   LR            +    L  ++ ++I 
Sbjct: 75  EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +A  + YL        VHRD+++ N L+   L   + DFG++R ++S    R    G 
Sbjct: 135 QQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV---GG 188
Query: 257 HG-----YIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSS 298
           H      ++ PE       T + DV+S GVV  E+   G+ P   LS+
Sbjct: 189 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 236

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 14/213 (6%)
Query: 85  IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAH 139
           IV+  D   KY     IG G  G+VY A  + +G++VA+++++  +      E    E  
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEIL 69
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           ++ + ++ NIV      L    ++++ +Y+  GSL  ++        +D  +   + +  
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 125
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
             AL +LH +    ++HRDI S+NILL       + DFG    +  + S R+ + GT  +
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +APE+        K D++S G++A+E++ G  P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 131/274 (47%), Gaps = 44/274 (16%)
Query: 97  IGTGGYGSVYRA-QLPSGK-----KVALKKLH---HSETELAFLESFQTEAHLLSQIRHR 147
           +G G +G V  A     GK     KVA+K L    H++ + A +   +  +HL    +H 
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL---GQHE 102
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI-------RLDWTKRVNIVKSMA 200
           NIV L G C H   + +I +Y   G L   LR   EA         L+    ++    +A
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 162
Query: 201 HALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
             +++L   +CI    HRD+++ N+LL +   A + DFG+AR + +DS+   +V G    
Sbjct: 163 QGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKGNARL 216
Query: 258 --GYIAPELAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDL-LDQ 311
              ++APE  +  V T + DV+S+G++  E+    +  +PG L++S   K++     + Q
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 276
Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
              +P +  +++Q          AC   +PT RP
Sbjct: 277 PAFAPKNIYSIMQ----------ACWALEPTHRP 300

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 78
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+    A R+D  K +     +   + YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQA--HAERIDHIKLLQYTSQICKGMEYL--- 133
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 194 ESKFSVASDVWSFGVVLYELF 214

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 131/274 (47%), Gaps = 44/274 (16%)
Query: 97  IGTGGYGSVYRA-QLPSGK-----KVALKKLH---HSETELAFLESFQTEAHLLSQIRHR 147
           +G G +G V  A     GK     KVA+K L    H++ + A +   +  +HL    +H 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL---GQHE 110
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR-------LDWTKRVNIVKSMA 200
           NIV L G C H   + +I +Y   G L   LR   EA         L+    ++    +A
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 170
Query: 201 HALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
             +++L   +CI    HRD+++ N+LL +   A + DFG+AR + +DS+   +V G    
Sbjct: 171 QGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKGNARL 224
Query: 258 --GYIAPELAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDL-LDQ 311
              ++APE  +  V T + DV+S+G++  E+    +  +PG L++S   K++     + Q
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 284
Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
              +P +  +++Q          AC   +PT RP
Sbjct: 285 PAFAPKNIYSIMQ----------ACWALEPTHRP 308

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 14/213 (6%)
Query: 85  IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAH 139
           IV+  D   KY     IG G  G+VY A  + +G++VA+++++  +      E    E  
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEIL 69
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           ++ + ++ NIV      L    ++++ +Y+  GSL  ++        +D  +   + +  
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 125
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
             AL +LH +    ++HRDI S+NILL       + DFG    +  + S R+ + GT  +
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 182
Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +APE+        K D++S G++A+E++ G  P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G V       G KVA+K + +  T  AFL     EA +++Q+RH N+V+L G  
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFL----AEASVMTQLRHSNLVQLLGVI 255
Query: 157 LHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           + +K  ++++ +YM +GSL   LR+   ++ L     +     +  A+ YL  +   + V
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NFV 311
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCD 275
           HRD+++ N+L++    A V+DFG+ +     SS +        + APE       + K D
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 276 VYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLL 309
           V+SFG++  E+   GR P        P+I L D++
Sbjct: 369 VWSFGILLWEIYSFGRVP-------YPRIPLKDVV 396

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 14/213 (6%)
Query: 85  IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAH 139
           IV+  D   KY     IG G  G+VY A  + +G++VA+++++  +      E    E  
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEIL 70
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           ++ + ++ NIV      L    ++++ +Y+  GSL  ++        +D  +   + +  
Sbjct: 71  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 126
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
             AL +LH +    ++HRDI S+NILL       + DFG    +  + S R+ + GT  +
Sbjct: 127 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 183
Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +APE+        K D++S G++A+E++ G  P
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G V       G KVA+K + +  T  AFL     EA +++Q+RH N+V+L G  
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFL----AEASVMTQLRHSNLVQLLGVI 68
Query: 157 LHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           + +K  ++++ +YM +GSL   LR+   ++ L     +     +  A+ YL  +   + V
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NFV 124
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCD 275
           HRD+++ N+L++    A V+DFG+ +     SS +        + APE       + K D
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 276 VYSFGVVALEVL-MGRHP 292
           V+SFG++  E+   GR P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHS-ETELAFLESFQTEAHLLSQI 144
           + +DF I   +GTG +G V+  +   +G+  A+K L       L  +E    E  +LS +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H  I++++G     + +F+I  Y+  G LF +LR   ++ R            +  AL 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALE 120
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           YLH      I++RD+   NILL+      + DFG A+ +   +     + GT  YIAPE+
Sbjct: 121 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YXLCGTPDYIAPEV 174
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             T    +  D +SFG++  E+L G  P
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G +G V       G KVA+K + +  T  AFL     EA +++Q+RH N+V+L G  
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFL----AEASVMTQLRHSNLVQLLGVI 83
Query: 157 LHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           + +K  ++++ +YM +GSL   LR+   ++ L     +     +  A+ YL  +   + V
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NFV 139
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCD 275
           HRD+++ N+L++    A V+DFG+ +     SS +        + APE       + K D
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 276 VYSFGVVALEVL-MGRHP 292
           V+SFG++  E+   GR P
Sbjct: 197 VWSFGILLWEIYSFGRVP 214

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 78
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +++  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 133
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 194 ESKFSVASDVWSFGVVLYELF 214

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 44/276 (15%)
Query: 97  IGTGGYGSVYRA-QLPSGK-----KVALKKLH---HSETELAFLESFQTEAHLLSQIRHR 147
           +G G +G V  A     GK     KVA+K L    H++ + A +   +  +HL    +H 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG---QHE 110
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           NIV L G C H   + +I +Y   G L   LR     +  D      I  S A     LH
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD--PAFAIANSTASTRDLLH 168
Query: 208 CD----------CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
                          + +HRD+++ N+LL +   A + DFG+AR + +DS+   +V G  
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKGNA 226
Query: 258 ----GYIAPELAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDL-L 309
                ++APE  +  V T + DV+S+G++  E+    +  +PG L++S   K++     +
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 310 DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            Q   +P +  +++Q          AC   +PT RP
Sbjct: 287 AQPAFAPKNIYSIMQ----------ACWALEPTHRP 312

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 14/213 (6%)
Query: 85  IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAH 139
           IV+  D   KY     IG G  G+VY A  + +G++VA+++++  +      E    E  
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEIL 69
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           ++ + ++ NIV      L    ++++ +Y+  GSL  ++        +D  +   + +  
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 125
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
             AL +LH +    ++HRDI S+NILL       + DFG    +  + S R+ + GT  +
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYW 182
Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +APE+        K D++S G++A+E++ G  P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G  G V  A +  SG++VA+K +        EL F      E  ++   +H N+V++
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQHFNVVEM 107
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y   L  + ++++ ++++ G+L  I+      +RL+  +   + +++  AL+YLH     
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ--- 160
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI S++ILL       ++DFG    +  D   R  + GT  ++APE+    +   
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYAT 220
Query: 273 KCDVYSFGVVALEVLMGRHP 292
           + D++S G++ +E++ G  P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPP 240

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           DF+    +G G +G V +A+     +  A+KK+ H+E +L+   +  +E  LL+ + H+ 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNHQY 63
Query: 149 IVKLYGFCLH-------------KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI 195
           +V+ Y   L              K  +F+  +Y   G+L+ ++ +++   + D   R  +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR--L 121
Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH----------- 244
            + +  ALSY+H      I+HRD+   NI ++      + DFG+A+ +H           
Sbjct: 122 FRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 245 ---SDSSNRTVVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN 300
                S N T   GT  Y+A E L  T    EK D+YS G++  E++     G    ++ 
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNIL 238
Query: 301 PKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQR 348
            K+  + +     P   DD  +  +     KI+   +   P  RP  R
Sbjct: 239 KKLRSVSI---EFPPDFDDNKMKVE----KKIIRLLIDHDPNKRPGAR 279

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 75
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 130
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HRD+++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 121/257 (47%), Gaps = 22/257 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +GTG +G V   +      VA+K +   S +E  F+E    EA ++  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
           C  ++ +F+I +YM  G L   LR  +   R    + + + K +  A+ YL        +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 127
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSD--SSNRTVVAGTHGYIAPELAYTMVLTEK 273
           HRD+++ N L+N +    V+DFG++R +  D  +S+R        +  PE+      + K
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR-WSPPEVLMYSKFSSK 186
Query: 274 CDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI 332
            D+++FGV+  E+  +G+ P +  ++      +   L    P    ++        V  I
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--------VYTI 238
Query: 333 VFACLRSKPTSRPMQRV 349
           +++C   K   RP  ++
Sbjct: 239 MYSCWHEKADERPTFKI 255

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 26/271 (9%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           + ++  ED  +   IG G +G V+  +L +   +   K             F  EA +L 
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H NIV+L G C  K+ ++++ + ++ G     LR   E  RL     + +V   A  
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAG 225
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---- 258
           + YL   C    +HRD+++ N L+  K    ++DFG++R          V A + G    
Sbjct: 226 MEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVXAASGGLRQV 277
Query: 259 ---YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVP 314
              + APE       + + DV+SFG++  E   +G  P   LS+   +  +      R+P
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK--GGRLP 335
Query: 315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            P     +  D +   +++  C   +P  RP
Sbjct: 336 CP----ELCPDAVF--RLMEQCWAYEPGQRP 360

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKL-----HHSETELAFLESFQTEAH 139
           +  E + I   +G GG  +VY A+      KVA+K +        ET    L+ F+ E H
Sbjct: 8   IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEET----LKRFEREVH 63
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
             SQ+ H+NIV +        C +L+ +Y+   +L   + +      L     +N    +
Sbjct: 64  NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQI 120
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-VAGTHG 258
              + + H      IVHRDI   NIL++S     + DFG+A+ L   S  +T  V GT  
Sbjct: 121 LDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y +PE A      E  D+YS G+V  E+L+G  P
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 84  MIVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEA 138
           +IV+  D   KY     IG G  G+VY A  + +G++VA+++++  +      E    E 
Sbjct: 12  IIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEI 69
Query: 139 HLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS 198
            ++ + ++ NIV      L    ++++ +Y+  GSL  ++        +D  +   + + 
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRE 125
Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
              AL +LH +    ++HR+I S+NILL       + DFG    +  + S R+ + GT  
Sbjct: 126 CLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 182
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           ++APE+        K D++S G++A+E++ G  P
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 26/271 (9%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           + ++  ED  +   IG G +G V+  +L +   +   K             F  EA +L 
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H NIV+L G C  K+ ++++ + ++ G     LR   E  RL     + +V   A  
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAG 225
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---- 258
           + YL   C    +HRD+++ N L+  K    ++DFG++R          V A + G    
Sbjct: 226 MEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVYAASGGLRQV 277
Query: 259 ---YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVP 314
              + APE       + + DV+SFG++  E   +G  P   LS+   +  +      R+P
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK--GGRLP 335
Query: 315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            P     +  D +   +++  C   +P  RP
Sbjct: 336 CP----ELCPDAVF--RLMEQCWAYEPGQRP 360

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 97  IGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV        Q  +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 76
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYL--- 131
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAY 266
                +HR++++ NIL+ ++    + DFG+ ++L  D     V         + APE   
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 267 TMVLTEKCDVYSFGVVALEVL 287
               +   DV+SFGVV  E+ 
Sbjct: 192 ESKFSVASDVWSFGVVLYELF 212

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 29/234 (12%)
Query: 97  IGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G+G +G+VY+   +P G+ V    A+K L+ +    A +E F  EA +++ + H ++V+
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 104
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR----LDWTKRVNIVKSMAHALSYLH 207
           L G CL    + L+ + M  G L   +    + I     L+W   V I K M +      
Sbjct: 105 LLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC--VQIAKGMMYLEER-- 159
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYIAPELA 265
                 +VHRD+++ N+L+ S     + DFG+ARLL  D        G     ++A E  
Sbjct: 160 -----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 266 YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLD--QRVPSP 316
           +    T + DV+S+GV   E++  G  P D +    P   + DLL+  +R+P P
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI----PTREIPDLLEKGERLPQP 264

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 48/278 (17%)
Query: 97  IGTGGYGSVYRA-QLPSGK-----KVALKKLH---HSETELAFLESFQTEAHLLSQIRHR 147
           +G G +G V  A     GK     KVA+K L    H++ + A +   +  +HL    +H 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG---QHE 110
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV-----------NIV 196
           NIV L G C H   + +I +Y   G L   LR     +  D    +           +  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFS 170
Query: 197 KSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
             +A  +++L   +CI    HRD+++ N+LL +   A + DFG+AR + +DS+   +V G
Sbjct: 171 SQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKG 224
Query: 256 TH----GYIAPELAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDL 308
                  ++APE  +  V T + DV+S+G++  E+    +  +PG L++S   K++    
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284
Query: 309 -LDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            + Q   +P +  +++Q          AC   +PT RP
Sbjct: 285 QMAQPAFAPKNIYSIMQ----------ACWALEPTHRP 312

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 29/234 (12%)
Query: 97  IGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G+G +G+VY+   +P G+ V    A+K L+ +    A +E F  EA +++ + H ++V+
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 81
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR----LDWTKRVNIVKSMAHALSYLH 207
           L G CL    + L+ + M  G L   +    + I     L+W   V I K M +      
Sbjct: 82  LLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC--VQIAKGMMYLEER-- 136
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYIAPELA 265
                 +VHRD+++ N+L+ S     + DFG+ARLL  D        G     ++A E  
Sbjct: 137 -----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 266 YTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLD--QRVPSP 316
           +    T + DV+S+GV   E++  G  P D +    P   + DLL+  +R+P P
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI----PTREIPDLLEKGERLPQP 241

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 110/218 (50%), Gaps = 21/218 (9%)
Query: 89  EDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELA------FLESFQTEAHLL 141
           + +D K  IG G    V R     +G + A+K +  +   L+        E+ + E H+L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 142 SQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMA 200
            Q+  H +I+ L         MFL++  MR+G LF  L    E + L   +  +I++S+ 
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLL 210
Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
            A+S+LH +   +IVHRD+   NILL+  ++  ++DFG +  L      R  + GT GY+
Sbjct: 211 EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-LCGTPGYL 266
Query: 261 APE-LAYTMVLT-----EKCDVYSFGVVALEVLMGRHP 292
           APE L  +M  T     ++ D+++ GV+   +L G  P
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 119/261 (45%), Gaps = 18/261 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G G YG VY+A+   G+ VALK++     +     +   E  LL ++ H NIV L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK--RVNIVKSMAHALSYLHCDCIPSI 214
             ++C+ L++++M +  L  +L  +   ++    K     +++ +AH   +        I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-------RI 140
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTEK 273
           +HRD+   N+L+NS     +ADFG+AR       + T    T  Y AP+ L  +   +  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 274 CDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK 331
            D++S G +  E++ G+   PG       PKI  I       P+P  +   +Q++ L  +
Sbjct: 201 VDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI----LGTPNP-REWPQVQELPLWKQ 255
Query: 332 IVFACLRSKPTSRPMQRVSQE 352
             F     KP S  +    QE
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQE 276

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 119/261 (45%), Gaps = 18/261 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           +G G YG VY+A+   G+ VALK++     +     +   E  LL ++ H NIV L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK--RVNIVKSMAHALSYLHCDCIPSI 214
             ++C+ L++++M +  L  +L  +   ++    K     +++ +AH   +        I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-------RI 140
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTEK 273
           +HRD+   N+L+NS     +ADFG+AR       + T    T  Y AP+ L  +   +  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 274 CDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK 331
            D++S G +  E++ G+   PG       PKI  I       P+P  +   +Q++ L  +
Sbjct: 201 VDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI----LGTPNP-REWPQVQELPLWKQ 255
Query: 332 IVFACLRSKPTSRPMQRVSQE 352
             F     KP S  +    QE
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQE 276

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 27/240 (11%)
Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRN 148
           F++   +G G YG VY+ + + +G+  A+K +  +  E    E  + E ++L +   HRN
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 82
Query: 149 IVKLYGFCLHKKC------MFLIYKYMRRGSLFCILRN-DDEAIRLDWTKRVNIVKSMAH 201
           I   YG  + K        ++L+ ++   GS+  +++N     ++ +W     I + +  
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILR 140
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
            LS+LH      ++HRDI   N+LL    E  + DFGV+  L      R    GT  ++A
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 262 PELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
           PE+             K D++S G+ A+E+  G  P   L  ++P   L   L  R P+P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LCDMHPMRAL--FLIPRNPAP 252

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 96  CIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           C+G G YG V+R  L  G+ VA+K     + +  F E   TE +    +RH NI+     
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRE---TEIYNTVLLRHDNILGFIAS 70
Query: 156 CLHKKC----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            +  +     ++LI  Y   GSL+  L+       L     + +  S A  L++LH +  
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHL----ALRLAVSAACGLAHLHVEIF 126
Query: 212 -----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-----GTHGYIA 261
                P+I HRD  S N+L+ S L+  +AD G+A ++HS  S+   +      GT  Y+A
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKRYMA 185
Query: 262 PELAYTMVLTE------KCDVYSFGVVALEV 286
           PE+    + T+        D+++FG+V  E+
Sbjct: 186 PEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 116/253 (45%), Gaps = 22/253 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G V+     +  KVA+K +          E F  EA ++ ++ H  +V+LYG C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L +  + L++++M  G L   LR        +    + +   +   ++YL   C   ++H
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVLTEK 273
           RD+++ N L+       V+DFG+ R +  D    T   GT     + +PE+      + K
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 274 CDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI 332
            DV+SFGV+  EV   G+ P +  S  N +++       R+  P    T       V +I
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRLYKPRLAST------HVYQI 239
Query: 333 VFACLRSKPTSRP 345
           +  C R +P  RP
Sbjct: 240 MNHCWRERPEDRP 252

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G  G V  A +  SGK VA+KK+        EL F      E  ++   +H N+V++
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 213
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y   L    ++++ +++  G+L  I+ +     R++  +   +  ++  ALS LH     
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ--- 266
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI S++ILL       ++DFG    +  +   R  + GT  ++APEL   +    
Sbjct: 267 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 326
Query: 273 KCDVYSFGVVALEVLMGRHP 292
           + D++S G++ +E++ G  P
Sbjct: 327 EVDIWSLGIMVIEMVDGEPP 346

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 57/287 (19%)
Query: 97  IGTGGYGSVYRA-QLPSGK-----KVALKKLH---HSETELAFLESFQTEAHLLSQIRHR 147
           +G G +G V  A     GK     KVA+K L    H++ + A +   +  +HL    +H 
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL---GQHE 95
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI--------------------RL 187
           NIV L G C H   + +I +Y   G L   LR   EA+                     L
Sbjct: 96  NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPL 155
Query: 188 DWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
           +    ++    +A  +++L   +CI    HRD+++ N+LL +   A + DFG+AR + +D
Sbjct: 156 ELRDLLHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 247 SSNRTVVAGTH----GYIAPELAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSV 299
           S+   +V G       ++APE  +  V T + DV+S+G++  E+    +  +PG L++S 
Sbjct: 212 SN--YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 269
Query: 300 NPKIMLIDL-LDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             K++     + Q   +P +  +++Q          AC   +PT RP
Sbjct: 270 FYKLVKDGYQMAQPAFAPKNIYSIMQ----------ACWALEPTHRP 306

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 97  IGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L    GKK+  A+K L+   T++  +  F TE  ++    H N++ L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 153 YGFCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            G CL  +    ++  YM+ G L   +RN+     +     +     +A  + YL     
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK-- 151
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTVVAGTHGYIAPELAYT 267
              VHRD+++ N +L+ K    VADFG+AR ++        N+T       ++A E   T
Sbjct: 152 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T K DV+SFGV+  E++    P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 82  QEMIVATEDFDIKY--CIGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQ 135
           Q +++      + +   IG G +G VY   L    GKK+  A+K L+   T++  +  F 
Sbjct: 13  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFL 71
Query: 136 TEAHLLSQIRHRNIVKLYGFCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
           TE  ++    H N++ L G CL  +    ++  YM+ G L   +RN+     +     + 
Sbjct: 72  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIG 129
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS----SNR 250
               +A  + YL        VHRD+++ N +L+ K    VADFG+AR ++        N+
Sbjct: 130 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 186
Query: 251 TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           T       ++A E   T   T K DV+SFGV+  E++    P
Sbjct: 187 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G  G V  A +  +GK+VA+KK+        EL F      E  ++    H N+V +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDYHHDNVVDM 107
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y   L    ++++ +++  G+L  I+ +     R++  +   +  S+  ALSYLH     
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ--- 160
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI S++ILL S     ++DFG    +  +   R  + GT  ++APE+   +    
Sbjct: 161 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGT 220
Query: 273 KCDVYSFGVVALEVLMGRHP 292
           + D++S G++ +E++ G  P
Sbjct: 221 EVDIWSLGIMVIEMIDGEPP 240

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G  G V  A +  SGK VA+KK+        EL F      E  ++   +H N+V++
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 91
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y   L    ++++ +++  G+L  I+ +     R++  +   +  ++  ALS LH     
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ--- 144
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI S++ILL       ++DFG    +  +   R  + GT  ++APEL   +    
Sbjct: 145 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 204
Query: 273 KCDVYSFGVVALEVLMGRHP 292
           + D++S G++ +E++ G  P
Sbjct: 205 EVDIWSLGIMVIEMVDGEPP 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G  G V  A +  SGK VA+KK+        EL F      E  ++   +H N+V++
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 93
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y   L    ++++ +++  G+L  I+ +     R++  +   +  ++  ALS LH     
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ--- 146
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI S++ILL       ++DFG    +  +   R  + GT  ++APEL   +    
Sbjct: 147 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 206
Query: 273 KCDVYSFGVVALEVLMGRHP 292
           + D++S G++ +E++ G  P
Sbjct: 207 EVDIWSLGIMVIEMVDGEPP 226

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 97  IGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L    GKK+  A+K L+   T++  +  F TE  ++    H N++ L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 153 YGFCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            G CL  +    ++  YM+ G L   +RN+     +     +     +A  + YL     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK-- 152
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS----SNRTVVAGTHGYIAPELAYT 267
              VHRD+++ N +L+ K    VADFG+AR ++        N+T       ++A E   T
Sbjct: 153 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T K DV+SFGV+  E++    P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 97  IGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L    GKK+  A+K L+   T++  +  F TE  ++    H N++ L
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 153 YGFCLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            G CL  +    ++  YM+ G L   +RN+     +     +     +A  + YL     
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK-- 170
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS----SNRTVVAGTHGYIAPELAYT 267
              VHRD+++ N +L+ K    VADFG+AR ++        N+T       ++A E   T
Sbjct: 171 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T K DV+SFGV+  E++    P
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 121
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 82  QEMIVATEDFDIKY--CIGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQ 135
           Q +++      + +   IG G +G VY   L    GKK+  A+K L+   T++  +  F 
Sbjct: 40  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFL 98
Query: 136 TEAHLLSQIRHRNIVKLYGFCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
           TE  ++    H N++ L G CL  +    ++  YM+ G L   +RN+     +     + 
Sbjct: 99  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIG 156
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS----SNR 250
               +A  + YL        VHRD+++ N +L+ K    VADFG+AR ++        N+
Sbjct: 157 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 213
Query: 251 TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           T       ++A E   T   T K DV+SFGV+  E++    P
Sbjct: 214 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 122
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 97  IGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L    GKK+  A+K L+   T++  +  F TE  ++    H N++ L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 153 YGFCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            G CL  +    ++  YM+ G L   +RN+     +     +     +A  + YL     
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK-- 149
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS----SNRTVVAGTHGYIAPELAYT 267
              VHRD+++ N +L+ K    VADFG+AR ++        N+T       ++A E   T
Sbjct: 150 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T K DV+SFGV+  E++    P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 97  IGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L    GKK+  A+K L+   T++  +  F TE  ++    H N++ L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 153 YGFCLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            G CL  +    ++  YM+ G L   +RN+     +     +     +A  + YL     
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK-- 150
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS----SNRTVVAGTHGYIAPELAYT 267
              VHRD+++ N +L+ K    VADFG+AR ++        N+T       ++A E   T
Sbjct: 151 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T K DV+SFGV+  E++    P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G  G V  A +  SGK VA+KK+        EL F      E  ++   +H N+V++
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 136
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y   L    ++++ +++  G+L  I+ +     R++  +   +  ++  ALS LH     
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ--- 189
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI S++ILL       ++DFG    +  +   R  + GT  ++APEL   +    
Sbjct: 190 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 249
Query: 273 KCDVYSFGVVALEVLMGRHP 292
           + D++S G++ +E++ G  P
Sbjct: 250 EVDIWSLGIMVIEMVDGEPP 269

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 121
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 97  IGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L    GKK+  A+K L+   T++  +  F TE  ++    H N++ L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 153 YGFCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            G CL  +    ++  YM+ G L   +RN+     +     +     +A  + YL     
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK-- 151
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS----SNRTVVAGTHGYIAPELAYT 267
              VHRD+++ N +L+ K    VADFG+AR ++        N+T       ++A E   T
Sbjct: 152 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T K DV+SFGV+  E++    P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           DF+    +G G +G V +A+     +  A+KK+ H+E +L+   +  +E  LL+ + H+ 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNHQY 63
Query: 149 IVKLYGFCLH-------------KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI 195
           +V+ Y   L              K  +F+  +Y    +L+ ++ +++   + D   R  +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR--L 121
Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH----------- 244
            + +  ALSY+H      I+HRD+   NI ++      + DFG+A+ +H           
Sbjct: 122 FRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 245 ---SDSSNRTVVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN 300
                S N T   GT  Y+A E L  T    EK D+YS G++  E++     G    ++ 
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNIL 238
Query: 301 PKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQR 348
            K+  + +     P   DD  +  +     KI+   +   P  RP  R
Sbjct: 239 KKLRSVSI---EFPPDFDDNKMKVE----KKIIRLLIDHDPNKRPGAR 279

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G  G V  A +  SGK VA+KK+        EL F      E  ++   +H N+V++
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 82
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y   L    ++++ +++  G+L  I+ +     R++  +   +  ++  ALS LH     
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ--- 135
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI S++ILL       ++DFG    +  +   R  + GT  ++APEL   +    
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 195
Query: 273 KCDVYSFGVVALEVLMGRHP 292
           + D++S G++ +E++ G  P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 97  IGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L    GKK+  A+K L+   T++  +  F TE  ++    H N++ L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 153 YGFCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            G CL  +    ++  YM+ G L   +RN+     +     +     +A  + YL     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK-- 152
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS----SNRTVVAGTHGYIAPELAYT 267
              VHRD+++ N +L+ K    VADFG+AR ++        N+T       ++A E   T
Sbjct: 153 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T K DV+SFGV+  E++    P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 54/282 (19%)
Query: 97  IGTGGYGSVYRA-QLPSGK-----KVALKKLH---HSETELAFLESFQTEAHLLSQIRHR 147
           +G G +G V  A     GK     KVA+K L    H++ + A +   +  +HL    +H 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL---GQHE 110
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR---------------NDDEAIRLDWTKR 192
           NIV L G C H   + +I +Y   G L   LR               N +E  +L     
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE--QLSSRDL 168
Query: 193 VNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
           ++    +A  +++L   +CI    HRD+++ N+LL +   A + DFG+AR + +DS+   
Sbjct: 169 LHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--Y 222
Query: 252 VVAGTH----GYIAPELAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIM 304
           +V G       ++APE  +  V T + DV+S+G++  E+    +  +PG L++S   K++
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 282
Query: 305 LIDL-LDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                + Q   +P +  +++Q          AC   +PT RP
Sbjct: 283 KDGYQMAQPAFAPKNIYSIMQ----------ACWALEPTHRP 314

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 97  IGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L    GKK+  A+K L+   T++  +  F TE  ++    H N++ L
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 153 YGFCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            G CL  +    ++  YM+ G L   +RN+     +     +     +A  + YL     
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK-- 147
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS----SNRTVVAGTHGYIAPELAYT 267
              VHRD+++ N +L+ K    VADFG+AR ++        N+T       ++A E   T
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T K DV+SFGV+  E++    P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 84  MIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHH-SETELAFLESFQTEAHLLS 142
           M++   +      IG+G +G V+     +  KVA+K +   S +E  F+E    EA ++ 
Sbjct: 22  MVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE----EAEVMM 77
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           ++ H  +V+LYG CL +  + L++++M  G L   LR        +    + +   +   
Sbjct: 78  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEG 135
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GY 259
           ++YL   C   ++HRD+++ N L+       V+DFG+ R +  D    T   GT     +
Sbjct: 136 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKW 190
Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVL 287
            +PE+      + K DV+SFGV+  EV 
Sbjct: 191 ASPEVFSFSRYSSKSDVWSFGVLMWEVF 218

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G V+     +  KVA+K +          E F  EA ++ ++ H  +V+LYG C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L +  + L++++M  G L   LR        +    + +   +   ++YL   C   ++H
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVLTEK 273
           RD+++ N L+       V+DFG+ R +  D    T   GT     + +PE+      + K
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 274 CDVYSFGVVALEVL 287
            DV+SFGV+  EV 
Sbjct: 183 SDVWSFGVLMWEVF 196

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 37/222 (16%)
Query: 97  IGTGGYGSVYRAQLPS------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           IG G +G V++A+ P          VA+K L   E        FQ EA L+++  + NIV
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDNPNIV 113
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSL-----------FCILRNDDEAIR----------LDW 189
           KL G C   K M L+++YM  G L            C L + D + R          L  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
            +++ I + +A  ++YL        VHRD+++ N L+   +   +ADFG++R ++  S++
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY--SAD 228
Query: 250 RTVVAGTHG----YIAPELAYTMVLTEKCDVYSFGVVALEVL 287
                G       ++ PE  +    T + DV+++GVV  E+ 
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G V+     +  KVA+K +          E F  EA ++ ++ H  +V+LYG C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L +  + L++++M  G L   LR        +    + +   +   ++YL   C   ++H
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVLTEK 273
           RD+++ N L+       V+DFG+ R +  D    T   GT     + +PE+      + K
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 274 CDVYSFGVVALEVL 287
            DV+SFGV+  EV 
Sbjct: 185 SDVWSFGVLMWEVF 198

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 114/237 (48%), Gaps = 12/237 (5%)
Query: 84  MIVATEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           M +  +DF+    +G G  G V++ +  PSG  +A +KL H E + A       E  +L 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIRELQVLH 59
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           +     IV  YG       + +  ++M  GSL  +L+   +A R+       +  ++   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKG 116
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L+YL       I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++P
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSP 172
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRH---PGDLLSSVNPKIMLIDLLDQRVPSP 316
           E       + + D++S G+  +E+ +GR+   P D      P + + +LLD  V  P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEP 229

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G  G V  A +  SGK VA+KK+        EL F      E  ++   +H N+V++
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 86
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           Y   L    ++++ +++  G+L  I+ +     R++  +   +  ++  ALS LH     
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ--- 139
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
            ++HRDI S++ILL       ++DFG    +  +   R  + GT  ++APEL   +    
Sbjct: 140 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 199
Query: 273 KCDVYSFGVVALEVLMGRHP 292
           + D++S G++ +E++ G  P
Sbjct: 200 EVDIWSLGIMVIEMVDGEPP 219

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  + + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 122
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 30/284 (10%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQL--PSGKKVA-----LKKLHHSETELAFLESFQTE 137
           ++  +D  +   +G G +G V R +   PSGK V+     LK    S+ E   ++ F  E
Sbjct: 8   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIRE 65
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
            + +  + HRN+++LYG  L    M ++ +    GSL   LR       L    R  +  
Sbjct: 66  VNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 122
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL        +HRD+++ N+LL ++    + DFG+ R L  +  +   V   H
Sbjct: 123 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--YVMQEH 177
Query: 258 -----GYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ 311
                 + APE   T   +   D + FGV   E+   G+ P   L+  +  +  ID   +
Sbjct: 178 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKIDKEGE 236
Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLV 355
           R+P P D     QDI     ++  C   KP  RP     ++FL+
Sbjct: 237 RLPRPED---CPQDIY---NVMVQCWAHKPEDRPTFVALRDFLL 274

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 125/286 (43%), Gaps = 34/286 (11%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQL--PSGKKVA-----LKKLHHSETELAFLESFQTE 137
           ++  +D  +   +G G +G V R +   PSGK V+     LK    S+ E   ++ F  E
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIRE 71
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
            + +  + HRN+++LYG  L    M ++ +    GSL   LR       L    R  +  
Sbjct: 72  VNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 128
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL        +HRD+++ N+LL ++    + DFG+ R L  +  +   V   H
Sbjct: 129 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--XVMQEH 183
Query: 258 -----GYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIML--IDLL 309
                 + APE   T   +   D + FGV   E+   G+ P      +N   +L  ID  
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKE 240
Query: 310 DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLV 355
            +R+P P D     QDI     ++  C   KP  RP     ++FL+
Sbjct: 241 GERLPRPED---CPQDIY---NVMVQCWAHKPEDRPTFVALRDFLL 280

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 121
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 121
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 121
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 121
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 19/224 (8%)
Query: 75  YDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLE 132
           +DGR+     I+          +G G +G V   +   +G KVA+K L+  +   L  + 
Sbjct: 9   HDGRVKIGHYILGD-------TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG 61
Query: 133 SFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTK 191
             + E   L   RH +I+KLY        +F++ +Y+  G LF  I +N     RLD  +
Sbjct: 62  KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG----RLDEKE 117
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
              + + +   + Y H   +   VHRD+   N+LL++ + A +ADFG++ ++ SD     
Sbjct: 118 SRRLFQQILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLR 173
Query: 252 VVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPGD 294
              G+  Y APE ++  +    + D++S GV+   +L G  P D
Sbjct: 174 XSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 125/286 (43%), Gaps = 34/286 (11%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQL--PSGKKVA-----LKKLHHSETELAFLESFQTE 137
           ++  +D  +   +G G +G V R +   PSGK V+     LK    S+ E   ++ F  E
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIRE 71
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
            + +  + HRN+++LYG  L    M ++ +    GSL   LR       L    R  +  
Sbjct: 72  VNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 128
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL        +HRD+++ N+LL ++    + DFG+ R L  +  +   V   H
Sbjct: 129 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--YVMQEH 183
Query: 258 -----GYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIML--IDLL 309
                 + APE   T   +   D + FGV   E+   G+ P      +N   +L  ID  
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKE 240
Query: 310 DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLV 355
            +R+P P D     QDI     ++  C   KP  RP     ++FL+
Sbjct: 241 GERLPRPED---CPQDIY---NVMVQCWAHKPEDRPTFVALRDFLL 280

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 122
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 121
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 120
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 30/284 (10%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQL--PSGKKVA-----LKKLHHSETELAFLESFQTE 137
           ++  +D  +   +G G +G V R +   PSGK V+     LK    S+ E   ++ F  E
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIRE 61
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
            + +  + HRN+++LYG  L    M ++ +    GSL   LR       L    R  +  
Sbjct: 62  VNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 118
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL        +HRD+++ N+LL ++    + DFG+ R L  +  +   V   H
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--XVMQEH 173
Query: 258 -----GYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ 311
                 + APE   T   +   D + FGV   E+   G+ P   L+  +  +  ID   +
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKIDKEGE 232
Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLV 355
           R+P P D     QDI     ++  C   KP  RP     ++FL+
Sbjct: 233 RLPRPED---CPQDIY---NVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 115/253 (45%), Gaps = 22/253 (8%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G V+     +  KVA+K +          E F  EA ++ ++ H  +V+LYG C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L +  + L+ ++M  G L   LR        +    + +   +   ++YL   C   ++H
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVLTEK 273
           RD+++ N L+       V+DFG+ R +  D    T   GT     + +PE+      + K
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 274 CDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI 332
            DV+SFGV+  EV   G+ P +  S  N +++       R+  P    T       V +I
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRLYKPRLAST------HVYQI 237
Query: 333 VFACLRSKPTSRP 345
           +  C R +P  RP
Sbjct: 238 MNHCWRERPEDRP 250

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 16/229 (6%)
Query: 89  EDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +DF+    +G G  G V++ +  PSG  +A +KL H E + A       E  +L +    
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIRELQVLHECNSP 67
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
            IV  YG       + +  ++M  GSL  +L+   +A R+       +  ++   L+YL 
Sbjct: 68  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NIL+NS+ E  + DFGV+  L  + +N  V  GT  Y++PE    
Sbjct: 125 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV--GTRSYMSPERLQG 180
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
              + + D++S G+  +E+ +GR+P        P + + +LLD  V  P
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYP-------RPPMAIFELLDYIVNEP 222

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 121
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 30/284 (10%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQL--PSGKKVA-----LKKLHHSETELAFLESFQTE 137
           ++  +D  +   +G G +G V R +   PSGK V+     LK    S+ E   ++ F  E
Sbjct: 8   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIRE 65
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
            + +  + HRN+++LYG  L    M ++ +    GSL   LR       L    R  +  
Sbjct: 66  VNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 122
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL        +HRD+++ N+LL ++    + DFG+ R L  +  +   V   H
Sbjct: 123 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--YVMQEH 177
Query: 258 -----GYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ 311
                 + APE   T   +   D + FGV   E+   G+ P   L+  +  +  ID   +
Sbjct: 178 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKIDKEGE 236
Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLV 355
           R+P P D     QDI     ++  C   KP  RP     ++FL+
Sbjct: 237 RLPRPED---CPQDIY---NVMVQCWAHKPEDRPTFVALRDFLL 274

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 122
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 122
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 121
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 122
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 122
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 30/284 (10%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQL--PSGKKVA-----LKKLHHSETELAFLESFQTE 137
           ++  +D  +   +G G +G V R +   PSGK V+     LK    S+ E   ++ F  E
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIRE 61
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
            + +  + HRN+++LYG  L    M ++ +    GSL   LR       L    R  +  
Sbjct: 62  VNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 118
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL        +HRD+++ N+LL ++    + DFG+ R L  +  +   V   H
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--YVMQEH 173
Query: 258 -----GYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ 311
                 + APE   T   +   D + FGV   E+   G+ P   L+  +  +  ID   +
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKIDKEGE 232
Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLV 355
           R+P P D     QDI     ++  C   KP  RP     ++FL+
Sbjct: 233 RLPRPED---CPQDIY---NVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 121
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 17/222 (7%)
Query: 82  QEMIVATEDFDIKY--CIGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQ 135
           Q +++      + +   IG G +G VY   L    GKK+  A+K L+   T++  +  F 
Sbjct: 80  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFL 138
Query: 136 TEAHLLSQIRHRNIVKLYGFCLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
           TE  ++    H N++ L G CL  +    ++  YM+ G L   +RN+     +     + 
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIG 196
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS---DS-SNR 250
               +A  + +L        VHRD+++ N +L+ K    VADFG+AR ++    DS  N+
Sbjct: 197 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 251 TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           T       ++A E   T   T K DV+SFGV+  E++    P
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 9/209 (4%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +VK YG        +L  +Y   G LF  +  D   I +           +   + YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELAY 266
                I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL  
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 267 TMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                 E  DV+S G+V   +L G  P D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 9/209 (4%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           ED+D+   +G G YG V  A     ++    K+   +  +   E+ + E  +   + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +VK YG        +L  +Y   G LF  +  D   I +           +   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELAY 266
                I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL  
Sbjct: 123 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 267 TMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                 E  DV+S G+V   +L G  P D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 112/234 (47%), Gaps = 16/234 (6%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            E ++I   +G G +G VY+A+      +A  K+  +++E   LE +  E  +L+   H 
Sbjct: 10  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHP 68
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV-KSMAHALSYL 206
            IVKL G   H   ++++ ++   G++  I+   D  +      ++ +V + M  AL++L
Sbjct: 69  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFL 125
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      I+HRD+ + N+L+  + +  +ADFGV+         R    GT  ++APE+  
Sbjct: 126 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 182
Query: 267 TMVLTE-----KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS 315
              + +     K D++S G+  +E+     P      +NP  +L+ +     P+
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSDPPT 233

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 17/222 (7%)
Query: 82  QEMIVATEDFDIKY--CIGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQ 135
           Q +++      + +   IG G +G VY   L    GKK+  A+K L+   T++  +  F 
Sbjct: 21  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFL 79
Query: 136 TEAHLLSQIRHRNIVKLYGFCLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
           TE  ++    H N++ L G CL  +    ++  YM+ G L   +RN+     +     + 
Sbjct: 80  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIG 137
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS---DS-SNR 250
               +A  + +L        VHRD+++ N +L+ K    VADFG+AR ++    DS  N+
Sbjct: 138 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 194
Query: 251 TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           T       ++A E   T   T K DV+SFGV+  E++    P
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 30/284 (10%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQL--PSGKKVA-----LKKLHHSETELAFLESFQTE 137
           ++  +D  +   +G G +G V R +   PSGK V+     LK    S+ E   ++ F  E
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIRE 61
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
            + +  + HRN+++LYG  L    M ++ +    GSL   LR       L    R  +  
Sbjct: 62  VNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 118
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL        +HRD+++ N+LL ++    + DFG+ R L  +  +   V   H
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--YVMQEH 173
Query: 258 -----GYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ 311
                 + APE   T   +   D + FGV   E+   G+ P   L+  +  +  ID   +
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKIDKEGE 232
Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLV 355
           R+P P D     QDI     ++  C   KP  RP     ++FL+
Sbjct: 233 RLPRPED---CPQDIY---NVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 112/234 (47%), Gaps = 16/234 (6%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            E ++I   +G G +G VY+A+      +A  K+  +++E   LE +  E  +L+   H 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHP 76
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV-KSMAHALSYL 206
            IVKL G   H   ++++ ++   G++  I+   D  +      ++ +V + M  AL++L
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFL 133
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      I+HRD+ + N+L+  + +  +ADFGV+         R    GT  ++APE+  
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 267 TMVLTE-----KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS 315
              + +     K D++S G+  +E+     P      +NP  +L+ +     P+
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSDPPT 241

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 44/289 (15%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           DF+    +G G +G V +A+     +  A+KK+ H+E +L+   +  +E  LL+ + H+ 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVXLLASLNHQY 63
Query: 149 IVKLYGFCLH-------------KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI 195
           +V+ Y   L              K  +F+  +Y    +L+ ++ +++   + D   R  +
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR--L 121
Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH----------- 244
            + +  ALSY+H      I+HR++   NI ++      + DFG+A+ +H           
Sbjct: 122 FRQILEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 245 ---SDSSNRTVVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN 300
                S N T   GT  Y+A E L  T    EK D YS G++  E +     G    ++ 
Sbjct: 179 NLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNIL 238
Query: 301 PKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRV 349
            K+  + +     P   DD     +     KI+   +   P  RP  R 
Sbjct: 239 KKLRSVSI---EFPPDFDDNKXKVE----KKIIRLLIDHDPNKRPGART 280

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 97  IGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L    GKK+  A+K L+   T++  +  F TE  ++    H N++ L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 153 YGFCLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            G CL  +    ++  YM+ G L   +RN+     +     +     +A  + +L     
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK-- 150
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHS---DS-SNRTVVAGTHGYIAPELAYT 267
              VHRD+++ N +L+ K    VADFG+AR ++    DS  N+T       ++A E   T
Sbjct: 151 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T K DV+SFGV+  E++    P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 17/222 (7%)
Query: 82  QEMIVATEDFDIKY--CIGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQ 135
           Q +++      + +   IG G +G VY   L    GKK+  A+K L+   T++  +  F 
Sbjct: 22  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFL 80
Query: 136 TEAHLLSQIRHRNIVKLYGFCLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
           TE  ++    H N++ L G CL  +    ++  YM+ G L   +RN+     +     + 
Sbjct: 81  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIG 138
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS---DS-SNR 250
               +A  + +L        VHRD+++ N +L+ K    VADFG+AR ++    DS  N+
Sbjct: 139 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 195
Query: 251 TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           T       ++A E   T   T K DV+SFGV+  E++    P
Sbjct: 196 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 17/217 (7%)
Query: 82  QEMIVATEDFDIKY--CIGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQ 135
           Q +++      + +   IG G +G VY   L    GKK+  A+K L+   T++  +  F 
Sbjct: 26  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFL 84
Query: 136 TEAHLLSQIRHRNIVKLYGFCLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
           TE  ++    H N++ L G CL  +    ++  YM+ G L   +RN+     +     + 
Sbjct: 85  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIG 142
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS---DS-SNR 250
               +A  + +L        VHRD+++ N +L+ K    VADFG+AR ++    DS  N+
Sbjct: 143 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 199
Query: 251 TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
           T       ++A E   T   T K DV+SFGV+  E++
Sbjct: 200 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 236

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 97  IGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L    GKK+  A+K L+   T++  +  F TE  ++    H N++ L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 153 YGFCLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            G CL  +    ++  YM+ G L   +RN+     +     +     +A  + +L     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK-- 152
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHS---DS-SNRTVVAGTHGYIAPELAYT 267
              VHRD+++ N +L+ K    VADFG+AR ++    DS  N+T       ++A E   T
Sbjct: 153 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              T K DV+SFGV+  E++    P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG+G +G V+     +  KVA+K +          E F  EA ++ ++ H  +V+LYG C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 157 LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH 216
           L +  + L++++M  G L   LR        +    + +   +   ++YL      S++H
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLE---EASVIH 126
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVLTEK 273
           RD+++ N L+       V+DFG+ R +  D    T   GT     + +PE+      + K
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 274 CDVYSFGVVALEVL 287
            DV+SFGV+  EV 
Sbjct: 185 SDVWSFGVLMWEVF 198

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 12/229 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +DF+    +G G  G V++ +  PSG  +A +KL H E + A       E  +L +    
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIRELQVLHECNSP 83
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
            IV  YG       + +  ++M  GSL  +L+   +A R+       +  ++   L+YL 
Sbjct: 84  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++PE    
Sbjct: 141 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQG 196
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
              + + D++S G+  +E+ +GR+P   + S +  + + +LLD  V  P
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYP---IGSGSGSMAIFELLDYIVNEP 242

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +DF+    +G G  G V + Q  PSG  +A +KL H E + A       E  +L +    
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMA-RKLIHLEIKPAIRNQIIRELQVLHECNSP 74
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
            IV  YG       + +  ++M  GSL  +L+   EA R+       +  ++   L+YL 
Sbjct: 75  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y+APE    
Sbjct: 132 EKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMAPERLQG 187
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              + + D++S G+  +E+ +GR+P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 13/219 (5%)
Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           F  K  +G+G +G V+  +   SG +  +K ++   +++  +E  + E  +L  + H NI
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLDHPNI 82
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFC-ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +K++        M+++ +    G L   I+        L       ++K M +AL+Y H 
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 209 DCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
                +VH+D+   NIL           + DFG+A L  SD  + T  AGT  Y+APE+ 
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEV- 197
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPK 302
           +   +T KCD++S GVV   +L G  P  G  L  V  K
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 73
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 130
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 131 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 245

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 20/223 (8%)
Query: 79  ITFQEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTE 137
           + FQ M    E ++    +G G YG V + +   +G+ VA+KK   S+ +    +    E
Sbjct: 19  LYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE 74
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVN 194
             LL Q+RH N+V L   C  KK  +L+++++    L      DD  +    LD+     
Sbjct: 75  IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTIL------DDLELFPNGLDYQVVQK 128
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
            +  + + + + H     +I+HRDI   NIL++      + DFG AR L +         
Sbjct: 129 YLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV 185
Query: 255 GTHGYIAPELAYTMVLTEKC-DVYSFGVVALEVLMGR--HPGD 294
            T  Y APEL    V   K  DV++ G +  E+ MG    PGD
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 96  CIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +G G +G V   +   +G++ A+K +   +  +    ES   E  LL Q+ H NI+KLY
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVNIVKSMAHALSYLHCDC 210
            F   K   +L+ +    G LF      DE I   R        I++ +   ++Y+H + 
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVLSGITYMHKN- 145
Query: 211 IPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
              IVHRD+   N+LL SK +     + DFG++    +    +  + GT  YIAPE+ + 
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-GTAYYIAPEVLHG 202
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
               EKCDV+S GV+   +L G  P
Sbjct: 203 -TYDEKCDVWSTGVILYILLSGCPP 226

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 96  CIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +G G +G V   +   +G++ A+K +   +  +    ES   E  LL Q+ H NI+KLY
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVNIVKSMAHALSYLHCDC 210
            F   K   +L+ +    G LF      DE I   R        I++ +   ++Y+H + 
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVLSGITYMHKN- 151
Query: 211 IPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
              IVHRD+   N+LL SK +     + DFG++    +    +  + GT  YIAPE+ + 
Sbjct: 152 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-GTAYYIAPEVLHG 208
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
               EKCDV+S GV+   +L G  P
Sbjct: 209 -TYDEKCDVWSTGVILYILLSGCPP 232

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 69
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 241

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD-FLMEALIISKFNHQNIV 111
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++  S  R          ++ 
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 286
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 287 GP------VYRIMTQCWQHQPEDRP 305

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 117/265 (44%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S++ H+NIV
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKLNHQNIV 111
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++  S  R          ++ 
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 286
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 287 GP------VYRIMTQCWQHQPEDRP 305

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 21  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 79
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 136
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 137 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 251

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 70
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYL--LNWCVQI 127
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 128 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 242

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 122/248 (49%), Gaps = 18/248 (7%)
Query: 77  GRITFQEMIVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFL 131
           G +    ++  TE   IK  +G+G +G+VY+   +P G+KV    A+K+L  + +  A  
Sbjct: 1   GAMALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 59
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E    EA++++ + + ++ +L G CL      LI + M  G L   +R   + I   +  
Sbjct: 60  EILD-EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL- 116
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
            +N    +A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++     
Sbjct: 117 -LNWCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 172
Query: 252 VVAGTH--GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDL 308
              G     ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I  
Sbjct: 173 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILE 230
Query: 309 LDQRVPSP 316
             +R+P P
Sbjct: 231 KGERLPQP 238

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 70
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 127
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 128 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 242

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 71
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 128
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 243

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 72
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 129
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 244

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 72
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 129
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 244

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 69
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 241

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 17/222 (7%)
Query: 82  QEMIVATEDFDIKY--CIGTGGYGSVYRAQL--PSGKKV--ALKKLHHSETELAFLESFQ 135
           Q +++      + +   IG G +G VY   L    GKK+  A+K L+   T++  +  F 
Sbjct: 22  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFL 80
Query: 136 TEAHLLSQIRHRNIVKLYGFCLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
           TE  ++    H N++ L G CL  +    ++  YM+ G L   +RN+     +     + 
Sbjct: 81  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIG 138
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL---HSDS-SNR 250
               +A  + +L        VHRD+++ N +L+ K    VADFG+AR +     DS  N+
Sbjct: 139 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNK 195
Query: 251 TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           T       ++A E   T   T K DV+SFGV+  E++    P
Sbjct: 196 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 69
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 241

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 117/265 (44%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S++ H+NIV
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKLNHQNIV 97
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++  S  R          ++ 
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 272
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 273 GP------VYRIMTQCWQHQPEDRP 291

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 69
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 241

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 76
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 133
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 248

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 36  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 94
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 151
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 152 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 266

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 72
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 129
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 244

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 72
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 129
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 244

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 71
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 128
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 243

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 111/234 (47%), Gaps = 17/234 (7%)
Query: 89  EDF-DIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           EDF +I   +G G +G VY+AQ      +A  K+  +++E   LE +  E  +L+   H 
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHP 94
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV-KSMAHALSYL 206
           NIVKL     ++  ++++ ++   G++  ++   +  +      ++ +V K    AL+YL
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYL 151
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H +    I+HRD+ + NIL     +  +ADFGV+         R    GT  ++APE+  
Sbjct: 152 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 267 TMVLTE-----KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS 315
                +     K DV+S G+  +E+     P      +NP  +L+ +     P+
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPH---HELNPMRVLLKIAKSEPPT 259

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 96  CIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +G G +G V   +   +G++ A+K +   +  +    ES   E  LL Q+ H NI+KLY
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVNIVKSMAHALSYLHCDC 210
            F   K   +L+ +    G LF      DE I   R        I++ +   ++Y+H + 
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVLSGITYMHKN- 168
Query: 211 IPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
              IVHRD+   N+LL SK +     + DFG++    +    +  + GT  YIAPE+ + 
Sbjct: 169 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-GTAYYIAPEVLHG 225
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
               EKCDV+S GV+   +L G  P
Sbjct: 226 -TYDEKCDVWSTGVILYILLSGCPP 249

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 96  CIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +G G +G V   +   +G++ A+K +   +  +    ES   E  LL Q+ H NI+KLY
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVNIVKSMAHALSYLHCDC 210
            F   K   +L+ +    G LF      DE I   R        I++ +   ++Y+H + 
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVLSGITYMHKN- 169
Query: 211 IPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
              IVHRD+   N+LL SK +     + DFG++    +    +  + GT  YIAPE+ + 
Sbjct: 170 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-GTAYYIAPEVLHG 226
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
               EKCDV+S GV+   +L G  P
Sbjct: 227 -TYDEKCDVWSTGVILYILLSGCPP 250

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 111
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++  S  R          ++ 
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 286
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 287 GP------VYRIMTQCWQHQPEDRP 305

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 88
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++  S  R          ++ 
Sbjct: 149 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 263
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 264 GP------VYRIMTQCWQHQPEDRP 282

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 117/255 (45%), Gaps = 41/255 (16%)
Query: 69  EFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK-----KLHH 123
           +F  + YD +  F       E+ +    +G+G +G V  A      K  +      K+  
Sbjct: 30  DFREYEYDLKWEF-----PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 84
Query: 124 SETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD 182
            + + +  E+  +E  +++Q+  H NIV L G C     ++LI++Y   G L   LR+  
Sbjct: 85  EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 183 EAI-----------RLDWTKRVNIVK---------SMAHALSYLHCDCIPSIVHRDISSN 222
           E             RL+  + +N++           +A  + +L      S VHRD+++ 
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 201
Query: 223 NILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVLTEKCDVYS 278
           N+L+       + DFG+AR + SDS+   VV G       ++APE  +  + T K DV+S
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 259
Query: 279 FGVVALEVL-MGRHP 292
           +G++  E+  +G +P
Sbjct: 260 YGILLWEIFSLGVNP 274

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 96
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++  S  R          ++ 
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 271
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 272 GP------VYRIMTQCWQHQPEDRP 290

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 113
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++  S  R          ++ 
Sbjct: 174 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 230
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 231 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 288
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 289 GP------VYRIMTQCWQHQPEDRP 307

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 101
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 195 IVKSMAHALSYLHCD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
               +A  + YL    CI    HRD+++ N+L+       +ADFG+AR +++    +   
Sbjct: 162 CTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 254 AG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 17  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 75
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 132
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 133 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 247

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 103
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++  S  R          ++ 
Sbjct: 164 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 220
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 221 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 278
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 279 GP------VYRIMTQCWQHQPEDRP 297

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 96
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++  S  R          ++ 
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 271
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 272 GP------VYRIMTQCWQHQPEDRP 290

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 123
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++  S  R          ++ 
Sbjct: 184 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 240
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 241 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 298
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 299 GP------VYRIMTQCWQHQPEDRP 317

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 97
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++  S  R          ++ 
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 272
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 273 GP------VYRIMTQCWQHQPEDRP 291

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 63
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 120
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 235

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 111/234 (47%), Gaps = 17/234 (7%)
Query: 89  EDF-DIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           EDF +I   +G G +G VY+AQ      +A  K+  +++E   LE +  E  +L+   H 
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHP 94
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV-KSMAHALSYL 206
           NIVKL     ++  ++++ ++   G++  ++   +  +      ++ +V K    AL+YL
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYL 151
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H +    I+HRD+ + NIL     +  +ADFGV+         R    GT  ++APE+  
Sbjct: 152 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 267 TMVLTE-----KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS 315
                +     K DV+S G+  +E+     P      +NP  +L+ +     P+
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPH---HELNPMRVLLKIAKSEPPT 259

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 25/280 (8%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQT 136
            +++++  + F +   +G G +GSV  AQL     S  KVA+K L       + +E F  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCM------FLIYKYMRRGSLFCIL---RNDDEAIRL 187
           EA  + +  H ++ KL G  L  +         +I  +M+ G L   L   R  +    L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 188 DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
                V  +  +A  + YL      + +HRD+++ N +L   +   VADFG++R ++S  
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 248 SNRTVVAGTH--GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIML 305
             R   A      ++A E     + T   DV++FGV   E+ M R         N +I  
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI-MTRGQTPYAGIENAEIYN 250
Query: 306 IDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             +   R+  P +    + D++      + C  + P  RP
Sbjct: 251 YLIGGNRLKQPPECMEEVYDLM------YQCWSADPKQRP 284

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 101
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 195 IVKSMAHALSYLHCD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
               +A  + YL    CI    HRD+++ N+L+       +ADFG+AR +++    +   
Sbjct: 162 CTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 254 AG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 111/234 (47%), Gaps = 17/234 (7%)
Query: 89  EDF-DIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           EDF +I   +G G +G VY+AQ      +A  K+  +++E   LE +  E  +L+   H 
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHP 94
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV-KSMAHALSYL 206
           NIVKL     ++  ++++ ++   G++  ++   +  +      ++ +V K    AL+YL
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYL 151
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H +    I+HRD+ + NIL     +  +ADFGV+         R    GT  ++APE+  
Sbjct: 152 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 208
Query: 267 TMVLTE-----KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS 315
                +     K DV+S G+  +E+     P      +NP  +L+ +     P+
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPH---HELNPMRVLLKIAKSEPPT 259

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 112/230 (48%), Gaps = 21/230 (9%)
Query: 97  IGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G+G +G+VY+   +P G+ V    A+K L  + +  A  E    EA++++ +    + +
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAGVGSPYVSR 83
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
           L G CL      L+ + M  G L   +R +    RL     +N    +A  +SYL  D  
Sbjct: 84  LLGICLTSTVQ-LVTQLMPYGCLLDHVRENRG--RLGSQDLLNWCMQIAKGMSYLE-DV- 138
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYIAPELAYTMV 269
             +VHRD+++ N+L+ S     + DFG+ARLL  D +      G     ++A E      
Sbjct: 139 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 270 LTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLD--QRVPSP 316
            T + DV+S+GV   E++  G  P D +    P   + DLL+  +R+P P
Sbjct: 198 FTHQSDVWSYGVTVWELMTFGAKPYDGI----PAREIPDLLEKGERLPQP 243

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 9/210 (4%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            ED+D+   +G G  G V  A     ++    K+   +  +   E+ + E  +   + H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 121
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R +  + GT  Y+APEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 266 YTMVL-TEKCDVYSFGVVALEVLMGRHPGD 294
                  E  DV+S G+V   +L G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 71
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 128
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG A+LL ++        G    
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 243

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 73
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 130
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG A+LL ++        G    
Sbjct: 131 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 245

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 96  CIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +G G +G V   +   +G++ A+K +   +  +    ES   E  LL Q+ H NI KLY
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVNIVKSMAHALSYLHCDC 210
            F   K   +L+ +    G LF      DE I   R        I++ +   ++Y H + 
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVLSGITYXHKN- 145
Query: 211 IPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
              IVHRD+   N+LL SK +     + DFG++    +    +  + GT  YIAPE+ + 
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI-GTAYYIAPEVLHG 202
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
               EKCDV+S GV+   +L G  P
Sbjct: 203 -TYDEKCDVWSTGVILYILLSGCPP 226

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 71
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 128
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG A+LL ++        G    
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 243

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 71
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 128
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG A+LL ++        G    
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 243

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 89  EDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +DF+    +G G  G V++ +  PSG  +A +KL H E + A       E  +L +    
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIRELQVLHECNSP 126
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
            IV  YG       + +  ++M  GSL  +L+   +A R+       +  ++   L+YL 
Sbjct: 127 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++PE    
Sbjct: 184 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQG 239
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              + + D++S G+  +E+ +GR+P
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 111/251 (44%), Gaps = 17/251 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELA--FLESFQTEAHLLSQIRHRNIVKLYG 154
           +G GG+   +       K+V   K+      L     E    E  +   + H+++V  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F      +F++ +  RR SL  + +       L   +    ++ +     YLH +    +
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           +HRD+   N+ LN  LE  + DFG+A  +  D   + V+ GT  YIAPE+      + + 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 275 DVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVF 334
           DV+S G +   +L+G+ P +  S +    + I   +  +P  I+         + + ++ 
Sbjct: 197 DVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINP--------VAASLIQ 247
Query: 335 ACLRSKPTSRP 345
             L++ PT+RP
Sbjct: 248 KMLQTDPTARP 258

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 97  IGTGGYGSVYRAQ---LPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+   L   K     KVA+K L    TE   L    +E  ++  I +H+
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHK 79
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSL-------------FCILRNDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L             +C   + +   +L     V+
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +A  + YL        +HRD+++ N+L+       +ADFG+AR +H     +    
Sbjct: 140 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 255 G--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 69
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG A+LL ++        G    
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 241

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 97  IGTGGYGSVY--RAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           +G+G YG V   R ++   ++ A+K +  +    +       E  +L  + H NI+KLY 
Sbjct: 45  LGSGAYGEVLLCRDKVTHVER-AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVNIVKSMAHALSYLHCDCI 211
           F   K+  +L+ +  + G LF      DE I   + +      I+K +   ++YLH    
Sbjct: 104 FFEDKRNYYLVMECYKGGELF------DEIIHRMKFNEVDAAVIIKQVLSGVTYLHK--- 154
Query: 212 PSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
            +IVHRD+   N+LL SK +     + DFG++ +  +    +  + GT  YIAPE+    
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-GTAYYIAPEVLRKK 213
Query: 269 VLTEKCDVYSFGVVALEVLMGRHP 292
              EKCDV+S GV+   +L G  P
Sbjct: 214 -YDEKCDVWSIGVILFILLAGYPP 236

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 116/263 (44%), Gaps = 19/263 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELA--FLESFQTEAHLLSQIRHRNIVKLYG 154
           +G GG+   +       K+V   K+      L     E    E  +   + H+++V  +G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F      +F++ +  RR SL  + +       L   +    ++ +     YLH +    +
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           +HRD+   N+ LN  LE  + DFG+A  +  D   + V+ GT  YIAPE+      + + 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 220
Query: 275 DVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVF 334
           DV+S G +   +L+G+ P +  S +    + I   +  +P  I+         + + ++ 
Sbjct: 221 DVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINP--------VAASLIQ 271
Query: 335 ACLRSKPTSRPM--QRVSQEFLV 355
             L++ PT+RP   + ++ EF  
Sbjct: 272 KMLQTDPTARPTINELLNDEFFT 294

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 76
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 133
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG A+LL ++        G    
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 248

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 97  IGTGGYGSVYRAQ---LPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+   L   K     KVA+K L    TE   L    +E  ++  I +H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHK 94
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSL-------------FCILRNDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L             +C   + +   +L     V+
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +A  + YL        +HRD+++ N+L+       +ADFG+AR +H     +    
Sbjct: 155 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 255 G--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 116/263 (44%), Gaps = 19/263 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELA--FLESFQTEAHLLSQIRHRNIVKLYG 154
           +G GG+   +       K+V   K+      L     E    E  +   + H+++V  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F      +F++ +  RR SL  + +       L   +    ++ +     YLH +    +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           +HRD+   N+ LN  LE  + DFG+A  +  D   + V+ GT  YIAPE+      + + 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 275 DVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVF 334
           DV+S G +   +L+G+ P +  S +    + I   +  +P  I+         + + ++ 
Sbjct: 223 DVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINP--------VAASLIQ 273
Query: 335 ACLRSKPTSRPM--QRVSQEFLV 355
             L++ PT+RP   + ++ EF  
Sbjct: 274 KMLQTDPTARPTINELLNDEFFT 296

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 101
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +A  + YL        +HRD+++ N+L+       +ADFG+AR +++    +    
Sbjct: 162 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 255 G--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 108/230 (46%), Gaps = 28/230 (12%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSE-TELAFLESFQTEAHLLSQ 143
           V  + F+I   IG G +G V   Q    KK+ A+K ++  +  E   + +   E  ++  
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSM 199
           + H  +V L+     ++ MF++   +  G L   L+ +    +E ++L        +  +
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-------FICEL 124
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
             AL YL       I+HRD+  +NILL+      + DF +A +L  ++   T +AGT  Y
Sbjct: 125 VMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPY 180
Query: 260 IAPEL-------AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK 302
           +APE+        Y+  +    D +S GV A E+L GR P  + SS + K
Sbjct: 181 MAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRPYHIRSSTSSK 226

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           +AT  ++    IG G YG+VY+A+ P SG  VALK +     E     S   E  LL ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 145 R---HRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
               H N+V+L   C   +      + L+++++ +     + +     +  +  K  +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--DLM 118
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           +     L +LH +CI   VHRD+   NIL+ S     +ADFG+AR+     +   VV  T
Sbjct: 119 RQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV-T 174
Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
             Y APE+          D++S G +  E+ 
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           +AT  ++    IG G YG+VY+A+ P SG  VALK +     E     S   E  LL ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 145 R---HRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
               H N+V+L   C   +      + L+++++ +     + +     +  +  K  +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--DLM 118
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           +     L +LH +CI   VHRD+   NIL+ S     +ADFG+AR+     +   VV  T
Sbjct: 119 RQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV-T 174
Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
             Y APE+          D++S G +  E+ 
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 30/207 (14%)
Query: 100 GGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS--QIRHRNIVKLYGFCL 157
           G +G V++AQL + + VA+K     + +     S+Q E  + S   ++H NI++  G   
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQ-----SWQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 158 HKKC----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC--- 210
                   ++LI  +  +GSL   L+    A  + W +  +I ++MA  L+YLH D    
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 211 ----IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA--GTHGYIAPEL 264
                P+I HRDI S N+LL + L A +ADFG+A    +  S        GT  Y+APE+
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204
Query: 265 AYTMVLTE-----KCDVYSFGVVALEV 286
               +  +     + D+Y+ G+V  E+
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 9/210 (4%)
Query: 84  MIVATEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           M +  +DF+    +G G  G V++ +  PSG  +A +KL H E + A       E  +L 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIRELQVLH 59
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           +     IV  YG       + +  ++M  GSL  +L+   +A R+       +  ++   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKG 116
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L+YL       I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++P
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSP 172
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E       + + D++S G+  +E+ +GR+P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G YG VY+AQ   G+  ALKK+   + +     +   E  +L +++H NIVKLY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 157 LHKKCMFLIYKYMRRG--SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
             KK + L+++++ +    L  +     E++        + +  + + ++Y H      +
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAYCHDR---RV 121
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTEK 273
           +HRD+   N+L+N + E  +ADFG+AR         T    T  Y AP+ L  +   +  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTT 181
Query: 274 CDVYSFGVVALEVLMG 289
            D++S G +  E++ G
Sbjct: 182 IDIWSVGCIFAEMVNG 197

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 89  EDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +DF+    +G G  G V++ +  PSG  +A +KL H E + A       E  +L +    
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
            IV  YG       + +  ++M  GSL  +L+   +A R+       +  ++   L+YL 
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++PE    
Sbjct: 149 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQG 204
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              + + D++S G+  +E+ +GR+P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 115/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 114
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++     R          ++ 
Sbjct: 175 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 231
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 232 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 289
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 290 GP------VYRIMTQCWQHQPEDRP 308

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 115/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 137
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+AR ++     R          ++ 
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 312
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 313 GP------VYRIMTQCWQHQPEDRP 331

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 9/210 (4%)
Query: 84  MIVATEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           M +  +DF+    +G G  G V++ +  PSG  +A +KL H E + A       E  +L 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIRELQVLH 59
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           +     IV  YG       + +  ++M  GSL  +L+   +A R+       +  ++   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKG 116
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L+YL       I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++P
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSP 172
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E       + + D++S G+  +E+ +GR+P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 97  IGTGGYGSVYRAQ---LPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+   L   K     KVA+K L    TE   L    +E  ++  I +H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHK 94
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSL-------------FCILRNDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L             F    + +   +L     V+
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 195 IVKSMAHALSYLHCD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
               +A  + YL    CI    HRD+++ N+L+       +ADFG+AR +H     +   
Sbjct: 155 CAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 254 AG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 101
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +A  + YL        +HRD+++ N+L+       +ADFG+AR +++    +    
Sbjct: 162 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 255 G--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G YG VY+AQ   G+  ALKK+   + +     +   E  +L +++H NIVKLY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 157 LHKKCMFLIYKYMRRG--SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
             KK + L+++++ +    L  +     E++        + +  + + ++Y H      +
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAYCHDR---RV 121
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTEK 273
           +HRD+   N+L+N + E  +ADFG+AR         T    T  Y AP+ L  +   +  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTT 181
Query: 274 CDVYSFGVVALEVLMG 289
            D++S G +  E++ G
Sbjct: 182 IDIWSVGCIFAEMVNG 197

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 9/210 (4%)
Query: 84  MIVATEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           M +  +DF+    +G G  G V++ +  PSG  +A +KL H E + A       E  +L 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIRELQVLH 59
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           +     IV  YG       + +  ++M  GSL  +L+   +A R+       +  ++   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKG 116
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L+YL       I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++P
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSP 172
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E       + + D++S G+  +E+ +GR+P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 9/210 (4%)
Query: 84  MIVATEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           M +  +DF+    +G G  G V++ +  PSG  +A +KL H E + A       E  +L 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIRELQVLH 59
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           +     IV  YG       + +  ++M  GSL  +L+   +A R+       +  ++   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKG 116
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L+YL       I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++P
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSP 172
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E       + + D++S G+  +E+ +GR+P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-EDLSDLVSEMEMMKMIGKHK 101
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +A  + YL        +HRD+++ N+L+       +ADFG+AR +++    +    
Sbjct: 162 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 255 G--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 104/237 (43%), Gaps = 23/237 (9%)
Query: 69  EFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSET- 126
           E+  W        ++M +  EDF+I   IG G +G V   +L +  KV A+K L+  E  
Sbjct: 54  EYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML 113
Query: 127 ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCIL-----RND 181
           + A    F+ E  +L     + I  L+        ++L+  Y   G L  +L     R  
Sbjct: 114 KRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP 173
Query: 182 DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA- 240
           +E  R    + V  + S+ H L Y         VHRDI  +NIL++      +ADFG   
Sbjct: 174 EEMARFYLAEMVIAIDSV-HQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMV-----LTEKCDVYSFGVVALEVLMGRHP 292
           +L+   +   +V  GT  YI+PE+   M         +CD +S GV   E+L G  P
Sbjct: 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 88
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G   C+L+   +    D T        +  AL
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNG---CLLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL      ++  D+++ G +  +++ G  P
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+KV    A+ +L  + +  A  E    EA+
Sbjct: 45  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILD-EAY 103
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 160
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 161 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 275

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 28/265 (10%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 97
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVA---DFGVARLLHSDSSNRTVVAGTHG--YIA 261
             +     +HRDI++ N LL       VA   DFG+A+ ++  S  R          ++ 
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMP 214
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE     + T K D +SFGV+  E+  +G  P    S  N +++       R+  P +  
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPPKNCP 272
Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                   V +I+  C + +P  RP
Sbjct: 273 GP------VYRIMTQCWQHQPEDRP 291

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 112/239 (46%), Gaps = 24/239 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPS-----GKKVALKKLHHSETELAFLESFQTEAHL 140
           +  +DFD+   IG G Y  V   +L         KV  K+L + + ++ ++   QTE H+
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV---QTEKHV 62
Query: 141 LSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNI 195
             Q   H  +V L+     +  +F + +Y+  G L   ++      +E  R  ++  +++
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISL 121
Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
                 AL+YLH      I++RD+  +N+LL+S+    + D+G+ +         +   G
Sbjct: 122 ------ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCG 172
Query: 256 THGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLL-SSVNPKIMLIDLLDQRV 313
           T  YIAPE+          D ++ GV+  E++ GR P D++ SS NP     D L Q +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G YG VY+AQ   G+  ALKK+   + +     +   E  +L +++H NIVKLY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 157 LHKKCMFLIYKYMRRG--SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
             KK + L+++++ +    L  +     E++        + +  + + ++Y H      +
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAYCHDR---RV 121
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTEK 273
           +HRD+   N+L+N + E  +ADFG+AR         T    T  Y AP+ L  +   +  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 274 CDVYSFGVVALEVLMG 289
            D++S G +  E++ G
Sbjct: 182 IDIWSVGCIFAEMVNG 197

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           +G+G YG V   +   +G + A+K +  S  T  +   +   E  +L Q+ H NI+KLY 
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 155 FCLHKKCMFLIYKYMRRGSLF--CILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           F   K+  +L+ +  R G LF   ILR      +        I+K +    +YLH     
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIILRQ-----KFSEVDAAVIMKQVLSGTTYLHKH--- 140
Query: 213 SIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
           +IVHRD+   N+LL SK       + DFG++         +  + GT  YIAPE+     
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-GTAYYIAPEVLRKK- 198
Query: 270 LTEKCDVYSFGVVALEVLMGRHP 292
             EKCDV+S GV+   +L G  P
Sbjct: 199 YDEKCDVWSCGVILYILLCGYPP 221

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 112/239 (46%), Gaps = 24/239 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPS-----GKKVALKKLHHSETELAFLESFQTEAHL 140
           +  +DFD+   IG G Y  V   +L         KV  K+L + + ++ ++   QTE H+
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV---QTEKHV 58
Query: 141 LSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNI 195
             Q   H  +V L+     +  +F + +Y+  G L   ++      +E  R  ++  +++
Sbjct: 59  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISL 117
Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
                 AL+YLH      I++RD+  +N+LL+S+    + D+G+ +         +   G
Sbjct: 118 ------ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCG 168
Query: 256 THGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLL-SSVNPKIMLIDLLDQRV 313
           T  YIAPE+          D ++ GV+  E++ GR P D++ SS NP     D L Q +
Sbjct: 169 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 227

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           +G+G YG V   +   +G + A+K +  S  T  +   +   E  +L Q+ H NI+KLY 
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 155 FCLHKKCMFLIYKYMRRGSLF--CILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           F   K+  +L+ +  R G LF   ILR      +        I+K +    +YLH     
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQ-----KFSEVDAAVIMKQVLSGTTYLHK---H 123
Query: 213 SIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
           +IVHRD+   N+LL SK       + DFG++         +  + GT  YIAPE+     
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-GTAYYIAPEVLRKK- 181
Query: 270 LTEKCDVYSFGVVALEVLMGRHP 292
             EKCDV+S GV+   +L G  P
Sbjct: 182 YDEKCDVWSCGVILYILLCGYPP 204

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 101
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 195 IVKSMAHALSYLHCD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
               +A  + YL    CI    HRD+++ N+L+       +ADFG+AR +++    +   
Sbjct: 162 CTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 254 AG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           +AT  ++    IG G YG+VY+A+ P SG  VALK +     E     S   E  LL ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 145 R---HRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
               H N+V+L   C   +      + L+++++ +     + +     +  +  K  +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--DLM 118
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           +     L +LH +CI   VHRD+   NIL+ S     +ADFG+AR+     +   VV  T
Sbjct: 119 RQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-T 174
Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
             Y APE+          D++S G +  E+ 
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 111/237 (46%), Gaps = 24/237 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPS-----GKKVALKKLHHSETELAFLESFQTEAHL 140
           +  +DFD+   IG G Y  V   +L         KV  K+L + + ++ ++   QTE H+
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV---QTEKHV 73
Query: 141 LSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNI 195
             Q   H  +V L+     +  +F + +Y+  G L   ++      +E  R  ++  +++
Sbjct: 74  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISL 132
Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
                 AL+YLH      I++RD+  +N+LL+S+    + D+G+ +         +   G
Sbjct: 133 ------ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCG 183
Query: 256 THGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLL-SSVNPKIMLIDLLDQ 311
           T  YIAPE+          D ++ GV+  E++ GR P D++ SS NP     D L Q
Sbjct: 184 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 240

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 93
Query: 144 IRHRNIVKLYGFCLHK-KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           + H   VKLY FC    + ++    Y + G L   +R        D T        +  A
Sbjct: 94  LDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSA 149
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYI 260
           L YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y+
Sbjct: 150 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 207 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 101
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +A  + YL        +HRD+++ N+L+       +ADFG+AR +++    +    
Sbjct: 162 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 255 G--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 66
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 123
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 124 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 180
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 181 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     + +G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 76
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 133
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 248

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     + +G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 11  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 69
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 241

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 101
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I  Y  +G+L   LR             N     ++ +   V+
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 195 IVKSMAHALSYLHCD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
               +A  + YL    CI    HRD+++ N+L+       +ADFG+AR +++    +   
Sbjct: 162 CTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 254 AG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 115/263 (43%), Gaps = 19/263 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELA--FLESFQTEAHLLSQIRHRNIVKLYG 154
           +G GG+   +       K+V   K+      L     E    E  +   + H+++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F      +F++ +  RR SL  + +       L   +    ++ +     YLH +    +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           +HRD+   N+ LN  LE  + DFG+A  +  D   +  + GT  YIAPE+      + + 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV 198
Query: 275 DVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVF 334
           DV+S G +   +L+G+ P +  S +    + I   +  +P  I+         + + ++ 
Sbjct: 199 DVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINP--------VAASLIQ 249
Query: 335 ACLRSKPTSRPM--QRVSQEFLV 355
             L++ PT+RP   + ++ EF  
Sbjct: 250 KMLQTDPTARPTINELLNDEFFT 272

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKV----ALKKLHHSETELAFLESFQTEAH 139
           I+   +F     + +G +G+VY+   +P G+KV    A+K+L  + +  A  E    EA+
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAY 76
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL      LI + M  G L   +R   + I   +   +N    +
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 133
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH-- 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++        G    
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D + +   +I  I    +R+P P
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP 248

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 147
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +A  + YL        +HRD+++ N+L+       +ADFG+AR +++    +    
Sbjct: 208 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 255 G--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 110/251 (43%), Gaps = 17/251 (6%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELA--FLESFQTEAHLLSQIRHRNIVKLYG 154
           +G GG+   +       K+V   K+      L     E    E  +   + H+++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F      +F++ +  RR SL  + +       L   +    ++ +     YLH +    +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           +HRD+   N+ LN  LE  + DFG+A  +  D   +  + GT  YIAPE+      + + 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV 198
Query: 275 DVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVF 334
           DV+S G +   +L+G+ P +  S +    + I   +  +P  I+         + + ++ 
Sbjct: 199 DVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINP--------VAASLIQ 249
Query: 335 ACLRSKPTSRP 345
             L++ PT+RP
Sbjct: 250 KMLQTDPTARP 260

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 101
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I  Y  +G+L   LR             N     ++ +   V+
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +A  + YL        +HRD+++ N+L+       +ADFG+AR +++    +    
Sbjct: 162 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 255 G--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 65
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 122
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 123 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 179
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 180 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 112/239 (46%), Gaps = 24/239 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPS-----GKKVALKKLHHSETELAFLESFQTEAHL 140
           +  +DFD+   IG G Y  V   +L         +V  K+L + + ++ ++   QTE H+
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV---QTEKHV 105
Query: 141 LSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNI 195
             Q   H  +V L+     +  +F + +Y+  G L   ++      +E  R  ++  +++
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISL 164
Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
                 AL+YLH      I++RD+  +N+LL+S+    + D+G+ +         +   G
Sbjct: 165 ------ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 256 THGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLL-SSVNPKIMLIDLLDQRV 313
           T  YIAPE+          D ++ GV+  E++ GR P D++ SS NP     D L Q +
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           E ++I   +G G +G V + +   + ++ A+K ++ +  +     +   E  LL ++ H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVNIVKSMAHALS 204
           NI+KL+         +++ +    G LF      DE I   R        I+K +   ++
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 205 YLHCDCIPSIVHRDISSNNILLNSK---LEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           Y+H     +IVHRD+   NILL SK    +  + DFG++     ++  +  + GT  YIA
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIA 191
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+       EKCDV+S GV+   +L G  P
Sbjct: 192 PEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKV----ALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           F++   +G G +G V+  +  SG       A+K L  +  ++      + E  +L ++ H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 147 RNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAH 201
             IVKL Y F    K ++LI  ++R G LF  L  +    +E ++         +  +A 
Sbjct: 86  PFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELAL 137
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL +LH      I++RD+   NILL+ +    + DFG+++             GT  Y+A
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      T+  D +SFGV+  E+L G  P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 97  IGTGGYG-SVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G ++       G++  +K+++ S       E  + E  +L+ ++H NIV+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 156 CLHKKCMFLIYKYMRRGSLF-------CILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
                 ++++  Y   G LF        +L  +D+   LDW  ++ +      AL ++H 
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI--LDWFVQICL------ALKHVHD 143
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
                I+HRDI S NI L       + DFG+AR+L+S         GT  Y++PE+    
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200
Query: 269 VLTEKCDVYSFGVVALEVLMGRH 291
               K D+++ G V  E+   +H
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKH 223

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 115/263 (43%), Gaps = 19/263 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELA--FLESFQTEAHLLSQIRHRNIVKLYG 154
           +G GG+   +       K+V   K+      L     E    E  +   + H+++V  +G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F      +F++ +  RR SL  + +       L   +    ++ +     YLH +    +
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           +HRD+   N+ LN  LE  + DFG+A  +  D   +  + GT  YIAPE+      + + 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV 202
Query: 275 DVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVF 334
           DV+S G +   +L+G+ P +  S +    + I   +  +P  I+         + + ++ 
Sbjct: 203 DVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINP--------VAASLIQ 253
Query: 335 ACLRSKPTSRPM--QRVSQEFLV 355
             L++ PT+RP   + ++ EF  
Sbjct: 254 KMLQTDPTARPTINELLNDEFFT 276

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            E ++I   +G G +G V + +   + ++ A+K ++ +  +     +   E  LL ++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVNIVKSMAHAL 203
            NI+KL+         +++ +    G LF      DE I   R        I+K +   +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSK---LEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
           +Y+H     +IVHRD+   NILL SK    +  + DFG++     ++  +  + GT  YI
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYI 190
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           APE+       EKCDV+S GV+   +L G  P
Sbjct: 191 APEVL-RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 64
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 121
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 122 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 178
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            E ++I   +G G +G V + +   + ++ A+K ++ +  +     +   E  LL ++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVNIVKSMAHAL 203
            NI+KL+         +++ +    G LF      DE I   R        I+K +   +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSK---LEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
           +Y+H     +IVHRD+   NILL SK    +  + DFG++     ++  +  + GT  YI
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYI 190
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           APE+       EKCDV+S GV+   +L G  P
Sbjct: 191 APEVL-RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 34/268 (12%)
Query: 97  IGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           +G G +GSV    L     +  KVA+K +    +    +E F +EA  +    H N+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 153 YGFCLHKKCM-----FLIYKYMRRGSLFCIL---RNDDEAIRLDWTKRVNIVKSMAHALS 204
            G C+           +I  +M+ G L   L   R +     +     +  +  +A  + 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAP 262
           YL      + +HRD+++ N +L   +   VADFG+++ ++S    R   +      +IA 
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVL---MGRHPGDLLSSVNPKIMLIDLLDQRVPSPID- 318
           E     V T K DV++FGV   E+    M  +PG      N ++    L   R+  P D 
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG----VQNHEMYDYLLHGHRLKQPEDC 274
Query: 319 -DQTVIQDIILVSKIVFACLRSKPTSRP 345
            D+        + +I+++C R+ P  RP
Sbjct: 275 LDE--------LYEIMYSCWRTDPLDRP 294

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 63
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 64  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 120
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 121 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 177
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 178 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 88
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +A  + YL        +HRD+++ N+L+       +ADFG+AR +++    +    
Sbjct: 149 CTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 255 G--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 90
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +A  + YL        +HRD+++ N+L+       +ADFG+AR +++    +    
Sbjct: 151 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 255 G--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 248

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G+G YG+V  A    +G KVA+KKL+       F +    E  LL  +RH N++ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 156 CLHKKCM------FLIYKYMRR--GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
               + +      +L+  +M    G L    +  ++ I+        +V  M   L Y+H
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF-------LVYQMLKGLRYIH 145
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+   N+ +N   E  + DFG+AR   S+     V   T  Y APE+   
Sbjct: 146 A---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV---TRWYRAPEVILN 199
Query: 268 -MVLTEKCDVYSFGVVALEVLMGR 290
            M  T+  D++S G +  E++ G+
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE   L    +E  ++  I +H+
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 93
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +A  + YL        +HRD+++ N+L+       +ADFG+AR +++    +    
Sbjct: 154 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 255 G--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 251

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 86
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 143
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVS 200
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 88
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 145
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKV----ALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           F++   +G G +G V+  +  SG       A+K L  +  ++      + E  +L ++ H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 147 RNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAH 201
             IVKL Y F    K ++LI  ++R G LF  L  +    +E ++         +  +A 
Sbjct: 86  PFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELAL 137
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL +LH      I++RD+   NILL+ +    + DFG+++             GT  Y+A
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      T+  D +SFGV+  E+L G  P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 88
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 145
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 109/211 (51%), Gaps = 15/211 (7%)
Query: 88  TEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           ++++D+K  +G G +  V R     +G + A K ++  +      +  + EA +  +++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK--RVNIVKSMAHALS 204
            NIV+L+     +   +L++  +  G LF     +D   R  +++    + ++ +  +++
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQILESIA 142
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           Y H +    IVHR++   N+LL SK +     +ADFG+A +  +DS      AGT GY++
Sbjct: 143 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLS 198
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      ++  D+++ GV+   +L+G  P
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 86
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 143
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 19/224 (8%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHS-ETELAFLESFQTEAHLLSQIR 145
           ++ +++   +G GG   V+ A+ L   + VA+K L      + +F   F+ EA   + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 146 HRNIVKLYGFCLHKKCM----FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
           H  IV +Y     +       +++ +Y+   +L  I+  +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR----TVVAGTH 257
           AL++ H +    I+HRD+   NIL+++     V DFG+AR + +DS N       V GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAI-ADSGNSVXQTAAVIGTA 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSV 299
            Y++PE A    +  + DVYS G V  EVL G  P  GD   SV
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            IG G +  V  A+ + +GK+VA+K +  ++   + L+    E  ++  + H NIVKL+ 
Sbjct: 14  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI---VKSMAHALSYLHCDCI 211
               +K ++L+ +Y   G +F      D  +   W K        + +  A+ Y H    
Sbjct: 74  VIETEKTLYLVMEYASGGEVF------DYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF- 126
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
             IVHRD+ + N+LL++ +   +ADFG +    +  +      G+  Y APEL       
Sbjct: 127 --IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 272 -EKCDVYSFGVVALEVLMGRHPGD 294
             + DV+S GV+   ++ G  P D
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G+G YGSV  A    SG+KVA+KKL        F +    E  LL  ++H N++ L   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVNIVKSMAHALSYLHCDCIP 212
                 +   Y +     +   ++ D + I   +    K   +V  M   L Y+H     
Sbjct: 92  FTPASSLRNFYDFYL---VMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS---A 145
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLT 271
            +VHRD+   N+ +N   E  + DFG+AR  H+D+     V  T  Y APE+  + M   
Sbjct: 146 GVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV-TRWYRAPEVILSWMHYN 202
Query: 272 EKCDVYSFGVVALEVLMGR 290
           +  D++S G +  E+L G+
Sbjct: 203 QTVDIWSVGCIMAEMLTGK 221

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKV----ALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           F++   +G G +G V+  +  SG       A+K L  +  ++      + E  +L ++ H
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 147 RNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAH 201
             IVKL Y F    K ++LI  ++R G LF  L  +    +E ++         +  +A 
Sbjct: 87  PFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELAL 138
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL +LH      I++RD+   NILL+ +    + DFG+++             GT  Y+A
Sbjct: 139 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 195
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      T+  D +SFGV+  E+L G  P
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 89
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 146
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 147 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 203
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 86
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 143
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 16/227 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G G +GSV +      KK   VA+K L    TE A  E    EA ++ Q+ +  IV+L 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
           G C   + + L+ +    G L   L    E I +  +    ++  ++  + YL      +
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLE---EKN 130
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAYTMVL 270
            VHRD+++ N+LL ++  A ++DFG+++ L +D S  T  +       + APE       
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 271 TEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
           + + DV+S+GV   E L  G+ P   +    P++M      +R+  P
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKRMECP 235

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 88
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 145
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 109/211 (51%), Gaps = 15/211 (7%)
Query: 88  TEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           ++++D+K  +G G +  V R     +G + A K ++  +      +  + EA +  +++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK--RVNIVKSMAHALS 204
            NIV+L+     +   +L++  +  G LF     +D   R  +++    + ++ +  +++
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQILESIA 118
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           Y H +    IVHR++   N+LL SK +     +ADFG+A +  +DS      AGT GY++
Sbjct: 119 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLS 174
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      ++  D+++ GV+   +L+G  P
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 88  TEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           T+++ +   IG G +  V R  +L +G + A K ++  +      +  + EA +   ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL-SY 205
            NIV+L+     +   +L++  +  G LF      ++ +  ++    +    +   L + 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILEAV 116
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           LHC  +  +VHRD+   N+LL SK +     +ADFG+A  +  D       AGT GY++P
Sbjct: 117 LHCHQM-GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E+       +  D+++ GV+   +L+G  P
Sbjct: 176 EVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 88
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 145
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 88
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 145
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 89
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 146
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 147 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 203
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 75  YDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLE 132
           +DGR+     ++          +G G +G V   +   +G KVA+K L+  +   L  + 
Sbjct: 4   HDGRVKIGHYVLGD-------TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG 56
Query: 133 SFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR 192
             + E   L   RH +I+KLY         F++ +Y+  G LF  +       R++  + 
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEA 113
Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
             + + +  A+ Y H   +   VHRD+   N+LL++ + A +ADFG++ ++ SD      
Sbjct: 114 RRLFQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRT 169
Query: 253 VAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPGD 294
             G+  Y APE ++  +    + D++S GV+   +L G  P D
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 109/211 (51%), Gaps = 15/211 (7%)
Query: 88  TEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           ++++D+K  +G G +  V R     +G + A K ++  +      +  + EA +  +++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK--RVNIVKSMAHALS 204
            NIV+L+     +   +L++  +  G LF     +D   R  +++    + ++ +  +++
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQILESIA 119
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           Y H +    IVHR++   N+LL SK +     +ADFG+A +  +DS      AGT GY++
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLS 175
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      ++  D+++ GV+   +L+G  P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 19/224 (8%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHS-ETELAFLESFQTEAHLLSQIR 145
           ++ +++   +G GG   V+ A+ L   + VA+K L      + +F   F+ EA   + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 146 HRNIVKLYGFCLHKKCM----FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
           H  IV +Y     +       +++ +Y+   +L  I+  +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR----TVVAGTH 257
           AL++ H +    I+HRD+   NI++++     V DFG+AR + +DS N       V GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSV 299
            Y++PE A    +  + DVYS G V  EVL G  P  GD   SV
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSV 227

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 91
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 92  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 148
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 149 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 205
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 103/210 (49%), Gaps = 12/210 (5%)
Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           T+++ +   +G G +  V R  ++P+G++ A K ++  +      +  + EA +   ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL-SY 205
            NIV+L+     +   +L++  +  G LF      ++ +  ++    +    +   L S 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILESV 116
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAP 262
            HC  +  IVHRD+   N+LL SK +     +ADFG+A  +  D       AGT GY++P
Sbjct: 117 NHCH-LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E+       +  D+++ GV+   +L+G  P
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 109/211 (51%), Gaps = 15/211 (7%)
Query: 88  TEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           ++++D+K  +G G +  V R     +G + A K ++  +      +  + EA +  +++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK--RVNIVKSMAHALS 204
            NIV+L+     +   +L++  +  G LF     +D   R  +++    + ++ +  +++
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQILESIA 119
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           Y H +    IVHR++   N+LL SK +     +ADFG+A +  +DS      AGT GY++
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLS 175
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      ++  D+++ GV+   +L+G  P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 14/214 (6%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ----LPSGKKVALKKLHHSETELAFLESFQTEA--H 139
           +  E F++   +G GGYG V++ +      +GK  A+K L  +       ++  T+A  +
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 140 LLSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS 198
           +L +++H  IV L Y F    K ++LI +Y+  G LF  L  + E I ++ T    + + 
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQL--EREGIFMEDTACFYLAE- 129
Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           ++ AL +LH      I++RD+   NI+LN +    + DFG+ +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+          D +S G +  ++L G  P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 33/223 (14%)
Query: 97  IGTGGYGSVYRAQ---LPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+   L   K     KVA+K L    TE   L    +E  ++  I +H+
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHK 87
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR---------------NDDEAIRLDWTKR 192
           NI+ L G C     +++I +Y  +G+L   L+               N +E  +L     
Sbjct: 88  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKDL 145
Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
           V+    +A  + YL        +HRD+++ N+L+       +ADFG+AR +H     +  
Sbjct: 146 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 253 VAG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
             G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 245

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 33/223 (14%)
Query: 97  IGTGGYGSVYRAQ---LPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+   L   K     KVA+K L    TE   L    +E  ++  I +H+
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHK 86
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR---------------NDDEAIRLDWTKR 192
           NI+ L G C     +++I +Y  +G+L   L+               N +E  +L     
Sbjct: 87  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKDL 144
Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
           V+    +A  + YL        +HRD+++ N+L+       +ADFG+AR +H     +  
Sbjct: 145 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 253 VAG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
             G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 244

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 103/210 (49%), Gaps = 12/210 (5%)
Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           T+++ +   +G G +  V R  ++P+G++ A K ++  +      +  + EA +   ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL-SY 205
            NIV+L+     +   +L++  +  G LF      ++ +  ++    +    +   L S 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILESV 116
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAP 262
            HC  +  IVHRD+   N+LL SK +     +ADFG+A  +  D       AGT GY++P
Sbjct: 117 NHCH-LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E+       +  D+++ GV+   +L+G  P
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 35/224 (15%)
Query: 97  IGTGGYGSVYRAQ---LPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+   L   K     KVA+K L    TE   L    +E  ++  I +H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHK 94
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR---------------NDDEAIRLDWTKR 192
           NI+ L G C     +++I +Y  +G+L   L+               N +E  +L     
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEE--QLSSKDL 152
Query: 193 VNIVKSMAHALSYLHCD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
           V+    +A  + YL    CI    HRD+++ N+L+       +ADFG+AR +H     + 
Sbjct: 153 VSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 252 VVAG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 33/223 (14%)
Query: 97  IGTGGYGSVYRAQ---LPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+   L   K     KVA+K L    TE   L    +E  ++  I +H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHK 94
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR---------------NDDEAIRLDWTKR 192
           NI+ L G C     +++I +Y  +G+L   L+               N +E  +L     
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKDL 152
Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
           V+    +A  + YL        +HRD+++ N+L+       +ADFG+AR +H     +  
Sbjct: 153 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 253 VAG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
             G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 70
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 71  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 127
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 128 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 184
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 185 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 33/223 (14%)
Query: 97  IGTGGYGSVYRAQ---LPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+   L   K     KVA+K L    TE   L    +E  ++  I +H+
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHK 83
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR---------------NDDEAIRLDWTKR 192
           NI+ L G C     +++I +Y  +G+L   L+               N +E  +L     
Sbjct: 84  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKDL 141
Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
           V+    +A  + YL        +HRD+++ N+L+       +ADFG+AR +H     +  
Sbjct: 142 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 253 VAG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
             G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 241

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 128/287 (44%), Gaps = 54/287 (18%)
Query: 96  CIGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
            +G G +G V +A     +  +G      K+       + L    +E ++L Q+ H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN-----------------------DDEAIRL 187
           KLYG C     + LI +Y + GSL   LR                        D+ A+ +
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 188 DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
                ++    ++  + YL      S+VHRD+++ NIL+    +  ++DFG++R ++ + 
Sbjct: 150 --GDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 248 SNRTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNP 301
           S    V  + G     ++A E  +  + T + DV+SFGV+  E++ +G +P      + P
Sbjct: 205 S---XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP---YPGIPP 258
Query: 302 KIMLIDLL--DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPM 346
           +  L +LL    R+  P +    +  ++L       C + +P  RP+
Sbjct: 259 E-RLFNLLKTGHRMERPDNCSEEMYRLML------QCWKQEPDKRPV 298

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 13/232 (5%)
Query: 69  EFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSET- 126
           EF  W        +EM +  EDF+I   IG G +G V   ++ + +++ A+K L+  E  
Sbjct: 54  EFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEML 113
Query: 127 ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR 186
           + A    F+ E  +L     + I  L+     +  ++L+  Y   G L  +L   ++ + 
Sbjct: 114 KRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLP 173
Query: 187 LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
            D  +    +  M  A+  +H       VHRDI  +N+LL+      +ADFG    ++ D
Sbjct: 174 EDMARFY--IGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDD 228
Query: 247 SSNRTVVA-GTHGYIAPELAYTMV-----LTEKCDVYSFGVVALEVLMGRHP 292
            + ++ VA GT  YI+PE+   M         +CD +S GV   E+L G  P
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 35/224 (15%)
Query: 97  IGTGGYGSVYRAQ---LPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+   L   K     KVA+K L    TE   L    +E  ++  I +H+
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHK 135
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR---------------NDDEAIRLDWTKR 192
           NI+ L G C     +++I +Y  +G+L   L+               N +E  +L     
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKDL 193
Query: 193 VNIVKSMAHALSYLHCD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
           V+    +A  + YL    CI    HRD+++ N+L+       +ADFG+AR +H     + 
Sbjct: 194 VSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 252 VVAG--THGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 14/214 (6%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ----LPSGKKVALKKLHHSETELAFLESFQTEA--H 139
           +  E F++   +G GGYG V++ +      +GK  A+K L  +       ++  T+A  +
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 140 LLSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS 198
           +L +++H  IV L Y F    K ++LI +Y+  G LF  L  + E I ++ T    + + 
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQL--EREGIFMEDTACFYLAE- 129
Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           ++ AL +LH      I++RD+   NI+LN +    + DFG+ +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+          D +S G +  ++L G  P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 13/232 (5%)
Query: 69  EFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSET- 126
           EF  W        +EM +  EDF+I   IG G +G V   ++ + +++ A+K L+  E  
Sbjct: 70  EFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEML 129
Query: 127 ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR 186
           + A    F+ E  +L     + I  L+     +  ++L+  Y   G L  +L   ++ + 
Sbjct: 130 KRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLP 189
Query: 187 LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
            D  +    +  M  A+  +H       VHRDI  +N+LL+      +ADFG    ++ D
Sbjct: 190 EDMARFY--IGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDD 244
Query: 247 SSNRTVVA-GTHGYIAPELAYTMV-----LTEKCDVYSFGVVALEVLMGRHP 292
            + ++ VA GT  YI+PE+   M         +CD +S GV   E+L G  P
Sbjct: 245 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 85
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 142
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 143 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 199
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G+G YGSV  A    SG+KVA+KKL        F +    E  LL  ++H N++ L   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAI---RLDWTKRVNIVKSMAHALSYLHCDCIP 212
                 +   Y +     +   ++ D + I        K   +V  M   L Y+H     
Sbjct: 110 FTPASSLRNFYDFYL---VMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS---A 163
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLT 271
            +VHRD+   N+ +N   E  + DFG+AR  H+D+     V  T  Y APE+  + M   
Sbjct: 164 GVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV-TRWYRAPEVILSWMHYN 220
Query: 272 EKCDVYSFGVVALEVLMGR 290
           +  D++S G +  E+L G+
Sbjct: 221 QTVDIWSVGCIMAEMLTGK 239

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 91  FDIKYCIGTGGYGSVYR-AQLPSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRH 146
           +DI   +GTG +G V+R  +  +G   A K +   H S+ E     + + E   +S +RH
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-----TVRKEIQTMSVLRH 213
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +V L+        M +IY++M  G LF  +   DE  ++   + V  ++ +   L ++
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 207 HCDCIPSIVHRDISSNNILLNSKL--EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           H +   + VH D+   NI+  +K   E  + DFG+   L    S + V  GT  + APE+
Sbjct: 272 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-VTTGTAEFAAPEV 327
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           A    +    D++S GV++  +L G  P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 121/271 (44%), Gaps = 34/271 (12%)
Query: 48  LRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYR 107
           L  P +RK K  +   +R  D  +          +++ +  ED+++   IG G +G V  
Sbjct: 41  LDFPALRKNKNIDNFLSRYKDTIN--------KIRDLRMKAEDYEVVKVIGRGAFGEVQL 92
Query: 108 AQLPSGKKV-ALKKLHHSE----TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM 162
            +  S +KV A+K L   E    ++ AF   F  E  +++      +V+L+      + +
Sbjct: 93  VRHKSTRKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQLFYAFQDDRYL 149
Query: 163 FLIYKYMRRGSLFCILRNDD--EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDIS 220
           +++ +YM  G L  ++ N D  E     +T  V +     H++ +         +HRD+ 
Sbjct: 150 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVK 200
Query: 221 SNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-GTHGYIAPELAYTM----VLTEKCD 275
            +N+LL+      +ADFG    ++ +   R   A GT  YI+PE+  +         +CD
Sbjct: 201 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 260
Query: 276 VYSFGVVALEVLMGRHP--GDLLSSVNPKIM 304
            +S GV   E+L+G  P   D L     KIM
Sbjct: 261 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 91  FDIKYCIGTGGYGSVYR-AQLPSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRH 146
           +DI   +GTG +G V+R  +  +G   A K +   H S+ E     + + E   +S +RH
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-----TVRKEIQTMSVLRH 107
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +V L+        M +IY++M  G LF  +   DE  ++   + V  ++ +   L ++
Sbjct: 108 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHM 165
Query: 207 HCDCIPSIVHRDISSNNILLNSKL--EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           H +   + VH D+   NI+  +K   E  + DFG+   L    S + V  GT  + APE+
Sbjct: 166 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-VTTGTAEFAAPEV 221
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           A    +    D++S GV++  +L G  P
Sbjct: 222 AEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 19/224 (8%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHS-ETELAFLESFQTEAHLLSQIR 145
           ++ +++   +G GG   V+ A+ L   + VA+K L      + +F   F+ EA   + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 146 HRNIVKLYGFCLHKKCM----FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
           H  IV +Y     +       +++ +Y+   +L  I+  +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR----TVVAGTH 257
           AL++ H +    I+HRD+   NI++++     V DFG+AR + +DS N       V GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSV 299
            Y++PE A    +  + DVYS G V  EVL G  P  GD   SV
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 89  EDFDIKYC--IGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLL 141
           E+  +KY   +G G +GSV   +       +G  VA+K+L HS  +      FQ E  +L
Sbjct: 9   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQREIQIL 66
Query: 142 SQIRHRNIVKLYG--FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
             +    IVK  G  +   ++ + L+ +Y+  G L   L+      RLD ++ +     +
Sbjct: 67  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQI 124
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG- 258
              + YL        VHRD+++ NIL+ S+    +ADFG+A+LL  D     V       
Sbjct: 125 CKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 181
Query: 259 --YIAPELAYTMVLTEKCDVYSFGVVALEVL 287
             + APE     + + + DV+SFGVV  E+ 
Sbjct: 182 IFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 34/268 (12%)
Query: 51  PKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQL 110
           P +RK K  +   +R  D  +          +++ +  ED+++   IG G +G V   + 
Sbjct: 39  PALRKNKNIDNFLSRYKDTIN--------KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90
Query: 111 PSGKKV-ALKKLHHSE----TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI 165
            S +KV A+K L   E    ++ AF   F  E  +++      +V+L+      + ++++
Sbjct: 91  KSTRKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147
Query: 166 YKYMRRGSLFCILRNDD--EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNN 223
            +YM  G L  ++ N D  E     +T  V +     H++ +         +HRD+  +N
Sbjct: 148 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVKPDN 198
Query: 224 ILLNSKLEAFVADFGVARLLHSDSSNRTVVA-GTHGYIAPELAYTM----VLTEKCDVYS 278
           +LL+      +ADFG    ++ +   R   A GT  YI+PE+  +         +CD +S
Sbjct: 199 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 258
Query: 279 FGVVALEVLMGRHP--GDLLSSVNPKIM 304
            GV   E+L+G  P   D L     KIM
Sbjct: 259 VGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +V  A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 85
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 142
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 143 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 199
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 34/268 (12%)
Query: 51  PKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQL 110
           P +RK K  +   +R  D  +          +++ +  ED+++   IG G +G V   + 
Sbjct: 44  PALRKNKNIDNFLSRYKDTIN--------KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 95
Query: 111 PSGKKV-ALKKLHHSE----TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI 165
            S +KV A+K L   E    ++ AF   F  E  +++      +V+L+      + ++++
Sbjct: 96  KSTRKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 152
Query: 166 YKYMRRGSLFCILRNDD--EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNN 223
            +YM  G L  ++ N D  E     +T  V +     H++ +         +HRD+  +N
Sbjct: 153 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVKPDN 203
Query: 224 ILLNSKLEAFVADFGVARLLHSDSSNRTVVA-GTHGYIAPELAYTM----VLTEKCDVYS 278
           +LL+      +ADFG    ++ +   R   A GT  YI+PE+  +         +CD +S
Sbjct: 204 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 263
Query: 279 FGVVALEVLMGRHP--GDLLSSVNPKIM 304
            GV   E+L+G  P   D L     KIM
Sbjct: 264 VGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 89  EDFDIKYC--IGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLL 141
           E+  +KY   +G G +GSV   +       +G  VA+K+L HS  +      FQ E  +L
Sbjct: 8   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQREIQIL 65
Query: 142 SQIRHRNIVKLYG--FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
             +    IVK  G  +   ++ + L+ +Y+  G L   L+      RLD ++ +     +
Sbjct: 66  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQI 123
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG- 258
              + YL        VHRD+++ NIL+ S+    +ADFG+A+LL  D     V       
Sbjct: 124 CKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 180
Query: 259 --YIAPELAYTMVLTEKCDVYSFGVVALEVL 287
             + APE     + + + DV+SFGVV  E+ 
Sbjct: 181 IFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 89  EDFDIKYC--IGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLL 141
           E+  +KY   +G G +GSV   +       +G  VA+K+L HS  +      FQ E  +L
Sbjct: 5   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQREIQIL 62
Query: 142 SQIRHRNIVKLYG--FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
             +    IVK  G  +   +  + L+ +Y+  G L   L+      RLD ++ +     +
Sbjct: 63  KALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQI 120
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG- 258
              + YL        VHRD+++ NIL+ S+    +ADFG+A+LL  D     V       
Sbjct: 121 CKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSP 177
Query: 259 --YIAPELAYTMVLTEKCDVYSFGVVALEVL 287
             + APE     + + + DV+SFGVV  E+ 
Sbjct: 178 IFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC 156
           IG G YG V+  +   G+KVA+K    +E    F E   TE +    +RH NI+      
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE---TEIYQTVLMRHENILGFIAAD 100
Query: 157 LHKKC----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI- 211
           +        ++LI  Y   GSL+  L+    +  LD    + +  S    L +LH +   
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 212 ----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV----AGTHGYIAPE 263
               P+I HRD+ S NIL+       +AD G+A    SD++   +      GT  Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 264 L-----------AYTMVLTEKCDVYSFGVVALEV 286
           +           +Y M      D+YSFG++  EV
Sbjct: 217 VLDESLNRNHFQSYIM-----ADMYSFGLILWEV 245

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKV----ALKK---LHHSETELAFLESFQTEA 138
           +  EDF++   +G G +G V+ A+     +     ALKK   L   + E   +E      
Sbjct: 15  LKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK----- 69
Query: 139 HLLS-QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
            +LS    H  +  ++     K+ +F + +Y+  G L   +++     + D ++      
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAA 126
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +   L +LH      IV+RD+  +NILL+      +ADFG+ +      +      GT 
Sbjct: 127 EIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTP 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
            YIAPE+          D +SFGV+  E+L+G+ P
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 75  YDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLE 132
           +DGR+     ++          +G G +G V   +   +G KVA+K L+  +   L  + 
Sbjct: 4   HDGRVKIGHYVLGD-------TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG 56
Query: 133 SFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR 192
             + E   L   RH +I+KLY         F++ +Y+  G LF  +       R++  + 
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEA 113
Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
             + + +  A+ Y H   +   VHRD+   N+LL++ + A +ADFG++ ++ SD      
Sbjct: 114 RRLFQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRD 169
Query: 253 VAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPGD 294
             G+  Y APE ++  +    + D++S GV+   +L G  P D
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHLLSQ 143
           EDF     +G G + +   A +L + ++ A+K L       E ++ ++     E  ++S+
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYV---TRERDVMSR 86
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + H   VKLY      + ++    Y + G L   +R        D T        +  AL
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 143
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIA 261
            YLH      I+HRD+   NILLN  +   + DFG A++L  +S  +      GT  Y++
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PEL       +  D+++ G +  +++ G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 89  EDFDIKYC--IGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLL 141
           E+  +KY   +G G +GSV   +       +G  VA+K+L HS  +      FQ E  +L
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQREIQIL 78
Query: 142 SQIRHRNIVKLYG--FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
             +    IVK  G  +   ++ + L+ +Y+  G L   L+      RLD ++ +     +
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQI 136
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG- 258
              + YL        VHRD+++ NIL+ S+    +ADFG+A+LL  D     V       
Sbjct: 137 CKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 259 --YIAPELAYTMVLTEKCDVYSFGVVALEVL 287
             + APE     + + + DV+SFGVV  E+ 
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G YG VY  + L +  ++A+K++   E +  + +    E  L   ++H+NIV+  G 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
                 + +  + +  GSL  +LR+    ++ +        K +   L YLH +    IV
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 216 HRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPEL--AYTMVLTE 272
           HRDI  +N+L+N+      ++DFG ++ L   +       GT  Y+APE+         +
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 273 KCDVYSFGVVALEVLMGRHP 292
             D++S G   +E+  G+ P
Sbjct: 205 AADIWSLGCTIIEMATGKPP 224

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 19/224 (8%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHS-ETELAFLESFQTEAHLLSQIR 145
           ++ +++   +G GG   V+ A+ L   + VA+K L      + +F   F+ EA   + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 146 HRNIVKLYGFCLHKKCM----FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
           H  IV +Y     +       +++ +Y+   +L  I+  +     +   + + ++     
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR----TVVAGTH 257
           AL++ H +    I+HRD+   NI++++     V DFG+AR + +DS N       V GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSV 299
            Y++PE A    +  + DVYS G V  EVL G  P  GD   SV
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 31/283 (10%)
Query: 59  TETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVAL 118
           +E  + +   +F  W     +  +E+ +  +DF+I   IG G +  V   ++    +V  
Sbjct: 31  SELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYA 90
Query: 119 KKLHHSETEL--AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFC 176
            K+ +    L    +  F+ E  +L     R I +L+     +  ++L+ +Y   G L  
Sbjct: 91  MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150
Query: 177 ILRNDDEAIRLDWTK----RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEA 232
           +L    E I  +  +     + +     H L Y         VHRDI  +NILL+     
Sbjct: 151 LLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY---------VHRDIKPDNILLDRCGHI 201
Query: 233 FVADFGVARLLHSDSSNRTVVA-GTHGYIAPELAYTMVLTE-------KCDVYSFGVVAL 284
            +ADFG    L +D + R++VA GT  Y++PE+   +           +CD ++ GV A 
Sbjct: 202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261
Query: 285 EVLMGRHP--GDLLSSVNPKI------MLIDLLDQRVPSPIDD 319
           E+  G+ P   D  +    KI      + + L+D+ VP    D
Sbjct: 262 EMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD 304

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            IG G +  V  A+ + +GK+VA+K +  ++   + L+    E  ++  + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 155 FCLHKKCMFLIYKYMRRGSLFCIL----RNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
               +K ++L+ +Y   G +F  L    R  ++  R  +       + +  A+ Y H   
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-------RQIVSAVQYCHQKF 133
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL 270
              IVHRD+ + N+LL++ +   +ADFG +    +  +      G+  Y APEL      
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 271 T-EKCDVYSFGVVALEVLMGRHPGD 294
              + DV+S GV+   ++ G  P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            IG G +  V  A+ + +GK+VA+K +  ++   + L+    E  ++  + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 155 FCLHKKCMFLIYKYMRRGSLFCIL----RNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
               +K ++L+ +Y   G +F  L    R  ++  R  +       + +  A+ Y H   
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-------RQIVSAVQYCHQKF 133
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL 270
              IVHRD+ + N+LL++ +   +ADFG +    +  +      G+  Y APEL      
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 271 T-EKCDVYSFGVVALEVLMGRHPGD 294
              + DV+S GV+   ++ G  P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 33/210 (15%)
Query: 100 GGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQ--IRHRNIVKLY---- 153
           G +G V++AQL +   VA+K        L   +S+Q+E  + S   ++H N+++      
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIF-----PLQDKQSWQSEREIFSTPGMKHENLLQFIAAEK 79
Query: 154 -GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI- 211
            G  L  + ++LI  +  +GSL   L+ +     + W +  ++ ++M+  LSYLH D   
Sbjct: 80  RGSNLEVE-LWLITAFHDKGSLTDYLKGN----IITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 212 -------PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIAP 262
                  PSI HRD  S N+LL S L A +ADFG+A          +     GT  Y+AP
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 263 ELAYTMVLTE-----KCDVYSFGVVALEVL 287
           E+    +  +     + D+Y+ G+V  E++
Sbjct: 195 EVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 32/234 (13%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSE----TELAFLESFQTEAHLLS 142
            ED+D+   IG G +G V   +  + +KV A+K L   E    ++ AF   F  E  +++
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAF---FWEERDIMA 130
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
                 +V+L+      K ++++ +YM  G L  ++ N D  +   W K       +  A
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFY--TAEVVLA 186
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV------ARLLHSDSSNRTVVAGT 256
           L  +H      ++HRD+  +N+LL+      +ADFG         ++H D++      GT
Sbjct: 187 LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-----VGT 238
Query: 257 HGYIAPELAYTM----VLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIM 304
             YI+PE+  +         +CD +S GV   E+L+G  P   D L     KIM
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 12/211 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQT--EAHLLSQ 143
           V   DFD    +G G +G V   +  +  +    K+   E  +A  E   T  E+ +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 144 IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS-MAH 201
            RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+   +R     + +  
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVS 116
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL YLH      +V+RDI   N++L+      + DFG+ +   SD +      GT  Y+A
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+          D +  GVV  E++ GR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 16/227 (7%)
Query: 97  IGTGGYGSVYRAQLPSGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G G +GSV +      KK   VA+K L    TE A  E    EA ++ Q+ +  IV+L 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
           G C   + + L+ +    G L   L    E I +  +    ++  ++  + YL      +
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK---N 456
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAYTMVL 270
            VHR++++ N+LL ++  A ++DFG+++ L +D S  T  +       + APE       
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 271 TEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
           + + DV+S+GV   E L  G+ P   +    P++M      +R+  P
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKRMECP 561

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 9/201 (4%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            IG G +  V  A+ + +G++VA+K +  ++     L+    E  ++  + H NIVKL+ 
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
               +K ++LI +Y   G +F  L       R+   +  +  + +  A+ Y H      I
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---KRI 132
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLT-EK 273
           VHRD+ + N+LL++ +   +ADFG +          T   G+  Y APEL         +
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-FCGSPPYAAPELFQGKKYDGPE 191
Query: 274 CDVYSFGVVALEVLMGRHPGD 294
            DV+S GV+   ++ G  P D
Sbjct: 192 VDVWSLGVILYTLVSGSLPFD 212

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G YG VY  + L +  ++A+K++   E +  + +    E  L   ++H+NIV+  G 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
                 + +  + +  GSL  +LR+    ++ +        K +   L YLH +    IV
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 130
Query: 216 HRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPEL--AYTMVLTE 272
           HRDI  +N+L+N+      ++DFG ++ L   +       GT  Y+APE+         +
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 190
Query: 273 KCDVYSFGVVALEVLMGRHP 292
             D++S G   +E+  G+ P
Sbjct: 191 AADIWSLGCTIIEMATGKPP 210

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 12/211 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQT--EAHLLSQ 143
           V   DFD    +G G +G V   +  +  +    K+   E  +A  E   T  E+ +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 144 IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS-MAH 201
            RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+   +R     + +  
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVS 116
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL YLH      +V+RDI   N++L+      + DFG+ +   SD +      GT  Y+A
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+          D +  GVV  E++ GR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 12/211 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQT--EAHLLSQ 143
           V   DFD    +G G +G V   +  +  +    K+   E  +A  E   T  E+ +L  
Sbjct: 5   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 144 IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS-MAH 201
            RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+   +R     + +  
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVS 119
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL YLH      +V+RDI   N++L+      + DFG+ +   SD +      GT  Y+A
Sbjct: 120 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 176
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+          D +  GVV  E++ GR P
Sbjct: 177 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 91  FDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           FDI+  IG G + +VY+     +  +VA  +L   +   +  + F+ EA  L  ++H NI
Sbjct: 30  FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNI 87
Query: 150 VKLY----GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS----MAH 201
           V+ Y         KKC+ L+ +    G+L   L+            ++ +++S    +  
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFK-------VXKIKVLRSWCRQILK 140
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYI 260
            L +LH    P I+HRD+  +NI +     +  + D G+A L    +S    V GT  + 
Sbjct: 141 GLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFX 197
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           APE  Y     E  DVY+FG   LE     +P
Sbjct: 198 APE-XYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 38/284 (13%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 62
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR       N+        
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R +      
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV-LMGRHPGDLLSS--VNP 301
           R    G  G     +++PE     V T   DV+SFGVV  E+  +   P   LS+  V  
Sbjct: 180 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236
Query: 302 KIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            +M   LLD+    P        D++L  +++  C +  P  RP
Sbjct: 237 FVMEGGLLDKPDNCP--------DMLL--ELMRMCWQYNPKMRP 270

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 12/211 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQT--EAHLLSQ 143
           V   DFD    +G G +G V   +  +  +    K+   E  +A  E   T  E+ +L  
Sbjct: 7   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 144 IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS-MAH 201
            RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+   +R     + +  
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVS 121
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL YLH      +V+RDI   N++L+      + DFG+ +   SD +      GT  Y+A
Sbjct: 122 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 178
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+          D +  GVV  E++ GR P
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 127/287 (44%), Gaps = 54/287 (18%)
Query: 96  CIGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
            +G G +G V +A     +  +G      K+       + L    +E ++L Q+ H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN-----------------------DDEAIRL 187
           KLYG C     + LI +Y + GSL   LR                        D+ A+ +
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 188 DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
                ++    ++  + YL       +VHRD+++ NIL+    +  ++DFG++R ++ + 
Sbjct: 150 --GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 248 SNRTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNP 301
           S    V  + G     ++A E  +  + T + DV+SFGV+  E++ +G +P      + P
Sbjct: 205 S---XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP---YPGIPP 258
Query: 302 KIMLIDLL--DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPM 346
           +  L +LL    R+  P +    +  ++L       C + +P  RP+
Sbjct: 259 E-RLFNLLKTGHRMERPDNCSEEMYRLML------QCWKQEPDKRPV 298

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 12/211 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQT--EAHLLSQ 143
           V   DFD    +G G +G V   +  +  +    K+   E  +A  E   T  E+ +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 144 IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS-MAH 201
            RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+   +R     + +  
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVS 116
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL YLH      +V+RDI   N++L+      + DFG+ +   SD +      GT  Y+A
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+          D +  GVV  E++ GR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 127/287 (44%), Gaps = 54/287 (18%)
Query: 96  CIGTGGYGSVYRA-----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
            +G G +G V +A     +  +G      K+       + L    +E ++L Q+ H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN-----------------------DDEAIRL 187
           KLYG C     + LI +Y + GSL   LR                        D+ A+ +
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 188 DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
                ++    ++  + YL       +VHRD+++ NIL+    +  ++DFG++R ++ + 
Sbjct: 150 --GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 248 SNRTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNP 301
           S    V  + G     ++A E  +  + T + DV+SFGV+  E++ +G +P      + P
Sbjct: 205 S---YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP---YPGIPP 258
Query: 302 KIMLIDLL--DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPM 346
           +  L +LL    R+  P +    +  ++L       C + +P  RP+
Sbjct: 259 E-RLFNLLKTGHRMERPDNCSEEMYRLML------QCWKQEPDKRPV 298

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            IG G +  V  A+ + +G++VA+K +  ++     L+    E  ++  + H NIVKL+ 
Sbjct: 22  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
               +K ++LI +Y   G +F  L       R+   +  +  + +  A+ Y H      I
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---KRI 135
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLT-EK 273
           VHRD+ + N+LL++ +   +ADFG +    +         G   Y APEL         +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 274 CDVYSFGVVALEVLMGRHPGD 294
            DV+S GV+   ++ G  P D
Sbjct: 195 VDVWSLGVILYTLVSGSLPFD 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 19/224 (8%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHS-ETELAFLESFQTEAHLLSQIR 145
           ++ +++   +G GG   V+ A+ L   + VA+K L      + +F   F+ EA   + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 146 HRNIVKLYGFCLHKKCM----FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
           H  IV +Y     +       +++ +Y+   +L  I+  +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR----TVVAGTH 257
           AL++ H +    I+HRD+   NI++++     V DFG+AR + +DS N       V GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSV 299
            Y++PE A    +  + DVYS G V  EVL G  P  GD   SV
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 12/211 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQT--EAHLLSQ 143
           V   DFD    +G G +G V   +  +  +    K+   E  +A  E   T  E+ +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 144 IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS-MAH 201
            RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+   +R     + +  
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVS 116
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL YLH      +V+RDI   N++L+      + DFG+ +   SD +      GT  Y+A
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+          D +  GVV  E++ GR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 12/211 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQT--EAHLLSQ 143
           V   DFD    +G G +G V   +  +  +    K+   E  +A  E   T  E+ +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 144 IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS-MAH 201
            RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+   +R     + +  
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVS 116
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL YLH      +V+RDI   N++L+      + DFG+ +   SD +      GT  Y+A
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+          D +  GVV  E++ GR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            IG G +  V  A+ + +GK+VA+K +  ++   + L+    E  ++  + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 155 FCLHKKCMFLIYKYMRRGSLFCIL----RNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
               +K ++L+ +Y   G +F  L    R  ++  R  +       + +  A+ Y H   
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-------RQIVSAVQYCHQKF 133
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL 270
              IVHRD+ + N+LL++ +   +ADFG +    +  +      G   Y APEL      
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 271 T-EKCDVYSFGVVALEVLMGRHPGD 294
              + DV+S GV+   ++ G  P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +D +  +GTG +  V  A+    +K+   K    E       S + E  +L +I+H NIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
            L         ++LI + +  G LF  +         D ++   ++  +  A+ YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD-- 134
Query: 211 IPSIVHRDISSNNIL---LNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
              IVHRD+   N+L   L+   +  ++DFG++++     S  +   GT GY+APE+   
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              ++  D +S GV+A  +L G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 47/281 (16%)
Query: 92  DIKY--CIGTGGYGSVYRAQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           DIK+   IG G +G V +A++         A+K++    ++      F  E  +L ++ H
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGH 84
Query: 147 R-NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-------------DDEAIRLDWTKR 192
             NI+ L G C H+  ++L  +Y   G+L   LR              +  A  L   + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
           ++    +A  + YL        +HRD+++ NIL+     A +ADFG++R           
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVY 195
Query: 253 VAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLI 306
           V  T G     ++A E     V T   DV+S+GV+  E++ +G  P   ++       L 
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LY 251
Query: 307 DLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           + L Q  R+  P++    + D++        C R KP  RP
Sbjct: 252 EKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERP 286

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 47/281 (16%)
Query: 92  DIKY--CIGTGGYGSVYRAQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           DIK+   IG G +G V +A++         A+K++    ++      F  E  +L ++ H
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGH 74
Query: 147 R-NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-------------DDEAIRLDWTKR 192
             NI+ L G C H+  ++L  +Y   G+L   LR              +  A  L   + 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
           ++    +A  + YL        +HRD+++ NIL+     A +ADFG++R           
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVY 185
Query: 253 VAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLI 306
           V  T G     ++A E     V T   DV+S+GV+  E++ +G  P   ++       L 
Sbjct: 186 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LY 241
Query: 307 DLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           + L Q  R+  P++    + D++        C R KP  RP
Sbjct: 242 EKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERP 276

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 9/210 (4%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAF-LESFQTEAHLLS- 142
           +  EDF +   +G G +G V+ A+   + +  A+K L      +   +E    E  +LS 
Sbjct: 14  LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
              H  +  ++     K+ +F + +Y+  G L   +++     + D ++       +   
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILG 130
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L +LH      IV+RD+  +NILL+      +ADFG+ +      +      GT  YIAP
Sbjct: 131 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E+          D +SFGV+  E+L+G+ P
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 77
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLD-------W 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR+   A+  +        
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R ++     
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     +++PE     V T   DV+SFGVV  E+
Sbjct: 195 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +D +  +GTG +  V  A+    +K+   K    E       S + E  +L +I+H NIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
            L         ++LI + +  G LF  +         D ++   ++  +  A+ YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD-- 134
Query: 211 IPSIVHRDISSNNIL---LNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
              IVHRD+   N+L   L+   +  ++DFG++++     S  +   GT GY+APE+   
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              ++  D +S GV+A  +L G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            IG G +  V  A+ + +GK+VA++ +  ++   + L+    E  ++  + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 155 FCLHKKCMFLIYKYMRRGSLFCIL----RNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
               +K ++L+ +Y   G +F  L    R  ++  R  +       + +  A+ Y H   
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-------RQIVSAVQYCHQKF 133
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL 270
              IVHRD+ + N+LL++ +   +ADFG +    +  +      G+  Y APEL      
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 271 T-EKCDVYSFGVVALEVLMGRHPGD 294
              + DV+S GV+   ++ G  P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 19/224 (8%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHS-ETELAFLESFQTEAHLLSQIR 145
           ++ +++   +G GG   V+ A+ L   + VA+K L      + +F   F+ EA   + + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 146 HRNIVKLYGFCLHKKCM----FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
           H  IV +Y     +       +++ +Y+   +L  I+  +     +   + + ++     
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 144
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR----TVVAGTH 257
           AL++ H +    I+HRD+   NI++++     V DFG+AR + +DS N       V GT 
Sbjct: 145 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 200
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSV 299
            Y++PE A    +  + DVYS G V  EVL G  P  GD   SV
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 244

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 90  DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           ++ ++  IG G +  V  A+ + +G++VA+K +  ++     L+    E  ++  + H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCIL----RNDDEAIRLDWTKRVNIVKSMAHALS 204
           IVKL+     +K ++L+ +Y   G +F  L    R  ++  R  +       + +  A+ 
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-------RQIVSAVQ 128
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y H      IVHRD+ + N+LL+  +   +ADFG +      +   T   G+  Y APEL
Sbjct: 129 YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT-FCGSPPYAAPEL 184
Query: 265 AYTMVLT-EKCDVYSFGVVALEVLMGRHPGD 294
                    + DV+S GV+   ++ G  P D
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 77
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR       N+        
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R ++     
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     +++PE     V T   DV+SFGVV  E+
Sbjct: 195 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKL---HHSETELAFLESFQTEAHLL 141
           +AT  ++    IG G YG+VY+A+ P SG  VALK +   +          S   E  LL
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 142 SQIR---HRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV 193
            ++    H N+V+L   C   +      + L+++++ +     + +     +  +  K  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK-- 123
Query: 194 NIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
           ++++     L +LH +CI   VHRD+   NIL+ S     +ADFG+AR ++S     T V
Sbjct: 124 DLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTPV 179
Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
             T  Y APE+          D++S G +  E+ 
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 67
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLD-------W 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR+   A+  +        
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R ++     
Sbjct: 128 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     +++PE     V T   DV+SFGVV  E+
Sbjct: 185 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 11/215 (5%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLS 142
           +V  E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL 
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLK 61
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           ++ H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQG 119
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L++ H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y AP
Sbjct: 120 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 176
Query: 263 E-LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           E L      +   D++S G +  E++  R   PGD
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK---KLHHSETELAFLESFQTEAHLLS 142
           +  E  ++  CIG G +G V++    S +  A+    K   + T  +  E F  EA  + 
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H +IVKL G  + +  +++I +    G L   L+       LD    +     ++ A
Sbjct: 67  QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTA 123
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYI 260
           L+YL        VHRDI++ N+L++S     + DFG++R +  DS+      G     ++
Sbjct: 124 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWM 179
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM 288
           APE       T   DV+ FGV   E+LM
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEILM 207

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 64
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR       N+        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R ++     
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     +++PE     V T   DV+SFGVV  E+
Sbjct: 182 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +D +  +GTG +  V  A+    +K+   K    E       S + E  +L +I+H NIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
            L         ++LI + +  G LF  +         D ++   ++  +  A+ YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD-- 134
Query: 211 IPSIVHRDISSNNIL---LNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
              IVHRD+   N+L   L+   +  ++DFG++++     S  +   GT GY+APE+   
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              ++  D +S GV+A  +L G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 71
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR       N+        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R +      
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     +++PE     V T   DV+SFGVV  E+
Sbjct: 189 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALK-----KLHHSETELAFLESFQTEAHLLSQI 144
           F+ K  +GTG +  V  A+   +GK  A+K      L   E+      S + E  +L +I
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES------SIENEIAVLRKI 77
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           +H NIV L         ++L+ + +  G LF  +         D +    +++ +  A+ 
Sbjct: 78  KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---TLIRQVLDAVY 134
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEA---FVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           YLH      IVHRD+   N+L  S+ E     ++DFG++++        +   GT GY+A
Sbjct: 135 YLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-EGKGDVMSTACGTPGYVA 190
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      ++  D +S GV+A  +L G  P
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 70
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR       N+        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R ++     
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     +++PE     V T   DV+SFGVV  E+
Sbjct: 188 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 68
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR       N+        
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R ++     
Sbjct: 129 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 185
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     +++PE     V T   DV+SFGVV  E+
Sbjct: 186 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 70
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR       N+        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R ++     
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     +++PE     V T   DV+SFGVV  E+
Sbjct: 188 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 120/271 (44%), Gaps = 34/271 (12%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G   +G VY+  L         + VA+K L   + E    E F+ EA L ++++H N+V
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSL--FCILR---------NDDEAIR--LDWTKRVNIVK 197
            L G     + + +I+ Y   G L  F ++R         +DD  ++  L+    V++V 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL       +VH+D+++ N+L+  KL   ++D G+ R +++    + +     
Sbjct: 136 QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 258 G--YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVP 314
              ++APE       +   D++S+GVV  EV   G  P       N  ++ +    Q +P
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQDVVEMIRNRQVLP 250
Query: 315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            P D          V  ++  C    P+ RP
Sbjct: 251 CPDDCPA------WVYALMIECWNEFPSRRP 275

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 71
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR       N+        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R ++     
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     +++PE     V T   DV+SFGVV  E+
Sbjct: 189 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 120/271 (44%), Gaps = 34/271 (12%)
Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G   +G VY+  L         + VA+K L   + E    E F+ EA L ++++H N+V
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSL--FCILR---------NDDEAIR--LDWTKRVNIVK 197
            L G     + + +I+ Y   G L  F ++R         +DD  ++  L+    V++V 
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + YL       +VH+D+++ N+L+  KL   ++D G+ R +++    + +     
Sbjct: 153 QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 258 G--YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVP 314
              ++APE       +   D++S+GVV  EV   G  P       N  ++ +    Q +P
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQDVVEMIRNRQVLP 267
Query: 315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            P D          V  ++  C    P+ RP
Sbjct: 268 CPDDCPA------WVYALMIECWNEFPSRRP 292

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 38/284 (13%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 64
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR       N+        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N  +       + DFG+ R ++     
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV-LMGRHPGDLLSS--VNP 301
           R    G  G     +++PE     V T   DV+SFGVV  E+  +   P   LS+  V  
Sbjct: 182 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 302 KIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            +M   LLD+    P        D++L  +++  C +  P  RP
Sbjct: 239 FVMEGGLLDKPDNCP--------DMLL--ELMRMCWQYNPKMRP 272

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 61
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   LS+ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFC 119
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            IG G +  V  A+ + +GK+VA++ +  ++   + L+    E  ++  + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 155 FCLHKKCMFLIYKYMRRGSLFCIL----RNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
               +K ++L+ +Y   G +F  L    R  ++  R  +       + +  A+ Y H   
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-------RQIVSAVQYCHQKF 133
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL 270
              IVHRD+ + N+LL++ +   +ADFG +    +  +      G+  Y APEL      
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDEFCGSPPYAAPELFQGKKY 189
Query: 271 T-EKCDVYSFGVVALEVLMGRHPGD 294
              + DV+S GV+   ++ G  P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS---ADI 142
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 199
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK---KLHHSETELAFLESFQTEAHLLS 142
           +  E  ++  CIG G +G V++    S +  AL    K   + T  +  E F  EA  + 
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H +IVKL G  + +  +++I +    G L   L+       LD    +     ++ A
Sbjct: 64  QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTA 120
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYI 260
           L+YL        VHRDI++ N+L++S     + DFG++R +  DS+      G     ++
Sbjct: 121 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 176
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM 288
           APE       T   DV+ FGV   E+LM
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILM 204

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK---KLHHSETELAFLESFQTEAHLLS 142
           +  E  ++  CIG G +G V++    S +  AL    K   + T  +  E F  EA  + 
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H +IVKL G  + +  +++I +    G L   L+    +  LD    +     ++ A
Sbjct: 67  QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTA 123
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYI 260
           L+YL        VHRDI++ N+L++S     + DFG++R +  DS+      G     ++
Sbjct: 124 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 179
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM 288
           APE       T   DV+ FGV   E+LM
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEILM 207

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK---KLHHSETELAFLESFQTEAHLLS 142
           +  E  ++  CIG G +G V++    S +  AL    K   + T  +  E F  EA  + 
Sbjct: 10  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 69
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H +IVKL G  + +  +++I +    G L   L+       LD    +     ++ A
Sbjct: 70  QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTA 126
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYI 260
           L+YL        VHRDI++ N+L++S     + DFG++R +  DS+      G     ++
Sbjct: 127 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 182
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM 288
           APE       T   DV+ FGV   E+LM
Sbjct: 183 APESINFRRFTSASDVWMFGVCMWEILM 210

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           IG+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 151
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 208
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 96  CIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQT-EAHLLS--QIRHRNIVK 151
            +G+G +G+V++   +P G+ + +        + +  +SFQ    H+L+   + H +IV+
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR----LDWTKRVNIVKSMAHALSYLH 207
           L G C     + L+ +Y+  GSL   +R    A+     L+W   V I K M +   +  
Sbjct: 98  LLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGMYYLEEH-- 152
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD------SSNRTVVAGTHGYIA 261
                 +VHR++++ N+LL S  +  VADFGVA LL  D      S  +T +     ++A
Sbjct: 153 -----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMA 203
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL 287
            E  +    T + DV+S+GV   E++
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 68
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 61
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK---KLHHSETELAFLESFQTEAHLLS 142
           +  E  ++  CIG G +G V++    S +  AL    K   + T  +  E F  EA  + 
Sbjct: 9   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 68
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H +IVKL G  + +  +++I +    G L   L+       LD    +     ++ A
Sbjct: 69  QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTA 125
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYI 260
           L+YL        VHRDI++ N+L++S     + DFG++R +  DS+      G     ++
Sbjct: 126 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 181
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM 288
           APE       T   DV+ FGV   E+LM
Sbjct: 182 APESINFRRFTSASDVWMFGVCMWEILM 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK---KLHHSETELAFLESFQTEAHLLS 142
           +  E  ++  CIG G +G V++    S +  AL    K   + T  +  E F  EA  + 
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 71
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H +IVKL G  + +  +++I +    G L   L+       LD    +     ++ A
Sbjct: 72  QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTA 128
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYI 260
           L+YL        VHRDI++ N+L++S     + DFG++R +  DS+      G     ++
Sbjct: 129 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 184
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM 288
           APE       T   DV+ FGV   E+LM
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILM 212

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 91  FDIKYCIGTGGYGSVYRAQ------LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           +D +  +GTG +  V  A+      L + K +A K L   E       S + E  +L +I
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG------SMENEIAVLHKI 73
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           +H NIV L         ++LI + +  G LF  +         D ++   ++  +  A+ 
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVK 130
Query: 205 YLHCDCIPSIVHRDISSNNIL---LNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           YLH      IVHRD+   N+L   L+   +  ++DFG++++     S  +   GT GY+A
Sbjct: 131 YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVA 186
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      ++  D +S GV+A  +L G  P
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY        +     +VA+K ++ + +    +E F  
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 99
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR       N+        
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R ++     
Sbjct: 160 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     +++PE     V T   DV+SFGVV  E+
Sbjct: 217 RK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 142
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAPEIMLNWMHYNQT 199
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 166
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXVA-TRWYRAPEIMLNWMHYNQT 223
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 224 VDIWSVGCIMAELLTGR 240

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK---KLHHSETELAFLESFQTEAHLLS 142
           +  E  ++  CIG G +G V++    S +  AL    K   + T  +  E F  EA  + 
Sbjct: 35  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 94
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H +IVKL G  + +  +++I +    G L   L+    +  LD    +     ++ A
Sbjct: 95  QFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTA 151
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYI 260
           L+YL        VHRDI++ N+L++S     + DFG++R +  DS+      G     ++
Sbjct: 152 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 207
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM 288
           APE       T   DV+ FGV   E+LM
Sbjct: 208 APESINFRRFTSASDVWMFGVCMWEILM 235

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 93  IKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           ++  IG G +G V+R +   G++VA+K     E    F E+   E +    +RH NI+  
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENIL-- 99
Query: 153 YGFCLHKK-------CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
            GF             ++L+  Y   GSLF  L      +       + +  S A  L++
Sbjct: 100 -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAH 154
Query: 206 LHCDCI-----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-----G 255
           LH + +     P+I HRD+ S NIL+       +AD G+A + H  +++   +A     G
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 213
Query: 256 THGYIAPEL---AYTMVLTE---KCDVYSFGVVALEV 286
           T  Y+APE+   +  M   E   + D+Y+ G+V  E+
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            IG G +  V  A+ + +GK+VA+K +  ++   + L+    E  +   + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 155 FCLHKKCMFLIYKYMRRGSLFCIL----RNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
               +K ++L+ +Y   G +F  L    R  ++  R  +       + +  A+ Y H   
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF-------RQIVSAVQYCHQKF 133
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL 270
              IVHRD+ + N+LL++     +ADFG +    +  +      G   Y APEL      
Sbjct: 134 ---IVHRDLKAENLLLDADXNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 271 T-EKCDVYSFGVVALEVLMGRHPGD 294
              + DV+S GV+   ++ G  P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 142
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 199
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 68
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 96  CIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEA-HLLS--QIRHRNIVK 151
            +G+G +G+V++   +P G+ + +        + +  +SFQ    H+L+   + H +IV+
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR----LDWTKRVNIVKSMAHALSYLH 207
           L G C     + L+ +Y+  GSL   +R    A+     L+W   V I K M +   +  
Sbjct: 80  LLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGMYYLEEH-- 134
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD------SSNRTVVAGTHGYIA 261
                 +VHR++++ N+LL S  +  VADFGVA LL  D      S  +T +     ++A
Sbjct: 135 -----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMA 185
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVL 287
            E  +    T + DV+S+GV   E++
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 156
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 157 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 213
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 214 VDIWSVGCIMAELLTGR 230

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 91  FDIKYCIGTGGYGSVY---RAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           F++   +G G +G V+   +   P SG   A+K L  +  ++      + E  +L+ + H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 147 RNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAH 201
             +VKL Y F    K ++LI  ++R G LF  L  +    +E ++         +  +A 
Sbjct: 90  PFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELAL 141
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
            L +LH      I++RD+   NILL+ +    + DFG+++             GT  Y+A
Sbjct: 142 GLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMA 198
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      +   D +S+GV+  E+L G  P
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 165
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 222
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 223 VDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 166
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 223
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 224 VDIWSVGCIMAELLTGR 240

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 22/222 (9%)
Query: 79  ITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEA 138
           I  QE  +  E  +I   IG G +G VY  +     +VA++ +         L++F+ E 
Sbjct: 23  IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREV 80
Query: 139 HLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS 198
               Q RH N+V   G C+    + +I    +  +L+ ++R  D  I LD  K   I + 
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQE 138
Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-----TVV 253
           +   + YLH      I+H+D+ S N+  ++  +  + DFG+  +     + R      + 
Sbjct: 139 IVKGMGYLHAK---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 254 AGTHGYIAPELAYTMV---------LTEKCDVYSFGVVALEV 286
            G   ++APE+   +           ++  DV++ G +  E+
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
             E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 157
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 158 IHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 214
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 215 VDIWSVGCIMAELLTGR 231

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE 
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 175
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 151
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 208
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 47/281 (16%)
Query: 92  DIKY--CIGTGGYGSVYRAQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           DIK+   IG G +G V +A++         A+K++    ++      F  E  +L ++ H
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGH 81
Query: 147 R-NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-------------DDEAIRLDWTKR 192
             NI+ L G C H+  ++L  +Y   G+L   LR              +  A  L   + 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
           ++    +A  + YL        +HR++++ NIL+     A +ADFG++R           
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR------GQEVY 192
Query: 253 VAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLI 306
           V  T G     ++A E     V T   DV+S+GV+  E++ +G  P   ++       L 
Sbjct: 193 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LY 248
Query: 307 DLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           + L Q  R+  P++    + D++        C R KP  RP
Sbjct: 249 EKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERP 283

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK---KLHHSETELAFLESFQTEAHLLS 142
           +  E  ++  CIG G +G V++    S +  A+    K   + T  +  E F  EA  + 
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H +IVKL G  + +  +++I +    G L   L+    +  LD    +     ++ A
Sbjct: 67  QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTA 123
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYI 260
           L+YL        VHRDI++ N+L++S     + DFG++R +  DS+      G     ++
Sbjct: 124 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 179
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM 288
           APE       T   DV+ FGV   E+LM
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEILM 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 90  DFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLES-FQTEAHLLSQIRHR 147
           ++ I   +G G +G V  A    +G+KVALK ++      + ++   + E   L  +RH 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           +I+KLY     K  + ++ +Y        I++ D    ++   +     + +  A+ Y H
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCH 120
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAY 266
                 IVHRD+   N+LL+  L   +ADFG++ ++ +D +      G+  Y APE ++ 
Sbjct: 121 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 176
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGD 294
            +    + DV+S GV+   +L  R P D
Sbjct: 177 KLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 61
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK---KLHHSETELAFLESFQTEAHLLS 142
           +  E  ++  CIG G +G V++    S +  A+    K   + T  +  E F  EA  + 
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 446
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H +IVKL G  + +  +++I +    G L   L+       LD    +     ++ A
Sbjct: 447 QFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTA 503
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYI 260
           L+YL        VHRDI++ N+L++S     + DFG++R +  DS+      G     ++
Sbjct: 504 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 559
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM 288
           APE       T   DV+ FGV   E+LM
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILM 587

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 93  IKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           ++  IG G +G V+R +   G++VA+K     E    F E+   E +    +RH NI+  
Sbjct: 33  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENIL-- 86
Query: 153 YGFCLHKK-------CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
            GF             ++L+  Y   GSLF  L      +       + +  S A  L++
Sbjct: 87  -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAH 141
Query: 206 LHCDCI-----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-----G 255
           LH + +     P+I HRD+ S NIL+       +AD G+A + H  +++   +A     G
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 200
Query: 256 THGYIAPEL---AYTMVLTE---KCDVYSFGVVALEV 286
           T  Y+APE+   +  M   E   + D+Y+ G+V  E+
Sbjct: 201 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGXVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 143
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 200
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 201 VDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 142
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 199
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 144
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 145 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 201
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 202 VDIWSVGCIMAELLTGR 218

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 151
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 208
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 145
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 146 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 202
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 203 VDIWSVGCIMAELLTGR 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 148
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 205
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 157
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 158 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 214
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 215 VDIWSVGCIMAELLTGR 231

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 143
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 200
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 201 VDIWSVGCIMAELLTGR 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 169
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 226
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 227 VDIWSVGCIMAELLTGR 243

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 90  DFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLES-FQTEAHLLSQIRHR 147
           ++ I   +G G +G V  A    +G+KVALK ++      + ++   + E   L  +RH 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           +I+KLY     K  + ++ +Y        I++ D    ++   +     + +  A+ Y H
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCH 124
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAY 266
                 IVHRD+   N+LL+  L   +ADFG++ ++ +D +      G+  Y APE ++ 
Sbjct: 125 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 180
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGD 294
            +    + DV+S GV+   +L  R P D
Sbjct: 181 KLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNAMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 166
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 223
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 224 VDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 165
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 222
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 223 VDIWSVGCIMAELLTGR 239

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 158
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 215
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 216 VDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 158
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 215
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 216 VDIWSVGCIMAELLTGR 232

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 152
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 209
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 152
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 209
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 93  IKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           ++  IG G +G V+R +   G++VA+K     E    F E+   E +    +RH NI+  
Sbjct: 13  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENIL-- 66
Query: 153 YGFCLHKK-------CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
            GF             ++L+  Y   GSLF  L      +       + +  S A  L++
Sbjct: 67  -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAH 121
Query: 206 LHCDCI-----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-----G 255
           LH + +     P+I HRD+ S NIL+       +AD G+A + H  +++   +A     G
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 180
Query: 256 THGYIAPEL---AYTMVLTE---KCDVYSFGVVALEV 286
           T  Y+APE+   +  M   E   + D+Y+ G+V  E+
Sbjct: 181 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 153
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 210
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 151
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 208
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 93  IKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           ++  IG G +G V+R +   G++VA+K     E    F E+   E +    +RH NI+  
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENIL-- 60
Query: 153 YGFCLHKK-------CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
            GF             ++L+  Y   GSLF  L      +       + +  S A  L++
Sbjct: 61  -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAH 115
Query: 206 LHCDCI-----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-----G 255
           LH + +     P+I HRD+ S NIL+       +AD G+A + H  +++   +A     G
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 174
Query: 256 THGYIAPEL---AYTMVLTE---KCDVYSFGVVALEV 286
           T  Y+APE+   +  M   E   + D+Y+ G+V  E+
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 148
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 205
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 93  IKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           ++  IG G +G V+R +   G++VA+K     E    F E+   E +    +RH NI+  
Sbjct: 10  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENIL-- 63
Query: 153 YGFCLHKK-------CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
            GF             ++L+  Y   GSLF  L      +       + +  S A  L++
Sbjct: 64  -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAH 118
Query: 206 LHCDCI-----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-----G 255
           LH + +     P+I HRD+ S NIL+       +AD G+A + H  +++   +A     G
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 177
Query: 256 THGYIAPEL---AYTMVLTE---KCDVYSFGVVALEV 286
           T  Y+APE+   +  M   E   + D+Y+ G+V  E+
Sbjct: 178 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/270 (22%), Positives = 115/270 (42%), Gaps = 33/270 (12%)
Query: 97  IGTGGYGSVYR------AQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +G GG+   Y        ++ +GK   K  L K H  E          TE  +   + + 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-------KMSTEIAIHKSLDNP 102
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           ++V  +GF      ++++ +  RR SL  + +        +       ++     + YLH
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEAR---YFMRQTIQGVQYLH 159
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
            +    ++HRD+   N+ LN  ++  + DFG+A  +  D   +  + GT  YIAPE+   
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCK 216
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
              + + D++S G +   +L+G+ P +  S +    + I   +  VP  I+         
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINP-------- 267
Query: 328 LVSKIVFACLRSKPTSRP--MQRVSQEFLV 355
           + S ++   L + PT RP   + ++ EF  
Sbjct: 268 VASALIRRMLHADPTLRPSVAELLTDEFFT 297

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 93  IKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           ++  IG G +G V+R +   G++VA+K     E    F E+   E +    +RH NI+  
Sbjct: 8   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENIL-- 61
Query: 153 YGFCLHKK-------CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
            GF             ++L+  Y   GSLF  L      +       + +  S A  L++
Sbjct: 62  -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAH 116
Query: 206 LHCDCI-----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-----G 255
           LH + +     P+I HRD+ S NIL+       +AD G+A + H  +++   +A     G
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 175
Query: 256 THGYIAPEL---AYTMVLTE---KCDVYSFGVVALEV 286
           T  Y+APE+   +  M   E   + D+Y+ G+V  E+
Sbjct: 176 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 148
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 205
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 90  DFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLES-FQTEAHLLSQIRHR 147
           ++ I   +G G +G V  A    +G+KVALK ++      + ++   + E   L  +RH 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           +I+KLY     K  + ++ +Y        I++ D    ++   +     + +  A+ Y H
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCH 130
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAY 266
                 IVHRD+   N+LL+  L   +ADFG++ ++ +D +      G+  Y APE ++ 
Sbjct: 131 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 186
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGD 294
            +    + DV+S GV+   +L  R P D
Sbjct: 187 KLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 158
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 215
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 216 VDIWSVGCIMAELLTGR 232

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 90  DFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLES-FQTEAHLLSQIRHR 147
           ++ I   +G G +G V  A    +G+KVALK ++      + ++   + E   L  +RH 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           +I+KLY     K  + ++ +Y        I++ D    ++   +     + +  A+ Y H
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCH 129
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAY 266
                 IVHRD+   N+LL+  L   +ADFG++ ++ +D +      G+  Y APE ++ 
Sbjct: 130 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 185
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGD 294
            +    + DV+S GV+   +L  R P D
Sbjct: 186 KLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 148
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 205
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 169
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGYVA-TRWYRAPEIMLNWMHYNQT 226
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 227 VDIWSVGCIMAELLTGR 243

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 114/255 (44%), Gaps = 21/255 (8%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSG----KKVALKKLHHSE--TELAFLESFQTEAH 139
           V  E+F++   +GTG YG V+  +  SG    K  A+K L  +    +    E  +TE  
Sbjct: 51  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 140 LLSQIRHRN-IVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI-V 196
           +L  IR    +V L Y F    K + LI  Y+  G LF  L   +          V I V
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTE----HEVQIYV 165
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-VAG 255
             +  AL +LH      I++RDI   NILL+S     + DFG+++   +D + R     G
Sbjct: 166 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 256 THGYIAPEL--AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI-DLLDQR 312
           T  Y+AP++         +  D +S GV+  E+L G  P  +    N +  +   +L   
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
Query: 313 VPSPIDDQTVIQDII 327
            P P +   + +D+I
Sbjct: 283 PPYPQEMSALAKDLI 297

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           DF+   C+G GG+G V+ A+        A+K++     ELA  E    E   L+++ H  
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHPG 64
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR------------VNIV 196
           IV+ +   L K     +     +  L+  ++   +    DW               ++I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-- 254
             +A A+ +LH      ++HRD+  +NI         V DFG+   +  D   +TV+   
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 255 ----------GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
                     GT  Y++PE  +    + K D++S G++  E+L
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 105/219 (47%), Gaps = 18/219 (8%)
Query: 79  ITFQEMIVATEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTE 137
           + FQ M    E+      +G G +  V R  ++ +G++ A K ++  +      +  + E
Sbjct: 18  LYFQSMYQLFEE------LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLERE 71
Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
           A +   ++H NIV+L+     +   +LI+  +  G LF      ++ +  ++    +   
Sbjct: 72  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASH 125
Query: 198 SMAHAL-SYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVV 253
            +   L + LHC  +  +VHRD+   N+LL SKL+     +ADFG+A  +  +       
Sbjct: 126 CIQQILEAVLHCHQM-GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 184
Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           AGT GY++PE+       +  D+++ GV+   +L+G  P
Sbjct: 185 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/270 (22%), Positives = 115/270 (42%), Gaps = 33/270 (12%)
Query: 97  IGTGGYGSVYR------AQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +G GG+   Y        ++ +GK   K  L K H  E          TE  +   + + 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-------KMSTEIAIHKSLDNP 102
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           ++V  +GF      ++++ +  RR SL  + +        +       ++     + YLH
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEAR---YFMRQTIQGVQYLH 159
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
            +    ++HRD+   N+ LN  ++  + DFG+A  +  D   +  + GT  YIAPE+   
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCK 216
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
              + + D++S G +   +L+G+ P +  S +    + I   +  VP  I+         
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINP-------- 267
Query: 328 LVSKIVFACLRSKPTSRP--MQRVSQEFLV 355
           + S ++   L + PT RP   + ++ EF  
Sbjct: 268 VASALIRRMLHADPTLRPSVAELLTDEFFT 297

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 119/276 (43%), Gaps = 47/276 (17%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           DF     IG+GG+G V++A+    GK   +K++ ++       E  + E   L+++ H N
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVN 65
Query: 149 IVKLYGFCL-----------------HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           IV  Y  C                    KC+F+  ++  +G+L   +       +LD   
Sbjct: 66  IVH-YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVL 123
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
            + + + +   + Y+H      +++RD+  +NI L    +  + DFG+   L +D   R 
Sbjct: 124 ALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-RX 179
Query: 252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ 311
              GT  Y++PE   +    ++ D+Y+ G++  E+L   H  D  ++        DL D 
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCD--TAFETSKFFTDLRDG 234
Query: 312 RVPSPID--DQTVIQDIILVSKIVFACLRSKPTSRP 345
            +    D  ++T++Q +          L  KP  RP
Sbjct: 235 IISDIFDKKEKTLLQKL----------LSKKPEDRP 260

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLES-FQTEAHLLSQIRHRNIVKLYG 154
           +G+G +  V+   Q  +GK  ALK +  S    AF +S  + E  +L +I+H NIV L  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN--IVKSMAHALSYLHCDCIP 212
                   +L+ + +  G LF     D    R  +T++    +++ +  A+ YLH +   
Sbjct: 74  IYESTTHYYLVMQLVSGGELF-----DRILERGVYTEKDASLVIQQVLSAVKYLHEN--- 125
Query: 213 SIVHRDISSNNILL-----NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
            IVHRD+   N+L      NSK+   + DFG++++    +   +   GT GY+APE+   
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKI--MITDFGLSKM--EQNGIMSTACGTPGYVAPEVLAQ 181
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              ++  D +S GV+   +L G  P
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALK---KLHHSETELAFLESFQTEAHLLS 142
           +  E  ++  CIG G +G V++    S +  A+    K   + T  +  E F  EA  + 
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q  H +IVKL G  + +  +++I +    G L   L+       LD    +     ++ A
Sbjct: 67  QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTA 123
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYI 260
           L+YL        VHRDI++ N+L+++     + DFG++R +  DS+      G     ++
Sbjct: 124 LAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 179
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM 288
           APE       T   DV+ FGV   E+LM
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEILM 207

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 152
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 209
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 129/280 (46%), Gaps = 30/280 (10%)
Query: 79  ITFQEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTE 137
           I  Q   V  +D +    +G G YG V + + +PSG+ +A+K++       A + S + +
Sbjct: 41  IGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR------ATVNSQEQK 94
Query: 138 AHLLS-QIRHRNI-----VKLYGFCLHKKCMFLIYKYMRRG--SLFCILRNDDEAIRLDW 189
             L+   I  R +     V  YG    +  +++  + M       +  + +  + I  D 
Sbjct: 95  RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI 154
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
             ++ +  S+  AL +LH     S++HRD+  +N+L+N+  +  + DFG++  L  DS  
Sbjct: 155 LGKIAV--SIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDSVA 209
Query: 250 RTVVAGTHGYIAPELAYTMV----LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIML 305
           +T+ AG   Y+APE     +     + K D++S G+  +E+ + R P D  S   P   L
Sbjct: 210 KTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD--SWGTPFQQL 267
Query: 306 IDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             ++++  P    D+   + +   S+    CL+     RP
Sbjct: 268 KQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERP 303

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H NIVKL+     +   FL+ + +  G LF  ++   +      T+   I++ +  A+S+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK---KKKHFSETEASYIMRKLVSAVSH 121
Query: 206 LHCDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           +H      +VHRD+   N+L    N  LE  + DFG ARL   D+        T  Y AP
Sbjct: 122 MH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           EL       E CD++S GV+   +L G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 152
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 209
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 116/263 (44%), Gaps = 19/263 (7%)
Query: 90  DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLES-FQTEAHLLSQIRHR 147
           +F I+  IG G +  VYRA  L  G  VALKK+   +   A   +    E  LL Q+ H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV-NIVKSMAHALSYL 206
           N++K Y   +    + ++ +    G L  ++++  +  RL   + V      +  AL ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      ++HRDI   N+ + +     + D G+ R   S ++    + GT  Y++PE  +
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP--GDLLS--SVNPKIMLIDLLDQRVPSPIDDQTV 322
                 K D++S G +  E+   + P  GD ++  S+  KI   D      P P D  + 
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY----PPLPSDHYSE 265
Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
                 + ++V  C+   P  RP
Sbjct: 266 -----ELRQLVNMCINPDPEKRP 283

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/270 (22%), Positives = 115/270 (42%), Gaps = 33/270 (12%)
Query: 97  IGTGGYGSVYR------AQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +G GG+   Y        ++ +GK   K  L K H  E          TE  +   + + 
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-------KMSTEIAIHKSLDNP 86
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           ++V  +GF      ++++ +  RR SL  + +        +       ++     + YLH
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEAR---YFMRQTIQGVQYLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
            +    ++HRD+   N+ LN  ++  + DFG+A  +  D   +  + GT  YIAPE+   
Sbjct: 144 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK 200
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
              + + D++S G +   +L+G+ P +  S +    + I   +  VP  I+         
Sbjct: 201 KGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINP-------- 251
Query: 328 LVSKIVFACLRSKPTSRP--MQRVSQEFLV 355
           + S ++   L + PT RP   + ++ EF  
Sbjct: 252 VASALIRRMLHADPTLRPSVAELLTDEFFT 281

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 97  IGTGGYGSVYRAQLPSGKK-VALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           +G G + +VY+A+  +  + VA+KK+   H SE +     +   E  LL ++ H NI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
                HK  + L++ +M    L  I++++   +     K   ++      L YLH   I 
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT--LQGLEYLHQHWI- 133
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY-TMVLT 271
             +HRD+  NN+LL+      +ADFG+A+   S +        T  Y APEL +   +  
Sbjct: 134 --LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 272 EKCDVYSFGVVALEVLM 288
              D+++ G +  E+L+
Sbjct: 192 VGVDMWAVGCILAELLL 208

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           + DF +K  +G G YG V  A   P+G+ VA+KK+   +  L  L + + E  +L   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 147 RNIVKLYGF----CLHKKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIVKSM 199
            NI+ ++               I + + +  L  ++      D+ I+         +   
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-------FIYQT 121
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG---- 255
             A+  LH     +++HRD+  +N+L+NS  +  V DFG+AR++   +++ +   G    
Sbjct: 122 LRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 256 ------THGYIAPELAYTMV-LTEKCDVYSFGVVALEVLMGR 290
                 T  Y APE+  T    +   DV+S G +  E+ + R
Sbjct: 179 MTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           + DF +K  +G G YG V  A   P+G+ VA+KK+   +  L  L + + E  +L   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 147 RNIVKLYGF----CLHKKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIVKSM 199
            NI+ ++               I + + +  L  ++      D+ I+         +   
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-------FIYQT 121
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG---- 255
             A+  LH     +++HRD+  +N+L+NS  +  V DFG+AR++   +++ +   G    
Sbjct: 122 LRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 256 ------THGYIAPELAYTMV-LTEKCDVYSFGVVALEVLMGR 290
                 T  Y APE+  T    +   DV+S G +  E+ + R
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKK----VALKKLHHSETELAFLESFQTEAHLL 141
           +  E  ++  CIG G +G V++    S +     VA+K   +  ++ +  E F  EA  +
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-SVREKFLQEALTM 445
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
            Q  H +IVKL G  + +  +++I +    G L   L+       LD    +     ++ 
Sbjct: 446 RQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLST 502
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GY 259
           AL+YL        VHRDI++ N+L+++     + DFG++R +  DS+      G     +
Sbjct: 503 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKW 558
Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLM 288
           +APE       T   DV+ FGV   E+LM
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILM 587

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           + DF +K  +G G YG V  A   P+G+ VA+KK+   +  L  L + + E  +L   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 147 RNIVKLYGF----CLHKKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIVKSM 199
            NI+ ++               I + + +  L  ++      D+ I+         +   
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-------FIYQT 121
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG---- 255
             A+  LH     +++HRD+  +N+L+NS  +  V DFG+AR++   +++ +   G    
Sbjct: 122 LRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 256 ------THGYIAPELAYTMV-LTEKCDVYSFGVVALEVLMGR 290
                 T  Y APE+  T    +   DV+S G +  E+ + R
Sbjct: 179 MTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/270 (22%), Positives = 115/270 (42%), Gaps = 33/270 (12%)
Query: 97  IGTGGYGSVYR------AQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +G GG+   Y        ++ +GK   K  L K H  E          TE  +   + + 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-------KMSTEIAIHKSLDNP 102
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           ++V  +GF      ++++ +  RR SL  + +        +       ++     + YLH
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEAR---YFMRQTIQGVQYLH 159
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
            +    ++HRD+   N+ LN  ++  + DFG+A  +  D   +  + GT  YIAPE+   
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK 216
Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
              + + D++S G +   +L+G+ P +  S +    + I   +  VP  I+         
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINP-------- 267
Query: 328 LVSKIVFACLRSKPTSRP--MQRVSQEFLV 355
           + S ++   L + PT RP   + ++ EF  
Sbjct: 268 VASALIRRMLHADPTLRPSVAELLTDEFFT 297

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + D+G+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  ++ +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+ R  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 121/270 (44%), Gaps = 28/270 (10%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT---EAHLLSQIRHRNIVKL 152
           IG G +G+VY A+ + + + VA+KK+ +S  +    E +Q    E   L ++RH N ++ 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
            G  L +   +L+ +Y   GS   +L    + ++    +   +       L+YLH     
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE--VEIAAVTHGALQGLAYLHSH--- 173
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           +++HRD+ + NILL+      + DFG A ++    +      GT  ++APE+   M   +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAPEVILAMDEGQ 229
Query: 273 ---KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILV 329
              K DV+S G+  +E+   + P   L ++N    L  +     P+              
Sbjct: 230 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNESPALQSGHWS----EYF 282
Query: 330 SKIVFACLRSKPTSRPMQRV--SQEFLVRK 357
              V +CL+  P  RP   V     F++R+
Sbjct: 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 121/270 (44%), Gaps = 28/270 (10%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT---EAHLLSQIRHRNIVKL 152
           IG G +G+VY A+ + + + VA+KK+ +S  +    E +Q    E   L ++RH N ++ 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
            G  L +   +L+ +Y   GS   +L    + ++    +   +       L+YLH     
Sbjct: 81  RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE--VEIAAVTHGALQGLAYLHSH--- 134
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           +++HRD+ + NILL+      + DFG A ++    +      GT  ++APE+   M   +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAPEVILAMDEGQ 190
Query: 273 ---KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILV 329
              K DV+S G+  +E+   + P   L ++N    L  +     P+              
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNESPALQSGHWS----EYF 243
Query: 330 SKIVFACLRSKPTSRPMQRV--SQEFLVRK 357
              V +CL+  P  RP   V     F++R+
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  +  + SG K+A+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F            Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 175
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+D      VA T  Y APE+    M     
Sbjct: 176 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNMT 232
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 233 VDIWSVGCIMAELLTGR 249

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 114/271 (42%), Gaps = 40/271 (14%)
Query: 97  IGTGGYGSVYRA----QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY      Q  +  + A+K L    TE+  +E+F  E  L+  + H N++ L
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 153 YGFCLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
            G  L  + +  ++  YM  G L   +R+      +     ++    +A  + YL     
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL---AE 142
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPELAY 266
              VHRD+++ N +L+      VADFG+AR +  D    +V    H      + A E   
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD--------QRVPSPID 318
           T   T K DV+SFGV+  E         LL+   P    ID  D        +R+P P  
Sbjct: 202 TYRFTTKSDVWSFGVLLWE---------LLTRGAPPYRHIDPFDLTHFLAQGRRLPQP-- 250
Query: 319 DQTVIQDIILVSKIVFACLRSKPTSRPMQRV 349
                 D +   +++  C  + P  RP  RV
Sbjct: 251 --EYCPDSLY--QVMQQCWEADPAVRPTFRV 277

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 63
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 121
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 178
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE L 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 97  IGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +G V   +       +G++VA+K L   E+    +   + E  +L  + H NIVK
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 152 LYGFCLHK--KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR--VNIVKSMAHALSYLH 207
             G C       + LI +++  GSL   L  +   I L    +  V I K M +  S  +
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY 147
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPEL 264
                  VHRD+++ N+L+ S+ +  + DFG+ + + +D    TV         + APE 
Sbjct: 148 -------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 265 AYTMVLTEKCDVYSFGVVALEVL 287
                     DV+SFGV   E+L
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELL 223

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE L 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 93  IKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLE-SFQTEAHLLSQIRHRNIV 150
           I+  +G G +G V  A    + +KVALK +     + + +    + E   L  +RH +I+
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
           KLY        + ++ +Y   G LF  +    E  R+   +     + +  A+ Y H   
Sbjct: 73  KLYDVITTPTDIVMVIEYAG-GELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRH- 127
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMV 269
              IVHRD+   N+LL+  L   +ADFG++ ++ +D +      G+  Y APE +   + 
Sbjct: 128 --KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 270 LTEKCDVYSFGVVALEVLMGRHPGD 294
              + DV+S G+V   +L+GR P D
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 103/210 (49%), Gaps = 12/210 (5%)
Query: 88  TEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           TE++ +   +G G +  V R  ++ +G++ A   ++  +      +  + EA +   ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL-SY 205
            NIV+L+     +   +LI+  +  G LF      ++ +  ++    +    +   L + 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQQILEAV 123
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           LHC  +  +VHR++   N+LL SKL+     +ADFG+A  +  +       AGT GY++P
Sbjct: 124 LHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E+       +  D+++ GV+   +L+G  P
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VAL K+   +ETE     +   E  LL ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETE-GVPSTAIREISLLKELNH 61
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VAL K+   +ETE     +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETE-GVPSTAIREISLLKELNH 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V++ +   +G+ VA+KK   SE +    +    E  +L Q++H N+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMA----HALSYLH-CDC 210
              K+ + L+++Y     L        E  R       ++VKS+      A+++ H  +C
Sbjct: 71  FRRKRRLHLVFEYCDHTVLH-------ELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY-TMV 269
           I    HRD+   NIL+       + DFG ARLL   S        T  Y +PEL      
Sbjct: 124 I----HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 270 LTEKCDVYSFGVVALEVLMG 289
                DV++ G V  E+L G
Sbjct: 180 YGPPVDVWAIGCVFAELLSG 199

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 118 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 108/224 (48%), Gaps = 24/224 (10%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALK-----KLHHSETELAFLESF 134
           FQ M+   + +++   +G+G +  V +  Q  +GK+ A K     +L  S   ++  E  
Sbjct: 20  FQSMV--EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVS-REEI 76
Query: 135 QTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
           + E ++L +IRH NI+ L+    +K  + LI + +  G LF  L   +     + T+   
Sbjct: 77  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ--- 133
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILL------NSKLEAFVADFGVARLLHSDSS 248
            +K +   + YLH      I H D+   NI+L      N +++  + DFG+A  + + + 
Sbjct: 134 FLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIEAGNE 188
Query: 249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
            + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 189 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 120/289 (41%), Gaps = 60/289 (20%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           DF     IG+GG+G V++A+    GK   ++++ ++       E  + E   L+++ H N
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN------EKAEREVKALAKLDHVN 66
Query: 149 IVKLYGFCLH------------------------------KKCMFLIYKYMRRGSLFCIL 178
           IV  Y  C                                 KC+F+  ++  +G+L   +
Sbjct: 67  IVH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI 125
Query: 179 RNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG 238
                  +LD    + + + +   + Y+H      ++HRD+  +NI L    +  + DFG
Sbjct: 126 EKR-RGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS 298
           +   L +D   RT   GT  Y++PE   +    ++ D+Y+ G++  E+L   H  D  ++
Sbjct: 182 LVTSLKND-GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCD--TA 235
Query: 299 VNPKIMLIDLLDQRVPSPID--DQTVIQDIILVSKIVFACLRSKPTSRP 345
                   DL D  +    D  ++T++Q +          L  KP  RP
Sbjct: 236 FETSKFFTDLRDGIISDIFDKKEKTLLQKL----------LSKKPEDRP 274

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 97  IGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +G V   +       +G++VA+K L   E+    +   + E  +L  + H NIVK
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 152 LYGFCLHK--KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR--VNIVKSMAHALSYLH 207
             G C       + LI +++  GSL   L  +   I L    +  V I K M +  S  +
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY 135
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPEL 264
                  VHRD+++ N+L+ S+ +  + DFG+ + + +D    TV         + APE 
Sbjct: 136 -------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 265 AYTMVLTEKCDVYSFGVVALEVL 287
                     DV+SFGV   E+L
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELL 211

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V   Y       K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           G C  +  M L+ +    G L   L+ +    D+ I       + +V  ++  + YL   
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI-------IELVHQVSMGMKYLEES 146
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
              + VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG     + APE 
Sbjct: 147 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPEC 201
Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 + K DV+SFGV+  E    G+ P
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V   Y       K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           G C  +  M L+ +    G L   L+ +    D+ I       + +V  ++  + YL   
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI-------IELVHQVSMGMKYLEES 146
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
              + VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG     + APE 
Sbjct: 147 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPEC 201
Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 + K DV+SFGV+  E    G+ P
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 9/204 (4%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +DI   +G+G +G V+R    +  +V + K  ++   L    + + E  +++Q+ H  ++
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLI 111
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
            L+     K  M LI +++  G LF  +  +D   ++   + +N ++     L ++H   
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH- 168
Query: 211 IPSIVHRDISSNNILLNSKLEAFVA--DFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
             SIVH DI   NI+  +K  + V   DFG+A  L+ D   + V   T  + APE+    
Sbjct: 169 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK-VTTATAEFAAPEIVDRE 225
Query: 269 VLTEKCDVYSFGVVALEVLMGRHP 292
            +    D+++ GV+   +L G  P
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
           E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++ H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 62
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L++ 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 120
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
           H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE L 
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 266 YTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                +   D++S G +  E++  R   PGD
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V   Y       K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           G C  +  M L+ +    G L   L+ +    D+ I       + +V  ++  + YL   
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI-------IELVHQVSMGMKYLEES 130
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
              + VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG     + APE 
Sbjct: 131 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--XYKAQTHGKWPVKWYAPEC 185
Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 + K DV+SFGV+  E    G+ P
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 91  FDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           +++K  +GTGG+G V R     +G++VA+K+    E      E +  E  ++ ++ H N+
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERWCLEIQIMKKLNHPNV 75
Query: 150 VKLYGF--CLHK----KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           V        L K        L  +Y   G L   L   +    L       ++  ++ AL
Sbjct: 76  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 135
Query: 204 SYLHCDCIPSIVHRDISSNNILLN---SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
            YLH +    I+HRD+   NI+L     +L   + D G A+ L       T   GT  Y+
Sbjct: 136 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC-TEFVGTLQYL 191
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           APEL      T   D +SFG +A E + G  P
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 91  FDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           +++K  +GTGG+G V R     +G++VA+K+    E      E +  E  ++ ++ H N+
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 150 VKLYGF--CLHK----KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           V        L K        L  +Y   G L   L   +    L       ++  ++ AL
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 204 SYLHCDCIPSIVHRDISSNNILLN---SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
            YLH +    I+HRD+   NI+L     +L   + D G A+ L       T   GT  Y+
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC-TEFVGTLQYL 190
Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           APEL      T   D +SFG +A E + G  P
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++       +  +    I L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V   Y       K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           G C  +  M L+ +    G L   L+ +    D+ I       + +V  ++  + YL   
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI-------IELVHQVSMGMKYLEES 144
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
              + VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG     + APE 
Sbjct: 145 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPEC 199
Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 + K DV+SFGV+  E    G+ P
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++       +  +    I L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V   Y       K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           G C  +  M L+ +    G L   L+ +    D+ I       + +V  ++  + YL   
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI-------IELVHQVSMGMKYLEES 130
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
              + VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG     + APE 
Sbjct: 131 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPEC 185
Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 + K DV+SFGV+  E    G+ P
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V   Y       K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           G C  +  M L+ +    G L   L+ +    D+ I       + +V  ++  + YL   
Sbjct: 437 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI-------IELVHQVSMGMKYLEES 488
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
              + VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG     + APE 
Sbjct: 489 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPEC 543
Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 + K DV+SFGV+  E    G+ P
Sbjct: 544 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G YGSV   Y A+L   +KVA+KKL      L        E  LL  ++H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIVKSMAHALS 204
                   +      +L+   M    L  I+++    DE ++        +V  +   L 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKSQALSDEHVQF-------LVYQLLRGLK 145
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           Y+H      I+HRD+  +N+ +N   E  + DFG+AR   +D      VA T  Y APE+
Sbjct: 146 YIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVA-TRWYRAPEI 199
Query: 265 AYT-MVLTEKCDVYSFGVVALEVLMGR 290
               M   +  D++S G +  E+L G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++       +  +    I L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V   Y       K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           G C  +  M L+ +    G L   L+ +    D+ I       + +V  ++  + YL   
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI-------IELVHQVSMGMKYLEES 136
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
              + VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG     + APE 
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPEC 191
Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 + K DV+SFGV+  E    G+ P
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  +  FG+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 153
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+ +   T    T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLAR--HT-ADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V   Y       K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           G C  +  M L+ +    G L   L+ +    D+ I       + +V  ++  + YL   
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI-------IELVHQVSMGMKYLE-- 122
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
              + VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG     + APE 
Sbjct: 123 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPEC 179
Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 + K DV+SFGV+  E    G+ P
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 153
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+ +   T    T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLAR--HT-ADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++       +  +    I L   K  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V   Y       K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           G C  +  M L+ +    G L   L+ +    D+ I       + +V  ++  + YL   
Sbjct: 438 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI-------IELVHQVSMGMKYLEES 489
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
              + VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG     + APE 
Sbjct: 490 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPEC 544
Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 + K DV+SFGV+  E    G+ P
Sbjct: 545 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V   Y       K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           G C  +  M L+ +    G L   L+ +    D+ I       + +V  ++  + YL   
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI-------IELVHQVSMGMKYLE-- 124
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
              + VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG     + APE 
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPEC 181
Query: 265 AYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 + K DV+SFGV+  E    G+ P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 153
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DFG+AR  H+ +   T    T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLAR--HT-ADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 110/228 (48%), Gaps = 23/228 (10%)
Query: 77  GRITFQEMIVATEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALK-----KLHHSETELAF 130
           G  TF++  V  + +++   +G+G +  V +  Q  +GK+ A K     +L  S   ++ 
Sbjct: 1   GMSTFRQEDVE-DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVS- 58
Query: 131 LESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWT 190
            E  + E ++L +IRH NI+ L+    +K  + LI + +  G LF  L   +     + T
Sbjct: 59  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 118
Query: 191 KRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL------NSKLEAFVADFGVARLLH 244
           +    +K +   + YLH      I H D+   NI+L      N +++  + DFG+A  + 
Sbjct: 119 Q---FLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIE 170
Query: 245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           + +  + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 171 AGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 91  FDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           F+++  +G G    VYR  Q  + K  ALK L  +  +    +  +TE  +L ++ H NI
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK----KIVRTEIGVLLRLSHPNI 110
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR--VNIVKSMAHALSYLH 207
           +KL         + L+ + +  G LF     D    +  +++R   + VK +  A++YLH
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELF-----DRIVEKGYYSERDAADAVKQILEAVAYLH 165
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
            +    IVHRD+   N+L  +        +ADFG+++++      +TV  GT GY APE+
Sbjct: 166 EN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV-CGTPGYCAPEI 221
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                   + D++S G++   +L G  P
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + DF +AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH-HSETELAFLESFQTEAHLLSQI 144
           + E+F     IG G YG VY+A+   +G+ VALKK+   +ETE     +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIVKL      +  ++L+++++ +     +  +    I L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE- 263
           + H      ++HRD+   N+L+N++    +ADFG+AR              T  Y APE 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           L      +   D++S G +  E++  R   PGD
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G YGSV   Y A+L   +KVA+KKL      L        E  LL  ++H N++ L 
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 154 G-FCLHKKCMFLIYKYMRRGSLFCILRN-------DDEAIRLDWTKRVNIVKSMAHALSY 205
             F            Y+    +   L N        DE ++        +V  +   L Y
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-------LVYQLLRGLKY 138
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           +H      I+HRD+  +N+ +N   E  + DFG+AR   +D      VA T  Y APE+ 
Sbjct: 139 IHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEMTGYVA-TRWYRAPEIM 192
Query: 266 YT-MVLTEKCDVYSFGVVALEVLMGR 290
              M   +  D++S G +  E+L G+
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + D G+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 90  DFDIKYCIGTGGYGSVYRAQLPSGK-----KVALKKLHHSETELAFLESFQTEAHLLSQI 144
           DF     IG G +G V  A+  + +     KV  KK    + E   + S +    LL  +
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV--LLKNV 96
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           +H  +V L+        ++ +  Y+  G LF  L+   E   L+   R      +A AL 
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARF-YAAEIASALG 153
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           YLH     +IV+RD+   NILL+S+    + DFG+ +     +S  +   GT  Y+APE+
Sbjct: 154 YLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
            +        D +  G V  E+L G  P
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 131/287 (45%), Gaps = 29/287 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPS--GKKVALK-KLHHSETELAFLESFQTEAHLLS 142
           +A ED  +   +G G +G VY     +  G+K+ +  K    +  L   E F +EA ++ 
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWT--KRVNIVKSMA 200
            + H +IVKL G  + ++  ++I +    G L   L  +  ++++       + I K+MA
Sbjct: 65  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 123
Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGY 259
           + L  ++C      VHRDI+  NIL+ S     + DFG++R +   D    +V      +
Sbjct: 124 Y-LESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 176
Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSP 316
           ++PE       T   DV+ F V   E+L  G+ P   L + +    +I +L++  R+P P
Sbjct: 177 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLEKGDRLPKP 232
Query: 317 IDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVRKTLYQLK 363
                V+  ++        C    P+ RP  R ++       +YQ++
Sbjct: 233 DLCPPVLYTLMT------RCWDYDPSDRP--RFTELVCSLSDVYQME 271

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 91  FDIKYCIGTGGYGSVYR-AQLPSGKKVALK-----KLHHSETELAFLESFQTEAHLLSQI 144
           +++   +G+G +  V +  Q  +GK+ A K     +L  S   ++  E  + E ++L +I
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVS-REEIEREVNILREI 65
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           RH NI+ L+    +K  + LI + +  G LF  L   +     + T+    +K +   + 
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ---FLKQILDGVH 122
Query: 205 YLHCDCIPSIVHRDISSNNILL------NSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           YLH      I H D+   NI+L      N +++  + DFG+A  + + +  + +  GT  
Sbjct: 123 YLHS---KRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIEAGNEFKNIF-GTPE 176
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           ++APE+     L  + D++S GV+   +L G  P
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 131/287 (45%), Gaps = 29/287 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPS--GKKVALK-KLHHSETELAFLESFQTEAHLLS 142
           +A ED  +   +G G +G VY     +  G+K+ +  K    +  L   E F +EA ++ 
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWT--KRVNIVKSMA 200
            + H +IVKL G  + ++  ++I +    G L   L  +  ++++       + I K+MA
Sbjct: 81  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 139
Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGY 259
           + L  ++C      VHRDI+  NIL+ S     + DFG++R +   D    +V      +
Sbjct: 140 Y-LESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 192
Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSP 316
           ++PE       T   DV+ F V   E+L  G+ P   L + +    +I +L++  R+P P
Sbjct: 193 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLEKGDRLPKP 248
Query: 317 IDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVRKTLYQLK 363
                V+  ++        C    P+ RP  R ++       +YQ++
Sbjct: 249 DLCPPVLYTLMT------RCWDYDPSDRP--RFTELVCSLSDVYQME 287

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + D G+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G YGSV   Y A+L   +KVA+KKL      L        E  LL  ++H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 154 G-FCLHKKCMFLIYKYMRRGSLFCILRN-------DDEAIRLDWTKRVNIVKSMAHALSY 205
             F            Y+    +   L N        DE ++        +V  +   L Y
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-------LVYQLLRGLKY 146
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           +H      I+HRD+  +N+ +N   E  + DFG+AR   +D      VA T  Y APE+ 
Sbjct: 147 IHS---AGIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVA-TRWYRAPEIM 200
Query: 266 YT-MVLTEKCDVYSFGVVALEVLMGR 290
              M   +  D++S G +  E+L G+
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 131/287 (45%), Gaps = 29/287 (10%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPS--GKKVALK-KLHHSETELAFLESFQTEAHLLS 142
           +A ED  +   +G G +G VY     +  G+K+ +  K    +  L   E F +EA ++ 
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWT--KRVNIVKSMA 200
            + H +IVKL G  + ++  ++I +    G L   L  +  ++++       + I K+MA
Sbjct: 69  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHGY 259
           + L  ++C      VHRDI+  NIL+ S     + DFG++R +   D    +V      +
Sbjct: 128 Y-LESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQ--RVPSP 316
           ++PE       T   DV+ F V   E+L  G+ P   L + +    +I +L++  R+P P
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLEKGDRLPKP 236
Query: 317 IDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVRKTLYQLK 363
                V+  ++        C    P+ RP  R ++       +YQ++
Sbjct: 237 DLCPPVLYTLMT------RCWDYDPSDRP--RFTELVCSLSDVYQME 275

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 9/197 (4%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG- 154
           +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
           F   +        Y+    +   L N  +  +L       ++  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEK 273
           +HRD+  +N+ +N   E  + D G+AR  H+D      VA T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 203
Query: 274 CDVYSFGVVALEVLMGR 290
            D++S G +  E+L GR
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 116/260 (44%), Gaps = 30/260 (11%)
Query: 51  PKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQL 110
           P   KA+P  T  +      ++       +F       ++++I   IG G YG V  A+ 
Sbjct: 20  PGPVKAEPAHTAASVAAKNLALLKAR---SFDVTFDVGDEYEIIETIGNGAYGVVSSARR 76
Query: 111 P-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL---------YGFCLHKK 160
             +G++VA+KK+ ++   +   +    E  +L   +H NI+ +         YG     K
Sbjct: 77  RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG---EFK 133
Query: 161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDIS 220
            ++++   M    L  I+ +  + + L+  +    +  +   L Y+H      ++HRD+ 
Sbjct: 134 SVYVVLDLME-SDLHQII-HSSQPLTLEHVR--YFLYQLLRGLKYMHSA---QVIHRDLK 186
Query: 221 SNNILLNSKLEAFVADFGVARLLHSDSSNR----TVVAGTHGYIAPELAYTM-VLTEKCD 275
            +N+L+N   E  + DFG+AR L +  +      T    T  Y APEL  ++   T+  D
Sbjct: 187 PSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAID 246
Query: 276 VYSFGVVALEVLMGRH--PG 293
           ++S G +  E+L  R   PG
Sbjct: 247 LWSVGCIFGEMLARRQLFPG 266

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 138/313 (44%), Gaps = 40/313 (12%)
Query: 51  PKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQL 110
           P   KA+P  T  +      ++       +F       ++++I   IG G YG V  A+ 
Sbjct: 19  PGPVKAEPAHTAASVAAKNLALLKAR---SFDVTFDVGDEYEIIETIGNGAYGVVSSARR 75
Query: 111 P-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL---------YGFCLHKK 160
             +G++VA+KK+ ++   +   +    E  +L   +H NI+ +         YG     K
Sbjct: 76  RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG---EFK 132
Query: 161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDIS 220
            ++++   M    L  I+ +  + + L+  +    +  +   L Y+H      ++HRD+ 
Sbjct: 133 SVYVVLDLME-SDLHQII-HSSQPLTLEHVR--YFLYQLLRGLKYMHS---AQVIHRDLK 185
Query: 221 SNNILLNSKLEAFVADFGVARLLHSDSSNR----TVVAGTHGYIAPELAYTM-VLTEKCD 275
            +N+L+N   E  + DFG+AR L +  +      T    T  Y APEL  ++   T+  D
Sbjct: 186 PSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAID 245
Query: 276 VYSFGVVALEVLMGRH--PGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIV 333
           ++S G +  E+L  R   PG         IM++       PSP     VIQ +   ++ V
Sbjct: 246 LWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV----LGTPSP----AVIQAV--GAERV 295
Query: 334 FACLRSKPTSRPM 346
            A ++S P  +P+
Sbjct: 296 RAYIQSLPPRQPV 308

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 9/210 (4%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQ 143
           +  ++F+    +G G +G V  A++  +G   A+K L      +   +E   TE  +LS 
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 144 IR-HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
            R H  + +L+        +F + +++  G L   ++   ++ R D  +       +  A
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISA 136
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L +LH      I++RD+  +N+LL+ +    +ADFG+ +    +        GT  YIAP
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAP 193
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E+   M+     D ++ GV+  E+L G  P
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 79  ITFQEMIVAT---EDFDIKYCIGTGGYGSVYR------AQLPSGKKVALKKLHHSETELA 129
           + FQ M   T   +D+ +   +G G +  V R       Q  + K +  KKL   + +  
Sbjct: 18  LYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ-- 75
Query: 130 FLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDW 189
                + EA +   ++H NIV+L+     +   +L++  +  G LF  +   +     D 
Sbjct: 76  ---KLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADA 132
Query: 190 TKRVN-IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHS 245
           +  ++ I++S+ H   +        IVHRD+   N+LL SK +     +ADFG+A  +  
Sbjct: 133 SHCIHQILESVNHIHQH-------DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG 185
Query: 246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +       AGT GY++PE+       +  D+++ GV+   +L+G  P
Sbjct: 186 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHL 140
           V   +F+    +G G +G V    +  +G+  A+K L      ++ E+A      TE  +
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRV 204
Query: 141 LSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS- 198
           L   RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+    R     + 
Sbjct: 205 LQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRE----RVFSEDRARFYGAE 259
Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           +  AL YLH +   ++V+RD+   N++L+      + DFG+ +    D +      GT  
Sbjct: 260 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 317
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+          D +  GVV  E++ GR P
Sbjct: 318 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHL 140
           V   +F+    +G G +G V    +  +G+  A+K L      ++ E+A      TE  +
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRV 201
Query: 141 LSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS- 198
           L   RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+    R     + 
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRE----RVFSEDRARFYGAE 256
Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           +  AL YLH +   ++V+RD+   N++L+      + DFG+ +    D +      GT  
Sbjct: 257 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 314
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+          D +  GVV  E++ GR P
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 127/275 (46%), Gaps = 30/275 (10%)
Query: 84  MIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           M V  +D +    +G G YG V + + +PSG+ +A+K++       A + S + +  L+ 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR------ATVNSQEQKRLLMD 55
Query: 143 -QIRHRNI-----VKLYGFCLHKKCMFLIYKYMRRG--SLFCILRNDDEAIRLDWTKRVN 194
             I  R +     V  YG    +  +++  + M       +  + +  + I  D   ++ 
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115
Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
           +  S+  AL +LH     S++HRD+  +N+L+N+  +  + DFG++  L  D + + + A
Sbjct: 116 V--SIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-KDIDA 170
Query: 255 GTHGYIAPELAYTMV----LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD 310
           G   Y+APE     +     + K D++S G+  +E+ + R P D  S   P   L  +++
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD--SWGTPFQQLKQVVE 228
Query: 311 QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +  P    D+   + +   S+    CL+     RP
Sbjct: 229 EPSPQLPADKFSAEFVDFTSQ----CLKKNSKERP 259

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHL 140
           V   +F+    +G G +G V    +  +G+  A+K L      ++ E+A      TE  +
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRV 63
Query: 141 LSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS- 198
           L   RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+    R     + 
Sbjct: 64  LQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRE----RVFSEDRARFYGAE 118
Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           +  AL YLH +   ++V+RD+   N++L+      + DFG+ +    D +      GT  
Sbjct: 119 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE 176
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+          D +  GVV  E++ GR P
Sbjct: 177 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHL 140
           V   +F+    +G G +G V    +  +G+  A+K L      ++ E+A      TE  +
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRV 61
Query: 141 LSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS- 198
           L   RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+    R     + 
Sbjct: 62  LQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRE----RVFSEDRARFYGAE 116
Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           +  AL YLH +   ++V+RD+   N++L+      + DFG+ +    D +      GT  
Sbjct: 117 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE 174
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+          D +  GVV  E++ GR P
Sbjct: 175 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 7/208 (3%)
Query: 89  EDFDIKY-CIGTGGYGSVYRAQLPSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIR 145
           ED+ + +  +G GG+G V+  Q+ +  K+    K       +    +    E  +L+++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            R IV L      K  + L+   M  G + + I   D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           +LH     +I++RD+   N+LL+      ++D G+A  L +  +     AGT G++APEL
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                     D ++ GV   E++  R P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 25/225 (11%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G VY+A+L  SG+ VA+KK+   +   AF      E  ++ ++ H NIV+L  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGK---AFKNR---ELQIMRKLDHCNIVRLRYF 81
Query: 156 CL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI-VKSMAHALSYLHC 208
                 KK    + L+  Y+   +++ + R+   A +      V + +  +  +L+Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYV-PATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 209 DCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                I HRDI   N+LL+       + DFG A+ L     N + +   + Y APEL + 
Sbjct: 141 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFG 196
Query: 268 MV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
               T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 239

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 7/208 (3%)
Query: 89  EDFDIKY-CIGTGGYGSVYRAQLPSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIR 145
           ED+ + +  +G GG+G V+  Q+ +  K+    K       +    +    E  +L+++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            R IV L      K  + L+   M  G + + I   D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           +LH     +I++RD+   N+LL+      ++D G+A  L +  +     AGT G++APEL
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                     D ++ GV   E++  R P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 7/208 (3%)
Query: 89  EDFDIKY-CIGTGGYGSVYRAQLPSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIR 145
           ED+ + +  +G GG+G V+  Q+ +  K+    K       +    +    E  +L+++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            R IV L      K  + L+   M  G + + I   D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           +LH     +I++RD+   N+LL+      ++D G+A  L +  +     AGT G++APEL
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                     D ++ GV   E++  R P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G VY+A+L  SG+ VA+KK+   +   AF      E  ++ ++ H NIV+L  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGK---AFKNR---ELQIMRKLDHCNIVRLRYF 81
Query: 156 CL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALSY 205
                 KK    + L+  Y+       + R      R   T  V  VK     +  +L+Y
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           +H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APEL
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 193
Query: 265 AYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
            +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 239

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 7/208 (3%)
Query: 89  EDFDIKY-CIGTGGYGSVYRAQLPSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIR 145
           ED+ + +  +G GG+G V+  Q+ +  K+    K       +    +    E  +L+++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            R IV L      K  + L+   M  G + + I   D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           +LH     +I++RD+   N+LL+      ++D G+A  L +  +     AGT G++APEL
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                     D ++ GV   E++  R P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH----SETELAFLESFQTEAHL 140
           V   +F+    +G G +G V    +  +G+  A+K L      ++ E+A      TE  +
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRV 62
Query: 141 LSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS- 198
           L   RH  +  L Y F  H +  F++ +Y   G LF  L  +    R+    R     + 
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRE----RVFSEDRARFYGAE 117
Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
           +  AL YLH +   ++V+RD+   N++L+      + DFG+ +    D +      GT  
Sbjct: 118 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE 175
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+          D +  GVV  E++ GR P
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 119/282 (42%), Gaps = 58/282 (20%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHS---ETELAFLESFQTEAHLLSQIRH 146
           + +K  IG G YG V  A     + + A+K ++ +   +     +E  +TE  L+ ++ H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLF-------------CIL-----------RNDD 182
            NI +LY     ++ + L+ +    G L              C +             ++
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 183 EAIR---------LDWTKR----VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL--N 227
           EAI          LD+ +R     NI++ +  AL YLH      I HRDI   N L   N
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTN 204
Query: 228 SKLEAFVADFGVAR----LLHSDSSNRTVVAGTHGYIAPELAYTM--VLTEKCDVYSFGV 281
              E  + DFG+++    L + +    T  AGT  ++APE+  T       KCD +S GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 282 VALEVLMGRHP------GDLLSSVNPKIMLIDLLDQRVPSPI 317
           +   +LMG  P       D +S V  K +  +  +  V SP+
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPL 306

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNI 149
           +G G +G V  A      +  +   VA+K L  S   L   E+  +E  +LS +  H NI
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNI 105
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK---------------RVN 194
           V L G C       +I +Y   G L   LR   ++     T                 ++
Sbjct: 106 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 195 IVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
               +A  +++L   +CI    HRD+++ NILL       + DFG+AR + +DS+   VV
Sbjct: 166 FSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVV 219
Query: 254 AGTH----GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            G       ++APE  +  V T + DV+S+G+   E+  +G  P
Sbjct: 220 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G VY+A+L  SG+ VA+KK+   +   AF      E  ++ ++ H NIV+L  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGK---AFKNR---ELQIMRKLDHCNIVRLRYF 81
Query: 156 CL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALSY 205
                 KK    + L+  Y+       + R      R   T  V  VK     +  +L+Y
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           +H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APEL
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 193
Query: 265 AYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
            +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 239

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKL-- 152
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 153 --YGFCLHKKCMF--LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
             Y     K  ++  L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPE 192
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 239

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 97  IGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G +G V++  +  +G K+A K +      +   E  + E  +++Q+ H N+++LY  
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKII--KTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
              K  + L+ +Y+  G LF   R  DE+  L     +  +K +   + ++H      I+
Sbjct: 155 FESKNDIVLVMEYVDGGELFD--RIIDESYNLTELDTILFMKQICEGIRHMHQ---MYIL 209
Query: 216 HRDISSNNIL-LNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           H D+   NIL +N   +   + DFG+AR  +       V  GT  ++APE+     ++  
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKLKVNFGTPEFLAPEVVNYDFVSFP 268
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D++S GV+A  +L G  P
Sbjct: 269 TDMWSVGVIAYMLLSGLSP 287

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNI 149
           +G G +G V  A      +  +   VA+K L  S   L   E+  +E  +LS +  H NI
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNI 107
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK---------------RVN 194
           V L G C       +I +Y   G L   LR   ++     T                 ++
Sbjct: 108 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 195 IVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
               +A  +++L   +CI    HRD+++ NILL       + DFG+AR + +DS+   VV
Sbjct: 168 FSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVV 221
Query: 254 AGTH----GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            G       ++APE  +  V T + DV+S+G+   E+  +G  P
Sbjct: 222 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 42/277 (15%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNI 149
           +G G +G V  A      +  +   VA+K L  S   L   E+  +E  +LS +  H NI
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNI 112
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK---------------RVN 194
           V L G C       +I +Y   G L   LR   ++     T                 ++
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 195 IVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
               +A  +++L   +CI    HRD+++ NILL       + DFG+AR + +DS+   VV
Sbjct: 173 FSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARHIKNDSN--YVV 226
Query: 254 AGTH----GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDL 308
            G       ++APE  +  V T + DV+S+G+   E+  +G  P   +  V+ K   +  
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSKFYKMIK 285
Query: 309 LDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
              R+ SP      + DI+        C  + P  RP
Sbjct: 286 EGFRMLSPEHAPAEMYDIMKT------CWDADPLKRP 316

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNI 149
           +G G +G V  A      +  +   VA+K L  S   L   E+  +E  +LS +  H NI
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNI 112
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK---------------RVN 194
           V L G C       +I +Y   G L   LR   ++     T                 ++
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 195 IVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
               +A  +++L   +CI    HRD+++ NILL       + DFG+AR + +DS+   VV
Sbjct: 173 FSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVV 226
Query: 254 AGTH----GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            G       ++APE  +  V T + DV+S+G+   E+  +G  P
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQ--LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           A + ++    IG G YG V++A+     G+ VALK++     E     S   E  +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 145 R---HRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
               H N+V+L+  C   +      + L+++++ +     + +  +  +  +  K  +++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMM 126
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
             +   L +LH      +VHRD+   NIL+ S  +  +ADFG+AR ++S     T V  T
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVT 182
Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
             Y APE+          D++S G +  E+ 
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQ--LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           A + ++    IG G YG V++A+     G+ VALK++     E     S   E  +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 145 R---HRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
               H N+V+L+  C   +      + L+++++ +     + +  +  +  +  K  +++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMM 126
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
             +   L +LH      +VHRD+   NIL+ S  +  +ADFG+AR ++S     T V  T
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVT 182
Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
             Y APE+          D++S G +  E+ 
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 87  ATEDFDIKYCIGTGGYGSVYRAQ--LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           A + ++    IG G YG V++A+     G+ VALK++     E     S   E  +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 145 R---HRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
               H N+V+L+  C   +      + L+++++ +     + +  +  +  +  K  +++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMM 126
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
             +   L +LH      +VHRD+   NIL+ S  +  +ADFG+AR ++S     T V  T
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVT 182
Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
             Y APE+          D++S G +  E+ 
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 21/230 (9%)
Query: 77  GRITFQEMIVATEDF-DIKYCIGTGGYGSVYRAQ-----LPSGKKVALKKLHHSETELAF 130
           G  TF++  V  EDF DI   +G+G +  V + +     L    K   K+   +      
Sbjct: 1   GMETFKQQKV--EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVC 58
Query: 131 LESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWT 190
            E  + E  +L Q+ H NI+ L+    ++  + LI + +  G LF  L   +    L   
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEE 115
Query: 191 KRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSD 246
           +  + +K +   ++YLH      I H D+   NI+L  K        + DFG+A  +  D
Sbjct: 116 EATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-D 171
Query: 247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GD 294
                 + GT  ++APE+     L  + D++S GV+   +L G  P  GD
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 32/229 (13%)
Query: 96  CIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
            IG G +G V++A+L    +VA+KK+          + F+  E  ++  ++H N+V L  
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQD-------KRFKNRELQIMRIVKHPNVVDLKA 99
Query: 155 FCL----HKKCMF--LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F       K  +F  L+ +Y+       + R      +L  T  + ++K     +  +L+
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A++L +   N + +   + Y APE
Sbjct: 156 YIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-YRAPE 211
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   D++S G V  E++ G+   PG+  S ++  + +I +L
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE--SGIDQLVEIIKVL 258

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNI 149
           +G G +G V  A      +  +   VA+K L  S   L   E+  +E  +LS +  H NI
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNI 89
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK---------------RVN 194
           V L G C       +I +Y   G L   LR   ++     T                 ++
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 195 IVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
               +A  +++L   +CI    HRD+++ NILL       + DFG+AR + +DS+   VV
Sbjct: 150 FSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVV 203
Query: 254 AGTH----GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            G       ++APE  +  V T + DV+S+G+   E+  +G  P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG+V++A+   + + VALK++   + +     S   E  LL +++H+NIV+L+  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 156 CLHKKCMFLIYKY----MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
               K + L++++    +++    C    D E ++       + +  +   L + H    
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-------SFLFQLLKGLGFCHSR-- 120
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL- 270
            +++HRD+   N+L+N   E  +ADFG+AR         +    T  Y  P++ +   L 
Sbjct: 121 -NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 271 TEKCDVYSFGVVALEVLMGRHP 292
           +   D++S G +  E+     P
Sbjct: 180 STSIDMWSAGCIFAELANAARP 201

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 39/224 (17%)
Query: 97  IGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN---IVKL 152
           IG G YGSV +    PSG+ +A+K++  +  E    E  Q    L   +R  +   IV+ 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK---EQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 153 YGFCLHKK----CMFLI-------YKYMRRGSLFCILRNDDEAIRLDWTKRVNI--VKSM 199
           YG    +     CM L+       YKY     ++ +L   D+ I  +   ++ +  VK++
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKY-----VYSVL---DDVIPEEILGKITLATVKAL 138
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
            H    L       I+HRDI  +NILL+      + DFG++  L  DS  +T  AG   Y
Sbjct: 139 NHLKENLK------IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPY 191
Query: 260 IAPEL----AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV 299
           +APE     A       + DV+S G+   E+  GR P    +SV
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPE 192
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 81
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 138 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPE 193
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 240

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPE 192
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 239

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 27/226 (11%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 99
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI-VKSMAHALSYLH 207
           F      KK    + L+  Y+   +++ + R+   A +      V + +  +  +L+Y+H
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
                 I HRDI   N+LL+       + DFG A+ L     N + +   + Y APEL +
Sbjct: 159 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 214
Query: 267 TMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
                T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 215 GATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 258

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 40/254 (15%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYG 154
           +G G YG V+++    +G+ VA+KK+  +       +    E  +L+++  H NIV L  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 155 F--CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
                + + ++L++ YM    L  ++R    A  L+   +  +V  +   + YLH     
Sbjct: 77  VLRADNDRDVYLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSG--- 128
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVAR--------------LLHSDSSN-------RT 251
            ++HRD+  +NILLN++    VADFG++R               ++ ++ N        T
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 252 VVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDL 308
               T  Y APE L  +   T+  D++S G +  E+L G+   PG   S++N    +I +
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS--STMNQLERIIGV 246
Query: 309 LDQRVPSPIDDQTV 322
           +D   PS  D +++
Sbjct: 247 ID--FPSNEDVESI 258

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 27/226 (11%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 84
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI-VKSMAHALSYLH 207
           F      KK    + L+  Y+   +++ + R+   A +      V + +  +  +L+Y+H
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
                 I HRDI   N+LL+       + DFG A+ L     N + +   + Y APEL +
Sbjct: 144 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 199
Query: 267 TMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
                T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 200 GATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 243

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 88
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 145 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPE 200
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 247

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLH-------HSETELAFLESFQTEAHL 140
           E+++ K  +G G    V R    P+ K+ A+K +         +E      E+   E  +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 141 LSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           L ++  H NI++L          FL++  M++G LF  L    E + L   +   I++++
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 133
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
              +  LH     +IVHRD+   NILL+  +   + DFG +  L      R+ V GT  Y
Sbjct: 134 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS-VCGTPSY 189
Query: 260 IAPELAYTMV------LTEKCDVYSFGVVALEVLMGRHP 292
           +APE+    +        ++ D++S GV+   +L G  P
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 92
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 149 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPE 204
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 251

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 171 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPE 226
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 273

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 92
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 149 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPE 204
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 251

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLH-------HSETELAFLESFQTEAHL 140
           E+++ K  +G G    V R    P+ K+ A+K +         +E      E+   E  +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 141 LSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           L ++  H NI++L          FL++  M++G LF  L    E + L   +   I++++
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 120
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
              +  LH     +IVHRD+   NILL+  +   + DFG +  L      R  V GT  Y
Sbjct: 121 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSY 176
Query: 260 IAPELAYTMV------LTEKCDVYSFGVVALEVLMGRHP 292
           +APE+    +        ++ D++S GV+   +L G  P
Sbjct: 177 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQT 136
           E  V+ E   +   +G G +G VY           +  +VA+K ++ S +    +E F  
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLN 69
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++      ++V+L G     +   ++ + M  G L   LR       N+        
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
            + + +   +A  ++YL+       VHRD+++ N ++       + DFG+ R ++  +  
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYY 186
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     ++APE     V T   D++SFGVV  E+
Sbjct: 187 RK---GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 108
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 165 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPE 220
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 267

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPE 192
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 239

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 27/226 (11%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 93
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI-VKSMAHALSYLH 207
           F      KK    + L+  Y+   +++ + R+   A +      V + +  +  +L+Y+H
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
                 I HRDI   N+LL+       + DFG A+ L     N + +   + Y APEL +
Sbjct: 153 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 208
Query: 267 TMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
                T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 209 GATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 252

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G Y +VY+     +G  VALK++   ++E     +   E  L+ +++H NIV+LY  
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR---VNIVK----SMAHALSYLHC 208
              +  + L++++M        L+   ++  +  T R   +N+VK     +   L++ H 
Sbjct: 72  IHTENKLTLVFEFMDND-----LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYT 267
           +    I+HRD+   N+L+N + +  + DFG+AR      +  +    T  Y AP+ L  +
Sbjct: 127 N---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              +   D++S G +  E++ G+
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGK 206

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 171 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPE 226
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 273

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQT 136
           E  V+ E   +   +G G +G VY           +  +VA+K ++ S +    +E F  
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLN 69
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++      ++V+L G     +   ++ + M  G L   LR       N+        
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
            + + +   +A  ++YL+       VHRD+++ N ++       + DFG+ R +      
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX 186
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     ++APE     V T   D++SFGVV  E+
Sbjct: 187 RK---GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 116
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 173 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPE 228
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 275

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQT 136
           E  V+ E   +   +G G +G VY           +  +VA+K ++ S +    +E F  
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLN 69
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++      ++V+L G     +   ++ + M  G L   LR       N+        
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
            + + +   +A  ++YL+       VHRD+++ N ++       + DFG+ R +      
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX 186
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     ++APE     V T   D++SFGVV  E+
Sbjct: 187 RK---GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 118
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 175 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPE 230
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 277

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQT 136
           E  V+ E   +   +G G +G VY           +  +VA+K ++ S +    +E F  
Sbjct: 8   EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLN 66
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++      ++V+L G     +   ++ + M  G L   LR       N+        
Sbjct: 67  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 126
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
            + + +   +A  ++YL+       VHRD+++ N ++       + DFG+ R +      
Sbjct: 127 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX 183
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     ++APE     V T   D++SFGVV  E+
Sbjct: 184 RK---GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 17/214 (7%)
Query: 89  EDF-DIKYCIGTGGYGSVYRAQ-----LPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           EDF DI   +G+G +  V + +     L    K   K+   +       E  + E  +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q+ H N++ L+    ++  + LI + +  G LF  L   +    L   +  + +K +   
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDG 127
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVVAGTHG 258
           ++YLH      I H D+   NI+L  K        + DFG+A  +  D      + GT  
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPE 183
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           ++APE+     L  + D++S GV+   +L G  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 85
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 142 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPE 197
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 244

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLH-------HSETELAFLESFQTEAHL 140
           E+++ K  +G G    V R    P+ K+ A+K +         +E      E+   E  +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 141 LSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           L ++  H NI++L          FL++  M++G LF  L    E + L   +   I++++
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 133
Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
              +  LH     +IVHRD+   NILL+  +   + DFG +  L      R  V GT  Y
Sbjct: 134 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSY 189
Query: 260 IAPELAYTMV------LTEKCDVYSFGVVALEVLMGRHP 292
           +APE+    +        ++ D++S GV+   +L G  P
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQT 136
           E  V+ E   +   +G G +G VY           +  +VA+K ++ S +    +E F  
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLN 69
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++      ++V+L G     +   ++ + M  G L   LR       N+        
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
            + + +   +A  ++YL+       VHRD+++ N ++       + DFG+ R ++     
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 186
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     ++APE     V T   D++SFGVV  E+
Sbjct: 187 RK---GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 19/218 (8%)
Query: 89  EDF-DIKYCIGTGGYGSVYRAQ-----LPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           EDF DI   +G+G +  V + +     L    K   K+   +       E  + E  +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q+ H N++ L+    ++  + LI + +  G LF  L   +    L   +  + +K +   
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDG 127
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVVAGTHG 258
           ++YLH      I H D+   NI+L  K        + DFG+A  +  D      + GT  
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPE 183
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GD 294
           ++APE+     L  + D++S GV+   +L G  P  GD
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQT-EAHLLSQIRHRNIVKLYG 154
           IG G +G VY+A+L  SG+ VA+KK+          + F+  E  ++ ++ H NIV+L  
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRY 159
Query: 155 FCL---HKK---CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK----SMAHALS 204
           F      KK    + L+  Y+       + R      R   T  V  VK     +  +L+
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   + Y APE
Sbjct: 216 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPE 271
Query: 264 LAYTMV-LTEKCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLIDLL 309
           L +     T   DV+S G V  E+L+G+   PGD  S V+  + +I +L
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVL 318

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 44/223 (19%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHL--LSQIRHRNIVKLYG 154
           IG G YG+VY+  L   + VA+K         A  ++F  E ++  +  + H NI +   
Sbjct: 21  IGRGRYGAVYKGSLDE-RPVAVKVF-----SFANRQNFINEKNIYRVPLMEHDNIAR--- 71
Query: 155 FCLHKKCM--------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
           F +  + +         L+ +Y   GSL   L         DW     +  S+   L+YL
Sbjct: 72  FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYL 127
Query: 207 HCDC------IPSIVHRDISSNNILLNSKLEAFVADFGVA------RLLHSDSSNRTVVA 254
           H +        P+I HRD++S N+L+ +     ++DFG++      RL+     +   ++
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 255 --GTHGYIAPELAYTMV-------LTEKCDVYSFGVVALEVLM 288
             GT  Y+APE+    V         ++ D+Y+ G++  E+ M
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH------SETELAFLESFQTEAHLL 141
           +++ +   +G+G  G V  A +  + KKVA+K +        S  E     + +TE  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
            ++ H  I+K+  F    +  +++ + M  G LF  +  +    RL           M  
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLL 125
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHG 258
           A+ YLH +    I+HRD+   N+LL+S+ E     + DFG +++L   S  RT + GT  
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 181
Query: 259 YIAPEL---AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+     T       D +S GV+    L G  P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH------SETELAFLESFQTEAHLL 141
           +++ +   +G+G  G V  A +  + KKVA+K +        S  E     + +TE  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
            ++ H  I+K+  F    +  +++ + M  G LF  +  +    RL           M  
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLL 125
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHG 258
           A+ YLH +    I+HRD+   N+LL+S+ E     + DFG +++L   S  RT + GT  
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 181
Query: 259 YIAPEL---AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+     T       D +S GV+    L G  P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 35/271 (12%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKK-LHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           +G GG+  V   + L  G   ALK+ L H + +    E  Q EA +     H NI++L  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNHPNILRLVA 93
Query: 155 FCLHKKC----MFLIYKYMRRGSLFC-ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           +CL ++      +L+  + +RG+L+  I R  D+   L   + + ++  +   L  +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVAR--LLHSDSSNRTVVAG-------THGYI 260
                 HRD+   NILL  + +  + D G      +H + S + +          T  Y 
Sbjct: 154 ---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 261 APELAYTM---VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPI 317
           APEL       V+ E+ DV+S G V   ++ G  P D++      + L           +
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----------AV 260
Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRPMQR 348
            +Q  I      S  ++  L S  T  P QR
Sbjct: 261 QNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAH 139
           FQ M+ + + + +K  IG G Y    R     +  + A+K +  S+ + +  E  +    
Sbjct: 20  FQSMVFS-DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS--EEIEI--- 73
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTKRVNIVKS 198
           LL   +H NI+ L       K ++L+ + MR G L   ILR    + R    +   ++ +
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSER----EASFVLHT 129
Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILL---NSKLEAF-VADFGVARLLHSDSSNRTVVA 254
           +   + YLH      +VHRD+  +NIL    +   E   + DFG A+ L +++       
Sbjct: 130 IGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
            T  ++APE+       E CD++S G++   +L G  P
Sbjct: 187 YTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 19/218 (8%)
Query: 89  EDF-DIKYCIGTGGYGSVYRAQ-----LPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           EDF DI   +G+G +  V + +     L    K   K+   +       E  + E  +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q+ H N++ L+    ++  + LI + +  G LF  L   +    L   +  + +K +   
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDG 127
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVVAGTHG 258
           ++YLH      I H D+   NI+L  K        + DFG+A  +  D      + GT  
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPE 183
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GD 294
           ++APE+     L  + D++S GV+   +L G  P  GD
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH------SETELAFLESFQTEAHLL 141
           +++ +   +G+G  G V  A +  + KKVA+K +        S  E     + +TE  +L
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
            ++ H  I+K+  F    +  +++ + M  G LF  +  +    RL           M  
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLL 131
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHG 258
           A+ YLH +    I+HRD+   N+LL+S+ E     + DFG +++L   S  RT + GT  
Sbjct: 132 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 187
Query: 259 YIAPEL---AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+     T       D +S GV+    L G  P
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH------SETELAFLESFQTEAHLL 141
           +++ +   +G+G  G V  A +  + KKVA+K +        S  E     + +TE  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
            ++ H  I+K+  F    +  +++ + M  G LF  +  +    RL           M  
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLL 125
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHG 258
           A+ YLH +    I+HRD+   N+LL+S+ E     + DFG +++L   S  RT + GT  
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 181
Query: 259 YIAPEL---AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+     T       D +S GV+    L G  P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH------SETELAFLESFQTEAHLL 141
           +++ +   +G+G  G V  A +  + KKVA+K +        S  E     + +TE  +L
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
            ++ H  I+K+  F    +  +++ + M  G LF  +  +    RL           M  
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLL 124
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHG 258
           A+ YLH +    I+HRD+   N+LL+S+ E     + DFG +++L   S  RT + GT  
Sbjct: 125 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 180
Query: 259 YIAPEL---AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+     T       D +S GV+    L G  P
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 19/218 (8%)
Query: 89  EDF-DIKYCIGTGGYGSVYRAQ-----LPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           EDF DI   +G+G +  V + +     L    K   K+   +       E  + E  +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q+ H N++ L+    ++  + LI + +  G LF  L   +    L   +  + +K +   
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDG 127
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVVAGTHG 258
           ++YLH      I H D+   NI+L  K        + DFG+A  +  D      + GT  
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPE 183
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GD 294
           ++APE+     L  + D++S GV+   +L G  P  GD
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 116/269 (43%), Gaps = 31/269 (11%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 93
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK---SMAHALSY 205
           V L G C      + +I ++ + G+L   LR+     R ++    ++ K   ++ H + Y
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK----RNEFVPYKDLYKDFLTLEHLIXY 149
Query: 206 -------LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGT 256
                  +        +HRD+++ NILL+ K    + DFG+AR ++ D     +      
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
             ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +R+   
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFXRRLKEG 263
Query: 317 IDDQTVIQDIILVSKIVFACLRSKPTSRP 345
              +        + + +  C   +P+ RP
Sbjct: 264 TRMRAPDYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 19/218 (8%)
Query: 89  EDF-DIKYCIGTGGYGSVYRAQ-----LPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           EDF DI   +G+G +  V + +     L    K   K+   +       E  + E  +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           Q+ H N++ L+    ++  + LI + +  G LF  L   +    L   +  + +K +   
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDG 127
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVVAGTHG 258
           ++YLH      I H D+   NI+L  K        + DFG+A  +  D      + GT  
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPE 183
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GD 294
           ++APE+     L  + D++S GV+   +L G  P  GD
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAH 139
           V+ E   +   +G G +G VY           +  +VA+K ++ S +    +E F  EA 
Sbjct: 13  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEAS 71
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDWTKR 192
           ++      ++V+L G     +   ++ + M  G L   LR       N+         + 
Sbjct: 72  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
           + +   +A  ++YL+       VHRD+++ N ++       + DFG+ R ++     R  
Sbjct: 132 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK- 187
Query: 253 VAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
             G  G     ++APE     V T   D++SFGVV  E+
Sbjct: 188 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 12/218 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           E + I   +G G +G V+R    S KK  + K    +     L   + E  +L+  RHRN
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRN 62
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I+ L+      + + +I++++    +F   R +  A  L+  + V+ V  +  AL +LH 
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFE--RINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVA--DFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
             I    H DI   NI+  ++  + +   +FG AR L    + R +      Y APE+  
Sbjct: 121 HNIG---HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE-YYAPEVHQ 176
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM 304
             V++   D++S G +   +L G +P   L+  N +I+
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQII 212

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 122/286 (42%), Gaps = 51/286 (17%)
Query: 87  ATEDFDIK-------YCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEA 138
           A E+F++K         +G G YG V + + +PSG+  A+K++                A
Sbjct: 25  AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIR---------------A 69
Query: 139 HLLSQIRHRNIVKLYGFCLHKKCMFLIYKY---MRRGSLFCILRNDDEAIRLDWTKRVN- 194
            + SQ + R +  L        C F +  Y    R G ++      D ++   + + ++ 
Sbjct: 70  TVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDK 129
Query: 195 -----------IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243
                      I  S+  AL +LH     S++HRD+  +N+L+N+  +    DFG++  L
Sbjct: 130 GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYL 187
Query: 244 HSDSSNRTVVAGTHGYIAPELAYTMV----LTEKCDVYSFGVVALEVLMGRHPGDLLSSV 299
             D + + + AG   Y APE     +     + K D++S G+  +E+ + R P D  S  
Sbjct: 188 VDDVA-KDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYD--SWG 244
Query: 300 NPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            P   L  ++++  P    D+   + +   S+    CL+     RP
Sbjct: 245 TPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERP 286

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG+V++A+   + + VALK++   + +     S   E  LL +++H+NIV+L+  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 156 CLHKKCMFLIYKY----MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
               K + L++++    +++    C    D E ++       + +  +   L + H    
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-------SFLFQLLKGLGFCHSR-- 120
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL- 270
            +++HRD+   N+L+N   E  +A+FG+AR         +    T  Y  P++ +   L 
Sbjct: 121 -NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 271 TEKCDVYSFGVVALEVLMGRHP 292
           +   D++S G +  E+     P
Sbjct: 180 STSIDMWSAGCIFAELANAGRP 201

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I+KS+  A+ YLH     +I 
Sbjct: 91  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHSI---NIA 143
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 144 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 202
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD++S GV+   +L G  P
Sbjct: 203 SCDMWSLGVIMYILLCGYPP 222

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYR-AQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQ 143
           +V ++ + +K  IG G Y    R     +  + A+K +  S+ +     S + E  LL  
Sbjct: 23  LVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRD----PSEEIEI-LLRY 77
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTKRVNIVKSMAHA 202
            +H NI+ L       K ++L+ + MR G L   ILR    + R    +   ++ ++   
Sbjct: 78  GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSER----EASFVLHTIGKT 133
Query: 203 LSYLHCDCIPSIVHRDISSNNILL---NSKLEAF-VADFGVARLLHSDSSNRTVVAGTHG 258
           + YLH      +VHRD+  +NIL    +   E   + DFG A+ L +++        T  
Sbjct: 134 VEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           ++APE+       E CD++S G++   +L G  P
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I+KS+  A+ YLH     +I 
Sbjct: 92  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHSI---NIA 144
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 145 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 203
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD++S GV+   +L G  P
Sbjct: 204 SCDMWSLGVIMYILLCGYPP 223

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I+KS+  A+ YLH     +I 
Sbjct: 93  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHSI---NIA 145
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 146 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 204
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD++S GV+   +L G  P
Sbjct: 205 SCDMWSLGVIMYILLCGYPP 224

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I+KS+  A+ YLH     +I 
Sbjct: 101 RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHSI---NIA 153
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 154 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 212
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD++S GV+   +L G  P
Sbjct: 213 SCDMWSLGVIMYILLCGYPP 232

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 15/154 (9%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G V++A+   +G+KVALKK+     +  F  +   E  +L  ++H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 156 CLHK-----KC---MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           C  K     +C   ++L++ +     L  +L N      L   KRV  ++ + + L Y+H
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYIH 142
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
            +    I+HRD+ + N+L+       +ADFG+AR
Sbjct: 143 RN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I+KS+  A+ YLH     +I 
Sbjct: 131 RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHSI---NIA 183
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 242
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD++S GV+   +L G  P
Sbjct: 243 SCDMWSLGVIMYILLCGYPP 262

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 15/154 (9%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G V++A+   +G+KVALKK+     +  F  +   E  +L  ++H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 156 CLHK-----KC---MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           C  K     +C   ++L++ +     L  +L N      L   KRV  ++ + + L Y+H
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYIH 142
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
            +    I+HRD+ + N+L+       +ADFG+AR
Sbjct: 143 RN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 15/154 (9%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G V++A+   +G+KVALKK+     +  F  +   E  +L  ++H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 156 CLHK-----KC---MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           C  K     +C   ++L++ +     L  +L N      L   KRV  ++ + + L Y+H
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYIH 142
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
            +    I+HRD+ + N+L+       +ADFG+AR
Sbjct: 143 RN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I+KS+  A+ YLH     +I 
Sbjct: 137 RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHSI---NIA 189
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 190 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 248
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD++S GV+   +L G  P
Sbjct: 249 SCDMWSLGVIMYILLCGYPP 268

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I+KS+  A+ YLH     +I 
Sbjct: 87  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHSI---NIA 139
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 198
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD++S GV+   +L G  P
Sbjct: 199 SCDMWSLGVIMYILLCGYPP 218

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I+KS+  A+ YLH     +I 
Sbjct: 87  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHSI---NIA 139
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 198
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD++S GV+   +L G  P
Sbjct: 199 SCDMWSLGVIMYILLCGYPP 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I+KS+  A+ YLH     +I 
Sbjct: 85  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHSI---NIA 137
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 196
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD++S GV+   +L G  P
Sbjct: 197 SCDMWSLGVIMYILLCGYPP 216

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I+KS+  A+ YLH     +I 
Sbjct: 86  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHSI---NIA 138
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 139 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 197
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD++S GV+   +L G  P
Sbjct: 198 SCDMWSLGVIMYILLCGYPP 217

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQT 136
           E  V+ E   +   +G G +G VY           +  +VA+K ++ S +    +E F  
Sbjct: 12  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLN 70
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++      ++V+L G     +   ++ + M  G L   LR       N+        
Sbjct: 71  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 130
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
            + + +   +A  ++YL+       VHR++++ N ++       + DFG+ R ++     
Sbjct: 131 QEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 187
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     ++APE     V T   D++SFGVV  E+
Sbjct: 188 RK---GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 116/269 (43%), Gaps = 31/269 (11%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 93
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK---SMAHALSY 205
           V L G C      + +I ++ + G+L   LR+     R ++    ++ K   ++ H + Y
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK----RNEFVPYKDLYKDFLTLEHLICY 149
Query: 206 -------LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGT 256
                  +        +HRD+++ NILL+ K    + DFG+AR ++ D     +      
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
             ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +R+   
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRRLKEG 263
Query: 317 IDDQTVIQDIILVSKIVFACLRSKPTSRP 345
              +        + + +  C   +P+ RP
Sbjct: 264 TRMRAPDYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 15/154 (9%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +G V++A+   +G+KVALKK+     +  F  +   E  +L  ++H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 156 CLHK-----KC---MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           C  K     +C   ++L++ +     L  +L N      L   KRV  ++ + + L Y+H
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYIH 141
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
            +    I+HRD+ + N+L+       +ADFG+AR
Sbjct: 142 RN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH------SETELAFLESFQTEAHLL 141
           +++ +   +G+G  G V  A +  + KKVA++ +        S  E     + +TE  +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
            ++ H  I+K+  F    +  +++ + M  G LF  +  +    RL           M  
Sbjct: 195 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLL 250
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHG 258
           A+ YLH +    I+HRD+   N+LL+S+ E     + DFG +++L   S  RT + GT  
Sbjct: 251 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 306
Query: 259 YIAPEL---AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+     T       D +S GV+    L G  P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 91  FDIKYCIGTGGYGSVYRAQ-----LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +D    +G+G +  V + +     L    K   K+   S       E  + E  +L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H N++ L+    +K  + LI + +  G LF  L   +     + T+    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYY 129
Query: 206 LHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           LH      I H D+   NI+L      K    + DFG+A  +   +  + +  GT  ++A
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPAFVA 185
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GD 294
           PE+     L  + D++S GV+   +L G  P  GD
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            IGTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +YM  G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    VADFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 25/222 (11%)
Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQT 136
           E  V+ E   +   +G G +G VY           +  +VA+K ++ S +    +E F  
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLN 69
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++      ++V+L G     +   ++ + M  G L   LR       N+        
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
            + + +   +A  ++YL+       VHR++++ N ++       + DFG+ R ++     
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 186
Query: 250 RTVVAGTHG-----YIAPELAYTMVLTEKCDVYSFGVVALEV 286
           R    G  G     ++APE     V T   D++SFGVV  E+
Sbjct: 187 RK---GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLL-SQIRHRNIVKLYG 154
           +G G +G V+R +   +G + A+KK+         LE F+ E  +  + +    IV LYG
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR--------LEVFRAEELMACAGLTSPRIVPLYG 152
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
                  + +  + +  GSL  +++   E   L   + +  +      L YLH      I
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVK---EQGCLPEDRALYYLGQALEGLEYLHSR---RI 206
Query: 215 VHRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRTV-----VAGTHGYIAPELAYTM 268
           +H D+ ++N+LL+S    A + DFG A  L  D   +++     + GT  ++APE+    
Sbjct: 207 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR 266
Query: 269 VLTEKCDVYSFGVVALEVLMGRHP 292
               K DV+S   + L +L G HP
Sbjct: 267 SCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            IGTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +YM  G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    VADFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHH------SETELAFLESFQTEAHLL 141
           +++ +   +G+G  G V  A +  + KKVA++ +        S  E     + +TE  +L
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
            ++ H  I+K+  F    +  +++ + M  G LF  +  +    RL           M  
Sbjct: 209 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLL 264
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHG 258
           A+ YLH +    I+HRD+   N+LL+S+ E     + DFG +++L   S  RT + GT  
Sbjct: 265 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 320
Query: 259 YIAPEL---AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+     T       D +S GV+    L G  P
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 70/140 (50%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I KS+  A+ YLH     +I 
Sbjct: 131 RKCLLIVXECLDGGELFSRIQDRGDQA----FTEREASEIXKSIGEAIQYLHSI---NIA 183
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 242
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD +S GV+   +L G  P
Sbjct: 243 SCDXWSLGVIXYILLCGYPP 262

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 118 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 172 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 119 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 173 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 118 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 172 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 119 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 173 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 119 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 173 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLYQMLXGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 200 MGYKENVDIWSVGCIMGE--MVRH 221

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 119 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 173 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 119 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 173 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 119 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 173 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 11/210 (5%)
Query: 91  FDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLH---HSETELAFLESFQTEAHLLSQIRH 146
           +++   IG G +  V R     +G++ A+K +     + +     E  + EA +   ++H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
            +IV+L         +++++++M    L F I++  D           + ++ +  AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAP 262
            H +   +I+HRD+   N+LL SK  +    + DFGVA  L           GT  ++AP
Sbjct: 146 CHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E+       +  DV+  GV+   +L G  P
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 116/272 (42%), Gaps = 35/272 (12%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 95
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRND--------DEAIRLDWTKRVNIVK--- 197
           V L G C      + +I ++ + G+L   LR+          E +  D+    +++    
Sbjct: 96  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +A  + +L        +HRD+++ NILL+ K    + DFG+AR +  D     V  G  
Sbjct: 156 QVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD--XVRKGDA 210
Query: 258 ----GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV 313
                ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +R+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRRL 264
Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                 +        + + +  C   +P+ RP
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 119 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 173 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 13/169 (7%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 119 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GD 294
             + +  GT  ++APE+     L  + D++S GV+   +L G  P  GD
Sbjct: 173 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 122/274 (44%), Gaps = 34/274 (12%)
Query: 86  VATEDFDI-KYCIGTGGYGSVYRA-QLPSGKKVALKKLHHS---ETELAFLESFQTEAHL 140
             T+D+ + K  +G G  G V       +G+K ALK L+ S     E+          H+
Sbjct: 6   AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHI 65
Query: 141 LSQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFC-ILRNDDEAIRLDWTKR--VNIV 196
           +       I+ +Y    H K+C+ +I + M  G LF  I    D+A     T+R    I+
Sbjct: 66  VC------ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF----TEREAAEIM 115
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVV 253
           + +  A+ +LH     +I HRD+   N+L  SK +  V    DFG A+   +  +     
Sbjct: 116 RDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTP 170
Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIM-LIDLLD 310
             T  Y+APE+       + CD++S GV+   +L G  P   +   +++P +   I L  
Sbjct: 171 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 230
Query: 311 QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSR 344
              P+P +   V +D     +++   L++ PT R
Sbjct: 231 YGFPNP-EWSEVSED---AKQLIRLLLKTDPTER 260

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 159 KKCMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKR--VNIVKSMAHALSYLHCDCIPSIV 215
           +KC+ ++ + +  G LF  +++  D+A    +T+R    I+KS+  A+ YLH     +I 
Sbjct: 85  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHSI---NIA 137
Query: 216 HRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTE 272
           HRD+   N+L  SK    +    DFG A+   S +S  T    T  Y+APE+       +
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTEPCYTPYYVAPEVLGPEKYDK 196
Query: 273 KCDVYSFGVVALEVLMGRHP 292
            CD++S GV+   +L G  P
Sbjct: 197 SCDMWSLGVIMYILLCGYPP 216

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 34/274 (12%)
Query: 86  VATEDFDI-KYCIGTGGYGSVYRA-QLPSGKKVALKKLHHS---ETELAFLESFQTEAHL 140
             T+D+ + K  +G G  G V       +G+K ALK L+ S     E+          H+
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHI 84
Query: 141 LSQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFC-ILRNDDEAIRLDWTKR--VNIV 196
           +       I+ +Y    H K+C+ +I + M  G LF  I    D+A    +T+R    I+
Sbjct: 85  VC------ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----FTEREAAEIM 134
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVV 253
           + +  A+ +LH     +I HRD+   N+L  SK +  V    DFG A+   +  +     
Sbjct: 135 RDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTP 189
Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIM-LIDLLD 310
             T  Y+APE+       + CD++S GV+   +L G  P   +   +++P +   I L  
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249
Query: 311 QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSR 344
              P+P +   V +D     +++   L++ PT R
Sbjct: 250 YGFPNP-EWSEVSED---AKQLIRLLLKTDPTER 279

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLVGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S GV+  E++ G
Sbjct: 200 MGYKENVDIWSVGVIMGEMIKG 221

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G YG VY+A    + + VA+K++     E     +   E  LL +++HRNI++L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL----SYLHC-DC 210
             H   + LI++Y        + +N D ++R        ++KS  + L    ++ H   C
Sbjct: 102 IHHNHRLHLIFEYAENDLKKYMDKNPDVSMR--------VIKSFLYQLINGVNFCHSRRC 153
Query: 211 IPSIVHRDISSNNILLN----SKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPE-L 264
           +    HRD+   N+LL+    S+     + DFG+AR         T    T  Y  PE L
Sbjct: 154 L----HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
             +   +   D++S   +  E+LM     PGD
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLVGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S GV+  E++ G
Sbjct: 200 MGYKENVDIWSVGVIMGEMIKG 221

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 91  FDIKYCIGTGGYGSVYRAQ-----LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           +D    +G+G +  V + +     L    K   K+   S       E  + E  +L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H N++ L+    +K  + LI + +  G LF  L   +     + T+    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYY 129
Query: 206 LHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           LH      I H D+   NI+L      K    + DFG+A  +   +  + +  GT  ++A
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GD 294
           PE+     L  + D++S GV+   +L G  P  GD
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATE 118
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 119 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 173 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           E  + E  +L +I+H N++ L+    +K  + LI + +  G LF  L   +     + T+
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
               +K + + + YLH      I H D+   NI+L      K    + DFG+A  +   +
Sbjct: 119 ---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             + +  GT  ++APE+     L  + D++S GV+   +L G  P
Sbjct: 173 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLL-SQIRHRNIVKLYG 154
           +G G +G V+R +   +G + A+KK+         LE F+ E  +  + +    IV LYG
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR--------LEVFRAEELMACAGLTSPRIVPLYG 133
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
                  + +  + +  GSL  +++   E   L   + +  +      L YLH      I
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVK---EQGCLPEDRALYYLGQALEGLEYLHSR---RI 187
Query: 215 VHRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRTV-----VAGTHGYIAPELAYTM 268
           +H D+ ++N+LL+S    A + DFG A  L  D   + +     + GT  ++APE+    
Sbjct: 188 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR 247
Query: 269 VLTEKCDVYSFGVVALEVLMGRHP 292
               K DV+S   + L +L G HP
Sbjct: 248 SCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     +AGT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLAGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 37/274 (13%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 93
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRND----------DEAIRLDWTKRVNIV-- 196
           V L G C      + +I ++ + G+L   LR+            E +  D+    +++  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 197 -KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
              +A  + +L        +HRD+++ NILL+ K    + DFG+AR ++ D     V  G
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--XVRKG 208
Query: 256 TH----GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ 311
                  ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCR 262
Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           R+      +        + + +  C   +P+ RP
Sbjct: 263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 97  IGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G Y +VY+ +   +   VALK++     E A   + + E  LL  ++H NIV L+  
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 68
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
              +K + L+++Y+ +  L   L +    I +   K    +  +   L+Y H      ++
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKL--FLFQLLRGLAYCHRQ---KVL 122
Query: 216 HRDISSNNILLNSKLEAFVADFGVARL--LHSDSSNRTVVAGTHGYIAPE-LAYTMVLTE 272
           HRD+   N+L+N + E  +ADFG+AR   + + + +  VV  T  Y  P+ L  +   + 
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYST 180
Query: 273 KCDVYSFGVVALEVLMGR--HPGDLLSSVNPKIMLI 306
           + D++  G +  E+  GR   PG   S+V  ++  I
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPG---STVEEQLHFI 213

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 113/250 (45%), Gaps = 46/250 (18%)
Query: 67  GDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSET 126
           G   S+   DG      +IV    F  K  +G G  G++    +   + VA+K++     
Sbjct: 2   GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI----- 56
Query: 127 ELAFLESF-QTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEA 184
            L    SF   E  LL +   H N+++   FC  K   F   +Y+      C     +  
Sbjct: 57  -LPECFSFADREVQLLRESDEHPNVIRY--FCTEKDRQF---QYI--AIELCAATLQEYV 108
Query: 185 IRLDWT----KRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL-----NSKLEAFVA 235
            + D+     + + +++     L++LH     +IVHRD+  +NIL+     + K++A ++
Sbjct: 109 EQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMIS 165
Query: 236 DFGVARLL----HSDSSNRTVVAGTHGYIAPELAYTMVLTEKC--------DVYSFGVVA 283
           DFG+ + L    HS  S R+ V GT G+IAPE+     L+E C        D++S G V 
Sbjct: 166 DFGLCKKLAVGRHS-FSRRSGVPGTEGWIAPEM-----LSEDCKENPTYTVDIFSAGCVF 219
Query: 284 LEVLM-GRHP 292
             V+  G HP
Sbjct: 220 YYVISEGSHP 229

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLYQMLXGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 200 MGYKENVDIWSVGCIMGE--MVRH 221

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 116/272 (42%), Gaps = 33/272 (12%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 95
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRND----------DEAIRLDWTKRVNIV-- 196
           V L G C      + +I ++ + G+L   LR+            E +  D+    +++  
Sbjct: 96  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 197 -KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVV 253
              +A  + +L        +HRD+++ NILL+ K    + DFG+AR ++ D     +   
Sbjct: 156 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV 313
                ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +R+
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRRL 266
Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                 +        + + +  C   +P+ RP
Sbjct: 267 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 298

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK---- 151
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH N++     
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQ-TYCQRTLREIQILLRFRHENVIGIRDI 109
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
           L    L       I + +    L+ +L++     +L        +  +   L Y+H    
Sbjct: 110 LRASTLEAMRDVYIVQDLMETDLYKLLKSQ----QLSNDHICYFLYQILRGLKYIHS--- 162
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLL---HSDSSNRTVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+L+N+  +  + DFG+AR+    H  +   T    T  Y APE+   +
Sbjct: 163 ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNS 222
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 116/272 (42%), Gaps = 33/272 (12%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 93
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRND----------DEAIRLDWTKRVNIV-- 196
           V L G C      + +I ++ + G+L   LR+            E +  D+    +++  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 197 -KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVV 253
              +A  + +L        +HRD+++ NILL+ K    + DFG+AR ++ D     +   
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV 313
                ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +R+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRRL 264
Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                 +        + + +  C   +P+ RP
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 35/273 (12%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 130
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRND----------DEAIRLDWTKRVNIV-- 196
           V L G C      + +I ++ + G+L   LR+            E +  D+    +++  
Sbjct: 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 197 -KSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTV 252
              +A  + +L    CI    HRD+++ NILL+ K    + DFG+AR ++ D     +  
Sbjct: 191 SFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 253 VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR 312
                 ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +R
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRR 300
Query: 313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +      +        + + +  C   +P+ RP
Sbjct: 301 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 333

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLYQMLXGIKHLH 136
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 192
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 193 MGYKENVDIWSVGCIMGE--MVRH 214

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 142
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 109
Query: 156 CL-----HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
                    K ++L+  ++    L+ +L+       L        +  +   L Y+H   
Sbjct: 110 IRAPTIEQMKDVYLV-THLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS-- 162
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY- 266
             +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   
Sbjct: 163 -ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 267 TMVLTEKCDVYSFGVVALEVLMGR 290
           +   T+  D++S G +  E+L  R
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 156 CL-----HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
                    K ++++   M    L+ +L+       L        +  +   L Y+H   
Sbjct: 90  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS-- 142
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY- 266
             +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   
Sbjct: 143 -ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 267 TMVLTEKCDVYSFGVVALEVLMGR 290
           +   T+  D++S G +  E+L  R
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 104/237 (43%), Gaps = 46/237 (19%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALK----KLHHSETELAFLESFQ 135
           F++M   T +      +G G Y  V  A  L +GK+ A+K    +  HS + +     F+
Sbjct: 10  FEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV-----FR 59
Query: 136 TEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-----NDDEAIRLDWT 190
               L     ++NI++L  F       +L+++ ++ GS+   ++     N+ EA R    
Sbjct: 60  EVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASR---- 115
Query: 191 KRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDS 247
               +V+ +A AL +LH      I HRD+   NIL  S  +     + DF +   +  ++
Sbjct: 116 ----VVRDVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNN 168
Query: 248 S-------NRTVVAGTHGYIAPELAYTMV-----LTEKCDVYSFGVVALEVLMGRHP 292
           S         T   G+  Y+APE+            ++CD++S GVV   +L G  P
Sbjct: 169 SCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 142
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 116/272 (42%), Gaps = 33/272 (12%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 84
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRND----------DEAIRLDWTKRVNIV-- 196
           V L G C      + +I ++ + G+L   LR+            E +  D+    +++  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 197 -KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVV 253
              +A  + +L        +HRD+++ NILL+ K    + DFG+AR ++ D     +   
Sbjct: 145 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV 313
                ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +R+
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRRL 255
Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                 +        + + +  C   +P+ RP
Sbjct: 256 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 116/272 (42%), Gaps = 33/272 (12%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 84
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRND----------DEAIRLDWTKRVNIV-- 196
           V L G C      + +I ++ + G+L   LR+            E +  D+    +++  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 197 -KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVV 253
              +A  + +L        +HRD+++ NILL+ K    + DFG+AR ++ D     +   
Sbjct: 145 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV 313
                ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +R+
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRRL 255
Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                 +        + + +  C   +P+ RP
Sbjct: 256 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 92/212 (43%), Gaps = 9/212 (4%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAF--LESFQTEAHLLSQ 143
           V   DF+    +G G +G V  A     +++   K+   +  +    +E    E  +L+ 
Sbjct: 16  VKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLAL 75
Query: 144 IRHRNIVKLYGFCLHK-KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           +     +     C      ++ + +Y+  G L   ++   +  +    + V     ++  
Sbjct: 76  LDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISIG 132
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L +LH      I++RD+  +N++L+S+    +ADFG+ +    D        GT  YIAP
Sbjct: 133 LFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAP 189
Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHPGD 294
           E+       +  D +++GV+  E+L G+ P D
Sbjct: 190 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYXQRTLREIKILLRFRHENIIGINDI 93
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 146
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 147 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 142
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 97
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 150
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 151 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 210
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 211 KGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 142
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 91
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 144
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 146
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 147 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 200 MGYKENVDIWSVGCIMGE--MVRH 221

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 87/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            IGTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    VADFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 87
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 140
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 141 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 116/273 (42%), Gaps = 36/273 (13%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 94
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRND---------DEAIRLDWTKRVNIV--- 196
           V L G C      + +I ++ + G+L   LR+           E +  D+    +++   
Sbjct: 95  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
             +A  + +L        +HRD+++ NILL+ K    + DFG+AR +  D     V  G 
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD--XVRKGD 209
Query: 257 H----GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR 312
                 ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +R
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRR 263
Query: 313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +      +        + + +  C   +P+ RP
Sbjct: 264 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/281 (22%), Positives = 124/281 (44%), Gaps = 33/281 (11%)
Query: 81  FQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHL 140
           FQ M V    + I   IG+GG   V++      +  A+K ++  E +   L+S++ E   
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 141 LSQIRHRN--IVKLYGFCLHKKCMFLIYKYMRRGS--LFCILRNDDEAIRLDWTKRVNIV 196
           L++++  +  I++LY + +  + ++++   M  G+  L   L+   +   +D  +R +  
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYW 133
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVA 254
           K+M  A+  +H      IVH D+   N L+   +   + DFG+A  +  D+++  +    
Sbjct: 134 KNMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV 189
Query: 255 GTHGYIAPELAYTMVLTEK-----------CDVYSFGVVALEVLMGRHPGDLLSSVNPKI 303
           GT  Y+ PE    M  + +            DV+S G +   +  G+ P   + +   K+
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249
Query: 304 MLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSR 344
             I   +  +  P   +  +QD++        CL+  P  R
Sbjct: 250 HAIIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQR 284

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 87
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 140
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 141 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 109
Query: 156 CL-----HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
                    K ++++   M    L+ +L+       L        +  +   L Y+H   
Sbjct: 110 IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS-- 162
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY- 266
             +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   
Sbjct: 163 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 267 TMVLTEKCDVYSFGVVALEVLMGR 290
           +   T+  D++S G +  E+L  R
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 94
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 147
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 207
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 95
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 148
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 149 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 208
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 209 KGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 86
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 139
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 140 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 199
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 200 KGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 146
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 116/274 (42%), Gaps = 37/274 (13%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 93
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRND----------DEAIRLDWTKRVNIV-- 196
           V L G C      + +I ++ + G+L   LR+            E +  D+    +++  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 197 -KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
              +A  + +L        +HRD+++ NILL+ K    + DFG+AR +  D     V  G
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD--XVRKG 208
Query: 256 TH----GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ 311
                  ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCR 262
Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           R+      +        + + +  C   +P+ RP
Sbjct: 263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 116/274 (42%), Gaps = 37/274 (13%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 84
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRND----------DEAIRLDWTKRVNIV-- 196
           V L G C      + +I ++ + G+L   LR+            E +  D+    +++  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 197 -KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
              +A  + +L        +HRD+++ NILL+ K    + DFG+AR +  D     V  G
Sbjct: 145 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD--XVRKG 199
Query: 256 TH----GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ 311
                  ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCR 253
Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           R+      +        + + +  C   +P+ RP
Sbjct: 254 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 117/275 (42%), Gaps = 39/275 (14%)
Query: 97  IGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-NI 149
           +G G +G V  A      +  + + VA+K L    T      +  +E  +L  I H  N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 84
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRND----------DEAIRLDWTKRVNIV-- 196
           V L G C      + +I ++ + G+L   LR+            E +  D+    +++  
Sbjct: 85  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 197 -KSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
              +A  + +L    CI    HRD+++ NILL+ K    + DFG+AR +  D     V  
Sbjct: 145 SFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIXKDPD--XVRK 198
Query: 255 GTH----GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD 310
           G       ++APE  +  V T + DV+SFGV+  E+        L +S  P + + +   
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFC 252
Query: 311 QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +R+      +        + + +  C   +P+ RP
Sbjct: 253 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           + ++  IG G +G V +  +  G ++  A KK+     E   ++ F+ E  ++  + H N
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPN 67
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFC------ILRNDDEAIRLDWTKRVNIVKSMAHA 202
           I++LY        ++L+ +    G LF       + R  D A          I+K +  A
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLSA 118
Query: 203 LSYLHCDCIPSIVHRDISSNNILL-----NSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
           ++Y H     ++ HRD+   N L      +S L+  + DFG+A         RT V GT 
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTKV-GTP 172
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
            Y++P++   +   E CD +S GV+   +L G  P
Sbjct: 173 YYVSPQVLEGLYGPE-CDEWSAGVMMYVLLCGYPP 206

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 62/131 (47%), Gaps = 6/131 (4%)
Query: 162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISS 221
           ++ + +Y+  G L   ++   +  R      V     +A  L +L       I++RD+  
Sbjct: 96  LYFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKL 149
Query: 222 NNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGV 281
           +N++L+S+    +ADFG+ +    D        GT  YIAPE+       +  D ++FGV
Sbjct: 150 DNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 209
Query: 282 VALEVLMGRHP 292
           +  E+L G+ P
Sbjct: 210 LLYEMLAGQAP 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 62/131 (47%), Gaps = 6/131 (4%)
Query: 162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISS 221
           ++ + +Y+  G L   ++   +  R      V     +A  L +L       I++RD+  
Sbjct: 417 LYFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKL 470
Query: 222 NNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGV 281
           +N++L+S+    +ADFG+ +    D        GT  YIAPE+       +  D ++FGV
Sbjct: 471 DNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 530
Query: 282 VALEVLMGRHP 292
           +  E+L G+ P
Sbjct: 531 LLYEMLAGQAP 541

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 88  TEDFDIKYCIGTGGYG--SVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           ++ +D    IG+G +G   + R +L + + VA+K +   E   A  E+ Q E      +R
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYI---ERGAAIDENVQREIINHRSLR 74
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H NIV+     L    + +I +Y   G L+  + N   A R    +     + +   +SY
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSY 131
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAF--VADFGVAR--LLHSDSSNRTVVAGTHGYIA 261
            H      I HRD+   N LL+        + DFG ++  +LHS   +     GT  YIA
Sbjct: 132 CHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIA 185
Query: 262 PELAYTMVLTEK-CDVYSFGVVALEVLMGRHP 292
           PE+        K  DV+S GV    +L+G +P
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 200 MGYKENVDIWSVGCIMGE--MVRH 221

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L   RH NI+ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLAFRHENIIGINDI 91
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 144
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLVGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKV--ALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           + ++  IG G +G V +  +  G ++  A KK+     E   ++ F+ E  ++  + H N
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPN 84
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFC------ILRNDDEAIRLDWTKRVNIVKSMAHA 202
           I++LY        ++L+ +    G LF       + R  D A          I+K +  A
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLSA 135
Query: 203 LSYLHCDCIPSIVHRDISSNNILL-----NSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
           ++Y H     ++ HRD+   N L      +S L+  + DFG+A         RT V GT 
Sbjct: 136 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTKV-GTP 189
Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
            Y++P++   +   E CD +S GV+   +L G  P
Sbjct: 190 YYVSPQVLEGLYGPE-CDEWSAGVMMYVLLCGYPP 223

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLL-SQIRHRNIVKLYG 154
           +G G +G V+R +   +G + A+KK+         LE F+ E  +  + +    IV LYG
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSPRIVPLYG 117
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
                  + +  + +  GSL  +++   +   L   + +  +      L YLH      I
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 215 VHRDISSNNILLNS-KLEAFVADFGVARLLHSDSSNRTV-----VAGTHGYIAPELAYTM 268
           +H D+ ++N+LL+S    A + DFG A  L  D   +++     + GT  ++APE+    
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 269 VLTEKCDVYSFGVVALEVLMGRHP 292
               K D++S   + L +L G HP
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLXGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/280 (21%), Positives = 125/280 (44%), Gaps = 35/280 (12%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVA-LKKLHHSETELAFL--------ESFQT 136
           +  ED      +G G +  +++      ++V    +LH +E  L  L        ESF  
Sbjct: 5   IRNEDLIFNESLGQGTFTKIFKG---VRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
            A ++S++ H+++V  YG C       L+ ++++ GSL   L+ +   I + W  ++ + 
Sbjct: 62  AASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVA 119
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTV 252
           K +A A+ +L  +   +++H ++ + NILL  + +    +    +L     S     + +
Sbjct: 120 KQLAWAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 253 VAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDL-LSSVNPKIMLIDLLD 310
           +     ++ PE +     L    D +SFG    E+  G   GD  LS+++ +  L    D
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG---GDKPLSALDSQRKLQFYED 233
Query: 311 Q-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRV 349
           + ++P+P   +        ++ ++  C+  +P  RP  R 
Sbjct: 234 RHQLPAPKAAE--------LANLINNCMDYEPDHRPSFRA 265

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 146
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV---AGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +   +     T  Y APE+   +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 94
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 147
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV---AGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +   +     T  Y APE+   +
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLL-SQIRHRNIVKLYG 154
           +G G +G V+R +   +G + A+KK+         LE F+ E  +  + +    IV LYG
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSPRIVPLYG 133
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
                  + +  + +  GSL  +++   +   L   + +  +      L YLH      I
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTR---RI 187
Query: 215 VHRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRTV-----VAGTHGYIAPELAYTM 268
           +H D+ ++N+LL+S    A + DFG A  L  D   +++     + GT  ++APE+    
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 269 VLTEKCDVYSFGVVALEVLMGRHP 292
               K D++S   + L +L G HP
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L + RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK----CQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 178
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGAT---WTLCGTPEYLAPEIIL 232
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 49/246 (19%)
Query: 81  FQEMIVAT----EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQ 135
           FQ  I+      ++++IK+ IG G YG VY A    + K VA+KK++    +L   +   
Sbjct: 16  FQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRIL 75
Query: 136 TEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI 195
            E  +L++++   I++L+   + +  +       +   L+ +L   D  ++  +   + +
Sbjct: 76  REITILNRLKSDYIIRLHDLIIPEDLL-------KFDELYIVLEIADSDLKKLFKTPIFL 128
Query: 196 ----VKSMAHAL----SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
               VK++ + L     ++H      I+HRD+   N LLN      + DFG+AR ++SD 
Sbjct: 129 TEQHVKTILYNLLLGEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185
Query: 248 SNRTV----------VAGTHG---------------YIAPELAYTMV-LTEKCDVYSFGV 281
               V            G H                Y APEL       T   D++S G 
Sbjct: 186 DIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGC 245
Query: 282 VALEVL 287
           +  E+L
Sbjct: 246 IFAELL 251

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA++K+   E +  + +    E  +L + RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 146
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 144
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 145 HS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 198
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 97  IGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G YG V  A     K +VA+KK+   E +  + +    E  +L   RH NI+ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLAFRHENIIGINDI 91
Query: 156 ----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                + +     I + +    L+ +L+       L        +  +   L Y+H    
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--- 144
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAY-T 267
            +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    T    T  Y APE+   +
Sbjct: 145 ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 268 MVLTEKCDVYSFGVVALEVLMGR 290
              T+  D++S G +  E+L  R
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/280 (21%), Positives = 126/280 (45%), Gaps = 35/280 (12%)
Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVA-LKKLHHSETELAFL--------ESFQT 136
           +  ED      +G G +  +++      ++V    +LH +E  L  L        ESF  
Sbjct: 5   IRNEDLIFNESLGQGTFTKIFKG---VRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
            A ++S++ H+++V  YG C+      L+ ++++ GSL   L+ +   I + W  ++ + 
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVA 119
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTV 252
           K +A A+ +L  +   +++H ++ + NILL  + +    +    +L     S     + +
Sbjct: 120 KQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 253 VAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDL-LSSVNPKIMLIDLLD 310
           +     ++ PE +     L    D +SFG    E+  G   GD  LS+++ +  L    D
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG---GDKPLSALDSQRKLQFYED 233
Query: 311 Q-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRV 349
           + ++P+P   +        ++ ++  C+  +P  RP  R 
Sbjct: 234 RHQLPAPKAAE--------LANLINNCMDYEPDHRPSFRA 265

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 42/231 (18%)
Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +++ IK+ IG G YG VY A    + K VA+KK++    +L   +    E  +L++++  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI----VKSMAHAL 203
            I++LY   +    +       +   L+ +L   D  ++  +   + +    +K++ + L
Sbjct: 86  YIIRLYDLIIPDDLL-------KFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 204 ----SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV------- 252
               +++H      I+HRD+   N LLN      V DFG+AR ++S+     V       
Sbjct: 139 LLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 253 VAGTHG---------------YIAPELAYTMV-LTEKCDVYSFGVVALEVL 287
             G H                Y APEL       T+  D++S G +  E+L
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 181
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 182 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 237
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 238 MGYKENVDIWSVGCIMGE--MVRH 259

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 200 MGYKENVDIWSVGCIMGE--MVRH 221

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG+G  G V  A     G  VA+KKL          +    E  LL  + H+NI+ L   
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 156 CLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
              +K +      +L+ + M   +L  ++      + LD  +   ++  M   + +LH  
Sbjct: 90  FTPQKTLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS- 142
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYT 267
               I+HRD+  +NI++ S     + DFG+AR   + S+N   T    T  Y APE+   
Sbjct: 143 --AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAPEVILG 197
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S G +  E++ G
Sbjct: 198 MGYKENVDIWSVGCIMGELVKG 219

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFXEPHARFYAAQIVLTFEYL 152
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 153 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 206
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFXEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 158
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 212
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 200 MGYKENVDIWSVGCIMGE--MVRH 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 144
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 145 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 200
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 201 MGYKENVDIWSVGCIMGE--MVRH 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 137
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 138 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 193
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 194 MGYKENVDIWSVGCIMGE--MVRH 215

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLL-SQIRHRNIVKLYG 154
           +G G +G V+R +   +G + A+KK+         LE F+ E  +  + +    IV LYG
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSPRIVPLYG 131
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
                  + +  + +  GSL  +++   +   L   + +  +      L YLH      I
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTR---RI 185
Query: 215 VHRDISSNNILLNS-KLEAFVADFGVARLLHSDSSNRTV-----VAGTHGYIAPELAYTM 268
           +H D+ ++N+LL+S    A + DFG A  L  D   +++     + GT  ++APE+    
Sbjct: 186 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 269 VLTEKCDVYSFGVVALEVLMGRHP 292
               K D++S   + L +L G HP
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 142
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 143 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 198
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 199 MGYKENVDIWSVGCIMGE--MVRH 220

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 144
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 145 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 200
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 201 MGYKENVDIWSVGCIMGE--MVRH 222

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 85  IVATEDFDIKYCIGTGGYGSVYRA--QLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           IVA + +++K CI  GG G +Y A  +  +G+ V LK L HS  +         E   L+
Sbjct: 77  IVAGQ-YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLA 134
Query: 143 QIRHRNIVKLYGFCLHKK-----CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
           ++ H +IV+++ F  H         +++ +Y+   SL        +  +L   + +  + 
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLL 189
Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +  ALSYLH      +V+ D+   NI+L  +    + D G    ++S       + GT 
Sbjct: 190 EILPALSYLHSI---GLVYNDLKPENIMLTEEQLKLI-DLGAVSRINSFG----YLYGTP 241
Query: 258 GYIAPELAYTMVLTEKCDVYSFG 280
           G+ APE+  T   T   D+Y+ G
Sbjct: 242 GFQAPEIVRTGP-TVATDIYTVG 263

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 136
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 192
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 193 MGYKENVDIWSVGCIMGE--MVRH 214

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFXEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 137
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 138 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 193
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 194 MGYKENVDIWSVGCIMGE--MVRH 215

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFXEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +L+ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 181
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 182 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 237
Query: 268 MVLTEKCDVYSFGVVALEVLMGRH 291
           M   E  D++S G +  E  M RH
Sbjct: 238 MGYKENVDIWSVGCIMGE--MVRH 259

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 34  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 93
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 147
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEYLAPEIILSKGYNKA 204
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 205 VDWWALGVLIYEMAAGYPP 223

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           T+ +++K  IG G Y    R     +  + A+K +  S+ +    E  +    LL   +H
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT--EEIEI---LLRYGQH 75
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
            NI+ L       K ++++ + M+ G L   ILR    + R    +   ++ ++   + Y
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER----EASAVLFTITKTVEY 131
Query: 206 LHCDCIPSIVHRDISSNNILL---NSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           LH      +VHRD+  +NIL    +   E+  + DFG A+ L +++        T  ++A
Sbjct: 132 LHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+         CD++S GV+   +L G  P
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 81/172 (47%), Gaps = 23/172 (13%)
Query: 133 SFQTEAHLLSQIRHRNIVKLYG--FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWT 190
           + + E  LL ++RH+N+++L    +   K+ M+++ +Y       C ++   +++     
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY-----CVCGMQEMLDSVP---E 103
Query: 191 KRVNIVKSMAH------ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
           KR  + ++  +       L YLH      IVH+DI   N+LL +     ++  GVA  LH
Sbjct: 104 KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 245 SDSSNRT--VVAGTHGYIAPELAYTMVLTE--KCDVYSFGVVALEVLMGRHP 292
             +++ T     G+  +  PE+A  +      K D++S GV    +  G +P
Sbjct: 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 144
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 145 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 200
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S G +  E++ G
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKG 222

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFAEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFXEPHARFYAAQIVLTFEYL 178
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 232
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 122/284 (42%), Gaps = 33/284 (11%)
Query: 78  RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTE 137
            + FQ M V    + I   IG+GG   V++      +  A+K ++  E +   L+S++ E
Sbjct: 17  NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 76
Query: 138 AHLLSQIRHRN--IVKLYGFCLHKKCMFLIYKYMRRGS--LFCILRNDDEAIRLDWTKRV 193
              L++++  +  I++LY + +  + ++++   M  G+  L   L+   +   +D  +R 
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERK 130
Query: 194 NIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RT 251
           +  K+M  A+  +H      IVH D+   N L+   +   + DFG+A  +  D     + 
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKD 186
Query: 252 VVAGTHGYIAPELAYTMVLTEK-----------CDVYSFGVVALEVLMGRHPGDLLSSVN 300
              GT  Y+ PE    M  + +            DV+S G +   +  G+ P   + +  
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 301 PKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSR 344
            K+  I   +  +  P   +  +QD++        CL+  P  R
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQR 284

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPEVVTRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 162
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEYLAPEIILSKGYNKA 219
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N++++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIII 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKK----VALKKLHHSETELAFLESFQTEAHLLSQ 143
           ++ +++   IG G +G    A+L   K+    VA+K +   E      E+ + E      
Sbjct: 18  SDRYELVKDIGAGNFGV---ARLMRDKQANELVAVKYIERGEK---IDENVKREIINHRS 71
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           +RH NIV+     L    + ++ +Y   G LF  + N   A R    +     + +   +
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGV 128
Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAF--VADFGV--ARLLHSDSSNRTVVAGTHGY 259
           SY H      + HRD+   N LL+        +ADFG   A +LHS   +     GT  Y
Sbjct: 129 SYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKS---AVGTPAY 182
Query: 260 IAPELAYTMVLTEK-CDVYSFGVVALEVLMGRHP 292
           IAPE+        K  DV+S GV    +L+G +P
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 162
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 219
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  ++  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFXEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFXEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 145
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   +       V  T  Y APE+   
Sbjct: 146 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV-TRYYRAPEVILG 201
Query: 268 MVLTEKCDVYSFGVVALEVLMG 289
           M   E  D++S G +  E++ G
Sbjct: 202 MGYKENVDIWSVGCIMGEMIKG 223

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFXEPHARFYAAQIVLTFEYLHS---LD 162
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 219
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y   G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N++++ +    V DFG+A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y   G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N++++ +    V DFG+A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+AP +  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPAIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 7/198 (3%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHRNIVKLYG 154
           +G GG+G V   Q+  +GK  A KKL     +    E+    E  +L ++  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
               K  + L+   M  G L   + +  +A      + V     +   L  LH +    I
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGLEDLHRE---RI 307
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           V+RD+   NILL+      ++D G+A  +    + +  V GT GY+APE+      T   
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSP 366
Query: 275 DVYSFGVVALEVLMGRHP 292
           D ++ G +  E++ G+ P
Sbjct: 367 DWWALGCLLYEMIAGQSP 384

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y   G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N++++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 17/200 (8%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG+G  G V  A     G  VA+KKL          +    E  LL  + H+NI+ L   
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 156 CLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
              +K +      +L+ + M       I       + LD  +   ++  M   + +LH  
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVI------HMELDHERMSYLLYQMLCGIKHLHS- 144
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
               I+HRD+  +NI++ S     + DFG+AR   ++      V  T  Y APE+   M 
Sbjct: 145 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMG 201
Query: 270 LTEKCDVYSFGVVALEVLMG 289
                D++S G +  E++ G
Sbjct: 202 YAANVDIWSVGCIMGELVKG 221

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 18/211 (8%)
Query: 90  DFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHR 147
           DF +   IG GG+G VY   +  +GK  A+K L     ++   E+    E  +LS +   
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 148 N----IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWT-KRVNIVKSMAHA 202
           +    +   Y F    K  F++   M  G L   L         D       I+  + H 
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
            +         +V+RD+   NILL+      ++D G+A        + +V  GTHGY+AP
Sbjct: 309 HNRF-------VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAP 359
Query: 263 E-LAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E L   +      D +S G +  ++L G  P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 18/211 (8%)
Query: 90  DFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHR 147
           DF +   IG GG+G VY   +  +GK  A+K L     ++   E+    E  +LS +   
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 148 N----IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWT-KRVNIVKSMAHA 202
           +    +   Y F    K  F++   M  G L   L         D       I+  + H 
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
            +         +V+RD+   NILL+      ++D G+A        + +V  GTHGY+AP
Sbjct: 309 HNRF-------VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAP 359
Query: 263 E-LAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E L   +      D +S G +  ++L G  P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 18/211 (8%)
Query: 90  DFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHR 147
           DF +   IG GG+G VY   +  +GK  A+K L     ++   E+    E  +LS +   
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 148 N----IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWT-KRVNIVKSMAHA 202
           +    +   Y F    K  F++   M  G L   L         D       I+  + H 
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
            +         +V+RD+   NILL+      ++D G+A        + +V  GTHGY+AP
Sbjct: 309 HNRF-------VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAP 359
Query: 263 E-LAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E L   +      D +S G +  ++L G  P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 18/211 (8%)
Query: 90  DFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHR 147
           DF +   IG GG+G VY   +  +GK  A+K L     ++   E+    E  +LS +   
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 248
Query: 148 N----IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWT-KRVNIVKSMAHA 202
           +    +   Y F    K  F++   M  G L   L         D       I+  + H 
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 307
Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
            +         +V+RD+   NILL+      ++D G+A        + +V  GTHGY+AP
Sbjct: 308 HNRF-------VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAP 358
Query: 263 E-LAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           E L   +      D +S G +  ++L G  P
Sbjct: 359 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y   G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N++++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 100/237 (42%), Gaps = 48/237 (20%)
Query: 91  FDIKYCIGTGGYGSVY--RAQLPSG--KKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           F I+  IG G + SVY   AQL  G  +K+ALK L  +   +      Q     L+    
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQC----LTVAGG 78
Query: 147 RNIVKLYGFCLHKKCMFLI-YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           ++ V    +C  K    +I   Y+   S   IL +      L + +    + ++  AL  
Sbjct: 79  QDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKR 132
Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSD-----------------S 247
           +H      IVHRD+  +N L N +L+ + + DFG+A+  H                   S
Sbjct: 133 IHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCS 189
Query: 248 SNRTVV-----------AGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
            N+  +           AGT G+ APE L      T   D++S GV+ L +L GR+P
Sbjct: 190 QNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 7/198 (3%)
Query: 97  IGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQ-TEAHLLSQIRHRNIVKLYG 154
           +G GG+G V   Q+  +GK  A KKL     +    E+    E  +L ++  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
               K  + L+   M  G L   + +  +A      + V     +   L  LH +    I
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGLEDLHRE---RI 307
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKC 274
           V+RD+   NILL+      ++D G+A  +    + +  V GT GY+APE+      T   
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSP 366
Query: 275 DVYSFGVVALEVLMGRHP 292
           D ++ G +  E++ G+ P
Sbjct: 367 DWWALGCLLYEMIAGQSP 384

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   +   +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   +   +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   +   +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT---EAHLLSQIRHRNIVKL 152
           +G G   +V+R +   +G   A+K  ++    ++FL        E  +L ++ H+NIVKL
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 153 YGF-----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           +         HK    LI ++   GSL+ +L     A  L  ++ + +++ +   +++L 
Sbjct: 73  FAIEEETTTRHK---VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 208 CDCIPSIVHRDISSNNILL----NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
            +    IVHR+I   NI+     + +    + DFG AR L  D      + GT  Y+ P+
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVXLYGTEEYLHPD 185
Query: 264 LAYTMVLTEK--------CDVYSFGVVALEVLMGRHP 292
           +    VL +          D++S GV       G  P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           T+ +++K  IG G Y    R     +  + A+K +  S+ +    E  +    LL   +H
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPT--EEIEI---LLRYGQH 75
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
            NI+ L       K ++++ +  + G L   ILR    + R    +   ++ ++   + Y
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSER----EASAVLFTITKTVEY 131
Query: 206 LHCDCIPSIVHRDISSNNILL---NSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           LH      +VHRD+  +NIL    +   E+  + DFG A+ L +++        T  ++A
Sbjct: 132 LHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVA 188
Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+         CD++S GV+    L G  P
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y   G +F  LR      R            +     YLH      
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLR---RIGRFXEPHARFYAAQIVLTFEYLHS---LD 161
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N++++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   +   +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 154
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 211
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 212 VDWWALGVLIYEMAAGYPP 230

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   +   +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 162
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 219
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/265 (21%), Positives = 118/265 (44%), Gaps = 33/265 (12%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN--IVKLYG 154
           IG+GG   V++      +  A+K ++  E +   L+S++ E   L++++  +  I++LY 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 155 FCLHKKCMFLIYKYMRRGS--LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           + +  + ++++   M  G+  L   L+   +   +D  +R +  K+M  A+  +H     
Sbjct: 124 YEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVL 270
            IVH D+   N L+   +   + DFG+A  +  D+++  +    GT  Y+ PE    M  
Sbjct: 175 GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 271 TEK-----------CDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
           + +            DV+S G +   +  G+ P   + +   K+  I   +  +  P   
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 320 QTVIQDIILVSKIVFACLRSKPTSR 344
           +  +QD++        CL+  P  R
Sbjct: 294 EKDLQDVLK------CCLKRDPKQR 312

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTE 272
           +HRD+++ NILL+ K    + DFG+AR ++ D     +        ++APE  +  V T 
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 273 KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI 332
           + DV+SFGV+  E+        L +S  P + + +   +R+      +        + + 
Sbjct: 280 QSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 333
Query: 333 VFACLRSKPTSRP 345
           +  C   +P+ RP
Sbjct: 334 MLDCWHGEPSQRP 346

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/265 (21%), Positives = 118/265 (44%), Gaps = 33/265 (12%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN--IVKLYG 154
           IG+GG   V++      +  A+K ++  E +   L+S++ E   L++++  +  I++LY 
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 155 FCLHKKCMFLIYKYMRRGS--LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           + +  + ++++   M  G+  L   L+   +   +D  +R +  K+M  A+  +H     
Sbjct: 80  YEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH--- 130
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVL 270
            IVH D+   N L+   +   + DFG+A  +  D+++  +    GT  Y+ PE    M  
Sbjct: 131 GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 189
Query: 271 TEK-----------CDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
           + +            DV+S G +   +  G+ P   + +   K+  I   +  +  P   
Sbjct: 190 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 249
Query: 320 QTVIQDIILVSKIVFACLRSKPTSR 344
           +  +QD++        CL+  P  R
Sbjct: 250 EKDLQDVLK------CCLKRDPKQR 268

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTE 272
           +HRD+++ NILL+ K    + DFG+AR ++ D     +        ++APE  +  V T 
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 273 KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI 332
           + DV+SFGV+  E+        L +S  P + + +   +R+      +        + + 
Sbjct: 275 QSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328
Query: 333 VFACLRSKPTSRP 345
           +  C   +P+ RP
Sbjct: 329 MLDCWHGEPSQRP 341

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   +   +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 162
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 219
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   +   +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 162
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 219
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTE 272
           +HRD+++ NILL+ K    + DFG+AR ++ D     +        ++APE  +  V T 
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 281
Query: 273 KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI 332
           + DV+SFGV+  E+        L +S  P + + +   +R+      +        + + 
Sbjct: 282 QSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 335
Query: 333 VFACLRSKPTSRP 345
           +  C   +P+ RP
Sbjct: 336 MLDCWHGEPSQRP 348

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/265 (21%), Positives = 117/265 (44%), Gaps = 33/265 (12%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN--IVKLYG 154
           IG+GG   V++      +  A+K ++  E +   L+S++ E   L++++  +  I++LY 
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 155 FCLHKKCMFLIYKYMRRGS--LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           + +  + ++++   M  G+  L   L+       +D  +R +  K+M  A+  +H     
Sbjct: 76  YEITDQYIYMV---MECGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH--- 126
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVL 270
            IVH D+   N L+   +   + DFG+A  +  D+++  +    GT  Y+ PE    M  
Sbjct: 127 GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 185
Query: 271 TEK-----------CDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
           + +            DV+S G +   +  G+ P   + +   K+  I   +  +  P   
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 245
Query: 320 QTVIQDIILVSKIVFACLRSKPTSR 344
           +  +QD++        CL+  P  R
Sbjct: 246 EKDLQDVLK------CCLKRDPKQR 264

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTE 272
           +HRD+++ NILL+ K    + DFG+AR ++ D     +        ++APE  +  V T 
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 272
Query: 273 KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI 332
           + DV+SFGV+  E+        L +S  P + + +   +R+      +        + + 
Sbjct: 273 QSDVWSFGVLLWEIF------SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 326
Query: 333 VFACLRSKPTSRP 345
           +  C   +P+ RP
Sbjct: 327 MLDCWHGEPSQRP 339

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 7/165 (4%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWT 190
           E  + EA +   ++H +IV+L         +++++++M    L F I++  D        
Sbjct: 73  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 132
Query: 191 KRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDS 247
              + ++ +  AL Y H +   +I+HRD+  + +LL SK  +    +  FGVA  L    
Sbjct: 133 VASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 189
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                  GT  ++APE+       +  DV+  GV+   +L G  P
Sbjct: 190 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT---EAHLLSQIRHRNIVKL 152
           +G G   +V+R +   +G   A+K  ++    ++FL        E  +L ++ H+NIVKL
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 153 YGF-----CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           +         HK    LI ++   GSL+ +L     A  L  ++ + +++ +   +++L 
Sbjct: 73  FAIEEETTTRHK---VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 208 CDCIPSIVHRDISSNNILL----NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
            +    IVHR+I   NI+     + +    + DFG AR L  D    ++  GT  Y+ P+
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPD 185
Query: 264 LAYTMVLTEK--------CDVYSFGVVALEVLMGRHP 292
           +    VL +          D++S GV       G  P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   +   +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFXEPHARFYAAQIVLTFEYLHS---LD 154
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 211
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 212 VDWWALGVLIYEMAAGYPP 230

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 7/165 (4%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWT 190
           E  + EA +   ++H +IV+L         +++++++M    L F I++  D        
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 191 KRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDS 247
              + ++ +  AL Y H +   +I+HRD+  + +LL SK  +    +  FGVA  L    
Sbjct: 131 VASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                  GT  ++APE+       +  DV+  GV+   +L G  P
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/265 (21%), Positives = 118/265 (44%), Gaps = 33/265 (12%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN--IVKLYG 154
           IG+GG   V++      +  A+K ++  E +   L+S++ E   L++++  +  I++LY 
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 155 FCLHKKCMFLIYKYMRRGS--LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           + +  + ++++   M  G+  L   L+   +   +D  +R +  K+M  A+  +H     
Sbjct: 77  YEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVL 270
            IVH D+   N L+   +   + DFG+A  +  D+++  +    GT  Y+ PE    M  
Sbjct: 128 GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 271 TEK-----------CDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
           + +            DV+S G +   +  G+ P   + +   K+  I   +  +  P   
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 320 QTVIQDIILVSKIVFACLRSKPTSR 344
           +  +QD++        CL+  P  R
Sbjct: 247 EKDLQDVLK------CCLKRDPKQR 265

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 21/200 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 37  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 95  NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 148
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 149 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 204
Query: 268 MVLTEKCDVYSFGVVALEVL 287
           M   E  D++S G +  E++
Sbjct: 205 MGYKENVDLWSVGCIMGEMV 224

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   +   +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 69  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y+  G +F  LR      R            +     YLH      
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 182
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 239
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 240 VDWWALGVLIYEMAAGYPP 258

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 11/206 (5%)
Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +   +     + GT   +APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEALAPEIIL 211
Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
           +    +  D ++ GV+  E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 94/201 (46%), Gaps = 27/201 (13%)
Query: 132 ESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLD--W 189
           + F+ E  +++ I++   +   G   +   +++IY+YM   S   IL+ D+    LD  +
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS---ILKFDEYFFVLDKNY 144
Query: 190 TKRVNI------VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243
           T  + I      +KS+ ++ SY+H +   +I HRD+  +NIL++      ++DFG +  +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 244 HSDSSNRTVVAGTHGYIAPEL--AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP 301
                  +   GT+ ++ PE     +     K D++S G+    +     P  L      
Sbjct: 203 VDKKIKGS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL------ 254
Query: 302 KIMLIDLLD----QRVPSPID 318
           KI L++L +    + +  P+D
Sbjct: 255 KISLVELFNNIRTKNIEYPLD 275

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLE-SFQTEAHLLSQIRHRNIVKLYGF 155
           +G G  G+V       G+ VA+K++     ++A +E    TE+       H N+++ Y  
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD-----DHPNVIRYYCS 95
Query: 156 CLHKKCMFLIYKY--MRRGSLFCILRNDDEAIRLDWTKR-VNIVKSMAHALSYLHCDCIP 212
               + +++  +   +    L       DE ++L      +++++ +A  +++LH     
Sbjct: 96  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 152
Query: 213 SIVHRDISSNNILLNS-------------KLEAFVADFGVARLLHSDS----SNRTVVAG 255
            I+HRD+   NIL+++              L   ++DFG+ + L S       N    +G
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 212
Query: 256 THGYIAPEL---AYTMVLTEKCDVYSFGVVALEVL-MGRHP-GDLLSSVNPKIMLIDLLD 310
           T G+ APEL   +    LT   D++S G V   +L  G+HP GD  S  +  I  I  LD
Sbjct: 213 TSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLD 272
Query: 311 Q 311
           +
Sbjct: 273 E 273

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 21/200 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   +       V  T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV-TRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVL 287
           M   E  D++S G +  E++
Sbjct: 200 MGYKENVDIWSVGCIMGEMV 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 21/200 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 26  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 137
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   + S   T    T  Y APE+   
Sbjct: 138 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 193
Query: 268 MVLTEKCDVYSFGVVALEVL 287
           M   E  D++S G +  E++
Sbjct: 194 MGYKENVDLWSVGCIMGEMV 213

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/265 (21%), Positives = 118/265 (44%), Gaps = 33/265 (12%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN--IVKLYG 154
           IG+GG   V++      +  A+K ++  E +   L+S++ E   L++++  +  I++LY 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 155 FCLHKKCMFLIYKYMRRGS--LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           + +  + ++++   M  G+  L   L+   +   +D  +R +  K+M  A+  +H     
Sbjct: 124 YEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVL 270
            IVH D+   N L+   +   + DFG+A  +  D+++  +    GT  Y+ PE    M  
Sbjct: 175 GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 271 TEK-----------CDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
           + +            DV+S G +   +  G+ P   + +   K+  I   +  +  P   
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 320 QTVIQDIILVSKIVFACLRSKPTSR 344
           +  +QD++        CL+  P  R
Sbjct: 294 EKDLQDVLK------CCLKRDPKQR 312

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLE-SFQTEAHLLSQIRHRNIVKLYGF 155
           +G G  G+V       G+ VA+K++     ++A +E    TE+       H N+++ Y  
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD-----DHPNVIRYYCS 95
Query: 156 CLHKKCMFLIYKY--MRRGSLFCILRNDDEAIRLDWTKR-VNIVKSMAHALSYLHCDCIP 212
               + +++  +   +    L       DE ++L      +++++ +A  +++LH     
Sbjct: 96  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 152
Query: 213 SIVHRDISSNNILLNS-------------KLEAFVADFGVARLLHSDS----SNRTVVAG 255
            I+HRD+   NIL+++              L   ++DFG+ + L S       N    +G
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 212
Query: 256 THGYIAPEL---AYTMVLTEKCDVYSFGVVALEVL-MGRHP-GDLLSSVNPKIMLIDLLD 310
           T G+ APEL   +    LT   D++S G V   +L  G+HP GD  S  +  I  I  LD
Sbjct: 213 TSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLD 272
Query: 311 Q 311
           +
Sbjct: 273 E 273

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSET------ELAFLESFQTEAHLLSQIRHRNI 149
           +G+G +G V+ A      K+V +K +   +       E   L     E  +LS++ H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           +K+     ++    L+ +  + GS   +    D   RLD      I + +  A+ YL   
Sbjct: 92  IKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR-- 147
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTM 268
            +  I+HRDI   NI++       + DFG A  L       T   GT  Y APE L    
Sbjct: 148 -LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPEVLMGNP 205
Query: 269 VLTEKCDVYSFGVVALEVLMGRHP 292
               + +++S GV    ++   +P
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 13/181 (7%)
Query: 112 SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC--LHKKCMFLIYKYM 169
           +G+ VA+K L  ++        ++ E  +L  + H +I+K  G C       + L+ +Y+
Sbjct: 59  TGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK 229
             GSL   L      +     + +   + +   ++YLH       +HRD+++ N+LL++ 
Sbjct: 118 PLGSLRDYLPRHSIGL----AQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDND 170
Query: 230 LEAFVADFGVARLL---HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEV 286
               + DFG+A+ +   H     R        + APE           DV+SFGV   E+
Sbjct: 171 RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230
Query: 287 L 287
           L
Sbjct: 231 L 231

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 97  IGTGGYG-SVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG+G +G +       S + VA+K +   E      E+ + E      +RH NIV+    
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEK---IDENVKREIINHRSLRHPNIVRFKEV 82
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
            L    + ++ +Y   G LF  + N   A R    +     + +   +SY H      + 
Sbjct: 83  ILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA---MQVC 136
Query: 216 HRDISSNNILLNSKLEAF--VADFGVAR--LLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
           HRD+   N LL+        + DFG ++  +LHS   +     GT  YIAPE+       
Sbjct: 137 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKEYD 193
Query: 272 EK-CDVYSFGVVALEVLMGRHP 292
            K  DV+S GV    +L+G +P
Sbjct: 194 GKVADVWSCGVTLYVMLVGAYP 215

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 84/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y   G +F  LR      R            +     YLH      
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 162
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N++++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 219
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 84/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y   G +F  LR      R            +     YLH      
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 162
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N++++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 219
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLE-SFQTEAHLLSQIRHRNIVKLYGF 155
           +G G  G+V       G+ VA+K++     ++A +E    TE+       H N+++ Y  
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD-----DHPNVIRYYCS 77
Query: 156 CLHKKCMFLIYKY--MRRGSLFCILRNDDEAIRLDWTKR-VNIVKSMAHALSYLHCDCIP 212
               + +++  +   +    L       DE ++L      +++++ +A  +++LH     
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 213 SIVHRDISSNNILLNS-------------KLEAFVADFGVARLLHS-DSSNRTVV---AG 255
            I+HRD+   NIL+++              L   ++DFG+ + L S  SS RT +   +G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 256 THGYIAPE-------LAYTMVLTEKCDVYSFGVVALEVL-MGRHP-GD 294
           T G+ APE       L     LT   D++S G V   +L  G+HP GD
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 21/200 (10%)
Query: 97  IGTGGYGSV---YRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           IG+G  G V   Y A L   + VA+KKL          +    E  L+  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
                +K +      +++ + M   +L  +++     + LD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NI++ S     + DFG+AR   +       V  T  Y APE+   
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV-TRYYRAPEVILG 199
Query: 268 MVLTEKCDVYSFGVVALEVL 287
           M   E  D++S G +  E++
Sbjct: 200 MGYKENVDLWSVGCIMGEMV 219

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 84/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   +   +G   A+K L   +  +L  +E    E  +L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y   G +F  LR      R            +     YLH      
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LD 162
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N++++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 219
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 112 SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLIYKYM 169
           +G+ VA+K L  ++        ++ E  +L  + H +I+K  G C  +  K + L+ +Y+
Sbjct: 42  TGEMVAVKALK-ADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK 229
             GSL    R+      +   + +   + +   ++YLH       +HR++++ N+LL++ 
Sbjct: 101 PLGSL----RDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDND 153
Query: 230 LEAFVADFGVARLL---HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEV 286
               + DFG+A+ +   H     R        + APE           DV+SFGV   E+
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213
Query: 287 L 287
           L
Sbjct: 214 L 214

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 84/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   + + +G   A+K L   +  +L  +E    E  +L  +    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y   G +F  LR      R            +     YLH      
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLR---RIGRFXEPHARFYAAQIVLTFEYLHS---LD 162
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N++++ +    V DFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 219
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCI-------LRNDDEAIRLDWTKRVNIVKSMAH 201
           ++ L+    +   + LI +Y   G +F +       + ++++ IRL        +K +  
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL--------IKQILE 142
Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKL---EAFVADFGVARLLHSDSSNRTVVAGTHG 258
            + YLH +   +IVH D+   NILL+S     +  + DFG++R +      R ++ GT  
Sbjct: 143 GVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-GTPE 198
Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y+APE+     +T   D+++ G++A  +L    P
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETEL--------AFL-ESFQTEAHLL 141
           + ++  I +G YG+V       G  VA+K++ ++ ++         +FL +    E  LL
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 142 SQIRHRNIVKLYGFCLH-----KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           +   H NI+ L    +H        ++L+ + MR      I    D+ I +      +I 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI---HDQRIVI---SPQHIQ 137
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
             M H L  LH      +VHRD+   NILL    +  + DF +AR   +D +N+T     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTH 196
Query: 257 HGYIAPELAYTMV-LTEKCDVYSFGVVALEVL 287
             Y APEL       T+  D++S G V  E+ 
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 11/199 (5%)
Query: 96  CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLY 153
            +GTG +G V   +   +G   A+K L   +  +L  +E    E  +   +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLE 108
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   ++++ +Y   G +F  LR      R            +     YLH      
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LD 162
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEK 273
           +++RD+   N+L++ +    VADFG A+ +   +     + GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 219
Query: 274 CDVYSFGVVALEVLMGRHP 292
            D ++ GV+  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 97  IGTGGYG-SVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG+G +G +       S + VA+K +   E   A   + + E      +RH NIV+    
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAA---NVKREIINHRSLRHPNIVRFKEV 83
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
            L    + ++ +Y   G LF  + N   A R    +     + +   +SY H      + 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA---MQVC 137
Query: 216 HRDISSNNILLNSKLEAF--VADFGVAR--LLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
           HRD+   N LL+        + DFG ++  +LHS   +     GT  YIAPE+       
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKEYD 194
Query: 272 EK-CDVYSFGVVALEVLMGRHP 292
            K  DV+S GV    +L+G +P
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYP 216

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETEL--------AFL-ESFQTEAHLL 141
           + ++  I +G YG+V       G  VA+K++ ++ ++         +FL +    E  LL
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 142 SQIRHRNIVKLYGFCLH-----KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           +   H NI+ L    +H        ++L+ + MR      I    D+ I +      +I 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI---HDQRIVI---SPQHIQ 137
Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
             M H L  LH      +VHRD+   NILL    +  + DF +AR   +D +N+T     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTH 196
Query: 257 HGYIAPELAYTMV-LTEKCDVYSFGVVALEVL 287
             Y APEL       T+  D++S G V  E+ 
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 112 SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLIYKYM 169
           +G+ VA+K L  ++        ++ E  +L  + H +I+K  G C  +  K + L+ +Y+
Sbjct: 42  TGEMVAVKALK-ADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK 229
             GSL    R+      +   + +   + +   ++YLH       +HR++++ N+LL++ 
Sbjct: 101 PLGSL----RDYLPRHSIGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDND 153
Query: 230 LEAFVADFGVARLL---HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEV 286
               + DFG+A+ +   H     R        + APE           DV+SFGV   E+
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213
Query: 287 L 287
           L
Sbjct: 214 L 214

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 15/107 (14%)
Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
           ++I   +A A+ +LH      ++HRD+  +NI         V DFG+   +  D   +TV
Sbjct: 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 253 VA------------GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL 287
           +             GT  Y++PE  +    + K D++S G++  E+L
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 36/240 (15%)
Query: 93  IKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIV 150
           ++  +  GG+  VY AQ + SG++ ALK+L  +E E     +   E   + ++  H NIV
Sbjct: 32  VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHPNIV 89
Query: 151 KLYGFCLHK----------KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMA 200
           +   FC             +  FL+   + +G L   L+  +    L     + I     
Sbjct: 90  Q---FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL-----HSDSSNRTVVA- 254
            A+ ++H    P I+HRD+   N+LL+++    + DFG A  +     +S S+ R  +  
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 255 ------GTHGYIAPE---LAYTMVLTEKCDVYSFGVVALEVLMGRHP---GDLLSSVNPK 302
                  T  Y  PE   L     + EK D+++ G +   +   +HP   G  L  VN K
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 18/202 (8%)
Query: 97  IGTGGYG-SVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG+G +G +       S + VA+K +   E      E+ + E      +RH NIV+    
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEK---IDENVKREIINHRSLRHPNIVRFKEV 83
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
            L    + ++ +Y   G LF  + N   A R    +     + +   +SY H      + 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA---MQVC 137
Query: 216 HRDISSNNILLNS----KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
           HRD+   N LL+     +L+     +  + +LHS   +     GT  YIAPE+       
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKD---TVGTPAYIAPEVLLKKEYD 194
Query: 272 EK-CDVYSFGVVALEVLMGRHP 292
            K  DV+S GV    +L+G +P
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYP 216

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 91  FDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           ++I++ IGTG YG V  A     K+V A+KK+     +L   +    E  +L+++ H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI----VKSMAHAL-- 203
           VK+    + K     + K+     L+ +L   D   +  +   V +    +K++ + L  
Sbjct: 115 VKVLDIVIPKD----VEKF---DELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 204 --SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL------------------ 243
              Y+H      I+HRD+   N L+N      V DFG+AR +                  
Sbjct: 168 GVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 244 -------HSDSSNRTVVAG--THGYIAPELAYTMV-LTEKCDVYSFGVVALEVL 287
                  H+ +  R +     T  Y APEL       TE  DV+S G +  E+L
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 18/202 (8%)
Query: 97  IGTGGYG-SVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG+G +G +       S + VA+K +   E      E+ + E      +RH NIV+    
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEK---IDENVKREIINHRSLRHPNIVRFKEV 83
Query: 156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIV 215
            L    + ++ +Y   G LF  + N   A R    +     + +   +SY H      + 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA---MQVC 137
Query: 216 HRDISSNNILLNS----KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
           HRD+   N LL+     +L+     +  + +LHS   +     GT  YIAPE+       
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKEYD 194
Query: 272 EK-CDVYSFGVVALEVLMGRHP 292
            K  DV+S GV    +L+G +P
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYP 216

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 33/265 (12%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN--IVKLYG 154
           IG+GG   V++      +  A+K ++  E +   L+S++ E   L++++  +  I++LY 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 155 FCLHKKCMFLIYKYMRRGS--LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
           + +  + ++++   M  G+  L   L+   +   +D  +R +  K+M  A+  +H     
Sbjct: 124 YEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVL 270
            IVH D+   N L+   +   + DFG+A  +  D+++  +    G   Y+ PE    M  
Sbjct: 175 GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 271 TEK-----------CDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
           + +            DV+S G +   +  G+ P   + +   K+  I   +  +  P   
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 320 QTVIQDIILVSKIVFACLRSKPTSR 344
           +  +QD++        CL+  P  R
Sbjct: 294 EKDLQDVLK------CCLKRDPKQR 312

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 13/181 (7%)
Query: 112 SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLIYKYM 169
           +G+ VA+K L            +Q E  +L  + H +IVK  G C  +  K + L+ +Y+
Sbjct: 36  TGEMVAVKALKEG-CGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 94
Query: 170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK 229
             GSL   L      +     + +   + +   ++YLH       +HR +++ N+LL++ 
Sbjct: 95  PLGSLRDYLPRHCVGL----AQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDND 147
Query: 230 LEAFVADFGVARLL---HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEV 286
               + DFG+A+ +   H     R        + APE           DV+SFGV   E+
Sbjct: 148 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 207
Query: 287 L 287
           L
Sbjct: 208 L 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 13/181 (7%)
Query: 112 SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLIYKYM 169
           +G+ VA+K L            +Q E  +L  + H +IVK  G C  +  K + L+ +Y+
Sbjct: 37  TGEMVAVKALKEG-CGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 95
Query: 170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK 229
             GSL   L      +     + +   + +   ++YLH       +HR +++ N+LL++ 
Sbjct: 96  PLGSLRDYLPRHCVGL----AQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDND 148
Query: 230 LEAFVADFGVARLL---HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEV 286
               + DFG+A+ +   H     R        + APE           DV+SFGV   E+
Sbjct: 149 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 208
Query: 287 L 287
           L
Sbjct: 209 L 209

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 22/172 (12%)
Query: 137 EAHLLSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI 195
           E  +L Q + HRN+++L  F   +   +L+++ MR GS   IL +  +    +  +   +
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS---ILSHIHKRRHFNELEASVV 116
Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILL---NSKLEAFVADFGVAR--LLHSDSSNR 250
           V+ +A AL +LH      I HRD+   NIL    N      + DFG+     L+ D S  
Sbjct: 117 VQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPI 173
Query: 251 T-----VVAGTHGYIAPELAYTM-----VLTEKCDVYSFGVVALEVLMGRHP 292
           +        G+  Y+APE+         +  ++CD++S GV+   +L G  P
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 91  FDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRN 148
           ++I   IG G +G V +A      + VA+K + + +   AFL   Q E  LL  + +H  
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDT 112
Query: 149 IVKLYGFCLHKKCMF-----LIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHA 202
            +K Y   L +  MF     L+++ M   +L+ +LRN +   + L+ T++    + M  A
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTA 169
Query: 203 LSYLHCDCIPSIVHRDISSNNILL-NSKLEAF-VADFG----VARLLHSDSSNRTVVAGT 256
           L +L    + SI+H D+   NILL N K  A  + DFG    + + ++    +R      
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRF----- 223
Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGD-LLSSVN 300
             Y +PE+   M      D++S G + +E+    H G+ L S  N
Sbjct: 224 --YRSPEVLLGMPYDLAIDMWSLGCILVEM----HTGEPLFSGAN 262

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 49/86 (56%), Gaps = 8/86 (9%)
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVA-RLLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
            ++HRD+  +NILL+ + +  + DFG++ RL+   + +R+  AG   Y+APE       T
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--AGCAAYMAPERIDPPDPT 202
Query: 272 E-----KCDVYSFGVVALEVLMGRHP 292
           +     + DV+S G+  +E+  G+ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 91  FDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRN 148
           ++I   IG G +G V +A      + VA+K + + +   AFL   Q E  LL  + +H  
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDT 93
Query: 149 IVKLYGFCLHKKCMF-----LIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHA 202
            +K Y   L +  MF     L+++ M   +L+ +LRN +   + L+ T++    + M  A
Sbjct: 94  EMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTA 150
Query: 203 LSYLHCDCIPSIVHRDISSNNILL-NSKLEAF-VADFG----VARLLHSDSSNRTVVAGT 256
           L +L    + SI+H D+   NILL N K  A  + DFG    + + ++    +R      
Sbjct: 151 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRF----- 204
Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGD-LLSSVN 300
             Y +PE+   M      D++S G + +E+    H G+ L S  N
Sbjct: 205 --YRSPEVLLGMPYDLAIDMWSLGCILVEM----HTGEPLFSGAN 243

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 91  FDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRN 148
           ++I   IG G +G V +A      + VA+K + + +   AFL   Q E  LL  + +H  
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDT 112
Query: 149 IVKLYGFCLHKKCMF-----LIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHA 202
            +K Y   L +  MF     L+++ M   +L+ +LRN +   + L+ T++    + M  A
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTA 169
Query: 203 LSYLHCDCIPSIVHRDISSNNILL-NSKLEAF-VADFG----VARLLHSDSSNRTVVAGT 256
           L +L    + SI+H D+   NILL N K  A  + DFG    + + ++    +R      
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSRF----- 223
Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGD-LLSSVN 300
             Y +PE+   M      D++S G + +E+    H G+ L S  N
Sbjct: 224 --YRSPEVLLGMPYDLAIDMWSLGCILVEM----HTGEPLFSGAN 262

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 38/228 (16%)
Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLE-SFQTEAHLLSQIRHRNIVKLYGF 155
           +G G  G+V       G+ VA+K++     ++A +E    TE+       H N+++ Y  
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD-----DHPNVIRYYCS 77
Query: 156 CLHKKCMFLIYKY--MRRGSLFCILRNDDEAIRLDWTKR-VNIVKSMAHALSYLHCDCIP 212
               + +++  +   +    L       DE ++L      +++++ +A  +++LH     
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 213 SIVHRDISSNNILLNS-------------KLEAFVADFGVARLLHSDS----SNRTVVAG 255
            I+HRD+   NIL+++              L   ++DFG+ + L S       N    +G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 194
Query: 256 THGYIAPE-------LAYTMVLTEKCDVYSFGVVALEVL-MGRHP-GD 294
           T G+ APE       L     LT   D++S G V   +L  G+HP GD
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 19/218 (8%)
Query: 105 VYRAQLPSGKKVALKKLHHSET---ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC 161
           VY A+    +++   KL  SET   +  F    Q EA    +++  ++V ++ F      
Sbjct: 50  VYEAEDTVRERIVALKLX-SETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQ 108
Query: 162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISS 221
           +++  + +    L   LR       L   + V IV+ +    S L         HRD+  
Sbjct: 109 LYVDXRLINGVDLAAXLRRQGP---LAPPRAVAIVRQIG---SALDAAHAAGATHRDVKP 162
Query: 222 NNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFG 280
            NIL+++   A++ DFG+A     +  +      GT  Y APE       T + D+Y+  
Sbjct: 163 ENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALT 222
Query: 281 VVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSP 316
            V  E L G  P  GD LS     I      +Q +P P
Sbjct: 223 CVLYECLTGSPPYQGDQLSVXGAHI------NQAIPRP 254

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/133 (24%), Positives = 60/133 (45%), Gaps = 8/133 (6%)
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHS--DSSNRTVVAGTHGYIAPELAYTMVLTE 272
           +HRD+++ NILL+      + DFG+AR ++   D   +        ++APE  +  + + 
Sbjct: 221 IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST 280
Query: 273 KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKI 332
           K DV+S+GV+  E+        L  S  P + + +    R+   +  +        + +I
Sbjct: 281 KSDVWSYGVLLWEIF------SLGGSPYPGVQMDEDFCSRLREGMRMRAPEYSTPEIYQI 334
Query: 333 VFACLRSKPTSRP 345
           +  C    P  RP
Sbjct: 335 MLDCWHRDPKERP 347

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 81/171 (47%), Gaps = 20/171 (11%)
Query: 131 LESFQTEAHLLSQIRHRNIVKLYGFC--LHKKCMFLIYKYMRRGSLFCILR----NDDEA 184
           +E    E  +L ++ H N+VKL       ++  ++++++ + +G +  +      ++D+A
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 185 IRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
            R  +       + +   + YLH      I+HRDI  +N+L+       +ADFGV+    
Sbjct: 140 -RFYF-------QDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 245 SDSSNRTVVAGTHGYIAPE-LAYT--MVLTEKCDVYSFGVVALEVLMGRHP 292
              +  +   GT  ++APE L+ T  +   +  DV++ GV     + G+ P
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 48/115 (41%), Gaps = 25/115 (21%)
Query: 194 NIVKSMAHALSYLHCDCIPSIVHRDISSNNIL-LNSKLEAF------------------V 234
           ++   + HAL +LH +    + H D+   NIL +NS+ E                    V
Sbjct: 127 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 235 ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMG 289
           ADFG A     D  + T +  T  Y  PE+   +   + CDV+S G +  E   G
Sbjct: 184 ADFGSATF---DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	363
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-89
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-85
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-73
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-64
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-52
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-51
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-50
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-49
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-48
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-48
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-43
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-37
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-37
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-36
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-35
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-34
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-33
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-32
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-32
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-32
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-32
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-32
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-32
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-31
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-31
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-30
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-30
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-30
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-30
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-27
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-26
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-26
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-25
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-09
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  270 bits (693), Expect = 3e-89
 Identities = 106/289 (36%), Positives = 157/289 (54%), Gaps = 22/289 (7%)

Query: 78  RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTE 137
           R + +E+ VA+++F  K  +G GG+G VY+ +L  G  VA+K+L    T+   L+ FQTE
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-FQTE 77

Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL-FCILRNDDEAIRLDWTKRVNIV 196
             ++S   HRN+++L GFC+      L+Y YM  GS+  C+    +    LDW KR  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN-RTVVAG 255
              A  L+YLH  C P I+HRD+ + NILL+ + EA V DFG+A+L+    ++  T V G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197

Query: 256 THGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN-PKIMLID------- 307
           T G+IAPE   T   +EK DV+ +GV+ LE++ G+   DL    N   +ML+D       
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257

Query: 308 ------LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRV 349
                 L+D  +     D+ V Q I    ++   C +S P  RP M  V
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLI----QVALLCTQSSPMERPKMSEV 302

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  260 bits (666), Expect = 3e-85
 Identities = 101/316 (31%), Positives = 138/316 (43%), Gaps = 33/316 (10%)

Query: 54  RKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSG 113
           + +K T +        + V     R+   ++  AT +FD K+ IG G +G VY+  L  G
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63

Query: 114 KKVALKKLHHS----ETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169
            KVALK+          E      F+TE   LS  RH ++V L GFC  +  M LIYKYM
Sbjct: 64  AKVALKRRTPESSQGIEE------FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 170 RRGSL-FCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS 228
             G+L   +  +D   + + W +R+ I    A  L YLH   I   +HRD+ S NILL+ 
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI---IHRDVKSINILLDE 174

Query: 229 KLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEV 286
                + DFG+++           TVV GT GYI PE      LTEK DVYSFGVV  EV
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234

Query: 287 LMGRHPGD---------LLSSVNPKI---MLIDLLDQRVPSPIDDQTVIQDIILVSKIVF 334
           L  R             L            L  ++D  +   I  +++ +          
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK----FGDTAV 290

Query: 335 ACLRSKPTSRP-MQRV 349
            CL      RP M  V
Sbjct: 291 KCLALSSEDRPSMGDV 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  228 bits (583), Expect = 6e-73
 Identities = 84/292 (28%), Positives = 133/292 (45%), Gaps = 28/292 (9%)

Query: 78  RITFQEMIVATEDFDIKYC------IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAF- 130
             +F E+   T +FD +        +G GG+G VY+  +     VA+KKL          
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 72

Query: 131 -LESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDW 189
             + F  E  ++++ +H N+V+L GF      + L+Y YM  GSL   L   D    L W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD--S 247
             R  I +  A+ +++LH +     +HRDI S NILL+    A ++DFG+AR       +
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID 307
              + + GT  Y+APE A    +T K D+YSFGVV LE++ G    D         +L+D
Sbjct: 190 VMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD---EHREPQLLLD 245

Query: 308 -----LLDQRVPSPIDD----QTVIQDIILVSKIVFACLRSKPTSRP-MQRV 349
                  +++      D          +  +  +   CL  K   RP +++V
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  204 bits (522), Expect = 7e-64
 Identities = 68/258 (26%), Positives = 123/258 (47%), Gaps = 17/258 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           ++ +++  +G G +G V +A+    K VA+K++          ++F  E   LS++ H N
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER----KAFIVELRQLSRVNHPN 62

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           IVKLYG CL+  C+  + +Y   GSL+ +L   +          ++     +  ++YLH 
Sbjct: 63  IVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 209 DCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
               +++HRD+   N+LL +      + DFG A  + +  +N     G+  ++APE+   
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEG 177

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
              +EKCDV+S+G++  EV+  R P D +     +IM       R P   +    I+ ++
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237

Query: 328 LVSKIVFACLRSKPTSRP 345
                   C    P+ RP
Sbjct: 238 T------RCWSKDPSQRP 249

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  204 bits (521), Expect = 9e-64
 Identities = 80/272 (29%), Positives = 134/272 (49%), Gaps = 9/272 (3%)

Query: 74  NYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLES 133
            + G +   +M +   D +IK  IG G +G+V+RA+   G  VA+K L   +     +  
Sbjct: 22  YFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE 80

Query: 134 FQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV 193
           F  E  ++ ++RH NIV   G       + ++ +Y+ RGSL+ +L       +LD  +R+
Sbjct: 81  FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140

Query: 194 NIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
           ++   +A  ++YLH    P IVHR++ S N+L++ K    V DFG++RL  S   +    
Sbjct: 141 SMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199

Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV 313
           AGT  ++APE+       EK DVYSFGV+  E+   + P   L+     +  +    +R+
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-VAAVGFKCKRL 258

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             P +    +  II        C  ++P  RP
Sbjct: 259 EIPRNLNPQVAAIIE------GCWTNEPWKRP 284

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  203 bits (517), Expect = 6e-63
 Identities = 67/304 (22%), Positives = 126/304 (41%), Gaps = 41/304 (13%)

Query: 79  ITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEA 138
           +  + +   +    +      G +G V++AQL   + VA+K     + + ++    + E 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQ--NEYEV 69

Query: 139 HLLSQIRHRNIVKLYGFCLH----KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
           + L  ++H NI++  G           ++LI  +  +GSL   L+ +     + W +  +
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCH 125

Query: 195 IVKSMAHALSYLHCDCI-------PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
           I ++MA  L+YLH D         P+I HRDI S N+LL + L A +ADFG+A    +  
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 248 S--NRTVVAGTHGYIAPELA-----YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS-- 298
           S  +     GT  Y+APE+      +      + D+Y+ G+V  E+       D      
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 299 ---------VNPKI--MLIDLLDQRV-PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP- 345
                     +P +  M   ++ ++  P   D       + ++ + +  C      +R  
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 346 MQRV 349
              V
Sbjct: 306 AGCV 309

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  193 bits (492), Expect = 1e-59
 Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 36/275 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETE-----LAFLESFQTEAHLLS 142
            + + +  IG GG+G V++ +L      VA+K L   ++E     +   + FQ E  ++S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
            + H NIVKLYG   +   M  + +++  G L+  L +  +A  + W+ ++ ++  +A  
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF-----VADFGVARLLHSDSSNRTVVAGTH 257
           + Y+     P IVHRD+ S NI L S  E       VADFG+++         + + G  
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGNF 190

Query: 258 GYIAPEL------AYTMVLTEKCDVYSFGVVALEVLMGRHP-GDLLSSVNPKIMLIDLLD 310
            ++APE       +Y    TEK D YSF ++   +L G  P  +        I +I    
Sbjct: 191 QWMAPETIGAEEESY----TEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246

Query: 311 QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            R   P D    ++++I        C    P  RP
Sbjct: 247 LRPTIPEDCPPRLRNVIE------LCWSGDPKKRP 275

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (483), Expect = 2e-58
 Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 24/267 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELA--FLESFQTEAHLLSQIRH 146
            +  ++  IG GG+G VYRA    G +VA+K   H   E     +E+ + EA L + ++H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NI+ L G CL +  + L+ ++ R G L  +L       R+     VN    +A  ++YL
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYL 121

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAF--------VADFGVARLLHSDSSNRTVVAGTHG 258
           H + I  I+HRD+ S+NIL+  K+E          + DFG+AR  H  +  +   AG + 
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYA 179

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID 318
           ++APE+    + ++  DV+S+GV+  E+L G  P   +  +      + +    +P P  
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-AYGVAMNKLALPIPST 238

Query: 319 DQTVIQDIILVSKIVFACLRSKPTSRP 345
                  ++        C    P SRP
Sbjct: 239 CPEPFAKLME------DCWNPDPHSRP 259

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  182 bits (464), Expect = 1e-55
 Identities = 49/262 (18%), Positives = 96/262 (36%), Gaps = 20/262 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           +  +    +     G +++ +   G  + +K L   +        F  E   L    H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 149 IVKLYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
           ++ + G C         LI  +M  GSL+ +L  +     +D ++ V     MA  +++L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL-- 264
           H    P I    ++S +++++  + A ++   V     S             ++APE   
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-----RMYAPAWVAPEALQ 181

Query: 265 -AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI 323
                      D++SF V+  E++    P   LS++    M + L   R   P      +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEGLRPTIPPGISPHV 240

Query: 324 QDIILVSKIVFACLRSKPTSRP 345
             ++        C+   P  RP
Sbjct: 241 SKLMK------ICMNEDPAKRP 256

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  182 bits (464), Expect = 3e-55
 Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 28/272 (10%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            D      +G G +G   +     +G+ + +K+L   + E     +F  E  ++  + H 
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET--QRTFLKEVKVMRCLEHP 67

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N++K  G     K +  I +Y++ G+L  I+++ D   +  W++RV+  K +A  ++YLH
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH 125

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--------------RTVV 253
                +I+HRD++S+N L+       VADFG+ARL+  + +               R  V
Sbjct: 126 S---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182

Query: 254 AGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV 313
            G   ++APE+       EK DV+SFG+V  E++   +             L        
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             P +       I         C    P  RP
Sbjct: 243 YCPPNCPPSFFPIT------VRCCDLDPEKRP 268

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  175 bits (446), Expect = 2e-52
 Identities = 54/249 (21%), Positives = 100/249 (40%), Gaps = 22/249 (8%)

Query: 58  PTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVA 117
           P           F        I  QE  +  E  +I   IG G +G VY  +     +VA
Sbjct: 2   PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEVA 59

Query: 118 LKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCI 177
           ++ +         L++F+ E     Q RH N+V   G C+    + +I    +  +L+ +
Sbjct: 60  IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119

Query: 178 LRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADF 237
           +R+    I LD  K   I + +   + YLH      I+H+D+ S N+  ++  +  + DF
Sbjct: 120 VRDAK--IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDNG-KVVITDF 173

Query: 238 GVARLLHSDSSNR-----TVVAGTHGYIAPELAYTMVL---------TEKCDVYSFGVVA 283
           G+  +     + R      +  G   ++APE+   +           ++  DV++ G + 
Sbjct: 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233

Query: 284 LEVLMGRHP 292
            E+     P
Sbjct: 234 YELHAREWP 242

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  173 bits (441), Expect = 4e-52
 Identities = 63/262 (24%), Positives = 123/262 (46%), Gaps = 16/262 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
               +   IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I+   G+      + ++ ++    SL+  L   +   + +  K ++I +  A  + YLH 
Sbjct: 82  ILLFMGYST-APQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHA 138

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH--SDSSNRTVVAGTHGYIAPEL-- 264
               SI+HRD+ SNNI L+      + DFG+A      S S     ++G+  ++APE+  
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 265 -AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI 323
              +   + + DVY+FG+V  E++ G+ P   +++ +  I ++                 
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255

Query: 324 QDIILVSKIVFACLRSKPTSRP 345
           + +    +++  CL+ K   RP
Sbjct: 256 KRM---KRLMAECLKKKRDERP 274

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  172 bits (438), Expect = 4e-51
 Identities = 65/330 (19%), Positives = 117/330 (35%), Gaps = 62/330 (18%)

Query: 79  ITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEA 138
               E  +  ++  +   IG G YG+VY+  L   + VA+K    +       ++F  E 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEK 56

Query: 139 --HLLSQIRHRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
             + +  + H NI +                 L+ +Y   GSL   L         DW  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVS 112

Query: 192 RVNIVKSMAHALSYLHCD------CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
              +  S+   L+YLH +        P+I HRD++S N+L+ +     ++DFG++  L  
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 246 DSSNR--------TVVAGTHGYIAPELAYTMV-------LTEKCDVYSFGVVALEVLMGR 290
           +   R            GT  Y+APE+    V         ++ D+Y+ G++  E+ M  
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 291 HPGDLLSSVNP-----------------KIMLIDLLDQRVPSPIDDQTVIQDIILVSKIV 333
                  SV                     +L+    QR   P   +     +  + + +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 334 FACLRSKPTSRP-MQRVSQEFLVRKTLYQL 362
             C      +R   Q         + + +L
Sbjct: 293 EDCWDQDAEARLTAQ------XAEERMAEL 316

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  169 bits (430), Expect = 7e-50
 Identities = 62/225 (27%), Positives = 96/225 (42%), Gaps = 27/225 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           +   +   IG G YG V+  +   G+KVA+K    +E    F E   TE +    +RH N
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE---TEIYQTVLMRHEN 92

Query: 149 IVKLYGFCLHKKC----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           I+      +        ++LI  Y   GSL+  L++      LD    + +  S    L 
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLC 148

Query: 205 YLHCD-----CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV----AG 255
           +LH +       P+I HRD+ S NIL+       +AD G+A    SD++   +      G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 256 THGYIAPE-LAYTMVL-----TEKCDVYSFGVVALEVLMGRHPGD 294
           T  Y+ PE L  ++           D+YSFG++  EV      G 
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  167 bits (424), Expect = 2e-49
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 27/226 (11%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
             D  +  C+G G YG V+R     G+ VA+K     + +  F E   TE +    +RH 
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHE 62

Query: 148 NIVKLYGFCLHKKC----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           NI+      +  +     ++LI  Y   GSL+  L+       LD    + IV S+A  L
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGL 118

Query: 204 SYLHCD-----CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTVVA 254
           ++LH +       P+I HRD+ S NIL+    +  +AD G+A +    ++          
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 255 GTHGYIAPEL------AYTMVLTEKCDVYSFGVVALEVLMGRHPGD 294
           GT  Y+APE+             ++ D+++FG+V  EV        
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  164 bits (416), Expect = 7e-48
 Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 27/225 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
               ++  IG G +G V+R +   G++VA+K     E    F E    E +    +RH N
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHEN 97

Query: 149 IVKLYGFCLHKK----CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           I+               ++L+  Y   GSLF  L        +     + +  S A  L+
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLA 153

Query: 205 YLHCD-----CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTVVAG 255
           +LH +       P+I HRD+ S NIL+       +AD G+A    S +           G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213

Query: 256 THGYIAPE-LAYTMVL-----TEKCDVYSFGVVALEVLMGRHPGD 294
           T  Y+APE L  ++ +      ++ D+Y+ G+V  E+      G 
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  150 bits (381), Expect = 3e-43
 Identities = 64/263 (24%), Positives = 112/263 (42%), Gaps = 33/263 (12%)

Query: 96  CIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            IG G + +VY+     +  +VA  +L   +   +  + F+ EA +L  ++H NIV+ Y 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 155 FCL----HKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYL 206
                   KKC+ L+ + M  G+L   L+       + +R  W +++         L +L
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS-WCRQI------LKGLQFL 145

Query: 207 HCDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           H    P I+HRD+  +NI +        + D G+A L    S  + V+ GT  ++APE+ 
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVI-GTPEFMAPEM- 201

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI---DLLDQRVPSPIDDQTV 322
           Y     E  DVY+FG+  LE+    +P     +   +I       +           +  
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRVTSGVKPASFDKVAIPE-- 258

Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
           +++II        C+R     R 
Sbjct: 259 VKEIIE------GCIRQNKDERY 275

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  146 bits (369), Expect = 8e-41
 Identities = 63/273 (23%), Positives = 107/273 (39%), Gaps = 31/273 (11%)

Query: 81  FQEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAH 139
           FQ M    E +     IG G +G     +    G++  +K+++ S       E  + E  
Sbjct: 20  FQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVA 75

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND-----DEAIRLDWTKRVN 194
           +L+ ++H NIV+          ++++  Y   G LF  +         E   LDW  +  
Sbjct: 76  VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ-- 133

Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
               +  AL ++H      I+HRDI S NI L       + DFG+AR+L+S         
Sbjct: 134 ----ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI 186

Query: 255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQR 312
           GT  Y++PE+        K D+++ G V  E+   +H      + ++  KI+        
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--PP 244

Query: 313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           V               +  +V    +  P  RP
Sbjct: 245 VSLHYSYD--------LRSLVSQLFKRNPRDRP 269

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  138 bits (351), Expect = 8e-39
 Identities = 61/297 (20%), Positives = 115/297 (38%), Gaps = 51/297 (17%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            DF     IG+GG+G V++A+    GK   +K++ ++       E  + E   L+++ H 
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHV 64

Query: 148 NIVKLYGF----------------CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
           NIV   G                     KC+F+  ++  +G+L   +       +LD   
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVL 123

Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
            + + + +   + Y+H      +++RD+  +NI L    +  + DFG+   L +D     
Sbjct: 124 ALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ 311
              GT  Y++PE   +    ++ D+Y+ G++  E+L         S     +      D 
Sbjct: 181 SK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR-----DG 234

Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP----------MQRVSQEFLVRKT 358
            +    D +           ++   L  KP  RP          + + S E   R T
Sbjct: 235 IISDIFDKK--------EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHT 283

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  138 bits (350), Expect = 1e-38
 Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 18/270 (6%)

Query: 84  MIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           M    ED+++ Y IGTG YG   + +    GK +  K+L +     A  +   +E +LL 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60

Query: 143 QIRHRNIVKLYG-FCLHKKCMFLIY-KYMRRGSLFCILRNDDEA-IRLDWTKRVNIVKSM 199
           +++H NIV+ Y            I  +Y   G L  ++    +    LD    + ++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 200 AHALSYLH--CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
             AL   H   D   +++HRD+   N+ L+ K    + DFG+AR+L+ D+S      GT 
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTP 180

Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPS 315
            Y++PE    M   EK D++S G +  E+     P        +  KI       +R+P 
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF--RRIPY 238

Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
              D+        +++I+   L  K   RP
Sbjct: 239 RYSDE--------LNEIITRMLNLKDYHRP 260

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  138 bits (350), Expect = 2e-38
 Identities = 61/264 (23%), Positives = 111/264 (42%), Gaps = 19/264 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRH 146
            +F I+  IG G +  VYRA  L  G  VALKK+      +         E  LL Q+ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEA-IRLDWTKRVNIVKSMAHALSY 205
            N++K Y   +    + ++ +    G L  ++++  +    +           +  AL +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           +H      ++HRDI   N+ + +     + D G+ R   S ++    + GT  Y++PE  
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLS--SVNPKIMLIDLLDQRVPSPIDDQT 321
           +      K D++S G +  E+   + P  GD ++  S+  KI       Q    P+    
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------QCDYPPLPSDH 262

Query: 322 VIQDIILVSKIVFACLRSKPTSRP 345
             +++    ++V  C+   P  RP
Sbjct: 263 YSEEL---RQLVNMCINPDPEKRP 283

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  135 bits (343), Expect = 1e-37
 Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 54/292 (18%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
             DF+    +G G +G V +A+     +  A+KK+ H+E +L    +  +E  LL+ + H
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNH 61

Query: 147 RNIVKLYGF-------------CLHKKCMFLIYKYMRRGSLFCILRN-----DDEAIRLD 188
           + +V+ Y                  K  +F+  +Y   G+L+ ++ +       +     
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-- 119

Query: 189 WTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-- 246
                 + + +  ALSY+H      I+HRD+   NI ++      + DFG+A+ +H    
Sbjct: 120 -----RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171

Query: 247 ------------SSNRTVVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPG 293
                       S N T   GT  Y+A E L  T    EK D+YS G++  E++     G
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231

Query: 294 DLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
               ++  K+  + +     P   DD  +  +  ++       +   P  RP
Sbjct: 232 MERVNILKKLRSVSI---EFPPDFDDNKMKVEKKIIRL----LIDHDPNKRP 276

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  135 bits (343), Expect = 2e-37
 Identities = 62/288 (21%), Positives = 122/288 (42%), Gaps = 35/288 (12%)

Query: 76  DGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQ 135
              + FQ M V    + I   IG+GG   V++      +  A+K ++  E +   L+S++
Sbjct: 15  TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYR 74

Query: 136 TEAHLLSQIRHRN--IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV 193
            E   L++++  +  I++LY + +  + ++++ +      L   L+       +D  +R 
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK---SIDPWERK 130

Query: 194 NIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSN- 249
           +  K+M  A+  +H      IVH D+   N L+     KL     DFG+A  +  D+++ 
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSV 183

Query: 250 -RTVVAGTHGYIAPEL-----------AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLS 297
            +    GT  Y+ PE                 ++ K DV+S G +   +  G+ P   + 
Sbjct: 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

Query: 298 SVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +   K+  I   +  +  P   +  +QD++        CL+  P  R 
Sbjct: 244 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRI 285

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  135 bits (341), Expect = 3e-37
 Identities = 79/269 (29%), Positives = 122/269 (45%), Gaps = 37/269 (13%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALK--KLHHSETELAFLESFQTEAHLLSQI 144
            E F     IG G +G V++     + K VA+K   L  +E E+   E  Q E  +LSQ 
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI---EDIQQEITVLSQC 77

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN---DDEAIRLDWTKRVNIVKSMAH 201
               + K YG  L    +++I +Y+  GS   +L     D+  I         I++ +  
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILK 130

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
            L YLH +     +HRDI + N+LL+   E  +ADFGVA  L      R    GT  ++A
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 187

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDLLDQRVPSPIDDQ 320
           PE+        K D++S G+ A+E+  G  P    S ++P K++   L+ +  P  ++  
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP---HSELHPMKVLF--LIPKNNPPTLEGN 242

Query: 321 TVIQDIILVSKI----VFACLRSKPTSRP 345
                    SK     V ACL  +P+ RP
Sbjct: 243 --------YSKPLKEFVEACLNKEPSFRP 263

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  134 bits (340), Expect = 5e-37
 Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 37/280 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRA-QLPSGKKVALK--KLHHSETELAFLESFQTEAHLLSQIR 145
           +D++++  IG+G    V  A   P  +KVA+K   L   +T +   +    E   +SQ  
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM---DELLKEIQAMSQCH 71

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-----DDEAIRLDWTKRVNIVKSMA 200
           H NIV  Y   + K  ++L+ K +  GS+  I+++     + ++  LD +    I++ + 
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL-----HSDSSNRTVVAG 255
             L YLH +     +HRD+ + NILL       +ADFGV+  L      + +  R    G
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 256 THGYIAPELAYTMVLTE------KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL 309
           T  ++APE     V+ +      K D++SFG+ A+E+  G  P        P  +L+  L
Sbjct: 189 TPCWMAPE-----VMEQVRGYDFKADIWSFGITAIELATGAAP---YHKYPPMKVLMLTL 240

Query: 310 DQRVPSPIDDQTVIQDIILVSKI----VFACLRSKPTSRP 345
               PS        + +    K     +  CL+  P  RP
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  135 bits (343), Expect = 9e-37
 Identities = 61/266 (22%), Positives = 107/266 (40%), Gaps = 28/266 (10%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           ED  +   IG G +G V+  +L +    VA+K    +       + F  EA +L Q  H 
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHP 172

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           NIV+L G C  K+ ++++ + ++ G     LR +   +R+     + +V   A  + YL 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLE 230

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----AP 262
                  +HRD+++ N L+  K    ++DFG++R            +G    +     AP
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA---SGGLRQVPVKWTAP 284

Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLM-GRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDD 319
           E       + + DV+SFG++  E    G  P            +        R+P P   
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----KGGRLPCPELC 340

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
              +  ++        C   +P  RP
Sbjct: 341 PDAVFRLME------QCWAYEPGQRP 360

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  133 bits (337), Expect = 9e-37
 Identities = 60/282 (21%), Positives = 112/282 (39%), Gaps = 39/282 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            DF+   C+G GG+G V+ A+        A+K++     ELA  E    E   L+++ H 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHP 63

Query: 148 NIVKLYGFCLHKKCM------------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI 195
            IV+ +   L K               ++  +  R+ +L   +         + +  ++I
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-------- 247
              +A A+ +LH      ++HRD+  +NI         V DFG+   +  D         
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 248 ----SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI 303
               +  T   GT  Y++PE  +    + K D++S G++  E+L   +P    S+   ++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP---FSTQMERV 234

Query: 304 MLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             +  +      P+  Q    + ++V       L   P  RP
Sbjct: 235 RTLTDVRNLKFPPLFTQKYPCEYVMVQD----MLSPSPMERP 272

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  134 bits (339), Expect = 1e-36
 Identities = 58/275 (21%), Positives = 116/275 (42%), Gaps = 35/275 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH-- 146
             + I   IG+GG   V++      +  A+K ++  E +   L+S++ E   L++++   
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             I++LY + +  + ++++ +      L   L+       +D  +R +  K+M  A+  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTI 124

Query: 207 HCDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIA 261
           H      IVH D+   N L+     KL     DFG+A  +  D+++  +    GT  Y+ 
Sbjct: 125 HQH---GIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 262 PEL-----------AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD 310
           PE                 ++ K DV+S G +   +  G+ P   + +   K+  I   +
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237

Query: 311 QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             +  P   +  +QD++        CL+  P  R 
Sbjct: 238 HEIEFPDIPEKDLQDVLK------CCLKRDPKQRI 266

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (336), Expect = 2e-36
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 17/205 (8%)

Query: 96  CIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG 154
            +G G YG VY    L +  ++A+K++   E +  + +    E  L   ++H+NIV+  G
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI 214
                  + +  + +  GSL  +LR+    ++ +        K +   L YLH +    I
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---I 143

Query: 215 VHRDISSNNILLNS-----KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE--LAYT 267
           VHRDI  +N+L+N+     K+    +DFG ++ L   +       GT  Y+APE      
Sbjct: 144 VHRDIKGDNVLINTYSGVLKI----SDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
               +  D++S G   +E+  G+ P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  134 bits (339), Expect = 3e-36
 Identities = 51/288 (17%), Positives = 110/288 (38%), Gaps = 19/288 (6%)

Query: 88  TEDFDIKYCIGTG--GYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
              +++   IG G     +V  A+  P+G+ V +++++        +   Q E H+    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NIV      +    ++++  +M  GS   ++        ++      I++ +  AL 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALD 142

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV-------AGTH 257
           Y+H       VHR + +++IL++   + +++       + S    + VV           
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 258 GYIAPELAYTMVL--TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS 315
            +++PE+    +     K D+YS G+ A E+  G  P      +    ML++ L+  VP 
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP---FKDMPATQMLLEKLNGTVPC 256

Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVRKTLYQLK 363
            +D  T+  + + +S            S              +    +
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR 304

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  132 bits (335), Expect = 4e-36
 Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 39/273 (14%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKK----VALKKLHHSETELAFLESFQTEAHLLSQ 143
            +F     +G+G +G+VY+    P G+K    VA+K+L  + +  A  E    EA++++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMAS 73

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + + ++ +L G CL    + LI + M  G L   +R   + I       +N    +A  +
Sbjct: 74  VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGM 130

Query: 204 SYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
           +YL           VHRD+++ N+L+ +     + DFG+A+LL ++           G +
Sbjct: 131 NYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGKV 181

Query: 261 -----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--R 312
                A E     + T + DV+S+GV   E++  G  P D +     +I    +L++  R
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEI--SSILEKGER 237

Query: 313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +P P      +  I+        C      SRP
Sbjct: 238 LPQPPICTIDVYMIMR------KCWMIDADSRP 264

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  131 bits (332), Expect = 4e-36
 Identities = 63/267 (23%), Positives = 114/267 (42%), Gaps = 36/267 (13%)

Query: 93  IKYCIGTGGYGSVYRAQLPSGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
               +G G +GSV +      KK   VA+K L     +    E    EA ++ Q+ +  I
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYI 72

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL--- 206
           V+L G C   + + L+ +    G L   L    E   +  +    ++  ++  + YL   
Sbjct: 73  VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK 129

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----A 261
           +       VHRD+++ N+LL ++  A ++DFG+++ L +D S     A + G       A
Sbjct: 130 NF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYA 181

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPID 318
           PE       + + DV+S+GV   E L  G+ P   +    P++  +  ++Q  R+  P +
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEV--MAFIEQGKRMECPPE 237

Query: 319 DQTVIQDIILVSKIVFACLRSKPTSRP 345
               +  ++        C   K   RP
Sbjct: 238 CPPELYALMS------DCWIYKWEDRP 258

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  131 bits (331), Expect = 6e-36
 Identities = 61/263 (23%), Positives = 117/263 (44%), Gaps = 36/263 (13%)

Query: 97  IGTGGYGSVYRAQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V +      K    VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL---HCDC 210
           G C   +   L+ +    G L   L+ +     +     + +V  ++  + YL   +   
Sbjct: 85  GICE-AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNF-- 138

Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APELA 265
               VHRD+++ N+LL ++  A ++DFG+++ L +D +     A THG       APE  
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECI 192

Query: 266 YTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTV 322
                + K DV+SFGV+  E    G+ P   +     ++    +L++  R+  P      
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEV--TAMLEKGERMGCPAGCPRE 248

Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
           + D++        C      +RP
Sbjct: 249 MYDLMN------LCWTYDVENRP 265

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  130 bits (329), Expect = 7e-36
 Identities = 64/268 (23%), Positives = 112/268 (41%), Gaps = 36/268 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
            +      IG+G +G V+     +  KVA+K +          E F  EA ++ ++ H  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPK 64

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL-- 206
           +V+LYG CL +  + L+ ++M  G L   LR             + +   +   ++YL  
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE 122

Query: 207 -HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI----- 260
                    +HRD+++ N L+       V+DFG+ R +  D       + T         
Sbjct: 123 ACV------IHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWA 172

Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPI 317
           +PE+      + K DV+SFGV+  EV   G+ P +  S  N ++  ++ +    R+  P 
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEV--VEDISTGFRLYKPR 228

Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRP 345
              T +  I+        C R +P  RP
Sbjct: 229 LASTHVYQIMN------HCWRERPEDRP 250

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  132 bits (334), Expect = 1e-35
 Identities = 57/275 (20%), Positives = 115/275 (41%), Gaps = 35/275 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH-- 146
             + I   IG+GG   V++      +  A+K ++  E +   L+S++ E   L++++   
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             I++LY + +  + ++++ +      L   L+       +D  +R +  K+M  A+  +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTI 171

Query: 207 HCDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIA 261
           H      IVH D+   N L+     KL     DFG+A  +  D+++  +    G   Y+ 
Sbjct: 172 HQH---GIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 262 PEL-----------AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD 310
           PE                 ++ K DV+S G +   +  G+ P   + +   K+  I   +
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284

Query: 311 QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             +  P   +  +QD++        CL+  P  R 
Sbjct: 285 HEIEFPDIPEKDLQDVLK------CCLKRDPKQRI 313

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  132 bits (333), Expect = 2e-35
 Identities = 78/272 (28%), Positives = 122/272 (44%), Gaps = 36/272 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKK----VALKKLHHSETELAFLESFQTEAHLLSQI 144
            +  I   +G G +G V   +L    K    VA+K L    TE    + F  EA ++ Q 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQF 103

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NI++L G     K + ++ +YM  GSL   LR  D   +    + V +++ +A  + 
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMK 161

Query: 205 YL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI- 260
           YL           VHRD+++ NIL+NS L   V+DFG+ R+L  D           G I 
Sbjct: 162 YLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE--AAYTTRGGKIP 213

Query: 261 ----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RV 313
               +PE       T   DV+S+G+V  EV+  G  P   +S  N  +  I  +D+  R+
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--NQDV--IKAVDEGYRL 269

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           P P+D    +  ++L       C +    +RP
Sbjct: 270 PPPMDCPAALYQLML------DCWQKDRNNRP 295

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  129 bits (326), Expect = 3e-35
 Identities = 64/266 (24%), Positives = 115/266 (43%), Gaps = 32/266 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           +D      +GTG +G V   +      VA+K +          + F  EA ++  + H  
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 80

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL-- 206
           +V+LYG C  ++ +F+I +YM  G L   LR      R    + + + K +  A+ YL  
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES 138

Query: 207 -HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---AP 262
                    +HRD+++ N L+N +    V+DFG++R +  D    T   G+   +    P
Sbjct: 139 KQF------LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPP 190

Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDD 319
           E+      + K D+++FGV+  E+   G+ P +  +  N +    + + Q  R+  P   
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSET--AEHIAQGLRLYRPHLA 246

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
              +  I+       +C   K   RP
Sbjct: 247 SEKVYTIMY------SCWHEKADERP 266

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  129 bits (327), Expect = 6e-35
 Identities = 75/272 (27%), Positives = 121/272 (44%), Gaps = 36/272 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKK----VALKKLHHSETELAFLESFQTEAHLLSQI 144
               I+  IG+G  G V   +L    +    VA+K L    TE    + F +EA ++ Q 
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQF 107

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H NI++L G     +   ++ +YM  GSL   LR  D   +    + V +++ +   + 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMR 165

Query: 205 YL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI- 260
           YL           VHRD+++ N+L++S L   V+DFG++R+L  D         T G I 
Sbjct: 166 YLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD--AAYTTTGGKIP 217

Query: 261 ----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RV 313
               APE       +   DV+SFGVV  EVL  G  P   ++  N  +  I  +++  R+
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--NRDV--ISSVEEGYRL 273

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           P+P+     +  ++L       C       RP
Sbjct: 274 PAPMGCPHALHQLML------DCWHKDRAQRP 299

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  129 bits (326), Expect = 6e-35
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 17/209 (8%)

Query: 97  IGTGGYGSVYRAQLPS-GKKVALKKLHHSETELA----FLESFQTEAHLLSQIRHRNIVK 151
           +G GG G VY A+     + VALK +      L+    F    Q EA    +++  ++V 
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMS---ETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
           ++ F      +++  + +    L  +LR       L   + V IV+ +  AL   H    
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA-- 153

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIAPELAYTMVL 270
               HRD+   NIL+++   A++ DFG+A     +   +     GT  Y+APE       
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 271 TEKCDVYSFGVVALEVLMGRHP--GDLLS 297
           T + D+Y+   V  E L G  P  GD LS
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLS 241

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (323), Expect = 1e-34
 Identities = 71/258 (27%), Positives = 111/258 (43%), Gaps = 25/258 (9%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELA----FLESFQTEAHLLSQIRHRNIVK 151
           +G GG  +VY A+      KVA+K +             L+ F+ E H  SQ+ H+NIV 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIF---IPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
           +        C +L+ +Y+   +L   +        L     +N    +   + + H    
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDM-- 130

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIAPELAYTMVL 270
             IVHRDI   NIL++S     + DFG+A+ L   S  +T  V GT  Y +PE A     
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 271 TEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI-I 327
            E  D+YS G+V  E+L+G  P  G+         + I  +   VP+   D  V +DI  
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGE-----TAVSIAIKHIQDSVPNVTTD--VRKDIPQ 242

Query: 328 LVSKIVFACLRSKPTSRP 345
            +S ++         +R 
Sbjct: 243 SLSNVILRATEKDKANRY 260

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  128 bits (324), Expect = 2e-34
 Identities = 48/220 (21%), Positives = 88/220 (40%), Gaps = 36/220 (16%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
                 +  +G G +G V+R +   +G + A+K       ++        E    + +  
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK-------KVRLEVFRVEELVACAGLSS 109

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHA 202
             IV LYG       + +  + +  GSL  +++      ++            +      
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-------YYLGQALEG 162

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRTV-----VAGT 256
           L YLH      I+H D+ ++N+LL+S    A + DFG A  L  D   +++     + GT
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 257 HGYIAPEL----AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             ++APE+            K D++S   + L +L G HP
Sbjct: 220 ETHMAPEVVMGKPC----DAKVDIWSSCCMMLHMLNGCHP 255

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  126 bits (320), Expect = 2e-34
 Identities = 60/268 (22%), Positives = 117/268 (43%), Gaps = 36/268 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           E+  +   +G+G +G V   +      VA+K +          + F  EA  + ++ H  
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPK 64

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL-- 206
           +VK YG C  +  ++++ +Y+  G L   LR+  +   L+ ++ + +   +   +++L  
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLES 122

Query: 207 -HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI----- 260
                    +HRD+++ N L++  L   V+DFG+ R +  D    +              
Sbjct: 123 HQF------IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWS 172

Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPI 317
           APE+ +    + K DV++FG++  EV   G+ P DL +  N ++  +  + Q  R+  P 
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--NSEV--VLKVSQGHRLYRPH 228

Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRP 345
                I  I+       +C    P  RP
Sbjct: 229 LASDTIYQIMY------SCWHELPEKRP 250

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  128 bits (323), Expect = 2e-34
 Identities = 61/286 (21%), Positives = 114/286 (39%), Gaps = 37/286 (12%)

Query: 82  QEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLH-HSETELAFLESFQTEAH 139
             +I+  + +     +G GG+  V   + L  G   ALK++  H + +    E  Q EA 
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREAD 78

Query: 140 LLSQIRHRNIVKLYGFCL----HKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTKRVN 194
           +     H NI++L  +CL     K   +L+  + +RG+L+  I R  D+   L   + + 
Sbjct: 79  MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138

Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
           ++  +   L  +H        HRD+   NILL  + +  + D G                
Sbjct: 139 LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195

Query: 255 ---------GTHGYIAPEL----AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP 301
                     T  Y APEL    ++ ++  E+ DV+S G V   ++ G  P D++     
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

Query: 302 KIMLIDLLDQRVPSPIDDQ--TVIQDIILVSKIVFACLRSKPTSRP 345
            + L   +  ++  P   +  + +  ++       + +   P  RP
Sbjct: 255 SVALA--VQNQLSIPQSPRHSSALWQLLN------SMMTVDPHQRP 292

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  132 bits (334), Expect = 3e-34
 Identities = 56/265 (21%), Positives = 98/265 (36%), Gaps = 47/265 (17%)

Query: 93  IKYCIGTGGYGSVYRA--QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +K CI  GG G +Y A  +  +G+ V LK L HS            E   L+++ H +IV
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVVHPSIV 142

Query: 151 KLYGFCLH-----KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           +++ F  H         +++ +Y+   SL           +L   + +  +  +  ALSY
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSY 197

Query: 206 LHCDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           LH      +V+ D+   NI+L     K    + D G    ++S       + GT G+ AP
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEEQLK----LIDLGAVSRINSFGY----LYGTPGFQAP 246

Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           E+  T   T   D+Y+ G     + +      G  +  +       D    +        
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE-----DDPVLKTYDSYGR- 299

Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                      ++   +   P  R 
Sbjct: 300 -----------LLRRAIDPDPRQRF 313

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  127 bits (322), Expect = 4e-34
 Identities = 83/271 (30%), Positives = 129/271 (47%), Gaps = 33/271 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL--PSGK---KVALKKLHHSETELAFLESFQTEAHLLSQ 143
                +  IG G +G VY+  L   SGK    VA+K L    TE   ++ F  EA ++ Q
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQ 102

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
             H NI++L G     K M +I +YM  G+L   LR  D        + V +++ +A  +
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGM 160

Query: 204 SYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
            YL   +       VHRD+++ NIL+NS L   V+DFG++R+L  D       +G    I
Sbjct: 161 KYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214

Query: 261 ---APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVP 314
              APE       T   DV+SFG+V  EV+  G  P   LS  N ++  +  ++   R+P
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEV--MKAINDGFRLP 270

Query: 315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +P+D  + I  +++       C + +   RP
Sbjct: 271 TPMDCPSAIYQLMM------QCWQQERARRP 295

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  126 bits (319), Expect = 4e-34
 Identities = 64/268 (23%), Positives = 115/268 (42%), Gaps = 27/268 (10%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            E ++I   +G G +G VY+A+   +G   A K +     E   LE +  E  +L+   H
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILATCDH 75

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             IVKL G   H   ++++ ++   G++  I+   D  +     +   + + M  AL++L
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFL 133

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      I+HRD+ + N+L+  + +  +ADFGV+         R    GT  ++APE+  
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 267 TMVLTE-----KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT 321
              + +     K D++S G+  +E+     P      +NP  M + L   +   P     
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPP---HHELNP--MRVLLKIAKSDPP----- 240

Query: 322 VIQDIILVSKI----VFACLRSKPTSRP 345
            +      S      +   L   P +RP
Sbjct: 241 TLLTPSKWSVEFRDFLKIALDKNPETRP 268

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  127 bits (321), Expect = 5e-34
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 39/273 (14%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKK----VALKKLHHSETELAFLESFQTEAHLLSQ 143
            +F     +G+G +G+VY+    P G+K    VA+K+L  + +  A  E    EA++++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMAS 73

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + + ++ +L G CL    + LI + M  G L   +R   +   +     +N    +A  +
Sbjct: 74  VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGM 130

Query: 204 SYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
           +YL           VHRD+++ N+L+ +     + DFG+A+LL ++           G +
Sbjct: 131 NYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGKV 181

Query: 261 -----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--R 312
                A E     + T + DV+S+GV   E++  G  P D +     +I    +L++  R
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEI--SSILEKGER 237

Query: 313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +P P      +  I++       C      SRP
Sbjct: 238 LPQPPICTIDVYMIMV------KCWMIDADSRP 264

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  125 bits (317), Expect = 6e-34
 Identities = 77/260 (29%), Positives = 133/260 (51%), Gaps = 23/260 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           EDF+I   +G G +G+VY A+   S   +ALK L  ++  +       + E  + S +RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NI++LYG+      ++LI +Y   G+++  L+      + D  +    +  +A+ALSY 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 125

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      ++HRDI   N+LL S  E  +ADFG +  +H+ SS RT + GT  Y+ PE+  
Sbjct: 126 HSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIE 180

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIML--IDLLDQRVPSPIDDQTVIQ 324
             +  EK D++S GV+  E L+G+ P +   +   +     I  ++   P  + +    +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFPDFVTEGA--R 235

Query: 325 DIILVSKIVFACLRSKPTSR 344
           D  L+S++    L+  P+ R
Sbjct: 236 D--LISRL----LKHNPSQR 249

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  126 bits (318), Expect = 6e-34
 Identities = 57/277 (20%), Positives = 108/277 (38%), Gaps = 45/277 (16%)

Query: 97  IGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +G V   +       +G++VA+K L         +   + E  +L  + H NIVK
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-IADLKKEIEILRNLYHENIVK 87

Query: 152 LYGFCLHKKC--MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL--- 206
             G C       + LI +++  GSL   L  +    +++  +++     +   + YL   
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSR 145

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----A 261
                   VHRD+++ N+L+ S+ +  + DFG+ + + +D                   A
Sbjct: 146 QY------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--YYTVKDDRDSPVFWYA 197

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM----------LIDLLD 310
           PE           DV+SFGV   E+L         ++     I           L++ L 
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257

Query: 311 Q--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +  R+P P +    +  ++        C   +P++R 
Sbjct: 258 EGKRLPCPPNCPDEVYQLMR------KCWEFQPSNRT 288

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  127 bits (321), Expect = 6e-34
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 9/205 (4%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           +DF+    +G G  G V++    PSG  +A K + H E + A       E  +L +    
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSP 91

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
            IV  YG       + +  ++M  GSL  +L+   +A R+       +  ++   L+YL 
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR 148

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                 I+HRD+  +NIL+NS+ E  + DFGV+  L  DS   + V GT  Y++PE    
Sbjct: 149 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRSYMSPERLQG 204

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHP 292
              + + D++S G+  +E+ +GR+P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYP 229

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  129 bits (327), Expect = 7e-34
 Identities = 69/269 (25%), Positives = 117/269 (43%), Gaps = 36/269 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHP 276

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+V+L G C  +   ++I ++M  G+L   LR  +    +     + +   ++ A+ YL 
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 335

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----AP 262
                + +HR++++ N L+       VADFG++RL+  D    T  A           AP
Sbjct: 336 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAP 388

Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSP 316
           E       + K DV++FGV+  E+   G  P        P I L  + +      R+  P
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------YPGIDLSQVYELLEKDYRMERP 441

Query: 317 IDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                 + +++       AC +  P+ RP
Sbjct: 442 EGCPEKVYELMR------ACWQWNPSDRP 464

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  126 bits (318), Expect = 9e-34
 Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 28/265 (10%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            E FD+   +G G YGSVY+A    +G+ VA+K++         L+    E  ++ Q   
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDS 83

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            ++VK YG       ++++ +Y   GS+  I+R  ++ +  D      I++S    L YL
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEYL 141

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H       +HRDI + NILLN++  A +ADFGVA  L    + R  V GT  ++APE+  
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 198

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP--KIMLIDLLDQRVPSPIDDQTVIQ 324
            +      D++S G+ A+E+  G+ P    + ++P   I +I       P P       +
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPP---YADIHPMRAIFMI----PTNPPP-----TFR 246

Query: 325 DIILVSKI----VFACLRSKPTSRP 345
              L S      V  CL   P  R 
Sbjct: 247 KPELWSDNFTDFVKQCLVKSPEQRA 271

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  125 bits (316), Expect = 9e-34
 Identities = 70/272 (25%), Positives = 117/272 (43%), Gaps = 42/272 (15%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGK-KVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
            D  +K+ +G G YG VY          VA+K L     E+   E F  EA ++ +I+H 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHP 69

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL- 206
           N+V+L G C  +   ++I ++M  G+L   LR  +    +     + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 128

Query: 207 --HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---- 260
             +       +HRD+++ N L+       VADFG++RL+  D    T  A          
Sbjct: 129 KKNF------IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKW 178

Query: 261 -APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RV 313
            APE       + K DV++FGV+  E+   G  P        P I L  + +      R+
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------YPGIDLSQVYELLEKDYRM 231

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             P      + +++       AC +  P+ RP
Sbjct: 232 ERPEGCPEKVYELMR------ACWQWNPSDRP 257

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (328), Expect = 1e-33
 Identities = 62/263 (23%), Positives = 114/263 (43%), Gaps = 36/263 (13%)

Query: 97  IGTGGYGSVYRAQLPSGKK---VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G G +GSV +      KK   VA+K L     +    E    EA ++ Q+ +  IV+L 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLI 402

Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL---HCDC 210
           G C   + + L+ +    G L   L    E   +  +    ++  ++  + YL   +   
Sbjct: 403 GVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNF-- 457

Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APELA 265
               VHR++++ N+LL ++  A ++DFG+++ L +D S     A + G       APE  
Sbjct: 458 ----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECI 511

Query: 266 YTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQTV 322
                + + DV+S+GV   E L  G+ P   +    P++  +  ++Q  R+  P +    
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEV--MAFIEQGKRMECPPECPPE 567

Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
           +  ++        C   K   RP
Sbjct: 568 LYALMS------DCWIYKWEDRP 584

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  125 bits (315), Expect = 2e-33
 Identities = 67/277 (24%), Positives = 123/277 (44%), Gaps = 38/277 (13%)

Query: 83  EMIVATED----FDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTE 137
             IV+  D    +     IG G  G+VY A  + +G++VA+++++  +      E    E
Sbjct: 10  RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINE 67

Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN---DDEAIRLDWTKRVN 194
             ++ + ++ NIV      L    ++++ +Y+  GSL  ++     D+  I         
Sbjct: 68  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------- 120

Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
           + +    AL +LH +    ++HRDI S+NILL       + DFG    +  + S R+ + 
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177

Query: 255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP--KIMLIDLLDQR 312
           GT  ++APE+        K D++S G++A+E++ G  P     + NP   + LI      
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYLI----AT 230

Query: 313 VPSPIDDQTVIQDIILVSKI----VFACLRSKPTSRP 345
             +P      +Q+   +S I    +  CL      R 
Sbjct: 231 NGTP-----ELQNPEKLSAIFRDFLNRCLEMDVEKRG 262

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  124 bits (313), Expect = 2e-33
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 34/272 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL--PSGK--KVALKKLHH-SETELAFLESFQTEAHLLSQ 143
           +D  +   +G G +G V R +   PSGK   VA+K L     ++   ++ F  E + +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           + HRN+++LYG  L    M ++ +    GSL   LR       L           +A  +
Sbjct: 78  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGM 134

Query: 204 SYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
            YL           +HRD+++ N+LL ++    + DFG+ R L  +      V   H  +
Sbjct: 135 GYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD--HYVMQEHRKV 186

Query: 261 -----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM-LIDLLDQRV 313
                APE   T   +   D + FGV   E+   G+ P   L+    +I+  ID   +R+
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKIDKEGERL 244

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           P P D    I ++++       C   KP  RP
Sbjct: 245 PRPEDCPQDIYNVMV------QCWAHKPEDRP 270

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  123 bits (312), Expect = 4e-33
 Identities = 54/280 (19%), Positives = 113/280 (40%), Gaps = 49/280 (17%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL--------PSGKKVALKKLHHSETELAFLESFQTEAHL 140
           ED      +G G +  +++               +V LK L  +    +  ESF   A +
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASM 65

Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMA 200
           +S++ H+++V  YG C+      L+ ++++ GSL   L+ +   I + W  ++ + K +A
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLA 123

Query: 201 HALSYL---HCDCIPSIVHRDISSNNILLNSKLEAF--------VADFGVARLLHSDSSN 249
            A+ +L           +H ++ + NILL  + +          ++D G++  +      
Sbjct: 124 AAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177

Query: 250 RTVVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLID 307
           +  +        PE +     L    D +SFG    E+   G  P   L   + +   + 
Sbjct: 178 QERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQRK--LQ 229

Query: 308 LLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             +   ++P+P   +  + ++I        C+  +P  RP
Sbjct: 230 FYEDRHQLPAPKAAE--LANLIN------NCMDYEPDHRP 261

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  123 bits (311), Expect = 4e-33
 Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 48/272 (17%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           ++  +   IG G +G V       G KVA+K + +  T  AFL     EA +++Q+RH N
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLA----EASVMTQLRHSN 75

Query: 149 IVKLYGFCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL- 206
           +V+L G  + +K  ++++ +YM +GSL   LR+   +  L     +     +  A+ YL 
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE 134

Query: 207 --HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---- 260
             +       VHRD+++ N+L++    A V+DFG+ +   S            G +    
Sbjct: 135 GNNF------VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--------GKLPVKW 180

Query: 261 -APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RV 313
            APE       + K DV+SFG++  E+   GR P        P+I L D++ +     ++
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPRVEKGYKM 233

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            +P      + +++        C       RP
Sbjct: 234 DAPDGCPPAVYEVMK------NCWHLDAAMRP 259

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  126 bits (319), Expect = 4e-33
 Identities = 58/272 (21%), Positives = 111/272 (40%), Gaps = 36/272 (13%)

Query: 90  DFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRN 148
            F  K  +G G  G++    +   + VA+K++               E  LL +   H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-----PECFSFADREVQLLRESDEHPN 79

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           +++ +     ++  ++  +     +L   + + D   + L+    + +++     L++LH
Sbjct: 80  VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLH 135

Query: 208 CDCIPSIVHRDISSNNILL-----NSKLEAFVADFGVARLLHSDSSNRTV---VAGTHGY 259
                +IVHRD+  +NIL+     + K++A ++DFG+ + L     + +    V GT G+
Sbjct: 136 SL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 260 IAPEL---AYTMVLTEKCDVYSFGVVALEVL-MGRHP-GDLLSSVNPKIMLIDLLDQRVP 314
           IAPE+         T   D++S G V   V+  G HP G        +   I L    + 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS----LQRQANILLGACSLD 248

Query: 315 SPIDDQTVIQDII-LVSKIVFACLRSKPTSRP 345
               ++        L+ K     +   P  RP
Sbjct: 249 CLHPEKHEDVIARELIEK----MIAMDPQKRP 276

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  123 bits (311), Expect = 5e-33
 Identities = 68/268 (25%), Positives = 126/268 (47%), Gaps = 36/268 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           E   +   +G G +G V+        KVA+K L          ++F  EA+L+ Q++H+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQR 69

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL-- 206
           +V+LY     ++ +++I +YM  GSL   L+      +L   K +++   +A  ++++  
Sbjct: 70  LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEE 127

Query: 207 -HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI----- 260
            +       +HRD+ + NIL++  L   +ADFG+ARL+  +       A           
Sbjct: 128 RNY------IHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWT 177

Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPI 317
           APE       T K DV+SFG++  E++  GR P   ++  NP++  I  L++  R+  P 
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEV--IQNLERGYRMVRPD 233

Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +    +  ++        C + +P  RP
Sbjct: 234 NCPEELYQLMR------LCWKERPEDRP 255

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  124 bits (313), Expect = 5e-33
 Identities = 65/274 (23%), Positives = 127/274 (46%), Gaps = 32/274 (11%)

Query: 83  EMIVATED----FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTE 137
            M+V   D     D    IG G  G V  A+   SG++VA+K +   + +    E    E
Sbjct: 35  RMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNE 92

Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
             ++   +H N+V++Y   L  + ++++ ++++ G+L  I+      +RL+  +   + +
Sbjct: 93  VVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCE 148

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
           ++  AL+YLH      ++HRDI S++ILL       ++DFG    +  D   R  + GT 
Sbjct: 149 AVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205

Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP--KIMLIDLLDQRVPS 315
            ++APE+    +   + D++S G++ +E++ G  P     S +P   +  +    +  P 
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP---YFSDSPVQAMKRL----RDSPP 258

Query: 316 PIDDQTVIQDIILVSKI----VFACLRSKPTSRP 345
           P      +++   VS +    +   L   P  R 
Sbjct: 259 P-----KLKNSHKVSPVLRDFLERMLVRDPQERA 287

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  123 bits (310), Expect = 6e-33
 Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 39/272 (14%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKK----VALKKLHHSETELAFLESFQTEAHLLSQI 144
           E  ++  CIG G +G V++    S +     VA+K   +  ++    E F  EA  + Q 
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQF 73

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H +IVKL G    +  +++I +    G L   L+    ++ L     +     ++ AL+
Sbjct: 74  DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALA 130

Query: 205 YL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI- 260
           YL           VHRDI++ N+L++S     + DFG++R +       T    + G + 
Sbjct: 131 YLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLP 180

Query: 261 ----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RV 313
               APE       T   DV+ FGV   E+LM G  P   +   N  +  I  ++   R+
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDV--IGRIENGERL 236

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           P P +    +  ++        C    P+ RP
Sbjct: 237 PMPPNCPPTLYSLMT------KCWAYDPSRRP 262

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  126 bits (319), Expect = 6e-33
 Identities = 67/266 (25%), Positives = 133/266 (50%), Gaps = 32/266 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           E   ++  +G G +G V+ A      KVA+K +      +   E+F  EA+++  ++H  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQHDK 244

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +VKL+     K+ +++I ++M +GSL   L++D+ + +    K ++    +A  ++++  
Sbjct: 245 LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---APELA 265
               + +HRD+ + NIL+++ L   +ADFG+AR++  +    T   G    I   APE  
Sbjct: 303 R---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAI 357

Query: 266 YTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPIDD 319
                T K DV+SFG++ +E++  GR P        P +   +++       R+P P + 
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIP-------YPGMSNPEVIRALERGYRMPRPENC 410

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
              + +I++       C +++P  RP
Sbjct: 411 PEELYNIMM------RCWKNRPEERP 430

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  127 bits (321), Expect = 7e-33
 Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 36/268 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++RH  
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 323

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+LY     ++ ++++ +YM +GSL   L+ +     L   + V++   +A  ++Y+  
Sbjct: 324 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVER 381

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APE 263
               + VHRD+ + NIL+   L   VADFG+ARL+  +                   APE
Sbjct: 382 M---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR----QGAKFPIKWTAPE 434

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 487

Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +    + D++        C R +P  RP
Sbjct: 488 ECPESLHDLMC------QCWRKEPEERP 509

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  123 bits (311), Expect = 1e-32
 Identities = 70/277 (25%), Positives = 111/277 (40%), Gaps = 46/277 (16%)

Query: 97  IGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV   +       +G  VA+K+L HS  +      FQ E  +L  +    IVK
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVK 88

Query: 152 LYGFCLHKKC--MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL--- 206
             G         + L+ +Y+  G L   L+      RLD ++ +     +   + YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR 146

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----A 261
            C      VHRD+++ NIL+ S+    +ADFG+A+LL  D      V    G       A
Sbjct: 147 RC------VHRDLAARNILVESEAHVKIADFGLAKLLPLDKD--YYVVREPGQSPIFWYA 198

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHP-------GDLLSSVNPKIMLIDLLDQ-- 311
           PE     + + + DV+SFGVV  E+                ++        L  LL+   
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258

Query: 312 ---RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
              R+P+P      + +++        C    P  RP
Sbjct: 259 EGQRLPAPPACPAEVHELMK------LCWAPSPQDRP 289

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  125 bits (317), Expect = 1e-32
 Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 50/273 (18%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           ++  +   IG G +G V       G KVA+K + +  T  AFL     EA +++Q+RH N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLA----EASVMTQLRHSN 247

Query: 149 IVKLYGFCLHKK-CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL- 206
           +V+L G  + +K  ++++ +YM +GSL   LR+   +  L     +     +  A+ YL 
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE 306

Query: 207 --HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR------TVVAGTHG 258
             +       VHRD+++ N+L++    A V+DFG+ +   S           T       
Sbjct: 307 GNNF------VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 353

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----R 312
             APE       + K DV+SFG++  E+   GR P        P+I L D++ +     +
Sbjct: 354 --APEALREKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPRVEKGYK 404

Query: 313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           + +P      + D++        C      +RP
Sbjct: 405 MDAPDGCPPAVYDVMK------NCWHLDAATRP 431

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  126 bits (317), Expect = 1e-32
 Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 36/268 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++RH  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 240

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+LY     ++ ++++ +YM +GSL   L+ +     L   + V++   +A  ++Y+  
Sbjct: 241 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVER 298

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APE 263
               + VHRD+ + NIL+   L   VADFG+ARL+  +                   APE
Sbjct: 299 M---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR----QGAKFPIKWTAPE 351

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-----RVPSPI 317
            A     T K DV+SFG++  E+   GR P        P ++  ++LDQ     R+P P 
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPP 404

Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +    + D++        C R +P  RP
Sbjct: 405 ECPESLHDLMC------QCWRKEPEERP 426

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  122 bits (309), Expect = 2e-32
 Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 41/274 (14%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGK----KVALKKLHHSETELAFLESFQTEAHLLSQ 143
            +      +G+G +G+V++    P G+     V +K +       +F          +  
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAIGS 71

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR----LDWTKRVNIVKSM 199
           + H +IV+L G C     + L+ +Y+  GSL   +R    A+     L+W   V I K M
Sbjct: 72  LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGM 128

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
            + L           VHR++++ N+LL S  +  VADFGVA LL  D         +   
Sbjct: 129 YY-LEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL---LYSEAK 178

Query: 260 I-----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-- 311
                 A E  +    T + DV+S+GV   E++  G  P   L     ++   DLL++  
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--LAEV--PDLLEKGE 234

Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           R+  P      +  +++       C       RP
Sbjct: 235 RLAQPQICTIDVYMVMV------KCWMIDENIRP 262

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (310), Expect = 2e-32
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 18/211 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
             +     +G GG+   +      + +  A K +  S   +    E    E  +   + H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-----NDDEAIRLDWTKRVNIVKSMAH 201
           +++V  +GF      +F++ +  RR SL  + +      + EA           ++ +  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY--------YLRQIVL 152

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
              YLH + +   +HRD+   N+ LN  LE  + DFG+A  +  D   + V+ GT  YIA
Sbjct: 153 GCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      + + DV+S G +   +L+G+ P
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  121 bits (306), Expect = 2e-32
 Identities = 68/272 (25%), Positives = 114/272 (41%), Gaps = 39/272 (14%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL--PSGKK--VALKKLHHSETELAFLESFQTEAHLLSQI 144
           ED  +   +G G +G VY        G+K  VA+K      T     E F +EA ++  +
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-KEKFMSEAVIMKNL 70

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H +IVKL G    ++  ++I +    G L   L  +  ++++     V     +  A++
Sbjct: 71  DHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMA 127

Query: 205 YL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI- 260
           YL   +C      VHRDI+  NIL+ S     + DFG++R +  +         +   + 
Sbjct: 128 YLESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLP 177

Query: 261 ----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RV 313
               +PE       T   DV+ F V   E+L  G+ P   L   N  +  I +L++  R+
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE--NKDV--IGVLEKGDRL 233

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           P P     V+  ++        C    P+ RP
Sbjct: 234 PKPDLCPPVLYTLMT------RCWDYDPSDRP 259

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  122 bits (308), Expect = 2e-32
 Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 36/266 (13%)

Query: 97  IGTGGYGSVYRAQ---LPSGKKVALKKLHHSETELA----FLESFQTEAHLLSQIRHRNI 149
           +G GG   V+ A+       + VA+K L     +LA    F   F+ EA   + + H  I
Sbjct: 20  LGFGGMSEVHLARDLRD--HRDVAVKVLR---ADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 150 VKLY--GF--CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           V +Y  G          +++ +Y+   +L  I+        +   + + ++     AL++
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNF 131

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT---VVAGTHGYIAP 262
            H +    I+HRD+   NI++++     V DFG+AR +    ++ T    V GT  Y++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           E A    +  + DVYS G V  EVL G  P  GD     +P  +    + +    P    
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPVSVAYQHVREDPIPPSA-- 241

Query: 321 TVIQDI-ILVSKIVFACLRSKPTSRP 345
              + +   +  +V   L   P +R 
Sbjct: 242 -RHEGLSADLDAVVLKALAKNPENRY 266

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  122 bits (308), Expect = 3e-32
 Identities = 68/278 (24%), Positives = 108/278 (38%), Gaps = 36/278 (12%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTE-AHLLSQ 143
              ED      IG G YGSV +    PSG+ +A+K++  S  +    +    +   ++  
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRS 77

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN------IVK 197
                IV+ YG    +   ++  + M   S     +     +       +       I  
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKY----VYSVLDDVIPEEILGKITL 132

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
           +   AL++L  +    I+HRDI  +NILL+      + DFG++  L  DS  +T  AG  
Sbjct: 133 ATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCR 189

Query: 258 GYIAPE----LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV 313
            Y+APE     A       + DV+S G+   E+  GR P       N    + D L Q V
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP---YPKWNS---VFDQLTQVV 243

Query: 314 --PSPIDDQTVIQDIILVSKI----VFACLRSKPTSRP 345
               P    +  ++    S      V  CL    + RP
Sbjct: 244 KGDPPQLSNSEEREF---SPSFINFVNLCLTKDESKRP 278

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  123 bits (310), Expect = 3e-32
 Identities = 66/265 (24%), Positives = 108/265 (40%), Gaps = 36/265 (13%)

Query: 97  IGTGGYGSVYRAQLPSGKK----VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L          A+K L+        +  F TE  ++    H N++ L
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFSHPNVLSL 155

Query: 153 YGFCLHKKC-MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL---HC 208
            G CL  +    ++  YM+ G L   +RN+           +     +A  + +L     
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKF 213

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APE 263
                 VHRD+++ N +L+ K    VADFG+AR ++    +  V   T   +     A E
Sbjct: 214 ------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS-VHNKTGAKLPVKWMALE 266

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPIDDQ 320
              T   T K DV+SFGV+  E++  G  P   +++ +    +   L Q  R+  P    
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGRRLLQPEYCP 322

Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
             + +++L       C   K   RP
Sbjct: 323 DPLYEVML------KCWHPKAEMRP 341

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  121 bits (306), Expect = 4e-32
 Identities = 50/266 (18%), Positives = 88/266 (33%), Gaps = 34/266 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RH 146
           + F     +G G YG V++ +    G+  A+K+                E     ++ +H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKRVNIVKSMAHA 202
              V+L         ++L  +     SL            EA    + +          A
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLR------DTLLA 169

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
           L++LH      +VH D+   NI L  +    + DFG+   L +  +      G   Y+AP
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAP 225

Query: 263 EL---AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
           EL   +Y        DV+S G+  LEV                      L     + +  
Sbjct: 226 ELLQGSY----GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY--LPPEFTAGLSS 279

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
           +  ++ +++        L   P  R 
Sbjct: 280 E--LRSVLV------MMLEPDPKLRA 297

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (305), Expect = 5e-32
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 18/211 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
             +     +G GG+   +      + +  A K +  S   +    E    E  +   + H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-----NDDEAIRLDWTKRVNIVKSMAH 201
           +++V  +GF      +F++ +  RR SL  + +      + EA           ++ +  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY--------YLRQIVL 126

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
              YLH + +   +HRD+   N+ LN  LE  + DFG+A  +  D   + V+ GT  YIA
Sbjct: 127 GCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+      + + DV+S G +   +L+G+ P
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  120 bits (304), Expect = 6e-32
 Identities = 58/210 (27%), Positives = 88/210 (41%), Gaps = 24/210 (11%)

Query: 97  IGTGGYGSVYRAQLPSGKK----VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY   L          A+K L+        +  F TE  ++    H N++ L
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFSHPNVLSL 91

Query: 153 YGFCLHKKC-MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL---HC 208
            G CL  +    ++  YM+ G L   +RN+           +     +A  + YL     
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKKF 149

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APE 263
                 VHRD+++ N +L+ K    VADFG+AR ++       V   T   +     A E
Sbjct: 150 ------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS-VHNKTGAKLPVKWMALE 202

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHP 292
              T   T K DV+SFGV+  E++  G  P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  120 bits (304), Expect = 8e-32
 Identities = 54/265 (20%), Positives = 102/265 (38%), Gaps = 21/265 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAH-LLSQIRH 146
            D +    +G+G  G V++ +   +G  +A+K++          +    +   +L     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILMDLDVVLKSHDC 83

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             IV+ +G  +    +F+  + M   +     R     I      +  +  ++  AL YL
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG-PIPERILGK--MTVAIVKALYYL 140

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
                  ++HRD+  +NILL+ + +  + DFG++  L  D   +   AG   Y+APE   
Sbjct: 141 KEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERID 197

Query: 267 TMVLTE-----KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDL-LDQRVPSPIDDQ 320
               T+     + DV+S G+  +E+  G+ P     +      ++   L +  P      
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFP---YKNCKTDFEVLTKVLQEEPPLLPGHM 254

Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
               D       V  CL      RP
Sbjct: 255 GFSGDFQ---SFVKDCLTKDHRKRP 276

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (315), Expect = 8e-32
 Identities = 63/277 (22%), Positives = 109/277 (39%), Gaps = 17/277 (6%)

Query: 90  DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
            +++K  +GTGG+G V R     +G++VA+K+     +     E +  E  ++ ++ H N
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-KNRERWCLEIQIMKKLNHPN 73

Query: 149 IVKLY------GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           +V                   L  +Y   G L   L   +    L       ++  ++ A
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGY 259
           L YLH +    I+HRD+   NI+L    +     + D G A+ L         V GT  Y
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQY 189

Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
           +APEL      T   D +SFG +A E + G  P   L +  P      + ++     +  
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP--FLPNWQPVQWHGKVREKSNEHIVVY 247

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEFLVR 356
             +   +   S +      S   +  ++R  Q  L+ 
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW 284

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  120 bits (303), Expect = 9e-32
 Identities = 73/278 (26%), Positives = 115/278 (41%), Gaps = 47/278 (16%)

Query: 97  IGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +GSV   +       +G+ VA+KKL HS  E   L  F+ E  +L  ++H NIVK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVK 75

Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL--- 206
             G C    ++ + LI +Y+  GSL   L+   E  R+D  K +     +   + YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK 133

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----A 261
                   +HRD+++ NIL+ ++    + DFG+ ++L  D           G       A
Sbjct: 134 RY------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--FFKVKEPGESPIFWYA 185

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM------------LIDLL 309
           PE       +   DV+SFGVV  E+           +   +++            LI+LL
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 310 DQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
               R+P P      I  I+        C  +    RP
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRP 277

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  120 bits (304), Expect = 1e-31
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 23/227 (10%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-R 145
              F++   +G G YG VY+ + + +G+  A+K +  +  E    E  + E ++L +   
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSH 79

Query: 146 HRNIVKLYGFCLHKKCMFLIYK------YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           HRNI   YG  + K    +  +      +   GS+  +++N  +   L       I + +
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREI 138

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
              LS+LH      ++HRDI   N+LL    E  + DFGV+  L      R    GT  +
Sbjct: 139 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 195

Query: 260 IAPELAYTMVLTE-----KCDVYSFGVVALEVLMGRHPGDLLSSVNP 301
           +APE+       +     K D++S G+ A+E+  G  P   L  ++P
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LCDMHP 239

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  119 bits (301), Expect = 1e-31
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 10/206 (4%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           +DFDI   +G G +G+VY A+   +   +ALK L  S+  +       + E  + S +RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NI+++Y +   +K ++L+ ++  RG L+  L+      R D  +    ++ +A AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYC 130

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      ++HRDI   N+L+  K E  +ADFG +  +H+ S  R  + GT  Y+ PE+  
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLPPEMIE 185

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHP 292
                EK D++  GV+  E L+G  P
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  121 bits (304), Expect = 2e-31
 Identities = 33/231 (14%), Positives = 70/231 (30%), Gaps = 26/231 (11%)

Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQ------LPSGKKVALKKLHHSETELAFLESFQT 136
           E  + ++   + + +G G +  VY A         + +K  LK    +     ++     
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG--TQ 116

Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI--RLDWTKRVN 194
               L        +K Y   L +    L+ +    G+L   +          +     ++
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF-----------VADFGVARLL 243
               M + +  +H      I+H DI  +N +L +                + D G +  +
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 244 HSDSSNRTVVA--GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                     A   T G+   E+        + D +        +L G + 
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  119 bits (300), Expect = 2e-31
 Identities = 61/280 (21%), Positives = 116/280 (41%), Gaps = 44/280 (15%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTE-AHLLSQ 143
           V  +D +    +G G YG V + + +PSG+ +A+K++  +       +    +    +  
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRT 62

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN------IVK 197
           +     V  YG    +  +++  + M   SL    +       +D  + +       I  
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQV-----IDKGQTIPEDILGKIAV 116

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
           S+  AL +LH     S++HRD+  +N+L+N+  +  + DFG++  L  D   + + AG  
Sbjct: 117 SIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCK 173

Query: 258 GYIAPE--------LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL 309
            Y+APE          Y++    K D++S G+  +E+ + R P    S   P   L  ++
Sbjct: 174 PYMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQVV 227

Query: 310 DQRVPSPIDDQTVIQDIILVSKI----VFACLRSKPTSRP 345
           ++  P    D+         S         CL+     RP
Sbjct: 228 EEPSPQLPADK--------FSAEFVDFTSQCLKKNSKERP 259

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  120 bits (302), Expect = 2e-31
 Identities = 73/286 (25%), Positives = 113/286 (39%), Gaps = 47/286 (16%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-----SGKKVALKKLHHSETELAFLESFQTEAHLLSQ 143
                   +G G +GSV   +       +G+ VA+KKL HS  E   L  F+ E  +L  
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKS 98

Query: 144 IRHRNIVKLYGFCLHKKC--MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
           ++H NIVK  G C       + LI +Y+  GSL   L+   E  R+D  K +     +  
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICK 156

Query: 202 ALSYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
            + YL           +HRD+++ NIL+ ++    + DFG+ ++L  D           G
Sbjct: 157 GMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--YYKVKEPG 208

Query: 259 YI-----APELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM--------- 304
                  APE       +   DV+SFGVV  E+           +   +++         
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268

Query: 305 ---LIDLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
              LI+LL    R+P P      I  I+        C  +    RP
Sbjct: 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRP 308

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  118 bits (299), Expect = 4e-31
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 24/210 (11%)

Query: 97  IGTGGYGSVYRAQLPSGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           IG G +G VY  +         + A+K L         +E+F  E  L+  + H N++ L
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ-VEAFLREGLLMRGLNHPNVLAL 87

Query: 153 YGFCLHKKCM-FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL---HC 208
            G  L  + +  ++  YM  G L   +R+      +     ++    +A  + YL     
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYLAEQKF 145

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APE 263
                 VHRD+++ N +L+      VADFG+AR +        V    H  +     A E
Sbjct: 146 ------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYS-VQQHRHARLPVKWTALE 198

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHP 292
              T   T K DV+SFGV+  E+L  G  P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  118 bits (299), Expect = 5e-31
 Identities = 58/241 (24%), Positives = 102/241 (42%), Gaps = 31/241 (12%)

Query: 74  NYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGK----KVALKKLHHSETELA 129
           + + +   +++++  + F +   +G G +GSV  AQL        KVA+K L       +
Sbjct: 8   SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS 67

Query: 130 FLESFQTEAHLLSQIRHRNIVKLYGFCL------HKKCMFLIYKYMRRGSLFCILRN--- 180
            +E F  EA  + +  H ++ KL G  L            +I  +M+ G L   L     
Sbjct: 68  DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127

Query: 181 DDEAIRLDWTKRVNIVKSMAHALSYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADF 237
            +    L     V  +  +A  + YL   +       +HRD+++ N +L   +   VADF
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADF 181

Query: 238 GVARLLHSDSSNRTVVAGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVLM-GRH 291
           G++R ++S    R    G    +     A E     + T   DV++FGV   E++  G+ 
Sbjct: 182 GLSRKIYSGDYYR---QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238

Query: 292 P 292
           P
Sbjct: 239 P 239

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  117 bits (296), Expect = 6e-31
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 19/212 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           EDF +   +G G +  VYRA+ + +G +VA+K +      +   ++  Q E  +  Q++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR------NDDEAIRLDWTKRVNIVKSMA 200
            +I++LY +      ++L+ +    G +   L+      +++EA           +  + 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--------FMHQII 122

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
             + YLH   I   +HRD++ +N+LL   +   +ADFG+A  L         + GT  YI
Sbjct: 123 TGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179

Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           +PE+A       + DV+S G +   +L+GR P
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  121 bits (306), Expect = 1e-30
 Identities = 68/272 (25%), Positives = 114/272 (41%), Gaps = 39/272 (14%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKK----VALKKLHHSETELAFLESFQTEAHLLSQI 144
           E  ++  CIG G +G V++    S +     VA+K   +  ++    E F  EA  + Q 
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEALTMRQF 448

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H +IVKL G    +  +++I +    G L   L+       LD    +     ++ AL+
Sbjct: 449 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALA 505

Query: 205 YL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI- 260
           YL           VHRDI++ N+L++S     + DFG++R +   +        + G + 
Sbjct: 506 YLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKLP 555

Query: 261 ----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RV 313
               APE       T   DV+ FGV   E+LM G  P   +   N  +  I  ++   R+
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDV--IGRIENGERL 611

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           P P +    +  ++        C    P+ RP
Sbjct: 612 PMPPNCPPTLYSLMT------KCWAYDPSRRP 637

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  117 bits (295), Expect = 2e-30
 Identities = 57/277 (20%), Positives = 103/277 (37%), Gaps = 47/277 (16%)

Query: 97  IGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK 151
           +G G +G V           +G+ VA+K L            ++ E  +L  + H +I+K
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH-RSGWKQEIDILRTLYHEHIIK 97

Query: 152 LYGFCLHKKC--MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL--- 206
             G C       + L+ +Y+  GSL   L        +   + +   + +   ++YL   
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ 153

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----A 261
           H       +HRD+++ N+LL++     + DFG+A+ +              G       A
Sbjct: 154 HY------IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--YYRVREDGDSPVFWYA 205

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIM----------LIDLLD 310
           PE           DV+SFGV   E+L          +     I           L +LL+
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265

Query: 311 Q--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +  R+P P      +  ++        C  ++ + RP
Sbjct: 266 RGERLPRPDKCPAEVYHLMK------NCWETEASFRP 296

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  117 bits (295), Expect = 2e-30
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 34/219 (15%)

Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+      PS  +VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 96

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 207 ---HCDCIPSIVHRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYI 260
              H       +HRDI++ N LL       V    DFG+AR ++  S  R    G    +
Sbjct: 157 EENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---KGGCAML 207

Query: 261 -----APE-LAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 PE      + T K D +SFGV+  E+  +G  P
Sbjct: 208 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP 245

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (296), Expect = 2e-30
 Identities = 28/289 (9%), Positives = 60/289 (20%), Gaps = 53/289 (18%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELA-FLESFQTEAHLLSQIRHRNIVKLYG 154
           +  G    V+    +   +  ALK            LE         +++   +  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 155 FCLHKKCM--------------------------FLIYKYMRRGSLFCILRNDDEAI--- 185
                                              L+        L  +    D      
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 186 -RLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
                     +   +    + L       +VH   + +N+ +       + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242

Query: 245 SDSSNRTVVAGTHGYIAPEL--AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK 302
              +     +    Y   E   A T   T   + +  G+    V     P  L++     
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302

Query: 303 IMLIDLLDQRVPSPIDDQTV------IQDIILVSKIVFACLRSKPTSRP 345
                 L       +   +       ++ +I         L      R 
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG------RFLNFDRRRRL 345

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  116 bits (294), Expect = 2e-30
 Identities = 53/232 (22%), Positives = 96/232 (41%), Gaps = 30/232 (12%)

Query: 82  QEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGK----KVALKKLHHSETELAFLESFQTE 137
           +++++      +   +G G +GSV    L        KVA+K +    +    +E F +E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86

Query: 138 AHLLSQIRHRNIVKLYGFCL-----HKKCMFLIYKYMRRGSLFCILRN---DDEAIRLDW 189
           A  +    H N+++L G C+           +I  +M+ G L   L     +     +  
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146

Query: 190 TKRVNIVKSMAHALSYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
              +  +  +A  + YL   +       +HRD+++ N +L   +   VADFG+++ ++S 
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200

Query: 247 SSNRTVVAGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHP 292
              R    G    +     A E     V T K DV++FGV   E+   G  P
Sbjct: 201 DYYR---QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  117 bits (296), Expect = 2e-30
 Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 18/219 (8%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELA-FLESFQTEAHLLSQIR 145
            + F     IG G +G+VY A+ + + + VA+KK+ +S  +     +    E   L ++R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H N ++  G  L +   +L+ +Y   GS   +L    + ++        +       L+Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAY 169

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           LH     +++HRD+ + NILL+      + DFG A ++    +      GT  ++APE+ 
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWMAPEVI 222

Query: 266 YTMVLTE---KCDVYSFGVVALEVLMGRHPGDLLSSVNP 301
             M   +   K DV+S G+  +E+   + P   L ++N 
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNA 258

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  117 bits (294), Expect = 3e-30
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 32/218 (14%)

Query: 97  IGTGGYGSVYRAQLPSGKK------VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY        K      VA+K ++ + +    +E F  EA ++ +    ++V
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 91

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDWTKRVNIVKSMAHAL 203
           +L G     +   +I + M RG L   LR       N+        +K + +   +A  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 204 SYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
           +YL           VHRD+++ N ++       + DFG+ R ++     R    G  G +
Sbjct: 152 AYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---KGGKGLL 202

Query: 261 -----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHP 292
                +PE     V T   DV+SFGVV  E+      P
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  117 bits (294), Expect = 5e-30
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 34/219 (15%)

Query: 97  IGTGGYGSVYRAQLPSGKK------VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G +G VY  Q+           VA+K L    +E   L+ F  EA ++S+  H+NIV
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 137

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYL 206
           +  G  L     F++ + M  G L   LR       +   L     +++ + +A    YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 207 ---HCDCIPSIVHRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYI 260
              H       +HRDI++ N LL       V    DFG+AR ++     R    G    +
Sbjct: 198 EENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---KGGCAML 248

Query: 261 -----APE-LAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 PE      + T K D +SFGV+  E+  +G  P
Sbjct: 249 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP 286

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (290), Expect = 5e-30
 Identities = 47/283 (16%), Positives = 91/283 (32%), Gaps = 45/283 (15%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-R 145
           T +F     IG+G +GSV++      G   A+K+           ++   E +  + + +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           H ++V+ +        M +  +Y   GSL   I  N          +  +++  +   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFV-------------------ADFGVARLLHS 245
           Y+H     S+VH DI  +NI ++                           D G    +  
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184

Query: 246 DSSNRTVVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM 304
             S+  V  G   ++A E L        K D+++  +  +               + +I 
Sbjct: 185 --SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH-EIR 241

Query: 305 LIDLLDQRVPSPIDDQ--TVIQDIILVSKIVFACLRSKPTSRP 345
                 Q     I         +++         +   P  RP
Sbjct: 242 ------QGRLPRIPQVLSQEFTELLK------VMIHPDPERRP 272

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  114 bits (287), Expect = 2e-29
 Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 20/222 (9%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
            +   + +   +G G   +V+R +   +G   A+K  ++       ++    E  +L ++
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64

Query: 145 RHRNIVKLYGF--CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
            H+NIVKL+        +   LI ++   GSL+ +L     A  L  ++ + +++ +   
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVVAGTHG 258
           +++L  +    IVHR+I   NI+     +      + DFG AR L  D    ++  GT  
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEE 180

Query: 259 YIAPELAYTMVL--------TEKCDVYSFGVVALEVLMGRHP 292
           Y+ P++    VL            D++S GV       G  P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  116 bits (292), Expect = 2e-29
 Identities = 58/292 (19%), Positives = 112/292 (38%), Gaps = 47/292 (16%)

Query: 88  TEDFDIKYC----IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQ 143
            +           +G G  G+V       G+ VA+K++      + F +    E  LL++
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-----LIDFCDIALMEIKLLTE 64

Query: 144 I-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRN---DDEAIRLDWTKRVNIVKS 198
              H N+++ Y      + +++  +     +L   +      D+          +++++ 
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF-------------VADFGVARLL-- 243
           +A  +++LH      I+HRD+   NIL+++                  ++DFG+ + L  
Sbjct: 124 IASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 244 --HSDSSNRTVVAGTHGYIAPEL-------AYTMVLTEKCDVYSFGVVALEVL-MGRHPG 293
              S  +N    +GT G+ APEL            LT   D++S G V   +L  G+HP 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 294 DLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
               S    I+        +    D   + +   L+S+     +   P  RP
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQ----MIDHDPLKRP 288

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  114 bits (286), Expect = 1e-28
 Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 20/222 (9%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
            +   + +   +G G   +V+R +   +G   A+K  ++       ++    E  +L ++
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64

Query: 145 RHRNIVKLYGF--CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
            H+NIVKL+        +   LI ++   GSL+ +L     A  L  ++ + +++ +   
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVVAGTHG 258
           +++L  +    IVHR+I   NI+     +      + DFG AR L  D    ++  GT  
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEE 180

Query: 259 YIAPELAYTMVL--------TEKCDVYSFGVVALEVLMGRHP 292
           Y+ P++    VL            D++S GV       G  P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  114 bits (288), Expect = 1e-28
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 24/215 (11%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           +E +     +G+G YG V       +  + A+K +  +    +       E  +L  + H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR--VNIVKSMAHALS 204
            NI+KLY F   K+  +L+ +  + G LF     D+   R+ + +     I+K +   ++
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELF-----DEIIHRMKFNEVDAAVIIKQVLSGVT 150

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           YLH     +IVHRD+   N+LL SK +     + DFG++ +  +    +  + GT  YIA
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-GTAYYIA 206

Query: 262 PELAYTMVL----TEKCDVYSFGVVALEVLMGRHP 292
           PE     VL     EKCDV+S GV+   +L G  P
Sbjct: 207 PE-----VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  111 bits (279), Expect = 2e-28
 Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 40/225 (17%)

Query: 97  IGTGGYGSVYRAQLPSGKK------VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G   +G VY+  L           VA+K L          E F+ EA L ++++H N+V
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHPNVV 75

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS------------ 198
            L G     + + +I+ Y   G L   L        +  T     VKS            
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 199 -----MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
                M + LS  H       VH+D+++ N+L+  KL   ++D G+ R +++    +   
Sbjct: 136 QIAAGMEY-LSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK--- 185

Query: 254 AGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVLM-GRHP 292
              +  +     APE       +   D++S+GVV  EV   G  P
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  111 bits (279), Expect = 3e-28
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 44/226 (19%)

Query: 97  IGTGGYGSVYRAQLPSGKK------VALKKLH-HSETELAFLESFQTEAHLLSQIRHRNI 149
           +G G +G V+ A+  +         VA+K L   SE+     + FQ EA LL+ ++H++I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQHQHI 105

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN--------------- 194
           V+ +G C   + + ++++YMR G L   LR+     +L                      
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 195 -IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
            +   M + L+ LH       VHRD+++ N L+   L   + DFG++R ++S    R   
Sbjct: 166 QVAAGMVY-LAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR--- 215

Query: 254 AGTHGYI-----APE-LAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            G    +      PE + Y    T + DV+SFGVV  E+   G+ P
Sbjct: 216 VGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP 260

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  112 bits (283), Expect = 6e-28
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            E ++I   +G G +G V +     + ++ A+K ++ +  +     +   E  LL ++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFC-ILRND----DEAIRLDWTKRVNIVKSMAH 201
            NI+KL+         +++ +    G LF  I++       +A          I+K +  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFS 132

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHG 258
            ++Y+H     +IVHRD+   NILL SK +     + DFG++     ++  +  + GT  
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAY 188

Query: 259 YIAPELAYTMVL----TEKCDVYSFGVVALEVLMGRHP 292
           YIAPE     VL     EKCDV+S GV+   +L G  P
Sbjct: 189 YIAPE-----VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  110 bits (277), Expect = 8e-28
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 43/224 (19%)

Query: 97  IGTGGYGSVYRAQLPSGK---KVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKL 152
           IG G +G V +A++         A+K++    ++    + F  E  +L ++  H NI+ L
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINL 91

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS-------------- 198
            G C H+  ++L  +Y   G+L   LR              N   S              
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 199 ---MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
              M + LS          +HRD+++ NIL+     A +ADFG++R           V  
Sbjct: 152 ARGMDY-LSQKQF------IHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKK 198

Query: 256 THGYI-----APE-LAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           T G +     A E L Y+ V T   DV+S+GV+  E++ +G  P
Sbjct: 199 TMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP 241

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  110 bits (277), Expect = 8e-28
 Identities = 44/230 (19%), Positives = 90/230 (39%), Gaps = 35/230 (15%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSE---------------TELAFLES 133
            D+ I   +  G +  +   +    K  ALKK   S                +  +  + 
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 134 FQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-----NDDEAIRLD 188
           F+ E  +++ I++   +   G   +   +++IY+YM   S+          + +    + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 189 WTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248
                 I+KS+ ++ SY+H +   +I HRD+  +NIL++      ++DFG +   +    
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDK 205

Query: 249 NRTVVAGTHGYIAPELAYTMVLTE------KCDVYSFGVVALEVLMGRHP 292
                 GT+ ++ PE        E      K D++S G+    +     P
Sbjct: 206 KIKGSRGTYEFMPPE----FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  110 bits (277), Expect = 9e-28
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 45/227 (19%)

Query: 97  IGTGGYGSVYRAQL------PSGKKVA---LKKLHHSETELAFLESFQTEAHLLSQI-RH 146
           +G G +G V  A         +  KVA   LK   H++ + A +     E  ++S + +H
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS----ELKIMSHLGQH 109

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN------------ 194
            NIV L G C H   + +I +Y   G L   LR     +  D    +             
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 195 ---IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
              + + MA  L+  +C      +HRD+++ N+LL +   A + DFG+AR + +DS+   
Sbjct: 170 SSQVAQGMAF-LASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI- 221

Query: 252 VVAGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                +  +     APE  +  V T + DV+S+G++  E+  +G +P
Sbjct: 222 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  108 bits (273), Expect = 1e-27
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 24/205 (11%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            E ++I   +G G +G V +     + ++ A+K ++ +  +     +   E  LL ++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR--VNIVKSMAHALS 204
            NI+KL+         +++ +    G LF     D+   R  +++     I+K +   ++
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGIT 135

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           Y+H     +IVHRD+   NILL SK +     + DFG++     ++  +  + GT  YIA
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIA 191

Query: 262 PELAYTMVL----TEKCDVYSFGVV 282
           PE     VL     EKCDV+S GV+
Sbjct: 192 PE-----VLRGTYDEKCDVWSAGVI 211

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  111 bits (280), Expect = 2e-27
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 39/223 (17%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALK-----KLHHSETELAFLESFQTEAHLL 141
           ++ +  +  +G G +G V       +G++ A+K     ++     +    ES   E  LL
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK----ESLLREVQLL 80

Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFC-ILRND----DEAIRLDWTKRVNIV 196
            Q+ H NI+KLY F   K   +L+ +    G LF  I+        +A          I+
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA--------ARII 132

Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVV 253
           + +   ++Y+H +    IVHRD+   N+LL SK +     + DFG++    +    +  +
Sbjct: 133 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189

Query: 254 AGTHGYIAPELAYTMVL----TEKCDVYSFGVVALEVLMGRHP 292
            GT  YIAPE     VL     EKCDV+S GV+   +L G  P
Sbjct: 190 -GTAYYIAPE-----VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  108 bits (273), Expect = 2e-27
 Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 43/226 (19%)

Query: 97  IGTGGYGSVYRAQLPSGKK------VALKKLH-HSETELAFLESFQTEAHLLSQIRHRNI 149
           +G G +G V+ A+  +         VA+K L   +         FQ EA LL+ ++H +I
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQHEHI 79

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS----------- 198
           VK YG C     + ++++YM+ G L   LR       +    +    K            
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 199 ------MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
                 M + L+  H       VHRD+++ N L+ + L   + DFG++R ++S    R  
Sbjct: 140 SQIASGMVY-LASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-- 190

Query: 253 VAGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
             G H  +      PE       T + DV+SFGV+  E+   G+ P
Sbjct: 191 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  109 bits (275), Expect = 2e-27
 Identities = 45/203 (22%), Positives = 89/203 (43%), Gaps = 11/203 (5%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALK---KLHHSETELAFLESFQTEAHLLSQ 143
            + +++   IG G +  V R     +G++ A+K       + +     E  + EA +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTKRVNIVKSMAHA 202
           ++H +IV+L         +++++++M    L   I++  D           + ++ +  A
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGY 259
           L Y H +   +I+HRD+  + +LL SK  +    +  FGVA  L           GT  +
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 260 IAPELAYTMVLTEKCDVYSFGVV 282
           +APE+       +  DV+  GV+
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVI 222

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  106 bits (267), Expect = 8e-27
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 19/204 (9%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            + F  K  +G+G +G V+   +  SG +  +K ++   +++  +E  + E  +L  + H
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLDH 79

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
            NI+K++        M+++ +    G L   I+        L       ++K M +AL+Y
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAP 262
            H      +VH+D+   NIL           + DFG+A L  SD  +     GT  Y+AP
Sbjct: 140 FHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-GTALYMAP 195

Query: 263 ELAYTMVL----TEKCDVYSFGVV 282
           E     V     T KCD++S GVV
Sbjct: 196 E-----VFKRDVTFKCDIWSAGVV 214

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  110 bits (276), Expect = 8e-27
 Identities = 66/230 (28%), Positives = 96/230 (41%), Gaps = 43/230 (18%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALK-----------KLHHSETELAFLESFQ 135
            E +     +G+G YG V    +     + A+K               ++    F E   
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 136 TEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR--- 192
            E  LL  + H NI+KL+     KK  +L+ ++   G LF          ++    +   
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE---------QIINRHKFDE 145

Query: 193 ---VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSD 246
               NI+K +   + YLH     +IVHRDI   NILL +K       + DFG++     D
Sbjct: 146 CDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202

Query: 247 SSNRTVVAGTHGYIAPELAYTMVL----TEKCDVYSFGVVALEVLMGRHP 292
              R  + GT  YIAPE     VL     EKCDV+S GV+   +L G  P
Sbjct: 203 YKLRDRL-GTAYYIAPE-----VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  107 bits (269), Expect = 9e-27
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 41/227 (18%)

Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE    +   +E  ++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHK 101

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 195 IVKSMAHALSYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
               +A  + YL    C      +HRD+++ N+L+       +ADFG+AR +++    + 
Sbjct: 162 CTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 214

Query: 252 VVAGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
               T+G +     APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 215 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  106 bits (268), Expect = 1e-26
 Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 43/228 (18%)

Query: 97  IGTGGYGSVYRAQLPSGKK------VALKKLHHSETELAFLESFQTEAHLLSQI-RHRNI 149
           +G G +G V  A      K      VA+K L  S           +E  +LS +  H NI
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHMNI 89

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN--------------- 194
           V L G C       +I +Y   G L   LR   ++     T                   
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 195 ----IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250
               + K MA  L+  +C      +HRD+++ NILL       + DFG+AR + +DS+  
Sbjct: 150 FSYQVAKGMAF-LASKNC------IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 251 TVVAGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                 +  +     APE  +  V T + DV+S+G+   E+  +G  P
Sbjct: 203 ---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (267), Expect = 1e-26
 Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 50/234 (21%)

Query: 97  IGTGGYGSVYRAQLPSGKK------VALKKL--HHSETELAFLESFQTEAHLLSQIRHRN 148
           +G G +G V +A     K       VA+K L  + S +EL       +E ++L Q+ H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL---RDLLSEFNVLKQVNHPH 87

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN---------------------DDEAIRL 187
           ++KLYG C     + LI +Y + GSL   LR                        +   L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 188 DWTKRVNIVKSMAHALSYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
                ++    ++  + YL           VHRD+++ NIL+    +  ++DFG++R ++
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVY 201

Query: 245 SDSSNRTVVAGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            + S       + G I     A E  +  + T + DV+SFGV+  E++ +G +P
Sbjct: 202 EEDSYV---KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  105 bits (265), Expect = 3e-26
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 42/227 (18%)

Query: 97  IGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNI 149
           +G G +G V  A         + + VA+K L    T         +E  +L  I  H N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGHHLNV 93

Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS---------- 198
           V L G C      + +I ++ + G+L   LR+             ++ K           
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 199 -------MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
                  M   L+   C      +HRD+++ NILL+ K    + DFG+AR ++ D     
Sbjct: 154 SFQVAKGMEF-LASRKC------IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV- 205

Query: 252 VVAGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                   +     APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 206 --RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  108 bits (271), Expect = 3e-26
 Identities = 50/206 (24%), Positives = 100/206 (48%), Gaps = 24/206 (11%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           TE++ +   +G G +  V R  ++ +G++ A   ++  +      +  + EA +   ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR--VNIVKSMAHALS 204
            NIV+L+     +   +LI+  +  G LF     +D   R  +++    + ++ +  A+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELF-----EDIVAREYYSEADASHCIQQILEAVL 124

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           + H      +VHR++   N+LL SKL+     +ADFG+A  +  +       AGT GY++
Sbjct: 125 HCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181

Query: 262 PELAYTMVL-----TEKCDVYSFGVV 282
           PE     VL      +  D+++ GV+
Sbjct: 182 PE-----VLRKDPYGKPVDLWACGVI 202

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  107 bits (269), Expect = 3e-26
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 41/218 (18%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLH------HSETELAFLESFQTEAHL 140
            +++ +   +G+G  G V  A +  + KKVA++ +        S  E     + +TE  +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRND----DEAIRLDWTKRVNI 195
           L ++ H  I+K+  F    +  +++ + M  G LF  ++ N                   
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC--------KLY 244

Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTV 252
              M  A+ YLH +    I+HRD+   N+LL+S+ E     + DFG +++L   S  RT+
Sbjct: 245 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301

Query: 253 VAGTHGYIAPELAYTMVL--------TEKCDVYSFGVV 282
             GT  Y+APE     VL            D +S GV+
Sbjct: 302 C-GTPTYLAPE-----VLVSVGTAGYNRAVDCWSLGVI 333

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  106 bits (266), Expect = 3e-26
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 36/227 (15%)

Query: 97  IGTGGYGSVYRAQLPSGKK------VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           IG G +G V++A+ P          VA+K L    +     + FQ EA L+++  + NIV
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPNIV 113

Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRN--DDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           KL G C   K M L+++YM  G L   LR+        L  +      +  +     L C
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 209 DCIPSI----------------VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
                I                VHRD+++ N L+   +   +ADFG++R ++S    +  
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-- 231

Query: 253 VAGTHGYI-----APE-LAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
            A  +  I      PE + Y    T + DV+++GVV  E+   G  P
Sbjct: 232 -ADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (265), Expect = 5e-26
 Identities = 49/206 (23%), Positives = 103/206 (50%), Gaps = 25/206 (12%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           ++++D+K  +G G +  V R     +G + A K ++  +      +  + EA +  +++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV--NIVKSMAHALS 204
            NIV+L+     +   +L++  +  G LF     +D   R  +++    + ++ +  +++
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQILESIA 142

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           Y H +    IVHR++   N+LL SK +     +ADFG+A  ++   +      GT GY++
Sbjct: 143 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-GTPGYLS 198

Query: 262 PELAYTMVL-----TEKCDVYSFGVV 282
           PE     VL     ++  D+++ GV+
Sbjct: 199 PE-----VLKKDPYSKPVDIWACGVI 219

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  107 bits (270), Expect = 5e-26
 Identities = 59/254 (23%), Positives = 102/254 (40%), Gaps = 19/254 (7%)

Query: 49  RRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVA--TEDFDIKYCI----GTGGY 102
           R   V +       K      +  + +D    +    V    +     Y I    GTG +
Sbjct: 111 RGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAF 170

Query: 103 GSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC 161
           G V+R  +  +G   A K +          E+ + E   +S +RH  +V L+        
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228

Query: 162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISS 221
           M +IY++M  G LF   +  DE  ++   + V  ++ +   L ++H +   + VH D+  
Sbjct: 229 MVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKP 283

Query: 222 NNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTEKCDVYS 278
            NI+  +K    +   DFG+   L    S +    GT  + APE      V     D++S
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPV-GYYTDMWS 341

Query: 279 FGVVALEVLMGRHP 292
            GV++  +L G  P
Sbjct: 342 VGVLSYILLSGLSP 355

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  105 bits (265), Expect = 6e-26
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 41/227 (18%)

Query: 97  IGTGGYGSVYRAQLPSGKK--------VALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+     K        VA+K L    TE    +   +E  ++  I +H+
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHK 147

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------------NDDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   LR             N     ++ +   V+
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 195 IVKSMAHALSYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
               +A  + YL    C      +HRD+++ N+L+       +ADFG+AR +++    + 
Sbjct: 208 CTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 260

Query: 252 VVAGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
               T+G +     APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 261 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  105 bits (265), Expect = 7e-26
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 41/227 (18%)

Query: 97  IGTGGYGSVYRAQLP--------SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHR 147
           +G G +G V  A+             KVA+K L    TE    +   +E  ++  I +H+
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGKHK 135

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-------------DDEAIRLDWTKRVN 194
           NI+ L G C     +++I +Y  +G+L   L+               +   +L     V+
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195

Query: 195 IVKSMAHALSYL---HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
               +A  + YL    C      +HRD+++ N+L+       +ADFG+AR +H     + 
Sbjct: 196 CAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK- 248

Query: 252 VVAGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
               T+G +     APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 249 --KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  105 bits (263), Expect = 9e-26
 Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 48/233 (20%)

Query: 97  IGTGGYGSVYRAQLPSGKK------VALKKLHHSETELAFLESFQTEAHLLSQI-RHRNI 149
           +G+G +G V  A      K      VA+K L              +E  +++Q+  H NI
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHENI 111

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN--------------- 194
           V L G C     ++LI++Y   G L   LR+  E    D  +  N               
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 195 ---------IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
                    + K M   L +  C      VHRD+++ N+L+       + DFG+AR + S
Sbjct: 172 EDLLCFAYQVAKGMEF-LEFKSC------VHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 246 DSSNRTVVAGTHGYI-----APELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
           DS+        +  +     APE  +  + T K DV+S+G++  E+  +G +P
Sbjct: 225 DSNYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  103 bits (259), Expect = 1e-25
 Identities = 49/210 (23%), Positives = 99/210 (47%), Gaps = 29/210 (13%)

Query: 88  TEDFDIKYCI----GTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           +  F   Y +    G G +  V R     +G + A K ++  +      +  + EA +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV--NIVKSMA 200
           +++H NIV+L+     +   +L++  +  G LF     +D   R  +++    + ++ + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQIL 115

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTH 257
            +++Y H +    IVHR++   N+LL SK +     +ADFG+A  ++   +      GT 
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-GTP 171

Query: 258 GYIAPELAYTMVL-----TEKCDVYSFGVV 282
           GY++PE     VL     ++  D+++ GV+
Sbjct: 172 GYLSPE-----VLKKDPYSKPVDIWACGVI 196

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  103 bits (259), Expect = 2e-25
 Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 46/292 (15%)

Query: 82  QEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLH-HSETELAFLESFQTEAH 139
           Q + +      ++  +  GG+  VY AQ + SG++ ALK+L  + E +     +   E  
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVC 77

Query: 140 LLSQIR-HRNIVKLYGFCL-------HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
            + ++  H NIV+               +  FL+   + +G L   L+  +    L    
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
            + I      A+ ++H    P I+HRD+   N+LL+++    + DFG A  +        
Sbjct: 138 VLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196

Query: 252 VVA------------GTHGYIAPELAYTM---VLTEKCDVYSFGVVALEVLMGRHP---G 293
                           T  Y  PE+        + EK D+++ G +   +   +HP   G
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256

Query: 294 DLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             L  VN K          +P      TV   +I       A L+  P  R 
Sbjct: 257 AKLRIVNGKY--------SIPPHDTQYTVFHSLIR------AMLQVNPEERL 294

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  102 bits (256), Expect = 2e-25
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 30/209 (14%)

Query: 88  TEDFDIKYCI----GTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
             D +  Y +    G G +G V  A Q  +  + A KK+   +  +  ++ F+ E  ++ 
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI--PKYFVEDVDRFKQEIEIMK 61

Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR--VNIVKSMA 200
            + H NI++LY        ++L+ +    G LF     +    +  + +     I+K + 
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGELF-----ERVVHKRVFRESDAARIMKDVL 116

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTH 257
            A++Y H     ++ HRD+   N L  +        + DFG+A         RT V GT 
Sbjct: 117 SAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-GTP 172

Query: 258 GYIAPELAYTMVL----TEKCDVYSFGVV 282
            Y++P+     VL      +CD +S GV+
Sbjct: 173 YYVSPQ-----VLEGLYGPECDEWSAGVM 196

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  104 bits (261), Expect = 3e-25
 Identities = 35/289 (12%), Positives = 84/289 (29%), Gaps = 58/289 (20%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIR--------- 145
           +G     +   A    +G+   +   + +E      ++  + E   L  +R         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 146 -------------HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI------- 185
                             K+    L ++ M+++ ++     +   L+   E +       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 186 -RLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
             L    R+ +   +   L+ LH   +   VH  +   +I+L+ +   F+  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGL---VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 245 SDSSNR-TVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHP--GDLL 296
           + + +            A  +         ++T   D ++ G+    +     P   D  
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322

Query: 297 SSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
              +  I       + +P P+              ++   LR     R 
Sbjct: 323 LGGSEWIF---RSCKNIPQPVRA------------LLEGFLRYPKEDRL 356

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  104 bits (260), Expect = 4e-25
 Identities = 54/249 (21%), Positives = 100/249 (40%), Gaps = 21/249 (8%)

Query: 54  RKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCI----GTGGYGSVYRA- 108
            K +           +    +   +   Q + V        Y I    G+G +G V+R  
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 109 QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168
           +  +G+    K ++          + + E  +++Q+ H  ++ L+     K  M LI ++
Sbjct: 72  EKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129

Query: 169 MRRGSLF--CILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL 226
           +  G LF         E  ++   + +N ++     L ++H     SIVH DI   NI+ 
Sbjct: 130 LSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMC 182

Query: 227 NSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVA 283
            +K  + V   DFG+A  L+ D   +     T  + APE +    V     D+++ GV+ 
Sbjct: 183 ETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDREPV-GFYTDMWAIGVLG 240

Query: 284 LEVLMGRHP 292
             +L G  P
Sbjct: 241 YVLLSGLSP 249

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  103 bits (258), Expect = 6e-25
 Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 25/204 (12%)

Query: 90  DFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
                  +G G +G V++  +  +G K+A K +     +    E  + E  +++Q+ H N
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISVMNQLDHAN 147

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLF--CILRNDD----EAIRLDWTKRVNIVKSMAHA 202
           +++LY     K  + L+ +Y+  G LF   I  + +    + I          +K +   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF--------MKQICEG 199

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYI 260
           + ++H      I+H D+   NIL  ++    +   DFG+AR        +    GT  ++
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFL 255

Query: 261 APE-LAYTMVLTEKCDVYSFGVVA 283
           APE + Y  V +   D++S GV+A
Sbjct: 256 APEVVNYDFV-SFPTDMWSVGVIA 278

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  102 bits (257), Expect = 7e-25
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 19/201 (9%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           ++ F+++  +G G    VYR  Q  + K  ALK L  +  +    +  +TE  +L ++ H
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK----KIVRTEIGVLLRLSH 107

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR--VNIVKSMAHALS 204
            NI+KL         + L+ + +  G LF     D    +  +++R   + VK +  A++
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELF-----DRIVEKGYYSERDAADAVKQILEAVA 162

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           YLH +    IVHRD+   N+L  +        +ADFG+++++      +TV  GT GY A
Sbjct: 163 YLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC-GTPGYCA 218

Query: 262 PELAYTMVLTEKCDVYSFGVV 282
           PE+        + D++S G++
Sbjct: 219 PEILRGCAYGPEVDMWSVGII 239

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  101 bits (254), Expect = 1e-24
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 41/218 (18%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLH------HSETELAFLESFQTEAHL 140
            +++ +   +G+G  G V  A +  + KKVA+K +        S  E     + +TE  +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRND----DEAIRLDWTKRVNI 195
           L ++ H  I+K+  F    +  +++ + M  G LF  ++ N                   
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC--------KLY 119

Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTV 252
              M  A+ YLH +    I+HRD+   N+LL+S+ E     + DFG +++L   S  RT+
Sbjct: 120 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176

Query: 253 VAGTHGYIAPELAYTMVL--------TEKCDVYSFGVV 282
             GT  Y+APE     VL            D +S GV+
Sbjct: 177 C-GTPTYLAPE-----VLVSVGTAGYNRAVDCWSLGVI 208

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  101 bits (253), Expect = 2e-24
 Identities = 62/259 (23%), Positives = 99/259 (38%), Gaps = 62/259 (23%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALK---KLHHSETELAFLESFQTEAHLLSQ 143
            + + +K  IG G YG V  A +  +    A+K   K    +     +E  +TE  L+ +
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-------------------------CIL 178
           + H NI +LY     ++ + L+ +    G L                          C  
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 179 RNDDEAIRLDWTKRV------------NIVKSMAHALSYLHCDCIPSIVHRDISSNNILL 226
            N++         R             NI++ +  AL YLH      I HRDI   N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201

Query: 227 NSKLEAFV--ADFGVARLLHSDSSNR----TVVAGTHGYIAPELAYTMVL-------TEK 273
           ++     +   DFG+++  +  ++      T  AGT  ++APE     VL         K
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-----VLNTTNESYGPK 256

Query: 274 CDVYSFGVVALEVLMGRHP 292
           CD +S GV+   +LMG  P
Sbjct: 257 CDAWSAGVLLHLLLMGAVP 275

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  100 bits (251), Expect = 2e-24
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 18/201 (8%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            + F     +G+G +  V+   Q  +GK  ALK +   ++      S + E  +L +I+H
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKH 65

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR--VNIVKSMAHALS 204
            NIV L          +L+ + +  G LF     D    R  +T++    +++ +  A+ 
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELF-----DRILERGVYTEKDASLVIQQVLSAVK 120

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           YLH +    IVHRD+   N+L  +  E     + DFG++++    +   +   GT GY+A
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTACGTPGYVA 175

Query: 262 PELAYTMVLTEKCDVYSFGVV 282
           PE+      ++  D +S GV+
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVI 196

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  101 bits (253), Expect = 2e-24
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 34/209 (16%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
           T+ +++K  IG G Y    R     +  + A+K +  S+      +  +    LL   +H
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-----RDPTEEIEILLRYGQH 75

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAI--RLDWTKR--VNIVKSMAHA 202
            NI+ L       K ++++ + M+ G L        + I  +  +++R    ++ ++   
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELL-------DKILRQKFFSEREASAVLFTITKT 128

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVVAGTHG 258
           + YLH      +VHRD+  +NIL   +        + DFG A+ L +++        T  
Sbjct: 129 VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185

Query: 259 YIAPELAYTMVL-----TEKCDVYSFGVV 282
           ++APE     VL        CD++S GV+
Sbjct: 186 FVAPE-----VLERQGYDAACDIWSLGVL 209

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 99.2 bits (248), Expect = 4e-24
 Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 30/212 (14%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALK-----KLHHSETELAFLESFQTEAHLL 141
            + +++   +G+G +  V +  Q  +GK+ A K     +L  S   ++  E  + E ++L
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVS-REEIEREVNIL 62

Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CILRN---DDEAIRLDWTKRVNIV 196
            +IRH NI+ L+    +K  + LI + +  G LF     +    +DEA +         +
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--------L 114

Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTV 252
           K +   + YLH      I H D+   NI+L  K        + DFG+A  + + +  + +
Sbjct: 115 KQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171

Query: 253 VAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVA 283
             GT  ++APE + Y  +   + D++S GV+ 
Sbjct: 172 F-GTPEFVAPEIVNYEPL-GLEADMWSIGVIT 201

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 99.6 bits (248), Expect = 6e-24
 Identities = 54/326 (16%), Positives = 103/326 (31%), Gaps = 82/326 (25%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVA----------------------LKKLHH-- 123
            DF+   C+G GG+G V+ A+        A                      L KL H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 124 --------------------------------SETELAFLESFQTEAHLLSQIRHRNIVK 151
                                             +  + +++   +   +     +N V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
                  K  +++  +  R+ +L   +         +    ++I   +A A+ +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS------------NRTVVAGTHGY 259
             ++HRD+  +NI         V DFG+   +  D                T   GT  Y
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
           ++PE  +    + K D++S G++  E+L           +     + D+ + + P     
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI-----ITDVRNLKFPLLFTQ 297

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
           +   +       +V   L   PT RP
Sbjct: 298 KYPQE-----HMMVQDMLSPSPTERP 318

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 99.2 bits (248), Expect = 8e-24
 Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 26/215 (12%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            E + I   +G G +G V+R  +  S K    K +    T+       + E  +L+  RH
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARH 60

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CILRND----DEAIRLDWTKRVNIVKSMA 200
           RNI+ L+      + + +I++++    +F             E +          V  + 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--------VHQVC 112

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHG 258
            AL +LH     +I H DI   NI+  ++  + +   +FG AR L    + R +      
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPE 168

Query: 259 YIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           Y APE   + +V +   D++S G +   +L G +P
Sbjct: 169 YYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINP 202

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 28/211 (13%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALK----KLHHSETELAFLESFQTEAHLLS 142
            + +DI   +G+G +  V +  +  +G + A K    +   +       E  + E  +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CILRN---DDEAIRLDWTKRVNIVK 197
           Q+ H NI+ L+    ++  + LI + +  G LF     +    ++EA           +K
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------IK 122

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVV 253
            +   ++YLH      I H D+   NI+L  K        + DFG+A  +      + + 
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

Query: 254 AGTHGYIAPE-LAYTMVLTEKCDVYSFGVVA 283
            GT  ++APE + Y  +   + D++S GV+ 
Sbjct: 180 -GTPEFVAPEIVNYEPL-GLEADMWSIGVIT 208

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 42/223 (18%)

Query: 87  ATEDFDIKY----CIGTGGYGSVYRA-QLPSGKKVALK-------KLHHSETELAFLESF 134
           +T  F   Y     +G G    V R    P+ K+ A+K           +E      E+ 
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 135 QTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV 193
             E  +L ++  H NI++L          FL++  M++G LF       + +    T++V
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-------DYL----TEKV 119

Query: 194 --------NIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
                    I++++   +  LH     +IVHRD+   NILL+  +   + DFG +  L  
Sbjct: 120 TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176

Query: 246 DSSNRTVVAGTHGYIAPE-LAYTMVL-----TEKCDVYSFGVV 282
               R V  GT  Y+APE +  +M        ++ D++S GV+
Sbjct: 177 GEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 47/211 (22%), Positives = 91/211 (43%), Gaps = 28/211 (13%)

Query: 88  TEDFDIKYCIGTGGYGSVYRA-QLPSGKKVALK----KLHHSETELAFLESFQTEAHLLS 142
            + +DI   +G+G +  V +  +  +G + A K    +   +       E  + E  +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CILRN---DDEAIRLDWTKRVNIVK 197
           Q+ H N++ L+    ++  + LI + +  G LF     +    ++EA           +K
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------IK 122

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVV 253
            +   ++YLH      I H D+   NI+L  K        + DFG+A  +      + + 
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

Query: 254 AGTHGYIAPE-LAYTMVLTEKCDVYSFGVVA 283
            GT  ++APE + Y  +   + D++S GV+ 
Sbjct: 180 -GTPEFVAPEIVNYEPL-GLEADMWSIGVIT 208

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 65/243 (26%), Positives = 109/243 (44%), Gaps = 32/243 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV-ALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           + F+I   IG G +G V   Q    KK+ A+K ++  +  E   + +   E  ++  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 147 RNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAH 201
             +V L Y F   +  MF++   +  G L   L+      +E ++L        +  +  
Sbjct: 75  PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKL-------FICELVM 126

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           AL YL       I+HRD+  +NILL+      + DF +A +L  ++   T +AGT  Y+A
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMA 182

Query: 262 PELAYTMVLTEKC--------DVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV 313
           PE     + + +         D +S GV A E+L GR P  + SS + K ++       V
Sbjct: 183 PE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237

Query: 314 PSP 316
             P
Sbjct: 238 TYP 240

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 41/222 (18%)

Query: 87  ATEDFDIKY----CIGTGGYGSVYRA-QLPSGKKVALK-----KLHHSETEL-AFLESFQ 135
           A ++F  KY     IG G    V R     +G + A+K         S  +L    E+ +
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 136 TEAHLLSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRV- 193
            E H+L Q+  H +I+ L         MFL++  MR+G LF       + +    T++V 
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF-------DYL----TEKVA 196

Query: 194 -------NIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
                  +I++S+  A+S+LH +   +IVHRD+   NILL+  ++  ++DFG +  L   
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253

Query: 247 SSNRTVVAGTHGYIAPE-LAYTMVLTEK-----CDVYSFGVV 282
              R +  GT GY+APE L  +M  T        D+++ GV+
Sbjct: 254 EKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 34/219 (15%)

Query: 85  IVATEDFDIKYCI----GTGGYGSVYRA-QLPSGKKVALK-----KLHHSETELAFLESF 134
           +   E+ D  Y      G+G +  V +  +  +G + A K     +   S   ++  E  
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS-REDI 61

Query: 135 QTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CILRND----DEAIRLDW 189
           + E  +L +I+H N++ L+    +K  + LI + +  G LF  +   +    +EA     
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-- 119

Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHS 245
                 +K + + + YLH      I H D+   NI+L  +        + DFG+A  +  
Sbjct: 120 ------LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170

Query: 246 DSSNRTVVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVA 283
            +  + +  GT  ++APE + Y  +   + D++S GV+ 
Sbjct: 171 GNEFKNIF-GTPEFVAPEIVNYEPL-GLEADMWSIGVIT 207

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 34/200 (17%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYG 154
           +G G +    +     S +  A+K +           + Q E   L     H NIVKL+ 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHE 73

Query: 155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAI--RLDWTKR--VNIVKSMAHALSYLHCDC 210
               +   FL+ + +  G LF       E I  +  +++     I++ +  A+S++H   
Sbjct: 74  VFHDQLHTFLVMELLNGGELF-------ERIKKKKHFSETEASYIMRKLVSAVSHMHDV- 125

Query: 211 IPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
              +VHRD+   N+L   + +     + DFG ARL   D+        T  Y APE    
Sbjct: 126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE---- 179

Query: 268 MVLT-----EKCDVYSFGVV 282
            +L      E CD++S GV+
Sbjct: 180 -LLNQNGYDESCDLWSLGVI 198

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 97.8 bits (243), Expect = 5e-23
 Identities = 39/294 (13%), Positives = 84/294 (28%), Gaps = 67/294 (22%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALK--------------------------KLHHSETELA 129
           +G     +   A    +G+   +                           +   ++ +  
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 130 FLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR-RGSLFC----ILRNDDEA 184
               F     L+   + + ++++         +   + Y R + +L      +L +    
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 185 IRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
             L    R+ +   +   L+ LH      +VH  +   +I+L+ +   F+  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 245 SDSSNRTVVAGTHGYIAPELAYTMVL-----------TEKCDVYSFGVVALEVLMGRHP- 292
                R V + + G+  PEL                 T   D ++ G+V   +     P 
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313

Query: 293 -GDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
             D     +  I       + +P P+          L+       LR     R 
Sbjct: 314 TKDAALGGSEWIF---RSCKNIPQPVRA--------LLEG----FLRYPKEDRL 352

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 96.9 bits (242), Expect = 5e-23
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 31/214 (14%)

Query: 88  TEDFDIKYCI-----GTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLL 141
            E+F+  Y +     G G +  V +     +G++ A K L               E  +L
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 142 SQIRHR-NIVKLYGFCLHKKCMFLIYKYMRRGSLF--CILRNDD-----EAIRLDWTKRV 193
              +    ++ L+    +   + LI +Y   G +F  C+    +     + IRL      
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL------ 136

Query: 194 NIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNR 250
             +K +   + YLH +   +IVH D+   NILL+S        + DFG++R +      R
Sbjct: 137 --IKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR 191

Query: 251 TVVAGTHGYIAPE-LAYTMVLTEKCDVYSFGVVA 283
            ++ GT  Y+APE L Y  + T   D+++ G++A
Sbjct: 192 EIM-GTPEYLAPEILNYDPI-TTATDMWNIGIIA 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 97.9 bits (244), Expect = 9e-23
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 21/246 (8%)

Query: 59  TETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-A 117
           +  ++ +   E+  W        ++M +  EDF+I   IG G +G V   +L +  KV A
Sbjct: 44  SPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFA 103

Query: 118 LKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFC 176
           +K L+  E  + A    F+ E  +L     + I  L+        ++L+  Y   G L  
Sbjct: 104 MKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163

Query: 177 ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEA 232
           +L   ++ +  +  +    +  M  A+  +H       VHRDI  +NIL++     +L  
Sbjct: 164 LLSKFEDRLPEEMARFY--LAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL-- 216

Query: 233 FVADFGVARLLHSDSSNRTVVA-GTHGYIAPELAYTMVLTEK-----CDVYSFGVVALEV 286
             ADFG    L  D + ++ VA GT  YI+PE+   M   +      CD +S GV   E+
Sbjct: 217 --ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274

Query: 287 LMGRHP 292
           L G  P
Sbjct: 275 LYGETP 280

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 62/249 (24%), Positives = 113/249 (45%), Gaps = 25/249 (10%)

Query: 59  TETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-A 117
           +E  + +   +F  W     +  +E+ +  +DF+I   IG G +  V   ++    +V A
Sbjct: 31  SELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYA 90

Query: 118 LKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLF 175
           +K ++  +  +   +  F+ E  +L     R I +L+ F    +  ++L+ +Y   G L 
Sbjct: 91  MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLL 149

Query: 176 CILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLE 231
            +L    E I  +  +    +  +  A+  +H       VHRDI  +NILL+     +L 
Sbjct: 150 TLLSKFGERIPAEMARFY--LAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRL- 203

Query: 232 AFVADFGVARLLHSDSSNRTVVA-GTHGYIAPELAYTMVLTEK-------CDVYSFGVVA 283
              ADFG    L +D + R++VA GT  Y++PE+   +            CD ++ GV A
Sbjct: 204 ---ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260

Query: 284 LEVLMGRHP 292
            E+  G+ P
Sbjct: 261 YEMFYGQTP 269

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 94.7 bits (236), Expect = 3e-22
 Identities = 63/307 (20%), Positives = 114/307 (37%), Gaps = 72/307 (23%)

Query: 88  TEDFDI-KYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
            + + + +  +G G +  V     L + ++ A+K +   +           E  +L Q +
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQ 68

Query: 146 -HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN--------IV 196
            HRN+++L  F   +   +L+++ MR GS+          I     KR +        +V
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSIL-------SHI----HKRRHFNELEASVVV 117

Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTV- 252
           + +A AL +LH      I HRD+   NIL     +     + DF +   +  +     + 
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174

Query: 253 ------VAGTHGYIAPELAYTMVL----------TEKCDVYSFGVVALEVLMGRHP--GD 294
                   G+  Y+APE     V+           ++CD++S GV+   +L G  P  G 
Sbjct: 175 TPELLTPCGSAEYMAPE-----VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229

Query: 295 LLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEF- 353
             S         D    R  +    Q ++ + I   K  F         +    +S    
Sbjct: 230 CGS---------DCGWDRGEACPACQNMLFESIQEGKYEF-------PDKDWAHISCAAK 273

Query: 354 -LVRKTL 359
            L+ K L
Sbjct: 274 DLISKLL 280

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 93.7 bits (233), Expect = 4e-22
 Identities = 31/255 (12%), Positives = 71/255 (27%), Gaps = 45/255 (17%)

Query: 96  CIGTGGYGSVYRA---QLPSGKKVALKKLH-HSETELAFLESFQTEAHLLSQIRHRNIVK 151
             G       ++A    L   ++VAL  +          L+   +    LS+I    + +
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCI 211
           +      +    ++ +++R GSL  +               +  ++S+A A    H    
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA-- 148

Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLT 271
             +       + + +                    S +  VV      +           
Sbjct: 149 -GVALSIDHPSRVRV--------------------SIDGDVVLAYPATMPDA-------N 180

Query: 272 EKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI-ILVS 330
            + D+   G     +L+ R P       +           +   P     + +DI   +S
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP---ADIDRDIPFQIS 237

Query: 331 KIVFACLRSKPTSRP 345
            +    ++     R 
Sbjct: 238 AVAARSVQGDGGIRS 252

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 95.5 bits (238), Expect = 5e-22
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 24/246 (9%)

Query: 59  TETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKV-A 117
              +K +  D F     D     +++ +  ED+++   IG G +G V   +  S +KV A
Sbjct: 39  PALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 98

Query: 118 LKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFC 176
           +K L   E  + +    F  E  +++      +V+L+      + ++++ +YM  G L  
Sbjct: 99  MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 158

Query: 177 ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVAD 236
           ++ N D  +   W +       +  AL  +H       +HRD+  +N+LL+      +AD
Sbjct: 159 LMSNYD--VPEKWARFY--TAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 211

Query: 237 FGVARLLHSDSSNRTVVA-GTHGYIAPELAYTMVLTEK---------CDVYSFGVVALEV 286
           FG    ++ +   R   A GT  YI+PE     VL  +         CD +S GV   E+
Sbjct: 212 FGTCMKMNKEGMVRCDTAVGTPDYISPE-----VLKSQGGDGYYGRECDWWSVGVFLYEM 266

Query: 287 LMGRHP 292
           L+G  P
Sbjct: 267 LVGDTP 272

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 94.8 bits (236), Expect = 8e-22
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 37/203 (18%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYG 154
           +G G  G V +     + +K ALK L             + E  L  +  +  +IV++  
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIVD 122

Query: 155 FC----LHKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTKR--VNIVKSMAHALSYLH 207
                   +KC+ ++ + +  G LF  I    D+A    +T+R    I+KS+  A+ YLH
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH 178

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
                +I HRD+   N+L  SK       + DFG A+   S +S  T    T  Y+APE 
Sbjct: 179 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPYYVAPE- 233

Query: 265 AYTMVLT-----EKCDVYSFGVV 282
               VL      + CD++S GV+
Sbjct: 234 ----VLGPEKYDKSCDMWSLGVI 252

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 90.6 bits (226), Expect = 5e-21
 Identities = 65/227 (28%), Positives = 102/227 (44%), Gaps = 45/227 (19%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQ-----T---EAHL 140
           E +     IG G YG VY+AQ   G+  ALKK+         LE        T   E  +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR--------LEKEDEGIPSTTIREISI 53

Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMA 200
           L +++H NIVKLY     KK + L+++++ +  L  +L  D     L+        KS  
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLE----SVTAKSFL 106

Query: 201 H----ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVA 254
                 ++Y H      ++HRD+   N+L+N + E  +ADFG+AR         T  +V 
Sbjct: 107 LQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV- 162

Query: 255 GTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
            T  Y AP++      Y+  +    D++S G +  E++ G    PG 
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTI----DIWSVGCIFAEMVNGTPLFPGV 204

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 91.2 bits (227), Expect = 6e-21
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 27/207 (13%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG G +  V  A+ + +G++VA+K +  ++     L+    E  ++  + H NIVKL+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 156 CLHKKCMFLIYKYMRRGSLF-CILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
              +K ++LI +Y   G +F  ++ +      EA            + +  A+ Y H   
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS--------KFRQIVSAVQYCHQKR 134

Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL----AY 266
              IVHRD+ + N+LL++ +   +ADFG +              G   Y APEL     Y
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-GAPPYAAPELFQGKKY 190

Query: 267 TMVLTEKCDVYSFGVVALEVLM-GRHP 292
                 + DV+S GV+ L  L+ G  P
Sbjct: 191 D---GPEVDVWSLGVI-LYTLVSGSLP 213

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 90.3 bits (225), Expect = 9e-21
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 45/227 (19%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQ-----T---EAHL 140
           E +     +G G YG VY+A+   G+ VALK++         L++       T   E  L
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR--------LDAEDEGIPSTAIREISL 72

Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMA 200
           L ++ H NIV L      ++C+ L++++M +  L  +L  D+    L      + +K   
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQ----DSQIKIYL 125

Query: 201 H----ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVA 254
           +     +++ H   I   +HRD+   N+L+NS     +ADFG+AR       + T  VV 
Sbjct: 126 YQLLRGVAHCHQHRI---LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV- 181

Query: 255 GTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
            T  Y AP++      Y+  +    D++S G +  E++ G+   PG 
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGKPLFPGV 223

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 37/212 (17%)

Query: 88  TEDFDI-KYCIGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR 145
           T+D+ + K  +G G  G V       +G+K ALK L   ++  A  E      H      
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL--YDSPKARQE----VDHHWQASG 80

Query: 146 HRNIVKLYGFC----LHKKCMFLIYKYMRRGSLFC-ILRNDDEAIRLDWTKR--VNIVKS 198
             +IV +          K+C+ +I + M  G LF  I    D+A    +T+R    I++ 
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----FTEREAAEIMRD 136

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAG 255
           +  A+ +LH     +I HRD+   N+L  SK +     + DFG A+    ++  +T    
Sbjct: 137 IGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPC-Y 191

Query: 256 THGYIAPELAYTMVLT-----EKCDVYSFGVV 282
           T  Y+APE     VL      + CD++S GV+
Sbjct: 192 TPYYVAPE-----VLGPEKYDKSCDMWSLGVI 218

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 89.1 bits (222), Expect = 2e-20
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 44/224 (19%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQ-----T---EAH 139
           + ++    IG G YG+V++A+   + + VALK++         L+        +   E  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--------LDDDDEGVPSSALREIC 53

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           LL +++H+NIV+L+      K + L++++  +  L      D     LD      IVKS 
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLD----PEIVKSF 106

Query: 200 AH----ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VV 253
                  L + H   +   +HRD+   N+L+N   E  +A+FG+AR         +  VV
Sbjct: 107 LFQLLKGLGFCHSRNV---LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163

Query: 254 AGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             T  Y  P++      Y+  +    D++S G +  E+     P
Sbjct: 164 --TLWYRPPDVLFGAKLYSTSI----DMWSAGCIFAELANAGRP 201

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 90.0 bits (223), Expect = 3e-20
 Identities = 57/278 (20%), Positives = 99/278 (35%), Gaps = 78/278 (28%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           +   +   +G G +G V  A         + + VA+K L       +   +  +E  +L 
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILI 80

Query: 143 QI-RHRNIVKLYGFCLHKKC-MFLIYKYMRRGSLFCILRN-------------------- 180
            I  H N+V L G C      + +I ++ + G+L   LR+                    
Sbjct: 81  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140

Query: 181 DDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS--------------------------- 213
              AI +D  +R++ + S   + S    +                               
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200

Query: 214 -------------IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
                         +HRD+++ NILL+ K    + DFG+AR ++ D             +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDARL 257

Query: 261 -----APELAYTMVLTEKCDVYSFGVVALEVL-MGRHP 292
                APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 88.4 bits (220), Expect = 5e-20
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 26/227 (11%)

Query: 78  RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT 136
            + FQ M    E ++    +G G YG V + +   +G+ VA+KK   S+ +    +    
Sbjct: 18  NLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR 73

Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           E  LL Q+RH N+V L   C  KK  +L+++++   ++   L      +     +    +
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ--KYL 130

Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVA 254
             + + + + H     +I+HRDI   NIL++      + DFG AR L +        V  
Sbjct: 131 FQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA- 186

Query: 255 GTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
            T  Y APEL      Y   +    DV++ G +  E+ MG    PGD
Sbjct: 187 -TRWYRAPELLVGDVKYGKAV----DVWAIGCLVTEMFMGEPLFPGD 228

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 88.6 bits (220), Expect = 5e-20
 Identities = 57/219 (26%), Positives = 87/219 (39%), Gaps = 30/219 (13%)

Query: 90  DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKL------HHSETELAFLESFQTEAHLLS 142
            +     +G+G +G V+ A      K+V +K +           E   L     E  +LS
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 143 QIRHRNIVKLYGFCLHKKCMFLIY-KYMRRGSLF-CILRNDDEAIRLDWTKRVNIVKSMA 200
           ++ H NI+K+     ++    L+  K+     LF  I R+     RLD      I + + 
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLV 140

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
            A+ YL    I   +HRDI   NI++       + DFG A  L       T   GT  Y 
Sbjct: 141 SAVGYLRLKDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-GTIEYC 196

Query: 261 APELAYTMVLTEK------CDVYSFGVVALEVLM-GRHP 292
           APE     VL          +++S GV  L  L+   +P
Sbjct: 197 APE-----VLMGNPYRGPELEMWSLGVT-LYTLVFEENP 229

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 88.4 bits (220), Expect = 7e-20
 Identities = 53/179 (29%), Positives = 85/179 (47%), Gaps = 24/179 (13%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESF-QT---EAHLLSQIRHRNIVK 151
           +G G + +VY+A+   + + VA+KK+          +   +T   E  LL ++ H NI+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH----ALSYLH 207
           L     HK  + L++ +M    L  I+   D ++ L      + +K+        L YLH
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLT----PSHIKAYMLMTLQGLEYLH 129

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAPEL 264
                 I+HRD+  NN+LL+      +ADFG+A+   S +   T  VV  T  Y APEL
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPEL 183

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 87.6 bits (218), Expect = 9e-20
 Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 11/179 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           E ++    IG G YG V++ +   +G+ VA+KK   SE +    +    E  +L Q++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+V L      K+ + L+++Y    ++   L      +     K  +I      A+++ H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK--SITWQTLQAVNFCH 119

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAPEL 264
                + +HRD+   NIL+       + DFG ARLL   S      V   T  Y +PEL
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWYRSPEL 173

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 50/192 (26%), Positives = 83/192 (43%), Gaps = 30/192 (15%)

Query: 93  IKYCIGTGGYGSVYRAQ---LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
               +G G YG VY+A+       K  ALK++           S   E  LL +++H N+
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIALLRELKHPNV 80

Query: 150 VKLYGFCLHK--KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN--IVKSMAH---- 201
           + L    L    + ++L++ Y     L+ I++    +       ++   +VKS+ +    
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRT-----V 252
            + YLH +    ++HRD+   NIL+  +        +AD G ARL +S           V
Sbjct: 140 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 253 VAGTHGYIAPEL 264
           V  T  Y APEL
Sbjct: 197 V--TFWYRAPEL 206

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 34/220 (15%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           EDF     +G G + +V  A+   + ++ A+K L      +   +     E  ++S++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS------MA 200
              VKLY      + ++    Y + G L   +R              +   +      + 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---------IGSFDETCTRFYTAEIV 140

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTH 257
            AL YLH      I+HRD+   NILLN  +   + DFG A++L  +S      + V GT 
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTA 196

Query: 258 GYIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
            Y++PE     +LTEK      D+++ G +  +++ G  P
Sbjct: 197 QYVSPE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           E +     +G G Y +VY+ +   +   VALK++   E E     +   E  LL  ++H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIREVSLLKDLKHA 60

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           NIV L+     +K + L+++Y+ +  L   L +    I +   K    +  +   L+Y H
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK--LFLFQLLRGLAYCH 117

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAPEL- 264
                 ++HRD+   N+L+N + E  +ADFG+AR     +      VV  T  Y  P++ 
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172

Query: 265 ----AYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                Y+  +    D++  G +  E+  GR   PG 
Sbjct: 173 LGSTDYSTQI----DMWGVGCIFYEMATGRPLFPGS 204

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 42/227 (18%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLH-HSETELAFLESF-QT---EAHLLS 142
             ++    IG G +G V++A+   +G+KVALKK+   +E E      F  T   E  +L 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-----GFPITALREIKILQ 71

Query: 143 QIRHRNIVKLYG--------FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
            ++H N+V L          +   K  ++L++ +     L  +L N      L   K   
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK--R 128

Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--- 251
           +++ + + L Y+H +    I+HRD+ + N+L+       +ADFG+AR      +++    
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 252 ---VVAGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGR 290
              VV  T  Y  PEL      Y        D++  G +  E+    
Sbjct: 186 TNRVV--TLWYRPPELLLGERDY----GPPIDLWGAGCIMAEMWTRS 226

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 85.3 bits (212), Expect = 5e-19
 Identities = 57/236 (24%), Positives = 104/236 (44%), Gaps = 50/236 (21%)

Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESF-QT---EAH 139
           + ++  F     +G G Y +VY+     +G  VALK++   ++E    E    T   E  
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSE----EGTPSTAIREIS 55

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIY--------KYMRRGSLFCILRNDDEAIRLDWTK 191
           L+ +++H NIV+LY     +  + L++        KYM   ++    R  +  +      
Sbjct: 56  LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL------ 109

Query: 192 RVNIVKSMAH----ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
               VK         L++ H +    I+HRD+   N+L+N + +  + DFG+AR      
Sbjct: 110 ----VKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162

Query: 248 SNRT--VVAGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           +  +  VV  T  Y AP++      Y+  +    D++S G +  E++ G+   PG 
Sbjct: 163 NTFSSEVV--TLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGKPLFPGT 212

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 52/233 (22%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQ-----T---EAH 139
           + +     +G G YG VY+A    + + VA+K++         LE  +     T   E  
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--------LEHEEEGVPGTAIREVS 85

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           LL +++HRNI++L     H   + LI++Y     L   +   D+   +     + ++KS 
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVS----MRVIKSF 137

Query: 200 AH----ALSYLHCDCIPSIVHRDISSNNILLNSKLEAF-----VADFGVARLLHSDSSNR 250
            +     +++ H       +HRD+   N+LL+    +      + DFG+AR         
Sbjct: 138 LYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194

Query: 251 T--VVAGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
           T  ++  T  Y  PE+      Y+  +    D++S   +  E+LM     PGD
Sbjct: 195 THEII--TLWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKTPLFPGD 241

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 52/236 (22%), Positives = 92/236 (38%), Gaps = 32/236 (13%)

Query: 78  RITFQEMIVATEDFDI--KY----CIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFL 131
           +       +  E   +   Y     I +G YG+V       G  VA+K++ ++ ++   +
Sbjct: 5   KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV 64

Query: 132 ESFQT---------EAHLLSQIRHRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCI 177
                         E  LL+   H NI+ L    +H +      ++L+ + MR   L  +
Sbjct: 65  NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQV 123

Query: 178 LRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS--IVHRDISSNNILLNSKLEAFVA 235
           + +    I     +    +  +   L  LH        +VHRD+   NILL    +  + 
Sbjct: 124 IHDQRIVISPQHIQ--YFMYHILLGLHVLH-----EAGVVHRDLHPGNILLADNNDITIC 176

Query: 236 DFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGR 290
           DF +AR   +D++    V     Y APEL       T+  D++S G V  E+   +
Sbjct: 177 DFNLAREDTADANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 47/231 (20%), Positives = 85/231 (36%), Gaps = 47/231 (20%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALK------------------------KLHHSETELAFL 131
           IG G YG V  A         A+K                                   +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 132 ESFQTEAHLLSQIRHRNIVKLYG--FCLHKKCMFLIYKYMRRGSLFCILRND----DEAI 185
           E    E  +L ++ H N+VKL       ++  ++++++ + +G +  +        D+A 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 186 RLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
                      + +   + YLH      I+HRDI  +N+L+       +ADFGV+     
Sbjct: 141 F--------YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 246 DSSNRTVVAGTHGYIAPEL---AYTMVLTEKCDVYSFGVVALEVLM-GRHP 292
             +  +   GT  ++APE       +   +  DV++ GV  L   + G+ P
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT-LYCFVFGQCP 239

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 83.0 bits (206), Expect = 2e-18
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           +G G +G V   +   +G KVA+K L+  +   L  +   + E   L   RH +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 155 FCLHKKCMFLIYKYMRRGSLFC-ILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
                   F++ +Y+  G LF  I ++     R++  +   + + +  A+ Y H      
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---M 131

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL----AYTMV 269
           +VHRD+   N+LL++ + A +ADFG++ ++      RT   G+  Y APE+     Y   
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYA-- 188

Query: 270 LTEKCDVYSFGVVALEVLM-GRHPGD 294
              + D++S GV+ L  L+ G  P D
Sbjct: 189 -GPEVDIWSCGVI-LYALLCGTLPFD 212

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 50/215 (23%), Positives = 80/215 (37%), Gaps = 36/215 (16%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLH----HSETELAFLESFQTEAHLLSQIRHR--NI 149
           +G+GG+GSVY    +     VA+K +         EL        E  LL ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 150 VKLYGFCLHKKCMFLIYKYMR-RGSLF--CILR---NDDEAIRLDWTKRVNIVKSMAHAL 203
           ++L  +        LI +       LF     R    ++ A              +  A+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--------FFWQVLEAV 162

Query: 204 SYLHCDCIPSIVHRDISSNNILLNS-KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
            + H      ++HRDI   NIL++  + E  + DFG   LL    +  T   GT  Y  P
Sbjct: 163 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPP 217

Query: 263 EL----AYTMVLTEKCDVYSFGVVALEVLM-GRHP 292
           E      Y         V+S G++ L  ++ G  P
Sbjct: 218 EWIRYHRYH---GRSAAVWSLGIL-LYDMVCGDIP 248

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 64/235 (27%), Positives = 99/235 (42%), Gaps = 59/235 (25%)

Query: 92  DIKYC----IGTGGYGSVYRAQL-PSGKKVALKK-LHHSETELAFLESFQTEAHLLSQIR 145
           ++ Y     IG G +G VY+A+L  SG+ VA+KK L     +         E  ++ ++ 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 105

Query: 146 HRNIVKLYGF------CLHKKCMFLIYKYMRRGSLFCILRNDDE----AIRLDWTKRVNI 195
           H NIV+L  F         +  + L+  Y+             E      R     +  +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVARHYSRAKQTL 153

Query: 196 ----VKS----MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSD 246
               VK     +  +L+Y+H      I HRDI   N+LL+       + DFG A+ L   
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210

Query: 247 SSNRTVVAGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGRH--PGD 294
             N + +  +  Y APEL      YT  +    DV+S G V  E+L+G+   PGD
Sbjct: 211 EPNVSYIC-SRYYRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQPIFPGD 260

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 32/212 (15%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           +G G +G V   +   +G KVA+K L+  +   L  +   + E   L   RH +I+KLY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 155 FCLHKKCMFLIYKYMRRGSLF-CILRND----DEAIRLDWTKRVNIVKSMAHALSYLHCD 209
                  +F++ +Y+  G LF  I +N      E+ RL       I+      + Y H  
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ----QIL----SGVDYCHRH 135

Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
            +   VHRD+   N+LL++ + A +ADFG++ ++      RT   G+  Y APE     V
Sbjct: 136 MV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYAAPE-----V 186

Query: 270 LTEK------CDVYSFGVVALEVLM-GRHPGD 294
           ++ +       D++S GV+ L  L+ G  P D
Sbjct: 187 ISGRLYAGPEVDIWSSGVI-LYALLCGTLPFD 217

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 48/224 (21%), Positives = 87/224 (38%), Gaps = 38/224 (16%)

Query: 90  DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLH----HSETELAFLESFQTEAHLLSQI 144
           ++ +   +G GG+G+V+    L    +VA+K +        + L+   +   E  LL ++
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 145 R----HRNIVKLYGFCLHKKCMFLIYKYMRRGS-LF--CILR---NDDEAIRLDWTKRVN 194
                H  +++L  +   ++   L+ +       LF     +    +  +          
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC-------- 143

Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRTVV 253
               +  A+ + H      +VHRDI   NIL++ +   A + DFG   LLH      T  
Sbjct: 144 FFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDF 198

Query: 254 AGTHGYIAPEL----AYTMVLTEKCDVYSFGVVALEVLM-GRHP 292
            GT  Y  PE      Y         V+S G++ L  ++ G  P
Sbjct: 199 DGTRVYSPPEWISRHQYH---ALPATVWSLGIL-LYDMVCGDIP 238

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 19/215 (8%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKL------HHSETELAFLESFQTEA 138
           V    F     +G GG+G V   Q+  +GK  A KKL            +A       E 
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-----LNEK 235

Query: 139 HLLSQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
            +L ++  R +V L  +    K  + L+   M  G L   + +  +A   +        +
Sbjct: 236 QILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +   L  LH +    IV+RD+   NILL+      ++D G+A  +    + +  V GT 
Sbjct: 295 -ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTV 349

Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           GY+APE+      T   D ++ G +  E++ G+ P
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 35/214 (16%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G YG V  A    + + VA+K +   +  +   E+ + E  +   + H N+VK YG 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRND-----DEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
                  +L  +Y   G LF  +  D      +A R            +   + YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHGI- 124

Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAYT 267
              I HRDI   N+LL+ +    ++DFG+A +   ++  R    +  GT  Y+APE    
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE---- 177

Query: 268 MVLTEK------CDVYSFGVVALEVLM-GRHPGD 294
            +L  +       DV+S G+V L  ++ G  P D
Sbjct: 178 -LLKRREFHAEPVDVWSCGIV-LTAMLAGELPWD 209

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 57/250 (22%), Positives = 102/250 (40%), Gaps = 51/250 (20%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKK-LHHSET---ELAFLESFQTEAHLLS 142
            + F ++   G G +G+V   +   +G  VA+KK +        EL  ++        L+
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ-------DLA 74

Query: 143 QIRHRNIVKLYGFCLHKK-------CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI 195
            + H NIV+L  +             + ++ +Y+   +L    RN     R        +
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRN---YYRRQVAPPPIL 130

Query: 196 VKS----MAHALSYLHCDCIPSIVHRDISSNNILLNS-----KLEAFVADFGVARLLHSD 246
           +K     +  ++  LH   + ++ HRDI  +N+L+N      KL     DFG A+ L   
Sbjct: 131 IKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKL----CDFGSAKKLSPS 185

Query: 247 SSNRTVVAGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGRH--PGDLLSSV 299
             N   +  +  Y APEL      Y    T   D++S G +  E+++G     GD  +S 
Sbjct: 186 EPNVAYIC-SRYYRAPELIFGNQHY----TTAVDIWSVGCIFAEMMLGEPIFRGD--NSA 238

Query: 300 NPKIMLIDLL 309
                ++ +L
Sbjct: 239 GQLHEIVRVL 248

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 28/221 (12%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKL------HHSETELAFLESFQTEA 138
           +  + F     +G GG+G V+  Q+  +GK  A KKL           + A       E 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-----MVEK 236

Query: 139 HLLSQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
            +L+++  R IV L  +    K  + L+   M  G +   + N DE        R     
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 198 S-MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +   L +LH     +I++RD+   N+LL+      ++D G+A  L +  +     AGT
Sbjct: 296 AQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT 352

Query: 257 HGYIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
            G++APE     +L  +      D ++ GV   E++  R P
Sbjct: 353 PGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 54/190 (28%), Positives = 81/190 (42%), Gaps = 38/190 (20%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLH-HSETELAFLESFQT--EAHLL---SQIRHRNI 149
           IG G YG+VY+A+   SG  VALK +   +           T  E  LL       H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 150 VKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI----VKSMA 200
           V+L   C   +      + L+++++          + D    LD      +    +K + 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHV----------DQDLRTYLDKAPPPGLPAETIKDLM 126

Query: 201 H----ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVA 254
                 L +LH +CI   VHRD+   NIL+ S     +ADFG+AR+       +   VV 
Sbjct: 127 RQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV-VV- 181

Query: 255 GTHGYIAPEL 264
            T  Y APE+
Sbjct: 182 -TLWYRAPEV 190

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 57/236 (24%), Positives = 95/236 (40%), Gaps = 62/236 (26%)

Query: 92  DIKYC----IGTGGYGSVYRAQLPSGKKVALKK-LHHSETELAFLESFQTEAHLLSQIRH 146
           +I Y     IG G +G V++A+L    +VA+KK L     +         E  ++  ++H
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-------RELQIMRIVKH 91

Query: 147 RNIVKLYGF------CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMA 200
            N+V L  F         +  + L+ +Y+           +          ++     M 
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYV----------PETVYRASRHYAKLKQTMPML 141

Query: 201 H----------ALSYLHCDCIPSIVHRDISSNNILLNS-----KLEAFVADFGVARLLHS 245
                      +L+Y+H      I HRDI   N+LL+      KL     DFG A++L +
Sbjct: 142 LIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKL----IDFGSAKILIA 194

Query: 246 DSSNRTVVAGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
              N + +  +  Y APEL      YT       D++S G V  E++ G+   PG+
Sbjct: 195 GEPNVSYIC-SRYYRAPELIFGATNYTT----NIDIWSTGCVMAELMQGQPLFPGE 245

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 77.4 bits (191), Expect = 3e-16
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 35/214 (16%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           +G G YG V  A    + + VA+K +   +  +   E+ + E  +   + H N+VK YG 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRND-----DEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
                  +L  +Y   G LF  +  D      +A R        ++      + YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH----QLM----AGVVYLHGI- 124

Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPELAYT 267
              I HRDI   N+LL+ +    ++DFG+A +   ++  R    +  GT  Y+APE    
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE---- 177

Query: 268 MVLTEK------CDVYSFGVVALEVLM-GRHPGD 294
            +L  +       DV+S G+V L  ++ G  P D
Sbjct: 178 -LLKRREFHAEPVDVWSCGIV-LTAMLAGELPWD 209

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 60/308 (19%), Positives = 120/308 (38%), Gaps = 53/308 (17%)

Query: 56  AKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGK 114
           AK     K++  ++F               V  + +     IG+G  G V  A      +
Sbjct: 34  AKHYNMSKSKVDNQFYSVEVGD----STFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDR 88

Query: 115 KVALKKLHHSETELAFLESFQTEAH---------LLSQIRHRNIVKLY------GFCLHK 159
            VA+KKL            FQ + H         L+  + H+NI+ L             
Sbjct: 89  NVAIKKLS---------RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139

Query: 160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDI 219
           + ++L+ + M   +L  +++ + +  R+ +     ++  M   + +LH      I+HRD+
Sbjct: 140 QDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS---AGIIHRDL 190

Query: 220 SSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSF 279
             +NI++ S     + DFG+AR   +       V  T  Y APE+   M   E  D++S 
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 249

Query: 280 GVVALEVLMGRH--PGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACL 337
           G +  E++  +   PG     ++      + + +++ +P  +      +  +   V   +
Sbjct: 250 GCIMGEMVRHKILFPGR--DYID----QWNKVIEQLGTPCPE-----FMKKLQPTVRNYV 298

Query: 338 RSKPTSRP 345
            ++P    
Sbjct: 299 ENRPKYAG 306

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 35/213 (16%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYG 154
           +G G +G V  A    + +KVALK +      +       + E   L  +RH +I+KLY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 155 FCLHKKCMFLIYKY---------MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
                  + ++ +Y         + +  +      +DE  R            +  A+ Y
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRM-----TEDEGRRFFQ--------QIICAIEY 123

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL- 264
            H      IVHRD+   N+LL+  L   +ADFG++ ++   +  +T   G+  Y APE+ 
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVI 179

Query: 265 ---AYTMVLTEKCDVYSFGVVALEVLMGRHPGD 294
               Y      + DV+S G+V   +L+GR P D
Sbjct: 180 NGKLYA---GPEVDVWSCGIVLYVMLVGRLPFD 209

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 34/215 (15%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALK-----KLHHSETELAFLESFQTEAHLLSQIRHRNIV 150
           +G G YG V       +  + A+K     KL           + + E  LL ++RH+N++
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPN---GEANVKKEIQLLRRLRHKNVI 69

Query: 151 KLYGFCLH--KKCMFLIYKYMRRGS--LFCILRN----DDEAIRLDWTKRVNIVKSMAHA 202
           +L     +  K+ M+++ +Y   G   +   +        +A              +   
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY--------FCQLIDG 121

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGTHGYI 260
           L YLH      IVH+DI   N+LL +     ++  GVA  LH  +++ T     G+  + 
Sbjct: 122 LEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 261 APELAYTMVLTE--KCDVYSFGVVALEVLM-GRHP 292
            PE+A  +      K D++S GV  L  +  G +P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVT-LYNITTGLYP 212

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 36/211 (17%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF 155
           IG+G +G     +   + + VA+K +   E   A  E+ Q E      +RH NIV+    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI---ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 156 CLHKKCMFLIYKYMRRGSLFCILRN-----DDEAIRLDWTKRVNIVKSMAHALSYLHCDC 210
            L    + +I +Y   G L+  + N     +DEA          ++      +SY H   
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ----QLL----SGVSYCHSM- 135

Query: 211 IPSIVHRDISSNNILLNSKLEAF--VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
              I HRD+   N LL+        + DFG ++     S  ++ V GT  YIAPE     
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE----- 187

Query: 269 VLTEK------CDVYSFGVVALEVLM-GRHP 292
           VL  +       DV+S GV  L V++ G +P
Sbjct: 188 VLLRQEYDGKIADVWSCGVT-LYVMLVGAYP 217

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 77.2 bits (191), Expect = 4e-16
 Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 60/239 (25%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ--LPSGKKVALKKLH-HSET---------ELAFLESFQT 136
           + ++    IG G YG V++A+     G+ VALK++   +           E+A L     
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--- 67

Query: 137 EAHLLSQIRHRNIVKLY-----GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
               L    H N+V+L+          +  + L+++++ +          D    LD   
Sbjct: 68  ----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----------DLTTYLDKVP 113

Query: 192 RVNI----VKSMAH----ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243
              +    +K M       L +LH   +   VHRD+   NIL+ S  +  +ADFG+AR+ 
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIY 170

Query: 244 HSDS--SNRTVVAGTHGYIAPEL----AYTMVLTEKCDVYSFGVVALEVLMGR--HPGD 294
                 ++  VV  T  Y APE+    +Y   +    D++S G +  E+   +    G 
Sbjct: 171 SFQMALTSV-VV--TLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRKPLFRGS 222

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 31/216 (14%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHA 202
             +VKL         ++++ +Y+  G +F  LR      +   R            +   
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIA 261
             YLH      +++RD+   N+L++ +    V DFG A+ +      RT  + GT   +A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEALA 206

Query: 262 PELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
           PE     ++  K      D ++ GV+  E+  G  P
Sbjct: 207 PE-----IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 50/217 (23%), Positives = 84/217 (38%), Gaps = 29/217 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV----ALKK---LHHSETELAFLESFQTEAHLL 141
            +F+    +G G +G V   +  +  +      LKK   +   E          TE  +L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA-----HTLTENRVL 202

Query: 142 SQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMA 200
              RH  +  L  +       +  + +Y   G LF  L  +         +       + 
Sbjct: 203 QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIV 258

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
            AL YLH +   ++V+RD+   N++L+      + DFG+ +    D +      GT  Y+
Sbjct: 259 SALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316

Query: 261 APELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
           APE     VL +       D +  GVV  E++ GR P
Sbjct: 317 APE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 56/276 (20%), Positives = 112/276 (40%), Gaps = 48/276 (17%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAH------- 139
            + +     IG+G  G V  A      + VA+KKL            FQ + H       
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS---------RPFQNQTHAKRAYRE 74

Query: 140 --LLSQIRHRNIVKLYGFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTK 191
             L+  + H+NI+ L      +K +      +++ + M   +L  +++ + +  R+ +  
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-- 131

Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
              ++  M   + +LH      I+HRD+  +NI++ S     + DFG+AR   +      
Sbjct: 132 ---LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185

Query: 252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRH--PGDLLSSVNPKIMLIDLL 309
            V  T  Y APE+   M   E  D++S G +  E++ G    PG     ++      + +
Sbjct: 186 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT--DHID----QWNKV 238

Query: 310 DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            +++ +P  +      +  +   V   + ++P    
Sbjct: 239 IEQLGTPCPE-----FMKKLQPTVRTYVENRPKYAG 269

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 55/216 (25%), Positives = 83/216 (38%), Gaps = 26/216 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLH------HSETELAFLESFQTEAHLL 141
            DF +   IG GG+G VY  +   +GK  A+K L            LA       E  +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-----LNERIML 243

Query: 142 SQI---RHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
           S +       IV +  +  H    +  I   M  G L   L                   
Sbjct: 244 SLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAA 299

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
            +   L ++H      +V+RD+   NILL+      ++D G+A        + +V  GTH
Sbjct: 300 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTH 354

Query: 258 GYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           GY+APE L   +      D +S G +  ++L G  P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 54/272 (19%), Positives = 101/272 (37%), Gaps = 65/272 (23%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKK-LHHSETELAFLESFQTEAHLLSQ 143
            +++ + +   +GTG +G V     + SGK+ ALKK L     +         E  ++  
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-------RELDIMKV 56

Query: 144 IRHRNIVKLYGF---CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR----VNIV 196
           + H NI+KL  +      ++                    ++    +         +N++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 197 K---------------------SMAH----------ALSYLHCDCIPSIVHRDISSNNIL 225
                                  M            A+ ++H      I HRDI   N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLL 173

Query: 226 LNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPEL-----AYTMVLTEKCDVYSF 279
           +NSK     + DFG A+ L     +   +  +  Y APEL      Y    T   D++S 
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEY----TPSIDLWSI 228

Query: 280 GVVALEVLMGRH--PGDLLSSVNPKIMLIDLL 309
           G V  E+++G+    G+  +S++  + +I ++
Sbjct: 229 GCVFGELILGKPLFSGE--TSIDQLVRIIQIM 258

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 46/237 (19%), Positives = 95/237 (40%), Gaps = 46/237 (19%)

Query: 73  WNYD-GRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLH---HSET- 126
           W+Y+   + +       +D+ +   +G G Y  V+ A  + + +KV +K L      +  
Sbjct: 23  WDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK 78

Query: 127 -ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH---KKCMFLIYKYMRRGSLFCILRN-D 181
            E+  LE+ +            NI+ L    +     +   L+++++       + +   
Sbjct: 79  REIKILENLR---------GGPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLT 128

Query: 182 DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-EAFVADFGVA 240
           D  IR         +  +  AL Y H      I+HRD+  +N++++ +  +  + D+G+A
Sbjct: 129 DYDIRF-------YMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

Query: 241 RLLHSDSSNRTVVAGTHGYIAPEL-----AYTMVLTEKCDVYSFGVVALEVLMGRHP 292
              H        VA +  +  PEL      Y   L    D++S G +   ++  + P
Sbjct: 179 EFYHPGQEYNVRVA-SRYFKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 50/202 (24%), Positives = 79/202 (39%), Gaps = 56/202 (27%)

Query: 97  IGTGGYGSVYRA-QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYG 154
           +G G  G V +     + +K ALK L             + E  L  +  +  +IV++  
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIVD 78

Query: 155 FC----LHKKCMFLIYKYMRRGSLF-CILRNDDEAIRLDWTKR--VNIVKSMAHALSYLH 207
                   +KC+ ++ + +  G LF  I    D+A    +T+R    I+KS+  A+ YLH
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH 134

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
                +I HRD+   N+L  SK       + DFG                      A E 
Sbjct: 135 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------FAKE- 169

Query: 265 AYTMVLTEK----CDVYSFGVV 282
                  EK    CD++S GV+
Sbjct: 170 ----TTGEKYDKSCDMWSLGVI 187

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 34/218 (15%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT-----EAHLL 141
            + +     +G+G YGSV  A    SG+KVA+KKL        F           E  LL
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-----PFQSEIFAKRAYRELLLL 77

Query: 142 SQIRHRNIVKLYGFCLHKKCM------FLIYKYMRRGSLFCILRND--DEAIRLDWTKRV 193
             ++H N++ L         +      +L+  +M+   L  I+     +E I+       
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY------ 130

Query: 194 NIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
            +V  M   L Y+H      +VHRD+   N+ +N   E  + DFG+AR      +  T  
Sbjct: 131 -LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGY 183

Query: 254 AGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGR 290
             T  Y APE+  + M   +  D++S G +  E+L G+
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 29/216 (13%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT-----EAHLL 141
              +     +G+G YG+V  A    +G KVA+KKL+       F           E  LL
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-----PFQSELFAKRAYRELRLL 78

Query: 142 SQIRHRNIVKLYGFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI 195
             +RH N++ L       + +      +L+  +M    L  +++++     L   +   +
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK----LGEDRIQFL 133

Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
           V  M   L Y+H      I+HRD+   N+ +N   E  + DFG+AR      S  T    
Sbjct: 134 VYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVV 187

Query: 256 THGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGR 290
           T  Y APE+    M  T+  D++S G +  E++ G+
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 50/227 (22%), Positives = 101/227 (44%), Gaps = 38/227 (16%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
              +     +G GG G V+ A      K+VA+KK+  ++ +     + + E  ++ ++ H
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV-KHALR-EIKIIRRLDH 67

Query: 147 RNIVKLY--------------GFCLHKKCMFLIYKYMRRGSLFCILRN---DDEAIRLDW 189
            NIVK++              G       ++++ +YM    L  +L      +E  RL  
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARL-- 124

Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDSS 248
                 +  +   L Y+H     +++HRD+   N+ +N++ L   + DFG+AR++    S
Sbjct: 125 -----FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 249 NRTV----VAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGR 290
           ++      +  T  Y +P L  +    T+  D+++ G +  E+L G+
Sbjct: 177 HKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.1 bits (175), Expect = 6e-14
 Identities = 62/287 (21%), Positives = 118/287 (41%), Gaps = 57/287 (19%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT-----EAHLL 141
           + DF +K  +G G YG V  A   P+G+ VA+KK+        F +         E  +L
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE------PFDKPLFALRTLREIKIL 63

Query: 142 SQIRHRNIVKLY-----GFCLHKKCMFLIYKYMRRGSLFCILRN---DDEAIRLDWTKRV 193
              +H NI+ ++         +   +++I + M+   L  ++      D+ I+       
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY------ 116

Query: 194 NIVKSMAHALSYLHCDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
             +     A+  LH        ++HRD+  +N+L+NS  +  V DFG+AR++   +++ +
Sbjct: 117 -FIYQTLRAVKVLH-----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

Query: 252 VVAGTHG----------YIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRH--PGDLLSS 298
              G             Y APE+  T    +   DV+S G +  E+ + R   PG     
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR--DY 228

Query: 299 VNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            +  +++  ++     +P  D   ++ I   S      ++S P    
Sbjct: 229 RHQLLLIFGII----GTPHSDN-DLRCIE--SPRAREYIKSLPMYPA 268

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 37/222 (16%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT-----EAHLL 141
              +     IG G YG V  A    +  +VA+KK+        F           E  +L
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQRTLREIKIL 79

Query: 142 SQIRHRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRN---DDEAIRLDWTKRV 193
            + RH NI+ +              ++++   M    L+ +L+     ++ I        
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICY------ 132

Query: 194 NIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV- 252
             +  +   L Y+H     +++HRD+  +N+LLN+  +  + DFG+AR+   D  +    
Sbjct: 133 -FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188

Query: 253 ---VAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGR 290
              VA T  Y APE+       T+  D++S G +  E+L  R
Sbjct: 189 TEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 45/223 (20%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           +DF I   +GTG +G V+  +   +G+  A+K L       L  +E    E  +LS + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-----DDEA------IRLDWTKRVNI 195
             I++++G     + +F+I  Y+  G LF +LR      +  A      + L        
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------- 117

Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVA 254
                 AL YLH      I++RD+   NILL+      + DFG A+ +     + T  + 
Sbjct: 118 ------ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLC 164

Query: 255 GTHGYIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
           GT  YIAPE     V++ K      D +SFG++  E+L G  P
Sbjct: 165 GTPDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 69.1 bits (170), Expect = 2e-13
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 54/230 (23%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGK--------KVALKK---LHHSETELAFLESFQTE 137
             F++   +G G +G V+  +  SG         KV LKK                 + E
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV-LKKATLKVRDRVRT------KME 76

Query: 138 AHLLSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRV 193
             +L ++ H  IVKL Y F    K ++LI  ++R G LF  L  +    E       + V
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE-------EDV 128

Query: 194 NI-VKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARL-LHSDS 247
              +  +A AL +LH      I++RD+   NILL+     KL     DFG+++  +  + 
Sbjct: 129 KFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKL----TDFGLSKESIDHEK 181

Query: 248 SNRTVVAGTHGYIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
              +   GT  Y+APE     V+  +      D +SFGV+  E+L G  P
Sbjct: 182 KAYSFC-GTVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 49/237 (20%)

Query: 80  TFQEMIVATEDFDI--KY----CIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLE 132
           TF    +    +++  +Y     +G+G YGSV  A    +G +VA+KKL           
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---------R 64

Query: 133 SFQTEAH---------LLSQIRHRNIVKLYGFCLHKKCM------FLIYKYMRRGSLFCI 177
            FQ+  H         LL  ++H N++ L       + +      +L+   M    L  I
Sbjct: 65  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNI 123

Query: 178 LRN---DDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFV 234
           ++     D+ ++        ++  +   L Y+H      I+HRD+  +N+ +N   E  +
Sbjct: 124 VKCQKLTDDHVQF-------LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI 173

Query: 235 ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGR 290
            DFG+AR     +   T    T  Y APE+    M   +  D++S G +  E+L GR
Sbjct: 174 LDFGLAR---HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 69/233 (29%), Positives = 100/233 (42%), Gaps = 54/233 (23%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGK--------KVALKK---LHHSETELAFLESFQTE 137
           E+F++   +GTG YG V+  +  SG         KV LKK   +  ++T     E  +TE
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV-LKKATIVQKAKT----TEHTRTE 108

Query: 138 AHLLSQIRHRN-IVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKR 192
             +L  IR    +V L Y F    K + LI  Y+  G LF  L       E         
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTE-------HE 160

Query: 193 VNIVKS-MAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDS 247
           V I    +  AL +LH      I++RDI   NILL+S     L     DFG+++   +D 
Sbjct: 161 VQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL----TDFGLSKEFVADE 213

Query: 248 SNRTV-VAGTHGYIAPELAYTMVLTEK-------CDVYSFGVVALEVLMGRHP 292
           + R     GT  Y+AP+     ++           D +S GV+  E+L G  P
Sbjct: 214 TERAYDFCGTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 50/229 (21%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGK--------KVALKK---LHHSETELAFLESFQTE 137
           E F++   +G GGYG V++ +  +G         KV LKK   + +++         + E
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKV-LKKAMIVRNAKD----TAHTKAE 71

Query: 138 AHLLSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRV 193
            ++L +++H  IV L Y F    K ++LI +Y+  G LF  L  +    E          
Sbjct: 72  RNILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME-------DTA 123

Query: 194 NI-VKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDSS 248
              +  ++ AL +LH      I++RD+   NI+LN     KL     DFG+ +    D +
Sbjct: 124 CFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKL----TDFGLCKESIHDGT 176

Query: 249 NRTVVAGTHGYIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
                 GT  Y+APE     +L         D +S G +  ++L G  P
Sbjct: 177 VTHTFCGTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 38/221 (17%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV----ALKK---LHHSETELAFLESFQTEAHLL 141
            DFD    +G G +G V   +  +  +      L+K   +   E          TE+ +L
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA-----HTVTESRVL 59

Query: 142 SQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIVK 197
              RH  +  L  +       +  + +Y   G LF  L  +    E       +R     
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE-------ERARFYG 111

Query: 198 S-MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
           + +  AL YLH      +V+RDI   N++L+      + DFG+ +   SD +      GT
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 168

Query: 257 HGYIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
             Y+APE     VL +       D +  GVV  E++ GR P
Sbjct: 169 PEYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 41/222 (18%), Positives = 84/222 (37%), Gaps = 36/222 (16%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT-----EAHLL 141
            + ++I++ IGTG YG V  A      + VA+KK+        F +         E  +L
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-----RVFEDLIDCKRILREIAIL 106

Query: 142 SQIRHRNIVKLY-----GFCLHKKCMFLIYKYMRRGSLFCILRND----DEAIRLDWTKR 192
           +++ H ++VK+              ++++ +         + R      +  I+      
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT----- 160

Query: 193 VNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
             ++ ++   + Y+H      I+HRD+   N L+N      V DFG+AR +    +  + 
Sbjct: 161 --LLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 253 VAGTHGYIAPELAYTMVLTEKCDVYSFGVV-----ALEVLMG 289
           +  +       L             +  VV     A E+++ 
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL 257

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 44/204 (21%), Positives = 83/204 (40%), Gaps = 37/204 (18%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQT-----EAHLL 141
            +++ IK+ IG G YG VY A    + K VA+KK++       F +         E  +L
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-----MFEDLIDCKRILREITIL 79

Query: 142 SQIRHRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCILRND----DEAIRLDWTKR 192
           ++++   I++LY   +         ++++ +      L  + +      +E I+      
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT----- 133

Query: 193 VNIVKSMAHALSYLHCDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250
             I+ ++    +++H        I+HRD+   N LLN      V DFG+AR ++S+    
Sbjct: 134 --ILYNLLLGENFIH-----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186

Query: 251 TV--VAGTHGYIAPELAYTMVLTE 272
            V  +                LT 
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTS 210

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 45/222 (20%), Positives = 89/222 (40%), Gaps = 42/222 (18%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR---------- 145
           +G G + +V+ A+ + +   VA+K +   +    + E+ + E  LL ++           
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 146 -HRNIVKLYGFCLHKKC----MFLIYKYMRRGSLFCIL-RNDDEAIRLDWTKRVNIVKSM 199
              +I+KL     HK      + ++++ +   +L  ++ + +   I L + K+  I K +
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQ--ISKQL 140

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF------VADFGVARLLHSDSSNRTVV 253
              L Y+H  C   I+H DI   N+L+             +AD G A       +N    
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN---S 195

Query: 254 AGTHGYIAPE----LAYTMVLTEKCDVYSFGVVALEVLMGRH 291
             T  Y +PE      +        D++S   +  E++ G  
Sbjct: 196 IQTREYRSPEVLLGAPWGC----GADIWSTACLIFELITGDF 233

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 39/212 (18%)

Query: 77  GRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQ 135
           GR+           +++   +G G YG V+++    +G+ VA+KK+       AF  S  
Sbjct: 1   GRVDRH----VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-----AFQNSTD 51

Query: 136 T-----EAHLLSQIR-HRNIVKLYGFCL--HKKCMFLIYKYMRRGS-LFCILRN---DDE 183
                 E  +L+++  H NIV L       + + ++L++ YM   + L  ++R    +  
Sbjct: 52  AQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPV 109

Query: 184 AIRLDWTKRVNIVKSMAHALSYLHCDCIPS--IVHRDISSNNILLNSKLEAFVADFGVAR 241
             +        +V  +   + YLH     S  ++HRD+  +NILLN++    VADFG++R
Sbjct: 110 HKQY-------VVYQLIKVIKYLH-----SGGLLHRDMKPSNILLNAECHVKVADFGLSR 157

Query: 242 LLHSDSSNRTVVAGTHGYIAPELAYTM-VLTE 272
              +       +  +             +LT+
Sbjct: 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTD 189

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 61.8 bits (149), Expect = 7e-11
 Identities = 33/256 (12%), Positives = 71/256 (27%), Gaps = 56/256 (21%)

Query: 79  ITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEA 138
           + F    + TE       IG G +G V++        VA+K +     +L      +T  
Sbjct: 11  VPFSH-CLPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 139 HLLSQI---------------RHRNIVKLYGFCLHK----KCMFLIYKYMRR-------- 171
            +L +I               R    + L      +      +   + +           
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 172 ------GSLFCILRNDD--------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHR 217
                   LF +L  +                    +I+  +  +L+           HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHR 186

Query: 218 DISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM--VLTEKCD 275
           D+   N+LL       +             + ++    + G     + YT+  +  +   
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTL---------NGKSSTIPSCGLQVSIIDYTLSRLERDGIV 237

Query: 276 VYSFGVVALEVLMGRH 291
           V+    +  ++  G  
Sbjct: 238 VFCDVSMDEDLFTGDG 253

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 27/216 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV----ALKK---LHHSETELAFLESFQTEAHLL 141
           EDF +   +G G +G V+ A+     +     ALKK   L   +      E    E  +L
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV-----ECTMVEKRVL 71

Query: 142 SQ-IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           S    H  +  +   F   +  +F + +Y+  G L   +++     + D ++       +
Sbjct: 72  SLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEI 127

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARL-LHSDSSNRTVVAGT 256
              L +LH      IV+RD+  +NILL+   +  +  ADFG+ +  +  D+   T   GT
Sbjct: 128 ILGLQFLHSK---GIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNTFC-GT 181

Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             YIAPE+          D +SFGV+  E+L+G+ P
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 45/210 (21%), Positives = 86/210 (40%), Gaps = 22/210 (10%)

Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-- 147
           +++   IG G +G V +A      + VALK + + +    F      E  +L  +R +  
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDK 155

Query: 148 ----NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-NDDEAIRLDWTKRVNIVKSMAHA 202
               N++ +      +  + + ++ +   +L+ +++ N  +   L   ++     S+   
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK--FAHSILQC 212

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF--VADFGVARLLHSDSSNRTVVAGTHGYI 260
           L  LH      I+H D+   NILL  +  +   V DFG +   H      T +     Y 
Sbjct: 213 LDALH-KN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TYIQSRF-YR 266

Query: 261 APELAYTMVLTEKCDVYSFGVVALEVLMGR 290
           APE+          D++S G +  E+L G 
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 47/226 (20%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV----ALKK---LHHSETELAFLESFQTEAHLL 141
            DF     IG G +G V  A+  + +       L+K   L   E +        +E ++L
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEK-----HIMSERNVL 92

Query: 142 SQ-IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNI- 195
            + ++H  +V L + F    K ++ +  Y+  G LF  L+ +    E        R    
Sbjct: 93  LKNVKHPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLE-------PRARFY 144

Query: 196 VKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDSSNRT 251
              +A AL YLH     +IV+RD+   NILL+S     L     DFG+ +     +S  +
Sbjct: 145 AAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVL----TDFGLCKENIEHNSTTS 197

Query: 252 VVAGTHGYIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
              GT  Y+APE     VL ++      D +  G V  E+L G  P
Sbjct: 198 TFCGTPEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 56/259 (21%), Positives = 104/259 (40%), Gaps = 32/259 (12%)

Query: 48  LRRPKVRKAKPTETKKTRCGDEFSVWNYDG--RITFQEMIVATEDFDIKYCIGTGGYGSV 105
           L    +     +  KK R        + +    +   E     + ++I   IG G +G V
Sbjct: 13  LGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKW--MDRYEIDSLIGKGSFGQV 70

Query: 106 YRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR------NIVKLYGFCLH 158
            +A      + VA+K + + +   AFL   Q E  LL  +          IV L    + 
Sbjct: 71  VKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127

Query: 159 KKCMFLIYKYMRRGSLFCILR-NDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHR 217
           +  + L+++ +   +L+ +LR  +   + L+ T++    + M  AL +L    + SI+H 
Sbjct: 128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK--FAQQMCTALLFLATPEL-SIIHC 183

Query: 218 DISSNNILL--NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE----LAYTMVLT 271
           D+   NILL    +    + DFG +  L         +     Y +PE    + Y +   
Sbjct: 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQSRF-YRSPEVLLGMPYDL--- 237

Query: 272 EKCDVYSFGVVALEVLMGR 290
              D++S G + +E+  G 
Sbjct: 238 -AIDMWSLGCILVEMHTGE 255

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 58.4 bits (142), Expect = 8e-10
 Identities = 60/262 (22%), Positives = 109/262 (41%), Gaps = 48/262 (18%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV----ALKK---LHHSETELAFLESFQTEAHLL 141
           +DFD+   IG G Y  V   +L    ++     +KK       + +       QTE H+ 
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID-----WVQTEKHVF 63

Query: 142 SQI-RHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNI-VKS 198
            Q   H  +V L+  C   +  +F + +Y+  G L   ++      +L   +        
Sbjct: 64  EQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLP-EEHARFYSAE 118

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL-LHSDSSNRTVVAGTH 257
           ++ AL+YLH      I++RD+  +N+LL+S+    + D+G+ +  L    +  T   GT 
Sbjct: 119 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTP 174

Query: 258 GYIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR 312
            YIAPE     +L  +      D ++ GV+  E++ GR P              D++   
Sbjct: 175 NYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP-------------FDIVGSS 216

Query: 313 VPSPIDDQTVIQDIILVSKIVF 334
                + +  +  +IL  +I  
Sbjct: 217 DNPDQNTEDYLFQVILEKQIRI 238

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 48/216 (22%), Positives = 92/216 (42%), Gaps = 27/216 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV----ALKKLH-HSETELAFLESFQTEAHLLSQ 143
            DF+    +G G +G V  ++     ++     LKK     + ++   E    E  +L+ 
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV---ECTMVEKRVLAL 397

Query: 144 I-RHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
             +   + +L+  C      ++ + +Y+  G L   ++      R      V     +A 
Sbjct: 398 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAI 453

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
            L +L       I++RD+  +N++L+S+    +ADFG+ +    D        GT  YIA
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 510

Query: 262 PELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
           PE     ++  +      D ++FGV+  E+L G+ P
Sbjct: 511 PE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 57/277 (20%), Positives = 98/277 (35%), Gaps = 86/277 (31%)

Query: 89  EDFDIKYCI----GTGGYGSVYRAQ-LPSGKKVALK--KLHHSETELAFLESFQTEAHLL 141
           + F+ +Y +    G G + +V+ +  +   K VA+K  K     TE A       E  LL
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-----LDEIRLL 87

Query: 142 SQIR--------HRNIVKLYG-FCL------HKKCMFLIYKYMRRGSLFCILRNDDEAIR 186
             +R           +V+L   F +      H  CM  +++ +    L  I++++ + + 
Sbjct: 88  KSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI-CM--VFEVLGHHLLKWIIKSNYQGLP 144

Query: 187 LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN------------------- 227
           L   K+  I++ +   L YLH  C   I+H DI   NILL+                   
Sbjct: 145 LPCVKK--IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 228 ------------------------------SKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
                                          KL+  +AD G A  +H      T    T 
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTR 257

Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGD 294
            Y + E+          D++S   +A E+  G +  +
Sbjct: 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 33/219 (15%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV----ALKK---LHHSETELAFLESFQTEAHLL 141
           ++F+    +G G +G V  A++     +     LKK   L   + E        TE  +L
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVE-----CTMTEKRIL 77

Query: 142 SQI-RHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           S    H  + +L   F    + +F + +++  G L   ++      R D  +       +
Sbjct: 78  SLARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEI 133

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL-LHSDSSNRTVVAGTHG 258
             AL +LH      I++RD+  +N+LL+ +    +ADFG+ +  + +  +  T   GT  
Sbjct: 134 ISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPD 189

Query: 259 YIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
           YIAPE     +L E       D ++ GV+  E+L G  P
Sbjct: 190 YIAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 60/265 (22%), Positives = 109/265 (41%), Gaps = 54/265 (20%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV----ALKK---LHHSETELAFLESFQTEAHLL 141
           +DFD+   IG G Y  V   +L    ++     +KK       + +       QTE H+ 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID-----WVQTEKHVF 106

Query: 142 SQI-RHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIV 196
            Q   H  +V L+  C   +  +F + +Y+  G L   ++      E       +     
Sbjct: 107 EQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-------EHARFY 158

Query: 197 KS-MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL-LHSDSSNRTVVA 254
            + ++ AL+YLH      I++RD+  +N+LL+S+    + D+G+ +  L    +  T   
Sbjct: 159 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC- 214

Query: 255 GTHGYIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL 309
           GT  YIAPE     +L  +      D ++ GV+  E++ GR P              D++
Sbjct: 215 GTPNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP-------------FDIV 256

Query: 310 DQRVPSPIDDQTVIQDIILVSKIVF 334
                   + +  +  +IL  +I  
Sbjct: 257 GSSDNPDQNTEDYLFQVILEKQIRI 281

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 55.7 bits (135), Expect = 7e-09
 Identities = 49/223 (21%), Positives = 94/223 (42%), Gaps = 41/223 (18%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKV----ALKK---LHHSETELAFLESFQTEAHLL 141
            DF+    +G G +G V  ++     ++     LKK   +   + E         E  +L
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE-----CTMVEKRVL 74

Query: 142 SQI-RHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +   +   + +L   F    + ++ + +Y+  G L   ++      R      V     +
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEI 130

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARL-LHSDSSNRTVVA 254
           A  L +L       I++RD+  +N++L+S    K+    ADFG+ +  +    + +T   
Sbjct: 131 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI----ADFGMCKENIWDGVTTKTFC- 182

Query: 255 GTHGYIAPELAYTMVLTEK-----CDVYSFGVVALEVLMGRHP 292
           GT  YIAPE     ++  +      D ++FGV+  E+L G+ P
Sbjct: 183 GTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 43/179 (24%), Positives = 68/179 (37%), Gaps = 53/179 (29%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALK-----KLHHSE-----TELAFLESFQTEAHLLSQIRH 146
           IG GG+G +Y A + S + V        K+  S+     TEL F +       +   IR 
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 147 RN-----IVKLYGFCLHKKCMFLIYKYM-----------------RRGSLFCILRNDDEA 184
           R      + K +G  LH K     Y++M                 +R S   +L+     
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ----- 156

Query: 185 IRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE--AFVADFGVAR 241
                     +   +   L Y+H       VH DI ++N+LLN K     ++ D+G+A 
Sbjct: 157 ----------LSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 34/176 (19%), Positives = 65/176 (36%), Gaps = 40/176 (22%)

Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLL 141
           E  V    F +   IG+G +G +Y    + + ++VA+K     E           E+ + 
Sbjct: 2   EPRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKIY 56

Query: 142 SQIR-HRNIVKLYGFCLHKKCMFLIYKYM------------RRGSLFCILRNDDEAIRLD 188
             ++    I  +  F +      L+   +            R+ SL  +L          
Sbjct: 57  RILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM--------- 107

Query: 189 WTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEA---FVADFGVAR 241
                 +   M + + ++H     S +HRDI  +N L+     A   ++ DFG+A+
Sbjct: 108 ------LADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 54/235 (22%), Positives = 94/235 (40%), Gaps = 52/235 (22%)

Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR-- 147
           F +   +G G +G V   Q + + K  A+K + + +    +  S + EA +L +I++   
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDI 93

Query: 148 ---NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-NDDEAIRLDWTKRVNIVKSMAHAL 203
              NIVK +G  ++   M LI++ +   SL+ I+  N+     ++  K       +  AL
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKL--YCIEILKAL 150

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAF-------------------------VADFG 238
           +YL      S+ H D+   NILL+                               + DFG
Sbjct: 151 NYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

Query: 239 VARLLHSDSSNRTVVAGTHGYIAPE----LAYTMVLTEKCDVYSFGVVALEVLMG 289
            A          +++     Y APE    L + +      D++SFG V  E+  G
Sbjct: 208 CATFKSDYHG--SIINTRQ-YRAPEVILNLGWDV----SSDMWSFGCVLAELYTG 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 32/179 (17%), Positives = 66/179 (36%), Gaps = 42/179 (23%)

Query: 82  QEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHL 140
             ++V   +F +   IG G +G +   + L + + VA+K L   ++    L     E   
Sbjct: 3   GVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHL---EYRF 57

Query: 141 LSQIRH-RNIVKLYGFCLHKKCMFLIYKYM------------RRGSLFCILRNDDEAIRL 187
             Q+     I ++Y F    K   ++ + +            R  SL  +L         
Sbjct: 58  YKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLM-------- 109

Query: 188 DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL-----NSKLEAFVADFGVAR 241
                  I   +   + Y+H     ++++RD+   N L+      ++    + DF +A+
Sbjct: 110 -------IAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 30/176 (17%), Positives = 65/176 (36%), Gaps = 40/176 (22%)

Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLL 141
           E+ V    + +   IG+G +G +Y    + +G++VA+K     E           E+ + 
Sbjct: 4   ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQLHIESKIY 58

Query: 142 SQIRH-RNIVKLYGFCLHKKCMFLIYKYM------------RRGSLFCILRNDDEAIRLD 188
             ++    I  +           ++ + +            R+ SL  +L          
Sbjct: 59  KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL--------- 109

Query: 189 WTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEA---FVADFGVAR 241
                 +   M   + Y+H     + +HRD+  +N L+    +    ++ DFG+A+
Sbjct: 110 ------LADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 36/175 (20%), Positives = 63/175 (36%), Gaps = 48/175 (27%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALK--KLHHSE-----TELAFLESFQTEAHL-----LSQ 143
           IG+GG+G +Y A      +K A    K+ + E     +EL F +    +  +       Q
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 144 IRHRNIVKLYGFCLH----KKCMFLI-----------YKYMRRGSLFCILRNDDEAIRLD 188
           + +  I   YG  L     +   F++                      +L+         
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ--------- 155

Query: 189 WTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE--AFVADFGVAR 241
                 +   M   L Y+H +     VH DI + N+LL  K     ++AD+G++ 
Sbjct: 156 ------LGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 33/180 (18%), Positives = 62/180 (34%), Gaps = 44/180 (24%)

Query: 82  QEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHL 140
           Q  +V    + +   IG G +G ++    L + ++VA+K     E   +     + E   
Sbjct: 4   QNNVVG-VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDAPQLRDEYRT 58

Query: 141 LSQIRH-RNIVKLYGFCLHKKCMFLI------------YKYMRRGSLFCILRNDDEAIRL 187
              +     I  +Y F        L+                R+ S+  +          
Sbjct: 59  YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM-------- 110

Query: 188 DWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL------NSKLEAFVADFGVAR 241
                    K M   +  +H     S+V+RDI  +N L+      N+ +  +V DFG+ +
Sbjct: 111 -------AAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 44/236 (18%), Positives = 89/236 (37%), Gaps = 58/236 (24%)

Query: 91  FDIKYCIGTGGYGSVYRAQ--LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR- 147
           ++I   +G G +G V         G+ VA+K + + +    + E+ ++E  +L  +    
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTD 72

Query: 148 -----NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDD------EAIRLDWTKRVNIV 196
                  V++  +  H   + ++++ +   S +  ++ +       + IR        + 
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIR-------KMA 124

Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVA-------------------DF 237
             +  ++++LH      + H D+   NIL                             DF
Sbjct: 125 YQICKSVNFLH-SN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 238 GVARLLHSDSSNRTVVAGTHGYIAPE----LAYTMVLTEKCDVYSFGVVALEVLMG 289
           G A       S  T+V+  H Y APE    L ++      CDV+S G + +E  +G
Sbjct: 182 GSATYDDEHHS--TLVSTRH-YRAPEVILALGWSQ----PCDVWSIGCILIEYYLG 230

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 49/231 (21%), Positives = 89/231 (38%), Gaps = 48/231 (20%)

Query: 91  FDIKYCIGTGGYGSVYRA--QLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR- 147
           ++I   +G G +G V           +VALK + +      + E+ + E ++L +I+ + 
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKD 77

Query: 148 -----NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-NDDEAIRLDWTKRVNIVKSMAH 201
                  V +  +      M + ++ + + + F  L+ N+ +   L   +   +   + H
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRH--MAYQLCH 134

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVA-------------------DFGVARL 242
           AL +LH +    + H D+   NIL  +     +                    DFG A  
Sbjct: 135 ALRFLH-EN--QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191

Query: 243 LHSDSSNRTVVAGTHGYIAPE----LAYTMVLTEKCDVYSFGVVALEVLMG 289
            H   +  T+VA  H Y  PE    L +       CDV+S G +  E   G
Sbjct: 192 DHEHHT--TIVATRH-YRPPEVILELGWAQ----PCDVWSIGCILFEYYRG 235

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 30/178 (16%), Positives = 55/178 (30%), Gaps = 51/178 (28%)

Query: 97  IGTGGYGSVYRAQ---------LPSGKKVALKKLHHS---ETELAFLESFQTEAHL---- 140
                 G +Y A           P  +K +LK          E  F +       +    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 141 -LSQIRHRNIVKLYGFCLH-KKCMFLI-----------YKYMRRG--SLFCILRNDDEAI 185
            L       I    GF +H  K  FL+                +   S   +L+      
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ------ 163

Query: 186 RLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEA--FVADFGVAR 241
                    +   +  AL +LH +     VH ++++ NI ++ + ++   +A +G A 
Sbjct: 164 ---------VACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 2e-04
 Identities = 50/353 (14%), Positives = 108/353 (30%), Gaps = 78/353 (22%)

Query: 43  FTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFQEMIVATEDFDIKYCIGTGGY 102
             F  L        K  E  +    +   + NY     F    + TE       + T  Y
Sbjct: 66  RLFWTLLS------KQEEMVQKFVEEVLRI-NYK----FLMSPIKTEQRQPS--MMTRMY 112

Query: 103 GSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF------C 156
               R +L +  +V   K + S  +       +     L ++R    V + G        
Sbjct: 113 IE-QRDRLYNDNQV-FAKYNVSRLQP--YLKLRQ---ALLELRPAKNVLIDGVLGSGKTW 165

Query: 157 L---------HKKCM-FLIY-----KYMRRGSLFCILRNDDEAIRLDWTKRVNI------ 195
           +          +  M F I+           ++  +L+     I  +WT R +       
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225

Query: 196 -VKSMAHALSYL-----HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS-DSS 248
            + S+   L  L     + +C+  +V  ++ +          AF  +     LL +    
Sbjct: 226 RIHSIQAELRRLLKSKPYENCL--LVLLNVQNAKA-----WNAF--NLSCKILLTTRFKQ 276

Query: 249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDL---LSSVNPKIML 305
               ++           ++M LT         ++   +     P DL   + + NP    
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPD---EVKSLLLKYLDCR--PQDLPREVLTTNP--RR 329

Query: 306 IDLLDQRVPSPID--DQTVIQDIILVSKIVFACLRS-KPTSRPMQRVSQEFLV 355
           + ++ + +   +   D     +   ++ I+ + L   +P     +++     V
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE--YRKMFDRLSV 380

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	363
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.25
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.1
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.88
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.76
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.68
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.57
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.42
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.2
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.15
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.14
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.07
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.8
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.69
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.64
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.59
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.59
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.58
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.48
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.21
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.17
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.07
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.89
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.75
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.1
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.51
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.06
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	94.81
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.81
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	92.58
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.37
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.3
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	92.01

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-60  Score=422.68  Aligned_cols=259  Identities=24%  Similarity=0.439  Sum_probs=204.9

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +..+++++.+.||+|+||+||+|++.+  .||||+++.........+.|.+|+.+|++++|||||+++|+|.+ +..++|
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            456788999999999999999998743  69999998766555667889999999999999999999999865 568999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      ||||++|+|.+++.....  ++++.+++.++.|||+||+|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus       110 mEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             EECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            999999999999976442  699999999999999999999999   999999999999999999999999999987643


Q ss_pred             CC--CCceeecccccccccccccc---ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          246 DS--SNRTVVAGTHGYIAPELAYT---MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       246 ~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      ..  ......+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.....   .......+......+....
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~---~~~~~~~~~~~~~~p~~~~  261 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN---RDQIIFMVGRGYASPDLSK  261 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHHHHHTTCCCCCSTT
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcCCCCCCccc
Confidence            22  22345679999999999863   4589999999999999999999999865432   2222222222211111000


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .....+..+.+|+.+||+.||++|| +.|++..|+.
T Consensus       262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            0111122488999999999999999 9999998864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.8e-60  Score=427.47  Aligned_cols=256  Identities=22%  Similarity=0.371  Sum_probs=211.3

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++..........+.+.+|+.+|++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999975 578999999998765555556889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      ||+||+|.+++..... ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999975432 2578999999999999999999999   99999999999999999999999999998764333


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCC-CCChhhHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP-IDDQTVIQDI  326 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  326 (363)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...   +.......+.....+.. ...+      
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~~~~~~~s------  250 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISGSFPPVSLHYS------  250 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCCCCTTSC------
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCCCCccCC------
Confidence            3334567999999999999999999999999999999999999998653   33445555555544322 2111      


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ..+.+||.+||+.||++|| +.|++++-+.++
T Consensus       251 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          251 YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            2488999999999999999 999988655443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.5e-60  Score=420.63  Aligned_cols=254  Identities=26%  Similarity=0.452  Sum_probs=209.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      .++|.+.+.||+|+||+||+|++.      ++..||||+++....  ...++|.+|+++|++++|||||+++|+|.+.+.
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh--HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            467889999999999999999763      467899999986543  335789999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc
Q 046084          162 MFLIYKYMRRGSLFCILRNDD----------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE  231 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  231 (363)
                      .++|||||++|+|.+++....          ....+++.+++.++.||++||+|||++   +|+||||||+|||+++++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence            999999999999999997542          234699999999999999999999999   9999999999999999999


Q ss_pred             eEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhh
Q 046084          232 AFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDL  308 (363)
Q Consensus       232 ~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~  308 (363)
                      +||+|||+++........  .....||+.|||||++.+..|+.++|||||||++|||+| |+.||...+   .......+
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i  243 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECI  243 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH
Confidence            999999999865433222  223468999999999999999999999999999999998 899987543   23334444


Q ss_pred             hccc-CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          309 LDQR-VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       309 ~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..+. ++.|...+.      .+.+|+.+||+.||++|| +.+++..|..
T Consensus       244 ~~~~~~~~p~~~~~------~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          244 TQGRVLQRPRTCPQ------EVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             HHTCCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HcCCCCCCCccchH------HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            4433 333333332      488999999999999999 9999887754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.1e-59  Score=421.81  Aligned_cols=255  Identities=26%  Similarity=0.441  Sum_probs=205.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      .++|.+.++||+|+||+||+|++.      +++.||||+++....  ...++|.+|+++|++++|||||+++|+|.+.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            467888899999999999999764      477899999976543  335789999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC
Q 046084          162 MFLIYKYMRRGSLFCILRNDDE------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK  229 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  229 (363)
                      .++|||||++|+|.++++....            ..++++.+++.++.|+|+||+|||+.   +|+||||||+|||++++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence            9999999999999999976432            23589999999999999999999999   99999999999999999


Q ss_pred             CceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHH
Q 046084          230 LEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLI  306 (363)
Q Consensus       230 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~  306 (363)
                      +.+||+|||+++.......  ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.....   .....
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~  271 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAID  271 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence            9999999999987643322  2234579999999999999999999999999999999999 8999875432   22333


Q ss_pred             hhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          307 DLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       307 ~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .+... +++.|...+.      .+.+|+.+||+.||++|| +.||++.|+.-
T Consensus       272 ~i~~g~~~~~p~~~~~------~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          272 CITQGRELERPRACPP------EVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             HHHHTCCCCCCTTCCH------HHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHcCCCCCCcccccH------HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            33332 3344433332      388999999999999999 99999988653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.2e-60  Score=421.42  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=210.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      .+++++.+.||+|+||+||+|.+      .+++.||||+++..... ...++|.+|+.++++++|||||+++|+|.+.+.
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG-PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh-HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            34677889999999999999976      24678999999765432 234789999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC
Q 046084          162 MFLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS  228 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~  228 (363)
                      .++|||||++|+|.+++.....             ...+++.++++++.|||+||+|||++   +++||||||+|||+++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence            9999999999999999965321             23589999999999999999999999   9999999999999999


Q ss_pred             CCceEEEeeccceeccCCC--CCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhH
Q 046084          229 KLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIML  305 (363)
Q Consensus       229 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~  305 (363)
                      ++.+||+|||+++......  .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.....   ....
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~  257 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV  257 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence            9999999999998764322  22334578999999999999999999999999999999998 8999875432   2333


Q ss_pred             Hhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          306 IDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       306 ~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+..+ .++.+...+.      .+.+|+.+||+.||++|| +.||++.|..-
T Consensus       258 ~~i~~~~~~~~p~~~~~------~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 EMIRNRQVLPCPDDCPA------WVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHTTCCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHcCCCCCCcccchH------HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            333333 2333433332      488999999999999999 99999998753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.8e-59  Score=423.13  Aligned_cols=254  Identities=24%  Similarity=0.371  Sum_probs=213.9

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      +.|++.+.||+|+||+||+|.+ .+|+.||||++.......  .+.+.+|+.+|+.++|||||++++++.+.+.+|+|||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5699999999999999999976 478999999997554322  3568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      ||+||+|.+++...    .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+....
T Consensus       152 y~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          152 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             CCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             CCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            99999999999753    599999999999999999999999   99999999999999999999999999999876665


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||....   .......+.....+........   ..
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~~~~~~~~---s~  298 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPRLKNLHKV---SP  298 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSSCCCCSCGGGS---CH
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCCCCccccC---CH
Confidence            55667789999999999999999999999999999999999999986532   2333333333322221111111   12


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .+.+||.+||+.||++|| +.|++++-+.++
T Consensus       299 ~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          299 SLKGFLDRLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence            488999999999999999 999998766543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.6e-58  Score=424.47  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=214.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .+.|++.+.||+|+||.||+|.+ .+|+.||||++.......  .+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            35699999999999999999976 468999999997654322  356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      |||+||+|.+++...    .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus       228 Ey~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          228 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             ECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             eCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            999999999999754    499999999999999999999999   9999999999999999999999999999987666


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      .......+||+.|||||++.+..|+.++|||||||++|||++|+.||....   ....+..+.....+........   .
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~~~~~~~~---s  374 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPRLKNLHKV---S  374 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCCSCTTSS---C
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCCCcccccC---C
Confidence            556667889999999999999999999999999999999999999986533   2233333333322211111111   1


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ..+.+||.+||+.||++|| +.|++++-+.++
T Consensus       375 ~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          375 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence            1488999999999999999 999998766543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-58  Score=411.91  Aligned_cols=246  Identities=24%  Similarity=0.379  Sum_probs=211.6

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|++..... .....+.+.+|+++|++++||||+++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999965 5789999999975432 2223467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      |||+||+|.+++...+   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999997654   699999999999999999999999   9999999999999999999999999999987533


Q ss_pred             C--CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          247 S--SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       247 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .  ....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||...   +.......+....+..+...+.   
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~p~~~s~---  259 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIKLEYDFPEKFFP---  259 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCCCTTCCH---
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCcccCH---
Confidence            2  2345678999999999999999999999999999999999999998643   3445556666666555543322   


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHH
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRV  349 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v  349 (363)
                         .+.+||.+||++||++|| +.|+
T Consensus       260 ---~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          260 ---KARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             ---HHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             ---HHHHHHHHHccCCHhHCcChHHH
Confidence               378899999999999999 8775

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.9e-58  Score=404.82  Aligned_cols=252  Identities=25%  Similarity=0.415  Sum_probs=203.7

Q ss_pred             CcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee----CCeEEEE
Q 046084           91 FDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH----KKCMFLI  165 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv  165 (363)
                      |++.++||+|+||+||+|.+ .++..||+|++..........+.|.+|+.++++++|||||++++++.+    .+.+|+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            36677899999999999976 468899999997765555556789999999999999999999999875    3468999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCeeecC-CCceEEEeecccee
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS--IVHRDISSNNILLNS-KLEAFVADFGVARL  242 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~  242 (363)
                      ||||++|+|.+++....   .+++..+..++.||+.||+|||++   +  |+||||||+|||+++ ++.+||+|||+|+.
T Consensus       108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            99999999999997654   699999999999999999999998   7  999999999999985 79999999999975


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ..  .....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.....  .......+.....+.... .. 
T Consensus       182 ~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~~~~~~~~-~~-  254 (290)
T 3fpq_A          182 KR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPASFD-KV-  254 (290)
T ss_dssp             CC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCCGGGG-GC-
T ss_pred             CC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcCCCCCCCC-cc-
Confidence            43  334456789999999998865 699999999999999999999999864322  222223333332221111 00 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                        ....+.+||.+||+.||++|| +.|++++-+.++
T Consensus       255 --~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          255 --AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             --CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             --CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence              111488999999999999999 999998766554

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.4e-59  Score=413.43  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=205.5

Q ss_pred             cCCcccCeeeecCceeEEEEEe----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ++|++.+.||+|+||+||+|+.    .+++.||+|+++...........+.+|+++|++++||||+++++++.+.+..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999975    246789999997653222222467889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      |||||+||+|.+++....   .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999998654   699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...   +.......+....++.+...+.   
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~~p~~~s~---  251 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLGMPQFLSP---  251 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCTTSCH---
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCCCCCCCcCCH---
Confidence            5444555678999999999999999999999999999999999999998643   3444555666666555543332   


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-h-----HHHHHHHhc
Q 046084          325 DIILVSKIVFACLRSKPTSRP-M-----QRVSQEFLV  355 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~-----~~v~~~l~~  355 (363)
                         .+.+||.+||+.||++|| +     .|++++-+.
T Consensus       252 ---~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f  285 (304)
T 3ubd_A          252 ---EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF  285 (304)
T ss_dssp             ---HHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred             ---HHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence               378899999999999999 4     466655443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.7e-57  Score=398.89  Aligned_cols=253  Identities=24%  Similarity=0.385  Sum_probs=199.6

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999976 4789999999976532 2233467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+ +|+|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 679999987654   699999999999999999999999   9999999999999999999999999999875432


Q ss_pred             CCCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                       ....+.+||+.|||||++.+..+ +.++||||+||++|||++|+.||...   +.......+.....+.+...+.    
T Consensus       166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~~~~~p~~~s~----  237 (275)
T 3hyh_A          166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNGVYTLPKFLSP----  237 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCCCTTSCH----
T ss_pred             -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCH----
Confidence             23345689999999999988776 57999999999999999999998643   3344445555555544433222    


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                        .+.+||.+||+.||++|| +.|++++-+.+..
T Consensus       238 --~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          238 --GAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             --HHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             --HHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence              378899999999999999 9999988766543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-57  Score=409.30  Aligned_cols=245  Identities=23%  Similarity=0.310  Sum_probs=202.8

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      +.|++.+.||+|+||+||+|++ .+|+.||||+++....       ..+|+.+++.++|||||++++++.+.+..|+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4688889999999999999976 4689999999975432       2469999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC-ceEEEeeccceeccCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLLHSD  246 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  246 (363)
                      ||+||+|.+++...+   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++.....
T Consensus       131 y~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            999999999997654   699999999999999999999999   999999999999999987 6999999999876543


Q ss_pred             CCC-----ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCC---CCC
Q 046084          247 SSN-----RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS---PID  318 (363)
Q Consensus       247 ~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~  318 (363)
                      ...     ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......   .....+.....+.   +..
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~  281 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCLKIASEPPPIREIPPS  281 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHHHHHHSCCGGGGSCTT
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHcCCCCchhcCcc
Confidence            221     23357999999999999999999999999999999999999998754332   2333333333221   111


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+      ..+.++|.+||++||++|| +.|+++++..
T Consensus       282 ~s------~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          282 CA------PLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             SC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC------HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            11      2488899999999999999 9999988743

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.8e-57  Score=405.13  Aligned_cols=267  Identities=24%  Similarity=0.344  Sum_probs=202.6

Q ss_pred             cCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----eEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK----CMFL  164 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l  164 (363)
                      ++|.+.+.||+|+||+||+|++ +|+.||||++.......   ..+..|+..+.+++||||++++|+|.+.+    ..++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~---~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh---HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            4688899999999999999998 68999999997654321   23445677777899999999999998764    5799


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD-----CIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      |||||++|+|.++++..    .+++..+++++.|+++||+|||++     +.++|+||||||+|||++.++.+||+|||+
T Consensus        79 V~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            99999999999999764    489999999999999999999976     245899999999999999999999999999


Q ss_pred             ceeccCCCCC----ceeeccccccccccccccc------cCCccccchHHHHHHHHHHhCCCCCCCCcCC----------
Q 046084          240 ARLLHSDSSN----RTVVAGTHGYIAPELAYTM------VLTEKCDVYSFGVVALEVLMGRHPGDLLSSV----------  299 (363)
Q Consensus       240 ~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g~~p~~~~~~~----------  299 (363)
                      ++........    ....+||+.|||||++.+.      .++.++|||||||++|||+||+.||......          
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            9876543322    2235799999999998654      4678999999999999999998876433211          


Q ss_pred             C--chhhHHhhhcccCCCCCCC-hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhhhhcC
Q 046084          300 N--PKIMLIDLLDQRVPSPIDD-QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQLK  363 (363)
Q Consensus       300 ~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~~~~~  363 (363)
                      .  .......+......+.... .........+.+|+.+||+.||++|| +.|+++.|..-....++|
T Consensus       235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ik  302 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK  302 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred             cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCCC
Confidence            1  1112222333333222211 11123334588999999999999999 999999997765555554

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.8e-57  Score=411.38  Aligned_cols=263  Identities=24%  Similarity=0.369  Sum_probs=214.4

Q ss_pred             HHHHHHHhcCCcccCeeeecCceeEEEEEeCC------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCC-Cceeeee
Q 046084           81 FQEMIVATEDFDIKYCIGTGGYGSVYRAQLPS------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRH-RNIVKLY  153 (363)
Q Consensus        81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~  153 (363)
                      ..++++..++|++.+.||+|+||+||+|.+..      ++.||||.+....... ..+.|.+|+.+|++++| ||||+++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~-~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH-HHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            45677888999999999999999999997532      3579999998765443 34779999999999965 8999999


Q ss_pred             eEEeeC-CeEEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCC
Q 046084          154 GFCLHK-KCMFLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDI  219 (363)
Q Consensus       154 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  219 (363)
                      |+|.+. +..++|||||++|+|.++++....             ...+++.+++.++.|||+||+|||++   +++||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence            999775 568999999999999999975321             23589999999999999999999999   9999999


Q ss_pred             CCCCeeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCC
Q 046084          220 SSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLL  296 (363)
Q Consensus       220 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~  296 (363)
                      ||+|||+++++.+||+|||+|+........  .....||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876544332  234578999999999999999999999999999999998 99998654


Q ss_pred             cCCCchhhHHhhhc-ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          297 SSVNPKIMLIDLLD-QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       297 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...  ......+.. .+++.|...+.      .+.+++.+||+.||++|| +.|++++|..
T Consensus       292 ~~~--~~~~~~i~~g~~~~~p~~~~~------~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          292 KID--EEFCRRLKEGTRMRAPDYTTP------EMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             CCS--HHHHHHHHHTCCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHH--HHHHHHHHcCCCCCCCccCCH------HHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            321  122222222 23333333322      388899999999999999 9999998854

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.9e-55  Score=391.20  Aligned_cols=253  Identities=23%  Similarity=0.394  Sum_probs=193.9

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-------
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-------  160 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------  160 (363)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++....+ ...+.+.+|+.+|++++|||||++++++.+.+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            4699999999999999999976 47899999999765543 33567999999999999999999999987654       


Q ss_pred             -----eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEE
Q 046084          161 -----CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVA  235 (363)
Q Consensus       161 -----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  235 (363)
                           ..|+|||||++|+|.+++.........++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                 3689999999999999998765444567778899999999999999999   99999999999999999999999


Q ss_pred             eeccceeccCCCCC------------ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchh
Q 046084          236 DFGVARLLHSDSSN------------RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI  303 (363)
Q Consensus       236 Dfg~~~~~~~~~~~------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~  303 (363)
                      |||+++........            ....+||+.|||||++.+..|+.++|||||||++|||++   ||....  +...
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~  235 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR  235 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence            99999876443221            233579999999999999999999999999999999996   764321  1111


Q ss_pred             hHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          304 MLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ....+.....+.     ..........+||.+||+.||++|| +.|++++-+.
T Consensus       236 ~~~~~~~~~~p~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~  283 (299)
T 4g31_A          236 TLTDVRNLKFPP-----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF  283 (299)
T ss_dssp             HHHHHHTTCCCH-----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHhcCCCCC-----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence            222222222221     1112222467899999999999999 9999886544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-53  Score=390.38  Aligned_cols=258  Identities=23%  Similarity=0.334  Sum_probs=204.0

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------Ce
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------KC  161 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  161 (363)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||+++.........+.+.+|+.+|+.++||||+++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999976 5799999999987655555567889999999999999999999987643      57


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      +|+|||||+ |+|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 67999987654   699999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCC----CCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCC-
Q 046084          242 LLHSD----SSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS-  315 (363)
Q Consensus       242 ~~~~~----~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  315 (363)
                      .+...    .......+||+.|||||++.+. .++.++||||+||++|||++|++||...+..+   .+..+......+ 
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p~  283 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTPS  283 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCC
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCC
Confidence            76432    2233456899999999998765 56999999999999999999999986543211   111111100000 


Q ss_pred             -------------------CCCChhhHH-----HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          316 -------------------PIDDQTVIQ-----DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       316 -------------------~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                         +...+..+.     ......+||.+||+.||++|| +.|++++-+.+
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence                               000000000     012477899999999999999 99999876654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.1e-51  Score=397.92  Aligned_cols=254  Identities=22%  Similarity=0.273  Sum_probs=208.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc----hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET----ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      -++|++.+.||+|+||+||+|+. .+|+.||+|++.....    ..........++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            36799999999999999999965 4789999999965421    112222334456778888999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      |+|||||+||+|.+++...+   .+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999998654   699999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ....  ...+.+||+.|||||++.. ..|+.++|+|||||++|||++|++||......+.......+....+..+...+.
T Consensus       342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~  419 (689)
T 3v5w_A          342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP  419 (689)
T ss_dssp             CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence            6433  2345689999999999864 579999999999999999999999997655444444444555555554443332


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-h-----HHHHHHHhc
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-M-----QRVSQEFLV  355 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~-----~~v~~~l~~  355 (363)
                            .+.+||.+||+.||++|+ .     .|+..+-.+
T Consensus       420 ------~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF  453 (689)
T 3v5w_A          420 ------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF  453 (689)
T ss_dssp             ------HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred             ------HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence                  378899999999999998 3     666665544

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.2e-51  Score=374.63  Aligned_cols=196  Identities=28%  Similarity=0.383  Sum_probs=169.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCe
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  161 (363)
                      ..++|++.+.||+|+||+||+|+.+    +++.||+|.+......    ..+.+|+++|+.+ +||||+++++++.+.+.
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~----~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP----IRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH----HHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH----HHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            4678999999999999999999652    4678999998765442    4577899999988 69999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-CceEEEeeccc
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVA  240 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~  240 (363)
                      .|+||||+++|+|.+++.      .+++.++..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+|
T Consensus        95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            999999999999999984      489999999999999999999999   99999999999999877 79999999999


Q ss_pred             eeccCCC----------------------------CCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCC
Q 046084          241 RLLHSDS----------------------------SNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRH  291 (363)
Q Consensus       241 ~~~~~~~----------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~  291 (363)
                      +......                            ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            7653221                            112335799999999998775 58999999999999999999999


Q ss_pred             CCCC
Q 046084          292 PGDL  295 (363)
Q Consensus       292 p~~~  295 (363)
                      ||..
T Consensus       246 Pf~~  249 (361)
T 4f9c_A          246 PFYK  249 (361)
T ss_dssp             SSSC
T ss_pred             CCCC
Confidence            9853

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.9e-51  Score=392.73  Aligned_cols=254  Identities=23%  Similarity=0.323  Sum_probs=211.3

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||.||+|.. .+|+.||+|++......  ..+.+.+|+.+|+.++||||+++++++.+.+..|+|||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh--hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            6899999999999999999965 57899999999765433  24678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC--CceEEEeeccceeccC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK--LEAFVADFGVARLLHS  245 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~  245 (363)
                      ||+||+|.+++.....  .+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++.+..
T Consensus       235 ~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          235 FMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             ecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            9999999999865432  589999999999999999999999   99999999999999854  8999999999998754


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      . ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...   +....+..+.......+.....  ..
T Consensus       310 ~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~--~~  383 (573)
T 3uto_A          310 K-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMDDSAFS--GI  383 (573)
T ss_dssp             T-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTCCCCCSGGGT--TS
T ss_pred             C-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHhCCCCCCccccc--CC
Confidence            3 3345568999999999999999999999999999999999999998653   3333444444443332221111  11


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...+.+||.+||+.||++|| +.|++++-+.
T Consensus       384 s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~  414 (573)
T 3uto_A          384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWL  414 (573)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence            12478899999999999999 9999987554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.8e-49  Score=354.37  Aligned_cols=254  Identities=23%  Similarity=0.382  Sum_probs=211.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|++.......  .+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            46899999999999999999975 578899999987554322  356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        97 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            999999999999764    489999999999999999999999   9999999999999999999999999999877655


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ........||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ......+.....+......   ...
T Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~---~~~  243 (297)
T 3fxz_A          170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPELQNPE---KLS  243 (297)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCCCSCGG---GSC
T ss_pred             ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCCcc---ccC
Confidence            5555566799999999999999999999999999999999999999865432   2222222222111111111   111


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+.+++.+||+.||++|| +.|++++-..+
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence            2488999999999999999 99999876554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.6e-50  Score=361.38  Aligned_cols=261  Identities=30%  Similarity=0.482  Sum_probs=206.9

Q ss_pred             HHHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           82 QEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      .++.+..++|++.+.||+|+||+||+|+. +|+.||+|++..........+.+.+|+.++++++||||+++++++.+.+.
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            34445677899999999999999999987 68899999998776555556789999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCeeecCCCceEEEeecc
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS--IVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      .++||||+++|+|.+++........+++..++.++.|++.||+|||+.   +  ++||||||+|||++.++.+||+|||+
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            999999999999999998765333489999999999999999999999   8  99999999999999999999999999


Q ss_pred             ceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhh--hcccCCCCC
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDL--LDQRVPSPI  317 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~  317 (363)
                      +..............||+.|+|||++.+..++.++||||||+++|||++|+.||.....   .......  .......+.
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~  262 (309)
T 3p86_A          186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCKRLEIPR  262 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCCCCCCCT
T ss_pred             CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCc
Confidence            98654443344456799999999999999999999999999999999999999875432   2222222  122222222


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..+.      .+.++|.+||+.||++|| +.++++.|..
T Consensus       263 ~~~~------~l~~li~~~l~~dP~~Rps~~~ll~~L~~  295 (309)
T 3p86_A          263 NLNP------QVAAIIEGCWTNEPWKRPSFATIMDLLRP  295 (309)
T ss_dssp             TSCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCH------HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            2221      388999999999999999 9999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.1e-49  Score=356.62  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=215.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46899999999999999999976 68999999999776555555678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            9999999999987654   589999999999999999999999   9999999999999999999999999999766433


Q ss_pred             CCCceeeccccccccccccccccCC-ccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLT-EKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      . .....+||+.|+|||++.+..++ .++|||||||++|||++|+.||+..   +.......+.......+...+.    
T Consensus       168 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~p~~~s~----  239 (328)
T 3fe3_A          168 G-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ---NLKELRERVLRGKYRIPFYMST----  239 (328)
T ss_dssp             C-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCTTSCH----
T ss_pred             C-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCCCCCH----
Confidence            2 33456799999999999887765 7999999999999999999998653   3334444555555544443332    


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                        .+.+|+.+||+.||++|| +.|++++-+..
T Consensus       240 --~~~~li~~~L~~dP~~R~t~~eil~h~~~~  269 (328)
T 3fe3_A          240 --DCENLLKRFLVLNPIKRGTLEQIMKDRWIN  269 (328)
T ss_dssp             --HHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred             --HHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence              378899999999999999 99998875543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.6e-49  Score=357.07  Aligned_cols=279  Identities=37%  Similarity=0.628  Sum_probs=223.0

Q ss_pred             CCccHHHHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEE
Q 046084           77 GRITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC  156 (363)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  156 (363)
                      ..+++.++....++|++.+.||+|+||.||+|...+|+.||+|++........ ...+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-CCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-HHHHHHHHHHHHhccCCCccceEEEE
Confidence            45778999999999999999999999999999988899999999976543211 23688999999999999999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEE
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDDE-AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVA  235 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  235 (363)
                      .+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+.++++||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            999999999999999999999986542 3359999999999999999999999877789999999999999999999999


Q ss_pred             eeccceeccCCCCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCC-chhhHHhhhcc--
Q 046084          236 DFGVARLLHSDSSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN-PKIMLIDLLDQ--  311 (363)
Q Consensus       236 Dfg~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~--  311 (363)
                      |||++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||+...... ...........  
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            99999876543332 233458999999999988889999999999999999999999986321110 01111111110  


Q ss_pred             -------cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          312 -------RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       312 -------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                             .................+.+++.+||+.||++|| +.+++++|+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence                   0011111112234445699999999999999999 99999999754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.4e-48  Score=350.37  Aligned_cols=265  Identities=24%  Similarity=0.381  Sum_probs=216.1

Q ss_pred             CCccHHHHHHHhcC----------CcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC
Q 046084           77 GRITFQEMIVATED----------FDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIR  145 (363)
Q Consensus        77 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~  145 (363)
                      +.++++++..+.+.          |+..+.||+|+||.||+|... +|+.||||++.......  .+.+.+|+.+++.++
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQ  100 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--HHHHHHHHHHHTTCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--HHHHHHHHHHHHhCC
Confidence            45677777666553          677789999999999999875 79999999987654322  367889999999999


Q ss_pred             CCceeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCee
Q 046084          146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNIL  225 (363)
Q Consensus       146 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  225 (363)
                      ||||+++++++...+..++||||+++++|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+|||
T Consensus       101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  173 (321)
T 2c30_A          101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL  173 (321)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence            999999999999999999999999999999998653    589999999999999999999999   9999999999999


Q ss_pred             ecCCCceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhH
Q 046084          226 LNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIML  305 (363)
Q Consensus       226 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~  305 (363)
                      ++.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ....
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~  250 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAM  250 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH
T ss_pred             ECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH
Confidence            9999999999999998775544444556799999999999999999999999999999999999999865332   2222


Q ss_pred             HhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          306 IDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+.....+......   .....+.+++.+||+.||++|| +.+++++....
T Consensus       251 ~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  299 (321)
T 2c30_A          251 KRLRDSPPPKLKNSH---KVSPVLRDFLERMLVRDPQERATAQELLDHPFLL  299 (321)
T ss_dssp             HHHHHSSCCCCTTGG---GSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred             HHHhcCCCCCcCccc---cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            233332222211111   1112488999999999999999 99999876654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.6e-48  Score=348.18  Aligned_cols=264  Identities=22%  Similarity=0.311  Sum_probs=208.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .++|++.+.||+|+||+||+|.+.+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            47899999999999999999998889999999997665444445678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++ +|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.......
T Consensus       100 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 78877765442  589999999999999999999999   99999999999999999999999999998775544


Q ss_pred             CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC--------
Q 046084          248 SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID--------  318 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------  318 (363)
                      .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||....................+....        
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            44555678999999998876 568999999999999999999999997655443322222222221111000        


Q ss_pred             --------ChhhH-----HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          319 --------DQTVI-----QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       319 --------~~~~~-----~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                              ....+     .....+.+|+.+||+.||++|| +.|++++-..+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  306 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD  306 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence                    00000     0112478999999999999999 999998766654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.5e-48  Score=351.10  Aligned_cols=270  Identities=36%  Similarity=0.523  Sum_probs=216.7

Q ss_pred             HHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           83 EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      ++....++|++.+.||+|+||.||+|.+.+|+.||+|++.......  .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG--IEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH--HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH--HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            3344678999999999999999999998889999999987654432  46789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          163 FLIYKYMRRGSLFCILRNDDE-AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      ++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999999876432 23589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCC--CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH----hhhccc---
Q 046084          242 LLHSDS--SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI----DLLDQR---  312 (363)
Q Consensus       242 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~~---  312 (363)
                      ......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.............    ......   
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            653322  12233468999999999988899999999999999999999999986543322111110    011111   


Q ss_pred             -CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          313 -VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       313 -~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                       ................+.+++.+||+.||++|| +.|+++.|....
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence             111111112234445689999999999999999 999999987543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.1e-48  Score=347.01  Aligned_cols=254  Identities=26%  Similarity=0.455  Sum_probs=207.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|.+.+.||+|+||+||++.+ .+++.||+|.+.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            46799999999999999999976 4688999999865433  33578999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++.....  .+++.+++.++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        87 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             ECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             EecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            99999999999986432  589999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCCc--------------eeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCC--chhhHHhhhc
Q 046084          247 SSNR--------------TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN--PKIMLIDLLD  310 (363)
Q Consensus       247 ~~~~--------------~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~  310 (363)
                      ....              ....||+.|+|||++.+..++.++||||||+++|||++|..|+.......  ..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            2211              14568999999999999999999999999999999999999976543221  1111222222


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          311 QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ...+.....        .+.+++.+||+.||++|| +.++++.|..-
T Consensus       242 ~~~~~~~~~--------~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          242 RYCPPNCPP--------SFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             HTCCTTCCT--------THHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCCCH--------HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            222222111        288899999999999999 99999988653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.6e-48  Score=349.77  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=210.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+++.. +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999764 689999999975421 112245688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999987644   589999999999999999999999   999999999999999999999999999986544


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      ........+||+.|+|||++.+..++.++||||||+++|||++|+.||...   +.......+.......+...+.    
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~----  230 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILMEEIRFPRTLSP----  230 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCTTSCH----
T ss_pred             CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCH----
Confidence            444455668999999999999999999999999999999999999998643   2333444444444444332222    


Q ss_pred             HHHHHHHHHHccCCCCCCCC------hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP------MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP------~~~v~~~l~~  355 (363)
                        .+.++|.+||+.||++||      +.|++++-..
T Consensus       231 --~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f  264 (337)
T 1o6l_A          231 --EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             --HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             --HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence              378899999999999997      5666665443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=361.26  Aligned_cols=259  Identities=19%  Similarity=0.264  Sum_probs=214.4

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            457899999999999999999965 5788999999987665555567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec---CCCceEEEeecccee
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN---SKLEAFVADFGVARL  242 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~  242 (363)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++   .++.+||+|||++..
T Consensus        89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999887654   599999999999999999999999   999999999999998   468899999999987


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|..||...   +.......+.......+....  
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~--  237 (444)
T 3soa_A          163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE---DQHRLYQQIKAGAYDFPSPEW--  237 (444)
T ss_dssp             CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCCCTTTT--
T ss_pred             ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCCCCcccc--
Confidence            765544445567999999999999989999999999999999999999998643   233334444444333222110  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ......+.++|.+||+.||++|| +.|++++-+..
T Consensus       238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~  272 (444)
T 3soa_A          238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS  272 (444)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence            01112488999999999999999 99999876654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.2e-48  Score=354.82  Aligned_cols=258  Identities=24%  Similarity=0.419  Sum_probs=210.0

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe--------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL--------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCL  157 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  157 (363)
                      ..++|++.+.||+|+||.||+|.+        .++..||+|+++..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH-HHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH-HHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            357899999999999999999975        23457999999866443 3357899999999999 8999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCe
Q 046084          158 HKKCMFLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNI  224 (363)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  224 (363)
                      +.+..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.   +++||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence            99999999999999999999976431             23589999999999999999999999   999999999999


Q ss_pred             eecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCc
Q 046084          225 LLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNP  301 (363)
Q Consensus       225 ll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~  301 (363)
                      |++.++.+||+|||++.........  .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....   
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---  311 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---  311 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence            9999999999999999876443221  222346789999999999999999999999999999999 9999865432   


Q ss_pred             hhhHHhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          302 KIMLIDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       302 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ......+... ....+...+      ..+.+++.+||+.||++|| +.|+++.|..-.
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          312 EELFKLLKEGHRMDKPANCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             GGHHHHHHTTCCCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            2222222222 222222222      2488999999999999999 999999987643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.5e-48  Score=354.13  Aligned_cols=256  Identities=23%  Similarity=0.377  Sum_probs=208.2

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (363)
                      ...++|++.+.||+|+||.||+++.. +|+.||+|++..... .....+.+..|..+++.+ +||||+++++++.+.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            44678999999999999999999764 688999999975432 222345678899999988 799999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      |+||||+++|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence            99999999999999997654   599999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ...........+||+.|+|||++.+..++.++|||||||++|||++|+.||...   +.......+.......+...+. 
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~~p~~~~~-  249 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILNDEVVYPTWLHE-  249 (353)
T ss_dssp             SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCTTSCH-
T ss_pred             cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCH-
Confidence            544444455678999999999999989999999999999999999999998653   3344555565555554433222 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-h------HHHHHHHhch
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-M------QRVSQEFLVR  356 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~------~~v~~~l~~~  356 (363)
                           .+.+++.+||+.||++|| +      .+++.+-..+
T Consensus       250 -----~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~  285 (353)
T 3txo_A          250 -----DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK  285 (353)
T ss_dssp             -----HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred             -----HHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence                 378899999999999999 7      6777765543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=347.65  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=206.2

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      ..++|++.+.||+|+||.||+|.+.    .+..||||.+...... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            3567899999999999999999773    3446999999865433 3357799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++||||+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999975532  589999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCCc---eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCC
Q 046084          243 LHSDSSNR---TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPI  317 (363)
Q Consensus       243 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~  317 (363)
                      ........   ....+|+.|+|||++.+..++.++||||||+++|||++ |..||.....   ......+... ..+.+.
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~  277 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGYRLPAPM  277 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCCCCCT
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCCCCCCC
Confidence            65433222   12335678999999998899999999999999999999 9999865432   2222222222 222222


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+      ..+.+++..||+.||++|| +.++++.|...
T Consensus       278 ~~~------~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          278 GCP------HALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             TCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            222      2488999999999999999 99999998653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-47  Score=355.17  Aligned_cols=257  Identities=23%  Similarity=0.376  Sum_probs=210.2

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  163 (363)
                      ..++|++.+.||+|+||.||+++.. +++.||+|+++.... .....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3568999999999999999999764 577899999976532 222235678899999877 8999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +||||+++|+|..++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       130 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            9999999999999987654   599999999999999999999999   9999999999999999999999999999864


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC------CchhhHHhhhcccCCCCC
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV------NPKIMLIDLLDQRVPSPI  317 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~  317 (363)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||......      ........+....+..+.
T Consensus       204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  283 (396)
T 4dc2_A          204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  283 (396)
T ss_dssp             CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred             ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence            44444555678999999999999999999999999999999999999999643211      122233444555544443


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-h------HHHHHHHhc
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-M------QRVSQEFLV  355 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~------~~v~~~l~~  355 (363)
                      ..+.      .+.+||.+||+.||++|| +      .|++.+-..
T Consensus       284 ~~s~------~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff  322 (396)
T 4dc2_A          284 SLSV------KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  322 (396)
T ss_dssp             TSCH------HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred             cCCH------HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence            3322      378899999999999999 5      566665544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6e-48  Score=344.23  Aligned_cols=262  Identities=23%  Similarity=0.322  Sum_probs=201.9

Q ss_pred             cCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      ++|++.+.||+|+||+||+|...+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57899999999999999999888899999999976554333346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +++ +|.+++.....  .+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            986 89888876432  589999999999999999999999   999999999999999999999999999987654433


Q ss_pred             Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc---------------
Q 046084          249 NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR---------------  312 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  312 (363)
                      ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...................               
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            3444568999999999875 458999999999999999999999987543221111111111100               


Q ss_pred             --CCC--CCCC-hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          313 --VPS--PIDD-QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       313 --~~~--~~~~-~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                        ...  +... .........+.+++.+||+.||++|| +.|++++-..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  285 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence              000  0000 00000112478999999999999999 99998876554

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.3e-48  Score=348.46  Aligned_cols=267  Identities=25%  Similarity=0.358  Sum_probs=207.7

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----eE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK----CM  162 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~  162 (363)
                      ..++|++.+.||+|+||+||+|++ .++.||||++......   ...+..|+.++++++||||+++++++....    ..
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ---SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             chhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchH---HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            357899999999999999999988 4789999999765432   245567999999999999999999998754    47


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCcEEeCCCCCCeeecCCCceEEE
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD-------CIPSIVHRDISSNNILLNSKLEAFVA  235 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~~i~H~dlkp~Nill~~~~~~kl~  235 (363)
                      ++||||+++|+|.+++...    .+++..++.++.|++.||+|||+.       +.++++||||||+|||++.++.+||+
T Consensus        98 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            9999999999999999764    489999999999999999999976       23389999999999999999999999


Q ss_pred             eeccceeccCCCCC--ceeecccccccccccccc-----ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc-------
Q 046084          236 DFGVARLLHSDSSN--RTVVAGTHGYIAPELAYT-----MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-------  301 (363)
Q Consensus       236 Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-------  301 (363)
                      |||++.........  .....||+.|+|||++.+     ..++.++||||||+++|||++|+.||........       
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999876543322  223568999999999876     4567789999999999999999999865433211       


Q ss_pred             ------hhhHHhhhcccCCCCCCC-hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhhhh
Q 046084          302 ------KIMLIDLLDQRVPSPIDD-QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQ  361 (363)
Q Consensus       302 ------~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~~~  361 (363)
                            .................. .........+.+||.+||+.||++|| +.++++.|.......+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~~  321 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTN  321 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence                  111111112211111111 11122334589999999999999999 9999999987655443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-47  Score=338.03  Aligned_cols=254  Identities=23%  Similarity=0.447  Sum_probs=210.0

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..++|++.+.||+|+||.||++...++..||+|++.......   +.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            457899999999999999999999888899999998765433   56889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             ECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999976432  489999999999999999999999   9999999999999999999999999999876443


Q ss_pred             CCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhH
Q 046084          247 SSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVI  323 (363)
Q Consensus       247 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  323 (363)
                      ... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||+....   ......+... ....+...+   
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~---  231 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKVSQGHRLYRPHLAS---  231 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCCCCTTSC---
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHHHHHcCCCCCCCCcCh---
Confidence            221 122345678999999998889999999999999999999 9999865432   2222222222 222222222   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                         ..+.+++.+||+.||++|| +.++++.|..-.
T Consensus       232 ---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          232 ---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             ---HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             ---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence               1488999999999999999 999999997654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.2e-47  Score=347.65  Aligned_cols=257  Identities=25%  Similarity=0.363  Sum_probs=205.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            468999999999999999999764 7889999998654432 22356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            9999999999987654   589999999999999999999999   9999999999999999999999999999865432


Q ss_pred             C--CCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          247 S--SNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       247 ~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      .  .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.........  ............. ..   
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~-~~---  232 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYLNP-WK---  232 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHHHTTCTTSTT-GG---
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHHhcccccCCc-cc---
Confidence            2  12234578999999999887665 77899999999999999999998765433221  1222221111111 01   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .....+.+|+.+||+.||++|| +.|++++.+...
T Consensus       233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence            1112478899999999999999 999998876654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.2e-47  Score=346.90  Aligned_cols=256  Identities=23%  Similarity=0.377  Sum_probs=210.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEecccc-chHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSE-TELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (363)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            467999999999999999999764 58899999997653 2333456788999999987 89999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            999999999999997644   589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcC------CCchhhHHhhhcccCCCCCC
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS------VNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~  318 (363)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .........+.......+..
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  241 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  241 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred             CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence            444445566899999999999999999999999999999999999999965322      11222333444444444332


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-h------HHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-M------QRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~------~~v~~~l~~  355 (363)
                      .+.      .+.++|.+||+.||++|| +      .+++.+-..
T Consensus       242 ~s~------~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f  279 (345)
T 3a8x_A          242 LSV------KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  279 (345)
T ss_dssp             SCH------HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred             CCH------HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence            222      378899999999999999 5      566655443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.2e-47  Score=351.49  Aligned_cols=251  Identities=25%  Similarity=0.384  Sum_probs=208.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999764 678999999865432 122346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+.+|+|.+++....   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999998654   599999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCceeecccccccccccccc---ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          246 DSSNRTVVAGTHGYIAPELAYT---MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      . ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||..............+.......+...+. 
T Consensus       168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~-  245 (384)
T 4fr4_A          168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ-  245 (384)
T ss_dssp             T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH-
T ss_pred             C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH-
Confidence            3 33445679999999999864   458999999999999999999999997655544444444444444444433222 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC--hHHHHH
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP--MQRVSQ  351 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP--~~~v~~  351 (363)
                           .+.+||.+||+.||++||  +.++..
T Consensus       246 -----~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          246 -----EMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -----HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -----HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                 388999999999999999  445444

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-47  Score=344.97  Aligned_cols=257  Identities=22%  Similarity=0.291  Sum_probs=212.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||++... +++.||+|.+......   ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc---HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            468999999999999999999764 6789999998755432   356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC--CCceEEEeeccceecc
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS--KLEAFVADFGVARLLH  244 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~  244 (363)
                      ||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++.  ++.+||+|||++....
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            9999999999997543  2589999999999999999999999   9999999999999987  7899999999998764


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .. .......||+.|+|||++.+..++.++||||||+++|+|++|..||....   .......+.......+.  .....
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~--~~~~~  229 (321)
T 1tki_A          156 PG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFDE--EAFKE  229 (321)
T ss_dssp             TT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCCH--HHHTT
T ss_pred             CC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHcCCCCCCh--hhhcc
Confidence            33 23345678999999999998889999999999999999999999986532   23334444444433221  00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      ....+.+++.+||+.||++|| +.|++++-+.+..
T Consensus       230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            123488999999999999999 9999998776544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.6e-47  Score=349.77  Aligned_cols=257  Identities=21%  Similarity=0.331  Sum_probs=211.9

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            356899999999999999999976 4688999999987654444567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC---CceEEEeecccee
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK---LEAFVADFGVARL  242 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~  242 (363)
                      |||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.+   +.+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999887654   589999999999999999999999   99999999999999765   4599999999987


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      .... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....   .......+.......+....  
T Consensus       181 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~--  254 (362)
T 2bdw_A          181 VNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPSPEW--  254 (362)
T ss_dssp             CTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCTTGG--
T ss_pred             ecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCcccc--
Confidence            6433 22344579999999999999899999999999999999999999986432   23333444444333322111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ......+.++|.+||+.||++|| +.+++.+-+.
T Consensus       255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  288 (362)
T 2bdw_A          255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI  288 (362)
T ss_dssp             GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence            11122488999999999999999 9999877544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-47  Score=338.74  Aligned_cols=253  Identities=26%  Similarity=0.441  Sum_probs=209.1

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..++|++.+.||+|+||.||++.+.+++.||+|++.......   +.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            356899999999999999999998888999999998765443   56889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             ECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EeCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999999976442  589999999999999999999999   9999999999999999999999999999765322


Q ss_pred             C-CCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhH
Q 046084          247 S-SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVI  323 (363)
Q Consensus       247 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  323 (363)
                      . .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ......+... ....+...+   
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~---  233 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRLYKPRLAS---  233 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCCCCTTSC---
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCccCCCCCcCC---
Confidence            1 11222346778999999998899999999999999999999 9999865332   2223333322 122222111   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                         ..+.+++.+||+.||++|| +.++++.|..-
T Consensus       234 ---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          234 ---THVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence               1388999999999999999 99999998654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.2e-47  Score=349.43  Aligned_cols=257  Identities=22%  Similarity=0.314  Sum_probs=210.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchH----HHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETEL----AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||.||++... +|+.||+|.+.......    ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            567999999999999999999764 68899999987654321    1236788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC----ceEEEeec
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL----EAFVADFG  238 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg  238 (363)
                      ++||||+++|+|.+++....   .+++..+..++.||+.||+|||+.   +++||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999997644   699999999999999999999999   999999999999998876    79999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      ++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...   +.......+.......+. 
T Consensus       165 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~-  239 (361)
T 2yab_A          165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITAVSYDFDE-  239 (361)
T ss_dssp             SCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTCCCCCH-
T ss_pred             CceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCCc-
Confidence            998765432 234457999999999999889999999999999999999999998653   233334444444333221 


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       .........+.++|.+||+.||++|| +.|++.+-+..
T Consensus       240 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          240 -EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             -HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             -hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence             00011122488999999999999999 99998876554

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-47  Score=341.82  Aligned_cols=263  Identities=20%  Similarity=0.303  Sum_probs=210.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC--eEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK--CMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  164 (363)
                      .++|.+.+.||+|+||+||+|... +++.||+|++...... ...+.+.+|+++++.++||||+++++++...+  ..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            467999999999999999999765 5889999999764432 12466789999999999999999999998765  7899


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee----cCCCceEEEeeccc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL----NSKLEAFVADFGVA  240 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~  240 (363)
                      ||||+++++|.+++........+++..++.++.|++.||+|||+.   +++||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999998765544599999999999999999999999   99999999999999    78888999999999


Q ss_pred             eeccCCCCCceeeccccccccccccc--------cccCCccccchHHHHHHHHHHhCCCCCCCCcCC-CchhhHHhhhcc
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAY--------TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV-NPKIMLIDLLDQ  311 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~  311 (363)
                      ....... ......||+.|+|||++.        +..++.++||||||+++|||++|+.||...... ........+...
T Consensus       164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            8765433 233456899999999876        567899999999999999999999998654332 223333333332


Q ss_pred             cCC-------------------CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          312 RVP-------------------SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       312 ~~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .++                   .+............+.+++.+||+.||++|| +.|++++..-
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            221                   1111111233344688999999999999999 9999998753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.6e-46  Score=335.70  Aligned_cols=271  Identities=31%  Similarity=0.516  Sum_probs=219.0

Q ss_pred             CCccHHHHHHHhcCCccc------CeeeecCceeEEEEEeCCCCEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCc
Q 046084           77 GRITFQEMIVATEDFDIK------YCIGTGGYGSVYRAQLPSGKKVALKKLHHSE--TELAFLESFQTEAHLLSQIRHRN  148 (363)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~n  148 (363)
                      ..+++.++..++++|...      +.||+|+||.||+|.. +++.||+|++....  ......+.+.+|+.+++.++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            346788999999888777      8999999999999987 68899999987542  22233567899999999999999


Q ss_pred             eeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC
Q 046084          149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS  228 (363)
Q Consensus       149 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~  228 (363)
                      |+++++++.+.+..+++|||+++++|.+++........+++..++.++.|++.||+|||+.   +++||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence            9999999999999999999999999999997654445699999999999999999999999   9999999999999999


Q ss_pred             CCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH
Q 046084          229 KLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI  306 (363)
Q Consensus       229 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~  306 (363)
                      ++.+||+|||++.........  .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.............
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK  247 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence            999999999999876433222  223468999999998765 47899999999999999999999987654432211111


Q ss_pred             -----------hhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          307 -----------DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       307 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                                 ..++.....     ........+.+++.+||+.||++|| +.++++.|..-.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          248 EEIEDEEKTIEDYIDKKMND-----ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHTTSCCHHHHSCSSCSC-----CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHhhhhhhhhhhhccccccc-----cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence                       111111111     1223344688999999999999999 999999887543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.6e-48  Score=356.85  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=209.1

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      +..++|.+.+.||+|+||.||+|.+. +++.||+|.++.... ....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            45678999999999999999999875 788999999876533 2334678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus       190 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            999999999999997543  2589999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc-ccCCCCCCCh
Q 046084          245 SDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPSPIDDQ  320 (363)
Q Consensus       245 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  320 (363)
                      .....  .....++..|+|||.+.+..++.++||||||+++|||++ |..||......   .....+.. .+++.+...+
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  341 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREFVEKGGRLPCPELCP  341 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHHHHTTCCCCCCTTCC
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCCCCCCCCC
Confidence            32111  111235678999999998889999999999999999998 99998654321   11111211 2233333222


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                            ..+.+|+.+||+.||++|| +.+++..|..-.
T Consensus       342 ------~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          342 ------DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             ------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                  2488999999999999999 999999987644

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.5e-47  Score=352.23  Aligned_cols=255  Identities=28%  Similarity=0.462  Sum_probs=197.6

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      ..++|++.+.||+|+||.||+|++.    ++..||||.++..... ...+.|.+|+.++++++||||+++++++.+.+..
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            3468999999999999999999764    5678999999765433 3357899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999999997653  2589999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCCc---eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCC
Q 046084          243 LHSDSSNR---TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPI  317 (363)
Q Consensus       243 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~  317 (363)
                      ........   ....++..|+|||++.+..++.++||||||+++|||++ |+.||.....   ......+... ..+.+.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~~~~~  273 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRLPPPM  273 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEECCCCT
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCc
Confidence            64432211   11234678999999998899999999999999999998 9999865432   2222222222 222232


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+      ..+.+++.+||+.||++|| +.++++.|...
T Consensus       274 ~~~------~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          274 DCP------AALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             TCB------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccc------HHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            222      2488999999999999999 99999988653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=338.93  Aligned_cols=254  Identities=21%  Similarity=0.313  Sum_probs=199.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch------------------------HHHHHHHHHHHHHHh
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE------------------------LAFLESFQTEAHLLS  142 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~e~~~l~  142 (363)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++......                        ....+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46899999999999999999976 46889999998754321                        112356889999999


Q ss_pred             cCCCCceeeeeeEEee--CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCC
Q 046084          143 QIRHRNIVKLYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDIS  220 (363)
Q Consensus       143 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk  220 (363)
                      .++||||+++++++.+  .+..++||||+++++|.+++...    .+++..++.++.|++.||+|||+.   +++|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            9999999999999987  56799999999999998865432    599999999999999999999999   99999999


Q ss_pred             CCCeeecCCCceEEEeeccceeccCCCCCceeecccccccccccccccc---CCccccchHHHHHHHHHHhCCCCCCCCc
Q 046084          221 SNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV---LTEKCDVYSFGVVALEVLMGRHPGDLLS  297 (363)
Q Consensus       221 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~p~~~~~  297 (363)
                      |+|||++.++.+||+|||++..............||+.|+|||.+.+..   ++.++||||||+++|||++|+.||....
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999999987655444344567999999999987654   4778999999999999999999986432


Q ss_pred             CCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          298 SVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                         .......+.......+.... .   ...+.+++.+||+.||++|| +.|++++-+.
T Consensus       245 ---~~~~~~~~~~~~~~~~~~~~-~---~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~  296 (298)
T 2zv2_A          245 ---IMCLHSKIKSQALEFPDQPD-I---AEDLKDLITRMLDKNPESRIVVPEIKLHPWV  296 (298)
T ss_dssp             ---HHHHHHHHHHCCCCCCSSSC-C---CHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred             ---HHHHHHHHhcccCCCCCccc-c---CHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence               22222233333322221111 1   11388999999999999999 9998876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.7e-47  Score=346.21  Aligned_cols=254  Identities=20%  Similarity=0.332  Sum_probs=210.0

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (363)
                      ...++|++.+.||+|+||.||+++.. +|+.||+|++..... .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            34578999999999999999999775 478899999975432 112245678899999988 899999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      |+||||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            99999999999999997644   589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ...........+||+.|+|||++.+..++.++||||||+++|||++|+.||...   +.......+.......+...+. 
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~-  246 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVAYPKSMSK-  246 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCTTSCH-
T ss_pred             cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCCCCCCCCH-
Confidence            544444455668999999999999999999999999999999999999998643   3344455555555544433222 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-h-----HHHHHHHh
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-M-----QRVSQEFL  354 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~-----~~v~~~l~  354 (363)
                           .+.+||.+||+.||++|| +     .+++.+-.
T Consensus       247 -----~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~  279 (353)
T 2i0e_A          247 -----EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  279 (353)
T ss_dssp             -----HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred             -----HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence                 388899999999999999 4     55555433

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.1e-47  Score=338.36  Aligned_cols=260  Identities=21%  Similarity=0.286  Sum_probs=203.3

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||+||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999764 68899999998665544445778899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++ ++.+++....  ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 5555554322  2599999999999999999999999   99999999999999999999999999998776555


Q ss_pred             CCceeecccccccccccccccc-CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc---ccCCC--------
Q 046084          248 SNRTVVAGTHGYIAPELAYTMV-LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD---QRVPS--------  315 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~--------  315 (363)
                      .......||+.|+|||++.+.. ++.++||||||+++|||++|..|+.....  .......+..   .....        
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhccc
Confidence            5555567899999999987765 79999999999999999998888532211  1111111111   00000        


Q ss_pred             ------CC---C---ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          316 ------PI---D---DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       316 ------~~---~---~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                            +.   .   ..........+.+|+.+||+.||++|| +.|++++-...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  287 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence                  00   0   000001112478999999999999999 99999876654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.9e-47  Score=339.96  Aligned_cols=262  Identities=25%  Similarity=0.354  Sum_probs=203.8

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67999999999999999999774 58999999998776665656788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999998887554   589999999999999999999999   99999999999999999999999999998775444


Q ss_pred             CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---------------
Q 046084          248 SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---------------  311 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------  311 (363)
                      .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..................               
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            44455678999999998875 66899999999999999999999998654432211111111110               


Q ss_pred             ---cCCCCCCChhh----HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          312 ---RVPSPIDDQTV----IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       312 ---~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                         ..+.+......    ......+.+++.+||+.||++|| +.|++++-..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  289 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE  289 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence               11111100000    01122478899999999999999 99999876554

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.6e-47  Score=349.51  Aligned_cols=261  Identities=19%  Similarity=0.268  Sum_probs=209.1

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETEL---AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|++.......   ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356799999999999999999976 468999999986432110   1236788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc---eEEEeec
Q 046084          163 FLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE---AFVADFG  238 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg  238 (363)
                      ++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999988775432 223589999999999999999999999   9999999999999986654   9999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      ++..............||+.|+|||++.+..++.++|||||||++|+|++|+.||....    ......+......... 
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~~~~~~~-  253 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKGKYKMNP-  253 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHTCCCCCH-
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcCCCCCCc-
Confidence            99887554444445679999999999999899999999999999999999999986532    2333334333332211 


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       .........+.+||.+||+.||++|| +.+++++-+.+
T Consensus       254 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  291 (351)
T 3c0i_A          254 -RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK  291 (351)
T ss_dssp             -HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             -cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence             00011122488999999999999999 99998765543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-47  Score=348.34  Aligned_cols=254  Identities=23%  Similarity=0.367  Sum_probs=208.1

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (363)
                      ...++|++.+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            45678999999999999999999764 688999999975431 111235677888888876 899999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      |+||||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999997644   589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ...........+||+.|+|||++.+..++.++||||||+++|||++|+.||...   +.......+.......+...+  
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s--  242 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRMDNPFYPRWLE--  242 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCTTSC--
T ss_pred             cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHhCCCCCCcccC--
Confidence            544444455668999999999999999999999999999999999999998643   233344444444433332222  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hH-HHHHHHh
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQ-RVSQEFL  354 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~-~v~~~l~  354 (363)
                          ..+.++|.+||+.||++|| +. ++..+-.
T Consensus       243 ----~~~~~li~~lL~~dp~~R~~~~~~i~~hp~  272 (345)
T 1xjd_A          243 ----KEAKDLLVKLFVREPEKRLGVRGDIRQHPL  272 (345)
T ss_dssp             ----HHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             ----HHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence                1388899999999999999 65 6655443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.6e-46  Score=336.92  Aligned_cols=256  Identities=27%  Similarity=0.431  Sum_probs=198.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhc--CCCCceeeeeeEEeeC----C
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQ--IRHRNIVKLYGFCLHK----K  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~  160 (363)
                      ..++|++.+.||+|+||+||+|+. +++.||||++.....     ..+..|.+++..  ++||||+++++++...    .
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE-----KSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH-----HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc-----hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            357899999999999999999988 789999999875432     344556666555  7999999999987653    4


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEEeCCCCCCeeecCCCce
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH--------CDCIPSIVHRDISSNNILLNSKLEA  232 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~Nill~~~~~~  232 (363)
                      ..++||||+++|+|.++++..    .+++..++.++.|++.||+|||        +.   +++||||||+|||++.++.+
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred             eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence            589999999999999999643    5899999999999999999999        77   99999999999999999999


Q ss_pred             EEEeeccceeccCCCCC----ceeeccccccccccccccc------cCCccccchHHHHHHHHHHhC----------CCC
Q 046084          233 FVADFGVARLLHSDSSN----RTVVAGTHGYIAPELAYTM------VLTEKCDVYSFGVVALEVLMG----------RHP  292 (363)
Q Consensus       233 kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g----------~~p  292 (363)
                      ||+|||++.........    .....||+.|+|||++.+.      .++.++||||||+++|||++|          +.|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            99999999876443322    1234689999999998876      556799999999999999999          788


Q ss_pred             CCCCcCCCch-hhHHhhhc--ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          293 GDLLSSVNPK-IMLIDLLD--QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       293 ~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      |......... ........  ...+..............+.+++.+||+.||++|| +.++++.|..
T Consensus       233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            7554332211 11222111  11111111111222344689999999999999999 9999998864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-46  Score=341.65  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=199.2

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe----CCCCEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL----PSGKKVALKKLHHSET--ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      ..++|++.+.||+|+||.||++..    .+|+.||+|++.....  .......+.+|+.+++.++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            357899999999999999999976    4788999999976532  1223456788999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..++||||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            9999999999999999997644   589999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      ..............||+.|+|||++.+..++.++||||||+++|||++|+.||....   .......+.......+...+
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~p~~~~  245 (327)
T 3a62_A          169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKCKLNLPPYLT  245 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCCCTTSC
T ss_pred             cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCCCCC
Confidence            765433333444579999999999998889999999999999999999999986532   23334444444444333222


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC------hHHHHHHHhc
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP------MQRVSQEFLV  355 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP------~~~v~~~l~~  355 (363)
                      .      .+.+++.+||+.||++||      +.+++.+-..
T Consensus       246 ~------~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f  280 (327)
T 3a62_A          246 Q------EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF  280 (327)
T ss_dssp             H------HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred             H------HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence            1      388999999999999998      3466665544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.2e-47  Score=338.58  Aligned_cols=254  Identities=24%  Similarity=0.439  Sum_probs=206.3

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +..++|++.+.||+|+||.||++.+.++..||+|++.......   +.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            3467899999999999999999999888899999998765443   5688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        98 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             EeccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            999999999999976332  589999999999999999999999   999999999999999999999999999976532


Q ss_pred             CCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc-CCCCCCChhh
Q 046084          246 DSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR-VPSPIDDQTV  322 (363)
Q Consensus       246 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  322 (363)
                      ... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......   .....+.... ...+...+  
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~--  247 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQGLRLYRPHLAS--  247 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTTCCCCCCTTCC--
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHHhcccCCCCCCcCC--
Confidence            211 1122346778999999998889999999999999999998 99998754432   2222222221 11222111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                          ..+.+++.+||+.||++|| +.+++++|...
T Consensus       248 ----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          248 ----EKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             ----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                1488999999999999999 99999998653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-46  Score=337.73  Aligned_cols=249  Identities=27%  Similarity=0.398  Sum_probs=207.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||++... +|+.||+|++...... ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999764 6899999999754321 12245678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999998654   589999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                         .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...   +.......+.......+...+.    
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~p~~~~~----  228 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELRFPPFFNE----  228 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCCCCTTSCH----
T ss_pred             ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCCCCCH----
Confidence               233457999999999999999999999999999999999999998643   3334444555554444432222    


Q ss_pred             HHHHHHHHHHccCCCCCCCC------hHHHHHHHh
Q 046084          326 IILVSKIVFACLRSKPTSRP------MQRVSQEFL  354 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP------~~~v~~~l~  354 (363)
                        .+.+++.+||+.||++||      +.+++.+-.
T Consensus       229 --~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~  261 (318)
T 1fot_A          229 --DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  261 (318)
T ss_dssp             --HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             --HHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence              388899999999999998      345554433

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.1e-47  Score=349.34  Aligned_cols=267  Identities=23%  Similarity=0.366  Sum_probs=212.6

Q ss_pred             cHHHHHHHhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeee
Q 046084           80 TFQEMIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKL  152 (363)
Q Consensus        80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l  152 (363)
                      ....+.+..++|++.+.||+|+||.||+|.+      .+++.||||++....... ..+.+.+|+++++++ +||||+++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH-HHHHHHHHHHHHHhhcCCcceeee
Confidence            3455667788999999999999999999963      345789999998654432 346799999999999 79999999


Q ss_pred             eeEEeeCCe-EEEEEEeccCCChhhhhhcCCC------------------------------------------------
Q 046084          153 YGFCLHKKC-MFLIYKYMRRGSLFCILRNDDE------------------------------------------------  183 (363)
Q Consensus       153 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------  183 (363)
                      ++++.+.+. .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999988654 8999999999999999976532                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          184 ---------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       184 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                                     ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           11288999999999999999999999   999999999999999999999999999986643322


Q ss_pred             --CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHH
Q 046084          249 --NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQ  324 (363)
Q Consensus       249 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  324 (363)
                        ......||+.|+|||++.+..++.++||||||+++|||++ |+.||......  ......+... ....+...+    
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~----  322 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTRMRAPDYTT----  322 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHHHHHTCCCCCCTTCC----
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHHHHHHHcCCCCCCCCCCC----
Confidence              2233567889999999999999999999999999999998 99998654322  1111222221 222222222    


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                        ..+.+++.+||+.||++|| +.|++++|.....
T Consensus       323 --~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          323 --PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence              1388999999999999999 9999999976443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.8e-46  Score=334.41  Aligned_cols=258  Identities=26%  Similarity=0.389  Sum_probs=202.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||++.+ .+++.||+|.+.... ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            56899999999999999999975 468899999986543 2334457899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999997654   589999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          246 DSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       246 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....   ............+... ......
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~-~~~~~~  239 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA---VSIAIKHIQDSVPNVT-TDVRKD  239 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH---HHHHHHHHSSCCCCHH-HHSCTT
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhhccCCCcc-hhcccC
Confidence            322 22335689999999999999999999999999999999999999865432   2222222222222110 000001


Q ss_pred             HHHHHHHHHHHccCCCCCCCC--hHHHHHHHhc
Q 046084          325 DIILVSKIVFACLRSKPTSRP--MQRVSQEFLV  355 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP--~~~v~~~l~~  355 (363)
                      .+..+.+++.+||+.||++||  +.++...|..
T Consensus       240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            112488999999999999999  5666665543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.1e-47  Score=344.71  Aligned_cols=253  Identities=24%  Similarity=0.358  Sum_probs=205.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|++....... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36799999999999999999976 678899999986543211 1235688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+ +|+|.+++....   .+++.+++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 678988886544   599999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      . ......+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||+......   ....+.......+...+    
T Consensus       161 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~~~~~~~p~~~s----  232 (336)
T 3h4j_B          161 G-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---LFKKVNSCVYVMPDFLS----  232 (336)
T ss_dssp             S-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---CBCCCCSSCCCCCTTSC----
T ss_pred             C-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---HHHHHHcCCCCCcccCC----
Confidence            3 23344579999999999988776 689999999999999999999986543221   11112222222222222    


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                        ..+.+|+.+||+.||.+|| +.|++++-+...
T Consensus       233 --~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          233 --PGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             --HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             --HHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence              1378899999999999999 999988776543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.6e-47  Score=344.78  Aligned_cols=253  Identities=22%  Similarity=0.366  Sum_probs=203.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCC--CceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH--RNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||++...+++.||+|++..........+.+.+|+.+++.++|  |||+++++++.+.+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            46799999999999999999998889999999998766555556789999999999976  9999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      || +.+++|.+++....   .+++.++..++.|++.||+|||+.   +++||||||+|||++ ++.+||+|||++.....
T Consensus        88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 56889999998754   689999999999999999999999   999999999999997 57899999999987643


Q ss_pred             CCC--Cceeecccccccccccccc-----------ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          246 DSS--NRTVVAGTHGYIAPELAYT-----------MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       246 ~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      ...  ......||+.|+|||++.+           ..++.++||||||+++|||++|+.||.....  .........+..
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~  237 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIIDPN  237 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHCTT
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHHHhcCC
Confidence            322  2234579999999999864           6788999999999999999999999864322  122223333322


Q ss_pred             CC--CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          313 VP--SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       313 ~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..  .+...+      ..+.+++.+||+.||++|| +.|++++.+.+
T Consensus       238 ~~~~~~~~~~------~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          238 HEIEFPDIPE------KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             SCCCCCCCSC------HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             cccCCcccCC------HHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            22  222111      1378999999999999999 99999887654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.6e-46  Score=338.93  Aligned_cols=257  Identities=24%  Similarity=0.422  Sum_probs=208.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      ..++|.+.+.||+|+||.||++..      .++..||+|.+...... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP-SELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH-HHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            467899999999999999999975      34578999999865433 33578899999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCC
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDE---------------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDI  219 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  219 (363)
                      ..++||||+++++|.+++.....                     ...+++..++.++.|+++||+|||+.   +++||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence            99999999999999999976432                     12488999999999999999999999   9999999


Q ss_pred             CCCCeeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCC
Q 046084          220 SSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLL  296 (363)
Q Consensus       220 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~  296 (363)
                      ||+||+++.++.+||+|||++.........  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876433221  223346788999999998889999999999999999999 99998654


Q ss_pred             cCCCchhhHHhhhccc-CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          297 SSVNPKIMLIDLLDQR-VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ...   .....+.... ...+...+      ..+.+++.+||+.||++|| +.++++.|...
T Consensus       257 ~~~---~~~~~~~~~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          257 PPE---RLFNLLKTGHRMERPDNCS------EEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             CGG---GHHHHHHTTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHH---HHHHHhhcCCcCCCCccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            332   2222222221 11222111      2488999999999999999 99999988653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.2e-46  Score=341.61  Aligned_cols=240  Identities=23%  Similarity=0.337  Sum_probs=203.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||++... +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367999999999999999999764 689999999865432 112346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999999997654   589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .   ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...   +.......+.......+...+.    
T Consensus       194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~p~~~~~----  263 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVRFPSHFSS----  263 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCTTCCH----
T ss_pred             C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCH----
Confidence            2   23457999999999999999999999999999999999999998643   3334445555555444433222    


Q ss_pred             HHHHHHHHHHccCCCCCCCC
Q 046084          326 IILVSKIVFACLRSKPTSRP  345 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP  345 (363)
                        .+.++|.+||+.||++||
T Consensus       264 --~~~~li~~lL~~dp~~R~  281 (350)
T 1rdq_E          264 --DLKDLLRNLLQVDLTKRF  281 (350)
T ss_dssp             --HHHHHHHHHSCSCTTTCT
T ss_pred             --HHHHHHHHHhhcCHHhcc
Confidence              388999999999999999

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.9e-47  Score=346.09  Aligned_cols=255  Identities=21%  Similarity=0.312  Sum_probs=208.9

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (363)
                      ..++|++.+.||+|+||.||++... +|+.||+|++.....      ...+|++++.++ +||||+++++++.+.+..++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            3567999999999999999999764 688999999976543      234678888877 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC----CceEEEeeccc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK----LEAFVADFGVA  240 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~  240 (363)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||+.++    +.+||+|||++
T Consensus        94 v~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             EECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            999999999999997654   589999999999999999999999   99999999999998543    35999999999


Q ss_pred             eeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      .............+||+.|+|||++.+..++.++||||||+++|||++|+.||..............+.......+....
T Consensus       168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  247 (342)
T 2qr7_A          168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW  247 (342)
T ss_dssp             EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred             ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence            87755544455667899999999998888999999999999999999999999765444444555555554443322110


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        ......+.+||.+||+.||++|| +.+++++-+.
T Consensus       248 --~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          248 --NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             --TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             --ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence              01112488999999999999999 9999887655

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-46  Score=347.11  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=199.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHH-HhcCCCCceeeeeeEEeeCCeEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHL-LSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      .++|++.+.||+|+||.||+++.. +++.||+|++..... .......+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999764 578899999976542 22223456667766 567899999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999997644   589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||...   +.......+.......+...+.   
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~---  264 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNKPLQLKPNITN---  264 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHHHSCCCCCSSSCH---
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcccCCCCCCCH---
Confidence            4444455668999999999999999999999999999999999999998643   3334445555554443332222   


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                         .+.+||.+||+.||++|| +.+.+.++
T Consensus       265 ---~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          265 ---SARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             ---HHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             ---HHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence               378899999999999999 75444443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=348.29  Aligned_cols=259  Identities=25%  Similarity=0.406  Sum_probs=210.4

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC--------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP--------SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFC  156 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (363)
                      +..++|.+.+.||+|+||.||+|...        ++..||+|++...... ...+.+.+|+++++.+ +||||+++++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-HHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            45678999999999999999999752        2357999999876443 3357789999999999 999999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNN  223 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  223 (363)
                      .+.+..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            999999999999999999999976431             23589999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCC
Q 046084          224 ILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVN  300 (363)
Q Consensus       224 ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~  300 (363)
                      ||++.++.+||+|||++........  ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.....  
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--  299 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  299 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999986643322  2223456789999999999999999999999999999999 9999865432  


Q ss_pred             chhhHHhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          301 PKIMLIDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       301 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                       ......+... ....+...+      ..+.+++.+||+.||++|| +.|+++.|....
T Consensus       300 -~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          300 -EELFKLLKEGHRMDKPSNCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             -HHHHHHHHTTCCCCCCSSCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHHHcCCCCCCCccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             2222222222 222222222      1488999999999999999 999999986543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-47  Score=346.59  Aligned_cols=260  Identities=26%  Similarity=0.423  Sum_probs=210.9

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCL  157 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  157 (363)
                      +....++|++.+.||+|+||.||+|...      +++.||+|.++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-HHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            3445788999999999999999999764      3478999999865433 33578999999999999999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEE
Q 046084          158 HKKCMFLIYKYMRRGSLFCILRNDDE---------------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH  216 (363)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  216 (363)
                      +.+..++||||+++|+|.+++.....                     ...+++.+++.++.|+++||+|||+.   +++|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            99999999999999999999976421                     14689999999999999999999999   9999


Q ss_pred             eCCCCCCeeecCCCceEEEeeccceeccCCC--CCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCC
Q 046084          217 RDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPG  293 (363)
Q Consensus       217 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~  293 (363)
                      |||||+|||++.++.+||+|||++.......  .......+++.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            9999999999999999999999997653322  12233457889999999998889999999999999999999 99998


Q ss_pred             CCCcCCCchhhHHhhhcccCC-CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          294 DLLSSVNPKIMLIDLLDQRVP-SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ....   .......+...... .+...+      ..+.+++.+||+.||++|| +.++++.|..-
T Consensus       278 ~~~~---~~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~  333 (343)
T 1luf_A          278 YGMA---HEEVIYYVRDGNILACPENCP------LELYNLMRLCWSKLPADRPSFCSIHRILQRM  333 (343)
T ss_dssp             TTSC---HHHHHHHHHTTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCC---hHHHHHHHhCCCcCCCCCCCC------HHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence            6543   22233333333322 222222      2488999999999999999 99999988653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.9e-46  Score=353.44  Aligned_cols=250  Identities=25%  Similarity=0.441  Sum_probs=205.5

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-eEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-CMFL  164 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~l  164 (363)
                      +..++|++.+.||+|+||.||+|.+ .|+.||||+++....    .+.|.+|+.+|++++||||+++++++.+.. ..++
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCTT----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCchH----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            3457889999999999999999988 478999999986542    367899999999999999999999988765 7899


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus       265 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            9999999999999976432 2478999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhh
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTV  322 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  322 (363)
                      ..   .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......   ....+... +++.+...+. 
T Consensus       341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~~~~~~p~~~~~-  413 (450)
T 1k9a_A          341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYKMDAPDGCPP-  413 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHHHTTCCCCCCTTCCH-
T ss_pred             cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCCCCCCcCCH-
Confidence            22   122357889999999999999999999999999999998 999987654322   22222222 2333332222 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                           .+.+||.+||+.||++|| +.+++..|...
T Consensus       414 -----~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          414 -----AVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             -----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                 488999999999999999 99999988654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.4e-46  Score=341.67  Aligned_cols=254  Identities=22%  Similarity=0.376  Sum_probs=202.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK------  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (363)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...... ...+.+.+|+.++++++||||+++++++.+..      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT-THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch-hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            467999999999999999999875 7899999999754432 23467899999999999999999999986643      


Q ss_pred             ---------------------------------------------------eEEEEEEeccCCChhhhhhcCCCCCCCCH
Q 046084          161 ---------------------------------------------------CMFLIYKYMRRGSLFCILRNDDEAIRLDW  189 (363)
Q Consensus       161 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~  189 (363)
                                                                         ..+++|||+++++|.+++.........++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               37999999999999999988765556778


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC------------Cceeecccc
Q 046084          190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS------------NRTVVAGTH  257 (363)
Q Consensus       190 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~g~~  257 (363)
                      ..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++........            ......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            88999999999999999999   999999999999999999999999999987654321            123346899


Q ss_pred             ccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHcc
Q 046084          258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACL  337 (363)
Q Consensus       258 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  337 (363)
                      .|+|||.+.+..++.++||||||+++|||++|..|+...     ............+     .........+.+++.+||
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l  310 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVRNLKFP-----LLFTQKYPQEHMMVQDML  310 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHHTTCCC-----HHHHHHCHHHHHHHHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhhccCCC-----cccccCChhHHHHHHHHc
Confidence            999999999999999999999999999999988773211     1111122222111     111222234789999999


Q ss_pred             CCCCCCCC-hHHHHHHHhc
Q 046084          338 RSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       338 ~~dP~~RP-~~~v~~~l~~  355 (363)
                      +.||++|| +.|++++-..
T Consensus       311 ~~~p~~Rps~~~~l~~~~f  329 (332)
T 3qd2_B          311 SPSPTERPEATDIIENAIF  329 (332)
T ss_dssp             CSSGGGSCCHHHHHHSTTC
T ss_pred             cCCCCcCCCHHHHhhchhh
Confidence            99999999 9999986554

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-46  Score=341.47  Aligned_cols=259  Identities=25%  Similarity=0.426  Sum_probs=192.8

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEeCCCC----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQLPSGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      .+..++|++.+.||+|+||.||+|.+....    .||+|.+..........+.+.+|+.+++.++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            345678999999999999999999765432    7999999765433344678999999999999999999999998876


Q ss_pred             eE------EEEEEeccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc
Q 046084          161 CM------FLIYKYMRRGSLFCILRNDD---EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE  231 (363)
Q Consensus       161 ~~------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  231 (363)
                      ..      +++|||+++|+|.+++....   ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence            54      89999999999999986432   223589999999999999999999999   9999999999999999999


Q ss_pred             eEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhh
Q 046084          232 AFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDL  308 (363)
Q Consensus       232 ~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~  308 (363)
                      +||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......   .....+
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~  252 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNYL  252 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHHH
Confidence            99999999986543322  1223346778999999999999999999999999999999 99998754332   222222


Q ss_pred             hccc-CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          309 LDQR-VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       309 ~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .... ...+...+      ..+.+++.+||+.||++|| +.++++.|..
T Consensus       253 ~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  295 (323)
T 3qup_A          253 IGGNRLKQPPECM------EEVYDLMYQCWSADPKQRPSFTCLRMELEN  295 (323)
T ss_dssp             HTTCCCCCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             hcCCCCCCCCccC------HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            2222 22222222      2488999999999999999 9999988864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.9e-46  Score=353.17  Aligned_cols=253  Identities=24%  Similarity=0.414  Sum_probs=211.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467999999999999999999764 7899999999754321 12346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999997644   699999999999999999999999   999999999999999999999999999987644


Q ss_pred             CCCCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      . ......+||+.|+|||++.+..+ +.++||||||+++|||++|+.||+...   .......+.......+...+.   
T Consensus       169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~---  241 (476)
T 2y94_A          169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH---VPTLFKKICDGIFYTPQYLNP---  241 (476)
T ss_dssp             T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---SHHHHHHHHTTCCCCCTTCCH---
T ss_pred             c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCcCCCccCCH---
Confidence            3 23345579999999999988765 689999999999999999999986532   333444455544443332222   


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                         .+.+||.+||+.||++|| +.+++.+-..+
T Consensus       242 ---~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~  271 (476)
T 2y94_A          242 ---SVISLLKHMLQVDPMKRATIKDIREHEWFK  271 (476)
T ss_dssp             ---HHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             ---HHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence               378899999999999999 99999876554

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=340.99  Aligned_cols=257  Identities=22%  Similarity=0.314  Sum_probs=208.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchH----HHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETEL----AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||.||++... +|+.||+|.+.......    ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456999999999999999999764 68899999987643211    1236788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC----ceEEEeec
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL----EAFVADFG  238 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg  238 (363)
                      ++||||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999997543   689999999999999999999999   999999999999998887    89999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      ++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....   .......+.......+. 
T Consensus       164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~-  238 (326)
T 2y0a_A          164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVNYEFED-  238 (326)
T ss_dssp             TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHTCCCCCH-
T ss_pred             CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHhcCCCcCc-
Confidence            998764332 2334569999999999998899999999999999999999999986432   22222333222222111 


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       .........+.+++.+||+.||++|| +.|++.+-..+
T Consensus       239 -~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  276 (326)
T 2y0a_A          239 -EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  276 (326)
T ss_dssp             -HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred             -cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence             00111122488999999999999999 99999876553

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.4e-47  Score=344.64  Aligned_cols=255  Identities=17%  Similarity=0.216  Sum_probs=207.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++......    +.+..|+.+++.+ +||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            46899999999999999999975 57889999998755432    4578899999999 999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc-----eEEEeeccc
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE-----AFVADFGVA  240 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~~  240 (363)
                      |||+ +++|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.     +||+|||++
T Consensus        84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             EEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            9999 999999998642  2699999999999999999999999   9999999999999998887     999999999


Q ss_pred             eeccCCCCC-------ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          241 RLLHSDSSN-------RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       241 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      .........       .....||+.|+|||++.+..++.++||||||+++|||++|+.||..............+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            876443221       2345799999999999999999999999999999999999999987654444333333332222


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      +.+... .....+ .+.+++..||+.||.+|| +.++.+.|.
T Consensus       238 ~~~~~~-~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          238 ATPIEV-LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             HSCHHH-HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             cCCHHH-HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            211100 000011 488999999999999999 999888775

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.5e-46  Score=345.52  Aligned_cols=256  Identities=23%  Similarity=0.315  Sum_probs=197.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||++... +++.||+|++.......   +.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            468999999999999999999765 78899999997654322   56789999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc--eEEEeeccceecc
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE--AFVADFGVARLLH  244 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~  244 (363)
                      ||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.  +||+|||+++...
T Consensus        96 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           96 EYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            9999999999987644   599999999999999999999999   9999999999999987765  9999999997543


Q ss_pred             CCCCCceeeccccccccccccccccCCcc-ccchHHHHHHHHHHhCCCCCCCCcCCCc-hhhHHhhhcccCCCCCCChhh
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEK-CDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      .. .......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||........ ......+.......+....  
T Consensus       170 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  246 (361)
T 3uc3_A          170 LH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--  246 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC--
T ss_pred             cc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC--
Confidence            22 22334569999999999988777655 8999999999999999999976544322 2223333333332222111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                        ....+.+||.+||+.||++|| +.|++++-+..+
T Consensus       247 --~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          247 --ISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             --CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             --CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence              111378999999999999999 999998866543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-47  Score=348.72  Aligned_cols=258  Identities=26%  Similarity=0.386  Sum_probs=207.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      ..++|++.+.||+|+||.||+|.+.      ++..||||++....... ....+.+|+.+++.++||||+++++++.+.+
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-DELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh-hHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            3568999999999999999999742      45689999997654332 2457889999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC---ceE
Q 046084          161 CMFLIYKYMRRGSLFCILRNDD----EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL---EAF  233 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~k  233 (363)
                      ..++||||+++|+|.+++....    ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999997542    223589999999999999999999999   999999999999998554   599


Q ss_pred             EEeeccceeccCCC--CCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc
Q 046084          234 VADFGVARLLHSDS--SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD  310 (363)
Q Consensus       234 l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  310 (363)
                      |+|||+++......  .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....   ......+..
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~i~~  301 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVTS  301 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHT
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc
Confidence            99999997542221  22233457889999999998899999999999999999998 9999865432   222333332


Q ss_pred             cc-CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          311 QR-VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       311 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .. ...+...+.      .+.+|+.+||+.||++|| +.++++.|....
T Consensus       302 ~~~~~~~~~~~~------~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          302 GGRMDPPKNCPG------PVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TCCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCccCCH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            22 222222221      388999999999999999 999999987643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8e-47  Score=343.88  Aligned_cols=261  Identities=25%  Similarity=0.403  Sum_probs=209.2

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEeCC------CCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQLPS------GKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFC  156 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (363)
                      +....++|++.+.||+|+||.||+|....      +..||+|.+...... ...+.+.+|+.+++.+ +||||+++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            44557889999999999999999997632      247999999866543 2347789999999999 899999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCee
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDD-----------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNIL  225 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  225 (363)
                      .+.+..++||||+++|+|.+++....           ....+++..++.++.|++.||+|||+.   +++||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence            99999999999999999999986431           123589999999999999999999999   9999999999999


Q ss_pred             ecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCch
Q 046084          226 LNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPK  302 (363)
Q Consensus       226 l~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~  302 (363)
                      ++.++.+||+|||++.........  .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......   
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---  273 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---  273 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---
Confidence            999999999999999865433321  223446788999999988889999999999999999998 99998654322   


Q ss_pred             hhHHhhhcccC--CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          303 IMLIDLLDQRV--PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       303 ~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ...........  ..+...+      ..+.+++.+||+.||++|| +.++++.|....
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          274 SKFYKLVKDGYQMAQPAFAP------KNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHHHHHHTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCCCC------HHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            12222222221  1122121      2488999999999999999 999999886543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=336.85  Aligned_cols=252  Identities=26%  Similarity=0.465  Sum_probs=197.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .++|++.+.||+|+||.||+++. .++.||+|.+.....    .+.+.+|+.++++++||||+++++++.+  ..++|||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e   79 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE----RKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME   79 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTH----HHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhH----HHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence            46789999999999999999988 578999999875432    3678899999999999999999998874  4789999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc-eEEEeeccceeccCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE-AFVADFGVARLLHSD  246 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~  246 (363)
                      |+++|+|.+++........+++..++.++.|+++||+|||+.+..+++||||||+|||++.++. +||+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            9999999999987654445889999999999999999999932228999999999999988876 799999999765322


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQD  325 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  325 (363)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||+....... ......... ..+.+...+     
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-----  230 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMWAVHNGTRPPLIKNLP-----  230 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHHHHHTTCCCCCBTTCC-----
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHHHHhcCCCCCcccccC-----
Confidence               2234589999999999998999999999999999999999999875433221 111122222 222222222     


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       ..+.+++.+||+.||++|| +.++++.|...
T Consensus       231 -~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          231 -KPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             -HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence             1388999999999999999 99999988654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=343.61  Aligned_cols=260  Identities=25%  Similarity=0.411  Sum_probs=207.8

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFC  156 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (363)
                      +.+..++|++.+.||+|+||.||+|.+      .++..||+|.+..... ....+.+.+|+.+++++ +||||+++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            344578899999999999999999975      2456899999975432 23346789999999999 899999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEE
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDDEA--------------------IRLDWTKRVNIVKSMAHALSYLHCDCIPSIVH  216 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  216 (363)
                      ...+..++||||+++|+|.+++......                    ..+++..++.++.|++.||+|||+.   +++|
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  195 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  195 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            9999999999999999999999765421                    2479999999999999999999999   9999


Q ss_pred             eCCCCCCeeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCC
Q 046084          217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPG  293 (363)
Q Consensus       217 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~  293 (363)
                      |||||+|||++.++.+||+|||++.........  .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999999999876443322  223456789999999988889999999999999999998 99998


Q ss_pred             CCCcCCCchhhHHhhhccc--CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          294 DLLSSVNPKIMLIDLLDQR--VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ......   ..........  .+.+...+      ..+.+++.+||+.||++|| +.+++..|...
T Consensus       276 ~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          276 PGIPVD---ANFYKLIQNGFKMDQPFYAT------EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             TTCCCS---HHHHHHHHTTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCcH---HHHHHHHhcCCCCCCCCCCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            654322   1222222222  12222221      2488999999999999999 99999988653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-46  Score=341.69  Aligned_cols=249  Identities=23%  Similarity=0.304  Sum_probs=183.7

Q ss_pred             CeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           95 YCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      +.||+|+||.||++... +|+.||+|++....     ...+.+|+.+++.+. ||||+++++++.+....++||||+++|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            77999999999999764 68899999996542     256778999999996 999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC---ceEEEeeccceeccCCCCC
Q 046084          173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL---EAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~  249 (363)
                      +|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++   .+||+|||++.........
T Consensus        92 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           92 ELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             BHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999998754   699999999999999999999999   999999999999997765   8999999999876554444


Q ss_pred             ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC----CchhhHHhhhcccCCCCCCChhhHHH
Q 046084          250 RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV----NPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......    ........+.......+.  ......
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~  243 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG--EAWKNV  243 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS--HHHHTS
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc--ccccCC
Confidence            55567899999999999999999999999999999999999999764432    122233333333332221  111122


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ...+.+||.+||+.||++|| +.+++.+-+.+
T Consensus       244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~  275 (325)
T 3kn6_A          244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ  275 (325)
T ss_dssp             CHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred             CHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence            33588999999999999999 99988776554

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=331.30  Aligned_cols=255  Identities=25%  Similarity=0.442  Sum_probs=186.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35799999999999999999976 57899999998654321 12246788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++....  ..+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999999997643  2689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .........|++.|+|||.+.+..++.++||||||+++|||++|+.||.......   ............+...+     
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~-----  236 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLADYEMPSFLS-----  236 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCCCCCTTSC-----
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHHHHhhcccCCccccC-----
Confidence            4433444578999999999998889999999999999999999999986543221   11222222222222111     


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       ..+.+++.+||+.||++|| +.+++.+-...
T Consensus       237 -~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  267 (278)
T 3cok_A          237 -IEAKDLIHQLLRRNPADRLSLSSVLDHPFMS  267 (278)
T ss_dssp             -HHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC
T ss_pred             -HHHHHHHHHHcccCHhhCCCHHHHhcCcccc
Confidence             2488999999999999999 99998866544

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3e-46  Score=347.01  Aligned_cols=255  Identities=21%  Similarity=0.359  Sum_probs=203.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC--CCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR--HRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||++...+++.||||++..........+.+.+|+.+++.++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3569999999999999999999888999999999766555555678999999999996  59999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      || +.+++|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+|||++ ++.+||+|||++.....
T Consensus       135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 66889999998654   688999999999999999999999   999999999999995 57999999999987643


Q ss_pred             CCC--Cceeecccccccccccccc-----------ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          246 DSS--NRTVVAGTHGYIAPELAYT-----------MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       246 ~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      ...  ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....  .......+.+..
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~~~~~  284 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIIDPN  284 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHCTT
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHHhCcc
Confidence            322  1234579999999998865           3688999999999999999999999864322  222233344333


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .........    ...+.+||.+||+.||++|| +.|++.+.+.+
T Consensus       285 ~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          285 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             SCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ccCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence            222111111    11388999999999999999 99999876543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.6e-47  Score=358.85  Aligned_cols=256  Identities=26%  Similarity=0.468  Sum_probs=209.4

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      +.+..++|++.+.||+|+||.||+|.+.++..||||+++.....   .+.|.+|+.+|+.++||||+++++++. .+..+
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            44567889999999999999999999988889999999865543   367999999999999999999999987 56689


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            99999999999999975421 2478899999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc-ccCCCCCCCh
Q 046084          244 HSDSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPSPIDDQ  320 (363)
Q Consensus       244 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  320 (363)
                      ..... ......++..|+|||++....++.++||||||+++|||++ |+.||.....   ......+.. .+.+.+...+
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~~~~~~~  411 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRMPRPENCP  411 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCCCCCTTSC
T ss_pred             CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCC
Confidence            33211 1122345778999999998889999999999999999999 9999865432   222222222 2233333222


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                            ..+.+||.+||+.||++|| +.+++..|...
T Consensus       412 ------~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          412 ------EELYNIMMRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             ------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ------HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                  2488999999999999999 99999988754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.5e-46  Score=329.83  Aligned_cols=257  Identities=21%  Similarity=0.333  Sum_probs=210.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|+.++++++||||+++++++.+.+..+++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999976 46889999999876655555678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc---eEEEeeccceec
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE---AFVADFGVARLL  243 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~  243 (363)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999988887654   589999999999999999999999   9999999999999976655   999999999876


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      .... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....   .......+.......+....  .
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~--~  232 (284)
T 3kk8_A          159 NDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPSPEW--D  232 (284)
T ss_dssp             CSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCTTTT--T
T ss_pred             ccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccccCCchhh--c
Confidence            4332 2334568999999999999999999999999999999999999986532   22233333333322221110  0


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .....+.+++.+||+.||++|| +.|++++-..+
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (284)
T 3kk8_A          233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC  266 (284)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred             ccCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence            0112488999999999999999 99998876544

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.3e-46  Score=344.71  Aligned_cols=262  Identities=19%  Similarity=0.295  Sum_probs=207.6

Q ss_pred             hcCCcccCeeeec--CceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           88 TEDFDIKYCIGTG--GYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      .++|++.+.||+|  +||.||++... +|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            5679999999999  99999999775 78999999998766555566788999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999976532 2589999999999999999999999   99999999999999999999999999886543


Q ss_pred             CCC-------CCceeecccccccccccccc--ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCC
Q 046084          245 SDS-------SNRTVVAGTHGYIAPELAYT--MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS  315 (363)
Q Consensus       245 ~~~-------~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  315 (363)
                      ...       .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.......   ..........+.
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~  256 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKLNGTVPC  256 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT---HHHHC-------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHhcCCCCc
Confidence            221       11122468899999999887  678999999999999999999999987543322   111111111100


Q ss_pred             CC----------------------------------------CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          316 PI----------------------------------------DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       316 ~~----------------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ..                                        ..+........+.+||.+||+.||++|| +.|++++-.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence            00                                        0000011123488999999999999999 999988755


Q ss_pred             ch
Q 046084          355 VR  356 (363)
Q Consensus       355 ~~  356 (363)
                      .+
T Consensus       337 f~  338 (389)
T 3gni_B          337 FK  338 (389)
T ss_dssp             GG
T ss_pred             HH
Confidence            44

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-46  Score=342.48  Aligned_cols=256  Identities=21%  Similarity=0.281  Sum_probs=208.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.......  ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh--HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999764 68899999987654322  357889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC--CCceEEEeeccceecc
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS--KLEAFVADFGVARLLH  244 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~  244 (363)
                      ||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++.  ++.+||+|||++....
T Consensus       128 E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          128 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            9999999999987543  2589999999999999999999999   9999999999999974  5789999999998764


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ......+.......+....  ..
T Consensus       203 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~--~~  276 (387)
T 1kob_A          203 PD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCDWEFDEDAF--SS  276 (387)
T ss_dssp             TT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCCCCCCSSTT--TT
T ss_pred             CC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCcccc--cc
Confidence            43 233445799999999999999999999999999999999999999865332   2223333332222111100  01


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ....+.++|.+||+.||++|| +.|++++-..+
T Consensus       277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (387)
T 1kob_A          277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  309 (387)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence            112488999999999999999 99999876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.1e-46  Score=340.28  Aligned_cols=251  Identities=25%  Similarity=0.457  Sum_probs=197.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCC----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||+||+|.+. +++    +||+|.+..... ....+.+.+|+.++++++||||++++++|.+.. .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            467999999999999999999753 444    468888765432 233467899999999999999999999998765 7


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++++||+.+|+|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            889999999999999976543  589999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc--cCCCCC
Q 046084          243 LHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ--RVPSPI  317 (363)
Q Consensus       243 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  317 (363)
                      .......  .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||+......    ....+..  ..+.+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~~~~~~~~  242 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQPP  242 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHHTTCCCCCCT
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHHHHHcCCCCCCCc
Confidence            6443322  223346789999999999999999999999999999999 999987543322    1222221  222222


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..+      ..+.+++.+||+.||++|| +.+++.+|..
T Consensus       243 ~~~------~~~~~li~~~l~~~p~~Rps~~ell~~l~~  275 (327)
T 3poz_A          243 ICT------IDVYMIMVKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             TBC------HHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred             cCC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            222      1388899999999999999 9999998854

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.8e-46  Score=331.39  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=196.8

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCC----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPS----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      +..++|++.+.||+|+||.||+|.+..    +..||+|.+...... ...+.+.+|+.++++++||||+++++++. .+.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            345789999999999999999997643    446999998765432 34578999999999999999999999985 456


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++||||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             cEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence            8999999999999999976432  589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc-CCCCCC
Q 046084          242 LLHSDSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR-VPSPID  318 (363)
Q Consensus       242 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~  318 (363)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......   .....+.... .+.+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~  241 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENGERLPMPPN  241 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTCCCCCCTT
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHHHcCCCCCCCCC
Confidence            7643322 1223346788999999988889999999999999999996 99998754332   2222222221 222222


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      .+      ..+.+++.+||+.||++|| +.++++.|.....
T Consensus       242 ~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          242 CP------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             CC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            22      2488999999999999999 9999999876443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.1e-46  Score=336.87  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=210.2

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLH  158 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (363)
                      ...++|++.+.||+|+||.||+|.+      .+++.||+|.+...... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            4467899999999999999999974      35678999999865543 2347899999999999 99999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDE---------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNN  223 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  223 (363)
                      .+..++||||+++|+|.+++.....               ...+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence            9999999999999999999976532               22489999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCC
Q 046084          224 ILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVN  300 (363)
Q Consensus       224 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~  300 (363)
                      |+++.++.+||+|||++.........  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... 
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-  254 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-  254 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-
Confidence            99999999999999999876543322  122346788999999988899999999999999999999 99998654322 


Q ss_pred             chhhHHhhhcccCCC--CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          301 PKIMLIDLLDQRVPS--PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                        .............  +...+      ..+.+++.+||+.||++|| +.++++.|....
T Consensus       255 --~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          255 --SKFYKMIKEGFRMLSPEHAP------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             --HHHHHHHHHTCCCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --hHHHHHhccCCCCCCcccCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence              1222222222111  11111      2488999999999999999 999999986543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-46  Score=359.60  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=209.0

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEeCC-CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      .+..++|++.+.||+|+||.||+|.+.. +..||||.++.....   .+.|.+|+.+|++++||||++++++|.+.+..+
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            3456778899999999999999998754 789999999865443   367899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +||||+++|+|.+++..... ..+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus       293 lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999999999976432 2589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc-ccCCCCCCCh
Q 046084          244 HSDSSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPSPIDDQ  320 (363)
Q Consensus       244 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  320 (363)
                      ...... .....++..|+|||++.+..++.++||||||+++|||++ |..||.......   ....+.. .+.+.+...+
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  445 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKDYRMERPEGCP  445 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTCCCCCCTTCC
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCCCCCCCCC
Confidence            433211 112335678999999998889999999999999999999 999987544321   2222211 1222222222


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                            ..+.+||.+||+.||++|| +.++++.|..
T Consensus       446 ------~~l~~li~~cl~~dP~~RPs~~el~~~L~~  475 (495)
T 1opk_A          446 ------EKVYELMRACWQWNPSDRPSFAEIHQAFET  475 (495)
T ss_dssp             ------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ------HHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence                  2388999999999999999 9999998865

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.4e-46  Score=327.02  Aligned_cols=250  Identities=19%  Similarity=0.294  Sum_probs=205.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|.+ +++.||+|++..........+.+.+|+.++++++||||+++++++.+.  +..+++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            46799999999999999999998 588999999987765555567899999999999999999999999887  778999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      |||+++|+|.+++..... ..+++..++.++.|++.||+|||+.   +  ++||||||+||+++.++.++|+|||++...
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999999986542 2589999999999999999999998   8  999999999999999999999999987543


Q ss_pred             cCCCCCceeeccccccccccccccccCCc---cccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC--CCCCC
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTE---KCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV--PSPID  318 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  318 (363)
                      ..     ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||.....   ............  ..+..
T Consensus       164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~  235 (271)
T 3kmu_A          164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVALEGLRPTIPPG  235 (271)
T ss_dssp             SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHHSCCCCCCCTT
T ss_pred             cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHhcCCCCCCCCC
Confidence            22     2235789999999988765544   79999999999999999999865432   222222222221  12221


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .+      ..+.+++..||+.||++|| +.++++.|...
T Consensus       236 ~~------~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          236 IS------PHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             CC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            11      1388999999999999999 99999988653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=330.35  Aligned_cols=257  Identities=21%  Similarity=0.381  Sum_probs=202.9

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      +|.....||+|+||.||+|.. .+++.||+|.+......  ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR--YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH--HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            455556899999999999975 56889999998765432  246789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC-CCceEEEeeccceeccCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS-KLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~  247 (363)
                      +++++|.+++........+++..+..++.|++.||+|||+.   +++||||||+||+++. ++.+||+|||++.......
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999999998765545678999999999999999999999   9999999999999987 8999999999998765433


Q ss_pred             CCceeecccccccccccccccc--CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMV--LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .......|++.|+|||.+.+..  ++.++||||||+++|+|++|+.||......................+...+     
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  252 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS-----  252 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC-----
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC-----
Confidence            3344557899999999987643  789999999999999999999998643322111111111121222222111     


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                       ..+.+++.+||+.||++|| +.+++.+-..+.
T Consensus       253 -~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~  284 (295)
T 2clq_A          253 -AEAKAFILKCFEPDPDKRACANDLLVDEFLKV  284 (295)
T ss_dssp             -HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred             -HHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence             1388899999999999999 999988765543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.1e-46  Score=336.90  Aligned_cols=267  Identities=20%  Similarity=0.303  Sum_probs=193.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+...... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            468999999999999999999764 6889999998754422 12356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          167 KYMRRGSLFCILRNDD---EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ||++ |+|.+++....   ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 59988886431   223589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc----------
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR----------  312 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------  312 (363)
                      ...........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...................          
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence            544444445578999999999876 468999999999999999999999986543221111111111000          


Q ss_pred             -------CCC--CCCChhh------HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhh
Q 046084          313 -------VPS--PIDDQTV------IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL  359 (363)
Q Consensus       313 -------~~~--~~~~~~~------~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~  359 (363)
                             ...  +......      ......+.+++.+||+.||++|| +.|++++-......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                   000  0000000      00112488999999999999999 99999877665543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.6e-46  Score=328.39  Aligned_cols=254  Identities=30%  Similarity=0.514  Sum_probs=194.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETE--LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|.+ .++.||+|++......  ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            46799999999999999999998 5889999998765332  23346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC--------CCceEEEee
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS--------KLEAFVADF  237 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--------~~~~kl~Df  237 (363)
                      |||+++++|.+++...    .+++..++.++.|++.||+|||+....+++||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999998643    5899999999999999999999992112999999999999986        778999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCC
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPI  317 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  317 (363)
                      |++.......  .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ..............+.
T Consensus       161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~  235 (271)
T 3dtc_A          161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGVAMNKLALPI  235 (271)
T ss_dssp             CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHTSCCCCCC
T ss_pred             Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHhhhcCCCCCCC
Confidence            9997654322  2244689999999999988899999999999999999999999865432   2222222222222211


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...    ....+.+++.+||+.||++|| +.|+++.|..
T Consensus       236 ~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          236 PST----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             Ccc----cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            111    112488999999999999999 9999998863

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.8e-46  Score=332.76  Aligned_cols=260  Identities=24%  Similarity=0.432  Sum_probs=197.4

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ++..++|++.+.||+|+||+||+|...  ..||+|+++.........+.+.+|+.+++.++||||+++++++. .+..++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEE
Confidence            345678999999999999999999864  36999999877665566688999999999999999999999764 456899


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+++++|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus        97 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence            999999999999996543  2589999999999999999999999   99999999999999999999999999997653


Q ss_pred             CCC--CCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCC
Q 046084          245 SDS--SNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       245 ~~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      ...  .......||+.|+|||.+.   +..++.++||||||+++|||++|+.||......  ..................
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHTSCCCCTTS
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcccccCcchhh
Confidence            221  2223356899999999886   567888999999999999999999998654321  122222222222211100


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                       ........+.+++.+||+.||++|| +.++++.|..
T Consensus       250 -~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  285 (289)
T 3og7_A          250 -VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE  285 (289)
T ss_dssp             -SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence             0001112488999999999999999 9999998864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.2e-47  Score=338.01  Aligned_cols=257  Identities=27%  Similarity=0.446  Sum_probs=202.2

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--  159 (363)
                      ..++|++.+.||+|+||+||++++     .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++...  
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            357899999999999999999974     3678999999976543  3357899999999999999999999998654  


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      ...++||||+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             CceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            458999999999999999976542  489999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCC---CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC---------Cchh---h
Q 046084          240 ARLLHSDSS---NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV---------NPKI---M  304 (363)
Q Consensus       240 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~---------~~~~---~  304 (363)
                      +........   ......++..|+|||.+.+..++.++||||||+++|||++|..|+......         ....   .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            987643322   122234677899999999999999999999999999999999997643210         0000   1


Q ss_pred             HHhhhc--ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          305 LIDLLD--QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       305 ~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ......  ...+.+...+      ..+.+++.+||+.||++|| +.|+++.|...
T Consensus       241 ~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCP------DEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCC------HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhccCcCCCCcCcC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111111  1222222222      2488999999999999999 99999998654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.4e-47  Score=336.37  Aligned_cols=258  Identities=26%  Similarity=0.435  Sum_probs=208.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee--CCeEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH--KKCMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  164 (363)
                      .++|++.+.||+|+||.||++... +|+.||+|.+..........+.+.+|+.++++++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467999999999999999999764 78899999998765444556789999999999999999999998854  567999


Q ss_pred             EEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----cEEeCCCCCCeeecCCCceEEEeec
Q 046084          165 IYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPS-----IVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      ||||+++++|.+++.... ....+++..++.++.|++.||+|||+.   +     ++||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999987532 223589999999999999999999998   7     9999999999999999999999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC-CCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP-SPI  317 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~  317 (363)
                      ++..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....   ......+.....+ .+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~  238 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREGKFRRIPY  238 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCCCT
T ss_pred             hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHhhcccccCCc
Confidence            997764433333345689999999999988899999999999999999999999875432   2223333333222 111


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ..+      ..+.+++.+||+.||++|| +.|++++++...
T Consensus       239 ~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          239 RYS------DELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             TSC------HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             ccC------HHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            111      2488999999999999999 999999887654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.4e-46  Score=340.98  Aligned_cols=255  Identities=24%  Similarity=0.320  Sum_probs=193.0

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.....    .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            3567999999999999999999775 578999999976432    25678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceEEEeecccee
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARL  242 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~  242 (363)
                      |||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.   ++.+||+|||++..
T Consensus       127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999999987654   589999999999999999999999   9999999999999975   88999999999986


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....  .......+.......+...  .
T Consensus       201 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~~~~~~~~~~--~  275 (349)
T 2w4o_A          201 VEHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILNCEYYFISPW--W  275 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHTTCCCCCTTT--T
T ss_pred             cCccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHhCCCccCCch--h
Confidence            54322 23345689999999999998999999999999999999999999864332  1223333333332221110  0


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ......+.+|+.+||+.||++|| +.|++++-...
T Consensus       276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  310 (349)
T 2w4o_A          276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT  310 (349)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred             hhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence            01112488999999999999999 99999876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.8e-46  Score=327.66  Aligned_cols=259  Identities=25%  Similarity=0.366  Sum_probs=208.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            467999999999999999999764 7889999998755432 22467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999987543   589999999999999999999999   9999999999999999999999999999865332


Q ss_pred             C--CCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          247 S--SNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       247 ~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      .  .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.........  ...........+. ..   
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~-~~---  232 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYLNP-WK---  232 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHHHHTTCTTSTT-GG---
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhhhcccccCc-hh---
Confidence            2  12234568999999999887665 77899999999999999999998765432221  1122221111111 00   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL  359 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~  359 (363)
                      .....+.+++.+||+.||++|| +.|++++...+...
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            1112488999999999999999 99999877665544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.5e-46  Score=354.50  Aligned_cols=259  Identities=24%  Similarity=0.316  Sum_probs=212.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|.+.+.||+|+||.||++... +|+.||+|++...... ....+.+..|+.+++.++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367889999999999999999774 6899999999754321 12245688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          166 YKYMRRGSLFCILRNDDE-AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      |||++||+|.+++..... ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999876432 33699999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC-CchhhHHhhhcccCCCCCCChhhH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV-NPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.......+...+.  
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~--  418 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP--  418 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH--
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH--
Confidence            5444444568999999999999999999999999999999999999999765432 2233444444444444432222  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-h-----HHHHHHHhc
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-M-----QRVSQEFLV  355 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~-----~~v~~~l~~  355 (363)
                          .+.++|.+||+.||++|| +     .++..+-..
T Consensus       419 ----~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff  452 (543)
T 3c4z_A          419 ----ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF  452 (543)
T ss_dssp             ----HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred             ----HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence                378899999999999999 5     556554433

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.8e-47  Score=336.53  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=209.6

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      +.+..++|++.+.||+|+||.||+|.+. ++..||+|.+......   .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            3345778999999999999999999775 4788999999765443   36788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++..
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            999999999999999976432 3589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCC
Q 046084          243 LHSDSSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDD  319 (363)
Q Consensus       243 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  319 (363)
                      ....... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....+... ....+...
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~  237 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKDYRMERPEGC  237 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTCCCCCCTTC
T ss_pred             ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhccCCCCCCCCC
Confidence            6433321 222346788999999998899999999999999999999 999986543322   12222111 12222222


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +      ..+.+++.+||+.||++|| +.++++.|..
T Consensus       238 ~------~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          238 P------EKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             C------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C------HHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence            2      2488999999999999999 9999998864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.4e-46  Score=353.93  Aligned_cols=254  Identities=21%  Similarity=0.307  Sum_probs=199.3

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            356899999999999999999975 5688999999975421 22234567889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||++...
T Consensus       226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            999999999999987654   68999999999999999999998 8   9999999999999999999999999999865


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ...........||+.|+|||++.+..++.++||||||+++|||++|+.||....   .......+.......+...+.  
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~--  374 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIRFPRTLGP--  374 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCH--
T ss_pred             cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCCCccCCH--
Confidence            444444555779999999999999999999999999999999999999986432   333344444444443332222  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC------hHHHHHHHhc
Q 046084          324 QDIILVSKIVFACLRSKPTSRP------MQRVSQEFLV  355 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP------~~~v~~~l~~  355 (363)
                          .+.+||.+||+.||++||      +.|++++-..
T Consensus       375 ----~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f  408 (446)
T 4ejn_A          375 ----EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF  408 (446)
T ss_dssp             ----HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             ----HHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence                388999999999999997      5566554433

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.9e-45  Score=327.85  Aligned_cols=251  Identities=28%  Similarity=0.484  Sum_probs=201.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch--HHH---HHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE--LAF---LESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++......  ...   .+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            56899999999999999999976 57889999998654322  111   157889999999999999999999997665 


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCeeecCCCc-----eEE
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS--IVHRDISSNNILLNSKLE-----AFV  234 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~-----~kl  234 (363)
                       ++||||+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +  ++||||||+|||++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence             699999999999988865442  689999999999999999999999   8  999999999999988776     999


Q ss_pred             EeeccceeccCCCCCceeecccccccccccc--ccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          235 ADFGVARLLHSDSSNRTVVAGTHGYIAPELA--YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       235 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      +|||++.....   ......||+.|+|||.+  ....++.++||||||+++|||++|+.||........ ..........
T Consensus       171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~  246 (287)
T 4f0f_A          171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIREEG  246 (287)
T ss_dssp             CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHHHHSC
T ss_pred             CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHHhccC
Confidence            99999975432   33445689999999998  455678999999999999999999999876543221 1122222222


Q ss_pred             CC--CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          313 VP--SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       313 ~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..  .+...+      ..+.+++.+||+.||++|| +.++++.|..
T Consensus       247 ~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          247 LRPTIPEDCP------PRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             CCCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCCCCCcccC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            22  222221      2488999999999999999 9999998853

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-45  Score=332.61  Aligned_cols=275  Identities=25%  Similarity=0.407  Sum_probs=207.0

Q ss_pred             ccHHHHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhc--CCCCceeeeeeEE
Q 046084           79 ITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQ--IRHRNIVKLYGFC  156 (363)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~  156 (363)
                      ..........++|++.+.||+|+||.||+|+. .++.||+|++.....     ..+..|.+++..  ++||||+++++++
T Consensus        27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             CCcccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            33444445668899999999999999999988 489999999865432     234445555554  4899999999999


Q ss_pred             eeC----CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCcEEeCCCCCCeeec
Q 046084          157 LHK----KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC-----IPSIVHRDISSNNILLN  227 (363)
Q Consensus       157 ~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nill~  227 (363)
                      ...    ...++||||+++|+|.+++...    .+++..++.++.|++.||+|||+..     .++++||||||+|||++
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~  176 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK  176 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence            887    6899999999999999999754    4899999999999999999999761     33899999999999999


Q ss_pred             CCCceEEEeeccceeccCCCCC----ceeeccccccccccccccccCCcc------ccchHHHHHHHHHHhC--------
Q 046084          228 SKLEAFVADFGVARLLHSDSSN----RTVVAGTHGYIAPELAYTMVLTEK------CDVYSFGVVALEVLMG--------  289 (363)
Q Consensus       228 ~~~~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~------~DvwslG~il~el~~g--------  289 (363)
                      .++.+||+|||++.........    .....||+.|+|||++.+...+..      +||||||+++|||++|        
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~  256 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE  256 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence            9999999999999766433322    123468999999999887766654      9999999999999999        


Q ss_pred             --CCCCCCCcCCCch-hhHHhhh-cccCCCCCC-ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhhhhcC
Q 046084          290 --RHPGDLLSSVNPK-IMLIDLL-DQRVPSPID-DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQLK  363 (363)
Q Consensus       290 --~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~~~~~  363 (363)
                        ..||......... ....... ......... ..........+.+++.+||+.||++|| +.+++++|.......++|
T Consensus       257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  336 (337)
T 3mdy_A          257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK  336 (337)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTCC
T ss_pred             cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcccC
Confidence              5665443322211 1111111 111111111 111123444689999999999999999 999999998877666554

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.2e-46  Score=337.41  Aligned_cols=258  Identities=24%  Similarity=0.418  Sum_probs=208.2

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC--------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP--------SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFC  156 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (363)
                      +..++|++.+.||+|+||.||+|.+.        ++..||+|++...... ...+.+.+|+.+++.+ +||||+++++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-HHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            34678999999999999999999763        4678999999865443 3357789999999999 899999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNN  223 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  223 (363)
                      .+.+..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence            999999999999999999999976532             22489999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCC
Q 046084          224 ILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVN  300 (363)
Q Consensus       224 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~  300 (363)
                      ||++.++.+||+|||++.........  .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....  
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--  265 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  265 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence            99999999999999999876443221  222346788999999988889999999999999999999 9999865432  


Q ss_pred             chhhHHhhhccc-CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          301 PKIMLIDLLDQR-VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       301 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       ......+.... ...+...+      ..+.+++.+||+.||++|| +.++++.|..-
T Consensus       266 -~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          266 -EELFKLLKEGHRMDKPANCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             -HHHHHHHHHTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHhcCCCCCCCccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             22222222221 22222222      2488999999999999999 99999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-45  Score=330.62  Aligned_cols=259  Identities=17%  Similarity=0.220  Sum_probs=208.9

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (363)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++......    +.+.+|+..++.+ +|+|++++++++.+....++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            356899999999999999999975 57889999998654432    4577899999999 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc-----eEEEeecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE-----AFVADFGV  239 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~  239 (363)
                      ||||+ +++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.     +||+|||+
T Consensus        84 v~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            99999 9999999986532  589999999999999999999999   9999999999999987766     99999999


Q ss_pred             ceeccCCCC-------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          240 ARLLHSDSS-------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       240 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      +........       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            987654322       1234568999999999999899999999999999999999999998765444333333332221


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ...+... ........+.+++.+||+.||++|| +.++++.|...
T Consensus       238 ~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          238 QSTPLRE-LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHSCHHH-HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cCccHHH-HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            1111000 0001112488999999999999999 99999888653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-46  Score=341.22  Aligned_cols=265  Identities=20%  Similarity=0.260  Sum_probs=196.9

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ...++|++.+.||+|+||+||+|.. .+++.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            3457899999999999999999965 478899999998766555445678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec-----CCCceEEEeecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN-----SKLEAFVADFGV  239 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-----~~~~~kl~Dfg~  239 (363)
                      ||||+++ +|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++     .++.+||+|||+
T Consensus       111 v~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999985 9999987665   589999999999999999999999   999999999999994     455699999999


Q ss_pred             ceeccCCCCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCC--
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP--  316 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  316 (363)
                      +..............+|+.|+|||++.+. .++.++||||||+++|||++|+.||.......................  
T Consensus       184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            98765444444556789999999998764 489999999999999999999999865432211111111111000000  


Q ss_pred             -------------CCChhhHH------HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          317 -------------IDDQTVIQ------DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       317 -------------~~~~~~~~------~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                                   ........      ....+.+||.+||+.||++|| +.|++++-..+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  324 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH  324 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence                         00000000      113478999999999999999 999998776554

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-46  Score=329.92  Aligned_cols=253  Identities=25%  Similarity=0.419  Sum_probs=208.3

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..++|++.+.||+|+||.||++...+++.||+|.+.......   +.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            356899999999999999999998888899999998765433   56889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        83 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CCCTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eCCCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            99999999999976532  589999999999999999999999   9999999999999999999999999999765321


Q ss_pred             C-CCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc-CCCCCCChhhH
Q 046084          247 S-SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR-VPSPIDDQTVI  323 (363)
Q Consensus       247 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  323 (363)
                      . .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....   .......+.... ...+...+   
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~---  231 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRLYKPRLAS---  231 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCCCCCTTSC---
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHHHHHhcCCcCCCCccCc---
Confidence            1 11122346778999999988889999999999999999999 899986532   222223332221 11122111   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                         ..+.+++.+||+.||++|| +.++++.|..-
T Consensus       232 ---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          232 ---THVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               2488999999999999999 99999998654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.7e-45  Score=329.23  Aligned_cols=253  Identities=22%  Similarity=0.390  Sum_probs=211.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|.+.+.||+|+||.||++... +++.||+|.+.... ......+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999765 57889999987553 2234457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++....   .+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999887644   589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .........|++.|+|||.+.+..++.++||||||+++|+|++|+.||....   .......+.......+...+.    
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~----  240 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYSIPKHINP----  240 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCCCCTTSCH----
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhhccCCCccccCH----
Confidence            4444555678999999999998889999999999999999999999986533   222233333333333322221    


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        .+.+++.+||+.||++|| +.+++.+...
T Consensus       241 --~~~~li~~~l~~~p~~Rps~~~ll~~~~~  269 (294)
T 2rku_A          241 --VAASLIQKMLQTDPTARPTINELLNDEFF  269 (294)
T ss_dssp             --HHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             --HHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence              388899999999999999 9999886544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=333.40  Aligned_cols=252  Identities=20%  Similarity=0.214  Sum_probs=196.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (363)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||++............+..|+..+..+ +||||++++++|.+.+..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            3468999999999999999999775 789999999876544333344555566655555 89999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+ +++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus       135 v~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 6689888865432  599999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+....      ....+.....+..    ....
T Consensus       209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~~~~~~~~~~~~~----~~~~  276 (311)
T 3p1a_A          209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------GWQQLRQGYLPPE----FTAG  276 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------HHHHHTTTCCCHH----HHTT
T ss_pred             cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHhccCCCcc----cccC
Confidence            332 2334568999999998876 68999999999999999999976643221      1111222111110    0011


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ....+.+++.+||+.||++|| +.|++++-+.+
T Consensus       277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (311)
T 3p1a_A          277 LSSELRSVLVMMLEPDPKLRATAEALLALPVLR  309 (311)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence            122488999999999999999 99999876654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.4e-46  Score=331.20  Aligned_cols=254  Identities=22%  Similarity=0.371  Sum_probs=202.6

Q ss_pred             HHhcCCcccC-eeeecCceeEEEEEe---CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           86 VATEDFDIKY-CIGTGGYGSVYRAQL---PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        86 ~~~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      +..++|.+.+ .||+|+||.||+|.+   .+++.||+|++..........+.+.+|+.+++.++||||+++++++ ..+.
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            3456788888 999999999999954   3467899999987654444467899999999999999999999999 5667


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++||||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             cEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            899999999999999998654   589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCCCc---eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc-CCCC
Q 046084          242 LLHSDSSNR---TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR-VPSP  316 (363)
Q Consensus       242 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~  316 (363)
                      .........   ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+.... ...+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~  242 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERMGCP  242 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCCCC
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCCC
Confidence            764433221   22345688999999988889999999999999999999 9999865432   22222222221 2222


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...+      ..+.+++.+||+.||++|| +.++++.|..
T Consensus       243 ~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          243 AGCP------REMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             TTCC------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            2122      2488999999999999999 9999998865

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-46  Score=339.61  Aligned_cols=257  Identities=24%  Similarity=0.361  Sum_probs=198.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----e
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK----C  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  161 (363)
                      .++|++.+.||+|+||.||++.+ .+++.||+|++..... .......+.+|+.+++.++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            56899999999999999999975 5788999999976532 3344578899999999999999999999987654    3


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++||||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            499999999999999997654   589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCC---CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          242 LLHSDSS---NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       242 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      .......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ..............+..
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~  241 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVREDPIPPSA  241 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCCCCCHHH
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCCCccc
Confidence            6543322   22234689999999999999999999999999999999999999865332   22222222222211100


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        ........+.+++.+||+.||++|| +.+++.+-+.
T Consensus       242 --~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  277 (311)
T 3ork_A          242 --RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  277 (311)
T ss_dssp             --HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             --ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence              0000112488999999999999999 7776665544

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=339.89  Aligned_cols=263  Identities=19%  Similarity=0.246  Sum_probs=197.5

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|.+.+.||+|+||+||+|... +++.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc-cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            57899999999999999999765 78899999997544321 11245679999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++ +|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cccc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            9974 88888876542  589999999999999999999999   99999999999999999999999999998765444


Q ss_pred             CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh------
Q 046084          248 SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ------  320 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  320 (363)
                      .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....................+......      
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            44445578999999998876 56899999999999999999999998754332211111111111111100000      


Q ss_pred             ---------------hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          321 ---------------TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       321 ---------------~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                                     ........+.+|+.+||+.||++|| +.|++++-.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                           0000112478999999999999999 9999988776544

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-45  Score=326.88  Aligned_cols=254  Identities=29%  Similarity=0.464  Sum_probs=206.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|... ++..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999664 5678999998654322 22245788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999987654   589999999999999999999999   999999999999999999999999999865432


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....   .......+.......+...+.    
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~----  232 (279)
T 3fdn_A          162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFTFPDFVTE----  232 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCCTTSCH----
T ss_pred             c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHHHHhCCCCCCCcCCH----
Confidence            2  2334568999999999999899999999999999999999999986432   222333333333333322221    


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                        .+.+++.+||+.||++|| +.|++++-.....
T Consensus       233 --~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          233 --GARDLISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             --HHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             --HHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence              378899999999999999 9999988766543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.7e-45  Score=333.33  Aligned_cols=273  Identities=24%  Similarity=0.351  Sum_probs=213.5

Q ss_pred             CccHHHHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhc--CCCCceeeeeeE
Q 046084           78 RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQ--IRHRNIVKLYGF  155 (363)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~  155 (363)
                      ..++.......++|++.+.||+|+||.||+|+. +|+.||+|++.....     ..+..|.+++..  ++||||++++++
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~l~h~ni~~~~~~  104 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAA  104 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGH-----HHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhH-----HHHHHHHHHHHHhhcCCCcEEEEEee
Confidence            344555556678999999999999999999988 689999999965432     456778888877  789999999999


Q ss_pred             EeeCC----eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEEeCCCCCC
Q 046084          156 CLHKK----CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH--------CDCIPSIVHRDISSNN  223 (363)
Q Consensus       156 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~N  223 (363)
                      +....    ..++||||+++|+|.+++...    .+++..++.++.|++.||+|||        +.   +++||||||+|
T Consensus       105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~N  177 (342)
T 1b6c_B          105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKN  177 (342)
T ss_dssp             EECCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGG
T ss_pred             ecccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHH
Confidence            98876    789999999999999999764    4899999999999999999999        77   99999999999


Q ss_pred             eeecCCCceEEEeeccceeccCCCCC----ceeeccccccccccccccc------cCCccccchHHHHHHHHHHhC----
Q 046084          224 ILLNSKLEAFVADFGVARLLHSDSSN----RTVVAGTHGYIAPELAYTM------VLTEKCDVYSFGVVALEVLMG----  289 (363)
Q Consensus       224 ill~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g----  289 (363)
                      ||++.++.+||+|||++.........    .....||+.|+|||++.+.      .++.++||||||+++|||++|    
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            99999999999999999876543321    2334689999999998765      344789999999999999999    


Q ss_pred             ------CCCCCCCcCCC--chhhHHhhhcccCCCCCCC-hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhh
Q 046084          290 ------RHPGDLLSSVN--PKIMLIDLLDQRVPSPIDD-QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL  359 (363)
Q Consensus       290 ------~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~  359 (363)
                            ..||.......  .......+........... .........+.+|+.+||+.||++|| +.+++++|..-...
T Consensus       258 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence                  77876543322  1222222222222222111 11123344689999999999999999 99999999887776


Q ss_pred             hhcC
Q 046084          360 YQLK  363 (363)
Q Consensus       360 ~~~~  363 (363)
                      .++|
T Consensus       338 ~~~~  341 (342)
T 1b6c_B          338 EGIK  341 (342)
T ss_dssp             TC--
T ss_pred             hcCC
Confidence            6654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-45  Score=331.65  Aligned_cols=252  Identities=30%  Similarity=0.462  Sum_probs=209.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .+.|++.+.||+|+||.||+|.. .+++.||+|.+...... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            46799999999999999999975 46889999999765432 22467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++...    .+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++......
T Consensus       100 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          100 EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             ECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999999998653    589999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCC-CCCChhhHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS-PIDDQTVIQD  325 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  325 (363)
                      ........|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ......+.....+. +...+     
T Consensus       173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~-----  244 (303)
T 3a7i_A          173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIPKNNPPTLEGNYS-----  244 (303)
T ss_dssp             BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCCCSSCC-----
T ss_pred             ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhhcCCCCCCccccC-----
Confidence            4444556789999999999998999999999999999999999999865432   22222222222211 11111     


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       ..+.+++.+||+.||++|| +.+++++....
T Consensus       245 -~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          245 -KPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             -HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             -HHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence             1388999999999999999 99999876553

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.5e-46  Score=338.79  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=202.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .+.|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35588999999999999999975 578899999997653 2334457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+. |+|.+++....  ..+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus       133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 57877775432  2689999999999999999999999   999999999999999999999999999976532


Q ss_pred             CCCCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          246 DSSNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                          .....||+.|+|||++.   ...++.++||||||+++|||++|+.||.....   ......+.....+..... ..
T Consensus       207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~-~~  278 (348)
T 1u5q_A          207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPALQSG-HW  278 (348)
T ss_dssp             ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCCCCT-TS
T ss_pred             ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCCC-CC
Confidence                23356899999999874   56789999999999999999999999865432   222223333222221111 11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                         ...+.++|.+||+.||++|| +.+++++...
T Consensus       279 ---~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~  309 (348)
T 1u5q_A          279 ---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  309 (348)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred             ---CHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence               11388999999999999999 9999876554

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.1e-46  Score=354.69  Aligned_cols=256  Identities=27%  Similarity=0.466  Sum_probs=204.0

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      +.+..++|++.+.||+|+||.||+|.+.++..||||+++.....   .+.|.+|+.+|++++||||+++++++.+ +..+
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            34556789999999999999999999988888999999865433   2578999999999999999999999876 6689


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus       255 iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            9999999999999996432 12589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCCh
Q 046084          244 HSDSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQ  320 (363)
Q Consensus       244 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  320 (363)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+... +.+.+...+
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~~~~~~~  407 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRMPCPPECP  407 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTSC
T ss_pred             CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCC
Confidence            43222 1223346788999999998899999999999999999999 9999865432   2222222222 223232222


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                            ..+.++|.+||+.||++|| +.++++.|...
T Consensus       408 ------~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~  438 (452)
T 1fmk_A          408 ------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  438 (452)
T ss_dssp             ------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             ------HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  2488999999999999999 99999988653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-46  Score=341.12  Aligned_cols=262  Identities=23%  Similarity=0.365  Sum_probs=211.1

Q ss_pred             HHHHHHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeE
Q 046084           82 QEMIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGF  155 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  155 (363)
                      +++.+..++|++.+.||+|+||.||+|.+.      +++.||+|.+...... .....+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            344566789999999999999999999653      3678999999865443 334678999999999999999999999


Q ss_pred             EeeCCeEEEEEEeccCCChhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC
Q 046084          156 CLHKKCMFLIYKYMRRGSLFCILRNDD-------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS  228 (363)
Q Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~  228 (363)
                      +.+.+..++||||+++|+|.+++....       ....+++..++.++.|++.||+|||+.   +++||||||+||+++.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence            999999999999999999999986522       123579999999999999999999999   9999999999999999


Q ss_pred             CCceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhH
Q 046084          229 KLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIML  305 (363)
Q Consensus       229 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~  305 (363)
                      ++.+||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....   ....
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~  250 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVL  250 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHH
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHH
Confidence            99999999999976533221  1122346788999999998889999999999999999999 8999865432   2222


Q ss_pred             HhhhcccC-CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          306 IDLLDQRV-PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       306 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..+..... ..+...+      ..+.+++.+||+.||++|| +.+++..|...
T Consensus       251 ~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          251 RFVMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             HHHHTTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHcCCcCCCCCCCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence            33333222 2222222      2388999999999999999 99999998653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.5e-46  Score=348.50  Aligned_cols=260  Identities=21%  Similarity=0.346  Sum_probs=210.0

Q ss_pred             HHHHHHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 046084           82 QEMIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGFCLHK  159 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (363)
                      .+.....++|++.+.||+|+||+||+++.. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344456789999999999999999999764 58899999986532111 1123477899999999999999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      +..|+||||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence            9999999999999999999754    489999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCC-Cceeecccccccccccccccc----CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc--
Q 046084          240 ARLLHSDSS-NRTVVAGTHGYIAPELAYTMV----LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR--  312 (363)
Q Consensus       240 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--  312 (363)
                      +........ .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+   .......+....  
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~  291 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMNHKNS  291 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHHHH
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC---hhhHHHHHHhcccc
Confidence            987644332 223567999999999987655    7899999999999999999999986433   233333333321  


Q ss_pred             CCCCC--CChhhHHHHHHHHHHHHHccCCCCCC--CC-hHHHHHHHhchh
Q 046084          313 VPSPI--DDQTVIQDIILVSKIVFACLRSKPTS--RP-MQRVSQEFLVRK  357 (363)
Q Consensus       313 ~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~--RP-~~~v~~~l~~~~  357 (363)
                      +..+.  ..+.      .+.+||.+||+.+|.+  || +.|++++-..+.
T Consensus       292 ~~~p~~~~~s~------~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          292 LTFPDDNDISK------EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             CCCCTTCCCCH------HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             ccCCCcccccH------HHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            22221  1221      3888999999999988  99 999998876653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.9e-46  Score=349.73  Aligned_cols=265  Identities=25%  Similarity=0.332  Sum_probs=210.7

Q ss_pred             HHHHHHHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 046084           81 FQEMIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETEL-AFLESFQTEAHLLSQIRHRNIVKLYGFCLH  158 (363)
Q Consensus        81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  158 (363)
                      +.+.....++|++.+.||+|+||+||+|+.. +++.||+|++....... ...+.+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3445566789999999999999999999875 47889999987532211 112347889999999999999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      .+..++||||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence            9999999999999999999986432  599999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCCC-ceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc-
Q 046084          239 VARLLHSDSSN-RTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ-  311 (363)
Q Consensus       239 ~~~~~~~~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-  311 (363)
                      +++........ ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+   .......+... 
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~  297 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHK  297 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHH
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC---hhHHHHhhhhcc
Confidence            99876443322 23357999999999986     5678999999999999999999999986533   22333333321 


Q ss_pred             -cCCCCCCChhhHHHHHHHHHHHHHccCCCCCC--CC-hHHHHHHHhch
Q 046084          312 -RVPSPIDDQTVIQDIILVSKIVFACLRSKPTS--RP-MQRVSQEFLVR  356 (363)
Q Consensus       312 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RP-~~~v~~~l~~~  356 (363)
                       ....+.......   ..+.+||.+||+.+|++  || +.|++++-..+
T Consensus       298 ~~~~~p~~~~~~s---~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          298 ERFQFPTQVTDVS---ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             HHCCCCSSCCCSC---HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             ccccCCcccccCC---HHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence             122222111111   13788999999998888  99 99998876654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.3e-45  Score=333.10  Aligned_cols=260  Identities=25%  Similarity=0.414  Sum_probs=198.8

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEeC----CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      .+..++|.+.+.||+|+||.||+|...    ++..||+|.+..........+.+.+|+.++++++||||+++++++.+.+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            345678999999999999999999653    3448999999876555555678999999999999999999999998765


Q ss_pred             e-----EEEEEEeccCCChhhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCce
Q 046084          161 C-----MFLIYKYMRRGSLFCILRND---DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEA  232 (363)
Q Consensus       161 ~-----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  232 (363)
                      .     .+++|||+++|+|.+++...   .....+++..++.++.|+++||.|||+.   +++||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence            3     59999999999999998532   2234699999999999999999999999   99999999999999999999


Q ss_pred             EEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhh
Q 046084          233 FVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLL  309 (363)
Q Consensus       233 kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~  309 (363)
                      ||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......   .....+.
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~  263 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDYLL  263 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHHH
Confidence            9999999976543321  2223456789999999999999999999999999999999 89998654332   2222222


Q ss_pred             cc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          310 DQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       310 ~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .. ....+...+      ..+.+++.+||+.||++|| +.+++..|...
T Consensus       264 ~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          264 HGHRLKQPEDCL------DELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             TTCCCCCBTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCcccc------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            22 222222221      2488999999999999999 99999988653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.9e-45  Score=335.08  Aligned_cols=253  Identities=22%  Similarity=0.390  Sum_probs=211.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|.+.+.||+|+||.||++.+. +++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999764 57889999987543 2234457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++....   .+++.+++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999887643   589999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .........|+..|+|||++.+..++.++||||||+++|||++|+.||....   .......+.......+...+.    
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~----  266 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYSIPKHINP----  266 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCCTTSCH----
T ss_pred             CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhcCCCCCCccCCH----
Confidence            4444555678999999999998889999999999999999999999986532   222233333333332222221    


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        .+.+++.+||+.||++|| +.|++.+-..
T Consensus       267 --~~~~li~~~l~~dp~~Rps~~ell~~~~~  295 (335)
T 2owb_A          267 --VAASLIQKMLQTDPTARPTINELLNDEFF  295 (335)
T ss_dssp             --HHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             --HHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence              378899999999999999 9999876554

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.3e-46  Score=339.17  Aligned_cols=249  Identities=22%  Similarity=0.358  Sum_probs=206.3

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchH------HHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETEL------AFLESFQTEAHLLSQIRHRNIVKLYGFCLHK  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (363)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++.......      ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            357899999999999999999975 578899999987653211      1124567899999999999999999999999


Q ss_pred             CeEEEEEEeccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          160 KCMFLIYKYMRRG-SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       160 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      +..++||||+.+| +|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 9999997654   599999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPI  317 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  317 (363)
                      ++....... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....         ........+.
T Consensus       176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~~~~~  245 (335)
T 3dls_A          176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVEAAIHPPY  245 (335)
T ss_dssp             TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTTTCCCCSS
T ss_pred             cceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHhhccCCCc
Confidence            998765433 3344679999999999988776 7899999999999999999999865322         1122222222


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ..+.      .+.+++.+||+.||++|| +.+++++-+...
T Consensus       246 ~~~~------~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          246 LVSK------ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             CCCH------HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             ccCH------HHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence            2221      388999999999999999 999999876644

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.8e-46  Score=338.30  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=198.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCE----EEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKK----VALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||.||+|.+. +++.    |++|.+...... .....+.+|+.+++.++||||+++++++.+ +..
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   89 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL   89 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC-SCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence            467999999999999999999753 4443    888887544321 112456789999999999999999999864 568


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++||||+.+|+|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence            899999999999999976532  588889999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc-ccCCCCCC
Q 046084          243 LHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPSPID  318 (363)
Q Consensus       243 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~  318 (363)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ....+.. .....+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~  241 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLLEKGERLAQPQI  241 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHHHTTCBCCCCTT
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHHHcCCCCCCCCc
Confidence            644322  2234567889999999998899999999999999999999 999987644322   1122221 12222222


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+.      .+.+++.+||+.||++|| +.+++++|..
T Consensus       242 ~~~------~~~~li~~~l~~dp~~Rps~~el~~~l~~  273 (325)
T 3kex_A          242 CTI------DVYMVMVKCWMIDENIRPTFKELANEFTR  273 (325)
T ss_dssp             BCT------TTTHHHHHHTCSCTTTSCCHHHHHHHHHH
T ss_pred             CcH------HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            222      278899999999999999 9999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-45  Score=327.04  Aligned_cols=255  Identities=24%  Similarity=0.375  Sum_probs=205.5

Q ss_pred             hcCCcccC-eeeecCceeEEEEEeC---CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           88 TEDFDIKY-CIGTGGYGSVYRAQLP---SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        88 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||+|.+...... ...+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            45677766 8999999999999753   5778999999875433 3457899999999999999999999999 456689


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +||||+++++|.+++....  ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9999999999999996543  2589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc-CCCCCC
Q 046084          244 HSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR-VPSPID  318 (363)
Q Consensus       244 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~  318 (363)
                      ......   .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+.... ...+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~  237 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRMECPPE  237 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCCCCCTT
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhcCCcCCCCCC
Confidence            433221   122346788999999988889999999999999999998 9999865432   22222222221 222222


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      .+      ..+.+++.+||+.||++|| +.++++.|...-.
T Consensus       238 ~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          238 CP------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             CC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            22      2488999999999999999 9999999876443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.2e-46  Score=338.90  Aligned_cols=263  Identities=25%  Similarity=0.373  Sum_probs=203.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||++... +|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            467999999999999999999764 5889999998776655555677889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.++.....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus       104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988876544   589999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc---------------
Q 046084          247 SSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD---------------  310 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------------  310 (363)
                      ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.................               
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence            4444556789999999998765 789999999999999999999999865433211111110000               


Q ss_pred             ---ccCCCCCCChhh----HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          311 ---QRVPSPIDDQTV----IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       311 ---~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                         ...+........    ......+.+|+.+||+.||++|| +.|++++-..+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~  311 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ  311 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence               001100000000    01123488999999999999999 99998876554

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=344.36  Aligned_cols=263  Identities=20%  Similarity=0.304  Sum_probs=209.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC--eEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK--CMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  164 (363)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++...... ...+.+.+|+++++.++||||+++++++...+  ..++
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            467999999999999999999765 5899999999764422 12366789999999999999999999998765  6899


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee----cCCCceEEEeeccc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL----NSKLEAFVADFGVA  240 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~  240 (363)
                      ||||+++|+|.+++........+++..++.++.|++.||+|||+.   +++||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999998765444599999999999999999999999   99999999999999    77888999999999


Q ss_pred             eeccCCCCCceeecccccccccccccc--------ccCCccccchHHHHHHHHHHhCCCCCCCCcC-CCchhhHHhhhcc
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYT--------MVLTEKCDVYSFGVVALEVLMGRHPGDLLSS-VNPKIMLIDLLDQ  311 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~  311 (363)
                      ....... ......||+.|+|||++.+        ..++.++||||||+++|||++|+.||..... .........+...
T Consensus       164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             EECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             eEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            8764332 2234568999999998765        5678899999999999999999999865443 2233334444333


Q ss_pred             cCCC-------------------CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          312 RVPS-------------------PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       312 ~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .++.                   +............+.+++..||+.||++|| +.++++++..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence            2211                   111111233344688999999999999999 9999888743

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.5e-46  Score=331.16  Aligned_cols=253  Identities=26%  Similarity=0.479  Sum_probs=205.2

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +..++|++.+.||+|+||.||+|...++..||+|.+......   .+.+.+|+++++.++||||+++++++.. +..+++
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   85 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence            456789999999999999999999888889999999765543   3578899999999999999999999874 458999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++.... ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.....
T Consensus        86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            99999999999986532 12589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhh
Q 046084          246 DSSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTV  322 (363)
Q Consensus       246 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  322 (363)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+... ....+...+  
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~--  236 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPDNCP--  236 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTCC--
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcccCCCCccccc--
Confidence            3211 122346778999999988889999999999999999999 9999865332   2222222222 111222111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                          ..+.+++.+||+.||++|| +.+++..|..
T Consensus       237 ----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  266 (279)
T 1qpc_A          237 ----EELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (279)
T ss_dssp             ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----HHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence                2488999999999999999 9999988864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.7e-45  Score=328.36  Aligned_cols=263  Identities=22%  Similarity=0.303  Sum_probs=198.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+..+++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45799999999999999999975 578999999997532 2334457889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          166 YKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      |||+++++|.+++.... ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999886421 123589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ..........+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........+.....+..... .   
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~-~---  262 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPPLPSD-H---  262 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCSCCCCTT-T---
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccCCCCccc-c---
Confidence            444334445689999999999988999999999999999999999999864322 11122222222222211111 1   


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      ....+.+++.+||+.||++|| +.+++..|..-+.
T Consensus       263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          263 YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            112488999999999999999 9999998876544

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.8e-45  Score=324.18  Aligned_cols=257  Identities=21%  Similarity=0.330  Sum_probs=209.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||+|... ++..||+|++.......  .+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            467999999999999999999764 56789999987654322  367889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee---cCCCceEEEeeccceec
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARLL  243 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~  243 (363)
                      ||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+||++   +.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           86 ELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            9999999999887654   589999999999999999999999   99999999999999   78899999999999876


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      .... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||....   .......+.......+..  ...
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~--~~~  232 (277)
T 3f3z_A          160 KPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFPEK--DWL  232 (277)
T ss_dssp             CTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCHH--HHT
T ss_pred             cCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCch--hhh
Confidence            4332 33445689999999988654 8999999999999999999999986533   233333343333332211  000


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL  359 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~  359 (363)
                      .....+.+++.+||+.||++|| +.+++++-..+..+
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            1122488999999999999999 99998876665543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-45  Score=337.99  Aligned_cols=267  Identities=24%  Similarity=0.307  Sum_probs=206.9

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc---hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET---ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|++.....   .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            34578899999999999999999976 5678999999865421   2233467899999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCC-------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 046084          161 CMFLIYKYMRRGSLFCILRNDD-------------------------------------EAIRLDWTKRVNIVKSMAHAL  203 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~l  203 (363)
                      ..++||||+++|+|.+++....                                     ....+++..++.++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            9999999999999999885210                                     011245777889999999999


Q ss_pred             HHHHhCCCCCcEEeCCCCCCeeecCCC--ceEEEeeccceeccCCCC----Cceeecccccccccccccc--ccCCcccc
Q 046084          204 SYLHCDCIPSIVHRDISSNNILLNSKL--EAFVADFGVARLLHSDSS----NRTVVAGTHGYIAPELAYT--MVLTEKCD  275 (363)
Q Consensus       204 ~~LH~~~~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~~D  275 (363)
                      +|||+.   +++||||||+|||++.++  .+||+|||++........    ......||+.|+|||.+.+  ..++.++|
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999   999999999999998776  899999999986543221    2234568999999999865  67889999


Q ss_pred             chHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          276 VYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       276 vwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      |||||+++|||++|+.||.....   ......+.......+...  .......+.++|.+||+.||++|| +.+++++-.
T Consensus       259 iwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~  333 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVND---ADTISQVLNKKLCFENPN--YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW  333 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCTTSGG--GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcccccCCcc--cccCCHHHHHHHHHHcCCChhHCCCHHHHhcChh
Confidence            99999999999999999865432   233334444333222111  111122488999999999999999 999998876


Q ss_pred             chhhh
Q 046084          355 VRKTL  359 (363)
Q Consensus       355 ~~~~~  359 (363)
                      .+...
T Consensus       334 ~~~~~  338 (345)
T 3hko_A          334 ISQFS  338 (345)
T ss_dssp             HHTTS
T ss_pred             hccCh
Confidence            65543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-45  Score=338.89  Aligned_cols=265  Identities=23%  Similarity=0.337  Sum_probs=206.4

Q ss_pred             ccHHHHHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-----CCceeee
Q 046084           79 ITFQEMIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-----HRNIVKL  152 (363)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l  152 (363)
                      +++++.....++|++.+.||+|+||+||+|.. .+++.||+|++.....   ..+.+..|+.+++.++     ||||+++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK---YTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH---HHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh---hhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            34444556678999999999999999999976 5788999999975332   2356778999999886     9999999


Q ss_pred             eeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC----
Q 046084          153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----  228 (363)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----  228 (363)
                      ++++...+..++||||+ +++|.+++...... .+++..+..++.|++.||+|||+.   +++||||||+|||++.    
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence            99999999999999999 89999999765422 589999999999999999999999   9999999999999975    


Q ss_pred             ---------------------CCceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHH
Q 046084          229 ---------------------KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL  287 (363)
Q Consensus       229 ---------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  287 (363)
                                           ++.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                                 789999999999865432   23456899999999999999999999999999999999


Q ss_pred             hCCCCCCCCcCCCchhhHHhhhcc-------------------------cCCCCCCChhhHH------------HHHHHH
Q 046084          288 MGRHPGDLLSSVNPKIMLIDLLDQ-------------------------RVPSPIDDQTVIQ------------DIILVS  330 (363)
Q Consensus       288 ~g~~p~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~------------~~~~l~  330 (363)
                      +|+.||..................                         ..+..........            ....+.
T Consensus       254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  333 (360)
T 3llt_A          254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC  333 (360)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred             HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence            999998654321111111111000                         0000000000000            013477


Q ss_pred             HHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          331 KIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       331 ~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      +|+.+||+.||++|| +.|++++-.
T Consensus       334 ~li~~~L~~dP~~Rpta~elL~hp~  358 (360)
T 3llt_A          334 DFLYSILQIDPTLRPSPAELLKHKF  358 (360)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             HHHHHHhcCChhhCCCHHHHhcCcc
Confidence            999999999999999 999987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=340.11  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=199.0

Q ss_pred             cCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           94 KYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      .+.||+|+||.||+|.. .+|+.||+|++......  ..+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            56799999999999976 56899999999865432  2467899999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee--cCCCceEEEeeccceeccCCCCCc
Q 046084          173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL--NSKLEAFVADFGVARLLHSDSSNR  250 (363)
Q Consensus       173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~  250 (363)
                      +|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||+  +.++.+||+|||++....... ..
T Consensus       172 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~  245 (373)
T 2x4f_A          172 ELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KL  245 (373)
T ss_dssp             EEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BC
T ss_pred             cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cc
Confidence            9999886543  2589999999999999999999999   99999999999999  567899999999998764432 23


Q ss_pred             eeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHH
Q 046084          251 TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVS  330 (363)
Q Consensus       251 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  330 (363)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+.......+...  .......+.
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~--~~~~~~~~~  320 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNILACRWDLEDEE--FQDISEEAK  320 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCSCSGG--GTTSCHHHH
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCChhh--hccCCHHHH
Confidence            34569999999999998889999999999999999999999986543   2333344444333222110  011122488


Q ss_pred             HHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          331 KIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       331 ~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +||.+||+.||++|| +.|++++-...
T Consensus       321 ~li~~~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          321 EFISKLLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence            999999999999999 99999865543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=346.84  Aligned_cols=263  Identities=24%  Similarity=0.338  Sum_probs=208.2

Q ss_pred             HHHHHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 046084           81 FQEMIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH  158 (363)
Q Consensus        81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  158 (363)
                      +.+.....++|++.+.||+|+||.||+++. .+|+.||+|++..... .....+.+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            444555678999999999999999999976 4789999999975332 11223457899999999999999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      .+..|+||||+++|+|.+++...+.  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence            9999999999999999999976432  589999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCCC-ceeeccccccccccccc-------cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc
Q 046084          239 VARLLHSDSSN-RTVVAGTHGYIAPELAY-------TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD  310 (363)
Q Consensus       239 ~~~~~~~~~~~-~~~~~g~~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  310 (363)
                      ++......... ....+||+.|+|||++.       ...++.++|||||||++|||++|+.||...+   .......+..
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~  284 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS---TAETYGKIVH  284 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHT
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC---HHHHHHHHHh
Confidence            99876543322 23457999999999987       3568999999999999999999999986533   2223333332


Q ss_pred             c--cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCC---C-hHHHHHHHhc
Q 046084          311 Q--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSR---P-MQRVSQEFLV  355 (363)
Q Consensus       311 ~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---P-~~~v~~~l~~  355 (363)
                      .  ....+.....   ....+.+||.+||+ +|++|   | +.|++.+-..
T Consensus       285 ~~~~~~~p~~~~~---~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff  331 (412)
T 2vd5_A          285 YKEHLSLPLVDEG---VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF  331 (412)
T ss_dssp             HHHHCCCC----C---CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred             cccCcCCCccccC---CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence            1  1222210000   11248899999999 99998   6 7888776554

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=340.45  Aligned_cols=252  Identities=26%  Similarity=0.427  Sum_probs=192.9

Q ss_pred             CCcccCeeeecCceeEEEEEeC--CC--CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP--SG--KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH-KKCMFL  164 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l  164 (363)
                      .|.+.+.||+|+||.||+|.+.  ++  ..||+|.+...... ...+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS-HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            4677889999999999999753  22  36899998754432 335789999999999999999999998765 457899


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+++|+|.+++.....  .+++..++.++.|+++||+|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus       169 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999976442  588999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCC----CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCC
Q 046084          245 SDSS----NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPID  318 (363)
Q Consensus       245 ~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  318 (363)
                      ....    ......+++.|+|||.+.+..++.++||||||+++|||++ |.+||......+.   ...+... ....+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~~~~~~~~~p~~  320 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQGRRLLQPEY  320 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHHHTTCCCCCCTT
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHHHcCCCCCCCCC
Confidence            3221    1123456788999999999999999999999999999999 7788765443322   2222222 2222222


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .+      ..+.+++.+||+.||++|| +.++++.|...
T Consensus       321 ~~------~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          321 CP------DPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             CC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            22      1488999999999999999 99999998653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.5e-45  Score=328.69  Aligned_cols=249  Identities=21%  Similarity=0.421  Sum_probs=200.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCC-C-------CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPS-G-------KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK  159 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (363)
                      .++|.+.+.||+|+||.||+|.... +       ..||+|.+......  ..+.+.+|+.++++++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN--YSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG--GHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            5689999999999999999996542 3       46999998765432  246789999999999999999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc--------
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE--------  231 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--------  231 (363)
                      +..++||||+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.        
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence            999999999999999999976542  489999999999999999999999   9999999999999998887        


Q ss_pred             eEEEeeccceeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCC-CCCCCCcCCCchhhHHhhh
Q 046084          232 AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGR-HPGDLLSSVNPKIMLIDLL  309 (363)
Q Consensus       232 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~-~p~~~~~~~~~~~~~~~~~  309 (363)
                      +||+|||++....    ......++..|+|||.+.+ ..++.++||||||+++|||++|. +|+.....    .......
T Consensus       160 ~kl~Dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~~~~~~~  231 (289)
T 4fvq_A          160 IKLSDPGISITVL----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS----QRKLQFY  231 (289)
T ss_dssp             EEECCCCSCTTTS----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHH
T ss_pred             eeeccCccccccc----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch----HHHHHHh
Confidence            9999999986542    2233457889999999887 77899999999999999999955 44433221    1112222


Q ss_pred             cccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          310 DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ......+...+.      .+.+++.+||+.||++|| +.++++.|....
T Consensus       232 ~~~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          232 EDRHQLPAPKAA------ELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             HTTCCCCCCSSC------TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             hccCCCCCCCCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            222222221111      288899999999999999 999999997643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.1e-45  Score=326.96  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=202.8

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee----CCeEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH----KKCMF  163 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  163 (363)
                      +.|.+.+.||+|+||.||+|.. .++..||+|.+..........+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            3478888999999999999976 467889999998765555556789999999999999999999999876    35689


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCeeec-CCCceEEEeeccc
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS--IVHRDISSNNILLN-SKLEAFVADFGVA  240 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~  240 (363)
                      +||||+++++|.+++....   .+++..++.++.|++.||+|||+.   +  ++||||||+|||++ .++.+||+|||++
T Consensus       106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            9999999999999997643   589999999999999999999999   8  99999999999997 7899999999999


Q ss_pred             eeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      .....  .......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.....  .............+..... 
T Consensus       180 ~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~-  253 (290)
T 1t4h_A          180 TLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPASFDK-  253 (290)
T ss_dssp             GGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCCGGGGG-
T ss_pred             ccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCCccccCC-
Confidence            75432  23344568999999998764 589999999999999999999999865332  1222222222211111100 


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                         .....+.+++.+||+.||++|| +.+++++-..+
T Consensus       254 ---~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~  287 (290)
T 1t4h_A          254 ---VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  287 (290)
T ss_dssp             ---CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ---CCCHHHHHHHHHHccCChhhCCCHHHHhhCcccc
Confidence               0112488999999999999999 99999876554

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-45  Score=333.75  Aligned_cols=253  Identities=30%  Similarity=0.471  Sum_probs=199.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCC-----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPS-----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||.||+|....     +..||+|.+...... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            4678888999999999999997542     235999999865433 3346789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++||||+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            999999999999999976432  589999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCC
Q 046084          243 LHSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPI  317 (363)
Q Consensus       243 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~  317 (363)
                      .......   .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+... ..+.+.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~~~~~~  273 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRLPTPM  273 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCCCCT
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCCcCCCcc
Confidence            6433221   112335778999999998889999999999999999999 9999865432   2222333222 222222


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..+      ..+.+++.+||+.||++|| +.++++.|..
T Consensus       274 ~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  306 (333)
T 1mqb_A          274 DCP------SAIYQLMMQCWQQERARRPKFADIVSILDK  306 (333)
T ss_dssp             TCB------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             cCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            222      2488999999999999999 9999998864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-45  Score=330.32  Aligned_cols=256  Identities=23%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..+++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999764 688999999976533 334457899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999997654   589999999999999999999999   999999999999999999999999999976543


Q ss_pred             CC-CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          246 DS-SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       246 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .. .......+++.|+|||.+.+..++.++||||||+++|||++|+.||......    ..........+.+....  ..
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~--~~  260 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAIPRPSTVR--PG  260 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCCCCGGGTS--TT
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCCCCccccC--CC
Confidence            32 1223456899999999999989999999999999999999999998653321    22222222221110000  00


Q ss_pred             HHHHHHHHHHHccCCCCCCCC--hHHHHHHHhc
Q 046084          325 DIILVSKIVFACLRSKPTSRP--MQRVSQEFLV  355 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP--~~~v~~~l~~  355 (363)
                      ....+.+++.+||+.||++||  +.+++..|..
T Consensus       261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~  293 (309)
T 2h34_A          261 IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHA  293 (309)
T ss_dssp             CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHH
Confidence            111488999999999999999  7777777653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.4e-45  Score=326.18  Aligned_cols=258  Identities=16%  Similarity=0.288  Sum_probs=204.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEE-eeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC-LHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++......    +.+.+|+.+++.++|++++..+.++ ...+..+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            56899999999999999999975 67889999998765432    4578899999999988766655555 566788999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee---cCCCceEEEeecccee
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARL  242 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~  242 (363)
                      |||+ +++|.+++.....  .+++..++.++.|++.||+|||++   +++||||||+|||+   +.++.+||+|||++..
T Consensus        84 ~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            9999 8999999974432  589999999999999999999999   99999999999999   4889999999999987


Q ss_pred             ccCCCC-------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCC
Q 046084          243 LHSDSS-------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS  315 (363)
Q Consensus       243 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  315 (363)
                      ......       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            654332       1234568999999999999899999999999999999999999998755444333333332222211


Q ss_pred             CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +... .....+..+.+++.+||+.||++|| +.++++.|...
T Consensus       238 ~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          238 PIEV-LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             CHHH-HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             chHH-HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            1000 0000112488999999999999999 99999988654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-45  Score=329.78  Aligned_cols=256  Identities=23%  Similarity=0.390  Sum_probs=201.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--C
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--K  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~  160 (363)
                      .++|++.+.||+|+||.||++.+     .+++.||+|++..... ....+.+.+|+.+++.++||||+++++++...  .
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            45689999999999999999983     4688999999975542 22346788999999999999999999999877  5


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..++||||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence            68999999999999999965432  589999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCC---CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcC-----------CCchhhHH
Q 046084          241 RLLHSDSS---NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS-----------VNPKIMLI  306 (363)
Q Consensus       241 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~-----------~~~~~~~~  306 (363)
                      ........   ......+|..|+|||.+.+..++.++||||||+++|||++|..|+.....           ........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            87654432   12234577889999999988899999999999999999999998543210           01111111


Q ss_pred             hhhcc--cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          307 DLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       307 ~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .....  ..+.+...+      ..+.+++.+||+.||++|| +.++++.|..
T Consensus       254 ~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCP------DEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHTTCCCCCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhccCCCCCCCCCC------HHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            11111  122222222      2488999999999999999 9999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.2e-45  Score=326.73  Aligned_cols=254  Identities=26%  Similarity=0.424  Sum_probs=200.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCC----CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSG----KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH-KKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  162 (363)
                      ..+|++.+.||+|+||.||+|.+.++    ..||+|.+...... ...+.+.+|+.++++++||||+++++++.+ .+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            35688899999999999999975432    25899998765443 335779999999999999999999998654 4578


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      +++|||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence            99999999999999997643  2589999999999999999999999   999999999999999999999999999976


Q ss_pred             ccCCC----CCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhccc-CCCC
Q 046084          243 LHSDS----SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQR-VPSP  316 (363)
Q Consensus       243 ~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~  316 (363)
                      .....    .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.......   ......... ...+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  254 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQGRRLLQP  254 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHHHTTCCCCCC
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHhcCCCCCCC
Confidence            54322    11223456788999999998899999999999999999999 566665443322   222222222 2222


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ...+      ..+.+++.+||+.||++|| +.++++.|...
T Consensus       255 ~~~~------~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          255 EYCP------DPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             TTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2222      1388999999999999999 99999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-45  Score=328.57  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=199.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|.+.+.||+|+||.||++.. .++..||+|++....... ..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch-hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            46799999999999999999976 468899999987654321 2467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee---cCCCceEEEeecccee
Q 046084          167 KYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARL  242 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~  242 (363)
                      ||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +++||||||+||++   +.++.+||+|||++..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            9999999999885421 123689999999999999999999999   99999999999999   4568899999999976


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ..... ......|++.|+|||.+. ..++.++||||||+++|||++|+.||.....   .....................
T Consensus       177 ~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~  251 (285)
T 3is5_A          177 FKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYKEPNYAVECRPL  251 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCC--CCC
T ss_pred             cCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccCCcccccccCcC
Confidence            54332 234456899999999875 4688999999999999999999999865432   122222221211111111101


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                         ...+.+++.+||+.||++|| +.|++.+-..+
T Consensus       252 ---~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~  283 (285)
T 3is5_A          252 ---TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK  283 (285)
T ss_dssp             ---CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred             ---CHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence               11378999999999999999 99999876554

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.6e-45  Score=350.72  Aligned_cols=259  Identities=22%  Similarity=0.254  Sum_probs=209.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            346799999999999999999976 47899999999654321 1223567899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||++||+|.+++..... ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       262 VmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999999876542 2589999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc-hhhHHhhhcccCCCCCCChhhH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.......+...+   
T Consensus       338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s---  413 (576)
T 2acx_A          338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS---  413 (576)
T ss_dssp             TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSC---
T ss_pred             cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCC---
Confidence            332 33445799999999999998999999999999999999999999976543322 2222233333322222222   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC------hHHHHHHHhch
Q 046084          324 QDIILVSKIVFACLRSKPTSRP------MQRVSQEFLVR  356 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP------~~~v~~~l~~~  356 (363)
                         ..+.+||.+||+.||++||      +.|++.+-..+
T Consensus       414 ---~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~  449 (576)
T 2acx_A          414 ---PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK  449 (576)
T ss_dssp             ---HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred             ---HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence               1388899999999999998      36676655443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.1e-45  Score=348.37  Aligned_cols=259  Identities=22%  Similarity=0.281  Sum_probs=198.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------C
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------K  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  160 (363)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++..........+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            47899999999999999999965 4688999999987654455567889999999999999999999999654      3


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..|+||||++++ |.+.+..     .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            579999999764 6555543     489999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh-------------
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID-------------  307 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~-------------  307 (363)
                      +..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.......             
T Consensus       212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          212 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             -----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             eecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            876432 233446799999999999999999999999999999999999999875432111111111             


Q ss_pred             ------hhcccCCC--------------CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          308 ------LLDQRVPS--------------PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       308 ------~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                            ........              +............+.+|+.+||+.||++|| +.|++++-...
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~  360 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  360 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence                  11111000              000111111133588999999999999999 99999887654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.7e-45  Score=326.47  Aligned_cols=259  Identities=16%  Similarity=0.287  Sum_probs=201.2

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEE-eeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFC-LHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l  164 (363)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++......    +.+..|+.+++.++|++++..++.+ ...+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            457899999999999999999975 57889999987654322    3577899999999888777666655 56778899


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee---cCCCceEEEeeccce
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL---NSKLEAFVADFGVAR  241 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~  241 (363)
                      +|||+ +++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||+   +.++.+||+|||++.
T Consensus        83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            99999 9999999875432  589999999999999999999999   99999999999999   788999999999998


Q ss_pred             eccCCCC-------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC
Q 046084          242 LLHSDSS-------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP  314 (363)
Q Consensus       242 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  314 (363)
                      .......       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            7654322       123456899999999999999999999999999999999999999876554433333333322222


Q ss_pred             CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .+... ........+.+++.+||+.||++|| +.++++.|...
T Consensus       237 ~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          237 TPIEV-LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             SCHHH-HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             chhhh-hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            11000 0000112488999999999999999 99999988653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.7e-45  Score=339.40  Aligned_cols=255  Identities=23%  Similarity=0.334  Sum_probs=194.1

Q ss_pred             hcCCccc-CeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHh-cCCCCceeeeeeEEee----CC
Q 046084           88 TEDFDIK-YCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLS-QIRHRNIVKLYGFCLH----KK  160 (363)
Q Consensus        88 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~  160 (363)
                      .++|.+. +.||+|+||+||++.+. +|+.||||++...       ..+.+|+.++. ..+||||+++++++..    ..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            3567666 68999999999999764 6889999998642       34567787764 4589999999999876    56


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceEEEee
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVADF  237 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df  237 (363)
                      ..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence            78999999999999999986432 3589999999999999999999999   9999999999999987   789999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc-hhhHHhhhcccCCCC
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDLLDQRVPSP  316 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~  316 (363)
                      |+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.......+
T Consensus       209 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          209 GFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  287 (400)
T ss_dssp             TTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred             ccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence            999875432 223456789999999999999999999999999999999999999975443221 112222322322222


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ....  ......+.+||.+||+.||++|| +.|++.+.+..
T Consensus       288 ~~~~--~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  326 (400)
T 1nxk_A          288 NPEW--SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  326 (400)
T ss_dssp             TTTT--TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             Cccc--ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence            1100  01112488999999999999999 99999876654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=331.08  Aligned_cols=266  Identities=25%  Similarity=0.311  Sum_probs=198.8

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch---HHHHHHHHHHHHHHhcC---CCCceeeeeeEEee
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE---LAFLESFQTEAHLLSQI---RHRNIVKLYGFCLH  158 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~  158 (363)
                      ...++|++.+.||+|+||+||+|.+ .+++.||+|++......   ......+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4567999999999999999999986 57889999998743211   01113455677766666   59999999999987


Q ss_pred             CC-----eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceE
Q 046084          159 KK-----CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF  233 (363)
Q Consensus       159 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  233 (363)
                      ..     ..+++|||+. ++|.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence            65     5799999997 599999876543 2489999999999999999999999   999999999999999999999


Q ss_pred             EEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          234 VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       234 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      |+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....................
T Consensus       161 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          161 LADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             ECSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999997654332 33445789999999999999999999999999999999999999865433221111111111110


Q ss_pred             CCCC-------------CChhh-----HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          314 PSPI-------------DDQTV-----IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       314 ~~~~-------------~~~~~-----~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ....             .....     ......+.+|+.+||+.||++|| +.|++++-+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~  302 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK  302 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence            0000             00000     01112478999999999999999 999998776654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=330.33  Aligned_cols=254  Identities=29%  Similarity=0.435  Sum_probs=202.4

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+.....    .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            4678999999999999999999764 589999999976543    25688899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus       103 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             eecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            99999999999986422  2589999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .........|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ............+ ....+..  .
T Consensus       178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~-~~~~~~~--~  251 (314)
T 3com_A          178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTNPPP-TFRKPEL--W  251 (314)
T ss_dssp             TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCC-CCSSGGG--S
T ss_pred             hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCc-ccCCccc--C
Confidence            44444456789999999999988899999999999999999999999865432   1111222122111 1111111  1


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...+.+++.+||+.||++|| +.+++.+-..
T Consensus       252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~  282 (314)
T 3com_A          252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFV  282 (314)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence            12488999999999999999 9999876544

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.4e-45  Score=325.19  Aligned_cols=255  Identities=25%  Similarity=0.358  Sum_probs=202.3

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCC----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPS----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      ..++|++.+.||+|+||.||+|.+.+    +..||+|.+...... ...+.+.+|+.+++.++||||+++++++.+. ..
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence            45789999999999999999997532    235999998865432 3357899999999999999999999998754 46


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      +++|||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            899999999999999976432  589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc-ccCCCCCCC
Q 046084          243 LHSDSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPSPIDD  319 (363)
Q Consensus       243 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  319 (363)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......   ....+.. ...+.+...
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~  239 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLEKGDRLPKPDLC  239 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHHHTCCCCCCTTC
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHhcCCCCCCCCCC
Confidence            543322 1223456788999999988889999999999999999998 999986543322   1222221 122222222


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      +      ..+.+++.+||+.||++|| +.+++..|..-.
T Consensus       240 ~------~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          240 P------PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             C------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C------HHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            2      1388999999999999999 999999987543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.1e-45  Score=332.82  Aligned_cols=257  Identities=21%  Similarity=0.312  Sum_probs=208.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchH----HHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETEL----AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||.||++... +|+.||+|.+.......    ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999764 68899999987643211    1236788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC----ceEEEeec
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL----EAFVADFG  238 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg  238 (363)
                      ++||||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            99999999999999997654   589999999999999999999999   999999999999999887    79999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      ++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....   .......+.......+. 
T Consensus       165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~-  239 (321)
T 2a2a_A          165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITSVSYDFDE-  239 (321)
T ss_dssp             TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTCCCCCH-
T ss_pred             cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcccccCh-
Confidence            998765432 2334568999999999998899999999999999999999999986432   22233333332222111 


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       .........+.++|.+||+.||++|| +.|++.+-...
T Consensus       240 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~  277 (321)
T 2a2a_A          240 -EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (321)
T ss_dssp             -HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred             -hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence             00011122488999999999999999 99999876553

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.2e-45  Score=330.73  Aligned_cols=267  Identities=23%  Similarity=0.366  Sum_probs=212.5

Q ss_pred             cHHHHHHHhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeee
Q 046084           80 TFQEMIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKL  152 (363)
Q Consensus        80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l  152 (363)
                      ....+....++|++.+.||+|+||.||+|.+      .+++.||+|.+...... ...+.+.+|+.++..+ +||||+++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhcccCCCeeeE
Confidence            3445556678999999999999999999964      35678999999865543 3346789999999999 79999999


Q ss_pred             eeEEeeCC-eEEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeC
Q 046084          153 YGFCLHKK-CMFLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRD  218 (363)
Q Consensus       153 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  218 (363)
                      ++++...+ ..+++|||+++|+|.+++.....             ...+++..++.++.|+++||+|||+.   +++|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            99988765 48999999999999999986542             11278999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCC
Q 046084          219 ISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDL  295 (363)
Q Consensus       219 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~  295 (363)
                      |||+||+++.++.+||+|||++.........  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999999876443322  223457889999999998899999999999999999998 9999865


Q ss_pred             CcCCCchhhHHhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          296 LSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      ....  ......+... ....+...+      ..+.+++.+||+.||++|| +.+++..|.....
T Consensus       254 ~~~~--~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          254 VKID--EEFCRRLKEGTRMRAPDYTT------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CCCS--HHHHHHHHHTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchh--HHHHHHhccCccCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            4322  1122222221 122222111      1388999999999999999 9999999875443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.9e-45  Score=332.30  Aligned_cols=259  Identities=20%  Similarity=0.338  Sum_probs=200.6

Q ss_pred             hcCCccc-CeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEE
Q 046084           88 TEDFDIK-YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        88 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (363)
                      .+.|.+. +.||+|+||.||+|.. .+++.||||++......  ..+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            4568875 7799999999999975 47889999999765432  236788999999885 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc---eEEEeeccce
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE---AFVADFGVAR  241 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~  241 (363)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.   +||+|||++.
T Consensus        89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999999999997654   589999999999999999999999   9999999999999988766   9999999987


Q ss_pred             eccCCCC-------Cceeecccccccccccccc-----ccCCccccchHHHHHHHHHHhCCCCCCCCcCCC---------
Q 046084          242 LLHSDSS-------NRTVVAGTHGYIAPELAYT-----MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN---------  300 (363)
Q Consensus       242 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------  300 (363)
                      .......       ......||+.|+|||++.+     ..++.++||||||+++|||++|+.||.......         
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            6532211       1223458999999999875     568899999999999999999999997544321         


Q ss_pred             ---chhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          301 ---PKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       301 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                         .......+.......+..  ........+.+|+.+||+.||++|| +.|++++-..+
T Consensus       243 ~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYEFPDK--DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             HHHHHHHHHHHHHCCCCCCHH--HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             hhHHHHHHHHHhccCcccCch--hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence               111223333333322210  0001122488999999999999999 99999876654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-45  Score=343.22  Aligned_cols=261  Identities=25%  Similarity=0.347  Sum_probs=192.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCC--eE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKK--CM  162 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~  162 (363)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|++............+.+|+.+++.+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            467899999999999999999975 57899999999765444444577889999999997 999999999997654  68


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      |+||||++ ++|..++...    .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999997 5898888753    589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCC---------------------CCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCC
Q 046084          243 LHSD---------------------SSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN  300 (363)
Q Consensus       243 ~~~~---------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~  300 (363)
                      ....                     .......+||+.|+|||++.+ ..++.++|||||||++|||++|++||...+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5321                     111233579999999999876 678999999999999999999999986543221


Q ss_pred             chhhHHhhhcccC--------------------------CCCC-CChhhH-----------HHHHHHHHHHHHccCCCCC
Q 046084          301 PKIMLIDLLDQRV--------------------------PSPI-DDQTVI-----------QDIILVSKIVFACLRSKPT  342 (363)
Q Consensus       301 ~~~~~~~~~~~~~--------------------------~~~~-~~~~~~-----------~~~~~l~~li~~cl~~dP~  342 (363)
                      ........+....                          .... ..-..+           .....+.+|+.+||+.||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            1111111110000                          0000 000000           0112478999999999999


Q ss_pred             CCC-hHHHHHHHhc
Q 046084          343 SRP-MQRVSQEFLV  355 (363)
Q Consensus       343 ~RP-~~~v~~~l~~  355 (363)
                      +|| +.|++++-..
T Consensus       319 ~R~t~~e~l~Hp~~  332 (388)
T 3oz6_A          319 KRISANDALKHPFV  332 (388)
T ss_dssp             GSCCHHHHTTSTTT
T ss_pred             cCCCHHHHhCCHHH
Confidence            999 9999887553

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-45  Score=334.65  Aligned_cols=270  Identities=20%  Similarity=0.284  Sum_probs=211.1

Q ss_pred             CCccHHHHHHHhcCCccc-CeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeee
Q 046084           77 GRITFQEMIVATEDFDIK-YCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLY  153 (363)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~  153 (363)
                      ..+.++......++|.+. +.||+|+||.||+|... +++.||+|++............+.+|+.+++.+ +||||++++
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            345556666777888887 88999999999999764 689999999876544333346788999999999 569999999


Q ss_pred             eEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CC
Q 046084          154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KL  230 (363)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~  230 (363)
                      +++.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.   +++||||||+|||++.   ++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence            99999999999999999999999986532 23689999999999999999999999   9999999999999988   78


Q ss_pred             ceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc
Q 046084          231 EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD  310 (363)
Q Consensus       231 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  310 (363)
                      .+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ......+..
T Consensus       172 ~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~  247 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQ  247 (327)
T ss_dssp             CEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH
T ss_pred             cEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHh
Confidence            99999999998764332 22345689999999999999999999999999999999999999865432   222222222


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          311 QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .....+....  ......+.++|.+||+.||++|| +.+++++-..+
T Consensus       248 ~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~  292 (327)
T 3lm5_A          248 VNVDYSEETF--SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ  292 (327)
T ss_dssp             TCCCCCTTTT--TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred             cccccCchhh--cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence            2222111100  01112488999999999999999 99998876553

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.6e-45  Score=360.97  Aligned_cols=254  Identities=20%  Similarity=0.332  Sum_probs=212.6

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  162 (363)
                      ...++|++.+.||+|+||.||++... +++.||||+++.... .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34578999999999999999999764 678899999975421 112235678899999988 799999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      |+||||+++|+|.+++....   .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            99999999999999998654   599999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ...........+||+.|+|||++.+..++.++||||||+++|||++|+.||...   +.......+....+..+...+. 
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~-  567 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVAYPKSMSK-  567 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHSSCCCCCTTSCH-
T ss_pred             cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCCCCccCCH-
Confidence            544444556678999999999999999999999999999999999999998653   3445556666666555543332 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-h-----HHHHHHHh
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-M-----QRVSQEFL  354 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~-----~~v~~~l~  354 (363)
                           .+.+||..||+.||++|| +     .|+.++-.
T Consensus       568 -----~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f  600 (674)
T 3pfq_A          568 -----EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  600 (674)
T ss_dssp             -----HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred             -----HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence                 388899999999999999 6     66665443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.7e-45  Score=324.99  Aligned_cols=254  Identities=18%  Similarity=0.259  Sum_probs=202.6

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  164 (363)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+............+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3567999999999999999999775 789999999986544333456788999999999 99999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---------------
Q 046084          165 IYKYMRRGSLFCILRNDDE-AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---------------  228 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---------------  228 (363)
                      ||||+++++|.+++..... ...+++..++.++.|++.||+|||+.   +++||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999975421 12589999999999999999999999   9999999999999984               


Q ss_pred             ----CCceEEEeeccceeccCCCCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchh
Q 046084          229 ----KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI  303 (363)
Q Consensus       229 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~  303 (363)
                          ...+||+|||.+.......    ...|++.|+|||.+.+. .++.++||||||+++|+|++|.+|+....      
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred             ccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence                4479999999998764332    23589999999998765 56789999999999999999998753221      


Q ss_pred             hHHhhhcccCC-CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhh
Q 046084          304 MLIDLLDQRVP-SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL  359 (363)
Q Consensus       304 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~  359 (363)
                      ....+.....+ .+...+      ..+.+++.+||+.||++|| +.+++++-......
T Consensus       236 ~~~~~~~~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          236 QWHEIRQGRLPRIPQVLS------QEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HHHHHHTTCCCCCSSCCC------HHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HHHHHHcCCCCCCCcccC------HHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            12222222222 111111      1388999999999999999 99999887766543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.2e-45  Score=324.04  Aligned_cols=254  Identities=29%  Similarity=0.437  Sum_probs=209.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            467999999999999999999764 5778999998654321 11235788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999987654   589999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ......+.......+...+     
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~-----  236 (284)
T 2vgo_A          167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETHRRIVNVDLKFPPFLS-----  236 (284)
T ss_dssp             S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCCCCCTTSC-----
T ss_pred             c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHHHHHhccccCCCCcCC-----
Confidence            2  23345689999999999998899999999999999999999999865432   2223333333333322222     


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                       ..+.++|.+||+.||++|| +.+++.+-..+..
T Consensus       237 -~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          237 -DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             -HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             -HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence             1378999999999999999 9999987665543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=333.05  Aligned_cols=253  Identities=25%  Similarity=0.421  Sum_probs=196.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCC----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||.||+|.+. +++    +|++|.+...... ...+.+.+|+.+++.++||||+++++++.... .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC-CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            568999999999999999999753 444    3577877544321 22467889999999999999999999998765 7


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++++||+.+|+|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             eEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            889999999999999976543  589999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCC
Q 046084          243 LHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPID  318 (363)
Q Consensus       243 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  318 (363)
                      .......  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......   ....+... ..+.+..
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~  243 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGERLPQPPI  243 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCCCCCCTT
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCCCCCCCcc
Confidence            6433221  222346778999999999999999999999999999999 999987644322   12222111 2222222


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .+.      .+.+++.+||+.||++|| +.|+++.|...
T Consensus       244 ~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          244 CTI------DVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             BCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            221      388999999999999999 99999988653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.8e-45  Score=322.31  Aligned_cols=256  Identities=23%  Similarity=0.402  Sum_probs=201.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|.+..... .....+.+.+|+..++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3468999999999999999999875 789999999875432 11234578899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            999999999999997654   589999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....   .......+.......+...+   
T Consensus       163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~---  235 (276)
T 2h6d_A          163 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRGGVFYIPEYLN---  235 (276)
T ss_dssp             C--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSC---
T ss_pred             CCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCcccCchhcC---
Confidence            322 2234568999999999887765 689999999999999999999986432   22233333333333222222   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                         ..+.+++.+||+.||++|| +.+++++-..+..
T Consensus       236 ---~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          236 ---RSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             ---HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ---HHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence               1388999999999999999 9999987665543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.3e-45  Score=329.30  Aligned_cols=254  Identities=22%  Similarity=0.363  Sum_probs=203.5

Q ss_pred             CcccCeeeecCceeEEEEEe-----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEE
Q 046084           91 FDIKYCIGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK--KCMF  163 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  163 (363)
                      |++.+.||+|+||+||++.+     .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.  ...+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP-QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh-HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            48999999999999998854     26788999999866432 3357799999999999999999999999884  6789


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +||||+++|+|.+++...    .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus       112 lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence            999999999999999765    389999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC--------C---chhhHHhhh
Q 046084          244 HSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV--------N---PKIMLIDLL  309 (363)
Q Consensus       244 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~--------~---~~~~~~~~~  309 (363)
                      ......   .....++..|+|||.+.+..++.++||||||+++|||++|+.||......        .   .........
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            543321   22345778899999999888999999999999999999999997643210        0   001111222


Q ss_pred             ccc--CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          310 DQR--VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       310 ~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      ...  .+.+...+      ..+.++|.+||+.||++|| +.++++.|.....
T Consensus       265 ~~~~~~~~~~~~~------~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          265 ERGERLPRPDKCP------AEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HTTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcccCCCCCcccc------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            222  12222222      2488999999999999999 9999998875443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.8e-45  Score=350.30  Aligned_cols=257  Identities=23%  Similarity=0.358  Sum_probs=207.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||+||++... +++.||+|++............+.+|+.++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            567999999999999999999764 7889999998654322222467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec---CCCceEEEeeccceec
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN---SKLEAFVADFGVARLL  243 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~  243 (363)
                      ||+.+|+|.+++....   .+++..+..++.|++.||.|||+.   +++||||||+|||++   .++.+||+|||++...
T Consensus       101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999999886644   589999999999999999999999   999999999999995   4568999999999765


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....   .......+...........  ..
T Consensus       175 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~--~~  247 (486)
T 3mwu_A          175 QQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLPQ--WR  247 (486)
T ss_dssp             CCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSCSGG--GG
T ss_pred             CCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCcc--cC
Confidence            433 22344579999999999876 58999999999999999999999986432   2333444444433322211  11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .....+.++|.+||+.||++|| +.+++.+-+.+.
T Consensus       248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence            1122488999999999999999 999998766543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=329.55  Aligned_cols=260  Identities=22%  Similarity=0.342  Sum_probs=200.8

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee----CC
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH----KK  160 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~  160 (363)
                      +..++|++.+.||+|+||.||++.. .+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++..    ..
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            3467899999999999999999976 6789999999865433  335778999999999999999999999873    34


Q ss_pred             eEEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      ..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            6899999999999999887521 123689999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCCC---------ceeecccccccccccccccc---CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh
Q 046084          240 ARLLHSDSSN---------RTVVAGTHGYIAPELAYTMV---LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID  307 (363)
Q Consensus       240 ~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~  307 (363)
                      +.........         .....|++.|+|||.+.+..   ++.++||||||+++|||++|+.||..............
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            8764321111         11234689999999987543   68899999999999999999999864322111111111


Q ss_pred             hhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          308 LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ......+.....+      ..+.+++.+||+.||++|| +.++++.|...
T Consensus       261 ~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          261 QNQLSIPQSPRHS------SALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             HCC--CCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hccCCCCccccCC------HHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence            1111122211111      2488999999999999999 99999998654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=324.34  Aligned_cols=252  Identities=25%  Similarity=0.360  Sum_probs=199.4

Q ss_pred             CCcccCeeeecCceeEEEEEeC-CC---CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE-EE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLP-SG---KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM-FL  164 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~l  164 (363)
                      .|...+.||+|+||+||+|.+. ++   ..||+|.+...... ...+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            4566789999999999999753 22   27999999765443 3357899999999999999999999999876654 89


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      +|||+.+|+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus       101 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999997643  2589999999999999999999999   99999999999999999999999999997553


Q ss_pred             CCC----CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCC-CCCCcCCCchhhHHhhhcc-cCCCCCC
Q 046084          245 SDS----SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP-GDLLSSVNPKIMLIDLLDQ-RVPSPID  318 (363)
Q Consensus       245 ~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p-~~~~~~~~~~~~~~~~~~~-~~~~~~~  318 (363)
                      ...    .......++..|+|||.+.+..++.++||||||+++|+|++|..| |.....   ......+... ..+.+..
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  252 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQGRRLPQPEY  252 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---GGHHHHHHTTCCCCCCTT
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH---HHHHHHhhcCCCCCCCcc
Confidence            221    122334578899999999999999999999999999999995555 433222   2222222222 1222222


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .+      ..+.+++.+||+.||++|| +.++++.|..-
T Consensus       253 ~~------~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          253 CP------DSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             CC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ch------HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            22      1488999999999999999 99999998653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.1e-45  Score=348.57  Aligned_cols=257  Identities=24%  Similarity=0.356  Sum_probs=203.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||+||+|... ++..||+|++............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999764 6889999999765433333467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceEEEeeccceec
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLL  243 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~  243 (363)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.   ++.+||+|||++...
T Consensus       116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999998886554   589999999999999999999999   9999999999999976   455999999999876


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||....   .......+.......+...  ..
T Consensus       190 ~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~--~~  262 (494)
T 3lij_A          190 ENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRKVEKGKYTFDSPE--WK  262 (494)
T ss_dssp             BTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCSGG--GT
T ss_pred             CCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCchh--cc
Confidence            543 2334457999999999876 468999999999999999999999986543   2333444444433322111  11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .....+.++|.+||+.||++|| +.|++++-+.+.
T Consensus       263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            1122488999999999999999 999987765543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.9e-45  Score=331.98  Aligned_cols=255  Identities=27%  Similarity=0.425  Sum_probs=204.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEe--eCC
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCL--HKK  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~  160 (363)
                      .++|++.+.||+|+||.||++.+     .+++.||+|++.....  ...+.+.+|++++++++||||+++++++.  +..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            56899999999999999999983     4678999999986543  33467999999999999999999999887  456


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..++||||+++++|.+++.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             eEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence            68999999999999999976432  589999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC-----------CchhhHH
Q 046084          241 RLLHSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV-----------NPKIMLI  306 (363)
Q Consensus       241 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-----------~~~~~~~  306 (363)
                      .........   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......           .......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            876443321   22245778899999999888999999999999999999999997543211           0001111


Q ss_pred             hhhccc--CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          307 DLLDQR--VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       307 ~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ......  .+.+...+      ..+.+++.+||+.||++|| +.+++++|..
T Consensus       255 ~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dP~~Rps~~ell~~L~~  300 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACP------AEVHELMKLCWAPSPQDRPSFSALGPQLDM  300 (327)
T ss_dssp             HHHHTTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhhcccCCCCCCccc------HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            122221  12222111      2488999999999999999 9999988864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3e-45  Score=335.94  Aligned_cols=263  Identities=21%  Similarity=0.312  Sum_probs=202.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-------  159 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  159 (363)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36799999999999999999976 5789999999876554333345678999999999999999999999874       


Q ss_pred             -CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          160 -KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                       +..++||||+++ +|.+.+.....  .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence             468999999986 77777765432  589999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCC----CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          239 VARLLHSDS----SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       239 ~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      ++.......    .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....................
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            998764221    22234568999999998876 5589999999999999999999999875432211111111111111


Q ss_pred             CCCCCC-----------------hhhHH------HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          314 PSPIDD-----------------QTVIQ------DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       314 ~~~~~~-----------------~~~~~------~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +.....                 .....      ....+.+||.+||+.||++|| +.|++++-...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  316 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  316 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence            110000                 00000      012478999999999999999 99999876654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-45  Score=334.95  Aligned_cols=261  Identities=21%  Similarity=0.274  Sum_probs=198.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE---LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++......   ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3578999999999999999999774 5889999998754322   11224678999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++||||+++ +|.+++....  ..+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 8888886543  2588889999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---cCCCCCC
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---RVPSPID  318 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~  318 (363)
                      ............+|+.|+|||++.+ ..++.++||||||+++|||++|.+||......   .....+...   .......
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSS
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHcCCCChhhhh
Confidence            6554444455678999999999865 45889999999999999999999998654321   112221111   0000000


Q ss_pred             --------------Chhh-----HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 --------------DQTV-----IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 --------------~~~~-----~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                    ....     ......+.+||.+||+.||++|| +.|++++....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~  296 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  296 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence                          0000     01112488999999999999999 99999877654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.1e-45  Score=336.05  Aligned_cols=256  Identities=19%  Similarity=0.290  Sum_probs=197.9

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCC------CCEEEEEEeccccchHH----H-----HHHHHHHHHHHhcCCCCceee
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPS------GKKVALKKLHHSETELA----F-----LESFQTEAHLLSQIRHRNIVK  151 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~----~-----~~~~~~e~~~l~~l~h~niv~  151 (363)
                      ..++|++.+.||+|+||.||+|.+.+      ++.||+|++........    .     ...+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999997754      47899999876542111    0     112345666778889999999


Q ss_pred             eeeEEeeC----CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec
Q 046084          152 LYGFCLHK----KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN  227 (363)
Q Consensus       152 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~  227 (363)
                      +++++...    ...++||||+ +++|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            99998875    4589999999 999999997643  2699999999999999999999999   999999999999999


Q ss_pred             --CCCceEEEeeccceeccCCCC-------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcC
Q 046084          228 --SKLEAFVADFGVARLLHSDSS-------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS  298 (363)
Q Consensus       228 --~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~  298 (363)
                        .++.+||+|||+++.......       ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              889999999999987543221       11334599999999999999999999999999999999999999875322


Q ss_pred             CCchhh---------HHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          299 VNPKIM---------LIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       299 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ......         .....+..++.. ..      +..+.+++..||+.||++|| +.++++.|..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~------~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~  326 (364)
T 3op5_A          267 DPKYVRDSKIRYRENIASLMDKCFPAA-NA------PGEIAKYMETVKLLDYTEKPLYENLRDILLQ  326 (364)
T ss_dssp             CHHHHHHHHHHHHHCHHHHHHHHSCTT-CC------CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhhhhHHHHHHHhcccc-cC------HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence            111000         011111111111 11      12488999999999999999 9999988764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.6e-45  Score=341.57  Aligned_cols=260  Identities=22%  Similarity=0.302  Sum_probs=196.6

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc------hHHHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET------ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH  158 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  158 (363)
                      ...++|.+.+.||+|+||.||+|.. .+++.||+|++.....      .......+.+|+.++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4568999999999999999999965 4678999999875431      1122235789999999999999999999975 


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC---CceEEE
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK---LEAFVA  235 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~  235 (363)
                      .+..++||||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.+   ..+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            455899999999999999887654   699999999999999999999999   99999999999999654   459999


Q ss_pred             eeccceeccCCCCCceeecccccccccccccc---ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          236 DFGVARLLHSDSSNRTVVAGTHGYIAPELAYT---MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       236 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      |||++...... .......||+.|+|||++.+   ..++.++||||||+++|+|++|+.||.......  .....+....
T Consensus       285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~~~~  361 (419)
T 3i6u_A          285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITSGK  361 (419)
T ss_dssp             CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHHTTC
T ss_pred             ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHhcCC
Confidence            99999876432 22344679999999998753   567889999999999999999999987543322  1122222222


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .....  .........+.+++.+||+.||++|| +.|++++-+.+.
T Consensus       362 ~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          362 YNFIP--EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             CCCCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCc--hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            22110  00011122488999999999999999 999998876643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.5e-44  Score=332.88  Aligned_cols=263  Identities=25%  Similarity=0.380  Sum_probs=210.6

Q ss_pred             HHHHHHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc------hHHHHHHHHHHHHHHhcC-CCCceeeee
Q 046084           82 QEMIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET------ELAFLESFQTEAHLLSQI-RHRNIVKLY  153 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l-~h~niv~l~  153 (363)
                      .......++|++.+.||+|+||.||+|.+. +|+.||||++.....      .....+.+.+|+.+++.+ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334445678999999999999999999874 799999999875431      123346788999999999 799999999


Q ss_pred             eEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceE
Q 046084          154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF  233 (363)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  233 (363)
                      +++...+..++||||+++++|.+++....   .+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999997543   589999999999999999999999   999999999999999999999


Q ss_pred             EEeeccceeccCCCCCceeecccccccccccccc------ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh
Q 046084          234 VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT------MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID  307 (363)
Q Consensus       234 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~  307 (363)
                      |+|||++....... ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||....   .......
T Consensus       241 l~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~  316 (365)
T 2y7j_A          241 LSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRM  316 (365)
T ss_dssp             ECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH
T ss_pred             EEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHH
Confidence            99999998765432 2344579999999998763      357889999999999999999999986432   2222233


Q ss_pred             hhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          308 LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +.........  +........+.+++.+||+.||++|| +.+++.+-..+
T Consensus       317 i~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          317 IMEGQYQFSS--PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HHHTCCCCCH--HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HHhCCCCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            3333222211  00011122488999999999999999 99999876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.6e-45  Score=324.01  Aligned_cols=257  Identities=22%  Similarity=0.348  Sum_probs=204.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchH----HHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETEL----AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||.||++... +|+.||+|.+.......    ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999775 68999999987643211    1246788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC----ceEEEeec
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL----EAFVADFG  238 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg  238 (363)
                      ++||||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999997543   589999999999999999999999   999999999999998877    89999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      ++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ......+.......+  
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~--  231 (283)
T 3bhy_A          158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNISAVNYDFD--  231 (283)
T ss_dssp             TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCCCCC--
T ss_pred             cceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHhHhcccCCc--
Confidence            998764332 22344689999999999988899999999999999999999999865332   222222222222111  


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..........+.+++.+||+.||++|| +.+++.+-..+
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  270 (283)
T 3bhy_A          232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK  270 (283)
T ss_dssp             HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred             chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence            000111122488999999999999999 99999865544

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.8e-45  Score=326.23  Aligned_cols=253  Identities=21%  Similarity=0.329  Sum_probs=204.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|.+.+.||+|+||.||++... +|+.||+|.+.......  .+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR--DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            567999999999999999999764 78999999997654322  356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee---cCCCceEEEeeccceec
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARLL  243 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~  243 (363)
                      ||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+||++   +.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           86 QLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            9999999999887544   589999999999999999999999   99999999999999   78899999999999754


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ..  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....   .......+.......+....  .
T Consensus       160 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~--~  232 (304)
T 2jam_A          160 QN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIKEGYYEFESPFW--D  232 (304)
T ss_dssp             CC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHCCCCCCTTTT--T
T ss_pred             CC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCcccc--c
Confidence            32  22233468999999999999999999999999999999999999986532   22233333333222111100  0


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .....+.+++.+||+.||++|| +.+++.+-..
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (304)
T 2jam_A          233 DISESAKDFICHLLEKDPNERYTCEKALSHPWI  265 (304)
T ss_dssp             TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence            1112488999999999999999 9999886554

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.6e-46  Score=357.56  Aligned_cols=254  Identities=27%  Similarity=0.475  Sum_probs=205.8

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +..++|++.+.||+|+||.||+|.+.++..||||+++.....   .+.|.+|+.+|++++||||+++++++.+ +..++|
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            445678888999999999999999988888999999865533   2578999999999999999999999876 668999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++|+|.+++.... ...+++.+++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++....
T Consensus       340 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             ECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            99999999999996432 12589999999999999999999999   999999999999999999999999999976532


Q ss_pred             CCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhh
Q 046084          246 DSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTV  322 (363)
Q Consensus       246 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  322 (363)
                      ... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.....   ......+... +++.+...+  
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~~~~~~~--  490 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRMPCPPECP--  490 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTCC--
T ss_pred             CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCC--
Confidence            111 1122346778999999998899999999999999999999 9999865432   2222222222 222222222  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                          ..+.+||.+||+.||++|| +.+++..|...
T Consensus       491 ----~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          491 ----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                2488999999999999999 99999988653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.3e-45  Score=331.68  Aligned_cols=257  Identities=27%  Similarity=0.401  Sum_probs=203.2

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      ..++|++.+.||+|+||.||+|.+      .++..||+|.+...... .....+.+|+.+++.++||||+++++++.+.+
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch-hhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            467899999999999999999974      35678999999755433 23467889999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceE
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDE----AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAF  233 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~k  233 (363)
                      ..++||||+++++|.+++.....    ...+++..++.++.|++.||.|||+.   +++||||||+|||++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999999976532    23589999999999999999999999   9999999999999984   45699


Q ss_pred             EEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc
Q 046084          234 VADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD  310 (363)
Q Consensus       234 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  310 (363)
                      |+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+..
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~  260 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVTS  260 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHT
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHHhc
Confidence            999999975533221  2223457889999999988889999999999999999998 9999865322   222222222


Q ss_pred             c-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          311 Q-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       311 ~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      . ....+...+      ..+.+++.+||+.||++|| +.++++.|...
T Consensus       261 ~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          261 GGRMDPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            2 222222222      1488999999999999999 99999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-45  Score=329.67  Aligned_cols=257  Identities=25%  Similarity=0.419  Sum_probs=198.5

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEee-----
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLH-----  158 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----  158 (363)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|++......   .+.+.+|+.+++++ +||||+++++++..     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3467899999999999999999976 57889999998765433   25688999999999 89999999999987     


Q ss_pred             -CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEee
Q 046084          159 -KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADF  237 (363)
Q Consensus       159 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  237 (363)
                       .+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeC
Confidence             467899999999999999997643 23689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      |++..............|++.|+|||++.     +..++.++||||||+++|+|++|+.||.....   ......+....
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~  250 (326)
T 2x7f_A          174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRNP  250 (326)
T ss_dssp             TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSC
T ss_pred             cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhcCc
Confidence            99987654333344457899999999986     56688999999999999999999999865432   22222222222


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .+...... .   ...+.++|.+||+.||++|| +.+++++-..+
T Consensus       251 ~~~~~~~~-~---~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          251 APRLKSKK-W---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             CCCCSCSC-S---CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             cccCCccc-c---CHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            22111110 1   11488999999999999999 99998865543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.7e-45  Score=348.03  Aligned_cols=258  Identities=27%  Similarity=0.379  Sum_probs=206.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchH-----------HHHHHHHHHHHHHhcCCCCceeeeeeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETEL-----------AFLESFQTEAHLLSQIRHRNIVKLYGF  155 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l~~~  155 (363)
                      .++|.+.+.||+|+||+||+|... +++.||+|++.......           ...+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            578999999999999999999764 67899999987643221           224678899999999999999999999


Q ss_pred             EeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC---ce
Q 046084          156 CLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL---EA  232 (363)
Q Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~  232 (363)
                      +.+....++||||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999999887644   599999999999999999999999   999999999999998775   69


Q ss_pred             EEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          233 FVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       233 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      ||+|||++...... .......||+.|+|||++. ..++.++||||||+++|+|++|+.||....   .......+....
T Consensus       189 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~  263 (504)
T 3q5i_A          189 KIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIKKVEKGK  263 (504)
T ss_dssp             EECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCC
T ss_pred             EEEECCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCC
Confidence            99999999876443 2334457999999999876 468999999999999999999999986532   333444444444


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      ...+..  ........+.+||.+||+.||++|| +.|++.+-+.+..
T Consensus       264 ~~~~~~--~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          264 YYFDFN--DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             CCCCHH--HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             CCCCcc--ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            332211  0011122488999999999999999 9999987766543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.6e-45  Score=358.72  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=196.8

Q ss_pred             CeeeecCceeEEEEEe---CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQL---PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||.||+|.+   ..++.||||+++.........+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954   245789999998765444445789999999999999999999999965 457899999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC---
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS---  248 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---  248 (363)
                      |+|.+++....   .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......   
T Consensus       454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999997654   689999999999999999999999   999999999999999999999999999987643322   


Q ss_pred             CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHHH
Q 046084          249 NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQDI  326 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  326 (363)
                      ......+|..|+|||++.+..++.++||||||+++|||++ |+.||.....   ......+... ....+...+      
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~~~p~~~~------  598 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERMGCPAGCP------  598 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTCC------
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCC------
Confidence            1222346788999999999899999999999999999998 9999865433   2222222222 222222222      


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..+.+||..||+.||++|| +.+++..|..
T Consensus       599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          599 REMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            2488999999999999999 9999998864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=355.74  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=198.5

Q ss_pred             cCCcccC-eeeecCceeEEEEEeC---CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           89 EDFDIKY-CIGTGGYGSVYRAQLP---SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        89 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      +++.+.+ .||+|+||.||+|.+.   ++..||||+++..... ...+.+.+|+.+|++++||||+++++++.. +..++
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  412 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML  412 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS-TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence            4444454 7999999999999663   4567999999865322 224779999999999999999999999976 55899


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus       413 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            999999999999997543  2589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCC
Q 046084          245 SDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDD  319 (363)
Q Consensus       245 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  319 (363)
                      .....   .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....   ......+... +++.+...
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~~~p~~~  564 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRMECPPEC  564 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHHHHTTCCCCCCTTC
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCCCCCcC
Confidence            32221   112235688999999998899999999999999999998 9999876433   2222222222 22333322


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +      ..+.+||.+||+.||++|| +.++++.|..
T Consensus       565 ~------~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          565 P------PELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             C------HHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             C------HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2      2488999999999999999 9999988865

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.1e-45  Score=330.69  Aligned_cols=254  Identities=26%  Similarity=0.446  Sum_probs=201.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCE--EEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKK--VALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  163 (363)
                      .++|++.+.||+|+||.||+|... ++..  +++|.+...... ...+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch-HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            468999999999999999999754 4554  499988754322 2346788999999999 8999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC
Q 046084          164 LIYKYMRRGSLFCILRNDD-------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL  230 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  230 (363)
                      +||||+++|+|.+++....             ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence            9999999999999997653             233689999999999999999999999   999999999999999999


Q ss_pred             ceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhh
Q 046084          231 EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLL  309 (363)
Q Consensus       231 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~  309 (363)
                      .+||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+.
T Consensus       180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~  255 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP  255 (327)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGG
T ss_pred             eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HHHHHHhh
Confidence            9999999998743221 12223356789999999988889999999999999999998 9999865432   22222222


Q ss_pred             cc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          310 DQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       310 ~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .. ....+...+      ..+.+++.+||+.||++|| +.+++..|..
T Consensus       256 ~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          256 QGYRLEKPLNCD------DEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             GTCCCCCCTTBC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCCCCCCCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            22 122222222      2488999999999999999 9999998865

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.2e-45  Score=349.08  Aligned_cols=258  Identities=24%  Similarity=0.373  Sum_probs=210.4

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ..++|++.+.||+|+||.||++... +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3567999999999999999999764 789999999865431 11224678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee---cCCCceEEEeeccce
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL---NSKLEAFVADFGVAR  241 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~  241 (363)
                      ||||+.+|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||+   +.++.+||+|||++.
T Consensus       104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999987654   689999999999999999999999   99999999999999   567899999999998


Q ss_pred             eccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....   .......+.......+...  
T Consensus       178 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~--  250 (484)
T 3nyv_A          178 HFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFELPQ--  250 (484)
T ss_dssp             HBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCSGG--
T ss_pred             Eccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCCcc--
Confidence            764332 3344579999999999866 68999999999999999999999986532   3333444444443332211  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .......+.++|.+||+.||++|| +.|++.+-+.+.
T Consensus       251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          251 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence            111122488999999999999999 999998776543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=334.52  Aligned_cols=261  Identities=18%  Similarity=0.221  Sum_probs=195.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC----CCCEEEEEEeccccchH----H-----HHHHHHHHHHHHhcCCCCceeeeee
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP----SGKKVALKKLHHSETEL----A-----FLESFQTEAHLLSQIRHRNIVKLYG  154 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~----~-----~~~~~~~e~~~l~~l~h~niv~l~~  154 (363)
                      .++|.+.+.||+|+||.||+|...    ++..+|+|+........    .     ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999875    57789999987654321    1     1123667889999999999999999


Q ss_pred             EEee----CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC
Q 046084          155 FCLH----KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL  230 (363)
Q Consensus       155 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  230 (363)
                      ++..    ....++||||+ +++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            9988    67899999999 999999997654   689999999999999999999999   999999999999998877


Q ss_pred             --ceEEEeeccceeccCCCC-------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc
Q 046084          231 --EAFVADFGVARLLHSDSS-------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP  301 (363)
Q Consensus       231 --~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~  301 (363)
                        .+||+|||+++.......       ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              999999999987633211       11345689999999999998999999999999999999999999854222111


Q ss_pred             -hhhHHhhhcccCCCCCCCh-hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          302 -KIMLIDLLDQRVPSPIDDQ-TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       302 -~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                       ............+...... ........+.+++.+||+.||++|| +.++++.|..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  325 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP  325 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred             HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence             1111111111111100000 0001112488999999999999999 9999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-44  Score=343.17  Aligned_cols=195  Identities=27%  Similarity=0.388  Sum_probs=157.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----Ce
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-----KC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (363)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++..........+.+.+|+.+++.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46899999999999999999965 4788999999976555555567899999999999999999999999543     56


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .|+||||+ +++|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 468999887654   699999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCC---------------------------Cceeecccccccccccc-ccccCCccccchHHHHHHHHHHhC
Q 046084          242 LLHSDSS---------------------------NRTVVAGTHGYIAPELA-YTMVLTEKCDVYSFGVVALEVLMG  289 (363)
Q Consensus       242 ~~~~~~~---------------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g  289 (363)
                      .......                           .....+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            7643211                           12335689999999976 466799999999999999999993

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.1e-45  Score=324.16  Aligned_cols=250  Identities=26%  Similarity=0.429  Sum_probs=197.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-CeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-KCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv  165 (363)
                      ..++|++.+.||+|+||.||+++. +|+.||+|.+.....    .+.+.+|+.+++.++||||+++++++.+. +..++|
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhH----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            357899999999999999999988 588999999976542    36788999999999999999999997655 468999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            999999999999975421 1378899999999999999999999   999999999999999999999999999876533


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVI  323 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  323 (363)
                      .   .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+... ....+...+   
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~---  240 (278)
T 1byg_A          170 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYKMDAPDGCP---  240 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTTTCCCCCCTTCC---
T ss_pred             c---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCCCCCcccCC---
Confidence            2   223357889999999988889999999999999999998 9999865432   2222222222 112222222   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                         ..+.+++.+||+.||++|| +.++++.|..-.
T Consensus       241 ---~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          241 ---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence               2488999999999999999 999999887643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-45  Score=334.89  Aligned_cols=258  Identities=23%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK------  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (363)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999976 57899999999765544555678899999999999999999999998763      


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..|+||||+ +++|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 78999998763    589999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhh----------
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL----------  309 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------  309 (363)
                      +.....   .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+.........          
T Consensus       176 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          176 RQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             EECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            875432   334568999999998876 678999999999999999999999987543211110000000          


Q ss_pred             ----------cccCCCCCCC--hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          310 ----------DQRVPSPIDD--QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       310 ----------~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                ..........  .........+.+|+.+||+.||++|| +.|++++-...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~  312 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  312 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence                      0000000000  00000112488999999999999999 99999876543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-44  Score=333.41  Aligned_cols=256  Identities=22%  Similarity=0.277  Sum_probs=196.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK------  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (363)
                      .++|++.+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46899999999999999999975 46889999999765544455678889999999999999999999998765      


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..++||||+++ +|.+++..     .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999975 78877753     488999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc---------
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ---------  311 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------  311 (363)
                      ....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..   .....+...         
T Consensus       175 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          175 RTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CCCCCHHHH
T ss_pred             ccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHH
Confidence            8654322 233456899999999999989999999999999999999999998654321   111111110         


Q ss_pred             -------------cCC--------------CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          312 -------------RVP--------------SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       312 -------------~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                   ...              .+............+.+|+.+||+.||++|| +.|++++-...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence                         000              0111111122234688999999999999999 99999876554

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3e-45  Score=330.65  Aligned_cols=261  Identities=23%  Similarity=0.370  Sum_probs=205.3

Q ss_pred             HHHHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC--CCceeeeeeEEee
Q 046084           81 FQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR--HRNIVKLYGFCLH  158 (363)
Q Consensus        81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~  158 (363)
                      ++.+.+..++|++.+.||+|+||.||++...+++.||+|++..........+.+.+|+.+++.++  ||||+++++++..
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            33444556789999999999999999999888999999999766555555678999999999997  5999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      .+..+++|| +.+++|.+++....   .+++..++.++.|+++||+|||+.   +++||||||+|||+++ +.+||+|||
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence            999999999 66889999998654   689999999999999999999999   9999999999999965 899999999


Q ss_pred             cceeccCCCC--Cceeecccccccccccccc-----------ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhH
Q 046084          239 VARLLHSDSS--NRTVVAGTHGYIAPELAYT-----------MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIML  305 (363)
Q Consensus       239 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~  305 (363)
                      ++........  ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||.....  .....
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~  249 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKL  249 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHH
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHH
Confidence            9986643322  1233468999999998865           4678899999999999999999999865432  11222


Q ss_pred             HhhhcccCC--CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          306 IDLLDQRVP--SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       306 ~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ....+....  .+...+      ..+.+++.+||+.||++|| +.|++++...+.
T Consensus       250 ~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          250 HAIIDPNHEIEFPDIPE------KDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             HHHHCTTSCCCCCCCSC------HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             HHHHhcccccCCcccch------HHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            233332221  121111      1388999999999999999 999998766543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.9e-45  Score=322.72  Aligned_cols=248  Identities=25%  Similarity=0.436  Sum_probs=203.6

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee-------
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH-------  158 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  158 (363)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+....      +.+.+|+++++.++||||+++++++..       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            4567999999999999999999875 78999999997654      346689999999999999999998864       


Q ss_pred             ---------CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC
Q 046084          159 ---------KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK  229 (363)
Q Consensus       159 ---------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  229 (363)
                               ....+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+.   +++||||||+||+++.+
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence                     345899999999999999997542 22689999999999999999999999   99999999999999999


Q ss_pred             CceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhh
Q 046084          230 LEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL  309 (363)
Q Consensus       230 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~  309 (363)
                      +.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|..|+...     ........
T Consensus       159 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~  232 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTDLR  232 (284)
T ss_dssp             TEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHHHH
T ss_pred             CCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHHhh
Confidence            999999999998765432 233456899999999999888999999999999999999999885321     11122222


Q ss_pred             cccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          310 DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      ....+...  +      ..+.+++.+||+.||++|| +.|+++.|.....
T Consensus       233 ~~~~~~~~--~------~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          233 DGIISDIF--D------KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             TTCCCTTS--C------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             cccccccC--C------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            22222211  1      1378899999999999999 9999999876543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=332.24  Aligned_cols=248  Identities=14%  Similarity=0.164  Sum_probs=197.0

Q ss_pred             HHhcCCcccCeeeecCceeEEEEE------eCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC---CCceeeeeeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQ------LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR---HRNIVKLYGFC  156 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~  156 (363)
                      ...++|.+.+.||+|+||+||+|.      ..+++.||+|++.....     .++..|+.+++.++   |+||+++++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-----WEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH-----HHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh-----hHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            346789999999999999999993      45788999999976542     45677788887776   99999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC------
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDD--EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS------  228 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~------  228 (363)
                      ...+..++||||+++|+|.+++....  ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence            99999999999999999999997421  223699999999999999999999999   9999999999999998      


Q ss_pred             -----CCceEEEeeccceeccCC--CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc
Q 046084          229 -----KLEAFVADFGVARLLHSD--SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP  301 (363)
Q Consensus       229 -----~~~~kl~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~  301 (363)
                           ++.+||+|||++......  ........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence                 899999999999765322  2233445799999999999999999999999999999999999999854322110


Q ss_pred             hhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC--hHHHHHHHh
Q 046084          302 KIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP--MQRVSQEFL  354 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--~~~v~~~l~  354 (363)
                            .......... .      ...+.+++..||+.+|.+||  +.++...|.
T Consensus       294 ------~~~~~~~~~~-~------~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~  335 (365)
T 3e7e_A          294 ------KPEGLFRRLP-H------LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK  335 (365)
T ss_dssp             ------EECSCCTTCS-S------HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred             ------eechhccccC-c------HHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence                  0111111111 1      11377899999999999997  555554443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-44  Score=333.45  Aligned_cols=258  Identities=24%  Similarity=0.351  Sum_probs=205.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||++.+. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            467999999999999999999764 688999999976543 334578899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.+  +++||||||+|||++.++.+||+|||++......
T Consensus       111 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             ECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999997654   5899999999999999999999832  7999999999999999999999999998754322


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCch------------------------
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK------------------------  302 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~------------------------  302 (363)
                        ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........                        
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence              223346899999999999999999999999999999999999998653321100                        


Q ss_pred             ---------------hhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          303 ---------------IMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       303 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                                     .....+.....+.... ..   ....+.+|+.+||+.||++|| +.|++++-..+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPS-GV---FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCT-TT---SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCc-cc---ccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence                           0001111111111110 00   112488999999999999999 999998776654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.9e-45  Score=327.45  Aligned_cols=257  Identities=24%  Similarity=0.393  Sum_probs=200.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            3578999999999999999999875 588999999875532  2246788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++.....  .+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        95 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             EECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999998865332  589999999999999999999999   999999999999999999999999998754322


Q ss_pred             CCCCceeecccccccccccc-----ccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          246 DSSNRTVVAGTHGYIAPELA-----YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      .........|++.|+|||.+     .+..++.++||||||+++|+|++|+.||.....   ......+.....+......
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~  246 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSDPPTLLTPS  246 (302)
T ss_dssp             HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCCSSGG
T ss_pred             cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHhccCCcccCCcc
Confidence            21222334689999999987     356788999999999999999999999865432   2222333332222211111


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .   ....+.+++.+||+.||++|| +.+++.+-...
T Consensus       247 ~---~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  280 (302)
T 2j7t_A          247 K---WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS  280 (302)
T ss_dssp             G---SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred             c---cCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence            1   112488999999999999999 99998765443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-45  Score=335.80  Aligned_cols=257  Identities=26%  Similarity=0.390  Sum_probs=203.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEe----CCCCEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCC
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL----PSGKKVALKKLHHSET--ELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKK  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  160 (363)
                      .++|++.+.||+|+||.||+++.    .+++.||||+++....  .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999976    4788999999875421  111124567899999999 6999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..++||||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999997644   589999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCC-CCceeecccccccccccccc--ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc-hhhHHhhhcccCCCC
Q 046084          241 RLLHSDS-SNRTVVAGTHGYIAPELAYT--MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDLLDQRVPSP  316 (363)
Q Consensus       241 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~  316 (363)
                      +...... .......||+.|+|||++.+  ..++.++||||||+++|||++|+.||........ ......+.....+.+
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  286 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP  286 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC
Confidence            8653322 22234579999999999875  4478899999999999999999999875443322 222233333333333


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC------hHHHHHHHhch
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP------MQRVSQEFLVR  356 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP------~~~v~~~l~~~  356 (363)
                      ...+.      .+.+||.+||+.||++||      +.+++++...+
T Consensus       287 ~~~~~------~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          287 QEMSA------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             TTSCH------HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             cccCH------HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence            22221      378899999999999997      46676665543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.2e-45  Score=331.33  Aligned_cols=260  Identities=23%  Similarity=0.366  Sum_probs=193.3

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHH--HHHHHHhcCCCCceeeeeeEEee-----C
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQ--TEAHLLSQIRHRNIVKLYGFCLH-----K  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~l~~~~~~-----~  159 (363)
                      ..++|++.+.||+|+||.||+|+. +++.||+|++.....     ..+.  .|+..+..++||||+++++.+..     .
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            356899999999999999999987 789999999975432     2333  34444556899999999986543     2


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCcEEeCCCCCCeeecCCCceE
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC------IPSIVHRDISSNNILLNSKLEAF  233 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~dlkp~Nill~~~~~~k  233 (363)
                      ...++||||+++|+|.+++....    .++..++.++.|+++||+|||+..      .++++||||||+|||++.++.+|
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            35789999999999999997654    588999999999999999999773      23899999999999999999999


Q ss_pred             EEeeccceeccCCC--------CCceeecccccccccccccc-------ccCCccccchHHHHHHHHHHhCCCCCCCCcC
Q 046084          234 VADFGVARLLHSDS--------SNRTVVAGTHGYIAPELAYT-------MVLTEKCDVYSFGVVALEVLMGRHPGDLLSS  298 (363)
Q Consensus       234 l~Dfg~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~g~~p~~~~~~  298 (363)
                      |+|||++.......        .......||+.|+|||++.+       ..++.++||||||+++|||++|..|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998764322        11223468999999999876       4567899999999999999999777533221


Q ss_pred             CCc-hh-------------hHHhhh---cccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          299 VNP-KI-------------MLIDLL---DQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       299 ~~~-~~-------------~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ... ..             ......   ..+...+............+.++|.+||+.||++|| +.|+++.|..-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            110 00             000001   111111211111122333589999999999999999 99999988653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=319.37  Aligned_cols=256  Identities=23%  Similarity=0.322  Sum_probs=201.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEe--eCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE--LAFLESFQTEAHLLSQIRHRNIVKLYGFCL--HKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  162 (363)
                      .++|++.+.||+|+||.||++.. .+++.||+|++......  ....+.+.+|+.+++.++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999976 46889999999764321  123467899999999999999999999984  44578


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++||||++++ |.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999886 6666654332 3689999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCC--Cceeecccccccccccccccc--CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          243 LHSDSS--NRTVVAGTHGYIAPELAYTMV--LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       243 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      ......  ......|++.|+|||++.+..  ++.++||||||+++|||++|+.||....   .......+.......+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~  235 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGKGSYAIPGD  235 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCCCCCSS
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhcCCCCCCCc
Confidence            643222  223456899999999987643  4779999999999999999999986532   223333333443333332


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .+.      .+.+++.+||+.||++|| +.|++++...+.
T Consensus       236 ~~~------~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          236 CGP------PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             SCH------HHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             cCH------HHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence            222      378899999999999999 999998765543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.2e-44  Score=337.85  Aligned_cols=199  Identities=27%  Similarity=0.393  Sum_probs=169.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----Ce
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-----KC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (363)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++..........+.+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            56899999999999999999976 4678899999986655555567899999999999999999999999876     56


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .|+||||+. ++|.+++....   .+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 59999997654   699999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCC----------------------Cceeecccccccccccc-ccccCCccccchHHHHHHHHHHhCCCCC
Q 046084          242 LLHSDSS----------------------NRTVVAGTHGYIAPELA-YTMVLTEKCDVYSFGVVALEVLMGRHPG  293 (363)
Q Consensus       242 ~~~~~~~----------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~p~  293 (363)
                      .......                      .....+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            7643321                      12456789999999985 5667999999999999999999865554

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.3e-45  Score=339.22  Aligned_cols=257  Identities=10%  Similarity=0.029  Sum_probs=183.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcC--CCCceeeee-------eEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQI--RHRNIVKLY-------GFC  156 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~  156 (363)
                      ..+|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345899999999999999999764 788999999987654 334456777885444444  799988755       444


Q ss_pred             eeC-----------------CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 046084          157 LHK-----------------KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKR------VNIVKSMAHALSYLHCDCIPS  213 (363)
Q Consensus       157 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~  213 (363)
                      ...                 ...++||||++ |+|.+++.....  .+.+..+      +.++.|++.||+|||++   +
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            433                 33799999998 899999976432  2344455      67789999999999999   9


Q ss_pred             cEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeecccccccccccccc--ccCCccccchHHHHHHHHHHhCCC
Q 046084          214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT--MVLTEKCDVYSFGVVALEVLMGRH  291 (363)
Q Consensus       214 i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~  291 (363)
                      ++||||||+|||++.++.+||+|||++.....   ......+++.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999986532   1213456799999999987  779999999999999999999999


Q ss_pred             CCCCCcCCCchhhH----HhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          292 PGDLLSSVNPKIML----IDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       292 p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ||............    ..........+...    .....+.+||.+||+.||++|| +.+++++-..+.
T Consensus       292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCT----PLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSS----CCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             CCCCcCcccccchhhhhhhhccccccchhhcc----CCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            99765332111100    11111111111100    1112488999999999999999 999987665543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-44  Score=331.07  Aligned_cols=260  Identities=20%  Similarity=0.317  Sum_probs=207.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHH---------------HHHHHHHHHHHHhcCCCCceeee
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELA---------------FLESFQTEAHLLSQIRHRNIVKL  152 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~h~niv~l  152 (363)
                      .++|++.+.||+|+||.||+|.. +|+.||+|.+........               ..+.+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999998 899999999875432110               11678899999999999999999


Q ss_pred             eeEEeeCCeEEEEEEeccCCChhhh------hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCee
Q 046084          153 YGFCLHKKCMFLIYKYMRRGSLFCI------LRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNIL  225 (363)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil  225 (363)
                      ++++.+.+..++||||+++++|.++      +.... ...+++..++.++.|++.||+|||+ .   +++||||+|+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            9999999999999999999999998      54321 3369999999999999999999999 8   9999999999999


Q ss_pred             ecCCCceEEEeeccceeccCCCCCceeeccccccccccccccc-cCCc-cccchHHHHHHHHHHhCCCCCCCCcCCCchh
Q 046084          226 LNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VLTE-KCDVYSFGVVALEVLMGRHPGDLLSSVNPKI  303 (363)
Q Consensus       226 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DvwslG~il~el~~g~~p~~~~~~~~~~~  303 (363)
                      ++.++.+||+|||++......  ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||......  ..
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence            999999999999999876433  33345689999999998876 6666 999999999999999999998754331  22


Q ss_pred             hHHhhhcccCCCCCCCh-------------hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          304 MLIDLLDQRVPSPIDDQ-------------TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ....+.......+....             ........+.+++.+||+.||++|| +.|++++-...
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~  327 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA  327 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence            33333333332221100             0011122488999999999999999 99999876553

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8e-46  Score=342.97  Aligned_cols=248  Identities=15%  Similarity=0.148  Sum_probs=191.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEecccc-chHHHHHHHHHHH---HHHhcCCCCceeeee-------eE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSE-TELAFLESFQTEA---HLLSQIRHRNIVKLY-------GF  155 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~  155 (363)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++.... ......+.+.+|+   ..++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46789999999999999999986 568999999987432 1222346788999   455566899999998       66


Q ss_pred             EeeCC-----------------eEEEEEEeccCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 046084          156 CLHKK-----------------CMFLIYKYMRRGSLFCILRNDDE----AIRLDWTKRVNIVKSMAHALSYLHCDCIPSI  214 (363)
Q Consensus       156 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  214 (363)
                      +...+                 ..+++|||+ +|+|.+++.....    ...+++..++.++.|++.||+|||+.   ++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            66553                 278999999 6799999975321    11244588889999999999999999   99


Q ss_pred             EEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeeccccccccccccccc-----------cCCccccchHHHHHH
Q 046084          215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-----------VLTEKCDVYSFGVVA  283 (363)
Q Consensus       215 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DvwslG~il  283 (363)
                      +||||||+|||++.++.+||+|||++.....   ......| +.|+|||++.+.           .++.++||||||+++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            9999999999999999999999999986422   3344567 999999999887           899999999999999


Q ss_pred             HHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          284 LEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       284 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      |||++|+.||.........   ..+....    ...+      ..+.+||.+||+.||++|| +.|++++-..+
T Consensus       304 ~elltg~~Pf~~~~~~~~~---~~~~~~~----~~~~------~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  364 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGS---EWIFRSC----KNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEYE  364 (377)
T ss_dssp             HHHHHSSCCC------CCS---GGGGSSC----CCCC------HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred             HHHHHCCCCCcccccccch---hhhhhhc----cCCC------HHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence            9999999998654432211   1111111    1111      1388999999999999999 99998865544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.6e-44  Score=322.08  Aligned_cols=260  Identities=23%  Similarity=0.360  Sum_probs=192.2

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|++..........+.+.++...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            457899999999999999999976 5788999999987655544445566666678889999999999999999999999


Q ss_pred             EEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          166 YKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      |||+++ +|.+++... .....+++..++.++.|++.||+|||+..  +++||||||+||+++.++.+||+|||++....
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            999975 887776531 11236999999999999999999999842  89999999999999999999999999997664


Q ss_pred             CCCCCceeecccccccccccc----ccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          245 SDSSNRTVVAGTHGYIAPELA----YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      ... ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||+....  .............+......
T Consensus       162 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~  238 (290)
T 3fme_A          162 DDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVEEPSPQLPADK  238 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHHSCCCCCCTTT
T ss_pred             ccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhccCCCCccccc
Confidence            332 23334689999999995    566789999999999999999999999865322  22222222222222111111


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       .   ...+.+++.+||+.||++|| +.|++++-..+
T Consensus       239 -~---~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~  271 (290)
T 3fme_A          239 -F---SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT  271 (290)
T ss_dssp             -S---CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             -C---CHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence             1   12488999999999999999 99998866554

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=336.85  Aligned_cols=258  Identities=19%  Similarity=0.214  Sum_probs=199.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCC---------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceee-------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPS---------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVK-------  151 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------  151 (363)
                      .++|++.+.||+|+||.||+|....         ++.||+|.+...       +.+.+|+.++++++||||++       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            4689999999999999999997753         789999998754       35778999999999999887       


Q ss_pred             --------eeeEEee-CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCC
Q 046084          152 --------LYGFCLH-KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSN  222 (363)
Q Consensus       152 --------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  222 (363)
                              +++++.. .+..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+.   +++||||||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~  188 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE  188 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence                    6777776 67889999999 999999998652 23699999999999999999999999   9999999999


Q ss_pred             CeeecCCC--ceEEEeeccceeccCCCC-------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCC
Q 046084          223 NILLNSKL--EAFVADFGVARLLHSDSS-------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPG  293 (363)
Q Consensus       223 Nill~~~~--~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~  293 (363)
                      |||++.++  .+||+|||++........       ......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  999999999976543221       112346899999999999989999999999999999999999998


Q ss_pred             CCCcCCCchh-hHH-hhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          294 DLLSSVNPKI-MLI-DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       294 ~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .......... ... ......................+.+++.+||+.||++|| +.++++.|..-.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            7643211111 111 111111111100000000012488999999999999999 999999886543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.3e-44  Score=331.47  Aligned_cols=271  Identities=22%  Similarity=0.301  Sum_probs=201.5

Q ss_pred             cHHHHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccc---------hHHHHHHHHHHHHHHhcCCCCcee
Q 046084           80 TFQEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSET---------ELAFLESFQTEAHLLSQIRHRNIV  150 (363)
Q Consensus        80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~niv  150 (363)
                      ...++....++|++.+.||+|+||.||+|...+|+.||||++.....         .....+.+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            34667778899999999999999999999988899999999865322         223347789999999999999999


Q ss_pred             eeeeEEeeC-----CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCee
Q 046084          151 KLYGFCLHK-----KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNIL  225 (363)
Q Consensus       151 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  225 (363)
                      ++++++...     ...++||||+. |+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence            999998543     36899999998 58888776543  2589999999999999999999999   9999999999999


Q ss_pred             ecCCCceEEEeeccceeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhh
Q 046084          226 LNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM  304 (363)
Q Consensus       226 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~  304 (363)
                      ++.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             ECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999997543322 2334568999999998876 6789999999999999999999999875432111000


Q ss_pred             HHh--------------------hhcccCC-CCCCCh--hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          305 LID--------------------LLDQRVP-SPIDDQ--TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       305 ~~~--------------------~~~~~~~-~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ...                    ....... .+....  ........+.+|+.+||+.||++|| +.|++++-..+.
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  322 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES  322 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence            000                    0000000 000000  0001122488999999999999999 999998776543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.1e-44  Score=318.89  Aligned_cols=259  Identities=24%  Similarity=0.321  Sum_probs=208.7

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEecccc-------chHHHHHHHHHHHHHHhcCC-CCceeeeeeEEe
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSE-------TELAFLESFQTEAHLLSQIR-HRNIVKLYGFCL  157 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  157 (363)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....       ......+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999764 68899999987543       11233567889999999995 999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEee
Q 046084          158 HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADF  237 (363)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  237 (363)
                      ..+..++||||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            9999999999999999999997643   589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccc------cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAY------TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ  311 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  311 (363)
                      |++....... ......+++.|+|||++.      ...++.++||||||+++|+|++|+.||....   .......+...
T Consensus       169 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~  244 (298)
T 1phk_A          169 GFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMSG  244 (298)
T ss_dssp             TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHT
T ss_pred             cchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHHHHHhcC
Confidence            9998764332 233456899999999875      4567889999999999999999999986432   22233333333


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ....+...  .......+.+++.+||+.||++|| +.+++++-..+.
T Consensus       245 ~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (298)
T 1phk_A          245 NYQFGSPE--WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  289 (298)
T ss_dssp             CCCCCTTT--GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CcccCccc--ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence            33222111  111122488999999999999999 999988665543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=328.83  Aligned_cols=256  Identities=21%  Similarity=0.335  Sum_probs=186.3

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEe------
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCL------  157 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~------  157 (363)
                      +...+|++.+.||+|+||.||++.+ .+++.||+|++.....  ...+.+.+|+.+++++. ||||+++++++.      
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch--HHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            3456899999999999999999976 4788999999865443  33467889999999995 999999999994      


Q ss_pred             --eCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCeeecCCCceE
Q 046084          158 --HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS--IVHRDISSNNILLNSKLEAF  233 (363)
Q Consensus       158 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~k  233 (363)
                        .....+++|||+. |+|.+++........+++..++.++.|++.||+|||+.   +  ++||||||+|||++.++.+|
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence              3345899999996 68988886533333699999999999999999999999   8  99999999999999999999


Q ss_pred             EEeeccceeccCCCCC------------ceeecccccccccccc---ccccCCccccchHHHHHHHHHHhCCCCCCCCcC
Q 046084          234 VADFGVARLLHSDSSN------------RTVVAGTHGYIAPELA---YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS  298 (363)
Q Consensus       234 l~Dfg~~~~~~~~~~~------------~~~~~g~~~y~aPE~~---~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~  298 (363)
                      |+|||++.........            .....+|+.|+|||++   .+..++.++||||||+++|||++|+.||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            9999999876432211            1134589999999988   566789999999999999999999999865332


Q ss_pred             CCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          299 VNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      ..   ......  ..+.....+.      .+.+++.+||+.||++|| +.|+++.|.....
T Consensus       259 ~~---~~~~~~--~~~~~~~~~~------~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          259 LR---IVNGKY--SIPPHDTQYT------VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ----------C--CCCTTCCSSG------GGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH---hhcCcc--cCCcccccch------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11   111111  1111111111      277899999999999999 9999999876443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=328.42  Aligned_cols=258  Identities=28%  Similarity=0.451  Sum_probs=204.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-----CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-----PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK-  160 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  160 (363)
                      ..++|++.+.||+|+||.||++..     .+++.||+|++......  ..+.+.+|+.+++.++||||+++++++...+ 
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH--HHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            356789999999999999999973     46889999999865432  3467999999999999999999999987654 


Q ss_pred             -eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          161 -CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       161 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                       ..++||||+++++|.+++.....  .+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CceEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence             68999999999999999976542  589999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcC--------CCc-hh---h
Q 046084          240 ARLLHSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSS--------VNP-KI---M  304 (363)
Q Consensus       240 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~--------~~~-~~---~  304 (363)
                      +.........   .....++..|+|||.+.+..++.++||||||+++|||++|..|+.....        ... ..   .
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            9876543321   1223467789999999888899999999999999999999999753210        000 00   1


Q ss_pred             HHhhhcc--cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          305 LIDLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       305 ~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ....+..  ..+.+...+      ..+.++|.+||+.||++|| +.++++.|....
T Consensus       272 ~~~~~~~~~~~~~~~~~~------~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDGCP------DEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHHTTCCCCCCTTCC------HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCccc------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1122221  222222222      2488999999999999999 999999986543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.2e-44  Score=325.26  Aligned_cols=257  Identities=24%  Similarity=0.318  Sum_probs=198.4

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc------hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET------ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (363)
                      ..++|++.+.||+|+||.||+|... +++.||||.+.....      .......+.+|+.+++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3568999999999999999999764 578999999875432      112234588999999999999999999998766


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc---eEEEe
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE---AFVAD  236 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~D  236 (363)
                      + .++||||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 899999999999999887544   689999999999999999999999   9999999999999987654   99999


Q ss_pred             eccceeccCCCCCceeeccccccccccccc---cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          237 FGVARLLHSDSSNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       237 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      ||++...... .......|++.|+|||++.   ...++.++||||||+++|+|++|+.||........  ....+.....
T Consensus       161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~  237 (322)
T 2ycf_A          161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITSGKY  237 (322)
T ss_dssp             CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHHTCC
T ss_pred             Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHhCcc
Confidence            9999876432 1223356899999999864   56688999999999999999999999875443221  1122222222


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ....  .........+.+++.+||+.||++|| +.+++++-..
T Consensus       238 ~~~~--~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~  278 (322)
T 2ycf_A          238 NFIP--EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL  278 (322)
T ss_dssp             CCCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             ccCc--hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence            1110  00011122488999999999999999 9999876554

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-44  Score=333.43  Aligned_cols=258  Identities=23%  Similarity=0.340  Sum_probs=185.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------C
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------K  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  160 (363)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999975 5788999999976544444557888999999999999999999998754      4


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..++++|++ +++|.+++...    .+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            579999998 67999888652    599999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhh----------
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL----------  309 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------  309 (363)
                      +.....   .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.........          
T Consensus       180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          180 RHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            765322   334578999999999876 678999999999999999999999986543221111111110          


Q ss_pred             ----------cccCCCCCCC-hh-hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          310 ----------DQRVPSPIDD-QT-VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       310 ----------~~~~~~~~~~-~~-~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                ......+... .. .......+.+|+.+||+.||++|| +.|++.+-...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~  316 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  316 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence                      0000000000 00 000112478999999999999999 99999876543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.6e-44  Score=337.93  Aligned_cols=199  Identities=21%  Similarity=0.313  Sum_probs=171.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC------CCCceeeeeeEEeeCC
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQI------RHRNIVKLYGFCLHKK  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~  160 (363)
                      ..+|++.+.||+|+||.||+|... +++.||||++.....   ..+.+.+|+.+++.+      +|+||+++++++...+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc---hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            467999999999999999999654 588999999976432   235677788877776      5789999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc--eEEEeec
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE--AFVADFG  238 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg  238 (363)
                      ..++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.  +||+|||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             eEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            9999999996 589888876542 2489999999999999999999999   9999999999999999887  9999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCc
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLS  297 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~  297 (363)
                      ++......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       248 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          248 SSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             TCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99765332   234578999999999999999999999999999999999999986543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.5e-44  Score=318.95  Aligned_cols=259  Identities=24%  Similarity=0.357  Sum_probs=207.5

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  164 (363)
                      ...++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            45678999999999999999999775 78899999987654333334678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC---CceEEEeeccce
Q 046084          165 IYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK---LEAFVADFGVAR  241 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~  241 (363)
                      ++||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||+|+||+++.+   +.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            999999999998886543   589999999999999999999999   99999999999999754   479999999997


Q ss_pred             eccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChh
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT  321 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ...... ......+++.|+|||.+.+. ++.++||||||+++|+|++|+.||....   .......+...........  
T Consensus       173 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~--  245 (287)
T 2wei_A          173 CFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLPQ--  245 (287)
T ss_dssp             TBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCSGG--
T ss_pred             eecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCchh--
Confidence            654332 22334588999999988654 8899999999999999999999986533   2223333333332222110  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          322 VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .......+.+++.+||+.||++|| +.+++..-..+.
T Consensus       246 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence            111122488999999999999999 999998765543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-43  Score=326.90  Aligned_cols=261  Identities=22%  Similarity=0.322  Sum_probs=202.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----Ce
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-----KC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (363)
                      .++|++.+.||+|+||.||++... +++.||+|++...... ...+.+.+|+.++++++||||+++++++...     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH-HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc-HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            457999999999999999999764 6788999999754433 3346789999999999999999999999765     36


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .+++|||+.+ +|.+++...    .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            8999999974 899988754    489999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCC---Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc-----
Q 046084          242 LLHSDSS---NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR-----  312 (363)
Q Consensus       242 ~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----  312 (363)
                      .......   ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...................     
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            7643221   1234578999999998654 458999999999999999999999987554322111111111100     


Q ss_pred             --------------CCCCCCChh---hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          313 --------------VPSPIDDQT---VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       313 --------------~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                                    .+.....+.   .......+.+|+.+||+.||++|| +.|++++-..+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  319 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ  319 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence                          000000000   000112488999999999999999 999998876654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.1e-43  Score=335.06  Aligned_cols=257  Identities=18%  Similarity=0.295  Sum_probs=204.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCC-CceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH-RNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++......    ..+..|+++++.++| +++..+..++...+..++|
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            46899999999999999999975 57899999988755432    347789999999976 5666777777888889999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee---cCCCceEEEeecccee
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARL  242 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~  242 (363)
                      |||+ +++|.+++.....  .+++..++.++.||+.||+|||+.   +|+||||||+|||+   +.++.+||+|||++..
T Consensus        82 me~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            9999 9999999975432  599999999999999999999999   99999999999999   6889999999999987


Q ss_pred             ccCCCCC-------ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCC
Q 046084          243 LHSDSSN-------RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS  315 (363)
Q Consensus       243 ~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  315 (363)
                      .......       .....||..|+|||.+.+..++.++||||||+++|||++|+.||..............+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            6543321       224579999999999999999999999999999999999999998765544433333332222111


Q ss_pred             CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ... .........+.+++..||+.||++|| +.++++.|..
T Consensus       236 ~~~-~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          236 SIE-ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             CHH-HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cHH-HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            100 00001122488999999999999999 9998887754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-44  Score=324.57  Aligned_cols=266  Identities=27%  Similarity=0.439  Sum_probs=187.9

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      .+..++|++.+.||+|+||.||+|.. .+++.||+|.+...... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            45578999999999999999999975 46889999998754332 23467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          164 LIYKYMRRGSLFCILRND-----DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      +||||+++++|.+++...     .....+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            999999999999988641     1123589999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCC-----CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          239 VARLLHSDS-----SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       239 ~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      ++.......     .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.......   .........
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~  243 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQND  243 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHTSS
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHHHhccC
Confidence            987653321     11233468999999998875 568999999999999999999999987643321   111122211


Q ss_pred             CCCCCCCh----hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          313 VPSPIDDQ----TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       313 ~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .+......    ........+.+++.+||+.||++|| +.+++++-..+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  293 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK  293 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence            11110000    0000112488999999999999999 999998765543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.3e-44  Score=318.45  Aligned_cols=258  Identities=24%  Similarity=0.390  Sum_probs=195.9

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC--CCC--EEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP--SGK--KVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      ..++|++.+.||+|+||.||+|.+.  +++  .||+|+++.... .....+.+.+|+.+++.++||||+++++++.... 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            3568999999999999999999752  333  689999875432 2234578999999999999999999999998765 


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++++||+++++|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            789999999999999987643  2589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccCCCCC
Q 046084          242 LLHSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPI  317 (363)
Q Consensus       242 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  317 (363)
                      ........   .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||....   .......+.......+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~  246 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERLPR  246 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCCCCCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HHHHHHHHHccCCCCCC
Confidence            76443321   123456778999999988889999999999999999999 999986543   22233333322222111


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ...    ....+.+++.+||+.||++|| +.++++.|....
T Consensus       247 ~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          247 PED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CcC----cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            111    112488999999999999999 999999886543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.2e-44  Score=331.00  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=194.7

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK----  159 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  159 (363)
                      ....++|++.+.||+|+||.||+|.+ .+|+.||+|++.....      ...+|+.+++.++||||+++++++...    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            34567899999999999999999965 5789999999865432      234799999999999999999998543    


Q ss_pred             ----------------------------------CeEEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHH
Q 046084          160 ----------------------------------KCMFLIYKYMRRGSLFCILRND-DEAIRLDWTKRVNIVKSMAHALS  204 (363)
Q Consensus       160 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~  204 (363)
                                                        ...++||||+++ +|.+.+... .....+++..+..++.|+++||+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                              348899999985 777666431 11236999999999999999999


Q ss_pred             HHHhCCCCCcEEeCCCCCCeeec-CCCceEEEeeccceeccCCCCCceeeccccccccccccccc-cCCccccchHHHHH
Q 046084          205 YLHCDCIPSIVHRDISSNNILLN-SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVV  282 (363)
Q Consensus       205 ~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~i  282 (363)
                      |||+.   +++||||||+|||++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++||||+||+
T Consensus       156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99999   999999999999997 68999999999998764333 33345689999999988764 48999999999999


Q ss_pred             HHHHHhCCCCCCCCcCCCchhhHHhhhc-----------cc---CCCCCCChhhHH------HHHHHHHHHHHccCCCCC
Q 046084          283 ALEVLMGRHPGDLLSSVNPKIMLIDLLD-----------QR---VPSPIDDQTVIQ------DIILVSKIVFACLRSKPT  342 (363)
Q Consensus       283 l~el~~g~~p~~~~~~~~~~~~~~~~~~-----------~~---~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~  342 (363)
                      +|||++|+.||......+..........           ..   ...+......+.      ....+.+|+.+||+.||+
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999875432211111111100           00   000000000000      112488999999999999


Q ss_pred             CCC-hHHHHHHHhch
Q 046084          343 SRP-MQRVSQEFLVR  356 (363)
Q Consensus       343 ~RP-~~~v~~~l~~~  356 (363)
                      +|| +.|++++-..+
T Consensus       312 ~R~t~~e~l~hp~f~  326 (383)
T 3eb0_A          312 LRINPYEAMAHPFFD  326 (383)
T ss_dssp             GSCCHHHHHTSGGGH
T ss_pred             hCCCHHHHhcCHHHH
Confidence            999 99999876654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=329.75  Aligned_cols=259  Identities=22%  Similarity=0.395  Sum_probs=202.1

Q ss_pred             HHHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           82 QEMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      +++.+..++|++.+.||+|+||.||+|...+  .+|+|++..........+.+.+|+.++++++||||+++++++.+.+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            4444567889999999999999999998743  59999987654333333567789999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .+++|||+++++|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++ ++.+||+|||++.
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             eEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            999999999999999997643  2588999999999999999999999   999999999999998 6799999999987


Q ss_pred             eccCC-----CCCceeecccccccccccccc---------ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh
Q 046084          242 LLHSD-----SSNRTVVAGTHGYIAPELAYT---------MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID  307 (363)
Q Consensus       242 ~~~~~-----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~  307 (363)
                      .....     ........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||.....   ......
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~  254 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQ  254 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHH
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence            54321     122233458899999998864         3578899999999999999999999865332   222222


Q ss_pred             hhcccCCCCC--CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          308 LLDQRVPSPI--DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       308 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      +.....+...  ..+.      .+.+++.+||+.||++|| +.++++.|..-.
T Consensus       255 ~~~~~~~~~~~~~~~~------~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          255 MGTGMKPNLSQIGMGK------EISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             HHTTCCCCCCCSSCCT------THHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             hccCCCCCCCcCCCCH------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            2222222111  1111      388999999999999999 999999987543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.2e-43  Score=321.45  Aligned_cols=260  Identities=17%  Similarity=0.321  Sum_probs=203.3

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe--CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCC------ceeeeeeEEee
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL--PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR------NIVKLYGFCLH  158 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~  158 (363)
                      ..++|++.+.||+|+||.||++..  .+++.||+|++....   ...+.+.+|+.+++.++|+      +++++++++..
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            356899999999999999999975  367899999997543   2346788899999888665      49999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC----------
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS----------  228 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----------  228 (363)
                      .+..++||||+ +++|.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+|||++.          
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            99999999999 8899999876542 3589999999999999999999999   9999999999999987          


Q ss_pred             ---------CCceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC
Q 046084          229 ---------KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV  299 (363)
Q Consensus       229 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~  299 (363)
                               ++.+||+|||++......   .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                     668999999999865332   23456899999999999989999999999999999999999998754332


Q ss_pred             CchhhHHhhhcccC------------------CCCCCCh-----------------hhHHHHHHHHHHHHHccCCCCCCC
Q 046084          300 NPKIMLIDLLDQRV------------------PSPIDDQ-----------------TVIQDIILVSKIVFACLRSKPTSR  344 (363)
Q Consensus       300 ~~~~~~~~~~~~~~------------------~~~~~~~-----------------~~~~~~~~l~~li~~cl~~dP~~R  344 (363)
                      ..............                  .......                 ........+.+|+.+||+.||++|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            11111111111000                  0000000                 001123358899999999999999


Q ss_pred             C-hHHHHHHHhchh
Q 046084          345 P-MQRVSQEFLVRK  357 (363)
Q Consensus       345 P-~~~v~~~l~~~~  357 (363)
                      | +.|++++-..+.
T Consensus       321 pt~~ell~hp~f~~  334 (339)
T 1z57_A          321 ITLREALKHPFFDL  334 (339)
T ss_dssp             CCHHHHTTSGGGGG
T ss_pred             cCHHHHhcCHHHHH
Confidence            9 999998766554

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-43  Score=322.21  Aligned_cols=255  Identities=18%  Similarity=0.270  Sum_probs=199.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEee--CCeEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLH--KKCMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~  163 (363)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....     +.+.+|+.+++.++ ||||+++++++.+  ....+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH-----HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch-----HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            46799999999999999999965 5788999999975432     56889999999997 9999999999998  56789


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC-ceEEEeecccee
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARL  242 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~  242 (363)
                      ++|||+.+++|.+++.      .+++..+..++.|++.||+|||+.   +++||||||+|||++.++ .+||+|||++..
T Consensus       110 lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            9999999999999885      388899999999999999999999   999999999999999776 899999999987


Q ss_pred             ccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchh-h---------HHhhh-c
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI-M---------LIDLL-D  310 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~-~---------~~~~~-~  310 (363)
                      ..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .         ..... .
T Consensus       181 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          181 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            64333 2334568999999999876 678999999999999999999999984322110000 0         00000 0


Q ss_pred             ccCCCC------------------CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          311 QRVPSP------------------IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       311 ~~~~~~------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ......                  ............+.+||.+||+.||++|| +.|++++-..+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  325 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  325 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence            000000                  00000000122488999999999999999 999998876654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.4e-44  Score=325.47  Aligned_cols=264  Identities=25%  Similarity=0.343  Sum_probs=199.1

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe--CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC---CCCceeeeeeEEe----
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL--PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI---RHRNIVKLYGFCL----  157 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----  157 (363)
                      ..++|++.+.||+|+||.||+|..  .+|+.||+|++............+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999987  4678899999875443221123455677777666   8999999999987    


Q ss_pred             -eCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEe
Q 046084          158 -HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVAD  236 (363)
Q Consensus       158 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  236 (363)
                       .....++||||+. |+|.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999998 599999876542 2489999999999999999999999   999999999999999999999999


Q ss_pred             eccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc----
Q 046084          237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR----  312 (363)
Q Consensus       237 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----  312 (363)
                      ||++....... ......++..|+|||++.+..++.++||||||+++|||++|+.||...................    
T Consensus       164 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          164 FGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             CCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             CcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            99997654222 2334568999999999998889999999999999999999999987543211111111100000    


Q ss_pred             CC-----------C---CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          313 VP-----------S---PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       313 ~~-----------~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .+           .   .............+.+|+.+||+.||++|| +.+++.+-..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  301 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ  301 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence            00           0   000000001112478999999999999999 99998765543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.2e-43  Score=349.24  Aligned_cols=263  Identities=25%  Similarity=0.396  Sum_probs=206.9

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEeCC----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQLPS----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK  159 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  159 (363)
                      ..+..++|++.+.||+|+||.||+|.+..    +..||+|.+...... ...+.+.+|+.++++++||||+++++++.+ 
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHPHIVKLIGVITE-  462 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            33456788999999999999999997632    457999998765432 345789999999999999999999999854 


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                      +..++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence            56899999999999999997643  2589999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCC
Q 046084          240 ARLLHSDSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSP  316 (363)
Q Consensus       240 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~  316 (363)
                      +........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+... ..+.+
T Consensus       538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~~~~  614 (656)
T 2j0j_A          538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERLPMP  614 (656)
T ss_dssp             CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHHTCCCCCC
T ss_pred             CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCCCCC
Confidence            987643322 1223446789999999988899999999999999999997 9999865432   2222223222 22222


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhhhhc
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQL  362 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~~~~  362 (363)
                      ...+      ..+.+++.+||+.||++|| +.++++.|.....-.++
T Consensus       615 ~~~~------~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~k~  655 (656)
T 2j0j_A          615 PNCP------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKL  655 (656)
T ss_dssp             TTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             cccc------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence            2222      2488999999999999999 99999998765444433

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.4e-44  Score=332.97  Aligned_cols=259  Identities=21%  Similarity=0.288  Sum_probs=194.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC------e
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK------C  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  161 (363)
                      ..+|++.+.||+|+||.||+|++.++..||+|++.....      ...+|+.+++.++||||+++++++...+      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            457999999999999999999987777899998865432      1236999999999999999999996543      3


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec-CCCceEEEeeccc
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN-SKLEAFVADFGVA  240 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~  240 (363)
                      .++||||++++.+............+++..+..++.|++.||+|||+.   +++||||||+|||++ .++.+||+|||++
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            789999998765443332222223689999999999999999999999   999999999999999 7999999999999


Q ss_pred             eeccCCCCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhh----------
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL----------  309 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------  309 (363)
                      +...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+..+.........          
T Consensus       190 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          190 KILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             EECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            8764333 23345689999999988764 58999999999999999999999987643221111111100          


Q ss_pred             ------cccCCCCCCChhh----HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          310 ------DQRVPSPIDDQTV----IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       310 ------~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                            ....+.....+..    ......+.+|+.+||+.||++|| +.|++.+-..+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  326 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD  326 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence                  0111110000000    00112488999999999999999 99999876543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-43  Score=318.06  Aligned_cols=254  Identities=26%  Similarity=0.452  Sum_probs=193.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee--------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH--------  158 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  158 (363)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.+....   ...+.+.+|+.+++.++||||+++++++.+        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            56799999999999999999976 478999999996432   334778999999999999999999998865        


Q ss_pred             -----CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceE
Q 046084          159 -----KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF  233 (363)
Q Consensus       159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  233 (363)
                           .+..++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+|
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence                 356899999999999999997543  2578899999999999999999999   999999999999999999999


Q ss_pred             EEeeccceeccCCC--------------CCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcC
Q 046084          234 VADFGVARLLHSDS--------------SNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSS  298 (363)
Q Consensus       234 l~Dfg~~~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~  298 (363)
                      |+|||++.......              .......|++.|+|||.+.+. .++.++||||||+++|||++   ||.... 
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-  232 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-  232 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence            99999997653221              122335689999999998754 68999999999999999998   543211 


Q ss_pred             CCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          299 VNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       +.......+.......+...+  ......+.+++.+||+.||++|| +.+++.+-+..
T Consensus       233 -~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (303)
T 1zy4_A          233 -ERVNILKKLRSVSIEFPPDFD--DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP  288 (303)
T ss_dssp             -HHHHHHHHHHSTTCCCCTTCC--TTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred             -hHHHHHHhccccccccCcccc--ccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence             111112222222211111111  01112478899999999999999 99999876653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-43  Score=327.89  Aligned_cols=257  Identities=24%  Similarity=0.340  Sum_probs=199.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE----
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM----  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----  162 (363)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            56899999999999999999975 4688999999987655555567899999999999999999999999887654    


Q ss_pred             --EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          163 --FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       163 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                        ++||||+. ++|.+++..     .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 588877743     489999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh------------
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID------------  307 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~------------  307 (363)
                      ......   .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..............            
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          192 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            765332   233568999999999877 7789999999999999999999999875432111100000            


Q ss_pred             --------hhcccCCCCCCChhh--HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          308 --------LLDQRVPSPIDDQTV--IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       308 --------~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                              ........+......  ......+.+||.+||+.||++|| +.|++++-..+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence                    000001111100000  01123488999999999999999 99999887654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-43  Score=324.90  Aligned_cols=260  Identities=22%  Similarity=0.335  Sum_probs=199.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----Ce
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-----KC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (363)
                      .++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++...     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            468999999999999999999764 688999999975443 23346788999999999999999999998764     57


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .+++|||+. ++|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            899999997 5899888753    589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCCC----------ceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhh-
Q 046084          242 LLHSDSSN----------RTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL-  309 (363)
Q Consensus       242 ~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~-  309 (363)
                      ........          .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||................ 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            76432211          122468999999998754 678999999999999999999999987543211111111110 


Q ss_pred             --------------------cccCCCCCCChh--hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          310 --------------------DQRVPSPIDDQT--VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       310 --------------------~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                          ......+.....  .......+.+++.+||+.||++|| +.|++++-..+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ  310 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence                                000000000000  001122478999999999999999 99999876654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-43  Score=332.72  Aligned_cols=258  Identities=24%  Similarity=0.324  Sum_probs=192.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------C
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------K  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  160 (363)
                      ..+|++.+.||+|+||.||+|.+. +|+.||||++.....      ...+|+++++.++||||+++++++...      .
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            346899999999999999999874 689999999865432      234699999999999999999988642      2


Q ss_pred             eEEEEEEeccCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-CceEEEeec
Q 046084          161 CMFLIYKYMRRGSLFCILRN-DDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFG  238 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg  238 (363)
                      ..++||||+++ ++.+.+.. ......+++..+..++.||++||+|||+.   +|+||||||+|||++.+ +.+||+|||
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence            36789999986 55555432 11123689999999999999999999999   99999999999999965 678999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhh---------
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDL---------  308 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~---------  308 (363)
                      +++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+........         
T Consensus       203 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          203 SAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998764332 23345689999999998764 7899999999999999999999998754321111111110         


Q ss_pred             --hccc---CCCCCCChhhHH------HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          309 --LDQR---VPSPIDDQTVIQ------DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       309 --~~~~---~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                        ....   ...+......+.      ....+.+||.+||+.||++|| +.|++++-...
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~  341 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  341 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence              0100   001100000010      112488999999999999999 99999876653

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2e-43  Score=324.84  Aligned_cols=265  Identities=20%  Similarity=0.230  Sum_probs=188.4

Q ss_pred             HHHHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 046084           82 QEMIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK  160 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  160 (363)
                      .......++|++.+.||+|+||.||+|.. .+|+.||||++......   ...+.+++..++.++||||+++++++...+
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~   92 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLG   92 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence            34456678999999999999999999976 46889999988654322   134567788888899999999999997643


Q ss_pred             e-------EEEEEEeccCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCcEEeCCCCCCeeecC-C
Q 046084          161 C-------MFLIYKYMRRGSLFCILRN-DDEAIRLDWTKRVNIVKSMAHALSYLH--CDCIPSIVHRDISSNNILLNS-K  229 (363)
Q Consensus       161 ~-------~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~dlkp~Nill~~-~  229 (363)
                      .       .++||||++++ |...+.. ......+++..+..++.|++.||.|||  +.   +++||||||+|||++. +
T Consensus        93 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           93 ERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             SSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred             cccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence            3       78999999874 4433321 122336899999999999999999999  88   9999999999999997 8


Q ss_pred             CceEEEeeccceeccCCCCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhh
Q 046084          230 LEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDL  308 (363)
Q Consensus       230 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~  308 (363)
                      +.+||+|||++....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......   .....+
T Consensus       169 ~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~  244 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEI  244 (360)
T ss_dssp             TEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred             CcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHH
Confidence            999999999998764332 23345689999999988654 4899999999999999999999998754321   111111


Q ss_pred             hcccC-----------CCC------CCChhhH---------HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          309 LDQRV-----------PSP------IDDQTVI---------QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       309 ~~~~~-----------~~~------~~~~~~~---------~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .....           +..      ......+         .....+.+|+.+||+.||++|| +.|++++-..+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  320 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE  320 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence            11000           000      0000000         0123588999999999999999 999998876654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=317.24  Aligned_cols=257  Identities=20%  Similarity=0.307  Sum_probs=185.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++..........+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467999999999999999999774 7899999999876655444455666667788889999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      ||+ ++.+..+.....  ..+++..++.++.|++.||.|||+ .   +++||||||+||+++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 555555554322  258999999999999999999998 6   899999999999999999999999999976543


Q ss_pred             CCCCceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          246 DSSNRTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      .. ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||.....  .......+.....+......
T Consensus       178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  254 (318)
T 2dyl_A          178 DK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPLLPGHM  254 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCCCCSSS
T ss_pred             Cc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCCCCccC
Confidence            22 223446899999999984     45688899999999999999999999865322  22223333333222111100


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..   ...+.+++.+||+.||++|| +.+++++-..+
T Consensus       255 ~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (318)
T 2dyl_A          255 GF---SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK  288 (318)
T ss_dssp             CC---CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             CC---CHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence            01   11388999999999999999 99998865543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.6e-43  Score=318.25  Aligned_cols=261  Identities=24%  Similarity=0.300  Sum_probs=179.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHH-HHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAH-LLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++........ ...+..|+. +++.++||||+++++++...+..++|
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            47899999999999999999977 4688999999987654433 244555555 77788999999999999999999999


Q ss_pred             EEeccCCChhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          166 YKYMRRGSLFCILRND--DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      |||+++ +|.+++...  .....+++..+..++.|++.||.|||+..  +++||||||+|||++.++.+||+|||++...
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            999986 777776531  11236899999999999999999999852  7999999999999999999999999999766


Q ss_pred             cCCCCCceeecccccccccccc----ccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCC
Q 046084          244 HSDSSNRTVVAGTHGYIAPELA----YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      .... ......|++.|+|||.+    .+..++.++||||||+++|||++|+.||.......  ...........+.....
T Consensus       177 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          177 VDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCCCCCCCC
T ss_pred             cccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHHhcCCCCCCCCc
Confidence            4332 22334689999999998    45668999999999999999999999987543211  11111222211111000


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       ........+.+++.+||+.||++|| +.++++.....
T Consensus       254 -~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          254 -EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             -SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             -ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence             0000112488999999999999999 99998765543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=328.54  Aligned_cols=260  Identities=23%  Similarity=0.345  Sum_probs=183.3

Q ss_pred             cCCcc-cCeeeecCceeEEEEEeC---CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee--CCeE
Q 046084           89 EDFDI-KYCIGTGGYGSVYRAQLP---SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH--KKCM  162 (363)
Q Consensus        89 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  162 (363)
                      +.|++ .+.||+|+||+||+|...   +++.||+|++......    ..+.+|+.+++.++||||+++++++..  ....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            44666 457999999999999864   5789999999765443    457789999999999999999999965  6689


Q ss_pred             EEEEEeccCCChhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee----cCCCce
Q 046084          163 FLIYKYMRRGSLFCILRND------DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL----NSKLEA  232 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~  232 (363)
                      ++||||+.+ +|.+++...      .....+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence            999999975 777776531      1223589999999999999999999999   99999999999999    677999


Q ss_pred             EEEeeccceeccCCC---CCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCC------ch
Q 046084          233 FVADFGVARLLHSDS---SNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN------PK  302 (363)
Q Consensus       233 kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~------~~  302 (363)
                      ||+|||++.......   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......      ..
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            999999998764322   22334578999999999887 458999999999999999999999996433210      01


Q ss_pred             hhHHhhhcc---cCCCCCCC---------------------hhhHH--------HHHHHHHHHHHccCCCCCCCC-hHHH
Q 046084          303 IMLIDLLDQ---RVPSPIDD---------------------QTVIQ--------DIILVSKIVFACLRSKPTSRP-MQRV  349 (363)
Q Consensus       303 ~~~~~~~~~---~~~~~~~~---------------------~~~~~--------~~~~l~~li~~cl~~dP~~RP-~~~v  349 (363)
                      ..+..+...   ........                     .....        ....+.+||.+||+.||++|| +.|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            111111110   00000000                     00000        012477899999999999999 9999


Q ss_pred             HHHHhch
Q 046084          350 SQEFLVR  356 (363)
Q Consensus       350 ~~~l~~~  356 (363)
                      +++-...
T Consensus       332 L~hp~f~  338 (405)
T 3rgf_A          332 MQDPYFL  338 (405)
T ss_dssp             HTSGGGT
T ss_pred             hcChhhc
Confidence            9887664

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.9e-43  Score=317.23  Aligned_cols=257  Identities=23%  Similarity=0.329  Sum_probs=175.0

Q ss_pred             HhcCCcccC-eeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee----CC
Q 046084           87 ATEDFDIKY-CIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH----KK  160 (363)
Q Consensus        87 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~  160 (363)
                      ..++|.+.+ .||+|+||.||+|... +|+.||+|++.....      ...+....++.++||||+++++++..    ..
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK------ARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH------HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            357888855 6999999999999765 689999999865322      11222334566799999999999876    44


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceEEEee
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVADF  237 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df  237 (363)
                      ..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+|||++.   ++.+||+||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             eEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence            58999999999999999986542 3699999999999999999999999   9999999999999976   456999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchh-hHHhhhcccCCCC
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI-MLIDLLDQRVPSP  316 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~  316 (363)
                      |++......  ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ....+.......+
T Consensus       176 g~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (336)
T 3fhr_A          176 GFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP  253 (336)
T ss_dssp             TTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred             ccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence            999865432  2334568999999999988889999999999999999999999986544322111 1111111111111


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ...  .......+.+|+.+||+.||++|| +.|++++.....
T Consensus       254 ~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          254 NPE--WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             TTT--STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             chh--hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            100  001112488999999999999999 999998776654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.6e-43  Score=320.21  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=197.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe-----
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC-----  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  161 (363)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            46799999999999999999976 468899999997765555556788999999999999999999999987654     


Q ss_pred             -EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          162 -MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       162 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                       .+++|||+. ++|.+++..     .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 588877743     489999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh------------
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID------------  307 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~------------  307 (363)
                      ......   .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..............            
T Consensus       174 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          174 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             cCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            765322   234568999999998876 6789999999999999999999999865432110000000            


Q ss_pred             --------hhcc---cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          308 --------LLDQ---RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       308 --------~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                              ....   ....... .........+.+++.+||+.||++|| +.+++.+-...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence                    0000   0000000 00001122488999999999999999 99999876553

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.2e-43  Score=326.73  Aligned_cols=259  Identities=20%  Similarity=0.274  Sum_probs=198.3

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC--------CCceeeeeeEEe
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR--------HRNIVKLYGFCL  157 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~  157 (363)
                      ..++|++.+.||+|+||+||+|.. .+++.||+|++....   ...+.+.+|+.+++.++        |+||+++++++.
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            357899999999999999999975 467899999997543   23467889999999885        788999999988


Q ss_pred             ----eCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC---
Q 046084          158 ----HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL---  230 (363)
Q Consensus       158 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---  230 (363)
                          .....++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++  +++||||||+|||++.++   
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence                455789999999 5566665544321 25899999999999999999999853  799999999999998775   


Q ss_pred             ----------------------------------------------ceEEEeeccceeccCCCCCceeeccccccccccc
Q 046084          231 ----------------------------------------------EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL  264 (363)
Q Consensus       231 ----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~  264 (363)
                                                                    .+||+|||++......   .....||+.|+|||+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence                                                          7999999999876432   233468999999999


Q ss_pred             cccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCch---hhHHhhhc--ccCC------------------------C
Q 046084          265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPK---IMLIDLLD--QRVP------------------------S  315 (363)
Q Consensus       265 ~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~--~~~~------------------------~  315 (363)
                      +.+..++.++|||||||++|||++|+.||.........   .....+..  +..+                        .
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99999999999999999999999999999755432211   01111100  0000                        0


Q ss_pred             --CCC--------ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          316 --PID--------DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       316 --~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        +..        ..........+.+|+.+||+.||++|| +.|++++-..
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  395 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL  395 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence              000        000122334588999999999999999 9999986554

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.8e-43  Score=329.95  Aligned_cols=253  Identities=22%  Similarity=0.310  Sum_probs=187.5

Q ss_pred             cCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      +.|...+.||+|+||+||.+...+|+.||||++....     .+.+.+|+.+++.+ +||||+++++++.+.+..++|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            3455678899999999987766689999999986543     24567899999876 89999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC-------------C
Q 046084          168 YMRRGSLFCILRNDDEAI----RLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-------------L  230 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-------------~  230 (363)
                      |+. |+|.+++.......    ..++..++.++.|++.||+|||+.   +++||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCce
Confidence            996 59999997654211    113334678999999999999999   99999999999999754             4


Q ss_pred             ceEEEeeccceeccCCCCC----ceeecccccccccccccc-------ccCCccccchHHHHHHHHHHh-CCCCCCCCcC
Q 046084          231 EAFVADFGVARLLHSDSSN----RTVVAGTHGYIAPELAYT-------MVLTEKCDVYSFGVVALEVLM-GRHPGDLLSS  298 (363)
Q Consensus       231 ~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~-g~~p~~~~~~  298 (363)
                      .+||+|||++.........    .....||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            8999999999876543221    234579999999999865       568999999999999999999 9999864322


Q ss_pred             CCchhhHHhhhcccCCCCC-CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          299 VNPKIMLIDLLDQRVPSPI-DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ..     ..+.......+. ...........+.++|.+||+.||++|| +.+++++-..
T Consensus       246 ~~-----~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f  299 (434)
T 2rio_A          246 RE-----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF  299 (434)
T ss_dssp             HH-----HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             hH-----HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence            11     122222211111 1111122234588999999999999999 9999986554

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.5e-43  Score=323.61  Aligned_cols=202  Identities=25%  Similarity=0.359  Sum_probs=170.5

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CC-----ceeeeeeEEeeC
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HR-----NIVKLYGFCLHK  159 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~  159 (363)
                      ..++|++.+.||+|+||+||+|... +++.||||++....   .....+..|+.+++.++ |+     +++++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            4678999999999999999999764 67889999997543   23466778888888774 44     499999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec--CCCceEEEee
Q 046084          160 KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN--SKLEAFVADF  237 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Df  237 (363)
                      +..++||||+. ++|.+++..... ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999999996 599999876532 2589999999999999999999952 12899999999999995  4788999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCc
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLS  297 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~  297 (363)
                      |++......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       206 G~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          206 GSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             TTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999876432   234568999999999999999999999999999999999999987543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.1e-43  Score=315.32  Aligned_cols=256  Identities=21%  Similarity=0.293  Sum_probs=192.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEe---------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCL---------  157 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~---------  157 (363)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++.         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh--HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            467999999999999999999775 488999999876543  33578899999999999999999999874         


Q ss_pred             -----eCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec-CCCc
Q 046084          158 -----HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN-SKLE  231 (363)
Q Consensus       158 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~  231 (363)
                           +....++||||++ |+|.+++...    .+++..++.++.|++.||+|||+.   +++||||||+|||++ +++.
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence                 3467899999998 5999998643    589999999999999999999999   999999999999997 5679


Q ss_pred             eEEEeeccceeccCCCC---Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh
Q 046084          232 AFVADFGVARLLHSDSS---NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID  307 (363)
Q Consensus       232 ~kl~Dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~  307 (363)
                      +||+|||++........   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......   .....
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~  236 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQL  236 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHH
Confidence            99999999986543211   1223457889999998765 67899999999999999999999998754321   11111


Q ss_pred             hhccc----------------------CCCCCCChh--hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          308 LLDQR----------------------VPSPIDDQT--VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       308 ~~~~~----------------------~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +....                      ...+.....  .......+.+++.+||+.||++|| +.|++++-...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS  310 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence            11110                      000000000  001122488999999999999999 99998876554

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=317.10  Aligned_cols=251  Identities=22%  Similarity=0.359  Sum_probs=194.5

Q ss_pred             HHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchH----HHHHHHHHHHHHHhcC----CCCceeeeeeE
Q 046084           85 IVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETEL----AFLESFQTEAHLLSQI----RHRNIVKLYGF  155 (363)
Q Consensus        85 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~l~~~  155 (363)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|++.......    .....+..|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34567899999999999999999976 468899999997654211    1123456788888888    89999999999


Q ss_pred             EeeCCeEEEEEEe-ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec-CCCceE
Q 046084          156 CLHKKCMFLIYKY-MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN-SKLEAF  233 (363)
Q Consensus       156 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~k  233 (363)
                      +...+..++++|+ +.+++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+||+++ .++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 78999999997644   589999999999999999999999   999999999999999 889999


Q ss_pred             EEeeccceeccCCCCCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          234 VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       234 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      |+|||++.......  .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||....         ......
T Consensus       181 l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~~~  249 (312)
T 2iwi_A          181 LIDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EILEAE  249 (312)
T ss_dssp             ECCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHTC
T ss_pred             EEEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------HHhhhc
Confidence            99999998764432  334568999999998876665 458999999999999999999986421         122222


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhh
Q 046084          313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKT  358 (363)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~  358 (363)
                      ...+...+      ..+.++|.+||+.||++|| +.|++.+-..+..
T Consensus       250 ~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          250 LHFPAHVS------PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             CCCCTTSC------HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             cCCcccCC------HHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            22222222      1388899999999999999 9999987766543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2e-43  Score=319.71  Aligned_cols=251  Identities=20%  Similarity=0.314  Sum_probs=201.6

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchH----HHHHHHHHHHHHHhcCC--CCceeeeeeEE
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETEL----AFLESFQTEAHLLSQIR--HRNIVKLYGFC  156 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~  156 (363)
                      .....++|++.+.||+|+||.||+|.. .+++.||+|.+.......    ...+.+..|+.+++.++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            344567899999999999999999975 578899999987643211    11234667899999996  59999999999


Q ss_pred             eeCCeEEEEEEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec-CCCceEE
Q 046084          157 LHKKCMFLIYKYMRR-GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN-SKLEAFV  234 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl  234 (363)
                      ...+..++++|++.+ ++|.+++....   .+++..++.++.|+++||+|||+.   +++||||||+|||++ +++.+||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence            999999999999976 89999987644   589999999999999999999999   999999999999999 7899999


Q ss_pred             EeeccceeccCCCCCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          235 ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       235 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      +|||++......  ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....         .......
T Consensus       192 ~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~~~~~~  260 (320)
T 3a99_A          192 IDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQV  260 (320)
T ss_dssp             CCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHCCC
T ss_pred             eeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------hhhcccc
Confidence            999999876432  2334568999999998876665 678999999999999999999986432         1122222


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ..+...+      ..+.+++.+||+.||++|| +.++++....+.
T Consensus       261 ~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~  299 (320)
T 3a99_A          261 FFRQRVS------SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  299 (320)
T ss_dssp             CCSSCCC------HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             cccccCC------HHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence            2222222      1388999999999999999 999998765543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.9e-42  Score=316.15  Aligned_cols=259  Identities=20%  Similarity=0.319  Sum_probs=199.2

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC-CC-CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCc------eeeeeeEEee
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP-SG-KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN------IVKLYGFCLH  158 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~  158 (363)
                      ..++|++.+.||+|+||.||+|... ++ +.||+|++....   ...+.+.+|+.+++.++|++      ++.+++++..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            3578999999999999999999764 34 689999997543   22467888999999887665      8999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeee------------
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILL------------  226 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill------------  226 (363)
                      .+..++||||+ ++++.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+|||+            
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CCeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence            99999999999 5677666655432 2589999999999999999999999   99999999999999            


Q ss_pred             -------cCCCceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC
Q 046084          227 -------NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV  299 (363)
Q Consensus       227 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~  299 (363)
                             +.++.+||+|||++......   .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                   56789999999999864332   23456899999999999989999999999999999999999998754332


Q ss_pred             CchhhHHhhhcccC------------------CCCCCC-----------------hhhHHHHHHHHHHHHHccCCCCCCC
Q 046084          300 NPKIMLIDLLDQRV------------------PSPIDD-----------------QTVIQDIILVSKIVFACLRSKPTSR  344 (363)
Q Consensus       300 ~~~~~~~~~~~~~~------------------~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~R  344 (363)
                      .............+                  ......                 .........+.+|+.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            11111111111000                  000000                 0001112358899999999999999


Q ss_pred             C-hHHHHHHHhch
Q 046084          345 P-MQRVSQEFLVR  356 (363)
Q Consensus       345 P-~~~v~~~l~~~  356 (363)
                      | +.|++++-...
T Consensus       326 pt~~e~l~hp~f~  338 (355)
T 2eu9_A          326 ITLAEALLHPFFA  338 (355)
T ss_dssp             CCHHHHTTSGGGG
T ss_pred             cCHHHHhcChhhc
Confidence            9 99998776554

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=330.05  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=188.2

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ...+|.+.+.||+|+||+||.....+|+.||||++.....     ..+.+|+.+++.+ +||||+++++++.+....++|
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            4567899999999999997665556899999999875432     2355799999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC-----CCceEEEeeccc
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS-----KLEAFVADFGVA  240 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~~  240 (363)
                      |||+. |+|.+++.....  .+.+..++.++.|++.||+|||+.   +|+||||||+|||++.     ...+||+|||++
T Consensus        97 ~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            99996 599999976543  244445678999999999999999   9999999999999943     346889999999


Q ss_pred             eeccCCC---CCceeeccccccccccccc---cccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccC
Q 046084          241 RLLHSDS---SNRTVVAGTHGYIAPELAY---TMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       241 ~~~~~~~---~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      .......   .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.....   . ..........
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~-~~~~~~~~~~  246 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---R-QANILLGACS  246 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---H-HHHHHTTCCC
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---H-HHHHHhccCC
Confidence            8764332   2233457999999999987   4567889999999999999999 9999853321   1 1111111111


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .......  ......+.+||.+||+.||++|| +.+++++-..
T Consensus       247 ~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f  287 (432)
T 3p23_A          247 LDCLHPE--KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF  287 (432)
T ss_dssp             CTTSCTT--CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred             ccccCcc--ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence            1111111  11222478899999999999999 9999976544

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.3e-42  Score=319.24  Aligned_cols=261  Identities=19%  Similarity=0.310  Sum_probs=198.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-----------CCceeeeeeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-----------HRNIVKLYGF  155 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~  155 (363)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....   ..+.+.+|+.+++.++           ||||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc---chhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            46899999999999999999976 5788999999975432   2366788999998886           8999999999


Q ss_pred             EeeCC----eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec----
Q 046084          156 CLHKK----CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN----  227 (363)
Q Consensus       156 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~----  227 (363)
                      +...+    ..+++||++ +++|.+++..... ..+++..++.++.|++.||+|||++.  +++||||||+|||++    
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence            98754    789999999 8899999876432 25899999999999999999999853  899999999999994    


Q ss_pred             --CCCceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCC---ch
Q 046084          228 --SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVN---PK  302 (363)
Q Consensus       228 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---~~  302 (363)
                        ..+.+||+|||++......   .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......   ..
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence              4458999999999876432   233468999999999999999999999999999999999999997543211   11


Q ss_pred             hhHHhhhc--ccCCC------------------------CC----------CChhhHHHHHHHHHHHHHccCCCCCCCC-
Q 046084          303 IMLIDLLD--QRVPS------------------------PI----------DDQTVIQDIILVSKIVFACLRSKPTSRP-  345 (363)
Q Consensus       303 ~~~~~~~~--~~~~~------------------------~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RP-  345 (363)
                      .....+..  +.++.                        ..          ...........+.+||.+||+.||++|| 
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            11111110  00000                        00          0000122334588999999999999999 


Q ss_pred             hHHHHHHHhchhh
Q 046084          346 MQRVSQEFLVRKT  358 (363)
Q Consensus       346 ~~~v~~~l~~~~~  358 (363)
                      +.|++++-..+..
T Consensus       328 ~~ell~hp~f~~~  340 (373)
T 1q8y_A          328 AGGLVNHPWLKDT  340 (373)
T ss_dssp             HHHHHTCGGGTTC
T ss_pred             HHHHhhChhhhcc
Confidence            9999988776554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.9e-42  Score=333.06  Aligned_cols=256  Identities=25%  Similarity=0.312  Sum_probs=195.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee------CC
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH------KK  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  160 (363)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++..      .+
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            37899999999999999999976 4688999999876533 3335779999999999999999999998765      56


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCc---eEEEee
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLE---AFVADF  237 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Df  237 (363)
                      ..++||||+++|+|.+++........+++..++.++.|++.||+|||+.   +++||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            7899999999999999998765555688999999999999999999999   9999999999999987664   999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCC-----------CchhhHH
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV-----------NPKIMLI  306 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-----------~~~~~~~  306 (363)
                      |++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......           .......
T Consensus       169 G~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          169 GYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            9998764433 233457899999999999999999999999999999999999998542100           0000000


Q ss_pred             hhhcc------cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHH
Q 046084          307 DLLDQ------RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVS  350 (363)
Q Consensus       307 ~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~  350 (363)
                      .....      ..+.+.....  .....+.+++..||+.||++|| +.+++
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~--~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSG--ILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCG--GGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhccccccccccCCchhhch--hhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            01111      1111111111  1223588999999999999999 76643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-41  Score=334.45  Aligned_cols=236  Identities=24%  Similarity=0.364  Sum_probs=190.4

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeC--CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe---
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLP--SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC---  161 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  161 (363)
                      ..++|++.+.||+|+||.||++.+.  +|+.||||++..... ....+.+.+|+.++++++||||+++++++...+.   
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            3578999999999999999999874  588999999876443 2335678999999999999999999999988665   


Q ss_pred             --EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecc
Q 046084          162 --MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGV  239 (363)
Q Consensus       162 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  239 (363)
                        .|+||||+++++|.+++..     .+++.+++.++.||+.||.|||+.   +|+||||||+|||++.+ .+||+|||+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence              7999999999999887654     589999999999999999999999   99999999999999886 899999999


Q ss_pred             ceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCC
Q 046084          240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD  319 (363)
Q Consensus       240 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      +......    ....||+.|+|||++.+. ++.++||||||+++|+|++|..||......            ..+.   .
T Consensus       228 a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------~~~~---~  287 (681)
T 2pzi_A          228 VSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD------------GLPE---D  287 (681)
T ss_dssp             CEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS------------SCCT---T
T ss_pred             chhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc------------cccc---c
Confidence            9876433    345699999999988765 488999999999999999999886542111            0110   1


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                      .........+.++|.+||+.||++|| +.+.+..
T Consensus       288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  321 (681)
T 2pzi_A          288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA  321 (681)
T ss_dssp             CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ccccccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence            11122223588999999999999999 5554443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.8e-41  Score=298.52  Aligned_cols=232  Identities=11%  Similarity=0.060  Sum_probs=182.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+.+|+..++.++||||+++++++.+.+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            467999999999999999999774 488999999986543 244457899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++...     ....++.+++.|++.||+|||++   +++||||||+|||++.++.+||+++|       
T Consensus       110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999998542     35567889999999999999999   99999999999999999999997443       


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                                   |++|       ++.++||||||+++|||++|+.||......................+.  ......
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  232 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA--DIDRDI  232 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH--HHCTTS
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh--hcccCC
Confidence                         3333       678999999999999999999998765432211111111111111100  000011


Q ss_pred             HHHHHHHHHHccCCCCCCCChHHHHHHHhch
Q 046084          326 IILVSKIVFACLRSKPTSRPMQRVSQEFLVR  356 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP~~~v~~~l~~~  356 (363)
                      ...+.+++.+||+.||++|-+.|+++.|...
T Consensus       233 ~~~l~~li~~~l~~dP~~Rs~~el~~~L~~~  263 (286)
T 3uqc_A          233 PFQISAVAARSVQGDGGIRSASTLLNLMQQA  263 (286)
T ss_dssp             CHHHHHHHHHHHCTTSSCCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcccCCccCCHHHHHHHHHHH
Confidence            1248899999999999999888888887653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.1e-40  Score=295.91  Aligned_cols=235  Identities=22%  Similarity=0.337  Sum_probs=179.9

Q ss_pred             hcCCccc-CeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHH-hcCCCCceeeeeeEEee----CC
Q 046084           88 TEDFDIK-YCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLL-SQIRHRNIVKLYGFCLH----KK  160 (363)
Q Consensus        88 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~  160 (363)
                      .++|.+. +.||+|+||.||++.. .+++.||+|++...       ..+.+|+.++ +..+||||+++++++..    ..
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            3567776 7799999999999976 57889999998642       3456788877 55699999999999987    66


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceEEEee
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVADF  237 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df  237 (363)
                      ..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+|||++.   ++.+||+||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             eEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            78999999999999999986532 3589999999999999999999999   9999999999999998   789999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhh-HHhhhcccCCCC
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM-LIDLLDQRVPSP  316 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~  316 (363)
                      |++....                      +..++.++||||||+++|||++|+.||........... ...+.......+
T Consensus       165 g~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          165 GFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  222 (299)
T ss_dssp             TTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred             ccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence            9986542                      23467789999999999999999999865432211000 011111111111


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                        ..........+.+++.+||+.||++|| +.|++++.....
T Consensus       223 --~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          223 --NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             --HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             --chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence              000011123488999999999999999 999998766544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-40  Score=312.00  Aligned_cols=246  Identities=15%  Similarity=0.149  Sum_probs=180.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCC-Cce---------e-----
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRH-RNI---------V-----  150 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~ni---------v-----  150 (363)
                      ..+|...+.||+|+||.||+|.+ .+|+.||||++..... .....+.+.+|+.+++.++| +|.         +     
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34577888999999999999974 5789999999884432 22335678999999999977 221         1     


Q ss_pred             -ee------eeEEee-----CCeEEEEEEeccCCChhhhhhc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 046084          151 -KL------YGFCLH-----KKCMFLIYKYMRRGSLFCILRN----DDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSI  214 (363)
Q Consensus       151 -~l------~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  214 (363)
                       .+      ..++..     ....+++|+++ +++|.+++..    ......+++..++.++.|+++||+|||+.   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence             11      111111     12356667755 6799988842    11223578889999999999999999999   99


Q ss_pred             EEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeecccccccccccc----------ccccCCccccchHHHHHHH
Q 046084          215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA----------YTMVLTEKCDVYSFGVVAL  284 (363)
Q Consensus       215 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DvwslG~il~  284 (363)
                      +||||||+|||++.++.+||+|||+++.....   .....| +.|+|||++          .+..++.++|||||||++|
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            99999999999999999999999999865332   334567 999999998          5566888999999999999


Q ss_pred             HHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          285 EVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       285 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ||++|+.||........   ...+.....    ..+      ..+.+||.+||+.||++|| +.++++.-.
T Consensus       309 elltg~~Pf~~~~~~~~---~~~~~~~~~----~~~------~~~~~li~~~l~~dP~~Rpt~~~~l~~~~  366 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGG---SEWIFRSCK----NIP------QPVRALLEGFLRYPKEDRLLPLQAMETPE  366 (413)
T ss_dssp             HHHHSSCCCCTTGGGSC---SGGGGSSCC----CCC------HHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             HHHHCCCCCCCcchhhh---HHHHHhhcc----cCC------HHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence            99999999875433221   111222111    111      2488999999999999999 988876543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.9e-40  Score=302.23  Aligned_cols=246  Identities=15%  Similarity=0.165  Sum_probs=184.8

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccc------hHHHHHHHHHHHHHHhcCC---------CCceee
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSET------ELAFLESFQTEAHLLSQIR---------HRNIVK  151 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~niv~  151 (363)
                      ..++|++.+.||+|+||+||+|+. +|+.||||++.....      .....+.+.+|+.+++.++         ||||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            456799999999999999999988 789999999976532      1122356778888888775         777777


Q ss_pred             eeeEEe-----------------e-------------CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH
Q 046084          152 LYGFCL-----------------H-------------KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH  201 (363)
Q Consensus       152 l~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~  201 (363)
                      +.+.+.                 +             .+..++||||+++|++.+.+...    .+++..+..++.||+.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----CCCHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----CCCHHHHHHHHHHHHH
Confidence            766543                 2             67899999999999777666432    5899999999999999


Q ss_pred             HHHHHH-hCCCCCcEEeCCCCCCeeecCCC--------------------ceEEEeeccceeccCCCCCceeeccccccc
Q 046084          202 ALSYLH-CDCIPSIVHRDISSNNILLNSKL--------------------EAFVADFGVARLLHSDSSNRTVVAGTHGYI  260 (363)
Q Consensus       202 ~l~~LH-~~~~~~i~H~dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~  260 (363)
                      ||+||| +.   +|+||||||+|||++.++                    .+||+|||+++.....     ...||+.|+
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~  244 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTT
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeeccc
Confidence            999999 89   999999999999999887                    8999999999876432     347999999


Q ss_pred             cccccccccCCccccchHHHHH-HHHHHhCCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccC
Q 046084          261 APELAYTMVLTEKCDVYSFGVV-ALEVLMGRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLR  338 (363)
Q Consensus       261 aPE~~~~~~~~~~~DvwslG~i-l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~  338 (363)
                      |||++.+.. +.++||||+|++ .+++++|..||.....  .......+... .................+.+||.+||+
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~  321 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLN  321 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGG
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhc
Confidence            999998766 889999998777 7788899999643110  01111122211 111111222223344569999999999


Q ss_pred             CCCCCCChHHHH-HH
Q 046084          339 SKPTSRPMQRVS-QE  352 (363)
Q Consensus       339 ~dP~~RP~~~v~-~~  352 (363)
                      .|    .+.|++ .+
T Consensus       322 ~d----sa~e~l~~H  332 (336)
T 2vuw_A          322 FS----SATDLLCQH  332 (336)
T ss_dssp             SS----SHHHHHHHC
T ss_pred             cC----CHHHHHhcC
Confidence            76    577777 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2e-34  Score=278.68  Aligned_cols=186  Identities=16%  Similarity=0.078  Sum_probs=132.9

Q ss_pred             eeecCceeEEEE-EeCCCCEEEEEEecccc--------chHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEE
Q 046084           97 IGTGGYGSVYRA-QLPSGKKVALKKLHHSE--------TELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        97 lg~G~~g~V~~~-~~~~~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .+.|+.|.+..+ +.-.|+.+++|.+....        ......++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            445555555443 22357889999986542        1233456799999999999 7999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||++|++|.+++...+   +++..   +|+.||+.||+|+|++   ||+||||||+|||+++++.+||+|||+++....+
T Consensus       322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999998765   56654   4889999999999999   9999999999999999999999999999887665


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCC
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP  292 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  292 (363)
                      .....+.+||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            5555667899999999998764 56789999999998877665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=9.5e-30  Score=244.72  Aligned_cols=186  Identities=16%  Similarity=0.215  Sum_probs=147.0

Q ss_pred             cccCeeeecCceeEEEEEeCCCCEEEEEEeccccc------hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           92 DIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSET------ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        92 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ...+.||+|+||.||++.. .+..+++|+......      .....+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999965 678899998654321      112245689999999999999999666666677778999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++++|.+++..           +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999875           457999999999999999   9999999999999999  999999999987643


Q ss_pred             CCCC-------ceeecccccccccccccc--ccCCccccchHHHHHHHHHHhCCCCCC
Q 046084          246 DSSN-------RTVVAGTHGYIAPELAYT--MVLTEKCDVYSFGVVALEVLMGRHPGD  294 (363)
Q Consensus       246 ~~~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~  294 (363)
                      ....       .....||+.|||||++..  ..|+..+|+||..+-.++.+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2211       134579999999999886  668888999999999999888877753

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.1e-25  Score=199.04  Aligned_cols=150  Identities=14%  Similarity=0.146  Sum_probs=119.3

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchH----------------HHHHHHHHHHHHHhcCCCCce
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETEL----------------AFLESFQTEAHLLSQIRHRNI  149 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~ni  149 (363)
                      .....|.+.+.||+|+||.||+|.+.+|+.||+|.++......                .....+.+|+.+++.++  | 
T Consensus        87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-  163 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-  163 (282)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred             hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence            3445677889999999999999988779999999996543211                13467899999999998  4 


Q ss_pred             eeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC
Q 046084          150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK  229 (363)
Q Consensus       150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  229 (363)
                      +++.+++.. +..++||||+++++|.+ +..         .....++.|++.||.|||+.   +++||||||+|||++ +
T Consensus       164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T
T ss_pred             CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C
Confidence            666665544 45699999999999988 421         12346999999999999999   999999999999999 9


Q ss_pred             CceEEEeeccceeccCCCCCceeeccccccccccccc
Q 046084          230 LEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY  266 (363)
Q Consensus       230 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~  266 (363)
                      +.+||+|||++...             ..++|||.+.
T Consensus       229 ~~vkl~DFG~a~~~-------------~~~~a~e~l~  252 (282)
T 1zar_A          229 EGIWIIDFPQSVEV-------------GEEGWREILE  252 (282)
T ss_dssp             TEEEECCCTTCEET-------------TSTTHHHHHH
T ss_pred             CcEEEEECCCCeEC-------------CCCCHHHHHH
Confidence            99999999999643             3467888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=1.9e-21  Score=169.86  Aligned_cols=138  Identities=21%  Similarity=0.254  Sum_probs=105.8

Q ss_pred             CcccCeeeecCceeEEEEEe-CCCCE--EEEEEeccccch----------------------HHHHHHHHHHHHHHhcCC
Q 046084           91 FDIKYCIGTGGYGSVYRAQL-PSGKK--VALKKLHHSETE----------------------LAFLESFQTEAHLLSQIR  145 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~  145 (363)
                      |++.+.||+|+||.||+|.. .+|+.  ||||+++.....                      ......+.+|+..+..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56888999999999999987 68888  999987543211                      111236788999999998


Q ss_pred             CCce--eeeeeEEeeCCeEEEEEEeccC-C----ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCcEEe
Q 046084          146 HRNI--VKLYGFCLHKKCMFLIYKYMRR-G----SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH-CDCIPSIVHR  217 (363)
Q Consensus       146 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~  217 (363)
                      |+++  +.++++    +..++||||+.+ |    +|.++...      .++..+..++.|++.||.||| +.   +++||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence            7754  334432    246899999943 4    56554432      223456789999999999999 88   99999


Q ss_pred             CCCCCCeeecCCCceEEEeeccceec
Q 046084          218 DISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       218 dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      ||||+|||+++  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=4.7e-18  Score=154.44  Aligned_cols=139  Identities=11%  Similarity=0.135  Sum_probs=100.1

Q ss_pred             CcccCeeeecCceeEEEEEeCCCCEEEEEEeccccc----------------hHHHH----HHHHHHHHHHhcCCCCcee
Q 046084           91 FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSET----------------ELAFL----ESFQTEAHLLSQIRHRNIV  150 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------~~~~~----~~~~~e~~~l~~l~h~niv  150 (363)
                      |++.+.||+|++|.||+|...+|+.||||+++....                .....    -....|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            899999999999999999999999999998753211                00000    1123566677776544432


Q ss_pred             eeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC
Q 046084          151 KLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL  230 (363)
Q Consensus       151 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  230 (363)
                      ...-+....  .++||||++|++|..+...         .....++.|++.+|.+||..   +++||||||.|||+++++
T Consensus       177 vp~p~~~~~--~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          177 VPEPIAQSR--HTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CCCEEEEET--TEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred             CCeeeeccC--ceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence            211111222  3699999999888665421         12346789999999999999   999999999999998776


Q ss_pred             ----------ceEEEeeccceec
Q 046084          231 ----------EAFVADFGVARLL  243 (363)
Q Consensus       231 ----------~~kl~Dfg~~~~~  243 (363)
                                .+.|+||+-+-..
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEET
T ss_pred             CcccccccccceEEEEeCCcccC
Confidence                      3889999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=2.9e-13  Score=118.10  Aligned_cols=144  Identities=13%  Similarity=0.065  Sum_probs=111.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  166 (363)
                      -..|++...++.|+.+.||++.. ++..+++|.........  ...+.+|+.+++.+. +.+++++++++...+..|+||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            35688888888899999999986 46899999987532111  135778999998884 677889999999989999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC------------------------------------  210 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------  210 (363)
                      ||++|.+|.+.+..        ......++.+++++++.||+..                                    
T Consensus        90 e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           90 SEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             ECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            99999998775321        1123468899999999999810                                    


Q ss_pred             --------------------CCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          211 --------------------IPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       211 --------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                                          .+.++|||++|.||+++++..+.|+||+.+..
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                13589999999999998766667999987743

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=2.5e-12  Score=111.76  Aligned_cols=137  Identities=18%  Similarity=0.118  Sum_probs=100.8

Q ss_pred             CCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCc--eeeeeeEEeeCCeEEEEEE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN--IVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e  167 (363)
                      ++.+....+.|..+.||++...+|..+++|......     ...+..|+.+++.+.+.+  +.+++++....+..+++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            344433334566699999988778889999976541     145678888888885434  5668888888788899999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC-------------------------------------  210 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------  210 (363)
                      |++|.++.  ...      .+.   ..++.++++.+..||+..                                     
T Consensus        96 ~i~G~~l~--~~~------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           96 EVPGQDLL--SSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             CCSSEETT--TSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             ecCCcccC--cCc------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99998884  211      222   257788888888888752                                     


Q ss_pred             ------------------CCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          211 ------------------IPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       211 ------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                                        ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              11299999999999998876677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.25  E-value=2.5e-11  Score=110.81  Aligned_cols=143  Identities=17%  Similarity=0.278  Sum_probs=106.3

Q ss_pred             ccCeeeecCceeEEEEEeCCCCEEEEEEec--cccchHHHHHHHHHHHHHHhcCC--CCceeeeeeEEeeC---CeEEEE
Q 046084           93 IKYCIGTGGYGSVYRAQLPSGKKVALKKLH--HSETELAFLESFQTEAHLLSQIR--HRNIVKLYGFCLHK---KCMFLI  165 (363)
Q Consensus        93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv  165 (363)
                      ..+.++.|.++.||+.... +..+++|+..  ..... .....+.+|..+++.+.  +.++++++.++.+.   +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            3566899999999999875 4688888876  32211 11256788999999886  45678899988876   458999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC-----------------------------------  210 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------  210 (363)
                      |||++|..+.+...     ..++..++..++.+++++|+.||+..                                   
T Consensus       120 me~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            99999987754211     13678888899999999999999731                                   


Q ss_pred             --------------------CCCcEEeCCCCCCeeecCCCc--eEEEeecccee
Q 046084          211 --------------------IPSIVHRDISSNNILLNSKLE--AFVADFGVARL  242 (363)
Q Consensus       211 --------------------~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~  242 (363)
                                          ...++|||+++.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                247999999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.10  E-value=1.2e-10  Score=103.74  Aligned_cols=183  Identities=21%  Similarity=0.198  Sum_probs=121.1

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCc--eeeeeeEEeeCC---eEEEEEE
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRN--IVKLYGFCLHKK---CMFLIYK  167 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e  167 (363)
                      .+.++.|....||+..    ..+++|.....    .....+.+|..+++.+ .+..  +.+++......+   ..|+||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            4568999999999864    46888886533    2246788999999887 3332  445555544333   3578999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD--------------------------------------  209 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------  209 (363)
                      +++|.++.+....     .++..++..++.++++.++.||+.                                      
T Consensus        97 ~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           97 KIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             ccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            9999888653321     367777888889999999999862                                      


Q ss_pred             -----------------CCCCcEEeCCCCCCeeecC--CCceEEEeeccceeccCCCCCceeecccccc---ccccccc-
Q 046084          210 -----------------CIPSIVHRDISSNNILLNS--KLEAFVADFGVARLLHSDSSNRTVVAGTHGY---IAPELAY-  266 (363)
Q Consensus       210 -----------------~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y---~aPE~~~-  266 (363)
                                       ..+.++|+|++|.||++++  +..+.|+||+.+..-..... .   .....+   ..|+... 
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l---~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-F---ISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-H---HTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-H---HHHHhhccccCHHHHHH
Confidence                             1135899999999999998  55678999999865321100 0   000000   1222110 


Q ss_pred             ---c-c---------cCCccccchHHHHHHHHHHhCCCCC
Q 046084          267 ---T-M---------VLTEKCDVYSFGVVALEVLMGRHPG  293 (363)
Q Consensus       267 ---~-~---------~~~~~~DvwslG~il~el~~g~~p~  293 (363)
                         . .         ......+.|++|.++|.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               0 0         0111258999999999999998774

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.76  E-value=5.9e-08  Score=84.59  Aligned_cols=135  Identities=19%  Similarity=0.187  Sum_probs=97.8

Q ss_pred             eeeecCce-eEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEEEeccCC
Q 046084           96 CIGTGGYG-SVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        96 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      .+..|..| .||+.... ++..+++|+-....     ...+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~-----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV-----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH-----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC-----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            34556555 68988664 45678899865321     356788999888774 444778899999999999999999998


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 046084          173 SLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC------------------------------------------  210 (363)
Q Consensus       173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------  210 (363)
                      ++.+......       .....+..+++..|+.||...                                          
T Consensus       106 ~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          106 TAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             EHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             cccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            8876553221       123346677777777777540                                          


Q ss_pred             -------------CCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          211 -------------IPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       211 -------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                                   .+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                         12479999999999999887777999988754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.68  E-value=2.5e-07  Score=82.17  Aligned_cols=136  Identities=17%  Similarity=0.127  Sum_probs=94.8

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCC---ceeeeeeEEe-eCCeEEEEEEec
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR---NIVKLYGFCL-HKKCMFLIYKYM  169 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~  169 (363)
                      .+.++.|....||+.    |..+++|.-...    .....+..|..+|+.+.+.   .+.+++.++. ..+..+++||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            345788888899988    567888885321    2246788999999998642   3566777664 345678999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD----------------------------------------  209 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------  209 (363)
                      +|.++.+..-.     .++..+...++.++++.|+.||+.                                        
T Consensus        96 ~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           96 QGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             CSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            99888653211     234455555666666666666643                                        


Q ss_pred             -----------------CCCCcEEeCCCCCCeeecC---CCc-eEEEeecccee
Q 046084          210 -----------------CIPSIVHRDISSNNILLNS---KLE-AFVADFGVARL  242 (363)
Q Consensus       210 -----------------~~~~i~H~dlkp~Nill~~---~~~-~kl~Dfg~~~~  242 (363)
                                       ..+.++|+|++|.||++++   ++. +.|+||+.+..
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             1235699999999999987   455 47999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.42  E-value=5.1e-07  Score=81.94  Aligned_cols=82  Identities=7%  Similarity=-0.019  Sum_probs=54.1

Q ss_pred             Cee-eecCceeEEEEEeC-------CCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCC-C--CceeeeeeEEeeC---
Q 046084           95 YCI-GTGGYGSVYRAQLP-------SGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIR-H--RNIVKLYGFCLHK---  159 (363)
Q Consensus        95 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~---  159 (363)
                      +.| +.|....+|+....       ++..+++|....... .......+.+|..+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888999998764       266888987654320 0000134567888887773 2  3567788887665   


Q ss_pred             CeEEEEEEeccCCChhh
Q 046084          160 KCMFLIYKYMRRGSLFC  176 (363)
Q Consensus       160 ~~~~lv~e~~~~g~L~~  176 (363)
                      +..+++|||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.20  E-value=1e-05  Score=71.68  Aligned_cols=138  Identities=19%  Similarity=0.204  Sum_probs=91.1

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC---CCceeeeeeEEeeCCeEEEEEEecc
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR---HRNIVKLYGFCLHKKCMFLIYKYMR  170 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~  170 (363)
                      .+.|+.|....+|+... ++..+++|......     ...+..|...|+.+.   ...+++++.++...+..++||||++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            45689999999999987 56789999875432     356788988888873   3568888998888888999999999


Q ss_pred             CCChhh-----------hhhcCCC-------------------CCCCCHHHHH---HHH----------------HHHHH
Q 046084          171 RGSLFC-----------ILRNDDE-------------------AIRLDWTKRV---NIV----------------KSMAH  201 (363)
Q Consensus       171 ~g~L~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~----------------~~i~~  201 (363)
                      +..+..           .++....                   ...-+|.+..   ++.                ..+.+
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            876521           1222111                   0012454321   111                11111


Q ss_pred             H-HHHHHh-CCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          202 A-LSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       202 ~-l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      . ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 223432 2346899999999999999887 7888873

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.15  E-value=7.3e-06  Score=75.44  Aligned_cols=77  Identities=9%  Similarity=0.072  Sum_probs=48.1

Q ss_pred             cCeeeecCceeEEEEEeC-CCCEEEEEEeccccc--hH---HHHHHHHHHHHHHhcCCC--C-ceeeeeeEEeeCCeEEE
Q 046084           94 KYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSET--EL---AFLESFQTEAHLLSQIRH--R-NIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~---~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l  164 (363)
                      .+.+|.|..+.||++... +++.+++|.......  ..   ...+.+..|.++++.+..  + .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            456899999999999754 467899997653211  00   012345678888877632  3 34456554  3445689


Q ss_pred             EEEeccCC
Q 046084          165 IYKYMRRG  172 (363)
Q Consensus       165 v~e~~~~g  172 (363)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.14  E-value=9.4e-06  Score=72.91  Aligned_cols=140  Identities=17%  Similarity=0.292  Sum_probs=77.2

Q ss_pred             eeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-----CCCceeeee-e--EEeeCCeEEEEEE
Q 046084           96 CIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-----RHRNIVKLY-G--FCLHKKCMFLIYK  167 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lv~e  167 (363)
                      .|+.|..+.||+....+| .+++|+.....      ..+..|..+++.+     ..|.++... |  +....+..+++|+
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRPE------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSCH------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCCH------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            455577899999987554 58999887532      1222344444433     234433310 1  1234567899999


Q ss_pred             eccCCChh--------------hhhhc----C--CCC-----CCCCHHHH------------------------------
Q 046084          168 YMRRGSLF--------------CILRN----D--DEA-----IRLDWTKR------------------------------  192 (363)
Q Consensus       168 ~~~~g~L~--------------~~l~~----~--~~~-----~~l~~~~~------------------------------  192 (363)
                      |++|..+.              ..++.    .  ...     ....|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              01111    0  000     01122211                              


Q ss_pred             -HHHHHHHHHHHHHHHh----------CCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          193 -VNIVKSMAHALSYLHC----------DCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       193 -~~i~~~i~~~l~~LH~----------~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                       ..+...+..++++|+.          .....++|||+++.|||++.++.+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             0111223445666653          0234899999999999998888899999998753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.07  E-value=1.4e-05  Score=70.08  Aligned_cols=80  Identities=18%  Similarity=0.203  Sum_probs=56.2

Q ss_pred             cCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-C--CceeeeeeEEeeCCeEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-H--RNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  165 (363)
                      ....-.+.+|.|..+.||+.+..+|+.|++|+-.......  ...|..|+..|+.+. .  -.+++++++.  .  .+++
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence            3455567799999999999999999999999865443211  245778988888774 2  1344555542  2  3789


Q ss_pred             EEeccCCCh
Q 046084          166 YKYMRRGSL  174 (363)
Q Consensus       166 ~e~~~~g~L  174 (363)
                      |||.+++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999887653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.80  E-value=8.4e-05  Score=68.88  Aligned_cols=77  Identities=10%  Similarity=0.005  Sum_probs=45.9

Q ss_pred             CCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCceeec--cccccccccccccc---cCCccccchHHHHHHHHH
Q 046084          212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA--GTHGYIAPELAYTM---VLTEKCDVYSFGVVALEV  286 (363)
Q Consensus       212 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~---~~~~~~DvwslG~il~el  286 (363)
                      +.++|||++|.|||++.++ +.++||+.+..-.... ......  -...|++|+.....   .-....++.+....+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            3899999999999998876 9999999886532100 000000  01235555543211   111234555777788887


Q ss_pred             HhCC
Q 046084          287 LMGR  290 (363)
Q Consensus       287 ~~g~  290 (363)
                      +++.
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.69  E-value=0.00012  Score=65.38  Aligned_cols=31  Identities=35%  Similarity=0.443  Sum_probs=27.2

Q ss_pred             CCcEEeCCCCCCeeecCC----CceEEEeecccee
Q 046084          212 PSIVHRDISSNNILLNSK----LEAFVADFGVARL  242 (363)
Q Consensus       212 ~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~~  242 (363)
                      ..++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            479999999999999875    6789999998865

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.64  E-value=0.00029  Score=62.57  Aligned_cols=158  Identities=12%  Similarity=0.083  Sum_probs=83.6

Q ss_pred             cHHHHHHHhcCCccc-----CeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCc--eeee
Q 046084           80 TFQEMIVATEDFDIK-----YCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN--IVKL  152 (363)
Q Consensus        80 ~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l  152 (363)
                      +.+++...-..|.+.     +.|+.|....+|+....+| .+++|.......    .+.+..|..+++.+...+  +.++
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcc
Confidence            334444444456542     3456688889999987555 688998875211    123445666666553111  2333


Q ss_pred             eeE------EeeCCeEEEEEEeccCCChhh--------------hhhcC--C--CC--CCC---CHHHHHH---------
Q 046084          153 YGF------CLHKKCMFLIYKYMRRGSLFC--------------ILRND--D--EA--IRL---DWTKRVN---------  194 (363)
Q Consensus       153 ~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~--~--~~--~~l---~~~~~~~---------  194 (363)
                      +..      ....+..+++++|++|..+..              .++..  .  ..  ...   .|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      123456789999998865421              01110  0  00  001   1222110         


Q ss_pred             ---HHHHHHHHHHHHHhC----CCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          195 ---IVKSMAHALSYLHCD----CIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       195 ---i~~~i~~~l~~LH~~----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                         +...+.+.++.++..    ....++|+|+.+.|||++++..+.++||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               001134445555432    234799999999999999876667999987753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.59  E-value=0.0002  Score=65.15  Aligned_cols=141  Identities=18%  Similarity=0.235  Sum_probs=81.4

Q ss_pred             CeeeecCceeEEEEEeC--------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEE
Q 046084           95 YCIGTGGYGSVYRAQLP--------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  165 (363)
                      +.+..|-...+|+....        ++..+++|+......   ......+|..+++.+. +.-..++++++.+    .+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            34666888899999874        247899988533211   1345668888888773 2223566666543    289


Q ss_pred             EEeccCCChhhh-----------------hhcCCC--CCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 046084          166 YKYMRRGSLFCI-----------------LRNDDE--AIRLD--WTKRVNIVKSMAH-------------------ALSY  205 (363)
Q Consensus       166 ~e~~~~g~L~~~-----------------l~~~~~--~~~l~--~~~~~~i~~~i~~-------------------~l~~  205 (363)
                      |||++|.+|..-                 ++....  .....  +.++.++..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            999998655311                 111110  11122  4455555544422                   1223


Q ss_pred             H----HhC-CCCCcEEeCCCCCCeeecCC----CceEEEeecccee
Q 046084          206 L----HCD-CIPSIVHRDISSNNILLNSK----LEAFVADFGVARL  242 (363)
Q Consensus       206 L----H~~-~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~~  242 (363)
                      |    ... ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    221 22368999999999999876    7899999988754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.59  E-value=0.00016  Score=63.73  Aligned_cols=71  Identities=13%  Similarity=0.099  Sum_probs=42.4

Q ss_pred             cCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEEEEEEec-cC
Q 046084           94 KYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI-VKLYGFCLHKKCMFLIYKYM-RR  171 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~  171 (363)
                      .+.|+.|....+|+.     ..+++|+.......   ......|...++.+...++ .++++++  .+.-++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence            567888999999998     56888887643211   1122456666666632122 4555543  33346899999 65


Q ss_pred             CCh
Q 046084          172 GSL  174 (363)
Q Consensus       172 g~L  174 (363)
                      .++
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.58  E-value=0.00078  Score=59.94  Aligned_cols=141  Identities=13%  Similarity=0.154  Sum_probs=78.9

Q ss_pred             eeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCC--CceeeeeeE-----EeeCCeEEEEEEe
Q 046084           96 CIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH--RNIVKLYGF-----CLHKKCMFLIYKY  168 (363)
Q Consensus        96 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~-----~~~~~~~~lv~e~  168 (363)
                      .++ |....||+....+|+.+++|.........   +.+..|..+++.+..  -.+++++..     ....+..+++++|
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            466 88889999887778789999986432211   345567777766631  123444432     1224566889999


Q ss_pred             ccCCChhh-----h---------hhc----CC--CCCCCCHHHH----HHHH---------------HHHHHHHHHHHhC
Q 046084          169 MRRGSLFC-----I---------LRN----DD--EAIRLDWTKR----VNIV---------------KSMAHALSYLHCD  209 (363)
Q Consensus       169 ~~~g~L~~-----~---------l~~----~~--~~~~l~~~~~----~~i~---------------~~i~~~l~~LH~~  209 (363)
                      ++|..+..     +         ++.    ..  .....++...    ..++               ..+...++.+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            98754321     0         111    00  0011222211    0010               1111222333221


Q ss_pred             ----CCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          210 ----CIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       210 ----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                          ....++|||+++.||+++ + .+.++||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                233689999999999999 4 889999987754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.48  E-value=0.00027  Score=65.63  Aligned_cols=73  Identities=22%  Similarity=0.297  Sum_probs=47.6

Q ss_pred             cCeeeecCceeEEEEEeCC--------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEEE
Q 046084           94 KYCIGTGGYGSVYRAQLPS--------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI-VKLYGFCLHKKCMFL  164 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~l  164 (363)
                      .+.|+.|....+|+....+        +..+++|+......    .+.+..|..+++.+...++ +++++.+.+    .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence            3457788889999998753        57899998744222    0234468888887742233 566665542    27


Q ss_pred             EEEeccCCCh
Q 046084          165 IYKYMRRGSL  174 (363)
Q Consensus       165 v~e~~~~g~L  174 (363)
                      ++||++|.++
T Consensus       150 v~e~l~G~~l  159 (429)
T 1nw1_A          150 LEEYIPSRPL  159 (429)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeCCccc
Confidence            8999987444

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.21  E-value=0.001  Score=59.66  Aligned_cols=31  Identities=23%  Similarity=0.461  Sum_probs=27.5

Q ss_pred             CCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          212 PSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       212 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ..++|+|+.+.||++++++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.17  E-value=0.0011  Score=61.96  Aligned_cols=73  Identities=19%  Similarity=0.175  Sum_probs=45.7

Q ss_pred             CeeeecCceeEEEEEeCC-CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEEEEEEeccCC
Q 046084           95 YCIGTGGYGSVYRAQLPS-GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI-VKLYGFCLHKKCMFLIYKYMRRG  172 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  172 (363)
                      +.|+.|-...+|+....+ +..+++|+.......   .-....|..+++.+...++ +++++.+.  +  .+|+||++|.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            457788889999998755 478888876432211   0112468888888854444 56777663  2  2599999875


Q ss_pred             Ch
Q 046084          173 SL  174 (363)
Q Consensus       173 ~L  174 (363)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            54

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.07  E-value=0.00082  Score=60.96  Aligned_cols=73  Identities=14%  Similarity=0.110  Sum_probs=41.9

Q ss_pred             CeeeecCceeEEEEEeCC---------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCc-eeeeeeEEeeCCeEEE
Q 046084           95 YCIGTGGYGSVYRAQLPS---------GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN-IVKLYGFCLHKKCMFL  164 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~l  164 (363)
                      +.++.|....+|+....+         +..+++|+.......   ......|..+++.+...+ ..++++..  .+  ++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~  111 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR  111 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence            457778888999997654         268888876543211   112346777777664223 34565543  22  68


Q ss_pred             EEEeccCCCh
Q 046084          165 IYKYMRRGSL  174 (363)
Q Consensus       165 v~e~~~~g~L  174 (363)
                      +|||++|..+
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.89  E-value=0.009  Score=49.20  Aligned_cols=103  Identities=19%  Similarity=0.085  Sum_probs=65.8

Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCCce
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT  251 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  251 (363)
                      -+|.++|...+.  +++++++|.++.|.+.+|.-+-...  .-..+=+.|..|++..+|.+.+.+ +.+.          
T Consensus        33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence            378888876553  7999999999999999988772210  101222356889999999987753 1110          


Q ss_pred             eeccccccccccccccccCCccccchHHHHHHHHHHhCCCC
Q 046084          252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP  292 (363)
Q Consensus       252 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  292 (363)
                        .....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              0122356888653 3346778899999999999965444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.10  E-value=0.0077  Score=55.50  Aligned_cols=140  Identities=9%  Similarity=0.099  Sum_probs=81.0

Q ss_pred             CeeeecCceeEEEEEeCC--------CCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEE
Q 046084           95 YCIGTGGYGSVYRAQLPS--------GKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  165 (363)
                      +.+..|-...+|+....+        +..+++++.......   .-+..+|..+++.+. +.-..++++.+  .+  ++|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I  148 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI  148 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence            456678888999998753        578999886442211   112346777777763 22234555533  22  688


Q ss_pred             EEeccCCChhh--h---------------hhc--------CC--CCCCCCHHHHHHHHHHHH------------------
Q 046084          166 YKYMRRGSLFC--I---------------LRN--------DD--EAIRLDWTKRVNIVKSMA------------------  200 (363)
Q Consensus       166 ~e~~~~g~L~~--~---------------l~~--------~~--~~~~l~~~~~~~i~~~i~------------------  200 (363)
                      +||++|.+|..  +               ++.        ..  ...+.-+.++.++..++-                  
T Consensus       149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  228 (424)
T 3mes_A          149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI  228 (424)
T ss_dssp             EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred             EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence            99999866421  0               000        00  111122444444443321                  


Q ss_pred             -HHHHHHHh---------------------CCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          201 -HALSYLHC---------------------DCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       201 -~~l~~LH~---------------------~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                       ..+..|..                     .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus       229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence             22233321                     11236899999999999 7888999999998864

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.51  E-value=0.011  Score=34.86  Aligned_cols=21  Identities=33%  Similarity=0.482  Sum_probs=9.9

Q ss_pred             HHHHHHHHHHHHHHhhccccc
Q 046084           34 VLLLILVCIFTFLCLRRPKVR   54 (363)
Q Consensus        34 ~~~~~l~~~~~~~~~~r~~~~   54 (363)
                      +++++++++++++++||++.+
T Consensus        21 v~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           21 LLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCC
T ss_pred             HHHHHHHHHHHHHHhhhhHhh
Confidence            333334444555555555443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.06  E-value=0.054  Score=49.50  Aligned_cols=30  Identities=30%  Similarity=0.473  Sum_probs=25.0

Q ss_pred             CcEEeCCCCCCeee------cCCCceEEEeecccee
Q 046084          213 SIVHRDISSNNILL------NSKLEAFVADFGVARL  242 (363)
Q Consensus       213 ~i~H~dlkp~Nill------~~~~~~kl~Dfg~~~~  242 (363)
                      .++|+|+.+.|||+      +++..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4467799999998854

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=94.81  E-value=0.0054  Score=36.03  Aligned_cols=28  Identities=11%  Similarity=0.407  Sum_probs=13.1

Q ss_pred             EEEehhHHHHHHHHHHHHHHHHhhccccc
Q 046084           26 LVVIILPIVLLLILVCIFTFLCLRRPKVR   54 (363)
Q Consensus        26 ~~~ii~~~~~~~~l~~~~~~~~~~r~~~~   54 (363)
                      ++.++++ +++++++++.+++++||++.+
T Consensus        14 Ia~~vVG-vll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           14 IISAVVG-ILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHH-HHHHHHHHHHHHHHHHHHCSC
T ss_pred             hHHHHHH-HHHHHHHHHHHHhheehhhhh
Confidence            3444444 334444444445555555444

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.81  E-value=0.015  Score=34.17  Aligned_cols=22  Identities=23%  Similarity=0.531  Sum_probs=10.5

Q ss_pred             HHHHHHHHHHHHHHhhcccccc
Q 046084           34 VLLLILVCIFTFLCLRRPKVRK   55 (363)
Q Consensus        34 ~~~~~l~~~~~~~~~~r~~~~~   55 (363)
                      +++++++++.+++++||++.++
T Consensus        20 v~~v~ii~~~~~~~~RRRr~~~   41 (44)
T 2l2t_A           20 LFILVIVGLTFAVYVRRKSIKK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHhhhhhhhh
Confidence            3333344445555555555443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=92.58  E-value=0.03  Score=31.96  Aligned_cols=25  Identities=24%  Similarity=0.304  Sum_probs=13.3

Q ss_pred             EEEehhHHHHHHHHHHHHHHHHhhc
Q 046084           26 LVVIILPIVLLLILVCIFTFLCLRR   50 (363)
Q Consensus        26 ~~~ii~~~~~~~~l~~~~~~~~~~r   50 (363)
                      ++.+++++++.++++..+.++++||
T Consensus        13 IAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A           13 IVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             eeeeehHHHHHHHHHHHHHHHHeec
Confidence            3445555555555555555666555

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.37  E-value=0.2  Score=41.08  Aligned_cols=117  Identities=5%  Similarity=0.078  Sum_probs=80.4

Q ss_pred             CCCceeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCe
Q 046084          145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNI  224 (363)
Q Consensus       145 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  224 (363)
                      .||+.+.. .+-.+.+.+.+.++--+.+.=+..+.      .++...+++++.+|+....++++     -+|--|.|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            68888866 56666676666555443222222232      47889999999999998866663     47889999999


Q ss_pred             eecCCCceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCC
Q 046084          225 LLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDL  295 (363)
Q Consensus       225 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~  295 (363)
                      +++.++.+++.-.|+...+                 +|..     .++..=.-.+=+++..+++++..|+.
T Consensus       111 ~f~~~~~p~i~~RGik~~l-----------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVV-----------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             EECTTSCEEESCCEETTTB-----------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EEcCCCCEEEEEccCccCC-----------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999999877764322                 2221     12222344677889999999988754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.30  E-value=0.38  Score=39.58  Aligned_cols=116  Identities=14%  Similarity=0.133  Sum_probs=78.9

Q ss_pred             CCCceeeeeeEEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCcEEeCCCCCC
Q 046084          145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS-YLHCDCIPSIVHRDISSNN  223 (363)
Q Consensus       145 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~dlkp~N  223 (363)
                      .||++  -..+-.+++.+.+.++--+++.-+..++      .++...+++++.+|+.... +++     .-+|--|.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence            57887  3455566777777776654443333343      4788999999999998776 555     45888999999


Q ss_pred             eeecCCCceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCC
Q 046084          224 ILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDL  295 (363)
Q Consensus       224 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~  295 (363)
                      ++++.++.+++.-.|+-..                 ++|...     ++.-=.-++=+++..++.++..|+.
T Consensus       115 L~f~~~~~p~i~hRGi~~~-----------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKES-----------------LPPDEW-----DDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             EEECTTCCEEESCCEETTT-----------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             EEEeCCCcEEEEEcCCccc-----------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999999987776432                 233211     1111233566788888888877643

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=92.01  E-value=0.02  Score=53.53  Aligned_cols=64  Identities=19%  Similarity=0.142  Sum_probs=19.0

Q ss_pred             cccCeeeecCceeEEEEEeCC-CCEEEE------EEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 046084           92 DIKYCIGTGGYGSVYRAQLPS-GKKVAL------KKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH  158 (363)
Q Consensus        92 ~~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  158 (363)
                      .+.+.||   ||.||+|.+.. ..+||+      |..+......+....|.+|..+++.++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3456676   99999998753 357888      7766544444444678889999999999999999887654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	363
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-61
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-52
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-52
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-49
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-46
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-42
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 3e-63
 Identities = 69/278 (24%), Positives = 136/278 (48%), Gaps = 18/278 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
               +   IG+G +G+VY+ +      VA+K L+ +      L++F+ E  +L + RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I+   G+      + ++ ++    SL+  L   +   + +  K ++I +  A  + YLH 
Sbjct: 66  ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA 122

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAY 266
               SI+HRD+ SNNI L+  L   + DFG+A +    S +     ++G+  ++APE+  
Sbjct: 123 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 267 TM---VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI 323
                  + + DVY+FG+V  E++ G+ P    S++N +  +I ++ +   SP   +   
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEF-LVRKTL 359
                + +++  CL+ K   RP   ++     L+ ++L
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 5e-61
 Identities = 66/288 (22%), Positives = 117/288 (40%), Gaps = 22/288 (7%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           +  +DF+    +G G  G V++    PSG  +A K +H      A       E  +L + 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHEC 61

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
               IV  YG       + +  ++M  GSL  +L+      R+       +  ++   L+
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLT 118

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           YL       I+HRD+  +NIL+NS+ E  + DFGV+  L    +N  V  GT  Y++PE 
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPER 174

Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
                 + + D++S G+  +E+ +GR+P     +   ++M    ++              
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 325 DIIL-----------VSKIVFACLRSKPTSRPMQRVSQEF--LVRKTL 359
             +            + +++   +   P   P    S EF   V K L
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-60
 Identities = 69/263 (26%), Positives = 122/263 (46%), Gaps = 14/263 (5%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           ED+++ Y IGTG YG   + +    GK +  K+L +     A  +   +E +LL +++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 148 NIVKLYGFCLHK--KCMFLIYKYMRRGSLFCIL-RNDDEAIRLDWTKRVNIVKSMAHALS 204
           NIV+ Y   + +    ++++ +Y   G L  ++ +   E   LD    + ++  +  AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 205 YLH--CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
             H   D   +++HRD+   N+ L+ K    + DFG+AR+L+ D+S      GT  Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 263 ELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
           E    M   EK D++S G +  E+     P    S       + +   +R+P    D+  
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE-- 241

Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
           + +II         L  K   RP
Sbjct: 242 LNEIIT------RMLNLKDYHRP 258

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-57
 Identities = 64/267 (23%), Positives = 120/267 (44%), Gaps = 17/267 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           E   +   +G G +G V+        KVA+K L          ++F  EA+L+ Q++H+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQR 69

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+LY     +  +++I +YM  GSL   L+     I+L   K +++   +A  ++++  
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN-RTVVAGTHGYIAPELAYT 267
                 +HRD+ + NIL++  L   +ADFG+ARL+  +    R        + APE    
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
              T K DV+SFG++  E++          + NP+++       R+  P +    +  ++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPDNCPEELYQLM 243

Query: 328 LVSKIVFACLRSKPTSRP-MQRVSQEF 353
                   C + +P  RP    +    
Sbjct: 244 R------LCWKERPEDRPTFDYLRSVL 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 3e-56
 Identities = 77/259 (29%), Positives = 125/259 (48%), Gaps = 19/259 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETE-LAFLESFQTEAHLLSQIRH 146
           EDF+I   +G G +G+VY A+   S   +ALK L  ++ E        + E  + S +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NI++LYG+      ++LI +Y   G+++  L+      + D  +    +  +A+ALSY 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      ++HRDI   N+LL S  E  +ADFG +   H+ SS RT + GT  Y+ PE+  
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPPEMIE 177

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
             +  EK D++S GV+  E L+G+ P     +   +     +       P       +D+
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGARDL 234

Query: 327 ILVSKIVFACLRSKPTSRP 345
           I         L+  P+ RP
Sbjct: 235 IS------RLLKHNPSQRP 247

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 9e-55
 Identities = 62/259 (23%), Positives = 112/259 (43%), Gaps = 18/259 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           +D      +GTG +G V   +      VA+K +          + F  EA ++  + H  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 60

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+LYG C  ++ +F+I +YM  G L   LR      R    + + + K +  A+ YL  
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES 118

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-VAGTHGYIAPELAYT 267
                 +HRD+++ N L+N +    V+DFG++R +  D    +V       +  PE+   
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 268 MVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
              + K D+++FGV+  E+  +G+ P +  +  N +         R+  P      +  I
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHIAQGLRLYRPHLASEKVYTI 233

Query: 327 ILVSKIVFACLRSKPTSRP 345
           +       +C   K   RP
Sbjct: 234 MY------SCWHEKADERP 246

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 2e-54
 Identities = 62/267 (23%), Positives = 113/267 (42%), Gaps = 17/267 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
            +      IG+G +G V+     +  KVA+K +          E F  EA ++ ++ H  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPK 61

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+LYG CL +  + L++++M  G L   LR             + +   +   ++YL  
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE 119

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-VAGTHGYIAPELAYT 267
            C   ++HRD+++ N L+       V+DFG+ R +  D    +        + +PE+   
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
              + K DV+SFGV+  EV           S N +++       R+  P    T +  I+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVYQIM 235

Query: 328 LVSKIVFACLRSKPTSRP-MQRVSQEF 353
                   C + +P  RP   R+ ++ 
Sbjct: 236 N------HCWKERPEDRPAFSRLLRQL 256

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 4e-54
 Identities = 67/261 (25%), Positives = 114/261 (43%), Gaps = 21/261 (8%)

Query: 91  FDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           FDI+  IG G + +VY+     +  +VA  +L   +   +  + F+ EA +L  ++H NI
Sbjct: 13  FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 150 VKLYGFCL----HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           V+ Y         KKC+ L+ + M  G+L   L+       +      +  + +   L +
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQF 127

Query: 206 LHCDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
           LH    P I+HRD+  +NI +        + D G+A L    +S    V GT  ++APE+
Sbjct: 128 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEM 184

Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
            Y     E  DVY+FG+  LE+    +P    S       +   +   V     D+  I 
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSGVKPASFDKVAIP 240

Query: 325 DIILVSKIVFACLRSKPTSRP 345
           ++    +I+  C+R     R 
Sbjct: 241 EVK---EIIEGCIRQNKDERY 258

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 9e-54
 Identities = 59/259 (22%), Positives = 115/259 (44%), Gaps = 16/259 (6%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            + +     IG G  G+VY A  + +G++VA+++++  +      E    E  ++ + ++
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKN 76

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIV      L    ++++ +Y+  GSL  ++        +D  +   + +    AL +L
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFL 132

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H +    ++HRDI S+NILL       + DFG    +  + S R+ + GT  ++APE+  
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
                 K D++S G++A+E++ G  P     + NP   L  +     P   + + +    
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYLIATNGTPELQNPEKLSAIF 246

Query: 327 ILVSKIVFACLRSKPTSRP 345
                 +  CL      R 
Sbjct: 247 R---DFLNRCLDMDVEKRG 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-53
 Identities = 65/258 (25%), Positives = 116/258 (44%), Gaps = 16/258 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           E   ++  +G G +G V+        +VA+K L          E+F  EA ++ ++RH  
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 73

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           +V+LY     +  ++++ +YM +GSL   L+ +         + V++   +A  ++Y+  
Sbjct: 74  LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER 131

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-SSNRTVVAGTHGYIAPELAYT 267
                 VHRD+ + NIL+   L   VADFG+ARL+  +  + R        + APE A  
Sbjct: 132 MNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
              T K DV+SFG++  E+                +  ++    R+P P +    + D++
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLM 247

Query: 328 LVSKIVFACLRSKPTSRP 345
                   C R +P  RP
Sbjct: 248 C------QCWRKEPEERP 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 6e-53
 Identities = 61/264 (23%), Positives = 110/264 (41%), Gaps = 19/264 (7%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            + ++I   +G G +G VY+AQ   +    A K +     E   LE +  E  +L+   H
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDH 68

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIVKL     ++  ++++ ++   G++  ++   +    L  ++   + K    AL+YL
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYL 126

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      I+HRD+ + NIL     +  +ADFGV+         R    GT  ++APE+  
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183

Query: 267 TMVL-----TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT 321
                      K DV+S G+  +E+     P      +NP  +L+ +     P+      
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPP---HHELNPMRVLLKIAKSEPPTLAQPSR 240

Query: 322 VIQDIILVSKIVFACLRSKPTSRP 345
              +       +  CL     +R 
Sbjct: 241 WSSNFK---DFLKKCLEKNVDARW 261

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 6e-53
 Identities = 60/267 (22%), Positives = 119/267 (44%), Gaps = 21/267 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           ++  +   IG G +G V       G KVA+K + +  T     ++F  EA +++Q+RH N
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA----QAFLAEASVMTQLRHSN 61

Query: 149 IVKLYGFCLH-KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           +V+L G  +  K  ++++ +YM +GSL   LR+   ++ L     +     +  A+ YL 
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE 120

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
                + VHRD+++ N+L++    A V+DFG+ +     SS +        + APE    
Sbjct: 121 G---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALRE 174

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
              + K DV+SFG++  E+            +   +  +     ++ +P      + +++
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYEVM 233

Query: 328 LVSKIVFACLRSKPTSRP-MQRVSQEF 353
                   C       RP   ++ ++ 
Sbjct: 234 K------NCWHLDAAMRPSFLQLREQL 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 1e-52
 Identities = 66/280 (23%), Positives = 122/280 (43%), Gaps = 24/280 (8%)

Query: 82  QEMIVATEDFDI-KYCIGTGGYGSVYRAQLPSGKK---VALKKLHHSETELAFLESFQTE 137
           +++ +  ++  I    +G G +GSV +      KK   VA+K L     + A  E    E
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMRE 59

Query: 138 AHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVK 197
           A ++ Q+ +  IV+L G C   + + L+ +    G L   L    E   +  +    ++ 
Sbjct: 60  AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLH 116

Query: 198 SMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN---RTVVA 254
            ++  + YL      + VHRD+++ N+LL ++  A ++DFG+++ L +D S    R+   
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 255 GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRV 313
               + APE       + + DV+S+GV   E L  G+ P   +    P++M      +R+
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKRM 231

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE 352
             P +    +  ++        C   K   RP    V Q 
Sbjct: 232 ECPPECPPELYALMS------DCWIYKWEDRPDFLTVEQR 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (441), Expect = 1e-52
 Identities = 66/279 (23%), Positives = 123/279 (44%), Gaps = 17/279 (6%)

Query: 78  RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQT 136
              + +  +   D  +K+ +G G YG VY          VA+K L     E+   E F  
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLK 62

Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
           EA ++ +I+H N+V+L G C  +   ++I ++M  G+L   LR  +    +     + + 
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 121

Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVAG 255
             ++ A+ YL      + +HRD+++ N L+       VADFG++RL+  D+         
Sbjct: 122 TQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178

Query: 256 THGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS 315
              + APE       + K DV++FGV+  E+            ++    + +LL++    
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKDYRM 235

Query: 316 PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF 353
              +    +    V +++ AC +  P+ RP    + Q F
Sbjct: 236 ERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAF 270

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (443), Expect = 1e-52
 Identities = 61/265 (23%), Positives = 114/265 (43%), Gaps = 26/265 (9%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHS-ETELAFLESFQTEAHLLSQIR 145
            + F     IG G +G+VY A+ + + + VA+KK+ +S +      +    E   L ++R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H N ++  G  L +   +L+ +Y    +   +  +      L   +   +       L+Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAY 130

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           LH     +++HRD+ + NILL+      + DFG A ++   +S      GT  ++APE+ 
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVI 183

Query: 266 YTM---VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT- 321
             M       K DV+S G+  +E+   + P   L ++N    L  +     P+       
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNESPALQSGHWS 240

Query: 322 -VIQDIILVSKIVFACLRSKPTSRP 345
              ++ +       +CL+  P  RP
Sbjct: 241 EYFRNFVD------SCLQKIPQDRP 259

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  173 bits (439), Expect = 3e-52
 Identities = 80/294 (27%), Positives = 131/294 (44%), Gaps = 34/294 (11%)

Query: 80  TFQEMIVATEDFD---------IKYCIGTGGYGSVYRAQLPSGKK----VALKKLHHSET 126
           TF++   A  +F          I+  IG G +G V    L    K    VA+K L    T
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 127 ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIR 186
           E      F +EA ++ Q  H N++ L G       + +I ++M  GSL   LR +D   +
Sbjct: 68  E-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124

Query: 187 LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
               + V +++ +A  + YL        VHRD+++ NIL+NS L   V+DFG++R L  D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 247 SSNRTVVA-----GTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVN 300
           +S+ T  +         + APE       T   DV+S+G+V  EV+  G  P   ++  N
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--N 239

Query: 301 PKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF 353
             ++     D R+P P+D  + +  ++L       C +     RP   ++    
Sbjct: 240 QDVINAIEQDYRLPPPMDCPSALHQLML------DCWQKDRNHRPKFGQIVNTL 287

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-52
 Identities = 64/261 (24%), Positives = 103/261 (39%), Gaps = 17/261 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           ED+D+   +G G YG V  A    + + VA+K +          E+ + E  +   + H 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHE 63

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           N+VK YG        +L  +Y   G LF  +  D   I +           +   + YLH
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 120

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELA 265
                 I HRDI   N+LL+ +    ++DFG+A +   ++  R    + GT  Y+APEL 
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 266 YTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
                  E  DV+S G+V   +L G  P D  S    +          +       +   
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237

Query: 325 DIILVSKIVFACLRSKPTSRP 345
            ++         L   P++R 
Sbjct: 238 ALLH------KILVENPSARI 252

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 6e-52
 Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 35/290 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
                   +G G +G V  A         +   VA+K L  S       E+  +E  +LS
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLS 81

Query: 143 QI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN---------------DDEAIR 186
            +  H NIV L G C       +I +Y   G L   LR                +D+ + 
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 187 LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
           LD    ++    +A  +++L      + +HRD+++ NILL       + DFG+AR + +D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 247 SSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM 304
           S+   +        ++APE  +  V T + DV+S+G+   E+            V+ K  
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258

Query: 305 LIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF 353
            +     R+ SP      + DI+        C  + P  RP  +++ Q  
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQLI 302

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 4e-51
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 19/261 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           EDF     +G G + +V  A+ L + ++ A+K L      +   +     E  ++S++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
              VKLY      + ++    Y + G L   +R        D T        +  AL YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYL 124

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPEL 264
           H      I+HRD+   NILLN  +   + DFG A++L  +S         GT  Y++PEL
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 265 AYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ 324
                  +  D+++ G +  +++ G  P     + N  ++   ++      P       +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPP---FRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238

Query: 325 DIILVSKIVFACLRSKPTSRP 345
           D++         L    T R 
Sbjct: 239 DLVE------KLLVLDATKRL 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 5e-51
 Identities = 58/256 (22%), Positives = 115/256 (44%), Gaps = 22/256 (8%)

Query: 97  IGTGGYGSVYRAQLP---SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLY 153
           +G+G +G+V +         K VA+K L +   + A  +    EA+++ Q+ +  IV++ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 154 GFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS 213
           G C  +  M L+ +    G L   L+ +     +     + +V  ++  + YL      +
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SN 127

Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN---RTVVAGTHGYIAPELAYTMVL 270
            VHRD+++ N+LL ++  A ++DFG+++ L +D +    +T       + APE       
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 271 TEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILV 329
           + K DV+SFGV+  E    G+ P   +     ++  +    +R+  P      + D++  
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKGERMGCPAGCPREMYDLMN- 244

Query: 330 SKIVFACLRSKPTSRP 345
                 C      +RP
Sbjct: 245 -----LCWTYDVENRP 255

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-50
 Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 41/298 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
               ++  IG G +G V+R +   G++VA+K     E    F E    E +    +RH N
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHEN 58

Query: 149 IVKLYGFC----LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
           I+               ++L+  Y   GSLF  L        +     + +  S A  L+
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLA 114

Query: 205 YLHCDCI-----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN----RTVVAG 255
           +LH + +     P+I HRD+ S NIL+       +AD G+A    S +           G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 256 THGYIAPELAYTMV------LTEKCDVYSFGVVALEVLMGRHPGD------------LLS 297
           T  Y+APE+    +        ++ D+Y+ G+V  E+      G             + S
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234

Query: 298 SVNPKIMLIDLLDQRVPSPIDDQTVIQDII-LVSKIVFACLRSKPTSRP-MQRVSQEF 353
             + + M   + +Q++   I ++    + + +++KI+  C  +   +R    R+ +  
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (423), Expect = 6e-50
 Identities = 64/303 (21%), Positives = 122/303 (40%), Gaps = 41/303 (13%)

Query: 81  FQEMIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESF 134
              +     + +    IG G +G V++A+ P          VA+K L    +       F
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADF 63

Query: 135 QTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-------------- 180
           Q EA L+++  + NIVKL G C   K M L+++YM  G L   LR+              
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 181 -------DDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAF 233
                        L   +++ I + +A  ++YL        VHRD+++ N L+   +   
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180

Query: 234 VADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRH 291
           +ADFG++R ++S    +     A    ++ PE  +    T + DV+++GVV  E+     
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 292 PGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVS 350
                  +  + ++  + D  + +  ++     ++     ++  C    P  RP    + 
Sbjct: 241 QPY--YGMAHEEVIYYVRDGNILACPEN--CPLELY---NLMRLCWSKLPADRPSFCSIH 293

Query: 351 QEF 353
           +  
Sbjct: 294 RIL 296

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 1e-49
 Identities = 62/286 (21%), Positives = 113/286 (39%), Gaps = 39/286 (13%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPS------GKKVALKKLHHSETELAFLESFQTEAHLLS 142
           E+ +    +G+G +G V  A            +VA+K L       +  E+  +E  +++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMT 95

Query: 143 QI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN--------------------D 181
           Q+  H NIV L G C     ++LI++Y   G L   LR+                    +
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 182 DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
           ++   L +   +     +A  + +L      S VHRD+++ N+L+       + DFG+AR
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 242 LLHSDSSNRTV--VAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSV 299
            + SDS+            ++APE  +  + T K DV+S+G++  E+            V
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272

Query: 300 NPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +     +     ++  P      I  I+       +C       RP
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQ------SCWAFDSRKRP 312

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-48
 Identities = 57/260 (21%), Positives = 108/260 (41%), Gaps = 18/260 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETEL-AFLESFQTEAHLLS-QIR 145
           EDF +   +G G +G V+ A+   + +  A+K L      +   +E    E  +LS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSY 205
           H  +  ++     K+ +F + +Y+  G L   +++     + D ++       +   L +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQF 118

Query: 206 LHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
           LH      IV+RD+  +NILL+      +ADFG+ +      +      GT  YIAPE+ 
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD 325
                    D +SFGV+  E+L+G+ P       + + +   +       P   +   +D
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232

Query: 326 IILVSKIVFACLRSKPTSRP 345
           +++           +P  R 
Sbjct: 233 LLV------KLFVREPEKRL 246

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  164 bits (417), Expect = 2e-48
 Identities = 64/263 (24%), Positives = 112/263 (42%), Gaps = 22/263 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           + +DI   +GTG +G V+R     +G   A K +       +  E+ + E   +S +RH 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHP 83

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
            +V L+        M +IY++M  G LF  +   DE  ++   + V  ++ +   L ++H
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
            +     VH D+   NI+  +K    +   DFG+   L    S +    GT  + APE+A
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVA 197

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDL-LDQRVPSPIDDQTV 322
               +    D++S GV++  +L G  P  G+        +   D  +D    S I +   
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED-- 255

Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
            +D I         L + P +R 
Sbjct: 256 GKDFIR------KLLLADPNTRM 272

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-48
 Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 22/277 (7%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQLPSG-----KKVALKKLHHSETELAFLESFQTEAHL 140
           +       +  IG G +G VY+  L +        VA+K L    TE      F  EA +
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGI 62

Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMA 200
           + Q  H NI++L G     K M +I +YM  G+L   LR  D        + V +++ +A
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIA 120

Query: 201 HALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN---RTVVAGTH 257
             + YL         HRD+++ NIL+NS L   V+DFG++R+L  D       +      
Sbjct: 121 AGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPI 317
            + APE       T   DV+SFG+V  EV+          S N ++M       R+P+P+
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFRLPTPM 236

Query: 318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF 353
           D  + I  +++       C + +   RP    +    
Sbjct: 237 DCPSAIYQLMM------QCWQQERARRPKFADIVSIL 267

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-48
 Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 25/297 (8%)

Query: 69  EFSVWNYDGRITFQEMIVATEDFDIKY--CIGTGGYGSVYRAQLPSGKK----VALKKLH 122
           + S  N +     Q +++      + +   IG G +G VY   L          A+K L+
Sbjct: 5   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64

Query: 123 HSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCILRND 181
                   +  F TE  ++    H N++ L G CL  +    ++  YM+ G L       
Sbjct: 65  RITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF--IR 121

Query: 182 DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
           +E         +     +A  +           VHRD+++ N +L+ K    VADFG+AR
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

Query: 242 LLHSDS----SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLS 297
            ++        N+T       ++A E   T   T K DV+SFGV+  E++    P     
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238

Query: 298 SVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF 353
           +    I +  L  +R+  P      + +++L       C   K   RP    +    
Sbjct: 239 N-TFDITVYLLQGRRLLQPEYCPDPLYEVML------KCWHPKAEMRPSFSELVSRI 288

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 1e-47
 Identities = 57/259 (22%), Positives = 100/259 (38%), Gaps = 11/259 (4%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            + +D +  +GTG +  V  A+   + K VA+K +     E     S + E  +L +I+H
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKH 66

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NIV L         ++LI + +  G LF  +                ++  +  A+ YL
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYL 123

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H   I     +  +     L+   +  ++DFG++++    S   T   GT GY+APE+  
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-GTPGYVAPEVLA 182

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
               ++  D +S GV+A  +L G  P       N   +   +L             I D 
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPP---FYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 327 ILVSKIVFACLRSKPTSRP 345
                 +   +   P  R 
Sbjct: 240 AK--DFIRHLMEKDPEKRF 256

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-47
 Identities = 59/279 (21%), Positives = 110/279 (39%), Gaps = 21/279 (7%)

Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQLPS----GKKVALKKLH-HSETELAFLESFQTEAH 139
           ++  +D  +   +G G +G V R +  +       VA+K L     ++   ++ F  E +
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
            +  + HRN+++LYG       M ++ +    GSL    R                   +
Sbjct: 64  AMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQV 120

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN---RTVVAGT 256
           A  + YL        +HRD+++ N+LL ++    + DFG+ R L  +  +   +      
Sbjct: 121 AEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
             + APE   T   +   D + FGV   E+        +  + +  +  ID   +R+P P
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237

Query: 317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL 354
            D    I ++++       C   KP  RP    +    L
Sbjct: 238 EDCPQDIYNVMV------QCWAHKPEDRPTFVALRDFLL 270

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  162 bits (411), Expect = 1e-47
 Identities = 55/260 (21%), Positives = 110/260 (42%), Gaps = 16/260 (6%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           + +DI   +G+G +G V+R     +G+    K ++          + + E  +++Q+ H 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLHHP 86

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
            ++ L+     K  M LI +++  G LF  +  +D   ++   + +N ++     L ++H
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH 144

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
                SIVH DI   NI+  +K  + V   DFG+A  L+ D   +     T  + APE+ 
Sbjct: 145 E---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIV 200

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD 325
               +    D+++ GV+   +L G  P    +  +    L ++         D  + +  
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP---FAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 326 IILVSKIVFACLRSKPTSRP 345
                  +   L+ +P  R 
Sbjct: 258 EAK--DFIKNLLQKEPRKRL 275

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-47
 Identities = 62/283 (21%), Positives = 114/283 (40%), Gaps = 30/283 (10%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKK---VALKKLHHSETELAFLESFQTEAHLLSQI- 144
            D   +  IG G +G V +A++         A+K++    ++      F  E  +L ++ 
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-HRDFAGELEVLCKLG 68

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-------------DDEAIRLDWTK 191
            H NI+ L G C H+  ++L  +Y   G+L   LR              +  A  L   +
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 192 RVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
            ++    +A  + YL        +HRD+++ NIL+     A +ADFG++R        +T
Sbjct: 129 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKT 184

Query: 252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ 311
           +      ++A E     V T   DV+S+GV+  E++          +       +     
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGY 243

Query: 312 RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF 353
           R+  P++    + D++        C R KP  RP   ++    
Sbjct: 244 RLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSL 280

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 6e-47
 Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 21/263 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPS----GKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           E  ++  CIG G +G V++    S       VA+K   +  ++ +  E F  EA  + Q 
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQF 65

Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALS 204
            H +IVKL G    +  +++I +    G L            LD    +     ++ AL+
Sbjct: 66  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALA 122

Query: 205 YLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVAGTHGYIAPE 263
           YL        VHRDI++ N+L++S     + DFG++R +   +  + +       ++APE
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
                  T   DV+ FGV   E+LM G  P   +   N  ++      +R+P P +    
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGERLPMPPNCPPT 237

Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
           +  ++        C    P+ RP
Sbjct: 238 LYSLMT------KCWAYDPSRRP 254

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  157 bits (397), Expect = 3e-46
 Identities = 62/267 (23%), Positives = 117/267 (43%), Gaps = 20/267 (7%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLH-HSETELAFLESFQTEAHLLSQIR 145
           ++ +++   +G GG   V+ A+ L   + VA+K L      + +F   F+ EA   + + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 146 HRNIVKLYGFCLHK----KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
           H  IV +Y     +       +++ +Y+   +L  I+  +     +   + + ++     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT---VVAGTHG 258
           AL++ H      I+HRD+   NI++++     V DFG+AR +    ++ T    V GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID 318
           Y++PE A    +  + DVYS G V  EVL G  P    S     +    + +  +P    
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDPIPPSAR 237

Query: 319 DQTVIQDIILVSKIVFACLRSKPTSRP 345
            + +  D+     +V   L   P +R 
Sbjct: 238 HEGLSADLD---AVVLKALAKNPENRY 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 6e-46
 Identities = 60/263 (22%), Positives = 109/263 (41%), Gaps = 23/263 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           E + I   +G G +G V+R     S K    K +    T+       + E  +L+  RHR
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHR 61

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           NI+ L+      + + +I++++    +F  +     A  L+  + V+ V  +  AL +LH
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH 119

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
                +I H DI   NI+  ++  + +   +FG AR L    + R +      Y APE+ 
Sbjct: 120 S---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYYAPEVH 175

Query: 266 YTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDL-LDQRVPSPIDDQTV 322
              V++   D++S G +   +L G +P   +    +   IM  +   D+     I  +  
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE-- 233

Query: 323 IQDIILVSKIVFACLRSKPTSRP 345
             D +         L  +  SR 
Sbjct: 234 AMDFVD------RLLVKERKSRM 250

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 1e-45
 Identities = 65/278 (23%), Positives = 126/278 (45%), Gaps = 24/278 (8%)

Query: 85  IVATEDFDIKYCIGTGGYGSVYRAQ-LPSGK----KVALKKLHHSETELAFLESFQTEAH 139
           I+   +F     +G+G +G+VY+   +P G+     VA+K+L  + +     +    EA+
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAY 63

Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           +++ + + ++ +L G CL    + LI + M  G L   +R   +   +     +N    +
Sbjct: 64  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQI 120

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR--TVVAGTH 257
           A  ++YL       +VHRD+++ N+L+ +     + DFG+A+LL ++             
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 258 GYIAPELAYTMVLTEKCDVYSFGVVALEVL-MGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
            ++A E     + T + DV+S+GV   E++  G  P D +     +I  I    +R+P P
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGERLPQP 235

Query: 317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF 353
                 +  I++       C      SRP  + +  EF
Sbjct: 236 PICTIDVYMIMV------KCWMIDADSRPKFRELIIEF 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  154 bits (390), Expect = 7e-45
 Identities = 66/259 (25%), Positives = 110/259 (42%), Gaps = 20/259 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           +DF I   +GTG +G V+  +   +G+  A+K L       L  +E    E  +LS + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             I++++G     + +F+I  Y+  G LF +LR      R            +  AL YL
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYL 120

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      I++RD+   NILL+      + DFG A+ +         + GT  YIAPE+  
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
           T    +  D +SFG++  E+L G  P       N       +L+  +  P      ++D+
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP---FYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231

Query: 327 ILVSKIVFACLRSKPTSRP 345
           +         +    + R 
Sbjct: 232 LS------RLITRDLSQRL 244

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  152 bits (384), Expect = 2e-43
 Identities = 59/274 (21%), Positives = 98/274 (35%), Gaps = 22/274 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLH----HSETELAFLESFQTEAHLLSQ 143
            DF +   IG GG+G VY  +   +GK  A+K L       +       + +    L+S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
                IV +         +  I   M  G L   L                    +   L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGL 120

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
            ++H      +V+RD+   NILL+      ++D G+A        + +V  GTHGY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175

Query: 264 -LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
            L   +      D +S G +  ++L G  P     + +   +    L   V  P      
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235

Query: 323 IQDIILVSKIVFACLRSKPTSRP--MQRVSQEFL 354
           ++ ++         L+     R   + R +QE  
Sbjct: 236 LRSLLE------GLLQRDVNRRLGCLGRGAQEVK 263

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 6e-43
 Identities = 52/266 (19%), Positives = 102/266 (38%), Gaps = 21/266 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLH----HSETELAFLESFQTEAHLLSQ 143
           + +D    +G+G +  V + +   +G + A K +      S       E  + E  +L +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
           I+H N++ L+    +K  + LI + +  G LF      D     +        + +   L
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELF------DFLAEKESLTEEEATEFLKQIL 123

Query: 204 SYLHCDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
           + ++      I H D+   NI+L      K    + DFG+A  +   +  + +  GT  +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEF 182

Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
           +APE+     L  + D++S GV+   +L G  P  L  +    +  +  ++         
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANVSAVNYEFEDEYFS 241

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
            T       + +     L   P  R 
Sbjct: 242 NTSALAKDFIRR----LLVKDPKKRM 263

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 7e-43
 Identities = 58/278 (20%), Positives = 113/278 (40%), Gaps = 26/278 (9%)

Query: 83  EMIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQT 136
           E  VA E   +   +G G +G VY              +VA+K ++ + +       F  
Sbjct: 14  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLN 72

Query: 137 EAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILR-------NDDEAIRLDW 189
           EA ++ +    ++V+L G     +   +I + M RG L   LR       N+        
Sbjct: 73  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 190 TKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249
           +K + +   +A  ++YL+ +     VHRD+++ N ++       + DFG+ R ++     
Sbjct: 133 SKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189

Query: 250 R--TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID 307
           R          +++PE     V T   DV+SFGVV  E+            ++ + +L  
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRF 247

Query: 308 LLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
           +++  +    D+      +    +++  C +  P  RP
Sbjct: 248 VMEGGLLDKPDN--CPDMLF---ELMRMCWQYNPKMRP 280

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (373), Expect = 1e-42
 Identities = 64/272 (23%), Positives = 111/272 (40%), Gaps = 27/272 (9%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLH-------HSETELAFLESFQTEAHL 140
           E+++ K  +G G    V R    P+ K+ A+K +         +E      E+   E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 141 LSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           L ++  H NI++L          FL++  M++G LF  L      + L   +   I++++
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRAL 119

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
              +  LH   I   VHRD+   NILL+  +   + DFG +  L      R V  GT  Y
Sbjct: 120 LEVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-GTPSY 175

Query: 260 IAPELAYTMVL------TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV 313
           +APE+    +        ++ D++S GV+   +L G  P          +ML  ++    
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---FWHRKQMLMLRMIMSGNY 232

Query: 314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                +     D +    +V   L  +P  R 
Sbjct: 233 QFGSPEWDDYSDTVK--DLVSRFLVVQPQKRY 262

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-42
 Identities = 61/290 (21%), Positives = 118/290 (40%), Gaps = 36/290 (12%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPS--------GKKVALKKLHHSETELAFLESFQTEAHL 140
           +   +   +G G +G V  A+             KVA+K L    TE   L    +E  +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71

Query: 141 LSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRN-------------DDEAIR 186
           +  I +H+NI+ L G C     +++I +Y  +G+L   L+               +   +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 187 LDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
           L     V+    +A  + YL        +HRD+++ N+L+       +ADFG+AR +H  
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 247 SSNRT--VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM 304
              +          ++APE  +  + T + DV+SFGV+  E+            V  ++ 
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELF 247

Query: 305 LIDLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF 353
            +     R+  P +    +  ++        C  + P+ RP  +++ ++ 
Sbjct: 248 KLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDL 291

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (366), Expect = 9e-42
 Identities = 62/274 (22%), Positives = 117/274 (42%), Gaps = 13/274 (4%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
           E +     IG G YG VY+AQ   G+  ALKK+   + +     +   E  +L +++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           IVKLY     KK + L+++++ +     +   +     L+     + +  + + ++Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYT 267
                ++HRD+   N+L+N + E  +ADFG+AR         T    T  Y AP+ L  +
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 268 MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII 327
              +   D++S G +  E++ G      +S  +  + +  +L         + T +    
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 328 LVSKIVFACLRSKPTSRPMQRVSQEF--LVRKTL 359
                 F      P    ++ + +    L+ K L
Sbjct: 236 ----PNFTVYEPLPWESFLKGLDESGIDLLSKML 265

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 56/262 (21%), Positives = 97/262 (37%), Gaps = 17/262 (6%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQ 143
           V   DFD    +G G +G V   +   +G+  A+K L          +    TE+ +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHAL 203
            RH  +  L         +  + +Y   G LF  L  +         +        A  +
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFY---GAEIV 115

Query: 204 SYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
           S L       +V+RDI   N++L+      + DFG+ +   SD +      GT  Y+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 264 LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI 323
           +          D +  GVV  E++ GR P     + + + +   +L + +  P       
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSPEA 232

Query: 324 QDIILVSKIVFACLRSKPTSRP 345
           + ++         L+  P  R 
Sbjct: 233 KSLLA------GLLKKDPKQRL 248

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-41
 Identities = 62/270 (22%), Positives = 107/270 (39%), Gaps = 18/270 (6%)

Query: 97  IGTGGYGSVYRAQ-LPSGKKVALKKL---HHSETELAFLESFQTEAHLLSQIRHRNIVKL 152
           +G G + +VY+A+   + + VA+KK+   H SE +     +   E  LL ++ H NI+ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIP 212
                HK  + L++ +M       I  N      L  +     +      L YLH   I 
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHWI- 121

Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VLT 271
             +HRD+  NN+LL+      +ADFG+A+   S +   T    T  Y APEL +   +  
Sbjct: 122 --LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 272 EKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDIILVSK 331
              D+++ G +  E+L+        S ++    + + L         D   + D      
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD-----Y 234

Query: 332 IVFACLRSKPTSRPMQRVSQEF--LVRKTL 359
           + F      P          +   L++   
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLF 264

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 1e-40
 Identities = 61/275 (22%), Positives = 114/275 (41%), Gaps = 13/275 (4%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           E+F     IG G YG VY+A+   +G+ VALKK+           +   E  LL ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           NIVKL      +  ++L+++++ +     +  +      +      + +  +   L++ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCH 119

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAY 266
                 ++HRD+   N+L+N++    +ADFG+AR         T    T  Y APE L  
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
               +   D++S G +  E++  R      S ++    +   L           T + D 
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 327 ILVSKIVFACLRSKPTSRPMQRVSQEF--LVRKTL 359
               K  F     +  S+ +  + ++   L+ + L
Sbjct: 237 ----KPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 8e-40
 Identities = 59/279 (21%), Positives = 106/279 (37%), Gaps = 31/279 (11%)

Query: 89  EDFDIKYCIGTGGYGSVYRA------QLPSGKKVALKKLHHSETELAFLESFQTEAHLLS 142
           +   +   +G G +G V  A      +  + + VA+K L    T             L+ 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 143 QIRHRNIVKLYGFCLHK-KCMFLIYKYMRRGSLFCILRN-------------DDEAIRLD 188
              H N+V L G C      + +I ++ + G+L   LR+             D     L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 189 WTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248
               +     +A  + +L        +HRD+++ NILL+ K    + DFG+AR ++ D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 249 N--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI 306
              +        ++APE  +  V T + DV+SFGV+  E+            ++ +    
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 307 DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                R+ +P      +   +L       C   +P+ RP
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTML------DCWHGEPSQRP 282

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (353), Expect = 1e-39
 Identities = 39/266 (14%), Positives = 96/266 (36%), Gaps = 21/266 (7%)

Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           + +   IG+G +G +Y    + +G++VA+K                 E+ +   ++    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVG 64

Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD 209
           +    +C  +    ++   +   SL  +        +      + +   M   + Y+H  
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS- 121

Query: 210 CIPSIVHRDISSNNILLNSK---LEAFVADFGVARLLHSDSSN-------RTVVAGTHGY 259
              + +HRD+  +N L+         ++ DFG+A+      ++          + GT  Y
Sbjct: 122 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 260 IAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDD 319
            +      +  + + D+ S G V +   +G  P   L +   +     + ++++ +PI+ 
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 320 QTVIQDIILVSKIVFACLRSKPTSRP 345
                        +  C   +   +P
Sbjct: 240 LCKGYPSEFA-TYLNFCRSLRFDDKP 264

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 5e-39
 Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 25/281 (8%)

Query: 90  DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN 148
            +     IG G +G VY+A+L  SG+ VA+KK+   +           E  ++ ++ H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74

Query: 149 IVKLYGFCLH------KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
           IV+L  F         +  + L+  Y+                 L        +  +  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 203 LSYLHCDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIA 261
           L+Y+H      I HRDI   N+LL+       + DFG A+ L     N + +   +    
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT 321
             +      T   DV+S G V  E+L+G+      S V+  + +I +L       I +  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 322 VIQDIILVSKIVFACLRSKPTSRPMQ-RVSQEF--LVRKTL 359
                   ++  F  +++ P ++  + R   E   L  + L
Sbjct: 252 -----PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 287

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 7e-39
 Identities = 60/285 (21%), Positives = 119/285 (41%), Gaps = 24/285 (8%)

Query: 87  ATEDFDIKYCIGTGGYGSVYRAQ--LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI 144
           A + ++    IG G YG V++A+     G+ VALK++     E     S   E  +L  +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 145 ---RHRNIVKLYGFCL-----HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIV 196
               H N+V+L+  C       +  + L+++++ +     + +  +    +      +++
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMM 122

Query: 197 KSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
             +   L +LH   +   VHRD+   NIL+ S  +  +ADFG+AR+     +  +VV  T
Sbjct: 123 FQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-VT 178

Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP 316
             Y APE+          D++S G +  E+   +      S V+    ++D++       
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 317 IDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEF--LVRKTL 359
                 +      SK       ++P  + +  + +    L+ K L
Sbjct: 239 WPRDVALPRQAFHSK------SAQPIEKFVTDIDELGKDLLLKCL 277

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (351), Expect = 8e-39
 Identities = 55/259 (21%), Positives = 104/259 (40%), Gaps = 20/259 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSE-TELAFLESFQTEAHLLSQIRH 146
           + FD    +GTG +G V   +   SG   A+K L   +  +L  +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
             +VKL         ++++ +Y+  G +F  LR      R            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
           H      +++RD+   N+L++ +    V DFG A+ +         + GT   +APE+  
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEALAPEIIL 211

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
           +    +  D ++ GV+  E+  G  P     +  P  +   ++  +V  P    + ++D+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP---FFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268

Query: 327 ILVSKIVFACLRSKPTSRP 345
           +         L+   T R 
Sbjct: 269 LR------NLLQVDLTKRF 281

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 8e-39
 Identities = 61/269 (22%), Positives = 116/269 (43%), Gaps = 27/269 (10%)

Query: 89  EDFDI-KYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-R 145
           +D+ +    +G G  G V +     + +K ALK L             + E  L  +  +
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQ 63

Query: 146 HRNIVKLYGFC----LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
             +IV++          +KC+ ++ + +  G LF  +++  +       +   I+KS+  
Sbjct: 64  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGE 122

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLE---AFVADFGVARLLHSDSSNRTVVAGTHG 258
           A+ YLH     +I HRD+   N+L  SK       + DFG A+   S +S  T    T  
Sbjct: 123 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPY 178

Query: 259 YIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP--GDLLSSVNPKIMLIDLLDQRVPSP 316
           Y+APE+       + CD++S GV+   +L G  P   +   +++P +     + Q     
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238

Query: 317 IDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            +   V +++     ++   L+++PT R 
Sbjct: 239 PEWSEVSEEVK---MLIRNLLKTEPTQRM 264

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-38
 Identities = 55/265 (20%), Positives = 97/265 (36%), Gaps = 31/265 (11%)

Query: 90  DFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHS----ETELAFLESFQTEAHLLSQI 144
            + +   +G+GG+GSVY    +     VA+K +         EL        E  LL ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 145 R--HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHA 202
                 +++L  +        LI +             +     L      +    +  A
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEA 122

Query: 203 LSYLHCDCIPSIVHRDISSNNILLN-SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
           + + H      ++HRDI   NIL++ ++ E  + DFG   LL    +  T   GT  Y  
Sbjct: 123 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSP 177

Query: 262 PE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ 320
           PE + Y         V+S G++  +++ G  P +    +    +      QRV S     
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---RQRVSSECQH- 233

Query: 321 TVIQDIILVSKIVFACLRSKPTSRP 345
                      ++  CL  +P+ RP
Sbjct: 234 -----------LIRWCLALRPSDRP 247

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-38
 Identities = 59/279 (21%), Positives = 106/279 (37%), Gaps = 13/279 (4%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
              +     IG G YG V  A    +  +VA+KK+   E +  + +    E  +L + RH
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRH 65

Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYL 206
            NI+ +           +   Y+    +   L    +   L        +  +   L Y+
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 207 HCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV---VAGTHGYIAPE 263
           H     +++HRD+  +N+LLN+  +  + DFG+AR+   D  +         T  Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 264 LAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV 322
           +       T+  D++S G +  E+L  R        ++    ++ +L    PS  D   +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS--PSQEDLNCI 240

Query: 323 IQDIILVSKIVFACLRSKPTSRPMQRVSQEF--LVRKTL 359
           I        +        P +R       +   L+ K L
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  134 bits (337), Expect = 2e-37
 Identities = 42/271 (15%), Positives = 84/271 (30%), Gaps = 29/271 (10%)

Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRN- 148
           + +   IG G +G ++    L + ++VA+K               + E      +     
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTG 62

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           I  +Y F        L+   +       +        +          K M   +  +H 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE 119

Query: 209 DCIPSIVHRDISSNNILLNSKLE-----AFVADFGVARLLHSDSSN-------RTVVAGT 256
               S+V+RDI  +N L+           +V DFG+ +      +        +  ++GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 257 HGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRH--PGDLLSSVNPKIMLIDLLDQRVP 314
             Y++         + + D+ + G V +  L G     G   ++   K   I    Q  P
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236

Query: 315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
                    ++     K +         + P
Sbjct: 237 LRELCAGFPEEFY---KYMHYARNLAFDATP 264

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 3e-37
 Identities = 51/275 (18%), Positives = 113/275 (41%), Gaps = 13/275 (4%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           + ++    IG G YG+V++A+   + + VALK++   + +     S   E  LL +++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLH 207
           NIV+L+      K + L++++  +         +             +   +   L  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLG 115

Query: 208 CDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY- 266
                +++HRD+   N+L+N   E  +A+FG+AR         +    T  Y  P++ + 
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 267 TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI 326
             + +   D++S G +  E+     P   L   N     +  + + + +P ++Q      
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 327 ILVSKIVFACLRSKPTSRPMQRVSQEF--LVRKTL 359
           +   K       +      + +++     L++  L
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLL 267

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-36
 Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 23/271 (8%)

Query: 86  VATEDFDIKYCIGTGGYGSVYRAQL----PSGKKVALKKLHHSE--TELAFLESFQTEAH 139
           V  E+F++   +GTG YG V+  +      +GK  A+K L  +    +    E  +TE  
Sbjct: 21  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80

Query: 140 LLSQIRHR-NIVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKS 198
           +L  IR    +V L+     +  + LI  Y+  G LF  L   +   R    +    V  
Sbjct: 81  VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGE 137

Query: 199 MAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTH 257
           +  AL +LH      I++RDI   NILL+S     + DFG+++   +D + R     GT 
Sbjct: 138 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 258 GYIAPELAYTMV--LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID-LLDQRVP 314
            Y+AP++         +  D +S GV+  E+L G  P  +    N +  +   +L    P
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254

Query: 315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRP 345
            P +   + +D+I         L   P  R 
Sbjct: 255 YPQEMSALAKDLIQ------RLLMKDPKKRL 279

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 8e-36
 Identities = 59/287 (20%), Positives = 106/287 (36%), Gaps = 23/287 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
             ++    IG G +G V++A+   +G+KVALKK+     +  F  +   E  +L  ++H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 148 NIVKLYGFCL--------HKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSM 199
           N+V L   C          K  ++L++ +        +     +   L   KRV     M
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV-----M 123

Query: 200 AHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTVVAG 255
              L+ L+      I+HRD+ + N+L+       +ADFG+AR      +      T    
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 256 THGYIAPE-LAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP 314
           T  Y  PE L          D++  G +  E+          +  + ++ LI  L   + 
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSIT 242

Query: 315 SPIDDQTVIQDIILVSKIVFACLRSKPTSRPMQRVSQEF--LVRKTL 359
             +       ++    ++V    R                 L+ K L
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-33
 Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 21/280 (7%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
             +     +G+G YG+V  A    +G KVA+KKL+       F +    E  LL  +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 148 NIVKLYGFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
           N++ L       + +      +L+  +M       +        +L   +   +V  M  
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-----KLGEDRIQFLVYQMLK 132

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
            L Y+H   I    HRD+   N+ +N   E  + DFG+AR   +DS     V        
Sbjct: 133 GLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVTRWYRAP 187

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQT 321
             +   M  T+  D++S G +  E++ G+        ++    ++ +     P     Q 
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT--GTPPAEFVQR 245

Query: 322 VIQDIILVSKIVFACLRSKPTSRPMQRVSQEF--LVRKTL 359
           +  D           L  K  +  +   S     L+ K L
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  124 bits (311), Expect = 3e-33
 Identities = 40/228 (17%), Positives = 88/228 (38%), Gaps = 24/228 (10%)

Query: 71  SVWNYDG-RITFQEMIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETEL 128
             W+Y+   + +       +D+ +   +G G Y  V+ A  + + +KV +K L   +   
Sbjct: 20  EYWDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--- 72

Query: 129 AFLESFQTEAHLLSQIR-HRNIVKLYGFCLH--KKCMFLIYKYMRRGSLFCILRNDDEAI 185
              +  + E  +L  +R   NI+ L         +   L+++++       + +      
Sbjct: 73  --KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------ 124

Query: 186 RLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLH 244
            L        +  +  AL Y H   I    HRD+  +N++++ +  +  + D+G+A   H
Sbjct: 125 TLTDYDIRFYMYEILKALDYCHSMGIM---HRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181

Query: 245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
                   VA  +      L    +     D++S G +   ++  + P
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 8e-32
 Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 17/211 (8%)

Query: 89  EDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHR 147
           + +     IG+G  G V  A      + VA+KKL          +    E  L+  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 148 NIVKLYGFCLHKKCM------FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
           NI+ L      +K +      +L+ + M       I    D        +   ++  M  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------RMSYLLYQMLC 130

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
            + +LH      I+HRD+  +NI++ S     + DFG+AR     S   T    T  Y A
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRA 186

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
           PE+   M   E  D++S G +  E++  +  
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 1e-31
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 15/211 (7%)

Query: 88  TEDFDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH 146
            E +     +G+G YGSV  A    +G +VA+KKL      +   +    E  LL  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 147 RNIVKLYGFC-----LHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAH 201
            N++ L         L +     +  ++    L  I++      +L       ++  +  
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILR 132

Query: 202 ALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
            L Y+H   I    HRD+  +N+ +N   E  + DFG+AR  H+D      VA       
Sbjct: 133 GLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAP 187

Query: 262 PELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
             +   M   +  D++S G +  E+L GR  
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (255), Expect = 3e-25
 Identities = 39/221 (17%), Positives = 85/221 (38%), Gaps = 26/221 (11%)

Query: 91  FDIKYCIGTGGYGSVYRAQ-LPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI 149
           + +   +G G + +V+ A+ + +   VA+K +   +    + E+ + E  LL ++   + 
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADN 71

Query: 150 VKLYGFCLH---------------KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVN 194
            K      +                  + ++++ +    L  I + +   I L + K+  
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ-- 129

Query: 195 IVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRT-- 251
           I K +   L Y+H  C   I+H DI   N+L+        +    +A L ++   +    
Sbjct: 130 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 252 VVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP 292
               T  Y +PE+          D++S   +  E++ G   
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.8 bits (201), Expect = 6e-19
 Identities = 25/162 (15%), Positives = 55/162 (33%), Gaps = 18/162 (11%)

Query: 97  IGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFL--------ESFQTEAHLLSQIRHRN 148
           +G G   +V+        +  +K      T    +          F   A   ++   R 
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC 208
           + KL G  + K   +         ++   L +  E  R+       ++  +   ++  + 
Sbjct: 68  LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250
                IVH D+S  N+L+ S+   ++ DF  +  +  +    
Sbjct: 122 RG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWRE 159

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	363
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.81
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.49
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.79
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.44
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.15
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.87

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-58  Score=401.03  Aligned_cols=259  Identities=25%  Similarity=0.359  Sum_probs=207.9

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++...... ...+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            35799999999999999999976 47899999999765432 22467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++.++..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        83 Ey~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          83 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            9999999999997554   699999999999999999999999   9999999999999999999999999999876433


Q ss_pred             C--CCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          247 S--SNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       247 ~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      .  ......+||+.|||||++.+..+ +.++|||||||++|||++|+.||........  .............. ...  
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~~~~~~~~~~~~-~~~--  231 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYLNP-WKK--  231 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHHHHHTTCTTSTT-GGG--
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHHHHhcCCCCCCc-ccc--
Confidence            2  22345679999999999987775 6789999999999999999999875443222  12222222111111 111  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTL  359 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~  359 (363)
                       ....+.+|+.+||+.||++|| +.|++++-+.++.+
T Consensus       232 -~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         232 -IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             -SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence             112477899999999999999 99998877665543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=402.31  Aligned_cols=253  Identities=23%  Similarity=0.381  Sum_probs=211.8

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.......  .+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            4799999999999999999975 578999999987654322  3678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++|+|.+++...    .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        98 y~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            99999999988654    489999999999999999999999   99999999999999999999999999999876555


Q ss_pred             CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHHH
Q 046084          248 SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDII  327 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ......+.....+.......   ...
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~---~s~  244 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPELQNPEK---LSA  244 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCCCSSGGG---SCH
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCCCCCccc---CCH
Confidence            555667899999999999999999999999999999999999999865332   22233333322221111111   112


Q ss_pred             HHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          328 LVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       328 ~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .+.+||.+||+.||++|| +.|++++-+.+
T Consensus       245 ~~~~li~~~L~~dP~~R~s~~eil~Hp~~~  274 (293)
T d1yhwa1         245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLK  274 (293)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence            488999999999999999 99998765543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-58  Score=404.50  Aligned_cols=260  Identities=25%  Similarity=0.438  Sum_probs=203.4

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +..++|++.+.||+|+||+||+|+++  ..||||+++.........+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            44678999999999999999999874  369999997665444456789999999999999999999999865 457999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++|+|.+++.....  .+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            999999999999975442  599999999999999999999999   999999999999999999999999999987643


Q ss_pred             CC--CCceeecccccccccccccc---ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCCh
Q 046084          246 DS--SNRTVVAGTHGYIAPELAYT---MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQ  320 (363)
Q Consensus       246 ~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      ..  .......||+.|||||++.+   ..|+.++|||||||++|||+||+.||......   .............+....
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~p~~~~  233 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIFMVGRGYLSPDLSK  233 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHHTSCCCCGGG
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH---HHHHHHHhcCCCCCcchh
Confidence            22  22344679999999999864   35889999999999999999999998754322   122222222111111000


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .....+..+.+|+.+||+.||++|| +.|++++|+.-
T Consensus       234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            0111122488999999999999999 99999998643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-57  Score=394.57  Aligned_cols=251  Identities=29%  Similarity=0.473  Sum_probs=212.7

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||+||+|.+ .+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999976 4688999999875432 2223467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++....   .+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||++..... 
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC-
Confidence            9999999999997654   599999999999999999999999   999999999999999999999999999976543 


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||...   +.......+.......+...+.     
T Consensus       159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~-----  229 (263)
T d2j4za1         159 -SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFTFPDFVTE-----  229 (263)
T ss_dssp             -CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTTCCCCCTTSCH-----
T ss_pred             -CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCCCccCCH-----
Confidence             2334567999999999999999999999999999999999999998643   3344445555555444433322     


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       .+.+|+.+||+.||++|| +.|++++-...
T Consensus       230 -~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         230 -GARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             -HHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             -HHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence             378899999999999999 99998865543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-58  Score=401.56  Aligned_cols=256  Identities=26%  Similarity=0.430  Sum_probs=198.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee--CCeEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH--KKCMFL  164 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  164 (363)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|.+..........+.+.+|++++++++||||+++++++.+  .+..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            36799999999999999999976 578999999998766555556789999999999999999999999865  456899


Q ss_pred             EEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          165 IYKYMRRGSLFCILRNDD-EAIRLDWTKRVNIVKSMAHALSYLHCDC--IPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       165 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      ||||+++|+|.+++.... ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999986422 2236999999999999999999999861  0139999999999999999999999999998


Q ss_pred             eccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCC-CCCCh
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPS-PIDDQ  320 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  320 (363)
                      .............||+.|+|||++.+..++.++|||||||++|||++|+.||...+   .......+.....+. +...+
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~s  239 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREGKFRRIPYRYS  239 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCCCCTTSC
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCCCCCcccC
Confidence            87655444556789999999999999999999999999999999999999986543   333344444443322 22222


Q ss_pred             hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHH
Q 046084          321 TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQE  352 (363)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~  352 (363)
                            ..+.+|+.+||+.||++|| +.|++++
T Consensus       240 ------~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         240 ------DELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ------HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                  1488999999999999999 9998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-57  Score=395.50  Aligned_cols=251  Identities=25%  Similarity=0.427  Sum_probs=199.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .++|++.+.||+|+||+||+|.+.+++.||||+++......   ++|.+|++++++++||||++++|+|.+.+..++|||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            46789999999999999999999888899999998655433   578999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++|+|.+++.....  .+++..++.++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             ecCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            9999999999876532  589999999999999999999999   99999999999999999999999999998764433


Q ss_pred             C-CceeeccccccccccccccccCCccccchHHHHHHHHHHhC-CCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHH
Q 046084          248 S-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMG-RHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQ  324 (363)
Q Consensus       248 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  324 (363)
                      . ......||+.|+|||++.+..++.++|||||||++|||+|+ ++||...   ........+... +...+...+    
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~~~~~~p~~~~----  228 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFRLYKPRLAS----  228 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC---CHHHHHHHHHHTCCCCCCTTSC----
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC---CHHHHHHHHHhcCCCCCccccC----
Confidence            2 22335689999999999999999999999999999999995 5554432   222223333222 222332222    


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        ..+.+|+.+||+.||++|| +.|++++|..
T Consensus       229 --~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         229 --THVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence              1488999999999999999 9999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-56  Score=397.44  Aligned_cols=261  Identities=29%  Similarity=0.471  Sum_probs=201.0

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCC---EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK---KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      .++|++.+.||+|+||+||+|.+. +|+   .||||.+...... ...+.|.+|+.+|++++||||++++|+|.+.+..+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            356788899999999999999764 232   5899988765443 33578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +|||||++|+|.+++.....  .+++.+++.++.||++||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999998876443  589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCCc-----eeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc-ccCCCC
Q 046084          244 HSDSSNR-----TVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPSP  316 (363)
Q Consensus       244 ~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~  316 (363)
                      .......     ....||+.|||||.+.+..++.++|||||||++|||+| |+.||.....   ......+.. .+++.+
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~~~  255 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIEQDYRLPPP  255 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCCCC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCC
Confidence            4432211     12357899999999999999999999999999999998 8999865432   222333322 233333


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc-hhhhhhcC
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV-RKTLYQLK  363 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~-~~~~~~~~  363 (363)
                      ...+.      .+.+|+.+||+.||++|| +.|+++.|.. .+.-+.||
T Consensus       256 ~~~~~------~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~slk  298 (299)
T d1jpaa_         256 MDCPS------ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK  298 (299)
T ss_dssp             TTCCH------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGT
T ss_pred             ccchH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhhCC
Confidence            33322      488999999999999999 9999999854 33444444

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-56  Score=387.99  Aligned_cols=250  Identities=25%  Similarity=0.459  Sum_probs=211.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      .++|++.+.||+|+||+||+|++++++.||||+++......   ++|.+|+.++++++||||++++|+|.+.+..++|||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            46899999999999999999999888899999998765443   578999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++|+|..++.....  .+++..+++++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++......
T Consensus        80 y~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          80 YMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CCTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             ccCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            9999999998765433  588999999999999999999999   99999999999999999999999999998764433


Q ss_pred             C-CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHH
Q 046084          248 S-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQ  324 (363)
Q Consensus       248 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  324 (363)
                      . ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+....   ......+... +++.+...+    
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~~p~~~~----  227 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRLYRPHLAS----  227 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCCCCCTTCC----
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHhCCCCCCccccc----
Confidence            2 2233568999999999999999999999999999999998 8999876543   2233333332 333333322    


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                        ..+.+||.+||+.||++|| +.+++++|+
T Consensus       228 --~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         228 --EKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             --HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             --HHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence              2488999999999999999 999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-57  Score=396.77  Aligned_cols=254  Identities=25%  Similarity=0.441  Sum_probs=206.5

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      +..++|++.+.||+|+||+||+|.++++..||||+++......   +.|.+|+.++++++||||++++|++.+ +..++|
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            4567899999999999999999999888899999997655432   579999999999999999999998865 457999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++|+|.+++.... ..++++..+++++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus        86 ~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence            99999999998876533 22589999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCC-CCCCcCCCchhhHHhhhcc-cCCCCCCChhh
Q 046084          246 DSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHP-GDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTV  322 (363)
Q Consensus       246 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  322 (363)
                      ... ......||+.|+|||++.+..++.++|||||||++|||+||..| +...   ........+... +++.+...+  
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~---~~~~~~~~i~~~~~~~~p~~~~--  236 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVRPDNCP--  236 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCCCCCCTTCC--
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC---CHHHHHHHHHhcCCCCCcccCh--
Confidence            332 22335688999999999988999999999999999999996555 3322   222223333322 222232222  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                          ..+.+|+.+||+.||++|| +.++++.|...
T Consensus       237 ----~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         237 ----EELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                2388999999999999999 99999887643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=396.43  Aligned_cols=254  Identities=25%  Similarity=0.367  Sum_probs=209.0

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      +.|++.+.||+|+||+||+|.+ .+|+.||+|++......  ..+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            5689999999999999999976 46889999999765432  24678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+++|+|.+++....  ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus        90 y~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~  164 (288)
T d2jfla1          90 FCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  164 (288)
T ss_dssp             CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred             cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence            999999999876533  2599999999999999999999999   99999999999999999999999999997654333


Q ss_pred             CCceeeccccccccccccc-----cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          248 SNRTVVAGTHGYIAPELAY-----TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      .......||+.|+|||++.     +..|+.++|||||||++|||++|+.||....   .......+.....+........
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~  241 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN---PMRVLLKIAKSEPPTLAQPSRW  241 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC---GGGHHHHHHHSCCCCCSSGGGS
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCCCCCccccC
Confidence            3334567999999999874     4568899999999999999999999986543   3334444444443322211111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                         ...+.+||.+||+.||++|| +.|++++-+.
T Consensus       242 ---s~~~~~li~~~L~~dp~~R~t~~ell~hp~~  272 (288)
T d2jfla1         242 ---SSNFKDFLKKCLEKNVDARWTTSQLLQHPFV  272 (288)
T ss_dssp             ---CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence               12488999999999999999 9999886544

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-56  Score=397.00  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=209.8

Q ss_pred             HHHHHhcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           83 EMIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      ++++..++|++.+.||+|+||+||+|.+. +|+.||||+++.....   .++|.+|+.+|++++||||++++++|.+.+.
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            34455678999999999999999999764 5889999999765543   3678999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .+++|||+++|+|.+++..... ..+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             eEEEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence            9999999999999999875432 3689999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCCC-ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc--cCCCCCC
Q 046084          242 LLHSDSSN-RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ--RVPSPID  318 (363)
Q Consensus       242 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  318 (363)
                      ........ .....|++.|+|||++.+..++.++|||||||++|||++|..|+....  +.. .....+..  +++.+..
T Consensus       164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~-~~~~~i~~~~~~~~~~~  240 (287)
T d1opja_         164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLS-QVYELLEKDYRMERPEG  240 (287)
T ss_dssp             TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHH-HHHHHHHTTCCCCCCTT
T ss_pred             ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHH-HHHHHHhcCCCCCCCcc
Confidence            76543322 223457889999999999999999999999999999999777643221  112 22223322  2222222


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+      ..+.+|+.+||+.||++|| +.|+++.|..
T Consensus       241 ~~------~~l~~li~~cl~~dP~~Rps~~ei~~~L~~  272 (287)
T d1opja_         241 CP------EKVYELMRACWQWNPSDRPSFAEIHQAFET  272 (287)
T ss_dssp             CC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ch------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            22      2488999999999999999 9999887753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=385.15  Aligned_cols=249  Identities=25%  Similarity=0.417  Sum_probs=200.8

Q ss_pred             CcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEee----CCeEEEE
Q 046084           91 FDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLH----KKCMFLI  165 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv  165 (363)
                      |++.+.||+|+||+||+|.+. +++.||+|.+..........+.+.+|+++|++++||||+++++++.+    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            366778999999999999764 68899999997765444556789999999999999999999999875    3468999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCeeec-CCCceEEEeecccee
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPS--IVHRDISSNNILLN-SKLEAFVADFGVARL  242 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~  242 (363)
                      |||+++|+|.+++....   .+++..+..++.||++||+|||++   +  |+||||||+|||++ +++.+||+|||+++.
T Consensus        91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            99999999999997654   689999999999999999999998   7  99999999999996 578999999999976


Q ss_pred             ccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ..  ........||+.|||||++.+ .++.++|||||||++|||++|+.||....  +.......+.....+.....   
T Consensus       165 ~~--~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i~~~~~~~~~~~---  236 (270)
T d1t4ha_         165 KR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKPASFDK---  236 (270)
T ss_dssp             CC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCCCGGGGG---
T ss_pred             cc--CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHHHHHcCCCCcccCc---
Confidence            43  233445689999999998865 59999999999999999999999986432  22222333333222211110   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                       .....+.+||.+||+.||++|| +.|++++-.
T Consensus       237 -~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~  268 (270)
T d1t4ha_         237 -VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  268 (270)
T ss_dssp             -CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             -cCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence             0112488999999999999999 999987644

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-56  Score=393.45  Aligned_cols=248  Identities=24%  Similarity=0.371  Sum_probs=207.6

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999976 5789999999875432 2223467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|.+++...+   .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999987654   699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC--CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          247 SS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       247 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...   +.......+....+..+...+.   
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~---  235 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKLEYDFPEKFFP---  235 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCCCCTTCCH---
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcCCCCCCccCCH---
Confidence            22  234467999999999999999999999999999999999999998643   3344455555555544433322   


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHH
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQ  351 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~  351 (363)
                         .+.+||.+||+.||++|| +.|++.
T Consensus       236 ---~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         236 ---KARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---HHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---HHHHHHHHHccCCHhHCcCHHHHcC
Confidence               378899999999999999 887643

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=388.13  Aligned_cols=244  Identities=24%  Similarity=0.389  Sum_probs=196.9

Q ss_pred             CeeeecCceeEEEEEeC---CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEeccC
Q 046084           95 YCIGTGGYGSVYRAQLP---SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR  171 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  171 (363)
                      +.||+|+||+||+|.+.   .++.||||+++....+....+.|.+|+.+|++++||||++++|+|..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            46999999999999753   345799999976554445567899999999999999999999999654 57899999999


Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC--
Q 046084          172 GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--  249 (363)
Q Consensus       172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  249 (363)
                      |+|.+++....   .+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++........  
T Consensus        92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999998655   699999999999999999999999   9999999999999999999999999999876543322  


Q ss_pred             -ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHHHH
Q 046084          250 -RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQDI  326 (363)
Q Consensus       250 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  326 (363)
                       .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....   ......+..+ +++.+...+      
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~~~p~~~~------  236 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERMGCPAGCP------  236 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTCC------
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcCCCCCCCcccC------
Confidence             223468999999999999999999999999999999998 8999875432   2222223222 333333322      


Q ss_pred             HHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          327 ILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ..+.+||.+||+.||++|| +.++...|.
T Consensus       237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         237 REMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            2488999999999999999 999987664

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=387.99  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=205.1

Q ss_pred             hcCCcccCe-eeecCceeEEEEEeC---CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           88 TEDFDIKYC-IGTGGYGSVYRAQLP---SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        88 ~~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      .++|.+.+. ||+|+||+||+|.+.   ++..||||+++..... ...++|.+|+++|++++||||++++|++.. +..+
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH-HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            456777774 999999999999653   3457999999765443 345789999999999999999999999865 4579


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +||||+++|+|.+++.....  .+++..++.++.|+++||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus        85 lvmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence            99999999999999865432  589999999999999999999999   9999999999999999999999999999877


Q ss_pred             cCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCC
Q 046084          244 HSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPID  318 (363)
Q Consensus       244 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  318 (363)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.....   ......+..+ +++.+..
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~~~~~~~p~~  236 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRMECPPE  236 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCCCCCTT
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCc
Confidence            543321   223458899999999998999999999999999999998 9999875432   2233333332 2333333


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+      ..+.+||.+||+.||++|| +.++.+.|..
T Consensus       237 ~~------~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         237 CP------PELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             CC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            32      2488999999999999999 9999887753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-56  Score=398.46  Aligned_cols=258  Identities=24%  Similarity=0.377  Sum_probs=206.4

Q ss_pred             HhcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ..++|++.+.||+|+||+||+|.. .+|+.||+|+++..... ...+.+.+|+.+|++++||||++++++|.+.+..++|
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT-THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467899999999999999999976 57889999999765332 2346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCCceEEEeeccceecc
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH  244 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  244 (363)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+ +   +|+||||||+|||++.++.+||+|||+|....
T Consensus        83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            99999999999997654   59999999999999999999996 5   89999999999999999999999999998654


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHH------------------
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLI------------------  306 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~------------------  306 (363)
                      ..  .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+.........                  
T Consensus       157 ~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         157 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             HH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             CC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            32  2334689999999999999999999999999999999999999986533211000000                  


Q ss_pred             --------------------hhhcccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          307 --------------------DLLDQRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       307 --------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                          .......+.......   ....+.+|+.+||+.||++|| +.|++++-..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~  302 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGV---FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  302 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTT---BCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCcccc---CCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence                                000001111111000   112478899999999999999 99999875554

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.5e-55  Score=387.85  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=205.1

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      +.|+..+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3589999999999999999975 5788999999976543 3444578999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      |||.+|+|..++....   .+++.+++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++..... 
T Consensus        95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            9999999987765543   699999999999999999999999   999999999999999999999999999986533 


Q ss_pred             CCCceeecccccccccccccc---ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          247 SSNRTVVAGTHGYIAPELAYT---MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                         .....||+.|||||++.+   ..|+.++|||||||++|||++|+.||....   .......+.....+...... . 
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~-~-  239 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPALQSGH-W-  239 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCCSCTT-S-
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCCCCC-C-
Confidence               234579999999999863   458999999999999999999999986432   23334444444333322211 1 


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                        ...+.+||.+||+.||++|| +.|++++-
T Consensus       240 --s~~~~~li~~~L~~dP~~Rpt~~ell~Hp  268 (309)
T d1u5ra_         240 --SEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (309)
T ss_dssp             --CHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             --CHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence              12488999999999999999 99987643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-55  Score=392.59  Aligned_cols=257  Identities=25%  Similarity=0.433  Sum_probs=207.2

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCC-C-----CEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPS-G-----KKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLH  158 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  158 (363)
                      +..++|++.+.||+|+||+||+|++.. +     ..||+|.+...... .....+.+|+.+++++ +||||+++++++.+
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH-HHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            456789999999999999999997632 2     26999998765432 2346788999999998 89999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeC
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDE--------------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRD  218 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  218 (363)
                      .+..++|||||++|+|.+++.....                    ...+++..++.++.|+++||+|||++   +|+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            9999999999999999999976432                    13589999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCC
Q 046084          219 ISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDL  295 (363)
Q Consensus       219 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~  295 (363)
                      |||+|||++.++.+||+|||+++........  .....||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876544332  224567999999999999999999999999999999998 8999865


Q ss_pred             CcCCCchhhHHhhhcc--cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          296 LSSVNPKIMLIDLLDQ--RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...   ...+..++..  +++.+...+.      .+.+||.+||+.||++|| +.|++++|..
T Consensus       270 ~~~---~~~~~~~~~~~~~~~~p~~~~~------~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         270 IPV---DANFYKLIQNGFKMDQPFYATE------EIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCC---SHHHHHHHHTTCCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCH---HHHHHHHHhcCCCCCCCCcCCH------HHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            432   2223333333  2333333322      488999999999999999 9999998854

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.2e-55  Score=388.53  Aligned_cols=255  Identities=23%  Similarity=0.314  Sum_probs=194.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .+.|++.+.||+|+||+||+|.. .+|+.||||++........ .+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46799999999999999999976 4688999999976543322 356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec---CCCceEEEeeccceec
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN---SKLEAFVADFGVARLL  243 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~  243 (363)
                      |||+||+|.+++....   .+++.++..++.||+.||+|||+.   +++||||||+|||++   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999997654   699999999999999999999999   999999999999994   5789999999999865


Q ss_pred             cCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhH
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVI  323 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      .... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....   .......+.......+...... 
T Consensus       161 ~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~-  235 (307)
T d1a06a_         161 DPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQILKAEYEFDSPYWDD-  235 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHTTCCCCCTTTTTT-
T ss_pred             cCCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCCCCCccccC-
Confidence            4332 3344679999999999999999999999999999999999999986432   2333444444433322211111 


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                       ....+.+||.+||+.||++|| +.|++++-..
T Consensus       236 -~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  267 (307)
T d1a06a_         236 -ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI  267 (307)
T ss_dssp             -SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             -CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence             112488999999999999999 9999987544

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-54  Score=380.36  Aligned_cols=254  Identities=29%  Similarity=0.435  Sum_probs=199.3

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCC-----CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSG-----KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||+||+|.+.++     ..||||++....... ...+|.+|+.++++++||||++++|++.+.+..
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-HHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            45788899999999999999976432     369999997655443 346799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      +++|||+.++++.+++.....  .+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999988765432  599999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc-cCCCCCC
Q 046084          243 LHSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ-RVPSPID  318 (363)
Q Consensus       243 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  318 (363)
                      .......   .....||+.|+|||++.+..++.++|||||||++|||++|..|+....  ........+.++ +++.+..
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~~~~~~  237 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFRLPTPMD  237 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCCCCTT
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHHhccCCCCCchh
Confidence            6443222   223457899999999999999999999999999999999666543221  222233333332 2233332


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .+      ..+.+||.+||+.||++|| +.|+++.|..
T Consensus       238 ~~------~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         238 CP------SAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             CB------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             hH------HHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence            22      2488999999999999999 9999998854

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=388.61  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=214.2

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      -++|++.+.||+|+||+||+|+. .+|+.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36799999999999999999976 5789999999975432 122346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999999998755   689999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      ........+||+.|+|||++.+..|+.++|||||||++|||++|++||...   +.......+....+..+...+.    
T Consensus       158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~---~~~~~~~~i~~~~~~~p~~~s~----  230 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILMEEIRFPRTLSP----  230 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCTTSCH----
T ss_pred             CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc---CHHHHHHHHhcCCCCCCccCCH----
Confidence            555556678999999999999999999999999999999999999998653   3344455555555555543332    


Q ss_pred             HHHHHHHHHHccCCCCCCCC------hHHHHHHHh
Q 046084          326 IILVSKIVFACLRSKPTSRP------MQRVSQEFL  354 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP------~~~v~~~l~  354 (363)
                        .+.+||.+||++||++||      +.|++++-.
T Consensus       231 --~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~  263 (337)
T d1o6la_         231 --EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             --HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             --HHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence              378899999999999999      356665433

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.5e-54  Score=389.20  Aligned_cols=254  Identities=22%  Similarity=0.319  Sum_probs=211.1

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++......  ..+.+.+|+.+|++++||||+++++++.+.+..|+|||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh--hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5899999999999999999976 57899999999765443  24678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC--CCceEEEeeccceeccC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS--KLEAFVADFGVARLLHS  245 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~  245 (363)
                      ||++|+|.+++.....  .+++..+..++.||+.||+|||++   +++||||||+|||++.  ++.+||+|||+++....
T Consensus       104 ~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         104 FMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             cCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            9999999999865432  599999999999999999999999   9999999999999964  57899999999987654


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      . .......||+.|||||++.+..++.++|||||||++|||++|+.||...   +.......+.......+.....  ..
T Consensus       179 ~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~--~~  252 (350)
T d1koaa2         179 K-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMDDSAFS--GI  252 (350)
T ss_dssp             T-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCSCCGGGG--GC
T ss_pred             c-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCccccc--CC
Confidence            3 3345567999999999999999999999999999999999999998643   3334444444443332221111  11


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...+.+||.+||+.||++|| +.|++.+-..
T Consensus       253 s~~~~~li~~~L~~dP~~R~t~~eil~hp~~  283 (350)
T d1koaa2         253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWL  283 (350)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHHSTTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            12488999999999999999 9999987443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.1e-54  Score=388.39  Aligned_cols=254  Identities=21%  Similarity=0.282  Sum_probs=210.6

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++.......  .+.+.+|+.+|++++||||+++++++.+++..|+|||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5799999999999999999976 579999999987654332  3678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec--CCCceEEEeeccceeccC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN--SKLEAFVADFGVARLLHS  245 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~  245 (363)
                      ||++|+|.+++....  .++++.+++.++.||+.||+|||+.   +|+||||||+|||++  .++.+||+|||++.....
T Consensus       107 ~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         107 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             cCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999998876543  2599999999999999999999999   999999999999997  578999999999988754


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+.......+......  .
T Consensus       182 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~--~  255 (352)
T d1koba_         182 D-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEFDEDAFSS--V  255 (352)
T ss_dssp             T-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCCCSSTTTT--S
T ss_pred             C-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCcccccC--C
Confidence            3 33455679999999999999999999999999999999999999986533   2333444444433322211110  1


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      ...+.+||.+||+.||++|| +.|++.+-+.
T Consensus       256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~  286 (352)
T d1koba_         256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWL  286 (352)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            11478999999999999999 9999886444

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-55  Score=383.91  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=200.0

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ..++|++.+.||+|+||+||+|.+++++.||||+++......   +.|.+|+.++++++||||++++|+|.+ +..++||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence            356899999999999999999999888899999997655432   679999999999999999999999865 5578999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+++|+|..++..... ..+++.+++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus        91 Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            99999999988865322 2589999999999999999999999   9999999999999999999999999999876433


Q ss_pred             C-CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhHH
Q 046084          247 S-SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVIQ  324 (363)
Q Consensus       247 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  324 (363)
                      . .......||+.|+|||++.+..++.++||||||+++|||++|..|+....  ........+... +.+.+...+    
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~----  240 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYRMPCPPECP----  240 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCCCCCTTSC----
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcCCCCCCcccC----
Confidence            2 22334568999999999999999999999999999999999766643221  222223323222 222222222    


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        ..+.++|.+||+.||++|| +.+|+..|..
T Consensus       241 --~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  270 (285)
T d1fmka3         241 --ESLHDLMCQCWRKEPEERPTFEYLQAFLED  270 (285)
T ss_dssp             --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --HHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence              2488999999999999999 9999887754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-54  Score=381.88  Aligned_cols=257  Identities=22%  Similarity=0.312  Sum_probs=210.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch----HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE----LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++......    ....+.+.+|+.+|++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999976 57899999998654321    11246789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC----ceEEEeec
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL----EAFVADFG  238 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg  238 (363)
                      |+|||||++|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999997654   699999999999999999999999   999999999999998776    59999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      ++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...   +.......+.......+..
T Consensus       163 ~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~  238 (293)
T d1jksa_         163 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEFEDE  238 (293)
T ss_dssp             TCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCCCCHH
T ss_pred             hhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCCCCCch
Confidence            998765433 334457899999999999999999999999999999999999998643   2333334444433332210


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                        ........+.+||.+||+.||++|| +.|++.+-..+
T Consensus       239 --~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  275 (293)
T d1jksa_         239 --YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  275 (293)
T ss_dssp             --HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred             --hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence              0111122478999999999999999 99998865543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=380.38  Aligned_cols=256  Identities=25%  Similarity=0.406  Sum_probs=198.0

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCC----CCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPS----GKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKC  161 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  161 (363)
                      +..++|++.+.||+|+||.||+|.+..    +..||||.++..... ...+.|.+|+.++++++||||++++|++. .+.
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            345789999999999999999997643    346889988755443 33578999999999999999999999996 456


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .++||||+++|+|.+++.....  .+++..++.++.||++||+|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence            8999999999999998765432  589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCC-CceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcc-cCCCCCC
Q 046084          242 LLHSDSS-NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQ-RVPSPID  318 (363)
Q Consensus       242 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  318 (363)
                      ....... ......||+.|+|||.+.+..++.++|||||||++|||++ |.+||.....   ......+... .++.+..
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i~~~~~~~~~~~  233 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERLPMPPN  233 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTCCCCCCTT
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCC
Confidence            7644332 2334568899999999999999999999999999999998 8999875543   2233333333 2233322


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      .+      ..+.+||.+||+.||++|| +.|+++.|..-.
T Consensus       234 ~~------~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         234 CP------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             CC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            22      2488999999999999999 999999886543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-53  Score=380.33  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=210.0

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999976 5689999999875432 2223467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||++||+|..++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999887665   588899999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                         ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...   +.......+.......+...+.     
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~-----  226 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELRFPPFFNE-----  226 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCCCCTTSCH-----
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHcCCCCCCCCCCH-----
Confidence               33467999999999999999999999999999999999999998643   3344455555555544433322     


Q ss_pred             HHHHHHHHHccCCCCCCC-----C-hHHHHHHHhc
Q 046084          327 ILVSKIVFACLRSKPTSR-----P-MQRVSQEFLV  355 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~R-----P-~~~v~~~l~~  355 (363)
                       .+.+++.+||+.||++|     | +.+++++-..
T Consensus       227 -~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f  260 (316)
T d1fota_         227 -DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF  260 (316)
T ss_dssp             -HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             -HHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence             37889999999999999     4 6777765443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=377.92  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=199.0

Q ss_pred             HhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-CeEEEE
Q 046084           87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-KCMFLI  165 (363)
Q Consensus        87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv  165 (363)
                      ..++|++.+.||+|+||.||+|.+ .|..||||+++....    .+.|.+|++++++++||||++++|+|.+. +..++|
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            356789999999999999999998 578999999976543    36788999999999999999999999654 568999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++|+|.+++..... ..+++..+++++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++....
T Consensus        80 ~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence            999999999999965421 2489999999999999999999999   999999999999999999999999999986533


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc-ccCCCCCCChhhH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPSPIDDQTVI  323 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  323 (363)
                      .   .....++..|+|||.+.+..++.++||||||+++|||+| |++||.....   ......+.. .+++.+...+   
T Consensus       156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~~~~~~~~~~~~~---  226 (262)
T d1byga_         156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYKMDAPDGCP---  226 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTTTCCCCCCTTCC---
T ss_pred             C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCCCCccCC---
Confidence            2   233467889999999999999999999999999999998 7888765432   223333332 2233333222   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                         ..+.+||.+||+.||++|| +.+++++|..-+
T Consensus       227 ---~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         227 ---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence               1488999999999999999 999999986544

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-53  Score=380.94  Aligned_cols=262  Identities=25%  Similarity=0.403  Sum_probs=211.8

Q ss_pred             HHHHHHHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeee
Q 046084           81 FQEMIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYG  154 (363)
Q Consensus        81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  154 (363)
                      +.+++...++|++.+.||+|+||+||+|+..      +++.||||+++..... ...++|.+|++++++++||||+++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-HHHHHHHHHHHHHHhcCCCCccccee
Confidence            3445556789999999999999999999763      3568999999765443 34578999999999999999999999


Q ss_pred             EEeeCCeEEEEEEeccCCChhhhhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 046084          155 FCLHKKCMFLIYKYMRRGSLFCILRNDD---------------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPS  213 (363)
Q Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  213 (363)
                      +|...+..+++|||+++|+|.+++....                     ....+++..++.++.|++.||+|||+.   +
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~  160 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K  160 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence            9999999999999999999999986422                     123489999999999999999999999   9


Q ss_pred             cEEeCCCCCCeeecCCCceEEEeeccceeccCCC--CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCC-
Q 046084          214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGR-  290 (363)
Q Consensus       214 i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-  290 (363)
                      ++||||||+|||++.++.+||+|||+++......  .......+++.|+|||.+.+..++.++|||||||++|||++|. 
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            9999999999999999999999999998653322  2223456889999999999999999999999999999999985 


Q ss_pred             CCCCCCcCCCchhhHHhhhcccCC-CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          291 HPGDLLSSVNPKIMLIDLLDQRVP-SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       291 ~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +||...   +.......+.++..+ .+...+.      .+.+|+.+||+.||++|| +.||++.|+.
T Consensus       241 ~p~~~~---~~~e~~~~v~~~~~~~~p~~~~~------~~~~li~~cl~~~P~~RPt~~ev~~~L~~  298 (301)
T d1lufa_         241 QPYYGM---AHEEVIYYVRDGNILACPENCPL------ELYNLMRLCWSKLPADRPSFCSIHRILQR  298 (301)
T ss_dssp             CTTTTS---CHHHHHHHHHTTCCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCC---CHHHHHHHHHcCCCCCCCccchH------HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            566543   233334444444332 2222221      388999999999999999 9999888764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-52  Score=382.37  Aligned_cols=253  Identities=22%  Similarity=0.285  Sum_probs=203.5

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchH----HHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETEL----AFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++.......    ........++.+++.++||||+++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5799999999999999999976 468999999986433211    11122334577788889999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +||||+++|+|.+++....   .+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus        84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999997654   589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhh
Q 046084          244 HSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTV  322 (363)
Q Consensus       244 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ...  ......||+.|+|||++.. ..|+.++|||||||++|||++|+.||......+...............+...+. 
T Consensus       158 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~-  234 (364)
T d1omwa3         158 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP-  234 (364)
T ss_dssp             SSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH-
T ss_pred             CCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH-
Confidence            443  2334579999999999864 568999999999999999999999997655444333333333333333332222 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-h-----HHHHHHHhc
Q 046084          323 IQDIILVSKIVFACLRSKPTSRP-M-----QRVSQEFLV  355 (363)
Q Consensus       323 ~~~~~~l~~li~~cl~~dP~~RP-~-----~~v~~~l~~  355 (363)
                           .+.+||.+||+.||++|| +     .|++.+-..
T Consensus       235 -----~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f  268 (364)
T d1omwa3         235 -----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF  268 (364)
T ss_dssp             -----HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred             -----HHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence                 388999999999999999 4     666655443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-52  Score=368.41  Aligned_cols=257  Identities=24%  Similarity=0.333  Sum_probs=210.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-------hHHHHHHHHHHHHHHhcCC-CCceeeeeeEEee
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-------ELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLH  158 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  158 (363)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.....       .....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36899999999999999999976 5788999999875431       1233457889999999996 9999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          159 KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      ++..|+||||+++|+|.+++....   .+++.++..++.||++||+|||+.   +++||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            999999999999999999997654   699999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCCCceeecccccccccccccc------ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhccc
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYT------MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQR  312 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  312 (363)
                      +++...... ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||....   .......+....
T Consensus       156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~~i~~~~  231 (277)
T d1phka_         156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMSGN  231 (277)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTC
T ss_pred             heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHHHHHhCC
Confidence            998875433 3344679999999998753      346889999999999999999999986533   333344444444


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          313 VPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ...+....  ......+.+|+.+||++||++|| +.|++++-+.+
T Consensus       232 ~~~~~~~~--~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~  274 (277)
T d1phka_         232 YQFGSPEW--DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  274 (277)
T ss_dssp             CCCCTTTG--GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             CCCCCccc--ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence            33222111  11122488999999999999999 99998875544

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-52  Score=380.83  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=210.8

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||.||+|.+ .+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999976 5799999999865432 2223467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCC
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD  246 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  246 (363)
                      ||+.+|+|..++....   .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999987654   599999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHHH
Q 046084          247 SSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQDI  326 (363)
Q Consensus       247 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                         .....||+.|||||++.+..++.++|||||||++|||++|+.||...   +.......+.......+...+.     
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~-----  263 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVRFPSHFSS-----  263 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCTTCCH-----
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCCCCCCccCCH-----
Confidence               33467999999999999999999999999999999999999998643   3344455555555554443332     


Q ss_pred             HHHHHHHHHccCCCCCCC-----C-hHHHHHHHhc
Q 046084          327 ILVSKIVFACLRSKPTSR-----P-MQRVSQEFLV  355 (363)
Q Consensus       327 ~~l~~li~~cl~~dP~~R-----P-~~~v~~~l~~  355 (363)
                       .+.++|.+||+.||++|     | +.+++++-.+
T Consensus       264 -~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f  297 (350)
T d1rdqe_         264 -DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF  297 (350)
T ss_dssp             -HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             -HHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence             37889999999999999     5 6777765444

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=379.42  Aligned_cols=251  Identities=25%  Similarity=0.428  Sum_probs=199.5

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCC----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGK----KVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  163 (363)
                      ++|++.+.||+|+||+||+|.+. +|+    +||+|+++.... ....+.|.+|+.++++++||||++++|+|.+++ .+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-ee
Confidence            57999999999999999999763 444    689998875432 223468999999999999999999999998754 67


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL  243 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  243 (363)
                      +++||+.+|+|.+++.....  .+++..+++++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            88899999999988876433  689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhc-ccCCCCCCC
Q 046084          244 HSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLD-QRVPSPIDD  319 (363)
Q Consensus       244 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  319 (363)
                      ......  .....||+.|+|||++.+..++.++|||||||++|||+| |..||+.....   .....+.. .+++.+...
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~~~~~~~~p~~~  238 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEKGERLPQPPIC  238 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHHHTCCCCCCTTB
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCCCCCccc
Confidence            543332  233468999999999999999999999999999999998 89998754432   22222222 223333333


Q ss_pred             hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          320 QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +.      .+.+|+.+||+.||++|| +.|++.+|..
T Consensus       239 ~~------~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         239 TI------DVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             CH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CH------HHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence            22      388999999999999999 9999998754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-53  Score=379.79  Aligned_cols=250  Identities=23%  Similarity=0.370  Sum_probs=208.0

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHh-cCCCCceeeeeeEEeeCCeEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLS-QIRHRNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  165 (363)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.... .....+.+..|..++. .++||||+++++++.+.+..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999976 4688999999975321 1122345666766655 68999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccC
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS  245 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  245 (363)
                      |||+++|+|.+++....   .+++.++..++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999997654   589999999999999999999999   999999999999999999999999999987665


Q ss_pred             CCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHHH
Q 046084          246 DSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQD  325 (363)
Q Consensus       246 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||...   +.......+....+..+...+.    
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~~p~~~s~----  228 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRMDNPFYPRWLEK----  228 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCTTSCH----
T ss_pred             ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCccCCH----
Confidence            555566678999999999999999999999999999999999999998653   3334444454554444433222    


Q ss_pred             HHHHHHHHHHccCCCCCCCC-hH-HHHHHH
Q 046084          326 IILVSKIVFACLRSKPTSRP-MQ-RVSQEF  353 (363)
Q Consensus       326 ~~~l~~li~~cl~~dP~~RP-~~-~v~~~l  353 (363)
                        .+.+||.+||+.||++|| +. +++++-
T Consensus       229 --~~~dli~~~L~~dP~~R~s~~~~l~~hp  256 (320)
T d1xjda_         229 --EAKDLLVKLFVREPEKRLGVRGDIRQHP  256 (320)
T ss_dssp             --HHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred             --HHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence              378999999999999999 64 676543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.2e-53  Score=370.77  Aligned_cols=257  Identities=23%  Similarity=0.379  Sum_probs=201.4

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----e
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK----C  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  161 (363)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||+++.... +....+.+.+|+.+++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999975 5789999999976543 3444578999999999999999999999988654    4


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .|+||||++|++|.+++....   .+++.+++.++.||+.||+|||++   +++||||||+|||++.++..+++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            789999999999999887654   699999999999999999999999   99999999999999999999999999987


Q ss_pred             eccCCC---CCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCC
Q 046084          242 LLHSDS---SNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPID  318 (363)
Q Consensus       242 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      ......   .......||+.|+|||++.+..++.++|||||||++|||+||+.||....   ........+......+..
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~  236 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVREDPIPPSA  236 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCCCCGGG
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHHHHHHhcCCCCCch
Confidence            654322   22344679999999999999999999999999999999999999986532   233333343333222111


Q ss_pred             ChhhHHHHHHHHHHHHHccCCCCCCCC--hHHHHHHHhc
Q 046084          319 DQTVIQDIILVSKIVFACLRSKPTSRP--MQRVSQEFLV  355 (363)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dP~~RP--~~~v~~~l~~  355 (363)
                      ..  ...+..+.++|.+||++||++||  +.++...|..
T Consensus       237 ~~--~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         237 RH--EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             TS--SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             hc--cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            00  00112488999999999999999  6777777654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=376.07  Aligned_cols=255  Identities=22%  Similarity=0.293  Sum_probs=211.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIY  166 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  166 (363)
                      .++|++.+.||+|+||+||+|.+. +|+.||+|.++....+.   ..+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~---~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH---HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH---HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            367999999999999999999764 68899999998765432   46789999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCC--CceEEEeeccceecc
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSK--LEAFVADFGVARLLH  244 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfg~~~~~~  244 (363)
                      |||+||+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.+  ..+||+|||++....
T Consensus        81 E~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            9999999999997643  2589999999999999999999999   99999999999999854  589999999998764


Q ss_pred             CCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCCCChhhHH
Q 046084          245 SDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPIDDQTVIQ  324 (363)
Q Consensus       245 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .. .......+++.|+|||...+..++.++||||+||++|+|++|+.||...   +.......+.......+...  ...
T Consensus       156 ~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~--~~~  229 (321)
T d1tkia_         156 PG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAEYTFDEEA--FKE  229 (321)
T ss_dssp             TT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCCCHHH--HTT
T ss_pred             cC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCChhh--ccC
Confidence            33 3344567899999999999999999999999999999999999998653   33344455555444332210  001


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          325 DIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       325 ~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ....+.+||.+||+.||++|| +.|++.+-+.+
T Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  262 (321)
T d1tkia_         230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence            122478999999999999999 99999865543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=372.66  Aligned_cols=268  Identities=24%  Similarity=0.338  Sum_probs=204.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----eEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK----CMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  163 (363)
                      .++|.+.+.||+|+||+||+|++ +|+.||||+++......   ..+..|+..+.+++||||++++++|.+.+    ..+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~---~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhH---HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            35688889999999999999997 68999999997543321   22345666667889999999999998754    579


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD-----CIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                      +||||+++|+|.++++..    .+++..+++++.|++.||+|||+.     ...+|+||||||+|||+++++.+||+|||
T Consensus        78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            999999999999999864    489999999999999999999963     12399999999999999999999999999


Q ss_pred             cceeccCCCC----Cceeeccccccccccccccc------cCCccccchHHHHHHHHHHhCCCCCCCCcCC---------
Q 046084          239 VARLLHSDSS----NRTVVAGTHGYIAPELAYTM------VLTEKCDVYSFGVVALEVLMGRHPGDLLSSV---------  299 (363)
Q Consensus       239 ~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g~~p~~~~~~~---------  299 (363)
                      ++........    ......||+.|+|||++.+.      .++.++|||||||++|||+||..|+......         
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            9987654332    22346799999999988754      3677899999999999999999887543221         


Q ss_pred             ---CchhhHHhhhcccCCCCCC-ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchhhhhhcC
Q 046084          300 ---NPKIMLIDLLDQRVPSPID-DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRKTLYQLK  363 (363)
Q Consensus       300 ---~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~~~~~~~  363 (363)
                         ...............+... ..........+.+|+.+||+.||++|| +.|++++|..-....+.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~  302 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK  302 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence               1111122222223222211 111222334588999999999999999 999999998777666655

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-53  Score=369.33  Aligned_cols=252  Identities=25%  Similarity=0.414  Sum_probs=194.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC--CC--CEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP--SG--KKVALKKLHHSET-ELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  162 (363)
                      .++|++.+.||+|+||.||+|++.  ++  ..||||++..... .....++|.+|+.+|++++||||++++|+|.++ ..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence            467999999999999999999753  23  3689999876432 223457899999999999999999999999764 57


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      ++||||+++|++.+++.....  .+++..++.++.|+++||+|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            899999999999988765432  589999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCC---ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCCchhhHHhhhcccC--CCC
Q 046084          243 LHSDSSN---RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVNPKIMLIDLLDQRV--PSP  316 (363)
Q Consensus       243 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  316 (363)
                      .......   .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||....   .......+.....  +.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~  237 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERLPRP  237 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCCCCCCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---HHHHHHHHHhCCCCCCCc
Confidence            6544332   223457889999999999999999999999999999998 899986543   3333344433332  222


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ...+      ..+.+||.+||+.||++|| +.|+.+.|.
T Consensus       238 ~~~~------~~l~~li~~cl~~dp~~RPt~~ei~~~L~  270 (273)
T d1u46a_         238 EDCP------QDIYNVMVQCWAHKPEDRPTFVALRDFLL  270 (273)
T ss_dssp             TTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccc------HHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            2222      2488999999999999999 999887664

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=371.09  Aligned_cols=263  Identities=23%  Similarity=0.365  Sum_probs=198.2

Q ss_pred             HHHHHHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeee
Q 046084           82 QEMIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYG  154 (363)
Q Consensus        82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~  154 (363)
                      ..+++..++|++.+.||+|+||.||+|.+.      +++.||||+++....... .+.+..|...+.++ +|+||+.+++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~-~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHH-HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHH-HHHHHHHHHHHHhhcCCCeEEEeee
Confidence            344556688999999999999999999753      346899999976554333 45677788877777 6899999999


Q ss_pred             EEeeC-CeEEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCC
Q 046084          155 FCLHK-KCMFLIYKYMRRGSLFCILRNDDE-------------AIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDIS  220 (363)
Q Consensus       155 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk  220 (363)
                      ++.+. ...+++||||++|+|.+++.....             ...+++.+++.++.||++||+|||++   +|+|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence            98765 468999999999999999965321             23589999999999999999999999   99999999


Q ss_pred             CCCeeecCCCceEEEeeccceeccCCCC--CceeeccccccccccccccccCCccccchHHHHHHHHHHhC-CCCCCCCc
Q 046084          221 SNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMG-RHPGDLLS  297 (363)
Q Consensus       221 p~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~p~~~~~  297 (363)
                      |+|||+++++.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++| .+||....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986544332  23345799999999999999999999999999999999986 56765433


Q ss_pred             CCCchhhHHhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          298 SVNPKIMLIDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       298 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      ..  ......+..+ +++.+...+.      .+.+++.+||+.||++|| +.|++++|..-
T Consensus       242 ~~--~~~~~~~~~~~~~~~~~~~~~------~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         242 ID--EEFCRRLKEGTRMRAPDYTTP------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CS--HHHHHHHHHTCCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH--HHHHHHHhcCCCCCCCccCCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            21  1122222222 2222222221      388999999999999999 99999998653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=366.95  Aligned_cols=249  Identities=26%  Similarity=0.409  Sum_probs=198.9

Q ss_pred             cCeeeecCceeEEEEEeCCC----CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-CeEEEEEEe
Q 046084           94 KYCIGTGGYGSVYRAQLPSG----KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-KCMFLIYKY  168 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  168 (363)
                      .+.||+|+||+||+|.+.++    ..||||+++.... ....++|.+|+++|++++||||++++|++.+. +..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            56799999999999986442    2589999975443 33457899999999999999999999998764 588999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      |++|+|.+++.....  .+++..+++++.|++.||.|||+.   +++||||||+|||+++++.+||+|||+++.......
T Consensus       111 ~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         111 MKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             CTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             eecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999999876543  578889999999999999999999   999999999999999999999999999987643322


Q ss_pred             ----CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcc-cCCCCCCChhhH
Q 046084          249 ----NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQ-RVPSPIDDQTVI  323 (363)
Q Consensus       249 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  323 (363)
                          ......||+.|+|||.+.+..++.++||||||+++|||+||..||.....  .......+..+ ++..+...+   
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~~~~~p~~~~---  260 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRLLQPEYCP---  260 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCCCCTTCC---
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCCCCcccCc---
Confidence                12234689999999999999999999999999999999998777654322  11222222222 333332222   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          324 QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       324 ~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                         ..+.+||.+||+.||++|| +.||+++|+.-
T Consensus       261 ---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         261 ---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               2488999999999999999 99999998654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=370.27  Aligned_cols=260  Identities=22%  Similarity=0.278  Sum_probs=201.0

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||+++.........+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999976 578999999997655444445788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      |+.++.+........  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            997654443333322  2599999999999999999999999   99999999999999999999999999998876655


Q ss_pred             CCceeecccccccccccccccc-CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc----------------
Q 046084          248 SNRTVVAGTHGYIAPELAYTMV-LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD----------------  310 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------------  310 (363)
                      .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..   .....+..                
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhccccccc
Confidence            5556668999999999877655 578999999999999999999998654321   11111110                


Q ss_pred             --ccCCCCCCChhhH-----HHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          311 --QRVPSPIDDQTVI-----QDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       311 --~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                        .....+.......     .....+.+|+.+||+.||++|| +.|++++-..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~  287 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhc
Confidence              0000000000000     0112478899999999999999 99999875443

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=372.16  Aligned_cols=254  Identities=23%  Similarity=0.339  Sum_probs=200.1

Q ss_pred             hcCCcccC-eeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCceeeeeeEEee----CC
Q 046084           88 TEDFDIKY-CIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQ-IRHRNIVKLYGFCLH----KK  160 (363)
Q Consensus        88 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~  160 (363)
                      .++|.+.. .||+|+||+||+|.+ .+|+.||||+++..       ..+.+|+.++.+ .+||||+++++++.+    ..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            35788875 599999999999975 57899999998643       346678988655 489999999999876    35


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC---CCceEEEee
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS---KLEAFVADF  237 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df  237 (363)
                      ..|+|||||+||+|.+++..... ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence            68999999999999999976432 3699999999999999999999999   9999999999999975   567999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchh-hHHhhhcccCCCC
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKI-MLIDLLDQRVPSP  316 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~  316 (363)
                      |+++...... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.......... ....+.......+
T Consensus       159 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         159 GFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             TTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             ceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            9998765433 3345679999999999999999999999999999999999999986544322111 1122222222222


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .  +........+.+||.+||+.||++|| +.|++.+-+.
T Consensus       238 ~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  275 (335)
T d2ozaa1         238 N--PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  275 (335)
T ss_dssp             T--THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred             C--cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence            1  11122233588999999999999999 9999886433

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=372.57  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=202.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEeC-CCC--EEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK--KVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFCLHKKCMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  163 (363)
                      -++|++.+.||+|+||+||+|.+. +|.  .||||++...... ...+.|.+|+++|+++ +||||++++|+|.+.+..+
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            368999999999999999999764 343  4788887654332 2346799999999999 7999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC
Q 046084          164 LIYKYMRRGSLFCILRND-------------DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL  230 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  230 (363)
                      +||||+++|+|.++++..             .....+++..+++++.||+.||.|||+.   +++||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence            999999999999999754             2234699999999999999999999999   999999999999999999


Q ss_pred             ceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCC-CCCCCCcCCCchhhHHhhh
Q 046084          231 EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGR-HPGDLLSSVNPKIMLIDLL  309 (363)
Q Consensus       231 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-~p~~~~~~~~~~~~~~~~~  309 (363)
                      .+||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|. +||...   +.......+.
T Consensus       165 ~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~~~~i~  240 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEKLP  240 (309)
T ss_dssp             CEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHGG
T ss_pred             ceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHHHHHHH
Confidence            99999999997653322 223456899999999999999999999999999999999975 565443   2333333333


Q ss_pred             cc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          310 DQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       310 ~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      .. +++.+...+.      .+.+||.+||+.||++|| +.|+++.|..
T Consensus       241 ~~~~~~~~~~~~~------~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         241 QGYRLEKPLNCDD------EVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             GTCCCCCCTTBCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hcCCCCCCccCCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            32 3333333222      488999999999999999 9999998754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=369.46  Aligned_cols=260  Identities=25%  Similarity=0.404  Sum_probs=209.8

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEe------CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFC  156 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (363)
                      +++..++|++.+.||+|+||.||+|++      .+++.||||+++..... .....|.+|+.+++.+ +||||++++++|
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH-HHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            345567899999999999999999975      34568999999865543 3346789999999999 699999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCC
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDD---------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISS  221 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp  221 (363)
                      .+.+..+++||||++|+|.+++....               ....+++..+..++.||++||+|||++   +++||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence            99999999999999999999987532               223589999999999999999999999   999999999


Q ss_pred             CCeeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcC
Q 046084          222 NNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSS  298 (363)
Q Consensus       222 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~  298 (363)
                      +|||++.++.+|++|||+++........  .....||+.|+|||.+.+..++.++||||||+++|||+| |.+||.....
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876543322  233568999999999999999999999999999999999 5555543322


Q ss_pred             CCchhhHHhhhcccC--CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          299 VNPKIMLIDLLDQRV--PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                         ......++....  ..+...+      ..+.+||.+||+.||++|| +.+++++|+..
T Consensus       254 ---~~~~~~~i~~~~~~~~~~~~~------~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         254 ---DSKFYKMIKEGFRMLSPEHAP------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             ---SHHHHHHHHHTCCCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHHHhcCCCCCCccccc------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence               222333333222  2222222      2488999999999999999 99999988754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.8e-52  Score=368.03  Aligned_cols=262  Identities=22%  Similarity=0.295  Sum_probs=202.0

Q ss_pred             cCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEe
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKY  168 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  168 (363)
                      ++|++.+.||+|+||+||+|++++|+.||||++..........+.+.+|+.+|++++||||+++++++...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57999999999999999999998999999999977654444457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCC
Q 046084          169 MRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS  248 (363)
Q Consensus       169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  248 (363)
                      +.++.+..+.....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||.+........
T Consensus        82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            98877777665443   699999999999999999999999   999999999999999999999999999987765555


Q ss_pred             Cceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc-----------------
Q 046084          249 NRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD-----------------  310 (363)
Q Consensus       249 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----------------  310 (363)
                      ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..........                 
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            5555678999999998875 4568999999999999999999999865432111000000000                 


Q ss_pred             ccCCCCCCC--hh-hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          311 QRVPSPIDD--QT-VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       311 ~~~~~~~~~--~~-~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      .........  .. .......+.+++.+||+.||++|| +.|++++-..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            000000000  00 000012478999999999999999 99998765543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=371.09  Aligned_cols=256  Identities=22%  Similarity=0.237  Sum_probs=196.0

Q ss_pred             cCeeeecCceeEEEEEe-CCCCEEEEEEeccccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEEec
Q 046084           94 KYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE---LAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM  169 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  169 (363)
                      .+.||+|+||+||+|.+ .+|+.||||+++.....   ....+.+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            56799999999999976 46899999998754322   122346889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCCCC
Q 046084          170 RRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN  249 (363)
Q Consensus       170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  249 (363)
                      .++++..+.....   .+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||++.........
T Consensus        83 ~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             cchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            9988776665433   588889999999999999999999   9999999999999999999999999999877665555


Q ss_pred             ceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCC--------------
Q 046084          250 RTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVP--------------  314 (363)
Q Consensus       250 ~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------  314 (363)
                      ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+......+.......              
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            556679999999998864 46799999999999999999999998654332111111111100000              


Q ss_pred             --CCCCChhh---HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          315 --SPIDDQTV---IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       315 --~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                        .....+..   ......+.+|+.+||+.||++|| +.|++++-..
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f  283 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  283 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence              00000000   00112488999999999999999 9999886544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=367.27  Aligned_cols=258  Identities=25%  Similarity=0.415  Sum_probs=204.5

Q ss_pred             HHhcCCcccCeeeecCceeEEEEEeCC--------CCEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 046084           86 VATEDFDIKYCIGTGGYGSVYRAQLPS--------GKKVALKKLHHSETELAFLESFQTEAHLLSQI-RHRNIVKLYGFC  156 (363)
Q Consensus        86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  156 (363)
                      +..++|++.+.||+|+||.||+|+...        +..||||+++....... ...+.+|...+.++ +||||++++++|
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH-HHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            446789999999999999999996522        24799999987654433 46788888888888 899999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 046084          157 LHKKCMFLIYKYMRRGSLFCILRNDD-------------EAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNN  223 (363)
Q Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  223 (363)
                      .+++..++||||+++|+|.+++....             ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N  165 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  165 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence            99999999999999999999997543             124689999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHh-CCCCCCCCcCCC
Q 046084          224 ILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLM-GRHPGDLLSSVN  300 (363)
Q Consensus       224 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~  300 (363)
                      ||++.++.+||+|||+++........  .....+++.|+|||.+.+..|+.++||||||+++|||++ |.+||.....  
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--  243 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  243 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--
Confidence            99999999999999999876543322  233568899999999999999999999999999999998 7888764332  


Q ss_pred             chhhHHhhhcc-cCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          301 PKIMLIDLLDQ-RVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       301 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                       ......+..+ .++.+...+.      .+.+||.+||+.||++|| +.|+++.|..-
T Consensus       244 -~~~~~~i~~~~~~~~p~~~~~------~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         244 -EELFKLLKEGHRMDKPSNCTN------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             -HHHHHHHHTTCCCCCCSSCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHHcCCCCCCCccchH------HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             2222222222 2233322222      388999999999999999 99999988643

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-52  Score=370.30  Aligned_cols=259  Identities=22%  Similarity=0.355  Sum_probs=211.6

Q ss_pred             HHHHhcCCcccCeeeecCceeEEEEEeC------CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 046084           84 MIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCL  157 (363)
Q Consensus        84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  157 (363)
                      +++..++|++.+.||+|+||+||+|.+.      ++..||||+++..... .....|.+|+.++++++||||++++|+|.
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh-HHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            4455688999999999999999999753      3568999999865443 33467999999999999999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC
Q 046084          158 HKKCMFLIYKYMRRGSLFCILRND-------DEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL  230 (363)
Q Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  230 (363)
                      ..+..++||||+++|+|.+++...       .....+++..+.+++.|+++||.|||+.   +++||||||+|||++.++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence            999999999999999999988642       2233579999999999999999999999   999999999999999999


Q ss_pred             ceEEEeeccceeccCCCCC--ceeeccccccccccccccccCCccccchHHHHHHHHHHhC-CCCCCCCcCCCchhhHHh
Q 046084          231 EAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMG-RHPGDLLSSVNPKIMLID  307 (363)
Q Consensus       231 ~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~p~~~~~~~~~~~~~~~  307 (363)
                      ++||+|||+++........  .....+|+.|+|||.+.+..++.++||||||+++|||+|| ..||...   +.......
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~~~  247 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRF  247 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHHHHH
Confidence            9999999999866433221  2234589999999999999999999999999999999998 4776543   23333344


Q ss_pred             hhcccC-CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          308 LLDQRV-PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       308 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                      +.++.. +.+...+.      .+.+||.+||+.||++|| +.+++++|..
T Consensus       248 i~~~~~~~~p~~~~~------~l~~li~~cl~~~P~~RPs~~~il~~L~~  291 (308)
T d1p4oa_         248 VMEGGLLDKPDNCPD------MLFELMRMCWQYNPKMRPSFLEIISSIKE  291 (308)
T ss_dssp             HHTTCCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred             HHhCCCCCCcccchH------HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            444332 22332221      488999999999999999 9999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=361.12  Aligned_cols=247  Identities=21%  Similarity=0.340  Sum_probs=199.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccch----HHHHHHHHHHHHHHhcCC--CCceeeeeeEEeeCC
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETE----LAFLESFQTEAHLLSQIR--HRNIVKLYGFCLHKK  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~  160 (363)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++......    .....++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            46799999999999999999976 57899999998653211    111234668999999986  899999999999999


Q ss_pred             eEEEEEEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC-CCceEEEeec
Q 046084          161 CMFLIYKYMRR-GSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS-KLEAFVADFG  238 (363)
Q Consensus       161 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg  238 (363)
                      ..++||||+.+ +++.+++....   .+++.++..++.|+++||+|||+.   +++||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            99999999976 57777776544   699999999999999999999999   9999999999999985 4799999999


Q ss_pred             cceeccCCCCCceeeccccccccccccccccC-CccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCCC
Q 046084          239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVL-TEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSPI  317 (363)
Q Consensus       239 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  317 (363)
                      ++......  ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....         .+.......+.
T Consensus       157 ~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~~~~~~~~~  225 (273)
T d1xwsa_         157 SGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFFRQ  225 (273)
T ss_dssp             TCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHCCCCCSS
T ss_pred             cceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHhhcccCCCC
Confidence            99875432  3345679999999999887665 577999999999999999999986421         22233333332


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                      ..+.      .+.+||.+||+.||++|| +.|++++-..+.
T Consensus       226 ~~s~------~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         226 RVSS------ECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             CCCH------HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             CCCH------HHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            2222      388999999999999999 999988765543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=359.93  Aligned_cols=262  Identities=23%  Similarity=0.351  Sum_probs=196.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CC-CCEEEEEEeccccchHHHHHHHHHHHHHHhcC---CCCceeeeeeEEee----
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PS-GKKVALKKLHHSETELAFLESFQTEAHLLSQI---RHRNIVKLYGFCLH----  158 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  158 (363)
                      .++|++.+.||+|+||+||+|.+ .+ ++.||||+++...........+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            57899999999999999999976 34 56799999875443322223456677776665   79999999999864    


Q ss_pred             -CCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEee
Q 046084          159 -KKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADF  237 (363)
Q Consensus       159 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  237 (363)
                       ....+++|||+.++.+........  ..+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence             246899999999887765544333  2589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc-------
Q 046084          238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD-------  310 (363)
Q Consensus       238 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------  310 (363)
                      |++...... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+..........       
T Consensus       161 g~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         161 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            998765332 234456799999999999999999999999999999999999999875432111111100000       


Q ss_pred             ------------ccCCCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          311 ------------QRVPSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       311 ------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                  .....+. ..........+.+|+.+||+.||++|| +.|++++-..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~  297 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ  297 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccchhhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence                        0000000 000000112377899999999999999 99998876554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-49  Score=353.90  Aligned_cols=263  Identities=20%  Similarity=0.273  Sum_probs=198.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-------  159 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  159 (363)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++..........+++.+|+.+|++++||||+++++++...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999976 5789999999876554444456788999999999999999999988653       


Q ss_pred             -CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeec
Q 046084          160 -KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFG  238 (363)
Q Consensus       160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  238 (363)
                       +..+++|||+.++.+..+.....   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence             45899999998877765544333   688999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCC----CCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          239 VARLLHSDS----SNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       239 ~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      ++.......    ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....................
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            997654322    122335699999999998754 689999999999999999999999875432211111111111100


Q ss_pred             CC----------------CCC----Chhh---HHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          314 PS----------------PID----DQTV---IQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       314 ~~----------------~~~----~~~~---~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                      +.                ...    ....   ......+.+|+.+||+.||++|| +.|++.+-.++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~  309 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  309 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence            00                000    0000   00112367899999999999999 99999886654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=355.40  Aligned_cols=258  Identities=23%  Similarity=0.325  Sum_probs=195.6

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC------
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK------  160 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  160 (363)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||+++.........+.+.+|+++|+.++||||++++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999976 56999999999866555555678999999999999999999999998765      


Q ss_pred             eEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccc
Q 046084          161 CMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVA  240 (363)
Q Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  240 (363)
                      ..|+||||+ +.+|..+....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence            469999999 56777776543    599999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhh-----------
Q 046084          241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDL-----------  308 (363)
Q Consensus       241 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~-----------  308 (363)
                      ......   .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+...........           
T Consensus       169 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         169 RQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             EECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            876432   344579999999998876 45689999999999999999999998654321110000000           


Q ss_pred             ---------hcccCCCCCCC--hhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          309 ---------LDQRVPSPIDD--QTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       309 ---------~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                               ...........  .........+.+||.+||+.||++|| +.|++++-..+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~  305 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  305 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence                     00000000000  00000011377899999999999999 99999875543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=346.11  Aligned_cols=259  Identities=21%  Similarity=0.285  Sum_probs=206.4

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKKCMFLIYK  167 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  167 (363)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++.........+++.+|+.+++.++||||+++++++.+....++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999976 578899999997665544556789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccceeccCCC
Q 046084          168 YMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS  247 (363)
Q Consensus       168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  247 (363)
                      ++.++++..++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.+.......
T Consensus        82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988877654   688999999999999999999999   99999999999999999999999999999876655


Q ss_pred             CCceeecccccccccccccccc-CCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhh---ccc-----------
Q 046084          248 SNRTVVAGTHGYIAPELAYTMV-LTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLL---DQR-----------  312 (363)
Q Consensus       248 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~-----------  312 (363)
                      .......++..|+|||.+.+.. ++.++|||||||++|||++|+.||......  ......+.   ...           
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhhhc
Confidence            5555566788999999887654 689999999999999999999996432211  11111100   000           


Q ss_pred             --------CCCCCC-ChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          313 --------VPSPID-DQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       313 --------~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                              ...... ..........+.+|+.+||+.||++|| +.|++++-+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f  286 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence                    000000 000001112477899999999999999 9999887544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=352.32  Aligned_cols=260  Identities=21%  Similarity=0.288  Sum_probs=195.5

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----eE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHKK----CM  162 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~  162 (363)
                      +++|++.+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|+.+|++++||||+++++++....    ..
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            35799999999999999999965 5899999999976543 333567899999999999999999999997653    23


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      +++++++.+|+|.+++...    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||++..
T Consensus        86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence            4555667799999999754    489999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCC---Cceeeccccccccccccc-cccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhc--------
Q 046084          243 LHSDSS---NRTVVAGTHGYIAPELAY-TMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLD--------  310 (363)
Q Consensus       243 ~~~~~~---~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------  310 (363)
                      ......   ......||+.|+|||++. +..++.++||||+||++|||++|+.||...+..+..........        
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            543222   234457899999999875 45678999999999999999999999865432111100000000        


Q ss_pred             -----------ccCCCCCCChh---hHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          311 -----------QRVPSPIDDQT---VIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       311 -----------~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                                 ...+.....+.   .......+.+|+.+||+.||++|| +.|++++-..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~  298 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL  298 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence                       00000000000   000012478999999999999999 9999987543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-48  Score=352.87  Aligned_cols=256  Identities=24%  Similarity=0.303  Sum_probs=192.1

Q ss_pred             CCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------CeE
Q 046084           90 DFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------KCM  162 (363)
Q Consensus        90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  162 (363)
                      +|+..+.||+|+||+||+|++ .+|+.||||++.....      .+.+|+++|++++||||+++++++...      ...
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            588889999999999999976 4689999999976542      234799999999999999999998653      347


Q ss_pred             EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC-ceEEEeeccce
Q 046084          163 FLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-EAFVADFGVAR  241 (363)
Q Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~  241 (363)
                      ++||||++++.+..+.........+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||++.
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence            89999998765444433222233699999999999999999999999   999999999999999775 89999999998


Q ss_pred             eccCCCCCceeecccccccccccccc-ccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh------------h
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYT-MVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID------------L  308 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~------------~  308 (363)
                      ...... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+.......            .
T Consensus       172 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         172 QLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             ECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             hccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            764433 3344579999999998764 5789999999999999999999999865432111100000            0


Q ss_pred             ----hcccCCCCCCCh----hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhc
Q 046084          309 ----LDQRVPSPIDDQ----TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLV  355 (363)
Q Consensus       309 ----~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~  355 (363)
                          .....+.....+    ........+.+|+.+||+.||++|| +.|++++-..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  306 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  306 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence                000111000000    0000112478899999999999999 9999986544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=349.35  Aligned_cols=255  Identities=27%  Similarity=0.399  Sum_probs=203.2

Q ss_pred             cCCcccCeeeecCceeEEEEEe----CCCCEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCC-CceeeeeeEEeeCCe
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL----PSGKKVALKKLHHSET--ELAFLESFQTEAHLLSQIRH-RNIVKLYGFCLHKKC  161 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  161 (363)
                      ++|++.+.||+|+||+||+|..    .+|+.||||+++....  +....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999964    2578999999865421  11123567899999999976 899999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .+++|||+.+|+|.+++....   .+.+..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999997665   578889999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCC-CCceeeccccccccccccccc--cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhH-HhhhcccCCCCC
Q 046084          242 LLHSDS-SNRTVVAGTHGYIAPELAYTM--VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIML-IDLLDQRVPSPI  317 (363)
Q Consensus       242 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~  317 (363)
                      ...... .......|++.|+|||.+.+.  .++.++|||||||++|||++|+.||............ ........+.+.
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~  257 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  257 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence            764332 233456789999999988654  4688999999999999999999999766544433332 223333333333


Q ss_pred             CChhhHHHHHHHHHHHHHccCCCCCCCC------hHHHHHHHhc
Q 046084          318 DDQTVIQDIILVSKIVFACLRSKPTSRP------MQRVSQEFLV  355 (363)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dP~~RP------~~~v~~~l~~  355 (363)
                      ..+      ..+.+++.+||++||++||      +.|++++-..
T Consensus       258 ~~s------~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff  295 (322)
T d1vzoa_         258 EMS------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  295 (322)
T ss_dssp             TSC------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             cCC------HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence            222      1488899999999999998      3667665433

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.9e-48  Score=343.38  Aligned_cols=255  Identities=16%  Similarity=0.276  Sum_probs=190.5

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCcee-eeeeEEeeCCeEEEEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIV-KLYGFCLHKKCMFLIY  166 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~  166 (363)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||++......    +++..|+++++.++|+|++ .+.+++.+.+..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            4699999999999999999976 56889999988765432    3577899999999876654 5556667778889999


Q ss_pred             EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeec---CCCceEEEeeccceec
Q 046084          167 KYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLN---SKLEAFVADFGVARLL  243 (363)
Q Consensus       167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~  243 (363)
                      ||+. +++...+.....  .+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+++..
T Consensus        83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          83 ELLG-PSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             ECCC-CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEcC-CchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9994 566665544332  689999999999999999999999   999999999999975   4567999999999876


Q ss_pred             cCCCC-------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccCCCC
Q 046084          244 HSDSS-------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRVPSP  316 (363)
Q Consensus       244 ~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  316 (363)
                      .....       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......................+
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            54322       22345799999999999999999999999999999999999999976554333222222211111111


Q ss_pred             CCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHh
Q 046084          317 IDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFL  354 (363)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~  354 (363)
                      ... .....+..+.+++..||+.||++|| +.++.+.|.
T Consensus       237 ~~~-~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         237 IEV-LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             HHH-HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             hhH-hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            000 0000112488999999999999999 776655443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.5e-47  Score=336.54  Aligned_cols=255  Identities=17%  Similarity=0.228  Sum_probs=199.8

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCC-CceeeeeeEEeeCCeEEEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH-RNIVKLYGFCLHKKCMFLI  165 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv  165 (363)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++......    ..+.+|++.++.++| +|++.+++++.+....++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            46899999999999999999976 46889999988654432    346778888998865 8999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecC-----CCceEEEeeccc
Q 046084          166 YKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNS-----KLEAFVADFGVA  240 (363)
Q Consensus       166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~~  240 (363)
                      |||+ +++|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+|||++.     ++.+||+|||++
T Consensus        80 me~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence            9998 6899998876443  589999999999999999999999   9999999999999964     578999999999


Q ss_pred             eeccCCCC-------CceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHhhhcccC
Q 046084          241 RLLHSDSS-------NRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLIDLLDQRV  313 (363)
Q Consensus       241 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      +.......       ......||+.|||||++.+..++.++||||||+++|||++|+.||..............+.....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~  233 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  233 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence            87643221       22345799999999999999999999999999999999999999976555443333322222111


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 046084          314 PSPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEF  353 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l  353 (363)
                      ..+.. ......+..+.+++..|++.+|++|| ...+...|
T Consensus       234 ~~~~~-~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l  273 (293)
T d1csna_         234 STPLR-ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF  273 (293)
T ss_dssp             HSCHH-HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred             CCChH-HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence            11000 00000112488899999999999999 76665544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=346.69  Aligned_cols=259  Identities=21%  Similarity=0.264  Sum_probs=194.1

Q ss_pred             cCCcccCeeeecCceeEEEEEeC-CCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------Ce
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQLP-SGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK------KC  161 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  161 (363)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++............+.+|+.++++++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999764 699999999987655555567899999999999999999999999643      57


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .|+||||+.++.+. .+..     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHH-HHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHH-hhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence            89999999775554 4432     489999999999999999999999   99999999999999999999999999987


Q ss_pred             eccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhh-----------------
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIM-----------------  304 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~-----------------  304 (363)
                      ..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+.......                 
T Consensus       168 ~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         168 TAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             ccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            65432 233455789999999999999999999999999999999999999864332110000                 


Q ss_pred             --HHhhhcccCC--------------CCCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhchh
Q 046084          305 --LIDLLDQRVP--------------SPIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVRK  357 (363)
Q Consensus       305 --~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~~  357 (363)
                        ..........              .+............+.+|+.+||+.||++|| +.|++++-+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence              0111111111              1111112223344588999999999999999 999998866543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.9e-47  Score=342.89  Aligned_cols=254  Identities=17%  Similarity=0.261  Sum_probs=195.7

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeC--CeEE
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHK--KCMF  163 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~  163 (363)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++....     +++.+|+++|+.++ ||||+++++++...  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH-----HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            35799999999999999999976 5788999999976442     56789999999995 99999999999754  4689


Q ss_pred             EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCC-ceEEEeecccee
Q 046084          164 LIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARL  242 (363)
Q Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~  242 (363)
                      +||||+.+++|..+.+      .+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||++..
T Consensus       109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence            9999999999977642      589999999999999999999999   999999999999998654 689999999987


Q ss_pred             ccCCCCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCc-hhhHHhh------------
Q 046084          243 LHSDSSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP-KIMLIDL------------  308 (363)
Q Consensus       243 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-~~~~~~~------------  308 (363)
                      ..... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ .......            
T Consensus       180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             ccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            65433 33455789999999987764 479999999999999999999999864332110 0000000            


Q ss_pred             ------------hcccCCC----CCCChhhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          309 ------------LDQRVPS----PIDDQTVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       309 ------------~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                                  .......    .............+.+||.+||+.||++|| +.|++++-.++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~  323 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  323 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                        0000000    000000001112478899999999999999 99998876554

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=345.20  Aligned_cols=259  Identities=22%  Similarity=0.296  Sum_probs=197.1

Q ss_pred             hcCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----Ce
Q 046084           88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNIVKLYGFCLHK-----KC  161 (363)
Q Consensus        88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  161 (363)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++..........+.+.+|+++|++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999975 5799999999987665555567889999999999999999999998643     33


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEEEeeccce
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR  241 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  241 (363)
                      .+++++|+.+|+|.+++...    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence            46677888899999998653    599999999999999999999999   99999999999999999999999999997


Q ss_pred             eccCCCCCceeeccccccccccccccc-cCCccccchHHHHHHHHHHhCCCCCCCCcCCCchhhHHh-------------
Q 046084          242 LLHSDSSNRTVVAGTHGYIAPELAYTM-VLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNPKIMLID-------------  307 (363)
Q Consensus       242 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~-------------  307 (363)
                      ....   ......|++.|+|||...+. .++.++|||||||++|+|++|+.||...+..........             
T Consensus       170 ~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         170 HTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             ccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence            6432   23345689999999986664 468899999999999999999999865432111100000             


Q ss_pred             -------hhcccCCCCCCCh--hhHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHHhch
Q 046084          308 -------LLDQRVPSPIDDQ--TVIQDIILVSKIVFACLRSKPTSRP-MQRVSQEFLVR  356 (363)
Q Consensus       308 -------~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RP-~~~v~~~l~~~  356 (363)
                             ........+...-  ........+.+||.+||+.||++|| +.|++++-..+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~  305 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  305 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence                   0000000000000  0000112478899999999999999 99999875543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.9e-41  Score=308.54  Aligned_cols=259  Identities=19%  Similarity=0.226  Sum_probs=188.8

Q ss_pred             cCCcccCeeeecCceeEEEEEe-CCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-----------CCceeeeeeEE
Q 046084           89 EDFDIKYCIGTGGYGSVYRAQL-PSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-----------HRNIVKLYGFC  156 (363)
Q Consensus        89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~  156 (363)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.....   .+.+.+|+.+++.++           |+||+++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~---~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH---HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc---hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            4599999999999999999976 57899999999765322   356778888888775           57899999888


Q ss_pred             eeC--CeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCC---
Q 046084          157 LHK--KCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKL---  230 (363)
Q Consensus       157 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~---  230 (363)
                      ...  ...+++++++..+..............+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++   
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence            653  4566777776665544333333334468999999999999999999998 6   999999999999997654   


Q ss_pred             ---ceEEEeeccceeccCCCCCceeeccccccccccccccccCCccccchHHHHHHHHHHhCCCCCCCCcCCCc---hhh
Q 046084          231 ---EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVLTEKCDVYSFGVVALEVLMGRHPGDLLSSVNP---KIM  304 (363)
Q Consensus       231 ---~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---~~~  304 (363)
                         .++++|||.+......   .....||+.|+|||++.+..++.++||||+||++++|++|+.||........   ...
T Consensus       167 ~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               3899999999865432   2345699999999999999999999999999999999999999865432110   000


Q ss_pred             HHh---hhc-----------------------ccCCCCCC----------ChhhHHHHHHHHHHHHHccCCCCCCCC-hH
Q 046084          305 LID---LLD-----------------------QRVPSPID----------DQTVIQDIILVSKIVFACLRSKPTSRP-MQ  347 (363)
Q Consensus       305 ~~~---~~~-----------------------~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~RP-~~  347 (363)
                      ...   .+.                       ........          ..........+.+|+.+||..||++|| +.
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            000   000                       00000000          000122334588999999999999999 99


Q ss_pred             HHHHHHhch
Q 046084          348 RVSQEFLVR  356 (363)
Q Consensus       348 ~v~~~l~~~  356 (363)
                      |++++-..+
T Consensus       324 e~L~Hp~f~  332 (362)
T d1q8ya_         324 GLVNHPWLK  332 (362)
T ss_dssp             HHHTCGGGT
T ss_pred             HHhcCcccC
Confidence            999876554

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=4.1e-26  Score=188.36  Aligned_cols=167  Identities=14%  Similarity=0.169  Sum_probs=121.4

Q ss_pred             CcccCeeeecCceeEEEEEeCCCCEEEEEEeccccc----------------hHHHHHHHHHHHHHHhcCCCCceeeeee
Q 046084           91 FDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSET----------------ELAFLESFQTEAHLLSQIRHRNIVKLYG  154 (363)
Q Consensus        91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~niv~l~~  154 (363)
                      +.+.+.||+|+||+||+|.+.+|+.||||+++....                ..........|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            346788999999999999988999999998753211                0111234567888999999999998876


Q ss_pred             EEeeCCeEEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCeeecCCCceEE
Q 046084          155 FCLHKKCMFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDCIPSIVHRDISSNNILLNSKLEAFV  234 (363)
Q Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl  234 (363)
                      +..    .+++|||++++.+..          ++......++.|++++++|||+.   +++||||||+|||++++ .++|
T Consensus        82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence            532    368999998866543          23334567899999999999999   99999999999999965 5889


Q ss_pred             EeeccceeccCCCCCceeeccccccccc--c---ccccccCCccccchHHHHHH
Q 046084          235 ADFGVARLLHSDSSNRTVVAGTHGYIAP--E---LAYTMVLTEKCDVYSFGVVA  283 (363)
Q Consensus       235 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aP--E---~~~~~~~~~~~DvwslG~il  283 (363)
                      +|||++.....+...        .|...  +   ......|+.++|+||..--+
T Consensus       144 iDFG~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            999999765322211        11111  0   11245678899999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.81  E-value=1.1e-08  Score=86.81  Aligned_cols=149  Identities=13%  Similarity=0.079  Sum_probs=101.9

Q ss_pred             HHHHHhcCCcccCeeeecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCe
Q 046084           83 EMIVATEDFDIKYCIGTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR-HRNIVKLYGFCLHKKC  161 (363)
Q Consensus        83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  161 (363)
                      ++...-+.|+..+..+.++.+.||+... +++.+++|+........  ...+.+|...+..+. +--+.+++.++.+.+.
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            3444456777666555455678999875 66678888876543221  134667888777663 4346778888888899


Q ss_pred             EEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 046084          162 MFLIYKYMRRGSLFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCDC-------------------------------  210 (363)
Q Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------  210 (363)
                      .++||++.+|.++.......     ..   ...++.++++.++.||+..                               
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             eEEEEEeccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            99999999998876544221     11   2235666777777777531                               


Q ss_pred             -------------------------CCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          211 -------------------------IPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       211 -------------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                                               ...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                     12479999999999999877677999988753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.49  E-value=1.6e-07  Score=78.88  Aligned_cols=130  Identities=18%  Similarity=0.111  Sum_probs=87.4

Q ss_pred             eeecCc-eeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCC--CCceeeeeeEEeeCCeEEEEEEeccCCC
Q 046084           97 IGTGGY-GSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIR--HRNIVKLYGFCLHKKCMFLIYKYMRRGS  173 (363)
Q Consensus        97 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~  173 (363)
                      +..|.. +.||+....++..+++|.-.....     ..+..|...++.+.  .-.+.+++.++.+.+..+++|++++|.+
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            344443 679999987888889998655432     23566777776663  2346778888888888999999998876


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 046084          174 LFCILRNDDEAIRLDWTKRVNIVKSMAHALSYLHCD--------------------------------------------  209 (363)
Q Consensus       174 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------  209 (363)
                      +.+..        .+..   ..+.++++.|+-||+.                                            
T Consensus        93 ~~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          93 LLSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             ccccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            53311        1111   1233444555555532                                            


Q ss_pred             -----------CCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          210 -----------CIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       210 -----------~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                                 ..+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                       112479999999999999887677999988753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.79  E-value=2.8e-05  Score=69.19  Aligned_cols=79  Identities=10%  Similarity=0.108  Sum_probs=46.9

Q ss_pred             cCeeeecCceeEEEEEeCC-CCEEEEEEecccc-----chHHHHHHHHHHHHHHhcCC-C--CceeeeeeEEeeCCeEEE
Q 046084           94 KYCIGTGGYGSVYRAQLPS-GKKVALKKLHHSE-----TELAFLESFQTEAHLLSQIR-H--RNIVKLYGFCLHKKCMFL  164 (363)
Q Consensus        94 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l  164 (363)
                      .+.||.|....||+....+ ++.+++|.-....     ......++...|.+.|+.+. +  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999998654 5688998643211     00001133445777776652 2  345666655  3445578


Q ss_pred             EEEeccCCCh
Q 046084          165 IYKYMRRGSL  174 (363)
Q Consensus       165 v~e~~~~g~L  174 (363)
                      +||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.44  E-value=0.00025  Score=61.11  Aligned_cols=136  Identities=13%  Similarity=0.151  Sum_probs=76.4

Q ss_pred             ceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCce--eeee-----eEEeeCCeEEEEEEeccCCCh
Q 046084          102 YGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI--VKLY-----GFCLHKKCMFLIYKYMRRGSL  174 (363)
Q Consensus       102 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L  174 (363)
                      --.||+++..+|+.+++|+.+......   +++..|...+..|...++  +...     ......+..+.++++..|..+
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            468999999999999999987543222   456677777777642222  1111     122345667889999877443


Q ss_pred             hh-----h---------hhc----C--CCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCC
Q 046084          175 FC-----I---------LRN----D--DEAIRLDWT----------------------KRVNIVKSMAHALSYL-HCDCI  211 (363)
Q Consensus       175 ~~-----~---------l~~----~--~~~~~l~~~----------------------~~~~i~~~i~~~l~~L-H~~~~  211 (363)
                      ..     +         ++.    .  ......+..                      .....+.++...+.-. .....
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            21     0         000    0  000111111                      1122223333332222 12223


Q ss_pred             CCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          212 PSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       212 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                      .+++|+|+.+.|||++++  ..++||+-++.
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            478999999999999754  45789998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.15  E-value=0.00081  Score=59.47  Aligned_cols=72  Identities=24%  Similarity=0.332  Sum_probs=47.0

Q ss_pred             CeeeecCceeEEEEEeCCC--------CEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEEEE
Q 046084           95 YCIGTGGYGSVYRAQLPSG--------KKVALKKLHHSETELAFLESFQTEAHLLSQIRHRNI-VKLYGFCLHKKCMFLI  165 (363)
Q Consensus        95 ~~lg~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv  165 (363)
                      +.|+.|-.-.+|+...+++        +.|.+++.......    ....+|..+++.+.-.++ +++++++.+    .+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~----idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE----SHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH----HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh----hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            4677788899999986543        45777766533221    234578888887742333 467777643    578


Q ss_pred             EEeccCCCh
Q 046084          166 YKYMRRGSL  174 (363)
Q Consensus       166 ~e~~~~g~L  174 (363)
                      +||++|.++
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.87  E-value=0.008  Score=50.86  Aligned_cols=159  Identities=12%  Similarity=0.031  Sum_probs=80.7

Q ss_pred             ccHHHHHHHhcCCcccCee-----eecCceeEEEEEeCCCCEEEEEEeccccchHHHHHHHHHHHHHHhcCCC-----Cc
Q 046084           79 ITFQEMIVATEDFDIKYCI-----GTGGYGSVYRAQLPSGKKVALKKLHHSETELAFLESFQTEAHLLSQIRH-----RN  148 (363)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-----~n  148 (363)
                      ++-+++...-++|.+.+..     ..|---+.|+.+..+| .+++|+.......    +.+..|++++..+..     |.
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~----~~l~~~~~~l~~L~~~g~pvp~   77 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPL   77 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH----HHHHHHHHHHHhhhhccccccc
Confidence            3456666666778775543     3455577899987655 5899988653221    234445666666532     22


Q ss_pred             eeeee-e--EEeeCCeEEEEEEeccCCChhhh--------------hhc----C--CCCCCCCH----------------
Q 046084          149 IVKLY-G--FCLHKKCMFLIYKYMRRGSLFCI--------------LRN----D--DEAIRLDW----------------  189 (363)
Q Consensus       149 iv~l~-~--~~~~~~~~~lv~e~~~~g~L~~~--------------l~~----~--~~~~~l~~----------------  189 (363)
                      .+... |  +.........++.+..+......              ++.    .  ........                
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            22110 0  12223455666776655432110              000    0  00000000                


Q ss_pred             --HHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCeeecCCCceEEEeecccee
Q 046084          190 --TKRVNIVKSMAHALSYLHC-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARL  242 (363)
Q Consensus       190 --~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  242 (363)
                        ......+......+...+. ....+++|+|+.+.||+++++...-+.||+.+..
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence              0111122222222222222 1234799999999999999987778999998853